data_6amw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6amw _Structure_validation_residue.Date_analyzed 2017-09-22 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.2 p . . . . . 0 C--O 1.243 0.763 0 CA-C-O 121.352 0.596 . . . . 71.219999999999999 111.639 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.9 mt -106.56 130.56 22.73 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 108.542 -0.91 . . . . 74.239999999999995 108.542 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -66.58 165.46 25.18 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 121.982 1.788 . . . . 62.43 110.618 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.18 147.2 31.39 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.601 0.239 . . . . 55.020000000000003 110.407 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.536 ' HB3' HD11 ' A' ' 23' ' ' ILE . 63.5 mt -85.85 94.07 9.07 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.249 -1.019 . . . . 74.200000000000003 108.249 176.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -98.15 -47.73 5.37 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.878 -1.055 . . . . 75.109999999999999 109.057 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -101.79 113.59 26.92 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 114.345 -1.298 . . . . 74.400000000000006 109.9 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' A' ' 20' ' ' LEU . 46.5 mm -115.75 120.18 64.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 106.083 -1.821 . . . . 74.540000000000006 106.083 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.8 tptm . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 121.478 0.656 . . . . 75.150000000000006 109.84 -177.351 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 N--CA 1.492 1.438 0 N-CA-C 113.144 0.402 . . . . 74.319999999999993 113.144 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.402 ' ND2' ' HA ' ' A' ' 140' ' ' SER . 9.6 m120 -56.36 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.951 0.782 . . . . 70.310000000000002 111.987 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.573 ' H ' ' HB3' ' A' ' 139' ' ' ASN . 50.3 tp -81.55 135.77 35.59 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.538 -1.21 . . . . 74.409999999999997 109.165 177.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -105.49 176.08 5.28 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.948 1.299 . . . . 75.299999999999997 109.359 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.35 143.13 23.52 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 N-CA-C 108.503 -0.925 . . . . 65.25 108.503 171.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.05 121.67 23.12 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.627 -0.508 . . . . 63.539999999999999 109.627 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 74.4 mt -82.42 -21.63 35.65 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.703 0.801 . . . . 74.239999999999995 111.252 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.574 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 84.5 m-85 -136.16 158.14 45.14 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.114 0.565 . . . . 74.319999999999993 109.585 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.51 145.58 39.04 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.689 -0.687 . . . . 74.150000000000006 109.835 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -153.23 111.16 3.59 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.236 -1.024 . . . . 74.019999999999996 108.236 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.4 t -82.54 138.71 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 109.074 -0.713 . . . . 73.430000000000007 109.074 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.65 116.25 4.61 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.087 0.555 . . . . 71.230000000000004 110.194 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.5 m -78.79 -11.05 59.97 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.718 0.807 . . . . 73.430000000000007 110.717 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.74 -172.68 41.62 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.587 -0.733 . . . . 63.310000000000002 111.28 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.53 -25.68 66.78 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.436 0.694 . . . . 72.030000000000001 110.719 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -70.2 -22.99 62.88 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.588 0.755 . . . . 73.439999999999998 112.456 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.7 p -113.71 157.74 21.81 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.408 0.683 . . . . 64.219999999999999 110.915 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.2 tp -109.93 131.15 55.32 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.734 0.814 . . . . 65.150000000000006 109.927 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.8 t -74.05 120.01 19.04 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 108.892 -0.781 . . . . 61.329999999999998 108.892 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.32 159.53 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.244 1.018 . . . . 72.219999999999999 108.775 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 60.0 m -135.78 148.15 48.64 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.265 -0.643 . . . . 74.310000000000002 109.265 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -54.84 123.38 13.21 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.095 0.558 . . . . 74.230000000000004 111.646 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.29 -9.54 49.81 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.388 -0.369 . . . . 63.119999999999997 113.095 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -85.01 131.89 34.41 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.557 0.743 . . . . 72.019999999999996 110.445 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HB3' HD12 ' A' ' 84' ' ' LEU . 8.7 mtmp? -83.52 115.48 22.11 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.773 0.829 . . . . 71.299999999999997 110.302 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.501 ' HA ' HG22 ' A' ' 123' ' ' THR . 15.7 mt -103.14 145.74 29.45 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.956 0.903 . . . . 73.510000000000005 109.965 -169.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.472 ' NH2' ' HG2' ' A' ' 122' ' ' GLN . 84.5 mtm180 -108.65 108.95 20.02 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.605 -0.887 . . . . 71.409999999999997 108.605 173.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 71.6 t -95.56 117.28 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 121.298 0.571 . . . . 73.299999999999997 110.249 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.5 mt -77.16 -28.73 54.25 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.251 1.421 . . . . 74.140000000000001 111.207 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.3 177.51 39.46 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.127 -0.488 . . . . 62.329999999999998 113.016 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.497 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 2.8 m-85 -107.15 168.41 9.23 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.833 0.853 . . . . 72.340000000000003 109.398 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -85.9 151.77 23.51 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 110.018 -0.364 . . . . 73.310000000000002 110.018 170.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -57.87 -32.29 67.53 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 113.185 0.809 . . . . 73.439999999999998 113.185 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -90.16 3.88 52.1 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.129 0.572 . . . . 72.150000000000006 110.465 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 61.59 31.16 76.77 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 111.03 -0.828 . . . . 73.549999999999997 111.03 -174.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -67.65 -70.45 0.26 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 107.934 -1.136 . . . . 74.299999999999997 107.934 -174.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -135.54 178.46 7.02 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 108.337 -0.986 . . . . 72.540000000000006 108.337 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.16 117.81 24.71 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.67 0.788 . . . . 63.310000000000002 109.058 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.92 108.65 3.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.279 0.632 . . . . 62.439999999999998 109.711 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.37 168.23 10.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.634 0.773 . . . . 55.229999999999997 110.784 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.472 ' HG2' ' NH2' ' A' ' 108' ' ' ARG . 61.6 tt0 -149.09 128.09 12.69 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.149 -1.056 . . . . 72.109999999999999 108.149 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.501 HG22 ' HA ' ' A' ' 107' ' ' LEU . 81.6 p -139.31 -174.46 3.87 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.701 0.801 . . . . 72.219999999999999 110.701 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -55.53 -28.87 57.31 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.6 0.76 . . . . 72.530000000000001 111.336 169.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -76.1 -13.3 60.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.547 0.739 . . . . 73.439999999999998 111.573 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 132.02 -130.95 6.09 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 111.905 -0.478 . . . . 70.450000000000003 111.905 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -150.73 146.58 26.53 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.338 0.655 . . . . 71.209999999999994 110.072 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 166.94 177.79 38.93 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 112.1 -0.4 . . . . 71.519999999999996 112.1 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -80.62 130.3 35.03 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.589 0.756 . . . . 72.409999999999997 110.887 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.03 151.54 61.65 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 124.286 1.034 . . . . 75.010000000000005 109.767 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.54 132.02 14.28 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 121.748 1.632 . . . . 62.310000000000002 111.636 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.477 ' HA ' HG12 ' A' ' 135' ' ' ILE . 41.8 p -61.58 -22.01 64.82 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.703 0.801 . . . . 71.510000000000005 111.901 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -68.36 -24.5 64.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.429 1.092 . . . . 62.049999999999997 111.926 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.574 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.1 m-85 -101.7 2.19 38.34 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.593 0.757 . . . . 74.329999999999998 112.153 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.477 HG12 ' HA ' ' A' ' 132' ' ' SER . 16.4 pt -131.21 161.92 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.66 0.384 . . . . 75.340000000000003 110.056 -173.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 11.0 t -151.16 147.92 21.55 Favored Pre-proline 0 N--CA 1.481 1.113 0 N-CA-C 108.593 -0.891 . . . . 75.400000000000006 108.593 170.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.446 ' HB2' ' HG ' ' A' ' 140' ' ' SER . 3.3 Cg_exo -74.94 150.59 38.68 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 121.971 1.781 . . . . 64.140000000000001 111.564 172.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.1 m -131.13 -44.52 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.155 0.582 . . . . 74.140000000000001 111.185 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.573 ' HB3' ' H ' ' A' ' 84' ' ' LEU . 58.2 t30 -95.5 17.96 13.66 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.411 1.101 . . . . 75.400000000000006 110.491 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.446 ' HG ' ' HB2' ' A' ' 137' ' ' PRO . 75.6 p -76.24 168.86 19.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.483 -0.78 . . . . 74.109999999999999 110.677 172.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 63.2 mt -62.98 -15.84 57.48 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 114.957 -1.019 . . . . 74.420000000000002 111.166 172.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -61.74 -26.77 68.27 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.269 1.428 . . . . 73.310000000000002 112.999 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -67.78 -18.11 64.76 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 122.768 0.427 . . . . 74.430000000000007 110.819 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -82.0 145.05 30.46 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.02 -0.733 . . . . 72.430000000000007 109.02 168.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.3 p -64.3 -19.91 65.73 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 112.884 0.698 . . . . 75.329999999999998 112.884 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.429 ' CE3' HG21 ' A' ' 218' ' ' VAL . 65.3 p-90 -77.72 -37.81 48.59 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 112.445 0.535 . . . . 64.120000000000005 112.445 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.401 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 22.7 t80 -102.22 138.6 38.94 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.143 -0.688 . . . . 71.129999999999995 109.143 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -129.56 22.37 5.51 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.682 0.393 . . . . 75.019999999999996 111.446 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 62.81 -156.19 40.57 Favored Glycine 0 CA--C 1.536 1.385 0 N-CA-C 115.092 0.797 . . . . 72.209999999999994 115.092 169.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 6.3 Cg_exo -76.37 104.59 1.93 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.391 2.727 . . . . 62.229999999999997 111.044 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.55 160.98 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.293 0.568 . . . . 75.140000000000001 112.02 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 18.2 m -71.26 161.73 30.6 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 114.924 -1.035 . . . . 60.530000000000001 110.916 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -64.02 -32.65 74.28 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.109 0.564 . . . . 73.549999999999997 110.114 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -65.11 -49.72 68.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.524 1.129 . . . . 64.129999999999995 110.416 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.02 -43.51 87.45 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.597 0.759 . . . . 73.450000000000003 110.406 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.46 -59.9 4.46 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.387 -1.279 . . . . 53.229999999999997 110.944 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.595 ' HG3' HG12 ' A' ' 190' ' ' VAL . 31.7 tt0 -67.73 -22.73 65.22 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.835 -0.62 . . . . 75.0 111.281 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -65.42 -56.38 12.83 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.996 0.519 . . . . 75.239999999999995 109.706 173.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.27 -35.91 80.44 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 116.431 -0.349 . . . . 75.209999999999994 111.148 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.499 HD23 HG13 ' A' ' 190' ' ' VAL . 34.4 tp -72.25 -26.72 62.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.013 0.525 . . . . 75.129999999999995 111.66 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.5 t -70.06 -16.28 63.12 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.976 0.51 . . . . 74.409999999999997 111.162 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.3 m -83.07 -17.79 41.94 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.263 0.625 . . . . 73.420000000000002 111.052 170.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.36 -179.64 51.02 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 116.154 -0.475 . . . . 64.420000000000002 113.431 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.1 pt -133.37 -166.45 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 125.864 1.666 . . . . 74.109999999999999 110.503 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 24.3 p-10 -60.15 129.95 44.24 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.62 0.368 . . . . 73.219999999999999 111.229 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.88 10.03 84.61 Favored Glycine 0 C--O 1.264 1.982 0 CA-C-O 119.997 -0.335 . . . . 64.129999999999995 113.061 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.63 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 75.2 m -82.58 141.2 32.76 Favored 'General case' 0 C--N 1.371 1.532 0 N-CA-C 110.086 -0.338 . . . . 74.209999999999994 110.086 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 183' ' ' SER . 16.4 p90 -136.68 161.48 35.8 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.756 0.789 . . . . 74.120000000000005 112.918 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 79.6 mt -135.13 131.96 37.48 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 114.213 -1.358 . . . . 74.420000000000002 108.04 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 32.5 t -108.02 130.05 61.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 106.053 -1.832 . . . . 70.129999999999995 106.053 170.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.55 163.48 39.92 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.999 0.52 . . . . 75.120000000000005 110.261 -171.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 15.7 pt-20 -117.91 164.49 14.99 Favored 'General case' 0 C--O 1.26 1.625 0 C-N-CA 123.263 0.625 . . . . 71.099999999999994 110.368 172.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.1 m -80.29 146.93 31.37 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.73 -1.123 . . . . 70.219999999999999 110.209 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -78.74 -43.46 25.66 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.694 1.197 . . . . 73.510000000000005 110.293 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.471 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 27.3 m -99.29 9.48 43.29 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.531 -1.213 . . . . 74.299999999999997 112.032 -173.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.4 t -147.61 108.73 3.82 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 122.521 0.328 . . . . 75.299999999999997 110.709 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.497 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 68.4 Cg_endo -74.5 135.21 19.78 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.003 2.469 . . . . 74.420000000000002 111.551 173.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.71 -25.74 12.67 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 116.172 -0.467 . . . . 63.140000000000001 113.509 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -81.3 116.54 21.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.03 0.915 . . . . 75.239999999999995 109.192 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.532 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 41.1 mtt-85 -129.41 157.14 42.8 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.099 -1.075 . . . . 72.430000000000007 108.099 -177.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.6 m -140.08 144.89 37.05 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 123.225 0.61 . . . . 73.439999999999998 109.825 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 55.3 mt -109.67 143.88 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.021 -1.103 . . . . 75.049999999999997 108.021 165.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.8 m -125.37 112.31 16.16 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.375 1.07 . . . . 64.140000000000001 108.349 -174.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.443 HD21 HD22 ' A' ' 232' ' ' LEU . 47.1 mt -102.81 143.38 32.51 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.362 0.665 . . . . 74.150000000000006 111.341 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -122.16 128.11 50.84 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 107.224 -1.398 . . . . 75.540000000000006 107.224 167.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 1.3 t80 -152.48 123.94 7.74 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.066 1.346 . . . . 75.019999999999996 107.991 -171.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 62.49 18.98 10.86 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.905 1.282 . . . . 65.439999999999998 112.33 -172.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.66 1.63 85.27 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-O 120.019 -0.323 . . . . 73.230000000000004 113.099 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -97.34 125.43 41.94 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.071 -0.714 . . . . 75.420000000000002 109.071 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.595 HG12 ' HG3' ' A' ' 157' ' ' GLU . 73.1 t -98.43 118.77 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.328 1.051 . . . . 74.430000000000007 109.506 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -138.73 140.23 38.64 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.972 0.909 . . . . 55.32 109.389 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -120.19 146.32 46.12 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.779 0.832 . . . . 75.430000000000007 109.059 -171.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -139.68 150.03 44.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.974 0.509 . . . . 73.409999999999997 110.478 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.46 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 12.4 tpp85 -88.37 132.44 34.43 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.108 -0.951 . . . . 72.439999999999998 111.308 -171.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 68.4 mt -81.45 113.51 20.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 108.159 -1.052 . . . . 74.120000000000005 108.159 164.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -83.78 132.05 34.86 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.375 -0.602 . . . . 65.200000000000003 109.375 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.0 m -110.79 116.96 32.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.505 0.722 . . . . 74.049999999999997 109.714 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.5 178.42 2.03 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.363 1.065 . . . . 75.329999999999998 112.035 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 79.8 p -58.56 -41.48 85.76 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.9 0.88 . . . . 73.439999999999998 113.035 -170.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -79.46 -20.12 48.17 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 116.24 -0.436 . . . . 73.329999999999998 110.67 -175.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 113.37 5.5 22.81 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.013 -0.54 . . . . 53.420000000000002 113.53 -174.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -66.26 142.12 57.79 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.625 0.713 . . . . 74.120000000000005 110.502 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 78.3 mt -103.46 146.13 28.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.427 0.691 . . . . 74.400000000000006 109.501 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -165.76 140.61 4.78 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.149 0.579 . . . . 74.230000000000004 110.531 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.4 t -97.91 -38.68 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.316 0.646 . . . . 64.120000000000005 109.722 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 40.7 t -109.05 154.69 21.87 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.614 0.766 . . . . 74.340000000000003 110.96 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.1 m -69.96 -21.13 63.28 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.143 -0.935 . . . . 71.409999999999997 111.04 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -84.64 -6.9 59.39 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.538 0.735 . . . . 72.120000000000005 111.497 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 59.1 m -136.69 147.9 47.06 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.888 0.475 . . . . 75.299999999999997 112.044 -168.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -140.65 134.05 29.86 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.791 1.236 . . . . 75.329999999999998 108.326 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -127.82 132.62 49.43 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.916 0.486 . . . . 74.519999999999996 110.117 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -83.8 -25.02 30.77 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.323 0.649 . . . . 73.439999999999998 110.236 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.0 p -128.99 150.31 50.45 Favored 'General case' 0 C--O 1.253 1.263 0 C-N-CA 123.185 0.594 . . . . 75.409999999999997 110.973 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 31.3 tp -69.71 -27.73 65.23 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.407 -0.815 . . . . 74.230000000000004 110.047 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.25 -44.92 92.36 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.345 0.658 . . . . 73.409999999999997 110.847 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -75.78 -29.63 58.83 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 116.191 -0.459 . . . . 65.230000000000004 111.377 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tt -58.17 -51.3 70.32 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 123.301 0.375 . . . . 73.340000000000003 110.51 172.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.429 HG21 ' CE3' ' A' ' 146' ' ' TRP . 94.9 t -69.47 -42.9 81.03 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 CA-C-N 115.41 -0.814 . . . . 73.129999999999995 111.097 -176.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -57.71 -53.93 52.57 Favored 'General case' 0 C--O 1.259 1.568 0 C-N-CA 123.386 0.674 . . . . 74.530000000000001 111.151 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.466 ' O ' HG21 ' A' ' 224' ' ' VAL . 35.9 t-80 -55.65 -54.75 40.31 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 114.846 -1.07 . . . . 75.450000000000003 109.585 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.424 ' HD1' HD22 ' A' ' 228' ' ' LEU . 4.5 m-70 -68.15 -16.54 64.04 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.758 0.651 . . . . 64.140000000000001 112.758 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 232' ' ' LEU . 44.4 t -74.56 -31.32 62.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.564 0.345 . . . . 62.350000000000001 110.243 173.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.4 t -107.56 -12.34 15.29 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 116.501 2.037 . . . . 71.239999999999995 116.501 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.47 ' O ' HG21 ' A' ' 231' ' ' THR . 27.7 m -105.86 167.2 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 N-CA-C 117.512 2.412 . . . . 74.420000000000002 117.512 -166.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.02 -1.49 58.02 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 130.075 3.35 . . . . 74.329999999999998 113.663 -173.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -77.58 12.77 1.48 Allowed 'General case' 0 CA--C 1.567 1.619 0 C-N-CA 130.532 3.533 . . . . 70.099999999999994 114.031 -136.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.48 16.5 4.63 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 124.95 1.262 . . . . 73.510000000000005 110.58 -170.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.424 HD22 ' HD1' ' A' ' 221' ' ' HIS . 90.6 mt -90.79 123.38 34.31 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.122 1.369 . . . . 71.209999999999994 110.8 173.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 68.5 mt -62.5 -39.54 84.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.795 -0.639 . . . . 74.420000000000002 109.384 170.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.9 t -138.44 144.46 40.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.431 -0.951 . . . . 70.299999999999997 108.431 166.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' THR . . . . . 0.47 HG21 ' O ' ' A' ' 224' ' ' VAL . 59.6 p -65.68 150.68 48.08 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 109.22 -0.659 . . . . 74.209999999999994 109.22 170.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.443 HD22 HD21 ' A' ' 184' ' ' LEU . 31.4 mt -64.36 100.16 0.34 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 108.044 -1.095 . . . . 74.239999999999995 108.044 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -90.23 -53.42 4.47 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 109.619 -0.511 . . . . 72.430000000000007 109.619 -169.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.63 ' O ' ' HA ' ' A' ' 167' ' ' SER . 1.0 OUTLIER -151.8 145.33 17.65 Favored Pre-proline 0 N--CA 1.479 0.983 0 CA-C-N 115.495 -0.775 . . . . 72.209999999999994 110.451 177.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -85.3 158.07 11.09 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 121.626 1.551 . . . . 74.530000000000001 113.809 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.39 128.29 87.59 Favored Pre-proline 0 C--O 1.245 0.842 0 N-CA-C 108.923 -0.769 . . . . 64.439999999999998 108.923 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.93 171.15 18.06 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.482 2.121 . . . . 64.450000000000003 114.185 -167.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 59.9 tttm . . . . . 0 CA--C 1.554 1.126 0 CA-C-N 114.265 -1.334 . . . . 74.5 108.664 172.786 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.9 p . . . . . 0 CA--C 1.547 0.836 0 CA-C-O 121.143 0.497 . . . . 74.230000000000004 111.743 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.0 mt -105.76 129.35 24.78 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 123.183 0.593 . . . . 73.519999999999996 109.455 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.63 171.62 17.42 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.477 2.118 . . . . 75.040000000000006 111.902 172.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.14 148.87 26.54 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.992 0.517 . . . . 71.329999999999998 111.236 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.503 HD23 HD13 ' A' ' 23' ' ' ILE . 83.6 mt -85.84 95.72 9.53 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.278 -1.008 . . . . 74.200000000000003 108.278 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -97.6 -53.42 3.44 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 120.762 0.315 . . . . 75.230000000000004 110.779 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -106.87 108.39 19.88 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.624 -0.717 . . . . 72.150000000000006 109.378 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.503 HD13 HD23 ' A' ' 20' ' ' LEU . 46.9 mm -124.3 114.07 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.291 0.636 . . . . 74.230000000000004 109.573 176.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.429 ' HG2' ' HZ2' ' A' ' 129' ' ' TRP . 20.0 pttp . . . . . 0 CA--C 1.544 0.734 0 CA-C-O 122.514 1.149 . . . . 74.319999999999993 108.509 169.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 CA--C 1.564 1.99 0 N-CA-C 113.3 0.461 . . . . 74.409999999999997 113.3 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -142.74 99.07 3.4 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.628 0.771 . . . . 62.219999999999999 110.687 -172.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.507 ' H ' ' HB3' ' A' ' 139' ' ' ASN . 24.1 tp -102.62 137.6 40.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.412 0.685 . . . . 73.540000000000006 109.483 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -120.02 176.52 5.39 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.826 1.651 . . . . 70.439999999999998 108.54 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.12 143.75 21.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 109.057 -0.72 . . . . 75.209999999999994 109.057 169.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.28 113.31 11.35 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.494 0.718 . . . . 64.409999999999997 109.112 172.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.2 mt -79.26 -20.14 48.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.516 0.726 . . . . 62.530000000000001 110.006 171.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.562 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 71.5 m-85 -136.1 151.61 49.98 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.06 0.544 . . . . 74.150000000000006 109.548 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -70.52 141.8 51.9 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.5 -0.773 . . . . 70.239999999999995 110.304 174.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.514 ' HB3' HG12 ' A' ' 101' ' ' ILE . 87.8 t80 -138.67 115.58 10.83 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.461 -0.57 . . . . 75.420000000000002 109.461 174.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.3 t -81.0 134.34 27.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 107.986 -1.116 . . . . 74.5 107.986 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.23 116.64 8.24 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.763 -0.458 . . . . 75.239999999999995 109.763 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.2 p -71.45 -23.87 61.91 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.465 0.706 . . . . 71.409999999999997 110.501 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.75 -172.01 29.67 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.273 -0.876 . . . . 75.510000000000005 112.097 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.44 -28.8 68.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.325 1.05 . . . . 75.439999999999998 110.72 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -75.25 -16.85 60.43 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.292 1.037 . . . . 71.150000000000006 113.019 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.5 p -109.3 158.6 17.71 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.679 0.792 . . . . 72.409999999999997 110.607 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 125' ' ' ASN . 66.8 tp -107.88 130.72 54.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.33 0.652 . . . . 74.230000000000004 109.701 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 p -78.12 113.38 16.01 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.308 -0.627 . . . . 73.349999999999994 109.308 172.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.514 HG12 ' HB3' ' A' ' 91' ' ' PHE . 34.2 pt -122.22 161.7 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.68 -0.859 . . . . 74.400000000000006 108.68 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.7 m -135.4 151.66 50.66 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 109.304 -0.628 . . . . 75.409999999999997 109.304 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -53.37 117.22 2.9 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.224 0.61 . . . . 71.450000000000003 111.089 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.59 -27.5 7.94 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.973 -0.558 . . . . 70.099999999999994 113.218 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -72.25 122.57 21.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.31 0.644 . . . . 72.430000000000007 110.323 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -84.31 124.61 31.44 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.935 0.494 . . . . 75.239999999999995 110.27 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 19.7 mt -105.55 135.28 47.23 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.702 0.801 . . . . 73.329999999999998 110.365 -168.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -95.35 107.53 19.67 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.111 -1.44 . . . . 74.530000000000001 107.111 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.7 t -97.51 124.47 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.987 -0.746 . . . . 75.329999999999998 108.987 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.4 mt -70.56 -36.27 73.55 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.529 0.681 . . . . 75.409999999999997 109.58 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.13 178.63 41.76 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 114.66 -1.155 . . . . 52.520000000000003 111.357 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 2.4 m-30 -94.99 174.33 7.14 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.785 -0.82 . . . . 72.349999999999994 108.785 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -72.33 159.12 34.56 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.612 -0.722 . . . . 74.349999999999994 109.795 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -58.07 -24.81 59.95 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.526 1.13 . . . . 65.430000000000007 111.76 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.433 ' HB3' ' HG2' ' A' ' 117' ' ' GLU . 56.5 t30 -95.98 -21.97 17.68 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.924 0.49 . . . . 74.049999999999997 111.144 174.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.04 -0.18 83.8 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 122.7 0.191 . . . . 63.210000000000001 113.025 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.433 ' HG2' ' HB3' ' A' ' 115' ' ' ASN . 8.4 pt-20 -57.68 -52.42 65.5 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.008 1.323 . . . . 71.409999999999997 112.081 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -118.58 177.28 4.89 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.28 1.032 . . . . 75.319999999999993 110.12 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -146.93 124.46 11.72 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.649 0.78 . . . . 65.310000000000002 109.411 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -85.24 105.8 16.19 Favored 'General case' 0 C--O 1.249 1.064 0 CA-C-O 121.071 0.462 . . . . 74.120000000000005 110.537 -173.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.11 153.21 20.53 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 115.102 -0.953 . . . . 72.299999999999997 110.086 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -141.8 124.72 16.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.789 0.836 . . . . 71.519999999999996 110.081 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 59.6 p -133.7 -167.3 1.92 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.563 0.745 . . . . 62.210000000000001 110.47 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -58.48 -22.5 55.09 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.539 1.135 . . . . 64.030000000000001 111.116 170.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.423 ' HB2' HD11 ' A' ' 99' ' ' LEU . 53.5 m-20 -84.99 6.11 26.47 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.894 1.278 . . . . 43.539999999999999 111.754 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.77 -128.98 9.75 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 111.001 -0.84 . . . . 74.430000000000007 111.001 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -151.53 162.17 41.42 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.53 0.665 . . . . 74.150000000000006 111.736 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 165.23 171.51 31.55 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.777 -0.647 . . . . 73.549999999999997 112.9 170.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.429 ' HZ2' ' HG2' ' A' ' 24' ' ' LYS . 94.7 m95 -79.29 117.55 20.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.549 0.74 . . . . 70.209999999999994 110.92 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.2 m -117.58 154.88 50.84 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.373 1.069 . . . . 73.239999999999995 108.564 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.38 131.57 15.24 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 121.557 1.505 . . . . 64.310000000000002 111.152 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.562 ' HA ' HG12 ' A' ' 135' ' ' ILE . 23.9 t -63.53 -14.97 56.46 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.921 0.488 . . . . 63.210000000000001 111.547 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -69.89 -25.46 63.71 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.22 1.008 . . . . 73.150000000000006 111.016 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.562 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 6.5 m-30 -95.58 -3.09 47.07 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.577 0.751 . . . . 74.120000000000005 112.739 -177.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.562 HG12 ' HA ' ' A' ' 132' ' ' SER . 12.6 pt -129.42 161.06 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 118.113 0.415 . . . . 74.329999999999998 110.847 -171.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 10.0 t -145.72 139.24 14.58 Favored Pre-proline 0 N--CA 1.483 1.218 0 C-N-CA 123.075 0.55 . . . . 72.310000000000002 110.045 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.49 ' HB2' ' HB2' ' A' ' 140' ' ' SER . 74.1 Cg_endo -74.52 116.64 4.68 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.3 2.0 . . . . 72.340000000000003 111.889 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.9 m -89.51 -25.76 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.069 0.547 . . . . 74.219999999999999 111.492 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.507 ' HB3' ' H ' ' A' ' 84' ' ' LEU . 65.6 t30 -94.17 18.67 10.45 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 122.01 0.91 . . . . 75.310000000000002 110.142 173.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 137' ' ' PRO . 32.3 t -64.84 162.84 15.41 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.445 0.698 . . . . 72.200000000000003 110.515 170.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.6 mt -73.6 -12.11 60.65 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 123.568 0.747 . . . . 75.420000000000002 109.828 173.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.698 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 39.2 tt0 -49.51 -27.65 4.57 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 127.38 2.272 . . . . 75.409999999999997 115.68 -175.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -31.04 70.27 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 118.625 0.648 . . . . 71.299999999999997 110.314 177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -79.63 123.59 27.77 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.047 -1.094 . . . . 74.409999999999997 108.047 166.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.0 p -61.11 -10.74 6.76 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.96 1.096 . . . . 73.219999999999999 113.96 -168.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.461 ' CE3' HG21 ' A' ' 218' ' ' VAL . 61.7 p-90 -71.17 -40.58 71.19 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 111.885 0.328 . . . . 72.209999999999994 111.885 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -97.62 146.78 24.97 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 110.172 -0.307 . . . . 74.129999999999995 110.172 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.698 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 61.6 m-70 -146.06 60.97 1.25 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.001 0.52 . . . . 73.329999999999998 110.687 175.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 57.53 -165.58 6.21 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 116.97 1.548 . . . . 55.509999999999998 116.97 164.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.09 102.86 1.48 Allowed 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.433 2.756 . . . . 64.510000000000005 112.263 168.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.44 HG22 HH21 ' A' ' 171' ' ' ARG . 21.3 t -139.31 155.36 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.132 0.973 . . . . 75.329999999999998 110.24 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.3 m -89.52 173.03 8.55 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.245 1.018 . . . . 75.129999999999995 113.425 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -62.96 -34.17 76.93 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.646 -1.161 . . . . 71.219999999999999 113.16 -173.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -61.64 -57.93 10.08 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 123.607 0.567 . . . . 75.420000000000002 110.595 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.91 -31.34 71.86 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.4 0.68 . . . . 60.039999999999999 111.017 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.737 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.1 -56.99 14.92 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.365 0.603 . . . . 75.109999999999999 111.255 173.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -71.75 -23.98 61.69 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.249 -0.887 . . . . 74.150000000000006 110.797 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -63.98 -51.79 62.63 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.981 0.912 . . . . 65.409999999999997 110.33 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.533 HD12 HH12 ' A' ' 171' ' ' ARG . 79.2 mt -68.9 -40.89 78.91 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.024 0.44 . . . . 71.209999999999994 110.931 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.433 HD23 HG12 ' A' ' 190' ' ' VAL . 34.2 tp -67.09 -22.65 65.82 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.479 -0.782 . . . . 73.540000000000006 112.272 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.9 t -58.26 -30.09 66.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.979 0.911 . . . . 72.450000000000003 111.447 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.8 t -88.11 8.5 26.53 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.419 0.687 . . . . 62.229999999999997 111.571 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -100.49 150.6 18.87 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 122.324 -0.235 . . . . 74.150000000000006 113.481 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.6 pt -97.43 -166.32 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.044 0.938 . . . . 74.420000000000002 109.47 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.77 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 25.4 p-10 -51.21 118.65 3.38 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.798 0.839 . . . . 70.230000000000004 112.619 -176.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.73 14.01 68.63 Favored Glycine 0 C--O 1.257 1.542 0 CA-C-N 116.253 -0.43 . . . . 70.349999999999994 113.768 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 63.2 p -70.94 138.78 50.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.316 -0.624 . . . . 65.209999999999994 109.316 174.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' A' ' 232' ' ' LEU . 18.5 p90 -139.28 156.24 47.19 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.231 0.826 . . . . 71.420000000000002 113.231 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.5 HD23 ' HB1' ' A' ' 236' ' ' ALA . 96.8 mt -134.16 134.5 42.22 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.428 -1.26 . . . . 70.010000000000005 108.581 169.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.409 HG23 HG12 ' A' ' 182' ' ' ILE . 25.8 t -114.63 126.98 72.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 107.057 -1.46 . . . . 60.25 107.057 174.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.737 HH11 ' HA ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -159.84 150.04 18.65 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.226 0.61 . . . . 75.329999999999998 110.019 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.607 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 14.1 pt-20 -94.77 163.96 13.14 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.973 -0.751 . . . . 74.400000000000006 108.973 177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.517 ' HB2' ' HB2' ' A' ' 176' ' ' SER . 35.4 m -87.03 141.12 28.9 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.645 0.26 . . . . 73.409999999999997 111.532 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.55 -37.46 86.2 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.849 0.859 . . . . 73.349999999999994 110.416 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 63.0 p -86.07 -10.2 55.37 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.207 -1.36 . . . . 71.230000000000004 112.471 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.517 ' HB2' ' HB2' ' A' ' 173' ' ' SER . 12.0 m -139.28 88.31 13.04 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.338 0.655 . . . . 72.439999999999998 109.533 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.39 124.25 13.48 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.96 2.44 . . . . 75.530000000000001 112.11 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.84 -22.25 29.42 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.868 -0.606 . . . . 71.140000000000001 113.744 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -82.8 117.67 22.85 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 108.878 -0.786 . . . . 75.519999999999996 108.878 176.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 70.1 mtt-85 -111.15 169.07 9.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.137 -0.938 . . . . 73.340000000000003 110.842 -170.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.557 ' HG ' ' HD3' ' A' ' 194' ' ' ARG . 39.5 m -152.0 149.75 29.22 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.722 0.809 . . . . 54.240000000000002 110.136 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.409 HG12 HG23 ' A' ' 170' ' ' VAL . 48.7 mt -116.95 139.96 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 108.732 -0.84 . . . . 73.400000000000006 108.732 169.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.6 m -118.75 111.64 18.74 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.13 1.372 . . . . 75.120000000000005 107.908 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.452 HD23 HD23 ' A' ' 232' ' ' LEU . 29.9 mt -106.14 137.94 43.2 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.317 1.047 . . . . 75.439999999999998 111.256 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -126.92 126.15 42.76 Favored 'General case' 0 C--O 1.256 1.401 0 N-CA-C 108.656 -0.868 . . . . 74.340000000000003 108.656 170.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 6.2 p90 -138.35 141.69 39.7 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.143 -1.058 . . . . 73.409999999999997 108.143 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 52.38 23.61 2.55 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.104 0.961 . . . . 74.510000000000005 113.547 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 96.82 -11.18 66.34 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 123.05 0.357 . . . . 74.430000000000007 113.576 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -101.98 126.76 48.97 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.751 0.82 . . . . 72.349999999999994 111.149 -173.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.433 HG12 HD23 ' A' ' 160' ' ' LEU . 80.0 t -95.14 142.42 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.199 1.0 . . . . 75.430000000000007 110.461 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.523 ' HH ' HG23 ' A' ' 230' ' ' THR . 23.2 p90 -146.41 154.5 41.69 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.325 1.05 . . . . 74.329999999999998 109.431 165.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -128.05 142.39 51.23 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.829 0.852 . . . . 74.549999999999997 108.732 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -141.76 151.55 42.98 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 120.985 0.421 . . . . 71.239999999999995 110.341 174.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.557 ' HD3' ' HG ' ' A' ' 181' ' ' SER . 21.3 mmt180 -78.95 145.29 34.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.29 -0.868 . . . . 74.5 111.304 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 79.8 mt -89.49 104.23 14.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 106.754 -1.573 . . . . 73.140000000000001 106.754 161.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -71.22 127.06 31.33 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.193 -0.912 . . . . 75.150000000000006 108.668 -177.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 31.8 m -99.52 116.58 31.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.168 0.587 . . . . 75.540000000000006 109.862 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.09 166.61 4.59 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.557 1.143 . . . . 74.549999999999997 111.575 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 55.9 p -62.29 -35.72 79.9 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.153 -0.476 . . . . 74.310000000000002 110.487 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -69.05 -12.77 61.98 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.533 0.733 . . . . 45.030000000000001 111.775 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 96.27 -5.49 65.42 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 116.458 -0.337 . . . . 62.32 112.313 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -62.49 141.93 58.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.561 0.744 . . . . 75.349999999999994 110.798 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 81.4 mt -93.87 144.36 25.51 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.195 -0.669 . . . . 74.150000000000006 109.195 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -162.78 161.49 26.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.094 0.558 . . . . 73.010000000000005 109.891 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 70.7 t -135.54 -55.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.375 -0.972 . . . . 75.120000000000005 108.375 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 9.9 m -90.96 169.86 10.54 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.379 0.671 . . . . 63.329999999999998 109.699 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 61.3 m -69.66 -48.22 60.55 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.509 0.559 . . . . 75.230000000000004 112.509 -171.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -73.62 -26.41 60.77 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.271 0.629 . . . . 75.120000000000005 110.795 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 58.0 m -67.91 118.19 10.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.234 1.014 . . . . 74.120000000000005 110.684 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -142.48 126.9 17.74 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.432 1.093 . . . . 75.219999999999999 108.324 175.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -135.64 141.26 45.02 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.033 0.379 . . . . 62.439999999999998 111.056 -173.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -91.58 -21.72 20.69 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.471 -0.786 . . . . 75.120000000000005 109.94 169.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 48.4 p -127.7 142.46 51.32 Favored 'General case' 0 C--N 1.363 1.185 0 CA-C-O 121.674 0.749 . . . . 74.099999999999994 111.88 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 30.1 tp -65.57 -28.7 69.34 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.404 -1.271 . . . . 74.329999999999998 110.764 175.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.89 97.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.408 0.683 . . . . 64.25 110.521 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.9 -30.27 63.8 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.474 0.31 . . . . 74.510000000000005 111.518 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.0 tt -61.04 -44.0 98.05 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.271 0.357 . . . . 75.530000000000001 110.555 170.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.461 HG21 ' CE3' ' A' ' 146' ' ' TRP . 42.5 t -70.18 -40.07 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.334 0.653 . . . . 74.430000000000007 111.006 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -60.42 -50.81 72.1 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.784 0.802 . . . . 74.439999999999998 110.486 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -56.32 -54.65 42.95 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.285 -1.325 . . . . 73.340000000000003 110.335 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -63.52 -25.18 68.14 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.137 0.575 . . . . 75.519999999999996 112.141 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 23.0 t -74.61 -28.2 60.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.272 0.229 . . . . 53.200000000000003 110.994 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.8 t -103.9 -22.49 13.49 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.021 1.86 . . . . 63.100000000000001 116.021 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.83 120.42 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 120.495 1.498 . . . . 75.209999999999994 114.344 -165.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.2 -1.32 9.87 Favored 'General case' 0 CA--C 1.57 1.715 0 C-N-CA 127.783 2.433 . . . . 74.109999999999999 112.745 171.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.19 14.72 1.1 Allowed 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 128.142 2.577 . . . . 74.540000000000006 114.311 -145.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.76 17.23 4.28 Favored Glycine 0 N--CA 1.467 0.755 0 O-C-N 121.805 -0.559 . . . . 64.530000000000001 111.926 -166.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 64.2 mt -91.36 133.73 35.2 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.045 -0.724 . . . . 75.129999999999995 109.045 156.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.4 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 93.4 mt -57.91 -52.48 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 109.233 -0.655 . . . . 75.019999999999996 109.233 172.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.523 HG23 ' HH ' ' A' ' 191' ' ' TYR . 12.3 t -130.52 150.35 51.77 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.944 -1.026 . . . . 72.439999999999998 108.282 167.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 69.8 p -80.02 170.6 16.24 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 109.05 -0.722 . . . . 75.019999999999996 109.05 171.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.452 HD23 HD23 ' A' ' 184' ' ' LEU . 26.2 mt -74.88 102.59 4.8 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 108.896 -0.779 . . . . 75.319999999999993 108.896 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -78.64 -57.62 3.67 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.16 -0.682 . . . . 75.510000000000005 109.16 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 167' ' ' SER . 7.3 p90 -154.8 151.17 22.8 Favored Pre-proline 0 N--CA 1.483 1.184 0 N-CA-C 109.832 -0.433 . . . . 72.329999999999998 109.832 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.82 138.52 44.98 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.105 1.87 . . . . 72.310000000000002 111.578 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . 0.5 ' HB1' HD23 ' A' ' 169' ' ' LEU . . . -58.83 127.06 82.45 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 109.231 -0.655 . . . . 73.129999999999995 109.231 173.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.06 158.69 28.82 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.853 2.368 . . . . 64.219999999999999 113.281 -172.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt . . . . . 0 C--N 1.348 0.511 0 N-CA-C 109.052 -0.722 . . . . 71.420000000000002 109.052 174.281 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 121.29 0.566 . . . . 64.230000000000004 111.801 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.9 mt -103.32 124.63 37.57 Favored Pre-proline 0 C--O 1.242 0.658 0 N-CA-C 108.1 -1.074 . . . . 72.239999999999995 108.1 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.02 168.62 21.37 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.289 1.993 . . . . 62.020000000000003 111.244 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.429 ' HB3' ' NE2' ' A' ' 21' ' ' HIS . . . -83.03 148.22 27.68 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.773 0.32 . . . . 74.140000000000001 110.446 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.509 HD23 HD12 ' A' ' 23' ' ' ILE . 73.6 mt -84.58 94.77 8.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.86 -1.163 . . . . 73.230000000000004 107.86 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.429 ' NE2' ' HB3' ' A' ' 19' ' ' ALA . 34.1 m170 -96.24 -50.12 4.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.684 -0.689 . . . . 73.409999999999997 110.522 -174.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.482 ' HB2' ' OD1' ' A' ' 113' ' ' ASN . 73.8 m-85 -102.76 107.35 18.19 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.875 -0.787 . . . . 75.010000000000005 108.875 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.509 HD12 HD23 ' A' ' 20' ' ' LEU . 45.4 mm -122.6 114.05 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.034 -1.098 . . . . 73.209999999999994 108.034 175.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 123.346 0.658 . . . . 75.310000000000002 110.161 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.499 1.843 0 N-CA-C 114.025 0.74 . . . . 73.099999999999994 114.025 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -135.48 67.07 1.49 Allowed 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.086 -1.079 . . . . 70.319999999999993 108.086 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.515 HD13 ' HB3' ' A' ' 106' ' ' LYS . 18.0 tp -85.83 114.53 22.84 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 121.275 0.559 . . . . 75.510000000000005 109.526 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 5.1 m-85 -104.8 175.09 5.61 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.777 1.631 . . . . 74.200000000000003 109.401 173.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.93 142.73 31.51 Favored 'Isoleucine or valine' 0 C--O 1.251 1.133 0 N-CA-C 108.073 -1.084 . . . . 73.420000000000002 108.073 169.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.448 ' HB2' HD12 ' A' ' 107' ' ' LEU . . . -77.42 117.65 19.1 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.548 0.53 . . . . 71.340000000000003 109.814 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.2 mt -80.67 -11.11 59.68 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.269 0.628 . . . . 71.319999999999993 111.284 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.439 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 54.1 m-85 -138.79 156.64 47.18 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.911 0.884 . . . . 74.25 109.025 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.84 130.88 35.29 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.066 -1.087 . . . . 73.239999999999995 108.066 168.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -141.0 124.1 16.41 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.563 -0.902 . . . . 74.430000000000007 108.563 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.31 138.95 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.037 -0.727 . . . . 75.340000000000003 109.037 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.02 133.89 56.49 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.297 0.639 . . . . 74.129999999999995 111.743 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.5 t -81.01 -6.17 58.47 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.355 1.062 . . . . 62.130000000000003 110.855 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.33 -162.11 35.91 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.649 -0.58 . . . . 74.040000000000006 111.649 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.52 -34.21 76.65 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.302 1.041 . . . . 71.319999999999993 111.084 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.471 ' ND2' HD13 ' A' ' 20' ' ' LEU . 30.0 p-10 -82.53 9.96 8.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.047 0.939 . . . . 74.349999999999994 112.59 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.1 p -135.49 153.96 51.56 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.335 1.054 . . . . 75.099999999999994 108.833 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.0 tp -110.25 135.7 50.59 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.869 0.468 . . . . 73.439999999999998 110.463 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.4 m -78.54 114.56 17.56 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.404 -0.962 . . . . 72.129999999999995 108.404 169.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.5 pt -118.87 144.72 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.611 0.765 . . . . 73.120000000000005 109.3 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.407 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 4.8 m -107.78 146.29 32.39 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.351 -0.611 . . . . 74.329999999999998 109.351 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -63.42 109.11 1.5 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.735 0.414 . . . . 75.299999999999997 110.995 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.73 1.69 34.56 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 116.064 -0.516 . . . . 41.340000000000003 112.748 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.62 136.36 33.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.326 1.05 . . . . 72.439999999999998 110.181 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HB3' HD13 ' A' ' 84' ' ' LEU . 66.4 mttm -82.8 112.99 20.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.832 0.853 . . . . 74.549999999999997 109.55 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.448 HD12 ' HB2' ' A' ' 87' ' ' ALA . 16.8 mt -100.72 138.05 38.3 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.781 0.832 . . . . 74.450000000000003 108.925 -173.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -108.59 107.32 17.77 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.139 -1.06 . . . . 70.109999999999999 108.139 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 88.1 t -100.14 129.88 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.422 0.689 . . . . 75.219999999999999 109.221 -173.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.4 mt -85.1 -22.82 28.74 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.7 0.4 . . . . 65.519999999999996 110.844 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.73 174.88 37.1 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.779 -0.646 . . . . 73.129999999999995 111.839 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 13.4 m-30 -94.84 174.92 6.86 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.267 0.627 . . . . 75.200000000000003 109.633 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.482 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 57.4 t30 -62.03 159.5 14.27 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.494 1.118 . . . . 73.129999999999995 109.572 173.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -65.91 -18.26 65.22 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 122.487 0.315 . . . . 74.209999999999994 110.696 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -111.44 5.89 19.91 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.555 0.742 . . . . 72.019999999999996 111.398 171.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.87 2.87 53.6 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 115.427 0.931 . . . . 72.310000000000002 115.427 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -60.67 -59.05 6.01 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.345 1.058 . . . . 65.409999999999997 110.907 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -104.49 179.34 4.3 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.142 -1.39 . . . . 73.340000000000003 109.55 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -150.89 121.46 7.44 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.996 0.918 . . . . 72.439999999999998 109.376 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -75.75 100.33 4.68 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 120.985 0.421 . . . . 73.019999999999996 110.207 -176.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -103.86 157.41 17.11 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.944 0.898 . . . . 73.340000000000003 110.242 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -142.92 126.78 17.17 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.86 0.864 . . . . 74.530000000000001 109.471 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.2 p -136.1 -171.61 2.92 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.49 1.116 . . . . 62.130000000000003 109.686 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -70.01 -7.3 39.79 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.363 0.665 . . . . 74.200000000000003 111.504 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -84.61 -13.19 52.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.116 0.967 . . . . 75.5 111.316 173.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 128.07 -142.36 13.45 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.853 -0.499 . . . . 62.25 111.853 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -151.69 145.68 25.22 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.376 0.67 . . . . 72.400000000000006 110.833 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 173.58 179.01 43.96 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.442 -0.799 . . . . 74.510000000000005 111.717 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -82.07 123.37 28.88 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.693 0.797 . . . . 73.349999999999994 110.433 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.88 148.32 41.87 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 124.738 1.215 . . . . 73.150000000000006 109.025 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.95 130.69 25.08 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 121.871 1.714 . . . . 54.25 111.008 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.1 m -61.42 -19.37 61.86 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.942 0.897 . . . . 73.430000000000007 112.698 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -72.97 -21.39 60.86 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.941 0.896 . . . . 71.239999999999995 111.537 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.439 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.1 m-85 -94.36 -3.99 49.33 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.566 0.746 . . . . 73.129999999999995 112.608 -175.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.4 pt -128.36 151.74 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.039 0.536 . . . . 75.129999999999995 110.525 -171.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 8.2 t -141.28 133.54 13.97 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 122.602 0.361 . . . . 44.25 110.637 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 59.2 Cg_endo -72.43 117.78 5.29 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.522 2.148 . . . . 70.120000000000005 112.116 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 22.9 m -80.22 -36.92 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.158 0.583 . . . . 75.230000000000004 110.11 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -73.43 -9.76 59.02 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.365 0.666 . . . . 74.109999999999999 111.295 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' A' ' 143' ' ' LYS . 28.6 t -39.16 129.28 1.69 Allowed 'General case' 0 C--N 1.363 1.174 0 C-N-CA 125.281 1.433 . . . . 73.200000000000003 112.447 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 72.0 mt -60.82 -10.07 5.01 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.482 0.713 . . . . 72.209999999999994 111.591 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -57.1 -19.59 20.52 Favored 'General case' 0 C--N 1.365 1.246 0 C-N-CA 124.732 1.213 . . . . 74.420000000000002 112.634 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 140' ' ' SER . 2.4 mmmp? -61.09 -24.99 66.64 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.164 0.506 . . . . 73.099999999999994 110.243 171.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -94.0 120.74 34.68 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 106.371 -1.714 . . . . 74.25 106.371 163.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.5 t -57.32 -17.42 12.15 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.257 1.206 . . . . 74.200000000000003 114.257 -166.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 51.2 p-90 -66.74 -50.43 62.8 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.689 0.626 . . . . 62.539999999999999 112.689 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.413 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 75.7 t80 -79.42 148.0 32.11 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.898 0.479 . . . . 75.200000000000003 110.426 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.434 ' CD2' HD22 ' A' ' 169' ' ' LEU . 87.9 m-70 -135.85 -27.16 1.15 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.203 0.601 . . . . 73.409999999999997 110.47 171.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 100.15 -151.28 19.11 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.139 -0.812 . . . . 74.319999999999993 114.609 171.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.04 89.47 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.273 2.649 . . . . 73.439999999999998 110.781 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 86.9 t -130.43 149.56 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 115.708 -0.678 . . . . 71.400000000000006 110.244 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.6 m -60.91 148.63 39.02 Favored 'General case' 0 C--O 1.246 0.921 0 C-N-CA 124.744 1.217 . . . . 74.530000000000001 112.333 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 41.0 ttt-85 -57.16 -39.35 75.1 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.451 -0.795 . . . . 72.400000000000006 110.033 172.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -60.27 -58.59 7.87 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.735 -1.121 . . . . 74.129999999999995 110.554 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -56.72 -39.08 73.26 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.035 0.835 . . . . 73.239999999999995 111.328 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.06 -61.54 2.56 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.362 -0.835 . . . . 63.299999999999997 111.776 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -70.5 -20.0 62.88 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.245 -0.889 . . . . 75.0 110.805 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -74.11 -51.29 16.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.701 0.8 . . . . 74.540000000000006 110.691 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 71.1 mt -63.8 -39.44 94.25 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.111 0.482 . . . . 74.340000000000003 109.892 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.4 tp -72.34 -18.61 61.75 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.142 -0.936 . . . . 64.200000000000003 111.197 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.476 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 17.3 t -67.17 -23.13 65.74 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.934 0.494 . . . . 73.430000000000007 110.902 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.1 t -91.12 8.63 34.64 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.89 0.876 . . . . 75.209999999999994 110.52 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.21 159.64 30.07 Favored Glycine 0 C--N 1.343 0.958 0 C-N-CA 123.088 0.375 . . . . 73.409999999999997 112.67 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 18.9 pt -126.09 -165.24 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 C-N-CA 124.184 0.994 . . . . 74.219999999999999 110.424 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 14.0 p-10 -56.86 99.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.815 1.043 . . . . 71.120000000000005 113.815 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 103.65 13.54 27.67 Favored Glycine 0 C--O 1.259 1.696 0 CA-C-N 116.162 -0.472 . . . . 63.530000000000001 112.818 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 23.0 t -77.65 136.47 38.22 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.854 -0.424 . . . . 63.509999999999998 109.854 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.469 ' HB3' HD23 ' A' ' 184' ' ' LEU . 17.1 p90 -139.49 159.87 41.16 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.125 0.787 . . . . 75.219999999999999 113.125 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.53 HD23 ' HB3' ' A' ' 236' ' ' ALA . 95.4 mt -137.61 134.4 35.5 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.33 1.052 . . . . 73.239999999999995 108.578 170.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 43.9 t -109.68 124.62 66.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 108.685 -0.857 . . . . 71.040000000000006 108.685 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.8 mtp-105 -142.81 168.38 19.86 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.936 0.894 . . . . 71.030000000000001 111.03 -174.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.777 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 2.9 pt-20 -120.46 166.1 14.05 Favored 'General case' 0 C--O 1.26 1.645 0 C-N-CA 124.547 1.139 . . . . 74.019999999999996 110.679 159.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.2 m -74.61 146.3 42.59 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.339 -1.3 . . . . 52.109999999999999 110.505 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.9 -43.16 75.8 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.67 0.788 . . . . 71.519999999999996 111.105 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.2 m -84.66 -43.91 13.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.483 -0.78 . . . . 63.229999999999997 111.709 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.6 t -112.56 97.09 39.25 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 109.289 -0.634 . . . . 73.230000000000004 109.289 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -69.18 147.17 65.98 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.074 2.516 . . . . 71.319999999999993 111.593 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.52 -23.85 8.14 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 116.329 -0.396 . . . . 75.439999999999998 112.996 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -80.69 116.12 20.54 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 107.127 -1.434 . . . . 73.109999999999999 107.127 170.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.777 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 83.7 mtt85 -122.45 166.48 14.69 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.13 0.572 . . . . 73.430000000000007 111.228 -168.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.434 ' HG ' ' HD3' ' A' ' 194' ' ' ARG . 65.4 m -151.84 138.03 18.35 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.235 1.014 . . . . 72.040000000000006 109.838 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 63.0 mt -105.17 140.37 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 107.849 -1.167 . . . . 74.319999999999993 107.849 165.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 15.5 m -116.29 113.6 23.2 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.384 1.074 . . . . 74.420000000000002 108.388 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.469 HD23 ' HB3' ' A' ' 168' ' ' PHE . 39.5 mt -104.3 144.01 32.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.153 0.981 . . . . 63.439999999999998 111.301 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.476 ' NH1' ' HA ' ' A' ' 161' ' ' SER . 21.1 ttt180 -134.48 138.16 44.5 Favored 'General case' 0 C--O 1.25 1.132 0 CA-C-N 114.637 -1.165 . . . . 74.310000000000002 110.03 172.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 10.2 p90 -157.71 139.18 13.73 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.838 -1.074 . . . . 74.420000000000002 108.108 171.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 54.49 31.37 14.65 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.583 1.153 . . . . 74.439999999999998 113.537 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.73 9.53 86.26 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.343 -0.39 . . . . 74.420000000000002 113.817 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 28.7 tpt180 -102.9 127.09 50.24 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.501 1.12 . . . . 73.099999999999994 109.411 175.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 94.9 t -114.08 129.85 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.78 1.232 . . . . 73.010000000000005 108.971 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.607 ' HH ' HG22 ' A' ' 230' ' ' THR . 22.5 p90 -145.36 160.73 41.09 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.051 0.941 . . . . 74.329999999999998 109.061 174.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -134.42 148.27 50.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.104 0.962 . . . . 75.219999999999999 108.506 -171.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -145.29 145.67 31.34 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.68 0.392 . . . . 71.25 110.867 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.434 ' HD3' ' HG ' ' A' ' 181' ' ' SER . 12.7 mmt180 -76.82 146.31 37.87 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.375 1.07 . . . . 75.450000000000003 112.149 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.745 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 64.3 mt -104.52 119.18 53.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 N-CA-C 107.393 -1.336 . . . . 74.510000000000005 107.393 163.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -91.02 145.04 25.03 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 109.637 -0.505 . . . . 74.030000000000001 109.637 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 18.1 m -106.02 128.07 53.59 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.969 0.908 . . . . 72.340000000000003 109.449 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.623 ' HB2' ' HB2' ' A' ' 202' ' ' LYS . . . -85.37 158.66 20.19 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.709 0.803 . . . . 73.340000000000003 109.432 170.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 15.8 t -65.6 -9.64 28.59 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.842 1.053 . . . . 75.540000000000006 113.842 -169.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.419 ' HB2' ' HG3' ' A' ' 202' ' ' LYS . 80.9 m-20 -87.46 11.73 13.99 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.117 0.567 . . . . 73.450000000000003 111.833 175.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 75.2 12.48 83.47 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 111.954 -0.458 . . . . 71.409999999999997 111.954 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.623 ' HB2' ' HB2' ' A' ' 198' ' ' ALA . 98.4 mttt -79.65 153.33 29.44 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 123.88 0.872 . . . . 75.540000000000006 110.441 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 90.5 mt -118.37 148.14 42.82 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.342 0.657 . . . . 73.219999999999999 109.41 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -162.91 154.99 18.33 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.193 0.597 . . . . 72.040000000000006 109.981 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 79.2 t -125.01 -63.59 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.09 -1.078 . . . . 64.120000000000005 108.09 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.4 t -113.02 -175.54 2.69 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.15 -0.932 . . . . 75.329999999999998 110.035 -174.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 49.9 m -62.33 -47.8 82.62 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.45 1.1 . . . . 64.310000000000002 112.979 -170.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -85.57 3.17 41.85 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 122.182 0.193 . . . . 75.140000000000001 111.124 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 73.0 m -98.81 106.41 18.67 Favored 'General case' 0 C--O 1.215 -0.732 0 C-N-CA 123.608 0.763 . . . . 74.120000000000005 109.97 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -143.31 118.37 10.07 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.842 1.257 . . . . 64.239999999999995 107.685 171.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -134.99 154.93 51.56 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.073 0.549 . . . . 74.049999999999997 110.659 -170.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -91.53 -31.39 15.96 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 123.677 0.611 . . . . 65.310000000000002 109.907 169.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' THR . . . . . 0.408 ' OG1' ' HG2' ' A' ' 216' ' ' GLU . 48.5 p -131.14 157.92 41.86 Favored 'General case' 0 C--O 1.253 1.289 0 CA-C-O 122.324 1.059 . . . . 64.109999999999999 112.104 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 23.1 tp -72.78 -27.92 62.29 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 113.765 -1.561 . . . . 73.230000000000004 111.396 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.84 -43.27 93.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.878 0.471 . . . . 74.439999999999998 110.521 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.408 ' HG2' ' OG1' ' A' ' 213' ' ' THR . 21.0 mm-40 -68.9 -35.04 76.38 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 115.768 -0.651 . . . . 72.420000000000002 110.146 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tt -55.78 -50.01 71.6 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.951 0.782 . . . . 64.150000000000006 110.91 171.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.8 -45.75 96.3 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 O-C-N 123.956 0.785 . . . . 64.239999999999995 111.055 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -58.01 -53.32 59.59 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.581 0.705 . . . . 71.409999999999997 111.14 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.423 ' CE1' HG11 ' A' ' 224' ' ' VAL . 61.5 t60 -54.48 -51.68 64.29 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.016 -0.993 . . . . 73.340000000000003 109.425 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.408 ' HB3' ' HG ' ' A' ' 232' ' ' LEU . 8.2 m-70 -66.54 -22.77 66.16 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.265 -0.88 . . . . 73.319999999999993 112.077 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.2 m -72.98 -27.05 61.57 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.745 0.418 . . . . 71.120000000000005 110.583 173.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.8 t -120.25 4.22 10.81 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 116.206 1.928 . . . . 63.219999999999999 116.206 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.423 HG11 ' CE1' ' A' ' 220' ' ' HIS . 26.8 m -107.92 156.44 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 116.085 1.883 . . . . 73.510000000000005 116.085 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -92.56 -0.49 57.32 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 111.111 -2.768 . . . . 63.420000000000002 113.274 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -77.62 14.3 1.06 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 128.169 2.588 . . . . 74.109999999999999 113.999 -143.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.46 17.52 4.77 Favored Glycine 0 N--CA 1.467 0.751 0 O-C-N 120.724 -1.235 . . . . 72.420000000000002 111.321 -169.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.1 mt -92.17 118.08 30.5 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.731 -1.234 . . . . 70.540000000000006 108.605 165.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.407 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 76.8 mt -59.74 -46.42 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 123.868 0.73 . . . . 61.240000000000002 109.478 173.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.607 HG22 ' HH ' ' A' ' 191' ' ' TYR . 15.1 t -130.77 142.7 50.42 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.109 -1.071 . . . . 71.349999999999994 108.109 167.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 55.6 p -69.02 157.35 36.97 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.777 0.431 . . . . 75.129999999999995 110.524 174.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.465 HD23 HD22 ' A' ' 184' ' ' LEU . 23.1 mt -66.96 101.37 0.84 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 108.729 -0.841 . . . . 74.530000000000001 108.729 177.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -88.26 -53.64 4.6 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.838 -0.801 . . . . 73.310000000000002 108.838 -173.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -158.91 145.43 12.63 Favored Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 115.083 -0.962 . . . . 63.210000000000001 110.793 -177.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.487 ' HB3' ' HA ' ' A' ' 146' ' ' TRP . 51.6 Cg_endo -68.59 163.43 36.91 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 121.781 1.654 . . . . 73.010000000000005 113.096 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . 0.53 ' HB3' HD23 ' A' ' 169' ' ' LEU . . . -73.42 125.57 90.61 Favored Pre-proline 0 C--O 1.244 0.812 0 N-CA-C 108.861 -0.792 . . . . 73.120000000000005 108.861 170.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.36 132.43 27.48 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.058 1.839 . . . . 73.420000000000002 111.642 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 21.3 pttp . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 123.62 0.768 . . . . 75.129999999999995 109.976 175.066 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.6 p . . . . . 0 CA--C 1.551 1.001 0 CA-C-O 121.143 0.497 . . . . 73.519999999999996 111.397 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.7 mt -103.89 133.28 20.34 Favored Pre-proline 0 N--CA 1.476 0.86 0 N-CA-C 108.77 -0.826 . . . . 73.420000000000002 108.77 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.26 169.8 19.84 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.387 2.058 . . . . 72.120000000000005 112.688 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.64 142.19 30.98 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.098 0.559 . . . . 74.010000000000005 110.63 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.427 ' HB3' HD13 ' A' ' 23' ' ' ILE . 75.6 mt -88.35 96.93 10.77 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.636 0.774 . . . . 73.239999999999995 109.035 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -97.04 -47.79 5.65 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.57 -0.741 . . . . 74.540000000000006 109.75 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -103.46 109.95 21.79 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.507 -0.77 . . . . 74.299999999999997 109.289 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.427 HD13 ' HB3' ' A' ' 20' ' ' LEU . 25.7 mm -117.29 120.01 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.387 1.075 . . . . 74.120000000000005 109.892 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.4 pttp . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 107.574 -1.269 . . . . 73.120000000000005 107.574 167.121 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.559 1.762 0 N-CA-C 113.922 0.701 . . . . 70.439999999999998 113.922 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -90.46 40.16 1.0 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.824 0.85 . . . . 74.519999999999996 111.672 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 57.4 tp -83.72 112.55 20.17 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.512 0.672 . . . . 75.25 110.553 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.41 173.33 6.37 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.813 1.645 . . . . 65.140000000000001 108.766 170.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.6 p -144.96 143.16 22.63 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 N-CA-C 108.706 -0.85 . . . . 74.25 108.706 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.556 ' HB1' HD11 ' A' ' 107' ' ' LEU . . . -80.26 135.84 36.32 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.858 0.463 . . . . 75.010000000000005 110.201 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.3 mt -95.12 -16.56 22.52 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.315 1.046 . . . . 70.120000000000005 110.767 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -138.98 145.96 40.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.838 0.855 . . . . 73.340000000000003 108.915 -177.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -79.43 117.82 20.74 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.07 -0.715 . . . . 74.409999999999997 109.07 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -121.18 117.74 27.89 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.024 0.93 . . . . 72.040000000000006 109.247 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.8 t -79.96 138.74 19.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 C-N-CA 123.659 0.784 . . . . 62.240000000000002 109.262 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.71 115.09 3.69 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.818 -0.808 . . . . 73.019999999999996 108.818 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.4 m -74.59 -11.92 60.32 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.926 0.891 . . . . 71.25 110.753 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.79 -163.34 28.9 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 110.554 -1.018 . . . . 75.329999999999998 110.554 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -73.6 -23.92 59.98 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.219 0.608 . . . . 74.140000000000001 111.043 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -72.67 -24.19 60.99 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.438 1.095 . . . . 64.219999999999999 112.282 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.1 p -110.41 158.63 18.26 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.836 0.854 . . . . 74.299999999999997 110.013 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.9 tp -109.17 132.73 53.84 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.223 -0.898 . . . . 73.540000000000006 109.226 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.2 t -82.0 124.84 30.14 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.767 -0.827 . . . . 63.439999999999998 108.767 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.1 pt -128.86 140.59 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 108.094 -1.076 . . . . 72.5 108.094 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.434 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 16.0 m -98.31 151.96 19.94 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.024 0.375 . . . . 72.120000000000005 110.211 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -60.12 111.4 1.5 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.199 0.6 . . . . 74.299999999999997 110.799 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.82 3.7 55.93 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 115.405 -0.816 . . . . 54.399999999999999 113.183 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -83.41 145.97 28.7 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.481 0.712 . . . . 75.549999999999997 110.346 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -87.92 113.32 23.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.398 1.079 . . . . 73.329999999999998 109.306 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.556 HD11 ' HB1' ' A' ' 87' ' ' ALA . 15.2 mt -108.07 133.84 51.8 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.464 -0.939 . . . . 73.439999999999998 108.464 -170.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -104.17 106.93 17.61 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.337 -0.616 . . . . 72.219999999999999 109.337 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 92.8 t -98.73 119.4 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 109.07 -0.715 . . . . 73.109999999999999 109.07 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.9 mt -67.83 -37.49 81.97 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.762 0.825 . . . . 74.230000000000004 109.924 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.05 -178.6 44.17 Favored Glycine 0 C--O 1.244 0.727 0 CA-C-N 114.431 -1.259 . . . . 52.350000000000001 111.167 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 14.4 m-30 -95.99 169.81 9.72 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.256 -0.646 . . . . 74.140000000000001 109.256 177.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -60.28 145.82 46.11 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.631 -1.248 . . . . 74.430000000000007 107.631 168.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -65.53 -25.59 67.52 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.46 0.304 . . . . 74.120000000000005 110.896 -176.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -81.76 -18.51 43.94 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.694 0.797 . . . . 74.219999999999999 110.56 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 174' ' ' GLU . . . 85.93 34.25 13.5 Favored Glycine 0 C--N 1.35 1.353 0 C-N-CA 123.484 0.564 . . . . 74.420000000000002 113.607 174.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -96.27 -64.14 1.08 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.577 0.703 . . . . 73.230000000000004 110.583 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -103.49 -179.0 3.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.589 1.156 . . . . 74.319999999999993 109.633 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -142.18 122.19 13.69 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.668 0.787 . . . . 72.349999999999994 109.477 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -79.98 101.77 8.84 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.179 0.514 . . . . 74.0 109.623 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -103.88 167.65 9.64 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.139 -0.937 . . . . 74.230000000000004 109.998 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -141.4 125.62 17.45 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 124.449 1.1 . . . . 74.530000000000001 108.502 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.8 p -138.15 -168.6 2.39 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.029 0.932 . . . . 75.099999999999994 110.661 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -54.41 -35.14 62.59 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.895 1.278 . . . . 73.409999999999997 111.159 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -83.92 8.01 16.44 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.556 -1.202 . . . . 62.409999999999997 111.424 -175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.55 -126.14 7.42 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 111.499 -0.64 . . . . 75.409999999999997 111.499 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -151.02 139.8 20.8 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.305 0.642 . . . . 75.439999999999998 109.324 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 179.2 -178.76 48.86 Favored Glycine 0 C--N 1.344 1.0 0 O-C-N 123.263 0.352 . . . . 71.310000000000002 112.338 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -89.66 131.97 35.38 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.255 0.622 . . . . 64.120000000000005 110.835 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.67 152.08 76.29 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 125.322 1.449 . . . . 75.150000000000006 109.095 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.08 132.98 23.93 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.272 1.982 . . . . 74.430000000000007 111.462 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.482 ' HA ' HG12 ' A' ' 135' ' ' ILE . 20.0 m -62.3 -17.81 59.66 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.11 0.964 . . . . 73.319999999999993 112.724 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -74.65 -20.81 59.74 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.03 0.932 . . . . 75.420000000000002 111.526 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -95.17 -6.51 41.56 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.828 0.851 . . . . 74.310000000000002 112.023 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.482 HG12 ' HA ' ' A' ' 132' ' ' SER . 14.8 pt -125.06 156.68 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.158 0.583 . . . . 74.510000000000005 110.059 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 11.3 t -149.86 136.38 10.75 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 122.701 0.4 . . . . 65.340000000000003 110.375 172.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.51 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 73.6 Cg_endo -75.38 140.19 24.17 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.487 2.125 . . . . 75.540000000000006 111.765 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.85 -36.54 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.002 0.521 . . . . 71.439999999999998 111.414 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.475 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 59.2 t30 -98.74 -9.39 24.58 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.71 0.404 . . . . 72.120000000000005 111.149 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 32.5 t -73.34 177.04 5.46 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.919 0.488 . . . . 73.129999999999995 109.902 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 64.4 mt -61.15 -16.24 42.37 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.698 0.999 . . . . 73.329999999999998 113.698 -172.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -59.37 -24.13 63.14 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.574 1.15 . . . . 75.219999999999999 112.666 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -67.19 -8.37 30.9 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.438 0.695 . . . . 74.540000000000006 112.135 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -89.1 151.76 22.04 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.765 0.826 . . . . 75.340000000000003 110.549 170.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 56.8 p -69.24 -36.21 76.95 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 123.625 0.77 . . . . 73.340000000000003 111.13 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -72.44 -31.35 65.4 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.607 -0.724 . . . . 73.420000000000002 112.638 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -97.27 120.95 38.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.873 -0.788 . . . . 74.349999999999994 108.873 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -103.13 5.05 37.65 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.87 -0.605 . . . . 75.209999999999994 111.663 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.81 -154.5 35.86 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.67 -0.517 . . . . 63.329999999999998 112.948 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.4 106.39 1.59 Allowed 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 123.152 2.568 . . . . 75.140000000000001 111.028 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.6 t -140.34 143.86 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.405 0.682 . . . . 73.030000000000001 109.404 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.2 t -64.54 161.88 16.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.061 0.944 . . . . 72.439999999999998 112.121 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -69.58 -31.86 70.26 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.673 0.789 . . . . 74.430000000000007 110.739 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -76.17 -43.89 40.6 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.23 0.612 . . . . 72.099999999999994 109.527 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.07 79.14 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.396 -0.82 . . . . 72.109999999999999 110.387 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.75 -56.23 24.64 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.715 -0.675 . . . . 75.040000000000006 110.214 171.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -60.49 -32.33 71.33 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.618 -0.719 . . . . 71.209999999999994 110.968 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -65.73 -52.22 52.94 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.222 1.009 . . . . 55.240000000000002 110.975 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.483 ' HB2' HD13 ' A' ' 169' ' ' LEU . 81.5 mt -67.03 -39.37 87.0 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.439 0.637 . . . . 74.299999999999997 110.788 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.428 HD23 HG11 ' A' ' 190' ' ' VAL . 27.2 tp -73.73 -20.14 60.6 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.682 -1.145 . . . . 72.329999999999998 111.604 -174.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.6 t -61.62 -27.22 68.5 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.842 0.857 . . . . 72.530000000000001 111.83 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.4 p -86.45 8.53 21.43 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.918 0.887 . . . . 74.299999999999997 111.719 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -97.39 170.16 25.51 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 116.374 -0.375 . . . . 72.340000000000003 112.605 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 32.4 pt -121.92 -163.59 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.95 0.9 . . . . 72.310000000000002 109.66 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.708 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 27.1 p-10 -49.48 118.15 2.6 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.729 0.811 . . . . 71.239999999999995 112.412 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.18 14.0 72.83 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.297 -0.41 . . . . 51.450000000000003 113.288 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 20.2 t -75.23 136.02 40.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.035 -0.728 . . . . 74.349999999999994 109.035 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.481 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 22.2 p90 -135.65 164.97 26.65 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.948 0.721 . . . . 74.340000000000003 112.948 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 159' ' ' LEU . 86.0 mt -137.41 135.48 36.97 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.549 1.139 . . . . 74.439999999999998 108.353 169.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.404 HG22 HG12 ' A' ' 182' ' ' ILE . 39.0 t -114.55 128.46 71.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 107.851 -1.166 . . . . 74.450000000000003 107.851 171.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 12.9 mtm105 -143.05 172.34 12.85 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.769 0.828 . . . . 73.310000000000002 109.483 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 13.9 pt-20 -116.25 163.06 16.54 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.642 -0.873 . . . . 74.400000000000006 108.642 160.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.5 m -88.58 134.85 33.75 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.155 0.582 . . . . 62.299999999999997 110.141 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.41 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 27.9 mt-10 -78.68 -26.27 44.95 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.115 0.966 . . . . 75.420000000000002 109.224 174.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.1 p -70.61 -37.24 73.81 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.619 -1.173 . . . . 70.430000000000007 110.584 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.9 m -140.48 94.38 8.45 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.056 0.942 . . . . 74.150000000000006 109.433 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.34 135.25 52.85 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.969 2.446 . . . . 70.219999999999999 111.501 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 91.33 -23.51 24.3 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 115.97 -0.559 . . . . 64.329999999999998 113.46 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -82.83 115.62 21.8 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.727 -1.212 . . . . 75.200000000000003 107.727 172.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 82.9 mtt-85 -112.31 159.87 18.23 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.066 0.546 . . . . 74.530000000000001 109.698 -171.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.9 t -152.44 146.67 25.48 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 122.837 0.455 . . . . 72.239999999999995 110.775 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.404 HG12 HG22 ' A' ' 170' ' ' VAL . 52.9 mt -113.94 150.9 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.112 0.965 . . . . 73.049999999999997 108.476 173.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 22.2 m -132.36 128.42 37.61 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.721 -0.844 . . . . 75.540000000000006 108.721 175.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.444 HD22 HD21 ' A' ' 232' ' ' LEU . 38.8 mt -110.66 147.44 34.31 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.328 1.451 . . . . 75.129999999999995 111.382 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -133.5 130.88 39.15 Favored 'General case' 0 C--O 1.253 1.255 0 C-N-CA 124.429 1.092 . . . . 72.140000000000001 108.434 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.708 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 3.7 p90 -154.66 143.55 20.92 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 124.146 0.904 . . . . 73.230000000000004 108.646 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 58.13 19.28 5.94 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 124.389 1.075 . . . . 71.319999999999993 112.941 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 76.65 30.06 56.83 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.984 -0.553 . . . . 61.240000000000002 112.663 -175.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -128.52 123.24 33.03 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.115 0.966 . . . . 65.450000000000003 108.569 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.428 HG11 HD23 ' A' ' 160' ' ' LEU . 48.8 t -104.13 138.2 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.257 1.023 . . . . 73.530000000000001 109.79 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.565 ' HH ' HG22 ' A' ' 230' ' ' THR . 28.7 p90 -143.15 157.94 44.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.939 0.895 . . . . 54.210000000000001 109.215 171.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -128.09 144.16 51.1 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.125 -1.065 . . . . 73.010000000000005 108.125 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -145.67 147.57 32.13 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.062 0.458 . . . . 73.409999999999997 110.644 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 20.9 tpp180 -82.35 133.43 35.23 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.056 -0.975 . . . . 73.25 110.431 -174.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 93.5 mt -75.1 102.68 2.51 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 N-CA-C 106.979 -1.489 . . . . 73.310000000000002 106.979 165.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -68.15 111.62 4.61 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.531 -1.213 . . . . 72.439999999999998 108.063 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 37.7 m -97.28 113.45 25.07 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.873 -0.603 . . . . 62.530000000000001 109.527 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.1 160.03 10.81 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.197 0.999 . . . . 71.420000000000002 111.862 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.3 m -62.09 -23.62 66.63 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.2 -0.909 . . . . 72.230000000000004 111.47 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -87.28 3.56 46.26 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.182 0.993 . . . . 74.409999999999997 111.104 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 83.83 -1.76 88.34 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 122.933 0.302 . . . . 64.010000000000005 113.35 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -77.19 131.19 38.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.518 0.727 . . . . 74.349999999999994 110.274 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.72 147.45 22.98 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.836 -0.802 . . . . 75.519999999999996 108.836 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -166.14 176.24 7.81 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.406 0.682 . . . . 75.349999999999994 110.143 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 75.7 t -140.38 -50.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 107.004 -1.48 . . . . 73.340000000000003 107.004 172.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 22.0 m -74.83 145.99 42.37 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.347 -0.842 . . . . 74.25 109.933 171.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.8 m -70.83 -26.15 63.16 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.521 0.728 . . . . 73.549999999999997 110.922 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -71.85 -41.75 67.72 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.319 -0.623 . . . . 75.340000000000003 109.319 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 18.4 m -91.67 135.13 34.11 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.284 -0.871 . . . . 73.400000000000006 110.865 -165.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -137.26 118.38 14.43 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 107.956 -1.128 . . . . 71.239999999999995 107.956 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -120.85 142.88 49.24 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 109.484 -0.561 . . . . 71.099999999999994 109.484 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -89.46 -24.18 21.91 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.778 -0.453 . . . . 73.019999999999996 109.778 171.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.8 p -124.53 144.81 49.91 Favored 'General case' 0 C--O 1.253 1.246 0 CA-C-O 121.87 0.843 . . . . 72.540000000000006 111.696 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 18.1 tp -69.57 -29.18 66.68 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 113.992 -1.458 . . . . 75.030000000000001 110.961 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.86 -37.12 85.33 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.324 0.649 . . . . 64.109999999999999 111.373 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -76.48 -31.93 58.06 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.884 0.474 . . . . 75.140000000000001 111.344 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.45 -45.88 90.34 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 110.118 -0.327 . . . . 74.209999999999994 110.118 170.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.9 t -70.8 -40.51 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.094 0.958 . . . . 74.239999999999995 110.971 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -59.74 -53.94 52.13 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.7 0.8 . . . . 74.5 109.583 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -53.69 -54.24 40.64 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.966 -1.015 . . . . 74.510000000000005 109.349 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -61.39 -26.33 67.77 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.609 -0.723 . . . . 74.040000000000006 112.286 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 32.4 t -75.17 -28.24 59.98 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 122.756 0.422 . . . . 61.030000000000001 111.236 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 15.4 t -117.56 1.43 12.27 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 116.094 1.887 . . . . 74.120000000000005 116.094 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.419 ' O ' HG21 ' A' ' 231' ' ' THR . 35.8 m -107.14 144.27 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.524 0 CA-C-N 121.465 1.938 . . . . 74.140000000000001 116.19 -175.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -82.11 -2.65 52.7 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 129.07 2.948 . . . . 74.219999999999999 112.187 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -79.34 14.25 1.62 Allowed 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 129.202 3.001 . . . . 62.329999999999998 113.354 -140.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.63 18.16 4.09 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 110.947 -0.861 . . . . 71.409999999999997 110.947 -169.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 86.0 mt -93.63 132.94 37.47 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.993 0.917 . . . . 75.450000000000003 109.951 160.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.463 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 85.3 mt -60.42 -60.06 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 108.749 -0.834 . . . . 75.109999999999999 108.749 170.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.565 HG22 ' HH ' ' A' ' 191' ' ' TYR . 9.5 t -119.65 141.63 49.17 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.149 -0.932 . . . . 72.409999999999997 108.668 173.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' THR . . . . . 0.419 HG21 ' O ' ' A' ' 224' ' ' VAL . 82.1 p -73.19 158.84 34.47 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 108.834 -0.802 . . . . 72.420000000000002 108.834 170.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.481 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 26.2 mt -69.47 99.54 1.26 Allowed 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 108.828 -0.805 . . . . 73.409999999999997 108.828 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -77.9 -45.76 23.22 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.28 0.632 . . . . 65.420000000000002 110.056 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 167' ' ' SER . 12.9 p90 -164.01 153.1 11.91 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 109.541 -0.54 . . . . 61.140000000000001 109.541 172.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.22 139.04 14.6 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 121.698 1.599 . . . . 71.200000000000003 112.273 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.98 118.17 39.93 Favored Pre-proline 0 C--N 1.352 0.689 0 N-CA-C 108.155 -1.054 . . . . 73.409999999999997 108.155 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -66.07 142.1 66.6 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.131 1.887 . . . . 51.310000000000002 112.188 -169.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt . . . . . 0 N--CA 1.477 0.901 0 C-N-CA 123.842 0.857 . . . . 72.219999999999999 110.745 176.333 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.8 m . . . . . 0 C--O 1.247 0.948 0 CA-C-O 121.308 0.575 . . . . 72.040000000000006 111.0 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.1 mt -103.45 125.26 35.43 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 107.88 -1.155 . . . . 74.430000000000007 107.88 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.419 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 67.0 Cg_endo -72.08 176.61 8.21 Favored 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 123.114 2.543 . . . . 74.530000000000001 112.437 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.08 141.69 38.64 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 116.395 -0.366 . . . . 71.230000000000004 111.073 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.534 ' HB3' HD12 ' A' ' 23' ' ' ILE . 66.7 mt -87.93 91.49 8.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.109 -0.7 . . . . 74.349999999999994 109.109 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -97.0 -48.49 5.39 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.676 0.79 . . . . 74.540000000000006 110.22 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -100.75 109.46 21.47 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.857 -1.065 . . . . 73.0 108.732 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.534 HD12 ' HB3' ' A' ' 20' ' ' LEU . 48.3 mm -118.69 119.35 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.697 0.799 . . . . 74.200000000000003 109.325 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.496 ' H ' ' HE1' ' A' ' 129' ' ' TRP . 75.0 mmtt . . . . . 0 C--O 1.241 0.633 0 N-CA-C 108.634 -0.876 . . . . 72.239999999999995 108.634 169.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 N--CA 1.493 1.473 0 N-CA-C 114.104 0.771 . . . . 62.409999999999997 114.104 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -92.35 41.96 1.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.531 0.732 . . . . 75.219999999999999 111.098 -174.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.1 tp -91.58 112.36 24.24 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.445 -0.798 . . . . 75.219999999999999 110.308 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -107.43 176.28 5.21 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.65 1.58 . . . . 63.100000000000001 109.549 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 9.9 p -147.73 149.34 15.5 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 C-N-CA 123.014 0.526 . . . . 74.310000000000002 109.868 171.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.58 113.66 20.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.624 0.77 . . . . 75.120000000000005 109.345 171.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.65 -12.59 53.62 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.058 0.543 . . . . 74.540000000000006 110.568 174.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -135.01 146.49 49.08 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.33 0.652 . . . . 70.430000000000007 110.091 -173.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -60.28 137.73 58.07 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.138 -0.937 . . . . 74.519999999999996 110.439 168.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -152.27 116.24 4.89 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.923 -0.399 . . . . 74.519999999999996 109.923 174.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.94 139.03 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 108.002 -1.11 . . . . 74.540000000000006 108.002 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.79 116.13 8.12 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 110.07 -0.345 . . . . 74.329999999999998 110.07 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.1 m -74.99 -17.66 60.5 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.313 0.645 . . . . 75.099999999999994 110.743 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -156.3 -177.54 29.57 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.611 -0.722 . . . . 71.340000000000003 111.747 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -73.57 -27.55 61.38 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.331 0.652 . . . . 71.519999999999996 110.575 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -69.7 -23.64 63.46 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.863 0.865 . . . . 74.310000000000002 111.922 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.4 p -99.83 157.14 16.72 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.284 0.634 . . . . 61.549999999999997 110.754 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.5 tp -110.32 117.16 32.88 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.531 0.733 . . . . 75.109999999999999 109.87 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -66.89 117.59 9.2 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.031 -0.729 . . . . 71.25 109.031 172.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.4 pt -122.39 130.76 74.28 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 N-CA-C 109.244 -0.65 . . . . 72.099999999999994 109.244 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.0 m -90.53 141.26 28.94 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.503 -0.554 . . . . 72.439999999999998 109.503 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -57.51 116.64 3.49 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.012 0.525 . . . . 60.100000000000001 110.794 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.16 -20.13 21.81 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 115.417 -0.81 . . . . 72.040000000000006 112.38 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -72.55 128.54 35.9 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.017 -0.735 . . . . 71.319999999999993 109.017 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 54.5 mtmt -84.0 126.99 33.56 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.165 0.507 . . . . 73.030000000000001 109.909 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.4 ' HA ' HG22 ' A' ' 123' ' ' THR . 14.5 mt -102.1 166.76 10.43 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.981 -1.008 . . . . 73.430000000000007 108.592 -169.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -128.34 107.4 9.73 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.728 -1.212 . . . . 73.310000000000002 107.728 168.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 98.3 t -96.46 116.52 38.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.625 -0.88 . . . . 75.319999999999993 108.625 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.42 HD12 ' NE2' ' A' ' 127' ' ' GLN . 47.5 mt -78.46 -25.42 45.85 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.065 -0.971 . . . . 71.310000000000002 110.116 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.03 161.02 25.9 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.458 -0.792 . . . . 74.219999999999999 111.421 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 3.8 m-30 -95.4 171.84 8.45 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.473 0.654 . . . . 73.219999999999999 109.424 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -66.84 144.87 56.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.668 1.187 . . . . 71.430000000000007 107.979 164.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -60.89 -38.09 84.47 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.43 0.692 . . . . 73.340000000000003 112.158 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -79.35 -11.94 59.93 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.75 0.82 . . . . 74.120000000000005 110.98 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.35 23.17 48.92 Favored Glycine 0 C--N 1.349 1.281 0 C-N-CA 123.529 0.585 . . . . 72.140000000000001 113.281 177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . 46.5 mt-10 -78.28 -72.21 0.38 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.722 0.772 . . . . 72.200000000000003 110.729 -177.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -104.33 -177.43 3.36 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.534 1.133 . . . . 73.150000000000006 109.439 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -149.23 126.82 11.65 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.338 0.655 . . . . 73.140000000000001 110.07 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -71.03 94.26 1.08 Allowed 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.078 -0.712 . . . . 72.239999999999995 109.078 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -104.88 162.57 13.21 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 124.005 0.922 . . . . 73.219999999999999 110.402 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -144.06 133.72 23.63 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.555 0.742 . . . . 64.409999999999997 109.241 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.4 HG22 ' HA ' ' A' ' 107' ' ' LEU . 62.9 p -139.67 -171.37 3.13 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.556 1.143 . . . . 75.439999999999998 110.454 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.517 ' HZ1' ' HB2' ' A' ' 124' ' ' LYS . 9.6 mtmp? -61.6 -19.77 62.59 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.382 -0.827 . . . . 73.049999999999997 111.196 170.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -85.69 1.93 47.36 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.882 0.873 . . . . 73.420000000000002 111.353 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.5 -130.4 9.54 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.619 -0.593 . . . . 61.409999999999997 111.619 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.42 ' NE2' HD12 ' A' ' 110' ' ' LEU . 57.2 tt0 -145.76 154.38 41.98 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.458 0.703 . . . . 74.219999999999999 109.837 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 166.54 -178.89 40.78 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 112.685 -0.166 . . . . 74.420000000000002 112.685 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.496 ' HE1' ' H ' ' A' ' 24' ' ' LYS . 86.4 m95 -89.85 127.07 35.92 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.767 0.827 . . . . 73.420000000000002 110.688 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.6 m -125.34 146.19 53.4 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.797 1.239 . . . . 72.439999999999998 108.68 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.41 141.5 42.73 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 121.937 1.758 . . . . 72.519999999999996 111.616 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.6 m -60.64 -19.94 59.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.931 0.892 . . . . 75.340000000000003 112.108 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -72.27 -27.49 62.52 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.503 0.721 . . . . 53.229999999999997 111.705 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -88.85 -11.75 43.85 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.661 0.784 . . . . 73.409999999999997 112.073 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.474 HD12 HG22 ' A' ' 109' ' ' VAL . 18.2 pt -122.64 161.43 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.002 0.521 . . . . 74.530000000000001 110.928 -170.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.0 t -155.9 143.05 13.7 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 122.727 0.411 . . . . 65.409999999999997 110.291 168.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.519 ' HB2' ' HB2' ' A' ' 140' ' ' SER . 5.7 Cg_exo -75.63 126.45 9.57 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.579 2.186 . . . . 52.219999999999999 111.217 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.0 m -94.28 -51.26 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 111.945 0.35 . . . . 74.239999999999995 111.945 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -92.52 18.91 7.88 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.175 0.512 . . . . 74.239999999999995 111.305 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 137' ' ' PRO . 22.7 t -64.45 177.51 0.87 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.818 0.847 . . . . 71.299999999999997 112.691 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 49.5 mt -65.31 -13.49 58.59 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.055 1.342 . . . . 64.340000000000003 111.98 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.479 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 42.6 tt0 -63.87 -8.9 12.4 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.856 0.863 . . . . 74.420000000000002 111.491 174.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.502 ' HB2' ' HZ2' ' A' ' 143' ' ' LYS . 4.3 ttmp? -55.16 -23.76 23.05 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.921 1.289 . . . . 72.140000000000001 110.515 167.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -99.36 143.64 29.38 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.974 0.909 . . . . 74.019999999999996 109.824 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.0 p -66.25 -15.41 63.17 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.369 0.668 . . . . 71.420000000000002 112.771 -175.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.403 ' CZ3' ' HB2' ' A' ' 147' ' ' TYR . 44.3 p-90 -80.29 -38.16 31.33 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 112.592 0.59 . . . . 74.219999999999999 112.592 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 28.8 t80 -91.67 140.47 29.69 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.81 -0.441 . . . . 71.549999999999997 109.81 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.479 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 63.3 m-70 -137.97 29.55 2.54 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.136 0.421 . . . . 72.25 112.136 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.63 -170.88 54.49 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 115.652 1.021 . . . . 60.009999999999998 115.652 165.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.04 102.77 1.49 Allowed 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.276 2.651 . . . . 62.299999999999997 111.341 172.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.403 HG23 ' NH2' ' A' ' 171' ' ' ARG . 60.4 t -140.02 156.9 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.458 0.703 . . . . 74.049999999999997 110.023 -175.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.6 t -61.62 145.15 53.09 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.965 1.306 . . . . 60.119999999999997 112.717 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -55.19 -32.87 62.54 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.506 -1.225 . . . . 74.510000000000005 112.019 171.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -66.3 -52.08 50.95 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.442 0.697 . . . . 71.450000000000003 110.553 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.84 75.69 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.228 0.611 . . . . 63.140000000000001 111.262 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.546 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.28 -53.44 58.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.141 -0.936 . . . . 72.019999999999996 110.416 173.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.561 ' HG3' HG13 ' A' ' 190' ' ' VAL . 34.6 tt0 -68.67 -27.46 66.0 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.661 -0.699 . . . . 64.439999999999998 111.079 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -67.62 -45.99 73.79 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.877 0.471 . . . . 72.409999999999997 111.45 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.2 mt -67.76 -38.4 83.39 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 110.146 -0.316 . . . . 64.430000000000007 110.146 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 183' ' ' SER . 29.3 tp -68.15 -21.29 64.92 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.292 0.637 . . . . 73.230000000000004 111.658 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.452 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 33.2 t -64.93 -24.35 67.5 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.505 0.722 . . . . 74.239999999999995 110.603 176.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.8 t -85.62 -2.54 58.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.903 0.881 . . . . 54.420000000000002 111.604 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -86.2 170.91 43.61 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 114.073 0.389 . . . . 61.420000000000002 114.073 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.422 HG13 ' HH ' ' A' ' 234' ' ' TYR . 15.4 pt -132.31 -165.05 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 124.568 1.147 . . . . 73.349999999999994 111.023 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.638 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 14.3 p-10 -58.09 102.81 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.03 0.932 . . . . 71.109999999999999 113.362 -172.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 104.06 11.79 31.19 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 115.977 -0.556 . . . . 61.140000000000001 112.776 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 23.0 t -75.76 142.35 42.38 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 109.853 -0.425 . . . . 61.509999999999998 109.853 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 235' ' ' PRO . 14.9 p90 -144.07 161.47 38.71 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.84 0.682 . . . . 73.430000000000007 112.84 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.474 HD21 ' HB1' ' A' ' 236' ' ' ALA . 95.7 mt -142.45 135.51 28.53 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.489 1.116 . . . . 74.239999999999995 108.358 170.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.5 t -110.91 113.52 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.327 -1.36 . . . . 75.420000000000002 107.327 174.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.546 HH11 ' HA ' ' A' ' 156' ' ' ALA . 17.2 mtp180 -141.12 143.28 34.21 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 107.602 -1.258 . . . . 74.219999999999999 107.602 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.685 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 15.3 pt-20 -95.14 161.29 14.18 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.074 0.397 . . . . 75.439999999999998 110.506 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 37.4 m -82.81 134.47 35.11 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 116.308 -0.406 . . . . 74.040000000000006 110.284 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -70.16 -41.67 73.53 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.214 1.006 . . . . 73.120000000000005 109.975 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 72.0 p -84.26 -9.17 58.72 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.366 1.066 . . . . 73.230000000000004 111.864 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.2 m -141.64 67.45 24.07 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.499 1.12 . . . . 75.409999999999997 108.812 173.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.71 149.11 42.71 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.655 2.237 . . . . 71.129999999999995 112.817 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.66 -26.01 6.17 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 114.665 -1.152 . . . . 74.329999999999998 112.049 -168.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -90.84 119.17 30.83 Favored 'General case' 0 C--O 1.259 1.574 0 N-CA-C 108.151 -1.055 . . . . 71.519999999999996 108.151 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.685 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 26.0 mtt85 -105.95 170.24 8.02 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.36 -0.836 . . . . 72.120000000000005 110.77 -173.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.8 m -144.11 144.14 31.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.699 0.8 . . . . 75.450000000000003 110.22 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 56.7 mt -112.91 139.25 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.18 -1.045 . . . . 75.0 108.18 168.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.532 ' HB3' HD22 ' A' ' 160' ' ' LEU . 23.6 m -116.04 115.09 25.5 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 124.661 1.184 . . . . 71.400000000000006 107.981 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.439 HD21 HD22 ' A' ' 232' ' ' LEU . 57.2 mt -104.77 142.99 33.73 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.474 0.71 . . . . 71.209999999999994 111.088 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.452 ' NH1' ' HA ' ' A' ' 161' ' ' SER . 20.3 ttt180 -131.99 126.55 34.25 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.61 -1.177 . . . . 72.230000000000004 108.773 170.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -150.21 141.46 23.19 Favored 'General case' 0 C--O 1.211 -0.945 0 N-CA-C 107.154 -1.424 . . . . 74.510000000000005 107.154 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 54.29 18.61 1.91 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 125.759 1.624 . . . . 74.519999999999996 113.442 -174.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.49 14.01 80.74 Favored Glycine 0 N--CA 1.475 1.294 0 O-C-N 122.284 -0.26 . . . . 45.100000000000001 113.049 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -103.21 127.73 50.42 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 125.4 1.48 . . . . 73.420000000000002 108.763 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.561 HG13 ' HG3' ' A' ' 157' ' ' GLU . 86.2 t -107.79 116.82 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.887 0.875 . . . . 74.5 110.304 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.49 ' HH ' ' HB3' ' A' ' 186' ' ' TYR . 15.0 p90 -139.55 141.13 37.26 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.44 1.096 . . . . 65.040000000000006 109.275 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -124.57 151.19 45.07 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.139 0.975 . . . . 73.349999999999994 108.963 -170.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -142.94 141.49 31.47 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.213 0.53 . . . . 70.109999999999999 110.752 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -77.68 131.28 37.65 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.815 -1.084 . . . . 72.319999999999993 110.828 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 80.4 mt -75.2 108.52 7.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 107.48 -1.304 . . . . 75.439999999999998 107.48 165.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -73.17 106.76 5.15 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.799 -1.185 . . . . 75.349999999999994 107.799 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' THR . . . . . 0.497 HG23 HD23 ' A' ' 203' ' ' LEU . 30.9 m -92.37 121.65 34.06 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.255 0.622 . . . . 74.140000000000001 109.717 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.21 153.52 34.28 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.454 0.702 . . . . 72.430000000000007 110.236 172.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 51.3 p -61.37 -22.36 64.88 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.405 0.682 . . . . 75.540000000000006 112.005 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -71.54 -14.99 62.27 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.883 1.273 . . . . 75.0 112.373 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 101.77 -2.68 52.56 Favored Glycine 0 C--N 1.348 1.223 0 C-N-CA 122.901 0.286 . . . . 63.140000000000001 112.671 -176.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -82.65 156.07 24.05 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.652 0.781 . . . . 71.129999999999995 109.79 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.497 HD23 HG23 ' A' ' 197' ' ' THR . 79.0 mt -113.69 151.2 32.18 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.581 0.752 . . . . 75.329999999999998 110.73 -171.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -163.78 171.97 14.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.888 0.875 . . . . 62.520000000000003 110.413 170.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.3 t -131.46 -56.34 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.414 -1.328 . . . . 74.420000000000002 107.414 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 8.9 m -76.25 153.12 36.27 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.508 -0.769 . . . . 65.319999999999993 108.932 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.9 m -61.32 -36.82 81.19 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.131 0.573 . . . . 72.299999999999997 111.067 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -82.67 -20.67 35.75 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.451 0.7 . . . . 71.200000000000003 111.461 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 68.7 m -63.49 135.91 57.21 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 122.707 0.403 . . . . 75.230000000000004 110.764 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -141.13 108.52 5.55 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.368 -0.975 . . . . 73.329999999999998 108.368 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -121.39 135.76 55.04 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.285 -0.635 . . . . 74.430000000000007 109.285 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -84.25 -30.5 25.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.956 0.502 . . . . 72.530000000000001 110.04 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 81.5 p -132.36 161.49 33.45 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-O 122.209 1.004 . . . . 75.420000000000002 111.609 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 37.6 tp -71.24 -24.5 62.2 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 114.159 -1.382 . . . . 72.030000000000001 110.992 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.18 -42.03 89.45 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.434 0.693 . . . . 71.129999999999995 109.93 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -65.02 -43.8 91.24 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.341 -0.845 . . . . 71.310000000000002 109.637 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.22 -46.25 86.23 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 124.077 0.861 . . . . 74.209999999999994 111.686 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 42.2 t -74.41 -40.55 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.084 0.553 . . . . 75.519999999999996 111.236 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -62.59 -47.07 85.4 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.107 0.479 . . . . 74.230000000000004 110.591 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.408 ' O ' HG22 ' A' ' 224' ' ' VAL . 52.9 t-80 -54.98 -54.46 42.6 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.066 -0.97 . . . . 75.109999999999999 109.961 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.466 ' HD2' HD21 ' A' ' 228' ' ' LEU . 40.3 m80 -65.85 -23.86 66.76 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.676 -0.693 . . . . 74.129999999999995 111.65 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 44.2 t -74.4 -24.44 59.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.019 0.528 . . . . 61.32 111.298 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.7 t -110.44 -21.73 12.03 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 116.336 1.976 . . . . 72.310000000000002 116.336 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 220' ' ' HIS . 26.9 m -93.84 157.35 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 115.435 1.643 . . . . 73.239999999999995 115.435 -164.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.16 -1.44 57.73 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.378 2.671 . . . . 73.349999999999994 112.666 -175.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -78.92 15.86 1.01 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 128.357 2.663 . . . . 70.150000000000006 113.751 -140.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.93 18.11 4.4 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 124.819 1.2 . . . . 54.530000000000001 110.529 -170.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.466 HD21 ' HD2' ' A' ' 221' ' ' HIS . 95.2 mt -93.19 126.73 38.45 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.989 1.315 . . . . 71.319999999999993 109.713 164.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 81.0 mt -67.01 -39.9 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 109.21 -0.663 . . . . 71.400000000000006 109.21 173.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.8 t -133.28 141.98 48.26 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 115.08 -0.964 . . . . 71.310000000000002 108.803 168.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 65.1 p -66.3 151.84 46.21 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 108.791 -0.818 . . . . 71.099999999999994 108.791 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.439 HD22 HD21 ' A' ' 184' ' ' LEU . 28.5 mt -62.11 102.69 0.31 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 108.126 -1.064 . . . . 74.519999999999996 108.126 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -89.43 -58.18 2.62 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.818 -0.808 . . . . 74.099999999999994 108.818 -173.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.576 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -151.95 141.34 14.24 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 123.058 0.543 . . . . 75.230000000000004 111.82 -178.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 65.5 Cg_endo -71.76 156.76 56.66 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 121.494 1.463 . . . . 71.239999999999995 112.45 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . 0.474 ' HB1' HD21 ' A' ' 169' ' ' LEU . . . -70.72 133.31 86.62 Favored Pre-proline 0 C--O 1.244 0.81 0 CA-C-N 115.935 -0.575 . . . . 74.439999999999998 109.752 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.45 132.1 39.24 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.22 2.614 . . . . 60.140000000000001 113.602 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt . . . . . 0 N--CA 1.476 0.85 0 C-N-CA 123.761 0.825 . . . . 72.129999999999995 110.829 171.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.7 p . . . . . 0 C--O 1.244 0.802 0 CA-C-O 121.169 0.509 . . . . 73.109999999999999 111.006 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.6 mt -108.31 130.62 22.53 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 109.064 -0.717 . . . . 75.439999999999998 109.064 -176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.27 172.7 9.7 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.301 2.001 . . . . 74.530000000000001 111.206 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.86 144.45 36.97 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 122.329 -0.232 . . . . 71.319999999999993 110.439 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.549 ' HB3' HD13 ' A' ' 23' ' ' ILE . 72.6 mt -84.84 92.38 8.25 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.486 -0.931 . . . . 71.340000000000003 108.486 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -96.27 -49.07 5.36 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.203 -0.908 . . . . 74.430000000000007 109.379 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -103.2 110.96 23.11 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.561 -1.2 . . . . 63.25 109.228 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.549 HD13 ' HB3' ' A' ' 20' ' ' LEU . 37.2 mm -116.99 113.01 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.954 0.902 . . . . 75.010000000000005 109.491 -177.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.677 ' HA ' ' HE1' ' A' ' 129' ' ' TRP . 2.2 tppp? . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 125.166 1.386 . . . . 74.209999999999994 112.739 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo . . . . . 0 CA--C 1.555 1.539 0 N-CA-C 112.817 0.276 . . . . 72.019999999999996 112.817 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -88.61 38.14 0.86 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.464 1.105 . . . . 75.430000000000007 110.738 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.563 HD21 ' HD2' ' A' ' 106' ' ' LYS . 20.8 tp -89.53 113.63 25.06 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-N 115.378 -0.828 . . . . 75.120000000000005 110.184 -173.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 3.0 m-85 -103.83 176.56 5.11 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.877 1.271 . . . . 72.099999999999994 108.78 174.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.1 p -141.58 148.46 20.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 108.624 -0.88 . . . . 70.129999999999995 108.624 170.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.88 127.96 33.14 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.162 0.585 . . . . 74.439999999999998 109.55 173.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.25 -22.78 24.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.45 1.1 . . . . 71.040000000000006 111.067 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -136.79 160.25 39.41 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.377 0.671 . . . . 75.010000000000005 109.924 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -81.53 123.09 28.34 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.415 -0.957 . . . . 72.439999999999998 108.415 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.433 ' HB3' HG12 ' A' ' 101' ' ' ILE . 91.8 t80 -125.8 116.68 21.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.417 -0.957 . . . . 72.430000000000007 108.417 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.6 p -80.67 139.03 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.072 0.549 . . . . 74.239999999999995 110.211 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.06 132.27 42.15 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.934 0.494 . . . . 73.519999999999996 110.917 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 t -74.36 -27.53 60.71 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.377 0.671 . . . . 65.420000000000002 109.737 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.48 -144.51 7.25 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.516 -0.634 . . . . 73.150000000000006 111.516 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -71.24 -24.23 62.15 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.692 0.797 . . . . 72.530000000000001 110.952 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.455 ' HB2' HD12 ' A' ' 23' ' ' ILE . 27.4 p-10 -67.93 -22.61 65.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.04 0.936 . . . . 75.409999999999997 111.238 -177.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.5 p -129.87 158.54 39.21 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.298 1.039 . . . . 62.229999999999997 110.226 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.2 tp -110.08 136.46 49.29 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.131 -0.692 . . . . 74.129999999999995 109.131 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.4 t -81.73 112.9 19.32 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 107.503 -1.295 . . . . 74.420000000000002 107.503 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.433 HG12 ' HB3' ' A' ' 91' ' ' PHE . 37.1 pt -119.95 157.8 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.569 0.748 . . . . 75.109999999999999 109.452 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.5 m -131.32 143.84 50.82 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.545 -0.539 . . . . 74.239999999999995 109.545 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -52.07 123.84 11.47 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.778 0.831 . . . . 73.310000000000002 111.533 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.92 -22.69 34.5 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.054 -0.521 . . . . 74.129999999999995 112.935 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -76.9 132.33 39.05 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 117.119 0.46 . . . . 52.240000000000002 110.26 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.563 ' HD2' HD21 ' A' ' 84' ' ' LEU . 41.2 mtmt -82.25 127.9 33.65 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 124.11 0.881 . . . . 74.420000000000002 109.661 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.9 mt -108.21 130.98 55.12 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.829 0.852 . . . . 74.400000000000006 109.241 -171.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -91.82 106.23 18.31 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.777 -0.823 . . . . 72.25 108.777 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 89.7 t -96.89 117.03 40.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.871 -0.789 . . . . 75.209999999999994 108.871 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.4 mt -71.38 -27.46 63.35 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.328 0.651 . . . . 75.340000000000003 110.418 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.79 175.61 34.87 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.482 -0.781 . . . . 72.219999999999999 111.792 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 2.1 m-30 -95.2 171.17 8.89 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.006 -1.109 . . . . 74.010000000000005 108.006 173.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.497 HD22 ' HB2' ' A' ' 117' ' ' GLU . 32.0 p30 -76.05 178.58 6.22 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.923 -0.399 . . . . 73.430000000000007 109.923 172.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -65.03 -16.65 63.69 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.331 0.493 . . . . 72.230000000000004 112.331 -172.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -109.7 -8.27 14.97 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-O 120.859 0.361 . . . . 72.129999999999995 111.564 176.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.558 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 74.18 21.92 78.4 Favored Glycine 0 N--CA 1.469 0.838 0 N-CA-C 114.185 0.434 . . . . 73.019999999999996 114.185 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.497 ' HB2' HD22 ' A' ' 113' ' ' ASN . 25.5 mt-10 -74.67 -55.52 5.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.993 0.902 . . . . 71.420000000000002 110.118 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -118.72 133.01 56.16 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 113.998 -1.455 . . . . 73.420000000000002 108.513 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -110.97 127.52 55.53 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.917 1.287 . . . . 72.430000000000007 110.401 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -77.58 106.43 9.37 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.033 0.444 . . . . 74.310000000000002 110.325 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.48 163.48 12.83 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.336 -0.847 . . . . 74.019999999999996 110.61 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -142.78 131.53 22.7 Favored 'General case' 0 C--O 1.249 1.051 0 C-N-CA 124.24 1.016 . . . . 73.349999999999994 108.581 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 81.4 p -143.66 -167.86 2.69 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.697 1.199 . . . . 74.049999999999997 109.463 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -57.93 -18.79 25.49 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.671 1.188 . . . . 73.439999999999998 112.028 173.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -89.62 -6.51 56.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.598 1.159 . . . . 65.439999999999998 111.692 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.38 -141.85 16.86 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 111.392 -0.683 . . . . 64.209999999999994 111.392 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -142.77 138.92 30.79 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.421 0.688 . . . . 73.310000000000002 110.63 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 176.32 -177.02 47.91 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 111.622 -0.591 . . . . 61.420000000000002 111.622 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.677 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 33.9 m95 -100.4 136.91 39.55 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.349 0.66 . . . . 64.230000000000004 110.816 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.23 149.85 74.83 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.331 1.053 . . . . 73.439999999999998 109.27 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.95 137.02 33.94 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 121.74 1.627 . . . . 75.5 110.94 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.449 ' HA ' HG12 ' A' ' 135' ' ' ILE . 26.3 m -61.4 -17.1 52.55 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.729 0.812 . . . . 55.200000000000003 112.64 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -71.1 -26.75 63.17 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.024 0.93 . . . . 64.109999999999999 111.175 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -98.94 3.94 47.22 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.923 0.889 . . . . 73.099999999999994 111.658 -173.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' A' ' 132' ' ' SER . 16.2 pt -130.63 157.62 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.779 0.432 . . . . 74.340000000000003 110.047 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 14.2 t -155.76 135.07 7.88 Favored Pre-proline 0 CA--C 1.555 1.159 0 O-C-N 123.349 0.406 . . . . 74.439999999999998 110.005 172.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 3.0 Cg_exo -74.94 117.03 4.77 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.955 2.437 . . . . 64.219999999999999 111.953 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.2 m -91.89 -34.37 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 122.988 0.515 . . . . 71.299999999999997 112.137 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -99.84 16.75 22.72 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.641 0.734 . . . . 70.219999999999999 110.077 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.1 t -92.74 -176.8 4.35 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.736 0.779 . . . . 72.349999999999994 110.649 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 51.7 mt -64.91 -12.59 50.96 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.441 1.496 . . . . 72.329999999999998 112.151 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -55.86 -23.36 30.45 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.65 1.18 . . . . 72.310000000000002 112.524 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -58.58 -19.66 40.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.538 0.735 . . . . 74.319999999999993 111.368 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -95.74 131.99 41.43 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.254 1.022 . . . . 73.349999999999994 108.332 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.2 m -70.8 -6.9 41.28 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.081 0.771 . . . . 74.349999999999994 113.081 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 33.4 p-90 -81.05 -27.6 35.69 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.258 0.223 . . . . 73.219999999999999 111.498 173.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -94.91 120.49 35.21 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.126 -0.694 . . . . 73.150000000000006 109.126 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -112.81 6.88 18.24 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 116.346 -0.388 . . . . 72.329999999999998 111.368 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.73 -150.8 48.52 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 119.032 -0.871 . . . . 74.219999999999999 113.461 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.55 104.28 0.92 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.279 2.652 . . . . 73.129999999999995 111.6 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.4 t -124.32 140.1 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 120.761 0.315 . . . . 72.25 110.838 -173.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.0 t -71.1 160.14 33.42 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.875 0.87 . . . . 74.400000000000006 111.088 172.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -62.91 -36.89 84.85 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.66 -0.7 . . . . 74.209999999999994 110.874 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -66.51 -51.62 54.7 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 123.714 0.634 . . . . 73.549999999999997 109.991 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.33 -42.27 81.57 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 124.002 0.814 . . . . 74.140000000000001 110.734 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.9 -59.63 4.77 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.694 -1.139 . . . . 73.310000000000002 111.257 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -67.11 -29.26 68.95 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 116.065 -0.516 . . . . 73.549999999999997 111.317 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -61.82 -53.78 51.25 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.453 0.701 . . . . 62.149999999999999 110.113 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.474 ' HB2' HD12 ' A' ' 169' ' ' LEU . 77.8 mt -67.35 -38.05 84.23 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.044 -0.526 . . . . 75.049999999999997 110.848 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.483 HD23 HG12 ' A' ' 190' ' ' VAL . 25.4 tp -71.22 -30.65 66.61 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.359 -0.837 . . . . 75.019999999999996 112.184 -172.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.4 m -68.35 -16.72 64.04 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.368 0.667 . . . . 72.340000000000003 111.963 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.3 m -82.23 3.86 25.78 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.703 0.801 . . . . 75.340000000000003 111.027 172.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -101.82 -178.89 28.04 Favored Glycine 0 C--N 1.344 0.978 0 C-N-CA 123.244 0.449 . . . . 73.439999999999998 113.228 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.4 pt -132.05 -163.89 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.508 1.123 . . . . 74.109999999999999 108.884 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.643 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 26.8 p-10 -50.75 112.09 0.65 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.452 0.701 . . . . 73.010000000000005 112.424 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 92.76 14.26 55.43 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.749 -0.659 . . . . 42.340000000000003 113.36 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 60.8 p -77.95 135.52 37.85 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.993 -0.743 . . . . 71.239999999999995 108.993 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' A' ' 183' ' ' SER . 21.3 p90 -136.62 162.2 33.79 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.019 0.748 . . . . 62.439999999999998 113.019 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.474 HD12 ' HB2' ' A' ' 159' ' ' LEU . 84.3 mt -137.78 133.99 34.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.179 0.991 . . . . 72.209999999999994 108.582 169.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.93 118.27 56.13 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 107.698 -1.223 . . . . 72.530000000000001 107.698 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -128.99 165.6 20.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.899 -1.046 . . . . 72.5 108.988 -171.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 17.0 pt-20 -117.06 161.89 18.68 Favored 'General case' 0 C--O 1.261 1.674 0 N-CA-C 108.214 -1.032 . . . . 73.329999999999998 108.214 161.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.8 t -77.68 144.61 37.19 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.415 0.686 . . . . 72.140000000000001 110.263 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.413 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 29.3 mt-10 -71.03 -44.0 66.73 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.609 -1.178 . . . . 72.25 109.701 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 18.8 m -91.46 3.14 55.68 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.23 -0.896 . . . . 54.420000000000002 111.702 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.4 t -155.89 77.86 4.5 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 109.256 -0.646 . . . . 71.040000000000006 109.256 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.485 ' HG2' ' HB2' ' A' ' 112' ' ' TYR . 36.1 Cg_exo -62.18 138.16 70.6 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.173 2.582 . . . . 73.409999999999997 112.559 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.07 -24.34 27.19 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.808 -0.633 . . . . 65.129999999999995 112.335 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -88.9 118.58 28.71 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.428 -1.323 . . . . 74.540000000000006 107.428 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 82.0 mtt85 -115.7 165.4 13.09 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 123.067 0.547 . . . . 74.420000000000002 112.298 -165.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 40.3 t -151.91 136.98 17.34 Favored 'General case' 0 C--O 1.247 0.972 0 C-N-CA 124.478 1.111 . . . . 50.009999999999998 109.437 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 58.1 mt -105.43 141.92 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 109.016 -0.735 . . . . 71.239999999999995 109.016 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 12.9 m -117.94 115.73 25.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.575 1.15 . . . . 61.229999999999997 108.508 -177.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.413 HD23 ' CD2' ' A' ' 232' ' ' LEU . 58.6 mt -105.31 143.96 32.75 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.909 0.883 . . . . 73.030000000000001 111.219 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 46.3 ttt-85 -133.64 131.12 39.19 Favored 'General case' 0 C--O 1.26 1.621 0 CA-C-N 114.818 -1.083 . . . . 74.129999999999995 109.564 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.643 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 9.2 p90 -152.44 139.7 19.4 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 124.503 1.127 . . . . 75.140000000000001 108.733 173.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 56.73 24.86 9.5 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 124.766 1.226 . . . . 71.239999999999995 112.937 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.85 8.04 80.16 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 116.651 -0.249 . . . . 71.319999999999993 112.973 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 26.5 tpt180 -102.35 123.35 45.98 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.394 1.078 . . . . 71.439999999999998 109.359 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.483 HG12 HD23 ' A' ' 160' ' ' LEU . 77.1 t -110.76 128.49 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.723 1.209 . . . . 74.030000000000001 109.149 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.479 ' HH ' HG22 ' A' ' 230' ' ' THR . 31.2 p90 -145.43 158.28 43.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.46 0.704 . . . . 72.540000000000006 109.135 173.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -130.9 141.53 50.3 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.509 -1.293 . . . . 73.230000000000004 107.509 -173.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -138.45 149.43 45.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.691 0.396 . . . . 74.209999999999994 110.002 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 13.3 tpp85 -84.38 137.2 33.53 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.262 -0.881 . . . . 75.519999999999996 111.088 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 65.0 mt -83.07 110.09 17.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 N-CA-C 108.321 -0.992 . . . . 72.510000000000005 108.321 166.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -68.04 119.43 12.65 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.341 1.056 . . . . 71.219999999999999 109.117 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.1 m -102.89 116.68 33.03 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.685 0.394 . . . . 73.319999999999993 109.971 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.16 167.08 12.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.462 1.105 . . . . 64.120000000000005 111.986 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.2 m -61.71 -30.15 70.57 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.685 0.794 . . . . 74.409999999999997 110.883 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.402 ' HB2' ' HG3' ' A' ' 202' ' ' LYS . 29.0 m-20 -70.76 -12.66 61.68 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.705 1.202 . . . . 71.540000000000006 111.783 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 87.77 2.73 81.24 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 111.818 -0.513 . . . . 53.340000000000003 111.818 -169.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.402 ' HG3' ' HB2' ' A' ' 200' ' ' ASP . 64.6 mttp -68.27 159.38 31.39 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 123.073 0.549 . . . . 73.310000000000002 110.111 175.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 79.6 mt -121.38 145.61 47.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.447 -0.945 . . . . 71.200000000000003 108.447 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -165.87 174.83 9.18 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.628 0.771 . . . . 74.030000000000001 110.018 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 78.2 t -138.47 -53.84 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 107.715 -1.217 . . . . 75.439999999999998 107.715 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 17.3 m -73.19 148.75 43.48 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.414 -0.812 . . . . 71.409999999999997 110.026 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.3 m -61.22 -42.2 98.19 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.239 1.016 . . . . 63.109999999999999 112.312 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -84.52 -36.52 22.14 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 122.742 0.417 . . . . 71.040000000000006 111.333 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.9 m -67.65 138.68 56.55 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.659 0.784 . . . . 75.019999999999996 111.665 -177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -142.37 119.85 11.68 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.555 1.142 . . . . 73.200000000000003 109.067 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -117.94 136.61 53.38 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 109.634 -0.506 . . . . 73.019999999999996 109.634 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -84.29 -26.25 28.71 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.347 0.659 . . . . 65.349999999999994 109.943 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 81.8 p -130.47 147.64 52.19 Favored 'General case' 0 C--O 1.256 1.411 0 CA-C-O 121.694 0.759 . . . . 73.239999999999995 111.115 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 35.2 tp -67.65 -29.27 68.53 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 114.529 -1.214 . . . . 73.349999999999994 111.08 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.74 92.02 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.609 0.363 . . . . 75.150000000000006 110.836 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -75.19 -32.38 61.22 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 116.522 -0.308 . . . . 75.019999999999996 110.763 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.53 -47.17 85.07 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 110.16 -0.311 . . . . 73.319999999999993 110.16 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 43.0 t -69.42 -44.65 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.061 0.945 . . . . 71.219999999999999 110.359 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -61.78 -45.43 93.92 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.249 0.547 . . . . 74.310000000000002 110.869 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.435 ' O ' HG21 ' A' ' 224' ' ' VAL . 49.7 t-80 -53.03 -54.48 34.77 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.843 -1.072 . . . . 74.430000000000007 108.727 175.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -61.99 -26.08 68.01 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.544 -0.753 . . . . 74.430000000000007 112.426 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 50.5 m -72.44 -30.15 64.34 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.8 0.44 . . . . 74.109999999999999 111.188 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -108.74 -17.04 14.04 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 115.578 1.696 . . . . 64.409999999999997 115.578 -176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 220' ' ' HIS . 30.8 m -98.38 148.02 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 115.936 1.828 . . . . 73.349999999999994 115.936 -165.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -83.51 -2.44 55.95 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 129.337 3.055 . . . . 71.400000000000006 112.635 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -79.11 13.41 1.82 Allowed 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 129.252 3.021 . . . . 72.150000000000006 113.331 -138.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.76 16.19 4.18 Favored Glycine 0 N--CA 1.466 0.687 0 N-CA-C 110.091 -1.204 . . . . 74.140000000000001 110.091 -169.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 69.1 mt -90.72 135.05 33.97 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.83 0.852 . . . . 73.099999999999994 109.766 163.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.431 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 84.2 mt -67.66 -44.38 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.868 -0.79 . . . . 74.049999999999997 108.868 172.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.479 HG22 ' HH ' ' A' ' 191' ' ' TYR . 11.3 t -137.7 142.86 41.04 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.327 -0.851 . . . . 72.530000000000001 109.491 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 73.5 p -74.77 157.55 35.0 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.24 0.616 . . . . 62.420000000000002 109.565 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.428 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . 23.5 mt -70.85 101.74 2.2 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 109.567 -0.531 . . . . 74.400000000000006 109.567 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -79.0 -49.7 12.29 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.46 0.704 . . . . 75.040000000000006 110.224 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 167' ' ' SER . 4.3 p90 -164.76 152.72 10.45 Favored Pre-proline 0 N--CA 1.494 1.741 0 CA-C-O 119.61 -0.233 . . . . 74.299999999999997 110.511 173.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.18 146.63 32.25 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 121.936 1.757 . . . . 74.540000000000006 112.505 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -76.25 144.91 75.66 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.242 0.617 . . . . 72.400000000000006 109.409 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -84.7 170.34 10.2 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.548 2.165 . . . . 71.430000000000007 113.733 -171.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.466 ' HZ1' ' HB3' ' A' ' 238' ' ' LYS . 8.1 mtpm? . . . . . 0 N--CA 1.48 1.026 0 C-N-CA 124.254 1.022 . . . . 72.129999999999995 109.204 169.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.548 0.88 0 CA-C-O 121.201 0.524 . . . . 75.140000000000001 111.936 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.4 mt -102.66 127.22 30.73 Favored Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 108.764 -0.828 . . . . 54.340000000000003 108.764 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.13 171.16 17.35 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.187 1.925 . . . . 71.400000000000006 111.31 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.68 146.87 27.99 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 122.409 0.283 . . . . 73.329999999999998 110.642 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.512 ' HB3' HD13 ' A' ' 23' ' ' ILE . 70.5 mt -85.54 92.51 8.55 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 107.89 -1.152 . . . . 74.209999999999994 107.89 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -97.71 -48.42 5.23 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.725 -0.472 . . . . 75.340000000000003 109.725 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -101.56 114.18 27.97 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.354 -0.839 . . . . 71.310000000000002 109.451 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' A' ' 20' ' ' LEU . 41.8 mm -117.65 113.62 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.588 -0.893 . . . . 75.010000000000005 108.588 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.554 ' HB3' ' HZ2' ' A' ' 129' ' ' TRP . 49.0 tttm . . . . . 0 C--O 1.243 0.747 0 CA-C-N 114.881 -1.054 . . . . 75.439999999999998 109.453 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 N--CA 1.488 1.173 0 CA-C-O 121.059 0.358 . . . . 74.450000000000003 111.786 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -82.36 27.01 0.52 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.415 1.086 . . . . 72.230000000000004 111.182 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 28.3 tp -86.09 116.24 24.18 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.391 0.676 . . . . 72.120000000000005 109.702 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 3.6 m-85 -104.62 177.18 4.92 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.816 1.646 . . . . 73.450000000000003 109.202 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.8 p -140.82 142.85 29.59 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 108.277 -1.008 . . . . 74.219999999999999 108.277 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.99 116.62 16.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.997 0.519 . . . . 74.239999999999995 109.825 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.52 -24.11 50.08 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.859 0.864 . . . . 73.450000000000003 110.689 172.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -130.83 158.75 39.33 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.983 0.513 . . . . 71.209999999999994 110.17 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.02 151.64 37.11 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.911 -0.586 . . . . 72.209999999999994 109.459 172.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.515 ' HB3' HG12 ' A' ' 101' ' ' ILE . 81.1 t80 -155.8 116.58 3.82 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.298 -0.63 . . . . 74.230000000000004 109.298 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.56 138.78 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 108.988 -0.745 . . . . 73.239999999999995 108.988 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.53 129.51 37.36 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 122.178 -0.326 . . . . 63.020000000000003 110.862 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 m -66.07 -23.95 66.62 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.385 0.674 . . . . 75.319999999999993 110.607 173.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.96 -153.33 12.93 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.42 -0.809 . . . . 73.549999999999997 111.261 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.6 -26.14 60.66 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.219 0.608 . . . . 74.510000000000005 110.58 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -69.73 -21.68 63.44 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.756 0.822 . . . . 71.450000000000003 112.014 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.0 p -117.02 155.0 29.94 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.407 1.083 . . . . 72.040000000000006 109.036 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.2 tp -108.93 123.93 49.86 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.242 -0.651 . . . . 74.310000000000002 109.242 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 p -69.46 115.38 8.66 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.653 -0.869 . . . . 75.25 108.653 171.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.515 HG12 ' HB3' ' A' ' 91' ' ' PHE . 34.5 pt -119.59 143.68 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.271 -0.64 . . . . 74.510000000000005 109.271 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 m -112.38 144.73 41.33 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.977 -0.749 . . . . 72.140000000000001 108.977 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -56.07 119.65 6.23 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.668 0.387 . . . . 74.409999999999997 110.148 173.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.13 -17.29 44.63 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.301 -0.409 . . . . 73.209999999999994 113.219 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -78.8 129.51 34.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.143 0.577 . . . . 71.530000000000001 110.226 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.413 ' HD2' HD23 ' A' ' 84' ' ' LEU . 48.0 mtmt -87.48 130.14 34.81 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.024 0.529 . . . . 71.319999999999993 110.566 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.465 ' HB3' ' HB1' ' A' ' 121' ' ' ALA . 18.8 mt -107.3 148.1 29.43 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.232 1.013 . . . . 74.409999999999997 108.937 -172.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -111.04 107.92 17.47 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.386 -0.968 . . . . 73.549999999999997 108.386 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.2 t -99.78 123.44 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.243 0.617 . . . . 65.319999999999993 110.078 -171.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.5 mt -94.86 -4.45 47.0 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.506 0.722 . . . . 74.230000000000004 111.457 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.48 165.33 18.11 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 112.5 -0.24 . . . . 63.009999999999998 112.5 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 2.4 m-85 -97.06 174.53 6.71 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.665 0.786 . . . . 63.329999999999998 109.993 172.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -72.5 150.33 43.34 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.131 -0.94 . . . . 73.120000000000005 108.687 171.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -63.0 -27.17 69.24 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.237 0.458 . . . . 74.439999999999998 112.237 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.416 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 64.0 t30 -92.22 -10.96 36.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.041 0.536 . . . . 73.230000000000004 110.689 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 81.61 22.32 60.3 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 116.199 -0.455 . . . . 73.019999999999996 113.419 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' A' ' 115' ' ' ASN . 78.8 mt-10 -67.42 -62.38 1.45 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.836 0.854 . . . . 73.409999999999997 110.332 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -120.17 -179.12 3.84 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.928 -1.033 . . . . 70.209999999999994 109.781 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -144.36 123.45 12.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.574 0.75 . . . . 61.43 109.703 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -70.94 95.04 1.12 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.499 0.72 . . . . 74.299999999999997 110.693 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 107' ' ' LEU . . . -105.45 145.21 31.16 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.444 0.698 . . . . 70.299999999999997 110.263 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.9 130.77 45.58 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.397 0.679 . . . . 65.030000000000001 110.195 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.9 p -133.93 -173.49 3.27 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.12 0.968 . . . . 73.439999999999998 109.643 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -61.94 -21.53 64.85 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.21 0.604 . . . . 70.299999999999997 111.339 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -76.07 -5.86 48.47 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.158 0.983 . . . . 73.040000000000006 111.836 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 116.41 -135.65 12.23 Favored Glycine 0 C--N 1.342 0.903 0 N-CA-C 110.316 -1.114 . . . . 61.200000000000003 110.316 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -151.13 156.63 41.39 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.541 0.67 . . . . 73.349999999999994 111.493 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 174.32 176.47 42.73 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.726 -0.67 . . . . 54.329999999999998 112.727 170.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.554 ' HZ2' ' HB3' ' A' ' 24' ' ' LYS . 86.9 m95 -84.54 118.7 24.49 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.495 -0.853 . . . . 74.549999999999997 110.037 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.91 153.93 47.01 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.742 1.217 . . . . 73.319999999999993 109.265 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -69.93 131.14 20.39 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 121.529 1.486 . . . . 73.430000000000007 111.059 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 27.4 p -59.63 -25.48 64.71 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.832 0.853 . . . . 75.120000000000005 111.828 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -74.91 -17.81 60.51 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.544 1.138 . . . . 74.340000000000003 112.094 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -95.34 -4.68 44.98 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.694 0.798 . . . . 65.430000000000007 112.386 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.7 pt -128.33 156.93 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.51 0.324 . . . . 72.109999999999999 110.721 -170.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.3 t -148.81 134.28 9.54 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 122.792 0.437 . . . . 62.509999999999998 109.957 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 74.3 Cg_endo -75.59 123.1 7.32 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.457 2.105 . . . . 64.209999999999994 112.918 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.9 m -98.3 -40.38 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.283 0.633 . . . . 73.400000000000006 111.825 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.0 t30 -99.01 5.39 47.15 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.104 0.562 . . . . 75.299999999999997 111.832 -172.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.8 p -83.9 -166.29 1.37 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.981 0.513 . . . . 65.5 110.655 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 214' ' ' LEU . 71.7 mt -77.38 -12.16 59.92 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.804 0.841 . . . . 75.010000000000005 111.998 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.21 -21.12 66.45 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.497 0.719 . . . . 64.25 111.56 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.461 ' HB2' ' HZ2' ' A' ' 143' ' ' LYS . 0.1 OUTLIER -57.68 -29.4 64.62 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.994 0.918 . . . . 71.409999999999997 110.604 174.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -79.57 137.71 37.24 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.66 0.784 . . . . 73.310000000000002 109.633 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.0 m -63.39 -17.96 63.19 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.59 0.756 . . . . 71.430000000000007 112.778 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -77.42 -35.55 54.04 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.324 0.49 . . . . 64.129999999999995 112.324 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -97.64 130.1 44.68 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.531 -0.544 . . . . 71.340000000000003 109.531 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -122.64 19.92 10.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.789 0.436 . . . . 75.040000000000006 111.574 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.5 -155.32 49.94 Favored Glycine 0 CA--C 1.536 1.366 0 N-CA-C 114.839 0.696 . . . . 72.349999999999994 114.839 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.26 99.06 1.24 Allowed 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 123.587 2.858 . . . . 73.430000000000007 112.049 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.5 t -142.7 145.92 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.188 0.995 . . . . 71.5 109.298 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.9 m -82.64 169.28 16.43 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.843 0.683 . . . . 72.010000000000005 112.843 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -53.71 -37.99 63.84 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 124.014 0.926 . . . . 72.299999999999997 112.488 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -56.04 -50.17 71.67 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.858 0.463 . . . . 73.219999999999999 111.746 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.89 -30.23 40.09 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 123.478 0.711 . . . . 64.329999999999998 110.465 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.703 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -59.57 -48.22 82.5 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.915 -0.584 . . . . 75.049999999999997 111.212 172.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.508 ' HG3' HG13 ' A' ' 190' ' ' VAL . 28.5 tt0 -78.85 -25.95 44.04 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.618 0.767 . . . . 73.230000000000004 109.574 -176.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.71 -52.78 63.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.665 0.786 . . . . 73.030000000000001 111.645 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.435 ' HB2' HD11 ' A' ' 169' ' ' LEU . 48.5 mt -72.22 -34.57 68.44 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 120.728 0.299 . . . . 75.510000000000005 111.042 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.427 HD21 ' HB3' ' A' ' 183' ' ' SER . 33.2 tp -66.72 -26.72 67.14 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.145 0.578 . . . . 73.329999999999998 111.898 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.3 t -64.28 -17.53 63.72 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.855 0.862 . . . . 75.420000000000002 111.715 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.0 m -89.26 -6.51 56.75 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.72 0.808 . . . . 73.109999999999999 111.565 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -97.62 161.11 21.18 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 114.616 0.606 . . . . 73.319999999999993 114.616 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.7 pt -102.59 -164.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.904 0.882 . . . . 74.049999999999997 110.221 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.844 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 13.3 p-10 -51.34 118.56 3.36 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.766 0.827 . . . . 74.319999999999993 113.124 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.59 14.37 68.2 Favored Glycine 0 C--O 1.256 1.499 0 CA-C-N 115.574 -0.739 . . . . 65.030000000000001 113.227 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.6 t -69.49 134.04 48.42 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.075 -0.713 . . . . 73.519999999999996 109.075 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 183' ' ' SER . 20.1 p90 -139.97 154.13 47.09 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.879 0.696 . . . . 72.439999999999998 112.879 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 159' ' ' LEU . 97.8 mt -133.08 133.73 43.36 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.708 -0.849 . . . . 75.310000000000002 108.708 169.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.415 HG22 HG12 ' A' ' 182' ' ' ILE . 22.7 t -106.55 118.0 53.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 107.363 -1.347 . . . . 71.209999999999994 107.363 174.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.703 HH11 ' HA ' ' A' ' 156' ' ' ALA . 28.9 mtt180 -147.42 152.03 37.44 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.198 0.999 . . . . 74.239999999999995 109.527 -174.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 16.1 pt-20 -106.76 162.6 13.64 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.8 -0.815 . . . . 72.450000000000003 108.8 172.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.5 t -77.27 134.54 38.53 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.657 0.383 . . . . 72.409999999999997 110.262 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -60.76 -43.78 97.56 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.404 0.682 . . . . 74.019999999999996 109.962 175.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 62.5 p -90.6 5.73 46.69 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.67 -1.15 . . . . 73.25 112.188 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.0 m -150.69 87.96 4.68 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.443 0.697 . . . . 73.129999999999995 109.333 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.439 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 27.1 Cg_endo -60.84 138.98 82.75 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.827 2.351 . . . . 61.140000000000001 111.89 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.83 -23.07 11.19 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 116.066 -0.516 . . . . 70.129999999999995 113.652 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -83.52 113.76 21.02 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.141 -0.689 . . . . 63.109999999999999 109.141 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.676 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 67.6 mtt-85 -114.77 170.71 8.13 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.088 -0.505 . . . . 75.439999999999998 110.124 -170.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.474 ' HB2' ' HD3' ' A' ' 194' ' ' ARG . 33.0 t -161.02 148.56 15.48 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.397 0.679 . . . . 60.340000000000003 110.048 -177.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.415 HG12 HG22 ' A' ' 170' ' ' VAL . 55.3 mt -112.78 141.06 29.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 107.955 -1.128 . . . . 71.049999999999997 107.955 166.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 20.0 m -118.12 112.29 19.99 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 124.287 1.035 . . . . 74.209999999999994 108.849 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.449 HD22 HD21 ' A' ' 232' ' ' LEU . 38.2 mt -104.78 142.25 35.04 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.486 0.585 . . . . 75.299999999999997 112.424 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -129.99 125.65 35.87 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 114.565 -1.198 . . . . 74.409999999999997 108.182 168.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.844 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 6.3 p90 -140.65 134.97 31.2 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 109.162 -0.681 . . . . 74.530000000000001 109.162 174.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 58.15 22.95 9.64 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.664 1.186 . . . . 73.400000000000006 112.48 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 84.07 7.99 84.56 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.203 -0.453 . . . . 45.200000000000003 113.654 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -102.49 124.99 49.04 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.422 0.689 . . . . 75.129999999999995 109.543 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.508 HG13 ' HG3' ' A' ' 157' ' ' GLU . 98.1 t -104.96 134.77 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.236 1.014 . . . . 71.329999999999998 110.478 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.552 ' HH ' HG21 ' A' ' 230' ' ' THR . 32.4 p90 -147.0 151.84 37.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.34 1.056 . . . . 63.219999999999999 108.811 168.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -121.47 150.94 40.83 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.588 -0.893 . . . . 72.200000000000003 108.588 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -146.19 139.62 26.01 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.631 0.373 . . . . 74.219999999999999 110.464 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.474 ' HD3' ' HB2' ' A' ' 181' ' ' SER . 32.5 mmt180 -82.76 140.6 32.92 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.75 0.786 . . . . 74.109999999999999 112.913 -172.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.676 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 84.9 mt -93.04 111.2 24.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-N 114.284 -1.325 . . . . 73.129999999999995 107.539 165.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -87.98 133.35 33.96 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 109.395 -0.594 . . . . 74.120000000000005 109.395 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.7 m -94.19 116.46 28.87 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.265 0.626 . . . . 72.0 109.717 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.51 160.36 27.78 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.433 0.693 . . . . 75.140000000000001 110.997 171.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.3 t -66.4 -10.16 40.96 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.796 0.839 . . . . 74.129999999999995 111.957 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -90.61 5.19 48.98 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.79 0.836 . . . . 64.230000000000004 111.8 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 81.08 -3.5 76.26 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 122.796 0.236 . . . . 72.030000000000001 113.097 -175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -83.5 135.19 34.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.692 0.797 . . . . 74.540000000000006 110.136 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.9 mt -92.97 157.32 16.39 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.508 0.723 . . . . 73.530000000000001 110.052 -177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -164.4 156.95 16.92 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.161 0.505 . . . . 64.140000000000001 111.29 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.3 t -117.04 -67.03 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 106.904 -1.517 . . . . 74.329999999999998 106.904 170.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.8 m -68.44 140.81 55.77 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.07 0.948 . . . . 73.140000000000001 110.257 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 54.7 p -62.86 -31.49 72.53 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.329 0.652 . . . . 75.120000000000005 111.666 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -88.08 3.31 49.46 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.513 0.725 . . . . 74.439999999999998 112.084 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.5 m -123.1 144.12 49.52 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.762 0.425 . . . . 61.450000000000003 111.453 -174.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 81.0 mmt-85 -143.03 135.43 27.39 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 107.609 -1.256 . . . . 74.310000000000002 107.609 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -131.33 135.73 47.51 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.708 -1.219 . . . . 75.219999999999999 107.708 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -75.07 -35.91 61.81 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 122.551 0.34 . . . . 72.319999999999993 110.122 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 77.4 p -124.26 150.51 45.26 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.479 0.712 . . . . 72.019999999999996 111.848 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.413 ' HB3' HD11 ' A' ' 141' ' ' LEU . 33.2 tp -69.64 -28.15 65.66 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.974 -1.012 . . . . 73.109999999999999 110.523 174.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.87 -44.58 91.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.042 0.537 . . . . 73.420000000000002 110.486 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -77.56 -29.32 52.13 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.815 -0.63 . . . . 74.129999999999995 112.273 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.3 tt -61.27 -46.34 90.74 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 118.363 0.529 . . . . 74.319999999999993 109.898 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 67.0 t -74.1 -42.09 51.99 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 C-N-CA 123.891 0.876 . . . . 64.200000000000003 111.129 -176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -58.77 -52.4 65.86 Favored 'General case' 0 C--O 1.262 1.74 0 CA-C-O 121.289 0.566 . . . . 72.439999999999998 111.223 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.436 ' O ' HG23 ' A' ' 224' ' ' VAL . 37.9 t-80 -54.67 -56.99 13.33 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 114.646 -1.161 . . . . 55.299999999999997 108.377 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.41 ' HA ' HG23 ' A' ' 224' ' ' VAL . 10.4 m170 -68.05 -14.65 63.14 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.17 0.804 . . . . 70.040000000000006 113.17 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.472 ' HA ' ' HB2' ' A' ' 232' ' ' LEU . 42.0 t -73.77 -34.65 64.77 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 110.169 -0.308 . . . . 71.310000000000002 110.169 171.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.9 t -108.5 -13.42 14.84 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 116.144 1.905 . . . . 72.329999999999998 116.144 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.467 ' O ' HG21 ' A' ' 231' ' ' THR . 34.1 m -103.63 165.84 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 116.316 1.969 . . . . 75.0 116.316 -165.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.85 -1.71 58.05 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.829 3.252 . . . . 62.140000000000001 113.854 -172.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -78.67 14.36 1.34 Allowed 'General case' 0 CA--C 1.576 1.955 0 C-N-CA 130.322 3.449 . . . . 65.219999999999999 113.519 -138.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.11 17.61 4.46 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 110.856 -0.897 . . . . 71.109999999999999 110.856 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 92.8 mt -92.36 124.03 36.12 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.828 1.251 . . . . 75.530000000000001 110.34 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.459 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 89.5 mt -61.73 -40.78 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 109.303 -0.628 . . . . 73.209999999999994 109.303 172.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.552 HG21 ' HH ' ' A' ' 191' ' ' TYR . 9.5 t -138.19 142.61 40.02 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.275 -0.875 . . . . 75.329999999999998 109.392 166.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 224' ' ' VAL . 82.3 p -66.65 149.59 50.28 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.989 -0.55 . . . . 74.209999999999994 109.547 169.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 222' ' ' SER . 40.9 mt -65.48 103.32 0.82 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.001 0.521 . . . . 74.420000000000002 109.956 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -75.62 -59.42 2.76 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.518 0.727 . . . . 74.129999999999995 109.809 -176.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -156.44 150.67 19.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 CA-C-O 119.326 -0.368 . . . . 73.349999999999994 110.212 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 31.2 Cg_endo -62.81 137.3 62.31 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.116 1.877 . . . . 63.520000000000003 111.855 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -59.59 135.74 89.29 Favored Pre-proline 0 C--O 1.243 0.747 0 C-N-CA 123.333 0.653 . . . . 63.530000000000001 111.045 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.01 117.21 3.88 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.387 2.058 . . . . 73.310000000000002 112.617 -174.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt . . . . . 0 CA--C 1.547 0.837 0 CA-C-N 114.542 -1.208 . . . . 73.420000000000002 109.843 170.308 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 121.073 0.463 . . . . 73.140000000000001 111.355 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.9 mt -104.79 128.46 26.75 Favored Pre-proline 0 C--O 1.241 0.644 0 N-CA-C 109.205 -0.665 . . . . 63.439999999999998 109.205 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -66.32 165.95 22.99 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.566 2.177 . . . . 63.020000000000003 111.865 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.98 146.71 31.9 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 120.809 0.337 . . . . 74.439999999999998 110.53 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.531 ' HB3' HD13 ' A' ' 23' ' ' ILE . 75.6 mt -87.02 93.17 9.28 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.524 -0.917 . . . . 75.299999999999997 108.524 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -95.26 -45.24 7.24 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.942 -1.026 . . . . 71.450000000000003 109.389 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -105.85 115.36 30.1 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.144 -0.935 . . . . 72.0 110.084 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' A' ' 20' ' ' LEU . 45.9 mm -116.47 113.84 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.298 -1.001 . . . . 75.040000000000006 108.298 175.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt . . . . . 0 N--CA 1.472 0.667 0 C-N-CA 123.81 0.844 . . . . 74.209999999999994 109.185 175.528 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.473 ' HG3' ' NH1' ' A' ' 108' ' ' ARG . 74.2 Cg_endo . . . . . 0 N--CA 1.502 1.979 0 N-CA-C 111.587 -0.197 . . . . 73.540000000000006 111.587 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 140' ' ' SER . 48.8 m-80 -66.14 85.99 0.1 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.898 0.856 . . . . 62.240000000000002 108.751 167.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 30.2 tp -87.4 122.91 31.77 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.306 -1.315 . . . . 74.239999999999995 109.865 -173.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -107.22 174.7 5.77 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.556 1.142 . . . . 74.439999999999998 109.225 174.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.24 142.55 19.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 108.464 -0.939 . . . . 72.540000000000006 108.464 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.43 ' HB2' HD12 ' A' ' 107' ' ' LEU . . . -78.39 123.28 26.83 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.513 0.508 . . . . 71.319999999999993 110.398 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.08 -22.92 41.7 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.34 0.656 . . . . 75.010000000000005 110.499 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.492 ' CD1' ' HA ' ' A' ' 134' ' ' TYR . 22.0 m-85 -127.15 162.0 27.15 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.939 0.896 . . . . 74.409999999999997 109.012 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.11 150.39 25.58 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.054 -1.091 . . . . 74.219999999999999 108.054 166.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -156.26 108.58 2.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.83 -1.174 . . . . 74.420000000000002 107.83 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 p -80.44 135.77 24.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.779 -0.823 . . . . 74.010000000000005 108.779 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.83 123.27 16.49 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.169 0.588 . . . . 73.099999999999994 110.687 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.2 t -84.39 8.26 16.82 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.554 0.742 . . . . 72.310000000000002 110.778 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.51 -171.64 44.14 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.789 -0.524 . . . . 74.530000000000001 111.789 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.5 -27.59 62.36 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.683 0.793 . . . . 73.530000000000001 110.682 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -74.84 -24.3 58.58 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.794 0.838 . . . . 74.120000000000005 112.74 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.9 p -102.03 157.58 16.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.603 0.761 . . . . 60.0 110.731 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.8 tp -110.0 131.83 54.71 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.516 0.727 . . . . 70.319999999999993 110.319 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.0 m -71.28 118.69 14.4 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.08 -0.711 . . . . 75.049999999999997 109.08 168.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.7 pt -124.03 147.18 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.566 0.746 . . . . 72.329999999999998 109.016 173.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.3 m -115.46 145.02 42.98 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.67 -0.493 . . . . 74.340000000000003 109.67 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -55.25 114.8 1.94 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.747 0.819 . . . . 75.319999999999993 110.856 174.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.78 -16.16 37.0 Favored Glycine 0 C--N 1.35 1.361 0 O-C-N 123.167 0.292 . . . . 73.400000000000006 112.763 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -78.38 137.24 37.92 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 124.153 0.981 . . . . 74.010000000000005 110.973 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.549 ' HD2' HD21 ' A' ' 84' ' ' LEU . 29.8 mtmt -77.44 134.72 38.31 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 124.044 0.84 . . . . 73.420000000000002 109.777 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 87' ' ' ALA . 19.0 mt -120.3 135.87 54.87 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.38 0.672 . . . . 73.129999999999995 109.255 -173.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.473 ' NH1' ' HG3' ' A' ' 82' ' ' PRO . 50.9 mtp85 -93.56 108.14 19.89 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.718 -0.845 . . . . 74.209999999999994 108.718 167.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.451 HG23 HD13 ' A' ' 135' ' ' ILE . 95.6 t -95.27 108.94 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.565 -0.902 . . . . 71.239999999999995 108.565 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.86 -28.97 64.97 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.025 0.93 . . . . 74.200000000000003 110.224 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.85 173.12 37.05 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-N 114.648 -1.16 . . . . 74.129999999999995 111.013 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 51.3 m-85 -96.8 175.02 6.51 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.648 -0.871 . . . . 71.109999999999999 108.648 176.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.43 ' HB3' ' H ' ' A' ' 117' ' ' GLU . 49.8 t-20 -63.4 144.39 57.01 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.69 -1.226 . . . . 72.340000000000003 107.69 173.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -54.37 -32.65 57.47 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.688 0.795 . . . . 72.230000000000004 110.905 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.53 -19.83 28.89 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.441 1.097 . . . . 74.299999999999997 111.797 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.07 34.46 7.18 Favored Glycine 0 N--CA 1.477 1.418 0 C-N-CA 123.121 0.391 . . . . 63.32 113.854 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.43 ' H ' ' HB3' ' A' ' 113' ' ' ASN . 28.5 mt-10 -99.4 -65.86 0.94 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.466 0.706 . . . . 64.349999999999994 111.043 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -103.01 -176.77 3.18 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.668 1.187 . . . . 73.219999999999999 110.207 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -143.66 117.16 9.14 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.563 0.745 . . . . 74.049999999999997 110.032 -177.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -73.81 97.96 2.85 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.615 -0.513 . . . . 65.439999999999998 109.615 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.78 168.14 9.33 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.145 -0.934 . . . . 74.030000000000001 110.718 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -147.48 127.81 13.94 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 108.57 -0.9 . . . . 75.430000000000007 108.57 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.6 p -139.71 -172.57 3.41 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.025 0.93 . . . . 75.519999999999996 109.785 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -63.02 -20.68 65.55 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.509 -0.768 . . . . 74.329999999999998 111.307 171.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -81.72 -4.11 55.43 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.056 0.943 . . . . 75.040000000000006 111.269 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 125.47 -135.07 9.07 Favored Glycine 0 C--N 1.355 1.589 0 N-CA-C 112.354 -0.298 . . . . 72.120000000000005 112.354 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -150.65 133.88 16.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.997 0.919 . . . . 74.340000000000003 109.155 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 176.18 -177.91 47.68 Favored Glycine 0 C--N 1.348 1.25 0 O-C-N 123.214 0.321 . . . . 43.25 112.867 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -88.37 126.53 35.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.374 1.07 . . . . 75.430000000000007 111.149 -174.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.05 154.7 55.79 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.914 1.286 . . . . 72.299999999999997 109.138 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.95 132.82 23.81 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 121.744 1.63 . . . . 71.430000000000007 110.398 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.3 m -63.8 -19.33 64.93 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.571 0.748 . . . . 74.340000000000003 112.108 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -72.22 -22.05 61.31 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.977 0.911 . . . . 75.409999999999997 111.302 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.492 ' HA ' ' CD1' ' A' ' 89' ' ' TYR . 2.5 m-85 -90.61 -7.4 52.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.763 0.825 . . . . 72.5 113.024 -175.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.451 HD13 HG23 ' A' ' 109' ' ' VAL . 16.1 pt -121.57 157.35 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 122.808 0.443 . . . . 74.530000000000001 110.409 -171.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.5 t -147.35 141.55 15.94 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 122.917 0.487 . . . . 55.340000000000003 110.248 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.81 147.15 43.93 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.632 2.221 . . . . 74.140000000000001 112.111 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 m -130.94 -59.96 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.55 0.74 . . . . 73.430000000000007 110.666 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.608 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.1 t30 -103.06 16.08 27.6 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 122.945 0.498 . . . . 74.25 111.06 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 41.3 m -60.62 170.78 1.31 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.028 0.531 . . . . 72.140000000000001 111.034 172.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 69.7 mt -55.65 -16.09 3.76 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.921 1.082 . . . . 74.299999999999997 113.921 -173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.533 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 31.4 tt0 -65.97 -6.29 12.15 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.536 1.134 . . . . 73.219999999999999 111.478 175.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -56.53 -31.11 63.83 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.271 1.428 . . . . 74.010000000000005 110.496 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -100.29 141.77 32.68 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.566 -0.743 . . . . 72.5 109.262 173.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.3 p -70.42 -5.81 31.14 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.242 0.83 . . . . 74.439999999999998 113.242 -170.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 42.5 p-90 -77.94 -33.64 51.55 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 111.806 0.299 . . . . 72.319999999999993 111.806 174.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -99.27 139.25 35.19 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.281 -0.637 . . . . 74.530000000000001 109.281 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.533 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 25.1 m-70 -134.12 38.51 3.15 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.894 0.478 . . . . 72.200000000000003 110.372 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 68.59 -171.16 38.04 Favored Glycine 0 CA--C 1.542 1.732 0 N-CA-C 116.305 1.282 . . . . 75.140000000000001 116.305 165.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.11 100.65 0.88 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.635 2.89 . . . . 73.200000000000003 111.553 171.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.493 ' HB ' ' HD2' ' A' ' 171' ' ' ARG . 78.0 t -142.66 148.47 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.772 0.829 . . . . 75.010000000000005 109.352 -174.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.5 m -70.83 151.34 44.89 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 123.93 0.892 . . . . 74.140000000000001 111.288 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -20.59 55.26 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.228 -0.896 . . . . 74.129999999999995 112.186 176.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.83 -59.13 5.6 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.303 1.041 . . . . 75.140000000000001 109.822 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.12 -31.72 69.39 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.842 0.857 . . . . 71.239999999999995 110.81 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.498 ' HA ' HH21 ' A' ' 171' ' ' ARG . . . -57.25 -54.06 51.08 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.43 -0.804 . . . . 72.349999999999994 110.738 171.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -73.1 -23.34 60.51 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.862 -0.608 . . . . 72.549999999999997 110.762 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -63.58 -49.37 73.66 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.743 0.817 . . . . 72.310000000000002 110.398 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.483 HD11 ' NH2' ' A' ' 171' ' ' ARG . 67.3 mt -71.32 -37.52 71.76 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.058 0.456 . . . . 74.510000000000005 110.79 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.402 HD23 HG12 ' A' ' 190' ' ' VAL . 29.1 tp -73.98 -17.27 61.02 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.854 -0.612 . . . . 73.340000000000003 112.269 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 38.9 t -68.86 -19.84 64.26 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.371 0.669 . . . . 71.230000000000004 110.651 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.9 t -99.82 6.82 45.34 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.472 0.709 . . . . 74.430000000000007 110.6 174.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.15 163.27 43.11 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 116.089 -0.505 . . . . 62.229999999999997 113.068 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.2 pt -126.35 -166.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.442 1.497 . . . . 74.430000000000007 110.396 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.677 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 24.7 p-10 -58.78 110.12 0.95 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.63 0.604 . . . . 73.129999999999995 112.63 -169.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 91.91 13.37 57.92 Favored Glycine 0 C--O 1.256 1.477 0 CA-C-N 115.91 -0.587 . . . . 53.32 113.168 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 67.4 m -77.69 131.35 37.67 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.023 -0.362 . . . . 74.150000000000006 110.023 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.453 ' HB3' HD21 ' A' ' 184' ' ' LEU . 16.2 p90 -133.13 154.88 50.18 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.834 0.679 . . . . 64.209999999999994 112.834 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.6 mt -135.46 133.82 38.94 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.931 -1.032 . . . . 74.230000000000004 108.459 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.74 118.07 54.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 107.838 -1.171 . . . . 73.439999999999998 107.838 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.498 HH21 ' HA ' ' A' ' 156' ' ' ALA . 18.7 mmt180 -118.62 167.58 11.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.059 0.944 . . . . 70.120000000000005 108.798 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.561 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 15.7 pt-20 -117.89 160.76 20.87 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 109.575 -0.528 . . . . 74.319999999999993 109.575 158.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 59.3 m -87.33 135.24 33.4 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.749 -0.66 . . . . 62.240000000000002 110.326 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -74.44 -36.42 63.38 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.007 0.923 . . . . 74.239999999999995 110.872 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 26.5 t -89.37 -16.26 31.41 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.551 0.741 . . . . 61.340000000000003 111.031 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 32.7 t -127.19 85.25 61.43 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 108.387 -0.968 . . . . 72.430000000000007 108.387 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.464 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 51.6 Cg_endo -65.64 140.38 62.09 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.161 2.574 . . . . 72.019999999999996 112.289 -176.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.6 -25.37 5.16 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 115.771 -0.649 . . . . 74.150000000000006 113.102 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -79.95 119.11 22.35 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 108.741 -0.837 . . . . 73.310000000000002 108.741 173.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.561 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 47.9 mtt85 -114.21 165.46 12.65 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 115.019 -0.991 . . . . 75.209999999999994 109.167 -176.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.3 m -146.71 139.01 24.87 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.495 -0.557 . . . . 72.150000000000006 109.495 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 47.4 mt -103.84 140.99 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.1 -1.074 . . . . 73.540000000000006 108.1 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 18.1 m -121.21 111.86 17.92 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.103 -0.953 . . . . 74.400000000000006 108.505 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 168' ' ' PHE . 33.9 mt -103.79 143.91 32.19 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.17 0.988 . . . . 53.509999999999998 111.212 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 48.3 ttt180 -131.71 133.6 45.01 Favored 'General case' 0 C--O 1.257 1.496 0 CA-C-N 114.825 -1.08 . . . . 75.239999999999995 108.536 168.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.677 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 24.3 p90 -143.73 133.52 23.85 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.862 -1.063 . . . . 74.420000000000002 108.21 173.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 47.64 37.47 6.81 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.674 1.19 . . . . 64.409999999999997 113.817 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 92.18 -5.41 78.3 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.621 -0.718 . . . . 55.020000000000003 113.779 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 40.8 ttm180 -102.93 123.99 47.59 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.1 0.56 . . . . 73.209999999999994 109.738 -175.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.402 HG12 HD23 ' A' ' 160' ' ' LEU . 84.7 t -106.27 137.55 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.238 1.015 . . . . 71.219999999999999 109.547 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.675 ' HH ' HG22 ' A' ' 230' ' ' THR . 24.3 p90 -145.73 151.33 37.82 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.751 0.821 . . . . 72.200000000000003 109.572 169.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -128.38 134.13 48.77 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.544 -1.28 . . . . 75.409999999999997 107.544 -173.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -136.8 139.36 41.72 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.242 0.544 . . . . 70.219999999999999 110.436 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.537 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 22.2 tpp180 -81.76 122.46 27.7 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.588 -1.187 . . . . 74.230000000000004 111.58 -171.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.434 ' HA ' HG22 ' A' ' 205' ' ' VAL . 73.4 mt -72.69 115.56 13.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 108.308 -0.997 . . . . 75.109999999999999 108.308 162.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -93.46 132.47 37.7 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 109.016 -0.735 . . . . 75.230000000000004 109.016 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.7 m -95.6 116.45 28.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.407 -0.815 . . . . 73.049999999999997 108.909 172.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.35 161.27 22.82 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.138 0.975 . . . . 73.5 111.693 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.3 t -70.06 -10.76 59.77 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.654 0.782 . . . . 71.400000000000006 110.803 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -71.77 -17.12 62.2 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.463 1.105 . . . . 70.340000000000003 111.206 172.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 88.25 2.28 80.41 Favored Glycine 0 C--N 1.355 1.62 0 C-N-CA 123.169 0.414 . . . . 63.340000000000003 112.081 -171.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -90.47 145.33 24.99 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.913 0.885 . . . . 74.400000000000006 110.773 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 86.8 mt -94.23 149.2 21.46 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 123.195 0.598 . . . . 74.299999999999997 109.621 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -162.43 166.94 24.37 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.668 0.605 . . . . 74.230000000000004 111.182 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 195' ' ' ILE . 92.8 t -140.88 -62.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.301 1.041 . . . . 72.329999999999998 108.632 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 12.7 m -98.79 -169.96 1.86 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.628 1.171 . . . . 74.329999999999998 111.196 -172.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.8 m -69.99 -47.68 61.22 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.532 0.733 . . . . 73.510000000000005 112.859 -169.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -84.36 -16.77 41.68 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.455 0.702 . . . . 75.439999999999998 109.257 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 71.6 m -64.41 106.59 1.16 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.32 0.648 . . . . 75.310000000000002 111.376 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -146.1 117.57 8.0 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.393 1.077 . . . . 75.120000000000005 109.18 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -136.54 152.71 50.8 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.145 0.578 . . . . 75.430000000000007 110.616 -171.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -82.07 -36.28 27.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.197 -0.668 . . . . 75.450000000000003 109.197 168.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 82.8 p -130.73 160.13 35.23 Favored 'General case' 0 C--O 1.252 1.2 0 CA-C-O 122.247 1.022 . . . . 71.5 112.598 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 21.4 tp -74.14 -22.04 59.61 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.15 -1.386 . . . . 72.239999999999995 110.807 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.23 -49.64 76.29 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.44 0.638 . . . . 62.439999999999998 110.41 171.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -62.23 -41.96 98.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.521 -1.218 . . . . 72.120000000000005 110.504 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.9 tt -57.88 -48.92 78.41 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.02 0.825 . . . . 75.310000000000002 111.612 177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.7 t -72.08 -38.47 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.083 0.553 . . . . 75.319999999999993 111.19 -174.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.461 ' HA ' ' HG ' ' A' ' 222' ' ' SER . 42.1 t-80 -65.43 -46.75 78.69 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.128 0.49 . . . . 75.129999999999995 110.938 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.447 ' O ' HG21 ' A' ' 224' ' ' VAL . 40.6 t-80 -56.07 -52.35 64.58 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.672 -0.695 . . . . 74.540000000000006 109.322 176.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.514 ' HD1' HD23 ' A' ' 228' ' ' LEU . 18.1 m-70 -70.19 -19.15 63.19 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.531 -0.759 . . . . 74.030000000000001 112.535 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.461 ' HG ' ' HA ' ' A' ' 219' ' ' HIS . 78.2 p -81.29 -20.2 41.36 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.127 0.421 . . . . 73.120000000000005 110.715 172.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 7.0 t -111.53 -12.99 13.9 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.251 1.945 . . . . 75.0 116.251 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 220' ' ' HIS . 30.3 m -105.59 158.34 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 121.145 1.793 . . . . 74.219999999999999 115.733 -167.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -90.7 0.61 57.35 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.855 2.862 . . . . 74.129999999999995 113.523 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -81.16 15.03 2.06 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 128.191 2.596 . . . . 64.510000000000005 113.157 -139.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.02 19.88 3.87 Favored Glycine 0 N--CA 1.464 0.563 0 N-CA-C 110.35 -1.1 . . . . 71.439999999999998 110.35 -170.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.514 HD23 ' HD1' ' A' ' 221' ' ' HIS . 95.7 mt -93.59 128.4 39.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.626 -1.287 . . . . 74.219999999999999 109.102 163.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.401 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 95.3 mt -64.04 -49.0 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.871 -0.788 . . . . 74.310000000000002 108.871 170.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.675 HG22 ' HH ' ' A' ' 191' ' ' TYR . 7.2 t -130.97 147.83 52.65 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.104 -1.072 . . . . 73.329999999999998 108.104 170.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.0 p -75.29 155.75 36.32 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.913 -0.403 . . . . 74.519999999999996 109.913 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 27.5 mt -64.58 103.32 0.66 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.397 -0.964 . . . . 74.239999999999995 108.397 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -88.28 -58.29 2.61 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.047 -0.723 . . . . 74.439999999999998 109.047 -172.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 167' ' ' SER . 14.5 p90 -152.3 149.14 22.29 Favored Pre-proline 0 N--CA 1.484 1.257 0 CA-C-N 116.017 -0.538 . . . . 74.439999999999998 110.272 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 26.8 Cg_exo -63.31 148.88 92.53 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.116 1.877 . . . . 74.340000000000003 112.958 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.72 134.22 78.92 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 108.378 -0.971 . . . . 73.209999999999994 108.378 169.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.07 137.99 59.88 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.417 2.078 . . . . 74.430000000000007 113.379 -171.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 65.3 tttm . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 108.284 -1.006 . . . . 74.319999999999993 108.284 170.149 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.546 0.806 0 CA-C-O 121.563 0.697 . . . . 75.299999999999997 111.297 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.4 mt -106.48 135.16 19.53 Favored Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 115.478 -0.783 . . . . 74.239999999999995 109.946 -173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.72 173.72 13.91 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.602 2.201 . . . . 63.020000000000003 111.874 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.06 148.85 26.6 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.957 0.503 . . . . 74.329999999999998 110.776 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.442 HD22 HD13 ' A' ' 23' ' ' ILE . 79.2 mt -86.3 93.48 9.09 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.79 -0.818 . . . . 72.209999999999994 108.79 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -97.17 -48.83 5.21 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.977 0.511 . . . . 74.209999999999994 110.427 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.459 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 64.1 m-85 -104.16 114.83 29.35 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.313 -0.625 . . . . 65.219999999999999 109.313 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.442 HD13 HD22 ' A' ' 20' ' ' LEU . 47.1 mm -121.77 120.99 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 109.4 -0.593 . . . . 72.209999999999994 109.4 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.432 ' H ' ' HE1' ' A' ' 129' ' ' TRP . 63.8 mttm . . . . . 0 N--CA 1.481 1.084 0 C-N-CA 123.917 0.887 . . . . 73.450000000000003 109.763 172.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 N--CA 1.5 1.888 0 N-CA-C 114.17 0.796 . . . . 63.130000000000003 114.17 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -91.21 17.03 8.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.795 0.838 . . . . 75.299999999999997 111.484 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.91 109.66 18.3 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 108.701 -0.852 . . . . 72.319999999999993 108.701 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 4.4 m-85 -105.69 175.79 5.38 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.49 1.516 . . . . 71.299999999999997 110.421 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.97 148.07 27.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.798 -1.186 . . . . 73.150000000000006 107.798 169.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.52 107.77 14.56 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.754 -0.832 . . . . 63.219999999999999 108.754 170.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.4 mt -62.52 -27.4 69.13 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.058 0.943 . . . . 64.109999999999999 111.198 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -141.17 166.35 25.01 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.699 0.8 . . . . 62.409999999999997 109.728 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.52 147.47 29.65 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.518 -0.764 . . . . 73.219999999999999 109.812 175.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -155.93 118.09 4.07 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.347 1.059 . . . . 75.140000000000001 108.496 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.44 140.73 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.79 -0.819 . . . . 71.200000000000003 108.79 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.92 117.46 3.98 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.073 0.549 . . . . 63.340000000000003 110.526 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 m -59.46 -44.17 93.06 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.313 1.045 . . . . 73.310000000000002 110.386 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -160.26 -147.6 4.97 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 114.712 -1.131 . . . . 62.049999999999997 111.752 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -69.56 -34.87 74.8 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.312 1.045 . . . . 74.140000000000001 111.775 -175.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -84.91 8.69 16.66 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 113.252 0.834 . . . . 74.319999999999993 113.252 -175.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.6 p -127.26 156.84 41.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.299 0.64 . . . . 73.400000000000006 110.552 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.4 tp -109.97 137.13 48.18 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.571 0.749 . . . . 74.109999999999999 109.579 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.4 t -82.86 115.22 21.65 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.369 -0.975 . . . . 74.230000000000004 108.369 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.6 pt -123.48 144.29 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.256 1.022 . . . . 73.329999999999998 109.966 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.2 m -110.73 151.39 27.8 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 109.732 -0.469 . . . . 72.530000000000001 109.732 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -54.82 111.17 0.77 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.353 0.661 . . . . 74.409999999999997 111.682 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.55 -14.69 24.87 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 123.291 0.472 . . . . 55.399999999999999 112.765 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.48 120.91 14.71 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.971 0.908 . . . . 74.129999999999995 109.467 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.631 ' HB2' ' HZ3' ' A' ' 106' ' ' LYS . 8.0 mtmp? -80.87 118.19 22.16 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.665 -0.865 . . . . 73.25 108.665 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 21.7 mt -99.42 160.59 14.17 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.394 -0.965 . . . . 75.430000000000007 108.394 -174.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -121.12 107.3 12.43 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.206 -1.035 . . . . 75.439999999999998 108.206 164.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 74.1 t -94.6 115.18 32.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 108.573 -0.899 . . . . 75.120000000000005 108.573 -176.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.46 -35.34 80.04 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 123.588 0.555 . . . . 74.510000000000005 109.691 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.66 174.57 46.2 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.735 -0.666 . . . . 75.329999999999998 112.209 173.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.537 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 21.5 m-85 -92.91 174.88 7.02 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 108.808 -0.812 . . . . 71.409999999999997 108.808 176.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 22' ' ' PHE . 12.8 m120 -64.07 167.85 5.98 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.945 -0.57 . . . . 74.400000000000006 110.13 164.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -72.31 -4.48 30.02 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 120.707 0.289 . . . . 71.420000000000002 110.324 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -105.21 -19.88 13.68 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.775 0.83 . . . . 74.530000000000001 110.754 170.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.537 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 80.15 12.93 82.71 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-N 116.633 -0.258 . . . . 71.219999999999999 113.603 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.4 ' HG3' ' OD1' ' A' ' 113' ' ' ASN . 9.5 pt-20 -68.4 -54.58 16.26 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.948 1.299 . . . . 72.430000000000007 111.794 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -116.18 173.19 6.72 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.796 0.838 . . . . 72.129999999999995 109.331 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.28 120.66 10.96 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.494 0.717 . . . . 64.530000000000001 110.735 -170.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -75.93 97.14 3.9 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.554 -0.536 . . . . 75.129999999999995 109.554 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -102.14 150.59 23.11 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.507 -0.77 . . . . 75.319999999999993 110.156 -174.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -132.22 122.54 25.39 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 124.047 0.939 . . . . 73.420000000000002 109.105 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 58.3 p -133.88 -176.73 4.27 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.275 1.43 . . . . 72.120000000000005 108.874 171.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -72.67 -3.19 23.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.982 0.513 . . . . 74.409999999999997 111.759 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -89.22 -1.18 57.97 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.786 0.834 . . . . 73.530000000000001 110.785 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.66 -156.23 15.89 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 111.759 -0.537 . . . . 63.420000000000002 111.759 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -144.6 131.53 20.32 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.173 0.589 . . . . 72.129999999999995 110.191 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -179.42 173.48 45.41 Favored Glycine 0 C--N 1.346 1.129 0 O-C-N 123.329 0.393 . . . . 62.539999999999999 112.694 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.432 ' HE1' ' H ' ' A' ' 24' ' ' LYS . 91.0 m95 -76.77 121.24 23.05 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.344 1.058 . . . . 64.319999999999993 111.517 -176.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.19 150.7 44.8 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 124.717 1.207 . . . . 70.319999999999993 108.904 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.51 126.08 14.94 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 121.799 1.666 . . . . 72.239999999999995 109.772 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 m -57.62 -26.79 62.08 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.723 0.809 . . . . 63.310000000000002 111.539 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -63.22 -28.68 70.2 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.657 1.183 . . . . 73.349999999999994 111.879 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -93.67 1.3 56.64 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.97 0.908 . . . . 74.299999999999997 112.774 -175.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 25.2 pt -133.75 164.68 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.347 0.521 . . . . 72.230000000000004 111.022 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.7 t -159.28 140.94 9.69 Favored Pre-proline 0 N--CA 1.484 1.241 0 O-C-N 123.455 0.472 . . . . 64.129999999999995 110.145 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 62.8 Cg_endo -71.68 114.54 3.98 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.269 1.98 . . . . 62.219999999999999 112.172 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.11 -36.04 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.757 0.823 . . . . 63.340000000000003 112.117 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -93.06 16.84 11.91 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.662 0.785 . . . . 72.540000000000006 110.111 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 137' ' ' PRO . 22.5 t -63.23 165.3 7.55 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.742 0.817 . . . . 75.219999999999999 110.808 175.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.4 mt -66.99 -10.24 47.46 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.35 1.06 . . . . 74.340000000000003 111.878 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 29.4 tt0 -66.0 -12.21 53.46 Favored 'General case' 0 C--N 1.369 1.439 0 C-N-CA 123.391 0.676 . . . . 73.109999999999999 111.922 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -61.25 -12.29 12.69 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 123.582 0.753 . . . . 74.109999999999999 110.428 167.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -105.85 150.12 25.89 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.979 1.711 . . . . 64.040000000000006 109.222 167.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.4 p -69.33 -20.49 63.87 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.61 0.967 . . . . 73.25 113.61 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.464 ' CE3' HG23 ' A' ' 218' ' ' VAL . 53.0 p-90 -77.38 -43.38 32.98 Favored 'General case' 0 C--O 1.25 1.108 0 N-CA-C 112.681 0.623 . . . . 73.040000000000006 112.681 -175.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -87.56 146.94 25.55 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.703 -0.48 . . . . 74.040000000000006 109.703 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.588 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 65.3 m-70 -143.21 39.59 1.45 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.12 0.968 . . . . 75.439999999999998 111.352 -174.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.25 -169.05 54.77 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 115.919 1.128 . . . . 73.549999999999997 115.919 163.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 174' ' ' GLU . 8.3 Cg_endo -89.09 95.66 0.34 Allowed 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 124.083 3.188 . . . . 74.409999999999997 111.23 171.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.08 153.04 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.389 1.076 . . . . 75.140000000000001 110.82 -170.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.7 m -75.68 156.87 34.35 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.437 1.095 . . . . 64.510000000000005 112.069 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -62.39 -33.51 74.89 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.769 0.828 . . . . 74.209999999999994 112.162 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -66.75 -45.18 79.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.686 0.795 . . . . 75.540000000000006 110.026 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.23 -31.97 70.89 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.571 0.748 . . . . 73.329999999999998 111.043 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.76 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.39 -51.09 71.29 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.699 -0.682 . . . . 51.009999999999998 110.31 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.47 -31.27 71.9 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.994 0.918 . . . . 74.150000000000006 111.562 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -63.99 -45.75 87.61 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.482 0.713 . . . . 74.430000000000007 111.319 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.445 HD13 HH12 ' A' ' 171' ' ' ARG . 66.5 mt -77.43 -39.08 48.17 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 120.867 0.365 . . . . 74.140000000000001 111.375 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.54 HD23 HG11 ' A' ' 190' ' ' VAL . 34.0 tp -74.85 -20.95 59.53 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.732 -0.667 . . . . 74.530000000000001 112.194 -171.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.1 p -60.21 -28.28 67.85 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.052 0.541 . . . . 71.519999999999996 111.456 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.8 m -75.31 -15.26 60.51 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.039 0.935 . . . . 60.310000000000002 112.353 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.15 165.31 50.54 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 113.785 0.274 . . . . 75.200000000000003 113.785 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.3 pt -113.35 -164.74 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.23 1.012 . . . . 74.299999999999997 109.465 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.73 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 25.3 p-10 -49.32 114.12 0.96 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.909 0.884 . . . . 72.349999999999994 112.375 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.39 14.22 60.45 Favored Glycine 0 C--O 1.258 1.605 0 CA-C-N 116.46 -0.337 . . . . 73.510000000000005 113.498 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 70.4 p -74.85 139.49 43.23 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 108.989 -0.745 . . . . 73.409999999999997 108.989 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.442 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 28.9 p90 -138.32 160.35 39.7 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.215 0.82 . . . . 75.450000000000003 113.215 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.439 HD11 ' NH1' ' A' ' 171' ' ' ARG . 96.4 mt -132.62 132.82 42.89 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.137 -1.431 . . . . 72.340000000000003 107.137 166.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 56.6 t -107.72 115.4 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 106.949 -1.501 . . . . 74.450000000000003 106.949 171.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.76 HH11 ' HA ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -159.1 152.34 22.44 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.204 0.602 . . . . 75.420000000000002 110.236 -175.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.632 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 10.9 pt-20 -107.7 156.55 18.96 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.942 0.401 . . . . 74.299999999999997 111.238 -177.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.9 m -90.71 113.45 25.55 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.065 -0.717 . . . . 64.25 109.065 173.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 33.0 tt0 -70.44 -26.47 63.67 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.427 0.691 . . . . 74.310000000000002 110.626 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.1 p -79.24 5.51 12.09 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.764 1.225 . . . . 62.43 112.183 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 37.5 m -142.93 123.22 7.99 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.668 0.787 . . . . 74.340000000000003 109.88 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.23 111.47 1.28 Allowed 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.298 2.665 . . . . 65.040000000000006 113.528 -171.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.58 9.83 52.25 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-N 115.774 -0.648 . . . . 75.129999999999995 114.552 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -87.53 115.31 24.87 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 109.175 -0.676 . . . . 72.430000000000007 109.175 -176.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.76 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 50.6 mtt85 -110.12 165.71 11.53 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.963 0.905 . . . . 72.019999999999996 108.825 176.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.472 ' HG ' ' HD3' ' A' ' 194' ' ' ARG . 65.9 m -149.85 142.71 24.76 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.754 0.421 . . . . 63.310000000000002 110.951 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 60.8 mt -111.93 130.77 64.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 N-CA-C 107.409 -1.33 . . . . 74.25 107.409 161.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 11.4 m -107.92 118.96 38.11 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.498 -1.228 . . . . 74.040000000000006 107.92 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.411 HD21 HD23 ' A' ' 232' ' ' LEU . 47.3 mt -110.03 135.78 50.32 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.334 1.054 . . . . 75.129999999999995 111.289 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 37.3 ttt-85 -121.18 130.78 53.88 Favored 'General case' 0 C--O 1.257 1.453 0 O-C-N 123.766 0.666 . . . . 75.25 109.276 169.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.73 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 15.6 p90 -147.65 136.85 22.34 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.366 1.041 . . . . 73.219999999999999 108.827 173.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 56.28 26.26 10.29 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 124.514 1.126 . . . . 74.540000000000006 113.263 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 97.04 -9.57 65.6 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.168 0.413 . . . . 73.430000000000007 113.222 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 18.9 ttm180 -98.89 124.28 43.72 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.275 0.63 . . . . 75.439999999999998 109.961 -171.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.54 HG11 HD23 ' A' ' 160' ' ' LEU . 59.1 t -104.87 132.96 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.494 1.117 . . . . 65.540000000000006 108.873 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.476 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 40.8 p90 -145.29 163.08 35.58 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.551 0.741 . . . . 74.230000000000004 109.423 171.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -128.62 151.77 49.11 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.006 0.923 . . . . 73.219999999999999 108.784 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -143.13 140.48 30.86 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 122.689 0.396 . . . . 74.420000000000002 110.056 168.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.472 ' HD3' ' HG ' ' A' ' 181' ' ' SER . 37.5 mmt180 -73.72 134.19 43.47 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.257 -0.883 . . . . 75.530000000000001 111.504 -178.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.76 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 80.5 mt -84.68 109.05 17.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 107.224 -1.399 . . . . 65.200000000000003 107.224 163.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -80.2 125.96 30.5 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.435 -0.802 . . . . 73.230000000000004 109.181 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 27.2 m -90.43 113.55 25.5 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.894 -0.78 . . . . 71.150000000000006 108.894 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -58.6 157.98 8.41 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.91 0.884 . . . . 71.400000000000006 111.082 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 23.3 t -68.27 -11.99 60.29 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.361 0.664 . . . . 74.540000000000006 111.569 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -71.46 -13.21 61.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.455 0.702 . . . . 73.219999999999999 111.436 170.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.9 5.47 86.19 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.984 -0.446 . . . . 64.129999999999995 111.984 -170.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -87.72 153.48 21.33 Favored 'General case' 0 C--N 1.346 0.444 0 C-N-CA 124.219 1.008 . . . . 74.140000000000001 109.29 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.415 HD21 HH11 ' A' ' 180' ' ' ARG . 97.3 mt -99.87 153.71 18.93 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.59 0.756 . . . . 71.430000000000007 110.19 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -166.4 169.53 13.89 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.953 0.783 . . . . 75.349999999999994 110.11 172.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.52 -58.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 105.996 -1.853 . . . . 75.019999999999996 105.996 172.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 37.8 t -81.61 131.98 35.29 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.374 -1.285 . . . . 74.430000000000007 107.587 168.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 74.2 p -65.28 -32.59 74.33 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.407 0.683 . . . . 73.230000000000004 112.4 -171.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -74.12 -23.92 59.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.721 0.809 . . . . 72.329999999999998 111.219 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 68.6 m -97.37 104.45 16.47 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.153 0.981 . . . . 75.530000000000001 110.104 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 20.2 mmt85 -114.51 137.49 51.79 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.749 0.819 . . . . 74.109999999999999 109.192 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 8.3 m-85 -132.89 133.58 43.45 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.652 0.595 . . . . 64.540000000000006 109.639 -173.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -72.29 -40.71 67.34 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.217 0.607 . . . . 71.230000000000004 110.037 169.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.0 p -123.02 153.87 39.25 Favored 'General case' 0 C--N 1.368 1.371 0 CA-C-O 121.903 0.859 . . . . 70.120000000000005 112.201 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 24.9 tp -70.19 -28.75 65.55 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.118 -1.401 . . . . 71.230000000000004 111.002 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.92 99.57 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.236 0.614 . . . . 64.540000000000006 110.852 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -75.82 -31.69 59.49 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.424 -0.807 . . . . 74.420000000000002 111.33 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tt -56.95 -46.83 81.83 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 123.856 0.722 . . . . 73.5 110.544 169.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.464 HG23 ' CE3' ' A' ' 146' ' ' TRP . 51.3 t -72.47 -37.63 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.892 0.877 . . . . 74.510000000000005 111.444 -175.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -60.14 -50.59 73.07 Favored 'General case' 0 C--O 1.258 1.528 0 CA-C-O 121.622 0.725 . . . . 75.109999999999999 110.033 173.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.414 ' CE1' HG13 ' A' ' 224' ' ' VAL . 50.0 t60 -52.51 -54.72 28.79 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.136 -1.393 . . . . 74.140000000000001 109.787 177.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -64.29 -25.42 68.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.866 -1.061 . . . . 73.430000000000007 112.051 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.2 t -74.0 -28.54 61.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.743 0.417 . . . . 63.43 111.793 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.7 t -109.86 -17.44 13.64 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.299 1.962 . . . . 73.420000000000002 116.299 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.414 HG13 ' CE1' ' A' ' 220' ' ' HIS . 36.0 m -96.04 152.47 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 115.371 1.619 . . . . 71.530000000000001 115.371 -166.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -90.98 -1.76 57.78 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.409 2.683 . . . . 72.340000000000003 112.523 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.17 13.94 1.33 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 128.326 2.65 . . . . 63.439999999999998 112.751 -141.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.1 18.0 3.94 Favored Glycine 0 C--N 1.346 1.139 0 C-N-CA 125.443 1.497 . . . . 73.530000000000001 110.933 -171.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.11 120.75 33.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.214 1.006 . . . . 74.109999999999999 109.84 165.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.476 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 80.1 mt -60.15 -40.36 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.391 1.077 . . . . 74.450000000000003 109.497 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.9 t -137.58 140.38 40.96 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 114.835 -1.075 . . . . 74.140000000000001 108.756 170.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 80.6 p -71.77 155.77 40.08 Favored 'General case' 0 C--O 1.247 0.93 0 N-CA-C 108.567 -0.901 . . . . 65.510000000000005 108.567 170.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.442 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 27.8 mt -67.82 100.8 0.98 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 108.661 -0.866 . . . . 75.409999999999997 108.661 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -80.28 -49.99 10.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.309 0.644 . . . . 74.030000000000001 109.886 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 167' ' ' SER . 9.6 p90 -160.57 150.41 14.49 Favored Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 109.675 -0.491 . . . . 75.329999999999998 109.675 173.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.89 138.95 17.09 Favored 'Trans proline' 0 C--N 1.365 1.436 0 C-N-CA 121.964 1.776 . . . . 71.219999999999999 112.495 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.31 142.94 97.1 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 108.68 -0.859 . . . . 64.0 108.68 168.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -69.09 169.55 17.79 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.795 2.33 . . . . 64.099999999999994 114.452 -170.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.476 ' NZ ' ' HG2' ' A' ' 142' ' ' GLU . 67.1 mttm . . . . . 0 N--CA 1.475 0.79 0 CA-C-N 114.536 -1.211 . . . . 75.439999999999998 109.678 165.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.6 p . . . . . 0 N--CA 1.475 0.798 0 CA-C-O 121.006 0.431 . . . . 62.149999999999999 111.299 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.8 mt -102.58 126.56 32.6 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 109.13 -0.693 . . . . 75.439999999999998 109.13 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.552 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 75.8 Cg_endo -74.03 174.49 12.32 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.785 2.323 . . . . 71.549999999999997 112.371 177.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.71 147.66 28.34 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.836 0.455 . . . . 64.310000000000002 111.491 -174.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.474 ' HB3' HD12 ' A' ' 23' ' ' ILE . 85.1 mt -88.19 93.69 9.58 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.366 -0.976 . . . . 72.340000000000003 108.366 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -96.84 -48.68 5.36 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.109 0.564 . . . . 75.329999999999998 110.876 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.513 ' HE1' ' HB2' ' A' ' 115' ' ' ASN . 84.0 m-85 -105.93 111.04 23.53 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.092 0.557 . . . . 73.430000000000007 110.183 178.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 20' ' ' LEU . 47.2 mm -118.08 110.44 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.006 0.523 . . . . 71.25 109.614 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.629 ' HB2' ' HZ3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.827 0 C-N-CA 124.868 1.267 . . . . 73.219999999999999 108.724 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 CA--C 1.548 1.219 0 N-CA-C 113.139 0.399 . . . . 60.340000000000003 113.139 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.487 ' HA ' ' HB3' ' A' ' 140' ' ' SER . 59.8 t30 -94.15 78.96 4.02 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 109.408 -0.59 . . . . 71.209999999999994 109.408 -176.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.639 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 33.5 tp -107.96 123.15 48.21 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.306 -0.861 . . . . 74.329999999999998 111.203 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.71 176.08 5.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.126 1.771 . . . . 75.040000000000006 108.879 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.43 148.88 24.34 Favored 'Isoleucine or valine' 0 C--O 1.252 1.234 0 N-CA-C 108.507 -0.923 . . . . 75.400000000000006 108.507 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.16 118.44 20.4 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 123.67 0.606 . . . . 61.299999999999997 109.654 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.2 mt -82.01 -25.23 34.87 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.969 0.908 . . . . 74.219999999999999 110.611 173.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -132.47 155.92 47.68 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.226 0.61 . . . . 73.209999999999994 110.614 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -72.61 146.05 46.9 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.012 -0.995 . . . . 74.239999999999995 110.542 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -160.65 112.31 1.9 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.693 0.797 . . . . 61.450000000000003 109.238 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.4 t -85.45 137.97 19.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.671 -0.863 . . . . 72.420000000000002 108.671 172.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.56 119.58 7.3 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.399 0.68 . . . . 75.530000000000001 110.576 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.6 m -70.69 -22.62 62.44 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.474 0.709 . . . . 75.340000000000003 110.626 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -159.11 -173.67 27.83 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.94 -0.864 . . . . 63.350000000000001 110.94 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.17 -32.42 73.99 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.938 0.895 . . . . 64.049999999999997 111.312 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -68.63 -24.47 64.56 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.125 0.97 . . . . 74.030000000000001 112.367 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.4 p -101.43 162.94 12.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.18 0.592 . . . . 62.119999999999997 110.065 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.428 HD21 HG21 ' A' ' 123' ' ' THR . 64.7 tp -114.75 137.94 51.33 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.555 0.342 . . . . 74.239999999999995 110.875 -177.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.7 m -78.11 116.11 18.33 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.885 -0.598 . . . . 74.310000000000002 110.051 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 pt -123.69 140.82 46.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.638 0.775 . . . . 75.430000000000007 110.334 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.7 m -115.88 148.14 40.31 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.498 -0.926 . . . . 65.340000000000003 108.498 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -53.89 130.99 39.17 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.954 0.502 . . . . 74.409999999999997 111.284 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.47 -21.61 45.11 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.584 -0.28 . . . . 73.420000000000002 112.806 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -76.84 130.26 37.36 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.309 -0.997 . . . . 73.010000000000005 108.309 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.443 ' HB3' HD12 ' A' ' 84' ' ' LEU . 43.7 mttp -89.87 130.58 36.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.779 0.432 . . . . 74.010000000000005 109.885 -175.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.02 133.82 53.11 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.97 0.908 . . . . 71.25 109.174 -166.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.7 mtm-85 -94.9 108.03 20.06 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 118.736 0.698 . . . . 63.439999999999998 109.429 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 76.8 t -95.11 129.52 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 117.948 0.34 . . . . 75.299999999999997 110.111 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -105.23 -3.77 22.49 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.079 0.952 . . . . 73.420000000000002 111.321 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.31 164.79 16.86 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.919 -0.872 . . . . 63.299999999999997 110.919 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -95.44 171.79 8.48 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.065 -0.717 . . . . 73.239999999999995 109.065 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -63.5 150.11 44.6 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.831 -0.803 . . . . 74.25 108.831 175.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -70.61 -11.04 60.69 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 122.872 0.469 . . . . 74.109999999999999 110.845 -176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.513 ' HB2' ' HE1' ' A' ' 22' ' ' PHE . 62.9 t30 -109.44 -2.98 17.36 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.342 1.057 . . . . 71.329999999999998 110.567 169.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.23 -16.32 59.07 Favored Glycine 0 N--CA 1.48 1.616 0 C-N-CA 123.775 0.703 . . . . 53.210000000000001 114.375 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . 33.7 mt-10 -54.17 -59.9 4.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.847 1.259 . . . . 73.310000000000002 112.955 -172.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -102.8 -179.88 4.09 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.814 -1.085 . . . . 75.340000000000003 109.026 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.63 129.6 12.56 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.52 0.728 . . . . 73.219999999999999 109.226 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -74.96 107.19 6.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.844 0.458 . . . . 73.310000000000002 110.555 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -110.58 160.14 16.93 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.547 0.739 . . . . 75.120000000000005 110.386 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -133.88 117.94 17.37 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.592 0.757 . . . . 75.120000000000005 109.732 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.428 HG21 HD21 ' A' ' 99' ' ' LEU . 68.4 p -113.46 -177.36 3.11 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.786 0.834 . . . . 74.129999999999995 110.273 175.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -70.73 -8.89 55.52 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.117 0.567 . . . . 72.219999999999999 110.849 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -79.77 -27.36 40.43 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.86 1.264 . . . . 64.310000000000002 110.598 173.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.3 -150.73 21.78 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.164 -0.774 . . . . 73.549999999999997 111.164 -173.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -128.25 154.1 46.24 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 117.724 0.762 . . . . 75.109999999999999 109.701 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 171.66 178.68 42.19 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 123.41 0.444 . . . . 72.040000000000006 112.018 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -89.94 120.57 31.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.383 0.673 . . . . 73.219999999999999 110.712 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.8 m -113.99 154.09 46.08 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 124.106 0.962 . . . . 74.25 109.475 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.24 127.98 17.63 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 121.502 1.468 . . . . 55.409999999999997 111.058 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.4 m -58.63 -19.52 39.64 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.822 0.849 . . . . 74.25 111.956 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -70.73 -24.63 62.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.585 1.154 . . . . 73.129999999999995 111.604 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -98.99 -0.7 41.54 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.09 0.956 . . . . 74.230000000000004 112.639 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.3 pt -126.92 153.21 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 118.231 0.468 . . . . 75.010000000000005 110.83 -171.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.5 t -148.73 134.4 9.64 Favored Pre-proline 0 N--CA 1.484 1.259 0 CA-C-O 119.613 -0.232 . . . . 61.219999999999999 110.717 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.97 131.82 32.23 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.434 2.09 . . . . 72.230000000000004 112.404 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.8 m -119.6 -61.1 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.613 0.765 . . . . 73.409999999999997 112.089 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.639 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 66.1 t30 -89.96 -16.85 29.03 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.508 0.723 . . . . 74.5 109.732 -175.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 83' ' ' ASN . 4.6 p -72.42 -157.75 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.382 1.473 . . . . 72.109999999999999 111.563 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.473 HD13 HD21 ' A' ' 214' ' ' LEU . 76.5 mt -57.35 -25.54 59.59 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.145 1.165 . . . . 73.510000000000005 114.145 -175.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -71.41 -14.2 62.08 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 119.054 0.843 . . . . 73.409999999999997 111.187 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -62.35 -22.36 66.03 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.424 0.69 . . . . 75.219999999999999 109.997 168.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -75.37 131.35 40.18 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 108.542 -0.91 . . . . 74.420000000000002 108.542 163.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.1 m -66.36 -15.51 63.33 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 112.55 0.574 . . . . 71.400000000000006 112.55 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.603 ' HB3' ' HG3' ' A' ' 235' ' ' PRO . 29.7 p-90 -85.31 -26.8 26.36 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 113.204 0.816 . . . . 73.420000000000002 113.204 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 42.2 t80 -94.01 132.22 38.71 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.311 -0.625 . . . . 73.349999999999994 109.311 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -126.25 13.42 7.72 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.944 0.72 . . . . 73.109999999999999 112.944 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.26 -159.25 53.53 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-O 119.548 -0.585 . . . . 65.049999999999997 114.54 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.21 104.22 1.75 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.302 2.668 . . . . 64.439999999999998 112.951 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.455 ' HB ' ' HD3' ' A' ' 171' ' ' ARG . 17.3 t -139.86 152.64 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 122.936 0.494 . . . . 73.409999999999997 109.782 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.7 m -73.87 158.48 34.42 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 123.831 0.852 . . . . 71.200000000000003 112.397 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.424 ' O ' ' HG3' ' A' ' 157' ' ' GLU . 52.7 ptt85 -65.97 -32.48 73.99 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.506 -1.225 . . . . 74.439999999999998 112.088 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -72.44 -42.17 65.34 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.106 0.562 . . . . 74.209999999999994 110.365 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.64 -39.58 93.96 Favored 'General case' 0 C--O 1.251 1.167 0 C-N-CA 123.242 0.617 . . . . 63.119999999999997 110.484 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.441 ' HB2' ' HD2' ' A' ' 171' ' ' ARG . . . -55.45 -47.96 75.24 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.087 -0.961 . . . . 74.319999999999993 111.105 172.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 43.8 mt-10 -71.99 -26.96 62.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.958 0.503 . . . . 75.340000000000003 112.064 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -62.52 -43.52 98.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.772 0.429 . . . . 74.239999999999995 110.343 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.612 HD12 HH22 ' A' ' 171' ' ' ARG . 66.8 mt -78.12 -30.1 49.25 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.955 -0.566 . . . . 73.349999999999994 112.258 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.467 HD21 HG11 ' A' ' 190' ' ' VAL . 37.4 tp -78.93 -31.07 45.02 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.916 0.486 . . . . 65.239999999999995 111.487 -174.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 67.8 p -63.53 -19.88 65.15 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.663 0.785 . . . . 64.549999999999997 111.158 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.4 m -80.59 20.65 0.71 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.124 1.37 . . . . 72.439999999999998 111.781 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.63 177.81 16.88 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 114.613 0.605 . . . . 75.239999999999995 114.613 -174.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.7 pt -123.58 -164.55 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 124.819 1.248 . . . . 73.409999999999997 108.757 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.744 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 26.5 p-10 -48.19 120.41 3.55 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.6 0.76 . . . . 74.129999999999995 112.566 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.42 13.81 75.38 Favored Glycine 0 C--O 1.258 1.633 0 CA-C-N 116.621 -0.263 . . . . 70.239999999999995 113.335 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.1 t -73.14 127.79 33.6 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.368 -0.975 . . . . 73.239999999999995 108.368 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 183' ' ' SER . 23.9 p90 -137.95 152.76 49.27 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.706 0.684 . . . . 75.299999999999997 112.575 -174.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.556 HD23 HH21 ' A' ' 171' ' ' ARG . 87.6 mt -131.2 131.72 44.18 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.91 -1.041 . . . . 74.530000000000001 108.59 171.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.499 HG22 HG12 ' A' ' 182' ' ' ILE . 38.9 t -109.09 120.53 60.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.199 -1.408 . . . . 72.409999999999997 107.199 174.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.612 HH22 HD12 ' A' ' 159' ' ' LEU . 16.9 ptp180 -159.17 153.32 23.65 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.707 -0.479 . . . . 73.209999999999994 109.707 -176.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 13.1 pt-20 -97.42 157.41 16.01 Favored 'General case' 0 C--O 1.25 1.096 0 O-C-N 123.704 0.628 . . . . 75.209999999999994 109.862 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 176' ' ' SER . 34.0 t -79.93 144.86 32.99 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.479 -0.782 . . . . 54.409999999999997 109.337 174.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -71.55 -42.79 67.43 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.63 -0.714 . . . . 72.25 110.805 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.8 t -89.52 -1.87 58.17 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.291 0.636 . . . . 62.219999999999999 112.03 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.633 ' HB2' ' HB3' ' A' ' 173' ' ' SER . 15.0 m -116.85 104.24 51.27 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 109.344 -0.613 . . . . 73.219999999999999 109.344 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.24 113.37 1.32 Allowed 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 123.402 2.735 . . . . 60.229999999999997 112.635 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.27 14.28 46.98 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 114.646 0.618 . . . . 75.530000000000001 114.646 173.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -89.55 112.93 24.26 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.25 -1.019 . . . . 72.439999999999998 108.25 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 78.2 mtt85 -104.3 161.23 14.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.904 -1.044 . . . . 74.310000000000002 108.807 -168.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.466 ' HG ' ' HD3' ' A' ' 194' ' ' ARG . 70.3 m -151.77 152.91 33.32 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 123.278 0.631 . . . . 75.409999999999997 109.763 -175.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.499 HG12 HG22 ' A' ' 170' ' ' VAL . 28.4 mt -118.8 137.68 51.97 Favored 'Isoleucine or valine' 0 C--O 1.25 1.123 0 N-CA-C 108.226 -1.027 . . . . 64.230000000000004 108.226 173.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 32.8 m -119.47 120.7 37.59 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.198 -1.038 . . . . 71.340000000000003 108.198 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.42 HD21 HD23 ' A' ' 232' ' ' LEU . 62.1 mt -103.61 141.3 36.28 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.528 0.731 . . . . 73.409999999999997 111.246 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -117.93 134.36 55.03 Favored 'General case' 0 C--O 1.26 1.636 0 N-CA-C 107.253 -1.388 . . . . 71.439999999999998 107.253 166.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.744 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 34.7 t80 -157.81 111.71 2.55 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.719 -1.128 . . . . 74.219999999999999 109.503 -172.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 50.96 44.17 28.54 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.881 1.272 . . . . 72.340000000000003 112.718 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.55 -1.5 87.23 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 114.717 0.647 . . . . 72.319999999999993 114.717 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -102.65 125.95 49.56 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.271 0.629 . . . . 74.140000000000001 109.448 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.467 HG11 HD21 ' A' ' 160' ' ' LEU . 72.1 t -115.1 117.35 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.961 0.904 . . . . 71.510000000000005 108.711 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.407 ' HH ' HG22 ' A' ' 230' ' ' THR . 6.7 p90 -136.58 144.52 44.2 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.413 0.625 . . . . 62.100000000000001 110.637 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -122.92 136.36 54.83 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.231 1.012 . . . . 72.040000000000006 109.766 -167.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -145.34 141.95 28.97 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.842 0.353 . . . . 71.540000000000006 111.343 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.466 ' HD3' ' HG ' ' A' ' 181' ' ' SER . 16.3 tpp180 -80.03 134.39 36.22 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.756 0.822 . . . . 72.299999999999997 111.081 -176.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 91.3 mt -77.24 101.99 3.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 N-CA-C 107.58 -1.267 . . . . 75.099999999999994 107.58 161.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -72.7 122.9 22.23 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.177 -0.92 . . . . 74.519999999999996 109.152 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 21.6 m -100.34 111.14 23.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.143 0.577 . . . . 71.319999999999993 109.77 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.16 157.97 27.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.893 0.877 . . . . 63.520000000000003 111.499 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 77.9 p -62.74 -18.8 63.18 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.315 -0.857 . . . . 72.219999999999999 111.413 174.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -69.05 -15.85 63.56 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.894 1.678 . . . . 72.420000000000002 111.803 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 86.5 2.52 84.91 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 111.605 -0.598 . . . . 73.019999999999996 111.605 -170.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -89.93 143.12 27.06 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.082 0.553 . . . . 74.030000000000001 111.036 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 83.3 mt -95.57 150.15 20.65 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.196 0.998 . . . . 73.409999999999997 110.059 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -164.87 158.37 17.21 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.214 0.606 . . . . 74.510000000000005 111.01 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 94.9 t -127.18 -56.67 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 124.564 1.146 . . . . 71.420000000000002 108.985 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.3 t -100.75 -169.08 1.66 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.902 1.281 . . . . 72.129999999999995 110.433 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 50.9 m -76.81 -43.34 36.96 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.475 0.71 . . . . 75.420000000000002 112.153 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.56 -29.86 63.91 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.242 0.544 . . . . 75.310000000000002 111.368 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.505 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 83.6 p -68.65 118.17 11.31 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.411 -0.813 . . . . 62.420000000000002 111.813 -173.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -147.16 114.48 6.28 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.983 1.313 . . . . 65.230000000000004 107.653 170.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.505 ' CE2' ' HB2' ' A' ' 209' ' ' SER . 21.3 m-85 -130.53 138.83 50.4 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 118.449 0.568 . . . . 65.230000000000004 111.805 -171.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -79.95 -31.11 40.0 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.963 0.505 . . . . 73.239999999999995 109.968 169.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 60.1 p -126.59 148.09 49.81 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.734 0.778 . . . . 72.0 111.966 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.473 HD21 HD13 ' A' ' 141' ' ' LEU . 24.9 tp -69.87 -21.67 63.31 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.22 -1.355 . . . . 63.439999999999998 111.194 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.87 -47.49 77.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.394 0.678 . . . . 72.129999999999995 110.515 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -70.14 -31.74 69.4 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 115.705 -0.68 . . . . 74.329999999999998 111.008 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 10.1 tt -55.47 -56.28 22.06 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 123.699 0.625 . . . . 72.439999999999998 109.859 172.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.58 -39.15 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.736 0.814 . . . . 64.430000000000007 111.622 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -59.83 -57.04 14.61 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.692 0.758 . . . . 73.230000000000004 111.222 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.421 ' CE1' HG11 ' A' ' 224' ' ' VAL . 40.4 t-80 -56.52 -44.16 80.53 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.771 -1.104 . . . . 74.510000000000005 109.854 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 217' ' ' LEU . 1.9 t60 -72.28 -19.96 61.6 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.535 1.134 . . . . 73.109999999999999 110.417 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 29.1 t -82.76 -20.26 36.26 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.016 0.926 . . . . 74.239999999999995 110.895 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.8 t -115.92 -8.52 11.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.401 2.0 . . . . 72.150000000000006 116.401 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.421 HG11 ' CE1' ' A' ' 220' ' ' HIS . 15.3 m -89.54 143.11 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 120.95 1.705 . . . . 72.340000000000003 114.505 -171.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.58 -0.53 57.58 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 128.713 2.805 . . . . 64.049999999999997 111.883 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -78.23 13.85 1.37 Allowed 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 130.066 3.347 . . . . 75.049999999999997 112.621 -146.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.83 18.68 3.51 Favored Glycine 0 C--N 1.343 0.928 0 C-N-CA 124.038 0.828 . . . . 62.329999999999998 111.43 -172.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 71.4 mt -92.06 121.47 33.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.627 0.771 . . . . 72.319999999999993 110.617 163.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 76.6 mt -53.76 -42.58 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.779 0.832 . . . . 73.25 109.546 169.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.407 HG22 ' HH ' ' A' ' 191' ' ' TYR . 8.9 t -140.87 140.42 34.57 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.673 -1.149 . . . . 63.009999999999998 108.446 173.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.1 p -69.45 162.98 26.32 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.933 -0.576 . . . . 74.310000000000002 109.565 171.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.42 HD23 HD21 ' A' ' 184' ' ' LEU . 57.2 mt -65.55 103.84 0.91 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 110.073 -0.343 . . . . 71.209999999999994 110.073 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -77.99 -60.91 2.18 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.194 -0.669 . . . . 71.549999999999997 109.194 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -158.36 149.53 16.49 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 120.492 -0.483 . . . . 74.400000000000006 112.143 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.603 ' HG3' ' HB3' ' A' ' 146' ' ' TRP . 46.5 Cg_exo -58.33 123.01 12.64 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.882 2.388 . . . . 53.109999999999999 112.195 172.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -58.27 135.21 84.86 Favored Pre-proline 0 C--O 1.246 0.893 0 O-C-N 123.665 0.603 . . . . 53.130000000000003 109.981 175.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.96 135.74 42.13 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.887 1.725 . . . . 75.25 113.979 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.504 ' HA ' HD22 ' A' ' 159' ' ' LEU . 18.3 ptpt . . . . . 0 CA--C 1.548 0.887 0 CA-C-N 114.71 -1.132 . . . . 70.209999999999994 109.235 162.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.1 m . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 121.218 0.532 . . . . 72.010000000000005 110.303 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.3 mt -107.23 125.15 33.14 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.103 -1.073 . . . . 72.549999999999997 108.103 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.17 174.51 8.89 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.786 2.324 . . . . 75.349999999999994 112.158 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.43 145.67 39.14 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.54 0.336 . . . . 64.299999999999997 110.124 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HB3' HD13 ' A' ' 23' ' ' ILE . 64.6 mt -89.46 101.96 14.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.373 1.069 . . . . 72.040000000000006 109.684 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -96.05 -50.92 4.65 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.419 0.688 . . . . 73.209999999999994 110.074 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -104.45 116.54 32.29 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.197 0.999 . . . . 74.329999999999998 110.077 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.466 HD13 ' HB3' ' A' ' 20' ' ' LEU . 37.3 mm -118.38 114.05 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.617 0.767 . . . . 70.340000000000003 111.124 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.537 ' H ' ' HE1' ' A' ' 129' ' ' TRP . 75.5 mmtt . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 125.07 1.348 . . . . 74.219999999999999 109.085 166.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 CA--C 1.556 1.614 0 N-CA-C 115.008 1.118 . . . . 64.140000000000001 115.008 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.03 73.94 0.7 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.771 0.796 . . . . 73.319999999999993 111.232 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.1 tp -91.11 119.53 31.31 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.668 0.747 . . . . 74.230000000000004 110.939 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -111.96 173.86 6.16 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.293 1.437 . . . . 74.219999999999999 109.417 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.31 154.18 12.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.633 -1.247 . . . . 72.439999999999998 107.633 174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.457 ' HB1' HD11 ' A' ' 107' ' ' LEU . . . -94.85 132.89 39.17 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.334 -0.247 . . . . 74.030000000000001 110.334 173.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.485 ' HG ' ' OG1' ' A' ' 136' ' ' THR . 79.3 mt -86.21 -20.94 27.78 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.479 0.711 . . . . 71.530000000000001 110.587 172.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -129.09 153.21 47.87 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.631 -0.713 . . . . 71.129999999999995 109.474 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.67 160.54 32.42 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.363 -0.835 . . . . 74.319999999999993 108.777 163.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' HB3' HG12 ' A' ' 101' ' ' ILE . 56.3 t80 -159.87 111.18 1.98 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.457 -0.942 . . . . 74.230000000000004 108.457 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.0 t -81.21 124.26 38.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 107.235 -1.394 . . . . 74.129999999999995 107.235 170.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.412 ' HB1' ' N ' ' A' ' 100' ' ' SER . . . -66.14 143.99 56.95 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.993 0.517 . . . . 74.519999999999996 110.799 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.5 m -76.59 -13.62 60.06 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.735 0.814 . . . . 60.240000000000002 110.655 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.68 -155.14 26.36 Favored Glycine 0 C--N 1.353 1.481 0 N-CA-C 111.823 -0.511 . . . . 71.140000000000001 111.823 176.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -65.91 -28.92 69.29 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.253 1.021 . . . . 72.120000000000005 111.416 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -69.38 -13.73 62.53 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.984 1.314 . . . . 74.329999999999998 112.419 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.0 p -128.82 162.8 26.62 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.348 1.059 . . . . 73.25 109.707 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.449 ' HB3' HG13 ' A' ' 130' ' ' VAL . 53.7 tp -111.39 121.61 45.67 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.198 0.599 . . . . 74.099999999999994 110.382 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.412 ' N ' ' HB1' ' A' ' 93' ' ' ALA . 16.0 p -72.12 116.08 12.12 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.524 -0.547 . . . . 72.319999999999993 109.524 173.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 91' ' ' PHE . 33.5 pt -122.18 161.51 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.145 0.578 . . . . 75.329999999999998 109.735 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 33.3 m -121.54 148.33 44.62 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.364 0.666 . . . . 75.010000000000005 110.172 -177.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -57.47 128.31 36.38 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.665 0.386 . . . . 72.030000000000001 110.255 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.06 -21.39 37.36 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 120.19 -0.228 . . . . 72.120000000000005 112.923 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -67.91 131.16 44.99 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.516 0.726 . . . . 74.099999999999994 110.282 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -78.71 121.21 24.44 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.146 0.578 . . . . 72.109999999999999 110.367 177.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.523 ' HA ' HG21 ' A' ' 123' ' ' THR . 14.7 mt -103.66 152.39 21.85 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.166 0.986 . . . . 74.349999999999994 108.424 -175.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 72.5 mtt-85 -123.25 104.74 9.34 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.809 -1.182 . . . . 75.5 107.809 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.596 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 53.9 t -96.01 114.22 32.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 108.449 -0.945 . . . . 54.25 108.449 -172.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.4 mt -79.74 -10.81 59.84 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.608 -1.178 . . . . 73.299999999999997 110.59 -174.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.89 157.19 9.2 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 110.521 -1.032 . . . . 64.409999999999997 110.521 173.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -94.11 168.01 11.21 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.601 -0.889 . . . . 74.430000000000007 108.601 174.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -77.63 147.46 35.56 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.578 -1.267 . . . . 62.549999999999997 107.578 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -70.04 -17.07 63.24 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.584 0.754 . . . . 75.310000000000002 112.371 -175.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.501 ' HB3' ' HG2' ' A' ' 117' ' ' GLU . 65.2 t30 -86.05 -11.49 52.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.79 0.436 . . . . 74.510000000000005 110.527 174.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.38 14.06 77.13 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.385 -0.37 . . . . 73.239999999999995 113.137 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 115' ' ' ASN . 7.9 pt-20 -75.38 -56.02 5.12 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.519 1.128 . . . . 75.239999999999995 110.629 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -124.59 179.09 5.1 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.796 1.238 . . . . 73.209999999999994 108.813 -176.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.3 133.88 16.59 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.243 0.617 . . . . 74.230000000000004 110.154 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -81.11 95.65 6.93 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 109.099 -0.704 . . . . 73.430000000000007 109.099 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.596 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -104.91 170.26 7.97 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.158 -0.928 . . . . 74.239999999999995 110.854 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -148.61 129.5 14.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.897 -1.047 . . . . 72.319999999999993 108.544 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.523 HG21 ' HA ' ' A' ' 107' ' ' LEU . 72.1 p -131.92 -171.13 2.55 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.526 1.13 . . . . 52.530000000000001 108.995 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -68.72 -8.55 43.78 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.607 0.763 . . . . 73.540000000000006 111.048 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.414 ' HB2' HD11 ' A' ' 99' ' ' LEU . 42.0 m-20 -83.16 -24.26 32.57 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.278 1.031 . . . . 75.400000000000006 110.144 173.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 127.99 -167.91 20.12 Favored Glycine 0 C--N 1.354 1.574 0 CA-C-O 119.668 -0.518 . . . . 72.430000000000007 112.183 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -100.14 157.76 16.34 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 117.699 0.749 . . . . 65.150000000000006 109.889 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.47 177.87 36.7 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 112.021 -0.432 . . . . 72.25 112.021 174.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.537 ' HE1' ' H ' ' A' ' 24' ' ' LYS . 84.3 m95 -91.08 134.67 34.33 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.367 0.603 . . . . 72.140000000000001 111.383 -176.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' A' ' 99' ' ' LEU . 5.4 m -136.47 140.4 32.31 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.726 1.61 . . . . 71.230000000000004 108.551 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.81 143.95 47.14 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.012 1.808 . . . . 64.450000000000003 111.679 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.1 m -60.32 -19.62 55.99 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 124.352 1.061 . . . . 74.25 113.12 -173.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -79.38 -27.03 41.89 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 112.298 0.481 . . . . 74.109999999999999 112.298 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -79.37 -18.92 51.43 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.507 0.504 . . . . 62.43 110.509 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.494 HD11 HG23 ' A' ' 109' ' ' VAL . 18.7 pt -118.65 146.0 23.86 Favored 'Isoleucine or valine' 0 C--N 1.364 1.201 0 C-N-CA 123.463 0.705 . . . . 74.129999999999995 110.278 -165.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.485 ' OG1' ' HG ' ' A' ' 88' ' ' LEU . 9.6 m -149.66 112.14 3.41 Favored Pre-proline 0 CA--C 1.559 1.291 0 CA-C-O 119.196 -0.431 . . . . 52.009999999999998 112.145 -163.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.92 116.35 4.25 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.426 2.084 . . . . 75.109999999999999 112.608 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.5 m -84.99 -26.63 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.089 0.471 . . . . 72.109999999999999 110.04 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -86.74 16.81 4.42 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.947 -1.024 . . . . 75.230000000000004 110.54 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.0 t -49.54 125.9 12.32 Favored 'General case' 0 C--N 1.361 1.081 0 C-N-CA 123.938 0.895 . . . . 61.439999999999998 110.833 177.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.3 mt -60.85 -11.28 7.28 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.595 1.158 . . . . 75.019999999999996 112.0 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -53.6 -14.45 0.86 Allowed 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.527 1.531 . . . . 75.219999999999999 113.593 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -55.81 -35.04 65.91 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 109.483 -0.562 . . . . 75.329999999999998 109.483 172.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -89.37 123.24 33.35 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.283 -1.377 . . . . 73.319999999999993 107.283 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.4 m -67.04 -6.56 17.69 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 114.197 1.184 . . . . 54.420000000000002 114.197 -166.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.445 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 38.7 p-90 -69.2 -35.68 76.49 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.04 0.385 . . . . 75.400000000000006 112.04 174.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -93.25 145.69 24.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.469 0.708 . . . . 74.140000000000001 109.187 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -135.38 7.16 3.32 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 112.986 0.735 . . . . 74.200000000000003 112.986 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 89.92 -167.57 33.42 Favored Glycine 0 N--CA 1.477 1.389 0 N-CA-C 115.091 0.797 . . . . 73.299999999999997 115.091 168.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.85 101.04 1.14 Allowed 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 123.399 2.733 . . . . 52.32 111.464 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.637 HG23 HH21 ' A' ' 171' ' ' ARG . 35.0 t -141.34 150.14 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 CA-C-N 116.065 -0.516 . . . . 73.349999999999994 110.027 -172.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.7 m -67.49 149.4 50.24 Favored 'General case' 0 C--O 1.252 1.205 0 C-N-CA 124.624 1.17 . . . . 74.230000000000004 111.965 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -57.72 -34.23 69.26 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.327 -0.851 . . . . 75.049999999999997 110.801 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -57.53 -55.15 38.6 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.379 0.672 . . . . 73.010000000000005 110.595 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.5 91.2 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.723 0.809 . . . . 63.310000000000002 111.005 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.18 -52.35 65.93 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.206 -0.907 . . . . 73.120000000000005 111.383 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -72.11 -27.72 62.82 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.953 0.901 . . . . 72.219999999999999 110.293 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -62.52 -47.65 82.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.043 0.537 . . . . 75.209999999999994 110.933 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.709 HD12 HH12 ' A' ' 171' ' ' ARG . 81.8 mt -66.88 -41.86 86.53 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.091 0.472 . . . . 73.420000000000002 110.746 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.428 HD22 HG13 ' A' ' 190' ' ' VAL . 31.5 tp -66.44 -24.29 66.42 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.273 -0.876 . . . . 75.519999999999996 111.984 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 36.5 t -63.97 -20.41 65.86 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.086 0.954 . . . . 72.109999999999999 112.432 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.8 p -105.73 15.83 26.22 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.337 0.655 . . . . 71.530000000000001 111.229 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -99.75 157.98 19.74 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 116.223 -0.444 . . . . 75.349999999999994 112.66 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 20.7 pt -107.14 -163.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.044 0.938 . . . . 74.129999999999995 110.172 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.764 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 26.7 p-10 -47.82 115.53 1.19 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.225 1.01 . . . . 75.430000000000007 113.125 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 86.04 13.65 68.57 Favored Glycine 0 C--O 1.255 1.419 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 112.581 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 22.2 t -72.66 133.72 44.76 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.623 -0.88 . . . . 74.340000000000003 108.623 176.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.527 ' HB3' HD22 ' A' ' 184' ' ' LEU . 14.5 p90 -142.25 162.55 35.18 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.405 0.52 . . . . 53.109999999999999 112.405 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.524 ' HB3' ' HD3' ' A' ' 171' ' ' ARG . 80.4 mt -141.93 133.15 26.31 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.253 -1.017 . . . . 75.319999999999993 108.253 172.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.43 110.9 32.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 107.543 -1.281 . . . . 71.450000000000003 107.543 174.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.709 HH12 HD12 ' A' ' 159' ' ' LEU . 4.4 mmm-85 -120.68 162.51 19.57 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.048 -1.093 . . . . 71.430000000000007 108.048 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.602 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 21.4 pt-20 -117.15 155.33 29.54 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.038 0.447 . . . . 75.239999999999995 110.099 165.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 37.2 m -86.02 127.73 34.71 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.95 -1.023 . . . . 74.319999999999993 110.424 -176.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -70.63 -34.71 72.39 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.103 1.361 . . . . 63.130000000000003 110.565 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 36.0 p -91.15 -14.76 30.54 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.577 1.151 . . . . 63.109999999999999 111.882 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 44.7 m -135.42 76.25 56.36 Favored Pre-proline 0 N--CA 1.477 0.924 0 N-CA-C 108.117 -1.068 . . . . 70.310000000000002 108.117 171.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.63 141.85 46.91 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.879 2.386 . . . . 72.019999999999996 112.968 -174.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.93 -22.65 27.65 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.726 -0.67 . . . . 75.040000000000006 111.903 -171.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -93.07 120.05 32.95 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.717 0.807 . . . . 74.230000000000004 109.104 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.602 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 52.1 mtt180 -110.52 169.57 8.66 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.205 -0.907 . . . . 74.420000000000002 109.724 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.7 t -152.18 137.3 17.36 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 123.731 0.812 . . . . 64.439999999999998 109.204 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.64 133.06 53.54 Favored 'Isoleucine or valine' 0 C--O 1.247 0.933 0 N-CA-C 107.601 -1.259 . . . . 75.299999999999997 107.601 171.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 19.8 m -111.49 117.28 32.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.661 -1.237 . . . . 75.400000000000006 107.661 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 168' ' ' PHE . 43.5 mt -103.84 143.26 33.06 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.508 1.123 . . . . 70.519999999999996 110.863 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 29.7 ttt180 -132.27 129.87 40.15 Favored 'General case' 0 C--O 1.256 1.442 0 C-N-CA 124.059 0.944 . . . . 73.519999999999996 108.47 169.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.764 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 4.4 p90 -147.74 137.52 22.68 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.418 -0.956 . . . . 74.030000000000001 108.418 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 55.12 33.61 20.82 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.172 0.989 . . . . 65.420000000000002 111.864 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.47 -7.01 80.81 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.556 -0.747 . . . . 74.310000000000002 113.816 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 18.6 tpp180 -99.83 123.44 44.09 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.564 0.746 . . . . 75.439999999999998 110.281 -171.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.428 HG13 HD22 ' A' ' 160' ' ' LEU . 72.6 t -101.23 133.57 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.694 1.197 . . . . 74.319999999999993 109.602 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.571 ' HH ' HG22 ' A' ' 230' ' ' THR . 33.9 p90 -146.0 156.96 43.85 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.787 0.835 . . . . 63.350000000000001 109.532 169.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -127.74 140.39 52.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.825 0.85 . . . . 74.329999999999998 108.842 -172.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -141.47 140.09 33.47 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 110.135 -0.321 . . . . 51.43 110.135 174.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -79.18 137.67 37.54 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.405 -0.816 . . . . 71.540000000000006 111.183 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 91.1 mt -78.39 102.49 4.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 107.045 -1.465 . . . . 74.420000000000002 107.045 162.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -75.57 124.64 27.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.391 -1.337 . . . . 75.239999999999995 107.391 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 56.6 m -102.67 121.01 41.56 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.03 0.532 . . . . 72.230000000000004 109.86 -174.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -74.62 145.41 43.3 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.749 -1.204 . . . . 71.430000000000007 107.749 170.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.7 m -69.24 -9.78 54.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.197 0.599 . . . . 75.120000000000005 111.492 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -65.74 -18.96 65.7 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.751 1.22 . . . . 65.019999999999996 110.709 172.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 97.8 -1.17 59.6 Favored Glycine 0 C--N 1.355 1.627 0 C-N-CA 123.809 0.718 . . . . 54.009999999999998 111.622 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -90.83 137.85 32.05 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 123.571 0.749 . . . . 70.25 110.049 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 89.2 mt -96.58 157.83 15.71 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.412 0.685 . . . . 71.329999999999998 110.149 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -164.83 174.28 10.8 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 123.913 0.758 . . . . 70.310000000000002 110.595 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.6 t -138.86 -65.68 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.487 -1.301 . . . . 74.450000000000003 107.487 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.0 t -91.48 -175.98 4.38 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.326 1.05 . . . . 75.120000000000005 110.797 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 32.7 t -66.47 -48.11 70.93 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.535 0.734 . . . . 74.129999999999995 111.761 -174.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -87.04 -3.78 59.11 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.229 0.612 . . . . 72.510000000000005 111.684 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 74.4 m -69.18 116.57 9.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.692 0.797 . . . . 62.450000000000003 110.555 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -144.85 106.83 4.3 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.786 1.234 . . . . 75.340000000000003 108.389 172.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -127.37 140.38 52.22 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 122.926 0.49 . . . . 74.219999999999999 110.697 -173.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -74.84 -37.78 62.17 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.727 0.642 . . . . 74.319999999999993 110.364 173.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 66.9 p -133.43 165.01 25.85 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.983 0.897 . . . . 62.329999999999998 112.15 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 23.4 tp -70.57 -27.88 64.46 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 113.855 -1.52 . . . . 74.25 110.999 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.34 -41.84 98.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.079 0.552 . . . . 74.349999999999994 110.22 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -69.03 -42.08 76.85 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.798 -1.092 . . . . 64.209999999999994 110.662 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.04 -42.75 90.97 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.811 0.695 . . . . 75.099999999999994 110.935 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.6 t -76.75 -41.22 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.705 0.802 . . . . 65.340000000000003 110.9 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -59.63 -50.34 74.26 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.358 0.526 . . . . 73.400000000000006 110.161 173.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -53.42 -54.82 31.34 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.696 -1.138 . . . . 73.439999999999998 109.499 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -63.16 -26.22 68.71 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.643 -0.708 . . . . 74.420000000000002 112.012 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 26.8 t -77.77 -21.2 52.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.85 0.46 . . . . 73.209999999999994 111.711 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.9 t -115.43 -18.85 10.9 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.22 1.933 . . . . 74.549999999999997 116.22 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 35.0 m -92.77 143.65 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 120.745 1.611 . . . . 65.319999999999993 114.277 -166.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.38 -1.96 57.45 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.23 2.212 . . . . 73.430000000000007 112.393 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -78.56 13.66 1.54 Allowed 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 128.158 2.583 . . . . 72.439999999999998 114.087 -143.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.21 17.39 4.06 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 123.932 0.777 . . . . 62.219999999999999 111.242 -167.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 52.1 mt -91.3 135.39 33.84 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.093 0.557 . . . . 70.430000000000007 109.742 157.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.403 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 77.3 mt -65.74 -44.8 93.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 O-C-N 124.176 0.922 . . . . 64.129999999999995 109.273 174.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.571 HG22 ' HH ' ' A' ' 191' ' ' TYR . 11.6 t -138.44 149.32 45.36 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.807 0.443 . . . . 62.039999999999999 109.909 169.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 82.7 p -74.28 156.13 37.51 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 109.076 -0.712 . . . . 75.430000000000007 109.076 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.483 HD23 HD21 ' A' ' 184' ' ' LEU . 38.8 mt -68.6 101.7 1.34 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 108.878 -0.786 . . . . 74.209999999999994 108.878 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -80.05 -57.5 3.6 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.077 0.551 . . . . 73.219999999999999 110.095 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 167' ' ' SER . 7.9 p90 -155.64 152.29 23.99 Favored Pre-proline 0 N--CA 1.484 1.229 0 N-CA-C 109.131 -0.692 . . . . 72.329999999999998 109.131 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' ' 146' ' ' TRP . 58.8 Cg_endo -70.62 138.63 35.49 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 121.666 1.577 . . . . 75.239999999999995 111.438 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -57.99 146.91 66.69 Favored Pre-proline 0 C--O 1.245 0.844 0 CA-C-O 118.671 -0.68 . . . . 73.519999999999996 110.761 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -52.35 118.33 4.51 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.627 2.218 . . . . 72.340000000000003 112.132 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.9 pttt . . . . . 0 CA--C 1.542 0.646 0 CA-C-N 114.733 -1.122 . . . . 73.329999999999998 110.929 174.877 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 C--O 1.246 0.869 0 CA-C-O 121.508 0.671 . . . . 74.030000000000001 111.069 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.1 mt -103.31 126.69 31.5 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 115.066 -0.97 . . . . 70.019999999999996 108.538 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.89 167.84 22.1 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.7 2.267 . . . . 63.130000000000003 112.147 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.83 145.2 32.9 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.961 0.41 . . . . 64.099999999999994 110.646 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.526 ' HB3' HD13 ' A' ' 23' ' ' ILE . 75.1 mt -87.6 92.57 9.15 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.465 -0.939 . . . . 75.430000000000007 108.465 177.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -91.14 -46.83 7.88 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.454 -0.943 . . . . 65.209999999999994 108.454 177.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -98.52 110.16 22.8 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.158 -1.383 . . . . 70.519999999999996 109.58 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.526 HD13 ' HB3' ' A' ' 20' ' ' LEU . 30.9 mm -116.62 112.12 38.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.673 -0.862 . . . . 75.540000000000006 108.673 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.488 ' HB3' ' HZ2' ' A' ' 129' ' ' TRP . 66.1 tttt . . . . . 0 CA--C 1.541 0.632 0 CA-C-N 114.768 -1.106 . . . . 74.420000000000002 109.187 173.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 140' ' ' SER . 38.7 Cg_endo . . . . . 0 CA--C 1.543 0.928 0 N-CA-C 111.58 -0.2 . . . . 64.329999999999998 111.58 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -96.65 56.2 1.48 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.927 -0.768 . . . . 75.230000000000004 108.927 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.697 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 24.8 tp -89.11 115.48 26.67 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.952 -0.758 . . . . 74.439999999999998 108.952 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -104.41 175.71 5.4 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.188 1.795 . . . . 71.329999999999998 109.327 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.96 146.52 33.83 Favored 'Isoleucine or valine' 0 C--O 1.256 1.447 0 N-CA-C 108.314 -0.995 . . . . 53.109999999999999 108.314 171.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.43 110.46 12.22 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 123.816 0.698 . . . . 60.109999999999999 110.048 173.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 90.3 mt -69.35 -28.55 66.31 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.481 1.112 . . . . 71.409999999999997 111.587 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.476 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 64.7 m-85 -135.43 152.66 51.6 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.054 -1.091 . . . . 72.219999999999999 108.054 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -71.37 146.02 49.02 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.167 -0.679 . . . . 72.319999999999993 109.167 169.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -149.37 108.25 3.87 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.165 -1.05 . . . . 71.519999999999996 108.165 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.47 133.93 28.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.133 -1.062 . . . . 71.030000000000001 108.133 170.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.86 128.9 37.72 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.837 0.455 . . . . 64.5 110.535 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.0 m -86.58 12.36 10.68 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.134 0.974 . . . . 75.400000000000006 111.215 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.58 179.34 37.9 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 110.586 -1.006 . . . . 74.129999999999995 110.586 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.81 -28.68 67.79 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.947 0.499 . . . . 72.329999999999998 110.689 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -68.09 -23.94 64.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.855 0.862 . . . . 73.310000000000002 111.798 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.2 p -103.98 158.51 16.37 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.36 0.664 . . . . 71.319999999999993 110.484 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.486 HD23 HG23 ' A' ' 123' ' ' THR . 49.8 tp -114.49 123.45 49.44 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.206 0.602 . . . . 73.310000000000002 110.488 -178.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.0 p -67.55 119.52 12.47 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.537 0.735 . . . . 74.400000000000006 109.807 173.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.453 HG23 HG22 ' A' ' 123' ' ' THR . 38.2 pt -128.53 129.27 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.483 -0.932 . . . . 75.519999999999996 108.483 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.7 m -95.64 137.85 34.13 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.457 -0.571 . . . . 71.400000000000006 109.457 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -51.16 119.25 3.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.54 0.736 . . . . 74.129999999999995 111.471 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.97 -3.46 48.47 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 116.015 -0.539 . . . . 72.140000000000001 113.198 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -86.05 143.98 27.8 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 117.411 0.606 . . . . 73.109999999999999 110.101 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.506 ' HB2' ' HZ3' ' A' ' 124' ' ' LYS . 56.9 mttm -81.91 135.96 35.36 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.205 1.002 . . . . 71.430000000000007 109.157 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.452 ' HA ' HG21 ' A' ' 123' ' ' THR . 14.8 mt -126.98 135.41 50.82 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 107.99 -1.115 . . . . 74.450000000000003 107.99 -168.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -98.69 108.96 21.77 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.857 0.753 . . . . 74.329999999999998 109.141 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 88.0 t -98.24 113.91 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 118.77 0.714 . . . . 70.140000000000001 109.82 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.37 -37.88 68.66 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.835 0.854 . . . . 72.400000000000006 110.238 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.3 176.22 47.88 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.245 -0.889 . . . . 65.340000000000003 111.708 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 0.8 OUTLIER -98.98 174.42 6.36 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.515 -0.92 . . . . 73.150000000000006 108.515 176.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -74.61 165.71 24.76 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.801 0.44 . . . . 74.420000000000002 110.341 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -58.9 -34.3 71.5 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.21 1.004 . . . . 74.299999999999997 111.632 177.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -107.21 7.33 29.38 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.87 0.868 . . . . 74.519999999999996 110.253 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 61.22 24.08 62.87 Favored Glycine 0 C--N 1.356 1.69 0 CA-C-N 115.66 -0.7 . . . . 50.409999999999997 114.407 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -69.66 -58.25 4.16 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.257 1.027 . . . . 72.219999999999999 108.689 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -112.4 -179.39 3.66 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.355 -1.748 . . . . 62.240000000000002 108.778 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -142.45 124.26 15.14 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.701 0.801 . . . . 54.439999999999998 108.854 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -72.39 100.91 2.78 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 109.403 -0.592 . . . . 74.230000000000004 109.403 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.7 170.11 8.56 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.316 -0.856 . . . . 61.420000000000002 111.246 -177.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.425 ' HG3' ' HB2' ' A' ' 127' ' ' GLN . 44.4 tt0 -148.03 125.13 11.4 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.342 -1.355 . . . . 74.200000000000003 107.342 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.486 HG23 HD23 ' A' ' 99' ' ' LEU . 67.7 p -128.27 -175.02 3.38 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.852 0.835 . . . . 62.109999999999999 111.585 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.506 ' HZ3' ' HB2' ' A' ' 106' ' ' LYS . 35.1 mttp -64.13 -23.83 67.46 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 113.85 -1.523 . . . . 75.109999999999999 109.722 174.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -85.79 -4.7 59.23 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.697 1.199 . . . . 65.400000000000006 111.931 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 131.19 -131.57 6.46 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-O 120.034 -0.314 . . . . 61.329999999999998 112.393 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.425 ' HB2' ' HG3' ' A' ' 122' ' ' GLN . 61.0 tt0 -152.21 153.18 33.29 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.444 0.698 . . . . 74.400000000000006 110.363 177.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.74 -170.0 38.14 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 112.187 -0.365 . . . . 71.319999999999993 112.187 176.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.488 ' HZ2' ' HB3' ' A' ' 24' ' ' LYS . 77.2 m95 -96.0 129.72 43.19 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.422 0.689 . . . . 74.450000000000003 110.494 -176.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.414 HG13 ' HB3' ' A' ' 99' ' ' LEU . 30.7 m -121.4 148.33 49.64 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 124.25 1.02 . . . . 73.510000000000005 109.915 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.27 132.67 19.75 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 121.868 1.712 . . . . 63.329999999999998 111.244 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.6 m -62.05 -18.59 61.1 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.987 0.915 . . . . 74.150000000000006 112.758 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -72.91 -23.38 60.7 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.015 0.926 . . . . 73.019999999999996 111.742 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.476 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.2 m-85 -96.74 -0.42 48.21 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.541 0.736 . . . . 74.400000000000006 112.179 -174.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.1 pt -129.15 154.23 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 122.879 0.471 . . . . 75.319999999999993 110.552 -173.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.1 t -154.35 138.57 11.2 Favored Pre-proline 0 N--CA 1.491 1.611 0 CA-C-O 119.467 -0.301 . . . . 70.219999999999999 110.801 172.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.446 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 56.6 Cg_endo -69.47 130.92 20.57 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 122.594 2.196 . . . . 74.409999999999997 113.267 -175.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.3 m -108.37 -58.63 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.802 0.841 . . . . 74.129999999999995 110.733 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.697 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.6 t30 -93.49 1.13 56.9 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.205 0.602 . . . . 72.209999999999994 110.957 -174.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.446 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 25.5 t -73.84 -178.43 3.22 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.022 0.529 . . . . 74.439999999999998 109.883 173.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.0 mt -58.03 -18.66 25.74 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.886 0.874 . . . . 75.310000000000002 112.933 -174.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.571 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 29.7 tt0 -64.69 -14.49 58.62 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.298 1.039 . . . . 71.239999999999995 112.137 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.67 -21.86 55.51 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.81 0.844 . . . . 74.099999999999994 111.037 173.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -100.4 139.06 36.62 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.095 -0.705 . . . . 74.430000000000007 109.095 170.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.9 p -63.57 -12.41 32.52 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.182 1.178 . . . . 73.430000000000007 114.182 -171.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -75.93 -42.28 49.27 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 111.814 0.301 . . . . 74.430000000000007 111.814 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 29.0 t80 -89.74 139.31 30.7 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.434 -0.58 . . . . 74.109999999999999 109.434 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.571 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 72.3 m-70 -131.23 16.75 5.02 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.469 0.544 . . . . 75.099999999999994 112.469 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 72.44 -159.04 53.53 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-O 119.466 -0.63 . . . . 74.230000000000004 114.44 174.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.07 109.6 2.74 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.322 2.681 . . . . 73.25 111.848 176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' HD3' ' A' ' 171' ' ' ARG . 6.5 t -136.92 155.56 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.258 0.551 . . . . 72.129999999999995 111.076 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.2 m -68.26 148.56 50.63 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 124.909 1.283 . . . . 63.299999999999997 111.803 171.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -30.56 70.77 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.744 0.818 . . . . 74.530000000000001 111.09 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.89 -52.75 54.81 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.215 0.606 . . . . 71.129999999999995 109.934 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.83 87.09 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.55 0.74 . . . . 72.409999999999997 111.042 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.438 ' HB2' ' HD2' ' A' ' 171' ' ' ARG . . . -55.41 -59.6 4.59 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.166 -0.925 . . . . 75.400000000000006 111.337 173.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.572 ' HG3' HG12 ' A' ' 190' ' ' VAL . 33.0 tt0 -64.84 -28.19 69.39 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.31 -0.859 . . . . 61.140000000000001 111.29 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -66.43 -50.82 62.13 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.295 1.038 . . . . 75.120000000000005 110.964 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.78 -40.05 84.0 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.933 -0.576 . . . . 73.519999999999996 110.919 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.545 HD21 HG13 ' A' ' 190' ' ' VAL . 37.4 tp -68.53 -29.16 67.68 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.485 -0.779 . . . . 72.409999999999997 112.227 -177.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 13.2 t -62.63 -23.25 66.97 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.538 0.735 . . . . 72.019999999999996 110.856 177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.8 m -82.43 -20.5 36.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.046 0.938 . . . . 72.040000000000006 110.968 176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.73 -175.43 23.61 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.932 -0.576 . . . . 70.439999999999998 112.851 175.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.4 pt -141.04 -165.92 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 124.988 1.315 . . . . 73.299999999999997 111.159 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.708 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 14.6 p-10 -52.52 106.06 0.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.532 1.133 . . . . 64.549999999999997 113.487 -175.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.22 13.3 52.72 Favored Glycine 0 C--O 1.257 1.543 0 CA-C-N 116.132 -0.486 . . . . 74.209999999999994 113.497 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 74.1 m -80.56 140.12 35.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.971 0.386 . . . . 73.219999999999999 110.684 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 183' ' ' SER . 23.1 p90 -136.73 159.66 41.16 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.441 0.639 . . . . 64.239999999999995 112.584 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.577 HD22 HH21 ' A' ' 171' ' ' ARG . 91.5 mt -136.29 133.31 36.81 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.608 -1.178 . . . . 73.150000000000006 108.266 170.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 22.6 t -114.98 127.05 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 107.616 -1.253 . . . . 71.439999999999998 107.616 176.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.577 HH21 HD22 ' A' ' 169' ' ' LEU . 14.7 ptp180 -162.1 148.88 13.67 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.452 0.301 . . . . 72.140000000000001 111.041 -176.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 15.5 pt-20 -93.53 165.8 12.57 Favored 'General case' 0 C--O 1.253 1.248 0 CA-C-O 121.398 0.618 . . . . 72.25 111.693 -178.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.7 t -73.36 154.42 40.08 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.339 -1.3 . . . . 65.25 111.087 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -77.73 -40.02 42.54 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.39 -1.277 . . . . 74.439999999999998 110.653 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.644 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 72.5 p -100.62 -14.12 18.29 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.327 0.651 . . . . 72.230000000000004 112.446 -175.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 46.9 m -124.28 101.72 34.34 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.021 0.528 . . . . 73.549999999999997 110.439 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.74 131.65 28.22 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.226 2.618 . . . . 72.040000000000006 112.111 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.33 -24.04 8.91 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 116.237 -0.438 . . . . 62.340000000000003 113.882 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -75.19 118.2 17.85 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.207 -1.034 . . . . 71.219999999999999 108.207 172.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 82.9 mtt85 -123.29 172.86 8.32 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.274 0.63 . . . . 71.340000000000003 111.074 -169.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 15.9 m -147.51 144.45 28.56 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.039 0.936 . . . . 62.229999999999997 109.461 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.425 HG12 HG21 ' A' ' 170' ' ' VAL . 52.1 mt -119.06 139.58 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 107.967 -1.123 . . . . 74.25 107.967 167.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 17.5 m -119.82 122.78 42.11 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.196 -1.038 . . . . 74.420000000000002 108.196 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.486 HD21 HD22 ' A' ' 232' ' ' LEU . 59.6 mt -105.45 142.18 35.65 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.367 1.067 . . . . 63.310000000000002 111.593 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 20.4 ttt180 -128.56 131.47 48.21 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-N 115.05 -0.977 . . . . 75.299999999999997 109.473 169.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.708 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 3.4 p90 -150.83 142.08 23.25 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.215 -1.032 . . . . 71.310000000000002 108.215 171.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 58.44 18.89 5.99 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 124.164 0.986 . . . . 74.230000000000004 113.343 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.56 12.12 73.17 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 122.882 0.277 . . . . 65.120000000000005 113.157 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 4.0 tpm_? -105.14 124.01 48.8 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.37 1.068 . . . . 73.25 109.151 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.572 HG12 ' HG3' ' A' ' 157' ' ' GLU . 98.3 t -112.9 110.41 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.145 0.978 . . . . 71.150000000000006 110.177 -177.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.646 ' HH ' HG22 ' A' ' 230' ' ' THR . 30.6 p90 -125.85 156.63 39.3 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.533 0.733 . . . . 75.540000000000006 109.245 175.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -131.82 146.94 52.42 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.714 0.806 . . . . 73.450000000000003 109.044 -167.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -145.06 148.74 34.02 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.811 0.444 . . . . 75.450000000000003 110.429 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 15.4 tpp180 -89.94 138.36 31.57 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.525 0.73 . . . . 73.340000000000003 110.817 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 84.7 mt -88.99 120.47 37.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.217 -1.031 . . . . 71.420000000000002 108.217 165.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.1 m-20 -95.86 137.5 34.84 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.004 0.922 . . . . 72.129999999999995 109.358 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 25.8 m -105.24 110.46 22.83 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.339 0.656 . . . . 74.230000000000004 109.478 176.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.81 171.93 1.91 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.495 1.118 . . . . 73.310000000000002 112.041 173.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.4 p -67.07 -29.24 68.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.375 0.67 . . . . 74.140000000000001 111.966 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -71.21 -17.79 62.49 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.028 0.531 . . . . 63.520000000000003 111.282 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 103.5 -5.99 48.89 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 111.786 -0.526 . . . . 72.340000000000003 111.786 -171.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -64.16 130.7 44.96 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.728 0.811 . . . . 73.150000000000006 111.797 -177.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 89.4 mt -89.51 147.33 24.03 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.101 -0.703 . . . . 72.140000000000001 109.101 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -165.2 161.75 19.56 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.586 0.554 . . . . 75.349999999999994 110.724 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.75 -46.75 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.925 0.89 . . . . 74.0 109.844 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' SER . . . . . 0.53 ' H ' ' HB2' ' A' ' 209' ' ' SER . 27.1 t -139.12 -172.73 3.4 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.559 0.743 . . . . 73.430000000000007 110.397 -170.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.9 m -60.62 -49.05 79.09 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.706 1.202 . . . . 54.539999999999999 113.826 -167.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -85.81 -0.08 54.33 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.023 0.529 . . . . 74.549999999999997 110.832 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.53 ' HB2' ' H ' ' A' ' 206' ' ' SER . 72.4 m -97.84 106.62 18.95 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.6 0.76 . . . . 74.209999999999994 110.711 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -145.23 118.37 8.88 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 125.145 1.378 . . . . 74.150000000000006 107.759 170.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -136.85 145.67 44.7 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 118.095 0.407 . . . . 71.430000000000007 111.736 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -87.57 -21.65 25.27 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 123.743 0.652 . . . . 75.510000000000005 109.919 168.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 72.2 p -135.34 148.76 49.54 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-O 121.697 0.761 . . . . 71.140000000000001 112.02 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 38.1 tp -66.79 -27.68 67.77 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.334 -1.303 . . . . 71.400000000000006 111.105 176.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.98 -50.0 75.74 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.69 0.796 . . . . 75.319999999999993 110.781 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -69.93 -32.49 70.79 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.056 -0.975 . . . . 75.310000000000002 110.807 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.45 -48.78 78.25 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.315 0.384 . . . . 73.420000000000002 110.811 172.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 56.0 t -68.77 -42.43 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.751 0.821 . . . . 71.319999999999993 110.443 -176.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -58.81 -52.79 64.2 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.799 0.809 . . . . 65.430000000000007 111.594 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.41 ' O ' HG21 ' A' ' 224' ' ' VAL . 48.2 t60 -55.05 -50.07 70.04 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.408 -1.269 . . . . 73.129999999999995 109.783 177.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -65.16 -24.92 67.53 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.686 -0.688 . . . . 75.209999999999994 112.112 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.4 m -73.13 -27.87 61.93 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.034 -0.416 . . . . 64.209999999999994 110.983 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 15.2 t -110.12 -14.52 14.19 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.659 2.096 . . . . 64.319999999999993 116.659 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 220' ' ' HIS . 27.0 m -99.84 156.97 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 N-CA-C 115.925 1.824 . . . . 72.0 115.925 -166.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.47 -0.25 57.59 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 110.738 -2.937 . . . . 71.540000000000006 113.358 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -77.89 13.05 1.48 Allowed 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 128.436 2.694 . . . . 74.239999999999995 113.371 -144.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.16 17.99 4.33 Favored Glycine 0 N--CA 1.46 0.286 0 C-N-CA 124.802 1.191 . . . . 73.540000000000006 111.183 -169.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 91.4 mt -92.51 117.25 29.75 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 113.832 -1.184 . . . . 74.140000000000001 109.767 163.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.465 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 85.6 mt -63.01 -41.2 91.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.481 0.712 . . . . 75.420000000000002 109.322 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.646 HG22 ' HH ' ' A' ' 191' ' ' TYR . 10.0 t -129.66 142.66 50.69 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.46 -0.941 . . . . 73.219999999999999 108.46 165.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 63.5 p -71.28 156.42 39.55 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 109.359 -0.608 . . . . 73.540000000000006 109.359 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.486 HD22 HD21 ' A' ' 184' ' ' LEU . 25.0 mt -65.92 103.6 0.96 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.913 -0.773 . . . . 72.25 108.913 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.0 -49.53 7.28 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.159 0.583 . . . . 73.5 109.579 -176.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -161.66 144.44 9.11 Favored Pre-proline 0 N--CA 1.492 1.636 0 C-N-CA 123.177 0.591 . . . . 73.420000000000002 112.418 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.65 140.08 18.49 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.724 1.616 . . . . 72.140000000000001 112.461 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -66.96 120.72 73.87 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 108.847 -0.797 . . . . 73.319999999999993 108.847 172.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.07 145.0 59.65 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 121.952 1.768 . . . . 72.099999999999994 112.095 -175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 109.188 -0.671 . . . . 72.329999999999998 109.188 169.639 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.242 0.669 0 CA-C-O 120.864 0.364 . . . . 74.409999999999997 111.476 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.7 mt -103.46 126.57 31.73 Favored Pre-proline 0 C--O 1.239 0.518 0 N-CA-C 109.014 -0.735 . . . . 73.420000000000002 109.014 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.16 169.75 21.87 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.999 2.466 . . . . 65.120000000000005 111.954 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.54 149.94 32.96 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.903 0.481 . . . . 70.200000000000003 110.551 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.536 ' HB3' HD11 ' A' ' 23' ' ' ILE . 80.7 mt -86.14 94.52 9.3 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.686 -0.857 . . . . 73.140000000000001 108.686 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -97.34 -48.76 5.19 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.047 -0.979 . . . . 73.319999999999993 110.667 -177.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.608 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 60.4 m-85 -103.65 108.52 19.84 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.953 -0.758 . . . . 72.230000000000004 108.953 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' A' ' 20' ' ' LEU . 37.7 mm -118.6 112.94 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.863 0.865 . . . . 73.140000000000001 110.226 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.211 -0.962 0 C-N-CA 124.229 1.012 . . . . 75.030000000000001 108.552 167.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo . . . . . 0 CA--C 1.553 1.453 0 CA-C-O 121.39 0.496 . . . . 75.209999999999994 111.161 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -104.62 80.69 1.69 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.504 1.122 . . . . 62.229999999999997 110.252 -177.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 35.0 tp -128.06 112.77 14.97 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.114 -0.699 . . . . 73.420000000000002 109.114 167.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -116.1 173.91 6.32 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.379 1.472 . . . . 73.540000000000006 110.043 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.5 p -147.56 144.85 19.33 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 C-N-CA 124.281 1.033 . . . . 75.140000000000001 108.674 171.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.528 ' HB3' HD13 ' A' ' 107' ' ' LEU . . . -81.73 128.68 34.23 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.711 0.404 . . . . 71.109999999999999 110.161 175.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.8 mt -86.15 -20.57 28.43 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.513 0.725 . . . . 72.030000000000001 110.837 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.548 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 74.9 m-85 -130.59 158.38 40.16 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.782 0.833 . . . . 73.140000000000001 109.335 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -83.55 140.23 32.39 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.757 -0.831 . . . . 73.540000000000006 108.757 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -155.13 111.91 3.26 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.676 -0.861 . . . . 72.230000000000004 108.676 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.43 140.67 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 109.304 -0.628 . . . . 73.409999999999997 109.304 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.21 115.95 2.75 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.336 0.654 . . . . 75.5 110.623 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.0 p -72.21 -27.93 62.86 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.535 0.734 . . . . 73.400000000000006 110.392 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -152.91 -173.36 22.19 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 114.85 -1.068 . . . . 43.439999999999998 110.984 175.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.22 -28.89 65.63 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.306 0.643 . . . . 71.310000000000002 110.855 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -70.02 -22.42 63.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.567 1.147 . . . . 71.420000000000002 111.967 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 74.3 p -105.77 160.92 14.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.283 1.033 . . . . 71.329999999999998 110.271 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.0 tp -109.41 144.29 37.83 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.164 0.586 . . . . 71.140000000000001 110.44 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.2 p -83.09 111.61 19.05 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.513 -0.921 . . . . 75.549999999999997 108.513 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.7 pt -117.89 139.07 46.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 123.836 0.854 . . . . 74.209999999999994 109.014 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 20.5 m -101.34 150.24 23.2 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.731 -0.47 . . . . 55.109999999999999 109.731 176.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -56.74 112.04 1.19 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 122.622 0.369 . . . . 74.230000000000004 110.082 167.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.38 -4.31 43.95 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.328 -0.396 . . . . 70.040000000000006 112.916 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.92 134.03 36.89 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.555 0.742 . . . . 75.129999999999995 109.624 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -83.31 112.52 19.97 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.934 -0.765 . . . . 64.310000000000002 108.934 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.528 HD13 ' HB3' ' A' ' 87' ' ' ALA . 18.8 mt -101.37 156.72 17.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.005 0.522 . . . . 73.329999999999998 109.818 -171.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -124.72 108.64 12.2 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.601 -0.518 . . . . 73.140000000000001 109.601 167.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.521 HG23 HD12 ' A' ' 135' ' ' ILE . 85.4 t -96.81 106.92 19.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.152 -0.931 . . . . 74.540000000000006 109.843 -176.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.414 HD13 ' NE2' ' A' ' 127' ' ' GLN . 69.1 mt -73.57 -14.56 61.22 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.365 -0.834 . . . . 75.329999999999998 111.427 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.37 163.24 21.99 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 116.252 -0.431 . . . . 71.239999999999995 112.419 172.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 7.4 m-30 -95.29 173.31 7.6 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.845 -0.798 . . . . 74.430000000000007 108.845 173.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.608 ' ND2' ' HB2' ' A' ' 22' ' ' PHE . 10.1 m120 -64.01 150.94 44.2 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.584 -1.265 . . . . 74.340000000000003 107.584 161.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -65.19 -22.64 66.92 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.041 0.382 . . . . 65.099999999999994 110.526 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -86.15 -14.89 42.76 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 122.793 0.437 . . . . 71.129999999999995 110.441 174.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 174' ' ' GLU . . . 84.41 25.91 41.54 Favored Glycine 0 C--N 1.355 1.603 0 C-N-CA 123.452 0.549 . . . . 71.040000000000006 113.59 175.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -79.81 -71.33 0.46 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.391 0.677 . . . . 73.420000000000002 110.779 -175.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -104.77 175.56 5.45 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.336 1.054 . . . . 70.019999999999996 109.013 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -151.22 116.0 5.2 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.825 0.85 . . . . 42.439999999999998 109.445 -172.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 36.5 tt0 -67.91 97.38 0.66 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.677 0.391 . . . . 62.119999999999997 110.162 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.31 153.74 19.38 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.246 -0.65 . . . . 60.119999999999997 109.246 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -138.48 131.86 30.36 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.713 0.805 . . . . 75.530000000000001 109.681 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 63.9 p -140.38 -170.7 3.05 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.635 1.174 . . . . 74.299999999999997 109.423 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -64.67 -14.59 58.95 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.279 0.632 . . . . 74.109999999999999 112.098 170.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -80.14 -11.66 59.73 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.73 0.812 . . . . 73.430000000000007 111.304 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 121.09 -133.63 9.73 Favored Glycine 0 C--N 1.35 1.317 0 N-CA-C 111.415 -0.674 . . . . 62.539999999999999 111.415 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.414 ' NE2' HD13 ' A' ' 110' ' ' LEU . 58.2 tt0 -151.51 144.99 24.86 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 117.182 0.491 . . . . 74.420000000000002 111.103 -175.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 171.43 168.93 33.73 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.542 0.526 . . . . 72.519999999999996 112.709 174.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -82.48 117.48 22.53 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.527 1.131 . . . . 74.239999999999995 111.408 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.54 154.52 47.81 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.997 1.319 . . . . 75.439999999999998 109.136 177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.54 132.47 33.34 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 121.585 1.523 . . . . 74.430000000000007 111.326 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 31.6 m -62.22 -17.74 59.14 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.707 0.803 . . . . 75.120000000000005 112.489 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -82.18 -14.99 54.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.976 0.91 . . . . 73.109999999999999 111.619 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.548 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.7 m-85 -93.95 -3.84 50.84 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.854 0.862 . . . . 64.549999999999997 112.306 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.521 HD12 HG23 ' A' ' 109' ' ' VAL . 18.2 pt -125.95 169.93 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.251 0.62 . . . . 72.239999999999995 110.362 -172.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.5 t -158.04 141.03 10.8 Favored Pre-proline 0 CA--C 1.554 1.106 0 O-C-N 123.563 0.539 . . . . 72.540000000000006 109.963 171.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.14 136.78 14.81 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.573 2.182 . . . . 45.219999999999999 111.841 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.7 m -108.25 -45.53 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.668 0.387 . . . . 75.420000000000002 111.162 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 67.2 t30 -101.25 20.12 16.38 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.473 0.654 . . . . 73.239999999999995 110.699 -174.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.5 p -73.97 -171.24 1.06 Allowed 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 121.471 0.653 . . . . 75.140000000000001 110.746 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' A' ' 214' ' ' LEU . 67.1 mt -69.95 -13.81 62.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.916 0.886 . . . . 74.519999999999996 111.669 176.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.8 -6.73 17.21 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.86 1.264 . . . . 72.540000000000006 111.524 176.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -55.6 -35.69 66.1 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.214 1.005 . . . . 74.239999999999995 109.902 168.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -93.49 135.44 34.74 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.0 -1.0 . . . . 75.120000000000005 108.812 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.8 m -67.84 -12.07 59.87 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.526 0.935 . . . . 75.430000000000007 113.526 -171.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -75.19 -34.04 61.49 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 111.881 0.326 . . . . 73.319999999999993 111.881 175.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -94.24 134.33 36.82 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.396 -0.594 . . . . 70.150000000000006 109.396 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -125.17 5.12 7.84 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 111.793 0.294 . . . . 73.519999999999996 111.793 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.25 -159.48 50.33 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 119.462 -0.632 . . . . 72.040000000000006 114.446 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.27 104.85 0.93 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.369 2.713 . . . . 72.129999999999995 112.297 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.559 HG13 HH21 ' A' ' 171' ' ' ARG . 32.6 t -140.56 153.51 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.137 0.575 . . . . 71.140000000000001 110.545 -174.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.9 m -68.83 148.17 50.67 Favored 'General case' 0 C--O 1.249 1.027 0 C-N-CA 124.555 1.142 . . . . 73.219999999999999 112.028 173.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -62.62 -29.72 70.82 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.486 0.714 . . . . 75.150000000000006 110.616 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -57.05 -57.11 13.99 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.552 1.141 . . . . 71.409999999999997 110.453 175.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.16 -39.31 89.69 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.049 0.94 . . . . 75.310000000000002 111.189 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.48 -53.54 56.32 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.888 -1.051 . . . . 74.510000000000005 110.751 174.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -69.39 -26.88 64.86 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.378 1.071 . . . . 74.299999999999997 110.882 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -67.88 -49.95 59.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.371 0.668 . . . . 75.129999999999995 110.573 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.525 HD11 HH12 ' A' ' 171' ' ' ARG . 66.6 mt -66.31 -37.26 85.0 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 120.802 0.334 . . . . 73.230000000000004 110.265 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.56 HD21 ' HB3' ' A' ' 183' ' ' SER . 39.6 tp -65.54 -34.32 77.99 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.191 -0.913 . . . . 74.439999999999998 111.435 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.9 t -57.82 -24.79 59.01 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.905 1.282 . . . . 74.230000000000004 112.049 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.568 ' HB2' ' HG2' ' A' ' 237' ' ' PRO . 3.8 m -87.91 -4.82 58.8 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.028 0.931 . . . . 71.519999999999996 111.895 -175.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -94.09 175.97 35.5 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.197 0.427 . . . . 73.409999999999997 113.912 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.6 pt -118.42 -165.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 124.531 1.133 . . . . 71.129999999999995 109.726 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.639 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 16.8 p-10 -57.58 110.69 0.92 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 113.007 0.743 . . . . 72.310000000000002 113.007 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.89 12.11 35.5 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 115.001 -0.999 . . . . 65.340000000000003 112.493 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 23.4 t -74.25 130.13 39.13 Favored 'General case' 0 C--N 1.349 0.579 0 N-CA-C 109.01 -0.737 . . . . 72.420000000000002 109.01 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 183' ' ' SER . 19.0 p90 -136.78 155.96 49.14 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.29 0.848 . . . . 74.450000000000003 113.29 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.544 HD13 ' NH1' ' A' ' 171' ' ' ARG . 89.0 mt -142.29 135.64 28.95 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.114 0.966 . . . . 44.299999999999997 109.345 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.417 HG22 HG12 ' A' ' 182' ' ' ILE . 15.7 t -109.8 115.61 50.1 Favored 'Isoleucine or valine' 0 C--O 1.252 1.194 0 N-CA-C 108.29 -1.004 . . . . 74.450000000000003 108.29 176.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.559 HH21 HG13 ' A' ' 151' ' ' VAL . 1.4 mmm180 -126.7 159.99 32.08 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.592 -1.262 . . . . 72.319999999999993 107.592 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.654 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 16.9 pt-20 -116.99 163.31 16.41 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 109.482 -0.562 . . . . 74.150000000000006 109.482 167.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.5 t -78.78 138.0 38.0 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.712 -0.677 . . . . 73.430000000000007 110.287 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.4 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 27.1 mt-10 -75.94 -37.84 58.23 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.306 -0.861 . . . . 63.409999999999997 108.989 172.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 47.3 m -83.28 -3.78 57.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.288 1.035 . . . . 73.510000000000005 111.615 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.3 t -157.81 75.14 3.97 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 109.148 -0.686 . . . . 65.019999999999996 109.148 173.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.35 141.39 89.16 Favored 'Trans proline' 0 C--N 1.386 2.508 0 C-N-CA 122.987 2.458 . . . . 74.150000000000006 112.395 175.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 96.8 -25.19 27.66 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 115.098 -0.956 . . . . 62.030000000000001 112.009 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -91.69 117.59 29.88 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.486 -0.931 . . . . 74.439999999999998 108.486 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.654 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 56.0 mtt180 -115.64 170.21 8.61 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 123.77 0.828 . . . . 74.439999999999998 110.562 -172.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.5 t -153.97 143.29 21.44 Favored 'General case' 0 C--O 1.25 1.09 0 C-N-CA 123.956 0.902 . . . . 75.430000000000007 109.09 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.417 HG12 HG22 ' A' ' 170' ' ' VAL . 45.1 mt -110.72 132.82 58.09 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 N-CA-C 108.098 -1.075 . . . . 74.340000000000003 108.098 170.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.56 ' HB3' HD21 ' A' ' 160' ' ' LEU . 13.8 m -106.08 135.94 46.65 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 124.854 1.262 . . . . 75.099999999999994 108.082 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.416 HD22 HD23 ' A' ' 232' ' ' LEU . 36.4 mt -125.89 137.19 53.72 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.607 1.163 . . . . 74.519999999999996 110.335 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.459 ' HB2' ' HG ' ' A' ' 160' ' ' LEU . 71.4 ttt-85 -120.42 133.77 55.37 Favored 'General case' 0 C--O 1.263 1.804 0 O-C-N 124.472 1.108 . . . . 74.109999999999999 108.848 169.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.639 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 21.4 p90 -147.57 133.97 19.65 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.759 1.287 . . . . 74.140000000000001 108.295 167.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 37.76 59.77 1.25 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 126.378 1.871 . . . . 74.219999999999999 114.116 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.453 ' HA2' ' NH2' ' A' ' 185' ' ' ARG . . . 79.57 -2.52 72.37 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.823 -0.626 . . . . 53.340000000000003 114.6 173.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 42.0 ttm180 -109.78 125.51 52.78 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.501 0.72 . . . . 74.319999999999993 110.393 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 28.7 m -111.51 143.8 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.075 0.95 . . . . 74.040000000000006 110.42 172.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.551 ' HH ' ' HB ' ' A' ' 229' ' ' ILE . 24.3 p90 -147.27 150.1 34.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.948 0.899 . . . . 63.520000000000003 109.778 172.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -125.02 116.46 22.17 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.212 -1.032 . . . . 73.200000000000003 108.212 -173.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -115.07 145.81 41.94 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.31 0.576 . . . . 73.209999999999994 110.475 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.499 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 18.9 tpp180 -84.45 128.6 34.68 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 114.681 -1.145 . . . . 62.420000000000002 111.522 -169.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 79.2 mt -80.43 107.22 12.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 107.418 -1.327 . . . . 72.319999999999993 107.418 164.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -77.73 131.26 37.58 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.491 -0.929 . . . . 71.540000000000006 108.491 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.1 m -105.63 141.2 37.5 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.15 0.58 . . . . 74.530000000000001 109.529 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 202' ' ' LYS . . . -95.81 174.8 6.78 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.463 1.105 . . . . 63.450000000000003 109.757 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.0 m -59.79 -39.03 83.58 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.266 0.627 . . . . 74.030000000000001 111.762 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -83.54 12.67 5.34 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.658 0.783 . . . . 75.219999999999999 112.129 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 76.43 12.66 84.1 Favored Glycine 0 C--N 1.352 1.421 0 C-N-CA 122.828 0.252 . . . . 71.219999999999999 112.609 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 198' ' ' ALA . 28.9 mtpp -73.35 126.74 30.84 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 109.871 -0.418 . . . . 72.209999999999994 109.871 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.465 HD12 HH11 ' A' ' 180' ' ' ARG . 80.9 mt -94.72 145.37 24.91 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.457 -0.942 . . . . 74.109999999999999 108.457 -178.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -166.85 136.2 2.92 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.329 0.652 . . . . 73.030000000000001 109.611 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.7 t -92.93 -56.99 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 107.677 -1.231 . . . . 75.519999999999996 107.677 169.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 2.8 p -83.84 147.06 27.76 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.146 -1.388 . . . . 75.040000000000006 109.679 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 20.7 t -68.76 -46.21 69.38 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.848 0.859 . . . . 60.340000000000003 112.37 -165.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -77.09 -4.02 42.27 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.425 0.69 . . . . 75.420000000000002 111.601 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 70.2 m -91.32 140.37 29.84 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 123.587 0.755 . . . . 71.549999999999997 110.128 173.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -142.75 110.36 5.8 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.014 -1.106 . . . . 74.340000000000003 108.014 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 14.6 m-85 -117.0 141.91 47.64 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 109.674 -0.491 . . . . 63.509999999999998 109.674 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -91.2 -18.69 24.03 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.358 0.663 . . . . 74.510000000000005 109.958 168.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 29.5 p -128.64 138.29 52.1 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.956 0.884 . . . . 62.450000000000003 111.715 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.475 ' HB3' HD11 ' A' ' 141' ' ' LEU . 29.3 tp -67.59 -26.43 66.26 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.031 -1.441 . . . . 73.530000000000001 110.831 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.33 -45.79 92.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.533 0.733 . . . . 74.219999999999999 110.445 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -74.7 -30.54 61.59 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.707 -0.679 . . . . 74.150000000000006 111.932 177.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.73 -51.21 70.73 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 110.133 -0.321 . . . . 75.540000000000006 110.133 172.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.38 -42.48 93.68 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 C-N-CA 124.069 0.948 . . . . 74.349999999999994 110.717 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -60.79 -51.52 68.97 Favored 'General case' 0 C--O 1.262 1.734 0 C-N-CA 123.963 0.905 . . . . 74.25 111.033 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -55.23 -53.15 59.69 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.72 -1.127 . . . . 72.299999999999997 109.748 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -73.1 -12.24 60.83 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.245 -0.434 . . . . 61.420000000000002 112.134 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.0 t -78.44 -27.4 46.48 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.835 0.454 . . . . 63.240000000000002 110.472 172.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -109.84 -22.48 11.86 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.974 1.842 . . . . 71.310000000000002 115.974 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.69 152.64 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 120.552 1.523 . . . . 73.530000000000001 114.379 -165.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.09 -1.14 57.96 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 111.905 -2.407 . . . . 71.219999999999999 112.866 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -78.7 14.91 1.16 Allowed 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 128.132 2.573 . . . . 61.43 113.512 -140.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.89 17.36 4.63 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 110.773 -0.931 . . . . 75.239999999999995 110.773 -168.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.68 125.7 35.75 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.35 -0.925 . . . . 75.310000000000002 109.7 165.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.551 ' HB ' ' HH ' ' A' ' 191' ' ' TYR . 77.7 mt -61.67 -44.17 98.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 O-C-N 124.133 0.896 . . . . 73.310000000000002 109.427 172.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.4 t -137.16 144.91 43.2 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.19 -0.914 . . . . 64.310000000000002 108.582 169.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 60.4 p -73.99 151.11 40.37 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.228 -0.656 . . . . 73.420000000000002 109.228 172.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.433 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 33.5 mt -64.48 101.19 0.42 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.244 -0.65 . . . . 73.109999999999999 109.244 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -80.81 -55.72 4.62 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.845 0.458 . . . . 72.129999999999995 109.972 -174.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -155.24 149.87 20.11 Favored Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 109.824 -0.435 . . . . 44.130000000000003 109.824 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 32.8 Cg_endo -63.08 142.54 87.78 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.192 1.928 . . . . 74.549999999999997 111.628 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.02 140.37 95.98 Favored Pre-proline 0 C--O 1.244 0.785 0 CA-C-O 119.255 -0.402 . . . . 73.099999999999994 110.511 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 162' ' ' SER . 17.9 Cg_endo -57.52 118.61 5.51 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 123.012 2.475 . . . . 52.350000000000001 113.811 -174.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 108.055 -1.091 . . . . 74.049999999999997 108.055 166.073 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.0 p . . . . . 0 CA--C 1.55 0.979 0 CA-C-O 121.304 0.573 . . . . 72.510000000000005 111.188 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.3 mt -108.3 134.68 20.11 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 123.981 0.912 . . . . 73.340000000000003 109.604 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -69.3 166.03 28.42 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.379 2.053 . . . . 71.430000000000007 110.908 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.8 142.87 29.47 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.727 0.299 . . . . 63.109999999999999 110.217 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.598 ' HB3' HD11 ' A' ' 23' ' ' ILE . 71.3 mt -87.01 95.54 9.97 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.934 0.893 . . . . 62.32 109.068 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -99.49 -49.66 4.35 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.49 0.662 . . . . 73.340000000000003 110.053 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -99.62 114.92 28.27 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.809 -1.087 . . . . 74.230000000000004 108.901 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.598 HD11 ' HB3' ' A' ' 20' ' ' LEU . 49.5 mm -116.29 117.84 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 108.609 -0.885 . . . . 71.329999999999998 108.609 -174.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.47 ' HB2' ' HE1' ' A' ' 129' ' ' TRP . 9.5 tmtt? . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.115 -0.698 . . . . 74.239999999999995 109.115 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo . . . . . 0 CA--C 1.55 1.303 0 N-CA-C 112.627 0.203 . . . . 72.420000000000002 112.627 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -96.71 33.32 1.87 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.674 0.79 . . . . 73.299999999999997 110.537 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 25.7 tp -80.83 113.6 19.14 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.919 -0.771 . . . . 73.310000000000002 108.919 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -103.5 176.42 5.15 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.927 1.691 . . . . 71.040000000000006 108.808 173.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.48 144.28 35.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 N-CA-C 108.721 -0.844 . . . . 74.129999999999995 108.721 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.91 113.3 12.06 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 123.532 0.52 . . . . 73.019999999999996 109.954 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.58 -26.2 62.51 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.006 0.922 . . . . 73.420000000000002 111.023 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.46 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 71.8 m-85 -134.95 155.46 50.69 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.85 -0.796 . . . . 74.209999999999994 108.85 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -74.41 141.68 45.05 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.88 -0.785 . . . . 73.340000000000003 108.88 170.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -143.44 112.59 6.72 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.94 -0.763 . . . . 72.25 108.94 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.6 t -79.47 129.64 37.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 107.877 -1.157 . . . . 63.299999999999997 107.877 172.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.58 146.68 54.24 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.397 0.679 . . . . 74.230000000000004 111.122 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.3 m -70.36 -25.31 63.21 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.858 0.863 . . . . 71.439999999999998 110.136 169.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.04 -140.55 6.21 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 115.723 -0.671 . . . . 64.519999999999996 112.245 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.17 -35.15 73.79 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.544 0.737 . . . . 71.319999999999993 111.013 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.563 ' HB2' HD13 ' A' ' 23' ' ' ILE . 28.7 p30 -70.08 -4.68 22.26 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.66 0.784 . . . . 74.129999999999995 112.676 -177.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.3 p -134.5 160.15 38.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.399 1.08 . . . . 72.329999999999998 109.047 177.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.5 tp -110.58 125.97 53.94 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.724 -0.473 . . . . 72.030000000000001 109.724 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.1 p -74.6 114.17 12.71 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 108.603 -0.888 . . . . 74.439999999999998 108.603 173.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.0 pt -117.23 155.23 18.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.971 -0.751 . . . . 70.200000000000003 108.971 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.8 m -120.71 145.71 47.2 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.151 -0.685 . . . . 72.099999999999994 109.151 175.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -53.3 114.84 1.63 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.552 0.741 . . . . 64.400000000000006 110.972 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.39 -14.34 33.06 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-O 119.87 -0.406 . . . . 74.310000000000002 112.828 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -76.33 132.41 39.77 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.209 0.604 . . . . 72.409999999999997 109.687 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.417 ' HB3' HD11 ' A' ' 84' ' ' LEU . 50.2 mtmt -84.7 119.69 25.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.685 0.794 . . . . 75.109999999999999 109.371 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.3 mt -104.29 139.48 39.22 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.523 1.129 . . . . 72.040000000000006 108.858 -170.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -101.39 106.93 18.14 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.416 -0.957 . . . . 75.510000000000005 108.416 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 93.9 t -93.07 109.18 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 109.235 -0.654 . . . . 75.310000000000002 109.235 -174.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.7 mt -68.02 -34.75 77.08 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.644 0.778 . . . . 72.230000000000004 110.376 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.66 173.6 38.65 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.337 -0.847 . . . . 60.119999999999997 111.887 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.686 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 14.2 m-85 -98.21 168.84 9.99 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.319 0.648 . . . . 72.439999999999998 109.536 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -71.38 152.15 43.42 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.059 -0.719 . . . . 75.219999999999999 109.059 172.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -58.11 -44.37 87.68 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.229 0.612 . . . . 74.329999999999998 111.472 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -79.13 -5.44 54.14 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 122.949 0.499 . . . . 72.430000000000007 110.315 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 72.6 34.31 60.09 Favored Glycine 0 C--N 1.352 1.44 0 C-N-CA 123.22 0.438 . . . . 72.109999999999999 113.349 174.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -85.44 -61.86 1.66 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.535 0.684 . . . . 72.239999999999995 109.498 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 129' ' ' TRP . 74.5 m95 -111.56 178.11 4.43 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.871 -1.059 . . . . 75.129999999999995 109.974 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -144.45 116.01 8.13 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.98 0.912 . . . . 73.230000000000004 108.658 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -76.58 110.83 11.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.89 0.376 . . . . 74.430000000000007 111.11 -174.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -105.5 165.35 11.2 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.223 -0.899 . . . . 51.439999999999998 110.195 177.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -142.61 125.27 15.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.34 0.656 . . . . 75.340000000000003 109.409 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.7 p -135.86 -164.31 1.53 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.315 1.046 . . . . 73.5 110.416 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -53.99 -33.28 56.64 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.487 1.515 . . . . 75.439999999999998 111.214 172.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -77.52 -1.85 32.59 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.88 1.272 . . . . 72.019999999999996 112.093 -177.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.09 -135.4 12.74 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.262 -0.735 . . . . 72.430000000000007 111.262 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -141.56 135.08 29.73 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.68 0.74 . . . . 73.140000000000001 110.63 -172.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -179.07 176.86 48.21 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 112.215 -0.354 . . . . 74.030000000000001 112.215 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.47 ' HE1' ' HB2' ' A' ' 24' ' ' LYS . 79.8 m95 -87.15 131.64 34.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.538 0.735 . . . . 72.549999999999997 111.309 -174.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.45 152.14 60.76 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.492 1.117 . . . . 73.530000000000001 109.294 175.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.71 131.52 17.34 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 121.819 1.68 . . . . 74.430000000000007 109.896 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.1 m -61.63 -18.73 60.64 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.988 0.915 . . . . 72.329999999999998 112.402 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -74.68 -18.73 60.48 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.322 1.049 . . . . 73.219999999999999 111.638 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.46 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 5.4 m-85 -97.93 1.24 47.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.595 0.758 . . . . 74.030000000000001 111.862 -177.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.3 pt -133.12 158.96 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 122.873 0.469 . . . . 74.25 110.435 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.3 t -150.61 140.86 14.23 Favored Pre-proline 0 N--CA 1.49 1.56 0 C-N-CA 122.527 0.331 . . . . 63.130000000000003 110.436 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.48 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 74.3 Cg_endo -72.85 132.37 18.4 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.91 2.407 . . . . 63.25 113.055 -177.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.7 m -113.86 -40.95 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 122.811 0.444 . . . . 74.019999999999996 111.693 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.426 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 62.8 t30 -100.97 0.42 38.21 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 122.859 0.464 . . . . 65.140000000000001 111.713 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 33.2 t -75.54 -178.94 4.34 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.11 0.564 . . . . 70.219999999999999 110.33 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 50.0 mt -56.86 -18.23 12.3 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.548 1.139 . . . . 74.25 112.708 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.572 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 28.2 tt0 -62.07 -19.13 62.6 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.89 0.876 . . . . 71.439999999999998 112.4 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -58.65 -23.73 59.71 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.419 0.688 . . . . 75.109999999999999 111.427 174.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -90.67 134.19 34.59 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.485 -0.931 . . . . 73.040000000000006 108.485 173.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.8 p -62.19 -20.56 64.29 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.013 0.745 . . . . 72.299999999999997 113.013 -172.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -73.51 -30.21 62.97 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.118 0.414 . . . . 63.530000000000001 112.118 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -103.33 135.02 45.74 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.553 -0.536 . . . . 74.450000000000003 109.553 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.572 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 16.6 m-70 -130.74 44.49 2.95 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.899 0.479 . . . . 74.329999999999998 110.667 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.45 -160.3 36.61 Favored Glycine 0 CA--C 1.541 1.669 0 N-CA-C 116.45 1.34 . . . . 64.409999999999997 116.45 164.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -83.37 108.97 1.56 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 124.178 3.252 . . . . 64.540000000000006 112.663 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 20.5 m -144.4 172.7 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 109.463 -0.569 . . . . 74.109999999999999 109.463 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.9 m -95.64 171.88 8.4 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 115.834 -0.621 . . . . 74.219999999999999 111.134 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -58.2 -25.29 61.41 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.002 0.921 . . . . 73.299999999999997 111.831 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -66.04 -56.45 11.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.068 0.947 . . . . 74.140000000000001 110.661 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.56 93.37 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.476 0.71 . . . . 73.209999999999994 110.614 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.465 ' HA ' ' NH2' ' A' ' 171' ' ' ARG . . . -56.59 -55.1 38.17 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-N 114.973 -1.012 . . . . 72.099999999999994 110.737 175.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.552 ' HG3' HG12 ' A' ' 190' ' ' VAL . 39.9 tt0 -68.59 -28.98 67.42 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.628 0.771 . . . . 71.230000000000004 110.927 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -61.17 -49.81 75.7 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.358 0.663 . . . . 74.420000000000002 110.5 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.537 HD13 HH22 ' A' ' 171' ' ' ARG . 38.4 mt -73.41 -32.98 64.73 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.85 -0.614 . . . . 72.109999999999999 111.811 177.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.498 HD23 ' HB3' ' A' ' 183' ' ' SER . 44.4 tp -69.88 -26.01 63.98 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.186 0.994 . . . . 74.409999999999997 111.326 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.7 t -69.52 -8.87 50.88 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.847 0.859 . . . . 75.450000000000003 111.594 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.9 t -95.94 12.03 31.79 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.588 0.755 . . . . 64.409999999999997 110.762 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.93 174.02 18.0 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 114.155 0.422 . . . . 73.040000000000006 114.155 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.6 pt -123.9 -165.55 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.512 1.125 . . . . 74.010000000000005 109.984 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.844 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 13.8 p-10 -52.64 108.65 0.32 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.08 0.952 . . . . 74.030000000000001 112.66 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 100.49 11.59 40.97 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.42 -0.809 . . . . 73.409999999999997 112.904 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.3 t -77.4 129.33 35.64 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.477 -0.934 . . . . 70.099999999999994 108.477 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -136.52 153.27 51.06 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.811 0.671 . . . . 74.340000000000003 112.811 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.721 HD11 HH21 ' A' ' 171' ' ' ARG . 88.9 mt -131.05 132.16 44.74 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.73 -1.211 . . . . 75.329999999999998 107.73 168.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.71 121.68 56.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 106.663 -1.606 . . . . 73.439999999999998 106.663 172.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.721 HH21 HD11 ' A' ' 169' ' ' LEU . 13.1 mmt180 -128.37 165.99 19.54 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.091 0.957 . . . . 74.340000000000003 108.781 -172.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 13.2 pt-20 -114.94 150.87 35.05 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 107.622 -1.251 . . . . 65.030000000000001 107.622 158.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.6 p -86.44 133.08 33.79 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.347 0.404 . . . . 75.150000000000006 109.915 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.76 -38.19 88.4 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.008 0.923 . . . . 64.439999999999998 110.869 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.42 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 32.9 p -81.31 -10.92 59.47 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.001 0.92 . . . . 70.549999999999997 112.418 -175.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 39.8 m -138.27 101.04 8.42 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 122.915 0.486 . . . . 74.049999999999997 110.477 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.686 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 56.5 Cg_endo -66.55 137.86 47.87 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.715 2.943 . . . . 74.329999999999998 112.462 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.36 -22.41 4.58 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 116.224 -0.443 . . . . 75.420000000000002 113.537 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -82.85 119.44 24.39 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.734 0.814 . . . . 70.019999999999996 109.335 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 77.8 mtt-85 -116.97 163.24 16.52 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 115.184 -0.916 . . . . 74.420000000000002 108.924 -176.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.2 m -147.92 148.0 30.33 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.143 0.577 . . . . 65.120000000000005 110.098 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 66.1 mt -110.58 137.74 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 108.864 -0.791 . . . . 72.420000000000002 108.864 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.498 ' HB3' HD23 ' A' ' 160' ' ' LEU . 29.1 m -114.01 115.51 27.73 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.665 1.186 . . . . 64.099999999999994 108.348 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.5 mt -105.0 144.95 31.11 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.808 0.843 . . . . 73.299999999999997 111.511 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.423 ' HB2' ' HG ' ' A' ' 160' ' ' LEU . 28.3 ttt180 -126.97 138.99 53.36 Favored 'General case' 0 C--O 1.256 1.405 0 N-CA-C 107.071 -1.455 . . . . 74.450000000000003 107.071 168.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.844 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 10.3 t80 -149.9 103.98 3.26 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.504 -1.225 . . . . 75.340000000000003 108.328 -168.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 56.02 35.66 25.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.682 1.193 . . . . 73.409999999999997 112.321 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.3 78.76 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.503 -0.771 . . . . 71.530000000000001 113.264 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -98.22 124.39 42.78 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.735 -0.839 . . . . 75.340000000000003 108.735 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.552 HG12 ' HG3' ' A' ' 157' ' ' GLU . 48.4 t -109.18 129.51 63.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.47 1.108 . . . . 73.310000000000002 108.78 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.459 ' HE2' ' HB3' ' A' ' 186' ' ' TYR . 13.1 p90 -146.85 143.85 28.88 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.231 1.013 . . . . 73.299999999999997 109.156 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -126.53 140.66 52.28 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.186 0.994 . . . . 64.239999999999995 108.814 -170.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -139.16 140.65 37.92 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.957 0.408 . . . . 75.349999999999994 111.056 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 23.1 tpp180 -77.04 131.2 38.29 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.903 -1.044 . . . . 74.540000000000006 110.705 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 96.3 mt -78.36 106.18 8.63 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 N-CA-C 107.555 -1.276 . . . . 63.119999999999997 107.555 164.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -75.5 124.94 28.04 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.531 -0.914 . . . . 64.549999999999997 108.531 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.3 m -99.7 115.46 29.53 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.931 0.893 . . . . 60.299999999999997 109.604 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.07 148.63 51.52 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.603 0.761 . . . . 64.340000000000003 109.033 167.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 75.1 p -66.71 -8.75 30.09 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.149 0.58 . . . . 71.430000000000007 112.382 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -83.58 -0.66 51.38 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.03 0.932 . . . . 74.519999999999996 111.14 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 86.83 -0.91 86.74 Favored Glycine 0 C--N 1.349 1.301 0 C-N-CA 123.12 0.39 . . . . 63.310000000000002 112.631 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -76.52 129.35 36.35 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 116.903 0.351 . . . . 74.319999999999993 110.105 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.5 mt -96.61 148.23 23.07 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.397 0.679 . . . . 72.519999999999996 109.261 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -164.61 167.49 19.18 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 123.747 0.655 . . . . 74.310000000000002 110.798 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.4 t -136.62 -63.47 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.815 -1.179 . . . . 73.530000000000001 107.815 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 30.2 t -86.38 167.49 14.68 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.179 0.992 . . . . 74.319999999999993 109.484 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 42.8 p -67.75 -39.79 84.15 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.585 0.754 . . . . 73.010000000000005 109.907 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -82.76 -2.52 54.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.841 0.856 . . . . 74.219999999999999 112.062 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.424 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 58.1 m -92.77 118.15 30.78 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.978 0.911 . . . . 75.299999999999997 109.581 171.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -144.87 118.19 9.0 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 124.684 1.193 . . . . 75.230000000000004 108.545 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 209' ' ' SER . 10.7 m-85 -135.39 150.43 49.9 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 118.295 0.498 . . . . 71.25 111.505 -172.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -92.03 -29.91 16.33 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.567 0.747 . . . . 62.520000000000003 110.47 171.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.1 p -124.4 147.42 48.27 Favored 'General case' 0 C--O 1.248 1.025 0 C-N-CA 123.527 0.731 . . . . 73.040000000000006 111.074 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 32.9 tp -65.56 -31.68 72.86 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 114.37 -1.287 . . . . 72.200000000000003 110.657 175.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.87 98.14 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.447 0.699 . . . . 71.310000000000002 111.154 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -73.7 -30.54 62.92 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 119.069 -0.491 . . . . 72.239999999999995 111.693 175.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.96 -47.54 84.73 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.514 0.509 . . . . 74.340000000000003 110.446 172.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.2 t -71.4 -37.32 64.51 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 C-N-CA 124.022 0.929 . . . . 74.010000000000005 110.808 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 14.4 t-160 -62.35 -56.14 21.23 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.719 0.807 . . . . 75.439999999999998 111.108 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -52.75 -53.53 46.65 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.641 -1.163 . . . . 70.209999999999994 109.393 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.411 ' HB3' ' HG ' ' A' ' 232' ' ' LEU . 8.0 m-70 -63.09 -27.72 69.59 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.979 -0.555 . . . . 74.329999999999998 112.388 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.5 t -71.23 -23.66 62.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.846 0.459 . . . . 74.329999999999998 110.841 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 15.4 t -119.07 -3.69 10.63 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 116.407 2.002 . . . . 72.299999999999997 116.407 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.406 ' O ' HG21 ' A' ' 231' ' ' THR . 27.0 m -106.03 154.67 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 116.422 2.008 . . . . 74.519999999999996 116.422 -172.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.7 -0.73 56.84 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 110.793 -2.912 . . . . 73.010000000000005 113.285 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -76.25 13.72 0.87 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 129.596 3.158 . . . . 71.150000000000006 113.56 -140.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.45 16.87 4.99 Favored Glycine 0 N--CA 1.464 0.545 0 C-N-CA 126.253 1.882 . . . . 73.230000000000004 111.629 -169.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.06 126.69 38.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.609 -1.295 . . . . 71.219999999999999 109.551 166.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 76.9 mt -58.36 -49.55 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.581 0.752 . . . . 73.010000000000005 109.428 170.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.8 t -134.24 148.13 50.79 Favored 'General case' 0 C--O 1.249 1.064 0 N-CA-C 107.826 -1.175 . . . . 71.329999999999998 107.826 169.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' THR . . . . . 0.406 HG21 ' O ' ' A' ' 224' ' ' VAL . 67.0 p -70.52 162.93 27.91 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 109.53 -0.544 . . . . 72.540000000000006 109.53 175.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.411 ' HG ' ' HB3' ' A' ' 221' ' ' HIS . 21.5 mt -68.58 100.52 1.13 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.154 -1.054 . . . . 62.240000000000002 108.154 176.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -90.89 -47.18 7.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.767 0.427 . . . . 64.409999999999997 111.253 -168.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -157.12 147.8 16.24 Favored Pre-proline 0 N--CA 1.485 1.319 0 N-CA-C 109.676 -0.49 . . . . 74.209999999999994 109.676 174.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.14 133.69 34.02 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.656 2.237 . . . . 72.209999999999994 112.626 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.71 150.25 97.9 Favored Pre-proline 0 C--O 1.246 0.882 0 C-N-CA 123.555 0.742 . . . . 72.219999999999999 110.414 174.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.437 ' O ' ' HB3' ' A' ' 159' ' ' LEU . 51.6 Cg_exo -56.95 132.57 52.44 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.341 2.694 . . . . 73.420000000000002 114.908 -172.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.422 ' HA ' HD12 ' A' ' 159' ' ' LEU . 54.3 tttp . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 106.721 -1.585 . . . . 60.439999999999998 106.721 158.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.0 p . . . . . 0 C--O 1.247 0.932 0 CA-C-O 121.325 0.583 . . . . 74.409999999999997 110.861 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.6 mt -107.9 123.71 36.97 Favored Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 108.405 -0.961 . . . . 71.120000000000005 108.405 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HG2' ' NE1' ' A' ' 118' ' ' TRP . 55.5 Cg_endo -71.73 173.77 12.13 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.812 2.341 . . . . 73.439999999999998 112.253 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.79 149.28 29.67 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.16 0.584 . . . . 64.439999999999998 111.32 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.517 HD22 HD12 ' A' ' 23' ' ' ILE . 89.2 mt -87.43 95.23 9.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.322 0.649 . . . . 73.540000000000006 109.767 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -97.44 -49.15 5.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.147 0.579 . . . . 70.349999999999994 110.485 175.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -99.87 107.78 19.87 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.91 -0.404 . . . . 74.409999999999997 109.91 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 97' ' ' ASN . 46.6 mm -124.26 121.04 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.103 0.961 . . . . 74.230000000000004 109.551 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 109.376 -0.602 . . . . 75.420000000000002 109.376 174.076 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo . . . . . 0 N--CA 1.499 1.837 0 N-CA-C 113.647 0.595 . . . . 70.150000000000006 113.647 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -88.67 72.6 8.66 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.638 0.732 . . . . 73.319999999999993 109.062 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.547 HD13 ' HB3' ' A' ' 106' ' ' LYS . 29.8 tp -89.95 130.92 36.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.952 -1.022 . . . . 75.019999999999996 108.878 177.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -113.84 174.97 5.67 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.008 1.723 . . . . 73.409999999999997 109.015 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.96 149.1 19.95 Favored 'Isoleucine or valine' 0 C--O 1.256 1.395 0 N-CA-C 109.081 -0.711 . . . . 71.129999999999995 109.081 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.25 124.5 33.92 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.387 -0.824 . . . . 74.420000000000002 109.828 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.4 mt -83.13 -17.74 41.97 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.264 1.026 . . . . 74.25 111.619 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.491 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 57.8 m-85 -135.44 166.37 23.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.71 0.804 . . . . 64.019999999999996 109.336 -175.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -78.79 145.8 34.13 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.271 -0.877 . . . . 70.430000000000007 109.172 168.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -155.46 112.75 3.29 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.687 -0.486 . . . . 65.510000000000005 109.687 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.98 139.12 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.192 -0.67 . . . . 64.530000000000001 109.192 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.13 127.74 34.18 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.963 -0.384 . . . . 73.040000000000006 109.963 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.6 p -65.66 -24.37 67.01 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.648 0.779 . . . . 70.109999999999999 110.919 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.97 -149.78 8.47 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.53 -1.028 . . . . 72.120000000000005 110.53 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.24 -30.59 69.67 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.819 0.848 . . . . 72.209999999999994 111.578 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.592 ' HB2' HD11 ' A' ' 23' ' ' ILE . 20.1 p30 -71.24 -23.31 61.97 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.029 0.932 . . . . 74.310000000000002 113.51 -172.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.6 p -113.26 163.12 15.21 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.747 0.819 . . . . 61.539999999999999 110.217 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.404 ' HB3' HG11 ' A' ' 130' ' ' VAL . 59.3 tp -111.06 125.72 54.05 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.13 -0.693 . . . . 74.099999999999994 109.13 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -74.43 119.66 18.92 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.677 -0.86 . . . . 73.219999999999999 108.677 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.0 pt -123.87 138.71 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.273 0.629 . . . . 75.209999999999994 109.546 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.4 m -97.23 150.06 21.34 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.336 -0.847 . . . . 65.310000000000002 109.756 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -61.22 113.58 2.68 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 109.484 -0.562 . . . . 74.019999999999996 109.484 172.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.25 -11.11 47.69 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.198 -0.455 . . . . 73.310000000000002 113.697 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -72.68 134.56 45.13 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.537 0.735 . . . . 74.409999999999997 110.387 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.547 ' HB3' HD13 ' A' ' 84' ' ' LEU . 34.8 mtmm -85.75 123.27 30.94 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.877 0.871 . . . . 74.239999999999995 109.7 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.594 ' HA ' HG21 ' A' ' 123' ' ' THR . 13.0 mt -107.88 158.36 17.4 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.898 -0.779 . . . . 74.120000000000005 108.898 -170.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtm-85 -123.07 108.64 13.12 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.846 -0.798 . . . . 75.049999999999997 108.846 164.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.487 HG21 HD11 ' A' ' 135' ' ' ILE . 98.6 t -88.71 109.46 20.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.334 -0.617 . . . . 75.219999999999999 109.334 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.471 HD12 ' NE2' ' A' ' 127' ' ' GLN . 75.8 mt -81.68 -12.23 58.75 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.198 -0.91 . . . . 71.030000000000001 111.092 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.72 159.13 18.67 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.39 -0.684 . . . . 54.25 111.39 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 4.1 m-85 -96.93 173.61 7.2 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.686 0.794 . . . . 74.310000000000002 110.28 178.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.439 HD21 ' HB2' ' A' ' 118' ' ' TRP . 32.3 t-20 -77.76 147.19 35.45 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.176 0.991 . . . . 72.239999999999995 108.555 173.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.507 ' HD2' ' HG2' ' A' ' 177' ' ' PRO . 34.0 m170 -63.7 -26.28 68.58 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.117 0.567 . . . . 71.430000000000007 111.645 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -87.66 -16.85 33.21 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.389 1.075 . . . . 63.530000000000001 110.512 175.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.94 0.68 77.59 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 123.911 0.767 . . . . 75.299999999999997 113.68 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -78.0 -47.29 18.8 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.158 0.983 . . . . 71.239999999999995 112.098 -172.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.439 ' HB2' HD21 ' A' ' 113' ' ' ASN . 83.2 m95 -105.61 174.63 5.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.857 0.863 . . . . 62.420000000000002 109.637 177.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -153.49 127.14 8.75 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.175 -1.046 . . . . 74.230000000000004 108.175 175.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -74.28 106.63 6.01 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.232 0.469 . . . . 73.420000000000002 110.409 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.66 163.65 12.18 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.317 -0.856 . . . . 74.340000000000003 109.698 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -139.71 122.78 16.78 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.6 -1.259 . . . . 64.439999999999998 107.6 178.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.594 HG21 ' HA ' ' A' ' 107' ' ' LEU . 78.9 p -131.81 -169.56 2.23 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.379 0.672 . . . . 75.120000000000005 110.611 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -54.1 -28.52 39.87 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.098 -1.41 . . . . 65.420000000000002 111.708 170.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -84.64 -2.36 57.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.33 1.052 . . . . 64.010000000000005 111.84 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.51 -132.79 10.15 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 111.418 -0.673 . . . . 72.209999999999994 111.418 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.471 ' NE2' HD12 ' A' ' 110' ' ' LEU . 63.3 tt0 -142.99 143.74 32.04 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.243 0.617 . . . . 75.109999999999999 110.29 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 174.91 -178.13 46.76 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.843 -0.617 . . . . 54.409999999999997 111.58 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -95.97 123.87 39.74 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.017 0.527 . . . . 72.450000000000003 110.762 -173.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.404 HG11 ' HB3' ' A' ' 99' ' ' LEU . 35.1 m -117.64 149.02 44.24 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.978 1.311 . . . . 73.450000000000003 109.601 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.78 132.53 23.48 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 121.669 1.579 . . . . 74.310000000000002 111.234 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.6 m -60.74 -21.56 63.1 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.177 0.991 . . . . 75.040000000000006 112.364 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -68.55 -24.65 64.65 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.879 0.872 . . . . 73.530000000000001 111.741 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.491 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.2 m-85 -94.94 0.84 55.06 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.791 0.836 . . . . 72.140000000000001 112.78 -177.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.487 HD11 HG21 ' A' ' 109' ' ' VAL . 15.9 pt -127.72 160.88 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 118.98 0.809 . . . . 74.25 111.365 -171.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.1 t -157.89 145.09 13.39 Favored Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 119.108 -0.472 . . . . 71.349999999999994 110.599 169.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.37 139.27 37.73 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.714 2.276 . . . . 74.230000000000004 111.804 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.28 -50.01 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.001 0.52 . . . . 74.239999999999995 112.037 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -100.74 -6.04 25.56 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.397 0.544 . . . . 75.439999999999998 110.916 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.5 t -60.32 177.75 0.25 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.27 1.028 . . . . 75.340000000000003 111.891 -176.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 84.7 mt -57.13 -17.66 11.75 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.981 0.912 . . . . 73.219999999999999 112.678 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -57.7 -24.7 58.18 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.506 1.122 . . . . 70.200000000000003 112.04 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -56.71 -36.19 69.39 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.409 1.083 . . . . 71.549999999999997 111.25 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 -74.33 141.71 45.2 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.369 -0.832 . . . . 75.230000000000004 109.342 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.1 t -62.69 -21.81 66.02 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.812 0.845 . . . . 75.120000000000005 112.075 -176.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.413 ' CE3' ' HB2' ' A' ' 147' ' ' TYR . 58.8 p-90 -80.05 -41.53 25.52 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.382 0.512 . . . . 73.510000000000005 112.382 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.413 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 29.5 t80 -99.98 138.04 37.6 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.375 0.534 . . . . 74.420000000000002 109.566 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -126.7 14.06 7.5 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 112.172 0.434 . . . . 64.109999999999999 112.172 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.15 -162.65 50.02 Favored Glycine 0 N--CA 1.474 1.23 0 CA-C-O 119.581 -0.566 . . . . 62.439999999999998 114.403 171.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.07 100.38 0.97 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.785 2.99 . . . . 61.439999999999998 111.558 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.537 HG11 ' NH2' ' A' ' 171' ' ' ARG . 84.1 t -138.93 150.92 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.818 0.447 . . . . 74.420000000000002 110.595 -172.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 18.4 m -59.2 139.34 57.04 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.598 1.159 . . . . 72.129999999999995 111.411 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -62.8 -27.59 69.41 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.736 0.814 . . . . 74.450000000000003 111.483 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -62.4 -50.3 72.07 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.529 0.732 . . . . 73.420000000000002 110.2 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.62 -33.83 76.81 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.461 0.705 . . . . 72.430000000000007 111.54 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.461 ' HB2' ' HG3' ' A' ' 171' ' ' ARG . . . -58.5 -52.36 65.97 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.256 -0.884 . . . . 60.539999999999999 110.573 173.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.461 ' HG3' HG12 ' A' ' 190' ' ' VAL . 35.0 tt0 -69.62 -27.41 65.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.537 0.735 . . . . 72.099999999999994 111.195 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -64.91 -49.42 70.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.856 0.862 . . . . 74.319999999999993 110.983 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.469 HD12 HH12 ' A' ' 171' ' ' ARG . 63.8 mt -70.77 -37.23 73.35 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 120.88 0.371 . . . . 74.25 110.739 175.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.7 tp -64.53 -25.38 67.96 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.547 -0.751 . . . . 75.349999999999994 112.094 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.6 t -59.96 -29.26 68.31 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.173 0.989 . . . . 62.119999999999997 111.228 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.2 t -77.17 -12.93 60.01 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.97 0.908 . . . . 74.340000000000003 111.969 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.59 165.61 32.43 Favored Glycine 0 C--N 1.344 1.001 0 N-CA-C 113.811 0.284 . . . . 61.539999999999999 113.811 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.0 pt -113.5 -164.28 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.58 1.152 . . . . 71.450000000000003 109.909 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.731 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 21.5 p-10 -52.99 115.18 1.72 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.725 0.81 . . . . 72.25 112.378 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.06 12.79 57.25 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 115.472 -0.785 . . . . 74.310000000000002 113.013 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 21.9 t -76.3 138.78 40.73 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.911 -0.774 . . . . 61.310000000000002 108.911 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.447 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 16.1 p90 -138.42 158.15 44.84 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.095 0.474 . . . . 72.25 111.979 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.496 HD12 ' NH1' ' A' ' 171' ' ' ARG . 84.9 mt -141.27 134.37 29.27 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.216 -1.031 . . . . 73.420000000000002 108.216 168.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.434 HG11 HD11 ' A' ' 214' ' ' LEU . 16.0 t -106.93 123.18 61.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.947 -1.131 . . . . 64.109999999999999 107.947 175.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.537 ' NH2' HG11 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -130.86 157.87 41.73 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.298 -1.371 . . . . 63.409999999999997 107.298 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 11.7 pt-20 -108.22 162.97 13.58 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 109.29 -0.633 . . . . 74.109999999999999 109.29 166.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' A' ' 176' ' ' SER . 48.1 t -82.67 136.94 34.62 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.22 -0.9 . . . . 71.230000000000004 111.038 -175.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.62 -22.35 63.5 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.139 -1.392 . . . . 70.430000000000007 111.567 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 30.1 t -111.24 -0.53 16.42 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.834 0.854 . . . . 74.019999999999996 111.384 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' A' ' 173' ' ' SER . 24.2 m -139.68 119.67 9.19 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 119.091 -0.481 . . . . 73.150000000000006 109.798 -178.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.507 ' HG2' ' HD2' ' A' ' 114' ' ' HIS . 21.4 Cg_exo -67.11 112.86 2.64 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 123.888 3.059 . . . . 74.319999999999993 113.401 -169.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.95 9.26 52.94 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.54 0.525 . . . . 62.43 114.024 175.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -85.05 114.55 22.28 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 107.71 -1.218 . . . . 72.120000000000005 107.71 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 57.2 mtt-85 -104.67 169.46 8.44 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.379 -0.6 . . . . 71.439999999999998 109.379 -169.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.0 m -155.0 136.42 14.15 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 123.875 0.87 . . . . 75.329999999999998 108.949 -173.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.426 HG12 HG23 ' A' ' 170' ' ' VAL . 54.7 mt -104.13 135.99 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 108.459 -0.941 . . . . 74.340000000000003 108.459 173.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.9 m -113.25 111.83 22.7 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.62 -1.173 . . . . 71.329999999999998 107.875 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.436 HD23 HD22 ' A' ' 232' ' ' LEU . 53.4 mt -105.0 139.81 39.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.753 0.821 . . . . 74.329999999999998 111.419 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -126.37 130.33 50.56 Favored 'General case' 0 C--O 1.261 1.685 0 O-C-N 124.056 0.848 . . . . 75.120000000000005 109.141 172.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.731 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 14.4 p90 -151.7 137.84 18.31 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 124.362 1.039 . . . . 75.5 108.492 172.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 55.36 28.94 12.18 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.044 1.338 . . . . 74.010000000000005 113.227 177.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.8 14.77 81.68 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 116.012 -0.54 . . . . 73.530000000000001 113.394 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -109.08 126.12 52.84 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.317 1.047 . . . . 74.409999999999997 108.698 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.461 HG12 ' HG3' ' A' ' 157' ' ' GLU . 91.5 t -109.81 135.58 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.509 0.724 . . . . 74.349999999999994 109.289 174.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.438 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 22.5 p90 -144.31 155.07 43.66 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.207 0.603 . . . . 74.019999999999996 109.538 171.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -129.17 136.34 50.03 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.156 -1.053 . . . . 72.150000000000006 108.156 -171.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -136.24 144.57 44.92 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 121.001 0.429 . . . . 75.530000000000001 110.738 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -76.91 131.71 38.71 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.73 -1.123 . . . . 72.230000000000004 110.365 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 77.8 mt -80.6 106.86 12.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 N-CA-C 108.298 -1.001 . . . . 72.530000000000001 108.298 164.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -69.74 123.72 22.12 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.436 -0.802 . . . . 70.209999999999994 109.558 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.3 m -104.88 107.99 19.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.427 0.691 . . . . 62.130000000000003 110.497 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.42 170.66 4.64 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.348 1.059 . . . . 71.209999999999994 111.293 173.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 41.2 p -59.21 -37.48 77.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.058 0.943 . . . . 75.540000000000006 112.191 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -76.1 -2.67 32.02 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.962 0.505 . . . . 75.340000000000003 111.862 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.92 6.89 84.65 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 111.811 -0.516 . . . . 74.530000000000001 111.811 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -69.83 128.29 35.88 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.74 -0.467 . . . . 73.219999999999999 109.74 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 80.8 mt -95.33 147.44 23.5 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.461 0.704 . . . . 74.329999999999998 109.784 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -163.6 164.88 23.96 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.425 0.69 . . . . 75.209999999999994 110.42 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 78.7 t -138.04 -52.64 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.11 0.964 . . . . 75.549999999999997 109.23 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 33.0 t -100.25 -178.28 3.78 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.774 0.83 . . . . 75.409999999999997 110.853 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.8 m -63.93 -46.23 85.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.641 1.177 . . . . 73.540000000000006 111.986 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.92 -14.42 41.91 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.263 0.625 . . . . 65.230000000000004 112.095 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 74.7 m -64.15 117.31 6.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.187 0.595 . . . . 63.130000000000003 111.186 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -146.53 112.73 5.83 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.654 1.182 . . . . 72.329999999999998 108.665 168.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -130.86 142.53 50.39 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.387 0.675 . . . . 74.439999999999998 109.417 -176.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -81.66 -34.81 30.55 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.661 0.384 . . . . 71.349999999999994 110.016 173.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 60.4 p -124.2 152.93 42.31 Favored 'General case' 0 C--O 1.255 1.363 0 CA-C-O 122.112 0.958 . . . . 72.109999999999999 111.287 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.434 HD11 HG11 ' A' ' 170' ' ' VAL . 35.9 tp -63.45 -31.14 72.21 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 113.671 -1.604 . . . . 64.299999999999997 111.266 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.96 95.65 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.497 0.719 . . . . 72.230000000000004 110.918 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -61.69 -44.13 97.54 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.478 0.711 . . . . 72.109999999999999 110.598 173.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.75 -41.08 85.67 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.709 0.631 . . . . 61.539999999999999 111.769 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.7 t -74.28 -41.99 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.645 0.778 . . . . 74.25 111.016 -175.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -58.81 -51.38 70.26 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.438 0.637 . . . . 70.129999999999995 110.1 174.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -54.14 -57.83 9.62 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.495 -1.229 . . . . 71.219999999999999 109.905 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -61.04 -26.7 67.81 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.337 0.655 . . . . 74.409999999999997 112.046 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 37.4 t -73.07 -27.76 61.92 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 122.913 0.485 . . . . 72.329999999999998 111.706 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.5 t -120.96 7.2 10.35 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 115.443 1.645 . . . . 71.010000000000005 115.443 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.74 156.14 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 121.069 1.759 . . . . 74.5 115.431 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.77 -2.47 58.25 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 129.986 3.314 . . . . 74.439999999999998 113.168 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -77.76 14.82 0.96 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 129.381 3.072 . . . . 73.439999999999998 113.51 -141.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.66 18.53 3.98 Favored Glycine 0 N--CA 1.47 0.921 0 C-N-CA 125.274 1.416 . . . . 75.409999999999997 111.377 -171.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 88.3 mt -91.26 134.49 34.53 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.206 1.002 . . . . 74.040000000000006 110.129 165.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.438 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 95.0 mt -67.83 -44.86 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 124.421 1.076 . . . . 72.420000000000002 108.695 170.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.5 t -135.04 142.13 46.3 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 114.992 -1.004 . . . . 71.299999999999997 108.866 173.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 67.4 p -70.38 155.98 39.95 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 108.606 -0.887 . . . . 75.129999999999995 108.606 171.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.447 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 32.1 mt -67.13 100.62 0.79 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.142 -1.058 . . . . 74.200000000000003 108.142 177.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -77.96 -50.29 12.46 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.066 0.547 . . . . 70.439999999999998 109.981 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 167' ' ' SER . 6.3 p90 -161.63 152.2 14.77 Favored Pre-proline 0 N--CA 1.488 1.455 0 C-N-CA 121.006 -0.278 . . . . 75.519999999999996 110.419 174.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.06 137.06 36.52 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.238 1.959 . . . . 74.129999999999995 111.538 173.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -57.99 130.7 83.12 Favored Pre-proline 0 C--O 1.246 0.9 0 O-C-N 123.558 0.536 . . . . 73.030000000000001 109.894 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.39 145.26 87.81 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.28 1.987 . . . . 72.209999999999994 112.143 -172.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt . . . . . 0 CA--C 1.545 0.766 0 CA-C-N 115.555 -0.748 . . . . 73.439999999999998 109.149 171.033 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.24 0.599 0 CA-C-O 121.796 0.808 . . . . 73.129999999999995 112.428 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.9 mt -107.72 133.28 20.5 Favored Pre-proline 0 C--O 1.241 0.62 0 CA-C-N 114.636 -1.165 . . . . 74.140000000000001 108.545 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.92 170.22 14.67 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.511 2.14 . . . . 75.25 111.99 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.89 144.67 29.06 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.051 0.541 . . . . 73.450000000000003 110.499 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.547 ' HB3' HD11 ' A' ' 23' ' ' ILE . 74.1 mt -87.43 94.85 9.81 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.557 0.743 . . . . 75.140000000000001 109.175 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -96.22 -47.09 6.18 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.023 -0.732 . . . . 75.200000000000003 109.023 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -99.77 113.77 26.47 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.143 -0.935 . . . . 72.230000000000004 109.815 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.547 HD11 ' HB3' ' A' ' 20' ' ' LEU . 39.1 mm -116.51 114.11 45.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 107.904 -1.147 . . . . 74.299999999999997 107.904 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.1 mttm . . . . . 0 N--CA 1.471 0.59 0 C-N-CA 123.202 0.601 . . . . 72.010000000000005 109.627 -175.861 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo . . . . . 0 CA--C 1.549 1.269 0 CA-C-O 120.608 0.17 . . . . 72.329999999999998 112.183 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -96.12 33.7 1.69 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.938 0.895 . . . . 73.209999999999994 110.368 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 33.9 tp -81.03 112.47 18.45 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.815 -0.809 . . . . 65.540000000000006 108.815 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.6 m-85 -104.45 177.73 4.76 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.918 1.687 . . . . 75.430000000000007 109.505 175.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 11.3 p -144.28 138.93 24.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.47 0.708 . . . . 74.299999999999997 109.161 171.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 102' ' ' THR . . . -78.23 112.8 15.58 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.98 0.912 . . . . 65.209999999999994 109.431 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.4 mt -74.72 -22.2 58.95 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.193 0.997 . . . . 73.239999999999995 111.925 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -130.88 152.55 50.08 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.103 0.961 . . . . 75.299999999999997 109.214 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -77.84 130.85 37.17 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.226 -1.027 . . . . 72.540000000000006 108.226 173.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.474 ' HB3' HG12 ' A' ' 101' ' ' ILE . 74.7 t80 -133.21 114.83 14.27 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 108.916 -0.772 . . . . 74.239999999999995 108.916 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.3 136.76 22.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 108.904 -0.776 . . . . 73.409999999999997 108.904 171.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.8 137.96 57.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.762 0.425 . . . . 75.329999999999998 110.537 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.1 t -75.73 -9.93 59.01 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.064 0.546 . . . . 75.010000000000005 110.152 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.12 -154.63 25.12 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 115.866 -0.606 . . . . 75.450000000000003 111.759 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.99 -40.25 95.0 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.258 1.023 . . . . 70.540000000000006 111.789 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -67.86 -25.06 65.34 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.769 0.828 . . . . 72.109999999999999 112.467 -172.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.9 p -106.29 158.49 16.83 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.626 0.77 . . . . 71.109999999999999 109.702 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.8 tp -109.66 124.94 52.05 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 122.999 0.52 . . . . 73.200000000000003 109.991 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 p -70.57 114.88 9.11 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.279 -0.873 . . . . 74.010000000000005 109.356 170.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.474 HG12 ' HB3' ' A' ' 91' ' ' PHE . 24.8 pt -119.7 156.98 22.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.023 -0.732 . . . . 75.140000000000001 109.023 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.451 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 1.9 m -117.35 143.65 45.74 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.318 -0.623 . . . . 53.109999999999999 109.318 -174.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -57.56 120.22 7.91 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 122.807 0.443 . . . . 74.219999999999999 110.367 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.53 -13.84 63.82 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.323 0.389 . . . . 73.349999999999994 113.455 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -85.74 130.98 34.41 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.846 0.858 . . . . 71.040000000000006 110.235 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.633 ' HB2' ' HZ3' ' A' ' 106' ' ' LYS . 9.1 mtmp? -83.7 142.72 30.53 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.813 0.845 . . . . 74.120000000000005 110.886 -177.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.1 mt -120.46 150.96 39.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.519 1.128 . . . . 72.230000000000004 108.282 -171.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -113.89 107.37 15.61 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.941 -1.133 . . . . 72.430000000000007 107.941 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.08 121.94 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 109.935 -0.394 . . . . 72.439999999999998 109.935 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 72.3 mt -83.38 -41.57 18.02 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.098 0.475 . . . . 75.409999999999997 109.95 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.52 172.34 44.07 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.58 -0.736 . . . . 70.140000000000001 111.828 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.477 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 13.3 m-85 -99.28 169.13 9.58 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.046 -0.724 . . . . 71.349999999999994 109.046 175.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -66.39 146.53 54.47 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.877 -1.156 . . . . 75.219999999999999 107.877 172.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . 0.685 ' HA ' ' HG3' ' A' ' 177' ' ' PRO . 31.0 m170 -68.59 -21.27 64.52 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.939 0.496 . . . . 72.099999999999994 112.217 -174.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -94.57 -12.23 27.92 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.17 0.588 . . . . 71.510000000000005 110.673 174.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.594 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 82.33 35.23 21.07 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 116.453 -0.339 . . . . 44.539999999999999 112.794 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -85.59 -65.68 0.98 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.518 0.727 . . . . 74.230000000000004 110.256 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -115.83 179.46 3.97 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.654 1.181 . . . . 71.439999999999998 109.5 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -135.31 127.45 29.91 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.91 0.884 . . . . 41.409999999999997 108.664 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -83.46 113.84 21.05 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.199 0.523 . . . . 73.310000000000002 110.668 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.76 163.49 18.04 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 114.966 -1.016 . . . . 72.239999999999995 110.47 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -133.16 141.64 48.23 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.103 0.961 . . . . 74.310000000000002 109.596 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.3 p -137.33 179.77 6.2 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.54 1.536 . . . . 74.420000000000002 108.053 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -73.96 -6.51 47.78 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.437 0.295 . . . . 54.420000000000002 110.753 172.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -76.88 -22.93 52.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.061 0.945 . . . . 75.049999999999997 110.177 169.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 130.13 -171.1 20.59 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 111.109 -0.796 . . . . 52.43 111.109 -174.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -115.96 147.05 41.58 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.642 0.777 . . . . 62.109999999999999 110.245 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 175.45 -176.81 47.4 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 123.442 0.464 . . . . 75.219999999999999 112.767 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -89.42 136.01 33.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.833 0.853 . . . . 70.230000000000004 110.631 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.76 154.95 80.78 Favored Pre-proline 0 N--CA 1.482 1.163 0 C-N-CA 124.465 1.106 . . . . 75.299999999999997 110.206 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.68 130.1 11.36 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.481 2.12 . . . . 53.0 111.236 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.49 ' HA ' HG12 ' A' ' 135' ' ' ILE . 13.6 p -63.43 -20.93 65.98 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.61 0.764 . . . . 74.420000000000002 111.897 178.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -70.73 -27.02 63.65 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.872 0.869 . . . . 73.340000000000003 111.537 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -95.39 2.25 54.53 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.554 0.742 . . . . 63.210000000000001 111.955 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.49 HG12 ' HA ' ' A' ' 132' ' ' SER . 14.4 pt -134.92 152.33 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 118.029 0.377 . . . . 73.439999999999998 110.544 -173.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.4 t -143.3 139.56 16.71 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.455 0.702 . . . . 60.119999999999997 109.117 171.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.541 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 56.0 Cg_endo -71.05 140.36 37.69 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 122.26 1.974 . . . . 71.549999999999997 112.058 175.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.4 m -111.1 -45.05 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.152 0.981 . . . . 74.310000000000002 110.613 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.523 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.5 t30 -100.04 6.8 45.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.964 0.506 . . . . 53.340000000000003 111.22 -174.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.541 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 31.0 t -86.42 176.19 8.0 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.241 0.543 . . . . 74.450000000000003 110.127 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.449 ' O ' ' HB3' ' A' ' 147' ' ' TYR . 80.7 mt -66.21 -13.93 61.08 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.129 0.971 . . . . 75.430000000000007 112.585 -176.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.87 -28.79 64.47 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.521 0.728 . . . . 74.019999999999996 111.785 176.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -64.18 -25.37 68.05 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.088 -0.505 . . . . 74.099999999999994 110.853 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -78.54 134.29 37.27 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.57 -0.9 . . . . 74.439999999999998 108.57 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.1 t -67.89 -18.87 64.93 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.167 0.803 . . . . 74.319999999999993 113.167 -171.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -78.99 -26.46 43.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.073 0.549 . . . . 75.400000000000006 111.849 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 46.7 t80 -109.72 125.62 52.86 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.244 0.618 . . . . 64.409999999999997 109.389 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -113.11 25.89 10.97 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.669 0.388 . . . . 63.509999999999998 111.482 -172.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 64.61 -156.6 46.05 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.769 -0.65 . . . . 63.240000000000002 114.323 172.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.41 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 56.6 Cg_endo -70.52 101.58 1.04 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 123.009 2.473 . . . . 70.439999999999998 111.008 173.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.3 p -143.19 145.1 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 120.911 0.386 . . . . 75.120000000000005 110.289 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 70.5 m -73.62 166.73 22.74 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.449 1.1 . . . . 75.540000000000006 112.747 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 44.6 mtt85 -65.35 -40.94 94.24 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.52 -1.218 . . . . 72.319999999999993 111.359 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -70.13 -42.93 71.95 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.059 0.849 . . . . 75.439999999999998 111.186 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.64 -42.72 86.25 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.127 0.971 . . . . 72.140000000000001 110.135 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.35 -52.71 64.46 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.728 -1.124 . . . . 73.140000000000001 110.02 173.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.509 ' HG3' HG11 ' A' ' 190' ' ' VAL . 37.9 tt0 -61.07 -29.17 69.58 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.322 0.649 . . . . 75.409999999999997 111.272 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -63.68 -52.71 59.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.664 0.785 . . . . 55.049999999999997 110.277 173.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.62 -33.85 75.86 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.806 -0.634 . . . . 73.019999999999996 111.162 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.506 HD21 HG12 ' A' ' 190' ' ' VAL . 28.9 tp -78.55 -23.39 46.18 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.092 -0.958 . . . . 74.329999999999998 111.595 -177.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 t -64.28 -23.6 67.36 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.66 0.784 . . . . 72.310000000000002 111.374 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.0 m -82.88 -7.97 59.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.016 0.926 . . . . 65.030000000000001 112.091 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.15 174.03 41.67 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 114.26 0.464 . . . . 50.210000000000001 114.26 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.0 pt -121.29 -164.24 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.027 0.931 . . . . 70.120000000000005 109.91 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.75 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 22.7 p-10 -49.56 117.18 2.08 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.163 0.985 . . . . 72.140000000000001 112.236 177.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.97 13.99 68.06 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-N 115.562 -0.744 . . . . 71.519999999999996 113.617 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 23.3 t -73.54 132.96 43.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.569 -0.901 . . . . 75.540000000000006 108.569 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.488 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 19.4 p90 -134.87 161.32 35.55 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.176 0.806 . . . . 75.430000000000007 113.176 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 76.9 mt -137.87 135.47 36.19 Favored 'General case' 0 C--O 1.215 -0.754 0 C-N-CA 124.901 1.281 . . . . 73.340000000000003 108.978 172.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 14.3 t -114.83 140.06 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 106.467 -1.679 . . . . 75.040000000000006 106.467 167.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.2 ptt85 -158.72 168.85 25.77 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.955 0.502 . . . . 73.310000000000002 110.474 -172.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.456 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 12.2 pt-20 -115.46 153.44 31.1 Favored 'General case' 0 C--O 1.257 1.448 0 C-N-CA 123.09 0.556 . . . . 64.319999999999993 109.543 167.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 176' ' ' SER . 17.1 m -88.43 123.76 33.29 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.072 -0.967 . . . . 74.099999999999994 109.291 -178.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.41 ' HG2' ' HB2' ' A' ' 150' ' ' PRO . 38.3 mt-10 -57.56 -39.36 76.51 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.421 1.089 . . . . 72.329999999999998 111.674 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.594 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 8.5 t -87.41 -6.26 58.51 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 115.167 -0.924 . . . . 74.439999999999998 111.969 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 173' ' ' SER . 14.9 m -131.72 100.21 16.38 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.425 0.69 . . . . 73.109999999999999 109.324 -176.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 114' ' ' HIS . 36.3 Cg_endo -60.35 113.55 1.73 Allowed 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.745 2.963 . . . . 74.209999999999994 112.061 -174.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.72 -20.38 19.56 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 116.101 -0.5 . . . . 44.43 113.666 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -73.79 116.84 14.87 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.648 0.724 . . . . 75.340000000000003 109.305 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.456 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 66.9 mtt85 -113.23 160.23 18.5 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 124.186 0.995 . . . . 74.230000000000004 110.279 -171.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 44.4 t -143.92 151.58 40.0 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.093 0.957 . . . . 74.430000000000007 110.48 -174.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 52.1 mt -119.06 145.85 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.214 1.006 . . . . 74.010000000000005 108.519 169.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 14.5 m -125.18 127.34 46.65 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.629 1.172 . . . . 73.439999999999998 108.148 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.44 HD21 HD23 ' A' ' 232' ' ' LEU . 57.9 mt -113.67 147.78 37.53 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.624 0.77 . . . . 75.420000000000002 111.891 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 19.7 ttt180 -133.86 131.01 38.68 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-N 114.536 -1.211 . . . . 74.340000000000003 109.651 172.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.75 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 9.5 p90 -149.38 141.03 23.49 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.562 1.145 . . . . 74.049999999999997 108.022 173.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 54.07 31.67 14.18 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.224 1.01 . . . . 71.420000000000002 113.232 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.19 3.68 90.62 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 116.343 -0.389 . . . . 64.230000000000004 112.782 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 10.3 tpp180 -102.13 124.21 47.33 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.151 0.98 . . . . 74.129999999999995 109.72 -176.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.509 HG11 ' HG3' ' A' ' 157' ' ' GLU . 81.0 t -107.45 135.89 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.265 1.026 . . . . 74.019999999999996 109.578 177.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.478 ' HH ' HG22 ' A' ' 230' ' ' THR . 26.7 p90 -145.87 163.11 36.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.202 1.001 . . . . 74.439999999999998 109.744 171.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -133.45 141.98 48.07 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.194 0.997 . . . . 75.140000000000001 108.477 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -143.17 152.62 41.97 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.43 0.692 . . . . 75.219999999999999 109.57 175.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -95.85 138.01 34.1 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.452 0.701 . . . . 72.200000000000003 111.62 -170.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 69.4 mt -83.58 113.8 23.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 124.229 1.012 . . . . 71.230000000000004 108.347 165.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -88.38 134.87 33.71 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.194 0.598 . . . . 73.519999999999996 109.686 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.2 m -104.35 120.34 40.97 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.13 0.972 . . . . 55.210000000000001 109.518 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -72.48 164.82 25.77 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.304 1.042 . . . . 72.299999999999997 111.697 175.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 52.6 p -68.94 -17.05 63.89 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.645 0.778 . . . . 75.349999999999994 111.068 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.57 -19.19 65.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.407 1.083 . . . . 64.319999999999993 111.577 173.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 91.93 -6.06 79.18 Favored Glycine 0 C--N 1.353 1.517 0 CA-C-N 115.848 -0.615 . . . . 70.230000000000004 111.921 -168.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -76.25 144.23 40.49 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.351 0.66 . . . . 73.310000000000002 110.934 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 47.1 mt -95.65 152.48 18.41 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.598 1.159 . . . . 73.099999999999994 108.518 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -166.5 172.28 10.98 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.661 0.6 . . . . 74.540000000000006 111.084 174.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.4 t -131.84 -41.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.377 1.071 . . . . 74.140000000000001 108.758 174.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.6 t -92.39 153.83 18.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.331 -0.618 . . . . 71.530000000000001 109.331 173.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.4 p -66.48 -29.35 69.45 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.122 0.569 . . . . 72.109999999999999 110.957 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -92.56 2.92 56.43 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.4 0.68 . . . . 71.310000000000002 112.144 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 211' ' ' PHE . 86.7 p -105.67 137.9 42.76 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.913 -0.773 . . . . 73.510000000000005 108.913 176.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -143.43 126.83 16.76 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.302 1.041 . . . . 74.430000000000007 108.194 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 209' ' ' SER . 14.4 m-85 -133.74 133.94 42.38 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.175 0.59 . . . . 74.310000000000002 109.422 -178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -74.88 -35.54 62.29 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.08 0.552 . . . . 72.510000000000005 110.403 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 61.9 p -123.22 147.44 46.89 Favored 'General case' 0 C--O 1.256 1.41 0 CA-C-O 122.267 1.032 . . . . 63.420000000000002 111.637 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.421 ' O ' HG21 ' A' ' 218' ' ' VAL . 25.1 tp -64.32 -28.62 69.84 Favored 'General case' 0 C--O 1.213 -0.832 0 CA-C-N 113.655 -1.611 . . . . 73.200000000000003 111.205 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.68 -42.53 95.28 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.316 0.646 . . . . 73.140000000000001 111.452 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -71.7 -35.03 70.11 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.975 0.51 . . . . 70.0 110.347 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.411 HD22 HD12 ' A' ' 182' ' ' ILE . 9.5 tt -56.54 -46.58 80.58 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.901 0.751 . . . . 73.540000000000006 110.384 170.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 214' ' ' LEU . 44.4 t -66.27 -44.97 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.738 0.815 . . . . 73.230000000000004 110.586 -177.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -61.78 -45.45 93.81 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.91 0.484 . . . . 64.140000000000001 110.145 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -52.35 -61.67 2.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.244 -0.889 . . . . 64.120000000000005 108.855 175.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -59.71 -23.45 63.16 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.88 -0.6 . . . . 71.230000000000004 111.92 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.412 ' O ' ' HB ' ' A' ' 231' ' ' THR . 35.6 t -75.21 -28.04 59.81 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.109 0.563 . . . . 74.120000000000005 111.713 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.8 t -118.17 -9.83 10.41 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.447 1.647 . . . . 51.310000000000002 115.447 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 27.6 m -92.71 148.45 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 123.632 1.682 . . . . 62.32 115.058 -167.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.6 0.16 54.99 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 110.96 -2.836 . . . . 74.25 111.359 173.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -78.9 15.46 1.08 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 128.959 2.904 . . . . 72.439999999999998 112.478 -143.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.05 18.39 4.67 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 124.525 1.059 . . . . 71.140000000000001 111.794 -170.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 56.0 mt -93.06 145.59 24.27 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.763 0.825 . . . . 75.409999999999997 111.47 162.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.461 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 63.9 mt -75.34 -43.42 43.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.644 -0.873 . . . . 71.25 108.644 170.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.478 HG22 ' HH ' ' A' ' 191' ' ' TYR . 11.9 t -139.02 144.62 38.94 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.323 -0.853 . . . . 75.010000000000005 109.217 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 222' ' ' SER . 40.8 p -75.49 155.17 36.45 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.597 0.759 . . . . 71.450000000000003 109.73 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.488 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 21.2 mt -67.72 101.78 1.1 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.554 -0.906 . . . . 74.319999999999993 108.554 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -83.1 -47.43 11.66 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.49 0.716 . . . . 75.409999999999997 110.075 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -163.3 152.3 12.29 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 109.572 -0.529 . . . . 74.430000000000007 109.572 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.51 144.39 60.83 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 121.932 1.755 . . . . 75.329999999999998 111.973 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -60.54 137.71 92.56 Favored Pre-proline 0 C--O 1.248 0.992 0 C-N-CA 123.359 0.664 . . . . 73.209999999999994 109.981 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.06 116.4 3.15 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.914 2.409 . . . . 61.439999999999998 111.742 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? . . . . . 0 C--O 1.241 0.617 0 N-CA-C 107.85 -1.166 . . . . 75.109999999999999 107.85 174.085 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.2 m . . . . . 0 C--O 1.246 0.905 0 CA-C-O 121.095 0.474 . . . . 74.409999999999997 110.75 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.7 mt -104.27 133.5 20.19 Favored Pre-proline 0 C--O 1.238 0.449 0 N-CA-C 108.092 -1.077 . . . . 75.340000000000003 108.092 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.22 169.36 13.92 Favored 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 122.493 2.129 . . . . 72.140000000000001 112.025 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.3 147.03 27.43 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.933 -0.766 . . . . 75.439999999999998 108.933 170.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.419 HD21 HD11 ' A' ' 23' ' ' ILE . 83.4 mt -88.04 93.57 9.52 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.228 -0.656 . . . . 74.209999999999994 109.228 -177.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -98.23 -53.0 3.49 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.576 0.35 . . . . 75.030000000000001 110.281 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.427 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 61.0 m-85 -106.3 108.97 20.75 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.051 0.541 . . . . 75.430000000000007 110.124 -175.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.419 HD11 HD21 ' A' ' 20' ' ' LEU . 49.8 mm -123.79 120.76 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.754 0.822 . . . . 71.129999999999995 111.003 -175.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt . . . . . 0 CA--C 1.542 0.64 0 C-N-CA 123.486 0.714 . . . . 74.329999999999998 110.531 169.301 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 CA--C 1.542 0.883 0 N-CA-C 114.045 0.748 . . . . 74.409999999999997 114.045 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -64.96 83.48 0.04 OUTLIER 'General case' 0 C--N 1.353 0.719 0 CA-C-O 121.766 0.793 . . . . 75.530000000000001 109.85 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 33.6 tp -125.07 119.01 27.44 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.363 -1.29 . . . . 74.409999999999997 107.904 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -105.14 176.23 5.23 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.646 1.579 . . . . 64.129999999999995 109.226 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.62 144.73 25.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 N-CA-C 108.641 -0.874 . . . . 72.099999999999994 108.641 172.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.28 118.52 19.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.433 0.693 . . . . 74.209999999999994 109.748 174.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.29 -21.29 39.43 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.91 0.884 . . . . 71.129999999999995 111.073 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.566 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 93.1 m-85 -134.46 169.28 17.5 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.405 0.682 . . . . 74.099999999999994 110.15 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.39 145.76 27.32 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.177 -0.919 . . . . 63.329999999999998 109.133 170.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.43 ' HB3' HG12 ' A' ' 101' ' ' ILE . 86.2 t80 -151.93 104.81 3.03 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.457 -0.942 . . . . 65.430000000000007 108.457 176.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.6 t -80.37 133.92 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 107.878 -1.156 . . . . 72.519999999999996 107.878 172.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.41 114.77 10.89 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.595 -0.52 . . . . 75.140000000000001 109.595 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.1 m -77.03 -23.19 52.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.009 0.524 . . . . 74.120000000000005 110.663 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.75 168.28 19.8 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 123.796 0.685 . . . . 52.030000000000001 111.734 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.52 -29.88 63.99 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.529 0.732 . . . . 62.43 110.29 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -71.43 -19.92 62.18 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.993 1.317 . . . . 72.010000000000005 112.235 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.3 p -98.47 154.87 17.57 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.256 0.622 . . . . 74.409999999999997 109.998 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.6 tp -107.08 128.35 54.3 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.877 -0.786 . . . . 74.0 108.877 -177.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.1 t -82.56 118.15 23.07 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 109.782 -0.451 . . . . 73.510000000000005 109.782 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.43 HG12 ' HB3' ' A' ' 91' ' ' PHE . 28.6 pt -119.6 165.42 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.075 0.95 . . . . 75.109999999999999 110.066 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.5 m -138.59 145.64 40.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.465 0.706 . . . . 75.140000000000001 109.214 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -54.54 118.67 4.36 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.813 0.845 . . . . 74.129999999999995 111.778 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.85 -14.87 29.08 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.032 -0.531 . . . . 64.409999999999997 112.842 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -78.49 124.36 28.05 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.596 0.758 . . . . 73.150000000000006 110.258 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.435 ' HB3' HD11 ' A' ' 84' ' ' LEU . 31.8 mtmm -75.01 116.9 16.27 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.364 0.666 . . . . 72.310000000000002 109.574 176.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.9 mt -101.14 163.61 12.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.694 -0.854 . . . . 71.129999999999995 108.694 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -126.38 110.12 12.99 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.56 -0.904 . . . . 74.049999999999997 108.56 163.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 99.1 t -90.23 124.35 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.127 -0.694 . . . . 72.430000000000007 109.127 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.4 mt -81.78 -37.83 26.55 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.567 1.147 . . . . 72.409999999999997 109.273 -174.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.81 176.28 47.88 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 113.936 -1.484 . . . . 61.310000000000002 110.51 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.518 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 56.7 m-85 -103.95 175.05 5.61 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 109.386 -0.598 . . . . 75.109999999999999 109.386 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 22' ' ' PHE . 43.7 t-20 -68.98 148.74 49.69 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.428 -0.953 . . . . 73.530000000000001 108.428 169.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -66.09 -17.81 64.94 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.758 0.823 . . . . 70.120000000000005 112.578 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -95.84 -5.28 42.07 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.493 0.717 . . . . 65.319999999999993 111.062 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.3 34.69 63.95 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.378 -0.689 . . . . 60.409999999999997 111.378 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.463 ' HG2' ' CD1' ' A' ' 118' ' ' TRP . 36.8 tt0 -89.03 -58.36 2.57 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.202 1.401 . . . . 73.420000000000002 109.282 -170.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.463 ' CD1' ' HG2' ' A' ' 117' ' ' GLU . 87.5 m95 -126.24 -176.96 3.8 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.587 1.155 . . . . 74.409999999999997 110.086 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -132.28 116.54 17.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.338 1.055 . . . . 64.510000000000005 109.698 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.46 107.53 14.3 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.795 -0.817 . . . . 74.129999999999995 108.795 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -121.12 165.42 15.37 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.939 0.896 . . . . 65.530000000000001 111.58 -172.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -143.42 131.31 21.56 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.101 0.96 . . . . 74.219999999999999 110.138 -175.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 45.1 p -141.06 -176.99 4.89 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.634 1.174 . . . . 64.329999999999998 110.973 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -60.79 -21.58 63.24 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.229 1.012 . . . . 71.120000000000005 111.41 171.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -72.71 -26.87 61.75 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.759 0.824 . . . . 73.430000000000007 110.127 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.22 -135.1 6.88 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.203 -0.759 . . . . 42.130000000000003 111.203 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -152.88 148.55 27.29 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 122.924 0.489 . . . . 75.25 110.116 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 161.49 -177.7 37.68 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 121.088 0.271 . . . . 62.549999999999997 113.137 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -84.34 134.78 34.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.528 0.731 . . . . 63.439999999999998 111.781 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.66 155.23 80.65 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.085 1.354 . . . . 74.200000000000003 108.766 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -69.66 129.65 18.08 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 121.789 1.659 . . . . 75.409999999999997 110.846 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.4 m -60.25 -20.55 59.45 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.773 0.829 . . . . 75.510000000000005 112.539 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -84.66 -19.02 33.55 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.635 0.774 . . . . 74.530000000000001 111.615 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.566 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.4 m-85 -89.66 5.05 47.49 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.548 0.739 . . . . 73.310000000000002 112.107 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.456 HD13 HG22 ' A' ' 109' ' ' VAL . 21.3 pt -134.32 167.43 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.442 0.697 . . . . 70.319999999999993 110.695 -174.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.3 t -160.88 141.9 8.73 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 122.781 0.432 . . . . 73.319999999999993 111.11 168.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.04 133.21 22.76 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.978 2.452 . . . . 73.120000000000005 112.285 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.6 m -113.89 -49.15 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.109 0.564 . . . . 72.25 111.459 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.2 t30 -100.97 -11.7 19.5 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.92 0.488 . . . . 73.430000000000007 111.058 -176.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.1 t -65.39 177.62 1.1 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.549 0.74 . . . . 73.120000000000005 111.044 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.72 -21.95 21.22 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.194 1.183 . . . . 74.420000000000002 114.194 -171.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.59 -13.29 60.88 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.004 0.922 . . . . 75.5 112.028 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -63.33 -22.46 66.89 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.979 0.912 . . . . 73.450000000000003 110.692 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -85.07 145.22 27.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.612 0.765 . . . . 75.430000000000007 110.431 171.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.7 t -66.51 -20.76 66.11 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.861 0.865 . . . . 73.200000000000003 112.261 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -83.61 -34.87 25.02 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.097 0.406 . . . . 63.210000000000001 112.097 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 33.7 t80 -93.8 138.71 31.69 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 109.494 -0.558 . . . . 74.219999999999999 109.494 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.649 ' HB3' HH21 ' A' ' 171' ' ' ARG . 75.9 m-70 -134.27 26.39 3.83 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.448 0.536 . . . . 73.420000000000002 112.448 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 67.86 -163.5 47.31 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 115.585 0.994 . . . . 65.549999999999997 115.585 170.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.21 102.68 1.59 Allowed 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.499 2.799 . . . . 74.430000000000007 112.874 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.404 ' HB ' ' HD3' ' A' ' 171' ' ' ARG . 38.9 t -138.05 157.58 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 123.247 0.619 . . . . 75.439999999999998 110.363 -176.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.0 m -75.24 153.67 37.92 Favored 'General case' 0 C--O 1.256 1.435 0 C-N-CA 124.581 1.152 . . . . 75.030000000000001 112.09 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -62.81 -31.92 73.01 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.523 -0.762 . . . . 73.450000000000003 111.085 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -54.93 -53.6 53.51 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.022 0.929 . . . . 73.239999999999995 110.264 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.04 77.56 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.409 -0.814 . . . . 74.5 110.848 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.516 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.08 -50.53 73.13 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.345 0.593 . . . . 74.319999999999993 111.69 176.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.46 ' HG3' HG12 ' A' ' 190' ' ' VAL . 33.0 tt0 -78.2 -25.05 46.89 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.106 -0.952 . . . . 73.430000000000007 110.263 -175.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -60.25 -53.46 57.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.112 0.565 . . . . 64.340000000000003 110.269 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 64.8 mt -65.23 -39.33 92.58 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 116.237 -0.438 . . . . 73.040000000000006 110.854 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.543 HD21 ' HB3' ' A' ' 183' ' ' SER . 36.4 tp -73.08 -24.21 60.63 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.878 -0.601 . . . . 75.329999999999998 112.105 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 35.4 t -65.77 -23.81 66.8 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.109 0.564 . . . . 72.120000000000005 111.322 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 80.6 p -91.8 -0.64 57.54 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.155 0.582 . . . . 74.200000000000003 111.129 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -83.96 163.23 39.7 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.941 -0.572 . . . . 70.140000000000001 112.89 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.1 pt -120.15 -166.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.317 1.047 . . . . 72.209999999999994 111.095 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -58.58 107.36 0.5 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.899 0.879 . . . . 75.510000000000005 112.777 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 98.2 13.53 42.0 Favored Glycine 0 C--O 1.259 1.658 0 CA-C-N 116.03 -0.532 . . . . 75.299999999999997 112.617 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 31.5 t -74.35 134.79 42.49 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 119.126 -0.464 . . . . 52.149999999999999 109.961 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 183' ' ' SER . 22.3 p90 -135.25 153.7 51.82 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 121.51 0.671 . . . . 73.299999999999997 112.669 177.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 236' ' ' ALA . 97.5 mt -134.49 133.81 40.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.908 -1.042 . . . . 71.109999999999999 108.302 169.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 20.0 t -112.87 120.5 63.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.394 -1.336 . . . . 74.099999999999994 107.394 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.649 HH21 ' HB3' ' A' ' 148' ' ' HIS . 0.6 OUTLIER -159.37 148.89 18.5 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.469 -0.567 . . . . 73.530000000000001 109.469 177.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.79 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 15.0 pt-20 -92.3 157.77 16.47 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-O 121.224 0.535 . . . . 73.510000000000005 111.258 -176.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 p -76.72 115.97 16.97 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.975 -1.011 . . . . 71.439999999999998 108.53 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.21 -31.33 67.23 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.796 0.838 . . . . 70.340000000000003 112.429 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.8 t -95.67 8.46 43.37 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.81 0.844 . . . . 72.319999999999993 111.4 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 57.0 m -149.86 83.21 6.33 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 108.434 -0.95 . . . . 55.149999999999999 108.434 172.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.518 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 42.8 Cg_endo -63.57 140.55 75.85 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.47 2.78 . . . . 73.430000000000007 112.491 -173.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.65 -23.54 10.14 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.924 -0.58 . . . . 74.340000000000003 112.9 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -86.65 115.87 24.39 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 108.818 -0.808 . . . . 74.140000000000001 108.818 174.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.79 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 42.8 mtt85 -114.57 153.15 30.6 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.025 -0.989 . . . . 75.340000000000003 108.957 -173.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.1 m -134.18 142.72 47.53 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 109.945 -0.391 . . . . 63.119999999999997 109.945 -177.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.418 HG12 HG23 ' A' ' 170' ' ' VAL . 50.6 mt -106.48 136.25 41.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.365 -0.976 . . . . 70.040000000000006 108.365 169.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.543 ' HB3' HD21 ' A' ' 160' ' ' LEU . 20.4 m -115.77 113.95 24.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.99 -1.115 . . . . 72.25 107.99 -177.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 52.7 mt -104.58 141.09 37.03 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.5 0.72 . . . . 73.310000000000002 111.167 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 26.7 ttt180 -124.2 120.91 33.64 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 107.361 -1.348 . . . . 75.310000000000002 107.361 165.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.79 127.38 28.87 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.588 -1.264 . . . . 74.420000000000002 107.588 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 54.85 28.86 10.99 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.039 0.936 . . . . 64.329999999999998 112.282 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 89.31 1.25 78.88 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.155 0.407 . . . . 73.129999999999995 113.433 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 8.7 tpm_? -100.57 123.26 44.54 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.035 0.934 . . . . 74.400000000000006 109.455 -174.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.471 HG13 HD23 ' A' ' 160' ' ' LEU . 95.0 t -98.58 124.3 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.135 0.974 . . . . 74.450000000000003 109.978 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.473 ' HH ' ' HB ' ' A' ' 229' ' ' ILE . 14.3 p90 -145.95 149.99 35.21 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.062 0.945 . . . . 60.240000000000002 109.75 176.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -125.86 148.78 49.07 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.961 0.904 . . . . 74.129999999999995 109.361 -171.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -145.39 148.4 33.3 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.215 0.531 . . . . 74.049999999999997 111.106 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -93.77 125.88 38.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.932 -1.031 . . . . 74.140000000000001 111.785 -171.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 68.9 mt -77.65 111.0 13.97 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 124.397 1.079 . . . . 75.540000000000006 108.536 162.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -87.46 139.27 30.71 Favored 'General case' 0 C--O 1.249 1.051 0 N-CA-C 109.417 -0.586 . . . . 74.010000000000005 109.417 173.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 46.5 m -110.6 132.16 54.43 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.974 0.796 . . . . 65.200000000000003 110.1 -176.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.58 169.19 18.74 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.059 0.944 . . . . 75.310000000000002 111.1 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 72.1 p -75.92 -8.59 57.29 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.841 0.456 . . . . 74.549999999999997 111.461 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -93.33 -7.55 44.49 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.062 0.945 . . . . 73.219999999999999 110.821 170.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 91.8 -1.27 74.63 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-O 119.501 -0.61 . . . . 54.420000000000002 113.324 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -70.61 128.85 37.52 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.538 0.669 . . . . 73.450000000000003 111.164 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 29.0 mt -91.77 148.59 22.13 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.925 0.89 . . . . 65.299999999999997 110.535 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -160.74 148.74 16.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.301 0.572 . . . . 74.030000000000001 111.149 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.7 t -112.7 -45.32 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 114.721 -1.127 . . . . 73.010000000000005 109.371 176.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 22.2 t -121.75 178.94 4.65 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.009 0.524 . . . . 74.310000000000002 109.976 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.2 t -68.05 -26.72 66.0 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.577 0.751 . . . . 71.150000000000006 112.04 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -86.48 -3.97 59.1 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.604 0.761 . . . . 74.239999999999995 110.663 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.476 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 19.9 m -94.72 121.76 36.62 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.893 0.877 . . . . 71.439999999999998 110.976 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -143.49 109.29 5.2 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 107.869 -1.16 . . . . 74.310000000000002 107.869 168.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 209' ' ' SER . 17.7 m-85 -123.42 136.26 54.53 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.291 -0.633 . . . . 73.430000000000007 109.291 -178.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.24 -10.17 45.29 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 122.625 0.37 . . . . 71.420000000000002 110.182 175.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 57.7 p -141.36 152.55 44.47 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.587 0.708 . . . . 74.019999999999996 111.141 173.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.26 -25.4 63.35 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.483 -1.235 . . . . 73.140000000000001 110.474 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.61 -50.14 73.76 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 123.723 0.809 . . . . 73.140000000000001 110.382 174.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -72.11 -29.22 63.87 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.416 -0.811 . . . . 73.409999999999997 111.62 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.49 -52.7 64.55 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.354 0.409 . . . . 74.319999999999993 110.065 171.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.69 -40.5 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.273 0.629 . . . . 73.329999999999998 111.221 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -64.06 -47.5 79.9 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.091 0.472 . . . . 73.430000000000007 110.949 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -63.26 -46.69 85.65 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.151 -0.685 . . . . 74.040000000000006 109.151 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.435 ' HA ' HG21 ' A' ' 224' ' ' VAL . 46.1 m80 -66.24 -25.22 66.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.969 0.508 . . . . 74.439999999999998 111.489 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' A' ' 231' ' ' THR . 45.9 t -71.07 -28.65 64.51 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.658 0.383 . . . . 62.439999999999998 111.114 174.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -106.72 -18.02 14.06 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 115.433 1.642 . . . . 75.420000000000002 115.433 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 221' ' ' HIS . 23.9 m -87.34 122.41 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-N 120.251 1.387 . . . . 74.209999999999994 114.232 -169.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.55 -1.54 19.05 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.315 2.246 . . . . 74.420000000000002 113.17 170.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -79.5 15.51 1.28 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 127.986 2.514 . . . . 75.099999999999994 112.914 -144.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.07 16.84 4.26 Favored Glycine 0 C--O 1.25 1.129 0 C-N-CA 123.507 0.575 . . . . 70.430000000000007 112.133 -168.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 46.9 mt -88.78 131.51 35.03 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.978 -0.611 . . . . 75.349999999999994 109.59 158.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.473 ' HB ' ' HH ' ' A' ' 191' ' ' TYR . 77.5 mt -59.24 -41.2 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 O-C-N 124.03 0.832 . . . . 65.109999999999999 109.694 172.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.7 t -141.17 144.43 34.8 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.969 -1.014 . . . . 63.399999999999999 109.536 168.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 222' ' ' SER . 67.3 p -71.84 151.33 43.52 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.791 -0.818 . . . . 74.530000000000001 108.791 168.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.22 100.23 0.33 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.543 -0.91 . . . . 71.510000000000005 108.543 178.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -85.86 -50.73 6.89 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.21 -0.663 . . . . 72.319999999999993 109.21 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.1 OUTLIER -163.24 148.08 9.19 Favored Pre-proline 0 N--CA 1.482 1.151 0 CA-C-N 115.376 -0.829 . . . . 70.420000000000002 110.922 179.308 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 52.3 Cg_endo -67.47 155.86 68.52 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 121.738 1.625 . . . . 71.219999999999999 112.293 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . 0.5 ' HB2' HD21 ' A' ' 169' ' ' LEU . . . -63.41 134.56 95.89 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-O 118.779 -0.629 . . . . 71.549999999999997 109.779 173.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.11 120.47 7.29 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.967 2.445 . . . . 62.130000000000003 111.689 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt . . . . . 0 N--CA 1.472 0.657 0 O-C-N 123.931 0.769 . . . . 75.420000000000002 110.477 178.717 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.245 0.867 0 CA-C-O 121.415 0.626 . . . . 72.219999999999999 111.322 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.6 mt -107.24 126.84 29.14 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 107.975 -1.12 . . . . 75.239999999999995 107.975 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.51 171.95 11.06 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.391 2.061 . . . . 64.299999999999997 111.632 173.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.23 144.35 32.99 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.847 0.459 . . . . 65.409999999999997 111.085 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.552 ' HB3' HD11 ' A' ' 23' ' ' ILE . 56.4 mt -86.1 93.89 9.12 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.073 0.949 . . . . 73.129999999999995 108.699 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -98.25 -42.15 7.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.815 -1.084 . . . . 75.420000000000002 109.285 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -96.85 111.86 23.87 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 114.583 -1.189 . . . . 75.030000000000001 108.547 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.552 HD11 ' HB3' ' A' ' 20' ' ' LEU . 44.1 mm -116.08 120.88 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.991 -1.114 . . . . 74.239999999999995 107.991 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? . . . . . 0 C--O 1.24 0.573 0 N-CA-C 108.45 -0.945 . . . . 75.310000000000002 108.45 -177.795 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo . . . . . 0 N--CA 1.489 1.22 0 CA-C-O 120.868 0.278 . . . . 75.409999999999997 112.774 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -93.05 66.7 4.17 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-O 121.792 0.806 . . . . 72.430000000000007 109.543 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.511 HD13 ' HB3' ' A' ' 106' ' ' LYS . 42.5 tp -85.78 117.63 24.77 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.797 -1.092 . . . . 73.420000000000002 109.007 175.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -109.09 176.51 5.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.694 1.598 . . . . 70.230000000000004 109.373 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.82 146.24 24.29 Favored 'Isoleucine or valine' 0 C--O 1.25 1.103 0 N-CA-C 108.722 -0.844 . . . . 75.140000000000001 108.722 170.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.03 120.64 25.06 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.282 0.633 . . . . 74.25 109.776 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.1 mt -77.05 -20.48 55.8 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.872 0.869 . . . . 74.439999999999998 111.446 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -141.78 149.11 39.98 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.831 -0.804 . . . . 72.25 108.831 -174.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.76 146.54 46.31 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.02 -0.733 . . . . 71.439999999999998 109.02 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -151.87 108.46 3.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.691 -1.226 . . . . 65.310000000000002 107.691 -176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.7 t -79.17 138.63 19.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 107.263 -1.384 . . . . 61.140000000000001 107.263 173.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.85 125.86 25.3 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.928 0.491 . . . . 73.010000000000005 110.867 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.2 t -72.52 -17.74 61.71 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.937 0.895 . . . . 74.349999999999994 110.283 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.36 -166.72 37.39 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 115.698 -0.683 . . . . 75.219999999999999 112.129 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -64.58 -32.33 73.94 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.635 1.174 . . . . 51.229999999999997 112.059 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -69.79 -25.7 63.91 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.866 0.866 . . . . 74.349999999999994 112.05 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.1 p -103.35 160.31 14.8 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.59 0.756 . . . . 73.129999999999995 110.777 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.1 tp -109.22 130.5 55.49 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.384 0.673 . . . . 74.329999999999998 109.21 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -77.02 117.44 18.61 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 108.345 -0.984 . . . . 74.200000000000003 108.345 172.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.8 pt -119.68 138.26 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.538 0.735 . . . . 75.409999999999997 109.194 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.1 m -94.07 145.82 24.4 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.507 -0.553 . . . . 73.129999999999995 109.507 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.625 ' HZ2' ' HB3' ' A' ' 103' ' ' LYS . 7.1 ttpm? -58.2 111.86 1.34 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.619 0.368 . . . . 74.200000000000003 110.705 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.71 5.93 50.47 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.122 0.391 . . . . 74.010000000000005 112.627 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -87.25 137.83 32.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.24 1.016 . . . . 75.349999999999994 109.83 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.511 ' HB3' HD13 ' A' ' 84' ' ' LEU . 63.0 mttm -88.33 123.77 33.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.288 0.635 . . . . 74.420000000000002 109.825 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 21.4 mt -108.64 139.96 42.69 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.053 0.941 . . . . 74.219999999999999 110.299 -168.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -95.26 107.15 19.24 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 106.002 -1.851 . . . . 71.5 106.002 172.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 68.7 t -100.19 111.56 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 119.364 0.984 . . . . 72.430000000000007 109.571 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.11 -25.62 64.5 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.484 -1.235 . . . . 74.120000000000005 111.018 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.51 173.05 22.98 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.675 -0.693 . . . . 24.140000000000001 112.104 173.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 1.8 m-30 -95.23 148.93 21.88 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 106.668 -1.605 . . . . 74.099999999999994 106.668 172.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.434 HD22 ' HB2' ' A' ' 117' ' ' GLU . 29.5 p30 -66.44 167.5 10.56 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 110.25 -0.278 . . . . 74.400000000000006 110.25 173.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -56.5 -32.04 64.66 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.508 0.929 . . . . 74.349999999999994 113.508 -167.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -96.93 -2.59 43.42 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.562 0.345 . . . . 75.239999999999995 111.617 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.77 18.58 79.57 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 123.157 0.408 . . . . 62.32 113.397 174.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.434 ' HB2' HD22 ' A' ' 113' ' ' ASN . 6.0 mm-40 -65.72 -65.65 0.65 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.522 1.129 . . . . 72.510000000000005 110.136 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -122.97 152.53 40.79 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.227 -1.351 . . . . 70.299999999999997 108.291 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -115.87 127.38 54.98 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.326 1.051 . . . . 74.019999999999996 109.379 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -76.72 101.44 5.8 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.04 -0.726 . . . . 70.209999999999994 109.04 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -104.87 169.02 8.68 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.315 -0.857 . . . . 75.420000000000002 110.298 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -148.08 138.24 22.7 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.219 1.008 . . . . 72.239999999999995 108.953 178.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 37.5 p -144.23 -171.02 3.49 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.403 1.081 . . . . 71.510000000000005 108.901 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -64.95 -16.48 63.39 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 122.971 0.508 . . . . 74.349999999999994 111.098 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -76.39 -14.11 60.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.712 0.805 . . . . 73.439999999999998 111.722 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 129.64 -137.06 9.3 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 111.866 -0.493 . . . . 74.420000000000002 111.866 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -149.91 144.21 25.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.355 0.662 . . . . 75.349999999999994 109.755 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 166.43 179.61 39.85 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-O 121.245 0.358 . . . . 61.32 113.235 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -79.85 130.79 35.6 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.09 0.956 . . . . 74.430000000000007 110.695 -176.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.7 m -124.36 146.86 53.32 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.75 1.22 . . . . 75.329999999999998 108.22 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.98 131.64 26.0 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 121.599 1.533 . . . . 71.430000000000007 110.889 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.7 m -59.22 -21.38 59.44 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.791 0.836 . . . . 75.239999999999995 111.898 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -73.16 -18.95 61.22 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.485 1.114 . . . . 63.119999999999997 112.184 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -102.18 -3.63 27.09 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.419 0.688 . . . . 75.219999999999999 112.603 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.0 pt -122.05 155.88 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 118.478 0.581 . . . . 74.230000000000004 111.134 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.1 t -153.58 136.12 9.53 Favored Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 123.309 0.381 . . . . 61.43 110.708 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -76.44 132.7 13.78 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.805 2.337 . . . . 63.350000000000001 113.163 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.1 m -109.36 -31.34 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.891 0.876 . . . . 74.109999999999999 111.741 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -97.64 0.07 46.55 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.24 0.616 . . . . 55.149999999999999 111.594 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 97.7 p -80.12 -171.0 2.74 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.835 0.826 . . . . 74.540000000000006 111.318 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.14 -9.77 12.22 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.569 1.148 . . . . 75.129999999999995 113.298 171.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -59.35 -20.57 55.72 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.252 0.834 . . . . 62.520000000000003 113.252 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.96 -8.14 52.74 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.253 0.621 . . . . 65.120000000000005 111.959 175.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -88.37 135.51 33.43 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 107.886 -1.153 . . . . 75.430000000000007 107.886 170.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.5 m -64.44 -28.0 69.37 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.584 0.754 . . . . 74.340000000000003 112.322 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -73.49 -32.15 64.12 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.117 0.414 . . . . 72.519999999999996 112.117 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -91.51 128.18 37.24 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.084 0.554 . . . . 74.239999999999995 109.572 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -121.03 2.16 10.43 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 112.303 0.483 . . . . 73.109999999999999 112.303 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.06 -155.56 33.13 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 119.584 -0.565 . . . . 75.109999999999999 114.11 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.12 101.43 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.988 2.459 . . . . 71.140000000000001 111.159 173.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.563 ' HB ' ' HD2' ' A' ' 171' ' ' ARG . 15.9 t -118.79 142.81 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 110.231 -0.285 . . . . 74.200000000000003 110.231 -173.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.6 m -73.94 161.99 29.54 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.967 0.907 . . . . 64.019999999999996 110.772 172.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -63.38 -44.59 94.31 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.234 0.614 . . . . 75.549999999999997 111.361 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -58.87 -51.89 68.1 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.071 0.948 . . . . 74.329999999999998 110.192 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.06 86.73 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.946 0.898 . . . . 44.229999999999997 111.59 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.97 -53.86 53.63 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.077 -0.965 . . . . 72.420000000000002 111.588 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.528 ' HG3' HG11 ' A' ' 190' ' ' VAL . 30.4 tt0 -70.87 -24.87 62.59 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.945 -1.025 . . . . 63.039999999999999 110.52 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -66.52 -43.22 85.83 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.143 0.577 . . . . 71.439999999999998 111.098 173.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' A' ' 238' ' ' LYS . 44.8 mt -72.85 -36.78 67.51 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.473 0.654 . . . . 72.25 110.789 175.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 183' ' ' SER . 39.5 tp -77.76 -19.81 54.48 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.223 -0.899 . . . . 72.0 112.28 -174.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 81.0 p -64.94 -26.06 68.14 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 120.861 0.362 . . . . 72.439999999999998 110.184 174.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.4 t -82.02 -5.85 58.68 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.416 1.086 . . . . 63.210000000000001 111.076 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.77 171.81 55.16 Favored Glycine 0 C--N 1.346 1.118 0 C-N-CA 122.917 0.294 . . . . 72.230000000000004 113.436 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.6 pt -133.95 -169.58 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.598 1.159 . . . . 73.120000000000005 110.09 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 18.1 p-10 -59.75 103.26 0.19 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.442 0.697 . . . . 72.409999999999997 112.435 -172.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 102.73 12.88 31.31 Favored Glycine 0 C--O 1.261 1.816 0 CA-C-N 116.184 -0.462 . . . . 71.329999999999998 113.082 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 78.7 p -79.75 137.78 37.11 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 109.991 -0.374 . . . . 72.25 109.991 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -137.01 155.91 49.1 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.282 0.563 . . . . 75.299999999999997 112.264 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.0 mt -131.74 134.22 45.64 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.994 -1.113 . . . . 74.329999999999998 107.994 170.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.409 HG22 HG21 ' A' ' 218' ' ' VAL . 52.2 t -114.0 126.25 71.45 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 108.354 -0.98 . . . . 74.310000000000002 108.354 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.563 ' HD2' ' HB ' ' A' ' 151' ' ' VAL . 17.9 mtm180 -140.32 170.19 16.27 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.741 -1.118 . . . . 64.310000000000002 109.005 -167.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 9.0 pm0 -117.4 163.5 16.28 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 108.695 -0.854 . . . . 74.340000000000003 108.695 153.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 176' ' ' SER . 48.8 m -82.68 131.92 35.19 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.434 -0.803 . . . . 75.420000000000002 110.308 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -53.6 -40.09 65.42 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.087 1.355 . . . . 73.340000000000003 112.205 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.8 t -98.49 6.25 47.33 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.558 0.743 . . . . 62.439999999999998 111.376 -174.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 173' ' ' SER . 28.8 m -147.08 86.97 6.31 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.32 0.648 . . . . 72.230000000000004 109.489 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.437 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 34.9 Cg_endo -62.58 136.73 60.17 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 123.327 2.684 . . . . 75.340000000000003 111.331 177.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.85 -24.92 5.57 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.901 -0.59 . . . . 74.439999999999998 113.306 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -84.11 116.35 22.85 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.002 -1.11 . . . . 72.239999999999995 108.002 175.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.636 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 58.2 mtt-85 -109.17 168.56 9.29 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.308 -0.86 . . . . 71.140000000000001 110.633 -170.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.4 t -155.91 145.91 21.4 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.323 0.649 . . . . 63.32 110.063 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 65.9 mt -115.94 147.91 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.587 0.755 . . . . 72.120000000000005 109.081 173.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.544 ' HB3' HD22 ' A' ' 160' ' ' LEU . 24.5 m -125.89 114.2 18.22 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.869 1.268 . . . . 73.120000000000005 108.602 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 76.7 mt -105.01 139.1 40.19 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.629 1.171 . . . . 74.5 111.448 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -120.79 132.18 54.88 Favored 'General case' 0 C--O 1.257 1.475 0 N-CA-C 107.24 -1.393 . . . . 74.140000000000001 107.24 161.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 28.5 t80 -151.94 123.6 7.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.736 -1.12 . . . . 74.400000000000006 108.678 -171.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 51.29 36.13 15.42 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.435 1.494 . . . . 74.129999999999995 112.359 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 89.23 3.34 75.83 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 114.995 -1.002 . . . . 64.349999999999994 114.088 173.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -115.02 127.73 55.83 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 117.722 0.761 . . . . 75.010000000000005 111.224 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.528 HG11 ' HG3' ' A' ' 157' ' ' GLU . 46.3 t -88.26 132.79 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 124.636 1.174 . . . . 74.409999999999997 109.854 171.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.475 ' HH ' ' HB ' ' A' ' 229' ' ' ILE . 17.4 p90 -146.39 153.35 40.38 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.118 1.367 . . . . 71.200000000000003 109.174 171.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -131.21 149.31 52.63 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.083 0.953 . . . . 75.400000000000006 109.335 -170.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -146.3 154.58 41.86 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.285 0.564 . . . . 75.099999999999994 111.713 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.496 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 20.8 tpp180 -85.75 135.26 33.82 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.761 1.224 . . . . 75.230000000000004 111.001 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.447 ' HA ' HG23 ' A' ' 205' ' ' VAL . 90.9 mt -85.69 110.27 19.45 Favored 'Isoleucine or valine' 0 C--O 1.245 0.858 0 N-CA-C 107.888 -1.153 . . . . 75.219999999999999 107.888 163.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -75.72 119.03 19.17 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.515 -0.766 . . . . 72.209999999999994 109.5 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 25.9 m -99.43 114.3 27.15 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.165 0.586 . . . . 74.450000000000003 109.892 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.02 163.18 12.72 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.198 0.999 . . . . 75.0 111.405 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 82.1 p -62.0 -24.72 67.21 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.384 0.674 . . . . 74.340000000000003 111.514 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.0 -5.79 50.1 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.145 0.978 . . . . 63.210000000000001 111.778 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 88.34 -3.97 85.35 Favored Glycine 0 C--N 1.352 1.465 0 C-N-CA 123.057 0.36 . . . . 62.219999999999999 112.56 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -74.42 142.46 44.97 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.578 0.751 . . . . 75.239999999999995 109.657 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 80.4 mt -98.05 153.57 18.31 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.672 0.789 . . . . 74.120000000000005 109.762 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -167.56 163.73 14.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.737 0.815 . . . . 64.310000000000002 109.648 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.447 HG23 ' HA ' ' A' ' 195' ' ' ILE . 71.5 t -131.92 -56.98 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 107.699 -1.223 . . . . 74.299999999999997 107.699 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 40.0 t -83.65 155.18 23.31 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.541 -0.754 . . . . 70.299999999999997 109.478 171.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.3 m -68.66 -33.63 74.32 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.309 0.643 . . . . 74.140000000000001 110.327 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -75.06 -19.11 60.15 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.302 -0.863 . . . . 72.310000000000002 111.408 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 48.0 m -104.58 127.36 52.29 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.245 1.018 . . . . 72.409999999999997 110.17 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -138.59 133.94 33.16 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.569 1.147 . . . . 75.209999999999994 108.721 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 11.2 m-85 -133.76 135.84 44.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.255 0.622 . . . . 74.019999999999996 110.639 -172.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -83.15 -30.35 27.93 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.622 0.769 . . . . 63.329999999999998 110.261 169.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 40.1 p -128.84 150.36 50.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.579 0.752 . . . . 61.420000000000002 111.502 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 38.2 tp -70.17 -31.31 68.73 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.57 -1.195 . . . . 72.349999999999994 110.824 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.87 -41.73 87.79 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.404 0.682 . . . . 74.239999999999995 110.435 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -80.85 -24.63 38.26 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.842 -0.617 . . . . 74.349999999999994 111.536 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.65 -49.06 79.04 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.728 -0.471 . . . . 74.310000000000002 109.728 168.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.409 HG21 HG22 ' A' ' 170' ' ' VAL . 76.3 t -67.29 -40.13 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.125 0.97 . . . . 64.219999999999999 110.588 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -63.94 -52.93 57.48 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.984 0.914 . . . . 71.310000000000002 111.312 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.43 ' CE1' HG11 ' A' ' 224' ' ' VAL . 26.9 t-80 -60.18 -47.79 84.47 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 115.054 -0.975 . . . . 75.310000000000002 109.086 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.466 ' HB3' ' HG ' ' A' ' 232' ' ' LEU . 7.9 m-70 -62.19 -29.6 70.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.337 0.655 . . . . 74.439999999999998 111.932 175.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 33.7 t -69.9 -26.15 64.03 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.157 0.583 . . . . 70.230000000000004 111.316 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.3 t -112.93 -11.3 13.43 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 115.902 1.815 . . . . 71.319999999999993 115.902 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 221' ' ' HIS . 24.1 m -92.47 139.4 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 120.982 1.719 . . . . 70.450000000000003 114.143 -171.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.38 -1.0 57.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.021 2.528 . . . . 65.409999999999997 112.295 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -79.22 15.87 1.1 Allowed 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 127.621 2.368 . . . . 74.219999999999999 112.009 -145.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 117.58 19.62 4.91 Favored Glycine 0 C--O 1.245 0.825 0 C-N-CA 125.028 1.299 . . . . 71.239999999999995 112.403 -172.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 52.0 mt -90.87 121.67 32.92 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.145 -1.028 . . . . 75.329999999999998 109.124 158.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.475 ' HB ' ' HH ' ' A' ' 191' ' ' TYR . 59.4 mt -53.0 -43.09 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 124.357 1.035 . . . . 73.230000000000004 110.307 173.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.1 t -133.14 142.77 48.84 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.428 -0.805 . . . . 73.219999999999999 109.172 171.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 41.6 p -70.14 145.39 51.59 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.684 -0.858 . . . . 61.140000000000001 108.684 166.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.466 ' HG ' ' HB3' ' A' ' 221' ' ' HIS . 21.2 mt -61.76 102.67 0.28 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.049 -0.723 . . . . 74.329999999999998 109.049 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 -87.1 -54.34 4.38 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.29 -0.633 . . . . 72.519999999999996 109.29 -171.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.582 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -157.58 150.12 17.97 Favored Pre-proline 0 N--CA 1.487 1.385 0 C-N-CA 123.503 0.721 . . . . 61.310000000000002 111.443 -177.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.99 145.55 45.2 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 121.903 1.735 . . . . 73.109999999999999 112.402 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.19 131.79 82.91 Favored Pre-proline 0 C--O 1.243 0.751 0 N-CA-C 109.199 -0.667 . . . . 72.540000000000006 109.199 173.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.1 147.45 54.37 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 121.874 1.716 . . . . 72.340000000000003 111.63 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HA ' HD21 ' A' ' 159' ' ' LEU . 38.6 ttpt . . . . . 0 CA--C 1.553 1.075 0 CA-C-N 115.296 -0.865 . . . . 75.319999999999993 109.344 171.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 121.547 0.689 . . . . 72.519999999999996 112.612 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.4 mt -103.05 125.83 34.13 Favored Pre-proline 0 C--O 1.239 0.511 0 N-CA-C 108.041 -1.096 . . . . 74.310000000000002 108.041 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.52 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 39.2 Cg_endo -69.57 171.58 14.01 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.367 2.045 . . . . 64.430000000000007 113.602 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.29 140.07 31.11 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.178 0.591 . . . . 74.140000000000001 111.39 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.449 HD23 HD13 ' A' ' 23' ' ' ILE . 78.4 mt -88.65 91.99 9.02 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.078 -1.082 . . . . 74.209999999999994 108.078 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -98.99 -43.5 6.67 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.383 -0.826 . . . . 73.120000000000005 109.81 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -103.34 108.61 19.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.474 -0.785 . . . . 55.020000000000003 109.714 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.449 HD13 HD23 ' A' ' 20' ' ' LEU . 41.7 mm -118.05 121.32 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 107.566 -1.272 . . . . 74.200000000000003 107.566 172.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt . . . . . 0 N--CA 1.471 0.588 0 C-N-CA 123.592 0.757 . . . . 75.319999999999993 110.988 -176.893 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo . . . . . 0 CA--C 1.547 1.135 0 N-CA-C 111.322 -0.299 . . . . 64.019999999999996 111.322 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.449 ' HA ' ' HB2' ' A' ' 140' ' ' SER . 82.3 m-20 -87.76 66.67 8.91 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.686 0.755 . . . . 75.510000000000005 109.461 176.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.408 HD21 ' HD2' ' A' ' 106' ' ' LYS . 40.1 tp -92.32 125.84 37.15 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 108.168 -1.049 . . . . 74.439999999999998 108.168 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 4.5 m-85 -104.0 175.46 5.48 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.583 1.153 . . . . 74.530000000000001 109.556 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 p -145.04 141.34 22.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 108.779 -0.823 . . . . 72.219999999999999 108.779 171.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -77.93 108.7 11.38 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.082 -0.711 . . . . 72.329999999999998 109.082 173.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.54 -26.51 66.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.901 0.881 . . . . 74.010000000000005 111.212 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -126.98 155.89 42.44 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.961 0.904 . . . . 74.25 109.127 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -69.81 145.46 52.12 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.37 -0.832 . . . . 73.230000000000004 109.485 169.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -153.3 108.47 3.21 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.497 -0.927 . . . . 63.240000000000002 108.497 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 52.8 t -81.56 131.95 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.952 -1.129 . . . . 70.310000000000002 107.952 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.84 136.62 57.95 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.454 0.472 . . . . 72.109999999999999 110.896 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.5 t -62.31 -25.06 67.66 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.696 0.798 . . . . 75.340000000000003 109.824 172.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.51 -133.42 3.75 Favored Glycine 0 C--N 1.353 1.513 0 CA-C-N 115.557 -0.747 . . . . 43.32 112.305 172.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.06 -25.86 66.46 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.785 1.234 . . . . 74.430000000000007 111.926 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -79.87 -11.28 59.82 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.381 1.072 . . . . 75.329999999999998 112.511 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.8 p -137.74 169.7 17.34 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.574 0.75 . . . . 44.420000000000002 111.441 -171.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.9 tp -115.65 134.72 54.76 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.933 0.893 . . . . 74.019999999999996 109.781 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.0 t -85.59 117.33 24.42 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.829 -0.804 . . . . 65.239999999999995 108.829 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.4 pt -119.51 131.94 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.648 0.779 . . . . 74.230000000000004 109.52 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.436 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 50.3 m -90.34 146.42 24.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.375 0.67 . . . . 72.209999999999994 110.111 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -52.94 112.95 0.94 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 122.84 0.456 . . . . 64.230000000000004 110.408 164.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 106.27 -13.12 44.17 Favored Glycine 0 N--CA 1.472 1.082 0 CA-C-N 116.701 -0.227 . . . . 44.119999999999997 112.901 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -76.67 126.96 31.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.183 0.993 . . . . 72.409999999999997 109.462 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HD2' HD21 ' A' ' 84' ' ' LEU . 31.8 mtmm -90.2 133.03 35.16 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.157 0.583 . . . . 71.140000000000001 110.733 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.8 mt -116.71 150.0 38.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.911 0.884 . . . . 75.409999999999997 110.731 -161.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -102.58 109.02 20.5 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.642 -0.873 . . . . 71.430000000000007 108.642 169.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.6 t -87.66 106.25 16.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 108.571 -0.9 . . . . 65.129999999999995 108.571 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 76.2 mt -72.4 -31.49 65.58 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 115.375 -0.83 . . . . 72.430000000000007 109.441 176.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.31 -174.61 42.96 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.093 -0.958 . . . . 73.420000000000002 111.259 172.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.3 m-30 -113.31 174.08 6.09 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.539 0.736 . . . . 74.209999999999994 109.427 167.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -64.95 145.99 55.57 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.066 -1.087 . . . . 74.540000000000006 108.066 166.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -65.22 -29.91 70.76 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.355 0.662 . . . . 73.450000000000003 111.62 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -85.95 -5.98 59.14 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.633 0.773 . . . . 73.310000000000002 111.253 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.17 33.07 41.51 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.805 -0.634 . . . . 63.100000000000001 113.274 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . 29.8 mt-10 -89.34 -73.09 0.52 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.129 0.572 . . . . 64.439999999999998 110.117 -177.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -100.53 -178.87 3.93 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.69 0.796 . . . . 75.310000000000002 109.64 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.28 117.91 22.33 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.165 0.986 . . . . 73.540000000000006 108.854 -177.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.62 92.72 1.17 Allowed 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.555 -1.276 . . . . 72.450000000000003 107.555 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -112.24 164.08 13.62 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.873 0.844 . . . . 74.239999999999995 111.111 -171.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -151.67 138.74 19.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.522 -1.217 . . . . 74.25 108.254 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 43.4 p -132.21 175.93 8.83 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.633 0.773 . . . . 64.340000000000003 109.638 171.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -70.53 -6.66 37.96 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 121.212 0.53 . . . . 74.230000000000004 110.168 174.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -89.33 -18.93 25.95 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.823 1.249 . . . . 75.239999999999995 111.217 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 154.91 -148.14 18.14 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 118.041 0.382 . . . . 75.420000000000002 113.034 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -151.15 157.25 42.47 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.44 0.62 . . . . 74.129999999999995 110.295 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 153.25 -171.17 32.18 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 122.966 0.317 . . . . 75.530000000000001 112.494 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -91.34 133.7 35.22 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.065 0.546 . . . . 65.299999999999997 110.53 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.31 156.19 72.9 Favored Pre-proline 0 N--CA 1.479 1.025 0 C-N-CA 124.484 1.114 . . . . 74.439999999999998 109.43 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.36 123.91 11.07 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.063 1.842 . . . . 42.439999999999998 110.92 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.4 m -59.41 -22.09 60.92 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.679 0.792 . . . . 75.310000000000002 111.47 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -73.33 -23.26 60.22 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.571 1.148 . . . . 75.030000000000001 111.719 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -94.58 -4.17 48.36 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.671 0.788 . . . . 72.420000000000002 112.393 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.4 pt -123.08 151.74 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 118.363 0.529 . . . . 73.420000000000002 110.397 -172.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.0 t -145.16 135.45 11.93 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.019 0.528 . . . . 55.229999999999997 109.639 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.543 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 59.3 Cg_endo -74.18 115.17 4.23 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.334 2.023 . . . . 72.530000000000001 111.938 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.1 m -87.64 -54.62 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.023 0.529 . . . . 74.420000000000002 111.028 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -80.97 -18.29 47.47 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.329 0.651 . . . . 73.519999999999996 111.308 -171.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 32.8 t -71.34 -179.87 2.63 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.609 0.763 . . . . 73.209999999999994 111.228 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.51 -14.6 43.63 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.406 1.082 . . . . 64.549999999999997 113.266 -174.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.86 -25.55 67.6 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.979 0.512 . . . . 73.340000000000003 111.63 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.14 -26.53 62.79 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.286 1.034 . . . . 73.430000000000007 111.337 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -78.86 169.6 17.97 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.918 0.887 . . . . 71.140000000000001 111.764 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.5 p -84.58 -26.18 28.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.364 0.666 . . . . 75.329999999999998 112.097 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . 0.446 ' CE3' HG23 ' A' ' 218' ' ' VAL . 55.3 p-90 -83.89 -42.36 16.43 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.066 -0.515 . . . . 72.099999999999994 111.485 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -95.42 126.36 40.67 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.847 -0.797 . . . . 75.329999999999998 108.847 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -110.57 5.3 21.03 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.8 -0.637 . . . . 75.120000000000005 111.259 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.82 -155.09 36.58 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.475 -0.625 . . . . 74.040000000000006 113.418 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.75 106.07 1.77 Allowed 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 123.196 2.597 . . . . 53.310000000000002 110.408 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.3 t -128.39 150.54 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 123.631 0.773 . . . . 63.32 109.154 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.2 t -86.3 167.27 14.95 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.849 0.86 . . . . 52.439999999999998 110.066 173.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -63.71 -33.33 75.41 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.33 0.652 . . . . 73.420000000000002 111.903 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -67.52 -55.21 14.42 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.291 0.636 . . . . 72.150000000000006 110.284 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.42 -37.37 80.66 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.965 0.79 . . . . 74.519999999999996 111.226 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.54 -57.54 12.24 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.66 -0.7 . . . . 71.420000000000002 110.849 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.51 -21.12 63.69 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.359 -0.837 . . . . 74.310000000000002 111.118 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -68.22 -53.25 26.08 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.687 0.795 . . . . 75.420000000000002 110.591 174.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.429 ' HB2' HD13 ' A' ' 169' ' ' LEU . 74.6 mt -68.06 -37.33 81.18 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.946 -0.57 . . . . 75.430000000000007 110.957 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.8 tp -73.51 -22.48 60.11 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.381 -0.827 . . . . 74.230000000000004 111.349 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.9 t -59.76 -26.84 66.03 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.48 0.712 . . . . 61.030000000000001 111.787 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.8 m -79.16 9.66 4.3 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.363 1.065 . . . . 62.539999999999999 112.246 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.04 159.24 14.46 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 122.98 0.324 . . . . 73.329999999999998 113.53 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.1 pt -115.57 -164.47 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.347 1.059 . . . . 75.219999999999999 109.859 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.661 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 17.4 p-10 -52.65 99.62 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.516 1.126 . . . . 63.020000000000003 113.142 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 107.85 13.71 19.31 Favored Glycine 0 C--N 1.355 1.632 0 CA-C-N 116.174 -0.466 . . . . 44.399999999999999 113.538 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.452 ' OG ' ' HB3' ' A' ' 185' ' ' ARG . 37.9 p -79.0 137.45 37.59 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.998 -0.707 . . . . 74.400000000000006 109.98 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.482 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 27.1 p90 -134.08 160.7 36.97 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 112.452 0.538 . . . . 74.209999999999994 112.452 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.451 HD21 ' HB1' ' A' ' 236' ' ' ALA . 82.4 mt -134.65 134.15 40.85 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.337 1.055 . . . . 72.219999999999999 108.292 166.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 32.3 t -106.14 128.45 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.113 -1.44 . . . . 70.120000000000005 107.113 171.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -158.43 161.11 37.45 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.908 0.483 . . . . 74.129999999999995 110.07 -174.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.68 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 12.5 pt-20 -109.21 161.62 15.06 Favored 'General case' 0 C--O 1.244 0.812 0 O-C-N 123.409 0.443 . . . . 64.040000000000006 109.806 169.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.2 m -83.41 135.53 34.66 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.627 -0.715 . . . . 70.319999999999993 109.395 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -71.19 -41.86 69.74 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.388 0.675 . . . . 64.340000000000003 110.213 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 25.0 m -78.57 -17.16 56.55 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.115 -0.948 . . . . 72.329999999999998 111.431 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 28.3 t -130.49 80.9 69.33 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.423 -0.954 . . . . 73.010000000000005 108.423 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.24 141.44 93.19 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.621 2.881 . . . . 53.140000000000001 112.837 -173.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 77.66 -23.07 2.55 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 116.208 -0.451 . . . . 72.010000000000005 114.071 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -84.25 116.38 22.94 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 108.177 -1.045 . . . . 72.129999999999995 108.177 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.68 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 44.5 mtt180 -110.88 169.78 8.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.168 -0.923 . . . . 75.329999999999998 111.209 -168.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.401 ' HB2' ' HD3' ' A' ' 194' ' ' ARG . 47.8 t -154.59 144.38 21.63 Favored 'General case' 0 C--O 1.253 1.244 0 C-N-CA 124.982 1.313 . . . . 74.409999999999997 108.722 -176.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.461 HD13 HD22 ' A' ' 217' ' ' LEU . 58.6 mt -109.33 135.38 48.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 107.221 -1.4 . . . . 74.450000000000003 107.221 166.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 19.3 m -112.26 114.06 26.63 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.229 -1.026 . . . . 75.420000000000002 108.229 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.3 mt -105.14 144.31 32.11 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.107 0.963 . . . . 74.310000000000002 111.035 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.452 ' HB3' ' OG ' ' A' ' 167' ' ' SER . 27.1 ttt85 -132.74 133.27 43.26 Favored 'General case' 0 C--O 1.259 1.579 0 CA-C-N 114.357 -1.292 . . . . 74.010000000000005 108.895 175.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.661 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 28.2 p90 -148.1 138.83 23.06 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 124.616 1.198 . . . . 71.209999999999994 108.804 171.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 58.58 19.1 6.34 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.934 1.293 . . . . 75.310000000000002 113.534 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.62 21.1 69.95 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 116.626 -0.261 . . . . 71.420000000000002 112.814 -175.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -118.16 126.9 53.14 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.511 1.125 . . . . 70.420000000000002 108.553 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 51.4 t -119.04 141.88 36.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 124.13 0.972 . . . . 72.200000000000003 110.722 -168.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.566 ' HH ' HG23 ' A' ' 230' ' ' THR . 18.2 p90 -145.19 151.13 37.94 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.507 1.123 . . . . 74.140000000000001 109.403 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -126.36 115.39 19.58 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 107.918 -1.141 . . . . 71.409999999999997 107.918 -173.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -117.46 132.63 56.52 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.637 -0.505 . . . . 64.409999999999997 109.637 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.401 ' HD3' ' HB2' ' A' ' 181' ' ' SER . 10.8 mmt85 -72.68 131.5 42.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.777 0.831 . . . . 75.340000000000003 112.07 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 82.0 mt -71.45 110.63 4.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 108.107 -1.071 . . . . 74.239999999999995 108.107 163.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -69.33 120.92 15.88 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.274 -0.875 . . . . 62.100000000000001 108.641 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.4 m -103.47 110.64 22.75 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 122.969 0.508 . . . . 64.420000000000002 109.804 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.404 ' HB1' ' HE1' ' A' ' 204' ' ' TYR . . . -61.38 156.53 18.82 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.959 0.904 . . . . 65.409999999999997 111.606 172.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.1 m -71.22 -12.47 61.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.707 0.803 . . . . 73.099999999999994 112.196 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -86.55 12.38 10.59 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.468 0.707 . . . . 72.019999999999996 111.16 171.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 75.05 4.91 74.1 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 123.179 0.419 . . . . 73.239999999999995 113.266 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -81.64 140.06 34.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.605 0.762 . . . . 73.409999999999997 109.991 -175.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.497 HD11 HD11 ' A' ' 214' ' ' LEU . 85.8 mt -103.13 147.29 27.19 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.515 0.726 . . . . 65.0 109.481 -175.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.404 ' HE1' ' HB1' ' A' ' 198' ' ' ALA . 28.7 p90 -167.49 177.39 5.99 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.118 0.967 . . . . 74.420000000000002 110.819 173.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 74.9 t -131.3 -54.89 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 107.452 -1.314 . . . . 75.049999999999997 107.452 174.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 12.1 t -86.08 153.55 22.03 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.916 -1.038 . . . . 62.149999999999999 108.961 172.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.1 t -68.88 -25.58 64.68 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.728 0.411 . . . . 71.109999999999999 110.424 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.75 -34.13 62.45 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.568 -0.742 . . . . 73.540000000000006 110.492 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.446 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 74.8 m -64.32 126.32 27.4 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.528 0.731 . . . . 62.350000000000001 109.28 172.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -144.65 112.56 6.32 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.202 1.001 . . . . 74.349999999999994 108.645 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.446 ' CE2' ' HB3' ' A' ' 209' ' ' SER . 17.4 m-85 -129.66 142.76 50.67 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 118.683 0.674 . . . . 74.519999999999996 111.315 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -90.58 -22.51 21.22 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.382 0.673 . . . . 74.409999999999997 109.66 172.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.0 p -129.87 147.02 51.59 Favored 'General case' 0 C--O 1.253 1.272 0 CA-C-O 122.182 0.992 . . . . 71.109999999999999 111.459 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.497 HD11 HD11 ' A' ' 203' ' ' LEU . 27.1 tp -67.23 -29.02 68.56 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 114.047 -1.433 . . . . 73.140000000000001 110.841 177.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.46 90.51 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.487 0.715 . . . . 72.540000000000006 111.029 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -66.53 -37.98 86.19 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.545 -0.752 . . . . 74.239999999999995 110.762 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.461 HD22 HD13 ' A' ' 182' ' ' ILE . 9.2 tt -55.64 -47.53 76.5 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.885 0.74 . . . . 74.109999999999999 111.486 174.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.446 HG23 ' CE3' ' A' ' 146' ' ' TRP . 70.4 t -70.53 -44.04 77.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 123.262 0.625 . . . . 73.329999999999998 111.263 -175.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -59.72 -49.63 76.98 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.632 0.73 . . . . 74.129999999999995 110.577 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -56.6 -56.47 20.88 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.961 -1.018 . . . . 72.439999999999998 109.684 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . 0.456 ' HA ' HG21 ' A' ' 224' ' ' VAL . 36.0 m80 -67.32 -16.74 64.43 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.168 0.433 . . . . 73.340000000000003 112.168 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' SER . . . . . 0.442 ' HA ' ' HB2' ' A' ' 232' ' ' LEU . 35.9 t -73.59 -31.57 63.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.555 0.342 . . . . 74.510000000000005 111.047 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.6 t -112.04 -6.62 14.17 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.27 1.952 . . . . 64.430000000000007 116.27 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 221' ' ' HIS . 33.8 m -104.21 158.4 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 116.199 1.925 . . . . 75.099999999999994 116.199 -171.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -90.89 -0.99 57.88 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 129.25 3.02 . . . . 54.0 113.543 -175.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -77.9 14.98 0.95 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 128.734 2.814 . . . . 71.409999999999997 113.766 -141.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.77 18.78 3.87 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 124.571 1.081 . . . . 43.420000000000002 111.817 -168.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.91 135.37 33.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.957 0.903 . . . . 73.239999999999995 110.555 167.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.48 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 85.8 mt -72.96 -34.86 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 109.321 -0.622 . . . . 75.120000000000005 109.321 171.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.566 HG23 ' HH ' ' A' ' 191' ' ' TYR . 7.8 t -143.25 142.24 31.31 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.59 -0.893 . . . . 73.219999999999999 108.59 168.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 67.8 p -67.92 147.48 52.43 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.802 -0.814 . . . . 73.209999999999994 108.802 171.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . 0.482 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 28.6 mt -62.68 99.91 0.17 Allowed 'General case' 0 CA--C 1.555 1.147 0 N-CA-C 108.89 -0.781 . . . . 64.129999999999995 108.89 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -81.8 -50.93 8.66 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.702 0.401 . . . . 72.209999999999994 110.277 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -156.76 148.37 17.1 Favored Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 120.689 -0.405 . . . . 74.010000000000005 110.191 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.05 138.78 20.96 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 121.843 1.696 . . . . 64.310000000000002 111.97 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . 0.451 ' HB1' HD21 ' A' ' 169' ' ' LEU . . . -67.67 140.63 94.53 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 108.793 -0.817 . . . . 74.400000000000006 108.793 171.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.77 156.4 64.23 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.833 2.356 . . . . 64.439999999999998 114.67 -164.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp . . . . . 0 N--CA 1.477 0.905 0 CA-C-N 114.567 -1.197 . . . . 72.310000000000002 109.898 170.618 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.7 p . . . . . 0 CA--C 1.545 0.756 0 CA-C-O 121.312 0.577 . . . . 72.049999999999997 111.116 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 94.6 mt -104.98 131.65 21.59 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.884 -0.598 . . . . 75.120000000000005 109.432 -176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 17' ' ' LEU . 8.2 Cg_exo -69.13 171.83 13.08 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.102 2.535 . . . . 62.340000000000003 112.267 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.56 149.15 25.56 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.867 0.467 . . . . 74.099999999999994 110.401 170.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.442 HD13 ' ND2' ' A' ' 97' ' ' ASN . 84.8 mt -86.05 94.2 9.18 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.938 -1.134 . . . . 75.140000000000001 107.938 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -97.31 -52.9 3.65 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.632 0.373 . . . . 75.319999999999993 110.948 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -105.16 102.87 12.33 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.925 -1.139 . . . . 74.040000000000006 107.925 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.441 HD11 HD23 ' A' ' 20' ' ' LEU . 48.0 mm -126.1 111.57 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.923 -0.769 . . . . 73.209999999999994 108.923 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.934 0 O-C-N 124.352 1.033 . . . . 71.540000000000006 108.714 173.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo . . . . . 0 N--CA 1.498 1.739 0 N-CA-C 114.32 0.854 . . . . 63.530000000000001 114.32 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.69 22.2 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.287 1.835 . . . . 74.319999999999993 109.24 176.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.5 tp -85.3 132.84 34.19 Favored 'General case' 0 C--N 1.359 1.007 0 CA-C-O 121.017 0.437 . . . . 75.129999999999995 109.894 -178.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -106.65 173.9 6.12 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.191 1.396 . . . . 72.430000000000007 110.086 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.49 145.96 25.06 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 107.925 -1.139 . . . . 72.109999999999999 107.925 171.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -74.95 117.93 17.34 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 123.039 0.212 . . . . 70.439999999999998 110.606 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.3 mt -65.41 -33.69 76.53 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.222 1.009 . . . . 64.010000000000005 111.556 171.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -140.35 159.0 43.16 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.172 0.589 . . . . 75.5 109.418 -175.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -74.7 152.19 39.15 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.107 -0.701 . . . . 75.230000000000004 109.107 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -156.04 115.93 3.63 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.602 0.761 . . . . 72.439999999999998 109.1 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.72 133.21 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.339 -0.985 . . . . 71.109999999999999 108.339 170.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.69 134.63 52.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.811 0.444 . . . . 73.150000000000006 110.91 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.9 m -67.59 -20.94 65.43 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.943 0.897 . . . . 73.219999999999999 111.391 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.35 -165.65 38.27 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.69 -0.686 . . . . 62.450000000000003 112.008 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -52.3 -38.77 59.34 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.7 1.2 . . . . 75.219999999999999 112.852 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.442 ' ND2' HD13 ' A' ' 20' ' ' LEU . 31.3 p-10 -72.19 -24.71 61.46 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.178 0.991 . . . . 74.049999999999997 112.69 -175.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 p -104.23 157.75 16.92 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.301 0.641 . . . . 53.509999999999998 110.022 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.466 ' HB3' HG11 ' A' ' 130' ' ' VAL . 64.2 tp -110.55 132.74 53.93 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.797 -0.638 . . . . 72.129999999999995 109.808 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.2 t -80.16 136.54 36.53 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.36 -0.608 . . . . 74.140000000000001 109.36 173.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 28.6 pt -137.89 144.55 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.484 0.713 . . . . 64.140000000000001 109.652 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 9.3 m -105.65 143.91 33.13 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.231 -0.655 . . . . 74.400000000000006 109.231 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -56.38 111.91 1.11 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 118.536 0.607 . . . . 75.5 111.046 174.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.13 1.8 35.91 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 116.707 -0.224 . . . . 74.319999999999993 113.254 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.538 ' HG3' ' HE2' ' A' ' 124' ' ' LYS . 36.5 tt0 -85.66 137.64 32.7 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.029 0.931 . . . . 74.319999999999993 110.511 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -76.4 119.14 19.85 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.603 0.761 . . . . 75.420000000000002 110.338 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.649 ' HA ' HG22 ' A' ' 123' ' ' THR . 11.4 mt -112.43 123.68 50.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.405 -0.961 . . . . 72.329999999999998 108.405 -173.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -95.6 106.76 18.89 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 107.769 -1.197 . . . . 74.409999999999997 107.769 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 67.1 t -99.66 114.55 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 109.229 -0.656 . . . . 73.409999999999997 109.229 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.38 -34.77 68.18 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.62 0.768 . . . . 71.540000000000006 109.934 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.35 167.09 35.69 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 114.783 -1.098 . . . . 74.150000000000006 111.422 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 3.0 m-30 -97.5 175.0 6.38 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.781 0.8 . . . . 74.239999999999995 110.063 177.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -75.13 147.1 40.8 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 114.411 -1.268 . . . . 73.319999999999993 108.304 169.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -60.08 -37.17 79.12 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.7 0.8 . . . . 75.319999999999993 112.328 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -92.92 7.52 43.6 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 121.07 0.462 . . . . 73.209999999999994 110.94 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 174' ' ' GLU . . . 70.91 27.96 71.4 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 116.079 -0.51 . . . . 72.019999999999996 113.898 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -68.41 -70.72 0.25 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 122.126 0.965 . . . . 75.430000000000007 110.245 178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -131.04 -178.58 4.88 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.57 1.148 . . . . 73.010000000000005 108.859 -172.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -138.48 122.22 17.56 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.973 0.509 . . . . 70.150000000000006 109.99 -175.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -72.23 96.84 1.87 Allowed 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.648 0.737 . . . . 70.120000000000005 109.816 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -109.68 165.69 11.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.709 -1.132 . . . . 73.340000000000003 111.097 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -140.75 118.65 11.8 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.608 -1.256 . . . . 74.120000000000005 107.608 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.649 HG22 ' HA ' ' A' ' 107' ' ' LEU . 71.7 p -132.05 -172.28 2.84 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.58 0.705 . . . . 73.530000000000001 111.123 -176.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.538 ' HE2' ' HG3' ' A' ' 105' ' ' GLU . 40.0 mtmt -57.44 -30.52 65.07 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 114.242 -1.344 . . . . 74.409999999999997 110.862 170.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -85.51 3.25 41.28 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.07 0.948 . . . . 75.430000000000007 111.759 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 118.97 -127.38 7.2 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 122.21 -0.306 . . . . 73.129999999999995 112.835 173.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -151.97 140.99 21.18 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.57 0.748 . . . . 73.019999999999996 110.384 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 167.72 -171.77 42.33 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.143 0.277 . . . . 51.100000000000001 112.446 176.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -88.57 125.24 34.7 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.113 0.565 . . . . 74.299999999999997 111.216 -175.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.466 HG11 ' HB3' ' A' ' 99' ' ' LEU . 30.8 m -120.62 152.26 55.36 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.724 1.21 . . . . 71.510000000000005 110.098 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 134' ' ' TYR . 56.9 Cg_endo -73.64 129.14 13.28 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 121.654 1.569 . . . . 75.310000000000002 111.347 -177.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 43.8 t -57.74 -27.14 62.74 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.648 0.779 . . . . 54.140000000000001 111.799 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -67.87 -21.25 65.17 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.312 1.045 . . . . 72.120000000000005 112.191 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . 0.41 ' HB2' ' HG2' ' A' ' 131' ' ' PRO . 2.0 m-85 -107.06 8.52 30.34 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.613 0.765 . . . . 75.420000000000002 111.681 -176.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.5 pt -128.26 155.2 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-N 118.545 0.611 . . . . 75.219999999999999 109.958 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.3 t -150.36 134.97 9.53 Favored Pre-proline 0 N--CA 1.495 1.779 0 C-N-CA 122.849 0.459 . . . . 73.25 110.175 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.558 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 74.4 Cg_endo -76.21 117.46 4.64 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.879 2.386 . . . . 72.430000000000007 114.282 -176.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.7 m -90.29 -49.7 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 122.841 0.457 . . . . 74.129999999999995 111.618 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -94.36 6.36 48.94 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.114 0.483 . . . . 75.319999999999993 111.405 -173.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.558 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 25.0 t -83.59 -178.69 7.11 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.126 0.489 . . . . 70.140000000000001 109.807 173.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 62.4 mt -63.16 -13.79 41.13 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.235 1.014 . . . . 71.329999999999998 112.644 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.554 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 36.5 tt0 -58.75 -24.59 61.88 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.856 0.862 . . . . 72.310000000000002 112.519 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.2 -25.3 66.95 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 123.469 0.708 . . . . 71.109999999999999 110.837 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -79.57 148.33 31.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.718 0.807 . . . . 74.219999999999999 110.705 170.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.6 p -65.72 -22.65 66.63 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.924 0.713 . . . . 74.099999999999994 112.924 -175.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 59.5 p-90 -81.6 -46.48 14.35 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.965 0.506 . . . . 65.340000000000003 112.32 -178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 30.5 t80 -88.37 137.37 32.39 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.441 -0.578 . . . . 72.040000000000006 109.441 -177.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' HIS . . . . . 0.554 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 25.0 m-70 -130.45 26.82 5.07 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 111.97 0.359 . . . . 73.239999999999995 111.97 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.93 -154.63 46.39 Favored Glycine 0 CA--C 1.54 1.644 0 N-CA-C 114.766 0.667 . . . . 71.530000000000001 114.766 171.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.452 ' HG3' ' OH ' ' A' ' 112' ' ' TYR . 72.2 Cg_endo -75.03 108.62 2.76 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 123.478 2.785 . . . . 64.230000000000004 111.901 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.495 HG13 ' HD3' ' A' ' 171' ' ' ARG . 1.6 p -155.23 138.5 7.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 115.493 -0.776 . . . . 71.450000000000003 109.659 -177.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.3 p -80.83 170.74 15.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.999 0.74 . . . . 74.140000000000001 112.999 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -63.41 -27.62 69.42 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 114.94 -1.027 . . . . 73.209999999999994 112.694 -169.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -68.54 -57.33 5.94 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.552 0.741 . . . . 74.540000000000006 110.072 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.12 -36.62 84.85 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.338 0.655 . . . . 70.510000000000005 110.695 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.446 ' HA ' ' NH1' ' A' ' 171' ' ' ARG . . . -53.26 -52.25 59.61 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.824 -1.08 . . . . 73.239999999999995 112.03 171.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.549 ' HG3' HG13 ' A' ' 190' ' ' VAL . 29.7 tt0 -76.9 -19.65 57.17 Favored 'General case' 0 C--O 1.212 -0.871 0 CA-C-N 114.856 -1.065 . . . . 74.140000000000001 110.71 -175.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -67.53 -51.16 54.19 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.873 0.469 . . . . 72.239999999999995 109.974 172.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.596 HD11 HH22 ' A' ' 171' ' ' ARG . 82.7 mt -64.93 -42.16 94.91 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.864 -0.607 . . . . 73.219999999999999 110.965 178.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.529 HD22 HG11 ' A' ' 190' ' ' VAL . 32.4 tp -71.77 -28.8 63.88 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.214 -0.903 . . . . 75.530000000000001 112.024 -177.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.5 t -57.03 -40.13 76.14 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.641 0.776 . . . . 61.130000000000003 110.327 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.404 ' HB2' ' HG2' ' A' ' 237' ' ' PRO . 10.5 m -81.93 -0.21 42.83 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 114.636 -1.166 . . . . 64.310000000000002 111.585 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -93.23 154.53 21.89 Favored Glycine 0 C--N 1.349 1.271 0 C-N-CA 123.068 0.366 . . . . 74.420000000000002 113.055 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 20.5 pt -103.76 -167.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 123.798 0.839 . . . . 72.040000000000006 112.13 -173.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.638 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 16.3 p-10 -59.52 103.94 0.23 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.008 0.923 . . . . 72.010000000000005 113.486 -171.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 103.82 13.25 28.08 Favored Glycine 0 C--O 1.26 1.768 0 CA-C-N 116.288 -0.414 . . . . 74.140000000000001 112.847 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 22.6 t -71.72 136.73 47.31 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-O 119.227 -0.416 . . . . 74.230000000000004 110.132 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 183' ' ' SER . 21.6 p90 -135.22 156.35 49.13 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.932 0.716 . . . . 71.120000000000005 112.932 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.566 HD23 HH21 ' A' ' 171' ' ' ARG . 84.0 mt -140.01 132.84 29.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.419 -1.264 . . . . 74.420000000000002 108.184 171.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 23.0 t -110.07 130.73 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 107.613 -1.255 . . . . 73.150000000000006 107.613 172.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.596 HH22 HD11 ' A' ' 159' ' ' LEU . 11.9 ptp180 -163.38 164.66 24.59 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.165 0.586 . . . . 74.219999999999999 110.206 -174.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 16.1 pt-20 -111.48 156.93 20.93 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.568 0.347 . . . . 75.329999999999998 110.068 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.2 t -75.06 139.1 42.59 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 116.065 -0.516 . . . . 75.040000000000006 110.582 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.42 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 94.4 mt-10 -65.51 -42.43 92.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.941 0.497 . . . . 74.420000000000002 110.01 172.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 54.7 p -77.75 -21.97 51.0 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.106 0.962 . . . . 75.239999999999995 111.852 -176.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 36.9 t -140.03 79.89 21.53 Favored Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 109.33 -0.618 . . . . 75.25 109.33 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -71.43 148.08 53.71 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 123.028 2.485 . . . . 74.349999999999994 111.675 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 88.43 -25.03 9.83 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 115.414 -0.812 . . . . 62.210000000000001 111.843 -170.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -90.46 118.07 29.65 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 108.687 -0.857 . . . . 75.329999999999998 108.687 168.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 61.2 mtt180 -103.44 172.41 6.82 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 114.7 -1.136 . . . . 65.299999999999997 110.252 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.5 m -155.96 140.18 16.56 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.512 1.125 . . . . 71.230000000000004 108.462 -169.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.424 HD12 ' CD2' ' A' ' 217' ' ' LEU . 53.1 mt -112.78 137.98 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.243 -1.021 . . . . 71.409999999999997 108.243 167.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.529 ' HB3' HD23 ' A' ' 160' ' ' LEU . 17.0 m -117.19 112.58 21.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.283 1.433 . . . . 72.329999999999998 107.735 -175.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 42.1 mt -110.62 139.46 45.87 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.138 0.975 . . . . 74.319999999999993 111.459 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 45.4 ttt-85 -129.0 134.92 48.34 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 115.649 -0.705 . . . . 75.510000000000005 109.726 171.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 12.2 p90 -153.19 139.85 18.88 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 124.67 1.231 . . . . 72.129999999999995 107.823 175.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 54.66 23.11 4.48 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 125.026 1.33 . . . . 74.129999999999995 114.233 176.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.56 6.22 73.82 Favored Glycine 0 N--CA 1.475 1.282 0 O-C-N 122.206 -0.309 . . . . 75.319999999999993 113.189 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 15.7 tpp180 -101.03 124.47 46.81 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.218 1.007 . . . . 74.239999999999995 108.746 177.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.549 HG13 ' HG3' ' A' ' 157' ' ' GLU . 97.0 t -106.85 133.52 51.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.64 1.176 . . . . 75.439999999999998 108.624 174.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . 0.527 ' HH ' HG23 ' A' ' 230' ' ' THR . 27.4 p90 -146.3 155.7 42.83 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.238 0.615 . . . . 74.329999999999998 109.986 169.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -134.66 122.22 21.95 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.842 -1.17 . . . . 75.140000000000001 107.842 -174.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -119.19 155.11 32.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.026 0.53 . . . . 71.420000000000002 109.917 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -99.72 135.0 41.8 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.15 0.5 . . . . 75.25 111.381 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 71.3 mt -82.74 111.79 19.58 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 CA-C-N 114.932 -1.031 . . . . 74.129999999999995 108.607 167.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -81.04 130.99 35.28 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.49 0.716 . . . . 74.030000000000001 109.185 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 48.1 m -97.31 125.55 41.96 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.323 0.649 . . . . 52.310000000000002 110.202 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.56 178.54 6.58 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.48 1.112 . . . . 74.209999999999994 111.727 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 45.3 t -60.7 -36.0 77.71 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.122 0.969 . . . . 73.219999999999999 112.059 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -74.07 -14.17 60.95 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.691 -0.686 . . . . 71.439999999999998 112.318 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 93.66 3.38 64.49 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.513 -0.635 . . . . 74.420000000000002 111.513 -170.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -72.27 160.61 32.1 Favored 'General case' 0 C--N 1.346 0.455 0 C-N-CA 124.123 0.969 . . . . 75.239999999999995 110.404 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 214' ' ' LEU . 72.7 mt -113.84 147.19 38.83 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.006 0.923 . . . . 70.129999999999995 110.359 -173.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -163.19 153.77 16.35 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.715 0.635 . . . . 72.519999999999996 109.977 175.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.7 t -125.26 -62.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.999 -1.112 . . . . 73.150000000000006 107.999 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.0 t -102.4 -178.4 3.68 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.253 1.021 . . . . 75.340000000000003 111.071 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.6 t -61.5 -47.41 85.75 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.333 1.053 . . . . 74.049999999999997 112.044 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -90.34 12.81 17.18 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.486 0.714 . . . . 71.430000000000007 111.643 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 66.8 m -98.51 111.54 23.87 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.373 0.669 . . . . 74.329999999999998 109.782 173.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -146.71 115.13 6.71 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.257 1.023 . . . . 73.420000000000002 109.304 171.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -135.8 142.26 44.85 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 117.843 0.292 . . . . 72.209999999999994 111.105 -171.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -83.85 -34.78 24.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.264 -0.643 . . . . 71.319999999999993 109.264 169.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 66.8 p -121.13 145.47 47.78 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-O 122.039 0.923 . . . . 74.209999999999994 111.72 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 203' ' ' LEU . 30.2 tp -68.3 -24.68 64.88 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.472 -1.24 . . . . 74.439999999999998 110.811 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.44 85.96 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.457 0.703 . . . . 73.510000000000005 110.542 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -67.89 -34.39 76.56 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 116.053 -0.521 . . . . 75.129999999999995 111.382 175.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.424 ' CD2' HD12 ' A' ' 182' ' ' ILE . 10.0 tt -58.6 -46.22 87.47 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.42 0.45 . . . . 74.209999999999994 110.981 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.94 -39.11 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.166 0.587 . . . . 63.549999999999997 110.828 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -61.66 -55.1 34.11 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.318 0.58 . . . . 74.549999999999997 111.328 176.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.41 ' O ' HG23 ' A' ' 224' ' ' VAL . 46.9 t60 -51.14 -54.77 22.19 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 114.589 -1.187 . . . . 74.310000000000002 109.662 177.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -65.23 -24.94 67.48 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.608 -0.724 . . . . 54.149999999999999 112.709 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.6 t -72.51 -25.41 61.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.854 0.462 . . . . 73.400000000000006 111.064 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.3 t -122.47 -2.9 8.9 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 116.408 2.003 . . . . 61.409999999999997 116.408 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 220' ' ' HIS . 27.8 m -101.61 154.17 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-N 121.123 1.783 . . . . 61.219999999999999 115.421 -172.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.66 -0.73 57.29 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 129.248 3.019 . . . . 71.140000000000001 113.487 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.23 14.56 0.89 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 129.027 2.931 . . . . 72.230000000000004 113.677 -145.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.4 16.42 4.7 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 122.225 0.903 . . . . 51.109999999999999 111.725 -170.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.14 120.02 32.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.257 -0.972 . . . . 75.409999999999997 110.927 169.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . 0.476 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 92.7 mt -59.23 -43.26 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 123.97 0.794 . . . . 74.209999999999994 109.39 172.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' THR . . . . . 0.527 HG23 ' HH ' ' A' ' 191' ' ' TYR . 8.8 t -136.09 148.74 48.42 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.694 -0.854 . . . . 73.450000000000003 108.694 165.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 80.7 p -72.4 159.71 33.54 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.566 -0.531 . . . . 65.430000000000007 109.566 171.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 20.4 mt -69.33 102.31 1.71 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.202 -1.036 . . . . 71.519999999999996 108.202 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -87.83 -50.52 6.4 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.461 -0.57 . . . . 74.430000000000007 109.461 -174.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -161.43 147.14 10.81 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 112.444 0.535 . . . . 73.439999999999998 112.444 -177.784 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.36 152.4 71.4 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.122 1.882 . . . . 74.239999999999995 112.736 -176.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.56 155.61 89.22 Favored Pre-proline 0 C--O 1.244 0.81 0 CA-C-N 115.774 -0.648 . . . . 72.319999999999993 110.667 175.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.404 ' HG2' ' HB2' ' A' ' 162' ' ' SER . 17.7 Cg_endo -56.85 140.02 90.58 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.801 2.334 . . . . 74.040000000000006 113.309 177.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt . . . . . 0 CA--C 1.543 0.709 0 CA-C-N 114.834 -1.075 . . . . 74.099999999999994 108.657 169.145 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.428 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.0 mpp? . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.856 -0.424 . . . . 75.099999999999994 109.856 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.64 38.29 61.45 Favored Glycine 0 C--N 1.35 1.35 0 O-C-N 123.167 0.292 . . . . 73.329999999999998 113.198 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -85.24 129.52 34.79 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.836 0.455 . . . . 72.439999999999998 110.351 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.86 68.7 3.42 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 123.914 0.886 . . . . 72.549999999999997 110.94 172.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.45 -12.18 22.69 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.723 2.282 . . . . 65.230000000000004 112.272 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.31 148.49 51.35 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-N 115.843 -0.617 . . . . 63.340000000000003 113.034 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -77.14 81.82 3.64 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.324 0.65 . . . . 73.430000000000007 110.886 -173.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.9 m -79.02 169.94 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 115.824 -0.626 . . . . 73.430000000000007 109.71 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.5 tp 63.25 93.58 0.05 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.886 0.875 . . . . 74.030000000000001 110.886 -175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.27 167.57 13.75 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.626 -0.716 . . . . 62.200000000000003 111.611 176.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.62 95.14 4.51 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 122.779 0.431 . . . . 72.430000000000007 110.045 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -164.31 153.86 13.94 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.041 0.537 . . . . 75.219999999999999 110.446 -175.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -66.06 143.44 57.33 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.917 -0.583 . . . . 74.239999999999995 109.474 167.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 52.05 71.71 1.4 Allowed Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 123.105 0.562 . . . . 72.310000000000002 109.864 -168.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HG2' ' HB3' ' A' ' 133' ' ' ASN . 9.8 Cg_exo -68.29 168.78 18.45 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.284 1.989 . . . . 73.340000000000003 111.063 174.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.2 p -67.41 165.81 15.83 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 121.352 0.596 . . . . 71.219999999999999 111.639 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.9 mt -106.56 130.56 22.73 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 108.542 -0.91 . . . . 74.239999999999995 108.542 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -66.58 165.46 25.18 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 121.982 1.788 . . . . 62.43 110.618 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.18 147.2 31.39 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.601 0.239 . . . . 55.020000000000003 110.407 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.536 ' HB3' HD11 ' A' ' 23' ' ' ILE . 63.5 mt -85.85 94.07 9.07 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.249 -1.019 . . . . 74.200000000000003 108.249 176.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -98.15 -47.73 5.37 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.878 -1.055 . . . . 75.109999999999999 109.057 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -101.79 113.59 26.92 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 114.345 -1.298 . . . . 74.400000000000006 109.9 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' A' ' 20' ' ' LEU . 46.5 mm -115.75 120.18 64.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 106.083 -1.821 . . . . 74.540000000000006 106.083 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -63.83 -47.43 80.81 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.478 0.656 . . . . 75.150000000000006 109.84 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.39 -48.66 0.92 Allowed Glycine 0 C--N 1.342 0.911 0 CA-C-N 115.008 -0.996 . . . . 75.109999999999999 111.278 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -138.36 -59.62 0.63 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.204 0.602 . . . . 75.340000000000003 110.001 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.49 -156.88 24.31 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 115.792 -0.64 . . . . 72.349999999999994 112.205 -176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.678 ' HB2' HD12 ' A' ' 110' ' ' LEU . 88.9 mttt -86.92 -166.33 1.54 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.996 0.518 . . . . 74.299999999999997 110.198 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.73 161.45 6.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.927 0.891 . . . . 72.439999999999998 109.948 171.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 61.62 80.38 0.22 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.52 1.128 . . . . 74.439999999999998 111.972 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 p -92.35 -60.6 1.8 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.266 -0.879 . . . . 74.340000000000003 110.255 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.1 t -178.82 138.04 0.15 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.754 1.222 . . . . 72.030000000000001 109.234 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -100.18 85.2 2.97 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 109.164 -0.68 . . . . 72.519999999999996 109.164 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -159.53 150.44 19.54 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.475 -0.784 . . . . 74.430000000000007 109.451 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.92 -108.25 1.82 Allowed Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.851 -0.9 . . . . 73.099999999999994 110.851 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.64 162.35 10.87 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-O 119.332 -0.705 . . . . 73.340000000000003 111.7 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.53 146.71 31.12 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.798 2.332 . . . . 73.329999999999998 111.792 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -96.76 43.14 1.08 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 122.123 0.963 . . . . 75.540000000000006 109.59 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.1 p -84.13 134.13 34.6 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.766 -1.198 . . . . 74.219999999999999 107.766 169.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -75.55 -22.77 56.75 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.394 0.278 . . . . 65.430000000000007 111.62 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.2 t -113.98 112.53 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.696 0.798 . . . . 72.219999999999999 109.532 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.57 140.96 1.08 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.981 0.912 . . . . 74.329999999999998 110.189 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.3 m -105.46 178.05 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.403 0.681 . . . . 75.140000000000001 111.107 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -89.82 161.9 15.76 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.204 0.602 . . . . 75.400000000000006 111.304 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -106.31 -50.17 3.2 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.941 -0.572 . . . . 64.409999999999997 109.983 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -126.9 -168.77 1.92 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.399 1.08 . . . . 74.439999999999998 109.709 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.17 149.57 50.1 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.049 0.54 . . . . 64.010000000000005 110.58 172.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.5 mt -96.73 122.72 39.98 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.071 -1.085 . . . . 75.219999999999999 108.071 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -73.32 107.49 5.66 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 113.951 1.093 . . . . 74.310000000000002 113.951 -164.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.418 ' HB3' HD11 ' A' ' 141' ' ' LEU . 20.5 ttm180 -129.72 89.75 45.51 Favored Pre-proline 0 C--O 1.245 0.842 0 N-CA-C 107.018 -1.475 . . . . 74.010000000000005 107.018 155.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.637 ' HA ' HG23 ' A' ' 213' ' ' THR . 52.8 Cg_endo -82.51 -139.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.629 2.219 . . . . 73.140000000000001 111.15 174.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.4 t -54.71 117.1 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 C-N-CA 123.615 0.766 . . . . 74.340000000000003 109.626 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.21 121.44 7.52 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.238 1.415 . . . . 73.409999999999997 113.74 -166.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.9 t -77.1 -29.64 54.94 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.983 0.913 . . . . 74.549999999999997 110.015 175.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -81.89 107.08 14.33 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.707 0.803 . . . . 75.409999999999997 110.145 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -124.46 -174.18 2.95 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.986 1.314 . . . . 74.439999999999998 108.331 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.705 ' HG2' ' HB3' ' A' ' 114' ' ' HIS . 29.4 tt0 71.12 73.02 0.27 Allowed Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.42 1.088 . . . . 74.510000000000005 109.588 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -95.55 139.33 0.87 Allowed 'Trans proline' 0 CA--C 1.558 1.688 0 C-N-CA 123.538 2.825 . . . . 73.219999999999999 114.885 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -135.9 114.22 11.59 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.822 0.849 . . . . 75.049999999999997 109.588 171.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.89 78.05 1.25 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.924 -0.471 . . . . 75.200000000000003 111.924 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.693 HD12 ' HA ' ' A' ' 115' ' ' ASN . 75.9 mt -73.1 143.06 47.52 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.701 0.801 . . . . 74.420000000000002 111.003 -177.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.7 p -66.16 94.05 0.23 Allowed 'General case' 0 CA--C 1.553 1.087 0 O-C-N 123.712 0.632 . . . . 73.319999999999993 110.717 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.85 130.61 41.47 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.213 -0.662 . . . . 73.219999999999999 109.213 176.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.79 -89.27 0.12 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.977 0.511 . . . . 74.109999999999999 111.69 -168.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.89 75.88 0.13 Allowed 'General case' 0 C--N 1.348 0.538 0 C-N-CA 123.132 0.573 . . . . 73.420000000000002 109.853 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -80.04 75.53 6.79 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.637 -0.875 . . . . 75.099999999999994 108.637 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -75.13 97.43 3.47 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 114.911 -1.04 . . . . 74.010000000000005 110.016 -177.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -173.49 155.8 2.88 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.601 -1.181 . . . . 75.109999999999999 108.309 174.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.2 m -149.64 85.98 1.45 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.027 0.531 . . . . 43.240000000000002 109.901 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -84.77 163.32 19.19 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.713 -0.847 . . . . 75.040000000000006 108.713 164.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -79.06 139.66 38.08 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.149 0.5 . . . . 74.340000000000003 111.772 -174.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -63.94 109.29 1.73 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.931 -1.031 . . . . 74.129999999999995 109.494 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.436 HD13 HD13 ' A' ' 88' ' ' LEU . 92.5 mt -82.54 63.85 6.9 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.634 0.731 . . . . 74.239999999999995 110.764 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.6 mt -84.87 108.73 17.66 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.333 -0.988 . . . . 74.209999999999994 108.333 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.473 ' H ' HG13 ' A' ' 138' ' ' VAL . . . -75.47 -57.31 3.96 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.036 0.535 . . . . 72.409999999999997 111.047 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.75 178.74 36.84 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 115.733 -0.667 . . . . 71.120000000000005 112.52 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 8.0 Cg_endo -95.86 -153.86 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 123.343 2.696 . . . . 62.439999999999998 113.999 -166.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.0 t -137.85 -167.51 2.16 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 106.904 -1.517 . . . . 74.25 106.904 167.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -74.45 -53.96 8.5 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.737 0.698 . . . . 74.409999999999997 111.567 -168.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -160.48 26.9 0.16 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.069 0.948 . . . . 62.549999999999997 109.426 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.04 158.96 33.26 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 115.158 -0.928 . . . . 74.230000000000004 110.989 -165.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.65 159.0 14.77 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 123.174 2.583 . . . . 74.319999999999993 113.144 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 50' ' ' ARG . 9.6 m120 -56.36 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.951 0.782 . . . . 70.310000000000002 111.987 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.573 ' H ' ' HB3' ' A' ' 139' ' ' ASN . 50.3 tp -81.55 135.77 35.59 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.538 -1.21 . . . . 74.409999999999997 109.165 177.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -105.49 176.08 5.28 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.948 1.299 . . . . 75.299999999999997 109.359 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.35 143.13 23.52 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 N-CA-C 108.503 -0.925 . . . . 65.25 108.503 171.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.05 121.67 23.12 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.627 -0.508 . . . . 63.539999999999999 109.627 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.436 HD13 HD13 ' A' ' 73' ' ' LEU . 74.4 mt -82.42 -21.63 35.65 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.703 0.801 . . . . 74.239999999999995 111.252 173.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.574 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 84.5 m-85 -136.16 158.14 45.14 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.114 0.565 . . . . 74.319999999999993 109.585 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.51 145.58 39.04 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.689 -0.687 . . . . 74.150000000000006 109.835 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -153.23 111.16 3.59 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.236 -1.024 . . . . 74.019999999999996 108.236 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.4 t -82.54 138.71 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 109.074 -0.713 . . . . 73.430000000000007 109.074 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.65 116.25 4.61 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.087 0.555 . . . . 71.230000000000004 110.194 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.5 m -78.79 -11.05 59.97 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.718 0.807 . . . . 73.430000000000007 110.717 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.74 -172.68 41.62 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.587 -0.733 . . . . 63.310000000000002 111.28 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.53 -25.68 66.78 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.436 0.694 . . . . 72.030000000000001 110.719 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -70.2 -22.99 62.88 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.588 0.755 . . . . 73.439999999999998 112.456 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.7 p -113.71 157.74 21.81 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.408 0.683 . . . . 64.219999999999999 110.915 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.2 tp -109.93 131.15 55.32 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.734 0.814 . . . . 65.150000000000006 109.927 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.8 t -74.05 120.01 19.04 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 108.892 -0.781 . . . . 61.329999999999998 108.892 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.32 159.53 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.244 1.018 . . . . 72.219999999999999 108.775 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 60.0 m -135.78 148.15 48.64 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.265 -0.643 . . . . 74.310000000000002 109.265 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -54.84 123.38 13.21 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.095 0.558 . . . . 74.230000000000004 111.646 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.29 -9.54 49.81 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.388 -0.369 . . . . 63.119999999999997 113.095 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -85.01 131.89 34.41 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.557 0.743 . . . . 72.019999999999996 110.445 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HB3' HD12 ' A' ' 84' ' ' LEU . 8.7 mtmp? -83.52 115.48 22.11 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.773 0.829 . . . . 71.299999999999997 110.302 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.501 ' HA ' HG22 ' A' ' 123' ' ' THR . 15.7 mt -103.14 145.74 29.45 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.956 0.903 . . . . 73.510000000000005 109.965 -169.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.472 ' NH2' ' HG2' ' A' ' 122' ' ' GLN . 84.5 mtm180 -108.65 108.95 20.02 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.605 -0.887 . . . . 71.409999999999997 108.605 173.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 71.6 t -95.56 117.28 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 121.298 0.571 . . . . 73.299999999999997 110.249 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.678 HD12 ' HB2' ' A' ' 28' ' ' LYS . 48.5 mt -77.16 -28.73 54.25 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.251 1.421 . . . . 74.140000000000001 111.207 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.3 177.51 39.46 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.127 -0.488 . . . . 62.329999999999998 113.016 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.497 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 2.8 m-85 -107.15 168.41 9.23 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.833 0.853 . . . . 72.340000000000003 109.398 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -85.9 151.77 23.51 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 110.018 -0.364 . . . . 73.310000000000002 110.018 170.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.705 ' HB3' ' HG2' ' A' ' 57' ' ' GLU . 18.1 p-80 -57.87 -32.29 67.53 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 113.185 0.809 . . . . 73.439999999999998 113.185 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.693 ' HA ' HD12 ' A' ' 61' ' ' LEU . 67.3 t30 -90.16 3.88 52.1 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.129 0.572 . . . . 72.150000000000006 110.465 -176.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 61.59 31.16 76.77 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 111.03 -0.828 . . . . 73.549999999999997 111.03 -174.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -67.65 -70.45 0.26 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 107.934 -1.136 . . . . 74.299999999999997 107.934 -174.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -135.54 178.46 7.02 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 108.337 -0.986 . . . . 72.540000000000006 108.337 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.16 117.81 24.71 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.67 0.788 . . . . 63.310000000000002 109.058 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.92 108.65 3.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.279 0.632 . . . . 62.439999999999998 109.711 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.37 168.23 10.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.634 0.773 . . . . 55.229999999999997 110.784 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.472 ' HG2' ' NH2' ' A' ' 108' ' ' ARG . 61.6 tt0 -149.09 128.09 12.69 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.149 -1.056 . . . . 72.109999999999999 108.149 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.501 HG22 ' HA ' ' A' ' 107' ' ' LEU . 81.6 p -139.31 -174.46 3.87 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.701 0.801 . . . . 72.219999999999999 110.701 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -55.53 -28.87 57.31 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.6 0.76 . . . . 72.530000000000001 111.336 169.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -76.1 -13.3 60.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.547 0.739 . . . . 73.439999999999998 111.573 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 132.02 -130.95 6.09 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 111.905 -0.478 . . . . 70.450000000000003 111.905 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -150.73 146.58 26.53 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.338 0.655 . . . . 71.209999999999994 110.072 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 166.94 177.79 38.93 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 112.1 -0.4 . . . . 71.519999999999996 112.1 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -80.62 130.3 35.03 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.589 0.756 . . . . 72.409999999999997 110.887 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.03 151.54 61.65 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 124.286 1.034 . . . . 75.010000000000005 109.767 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.54 132.02 14.28 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 121.748 1.632 . . . . 62.310000000000002 111.636 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.477 ' HA ' HG12 ' A' ' 135' ' ' ILE . 41.8 p -61.58 -22.01 64.82 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.703 0.801 . . . . 71.510000000000005 111.901 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.452 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 43.6 m-20 -68.36 -24.5 64.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.429 1.092 . . . . 62.049999999999997 111.926 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.574 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.1 m-85 -101.7 2.19 38.34 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.593 0.757 . . . . 74.329999999999998 112.153 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.477 HG12 ' HA ' ' A' ' 132' ' ' SER . 16.4 pt -131.21 161.92 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.66 0.384 . . . . 75.340000000000003 110.056 -173.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 11.0 t -151.16 147.92 21.55 Favored Pre-proline 0 N--CA 1.481 1.113 0 N-CA-C 108.593 -0.891 . . . . 75.400000000000006 108.593 170.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.446 ' HB2' ' HG ' ' A' ' 140' ' ' SER . 3.3 Cg_exo -74.94 150.59 38.68 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 121.971 1.781 . . . . 64.140000000000001 111.564 172.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.473 HG13 ' H ' ' A' ' 75' ' ' ALA . 15.1 m -131.13 -44.52 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.155 0.582 . . . . 74.140000000000001 111.185 176.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.573 ' HB3' ' H ' ' A' ' 84' ' ' LEU . 58.2 t30 -95.5 17.96 13.66 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.411 1.101 . . . . 75.400000000000006 110.491 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.446 ' HG ' ' HB2' ' A' ' 137' ' ' PRO . 75.6 p -76.24 168.86 19.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.483 -0.78 . . . . 74.109999999999999 110.677 172.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.418 HD11 ' HB3' ' A' ' 50' ' ' ARG . 63.2 mt -62.98 -15.84 57.48 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 114.957 -1.019 . . . . 74.420000000000002 111.166 172.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -61.74 -26.77 68.27 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.269 1.428 . . . . 73.310000000000002 112.999 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -67.78 -18.11 64.76 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 122.768 0.427 . . . . 74.430000000000007 110.819 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -82.0 145.05 30.46 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.02 -0.733 . . . . 72.430000000000007 109.02 168.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.3 p -64.3 -19.91 65.73 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 112.884 0.698 . . . . 75.329999999999998 112.884 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.429 ' CE3' HG21 ' A' ' 218' ' ' VAL . 65.3 p-90 -77.72 -37.81 48.59 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 112.445 0.535 . . . . 64.120000000000005 112.445 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.401 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 22.7 t80 -102.22 138.6 38.94 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.143 -0.688 . . . . 71.129999999999995 109.143 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -129.56 22.37 5.51 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.682 0.393 . . . . 75.019999999999996 111.446 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 62.81 -156.19 40.57 Favored Glycine 0 CA--C 1.536 1.385 0 N-CA-C 115.092 0.797 . . . . 72.209999999999994 115.092 169.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 6.3 Cg_exo -76.37 104.59 1.93 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.391 2.727 . . . . 62.229999999999997 111.044 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.55 160.98 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.293 0.568 . . . . 75.140000000000001 112.02 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 18.2 m -71.26 161.73 30.6 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 114.924 -1.035 . . . . 60.530000000000001 110.916 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -64.02 -32.65 74.28 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.109 0.564 . . . . 73.549999999999997 110.114 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -65.11 -49.72 68.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.524 1.129 . . . . 64.129999999999995 110.416 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.02 -43.51 87.45 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.597 0.759 . . . . 73.450000000000003 110.406 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.46 -59.9 4.46 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.387 -1.279 . . . . 53.229999999999997 110.944 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.595 ' HG3' HG12 ' A' ' 190' ' ' VAL . 31.7 tt0 -67.73 -22.73 65.22 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.835 -0.62 . . . . 75.0 111.281 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -65.42 -56.38 12.83 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.996 0.519 . . . . 75.239999999999995 109.706 173.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.27 -35.91 80.44 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 116.431 -0.349 . . . . 75.209999999999994 111.148 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.499 HD23 HG13 ' A' ' 190' ' ' VAL . 34.4 tp -72.25 -26.72 62.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.013 0.525 . . . . 75.129999999999995 111.66 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.5 t -70.06 -16.28 63.12 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.976 0.51 . . . . 74.409999999999997 111.162 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.3 m -83.07 -17.79 41.94 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.263 0.625 . . . . 73.420000000000002 111.052 170.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.36 -179.64 51.02 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 116.154 -0.475 . . . . 64.420000000000002 113.431 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.1 pt -133.37 -166.45 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 125.864 1.666 . . . . 74.109999999999999 110.503 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 24.3 p-10 -60.15 129.95 44.24 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.62 0.368 . . . . 73.219999999999999 111.229 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.88 10.03 84.61 Favored Glycine 0 C--O 1.264 1.982 0 CA-C-O 119.997 -0.335 . . . . 64.129999999999995 113.061 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.63 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 75.2 m -82.58 141.2 32.76 Favored 'General case' 0 C--N 1.371 1.532 0 N-CA-C 110.086 -0.338 . . . . 74.209999999999994 110.086 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 183' ' ' SER . 16.4 p90 -136.68 161.48 35.8 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.756 0.789 . . . . 74.120000000000005 112.918 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 79.6 mt -135.13 131.96 37.48 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 114.213 -1.358 . . . . 74.420000000000002 108.04 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 32.5 t -108.02 130.05 61.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 106.053 -1.832 . . . . 70.129999999999995 106.053 170.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.55 163.48 39.92 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.999 0.52 . . . . 75.120000000000005 110.261 -171.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 15.7 pt-20 -117.91 164.49 14.99 Favored 'General case' 0 C--O 1.26 1.625 0 C-N-CA 123.263 0.625 . . . . 71.099999999999994 110.368 172.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.1 m -80.29 146.93 31.37 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.73 -1.123 . . . . 70.219999999999999 110.209 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -78.74 -43.46 25.66 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.694 1.197 . . . . 73.510000000000005 110.293 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.471 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 27.3 m -99.29 9.48 43.29 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.531 -1.213 . . . . 74.299999999999997 112.032 -173.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.4 t -147.61 108.73 3.82 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 122.521 0.328 . . . . 75.299999999999997 110.709 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.497 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 68.4 Cg_endo -74.5 135.21 19.78 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.003 2.469 . . . . 74.420000000000002 111.551 173.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.71 -25.74 12.67 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 116.172 -0.467 . . . . 63.140000000000001 113.509 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -81.3 116.54 21.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.03 0.915 . . . . 75.239999999999995 109.192 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.532 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 41.1 mtt-85 -129.41 157.14 42.8 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.099 -1.075 . . . . 72.430000000000007 108.099 -177.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.6 m -140.08 144.89 37.05 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 123.225 0.61 . . . . 73.439999999999998 109.825 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 55.3 mt -109.67 143.88 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.021 -1.103 . . . . 75.049999999999997 108.021 165.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.8 m -125.37 112.31 16.16 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.375 1.07 . . . . 64.140000000000001 108.349 -174.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.443 HD21 HD22 ' A' ' 232' ' ' LEU . 47.1 mt -102.81 143.38 32.51 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.362 0.665 . . . . 74.150000000000006 111.341 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -122.16 128.11 50.84 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 107.224 -1.398 . . . . 75.540000000000006 107.224 167.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 1.3 t80 -152.48 123.94 7.74 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.066 1.346 . . . . 75.019999999999996 107.991 -171.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 62.49 18.98 10.86 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.905 1.282 . . . . 65.439999999999998 112.33 -172.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.66 1.63 85.27 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-O 120.019 -0.323 . . . . 73.230000000000004 113.099 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -97.34 125.43 41.94 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.071 -0.714 . . . . 75.420000000000002 109.071 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.595 HG12 ' HG3' ' A' ' 157' ' ' GLU . 73.1 t -98.43 118.77 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.328 1.051 . . . . 74.430000000000007 109.506 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -138.73 140.23 38.64 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.972 0.909 . . . . 55.32 109.389 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -120.19 146.32 46.12 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.779 0.832 . . . . 75.430000000000007 109.059 -171.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -139.68 150.03 44.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.974 0.509 . . . . 73.409999999999997 110.478 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.46 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 12.4 tpp85 -88.37 132.44 34.43 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.108 -0.951 . . . . 72.439999999999998 111.308 -171.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 68.4 mt -81.45 113.51 20.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 108.159 -1.052 . . . . 74.120000000000005 108.159 164.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -83.78 132.05 34.86 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.375 -0.602 . . . . 65.200000000000003 109.375 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.0 m -110.79 116.96 32.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.505 0.722 . . . . 74.049999999999997 109.714 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.5 178.42 2.03 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.363 1.065 . . . . 75.329999999999998 112.035 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 79.8 p -58.56 -41.48 85.76 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.9 0.88 . . . . 73.439999999999998 113.035 -170.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -79.46 -20.12 48.17 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 116.24 -0.436 . . . . 73.329999999999998 110.67 -175.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 113.37 5.5 22.81 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.013 -0.54 . . . . 53.420000000000002 113.53 -174.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -66.26 142.12 57.79 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.625 0.713 . . . . 74.120000000000005 110.502 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 78.3 mt -103.46 146.13 28.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.427 0.691 . . . . 74.400000000000006 109.501 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -165.76 140.61 4.78 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.149 0.579 . . . . 74.230000000000004 110.531 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.4 t -97.91 -38.68 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.316 0.646 . . . . 64.120000000000005 109.722 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 40.7 t -109.05 154.69 21.87 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.614 0.766 . . . . 74.340000000000003 110.96 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.1 m -69.96 -21.13 63.28 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.143 -0.935 . . . . 71.409999999999997 111.04 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -84.64 -6.9 59.39 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.538 0.735 . . . . 72.120000000000005 111.497 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 59.1 m -136.69 147.9 47.06 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.888 0.475 . . . . 75.299999999999997 112.044 -168.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -140.65 134.05 29.86 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.791 1.236 . . . . 75.329999999999998 108.326 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -127.82 132.62 49.43 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.916 0.486 . . . . 74.519999999999996 110.117 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -83.8 -25.02 30.77 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.323 0.649 . . . . 73.439999999999998 110.236 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.637 HG23 ' HA ' ' A' ' 51' ' ' PRO . 71.0 p -128.99 150.31 50.45 Favored 'General case' 0 C--O 1.253 1.263 0 C-N-CA 123.185 0.594 . . . . 75.409999999999997 110.973 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 31.3 tp -69.71 -27.73 65.23 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.407 -0.815 . . . . 74.230000000000004 110.047 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.25 -44.92 92.36 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.345 0.658 . . . . 73.409999999999997 110.847 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -75.78 -29.63 58.83 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 116.191 -0.459 . . . . 65.230000000000004 111.377 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tt -58.17 -51.3 70.32 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 123.301 0.375 . . . . 73.340000000000003 110.51 172.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.429 HG21 ' CE3' ' A' ' 146' ' ' TRP . 94.9 t -69.47 -42.9 81.03 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 CA-C-N 115.41 -0.814 . . . . 73.129999999999995 111.097 -176.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -57.71 -53.93 52.57 Favored 'General case' 0 C--O 1.259 1.568 0 C-N-CA 123.386 0.674 . . . . 74.530000000000001 111.151 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.466 ' O ' HG21 ' A' ' 224' ' ' VAL . 35.9 t-80 -55.65 -54.75 40.31 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 114.846 -1.07 . . . . 75.450000000000003 109.585 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.424 ' HD1' HD22 ' A' ' 228' ' ' LEU . 4.5 m-70 -68.15 -16.54 64.04 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.758 0.651 . . . . 64.140000000000001 112.758 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 232' ' ' LEU . 44.4 t -74.56 -31.32 62.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.564 0.345 . . . . 62.350000000000001 110.243 173.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.4 t -107.56 -12.34 15.29 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 116.501 2.037 . . . . 71.239999999999995 116.501 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.47 ' O ' HG21 ' A' ' 231' ' ' THR . 27.7 m -105.86 167.2 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 N-CA-C 117.512 2.412 . . . . 74.420000000000002 117.512 -166.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.02 -1.49 58.02 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 130.075 3.35 . . . . 74.329999999999998 113.663 -173.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -77.58 12.77 1.48 Allowed 'General case' 0 CA--C 1.567 1.619 0 C-N-CA 130.532 3.533 . . . . 70.099999999999994 114.031 -136.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.48 16.5 4.63 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 124.95 1.262 . . . . 73.510000000000005 110.58 -170.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.424 HD22 ' HD1' ' A' ' 221' ' ' HIS . 90.6 mt -90.79 123.38 34.31 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.122 1.369 . . . . 71.209999999999994 110.8 173.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 68.5 mt -62.5 -39.54 84.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.795 -0.639 . . . . 74.420000000000002 109.384 170.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.9 t -138.44 144.46 40.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.431 -0.951 . . . . 70.299999999999997 108.431 166.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' THR . . . . . 0.47 HG21 ' O ' ' A' ' 224' ' ' VAL . 59.6 p -65.68 150.68 48.08 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 109.22 -0.659 . . . . 74.209999999999994 109.22 170.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.443 HD22 HD21 ' A' ' 184' ' ' LEU . 31.4 mt -64.36 100.16 0.34 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 108.044 -1.095 . . . . 74.239999999999995 108.044 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -90.23 -53.42 4.47 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 109.619 -0.511 . . . . 72.430000000000007 109.619 -169.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.63 ' O ' ' HA ' ' A' ' 167' ' ' SER . 1.0 OUTLIER -151.8 145.33 17.65 Favored Pre-proline 0 N--CA 1.479 0.983 0 CA-C-N 115.495 -0.775 . . . . 72.209999999999994 110.451 177.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -85.3 158.07 11.09 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 121.626 1.551 . . . . 74.530000000000001 113.809 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.39 128.29 87.59 Favored Pre-proline 0 C--O 1.245 0.842 0 N-CA-C 108.923 -0.769 . . . . 64.439999999999998 108.923 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.93 171.15 18.06 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.482 2.121 . . . . 64.450000000000003 114.185 -167.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -79.02 152.99 30.61 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.265 -1.334 . . . . 74.5 108.664 172.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -49.69 -44.62 48.15 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 123.234 0.614 . . . . 73.049999999999997 111.642 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -86.93 124.06 32.72 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.01 -1.107 . . . . 74.329999999999998 108.01 169.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -67.33 116.65 38.86 Favored Pre-proline 0 CA--C 1.554 1.122 0 O-C-N 123.905 0.753 . . . . 74.109999999999999 110.257 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -89.68 165.6 5.11 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.919 2.413 . . . . 74.310000000000002 112.703 174.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 29.5 m -124.7 93.89 4.03 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.353 0.596 . . . . 74.239999999999995 110.454 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.51 146.66 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.274 1.03 . . . . 74.340000000000003 108.284 171.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -146.93 178.88 8.0 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.863 0.465 . . . . 71.019999999999996 110.575 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 164.19 142.94 3.55 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 111.201 -0.76 . . . . 74.340000000000003 111.201 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 60.1 t -129.58 -67.47 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.373 -0.973 . . . . 73.530000000000001 108.373 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 18.3 t 58.25 80.31 0.29 Allowed Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 124.163 0.985 . . . . 75.540000000000006 109.704 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -59.62 133.92 54.57 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.499 2.799 . . . . 73.129999999999995 113.106 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -74.52 112.38 10.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.734 0.814 . . . . 71.439999999999998 111.134 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -103.49 106.03 16.44 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.03 -1.1 . . . . 74.239999999999995 108.03 168.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.08 151.42 43.13 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.692 0.797 . . . . 70.329999999999998 112.668 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -157.15 118.57 3.71 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.553 -0.906 . . . . 74.329999999999998 108.553 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -86.08 -77.5 0.3 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.651 -0.87 . . . . 74.25 108.651 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 CA--C 1.552 1.052 0 C-N-CA 124.576 1.151 . . . . 74.230000000000004 108.103 177.583 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptm . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 110.337 -0.246 . . . . 71.409999999999997 110.337 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.86 -152.99 35.76 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.973 -0.558 . . . . 74.209999999999994 112.599 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -149.35 134.98 18.61 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.473 0.709 . . . . 74.049999999999997 109.658 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -73.06 124.19 90.4 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-O 118.791 -0.623 . . . . 75.349999999999994 109.653 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.82 -15.46 42.81 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.112 2.541 . . . . 73.25 113.755 174.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.52 -118.54 5.94 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 111.038 -0.825 . . . . 55.340000000000003 111.038 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -128.93 137.5 51.44 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.627 0.771 . . . . 60.229999999999997 109.476 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.6 154.21 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.104 0.961 . . . . 72.209999999999994 108.558 174.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -68.91 -10.52 57.62 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.864 0.465 . . . . 75.230000000000004 111.512 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.11 -162.84 20.09 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 115.913 -0.585 . . . . 73.5 111.676 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.43 91.57 2.26 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.736 0.779 . . . . 72.120000000000005 109.811 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -145.81 68.58 1.21 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.946 1.298 . . . . 75.430000000000007 109.072 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 64.43 125.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.684 1.194 . . . . 75.420000000000002 110.804 -174.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 59.07 66.22 2.43 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.137 0.975 . . . . 75.420000000000002 110.198 -171.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -60.36 162.05 18.51 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.375 2.05 . . . . 71.129999999999995 111.825 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.9 p -68.1 167.23 14.46 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.143 0.497 . . . . 74.230000000000004 111.743 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.0 mt -105.76 129.35 24.78 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 123.183 0.593 . . . . 73.519999999999996 109.455 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.63 171.62 17.42 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.477 2.118 . . . . 75.040000000000006 111.902 172.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.14 148.87 26.54 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.992 0.517 . . . . 71.329999999999998 111.236 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.503 HD23 HD13 ' A' ' 23' ' ' ILE . 83.6 mt -85.84 95.72 9.53 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.278 -1.008 . . . . 74.200000000000003 108.278 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -97.6 -53.42 3.44 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 120.762 0.315 . . . . 75.230000000000004 110.779 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -106.87 108.39 19.88 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.624 -0.717 . . . . 72.150000000000006 109.378 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.503 HD13 HD23 ' A' ' 20' ' ' LEU . 46.9 mm -124.3 114.07 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.291 0.636 . . . . 74.230000000000004 109.573 176.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.485 ' HE2' ' HG3' ' A' ' 58' ' ' PRO . 20.0 pttp -94.26 70.82 3.81 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 122.514 1.149 . . . . 74.319999999999993 108.509 169.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.45 -17.57 66.66 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 114.592 -1.186 . . . . 62.310000000000002 113.079 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.15 -12.73 20.2 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.048 0.939 . . . . 74.420000000000002 111.322 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.61 52.97 4.52 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-O 121.345 0.414 . . . . 73.450000000000003 112.685 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -111.97 22.97 14.29 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.354 1.062 . . . . 75.230000000000004 110.348 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -89.45 -11.08 44.09 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.218 0.607 . . . . 72.219999999999999 109.949 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' A' ' 56' ' ' PHE . 25.8 mt-10 -80.05 -13.82 59.01 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.855 1.262 . . . . 74.040000000000006 110.163 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 m -78.3 139.96 38.84 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 124.284 1.034 . . . . 65.439999999999998 111.526 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.9 p -99.67 124.11 44.59 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 107.665 -1.235 . . . . 74.420000000000002 107.665 169.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 74.56 96.94 0.07 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.774 1.23 . . . . 72.209999999999994 108.378 -161.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -153.27 137.93 16.93 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.617 -0.72 . . . . 75.0 109.828 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.51 -59.96 0.01 OUTLIER Glycine 0 C--N 1.34 0.768 0 N-CA-C 110.75 -0.94 . . . . 74.540000000000006 110.75 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.97 -112.5 3.95 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 118.739 -1.034 . . . . 70.340000000000003 112.181 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.77 135.48 38.55 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.922 2.414 . . . . 72.400000000000006 112.503 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -136.29 115.17 12.19 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.484 0.713 . . . . 72.239999999999995 109.396 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.7 p -84.17 178.52 7.78 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.908 0.883 . . . . 75.530000000000001 110.447 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -64.73 104.25 0.8 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.362 0.665 . . . . 64.209999999999994 109.948 175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.0 t -127.82 125.35 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.718 -1.216 . . . . 74.329999999999998 107.718 175.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -69.81 90.31 0.6 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.6 0.714 . . . . 71.019999999999996 109.571 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -140.49 119.76 11.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 107.305 -1.368 . . . . 73.310000000000002 107.305 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.45 ' HG3' ' CD2' ' A' ' 45' ' ' HIS . 15.2 tp10 -63.99 -48.91 74.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.535 0.734 . . . . 74.230000000000004 111.01 -171.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.45 ' CD2' ' HG3' ' A' ' 44' ' ' GLU . 98.6 m-70 -145.68 137.76 25.43 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.017 0.927 . . . . 75.200000000000003 109.007 175.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -107.6 152.53 24.15 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.603 0.761 . . . . 73.420000000000002 110.65 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.48 72.79 1.5 Allowed 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.757 -1.201 . . . . 65.219999999999999 107.757 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.0 mt -72.63 122.86 22.11 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.75 -0.659 . . . . 74.409999999999997 111.685 -171.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -143.82 -63.14 0.39 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.645 1.178 . . . . 75.340000000000003 108.028 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 59.06 105.1 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 125.386 1.475 . . . . 74.530000000000001 110.883 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.62 122.98 9.7 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.517 2.811 . . . . 72.239999999999995 113.339 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.7 t -58.28 117.9 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.309 0.643 . . . . 75.349999999999994 109.63 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.54 -51.12 68.62 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.39 0.676 . . . . 64.140000000000001 110.125 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.1 p -178.28 160.47 1.34 Allowed 'General case' 0 C--O 1.245 0.868 0 C-N-CA 124.839 1.256 . . . . 63.109999999999999 109.242 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.407 ' HA ' ' HG2' ' A' ' 30' ' ' GLU . 9.8 m-20 -77.66 138.5 39.12 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.9 -0.591 . . . . 64.129999999999995 109.963 172.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.428 ' H ' ' HG2' ' A' ' 30' ' ' GLU . 37.5 m-85 -76.46 -8.27 56.81 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.217 0.607 . . . . 73.209999999999994 109.885 169.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 67.17 76.93 0.26 Allowed Pre-proline 0 C--N 1.363 1.171 0 C-N-CA 123.812 0.845 . . . . 75.430000000000007 111.052 165.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.485 ' HG3' ' HE2' ' A' ' 24' ' ' LYS . 32.0 Cg_exo -58.28 96.86 0.08 OUTLIER 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.945 2.43 . . . . 41.119999999999997 111.969 -177.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 14.0 mm100 -70.07 153.33 43.31 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.754 -0.657 . . . . 75.209999999999994 110.756 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.24 147.92 19.44 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 123.452 0.47 . . . . 65.140000000000001 112.844 -175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.68 -172.83 2.11 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.215 1.006 . . . . 70.549999999999997 109.472 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.8 p -106.52 129.31 54.49 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.597 0.759 . . . . 62.549999999999997 109.543 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.06 160.43 32.49 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.817 0.447 . . . . 74.200000000000003 111.116 174.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.55 151.04 40.78 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.903 0.881 . . . . 63.5 109.621 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 63.83 26.47 14.35 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.262 1.025 . . . . 74.239999999999995 111.991 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.443 ' HG3' ' HB3' ' A' ' 175' ' ' SER . 0.0 OUTLIER -66.95 98.1 0.53 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.277 1.031 . . . . 74.329999999999998 110.967 -173.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 25.5 t90 -117.7 157.26 26.8 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.021 0.929 . . . . 71.140000000000001 109.66 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 62.46 78.77 0.28 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.704 1.201 . . . . 73.530000000000001 109.957 -173.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.1 m -145.55 86.75 1.76 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-N 115.032 -0.985 . . . . 75.239999999999995 109.607 -173.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -170.13 127.15 0.84 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.84 0.856 . . . . 64.430000000000007 109.461 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -161.27 148.52 15.0 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.078 -0.712 . . . . 74.420000000000002 109.078 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -80.75 96.2 6.87 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.116 0.566 . . . . 70.140000000000001 109.843 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.3 mt -72.84 139.63 47.08 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.038 0.535 . . . . 73.129999999999995 110.043 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 98.3 mt -126.7 87.91 2.74 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.822 0.849 . . . . 73.430000000000007 109.695 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . . . -90.81 137.77 32.11 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.149 0.58 . . . . 74.299999999999997 110.273 173.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -166.11 -83.65 0.05 OUTLIER Glycine 0 C--N 1.346 1.111 0 CA-C-O 119.178 -0.79 . . . . 74.209999999999994 112.251 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.2 122.75 12.08 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.518 2.812 . . . . 74.310000000000002 112.999 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.4 m -144.82 125.44 14.11 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.027 0.931 . . . . 74.409999999999997 109.494 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -100.1 -76.13 0.56 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.651 0.38 . . . . 74.120000000000005 111.092 -173.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.405 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.1 OUTLIER -171.47 5.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.642 0.777 . . . . 72.510000000000005 110.902 -171.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.411 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 6.4 p-10 -83.86 173.45 7.34 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 125.385 1.474 . . . . 62.229999999999997 110.456 -174.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 81' ' ' ASP . 55.9 Cg_endo -71.12 -63.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.008 1.806 . . . . 74.409999999999997 113.3 172.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -142.74 99.07 3.4 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.628 0.771 . . . . 62.219999999999999 110.687 -172.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.507 ' H ' ' HB3' ' A' ' 139' ' ' ASN . 24.1 tp -102.62 137.6 40.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.412 0.685 . . . . 73.540000000000006 109.483 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -120.02 176.52 5.39 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.826 1.651 . . . . 70.439999999999998 108.54 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.12 143.75 21.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 109.057 -0.72 . . . . 75.209999999999994 109.057 169.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.28 113.31 11.35 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.494 0.718 . . . . 64.409999999999997 109.112 172.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.2 mt -79.26 -20.14 48.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.516 0.726 . . . . 62.530000000000001 110.006 171.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.562 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 71.5 m-85 -136.1 151.61 49.98 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.06 0.544 . . . . 74.150000000000006 109.548 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -70.52 141.8 51.9 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.5 -0.773 . . . . 70.239999999999995 110.304 174.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.514 ' HB3' HG12 ' A' ' 101' ' ' ILE . 87.8 t80 -138.67 115.58 10.83 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.461 -0.57 . . . . 75.420000000000002 109.461 174.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.3 t -81.0 134.34 27.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 107.986 -1.116 . . . . 74.5 107.986 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.23 116.64 8.24 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.763 -0.458 . . . . 75.239999999999995 109.763 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.2 p -71.45 -23.87 61.91 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.465 0.706 . . . . 71.409999999999997 110.501 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.75 -172.01 29.67 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.273 -0.876 . . . . 75.510000000000005 112.097 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.44 -28.8 68.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.325 1.05 . . . . 75.439999999999998 110.72 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -75.25 -16.85 60.43 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.292 1.037 . . . . 71.150000000000006 113.019 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.5 p -109.3 158.6 17.71 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.679 0.792 . . . . 72.409999999999997 110.607 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 125' ' ' ASN . 66.8 tp -107.88 130.72 54.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.33 0.652 . . . . 74.230000000000004 109.701 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 p -78.12 113.38 16.01 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.308 -0.627 . . . . 73.349999999999994 109.308 172.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.514 HG12 ' HB3' ' A' ' 91' ' ' PHE . 34.2 pt -122.22 161.7 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.68 -0.859 . . . . 74.400000000000006 108.68 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.7 m -135.4 151.66 50.66 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 109.304 -0.628 . . . . 75.409999999999997 109.304 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -53.37 117.22 2.9 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.224 0.61 . . . . 71.450000000000003 111.089 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.59 -27.5 7.94 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.973 -0.558 . . . . 70.099999999999994 113.218 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -72.25 122.57 21.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.31 0.644 . . . . 72.430000000000007 110.323 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -84.31 124.61 31.44 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.935 0.494 . . . . 75.239999999999995 110.27 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 19.7 mt -105.55 135.28 47.23 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.702 0.801 . . . . 73.329999999999998 110.365 -168.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -95.35 107.53 19.67 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.111 -1.44 . . . . 74.530000000000001 107.111 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.7 t -97.51 124.47 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.987 -0.746 . . . . 75.329999999999998 108.987 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.4 mt -70.56 -36.27 73.55 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.529 0.681 . . . . 75.409999999999997 109.58 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.13 178.63 41.76 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 114.66 -1.155 . . . . 52.520000000000003 111.357 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 2.4 m-30 -94.99 174.33 7.14 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.785 -0.82 . . . . 72.349999999999994 108.785 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -72.33 159.12 34.56 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.612 -0.722 . . . . 74.349999999999994 109.795 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.449 ' HA ' ' O ' ' A' ' 59' ' ' GLN . 47.6 t60 -58.07 -24.81 59.95 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.526 1.13 . . . . 65.430000000000007 111.76 175.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.433 ' HB3' ' HG2' ' A' ' 117' ' ' GLU . 56.5 t30 -95.98 -21.97 17.68 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.924 0.49 . . . . 74.049999999999997 111.144 174.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.04 -0.18 83.8 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 122.7 0.191 . . . . 63.210000000000001 113.025 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.433 ' HG2' ' HB3' ' A' ' 115' ' ' ASN . 8.4 pt-20 -57.68 -52.42 65.5 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.008 1.323 . . . . 71.409999999999997 112.081 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -118.58 177.28 4.89 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.28 1.032 . . . . 75.319999999999993 110.12 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -146.93 124.46 11.72 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.649 0.78 . . . . 65.310000000000002 109.411 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -85.24 105.8 16.19 Favored 'General case' 0 C--O 1.249 1.064 0 CA-C-O 121.071 0.462 . . . . 74.120000000000005 110.537 -173.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.11 153.21 20.53 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 115.102 -0.953 . . . . 72.299999999999997 110.086 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -141.8 124.72 16.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.789 0.836 . . . . 71.519999999999996 110.081 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 59.6 p -133.7 -167.3 1.92 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.563 0.745 . . . . 62.210000000000001 110.47 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -58.48 -22.5 55.09 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.539 1.135 . . . . 64.030000000000001 111.116 170.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.423 ' HB2' HD11 ' A' ' 99' ' ' LEU . 53.5 m-20 -84.99 6.11 26.47 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.894 1.278 . . . . 43.539999999999999 111.754 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.77 -128.98 9.75 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 111.001 -0.84 . . . . 74.430000000000007 111.001 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -151.53 162.17 41.42 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.53 0.665 . . . . 74.150000000000006 111.736 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 165.23 171.51 31.55 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.777 -0.647 . . . . 73.549999999999997 112.9 170.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.429 ' HZ2' ' HG2' ' A' ' 24' ' ' LYS . 94.7 m95 -79.29 117.55 20.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.549 0.74 . . . . 70.209999999999994 110.92 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.2 m -117.58 154.88 50.84 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.373 1.069 . . . . 73.239999999999995 108.564 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.38 131.57 15.24 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 121.557 1.505 . . . . 64.310000000000002 111.152 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.562 ' HA ' HG12 ' A' ' 135' ' ' ILE . 23.9 t -63.53 -14.97 56.46 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.921 0.488 . . . . 63.210000000000001 111.547 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -69.89 -25.46 63.71 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.22 1.008 . . . . 73.150000000000006 111.016 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.562 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 6.5 m-30 -95.58 -3.09 47.07 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.577 0.751 . . . . 74.120000000000005 112.739 -177.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.562 HG12 ' HA ' ' A' ' 132' ' ' SER . 12.6 pt -129.42 161.06 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 118.113 0.415 . . . . 74.329999999999998 110.847 -171.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 10.0 t -145.72 139.24 14.58 Favored Pre-proline 0 N--CA 1.483 1.218 0 C-N-CA 123.075 0.55 . . . . 72.310000000000002 110.045 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.49 ' HB2' ' HB2' ' A' ' 140' ' ' SER . 74.1 Cg_endo -74.52 116.64 4.68 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.3 2.0 . . . . 72.340000000000003 111.889 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 17.9 m -89.51 -25.76 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.069 0.547 . . . . 74.219999999999999 111.492 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.507 ' HB3' ' H ' ' A' ' 84' ' ' LEU . 65.6 t30 -94.17 18.67 10.45 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 122.01 0.91 . . . . 75.310000000000002 110.142 173.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 137' ' ' PRO . 32.3 t -64.84 162.84 15.41 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.445 0.698 . . . . 72.200000000000003 110.515 170.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.6 mt -73.6 -12.11 60.65 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 123.568 0.747 . . . . 75.420000000000002 109.828 173.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.698 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 39.2 tt0 -49.51 -27.65 4.57 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 127.38 2.272 . . . . 75.409999999999997 115.68 -175.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -31.04 70.27 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 118.625 0.648 . . . . 71.299999999999997 110.314 177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -79.63 123.59 27.77 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.047 -1.094 . . . . 74.409999999999997 108.047 166.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.0 p -61.11 -10.74 6.76 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.96 1.096 . . . . 73.219999999999999 113.96 -168.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.461 ' CE3' HG21 ' A' ' 218' ' ' VAL . 61.7 p-90 -71.17 -40.58 71.19 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 111.885 0.328 . . . . 72.209999999999994 111.885 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -97.62 146.78 24.97 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 110.172 -0.307 . . . . 74.129999999999995 110.172 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.698 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 61.6 m-70 -146.06 60.97 1.25 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.001 0.52 . . . . 73.329999999999998 110.687 175.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 57.53 -165.58 6.21 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 116.97 1.548 . . . . 55.509999999999998 116.97 164.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.09 102.86 1.48 Allowed 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.433 2.756 . . . . 64.510000000000005 112.263 168.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.44 HG22 HH21 ' A' ' 171' ' ' ARG . 21.3 t -139.31 155.36 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.132 0.973 . . . . 75.329999999999998 110.24 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.3 m -89.52 173.03 8.55 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.245 1.018 . . . . 75.129999999999995 113.425 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -62.96 -34.17 76.93 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.646 -1.161 . . . . 71.219999999999999 113.16 -173.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -61.64 -57.93 10.08 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 123.607 0.567 . . . . 75.420000000000002 110.595 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.91 -31.34 71.86 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.4 0.68 . . . . 60.039999999999999 111.017 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.737 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.1 -56.99 14.92 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.365 0.603 . . . . 75.109999999999999 111.255 173.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -71.75 -23.98 61.69 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.249 -0.887 . . . . 74.150000000000006 110.797 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -63.98 -51.79 62.63 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.981 0.912 . . . . 65.409999999999997 110.33 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.533 HD12 HH12 ' A' ' 171' ' ' ARG . 79.2 mt -68.9 -40.89 78.91 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.024 0.44 . . . . 71.209999999999994 110.931 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.433 HD23 HG12 ' A' ' 190' ' ' VAL . 34.2 tp -67.09 -22.65 65.82 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.479 -0.782 . . . . 73.540000000000006 112.272 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.9 t -58.26 -30.09 66.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.979 0.911 . . . . 72.450000000000003 111.447 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.8 t -88.11 8.5 26.53 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.419 0.687 . . . . 62.229999999999997 111.571 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -100.49 150.6 18.87 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 122.324 -0.235 . . . . 74.150000000000006 113.481 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.6 pt -97.43 -166.32 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.044 0.938 . . . . 74.420000000000002 109.47 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.77 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 25.4 p-10 -51.21 118.65 3.38 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.798 0.839 . . . . 70.230000000000004 112.619 -176.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.73 14.01 68.63 Favored Glycine 0 C--O 1.257 1.542 0 CA-C-N 116.253 -0.43 . . . . 70.349999999999994 113.768 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 63.2 p -70.94 138.78 50.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.316 -0.624 . . . . 65.209999999999994 109.316 174.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' A' ' 232' ' ' LEU . 18.5 p90 -139.28 156.24 47.19 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.231 0.826 . . . . 71.420000000000002 113.231 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.5 HD23 ' HB1' ' A' ' 236' ' ' ALA . 96.8 mt -134.16 134.5 42.22 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.428 -1.26 . . . . 70.010000000000005 108.581 169.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.409 HG23 HG12 ' A' ' 182' ' ' ILE . 25.8 t -114.63 126.98 72.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 107.057 -1.46 . . . . 60.25 107.057 174.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.737 HH11 ' HA ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -159.84 150.04 18.65 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.226 0.61 . . . . 75.329999999999998 110.019 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.607 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 14.1 pt-20 -94.77 163.96 13.14 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.973 -0.751 . . . . 74.400000000000006 108.973 177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.517 ' HB2' ' HB2' ' A' ' 176' ' ' SER . 35.4 m -87.03 141.12 28.9 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.645 0.26 . . . . 73.409999999999997 111.532 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.55 -37.46 86.2 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.849 0.859 . . . . 73.349999999999994 110.416 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.443 ' HB3' ' HG3' ' A' ' 66' ' ' ARG . 63.0 p -86.07 -10.2 55.37 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.207 -1.36 . . . . 71.230000000000004 112.471 -176.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.517 ' HB2' ' HB2' ' A' ' 173' ' ' SER . 12.0 m -139.28 88.31 13.04 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.338 0.655 . . . . 72.439999999999998 109.533 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.39 124.25 13.48 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.96 2.44 . . . . 75.530000000000001 112.11 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.84 -22.25 29.42 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.868 -0.606 . . . . 71.140000000000001 113.744 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -82.8 117.67 22.85 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 108.878 -0.786 . . . . 75.519999999999996 108.878 176.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 70.1 mtt-85 -111.15 169.07 9.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.137 -0.938 . . . . 73.340000000000003 110.842 -170.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.557 ' HG ' ' HD3' ' A' ' 194' ' ' ARG . 39.5 m -152.0 149.75 29.22 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.722 0.809 . . . . 54.240000000000002 110.136 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.409 HG12 HG23 ' A' ' 170' ' ' VAL . 48.7 mt -116.95 139.96 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 108.732 -0.84 . . . . 73.400000000000006 108.732 169.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.6 m -118.75 111.64 18.74 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.13 1.372 . . . . 75.120000000000005 107.908 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.452 HD23 HD23 ' A' ' 232' ' ' LEU . 29.9 mt -106.14 137.94 43.2 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.317 1.047 . . . . 75.439999999999998 111.256 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -126.92 126.15 42.76 Favored 'General case' 0 C--O 1.256 1.401 0 N-CA-C 108.656 -0.868 . . . . 74.340000000000003 108.656 170.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 6.2 p90 -138.35 141.69 39.7 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.143 -1.058 . . . . 73.409999999999997 108.143 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 52.38 23.61 2.55 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.104 0.961 . . . . 74.510000000000005 113.547 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 96.82 -11.18 66.34 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 123.05 0.357 . . . . 74.430000000000007 113.576 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -101.98 126.76 48.97 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.751 0.82 . . . . 72.349999999999994 111.149 -173.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.433 HG12 HD23 ' A' ' 160' ' ' LEU . 80.0 t -95.14 142.42 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.199 1.0 . . . . 75.430000000000007 110.461 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.523 ' HH ' HG23 ' A' ' 230' ' ' THR . 23.2 p90 -146.41 154.5 41.69 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.325 1.05 . . . . 74.329999999999998 109.431 165.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -128.05 142.39 51.23 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.829 0.852 . . . . 74.549999999999997 108.732 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -141.76 151.55 42.98 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 120.985 0.421 . . . . 71.239999999999995 110.341 174.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.557 ' HD3' ' HG ' ' A' ' 181' ' ' SER . 21.3 mmt180 -78.95 145.29 34.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.29 -0.868 . . . . 74.5 111.304 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 79.8 mt -89.49 104.23 14.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 106.754 -1.573 . . . . 73.140000000000001 106.754 161.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -71.22 127.06 31.33 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.193 -0.912 . . . . 75.150000000000006 108.668 -177.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 31.8 m -99.52 116.58 31.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.168 0.587 . . . . 75.540000000000006 109.862 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.09 166.61 4.59 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.557 1.143 . . . . 74.549999999999997 111.575 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 55.9 p -62.29 -35.72 79.9 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.153 -0.476 . . . . 74.310000000000002 110.487 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -69.05 -12.77 61.98 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.533 0.733 . . . . 45.030000000000001 111.775 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 96.27 -5.49 65.42 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 116.458 -0.337 . . . . 62.32 112.313 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -62.49 141.93 58.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.561 0.744 . . . . 75.349999999999994 110.798 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 81.4 mt -93.87 144.36 25.51 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.195 -0.669 . . . . 74.150000000000006 109.195 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -162.78 161.49 26.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.094 0.558 . . . . 73.010000000000005 109.891 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 70.7 t -135.54 -55.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.375 -0.972 . . . . 75.120000000000005 108.375 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 9.9 m -90.96 169.86 10.54 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.379 0.671 . . . . 63.329999999999998 109.699 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 61.3 m -69.66 -48.22 60.55 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.509 0.559 . . . . 75.230000000000004 112.509 -171.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -73.62 -26.41 60.77 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.271 0.629 . . . . 75.120000000000005 110.795 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 58.0 m -67.91 118.19 10.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.234 1.014 . . . . 74.120000000000005 110.684 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -142.48 126.9 17.74 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.432 1.093 . . . . 75.219999999999999 108.324 175.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -135.64 141.26 45.02 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.033 0.379 . . . . 62.439999999999998 111.056 -173.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -91.58 -21.72 20.69 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.471 -0.786 . . . . 75.120000000000005 109.94 169.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 48.4 p -127.7 142.46 51.32 Favored 'General case' 0 C--N 1.363 1.185 0 CA-C-O 121.674 0.749 . . . . 74.099999999999994 111.88 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 30.1 tp -65.57 -28.7 69.34 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.404 -1.271 . . . . 74.329999999999998 110.764 175.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.89 97.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.408 0.683 . . . . 64.25 110.521 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.9 -30.27 63.8 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.474 0.31 . . . . 74.510000000000005 111.518 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.0 tt -61.04 -44.0 98.05 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.271 0.357 . . . . 75.530000000000001 110.555 170.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.461 HG21 ' CE3' ' A' ' 146' ' ' TRP . 42.5 t -70.18 -40.07 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.334 0.653 . . . . 74.430000000000007 111.006 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -60.42 -50.81 72.1 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.784 0.802 . . . . 74.439999999999998 110.486 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -56.32 -54.65 42.95 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.285 -1.325 . . . . 73.340000000000003 110.335 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -63.52 -25.18 68.14 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.137 0.575 . . . . 75.519999999999996 112.141 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 23.0 t -74.61 -28.2 60.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.272 0.229 . . . . 53.200000000000003 110.994 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.8 t -103.9 -22.49 13.49 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.021 1.86 . . . . 63.100000000000001 116.021 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.83 120.42 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 120.495 1.498 . . . . 75.209999999999994 114.344 -165.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.2 -1.32 9.87 Favored 'General case' 0 CA--C 1.57 1.715 0 C-N-CA 127.783 2.433 . . . . 74.109999999999999 112.745 171.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.19 14.72 1.1 Allowed 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 128.142 2.577 . . . . 74.540000000000006 114.311 -145.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.76 17.23 4.28 Favored Glycine 0 N--CA 1.467 0.755 0 O-C-N 121.805 -0.559 . . . . 64.530000000000001 111.926 -166.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 64.2 mt -91.36 133.73 35.2 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.045 -0.724 . . . . 75.129999999999995 109.045 156.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.4 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 93.4 mt -57.91 -52.48 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 109.233 -0.655 . . . . 75.019999999999996 109.233 172.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.523 HG23 ' HH ' ' A' ' 191' ' ' TYR . 12.3 t -130.52 150.35 51.77 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.944 -1.026 . . . . 72.439999999999998 108.282 167.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 69.8 p -80.02 170.6 16.24 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 109.05 -0.722 . . . . 75.019999999999996 109.05 171.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.452 HD23 HD23 ' A' ' 184' ' ' LEU . 26.2 mt -74.88 102.59 4.8 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 108.896 -0.779 . . . . 75.319999999999993 108.896 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -78.64 -57.62 3.67 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.16 -0.682 . . . . 75.510000000000005 109.16 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 167' ' ' SER . 7.3 p90 -154.8 151.17 22.8 Favored Pre-proline 0 N--CA 1.483 1.184 0 N-CA-C 109.832 -0.433 . . . . 72.329999999999998 109.832 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.82 138.52 44.98 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.105 1.87 . . . . 72.310000000000002 111.578 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . 0.5 ' HB1' HD23 ' A' ' 169' ' ' LEU . . . -58.83 127.06 82.45 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 109.231 -0.655 . . . . 73.129999999999995 109.231 173.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.06 158.69 28.82 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.853 2.368 . . . . 64.219999999999999 113.281 -172.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.49 141.6 58.7 Favored 'General case' 0 C--N 1.348 0.511 0 N-CA-C 109.052 -0.722 . . . . 71.420000000000002 109.052 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -46.3 -33.93 4.12 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.975 1.31 . . . . 74.019999999999996 112.748 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -56.49 -66.12 0.49 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 124.119 0.968 . . . . 74.150000000000006 110.371 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -175.67 160.34 2.05 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 123.73 0.812 . . . . 63.329999999999998 111.168 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.95 -178.81 4.79 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.925 2.416 . . . . 75.140000000000001 112.811 167.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 41.4 p -105.29 -72.81 0.7 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.552 0.741 . . . . 72.340000000000003 109.76 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 18.4 m -138.77 152.8 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 124.504 1.122 . . . . 55.530000000000001 110.204 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -99.54 -57.21 2.2 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.997 0.519 . . . . 64.420000000000002 109.993 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 144.94 -178.16 22.92 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-O 119.973 -0.348 . . . . 74.239999999999995 113.116 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.9 m -130.74 143.49 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 117.348 0.574 . . . . 74.0 111.622 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.0 m -88.47 120.35 70.34 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.003 0.921 . . . . 74.430000000000007 109.452 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.93 132.68 46.17 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.931 2.42 . . . . 75.129999999999995 112.803 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -80.85 162.66 23.89 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.932 0.493 . . . . 74.040000000000006 110.79 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -157.47 159.15 36.97 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.68 0.792 . . . . 71.200000000000003 110.479 -173.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -90.23 118.08 29.47 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.786 -0.82 . . . . 63.530000000000001 108.786 171.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.82 141.31 56.52 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.699 0.4 . . . . 74.319999999999993 110.858 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -70.8 164.77 24.53 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.191 0.596 . . . . 70.140000000000001 110.942 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 . . . . . 0 CA--C 1.561 1.394 0 C-N-CA 125.158 1.383 . . . . 72.019999999999996 111.848 174.343 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtm . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 109.348 -0.612 . . . . 74.409999999999997 109.348 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.24 68.72 1.1 Allowed Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.323 -0.711 . . . . 54.409999999999997 111.323 -177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -70.64 -68.68 0.41 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.264 0.626 . . . . 74.409999999999997 109.812 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 65.48 129.43 0.03 OUTLIER Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 125.161 1.384 . . . . 71.530000000000001 110.896 -171.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -61.46 -31.46 87.96 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.701 2.268 . . . . 65.439999999999998 111.878 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.33 -175.86 50.69 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.552 -0.749 . . . . 74.120000000000005 113.168 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.542 ' HD2' ' HA ' ' A' ' 68' ' ' ASN . 23.1 ttpp -88.89 148.88 23.61 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.921 -0.77 . . . . 74.310000000000002 108.921 173.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.7 m -70.93 158.42 6.21 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 CA-C-O 121.011 0.434 . . . . 63.109999999999999 110.682 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.1 tp -63.17 131.47 48.57 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.063 -0.972 . . . . 74.540000000000006 111.175 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.495 ' HA2' HD22 ' A' ' 68' ' ' ASN . . . -100.84 49.81 1.06 Allowed Glycine 0 C--N 1.345 1.044 0 CA-C-N 115.999 -0.546 . . . . 71.209999999999994 111.746 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -136.89 174.45 10.6 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.706 0.802 . . . . 65.439999999999998 111.146 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -79.73 179.78 7.34 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.611 -1.177 . . . . 73.25 111.603 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.3 ttm105 61.84 83.59 0.15 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.887 1.275 . . . . 73.329999999999998 110.721 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 46.25 77.96 0.43 Allowed Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 114.435 1.272 . . . . 74.120000000000005 114.435 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.64 165.81 31.39 Favored 'Trans proline' 0 C--N 1.365 1.411 0 C-N-CA 121.752 1.634 . . . . 64.420000000000002 109.689 161.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -66.13 169.23 7.27 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.29 0.566 . . . . 64.230000000000004 111.801 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.9 mt -103.32 124.63 37.57 Favored Pre-proline 0 C--O 1.242 0.658 0 N-CA-C 108.1 -1.074 . . . . 72.239999999999995 108.1 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.02 168.62 21.37 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.289 1.993 . . . . 62.020000000000003 111.244 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.429 ' HB3' ' NE2' ' A' ' 21' ' ' HIS . . . -83.03 148.22 27.68 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.773 0.32 . . . . 74.140000000000001 110.446 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.509 HD23 HD12 ' A' ' 23' ' ' ILE . 73.6 mt -84.58 94.77 8.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.86 -1.163 . . . . 73.230000000000004 107.86 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.429 ' NE2' ' HB3' ' A' ' 19' ' ' ALA . 34.1 m170 -96.24 -50.12 4.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.684 -0.689 . . . . 73.409999999999997 110.522 -174.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.482 ' HB2' ' OD1' ' A' ' 113' ' ' ASN . 73.8 m-85 -102.76 107.35 18.19 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.875 -0.787 . . . . 75.010000000000005 108.875 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.509 HD12 HD23 ' A' ' 20' ' ' LEU . 45.4 mm -122.6 114.05 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.034 -1.098 . . . . 73.209999999999994 108.034 175.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 21.09 15.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.346 0.658 . . . . 75.310000000000002 110.161 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.85 -91.6 0.27 Allowed Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.21 -0.905 . . . . 72.25 111.32 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -166.44 -23.21 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.22 1.008 . . . . 74.439999999999998 111.073 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.45 -168.14 53.6 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.379 0.425 . . . . 74.540000000000006 112.682 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -96.85 104.49 16.5 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.465 -0.939 . . . . 65.530000000000001 108.465 170.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.48 ' HD3' ' H ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -135.07 160.0 39.74 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.271 1.028 . . . . 71.340000000000003 109.505 -172.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -151.04 149.1 29.14 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.547 0.739 . . . . 71.430000000000007 109.554 174.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.0 t -153.73 93.56 1.68 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.349 -0.982 . . . . 73.109999999999999 108.349 176.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 p -90.04 79.85 6.46 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.821 0.848 . . . . 71.310000000000002 110.384 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -119.46 -156.88 0.68 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.112 0.965 . . . . 74.430000000000007 109.796 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -61.39 124.62 21.12 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.2 0.6 . . . . 74.430000000000007 111.255 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.47 163.61 19.18 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.832 -0.907 . . . . 71.049999999999997 110.832 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.67 -75.76 0.41 Allowed Glycine 0 C--N 1.344 0.998 0 CA-C-O 118.643 -1.087 . . . . 53.200000000000003 112.688 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HD3' HG11 ' A' ' 43' ' ' VAL . 11.8 Cg_endo -51.93 108.96 0.28 Allowed 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 123.992 3.128 . . . . 64.430000000000007 114.473 -172.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.448 ' HB2' ' HE2' ' A' ' 124' ' ' LYS . 14.4 t-160 -158.81 10.35 0.14 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.104 1.361 . . . . 74.439999999999998 109.304 174.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.9 t -158.51 156.52 30.38 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.834 0.854 . . . . 72.239999999999995 109.05 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -75.84 87.84 2.85 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.249 0.547 . . . . 61.420000000000002 110.005 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.5 p -153.37 148.88 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.114 0.966 . . . . 71.099999999999994 109.199 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -58.97 110.96 1.14 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.65 0.78 . . . . 65.109999999999999 110.777 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.406 HG11 ' HD3' ' A' ' 37' ' ' PRO . 41.8 t -89.86 116.07 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.916 -0.772 . . . . 75.430000000000007 108.916 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -94.3 -37.71 11.37 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.101 0.56 . . . . 65.0 111.772 -175.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 29.8 m170 59.83 22.12 11.04 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.073 0.949 . . . . 70.400000000000006 111.572 -172.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.45 139.65 47.84 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.765 -0.652 . . . . 62.420000000000002 110.253 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.22 148.44 11.46 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.77 0.828 . . . . 60.310000000000002 109.568 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.6 mt -116.61 111.45 19.9 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.289 -1.004 . . . . 72.239999999999995 108.289 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -65.59 135.67 55.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.008 0.523 . . . . 74.25 110.245 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -78.18 120.72 82.26 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.589 0.756 . . . . 73.109999999999999 109.132 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.37 -21.12 12.89 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 123.967 3.111 . . . . 65.25 115.031 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.41 -56.06 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 109.156 -0.683 . . . . 72.439999999999998 109.156 172.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 52.25 31.14 8.81 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.527 1.131 . . . . 71.420000000000002 112.198 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.517 ' HG ' ' HA ' ' A' ' 200' ' ' ASP . 47.3 t -155.46 162.7 40.68 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.353 1.061 . . . . 65.010000000000005 109.036 -170.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -144.85 160.42 41.31 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.262 0.625 . . . . 75.030000000000001 109.595 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -59.65 -36.01 75.56 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.025 0.93 . . . . 73.310000000000002 111.429 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.253 5.0 pt-20 53.59 73.38 0.93 Allowed Pre-proline 0 N--CA 1.485 1.295 0 C-N-CA 125.883 1.673 . . . . 74.239999999999995 112.27 175.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.39 86.57 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.932 2.422 . . . . 65.329999999999998 111.979 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -86.85 175.9 7.96 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.166 -0.924 . . . . 73.519999999999996 111.605 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.56 157.46 30.11 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 115.695 -0.684 . . . . 75.010000000000005 113.566 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.6 mt -116.38 -50.5 2.64 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.863 0.865 . . . . 75.5 109.953 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.8 p -172.74 71.46 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.632 0.773 . . . . 75.329999999999998 109.808 -174.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.21 140.1 26.34 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.885 0.874 . . . . 75.140000000000001 109.826 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -169.73 73.51 0.08 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.172 0.989 . . . . 70.200000000000003 109.401 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.22 95.88 5.08 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.862 -1.162 . . . . 71.430000000000007 107.862 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -72.55 81.04 1.08 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.656 0.782 . . . . 75.400000000000006 111.031 -165.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.473 ' HZ3' ' HG ' ' A' ' 175' ' ' SER . 4.1 p90 -59.45 -38.17 80.05 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.692 1.197 . . . . 75.040000000000006 111.197 -177.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.542 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 56.9 t30 -168.87 137.07 2.03 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.753 0.821 . . . . 74.530000000000001 109.65 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.4 t -159.61 125.67 4.32 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 108.029 -1.1 . . . . 75.310000000000002 108.029 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -161.47 -59.03 0.05 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.365 0.666 . . . . 70.510000000000005 110.39 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -167.78 164.22 14.2 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.458 0.703 . . . . 63.310000000000002 110.443 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -156.26 147.87 22.76 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.686 0.794 . . . . 65.450000000000003 109.977 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.9 mt -124.24 92.36 3.65 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.01 0.924 . . . . 70.299999999999997 108.706 176.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 79.1 mt -93.46 125.34 38.02 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.183 0.593 . . . . 72.140000000000001 109.676 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.85 169.68 19.97 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.795 0.838 . . . . 52.130000000000003 111.016 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.451 ' HA3' HG11 ' A' ' 138' ' ' VAL . . . 142.28 160.38 8.32 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.524 -0.762 . . . . 75.439999999999998 112.418 175.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.96 137.29 17.37 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 123.022 2.481 . . . . 71.019999999999996 111.46 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.691 ' HB2' ' HG3' ' A' ' 143' ' ' LYS . 7.9 t -68.0 95.31 0.54 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.057 0.543 . . . . 74.219999999999999 109.861 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.573 ' HB2' HD23 ' A' ' 84' ' ' LEU . 41.3 mt-10 -102.71 170.24 8.13 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.791 0.837 . . . . 73.430000000000007 110.985 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -94.67 96.08 9.18 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.245 0.618 . . . . 74.439999999999998 111.44 -169.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.814 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 13.9 t70 179.08 129.96 0.23 Allowed Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 125.572 1.549 . . . . 62.109999999999999 107.552 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -46.03 -47.56 14.22 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 124.239 3.293 . . . . 73.099999999999994 114.025 -168.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -135.48 67.07 1.49 Allowed 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.086 -1.079 . . . . 70.319999999999993 108.086 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.814 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 18.0 tp -85.83 114.53 22.84 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 121.275 0.559 . . . . 75.510000000000005 109.526 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 5.1 m-85 -104.8 175.09 5.61 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.777 1.631 . . . . 74.200000000000003 109.401 173.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.93 142.73 31.51 Favored 'Isoleucine or valine' 0 C--O 1.251 1.133 0 N-CA-C 108.073 -1.084 . . . . 73.420000000000002 108.073 169.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.448 ' HB2' HD12 ' A' ' 107' ' ' LEU . . . -77.42 117.65 19.1 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.548 0.53 . . . . 71.340000000000003 109.814 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.2 mt -80.67 -11.11 59.68 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.269 0.628 . . . . 71.319999999999993 111.284 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.439 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 54.1 m-85 -138.79 156.64 47.18 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.911 0.884 . . . . 74.25 109.025 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.84 130.88 35.29 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.066 -1.087 . . . . 73.239999999999995 108.066 168.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -141.0 124.1 16.41 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.563 -0.902 . . . . 74.430000000000007 108.563 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.31 138.95 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.037 -0.727 . . . . 75.340000000000003 109.037 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.02 133.89 56.49 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.297 0.639 . . . . 74.129999999999995 111.743 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.5 t -81.01 -6.17 58.47 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.355 1.062 . . . . 62.130000000000003 110.855 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.33 -162.11 35.91 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.649 -0.58 . . . . 74.040000000000006 111.649 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.52 -34.21 76.65 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.302 1.041 . . . . 71.319999999999993 111.084 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.471 ' ND2' HD13 ' A' ' 20' ' ' LEU . 30.0 p-10 -82.53 9.96 8.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.047 0.939 . . . . 74.349999999999994 112.59 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.1 p -135.49 153.96 51.56 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.335 1.054 . . . . 75.099999999999994 108.833 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.0 tp -110.25 135.7 50.59 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.869 0.468 . . . . 73.439999999999998 110.463 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.4 m -78.54 114.56 17.56 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.404 -0.962 . . . . 72.129999999999995 108.404 169.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.5 pt -118.87 144.72 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.611 0.765 . . . . 73.120000000000005 109.3 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.407 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 4.8 m -107.78 146.29 32.39 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.351 -0.611 . . . . 74.329999999999998 109.351 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -63.42 109.11 1.5 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.735 0.414 . . . . 75.299999999999997 110.995 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.73 1.69 34.56 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 116.064 -0.516 . . . . 41.340000000000003 112.748 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.62 136.36 33.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.326 1.05 . . . . 72.439999999999998 110.181 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HB3' HD13 ' A' ' 84' ' ' LEU . 66.4 mttm -82.8 112.99 20.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.832 0.853 . . . . 74.549999999999997 109.55 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.448 HD12 ' HB2' ' A' ' 87' ' ' ALA . 16.8 mt -100.72 138.05 38.3 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.781 0.832 . . . . 74.450000000000003 108.925 -173.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -108.59 107.32 17.77 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.139 -1.06 . . . . 70.109999999999999 108.139 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 88.1 t -100.14 129.88 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.422 0.689 . . . . 75.219999999999999 109.221 -173.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.4 mt -85.1 -22.82 28.74 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.7 0.4 . . . . 65.519999999999996 110.844 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.73 174.88 37.1 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.779 -0.646 . . . . 73.129999999999995 111.839 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 13.4 m-30 -94.84 174.92 6.86 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.267 0.627 . . . . 75.200000000000003 109.633 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.482 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 57.4 t30 -62.03 159.5 14.27 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.494 1.118 . . . . 73.129999999999995 109.572 173.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -65.91 -18.26 65.22 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 122.487 0.315 . . . . 74.209999999999994 110.696 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -111.44 5.89 19.91 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.555 0.742 . . . . 72.019999999999996 111.398 171.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.87 2.87 53.6 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 115.427 0.931 . . . . 72.310000000000002 115.427 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -60.67 -59.05 6.01 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.345 1.058 . . . . 65.409999999999997 110.907 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -104.49 179.34 4.3 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.142 -1.39 . . . . 73.340000000000003 109.55 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -150.89 121.46 7.44 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.996 0.918 . . . . 72.439999999999998 109.376 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -75.75 100.33 4.68 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 120.985 0.421 . . . . 73.019999999999996 110.207 -176.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -103.86 157.41 17.11 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.944 0.898 . . . . 73.340000000000003 110.242 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -142.92 126.78 17.17 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.86 0.864 . . . . 74.530000000000001 109.471 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.2 p -136.1 -171.61 2.92 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.49 1.116 . . . . 62.130000000000003 109.686 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.448 ' HE2' ' HB2' ' A' ' 38' ' ' HIS . 27.3 mtpp -70.01 -7.3 39.79 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.363 0.665 . . . . 74.200000000000003 111.504 175.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -84.61 -13.19 52.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.116 0.967 . . . . 75.5 111.316 173.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 128.07 -142.36 13.45 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.853 -0.499 . . . . 62.25 111.853 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -151.69 145.68 25.22 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.376 0.67 . . . . 72.400000000000006 110.833 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 173.58 179.01 43.96 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.442 -0.799 . . . . 74.510000000000005 111.717 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -82.07 123.37 28.88 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.693 0.797 . . . . 73.349999999999994 110.433 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.88 148.32 41.87 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 124.738 1.215 . . . . 73.150000000000006 109.025 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.95 130.69 25.08 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 121.871 1.714 . . . . 54.25 111.008 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.1 m -61.42 -19.37 61.86 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.942 0.897 . . . . 73.430000000000007 112.698 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -72.97 -21.39 60.86 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.941 0.896 . . . . 71.239999999999995 111.537 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.439 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.1 m-85 -94.36 -3.99 49.33 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.566 0.746 . . . . 73.129999999999995 112.608 -175.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.4 pt -128.36 151.74 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.039 0.536 . . . . 75.129999999999995 110.525 -171.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 8.2 t -141.28 133.54 13.97 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 122.602 0.361 . . . . 44.25 110.637 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 59.2 Cg_endo -72.43 117.78 5.29 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.522 2.148 . . . . 70.120000000000005 112.116 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.451 HG11 ' HA3' ' A' ' 76' ' ' GLY . 22.9 m -80.22 -36.92 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.158 0.583 . . . . 75.230000000000004 110.11 176.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -73.43 -9.76 59.02 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.365 0.666 . . . . 74.109999999999999 111.295 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' A' ' 143' ' ' LYS . 28.6 t -39.16 129.28 1.69 Allowed 'General case' 0 C--N 1.363 1.174 0 C-N-CA 125.281 1.433 . . . . 73.200000000000003 112.447 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 72.0 mt -60.82 -10.07 5.01 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.482 0.713 . . . . 72.209999999999994 111.591 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -57.1 -19.59 20.52 Favored 'General case' 0 C--N 1.365 1.246 0 C-N-CA 124.732 1.213 . . . . 74.420000000000002 112.634 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.691 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 2.4 mmmp? -61.09 -24.99 66.64 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.164 0.506 . . . . 73.099999999999994 110.243 171.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -94.0 120.74 34.68 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 106.371 -1.714 . . . . 74.25 106.371 163.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.5 t -57.32 -17.42 12.15 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.257 1.206 . . . . 74.200000000000003 114.257 -166.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 51.2 p-90 -66.74 -50.43 62.8 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.689 0.626 . . . . 62.539999999999999 112.689 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.413 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 75.7 t80 -79.42 148.0 32.11 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.898 0.479 . . . . 75.200000000000003 110.426 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.434 ' CD2' HD22 ' A' ' 169' ' ' LEU . 87.9 m-70 -135.85 -27.16 1.15 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.203 0.601 . . . . 73.409999999999997 110.47 171.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 100.15 -151.28 19.11 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.139 -0.812 . . . . 74.319999999999993 114.609 171.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.04 89.47 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.273 2.649 . . . . 73.439999999999998 110.781 175.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 86.9 t -130.43 149.56 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 115.708 -0.678 . . . . 71.400000000000006 110.244 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.6 m -60.91 148.63 39.02 Favored 'General case' 0 C--O 1.246 0.921 0 C-N-CA 124.744 1.217 . . . . 74.530000000000001 112.333 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 41.0 ttt-85 -57.16 -39.35 75.1 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.451 -0.795 . . . . 72.400000000000006 110.033 172.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -60.27 -58.59 7.87 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.735 -1.121 . . . . 74.129999999999995 110.554 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -56.72 -39.08 73.26 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.035 0.835 . . . . 73.239999999999995 111.328 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.06 -61.54 2.56 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.362 -0.835 . . . . 63.299999999999997 111.776 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -70.5 -20.0 62.88 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.245 -0.889 . . . . 75.0 110.805 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.461 ' HE2' HH21 ' A' ' 239' ' ' ARG . 50.6 t80 -74.11 -51.29 16.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.701 0.8 . . . . 74.540000000000006 110.691 176.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 71.1 mt -63.8 -39.44 94.25 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.111 0.482 . . . . 74.340000000000003 109.892 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.4 tp -72.34 -18.61 61.75 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.142 -0.936 . . . . 64.200000000000003 111.197 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.476 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 17.3 t -67.17 -23.13 65.74 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.934 0.494 . . . . 73.430000000000007 110.902 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.1 t -91.12 8.63 34.64 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.89 0.876 . . . . 75.209999999999994 110.52 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.21 159.64 30.07 Favored Glycine 0 C--N 1.343 0.958 0 C-N-CA 123.088 0.375 . . . . 73.409999999999997 112.67 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 18.9 pt -126.09 -165.24 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 C-N-CA 124.184 0.994 . . . . 74.219999999999999 110.424 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 14.0 p-10 -56.86 99.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.815 1.043 . . . . 71.120000000000005 113.815 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 103.65 13.54 27.67 Favored Glycine 0 C--O 1.259 1.696 0 CA-C-N 116.162 -0.472 . . . . 63.530000000000001 112.818 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 23.0 t -77.65 136.47 38.22 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.854 -0.424 . . . . 63.509999999999998 109.854 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.469 ' HB3' HD23 ' A' ' 184' ' ' LEU . 17.1 p90 -139.49 159.87 41.16 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.125 0.787 . . . . 75.219999999999999 113.125 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.53 HD23 ' HB3' ' A' ' 236' ' ' ALA . 95.4 mt -137.61 134.4 35.5 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.33 1.052 . . . . 73.239999999999995 108.578 170.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 43.9 t -109.68 124.62 66.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 108.685 -0.857 . . . . 71.040000000000006 108.685 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.8 mtp-105 -142.81 168.38 19.86 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.936 0.894 . . . . 71.030000000000001 111.03 -174.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.777 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 2.9 pt-20 -120.46 166.1 14.05 Favored 'General case' 0 C--O 1.26 1.645 0 C-N-CA 124.547 1.139 . . . . 74.019999999999996 110.679 159.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.2 m -74.61 146.3 42.59 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.339 -1.3 . . . . 52.109999999999999 110.505 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.9 -43.16 75.8 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.67 0.788 . . . . 71.519999999999996 111.105 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.473 ' HG ' ' HZ3' ' A' ' 67' ' ' TRP . 17.2 m -84.66 -43.91 13.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.483 -0.78 . . . . 63.229999999999997 111.709 -175.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.6 t -112.56 97.09 39.25 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 109.289 -0.634 . . . . 73.230000000000004 109.289 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -69.18 147.17 65.98 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.074 2.516 . . . . 71.319999999999993 111.593 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.52 -23.85 8.14 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 116.329 -0.396 . . . . 75.439999999999998 112.996 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -80.69 116.12 20.54 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 107.127 -1.434 . . . . 73.109999999999999 107.127 170.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.777 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 83.7 mtt85 -122.45 166.48 14.69 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.13 0.572 . . . . 73.430000000000007 111.228 -168.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.434 ' HG ' ' HD3' ' A' ' 194' ' ' ARG . 65.4 m -151.84 138.03 18.35 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.235 1.014 . . . . 72.040000000000006 109.838 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 63.0 mt -105.17 140.37 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 107.849 -1.167 . . . . 74.319999999999993 107.849 165.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 15.5 m -116.29 113.6 23.2 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.384 1.074 . . . . 74.420000000000002 108.388 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.469 HD23 ' HB3' ' A' ' 168' ' ' PHE . 39.5 mt -104.3 144.01 32.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.153 0.981 . . . . 63.439999999999998 111.301 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.476 ' NH1' ' HA ' ' A' ' 161' ' ' SER . 21.1 ttt180 -134.48 138.16 44.5 Favored 'General case' 0 C--O 1.25 1.132 0 CA-C-N 114.637 -1.165 . . . . 74.310000000000002 110.03 172.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 10.2 p90 -157.71 139.18 13.73 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.838 -1.074 . . . . 74.420000000000002 108.108 171.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 54.49 31.37 14.65 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.583 1.153 . . . . 74.439999999999998 113.537 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.73 9.53 86.26 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.343 -0.39 . . . . 74.420000000000002 113.817 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 28.7 tpt180 -102.9 127.09 50.24 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.501 1.12 . . . . 73.099999999999994 109.411 175.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 94.9 t -114.08 129.85 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.78 1.232 . . . . 73.010000000000005 108.971 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.607 ' HH ' HG22 ' A' ' 230' ' ' THR . 22.5 p90 -145.36 160.73 41.09 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.051 0.941 . . . . 74.329999999999998 109.061 174.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -134.42 148.27 50.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.104 0.962 . . . . 75.219999999999999 108.506 -171.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -145.29 145.67 31.34 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.68 0.392 . . . . 71.25 110.867 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.434 ' HD3' ' HG ' ' A' ' 181' ' ' SER . 12.7 mmt180 -76.82 146.31 37.87 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.375 1.07 . . . . 75.450000000000003 112.149 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.745 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 64.3 mt -104.52 119.18 53.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 N-CA-C 107.393 -1.336 . . . . 74.510000000000005 107.393 163.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -91.02 145.04 25.03 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 109.637 -0.505 . . . . 74.030000000000001 109.637 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 18.1 m -106.02 128.07 53.59 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.969 0.908 . . . . 72.340000000000003 109.449 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.623 ' HB2' ' HB2' ' A' ' 202' ' ' LYS . . . -85.37 158.66 20.19 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.709 0.803 . . . . 73.340000000000003 109.432 170.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 15.8 t -65.6 -9.64 28.59 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.842 1.053 . . . . 75.540000000000006 113.842 -169.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.517 ' HA ' ' HG ' ' A' ' 54' ' ' SER . 80.9 m-20 -87.46 11.73 13.99 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.117 0.567 . . . . 73.450000000000003 111.833 175.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 75.2 12.48 83.47 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 111.954 -0.458 . . . . 71.409999999999997 111.954 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.623 ' HB2' ' HB2' ' A' ' 198' ' ' ALA . 98.4 mttt -79.65 153.33 29.44 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 123.88 0.872 . . . . 75.540000000000006 110.441 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 90.5 mt -118.37 148.14 42.82 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.342 0.657 . . . . 73.219999999999999 109.41 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -162.91 154.99 18.33 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.193 0.597 . . . . 72.040000000000006 109.981 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 79.2 t -125.01 -63.59 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.09 -1.078 . . . . 64.120000000000005 108.09 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.4 t -113.02 -175.54 2.69 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.15 -0.932 . . . . 75.329999999999998 110.035 -174.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 49.9 m -62.33 -47.8 82.62 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.45 1.1 . . . . 64.310000000000002 112.979 -170.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -85.57 3.17 41.85 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 122.182 0.193 . . . . 75.140000000000001 111.124 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 73.0 m -98.81 106.41 18.67 Favored 'General case' 0 C--O 1.215 -0.732 0 C-N-CA 123.608 0.763 . . . . 74.120000000000005 109.97 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -143.31 118.37 10.07 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.842 1.257 . . . . 64.239999999999995 107.685 171.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -134.99 154.93 51.56 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.073 0.549 . . . . 74.049999999999997 110.659 -170.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -91.53 -31.39 15.96 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 123.677 0.611 . . . . 65.310000000000002 109.907 169.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.408 ' OG1' ' HG2' ' A' ' 216' ' ' GLU . 48.5 p -131.14 157.92 41.86 Favored 'General case' 0 C--O 1.253 1.289 0 CA-C-O 122.324 1.059 . . . . 64.109999999999999 112.104 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 23.1 tp -72.78 -27.92 62.29 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 113.765 -1.561 . . . . 73.230000000000004 111.396 -176.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.84 -43.27 93.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.878 0.471 . . . . 74.439999999999998 110.521 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.408 ' HG2' ' OG1' ' A' ' 213' ' ' THR . 21.0 mm-40 -68.9 -35.04 76.38 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 115.768 -0.651 . . . . 72.420000000000002 110.146 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tt -55.78 -50.01 71.6 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.951 0.782 . . . . 64.150000000000006 110.91 171.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.8 -45.75 96.3 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 O-C-N 123.956 0.785 . . . . 64.239999999999995 111.055 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -58.01 -53.32 59.59 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.581 0.705 . . . . 71.409999999999997 111.14 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.423 ' CE1' HG11 ' A' ' 224' ' ' VAL . 61.5 t60 -54.48 -51.68 64.29 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.016 -0.993 . . . . 73.340000000000003 109.425 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.408 ' HB3' ' HG ' ' A' ' 232' ' ' LEU . 8.2 m-70 -66.54 -22.77 66.16 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.265 -0.88 . . . . 73.319999999999993 112.077 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.2 m -72.98 -27.05 61.57 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.745 0.418 . . . . 71.120000000000005 110.583 173.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.8 t -120.25 4.22 10.81 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 116.206 1.928 . . . . 63.219999999999999 116.206 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.423 HG11 ' CE1' ' A' ' 220' ' ' HIS . 26.8 m -107.92 156.44 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 116.085 1.883 . . . . 73.510000000000005 116.085 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -92.56 -0.49 57.32 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 111.111 -2.768 . . . . 63.420000000000002 113.274 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -77.62 14.3 1.06 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 128.169 2.588 . . . . 74.109999999999999 113.999 -143.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.46 17.52 4.77 Favored Glycine 0 N--CA 1.467 0.751 0 O-C-N 120.724 -1.235 . . . . 72.420000000000002 111.321 -169.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.1 mt -92.17 118.08 30.5 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.731 -1.234 . . . . 70.540000000000006 108.605 165.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.407 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 76.8 mt -59.74 -46.42 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 123.868 0.73 . . . . 61.240000000000002 109.478 173.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.607 HG22 ' HH ' ' A' ' 191' ' ' TYR . 15.1 t -130.77 142.7 50.42 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.109 -1.071 . . . . 71.349999999999994 108.109 167.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 55.6 p -69.02 157.35 36.97 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.777 0.431 . . . . 75.129999999999995 110.524 174.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.465 HD23 HD22 ' A' ' 184' ' ' LEU . 23.1 mt -66.96 101.37 0.84 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 108.729 -0.841 . . . . 74.530000000000001 108.729 177.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -88.26 -53.64 4.6 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.838 -0.801 . . . . 73.310000000000002 108.838 -173.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -158.91 145.43 12.63 Favored Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 115.083 -0.962 . . . . 63.210000000000001 110.793 -177.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.487 ' HB3' ' HA ' ' A' ' 146' ' ' TRP . 51.6 Cg_endo -68.59 163.43 36.91 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 121.781 1.654 . . . . 73.010000000000005 113.096 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . 0.53 ' HB3' HD23 ' A' ' 169' ' ' LEU . . . -73.42 125.57 90.61 Favored Pre-proline 0 C--O 1.244 0.812 0 N-CA-C 108.861 -0.792 . . . . 73.120000000000005 108.861 170.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.36 132.43 27.48 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.058 1.839 . . . . 73.420000000000002 111.642 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -63.32 149.57 45.38 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.62 0.768 . . . . 75.129999999999995 109.976 175.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.461 HH21 ' HE2' ' A' ' 158' ' ' TYR . 4.5 ptp180 -50.85 -46.66 60.24 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.249 1.019 . . . . 62.310000000000002 113.603 -171.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -82.82 139.57 33.43 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.553 -0.906 . . . . 71.209999999999994 108.553 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.553 ' HZ2' ' HB3' ' A' ' 241' ' ' LYS . 0.0 OUTLIER -59.68 143.78 86.21 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 122.364 0.266 . . . . 74.430000000000007 111.454 -174.175 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -85.17 -144.87 0.03 OUTLIER 'Trans proline' 0 CA--C 1.555 1.57 0 C-N-CA 122.816 2.344 . . . . 62.5 110.128 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 77.6 m -67.94 126.92 30.97 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 109.283 -0.636 . . . . 62.350000000000001 109.283 170.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.54 -43.45 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.152 0.581 . . . . 71.319999999999993 111.273 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -94.85 136.53 35.06 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.098 0.559 . . . . 74.120000000000005 109.909 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -155.51 36.36 0.64 Allowed Glycine 0 N--CA 1.464 0.563 0 N-CA-C 110.367 -1.093 . . . . 62.32 110.367 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.4 m -107.59 164.92 4.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 124.272 1.029 . . . . 74.329999999999998 110.144 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 71.9 p -143.43 134.51 12.55 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.321 0.648 . . . . 72.439999999999998 109.884 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -67.33 154.05 75.16 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.202 2.601 . . . . 72.129999999999995 112.528 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -143.85 154.44 43.38 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.376 0.607 . . . . 75.340000000000003 110.897 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -134.08 140.64 46.76 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.892 -1.521 . . . . 72.120000000000005 106.892 169.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -137.28 129.31 29.2 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.653 0.381 . . . . 72.530000000000001 110.079 -172.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -150.65 130.79 13.54 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.601 0.76 . . . . 75.310000000000002 110.034 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -135.4 -179.01 5.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.57 1.148 . . . . 72.319999999999993 109.891 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 123.989 0.916 . . . . 71.439999999999998 108.769 173.545 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 109.198 -0.667 . . . . 75.129999999999995 109.198 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -88.88 167.04 34.39 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.507 0.505 . . . . 71.040000000000006 111.945 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -91.77 65.21 4.97 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.591 0.71 . . . . 73.420000000000002 110.726 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.84 67.23 7.1 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 115.196 -0.911 . . . . 70.120000000000005 109.404 171.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.61 -13.84 35.66 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.53 2.153 . . . . 63.409999999999997 111.663 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.43 -173.92 55.15 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 115.349 -0.841 . . . . 70.329999999999998 112.899 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -150.03 96.29 2.41 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.907 -1.146 . . . . 65.049999999999997 107.907 172.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 m -117.75 -176.94 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.824 0 C-N-CA 124.498 1.119 . . . . 75.219999999999999 109.615 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.514 HD11 ' HA ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -91.34 41.82 1.08 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.968 0.907 . . . . 74.209999999999994 110.588 -175.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.21 37.15 0.17 Allowed Glycine 0 C--N 1.347 1.151 0 C-N-CA 121.303 -0.475 . . . . 73.099999999999994 113.074 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -97.86 -178.11 3.99 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.949 0.5 . . . . 75.099999999999994 111.083 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.05 -144.83 0.11 Allowed 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 107.436 -1.32 . . . . 75.150000000000006 107.436 164.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 49.64 38.05 14.16 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 125.24 1.416 . . . . 74.430000000000007 113.479 163.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 61.56 80.63 0.25 Allowed Pre-proline 0 C--N 1.365 1.275 0 C-N-CA 124.205 1.002 . . . . 75.5 109.643 -173.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.04 166.88 21.46 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.83 2.353 . . . . 73.430000000000007 112.203 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.6 p -67.84 168.65 11.17 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 121.143 0.497 . . . . 73.519999999999996 111.397 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.7 mt -103.89 133.28 20.34 Favored Pre-proline 0 N--CA 1.476 0.86 0 N-CA-C 108.77 -0.826 . . . . 73.420000000000002 108.77 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.514 ' HA ' HD11 ' A' ' 9' ' ' LEU . 36.8 Cg_endo -71.26 169.8 19.84 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.387 2.058 . . . . 72.120000000000005 112.688 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.64 142.19 30.98 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.098 0.559 . . . . 74.010000000000005 110.63 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.427 ' HB3' HD13 ' A' ' 23' ' ' ILE . 75.6 mt -88.35 96.93 10.77 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.636 0.774 . . . . 73.239999999999995 109.035 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -97.04 -47.79 5.65 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.57 -0.741 . . . . 74.540000000000006 109.75 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -103.46 109.95 21.79 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.507 -0.77 . . . . 74.299999999999997 109.289 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.427 HD13 ' HB3' ' A' ' 20' ' ' LEU . 25.7 mm -117.29 120.01 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.387 1.075 . . . . 74.120000000000005 109.892 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -142.15 127.33 18.58 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.574 -1.269 . . . . 73.120000000000005 107.574 167.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -130.73 -159.12 9.51 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 111.961 -0.455 . . . . 74.239999999999995 111.961 -172.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 59.25 26.06 14.78 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.22 1.008 . . . . 73.310000000000002 111.414 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.09 117.37 4.67 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 115.236 -0.893 . . . . 71.540000000000006 112.256 -175.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -145.23 -47.48 0.23 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.152 0.981 . . . . 74.109999999999999 109.685 -170.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -78.66 -3.01 41.88 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 114.797 -1.092 . . . . 73.120000000000005 112.513 -170.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -72.01 2.32 5.89 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.935 0.894 . . . . 72.409999999999997 112.166 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.9 p -143.71 172.33 12.97 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.617 0.767 . . . . 73.230000000000004 110.762 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.3 p -70.31 -67.94 0.46 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.06 0.944 . . . . 73.450000000000003 111.144 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -158.7 110.96 2.23 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.415 0.686 . . . . 73.209999999999994 109.176 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -140.8 147.0 38.36 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.749 0.819 . . . . 75.299999999999997 110.076 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.75 -161.06 29.69 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 124.085 0.865 . . . . 75.510000000000005 111.04 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.12 171.53 43.97 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 119.477 -0.624 . . . . 75.420000000000002 112.512 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.28 144.09 55.41 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.361 2.708 . . . . 74.120000000000005 111.44 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -84.0 99.76 10.63 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.322 -0.621 . . . . 73.239999999999995 109.322 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.1 t -68.68 148.35 50.53 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.027 0.531 . . . . 74.230000000000004 109.912 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -84.32 82.79 8.23 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.379 0.609 . . . . 74.409999999999997 109.532 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.59 95.16 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.31 -0.859 . . . . 74.219999999999999 109.046 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -114.98 100.64 8.34 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.618 -0.882 . . . . 74.040000000000006 108.618 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.3 t -104.44 137.43 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.5 -1.296 . . . . 70.219999999999999 107.5 169.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.22 174.16 11.05 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.345 0.658 . . . . 74.310000000000002 111.494 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -114.99 154.92 27.92 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.313 -0.858 . . . . 75.140000000000001 110.189 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -151.08 145.9 25.8 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.5 -0.926 . . . . 70.530000000000001 108.5 170.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.4 104.76 0.14 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.717 0.807 . . . . 64.409999999999997 110.096 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 75.3 mt -68.18 79.8 0.24 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.614 0.766 . . . . 71.239999999999995 110.123 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.463 ' HG2' ' HG3' ' A' ' 50' ' ' ARG . 34.6 tt0 -98.43 142.07 30.51 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.517 -1.29 . . . . 74.530000000000001 107.517 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.463 ' HG3' ' HG2' ' A' ' 49' ' ' GLN . 66.8 mtm180 57.56 55.11 7.05 Favored Pre-proline 0 CA--C 1.564 1.515 0 O-C-N 123.878 0.737 . . . . 75.010000000000005 110.803 -177.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.13 -25.89 65.42 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.596 2.197 . . . . 73.239999999999995 112.578 -175.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 t -91.16 50.14 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 CA-C-O 122.428 1.109 . . . . 52.229999999999997 108.956 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.44 11.95 34.97 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.098 0.959 . . . . 65.519999999999996 110.314 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.8 p -66.23 -46.53 76.86 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.996 0.918 . . . . 74.430000000000007 110.251 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -161.25 164.45 30.3 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.854 -1.066 . . . . 72.400000000000006 109.386 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -141.03 141.44 34.33 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.434 1.094 . . . . 74.099999999999994 108.647 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 60.76 72.7 0.69 Allowed Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 124.425 1.09 . . . . 65.430000000000007 111.166 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.39 98.13 0.22 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.727 2.285 . . . . 73.420000000000002 112.504 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -102.31 87.9 3.16 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.85 -1.167 . . . . 75.329999999999998 107.85 172.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.94 -159.79 25.75 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.009 -0.996 . . . . 71.530000000000001 112.226 -174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.8 mt -122.28 151.64 40.89 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.422 0.689 . . . . 73.239999999999995 110.397 -176.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.9 t -61.72 -37.53 84.53 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.469 1.108 . . . . 70.310000000000002 110.637 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -98.21 33.82 2.1 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.593 -0.731 . . . . 74.120000000000005 111.392 -174.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.4 123.96 21.84 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 108.455 -0.943 . . . . 73.549999999999997 108.455 167.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.65 104.46 0.66 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.347 0.659 . . . . 74.109999999999999 110.771 -175.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -81.52 94.16 6.81 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.23 -1.026 . . . . 74.510000000000005 108.23 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -76.79 136.44 38.97 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.632 -0.713 . . . . 75.239999999999995 111.423 -173.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -77.15 141.48 40.12 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.667 -0.697 . . . . 64.209999999999994 109.766 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.3 p -160.86 161.75 31.95 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.356 1.062 . . . . 73.409999999999997 109.066 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.7 tttp 75.06 -4.4 2.39 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.997 1.319 . . . . 72.140000000000001 112.435 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -75.63 90.98 2.82 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-O 121.575 0.702 . . . . 73.299999999999997 110.136 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -106.07 106.08 16.42 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.48 -1.304 . . . . 64.349999999999994 107.48 172.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.9 mt -79.69 136.4 36.78 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.31 0.644 . . . . 71.120000000000005 111.19 -173.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.6 mt -78.96 165.86 23.0 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.005 0.922 . . . . 74.019999999999996 110.21 174.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.53 84.42 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.684 0.794 . . . . 72.439999999999998 110.559 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 64.43 -151.43 50.42 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 115.377 -0.829 . . . . 54.100000000000001 113.157 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.9 120.71 7.03 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.593 2.195 . . . . 75.409999999999997 111.1 171.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.4 p -60.88 117.39 5.37 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.404 0.682 . . . . 73.109999999999999 110.518 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.449 ' HA ' HH21 ' A' ' 108' ' ' ARG . 1.8 mp0 -83.09 131.08 35.17 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.904 0.882 . . . . 74.439999999999998 110.651 -169.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -155.83 32.37 0.35 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.726 1.21 . . . . 63.5 108.215 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -145.76 144.15 21.59 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 114.19 -1.368 . . . . 73.209999999999994 109.287 -170.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.48 -19.8 18.82 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.103 2.535 . . . . 70.439999999999998 113.922 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -90.46 40.16 1.0 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.824 0.85 . . . . 74.519999999999996 111.672 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 57.4 tp -83.72 112.55 20.17 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.512 0.672 . . . . 75.25 110.553 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.41 173.33 6.37 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.813 1.645 . . . . 65.140000000000001 108.766 170.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.6 p -144.96 143.16 22.63 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 N-CA-C 108.706 -0.85 . . . . 74.25 108.706 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.556 ' HB1' HD11 ' A' ' 107' ' ' LEU . . . -80.26 135.84 36.32 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.858 0.463 . . . . 75.010000000000005 110.201 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.3 mt -95.12 -16.56 22.52 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.315 1.046 . . . . 70.120000000000005 110.767 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -138.98 145.96 40.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.838 0.855 . . . . 73.340000000000003 108.915 -177.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -79.43 117.82 20.74 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.07 -0.715 . . . . 74.409999999999997 109.07 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -121.18 117.74 27.89 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.024 0.93 . . . . 72.040000000000006 109.247 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.8 t -79.96 138.74 19.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 C-N-CA 123.659 0.784 . . . . 62.240000000000002 109.262 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.71 115.09 3.69 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.818 -0.808 . . . . 73.019999999999996 108.818 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.4 m -74.59 -11.92 60.32 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.926 0.891 . . . . 71.25 110.753 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.79 -163.34 28.9 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 110.554 -1.018 . . . . 75.329999999999998 110.554 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -73.6 -23.92 59.98 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.219 0.608 . . . . 74.140000000000001 111.043 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -72.67 -24.19 60.99 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.438 1.095 . . . . 64.219999999999999 112.282 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.1 p -110.41 158.63 18.26 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.836 0.854 . . . . 74.299999999999997 110.013 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.9 tp -109.17 132.73 53.84 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.223 -0.898 . . . . 73.540000000000006 109.226 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.2 t -82.0 124.84 30.14 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.767 -0.827 . . . . 63.439999999999998 108.767 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.1 pt -128.86 140.59 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 108.094 -1.076 . . . . 72.5 108.094 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.434 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 16.0 m -98.31 151.96 19.94 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.024 0.375 . . . . 72.120000000000005 110.211 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -60.12 111.4 1.5 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.199 0.6 . . . . 74.299999999999997 110.799 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.82 3.7 55.93 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 115.405 -0.816 . . . . 54.399999999999999 113.183 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -83.41 145.97 28.7 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.481 0.712 . . . . 75.549999999999997 110.346 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -87.92 113.32 23.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.398 1.079 . . . . 73.329999999999998 109.306 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.556 HD11 ' HB1' ' A' ' 87' ' ' ALA . 15.2 mt -108.07 133.84 51.8 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.464 -0.939 . . . . 73.439999999999998 108.464 -170.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.449 HH21 ' HA ' ' A' ' 79' ' ' GLU . 65.9 mtt180 -104.17 106.93 17.61 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.337 -0.616 . . . . 72.219999999999999 109.337 175.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 92.8 t -98.73 119.4 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 109.07 -0.715 . . . . 73.109999999999999 109.07 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.9 mt -67.83 -37.49 81.97 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.762 0.825 . . . . 74.230000000000004 109.924 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.05 -178.6 44.17 Favored Glycine 0 C--O 1.244 0.727 0 CA-C-N 114.431 -1.259 . . . . 52.350000000000001 111.167 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 14.4 m-30 -95.99 169.81 9.72 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.256 -0.646 . . . . 74.140000000000001 109.256 177.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -60.28 145.82 46.11 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.631 -1.248 . . . . 74.430000000000007 107.631 168.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -65.53 -25.59 67.52 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.46 0.304 . . . . 74.120000000000005 110.896 -176.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -81.76 -18.51 43.94 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.694 0.797 . . . . 74.219999999999999 110.56 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 174' ' ' GLU . . . 85.93 34.25 13.5 Favored Glycine 0 C--N 1.35 1.353 0 C-N-CA 123.484 0.564 . . . . 74.420000000000002 113.607 174.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -96.27 -64.14 1.08 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.577 0.703 . . . . 73.230000000000004 110.583 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -103.49 -179.0 3.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.589 1.156 . . . . 74.319999999999993 109.633 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -142.18 122.19 13.69 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.668 0.787 . . . . 72.349999999999994 109.477 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -79.98 101.77 8.84 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.179 0.514 . . . . 74.0 109.623 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -103.88 167.65 9.64 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.139 -0.937 . . . . 74.230000000000004 109.998 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -141.4 125.62 17.45 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 124.449 1.1 . . . . 74.530000000000001 108.502 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.8 p -138.15 -168.6 2.39 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.029 0.932 . . . . 75.099999999999994 110.661 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -54.41 -35.14 62.59 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.895 1.278 . . . . 73.409999999999997 111.159 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -83.92 8.01 16.44 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.556 -1.202 . . . . 62.409999999999997 111.424 -175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.55 -126.14 7.42 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 111.499 -0.64 . . . . 75.409999999999997 111.499 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -151.02 139.8 20.8 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.305 0.642 . . . . 75.439999999999998 109.324 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 179.2 -178.76 48.86 Favored Glycine 0 C--N 1.344 1.0 0 O-C-N 123.263 0.352 . . . . 71.310000000000002 112.338 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -89.66 131.97 35.38 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.255 0.622 . . . . 64.120000000000005 110.835 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.67 152.08 76.29 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 125.322 1.449 . . . . 75.150000000000006 109.095 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.08 132.98 23.93 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.272 1.982 . . . . 74.430000000000007 111.462 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.482 ' HA ' HG12 ' A' ' 135' ' ' ILE . 20.0 m -62.3 -17.81 59.66 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.11 0.964 . . . . 73.319999999999993 112.724 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -74.65 -20.81 59.74 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.03 0.932 . . . . 75.420000000000002 111.526 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -95.17 -6.51 41.56 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.828 0.851 . . . . 74.310000000000002 112.023 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.482 HG12 ' HA ' ' A' ' 132' ' ' SER . 14.8 pt -125.06 156.68 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.158 0.583 . . . . 74.510000000000005 110.059 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 11.3 t -149.86 136.38 10.75 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 122.701 0.4 . . . . 65.340000000000003 110.375 172.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.51 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 73.6 Cg_endo -75.38 140.19 24.17 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.487 2.125 . . . . 75.540000000000006 111.765 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.85 -36.54 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.002 0.521 . . . . 71.439999999999998 111.414 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.475 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 59.2 t30 -98.74 -9.39 24.58 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.71 0.404 . . . . 72.120000000000005 111.149 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 32.5 t -73.34 177.04 5.46 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.919 0.488 . . . . 73.129999999999995 109.902 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 64.4 mt -61.15 -16.24 42.37 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.698 0.999 . . . . 73.329999999999998 113.698 -172.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -59.37 -24.13 63.14 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.574 1.15 . . . . 75.219999999999999 112.666 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -67.19 -8.37 30.9 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.438 0.695 . . . . 74.540000000000006 112.135 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -89.1 151.76 22.04 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.765 0.826 . . . . 75.340000000000003 110.549 170.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 56.8 p -69.24 -36.21 76.95 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 123.625 0.77 . . . . 73.340000000000003 111.13 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -72.44 -31.35 65.4 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.607 -0.724 . . . . 73.420000000000002 112.638 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -97.27 120.95 38.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.873 -0.788 . . . . 74.349999999999994 108.873 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -103.13 5.05 37.65 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.87 -0.605 . . . . 75.209999999999994 111.663 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.81 -154.5 35.86 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.67 -0.517 . . . . 63.329999999999998 112.948 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.4 106.39 1.59 Allowed 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 123.152 2.568 . . . . 75.140000000000001 111.028 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.6 t -140.34 143.86 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.405 0.682 . . . . 73.030000000000001 109.404 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.2 t -64.54 161.88 16.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.061 0.944 . . . . 72.439999999999998 112.121 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -69.58 -31.86 70.26 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.673 0.789 . . . . 74.430000000000007 110.739 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -76.17 -43.89 40.6 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.23 0.612 . . . . 72.099999999999994 109.527 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.07 79.14 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.396 -0.82 . . . . 72.109999999999999 110.387 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.75 -56.23 24.64 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.715 -0.675 . . . . 75.040000000000006 110.214 171.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -60.49 -32.33 71.33 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.618 -0.719 . . . . 71.209999999999994 110.968 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -65.73 -52.22 52.94 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.222 1.009 . . . . 55.240000000000002 110.975 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.483 ' HB2' HD13 ' A' ' 169' ' ' LEU . 81.5 mt -67.03 -39.37 87.0 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.439 0.637 . . . . 74.299999999999997 110.788 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.428 HD23 HG11 ' A' ' 190' ' ' VAL . 27.2 tp -73.73 -20.14 60.6 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.682 -1.145 . . . . 72.329999999999998 111.604 -174.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.6 t -61.62 -27.22 68.5 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.842 0.857 . . . . 72.530000000000001 111.83 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.4 p -86.45 8.53 21.43 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.918 0.887 . . . . 74.299999999999997 111.719 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -97.39 170.16 25.51 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 116.374 -0.375 . . . . 72.340000000000003 112.605 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 32.4 pt -121.92 -163.59 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.95 0.9 . . . . 72.310000000000002 109.66 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.708 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 27.1 p-10 -49.48 118.15 2.6 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.729 0.811 . . . . 71.239999999999995 112.412 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.18 14.0 72.83 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.297 -0.41 . . . . 51.450000000000003 113.288 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 20.2 t -75.23 136.02 40.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.035 -0.728 . . . . 74.349999999999994 109.035 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.481 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 22.2 p90 -135.65 164.97 26.65 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.948 0.721 . . . . 74.340000000000003 112.948 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 159' ' ' LEU . 86.0 mt -137.41 135.48 36.97 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.549 1.139 . . . . 74.439999999999998 108.353 169.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.404 HG22 HG12 ' A' ' 182' ' ' ILE . 39.0 t -114.55 128.46 71.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 107.851 -1.166 . . . . 74.450000000000003 107.851 171.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 12.9 mtm105 -143.05 172.34 12.85 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.769 0.828 . . . . 73.310000000000002 109.483 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 13.9 pt-20 -116.25 163.06 16.54 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.642 -0.873 . . . . 74.400000000000006 108.642 160.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.5 m -88.58 134.85 33.75 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.155 0.582 . . . . 62.299999999999997 110.141 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.41 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 27.9 mt-10 -78.68 -26.27 44.95 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.115 0.966 . . . . 75.420000000000002 109.224 174.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.1 p -70.61 -37.24 73.81 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.619 -1.173 . . . . 70.430000000000007 110.584 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.9 m -140.48 94.38 8.45 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.056 0.942 . . . . 74.150000000000006 109.433 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.34 135.25 52.85 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.969 2.446 . . . . 70.219999999999999 111.501 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 91.33 -23.51 24.3 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 115.97 -0.559 . . . . 64.329999999999998 113.46 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -82.83 115.62 21.8 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.727 -1.212 . . . . 75.200000000000003 107.727 172.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 82.9 mtt-85 -112.31 159.87 18.23 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.066 0.546 . . . . 74.530000000000001 109.698 -171.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.9 t -152.44 146.67 25.48 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 122.837 0.455 . . . . 72.239999999999995 110.775 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.404 HG12 HG22 ' A' ' 170' ' ' VAL . 52.9 mt -113.94 150.9 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.112 0.965 . . . . 73.049999999999997 108.476 173.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 22.2 m -132.36 128.42 37.61 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.721 -0.844 . . . . 75.540000000000006 108.721 175.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.444 HD22 HD21 ' A' ' 232' ' ' LEU . 38.8 mt -110.66 147.44 34.31 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.328 1.451 . . . . 75.129999999999995 111.382 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -133.5 130.88 39.15 Favored 'General case' 0 C--O 1.253 1.255 0 C-N-CA 124.429 1.092 . . . . 72.140000000000001 108.434 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.708 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 3.7 p90 -154.66 143.55 20.92 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 124.146 0.904 . . . . 73.230000000000004 108.646 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 58.13 19.28 5.94 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 124.389 1.075 . . . . 71.319999999999993 112.941 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 76.65 30.06 56.83 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.984 -0.553 . . . . 61.240000000000002 112.663 -175.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -128.52 123.24 33.03 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.115 0.966 . . . . 65.450000000000003 108.569 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.428 HG11 HD23 ' A' ' 160' ' ' LEU . 48.8 t -104.13 138.2 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.257 1.023 . . . . 73.530000000000001 109.79 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.565 ' HH ' HG22 ' A' ' 230' ' ' THR . 28.7 p90 -143.15 157.94 44.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.939 0.895 . . . . 54.210000000000001 109.215 171.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -128.09 144.16 51.1 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.125 -1.065 . . . . 73.010000000000005 108.125 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -145.67 147.57 32.13 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.062 0.458 . . . . 73.409999999999997 110.644 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 20.9 tpp180 -82.35 133.43 35.23 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.056 -0.975 . . . . 73.25 110.431 -174.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 93.5 mt -75.1 102.68 2.51 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 N-CA-C 106.979 -1.489 . . . . 73.310000000000002 106.979 165.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -68.15 111.62 4.61 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.531 -1.213 . . . . 72.439999999999998 108.063 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 37.7 m -97.28 113.45 25.07 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.873 -0.603 . . . . 62.530000000000001 109.527 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.1 160.03 10.81 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.197 0.999 . . . . 71.420000000000002 111.862 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.3 m -62.09 -23.62 66.63 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.2 -0.909 . . . . 72.230000000000004 111.47 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -87.28 3.56 46.26 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.182 0.993 . . . . 74.409999999999997 111.104 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 83.83 -1.76 88.34 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 122.933 0.302 . . . . 64.010000000000005 113.35 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -77.19 131.19 38.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.518 0.727 . . . . 74.349999999999994 110.274 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.72 147.45 22.98 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.836 -0.802 . . . . 75.519999999999996 108.836 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -166.14 176.24 7.81 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.406 0.682 . . . . 75.349999999999994 110.143 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 75.7 t -140.38 -50.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 107.004 -1.48 . . . . 73.340000000000003 107.004 172.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 22.0 m -74.83 145.99 42.37 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.347 -0.842 . . . . 74.25 109.933 171.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.8 m -70.83 -26.15 63.16 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.521 0.728 . . . . 73.549999999999997 110.922 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -71.85 -41.75 67.72 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.319 -0.623 . . . . 75.340000000000003 109.319 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 18.4 m -91.67 135.13 34.11 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.284 -0.871 . . . . 73.400000000000006 110.865 -165.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -137.26 118.38 14.43 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 107.956 -1.128 . . . . 71.239999999999995 107.956 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -120.85 142.88 49.24 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 109.484 -0.561 . . . . 71.099999999999994 109.484 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -89.46 -24.18 21.91 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.778 -0.453 . . . . 73.019999999999996 109.778 171.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.8 p -124.53 144.81 49.91 Favored 'General case' 0 C--O 1.253 1.246 0 CA-C-O 121.87 0.843 . . . . 72.540000000000006 111.696 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 18.1 tp -69.57 -29.18 66.68 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 113.992 -1.458 . . . . 75.030000000000001 110.961 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.86 -37.12 85.33 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.324 0.649 . . . . 64.109999999999999 111.373 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -76.48 -31.93 58.06 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.884 0.474 . . . . 75.140000000000001 111.344 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.45 -45.88 90.34 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 110.118 -0.327 . . . . 74.209999999999994 110.118 170.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.9 t -70.8 -40.51 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.094 0.958 . . . . 74.239999999999995 110.971 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -59.74 -53.94 52.13 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.7 0.8 . . . . 74.5 109.583 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -53.69 -54.24 40.64 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.966 -1.015 . . . . 74.510000000000005 109.349 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -61.39 -26.33 67.77 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.609 -0.723 . . . . 74.040000000000006 112.286 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 32.4 t -75.17 -28.24 59.98 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 122.756 0.422 . . . . 61.030000000000001 111.236 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 15.4 t -117.56 1.43 12.27 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 116.094 1.887 . . . . 74.120000000000005 116.094 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.419 ' O ' HG21 ' A' ' 231' ' ' THR . 35.8 m -107.14 144.27 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.524 0 CA-C-N 121.465 1.938 . . . . 74.140000000000001 116.19 -175.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -82.11 -2.65 52.7 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 129.07 2.948 . . . . 74.219999999999999 112.187 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -79.34 14.25 1.62 Allowed 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 129.202 3.001 . . . . 62.329999999999998 113.354 -140.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.63 18.16 4.09 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 110.947 -0.861 . . . . 71.409999999999997 110.947 -169.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 86.0 mt -93.63 132.94 37.47 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.993 0.917 . . . . 75.450000000000003 109.951 160.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.463 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 85.3 mt -60.42 -60.06 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 108.749 -0.834 . . . . 75.109999999999999 108.749 170.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.565 HG22 ' HH ' ' A' ' 191' ' ' TYR . 9.5 t -119.65 141.63 49.17 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.149 -0.932 . . . . 72.409999999999997 108.668 173.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' THR . . . . . 0.419 HG21 ' O ' ' A' ' 224' ' ' VAL . 82.1 p -73.19 158.84 34.47 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 108.834 -0.802 . . . . 72.420000000000002 108.834 170.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.481 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 26.2 mt -69.47 99.54 1.26 Allowed 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 108.828 -0.805 . . . . 73.409999999999997 108.828 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -77.9 -45.76 23.22 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.28 0.632 . . . . 65.420000000000002 110.056 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 167' ' ' SER . 12.9 p90 -164.01 153.1 11.91 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 109.541 -0.54 . . . . 61.140000000000001 109.541 172.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.22 139.04 14.6 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 121.698 1.599 . . . . 71.200000000000003 112.273 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.98 118.17 39.93 Favored Pre-proline 0 C--N 1.352 0.689 0 N-CA-C 108.155 -1.054 . . . . 73.409999999999997 108.155 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.421 ' HB2' ' HG2' ' A' ' 241' ' ' LYS . 54.1 Cg_endo -66.07 142.1 66.6 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.131 1.887 . . . . 51.310000000000002 112.188 -169.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -65.23 157.45 28.86 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.842 0.857 . . . . 72.219999999999999 110.745 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -46.76 -32.95 3.97 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.344 1.058 . . . . 75.430000000000007 113.171 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -94.24 75.46 3.98 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 108.289 -1.004 . . . . 64.219999999999999 108.289 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.54 ' HZ3' ' HB2' ' A' ' 241' ' ' LYS . 10.3 mtmp? -70.48 148.8 95.5 Favored Pre-proline 0 N--CA 1.478 0.952 0 CA-C-N 114.714 -1.13 . . . . 75.319999999999993 111.26 -174.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.32 155.23 71.36 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.84 2.36 . . . . 73.420000000000002 111.958 173.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 17.0 m -62.54 -36.42 82.56 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.476 0.71 . . . . 61.140000000000001 111.445 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.71 131.33 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.047 0.539 . . . . 73.450000000000003 110.022 176.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -163.57 121.54 1.9 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.984 0.913 . . . . 74.200000000000003 109.212 168.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 162.67 94.36 0.1 OUTLIER Glycine 0 C--N 1.344 0.973 0 O-C-N 123.441 0.463 . . . . 72.430000000000007 111.954 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 3.5 m -118.14 125.15 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.395 0.678 . . . . 73.420000000000002 109.371 173.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 34.1 p -135.86 75.27 55.75 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 107.937 -1.134 . . . . 73.140000000000001 107.937 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.73 -8.41 19.2 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.913 2.409 . . . . 72.200000000000003 113.501 -172.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.76 95.39 3.44 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 122.853 0.461 . . . . 75.349999999999994 110.154 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -76.22 117.12 17.58 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.267 1.027 . . . . 73.019999999999996 109.194 171.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -89.18 123.55 33.53 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.871 0.693 . . . . 71.120000000000005 112.871 -168.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.48 115.73 4.07 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 106.75 -1.574 . . . . 72.450000000000003 106.75 170.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -111.09 -49.8 2.99 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.65 0.78 . . . . 74.430000000000007 110.054 -172.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--O 1.249 1.032 0 N-CA-C 106.398 -1.704 . . . . 70.400000000000006 106.398 -179.555 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 mmt . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 109.501 -0.555 . . . . 73.549999999999997 109.501 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.37 179.88 46.6 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 116.377 -0.374 . . . . 64.230000000000004 113.05 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -166.02 -62.55 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.196 0.998 . . . . 64.409999999999997 109.513 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 54.87 83.03 0.23 Allowed Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 124.608 1.163 . . . . 74.439999999999998 110.238 -167.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.04 111.18 3.27 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.56 2.173 . . . . 54.43 111.621 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.99 -130.59 0.19 Allowed Glycine 0 C--N 1.341 0.843 0 CA-C-N 116.309 -0.405 . . . . 73.200000000000003 113.104 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -121.26 166.28 14.24 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.719 0.808 . . . . 75.239999999999995 109.415 174.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.0 t -72.87 96.33 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.73 -1.211 . . . . 74.430000000000007 107.73 171.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.06 130.82 48.33 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.448 -0.796 . . . . 75.200000000000003 110.87 178.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.46 144.49 47.56 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.473 -0.651 . . . . 74.340000000000003 111.473 173.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -117.35 23.61 11.69 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.709 0.804 . . . . 74.219999999999999 110.851 -174.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -74.9 -169.72 0.95 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.385 0.674 . . . . 74.319999999999993 111.508 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.608 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 3.7 tmm_? -65.48 130.67 44.14 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.811 -0.811 . . . . 74.450000000000003 108.811 171.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 50.42 68.42 3.43 Favored Pre-proline 0 C--O 1.243 0.762 0 O-C-N 124.177 0.923 . . . . 74.030000000000001 108.608 -165.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.05 158.81 20.2 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.104 2.536 . . . . 63.32 111.815 -170.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.8 m -65.92 165.35 13.29 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 121.308 0.575 . . . . 72.040000000000006 111.0 -171.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.1 mt -103.45 125.26 35.43 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 107.88 -1.155 . . . . 74.430000000000007 107.88 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.419 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 67.0 Cg_endo -72.08 176.61 8.21 Favored 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 123.114 2.543 . . . . 74.530000000000001 112.437 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.08 141.69 38.64 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 116.395 -0.366 . . . . 71.230000000000004 111.073 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.534 ' HB3' HD12 ' A' ' 23' ' ' ILE . 66.7 mt -87.93 91.49 8.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.109 -0.7 . . . . 74.349999999999994 109.109 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -97.0 -48.49 5.39 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.676 0.79 . . . . 74.540000000000006 110.22 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -100.75 109.46 21.47 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.857 -1.065 . . . . 73.0 108.732 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.534 HD12 ' HB3' ' A' ' 20' ' ' LEU . 48.3 mm -118.69 119.35 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.697 0.799 . . . . 74.200000000000003 109.325 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.496 ' H ' ' HE1' ' A' ' 129' ' ' TRP . 75.0 mmtt -110.42 142.02 42.7 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.634 -0.876 . . . . 72.239999999999995 108.634 169.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.27 143.54 42.99 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.445 0.466 . . . . 71.329999999999998 112.493 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.56 80.34 2.57 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.372 0.606 . . . . 72.209999999999994 110.706 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.36 -42.18 28.65 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.179 -0.919 . . . . 73.150000000000006 112.423 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 71.3 142.09 0.05 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.916 1.686 . . . . 72.200000000000003 111.974 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -132.36 163.71 28.08 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.714 0.806 . . . . 75.209999999999994 110.859 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -80.38 83.22 6.25 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.679 -1.23 . . . . 75.299999999999997 107.679 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.3 p -111.09 124.6 52.5 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.629 0.772 . . . . 71.109999999999999 110.35 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.2 m 68.34 -177.04 0.21 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.778 1.231 . . . . 74.430000000000007 112.938 173.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 -101.96 149.8 23.86 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.278 1.031 . . . . 74.120000000000005 109.403 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -64.37 155.65 31.73 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.983 0.513 . . . . 75.349999999999994 111.517 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.52 148.72 16.69 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.185 0.303 . . . . 72.310000000000002 112.685 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.94 110.69 3.08 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-O 119.126 -0.819 . . . . 72.019999999999996 112.724 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.567 ' HB2' ' HA ' ' A' ' 105' ' ' GLU . 20.6 Cg_endo -84.57 -159.55 0.1 Allowed 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.91 2.407 . . . . 65.209999999999994 112.828 -173.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -120.43 149.25 42.66 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.795 -0.817 . . . . 73.530000000000001 108.795 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.8 m -143.78 10.98 1.61 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.002 0.921 . . . . 72.150000000000006 109.492 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -69.72 166.59 18.9 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 123.816 0.847 . . . . 73.0 111.526 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 m -77.78 71.38 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.059 0.933 . . . . 74.120000000000005 111.224 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -74.26 158.6 33.77 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.982 -1.008 . . . . 65.129999999999995 110.229 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 71' ' ' GLU . 30.7 m -75.74 168.8 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 123.623 0.769 . . . . 71.230000000000004 113.038 -175.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -156.78 158.21 36.42 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.482 1.113 . . . . 73.299999999999997 108.4 167.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.98 90.15 0.44 Allowed 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.05 0.452 . . . . 53.420000000000002 111.969 -173.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.608 ' HA ' ' HB2' ' A' ' 13' ' ' ARG . 12.5 tp10 -63.92 120.09 11.29 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.228 0.537 . . . . 72.140000000000001 111.438 -176.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -161.97 138.41 7.99 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.011 -0.995 . . . . 74.030000000000001 109.601 -170.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.459 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 92.9 mt -113.6 94.92 5.08 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.052 -0.721 . . . . 75.239999999999995 109.052 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -62.26 -56.08 22.05 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.331 -0.989 . . . . 61.240000000000002 108.331 170.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -161.3 110.2 1.24 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 114.734 -1.121 . . . . 73.439999999999998 108.621 168.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 48' ' ' LEU . 84.1 Cg_endo -77.19 -156.98 0.07 OUTLIER 'Trans proline' 0 CA--C 1.554 1.522 0 C-N-CA 122.671 2.247 . . . . 63.240000000000002 112.249 173.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 p 47.58 56.95 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 126.023 1.729 . . . . 71.510000000000005 112.403 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.68 105.12 2.2 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.487 -1.233 . . . . 75.430000000000007 110.054 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -144.1 80.07 1.64 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.95 0.9 . . . . 70.129999999999995 108.778 173.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -75.69 -67.21 0.69 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.071 -0.715 . . . . 72.540000000000006 109.071 173.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -74.28 131.26 41.02 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.91 -1.144 . . . . 74.349999999999994 107.91 171.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 59.57 66.37 2.19 Favored Pre-proline 0 CA--C 1.556 1.184 0 O-C-N 124.445 1.091 . . . . 75.349999999999994 109.179 -164.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.44 -8.19 22.2 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.238 2.625 . . . . 64.209999999999994 112.758 -173.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -63.21 -37.42 87.15 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.101 0.961 . . . . 73.129999999999995 109.706 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.4 49.44 72.97 Favored Glycine 0 C--N 1.359 1.808 0 O-C-N 124.399 1.062 . . . . 74.129999999999995 112.674 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.4 mt -81.07 100.91 9.26 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.312 0.577 . . . . 72.310000000000002 110.651 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.2 m -103.34 77.58 1.53 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.237 -0.892 . . . . 74.540000000000006 109.575 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.74 -24.99 64.52 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.327 -0.851 . . . . 71.310000000000002 110.51 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.95 130.77 38.98 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.946 0.899 . . . . 74.140000000000001 110.321 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.82 167.95 20.71 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.222 0.609 . . . . 72.120000000000005 111.372 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -83.88 77.61 9.87 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.753 0.787 . . . . 63.240000000000002 110.068 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -90.03 96.06 10.5 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.083 -1.08 . . . . 73.420000000000002 108.083 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.52 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . 33.8 m-80 -71.43 87.85 0.88 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.102 -0.954 . . . . 71.019999999999996 109.562 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.5 p -93.24 134.05 35.83 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.188 0.995 . . . . 65.299999999999997 110.866 -175.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -139.25 96.1 3.05 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.198 0.999 . . . . 72.530000000000001 109.247 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.499 ' HB3' HG12 ' A' ' 43' ' ' VAL . 10.5 tp10 -168.64 151.39 5.2 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.479 1.512 . . . . 73.010000000000005 107.434 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -147.18 150.1 34.25 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.313 -0.995 . . . . 63.140000000000001 108.313 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.8 mt -126.1 149.5 48.87 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.424 -0.584 . . . . 74.430000000000007 109.424 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.6 mt -69.57 159.76 32.78 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.47 0.481 . . . . 74.230000000000004 111.025 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.609 ' HB1' ' HA ' ' A' ' 138' ' ' VAL . . . -67.07 152.44 45.77 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.753 0.821 . . . . 72.109999999999999 111.496 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -53.48 113.86 3.38 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-O 118.446 -1.197 . . . . 72.450000000000003 112.574 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -50.29 -59.59 1.14 Allowed 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 123.833 3.022 . . . . 73.329999999999998 114.207 -170.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 62.8 m -152.25 139.33 19.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.179 0.592 . . . . 71.439999999999998 111.556 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -159.99 174.22 14.69 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.618 0.767 . . . . 73.219999999999999 109.352 175.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -92.1 35.28 0.99 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.97 0.908 . . . . 74.129999999999995 112.644 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -141.94 107.17 5.82 Favored Pre-proline 0 N--CA 1.484 1.265 0 CA-C-O 119.257 -0.401 . . . . 75.430000000000007 111.421 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.77 -48.8 9.91 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.695 2.93 . . . . 62.409999999999997 114.104 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -92.35 41.96 1.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.531 0.732 . . . . 75.219999999999999 111.098 -174.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.1 tp -91.58 112.36 24.24 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.445 -0.798 . . . . 75.219999999999999 110.308 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -107.43 176.28 5.21 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.65 1.58 . . . . 63.100000000000001 109.549 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 9.9 p -147.73 149.34 15.5 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 C-N-CA 123.014 0.526 . . . . 74.310000000000002 109.868 171.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.58 113.66 20.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.624 0.77 . . . . 75.120000000000005 109.345 171.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.65 -12.59 53.62 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.058 0.543 . . . . 74.540000000000006 110.568 174.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -135.01 146.49 49.08 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.33 0.652 . . . . 70.430000000000007 110.091 -173.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -60.28 137.73 58.07 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.138 -0.937 . . . . 74.519999999999996 110.439 168.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -152.27 116.24 4.89 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.923 -0.399 . . . . 74.519999999999996 109.923 174.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.94 139.03 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 108.002 -1.11 . . . . 74.540000000000006 108.002 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.79 116.13 8.12 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 110.07 -0.345 . . . . 74.329999999999998 110.07 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.1 m -74.99 -17.66 60.5 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.313 0.645 . . . . 75.099999999999994 110.743 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -156.3 -177.54 29.57 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.611 -0.722 . . . . 71.340000000000003 111.747 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -73.57 -27.55 61.38 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.331 0.652 . . . . 71.519999999999996 110.575 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -69.7 -23.64 63.46 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.863 0.865 . . . . 74.310000000000002 111.922 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.4 p -99.83 157.14 16.72 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.284 0.634 . . . . 61.549999999999997 110.754 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.5 tp -110.32 117.16 32.88 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.531 0.733 . . . . 75.109999999999999 109.87 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -66.89 117.59 9.2 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.031 -0.729 . . . . 71.25 109.031 172.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.4 pt -122.39 130.76 74.28 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 N-CA-C 109.244 -0.65 . . . . 72.099999999999994 109.244 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.0 m -90.53 141.26 28.94 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.503 -0.554 . . . . 72.439999999999998 109.503 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -57.51 116.64 3.49 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.012 0.525 . . . . 60.100000000000001 110.794 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.16 -20.13 21.81 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 115.417 -0.81 . . . . 72.040000000000006 112.38 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 37' ' ' PRO . 69.9 tt0 -72.55 128.54 35.9 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.017 -0.735 . . . . 71.319999999999993 109.017 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 54.5 mtmt -84.0 126.99 33.56 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.165 0.507 . . . . 73.030000000000001 109.909 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.4 ' HA ' HG22 ' A' ' 123' ' ' THR . 14.5 mt -102.1 166.76 10.43 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.981 -1.008 . . . . 73.430000000000007 108.592 -169.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -128.34 107.4 9.73 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.728 -1.212 . . . . 73.310000000000002 107.728 168.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 98.3 t -96.46 116.52 38.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.625 -0.88 . . . . 75.319999999999993 108.625 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.42 HD12 ' NE2' ' A' ' 127' ' ' GLN . 47.5 mt -78.46 -25.42 45.85 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.065 -0.971 . . . . 71.310000000000002 110.116 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.03 161.02 25.9 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.458 -0.792 . . . . 74.219999999999999 111.421 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 3.8 m-30 -95.4 171.84 8.45 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.473 0.654 . . . . 73.219999999999999 109.424 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -66.84 144.87 56.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.668 1.187 . . . . 71.430000000000007 107.979 164.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -60.89 -38.09 84.47 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.43 0.692 . . . . 73.340000000000003 112.158 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -79.35 -11.94 59.93 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.75 0.82 . . . . 74.120000000000005 110.98 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.35 23.17 48.92 Favored Glycine 0 C--N 1.349 1.281 0 C-N-CA 123.529 0.585 . . . . 72.140000000000001 113.281 177.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . 46.5 mt-10 -78.28 -72.21 0.38 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.722 0.772 . . . . 72.200000000000003 110.729 -177.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -104.33 -177.43 3.36 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.534 1.133 . . . . 73.150000000000006 109.439 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -149.23 126.82 11.65 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.338 0.655 . . . . 73.140000000000001 110.07 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -71.03 94.26 1.08 Allowed 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.078 -0.712 . . . . 72.239999999999995 109.078 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -104.88 162.57 13.21 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 124.005 0.922 . . . . 73.219999999999999 110.402 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -144.06 133.72 23.63 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.555 0.742 . . . . 64.409999999999997 109.241 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.4 HG22 ' HA ' ' A' ' 107' ' ' LEU . 62.9 p -139.67 -171.37 3.13 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.556 1.143 . . . . 75.439999999999998 110.454 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.517 ' HZ1' ' HB2' ' A' ' 124' ' ' LYS . 9.6 mtmp? -61.6 -19.77 62.59 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.382 -0.827 . . . . 73.049999999999997 111.196 170.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -85.69 1.93 47.36 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.882 0.873 . . . . 73.420000000000002 111.353 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.5 -130.4 9.54 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.619 -0.593 . . . . 61.409999999999997 111.619 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.42 ' NE2' HD12 ' A' ' 110' ' ' LEU . 57.2 tt0 -145.76 154.38 41.98 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.458 0.703 . . . . 74.219999999999999 109.837 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 166.54 -178.89 40.78 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 112.685 -0.166 . . . . 74.420000000000002 112.685 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.496 ' HE1' ' H ' ' A' ' 24' ' ' LYS . 86.4 m95 -89.85 127.07 35.92 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.767 0.827 . . . . 73.420000000000002 110.688 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.6 m -125.34 146.19 53.4 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.797 1.239 . . . . 72.439999999999998 108.68 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.41 141.5 42.73 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 121.937 1.758 . . . . 72.519999999999996 111.616 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.6 m -60.64 -19.94 59.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.931 0.892 . . . . 75.340000000000003 112.108 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -72.27 -27.49 62.52 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.503 0.721 . . . . 53.229999999999997 111.705 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -88.85 -11.75 43.85 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.661 0.784 . . . . 73.409999999999997 112.073 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.474 HD12 HG22 ' A' ' 109' ' ' VAL . 18.2 pt -122.64 161.43 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.002 0.521 . . . . 74.530000000000001 110.928 -170.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.0 t -155.9 143.05 13.7 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 122.727 0.411 . . . . 65.409999999999997 110.291 168.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.519 ' HB2' ' HB2' ' A' ' 140' ' ' SER . 5.7 Cg_exo -75.63 126.45 9.57 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.579 2.186 . . . . 52.219999999999999 111.217 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.609 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 12.0 m -94.28 -51.26 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 111.945 0.35 . . . . 74.239999999999995 111.945 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -92.52 18.91 7.88 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.175 0.512 . . . . 74.239999999999995 111.305 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 137' ' ' PRO . 22.7 t -64.45 177.51 0.87 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.818 0.847 . . . . 71.299999999999997 112.691 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 49.5 mt -65.31 -13.49 58.59 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.055 1.342 . . . . 64.340000000000003 111.98 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.479 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 42.6 tt0 -63.87 -8.9 12.4 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.856 0.863 . . . . 74.420000000000002 111.491 174.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.502 ' HB2' ' HZ2' ' A' ' 143' ' ' LYS . 4.3 ttmp? -55.16 -23.76 23.05 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.921 1.289 . . . . 72.140000000000001 110.515 167.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -99.36 143.64 29.38 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.974 0.909 . . . . 74.019999999999996 109.824 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.0 p -66.25 -15.41 63.17 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.369 0.668 . . . . 71.420000000000002 112.771 -175.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.403 ' CZ3' ' HB2' ' A' ' 147' ' ' TYR . 44.3 p-90 -80.29 -38.16 31.33 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 112.592 0.59 . . . . 74.219999999999999 112.592 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 28.8 t80 -91.67 140.47 29.69 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.81 -0.441 . . . . 71.549999999999997 109.81 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.479 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 63.3 m-70 -137.97 29.55 2.54 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.136 0.421 . . . . 72.25 112.136 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.63 -170.88 54.49 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 115.652 1.021 . . . . 60.009999999999998 115.652 165.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.04 102.77 1.49 Allowed 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.276 2.651 . . . . 62.299999999999997 111.341 172.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.403 HG23 ' NH2' ' A' ' 171' ' ' ARG . 60.4 t -140.02 156.9 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.458 0.703 . . . . 74.049999999999997 110.023 -175.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.6 t -61.62 145.15 53.09 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.965 1.306 . . . . 60.119999999999997 112.717 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -55.19 -32.87 62.54 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.506 -1.225 . . . . 74.510000000000005 112.019 171.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -66.3 -52.08 50.95 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.442 0.697 . . . . 71.450000000000003 110.553 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.84 75.69 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.228 0.611 . . . . 63.140000000000001 111.262 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.546 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.28 -53.44 58.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.141 -0.936 . . . . 72.019999999999996 110.416 173.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.561 ' HG3' HG13 ' A' ' 190' ' ' VAL . 34.6 tt0 -68.67 -27.46 66.0 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.661 -0.699 . . . . 64.439999999999998 111.079 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -67.62 -45.99 73.79 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.877 0.471 . . . . 72.409999999999997 111.45 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.2 mt -67.76 -38.4 83.39 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 110.146 -0.316 . . . . 64.430000000000007 110.146 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 183' ' ' SER . 29.3 tp -68.15 -21.29 64.92 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.292 0.637 . . . . 73.230000000000004 111.658 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.452 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 33.2 t -64.93 -24.35 67.5 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.505 0.722 . . . . 74.239999999999995 110.603 176.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.8 t -85.62 -2.54 58.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.903 0.881 . . . . 54.420000000000002 111.604 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -86.2 170.91 43.61 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 114.073 0.389 . . . . 61.420000000000002 114.073 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.422 HG13 ' HH ' ' A' ' 234' ' ' TYR . 15.4 pt -132.31 -165.05 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 124.568 1.147 . . . . 73.349999999999994 111.023 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.638 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 14.3 p-10 -58.09 102.81 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.03 0.932 . . . . 71.109999999999999 113.362 -172.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 104.06 11.79 31.19 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 115.977 -0.556 . . . . 61.140000000000001 112.776 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 23.0 t -75.76 142.35 42.38 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 109.853 -0.425 . . . . 61.509999999999998 109.853 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 235' ' ' PRO . 14.9 p90 -144.07 161.47 38.71 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.84 0.682 . . . . 73.430000000000007 112.84 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.474 HD21 ' HB1' ' A' ' 236' ' ' ALA . 95.7 mt -142.45 135.51 28.53 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.489 1.116 . . . . 74.239999999999995 108.358 170.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.5 t -110.91 113.52 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.327 -1.36 . . . . 75.420000000000002 107.327 174.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.546 HH11 ' HA ' ' A' ' 156' ' ' ALA . 17.2 mtp180 -141.12 143.28 34.21 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 107.602 -1.258 . . . . 74.219999999999999 107.602 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.685 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 15.3 pt-20 -95.14 161.29 14.18 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.074 0.397 . . . . 75.439999999999998 110.506 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 37.4 m -82.81 134.47 35.11 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 116.308 -0.406 . . . . 74.040000000000006 110.284 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -70.16 -41.67 73.53 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.214 1.006 . . . . 73.120000000000005 109.975 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 72.0 p -84.26 -9.17 58.72 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.366 1.066 . . . . 73.230000000000004 111.864 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.2 m -141.64 67.45 24.07 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.499 1.12 . . . . 75.409999999999997 108.812 173.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.71 149.11 42.71 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.655 2.237 . . . . 71.129999999999995 112.817 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.66 -26.01 6.17 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 114.665 -1.152 . . . . 74.329999999999998 112.049 -168.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -90.84 119.17 30.83 Favored 'General case' 0 C--O 1.259 1.574 0 N-CA-C 108.151 -1.055 . . . . 71.519999999999996 108.151 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.685 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 26.0 mtt85 -105.95 170.24 8.02 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.36 -0.836 . . . . 72.120000000000005 110.77 -173.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.8 m -144.11 144.14 31.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.699 0.8 . . . . 75.450000000000003 110.22 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 56.7 mt -112.91 139.25 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.18 -1.045 . . . . 75.0 108.18 168.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.532 ' HB3' HD22 ' A' ' 160' ' ' LEU . 23.6 m -116.04 115.09 25.5 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 124.661 1.184 . . . . 71.400000000000006 107.981 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.439 HD21 HD22 ' A' ' 232' ' ' LEU . 57.2 mt -104.77 142.99 33.73 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.474 0.71 . . . . 71.209999999999994 111.088 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.452 ' NH1' ' HA ' ' A' ' 161' ' ' SER . 20.3 ttt180 -131.99 126.55 34.25 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.61 -1.177 . . . . 72.230000000000004 108.773 170.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -150.21 141.46 23.19 Favored 'General case' 0 C--O 1.211 -0.945 0 N-CA-C 107.154 -1.424 . . . . 74.510000000000005 107.154 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 54.29 18.61 1.91 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 125.759 1.624 . . . . 74.519999999999996 113.442 -174.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.49 14.01 80.74 Favored Glycine 0 N--CA 1.475 1.294 0 O-C-N 122.284 -0.26 . . . . 45.100000000000001 113.049 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -103.21 127.73 50.42 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 125.4 1.48 . . . . 73.420000000000002 108.763 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.561 HG13 ' HG3' ' A' ' 157' ' ' GLU . 86.2 t -107.79 116.82 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.887 0.875 . . . . 74.5 110.304 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.49 ' HH ' ' HB3' ' A' ' 186' ' ' TYR . 15.0 p90 -139.55 141.13 37.26 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.44 1.096 . . . . 65.040000000000006 109.275 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -124.57 151.19 45.07 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.139 0.975 . . . . 73.349999999999994 108.963 -170.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -142.94 141.49 31.47 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.213 0.53 . . . . 70.109999999999999 110.752 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -77.68 131.28 37.65 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.815 -1.084 . . . . 72.319999999999993 110.828 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 80.4 mt -75.2 108.52 7.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 107.48 -1.304 . . . . 75.439999999999998 107.48 165.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -73.17 106.76 5.15 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.799 -1.185 . . . . 75.349999999999994 107.799 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.497 HG23 HD23 ' A' ' 203' ' ' LEU . 30.9 m -92.37 121.65 34.06 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.255 0.622 . . . . 74.140000000000001 109.717 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.21 153.52 34.28 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.454 0.702 . . . . 72.430000000000007 110.236 172.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 51.3 p -61.37 -22.36 64.88 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.405 0.682 . . . . 75.540000000000006 112.005 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -71.54 -14.99 62.27 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.883 1.273 . . . . 75.0 112.373 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 101.77 -2.68 52.56 Favored Glycine 0 C--N 1.348 1.223 0 C-N-CA 122.901 0.286 . . . . 63.140000000000001 112.671 -176.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -82.65 156.07 24.05 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.652 0.781 . . . . 71.129999999999995 109.79 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.497 HD23 HG23 ' A' ' 197' ' ' THR . 79.0 mt -113.69 151.2 32.18 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.581 0.752 . . . . 75.329999999999998 110.73 -171.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -163.78 171.97 14.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.888 0.875 . . . . 62.520000000000003 110.413 170.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.3 t -131.46 -56.34 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.414 -1.328 . . . . 74.420000000000002 107.414 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 8.9 m -76.25 153.12 36.27 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.508 -0.769 . . . . 65.319999999999993 108.932 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.9 m -61.32 -36.82 81.19 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.131 0.573 . . . . 72.299999999999997 111.067 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -82.67 -20.67 35.75 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.451 0.7 . . . . 71.200000000000003 111.461 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 68.7 m -63.49 135.91 57.21 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 122.707 0.403 . . . . 75.230000000000004 110.764 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -141.13 108.52 5.55 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.368 -0.975 . . . . 73.329999999999998 108.368 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -121.39 135.76 55.04 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.285 -0.635 . . . . 74.430000000000007 109.285 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -84.25 -30.5 25.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.956 0.502 . . . . 72.530000000000001 110.04 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 81.5 p -132.36 161.49 33.45 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-O 122.209 1.004 . . . . 75.420000000000002 111.609 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 37.6 tp -71.24 -24.5 62.2 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 114.159 -1.382 . . . . 72.030000000000001 110.992 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.18 -42.03 89.45 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.434 0.693 . . . . 71.129999999999995 109.93 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -65.02 -43.8 91.24 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.341 -0.845 . . . . 71.310000000000002 109.637 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.22 -46.25 86.23 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 124.077 0.861 . . . . 74.209999999999994 111.686 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 42.2 t -74.41 -40.55 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.084 0.553 . . . . 75.519999999999996 111.236 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -62.59 -47.07 85.4 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.107 0.479 . . . . 74.230000000000004 110.591 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.408 ' O ' HG22 ' A' ' 224' ' ' VAL . 52.9 t-80 -54.98 -54.46 42.6 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.066 -0.97 . . . . 75.109999999999999 109.961 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.466 ' HD2' HD21 ' A' ' 228' ' ' LEU . 40.3 m80 -65.85 -23.86 66.76 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.676 -0.693 . . . . 74.129999999999995 111.65 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 44.2 t -74.4 -24.44 59.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.019 0.528 . . . . 61.32 111.298 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.7 t -110.44 -21.73 12.03 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 116.336 1.976 . . . . 72.310000000000002 116.336 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 220' ' ' HIS . 26.9 m -93.84 157.35 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 115.435 1.643 . . . . 73.239999999999995 115.435 -164.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.16 -1.44 57.73 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.378 2.671 . . . . 73.349999999999994 112.666 -175.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -78.92 15.86 1.01 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 128.357 2.663 . . . . 70.150000000000006 113.751 -140.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.93 18.11 4.4 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 124.819 1.2 . . . . 54.530000000000001 110.529 -170.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.466 HD21 ' HD2' ' A' ' 221' ' ' HIS . 95.2 mt -93.19 126.73 38.45 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.989 1.315 . . . . 71.319999999999993 109.713 164.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 81.0 mt -67.01 -39.9 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 109.21 -0.663 . . . . 71.400000000000006 109.21 173.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.8 t -133.28 141.98 48.26 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 115.08 -0.964 . . . . 71.310000000000002 108.803 168.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 65.1 p -66.3 151.84 46.21 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 108.791 -0.818 . . . . 71.099999999999994 108.791 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.439 HD22 HD21 ' A' ' 184' ' ' LEU . 28.5 mt -62.11 102.69 0.31 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 108.126 -1.064 . . . . 74.519999999999996 108.126 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -89.43 -58.18 2.62 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.818 -0.808 . . . . 74.099999999999994 108.818 -173.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.576 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -151.95 141.34 14.24 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 123.058 0.543 . . . . 75.230000000000004 111.82 -178.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 65.5 Cg_endo -71.76 156.76 56.66 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 121.494 1.463 . . . . 71.239999999999995 112.45 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . 0.474 ' HB1' HD21 ' A' ' 169' ' ' LEU . . . -70.72 133.31 86.62 Favored Pre-proline 0 C--O 1.244 0.81 0 CA-C-N 115.935 -0.575 . . . . 74.439999999999998 109.752 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.466 ' HB3' ' HD2' ' A' ' 242' ' ' PRO . 31.3 Cg_exo -61.45 132.1 39.24 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.22 2.614 . . . . 60.140000000000001 113.602 -175.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.44 ' HG2' ' HG3' ' A' ' 242' ' ' PRO . 19.3 ptpt -69.02 161.31 29.25 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.761 0.825 . . . . 72.129999999999995 110.829 171.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -53.38 -32.19 48.26 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.588 0.755 . . . . 74.540000000000006 112.284 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -79.28 83.85 5.27 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.917 -1.142 . . . . 74.150000000000006 107.917 170.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -44.23 103.91 0.35 Allowed Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 126.261 1.825 . . . . 74.349999999999994 114.519 -168.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 237' ' ' PRO . 93.2 Cg_endo -107.44 105.07 0.02 OUTLIER 'Trans proline' 0 CA--C 1.563 1.973 0 C-N-CA 123.886 3.057 . . . . 75.530000000000001 113.934 175.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 13.8 t -93.89 156.93 16.37 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.75 -0.594 . . . . 75.25 110.011 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 13.5 p -159.62 143.44 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.811 0.844 . . . . 65.329999999999998 109.642 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -104.98 104.59 14.36 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.21 1.004 . . . . 75.439999999999998 110.439 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -82.24 76.96 2.14 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.662 -0.699 . . . . 73.409999999999997 112.577 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.5 m -65.52 149.7 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.499 0.72 . . . . 74.25 111.234 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 48.4 t -151.33 140.1 13.39 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.265 0.626 . . . . 71.120000000000005 110.676 -172.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.63 146.63 67.85 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.286 1.99 . . . . 55.100000000000001 111.231 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -61.83 99.06 0.11 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.769 0.428 . . . . 65.230000000000004 110.177 175.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -146.57 17.93 1.31 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.581 0.752 . . . . 71.409999999999997 109.303 174.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -76.67 155.51 33.32 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.146 0.498 . . . . 72.019999999999996 111.121 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -115.7 166.31 12.07 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.818 0.847 . . . . 71.120000000000005 109.315 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -70.1 -55.99 8.03 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.79 -0.819 . . . . 72.510000000000005 108.79 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 . . . . . 0 C--O 1.248 0.991 0 C-N-CA 125.584 1.554 . . . . 73.239999999999995 107.676 174.203 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.3 mtt . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.339 -0.615 . . . . 74.319999999999993 109.339 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.22 79.46 0.52 Allowed Glycine 0 C--N 1.35 1.319 0 N-CA-C 110.758 -0.937 . . . . 74.510000000000005 110.758 173.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.422 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . 30.0 pt20 -74.39 -14.38 60.85 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.723 0.809 . . . . 72.540000000000006 112.0 -173.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 66.23 160.25 0.13 Allowed Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 124.777 1.231 . . . . 72.140000000000001 111.783 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.24 -28.24 84.61 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.359 2.039 . . . . 60.200000000000003 111.637 166.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.08 -69.42 3.38 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.199 -0.91 . . . . 62.43 111.007 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt 58.0 52.69 7.5 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.728 1.211 . . . . 72.439999999999998 109.896 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.57 107.48 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 114.186 -1.37 . . . . 73.040000000000006 109.322 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 79.7 mt -86.87 80.33 8.5 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.505 -0.77 . . . . 73.209999999999994 109.436 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.51 -34.23 88.83 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 114.727 -1.124 . . . . 75.310000000000002 114.335 -171.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -89.12 50.51 1.96 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.376 0.608 . . . . 63.020000000000003 111.366 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -134.84 153.8 51.89 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.538 1.135 . . . . 74.510000000000005 108.799 170.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -68.68 117.09 9.96 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.742 -1.207 . . . . 73.319999999999993 107.742 170.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.434 ' HB3' HH11 ' A' ' 14' ' ' ARG . 1.5 mmm180 61.01 73.38 0.61 Allowed Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 124.462 1.105 . . . . 74.230000000000004 109.311 -170.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.9 161.48 12.9 Favored 'Trans proline' 0 C--N 1.387 2.581 0 C-N-CA 123.344 2.696 . . . . 71.299999999999997 112.553 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.7 p -66.05 165.15 13.94 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 121.169 0.509 . . . . 73.109999999999999 111.006 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.6 mt -108.31 130.62 22.53 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 109.064 -0.717 . . . . 75.439999999999998 109.064 -176.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.27 172.7 9.7 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.301 2.001 . . . . 74.530000000000001 111.206 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.86 144.45 36.97 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 122.329 -0.232 . . . . 71.319999999999993 110.439 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.549 ' HB3' HD13 ' A' ' 23' ' ' ILE . 72.6 mt -84.84 92.38 8.25 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.486 -0.931 . . . . 71.340000000000003 108.486 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -96.27 -49.07 5.36 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.203 -0.908 . . . . 74.430000000000007 109.379 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -103.2 110.96 23.11 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.561 -1.2 . . . . 63.25 109.228 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.549 HD13 ' HB3' ' A' ' 20' ' ' LEU . 37.2 mm -116.99 113.01 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.954 0.902 . . . . 75.010000000000005 109.491 -177.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.677 ' HA ' ' HE1' ' A' ' 129' ' ' TRP . 2.2 tppp? 49.66 53.46 12.71 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.166 1.386 . . . . 74.209999999999994 112.739 175.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.18 53.47 4.79 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 114.78 -1.1 . . . . 65.450000000000003 110.817 173.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.35 85.58 5.82 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.536 0.734 . . . . 61.109999999999999 109.796 -176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.19 -10.41 85.38 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.503 -0.771 . . . . 62.329999999999998 111.925 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -100.5 108.5 20.48 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.178 0.991 . . . . 74.299999999999997 109.382 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -92.17 17.56 9.4 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.762 0.825 . . . . 74.310000000000002 110.629 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -96.35 19.1 12.52 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.582 1.153 . . . . 73.120000000000005 111.016 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.9 p -70.35 143.44 51.95 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.985 0.914 . . . . 70.030000000000001 110.047 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.1 m -65.22 103.67 0.81 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.768 0.427 . . . . 74.349999999999994 110.841 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -110.17 167.11 10.43 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.075 0.95 . . . . 74.129999999999995 110.642 -177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -73.03 127.8 33.61 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.209 0.604 . . . . 73.310000000000002 111.195 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.9 95.14 0.1 Allowed Glycine 0 C--N 1.341 0.857 0 N-CA-C 110.495 -1.042 . . . . 72.010000000000005 110.495 175.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.29 78.11 0.35 Allowed Glycine 0 C--N 1.35 1.315 0 CA-C-O 119.676 -0.514 . . . . 62.219999999999999 111.99 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.81 132.65 15.93 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.166 2.577 . . . . 62.329999999999998 111.232 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -72.81 159.91 33.01 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.007 0.432 . . . . 72.540000000000006 111.674 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.1 t -158.82 152.59 23.28 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.361 -0.836 . . . . 71.049999999999997 110.244 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -65.15 95.88 0.19 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.61 0.764 . . . . 74.349999999999994 109.462 172.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -76.35 88.25 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.454 0.702 . . . . 74.109999999999999 109.58 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -125.33 126.96 45.89 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.5 1.12 . . . . 74.299999999999997 108.269 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 p -102.39 153.49 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 123.265 0.626 . . . . 73.439999999999998 109.918 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.65 158.9 39.07 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 107.168 -1.419 . . . . 74.049999999999997 107.168 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -74.12 -17.7 60.9 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.657 0.662 . . . . 65.299999999999997 111.26 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -137.89 162.25 34.51 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.083 0.953 . . . . 73.049999999999997 110.079 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 70.54 24.77 4.4 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.63 1.172 . . . . 70.209999999999994 111.969 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.0 mt -86.25 75.66 9.82 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.068 0.461 . . . . 63.229999999999997 111.115 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -89.16 123.35 33.33 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.413 -0.958 . . . . 71.120000000000005 108.413 167.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -90.36 102.49 5.05 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.016 1.326 . . . . 75.219999999999999 109.83 -174.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -82.63 119.66 3.01 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.667 2.245 . . . . 63.109999999999999 111.917 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.4 t -89.58 118.56 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.396 -0.594 . . . . 74.409999999999997 109.396 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.77 143.42 54.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.277 0.631 . . . . 61.200000000000003 110.764 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.3 m -59.1 124.59 20.45 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.398 0.679 . . . . 52.109999999999999 110.695 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.85 97.06 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.854 0.862 . . . . 63.240000000000002 109.969 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -58.53 -36.95 74.65 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.843 0.857 . . . . 74.239999999999995 110.135 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 60.4 73.69 0.61 Allowed Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 114.492 -1.231 . . . . 74.340000000000003 109.934 -177.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.34 118.65 4.83 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.648 2.232 . . . . 71.0 111.279 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -62.78 -30.5 71.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.982 0.913 . . . . 74.409999999999997 111.045 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.84 130.33 2.13 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.701 -0.681 . . . . 73.340000000000003 112.657 174.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 73.2 mt -103.85 109.36 21.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.541 0.736 . . . . 74.439999999999998 109.124 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.5 p -72.3 99.37 2.39 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.538 0.735 . . . . 72.230000000000004 110.718 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -123.27 122.43 38.34 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.066 0.946 . . . . 70.420000000000002 109.71 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.465 ' HA ' ' HB2' ' A' ' 96' ' ' ASP . . . -94.43 70.56 3.68 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.6 0.714 . . . . 74.230000000000004 110.353 -175.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.84 121.92 21.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.029 -0.987 . . . . 73.299999999999997 110.846 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -120.34 -0.55 10.38 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.156 0.582 . . . . 72.430000000000007 110.977 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 30.5 t90 -73.92 88.75 1.85 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.346 -0.613 . . . . 63.439999999999998 109.346 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -85.77 64.32 8.54 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.194 -0.912 . . . . 72.120000000000005 110.809 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.2 p -61.25 -33.31 73.31 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.737 0.78 . . . . 64.409999999999997 110.175 172.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -106.63 131.03 54.24 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.254 -1.339 . . . . 74.310000000000002 109.032 173.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -122.17 163.44 19.54 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.389 0.676 . . . . 73.310000000000002 110.094 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -93.93 128.89 40.49 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.146 0.578 . . . . 74.310000000000002 110.554 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.6 mt -137.65 -45.56 0.54 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.579 1.152 . . . . 72.140000000000001 108.888 173.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 78.4 mt -74.24 104.42 5.01 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 114.933 -1.031 . . . . 65.319999999999993 109.48 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.62 81.63 2.05 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.354 1.062 . . . . 71.040000000000006 110.794 -172.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.04 66.42 0.26 Allowed Glycine 0 CA--C 1.534 1.246 0 CA-C-O 119.523 -0.598 . . . . 53.530000000000001 112.9 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.85 160.92 36.92 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.55 2.166 . . . . 55.0 112.435 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 62.1 m -72.82 125.7 28.17 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.415 0.686 . . . . 73.329999999999998 111.305 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.731 ' HG3' HD23 ' A' ' 84' ' ' LEU . 1.1 tm-20 -102.13 145.45 29.34 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.429 0.692 . . . . 72.140000000000001 109.682 176.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -164.92 30.13 0.06 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 107.327 -1.36 . . . . 74.450000000000003 107.327 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -147.96 142.89 17.02 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-N 115.47 -0.786 . . . . 60.119999999999997 111.057 -164.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.69 -12.88 12.15 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.157 2.572 . . . . 72.019999999999996 112.817 173.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -88.61 38.14 0.86 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.464 1.105 . . . . 75.430000000000007 110.738 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.731 HD23 ' HG3' ' A' ' 79' ' ' GLU . 20.8 tp -89.53 113.63 25.06 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-N 115.378 -0.828 . . . . 75.120000000000005 110.184 -173.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 3.0 m-85 -103.83 176.56 5.11 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.877 1.271 . . . . 72.099999999999994 108.78 174.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.1 p -141.58 148.46 20.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 108.624 -0.88 . . . . 70.129999999999995 108.624 170.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.88 127.96 33.14 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.162 0.585 . . . . 74.439999999999998 109.55 173.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.25 -22.78 24.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.45 1.1 . . . . 71.040000000000006 111.067 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -136.79 160.25 39.41 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.377 0.671 . . . . 75.010000000000005 109.924 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -81.53 123.09 28.34 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.415 -0.957 . . . . 72.439999999999998 108.415 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.433 ' HB3' HG12 ' A' ' 101' ' ' ILE . 91.8 t80 -125.8 116.68 21.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.417 -0.957 . . . . 72.430000000000007 108.417 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.6 p -80.67 139.03 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.072 0.549 . . . . 74.239999999999995 110.211 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.06 132.27 42.15 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.934 0.494 . . . . 73.519999999999996 110.917 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 t -74.36 -27.53 60.71 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.377 0.671 . . . . 65.420000000000002 109.737 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.48 -144.51 7.25 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.516 -0.634 . . . . 73.150000000000006 111.516 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.465 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 31.2 t70 -71.24 -24.23 62.15 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.692 0.797 . . . . 72.530000000000001 110.952 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.455 ' HB2' HD12 ' A' ' 23' ' ' ILE . 27.4 p-10 -67.93 -22.61 65.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.04 0.936 . . . . 75.409999999999997 111.238 -177.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.5 p -129.87 158.54 39.21 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.298 1.039 . . . . 62.229999999999997 110.226 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.2 tp -110.08 136.46 49.29 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.131 -0.692 . . . . 74.129999999999995 109.131 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.4 t -81.73 112.9 19.32 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 107.503 -1.295 . . . . 74.420000000000002 107.503 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.433 HG12 ' HB3' ' A' ' 91' ' ' PHE . 37.1 pt -119.95 157.8 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.569 0.748 . . . . 75.109999999999999 109.452 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.5 m -131.32 143.84 50.82 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.545 -0.539 . . . . 74.239999999999995 109.545 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -52.07 123.84 11.47 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.778 0.831 . . . . 73.310000000000002 111.533 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.92 -22.69 34.5 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.054 -0.521 . . . . 74.129999999999995 112.935 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -76.9 132.33 39.05 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 117.119 0.46 . . . . 52.240000000000002 110.26 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.563 ' HD2' HD21 ' A' ' 84' ' ' LEU . 41.2 mtmt -82.25 127.9 33.65 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 124.11 0.881 . . . . 74.420000000000002 109.661 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.9 mt -108.21 130.98 55.12 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.829 0.852 . . . . 74.400000000000006 109.241 -171.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -91.82 106.23 18.31 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.777 -0.823 . . . . 72.25 108.777 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 89.7 t -96.89 117.03 40.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.871 -0.789 . . . . 75.209999999999994 108.871 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.4 mt -71.38 -27.46 63.35 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.328 0.651 . . . . 75.340000000000003 110.418 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.79 175.61 34.87 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.482 -0.781 . . . . 72.219999999999999 111.792 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 2.1 m-30 -95.2 171.17 8.89 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.006 -1.109 . . . . 74.010000000000005 108.006 173.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.497 HD22 ' HB2' ' A' ' 117' ' ' GLU . 32.0 p30 -76.05 178.58 6.22 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.923 -0.399 . . . . 73.430000000000007 109.923 172.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -65.03 -16.65 63.69 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.331 0.493 . . . . 72.230000000000004 112.331 -172.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' A' ' 3' ' ' GLN . 63.1 t30 -109.7 -8.27 14.97 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-O 120.859 0.361 . . . . 72.129999999999995 111.564 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.558 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 74.18 21.92 78.4 Favored Glycine 0 N--CA 1.469 0.838 0 N-CA-C 114.185 0.434 . . . . 73.019999999999996 114.185 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.497 ' HB2' HD22 ' A' ' 113' ' ' ASN . 25.5 mt-10 -74.67 -55.52 5.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.993 0.902 . . . . 71.420000000000002 110.118 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -118.72 133.01 56.16 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 113.998 -1.455 . . . . 73.420000000000002 108.513 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -110.97 127.52 55.53 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.917 1.287 . . . . 72.430000000000007 110.401 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -77.58 106.43 9.37 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.033 0.444 . . . . 74.310000000000002 110.325 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.48 163.48 12.83 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.336 -0.847 . . . . 74.019999999999996 110.61 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -142.78 131.53 22.7 Favored 'General case' 0 C--O 1.249 1.051 0 C-N-CA 124.24 1.016 . . . . 73.349999999999994 108.581 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 81.4 p -143.66 -167.86 2.69 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.697 1.199 . . . . 74.049999999999997 109.463 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -57.93 -18.79 25.49 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.671 1.188 . . . . 73.439999999999998 112.028 173.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -89.62 -6.51 56.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.598 1.159 . . . . 65.439999999999998 111.692 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.38 -141.85 16.86 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 111.392 -0.683 . . . . 64.209999999999994 111.392 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -142.77 138.92 30.79 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.421 0.688 . . . . 73.310000000000002 110.63 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 176.32 -177.02 47.91 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 111.622 -0.591 . . . . 61.420000000000002 111.622 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.677 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 33.9 m95 -100.4 136.91 39.55 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.349 0.66 . . . . 64.230000000000004 110.816 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.23 149.85 74.83 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.331 1.053 . . . . 73.439999999999998 109.27 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.95 137.02 33.94 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 121.74 1.627 . . . . 75.5 110.94 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.449 ' HA ' HG12 ' A' ' 135' ' ' ILE . 26.3 m -61.4 -17.1 52.55 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.729 0.812 . . . . 55.200000000000003 112.64 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -71.1 -26.75 63.17 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.024 0.93 . . . . 64.109999999999999 111.175 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -98.94 3.94 47.22 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.923 0.889 . . . . 73.099999999999994 111.658 -173.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' A' ' 132' ' ' SER . 16.2 pt -130.63 157.62 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.779 0.432 . . . . 74.340000000000003 110.047 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 14.2 t -155.76 135.07 7.88 Favored Pre-proline 0 CA--C 1.555 1.159 0 O-C-N 123.349 0.406 . . . . 74.439999999999998 110.005 172.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 3.0 Cg_exo -74.94 117.03 4.77 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.955 2.437 . . . . 64.219999999999999 111.953 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.2 m -91.89 -34.37 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 122.988 0.515 . . . . 71.299999999999997 112.137 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -99.84 16.75 22.72 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.641 0.734 . . . . 70.219999999999999 110.077 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.1 t -92.74 -176.8 4.35 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.736 0.779 . . . . 72.349999999999994 110.649 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 51.7 mt -64.91 -12.59 50.96 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.441 1.496 . . . . 72.329999999999998 112.151 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -55.86 -23.36 30.45 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.65 1.18 . . . . 72.310000000000002 112.524 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -58.58 -19.66 40.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.538 0.735 . . . . 74.319999999999993 111.368 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -95.74 131.99 41.43 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.254 1.022 . . . . 73.349999999999994 108.332 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.2 m -70.8 -6.9 41.28 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.081 0.771 . . . . 74.349999999999994 113.081 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 33.4 p-90 -81.05 -27.6 35.69 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.258 0.223 . . . . 73.219999999999999 111.498 173.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -94.91 120.49 35.21 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.126 -0.694 . . . . 73.150000000000006 109.126 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -112.81 6.88 18.24 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 116.346 -0.388 . . . . 72.329999999999998 111.368 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.73 -150.8 48.52 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 119.032 -0.871 . . . . 74.219999999999999 113.461 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.55 104.28 0.92 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.279 2.652 . . . . 73.129999999999995 111.6 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.4 t -124.32 140.1 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 120.761 0.315 . . . . 72.25 110.838 -173.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.0 t -71.1 160.14 33.42 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.875 0.87 . . . . 74.400000000000006 111.088 172.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -62.91 -36.89 84.85 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.66 -0.7 . . . . 74.209999999999994 110.874 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -66.51 -51.62 54.7 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 123.714 0.634 . . . . 73.549999999999997 109.991 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.33 -42.27 81.57 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 124.002 0.814 . . . . 74.140000000000001 110.734 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.9 -59.63 4.77 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.694 -1.139 . . . . 73.310000000000002 111.257 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -67.11 -29.26 68.95 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 116.065 -0.516 . . . . 73.549999999999997 111.317 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -61.82 -53.78 51.25 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.453 0.701 . . . . 62.149999999999999 110.113 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.474 ' HB2' HD12 ' A' ' 169' ' ' LEU . 77.8 mt -67.35 -38.05 84.23 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.044 -0.526 . . . . 75.049999999999997 110.848 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.483 HD23 HG12 ' A' ' 190' ' ' VAL . 25.4 tp -71.22 -30.65 66.61 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.359 -0.837 . . . . 75.019999999999996 112.184 -172.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.4 m -68.35 -16.72 64.04 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.368 0.667 . . . . 72.340000000000003 111.963 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.3 m -82.23 3.86 25.78 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.703 0.801 . . . . 75.340000000000003 111.027 172.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -101.82 -178.89 28.04 Favored Glycine 0 C--N 1.344 0.978 0 C-N-CA 123.244 0.449 . . . . 73.439999999999998 113.228 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.4 pt -132.05 -163.89 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.508 1.123 . . . . 74.109999999999999 108.884 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.643 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 26.8 p-10 -50.75 112.09 0.65 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.452 0.701 . . . . 73.010000000000005 112.424 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 92.76 14.26 55.43 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.749 -0.659 . . . . 42.340000000000003 113.36 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 60.8 p -77.95 135.52 37.85 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.993 -0.743 . . . . 71.239999999999995 108.993 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' A' ' 183' ' ' SER . 21.3 p90 -136.62 162.2 33.79 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.019 0.748 . . . . 62.439999999999998 113.019 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.474 HD12 ' HB2' ' A' ' 159' ' ' LEU . 84.3 mt -137.78 133.99 34.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.179 0.991 . . . . 72.209999999999994 108.582 169.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.93 118.27 56.13 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 107.698 -1.223 . . . . 72.530000000000001 107.698 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -128.99 165.6 20.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.899 -1.046 . . . . 72.5 108.988 -171.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 17.0 pt-20 -117.06 161.89 18.68 Favored 'General case' 0 C--O 1.261 1.674 0 N-CA-C 108.214 -1.032 . . . . 73.329999999999998 108.214 161.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.8 t -77.68 144.61 37.19 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.415 0.686 . . . . 72.140000000000001 110.263 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.413 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 29.3 mt-10 -71.03 -44.0 66.73 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.609 -1.178 . . . . 72.25 109.701 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 18.8 m -91.46 3.14 55.68 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.23 -0.896 . . . . 54.420000000000002 111.702 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.4 t -155.89 77.86 4.5 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 109.256 -0.646 . . . . 71.040000000000006 109.256 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.485 ' HG2' ' HB2' ' A' ' 112' ' ' TYR . 36.1 Cg_exo -62.18 138.16 70.6 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.173 2.582 . . . . 73.409999999999997 112.559 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.07 -24.34 27.19 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.808 -0.633 . . . . 65.129999999999995 112.335 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -88.9 118.58 28.71 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.428 -1.323 . . . . 74.540000000000006 107.428 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 82.0 mtt85 -115.7 165.4 13.09 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 123.067 0.547 . . . . 74.420000000000002 112.298 -165.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 40.3 t -151.91 136.98 17.34 Favored 'General case' 0 C--O 1.247 0.972 0 C-N-CA 124.478 1.111 . . . . 50.009999999999998 109.437 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 58.1 mt -105.43 141.92 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 109.016 -0.735 . . . . 71.239999999999995 109.016 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 12.9 m -117.94 115.73 25.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.575 1.15 . . . . 61.229999999999997 108.508 -177.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.413 HD23 ' CD2' ' A' ' 232' ' ' LEU . 58.6 mt -105.31 143.96 32.75 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.909 0.883 . . . . 73.030000000000001 111.219 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 46.3 ttt-85 -133.64 131.12 39.19 Favored 'General case' 0 C--O 1.26 1.621 0 CA-C-N 114.818 -1.083 . . . . 74.129999999999995 109.564 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.643 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 9.2 p90 -152.44 139.7 19.4 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 124.503 1.127 . . . . 75.140000000000001 108.733 173.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 56.73 24.86 9.5 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 124.766 1.226 . . . . 71.239999999999995 112.937 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.85 8.04 80.16 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 116.651 -0.249 . . . . 71.319999999999993 112.973 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 26.5 tpt180 -102.35 123.35 45.98 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.394 1.078 . . . . 71.439999999999998 109.359 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.483 HG12 HD23 ' A' ' 160' ' ' LEU . 77.1 t -110.76 128.49 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.723 1.209 . . . . 74.030000000000001 109.149 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.479 ' HH ' HG22 ' A' ' 230' ' ' THR . 31.2 p90 -145.43 158.28 43.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.46 0.704 . . . . 72.540000000000006 109.135 173.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -130.9 141.53 50.3 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.509 -1.293 . . . . 73.230000000000004 107.509 -173.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -138.45 149.43 45.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.691 0.396 . . . . 74.209999999999994 110.002 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 13.3 tpp85 -84.38 137.2 33.53 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.262 -0.881 . . . . 75.519999999999996 111.088 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 65.0 mt -83.07 110.09 17.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 N-CA-C 108.321 -0.992 . . . . 72.510000000000005 108.321 166.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -68.04 119.43 12.65 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.341 1.056 . . . . 71.219999999999999 109.117 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.1 m -102.89 116.68 33.03 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.685 0.394 . . . . 73.319999999999993 109.971 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.16 167.08 12.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.462 1.105 . . . . 64.120000000000005 111.986 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.2 m -61.71 -30.15 70.57 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.685 0.794 . . . . 74.409999999999997 110.883 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.402 ' HB2' ' HG3' ' A' ' 202' ' ' LYS . 29.0 m-20 -70.76 -12.66 61.68 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.705 1.202 . . . . 71.540000000000006 111.783 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 87.77 2.73 81.24 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 111.818 -0.513 . . . . 53.340000000000003 111.818 -169.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.402 ' HG3' ' HB2' ' A' ' 200' ' ' ASP . 64.6 mttp -68.27 159.38 31.39 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 123.073 0.549 . . . . 73.310000000000002 110.111 175.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 79.6 mt -121.38 145.61 47.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.447 -0.945 . . . . 71.200000000000003 108.447 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -165.87 174.83 9.18 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.628 0.771 . . . . 74.030000000000001 110.018 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 78.2 t -138.47 -53.84 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 107.715 -1.217 . . . . 75.439999999999998 107.715 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 17.3 m -73.19 148.75 43.48 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.414 -0.812 . . . . 71.409999999999997 110.026 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.3 m -61.22 -42.2 98.19 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.239 1.016 . . . . 63.109999999999999 112.312 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -84.52 -36.52 22.14 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 122.742 0.417 . . . . 71.040000000000006 111.333 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.9 m -67.65 138.68 56.55 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.659 0.784 . . . . 75.019999999999996 111.665 -177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -142.37 119.85 11.68 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.555 1.142 . . . . 73.200000000000003 109.067 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -117.94 136.61 53.38 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 109.634 -0.506 . . . . 73.019999999999996 109.634 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -84.29 -26.25 28.71 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.347 0.659 . . . . 65.349999999999994 109.943 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 81.8 p -130.47 147.64 52.19 Favored 'General case' 0 C--O 1.256 1.411 0 CA-C-O 121.694 0.759 . . . . 73.239999999999995 111.115 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 35.2 tp -67.65 -29.27 68.53 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 114.529 -1.214 . . . . 73.349999999999994 111.08 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.74 92.02 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.609 0.363 . . . . 75.150000000000006 110.836 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -75.19 -32.38 61.22 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 116.522 -0.308 . . . . 75.019999999999996 110.763 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.53 -47.17 85.07 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 110.16 -0.311 . . . . 73.319999999999993 110.16 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 43.0 t -69.42 -44.65 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.061 0.945 . . . . 71.219999999999999 110.359 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -61.78 -45.43 93.92 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.249 0.547 . . . . 74.310000000000002 110.869 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.435 ' O ' HG21 ' A' ' 224' ' ' VAL . 49.7 t-80 -53.03 -54.48 34.77 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.843 -1.072 . . . . 74.430000000000007 108.727 175.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -61.99 -26.08 68.01 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.544 -0.753 . . . . 74.430000000000007 112.426 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 50.5 m -72.44 -30.15 64.34 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.8 0.44 . . . . 74.109999999999999 111.188 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -108.74 -17.04 14.04 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 115.578 1.696 . . . . 64.409999999999997 115.578 -176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 220' ' ' HIS . 30.8 m -98.38 148.02 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 115.936 1.828 . . . . 73.349999999999994 115.936 -165.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -83.51 -2.44 55.95 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 129.337 3.055 . . . . 71.400000000000006 112.635 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -79.11 13.41 1.82 Allowed 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 129.252 3.021 . . . . 72.150000000000006 113.331 -138.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.76 16.19 4.18 Favored Glycine 0 N--CA 1.466 0.687 0 N-CA-C 110.091 -1.204 . . . . 74.140000000000001 110.091 -169.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 69.1 mt -90.72 135.05 33.97 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.83 0.852 . . . . 73.099999999999994 109.766 163.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.431 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 84.2 mt -67.66 -44.38 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.868 -0.79 . . . . 74.049999999999997 108.868 172.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.479 HG22 ' HH ' ' A' ' 191' ' ' TYR . 11.3 t -137.7 142.86 41.04 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.327 -0.851 . . . . 72.530000000000001 109.491 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 73.5 p -74.77 157.55 35.0 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.24 0.616 . . . . 62.420000000000002 109.565 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.428 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . 23.5 mt -70.85 101.74 2.2 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 109.567 -0.531 . . . . 74.400000000000006 109.567 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -79.0 -49.7 12.29 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.46 0.704 . . . . 75.040000000000006 110.224 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 167' ' ' SER . 4.3 p90 -164.76 152.72 10.45 Favored Pre-proline 0 N--CA 1.494 1.741 0 CA-C-O 119.61 -0.233 . . . . 74.299999999999997 110.511 173.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.18 146.63 32.25 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 121.936 1.757 . . . . 74.540000000000006 112.505 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -76.25 144.91 75.66 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.242 0.617 . . . . 72.400000000000006 109.409 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -84.7 170.34 10.2 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.548 2.165 . . . . 71.430000000000007 113.733 -171.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.466 ' HZ1' ' HB3' ' A' ' 238' ' ' LYS . 8.1 mtpm? -86.02 162.86 18.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.254 1.022 . . . . 72.129999999999995 109.204 169.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 38.6 ttm105 -52.53 -30.22 29.39 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.69 0.757 . . . . 75.519999999999996 111.075 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -62.62 179.25 0.36 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 114.805 -1.089 . . . . 74.019999999999996 110.361 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -103.67 94.68 6.43 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.979 -0.748 . . . . 74.030000000000001 108.979 172.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.31 157.45 22.73 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.193 1.929 . . . . 63.310000000000002 111.327 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 5.1 t -124.43 107.34 11.0 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.204 -0.665 . . . . 74.430000000000007 109.204 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 11.2 m -134.46 142.73 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.142 0.977 . . . . 61.310000000000002 109.239 175.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -154.81 139.55 17.09 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.354 -0.98 . . . . 73.5 108.354 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 118.99 127.66 3.68 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 110.933 -0.867 . . . . 75.540000000000006 110.933 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.6 139.91 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.013 -1.106 . . . . 73.140000000000001 108.013 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 46.3 m -131.16 83.8 59.18 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.517 0.727 . . . . 75.129999999999995 109.607 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.16 130.76 7.42 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.825 2.35 . . . . 55.140000000000001 111.214 174.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -80.86 135.44 35.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.122 0.569 . . . . 74.400000000000006 110.218 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -142.49 100.88 3.78 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.112 0.965 . . . . 74.349999999999994 109.644 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -161.69 161.49 29.46 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.958 -0.756 . . . . 74.109999999999999 108.958 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.67 -35.18 78.37 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.919 0.487 . . . . 75.099999999999994 110.663 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -144.15 159.02 43.36 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.884 0.873 . . . . 73.219999999999999 109.887 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 CA--C 1.553 1.083 0 C-N-CA 124.05 0.94 . . . . 75.230000000000004 109.725 -179.12 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 tmm? . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 108.794 -0.817 . . . . 72.349999999999994 108.794 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.41 123.02 0.63 Allowed Glycine 0 C--N 1.338 0.668 0 N-CA-C 111.271 -0.731 . . . . 65.219999999999999 111.271 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -62.04 -56.3 20.35 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.213 0.506 . . . . 71.299999999999997 109.686 174.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 34.46 55.12 1.78 Allowed Pre-proline 0 CA--C 1.57 1.724 0 C-N-CA 126.563 1.945 . . . . 73.530000000000001 115.211 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.51 -33.32 3.25 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 121.842 1.695 . . . . 60.310000000000002 112.427 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.93 -84.8 0.07 OUTLIER Glycine 0 C--N 1.351 1.368 0 O-C-N 123.435 0.459 . . . . 73.230000000000004 113.608 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -159.56 27.51 0.19 Allowed 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.678 0.791 . . . . 74.239999999999995 110.193 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.808 ' HA ' ' HB2' ' A' ' 16' ' ' SER . 27.9 m -61.28 -31.33 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 122.449 0.3 . . . . 73.150000000000006 111.448 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.2 tp -108.07 137.43 46.08 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.996 0.918 . . . . 73.329999999999998 109.184 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.11 -176.15 43.16 Favored Glycine 0 C--O 1.24 0.512 0 N-CA-C 111.077 -0.809 . . . . 73.040000000000006 111.077 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -75.99 -15.35 60.16 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.037 0.535 . . . . 73.219999999999999 111.062 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -57.75 129.21 40.86 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.094 0.958 . . . . 65.540000000000006 111.94 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 137.73 58.34 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.962 -0.755 . . . . 72.319999999999993 108.962 172.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 54.85 69.59 1.99 Allowed Pre-proline 0 CA--C 1.555 1.151 0 O-C-N 123.859 0.725 . . . . 73.120000000000005 109.918 -168.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.5 160.72 22.93 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.674 2.249 . . . . 75.530000000000001 110.909 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.808 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 14.5 m -68.76 166.59 17.17 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 121.201 0.524 . . . . 75.140000000000001 111.936 -168.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.4 mt -102.66 127.22 30.73 Favored Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 108.764 -0.828 . . . . 54.340000000000003 108.764 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.13 171.16 17.35 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.187 1.925 . . . . 71.400000000000006 111.31 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.68 146.87 27.99 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 122.409 0.283 . . . . 73.329999999999998 110.642 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.512 ' HB3' HD13 ' A' ' 23' ' ' ILE . 70.5 mt -85.54 92.51 8.55 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 107.89 -1.152 . . . . 74.209999999999994 107.89 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -97.71 -48.42 5.23 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.725 -0.472 . . . . 75.340000000000003 109.725 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -101.56 114.18 27.97 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.354 -0.839 . . . . 71.310000000000002 109.451 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' A' ' 20' ' ' LEU . 41.8 mm -117.65 113.62 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.588 -0.893 . . . . 75.010000000000005 108.588 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.554 ' HB3' ' HZ2' ' A' ' 129' ' ' TRP . 49.0 tttm -100.24 120.37 39.81 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 114.881 -1.054 . . . . 75.439999999999998 109.453 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.91 118.18 6.84 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.648 0.592 . . . . 75.209999999999994 112.139 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.543 ' HB3' ' HD2' ' A' ' 29' ' ' ARG . . . -77.45 -43.83 31.05 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.153 0.581 . . . . 73.409999999999997 112.001 -175.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.01 -99.15 0.29 Allowed Glycine 0 C--N 1.347 1.171 0 O-C-N 123.491 0.495 . . . . 72.420000000000002 112.25 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -121.57 155.63 34.63 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.276 -1.009 . . . . 74.349999999999994 108.276 169.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.543 ' HD2' ' HB3' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -128.0 156.95 41.9 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.558 0.343 . . . . 75.019999999999996 111.146 -172.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -91.74 10.78 26.97 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.16 0.584 . . . . 72.219999999999999 110.893 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 m -63.13 109.32 1.48 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.086 0.555 . . . . 75.530000000000001 109.591 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.4 p -57.38 118.11 4.81 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.288 1.035 . . . . 70.209999999999994 111.941 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -112.33 169.29 8.97 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.316 0.646 . . . . 75.319999999999993 110.83 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -154.79 168.71 25.96 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.45 -0.796 . . . . 72.420000000000002 110.01 173.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.37 168.65 54.6 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 123.737 0.648 . . . . 71.219999999999999 112.911 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.57 -169.13 37.58 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-O 118.836 -0.98 . . . . 70.310000000000002 112.568 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -42.67 131.09 5.44 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 124.524 3.483 . . . . 42.109999999999999 114.709 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -56.43 106.13 0.26 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.193 0.997 . . . . 72.200000000000003 111.811 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.2 t -83.38 143.97 29.96 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.082 -1.081 . . . . 74.129999999999995 108.082 166.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -76.2 76.56 3.01 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.406 0.622 . . . . 65.530000000000001 110.407 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.39 145.47 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.134 -0.939 . . . . 73.420000000000002 108.911 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.48 138.03 31.88 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 109.625 -0.509 . . . . 73.040000000000006 109.625 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.458 HG22 ' H ' ' A' ' 46' ' ' GLU . 4.2 p -70.73 111.21 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 123.255 0.622 . . . . 71.540000000000006 110.58 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -80.53 -34.16 35.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.473 0.709 . . . . 74.319999999999993 110.777 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -68.08 -22.67 64.91 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.84 0.456 . . . . 75.299999999999997 111.484 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.458 ' H ' HG22 ' A' ' 43' ' ' VAL . 10.6 tp10 -72.94 125.11 26.83 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 109.275 -0.639 . . . . 71.310000000000002 109.275 173.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.41 -97.2 0.08 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.72 -0.844 . . . . 71.299999999999997 108.72 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.0 mt 46.78 -78.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 125.927 1.691 . . . . 63.039999999999999 113.453 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -55.72 -39.54 71.22 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 125.058 1.343 . . . . 73.219999999999999 111.546 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 58.95 87.22 0.14 Allowed Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 124.244 1.018 . . . . 74.420000000000002 109.824 -171.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -63.08 89.07 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.642 2.228 . . . . 71.409999999999997 111.466 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.9 t -83.43 74.32 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.784 0 N-CA-C 108.303 -0.999 . . . . 74.129999999999995 108.303 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.52 115.43 16.26 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.921 -1.036 . . . . 63.350000000000001 108.785 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.0 p -67.53 92.07 0.3 Allowed 'General case' 0 CA--C 1.547 0.85 0 O-C-N 123.892 0.745 . . . . 55.130000000000003 109.809 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.33 96.06 1.81 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-N 114.705 -1.134 . . . . 73.510000000000005 110.631 -173.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -120.71 103.47 9.14 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.751 -0.659 . . . . 74.420000000000002 109.629 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 61.6 75.84 0.42 Allowed Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.592 1.157 . . . . 73.349999999999994 112.267 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.23 95.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.384 2.723 . . . . 64.129999999999995 113.157 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -118.79 107.99 14.31 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.49 1.116 . . . . 71.129999999999995 108.78 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.97 171.02 33.81 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.38 -0.688 . . . . 64.329999999999998 111.38 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 74.6 mt -99.13 135.66 40.21 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.131 0.572 . . . . 72.299999999999997 110.153 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.2 m -78.24 79.42 4.68 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.413 0.625 . . . . 63.100000000000001 109.441 171.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -76.39 136.1 39.48 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.757 -1.11 . . . . 75.400000000000006 111.028 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.8 82.6 7.78 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.488 0.715 . . . . 72.420000000000002 110.184 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.93 104.82 3.07 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.918 -0.583 . . . . 63.229999999999997 109.456 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -82.5 50.25 1.61 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.271 1.028 . . . . 74.349999999999994 111.3 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -110.62 100.71 9.45 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.025 0.93 . . . . 73.319999999999993 109.938 -176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -124.46 93.2 3.84 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.337 -1.357 . . . . 71.519999999999996 107.337 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.3 t -90.71 108.67 19.97 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.827 0.451 . . . . 54.240000000000002 109.915 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.77 -18.28 64.18 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.156 0.583 . . . . 74.530000000000001 112.104 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -89.1 56.72 3.79 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.8 0.84 . . . . 74.140000000000001 110.949 -171.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -167.44 153.69 7.91 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.463 0.705 . . . . 65.310000000000002 109.443 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.1 mt -122.16 82.41 1.96 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.111 0.564 . . . . 64.540000000000006 110.287 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.3 mt -96.84 -73.96 0.58 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 109.615 -0.513 . . . . 72.209999999999994 109.615 169.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.16 123.02 11.29 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.05 0.54 . . . . 71.120000000000005 109.686 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -118.97 167.54 13.17 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-O 119.37 -0.683 . . . . 63.539999999999999 112.446 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HA ' ' HD2' ' A' ' 124' ' ' LYS . 39.1 Cg_exo -62.09 95.98 0.14 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 123.588 2.859 . . . . 71.019999999999996 111.786 176.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.7 m -77.5 98.28 5.29 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.372 -0.831 . . . . 75.219999999999999 110.511 -174.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -96.61 108.6 21.22 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.408 1.083 . . . . 74.329999999999998 110.408 -175.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -173.26 165.7 4.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 123.642 0.589 . . . . 74.510000000000005 110.892 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 79.85 137.36 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 126.245 1.818 . . . . 75.340000000000003 112.649 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -70.43 -7.89 22.31 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.311 2.674 . . . . 74.450000000000003 111.786 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -82.36 27.01 0.52 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.415 1.086 . . . . 72.230000000000004 111.182 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 28.3 tp -86.09 116.24 24.18 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.391 0.676 . . . . 72.120000000000005 109.702 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 3.6 m-85 -104.62 177.18 4.92 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.816 1.646 . . . . 73.450000000000003 109.202 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.8 p -140.82 142.85 29.59 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 108.277 -1.008 . . . . 74.219999999999999 108.277 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.99 116.62 16.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.997 0.519 . . . . 74.239999999999995 109.825 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.52 -24.11 50.08 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.859 0.864 . . . . 73.450000000000003 110.689 172.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -130.83 158.75 39.33 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.983 0.513 . . . . 71.209999999999994 110.17 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.02 151.64 37.11 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.911 -0.586 . . . . 72.209999999999994 109.459 172.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.515 ' HB3' HG12 ' A' ' 101' ' ' ILE . 81.1 t80 -155.8 116.58 3.82 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.298 -0.63 . . . . 74.230000000000004 109.298 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.56 138.78 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 108.988 -0.745 . . . . 73.239999999999995 108.988 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.53 129.51 37.36 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 122.178 -0.326 . . . . 63.020000000000003 110.862 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 m -66.07 -23.95 66.62 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.385 0.674 . . . . 75.319999999999993 110.607 173.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.96 -153.33 12.93 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.42 -0.809 . . . . 73.549999999999997 111.261 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.6 -26.14 60.66 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.219 0.608 . . . . 74.510000000000005 110.58 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -69.73 -21.68 63.44 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.756 0.822 . . . . 71.450000000000003 112.014 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.0 p -117.02 155.0 29.94 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.407 1.083 . . . . 72.040000000000006 109.036 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.2 tp -108.93 123.93 49.86 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.242 -0.651 . . . . 74.310000000000002 109.242 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 p -69.46 115.38 8.66 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.653 -0.869 . . . . 75.25 108.653 171.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.515 HG12 ' HB3' ' A' ' 91' ' ' PHE . 34.5 pt -119.59 143.68 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.271 -0.64 . . . . 74.510000000000005 109.271 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 m -112.38 144.73 41.33 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.977 -0.749 . . . . 72.140000000000001 108.977 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -56.07 119.65 6.23 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.668 0.387 . . . . 74.409999999999997 110.148 173.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.13 -17.29 44.63 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.301 -0.409 . . . . 73.209999999999994 113.219 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -78.8 129.51 34.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.143 0.577 . . . . 71.530000000000001 110.226 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.413 ' HD2' HD23 ' A' ' 84' ' ' LEU . 48.0 mtmt -87.48 130.14 34.81 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.024 0.529 . . . . 71.319999999999993 110.566 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.465 ' HB3' ' HB1' ' A' ' 121' ' ' ALA . 18.8 mt -107.3 148.1 29.43 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.232 1.013 . . . . 74.409999999999997 108.937 -172.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -111.04 107.92 17.47 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.386 -0.968 . . . . 73.549999999999997 108.386 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.2 t -99.78 123.44 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.243 0.617 . . . . 65.319999999999993 110.078 -171.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.426 HD13 ' HD3' ' A' ' 29' ' ' ARG . 91.5 mt -94.86 -4.45 47.0 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.506 0.722 . . . . 74.230000000000004 111.457 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.48 165.33 18.11 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 112.5 -0.24 . . . . 63.009999999999998 112.5 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 2.4 m-85 -97.06 174.53 6.71 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.665 0.786 . . . . 63.329999999999998 109.993 172.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -72.5 150.33 43.34 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.131 -0.94 . . . . 73.120000000000005 108.687 171.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -63.0 -27.17 69.24 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.237 0.458 . . . . 74.439999999999998 112.237 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.416 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 64.0 t30 -92.22 -10.96 36.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.041 0.536 . . . . 73.230000000000004 110.689 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 81.61 22.32 60.3 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 116.199 -0.455 . . . . 73.019999999999996 113.419 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' A' ' 115' ' ' ASN . 78.8 mt-10 -67.42 -62.38 1.45 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.836 0.854 . . . . 73.409999999999997 110.332 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -120.17 -179.12 3.84 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.928 -1.033 . . . . 70.209999999999994 109.781 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -144.36 123.45 12.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.574 0.75 . . . . 61.43 109.703 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -70.94 95.04 1.12 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.499 0.72 . . . . 74.299999999999997 110.693 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 107' ' ' LEU . . . -105.45 145.21 31.16 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.444 0.698 . . . . 70.299999999999997 110.263 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.9 130.77 45.58 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.397 0.679 . . . . 65.030000000000001 110.195 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.9 p -133.93 -173.49 3.27 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.12 0.968 . . . . 73.439999999999998 109.643 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.401 ' HD2' ' HA ' ' A' ' 77' ' ' PRO . 25.9 mtpp -61.94 -21.53 64.85 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.21 0.604 . . . . 70.299999999999997 111.339 174.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -76.07 -5.86 48.47 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.158 0.983 . . . . 73.040000000000006 111.836 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 116.41 -135.65 12.23 Favored Glycine 0 C--N 1.342 0.903 0 N-CA-C 110.316 -1.114 . . . . 61.200000000000003 110.316 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -151.13 156.63 41.39 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.541 0.67 . . . . 73.349999999999994 111.493 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 174.32 176.47 42.73 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.726 -0.67 . . . . 54.329999999999998 112.727 170.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.554 ' HZ2' ' HB3' ' A' ' 24' ' ' LYS . 86.9 m95 -84.54 118.7 24.49 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.495 -0.853 . . . . 74.549999999999997 110.037 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.91 153.93 47.01 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.742 1.217 . . . . 73.319999999999993 109.265 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -69.93 131.14 20.39 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 121.529 1.486 . . . . 73.430000000000007 111.059 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 27.4 p -59.63 -25.48 64.71 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.832 0.853 . . . . 75.120000000000005 111.828 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -74.91 -17.81 60.51 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.544 1.138 . . . . 74.340000000000003 112.094 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -95.34 -4.68 44.98 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.694 0.798 . . . . 65.430000000000007 112.386 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.7 pt -128.33 156.93 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.51 0.324 . . . . 72.109999999999999 110.721 -170.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.3 t -148.81 134.28 9.54 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 122.792 0.437 . . . . 62.509999999999998 109.957 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 74.3 Cg_endo -75.59 123.1 7.32 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.457 2.105 . . . . 64.209999999999994 112.918 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.9 m -98.3 -40.38 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.283 0.633 . . . . 73.400000000000006 111.825 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.0 t30 -99.01 5.39 47.15 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.104 0.562 . . . . 75.299999999999997 111.832 -172.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.8 p -83.9 -166.29 1.37 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.981 0.513 . . . . 65.5 110.655 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 214' ' ' LEU . 71.7 mt -77.38 -12.16 59.92 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.804 0.841 . . . . 75.010000000000005 111.998 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.21 -21.12 66.45 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.497 0.719 . . . . 64.25 111.56 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.461 ' HB2' ' HZ2' ' A' ' 143' ' ' LYS . 0.1 OUTLIER -57.68 -29.4 64.62 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.994 0.918 . . . . 71.409999999999997 110.604 174.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -79.57 137.71 37.24 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.66 0.784 . . . . 73.310000000000002 109.633 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.0 m -63.39 -17.96 63.19 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.59 0.756 . . . . 71.430000000000007 112.778 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 51.9 p-90 -77.42 -35.55 54.04 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.324 0.49 . . . . 64.129999999999995 112.324 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -97.64 130.1 44.68 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.531 -0.544 . . . . 71.340000000000003 109.531 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -122.64 19.92 10.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.789 0.436 . . . . 75.040000000000006 111.574 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.5 -155.32 49.94 Favored Glycine 0 CA--C 1.536 1.366 0 N-CA-C 114.839 0.696 . . . . 72.349999999999994 114.839 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.26 99.06 1.24 Allowed 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 123.587 2.858 . . . . 73.430000000000007 112.049 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.5 t -142.7 145.92 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.188 0.995 . . . . 71.5 109.298 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.9 m -82.64 169.28 16.43 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.843 0.683 . . . . 72.010000000000005 112.843 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -53.71 -37.99 63.84 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 124.014 0.926 . . . . 72.299999999999997 112.488 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -56.04 -50.17 71.67 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.858 0.463 . . . . 73.219999999999999 111.746 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.89 -30.23 40.09 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 123.478 0.711 . . . . 64.329999999999998 110.465 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.703 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -59.57 -48.22 82.5 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.915 -0.584 . . . . 75.049999999999997 111.212 172.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.508 ' HG3' HG13 ' A' ' 190' ' ' VAL . 28.5 tt0 -78.85 -25.95 44.04 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.618 0.767 . . . . 73.230000000000004 109.574 -176.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.71 -52.78 63.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.665 0.786 . . . . 73.030000000000001 111.645 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.435 ' HB2' HD11 ' A' ' 169' ' ' LEU . 48.5 mt -72.22 -34.57 68.44 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 120.728 0.299 . . . . 75.510000000000005 111.042 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.427 HD21 ' HB3' ' A' ' 183' ' ' SER . 33.2 tp -66.72 -26.72 67.14 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.145 0.578 . . . . 73.329999999999998 111.898 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.3 t -64.28 -17.53 63.72 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.855 0.862 . . . . 75.420000000000002 111.715 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.0 m -89.26 -6.51 56.75 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.72 0.808 . . . . 73.109999999999999 111.565 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -97.62 161.11 21.18 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 114.616 0.606 . . . . 73.319999999999993 114.616 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.7 pt -102.59 -164.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.904 0.882 . . . . 74.049999999999997 110.221 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.844 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 13.3 p-10 -51.34 118.56 3.36 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.766 0.827 . . . . 74.319999999999993 113.124 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.59 14.37 68.2 Favored Glycine 0 C--O 1.256 1.499 0 CA-C-N 115.574 -0.739 . . . . 65.030000000000001 113.227 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.6 t -69.49 134.04 48.42 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.075 -0.713 . . . . 73.519999999999996 109.075 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 183' ' ' SER . 20.1 p90 -139.97 154.13 47.09 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.879 0.696 . . . . 72.439999999999998 112.879 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 159' ' ' LEU . 97.8 mt -133.08 133.73 43.36 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.708 -0.849 . . . . 75.310000000000002 108.708 169.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.415 HG22 HG12 ' A' ' 182' ' ' ILE . 22.7 t -106.55 118.0 53.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 107.363 -1.347 . . . . 71.209999999999994 107.363 174.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.703 HH11 ' HA ' ' A' ' 156' ' ' ALA . 28.9 mtt180 -147.42 152.03 37.44 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.198 0.999 . . . . 74.239999999999995 109.527 -174.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 16.1 pt-20 -106.76 162.6 13.64 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.8 -0.815 . . . . 72.450000000000003 108.8 172.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.5 t -77.27 134.54 38.53 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.657 0.383 . . . . 72.409999999999997 110.262 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -60.76 -43.78 97.56 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.404 0.682 . . . . 74.019999999999996 109.962 175.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 62.5 p -90.6 5.73 46.69 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.67 -1.15 . . . . 73.25 112.188 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.0 m -150.69 87.96 4.68 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.443 0.697 . . . . 73.129999999999995 109.333 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.439 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 27.1 Cg_endo -60.84 138.98 82.75 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.827 2.351 . . . . 61.140000000000001 111.89 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.83 -23.07 11.19 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 116.066 -0.516 . . . . 70.129999999999995 113.652 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -83.52 113.76 21.02 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.141 -0.689 . . . . 63.109999999999999 109.141 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.676 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 67.6 mtt-85 -114.77 170.71 8.13 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.088 -0.505 . . . . 75.439999999999998 110.124 -170.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.474 ' HB2' ' HD3' ' A' ' 194' ' ' ARG . 33.0 t -161.02 148.56 15.48 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.397 0.679 . . . . 60.340000000000003 110.048 -177.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.415 HG12 HG22 ' A' ' 170' ' ' VAL . 55.3 mt -112.78 141.06 29.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 107.955 -1.128 . . . . 71.049999999999997 107.955 166.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 20.0 m -118.12 112.29 19.99 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 124.287 1.035 . . . . 74.209999999999994 108.849 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.449 HD22 HD21 ' A' ' 232' ' ' LEU . 38.2 mt -104.78 142.25 35.04 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.486 0.585 . . . . 75.299999999999997 112.424 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -129.99 125.65 35.87 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 114.565 -1.198 . . . . 74.409999999999997 108.182 168.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.844 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 6.3 p90 -140.65 134.97 31.2 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 109.162 -0.681 . . . . 74.530000000000001 109.162 174.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 58.15 22.95 9.64 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.664 1.186 . . . . 73.400000000000006 112.48 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 84.07 7.99 84.56 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.203 -0.453 . . . . 45.200000000000003 113.654 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -102.49 124.99 49.04 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.422 0.689 . . . . 75.129999999999995 109.543 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.508 HG13 ' HG3' ' A' ' 157' ' ' GLU . 98.1 t -104.96 134.77 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.236 1.014 . . . . 71.329999999999998 110.478 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.552 ' HH ' HG21 ' A' ' 230' ' ' THR . 32.4 p90 -147.0 151.84 37.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.34 1.056 . . . . 63.219999999999999 108.811 168.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -121.47 150.94 40.83 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.588 -0.893 . . . . 72.200000000000003 108.588 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -146.19 139.62 26.01 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.631 0.373 . . . . 74.219999999999999 110.464 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.474 ' HD3' ' HB2' ' A' ' 181' ' ' SER . 32.5 mmt180 -82.76 140.6 32.92 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.75 0.786 . . . . 74.109999999999999 112.913 -172.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.676 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 84.9 mt -93.04 111.2 24.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-N 114.284 -1.325 . . . . 73.129999999999995 107.539 165.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -87.98 133.35 33.96 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 109.395 -0.594 . . . . 74.120000000000005 109.395 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.7 m -94.19 116.46 28.87 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.265 0.626 . . . . 72.0 109.717 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.51 160.36 27.78 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.433 0.693 . . . . 75.140000000000001 110.997 171.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.3 t -66.4 -10.16 40.96 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.796 0.839 . . . . 74.129999999999995 111.957 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -90.61 5.19 48.98 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.79 0.836 . . . . 64.230000000000004 111.8 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 81.08 -3.5 76.26 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 122.796 0.236 . . . . 72.030000000000001 113.097 -175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -83.5 135.19 34.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.692 0.797 . . . . 74.540000000000006 110.136 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.9 mt -92.97 157.32 16.39 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.508 0.723 . . . . 73.530000000000001 110.052 -177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -164.4 156.95 16.92 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.161 0.505 . . . . 64.140000000000001 111.29 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.3 t -117.04 -67.03 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 106.904 -1.517 . . . . 74.329999999999998 106.904 170.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.8 m -68.44 140.81 55.77 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.07 0.948 . . . . 73.140000000000001 110.257 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 54.7 p -62.86 -31.49 72.53 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.329 0.652 . . . . 75.120000000000005 111.666 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -88.08 3.31 49.46 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.513 0.725 . . . . 74.439999999999998 112.084 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.5 m -123.1 144.12 49.52 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.762 0.425 . . . . 61.450000000000003 111.453 -174.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 81.0 mmt-85 -143.03 135.43 27.39 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 107.609 -1.256 . . . . 74.310000000000002 107.609 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -131.33 135.73 47.51 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.708 -1.219 . . . . 75.219999999999999 107.708 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -75.07 -35.91 61.81 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 122.551 0.34 . . . . 72.319999999999993 110.122 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 77.4 p -124.26 150.51 45.26 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.479 0.712 . . . . 72.019999999999996 111.848 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.413 ' HB3' HD11 ' A' ' 141' ' ' LEU . 33.2 tp -69.64 -28.15 65.66 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.974 -1.012 . . . . 73.109999999999999 110.523 174.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.87 -44.58 91.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.042 0.537 . . . . 73.420000000000002 110.486 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -77.56 -29.32 52.13 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.815 -0.63 . . . . 74.129999999999995 112.273 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.3 tt -61.27 -46.34 90.74 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 118.363 0.529 . . . . 74.319999999999993 109.898 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 67.0 t -74.1 -42.09 51.99 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 C-N-CA 123.891 0.876 . . . . 64.200000000000003 111.129 -176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -58.77 -52.4 65.86 Favored 'General case' 0 C--O 1.262 1.74 0 CA-C-O 121.289 0.566 . . . . 72.439999999999998 111.223 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.436 ' O ' HG23 ' A' ' 224' ' ' VAL . 37.9 t-80 -54.67 -56.99 13.33 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 114.646 -1.161 . . . . 55.299999999999997 108.377 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.41 ' HA ' HG23 ' A' ' 224' ' ' VAL . 10.4 m170 -68.05 -14.65 63.14 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.17 0.804 . . . . 70.040000000000006 113.17 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.472 ' HA ' ' HB2' ' A' ' 232' ' ' LEU . 42.0 t -73.77 -34.65 64.77 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 110.169 -0.308 . . . . 71.310000000000002 110.169 171.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.9 t -108.5 -13.42 14.84 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 116.144 1.905 . . . . 72.329999999999998 116.144 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.467 ' O ' HG21 ' A' ' 231' ' ' THR . 34.1 m -103.63 165.84 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 116.316 1.969 . . . . 75.0 116.316 -165.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.85 -1.71 58.05 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.829 3.252 . . . . 62.140000000000001 113.854 -172.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -78.67 14.36 1.34 Allowed 'General case' 0 CA--C 1.576 1.955 0 C-N-CA 130.322 3.449 . . . . 65.219999999999999 113.519 -138.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.11 17.61 4.46 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 110.856 -0.897 . . . . 71.109999999999999 110.856 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 92.8 mt -92.36 124.03 36.12 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.828 1.251 . . . . 75.530000000000001 110.34 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.459 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 89.5 mt -61.73 -40.78 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 109.303 -0.628 . . . . 73.209999999999994 109.303 172.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.552 HG21 ' HH ' ' A' ' 191' ' ' TYR . 9.5 t -138.19 142.61 40.02 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.275 -0.875 . . . . 75.329999999999998 109.392 166.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 224' ' ' VAL . 82.3 p -66.65 149.59 50.28 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.989 -0.55 . . . . 74.209999999999994 109.547 169.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 222' ' ' SER . 40.9 mt -65.48 103.32 0.82 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.001 0.521 . . . . 74.420000000000002 109.956 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -75.62 -59.42 2.76 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.518 0.727 . . . . 74.129999999999995 109.809 -176.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -156.44 150.67 19.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 CA-C-O 119.326 -0.368 . . . . 73.349999999999994 110.212 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 31.2 Cg_endo -62.81 137.3 62.31 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.116 1.877 . . . . 63.520000000000003 111.855 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -59.59 135.74 89.29 Favored Pre-proline 0 C--O 1.243 0.747 0 C-N-CA 123.333 0.653 . . . . 63.530000000000001 111.045 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.01 117.21 3.88 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.387 2.058 . . . . 73.310000000000002 112.617 -174.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.585 ' HE2' ' HB3' ' A' ' 240' ' ' ASN . 19.9 ptmt -63.71 158.27 22.02 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.542 -1.208 . . . . 73.420000000000002 109.843 170.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -61.51 -29.65 70.12 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.369 0.507 . . . . 74.319999999999993 112.369 -172.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.585 ' HB3' ' HE2' ' A' ' 238' ' ' LYS . 27.7 t-20 -82.83 137.24 34.38 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.426 -0.954 . . . . 62.420000000000002 108.426 169.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -56.94 108.83 1.36 Allowed Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 124.574 1.15 . . . . 74.209999999999994 113.099 -168.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -94.89 151.82 1.76 Allowed 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.045 2.496 . . . . 72.019999999999996 112.191 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 57.5 m -145.49 111.96 5.8 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.479 0.712 . . . . 73.319999999999993 109.547 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.7 t -89.03 93.82 4.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 108.612 -0.885 . . . . 74.340000000000003 108.612 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -102.72 131.45 49.54 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.548 -0.751 . . . . 73.420000000000002 108.988 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -167.84 -74.61 0.03 OUTLIER Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.786 -0.452 . . . . 75.540000000000006 112.281 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 92.2 t 63.71 100.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 125.0 1.32 . . . . 64.430000000000007 111.341 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 33.3 t -135.93 83.93 33.1 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.636 0.774 . . . . 65.099999999999994 109.16 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -82.16 76.66 4.13 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.853 2.369 . . . . 73.299999999999997 112.542 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -96.12 127.77 42.42 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.186 -0.672 . . . . 74.129999999999995 109.186 174.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -125.96 86.68 2.56 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.612 -0.884 . . . . 75.409999999999997 108.612 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -98.98 -177.9 3.77 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.392 -1.276 . . . . 65.329999999999998 110.045 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -159.29 -178.72 7.38 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.242 -0.89 . . . . 74.340000000000003 109.25 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -154.94 -68.55 0.13 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.43 -0.952 . . . . 73.510000000000005 108.43 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 124.174 0.99 . . . . 73.439999999999998 108.384 -179.01 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.9 tpp . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.892 -0.41 . . . . 62.439999999999998 109.892 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.69 178.97 19.27 Favored Glycine 0 C--N 1.342 0.916 0 O-C-N 123.405 0.441 . . . . 70.510000000000005 113.171 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.426 HE22 ' HG3' ' A' ' 5' ' ' PRO . 8.5 tm0? -168.71 109.19 0.5 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.223 -1.399 . . . . 75.120000000000005 107.223 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -159.95 86.83 1.99 Allowed Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.733 1.213 . . . . 74.209999999999994 108.276 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.426 ' HG3' HE22 ' A' ' 3' ' ' GLN . 13.2 Cg_exo -68.59 114.41 3.49 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.962 2.442 . . . . 73.239999999999995 112.186 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 7' ' ' LYS . . . 147.15 -146.74 16.91 Favored Glycine 0 C--N 1.341 0.826 0 O-C-N 123.93 0.769 . . . . 74.310000000000002 112.1 173.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 6' ' ' GLY . 3.4 ptpp? 61.73 15.02 6.6 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 126.318 1.847 . . . . 72.420000000000002 112.205 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.5 m -121.38 52.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.955 1.302 . . . . 72.219999999999999 109.599 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.06 124.48 24.19 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.741 -1.118 . . . . 71.340000000000003 110.078 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.76 62.53 4.59 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.557 -1.017 . . . . 75.549999999999997 110.557 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.75 -58.3 3.6 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.768 0.827 . . . . 71.400000000000006 110.579 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 66' ' ' ARG . 12.1 pt20 -141.62 -177.35 5.13 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.64 -0.709 . . . . 75.230000000000004 110.801 -176.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.507 ' HG3' ' HE2' ' A' ' 89' ' ' TYR . 13.5 ttt85 -75.5 127.01 32.16 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.208 -1.034 . . . . 74.329999999999998 108.208 170.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 61.64 76.82 0.38 Allowed Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.871 1.269 . . . . 75.319999999999993 110.655 -158.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -79.93 169.86 17.37 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.991 2.461 . . . . 71.239999999999995 110.439 167.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m -65.08 167.03 8.53 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.073 0.463 . . . . 73.140000000000001 111.355 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.9 mt -104.79 128.46 26.75 Favored Pre-proline 0 C--O 1.241 0.644 0 N-CA-C 109.205 -0.665 . . . . 63.439999999999998 109.205 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -66.32 165.95 22.99 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.566 2.177 . . . . 63.020000000000003 111.865 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.98 146.71 31.9 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 120.809 0.337 . . . . 74.439999999999998 110.53 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.531 ' HB3' HD13 ' A' ' 23' ' ' ILE . 75.6 mt -87.02 93.17 9.28 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.524 -0.917 . . . . 75.299999999999997 108.524 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -95.26 -45.24 7.24 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.942 -1.026 . . . . 71.450000000000003 109.389 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -105.85 115.36 30.1 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.144 -0.935 . . . . 72.0 110.084 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' A' ' 20' ' ' LEU . 45.9 mm -116.47 113.84 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.298 -1.001 . . . . 75.040000000000006 108.298 175.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -117.37 150.17 39.3 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.81 0.844 . . . . 74.209999999999994 109.185 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.18 58.46 0.18 Allowed Glycine 0 C--O 1.241 0.588 0 N-CA-C 110.161 -1.176 . . . . 72.049999999999997 110.161 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.06 -46.69 84.98 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.785 0.834 . . . . 74.329999999999998 110.787 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.97 171.31 13.97 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 115.753 -0.658 . . . . 72.230000000000004 112.176 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -77.38 73.44 3.95 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.102 0.561 . . . . 71.239999999999995 109.863 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -93.97 -28.05 16.0 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.375 0.67 . . . . 73.310000000000002 109.646 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.93 -162.05 1.2 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.526 1.131 . . . . 73.310000000000002 109.048 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.4 m 71.81 99.29 0.07 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.413 1.085 . . . . 70.439999999999998 111.71 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -69.87 144.78 52.42 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.774 -0.648 . . . . 73.409999999999997 111.145 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 -98.72 95.8 7.48 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.035 0.934 . . . . 62.439999999999998 109.735 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -73.39 -38.19 65.72 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.663 -0.699 . . . . 72.109999999999999 110.738 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.13 -164.97 23.84 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 115.76 -0.655 . . . . 52.240000000000002 112.41 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.23 159.19 7.91 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-O 119.384 -0.676 . . . . 62.340000000000003 111.79 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -78.92 136.63 13.35 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.779 2.32 . . . . 73.239999999999995 111.919 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -76.25 112.82 13.14 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.784 -1.191 . . . . 72.329999999999998 107.784 167.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 63.8 m -63.65 108.59 1.44 Allowed 'General case' 0 C--O 1.243 0.74 0 O-C-N 123.615 0.572 . . . . 73.230000000000004 110.443 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -69.22 128.29 36.08 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.971 -0.751 . . . . 75.040000000000006 108.971 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.6 t -88.21 127.39 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 116.357 -0.383 . . . . 64.420000000000002 111.0 -168.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -94.17 -47.28 6.72 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.097 0.959 . . . . 74.010000000000005 108.925 173.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.0 m -68.59 78.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 124.058 0.943 . . . . 63.140000000000001 112.337 -174.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -137.61 127.71 25.96 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.974 -0.557 . . . . 74.540000000000006 110.774 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -165.13 134.13 3.42 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.074 0.95 . . . . 75.25 108.444 171.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -84.12 130.56 34.84 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.507 -0.553 . . . . 73.25 109.507 174.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.98 107.48 9.12 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.15 -1.056 . . . . 75.310000000000002 108.15 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.5 mt 61.76 84.21 0.14 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.199 1.0 . . . . 72.409999999999997 110.3 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -72.29 131.58 42.89 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.416 -0.587 . . . . 72.230000000000004 109.416 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -101.42 94.65 4.28 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 108.577 -0.897 . . . . 74.540000000000006 108.577 172.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -94.4 179.15 0.85 Allowed 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.533 2.155 . . . . 75.310000000000002 112.863 172.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.1 t -124.25 85.97 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 107.149 -1.426 . . . . 71.239999999999995 107.149 175.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.63 104.17 3.72 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.793 0.837 . . . . 72.219999999999999 110.144 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.1 m 62.74 19.31 11.32 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.656 1.182 . . . . 72.109999999999999 112.893 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -70.14 100.57 1.68 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.103 0.561 . . . . 62.409999999999997 110.588 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -79.13 79.8 5.52 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.483 -0.932 . . . . 73.019999999999996 108.483 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 60.09 72.57 0.74 Allowed Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.983 0.913 . . . . 73.439999999999998 111.04 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -76.65 21.07 0.58 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.423 2.748 . . . . 37.530000000000001 114.138 -170.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -73.08 89.85 1.5 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.567 -0.531 . . . . 70.140000000000001 109.567 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -144.3 28.6 1.94 Allowed Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.915 -0.874 . . . . 24.350000000000001 110.915 176.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.0 mt -74.8 96.11 3.03 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.034 0.934 . . . . 74.420000000000002 109.962 -174.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 t -123.79 13.41 9.24 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.002 0.921 . . . . 71.109999999999999 110.453 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -70.3 -64.38 0.9 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.425 0.69 . . . . 63.210000000000001 110.361 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 55.53 40.86 31.19 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.91 1.284 . . . . 63.229999999999997 111.227 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.0 105.4 17.12 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.644 -0.707 . . . . 73.310000000000002 110.349 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HA ' ' HB3' ' A' ' 12' ' ' GLN . 7.0 mpt_? -80.88 82.55 6.83 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.151 0.58 . . . . 71.450000000000003 109.985 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -76.55 135.29 39.26 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.665 -0.865 . . . . 63.329999999999998 108.665 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -97.09 162.79 13.21 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.998 0.428 . . . . 75.329999999999998 110.913 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.7 m -125.49 137.16 53.95 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.986 0.914 . . . . 74.129999999999995 109.703 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -71.8 115.31 10.85 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.571 0.749 . . . . 74.340000000000003 111.004 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -75.92 -55.16 5.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.85 0.86 . . . . 73.310000000000002 111.513 -172.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -78.99 75.88 5.48 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.111 0.565 . . . . 74.200000000000003 111.373 -174.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.5 mt -92.63 54.22 2.21 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.146 -1.057 . . . . 73.439999999999998 108.146 167.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.8 mt -74.79 82.73 2.13 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.635 -1.166 . . . . 72.030000000000001 109.663 -175.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.67 95.95 4.62 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.885 -1.154 . . . . 73.230000000000004 107.885 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.73 81.82 0.35 Allowed Glycine 0 C--N 1.346 1.115 0 CA-C-O 119.488 -0.618 . . . . 53.450000000000003 112.498 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.92 -25.8 44.67 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.282 1.988 . . . . 64.439999999999998 111.106 169.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 t -107.03 96.98 6.82 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.759 -1.109 . . . . 53.149999999999999 109.759 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -87.82 -9.97 52.27 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.962 0.505 . . . . 62.530000000000001 111.945 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -89.51 9.43 26.6 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.624 0.37 . . . . 74.329999999999998 111.611 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.49 ' HB2' HD21 ' A' ' 139' ' ' ASN . 17.0 m-20 -69.73 155.73 92.98 Favored Pre-proline 0 N--CA 1.48 1.054 0 N-CA-C 109.454 -0.572 . . . . 75.420000000000002 109.454 166.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.473 ' HG3' ' NH1' ' A' ' 108' ' ' ARG . 74.2 Cg_endo -69.12 -145.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.377 2.718 . . . . 73.540000000000006 111.587 173.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 140' ' ' SER . 48.8 m-80 -66.14 85.99 0.1 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.898 0.856 . . . . 62.240000000000002 108.751 167.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 30.2 tp -87.4 122.91 31.77 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.306 -1.315 . . . . 74.239999999999995 109.865 -173.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -107.22 174.7 5.77 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.556 1.142 . . . . 74.439999999999998 109.225 174.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.24 142.55 19.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 108.464 -0.939 . . . . 72.540000000000006 108.464 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.43 ' HB2' HD12 ' A' ' 107' ' ' LEU . . . -78.39 123.28 26.83 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.513 0.508 . . . . 71.319999999999993 110.398 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.08 -22.92 41.7 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.34 0.656 . . . . 75.010000000000005 110.499 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.507 ' HE2' ' HG3' ' A' ' 13' ' ' ARG . 22.0 m-85 -127.15 162.0 27.15 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.939 0.896 . . . . 74.409999999999997 109.012 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.11 150.39 25.58 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.054 -1.091 . . . . 74.219999999999999 108.054 166.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -156.26 108.58 2.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.83 -1.174 . . . . 74.420000000000002 107.83 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 p -80.44 135.77 24.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.779 -0.823 . . . . 74.010000000000005 108.779 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.83 123.27 16.49 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.169 0.588 . . . . 73.099999999999994 110.687 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.2 t -84.39 8.26 16.82 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.554 0.742 . . . . 72.310000000000002 110.778 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.51 -171.64 44.14 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.789 -0.524 . . . . 74.530000000000001 111.789 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.5 -27.59 62.36 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.683 0.793 . . . . 73.530000000000001 110.682 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -74.84 -24.3 58.58 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.794 0.838 . . . . 74.120000000000005 112.74 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.9 p -102.03 157.58 16.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.603 0.761 . . . . 60.0 110.731 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.8 tp -110.0 131.83 54.71 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.516 0.727 . . . . 70.319999999999993 110.319 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.0 m -71.28 118.69 14.4 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.08 -0.711 . . . . 75.049999999999997 109.08 168.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.7 pt -124.03 147.18 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.566 0.746 . . . . 72.329999999999998 109.016 173.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.3 m -115.46 145.02 42.98 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.67 -0.493 . . . . 74.340000000000003 109.67 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -55.25 114.8 1.94 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.747 0.819 . . . . 75.319999999999993 110.856 174.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.78 -16.16 37.0 Favored Glycine 0 C--N 1.35 1.361 0 O-C-N 123.167 0.292 . . . . 73.400000000000006 112.763 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -78.38 137.24 37.92 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 124.153 0.981 . . . . 74.010000000000005 110.973 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.549 ' HD2' HD21 ' A' ' 84' ' ' LEU . 29.8 mtmt -77.44 134.72 38.31 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 124.044 0.84 . . . . 73.420000000000002 109.777 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' A' ' 87' ' ' ALA . 19.0 mt -120.3 135.87 54.87 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.38 0.672 . . . . 73.129999999999995 109.255 -173.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.473 ' NH1' ' HG3' ' A' ' 82' ' ' PRO . 50.9 mtp85 -93.56 108.14 19.89 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.718 -0.845 . . . . 74.209999999999994 108.718 167.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.451 HG23 HD13 ' A' ' 135' ' ' ILE . 95.6 t -95.27 108.94 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.565 -0.902 . . . . 71.239999999999995 108.565 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.86 -28.97 64.97 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.025 0.93 . . . . 74.200000000000003 110.224 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.85 173.12 37.05 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-N 114.648 -1.16 . . . . 74.129999999999995 111.013 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 51.3 m-85 -96.8 175.02 6.51 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.648 -0.871 . . . . 71.109999999999999 108.648 176.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.43 ' HB3' ' H ' ' A' ' 117' ' ' GLU . 49.8 t-20 -63.4 144.39 57.01 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.69 -1.226 . . . . 72.340000000000003 107.69 173.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -54.37 -32.65 57.47 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.688 0.795 . . . . 72.230000000000004 110.905 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.53 -19.83 28.89 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.441 1.097 . . . . 74.299999999999997 111.797 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.07 34.46 7.18 Favored Glycine 0 N--CA 1.477 1.418 0 C-N-CA 123.121 0.391 . . . . 63.32 113.854 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.43 ' H ' ' HB3' ' A' ' 113' ' ' ASN . 28.5 mt-10 -99.4 -65.86 0.94 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.466 0.706 . . . . 64.349999999999994 111.043 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -103.01 -176.77 3.18 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.668 1.187 . . . . 73.219999999999999 110.207 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -143.66 117.16 9.14 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.563 0.745 . . . . 74.049999999999997 110.032 -177.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -73.81 97.96 2.85 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.615 -0.513 . . . . 65.439999999999998 109.615 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.78 168.14 9.33 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.145 -0.934 . . . . 74.030000000000001 110.718 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -147.48 127.81 13.94 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 108.57 -0.9 . . . . 75.430000000000007 108.57 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.6 p -139.71 -172.57 3.41 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.025 0.93 . . . . 75.519999999999996 109.785 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -63.02 -20.68 65.55 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.509 -0.768 . . . . 74.329999999999998 111.307 171.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -81.72 -4.11 55.43 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.056 0.943 . . . . 75.040000000000006 111.269 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 125.47 -135.07 9.07 Favored Glycine 0 C--N 1.355 1.589 0 N-CA-C 112.354 -0.298 . . . . 72.120000000000005 112.354 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -150.65 133.88 16.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.997 0.919 . . . . 74.340000000000003 109.155 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 176.18 -177.91 47.68 Favored Glycine 0 C--N 1.348 1.25 0 O-C-N 123.214 0.321 . . . . 43.25 112.867 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -88.37 126.53 35.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.374 1.07 . . . . 75.430000000000007 111.149 -174.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.05 154.7 55.79 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.914 1.286 . . . . 72.299999999999997 109.138 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.95 132.82 23.81 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 121.744 1.63 . . . . 71.430000000000007 110.398 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.3 m -63.8 -19.33 64.93 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.571 0.748 . . . . 74.340000000000003 112.108 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -72.22 -22.05 61.31 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.977 0.911 . . . . 75.409999999999997 111.302 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.492 ' HA ' ' CD1' ' A' ' 89' ' ' TYR . 2.5 m-85 -90.61 -7.4 52.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.763 0.825 . . . . 72.5 113.024 -175.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.451 HD13 HG23 ' A' ' 109' ' ' VAL . 16.1 pt -121.57 157.35 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 122.808 0.443 . . . . 74.530000000000001 110.409 -171.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.5 t -147.35 141.55 15.94 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 122.917 0.487 . . . . 55.340000000000003 110.248 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.81 147.15 43.93 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.632 2.221 . . . . 74.140000000000001 112.111 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 m -130.94 -59.96 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.55 0.74 . . . . 73.430000000000007 110.666 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.608 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.1 t30 -103.06 16.08 27.6 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 122.945 0.498 . . . . 74.25 111.06 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 41.3 m -60.62 170.78 1.31 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.028 0.531 . . . . 72.140000000000001 111.034 172.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 69.7 mt -55.65 -16.09 3.76 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.921 1.082 . . . . 74.299999999999997 113.921 -173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.533 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 31.4 tt0 -65.97 -6.29 12.15 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.536 1.134 . . . . 73.219999999999999 111.478 175.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -56.53 -31.11 63.83 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.271 1.428 . . . . 74.010000000000005 110.496 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -100.29 141.77 32.68 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.566 -0.743 . . . . 72.5 109.262 173.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.3 p -70.42 -5.81 31.14 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.242 0.83 . . . . 74.439999999999998 113.242 -170.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 42.5 p-90 -77.94 -33.64 51.55 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 111.806 0.299 . . . . 72.319999999999993 111.806 174.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -99.27 139.25 35.19 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.281 -0.637 . . . . 74.530000000000001 109.281 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.533 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 25.1 m-70 -134.12 38.51 3.15 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.894 0.478 . . . . 72.200000000000003 110.372 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 68.59 -171.16 38.04 Favored Glycine 0 CA--C 1.542 1.732 0 N-CA-C 116.305 1.282 . . . . 75.140000000000001 116.305 165.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.11 100.65 0.88 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.635 2.89 . . . . 73.200000000000003 111.553 171.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.493 ' HB ' ' HD2' ' A' ' 171' ' ' ARG . 78.0 t -142.66 148.47 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.772 0.829 . . . . 75.010000000000005 109.352 -174.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.5 m -70.83 151.34 44.89 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 123.93 0.892 . . . . 74.140000000000001 111.288 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -20.59 55.26 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.228 -0.896 . . . . 74.129999999999995 112.186 176.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.83 -59.13 5.6 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.303 1.041 . . . . 75.140000000000001 109.822 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.12 -31.72 69.39 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.842 0.857 . . . . 71.239999999999995 110.81 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.498 ' HA ' HH21 ' A' ' 171' ' ' ARG . . . -57.25 -54.06 51.08 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.43 -0.804 . . . . 72.349999999999994 110.738 171.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -73.1 -23.34 60.51 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.862 -0.608 . . . . 72.549999999999997 110.762 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -63.58 -49.37 73.66 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.743 0.817 . . . . 72.310000000000002 110.398 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.483 HD11 ' NH2' ' A' ' 171' ' ' ARG . 67.3 mt -71.32 -37.52 71.76 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.058 0.456 . . . . 74.510000000000005 110.79 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.402 HD23 HG12 ' A' ' 190' ' ' VAL . 29.1 tp -73.98 -17.27 61.02 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.854 -0.612 . . . . 73.340000000000003 112.269 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 38.9 t -68.86 -19.84 64.26 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.371 0.669 . . . . 71.230000000000004 110.651 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.9 t -99.82 6.82 45.34 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.472 0.709 . . . . 74.430000000000007 110.6 174.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.15 163.27 43.11 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 116.089 -0.505 . . . . 62.229999999999997 113.068 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.2 pt -126.35 -166.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.442 1.497 . . . . 74.430000000000007 110.396 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.677 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 24.7 p-10 -58.78 110.12 0.95 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.63 0.604 . . . . 73.129999999999995 112.63 -169.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 91.91 13.37 57.92 Favored Glycine 0 C--O 1.256 1.477 0 CA-C-N 115.91 -0.587 . . . . 53.32 113.168 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 67.4 m -77.69 131.35 37.67 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.023 -0.362 . . . . 74.150000000000006 110.023 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.453 ' HB3' HD21 ' A' ' 184' ' ' LEU . 16.2 p90 -133.13 154.88 50.18 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.834 0.679 . . . . 64.209999999999994 112.834 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.6 mt -135.46 133.82 38.94 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.931 -1.032 . . . . 74.230000000000004 108.459 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.74 118.07 54.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 107.838 -1.171 . . . . 73.439999999999998 107.838 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.498 HH21 ' HA ' ' A' ' 156' ' ' ALA . 18.7 mmt180 -118.62 167.58 11.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.059 0.944 . . . . 70.120000000000005 108.798 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.561 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 15.7 pt-20 -117.89 160.76 20.87 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 109.575 -0.528 . . . . 74.319999999999993 109.575 158.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 59.3 m -87.33 135.24 33.4 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.749 -0.66 . . . . 62.240000000000002 110.326 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -74.44 -36.42 63.38 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.007 0.923 . . . . 74.239999999999995 110.872 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 26.5 t -89.37 -16.26 31.41 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.551 0.741 . . . . 61.340000000000003 111.031 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 32.7 t -127.19 85.25 61.43 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 108.387 -0.968 . . . . 72.430000000000007 108.387 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.464 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 51.6 Cg_endo -65.64 140.38 62.09 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.161 2.574 . . . . 72.019999999999996 112.289 -176.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.6 -25.37 5.16 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 115.771 -0.649 . . . . 74.150000000000006 113.102 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -79.95 119.11 22.35 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 108.741 -0.837 . . . . 73.310000000000002 108.741 173.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.561 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 47.9 mtt85 -114.21 165.46 12.65 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 115.019 -0.991 . . . . 75.209999999999994 109.167 -176.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.3 m -146.71 139.01 24.87 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.495 -0.557 . . . . 72.150000000000006 109.495 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 47.4 mt -103.84 140.99 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.1 -1.074 . . . . 73.540000000000006 108.1 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 18.1 m -121.21 111.86 17.92 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.103 -0.953 . . . . 74.400000000000006 108.505 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 168' ' ' PHE . 33.9 mt -103.79 143.91 32.19 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.17 0.988 . . . . 53.509999999999998 111.212 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 48.3 ttt180 -131.71 133.6 45.01 Favored 'General case' 0 C--O 1.257 1.496 0 CA-C-N 114.825 -1.08 . . . . 75.239999999999995 108.536 168.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.677 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 24.3 p90 -143.73 133.52 23.85 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.862 -1.063 . . . . 74.420000000000002 108.21 173.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 47.64 37.47 6.81 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.674 1.19 . . . . 64.409999999999997 113.817 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 92.18 -5.41 78.3 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.621 -0.718 . . . . 55.020000000000003 113.779 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 40.8 ttm180 -102.93 123.99 47.59 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.1 0.56 . . . . 73.209999999999994 109.738 -175.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.402 HG12 HD23 ' A' ' 160' ' ' LEU . 84.7 t -106.27 137.55 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.238 1.015 . . . . 71.219999999999999 109.547 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.675 ' HH ' HG22 ' A' ' 230' ' ' THR . 24.3 p90 -145.73 151.33 37.82 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.751 0.821 . . . . 72.200000000000003 109.572 169.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -128.38 134.13 48.77 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.544 -1.28 . . . . 75.409999999999997 107.544 -173.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -136.8 139.36 41.72 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.242 0.544 . . . . 70.219999999999999 110.436 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.537 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 22.2 tpp180 -81.76 122.46 27.7 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.588 -1.187 . . . . 74.230000000000004 111.58 -171.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.434 ' HA ' HG22 ' A' ' 205' ' ' VAL . 73.4 mt -72.69 115.56 13.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 108.308 -0.997 . . . . 75.109999999999999 108.308 162.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -93.46 132.47 37.7 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 109.016 -0.735 . . . . 75.230000000000004 109.016 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.7 m -95.6 116.45 28.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.407 -0.815 . . . . 73.049999999999997 108.909 172.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.35 161.27 22.82 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.138 0.975 . . . . 73.5 111.693 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.3 t -70.06 -10.76 59.77 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.654 0.782 . . . . 71.400000000000006 110.803 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -71.77 -17.12 62.2 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.463 1.105 . . . . 70.340000000000003 111.206 172.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 88.25 2.28 80.41 Favored Glycine 0 C--N 1.355 1.62 0 C-N-CA 123.169 0.414 . . . . 63.340000000000003 112.081 -171.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -90.47 145.33 24.99 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.913 0.885 . . . . 74.400000000000006 110.773 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 86.8 mt -94.23 149.2 21.46 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 123.195 0.598 . . . . 74.299999999999997 109.621 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -162.43 166.94 24.37 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.668 0.605 . . . . 74.230000000000004 111.182 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 195' ' ' ILE . 92.8 t -140.88 -62.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.301 1.041 . . . . 72.329999999999998 108.632 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 12.7 m -98.79 -169.96 1.86 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.628 1.171 . . . . 74.329999999999998 111.196 -172.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.8 m -69.99 -47.68 61.22 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.532 0.733 . . . . 73.510000000000005 112.859 -169.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -84.36 -16.77 41.68 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.455 0.702 . . . . 75.439999999999998 109.257 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 71.6 m -64.41 106.59 1.16 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.32 0.648 . . . . 75.310000000000002 111.376 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -146.1 117.57 8.0 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.393 1.077 . . . . 75.120000000000005 109.18 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -136.54 152.71 50.8 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.145 0.578 . . . . 75.430000000000007 110.616 -171.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -82.07 -36.28 27.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.197 -0.668 . . . . 75.450000000000003 109.197 168.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 82.8 p -130.73 160.13 35.23 Favored 'General case' 0 C--O 1.252 1.2 0 CA-C-O 122.247 1.022 . . . . 71.5 112.598 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 21.4 tp -74.14 -22.04 59.61 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.15 -1.386 . . . . 72.239999999999995 110.807 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.23 -49.64 76.29 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.44 0.638 . . . . 62.439999999999998 110.41 171.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -62.23 -41.96 98.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.521 -1.218 . . . . 72.120000000000005 110.504 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.9 tt -57.88 -48.92 78.41 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.02 0.825 . . . . 75.310000000000002 111.612 177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.7 t -72.08 -38.47 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.083 0.553 . . . . 75.319999999999993 111.19 -174.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.461 ' HA ' ' HG ' ' A' ' 222' ' ' SER . 42.1 t-80 -65.43 -46.75 78.69 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.128 0.49 . . . . 75.129999999999995 110.938 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.447 ' O ' HG21 ' A' ' 224' ' ' VAL . 40.6 t-80 -56.07 -52.35 64.58 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.672 -0.695 . . . . 74.540000000000006 109.322 176.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.514 ' HD1' HD23 ' A' ' 228' ' ' LEU . 18.1 m-70 -70.19 -19.15 63.19 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.531 -0.759 . . . . 74.030000000000001 112.535 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.461 ' HG ' ' HA ' ' A' ' 219' ' ' HIS . 78.2 p -81.29 -20.2 41.36 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.127 0.421 . . . . 73.120000000000005 110.715 172.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 7.0 t -111.53 -12.99 13.9 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.251 1.945 . . . . 75.0 116.251 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 220' ' ' HIS . 30.3 m -105.59 158.34 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 121.145 1.793 . . . . 74.219999999999999 115.733 -167.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -90.7 0.61 57.35 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.855 2.862 . . . . 74.129999999999995 113.523 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -81.16 15.03 2.06 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 128.191 2.596 . . . . 64.510000000000005 113.157 -139.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.02 19.88 3.87 Favored Glycine 0 N--CA 1.464 0.563 0 N-CA-C 110.35 -1.1 . . . . 71.439999999999998 110.35 -170.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.514 HD23 ' HD1' ' A' ' 221' ' ' HIS . 95.7 mt -93.59 128.4 39.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.626 -1.287 . . . . 74.219999999999999 109.102 163.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.401 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 95.3 mt -64.04 -49.0 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.871 -0.788 . . . . 74.310000000000002 108.871 170.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.675 HG22 ' HH ' ' A' ' 191' ' ' TYR . 7.2 t -130.97 147.83 52.65 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.104 -1.072 . . . . 73.329999999999998 108.104 170.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.0 p -75.29 155.75 36.32 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.913 -0.403 . . . . 74.519999999999996 109.913 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 27.5 mt -64.58 103.32 0.66 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.397 -0.964 . . . . 74.239999999999995 108.397 176.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -88.28 -58.29 2.61 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.047 -0.723 . . . . 74.439999999999998 109.047 -172.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 167' ' ' SER . 14.5 p90 -152.3 149.14 22.29 Favored Pre-proline 0 N--CA 1.484 1.257 0 CA-C-N 116.017 -0.538 . . . . 74.439999999999998 110.272 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 26.8 Cg_exo -63.31 148.88 92.53 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.116 1.877 . . . . 74.340000000000003 112.958 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.72 134.22 78.92 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 108.378 -0.971 . . . . 73.209999999999994 108.378 169.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.07 137.99 59.88 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.417 2.078 . . . . 74.430000000000007 113.379 -171.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -70.26 156.77 38.81 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.284 -1.006 . . . . 74.319999999999993 108.284 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -53.8 -32.89 54.23 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.787 0.835 . . . . 75.25 112.321 -172.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -98.62 122.91 42.42 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 108.262 -1.014 . . . . 63.520000000000003 108.262 166.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -150.08 113.88 3.36 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 122.477 0.311 . . . . 74.219999999999999 111.661 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.9 159.02 38.46 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.794 2.329 . . . . 63.539999999999999 112.187 166.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 15.1 t -113.12 147.35 37.51 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.643 0.777 . . . . 73.329999999999998 110.162 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 95.7 t -122.62 135.1 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.17 0.988 . . . . 75.230000000000004 108.567 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -90.98 -39.91 11.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.481 0.712 . . . . 61.350000000000001 110.059 -176.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 97.42 172.49 33.68 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.189 -0.914 . . . . 74.5 112.057 -174.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 16.8 m -139.96 155.78 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.725 0.81 . . . . 72.540000000000006 110.694 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 20.0 m 64.77 119.9 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 125.045 1.338 . . . . 65.209999999999994 113.529 171.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.48 179.02 6.73 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.418 2.079 . . . . 71.519999999999996 111.503 171.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -118.72 138.69 52.47 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.341 -0.614 . . . . 70.519999999999996 109.341 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -100.59 105.66 17.08 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.599 0.76 . . . . 71.439999999999998 109.021 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.72 -47.53 85.3 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.938 0.495 . . . . 72.409999999999997 110.184 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -88.19 168.1 13.04 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.296 0.638 . . . . 64.319999999999993 110.291 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 82.4 m95 59.08 90.08 0.05 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.221 1.008 . . . . 70.140000000000001 111.05 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 C--O 1.248 1.023 0 N-CA-C 107.153 -1.425 . . . . 74.299999999999997 107.153 179.164 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.463 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.599 -0.519 . . . . 65.129999999999995 109.599 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 125.27 -53.59 0.77 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 110.99 -0.844 . . . . 64.200000000000003 110.99 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -105.31 134.43 48.44 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.729 0.812 . . . . 74.510000000000005 109.534 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -102.61 104.54 39.08 Favored Pre-proline 0 C--O 1.241 0.643 0 N-CA-C 108.092 -1.077 . . . . 74.319999999999993 108.092 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.584 ' HG3' ' HB2' ' A' ' 62' ' ' SER . 97.1 Cg_endo -74.09 79.82 2.29 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 122.411 2.074 . . . . 73.049999999999997 111.511 -177.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.76 81.33 0.02 OUTLIER Glycine 0 C--N 1.36 1.867 0 O-C-N 124.02 0.825 . . . . 73.420000000000002 112.676 -175.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -131.73 90.32 2.82 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.827 1.251 . . . . 64.430000000000007 109.212 -170.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.5 m -120.12 159.44 21.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 CA-C-N 115.174 -0.921 . . . . 75.450000000000003 109.575 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.621 HD21 HD22 ' A' ' 133' ' ' ASN . 2.1 mm? -112.09 164.87 12.66 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.922 -1.035 . . . . 71.140000000000001 109.256 -173.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.01 53.74 0.1 OUTLIER Glycine 0 C--N 1.34 0.751 0 N-CA-C 111.144 -0.782 . . . . 65.329999999999998 111.144 -175.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.09 -160.21 0.23 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.209 1.004 . . . . 74.219999999999999 109.145 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -69.08 -157.77 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.272 0.629 . . . . 74.219999999999999 110.387 170.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -61.96 141.35 58.08 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.588 -0.695 . . . . 74.140000000000001 109.979 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 59.16 65.21 2.81 Favored Pre-proline 0 CA--C 1.558 1.285 0 O-C-N 124.327 1.017 . . . . 75.310000000000002 110.783 -170.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.7 166.93 16.53 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.329 2.019 . . . . 70.230000000000004 111.671 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.6 p -70.93 168.97 15.78 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.563 0.697 . . . . 75.299999999999997 111.297 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.4 mt -106.48 135.16 19.53 Favored Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 115.478 -0.783 . . . . 74.239999999999995 109.946 -173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.72 173.72 13.91 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.602 2.201 . . . . 63.020000000000003 111.874 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.06 148.85 26.6 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.957 0.503 . . . . 74.329999999999998 110.776 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.442 HD22 HD13 ' A' ' 23' ' ' ILE . 79.2 mt -86.3 93.48 9.09 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.79 -0.818 . . . . 72.209999999999994 108.79 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -97.17 -48.83 5.21 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.977 0.511 . . . . 74.209999999999994 110.427 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.459 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 64.1 m-85 -104.16 114.83 29.35 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.313 -0.625 . . . . 65.219999999999999 109.313 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.442 HD13 HD22 ' A' ' 20' ' ' LEU . 47.1 mm -121.77 120.99 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 109.4 -0.593 . . . . 72.209999999999994 109.4 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' H ' ' HE1' ' A' ' 129' ' ' TRP . 63.8 mttm -115.76 165.55 12.93 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.917 0.887 . . . . 73.450000000000003 109.763 172.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 179.83 44.35 0.08 OUTLIER Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.961 -0.855 . . . . 71.310000000000002 110.961 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -138.64 127.7 24.0 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.144 0.978 . . . . 72.450000000000003 110.045 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.75 111.77 1.11 Allowed Glycine 0 C--N 1.347 1.174 0 N-CA-C 111.736 -0.546 . . . . 71.530000000000001 111.736 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -79.55 -21.81 44.67 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.711 0.805 . . . . 74.209999999999994 111.582 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -73.46 84.05 1.49 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.622 1.201 . . . . 75.25 110.2 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -78.8 -175.91 4.69 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 113.605 -1.634 . . . . 64.439999999999998 110.448 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.2 m -98.62 10.33 41.28 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.993 0.517 . . . . 74.030000000000001 111.294 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.4 m -140.3 -148.67 0.25 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.064 1.346 . . . . 72.5 108.884 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -156.07 93.87 1.47 Allowed 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.067 -0.716 . . . . 74.439999999999998 109.067 168.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -77.1 122.06 24.45 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.625 -0.509 . . . . 74.340000000000003 109.625 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.14 171.86 55.14 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 116.556 -0.293 . . . . 63.25 113.423 -174.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.71 -171.28 47.54 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-O 119.567 -0.574 . . . . 45.340000000000003 113.204 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.14 152.82 56.85 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.925 2.417 . . . . 74.239999999999995 112.182 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -69.24 -50.93 42.56 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.855 -0.611 . . . . 72.099999999999994 109.547 174.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 57.6 m -90.37 112.39 23.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.242 1.017 . . . . 74.319999999999993 110.073 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -85.0 112.0 20.21 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.486 0.714 . . . . 74.219999999999999 109.821 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.5 m -74.94 -179.08 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 123.818 0.847 . . . . 72.450000000000003 111.703 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -62.49 143.7 56.84 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.107 0.563 . . . . 70.349999999999994 110.966 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.8 p -154.49 150.63 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.708 -0.849 . . . . 64.5 108.708 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -138.99 138.21 37.06 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.305 1.042 . . . . 70.329999999999998 108.191 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -81.86 87.84 6.36 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.432 0.634 . . . . 44.530000000000001 109.925 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -114.89 100.54 8.29 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.847 -1.07 . . . . 74.349999999999994 109.1 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.36 76.03 0.95 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.614 0.766 . . . . 73.299999999999997 110.585 -175.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 92.8 mt -89.12 77.64 7.53 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.168 0.987 . . . . 75.349999999999994 110.207 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -101.83 37.03 1.92 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.675 0.79 . . . . 75.329999999999998 110.322 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -59.16 -46.18 99.31 Favored Pre-proline 0 CA--C 1.564 1.491 0 CA-C-O 118.429 -0.796 . . . . 75.420000000000002 110.925 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.14 118.42 5.37 Favored 'Trans proline' 0 C--N 1.394 2.945 0 C-N-CA 121.457 1.438 . . . . 70.120000000000005 110.741 168.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.29 -11.02 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.169 0.587 . . . . 72.129999999999995 112.166 -176.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.9 176.36 9.88 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.254 0.621 . . . . 72.140000000000001 111.487 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.4 t -150.99 -171.7 4.01 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.181 0.992 . . . . 75.120000000000005 108.799 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -142.63 136.55 29.25 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.94 -0.763 . . . . 74.140000000000001 108.94 173.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -124.26 -170.92 2.23 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.889 0.876 . . . . 75.299999999999997 109.721 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 63.84 74.14 0.44 Allowed Pre-proline 0 N--CA 1.49 1.551 0 C-N-CA 124.09 0.956 . . . . 74.530000000000001 112.172 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.63 -161.15 0.12 Allowed 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 123.024 2.483 . . . . 61.299999999999997 112.155 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -148.35 169.76 19.45 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.168 0.587 . . . . 74.400000000000006 110.743 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.5 86.63 0.06 OUTLIER Glycine 0 C--N 1.348 1.24 0 N-CA-C 111.498 -0.641 . . . . 31.309999999999999 111.498 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.5 mt -118.68 145.84 45.18 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.886 0.875 . . . . 73.450000000000003 110.58 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.584 ' HB2' ' HG3' ' A' ' 5' ' ' PRO . 38.1 m -153.87 148.27 26.06 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.594 1.158 . . . . 63.520000000000003 108.433 170.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -114.45 93.89 4.54 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.737 0.815 . . . . 74.129999999999995 109.229 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.63 133.37 13.04 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 123.959 0.903 . . . . 73.439999999999998 108.868 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.16 90.27 1.51 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.306 0.503 . . . . 63.340000000000003 111.539 -175.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -164.66 145.31 7.74 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.284 -1.006 . . . . 73.129999999999995 108.284 166.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -127.16 172.18 10.78 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.382 0.673 . . . . 72.439999999999998 109.771 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -139.66 168.81 18.98 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.412 1.085 . . . . 74.030000000000001 108.722 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 62.0 p -78.11 122.17 25.26 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.209 -1.034 . . . . 74.400000000000006 108.209 169.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -84.61 135.11 34.32 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.304 0.642 . . . . 74.230000000000004 110.221 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -74.18 137.89 43.42 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.49 -0.559 . . . . 74.099999999999994 109.49 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -135.42 112.4 10.29 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 123.871 0.868 . . . . 64.219999999999999 110.055 -174.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.5 mt -132.52 102.5 5.74 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.36 1.064 . . . . 64.340000000000003 108.42 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.5 mt -76.59 106.37 8.2 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.806 0.442 . . . . 72.209999999999994 110.342 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.14 69.05 6.47 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.667 -0.864 . . . . 73.219999999999999 108.667 169.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.25 116.41 8.8 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 114.861 -1.063 . . . . 72.439999999999998 113.555 -168.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -87.41 -147.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.676 2.917 . . . . 74.120000000000005 110.028 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -66.31 -85.72 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 108.75 -0.833 . . . . 65.25 108.75 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 169.22 150.36 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.079 1.352 . . . . 75.209999999999994 110.069 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.42 ' H ' ' ND2' ' A' ' 139' ' ' ASN . 94.2 m-20 -133.72 -77.28 0.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.61 0.764 . . . . 72.340000000000003 109.63 171.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -143.88 158.78 55.4 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.566 1.146 . . . . 75.310000000000002 108.835 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.27 -19.3 33.99 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.092 2.528 . . . . 63.130000000000003 114.17 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -91.21 17.03 8.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.795 0.838 . . . . 75.299999999999997 111.484 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.91 109.66 18.3 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 108.701 -0.852 . . . . 72.319999999999993 108.701 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 4.4 m-85 -105.69 175.79 5.38 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.49 1.516 . . . . 71.299999999999997 110.421 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.97 148.07 27.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.798 -1.186 . . . . 73.150000000000006 107.798 169.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.52 107.77 14.56 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.754 -0.832 . . . . 63.219999999999999 108.754 170.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.4 mt -62.52 -27.4 69.13 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.058 0.943 . . . . 64.109999999999999 111.198 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -141.17 166.35 25.01 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.699 0.8 . . . . 62.409999999999997 109.728 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.52 147.47 29.65 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.518 -0.764 . . . . 73.219999999999999 109.812 175.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -155.93 118.09 4.07 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.347 1.059 . . . . 75.140000000000001 108.496 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.44 140.73 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.79 -0.819 . . . . 71.200000000000003 108.79 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.92 117.46 3.98 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.073 0.549 . . . . 63.340000000000003 110.526 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 m -59.46 -44.17 93.06 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.313 1.045 . . . . 73.310000000000002 110.386 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -160.26 -147.6 4.97 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 114.712 -1.131 . . . . 62.049999999999997 111.752 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -69.56 -34.87 74.8 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.312 1.045 . . . . 74.140000000000001 111.775 -175.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -84.91 8.69 16.66 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 113.252 0.834 . . . . 74.319999999999993 113.252 -175.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.6 p -127.26 156.84 41.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.299 0.64 . . . . 73.400000000000006 110.552 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.4 tp -109.97 137.13 48.18 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.571 0.749 . . . . 74.109999999999999 109.579 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.4 t -82.86 115.22 21.65 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.369 -0.975 . . . . 74.230000000000004 108.369 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.6 pt -123.48 144.29 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.256 1.022 . . . . 73.329999999999998 109.966 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.2 m -110.73 151.39 27.8 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 109.732 -0.469 . . . . 72.530000000000001 109.732 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -54.82 111.17 0.77 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.353 0.661 . . . . 74.409999999999997 111.682 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.55 -14.69 24.87 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 123.291 0.472 . . . . 55.399999999999999 112.765 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.48 120.91 14.71 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.971 0.908 . . . . 74.129999999999995 109.467 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.631 ' HB2' ' HZ3' ' A' ' 106' ' ' LYS . 8.0 mtmp? -80.87 118.19 22.16 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.665 -0.865 . . . . 73.25 108.665 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 21.7 mt -99.42 160.59 14.17 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.394 -0.965 . . . . 75.430000000000007 108.394 -174.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -121.12 107.3 12.43 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.206 -1.035 . . . . 75.439999999999998 108.206 164.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 74.1 t -94.6 115.18 32.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 108.573 -0.899 . . . . 75.120000000000005 108.573 -176.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.46 -35.34 80.04 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 123.588 0.555 . . . . 74.510000000000005 109.691 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.66 174.57 46.2 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.735 -0.666 . . . . 75.329999999999998 112.209 173.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.537 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 21.5 m-85 -92.91 174.88 7.02 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 108.808 -0.812 . . . . 71.409999999999997 108.808 176.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 22' ' ' PHE . 12.8 m120 -64.07 167.85 5.98 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.945 -0.57 . . . . 74.400000000000006 110.13 164.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -72.31 -4.48 30.02 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 120.707 0.289 . . . . 71.420000000000002 110.324 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -105.21 -19.88 13.68 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.775 0.83 . . . . 74.530000000000001 110.754 170.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.537 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 80.15 12.93 82.71 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-N 116.633 -0.258 . . . . 71.219999999999999 113.603 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.4 ' HG3' ' OD1' ' A' ' 113' ' ' ASN . 9.5 pt-20 -68.4 -54.58 16.26 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.948 1.299 . . . . 72.430000000000007 111.794 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -116.18 173.19 6.72 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.796 0.838 . . . . 72.129999999999995 109.331 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.28 120.66 10.96 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.494 0.717 . . . . 64.530000000000001 110.735 -170.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -75.93 97.14 3.9 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.554 -0.536 . . . . 75.129999999999995 109.554 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -102.14 150.59 23.11 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.507 -0.77 . . . . 75.319999999999993 110.156 -174.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -132.22 122.54 25.39 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 124.047 0.939 . . . . 73.420000000000002 109.105 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 58.3 p -133.88 -176.73 4.27 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.275 1.43 . . . . 72.120000000000005 108.874 171.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -72.67 -3.19 23.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.982 0.513 . . . . 74.409999999999997 111.759 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -89.22 -1.18 57.97 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.786 0.834 . . . . 73.530000000000001 110.785 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.66 -156.23 15.89 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 111.759 -0.537 . . . . 63.420000000000002 111.759 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -144.6 131.53 20.32 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.173 0.589 . . . . 72.129999999999995 110.191 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -179.42 173.48 45.41 Favored Glycine 0 C--N 1.346 1.129 0 O-C-N 123.329 0.393 . . . . 62.539999999999999 112.694 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.432 ' HE1' ' H ' ' A' ' 24' ' ' LYS . 91.0 m95 -76.77 121.24 23.05 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.344 1.058 . . . . 64.319999999999993 111.517 -176.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.19 150.7 44.8 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 124.717 1.207 . . . . 70.319999999999993 108.904 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.51 126.08 14.94 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 121.799 1.666 . . . . 72.239999999999995 109.772 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 m -57.62 -26.79 62.08 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.723 0.809 . . . . 63.310000000000002 111.539 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.621 HD22 HD21 ' A' ' 9' ' ' LEU . 33.5 m-20 -63.22 -28.68 70.2 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.657 1.183 . . . . 73.349999999999994 111.879 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -93.67 1.3 56.64 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.97 0.908 . . . . 74.299999999999997 112.774 -175.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 25.2 pt -133.75 164.68 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.347 0.521 . . . . 72.230000000000004 111.022 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.7 t -159.28 140.94 9.69 Favored Pre-proline 0 N--CA 1.484 1.241 0 O-C-N 123.455 0.472 . . . . 64.129999999999995 110.145 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 62.8 Cg_endo -71.68 114.54 3.98 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.269 1.98 . . . . 62.219999999999999 112.172 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.11 -36.04 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.757 0.823 . . . . 63.340000000000003 112.117 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 80' ' ' ASN . 63.9 t30 -93.06 16.84 11.91 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.662 0.785 . . . . 72.540000000000006 110.111 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 137' ' ' PRO . 22.5 t -63.23 165.3 7.55 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.742 0.817 . . . . 75.219999999999999 110.808 175.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.4 mt -66.99 -10.24 47.46 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.35 1.06 . . . . 74.340000000000003 111.878 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.588 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 29.4 tt0 -66.0 -12.21 53.46 Favored 'General case' 0 C--N 1.369 1.439 0 C-N-CA 123.391 0.676 . . . . 73.109999999999999 111.922 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -61.25 -12.29 12.69 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 123.582 0.753 . . . . 74.109999999999999 110.428 167.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -105.85 150.12 25.89 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.979 1.711 . . . . 64.040000000000006 109.222 167.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.4 p -69.33 -20.49 63.87 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.61 0.967 . . . . 73.25 113.61 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.464 ' CE3' HG23 ' A' ' 218' ' ' VAL . 53.0 p-90 -77.38 -43.38 32.98 Favored 'General case' 0 C--O 1.25 1.108 0 N-CA-C 112.681 0.623 . . . . 73.040000000000006 112.681 -175.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -87.56 146.94 25.55 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.703 -0.48 . . . . 74.040000000000006 109.703 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.588 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 65.3 m-70 -143.21 39.59 1.45 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.12 0.968 . . . . 75.439999999999998 111.352 -174.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.25 -169.05 54.77 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 115.919 1.128 . . . . 73.549999999999997 115.919 163.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 174' ' ' GLU . 8.3 Cg_endo -89.09 95.66 0.34 Allowed 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 124.083 3.188 . . . . 74.409999999999997 111.23 171.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.08 153.04 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.389 1.076 . . . . 75.140000000000001 110.82 -170.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.7 m -75.68 156.87 34.35 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.437 1.095 . . . . 64.510000000000005 112.069 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -62.39 -33.51 74.89 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.769 0.828 . . . . 74.209999999999994 112.162 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -66.75 -45.18 79.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.686 0.795 . . . . 75.540000000000006 110.026 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.23 -31.97 70.89 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.571 0.748 . . . . 73.329999999999998 111.043 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.76 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.39 -51.09 71.29 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.699 -0.682 . . . . 51.009999999999998 110.31 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.47 -31.27 71.9 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.994 0.918 . . . . 74.150000000000006 111.562 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -63.99 -45.75 87.61 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.482 0.713 . . . . 74.430000000000007 111.319 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.445 HD13 HH12 ' A' ' 171' ' ' ARG . 66.5 mt -77.43 -39.08 48.17 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 120.867 0.365 . . . . 74.140000000000001 111.375 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.54 HD23 HG11 ' A' ' 190' ' ' VAL . 34.0 tp -74.85 -20.95 59.53 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.732 -0.667 . . . . 74.530000000000001 112.194 -171.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.1 p -60.21 -28.28 67.85 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.052 0.541 . . . . 71.519999999999996 111.456 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.8 m -75.31 -15.26 60.51 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.039 0.935 . . . . 60.310000000000002 112.353 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.15 165.31 50.54 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 113.785 0.274 . . . . 75.200000000000003 113.785 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.3 pt -113.35 -164.74 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.23 1.012 . . . . 74.299999999999997 109.465 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.73 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 25.3 p-10 -49.32 114.12 0.96 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.909 0.884 . . . . 72.349999999999994 112.375 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.39 14.22 60.45 Favored Glycine 0 C--O 1.258 1.605 0 CA-C-N 116.46 -0.337 . . . . 73.510000000000005 113.498 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 70.4 p -74.85 139.49 43.23 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 108.989 -0.745 . . . . 73.409999999999997 108.989 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.442 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 28.9 p90 -138.32 160.35 39.7 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.215 0.82 . . . . 75.450000000000003 113.215 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.439 HD11 ' NH1' ' A' ' 171' ' ' ARG . 96.4 mt -132.62 132.82 42.89 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.137 -1.431 . . . . 72.340000000000003 107.137 166.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 56.6 t -107.72 115.4 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 106.949 -1.501 . . . . 74.450000000000003 106.949 171.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.76 HH11 ' HA ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -159.1 152.34 22.44 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.204 0.602 . . . . 75.420000000000002 110.236 -175.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.632 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 10.9 pt-20 -107.7 156.55 18.96 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.942 0.401 . . . . 74.299999999999997 111.238 -177.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.9 m -90.71 113.45 25.55 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.065 -0.717 . . . . 64.25 109.065 173.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 33.0 tt0 -70.44 -26.47 63.67 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.427 0.691 . . . . 74.310000000000002 110.626 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.1 p -79.24 5.51 12.09 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.764 1.225 . . . . 62.43 112.183 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 37.5 m -142.93 123.22 7.99 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.668 0.787 . . . . 74.340000000000003 109.88 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.23 111.47 1.28 Allowed 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.298 2.665 . . . . 65.040000000000006 113.528 -171.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.58 9.83 52.25 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-N 115.774 -0.648 . . . . 75.129999999999995 114.552 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -87.53 115.31 24.87 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 109.175 -0.676 . . . . 72.430000000000007 109.175 -176.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.76 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 50.6 mtt85 -110.12 165.71 11.53 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.963 0.905 . . . . 72.019999999999996 108.825 176.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.472 ' HG ' ' HD3' ' A' ' 194' ' ' ARG . 65.9 m -149.85 142.71 24.76 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.754 0.421 . . . . 63.310000000000002 110.951 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 60.8 mt -111.93 130.77 64.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 N-CA-C 107.409 -1.33 . . . . 74.25 107.409 161.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 11.4 m -107.92 118.96 38.11 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.498 -1.228 . . . . 74.040000000000006 107.92 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.411 HD21 HD23 ' A' ' 232' ' ' LEU . 47.3 mt -110.03 135.78 50.32 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.334 1.054 . . . . 75.129999999999995 111.289 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 37.3 ttt-85 -121.18 130.78 53.88 Favored 'General case' 0 C--O 1.257 1.453 0 O-C-N 123.766 0.666 . . . . 75.25 109.276 169.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.73 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 15.6 p90 -147.65 136.85 22.34 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.366 1.041 . . . . 73.219999999999999 108.827 173.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 56.28 26.26 10.29 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 124.514 1.126 . . . . 74.540000000000006 113.263 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 97.04 -9.57 65.6 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.168 0.413 . . . . 73.430000000000007 113.222 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 18.9 ttm180 -98.89 124.28 43.72 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.275 0.63 . . . . 75.439999999999998 109.961 -171.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.54 HG11 HD23 ' A' ' 160' ' ' LEU . 59.1 t -104.87 132.96 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.494 1.117 . . . . 65.540000000000006 108.873 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.476 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 40.8 p90 -145.29 163.08 35.58 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.551 0.741 . . . . 74.230000000000004 109.423 171.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -128.62 151.77 49.11 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.006 0.923 . . . . 73.219999999999999 108.784 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -143.13 140.48 30.86 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 122.689 0.396 . . . . 74.420000000000002 110.056 168.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.472 ' HD3' ' HG ' ' A' ' 181' ' ' SER . 37.5 mmt180 -73.72 134.19 43.47 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.257 -0.883 . . . . 75.530000000000001 111.504 -178.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.76 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 80.5 mt -84.68 109.05 17.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 107.224 -1.399 . . . . 65.200000000000003 107.224 163.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -80.2 125.96 30.5 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.435 -0.802 . . . . 73.230000000000004 109.181 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 27.2 m -90.43 113.55 25.5 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.894 -0.78 . . . . 71.150000000000006 108.894 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -58.6 157.98 8.41 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.91 0.884 . . . . 71.400000000000006 111.082 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 23.3 t -68.27 -11.99 60.29 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.361 0.664 . . . . 74.540000000000006 111.569 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -71.46 -13.21 61.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.455 0.702 . . . . 73.219999999999999 111.436 170.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.9 5.47 86.19 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.984 -0.446 . . . . 64.129999999999995 111.984 -170.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -87.72 153.48 21.33 Favored 'General case' 0 C--N 1.346 0.444 0 C-N-CA 124.219 1.008 . . . . 74.140000000000001 109.29 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.415 HD21 HH11 ' A' ' 180' ' ' ARG . 97.3 mt -99.87 153.71 18.93 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.59 0.756 . . . . 71.430000000000007 110.19 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -166.4 169.53 13.89 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.953 0.783 . . . . 75.349999999999994 110.11 172.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.52 -58.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 105.996 -1.853 . . . . 75.019999999999996 105.996 172.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 37.8 t -81.61 131.98 35.29 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.374 -1.285 . . . . 74.430000000000007 107.587 168.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 74.2 p -65.28 -32.59 74.33 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.407 0.683 . . . . 73.230000000000004 112.4 -171.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -74.12 -23.92 59.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.721 0.809 . . . . 72.329999999999998 111.219 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 68.6 m -97.37 104.45 16.47 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.153 0.981 . . . . 75.530000000000001 110.104 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 20.2 mmt85 -114.51 137.49 51.79 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.749 0.819 . . . . 74.109999999999999 109.192 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 8.3 m-85 -132.89 133.58 43.45 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.652 0.595 . . . . 64.540000000000006 109.639 -173.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -72.29 -40.71 67.34 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.217 0.607 . . . . 71.230000000000004 110.037 169.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.0 p -123.02 153.87 39.25 Favored 'General case' 0 C--N 1.368 1.371 0 CA-C-O 121.903 0.859 . . . . 70.120000000000005 112.201 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 24.9 tp -70.19 -28.75 65.55 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.118 -1.401 . . . . 71.230000000000004 111.002 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.92 99.57 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.236 0.614 . . . . 64.540000000000006 110.852 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -75.82 -31.69 59.49 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.424 -0.807 . . . . 74.420000000000002 111.33 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tt -56.95 -46.83 81.83 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 123.856 0.722 . . . . 73.5 110.544 169.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.464 HG23 ' CE3' ' A' ' 146' ' ' TRP . 51.3 t -72.47 -37.63 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.892 0.877 . . . . 74.510000000000005 111.444 -175.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -60.14 -50.59 73.07 Favored 'General case' 0 C--O 1.258 1.528 0 CA-C-O 121.622 0.725 . . . . 75.109999999999999 110.033 173.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.414 ' CE1' HG13 ' A' ' 224' ' ' VAL . 50.0 t60 -52.51 -54.72 28.79 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.136 -1.393 . . . . 74.140000000000001 109.787 177.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -64.29 -25.42 68.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.866 -1.061 . . . . 73.430000000000007 112.051 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.2 t -74.0 -28.54 61.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.743 0.417 . . . . 63.43 111.793 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.7 t -109.86 -17.44 13.64 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.299 1.962 . . . . 73.420000000000002 116.299 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.414 HG13 ' CE1' ' A' ' 220' ' ' HIS . 36.0 m -96.04 152.47 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 115.371 1.619 . . . . 71.530000000000001 115.371 -166.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -90.98 -1.76 57.78 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.409 2.683 . . . . 72.340000000000003 112.523 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.17 13.94 1.33 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 128.326 2.65 . . . . 63.439999999999998 112.751 -141.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.1 18.0 3.94 Favored Glycine 0 C--N 1.346 1.139 0 C-N-CA 125.443 1.497 . . . . 73.530000000000001 110.933 -171.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.11 120.75 33.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.214 1.006 . . . . 74.109999999999999 109.84 165.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.476 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 80.1 mt -60.15 -40.36 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.391 1.077 . . . . 74.450000000000003 109.497 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.9 t -137.58 140.38 40.96 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 114.835 -1.075 . . . . 74.140000000000001 108.756 170.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 80.6 p -71.77 155.77 40.08 Favored 'General case' 0 C--O 1.247 0.93 0 N-CA-C 108.567 -0.901 . . . . 65.510000000000005 108.567 170.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.442 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 27.8 mt -67.82 100.8 0.98 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 108.661 -0.866 . . . . 75.409999999999997 108.661 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -80.28 -49.99 10.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.309 0.644 . . . . 74.030000000000001 109.886 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 167' ' ' SER . 9.6 p90 -160.57 150.41 14.49 Favored Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 109.675 -0.491 . . . . 75.329999999999998 109.675 173.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.89 138.95 17.09 Favored 'Trans proline' 0 C--N 1.365 1.436 0 C-N-CA 121.964 1.776 . . . . 71.219999999999999 112.495 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.31 142.94 97.1 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 108.68 -0.859 . . . . 64.0 108.68 168.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -69.09 169.55 17.79 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.795 2.33 . . . . 64.099999999999994 114.452 -170.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.476 ' NZ ' ' HG2' ' A' ' 142' ' ' GLU . 67.1 mttm -65.0 161.13 19.32 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.536 -1.211 . . . . 75.439999999999998 109.678 165.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -61.97 -37.55 85.2 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 109.173 -0.677 . . . . 71.409999999999997 109.173 166.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -73.34 172.0 12.04 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.36 1.064 . . . . 71.519999999999996 109.858 170.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -57.73 130.14 81.82 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 123.215 0.606 . . . . 74.340000000000003 111.527 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -86.77 -160.62 0.11 Allowed 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 123.034 2.489 . . . . 71.129999999999995 112.088 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 45.9 m -135.16 124.18 24.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.812 0.845 . . . . 74.349999999999994 108.99 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 29.4 m -75.62 150.43 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.237 0.615 . . . . 74.430000000000007 109.795 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -129.57 155.7 45.37 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.015 -0.735 . . . . 74.340000000000003 109.015 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -140.79 -107.41 0.68 Allowed Glycine 0 N--CA 1.468 0.777 0 CA-C-O 119.28 -0.733 . . . . 52.32 111.754 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 65.0 t 56.38 88.9 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.703 1.201 . . . . 74.239999999999995 110.169 -174.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.2 t -89.45 111.31 44.87 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.863 0.865 . . . . 75.209999999999994 110.09 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -55.63 140.27 83.74 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.281 2.654 . . . . 64.140000000000001 112.157 171.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -141.0 -62.38 0.48 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.207 0.603 . . . . 75.340000000000003 109.696 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -94.84 71.17 3.46 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.301 0.64 . . . . 70.209999999999994 110.008 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.08 88.11 2.66 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.527 0.731 . . . . 72.010000000000005 109.33 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -168.84 119.83 0.75 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.942 0.897 . . . . 75.140000000000001 109.175 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -77.11 -61.96 1.81 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.79 -1.189 . . . . 44.119999999999997 107.79 170.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 N--CA 1.483 1.189 0 C-N-CA 124.359 1.063 . . . . 73.129999999999995 109.923 172.817 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 109.197 -0.668 . . . . 74.040000000000006 109.197 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 170.03 154.56 9.45 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 112.053 -0.419 . . . . 74.109999999999999 112.053 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -127.68 122.03 31.92 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.624 0.77 . . . . 75.010000000000005 111.361 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -100.42 117.2 63.41 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 108.091 -1.077 . . . . 75.420000000000002 108.091 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -48.56 -46.31 24.3 Favored 'Trans proline' 0 C--N 1.386 2.527 0 C-N-CA 124.011 3.14 . . . . 64.430000000000007 114.752 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.19 129.66 2.95 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-O 119.653 -0.526 . . . . 64.310000000000002 113.248 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -82.99 102.08 11.51 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.647 0.779 . . . . 71.420000000000002 109.67 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.2 t -76.37 135.47 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.563 0.745 . . . . 72.219999999999999 111.342 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -87.69 -178.35 6.06 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.595 1.158 . . . . 75.540000000000006 110.247 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.17 147.34 4.88 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.088 -0.405 . . . . 72.439999999999998 112.088 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -78.21 146.73 34.8 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.222 0.609 . . . . 75.450000000000003 109.561 177.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -169.53 141.75 2.46 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.654 0.382 . . . . 75.349999999999994 111.092 -172.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.85 147.99 48.47 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.845 -0.616 . . . . 74.349999999999994 109.952 171.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.6 mmm-85 56.87 76.72 0.46 Allowed Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 123.256 0.622 . . . . 72.340000000000003 109.324 -162.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.5 161.17 28.77 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.318 2.012 . . . . 72.25 111.443 176.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.6 p -69.65 169.72 12.22 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.006 0.431 . . . . 62.149999999999999 111.299 -174.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.8 mt -102.58 126.56 32.6 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 109.13 -0.693 . . . . 75.439999999999998 109.13 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.552 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 75.8 Cg_endo -74.03 174.49 12.32 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.785 2.323 . . . . 71.549999999999997 112.371 177.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.71 147.66 28.34 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.836 0.455 . . . . 64.310000000000002 111.491 -174.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.474 ' HB3' HD12 ' A' ' 23' ' ' ILE . 85.1 mt -88.19 93.69 9.58 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.366 -0.976 . . . . 72.340000000000003 108.366 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -96.84 -48.68 5.36 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.109 0.564 . . . . 75.329999999999998 110.876 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.513 ' HE1' ' HB2' ' A' ' 115' ' ' ASN . 84.0 m-85 -105.93 111.04 23.53 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.092 0.557 . . . . 73.430000000000007 110.183 178.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 20' ' ' LEU . 47.2 mm -118.08 110.44 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.006 0.523 . . . . 71.25 109.614 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.629 ' HB2' ' HZ3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -175.37 150.72 1.15 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.868 1.267 . . . . 73.219999999999999 108.724 179.05 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.27 69.88 2.93 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-O 119.886 -0.397 . . . . 64.040000000000006 113.396 -173.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -177.96 104.18 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.432 1.093 . . . . 75.209999999999994 109.537 172.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.16 -64.04 3.92 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.85 -0.5 . . . . 74.299999999999997 111.85 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.488 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . 32.8 ttmt -167.5 -6.43 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.315 0.646 . . . . 74.299999999999997 111.029 173.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 73.61 29.45 1.54 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.034 1.333 . . . . 73.219999999999999 111.122 -174.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.488 ' HG3' ' HB3' ' A' ' 28' ' ' LYS . 41.9 mt-10 -77.58 149.04 34.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.076 0.55 . . . . 62.130000000000003 111.058 175.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.9 p -147.34 87.89 1.68 Allowed 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.1 -0.954 . . . . 64.150000000000006 109.546 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.8 m -66.07 93.5 0.2 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.122 -0.945 . . . . 70.040000000000006 108.513 170.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -78.73 -168.64 1.47 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.664 0.987 . . . . 73.230000000000004 113.664 -164.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -49.82 133.57 21.75 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.644 1.177 . . . . 72.340000000000003 112.576 -169.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.768 ' HA3' ' HB3' ' A' ' 143' ' ' LYS . . . -88.1 -151.84 23.12 Favored Glycine 0 C--N 1.347 1.178 0 O-C-N 123.463 0.477 . . . . 73.409999999999997 113.719 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 168.6 113.08 0.28 Allowed Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.914 -0.937 . . . . 63.32 111.006 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -71.62 155.25 59.31 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.83 2.353 . . . . 74.040000000000006 113.345 -171.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.416 ' HE1' HD22 ' A' ' 40' ' ' ASN . 56.6 t-80 -154.67 106.86 2.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.489 0.716 . . . . 75.409999999999997 109.508 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.669 ' SG ' ' HA ' ' A' ' 69' ' ' SER . 66.5 m -86.5 144.45 27.25 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.59 0.709 . . . . 74.430000000000007 112.508 -176.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.462 ' H ' ' HE2' ' A' ' 241' ' ' LYS . 17.4 m120 -143.92 157.56 44.27 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.79 -1.55 . . . . 72.209999999999994 107.21 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.679 HG11 ' H ' ' A' ' 43' ' ' VAL . 26.3 t -61.82 145.62 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 110.017 -0.364 . . . . 75.319999999999993 110.017 174.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -75.72 3.11 10.39 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.484 0.714 . . . . 70.209999999999994 111.811 174.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.679 ' H ' HG11 ' A' ' 41' ' ' VAL . 2.2 m 64.42 -1.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 128.408 2.683 . . . . 75.519999999999996 113.662 175.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 58.42 76.47 0.34 Allowed 'General case' 0 C--N 1.354 0.772 0 C-N-CA 124.587 1.155 . . . . 62.420000000000002 109.363 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -109.48 169.27 8.81 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 115.044 -0.98 . . . . 64.129999999999995 111.361 -169.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -100.2 149.8 23.18 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.976 -0.557 . . . . 73.109999999999999 109.871 168.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.05 125.37 30.75 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.024 -0.732 . . . . 73.25 109.024 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.3 mt -71.21 116.44 11.53 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.08 0.4 . . . . 72.030000000000001 112.08 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -86.85 171.51 10.79 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.904 -0.776 . . . . 73.420000000000002 108.904 167.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -120.76 89.51 45.27 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 109.365 -0.605 . . . . 73.519999999999996 109.365 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -92.41 -178.63 0.98 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.748 2.299 . . . . 75.310000000000002 112.566 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.1 p -74.4 -28.76 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.979 0.511 . . . . 73.430000000000007 110.111 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.28 165.91 21.88 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.794 0.838 . . . . 65.310000000000002 109.993 171.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.0 t -136.01 104.73 5.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.406 0.682 . . . . 70.329999999999998 109.7 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -107.08 -175.32 2.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.148 0.979 . . . . 61.310000000000002 109.809 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -121.45 -54.07 1.99 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.062 0.393 . . . . 72.519999999999996 112.062 -168.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 58.45 71.08 1.06 Allowed Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 124.294 1.038 . . . . 74.319999999999993 110.535 -169.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.02 70.21 7.16 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.953 2.435 . . . . 75.319999999999993 110.235 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -123.01 150.76 42.62 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.059 -0.973 . . . . 74.140000000000001 109.616 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 167.05 167.52 27.86 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 114.951 -1.022 . . . . 75.310000000000002 111.746 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.461 ' H ' ' HB ' ' A' ' 43' ' ' VAL . 95.7 mt -135.27 141.5 45.74 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.721 0.808 . . . . 72.510000000000005 109.735 -174.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.6 t -70.35 114.73 8.77 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.906 -0.776 . . . . 52.43 108.906 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.01 -167.25 1.82 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.803 0.841 . . . . 72.510000000000005 111.314 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -160.13 -169.59 2.55 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.778 0.831 . . . . 52.399999999999999 109.646 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.15 98.19 3.13 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.573 -0.528 . . . . 74.420000000000002 109.573 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.452 ' HG3' ' HA3' ' A' ' 246' ' ' GLY . 3.3 mmp_? -139.35 -45.57 0.46 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.393 0.677 . . . . 74.230000000000004 110.099 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -80.29 150.95 29.79 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 115.919 -0.582 . . . . 72.329999999999998 111.356 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -79.21 161.76 26.17 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.373 -0.831 . . . . 73.150000000000006 109.533 169.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.669 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 61.0 m -69.68 -6.86 34.44 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 112.477 0.547 . . . . 53.520000000000003 112.477 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HZ3' ' HB3' ' A' ' 70' ' ' LYS . 7.2 mtpm? 60.63 49.64 6.28 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.747 1.219 . . . . 73.540000000000006 110.857 172.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -82.1 157.29 24.14 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 113.517 -1.674 . . . . 61.450000000000003 111.491 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -160.38 179.46 8.63 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.214 1.005 . . . . 74.310000000000002 111.053 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.3 mt 66.79 20.66 10.6 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 125.254 1.422 . . . . 72.010000000000005 112.944 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 70.8 mt -82.83 93.4 7.45 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.198 -0.667 . . . . 75.140000000000001 109.198 177.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.39 158.52 43.71 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.33 0.652 . . . . 74.010000000000005 110.963 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.28 -166.75 29.04 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.979 -0.9 . . . . 73.230000000000004 110.905 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.98 164.1 36.49 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.364 2.043 . . . . 72.519999999999996 112.265 171.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.4 p -70.1 82.91 0.51 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.111 0.564 . . . . 75.140000000000001 110.235 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -163.24 106.41 1.02 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.168 -1.049 . . . . 72.319999999999993 108.168 -173.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -119.55 -72.04 0.71 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.931 0.493 . . . . 71.109999999999999 111.654 -173.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 71.24 158.5 0.16 Allowed Pre-proline 0 N--CA 1.498 1.962 0 C-N-CA 124.106 0.962 . . . . 70.420000000000002 111.854 -174.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -66.55 -55.62 0.34 Allowed 'Trans proline' 0 C--N 1.39 2.711 0 C-N-CA 122.467 2.111 . . . . 60.340000000000003 113.139 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.487 ' HA ' ' HB3' ' A' ' 140' ' ' SER . 59.8 t30 -94.15 78.96 4.02 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 109.408 -0.59 . . . . 71.209999999999994 109.408 -176.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.639 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 33.5 tp -107.96 123.15 48.21 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.306 -0.861 . . . . 74.329999999999998 111.203 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.71 176.08 5.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.126 1.771 . . . . 75.040000000000006 108.879 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.43 148.88 24.34 Favored 'Isoleucine or valine' 0 C--O 1.252 1.234 0 N-CA-C 108.507 -0.923 . . . . 75.400000000000006 108.507 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.16 118.44 20.4 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 123.67 0.606 . . . . 61.299999999999997 109.654 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.2 mt -82.01 -25.23 34.87 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.969 0.908 . . . . 74.219999999999999 110.611 173.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -132.47 155.92 47.68 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.226 0.61 . . . . 73.209999999999994 110.614 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -72.61 146.05 46.9 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.012 -0.995 . . . . 74.239999999999995 110.542 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -160.65 112.31 1.9 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.693 0.797 . . . . 61.450000000000003 109.238 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.4 t -85.45 137.97 19.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.671 -0.863 . . . . 72.420000000000002 108.671 172.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.56 119.58 7.3 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.399 0.68 . . . . 75.530000000000001 110.576 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.6 m -70.69 -22.62 62.44 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.474 0.709 . . . . 75.340000000000003 110.626 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -159.11 -173.67 27.83 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.94 -0.864 . . . . 63.350000000000001 110.94 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.17 -32.42 73.99 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.938 0.895 . . . . 64.049999999999997 111.312 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -68.63 -24.47 64.56 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.125 0.97 . . . . 74.030000000000001 112.367 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.4 p -101.43 162.94 12.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.18 0.592 . . . . 62.119999999999997 110.065 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.428 HD21 HG21 ' A' ' 123' ' ' THR . 64.7 tp -114.75 137.94 51.33 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.555 0.342 . . . . 74.239999999999995 110.875 -177.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.7 m -78.11 116.11 18.33 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.885 -0.598 . . . . 74.310000000000002 110.051 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 pt -123.69 140.82 46.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.638 0.775 . . . . 75.430000000000007 110.334 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.7 m -115.88 148.14 40.31 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.498 -0.926 . . . . 65.340000000000003 108.498 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -53.89 130.99 39.17 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.954 0.502 . . . . 74.409999999999997 111.284 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.47 -21.61 45.11 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.584 -0.28 . . . . 73.420000000000002 112.806 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -76.84 130.26 37.36 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.309 -0.997 . . . . 73.010000000000005 108.309 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.443 ' HB3' HD12 ' A' ' 84' ' ' LEU . 43.7 mttp -89.87 130.58 36.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.779 0.432 . . . . 74.010000000000005 109.885 -175.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.02 133.82 53.11 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.97 0.908 . . . . 71.25 109.174 -166.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.7 mtm-85 -94.9 108.03 20.06 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 118.736 0.698 . . . . 63.439999999999998 109.429 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 76.8 t -95.11 129.52 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 117.948 0.34 . . . . 75.299999999999997 110.111 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -105.23 -3.77 22.49 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.079 0.952 . . . . 73.420000000000002 111.321 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.31 164.79 16.86 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.919 -0.872 . . . . 63.299999999999997 110.919 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -95.44 171.79 8.48 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.065 -0.717 . . . . 73.239999999999995 109.065 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -63.5 150.11 44.6 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.831 -0.803 . . . . 74.25 108.831 175.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -70.61 -11.04 60.69 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 122.872 0.469 . . . . 74.109999999999999 110.845 -176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.513 ' HB2' ' HE1' ' A' ' 22' ' ' PHE . 62.9 t30 -109.44 -2.98 17.36 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.342 1.057 . . . . 71.329999999999998 110.567 169.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.23 -16.32 59.07 Favored Glycine 0 N--CA 1.48 1.616 0 C-N-CA 123.775 0.703 . . . . 53.210000000000001 114.375 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . 33.7 mt-10 -54.17 -59.9 4.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.847 1.259 . . . . 73.310000000000002 112.955 -172.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -102.8 -179.88 4.09 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.814 -1.085 . . . . 75.340000000000003 109.026 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.63 129.6 12.56 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.52 0.728 . . . . 73.219999999999999 109.226 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -74.96 107.19 6.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.844 0.458 . . . . 73.310000000000002 110.555 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -110.58 160.14 16.93 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.547 0.739 . . . . 75.120000000000005 110.386 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -133.88 117.94 17.37 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.592 0.757 . . . . 75.120000000000005 109.732 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.428 HG21 HD21 ' A' ' 99' ' ' LEU . 68.4 p -113.46 -177.36 3.11 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.786 0.834 . . . . 74.129999999999995 110.273 175.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -70.73 -8.89 55.52 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.117 0.567 . . . . 72.219999999999999 110.849 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -79.77 -27.36 40.43 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.86 1.264 . . . . 64.310000000000002 110.598 173.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.3 -150.73 21.78 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.164 -0.774 . . . . 73.549999999999997 111.164 -173.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -128.25 154.1 46.24 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 117.724 0.762 . . . . 75.109999999999999 109.701 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 171.66 178.68 42.19 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 123.41 0.444 . . . . 72.040000000000006 112.018 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -89.94 120.57 31.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.383 0.673 . . . . 73.219999999999999 110.712 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.8 m -113.99 154.09 46.08 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 124.106 0.962 . . . . 74.25 109.475 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.24 127.98 17.63 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 121.502 1.468 . . . . 55.409999999999997 111.058 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.4 m -58.63 -19.52 39.64 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.822 0.849 . . . . 74.25 111.956 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -70.73 -24.63 62.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.585 1.154 . . . . 73.129999999999995 111.604 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -98.99 -0.7 41.54 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.09 0.956 . . . . 74.230000000000004 112.639 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.3 pt -126.92 153.21 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 118.231 0.468 . . . . 75.010000000000005 110.83 -171.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.5 t -148.73 134.4 9.64 Favored Pre-proline 0 N--CA 1.484 1.259 0 CA-C-O 119.613 -0.232 . . . . 61.219999999999999 110.717 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.97 131.82 32.23 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.434 2.09 . . . . 72.230000000000004 112.404 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.8 m -119.6 -61.1 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.613 0.765 . . . . 73.409999999999997 112.089 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.639 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 66.1 t30 -89.96 -16.85 29.03 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.508 0.723 . . . . 74.5 109.732 -175.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 83' ' ' ASN . 4.6 p -72.42 -157.75 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.382 1.473 . . . . 72.109999999999999 111.563 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.473 HD13 HD21 ' A' ' 214' ' ' LEU . 76.5 mt -57.35 -25.54 59.59 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.145 1.165 . . . . 73.510000000000005 114.145 -175.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -71.41 -14.2 62.08 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 119.054 0.843 . . . . 73.409999999999997 111.187 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.768 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 26.3 tptp -62.35 -22.36 66.03 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.424 0.69 . . . . 75.219999999999999 109.997 168.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -75.37 131.35 40.18 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 108.542 -0.91 . . . . 74.420000000000002 108.542 163.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.1 m -66.36 -15.51 63.33 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 112.55 0.574 . . . . 71.400000000000006 112.55 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.603 ' HB3' ' HG3' ' A' ' 235' ' ' PRO . 29.7 p-90 -85.31 -26.8 26.36 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 113.204 0.816 . . . . 73.420000000000002 113.204 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 42.2 t80 -94.01 132.22 38.71 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.311 -0.625 . . . . 73.349999999999994 109.311 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -126.25 13.42 7.72 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.944 0.72 . . . . 73.109999999999999 112.944 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.26 -159.25 53.53 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-O 119.548 -0.585 . . . . 65.049999999999997 114.54 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.21 104.22 1.75 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.302 2.668 . . . . 64.439999999999998 112.951 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.455 ' HB ' ' HD3' ' A' ' 171' ' ' ARG . 17.3 t -139.86 152.64 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 122.936 0.494 . . . . 73.409999999999997 109.782 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.7 m -73.87 158.48 34.42 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 123.831 0.852 . . . . 71.200000000000003 112.397 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.424 ' O ' ' HG3' ' A' ' 157' ' ' GLU . 52.7 ptt85 -65.97 -32.48 73.99 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.506 -1.225 . . . . 74.439999999999998 112.088 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -72.44 -42.17 65.34 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.106 0.562 . . . . 74.209999999999994 110.365 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.64 -39.58 93.96 Favored 'General case' 0 C--O 1.251 1.167 0 C-N-CA 123.242 0.617 . . . . 63.119999999999997 110.484 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.441 ' HB2' ' HD2' ' A' ' 171' ' ' ARG . . . -55.45 -47.96 75.24 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.087 -0.961 . . . . 74.319999999999993 111.105 172.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 43.8 mt-10 -71.99 -26.96 62.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.958 0.503 . . . . 75.340000000000003 112.064 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -62.52 -43.52 98.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.772 0.429 . . . . 74.239999999999995 110.343 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.612 HD12 HH22 ' A' ' 171' ' ' ARG . 66.8 mt -78.12 -30.1 49.25 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.955 -0.566 . . . . 73.349999999999994 112.258 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.467 HD21 HG11 ' A' ' 190' ' ' VAL . 37.4 tp -78.93 -31.07 45.02 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.916 0.486 . . . . 65.239999999999995 111.487 -174.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 67.8 p -63.53 -19.88 65.15 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.663 0.785 . . . . 64.549999999999997 111.158 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.4 m -80.59 20.65 0.71 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.124 1.37 . . . . 72.439999999999998 111.781 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.63 177.81 16.88 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 114.613 0.605 . . . . 75.239999999999995 114.613 -174.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.7 pt -123.58 -164.55 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 124.819 1.248 . . . . 73.409999999999997 108.757 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.744 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 26.5 p-10 -48.19 120.41 3.55 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.6 0.76 . . . . 74.129999999999995 112.566 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.42 13.81 75.38 Favored Glycine 0 C--O 1.258 1.633 0 CA-C-N 116.621 -0.263 . . . . 70.239999999999995 113.335 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.1 t -73.14 127.79 33.6 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.368 -0.975 . . . . 73.239999999999995 108.368 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 183' ' ' SER . 23.9 p90 -137.95 152.76 49.27 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.706 0.684 . . . . 75.299999999999997 112.575 -174.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.556 HD23 HH21 ' A' ' 171' ' ' ARG . 87.6 mt -131.2 131.72 44.18 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.91 -1.041 . . . . 74.530000000000001 108.59 171.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.499 HG22 HG12 ' A' ' 182' ' ' ILE . 38.9 t -109.09 120.53 60.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.199 -1.408 . . . . 72.409999999999997 107.199 174.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.612 HH22 HD12 ' A' ' 159' ' ' LEU . 16.9 ptp180 -159.17 153.32 23.65 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.707 -0.479 . . . . 73.209999999999994 109.707 -176.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 13.1 pt-20 -97.42 157.41 16.01 Favored 'General case' 0 C--O 1.25 1.096 0 O-C-N 123.704 0.628 . . . . 75.209999999999994 109.862 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 176' ' ' SER . 34.0 t -79.93 144.86 32.99 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.479 -0.782 . . . . 54.409999999999997 109.337 174.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -71.55 -42.79 67.43 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.63 -0.714 . . . . 72.25 110.805 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.8 t -89.52 -1.87 58.17 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.291 0.636 . . . . 62.219999999999999 112.03 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.633 ' HB2' ' HB3' ' A' ' 173' ' ' SER . 15.0 m -116.85 104.24 51.27 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 109.344 -0.613 . . . . 73.219999999999999 109.344 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.24 113.37 1.32 Allowed 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 123.402 2.735 . . . . 60.229999999999997 112.635 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.27 14.28 46.98 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 114.646 0.618 . . . . 75.530000000000001 114.646 173.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -89.55 112.93 24.26 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.25 -1.019 . . . . 72.439999999999998 108.25 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 78.2 mtt85 -104.3 161.23 14.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.904 -1.044 . . . . 74.310000000000002 108.807 -168.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.466 ' HG ' ' HD3' ' A' ' 194' ' ' ARG . 70.3 m -151.77 152.91 33.32 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 123.278 0.631 . . . . 75.409999999999997 109.763 -175.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.499 HG12 HG22 ' A' ' 170' ' ' VAL . 28.4 mt -118.8 137.68 51.97 Favored 'Isoleucine or valine' 0 C--O 1.25 1.123 0 N-CA-C 108.226 -1.027 . . . . 64.230000000000004 108.226 173.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 32.8 m -119.47 120.7 37.59 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.198 -1.038 . . . . 71.340000000000003 108.198 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.42 HD21 HD23 ' A' ' 232' ' ' LEU . 62.1 mt -103.61 141.3 36.28 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.528 0.731 . . . . 73.409999999999997 111.246 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -117.93 134.36 55.03 Favored 'General case' 0 C--O 1.26 1.636 0 N-CA-C 107.253 -1.388 . . . . 71.439999999999998 107.253 166.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.744 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 34.7 t80 -157.81 111.71 2.55 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.719 -1.128 . . . . 74.219999999999999 109.503 -172.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 50.96 44.17 28.54 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.881 1.272 . . . . 72.340000000000003 112.718 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.55 -1.5 87.23 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 114.717 0.647 . . . . 72.319999999999993 114.717 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -102.65 125.95 49.56 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.271 0.629 . . . . 74.140000000000001 109.448 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.467 HG11 HD21 ' A' ' 160' ' ' LEU . 72.1 t -115.1 117.35 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.961 0.904 . . . . 71.510000000000005 108.711 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.407 ' HH ' HG22 ' A' ' 230' ' ' THR . 6.7 p90 -136.58 144.52 44.2 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.413 0.625 . . . . 62.100000000000001 110.637 -177.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -122.92 136.36 54.83 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.231 1.012 . . . . 72.040000000000006 109.766 -167.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -145.34 141.95 28.97 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.842 0.353 . . . . 71.540000000000006 111.343 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.466 ' HD3' ' HG ' ' A' ' 181' ' ' SER . 16.3 tpp180 -80.03 134.39 36.22 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.756 0.822 . . . . 72.299999999999997 111.081 -176.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 91.3 mt -77.24 101.99 3.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 N-CA-C 107.58 -1.267 . . . . 75.099999999999994 107.58 161.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -72.7 122.9 22.23 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.177 -0.92 . . . . 74.519999999999996 109.152 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 21.6 m -100.34 111.14 23.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.143 0.577 . . . . 71.319999999999993 109.77 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.16 157.97 27.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.893 0.877 . . . . 63.520000000000003 111.499 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 77.9 p -62.74 -18.8 63.18 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.315 -0.857 . . . . 72.219999999999999 111.413 174.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -69.05 -15.85 63.56 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.894 1.678 . . . . 72.420000000000002 111.803 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 86.5 2.52 84.91 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 111.605 -0.598 . . . . 73.019999999999996 111.605 -170.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -89.93 143.12 27.06 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.082 0.553 . . . . 74.030000000000001 111.036 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 83.3 mt -95.57 150.15 20.65 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.196 0.998 . . . . 73.409999999999997 110.059 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -164.87 158.37 17.21 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.214 0.606 . . . . 74.510000000000005 111.01 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 94.9 t -127.18 -56.67 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 124.564 1.146 . . . . 71.420000000000002 108.985 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.3 t -100.75 -169.08 1.66 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.902 1.281 . . . . 72.129999999999995 110.433 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 50.9 m -76.81 -43.34 36.96 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.475 0.71 . . . . 75.420000000000002 112.153 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.56 -29.86 63.91 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.242 0.544 . . . . 75.310000000000002 111.368 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.505 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 83.6 p -68.65 118.17 11.31 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.411 -0.813 . . . . 62.420000000000002 111.813 -173.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -147.16 114.48 6.28 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.983 1.313 . . . . 65.230000000000004 107.653 170.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.505 ' CE2' ' HB2' ' A' ' 209' ' ' SER . 21.3 m-85 -130.53 138.83 50.4 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 118.449 0.568 . . . . 65.230000000000004 111.805 -171.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -79.95 -31.11 40.0 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.963 0.505 . . . . 73.239999999999995 109.968 169.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 60.1 p -126.59 148.09 49.81 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.734 0.778 . . . . 72.0 111.966 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.473 HD21 HD13 ' A' ' 141' ' ' LEU . 24.9 tp -69.87 -21.67 63.31 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.22 -1.355 . . . . 63.439999999999998 111.194 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.87 -47.49 77.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.394 0.678 . . . . 72.129999999999995 110.515 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -70.14 -31.74 69.4 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 115.705 -0.68 . . . . 74.329999999999998 111.008 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 10.1 tt -55.47 -56.28 22.06 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 123.699 0.625 . . . . 72.439999999999998 109.859 172.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.58 -39.15 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.736 0.814 . . . . 64.430000000000007 111.622 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -59.83 -57.04 14.61 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.692 0.758 . . . . 73.230000000000004 111.222 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.421 ' CE1' HG11 ' A' ' 224' ' ' VAL . 40.4 t-80 -56.52 -44.16 80.53 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.771 -1.104 . . . . 74.510000000000005 109.854 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 217' ' ' LEU . 1.9 t60 -72.28 -19.96 61.6 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.535 1.134 . . . . 73.109999999999999 110.417 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 29.1 t -82.76 -20.26 36.26 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.016 0.926 . . . . 74.239999999999995 110.895 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.8 t -115.92 -8.52 11.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.401 2.0 . . . . 72.150000000000006 116.401 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.421 HG11 ' CE1' ' A' ' 220' ' ' HIS . 15.3 m -89.54 143.11 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 120.95 1.705 . . . . 72.340000000000003 114.505 -171.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.58 -0.53 57.58 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 128.713 2.805 . . . . 64.049999999999997 111.883 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -78.23 13.85 1.37 Allowed 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 130.066 3.347 . . . . 75.049999999999997 112.621 -146.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.83 18.68 3.51 Favored Glycine 0 C--N 1.343 0.928 0 C-N-CA 124.038 0.828 . . . . 62.329999999999998 111.43 -172.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 71.4 mt -92.06 121.47 33.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.627 0.771 . . . . 72.319999999999993 110.617 163.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 76.6 mt -53.76 -42.58 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.779 0.832 . . . . 73.25 109.546 169.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.407 HG22 ' HH ' ' A' ' 191' ' ' TYR . 8.9 t -140.87 140.42 34.57 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.673 -1.149 . . . . 63.009999999999998 108.446 173.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.1 p -69.45 162.98 26.32 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.933 -0.576 . . . . 74.310000000000002 109.565 171.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.42 HD23 HD21 ' A' ' 184' ' ' LEU . 57.2 mt -65.55 103.84 0.91 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 110.073 -0.343 . . . . 71.209999999999994 110.073 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -77.99 -60.91 2.18 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.194 -0.669 . . . . 71.549999999999997 109.194 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.47 ' HH ' HG13 ' A' ' 43' ' ' VAL . 19.2 p90 -158.36 149.53 16.49 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 120.492 -0.483 . . . . 74.400000000000006 112.143 -175.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.603 ' HG3' ' HB3' ' A' ' 146' ' ' TRP . 46.5 Cg_exo -58.33 123.01 12.64 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.882 2.388 . . . . 53.109999999999999 112.195 172.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -58.27 135.21 84.86 Favored Pre-proline 0 C--O 1.246 0.893 0 O-C-N 123.665 0.603 . . . . 53.130000000000003 109.981 175.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.467 ' HA ' ' HD2' ' A' ' 241' ' ' LYS . 36.1 Cg_endo -65.96 135.74 42.13 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.887 1.725 . . . . 75.25 113.979 -175.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.504 ' HA ' HD22 ' A' ' 159' ' ' LEU . 18.3 ptpt -66.85 161.34 24.1 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.71 -1.132 . . . . 70.209999999999994 109.235 162.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -36.69 -39.26 0.2 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.575 1.55 . . . . 74.530000000000001 114.005 -173.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -133.89 126.7 31.0 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 108.697 -0.853 . . . . 74.109999999999999 108.697 171.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 237' ' ' PRO . 85.7 tttt -149.28 135.76 10.43 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 123.808 0.843 . . . . 74.409999999999997 108.753 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.99 154.26 68.15 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.902 2.402 . . . . 73.519999999999996 114.174 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 87.6 m -88.75 130.38 35.36 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.726 0.81 . . . . 55.420000000000002 109.661 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 41' ' ' VAL . 21.8 m -126.06 160.44 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.383 0.673 . . . . 75.340000000000003 109.908 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -141.43 -171.64 3.35 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.578 -0.897 . . . . 75.010000000000005 108.578 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.452 ' HA3' ' HG3' ' A' ' 66' ' ' ARG . . . 103.98 54.73 0.8 Allowed Glycine 0 C--N 1.342 0.894 0 O-C-N 123.43 0.457 . . . . 75.549999999999997 113.591 175.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.6 m -78.55 149.92 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.131 -1.063 . . . . 64.319999999999993 108.131 166.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.3 p -150.09 108.74 3.23 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 122.662 0.385 . . . . 74.310000000000002 110.861 -169.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.15 162.67 39.18 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.368 2.712 . . . . 73.200000000000003 112.968 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -140.94 -179.57 6.15 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.692 0.797 . . . . 75.310000000000002 109.7 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -123.31 145.74 48.47 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.141 0.576 . . . . 75.540000000000006 110.037 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -135.75 159.76 40.64 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.562 0.745 . . . . 72.329999999999998 110.032 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.496 ' HB3' ' HZ3' ' A' ' 253' ' ' LYS . 9.5 mtpm? -110.29 129.7 55.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.236 -0.893 . . . . 65.420000000000002 109.337 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -80.29 150.7 29.88 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.347 -0.612 . . . . 74.140000000000001 109.347 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 123.56 0.744 . . . . 74.430000000000007 110.932 -172.496 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 109.533 -0.543 . . . . 75.430000000000007 109.533 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.29 29.99 0.58 Allowed Glycine 0 C--N 1.346 1.137 0 O-C-N 123.246 0.341 . . . . 62.539999999999999 112.524 -177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -73.21 112.79 9.59 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.385 -0.598 . . . . 73.030000000000001 109.385 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -129.51 70.36 81.81 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 123.808 0.843 . . . . 75.25 109.263 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -81.73 -5.41 12.37 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.175 1.917 . . . . 51.200000000000003 112.633 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.75 132.65 5.7 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-O 119.315 -0.714 . . . . 72.219999999999999 111.58 -174.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -178.47 136.88 0.16 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.928 0.891 . . . . 71.239999999999995 108.783 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.31 -168.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 123.664 0.786 . . . . 74.200000000000003 110.245 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.431 HD13 HD22 ' A' ' 133' ' ' ASN . 0.3 OUTLIER -125.7 149.25 48.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.759 1.224 . . . . 74.230000000000004 109.617 176.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.06 36.23 0.66 Allowed Glycine 0 C--N 1.342 0.882 0 N-CA-C 111.539 -0.625 . . . . 75.120000000000005 111.539 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.76 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 1.2 m-20 -123.36 178.1 5.3 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.791 0.836 . . . . 75.530000000000001 109.309 -174.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.409 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 20.3 mm-40 -115.03 -74.43 0.61 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.507 0.723 . . . . 74.129999999999995 109.731 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -69.77 104.72 2.52 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.172 0.989 . . . . 74.5 109.479 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.1 mmm-85 54.17 77.13 0.46 Allowed Pre-proline 0 CA--C 1.553 1.08 0 O-C-N 124.269 0.981 . . . . 74.450000000000003 109.667 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.76 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 33.6 Cg_endo -63.86 166.53 15.91 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.252 1.968 . . . . 64.140000000000001 112.488 -177.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.1 m -65.23 170.54 4.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.218 0.532 . . . . 72.010000000000005 110.303 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.3 mt -107.23 125.15 33.14 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.103 -1.073 . . . . 72.549999999999997 108.103 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.17 174.51 8.89 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.786 2.324 . . . . 75.349999999999994 112.158 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.43 145.67 39.14 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.54 0.336 . . . . 64.299999999999997 110.124 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HB3' HD13 ' A' ' 23' ' ' ILE . 64.6 mt -89.46 101.96 14.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.373 1.069 . . . . 72.040000000000006 109.684 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -96.05 -50.92 4.65 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.419 0.688 . . . . 73.209999999999994 110.074 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -104.45 116.54 32.29 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.197 0.999 . . . . 74.329999999999998 110.077 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.466 HD13 ' HB3' ' A' ' 20' ' ' LEU . 37.3 mm -118.38 114.05 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.617 0.767 . . . . 70.340000000000003 111.124 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.537 ' H ' ' HE1' ' A' ' 129' ' ' TRP . 75.5 mmtt -115.62 157.55 24.01 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.07 1.348 . . . . 74.219999999999999 109.085 166.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.83 14.17 1.96 Allowed Glycine 0 C--N 1.343 0.932 0 CA-C-N 116.272 -0.422 . . . . 73.530000000000001 112.456 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.73 146.38 27.18 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.696 0.799 . . . . 72.310000000000002 110.564 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 146.25 86.1 0.06 OUTLIER Glycine 0 C--N 1.35 1.325 0 N-CA-C 111.889 -0.485 . . . . 74.109999999999999 111.889 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -78.46 84.73 4.59 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.337 0.655 . . . . 73.109999999999999 111.363 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -85.48 -59.43 2.32 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.489 1.116 . . . . 72.310000000000002 110.833 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.74 159.93 39.9 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 120.911 0.386 . . . . 72.150000000000006 110.632 168.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 22.4 p -165.08 94.23 0.64 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.027 -0.988 . . . . 74.540000000000006 108.769 166.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.426 ' HB2' ' NH2' ' A' ' 108' ' ' ARG . 16.2 m -64.49 143.99 57.52 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 108.987 -0.746 . . . . 63.210000000000001 108.987 173.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 45.5 mmm-85 -74.03 -26.38 60.39 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.734 0.642 . . . . 73.030000000000001 112.734 -171.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -81.25 147.11 30.11 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 120.864 0.364 . . . . 74.230000000000004 111.769 -172.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.91 -100.61 0.5 Allowed Glycine 0 C--N 1.343 0.924 0 N-CA-C 109.006 -1.638 . . . . 73.450000000000003 109.006 172.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.03 -115.55 4.04 Favored Glycine 0 CA--C 1.541 1.659 0 CA-C-O 118.469 -1.184 . . . . 72.049999999999997 115.252 166.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -65.19 126.59 16.67 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 123.994 3.13 . . . . 75.310000000000002 114.027 -170.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -148.39 167.17 25.97 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.939 0.895 . . . . 74.120000000000005 109.945 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.84 145.86 50.8 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.538 0.735 . . . . 74.209999999999994 111.478 -173.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -74.58 146.76 42.28 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.875 0.87 . . . . 75.420000000000002 110.217 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.488 HG23 HD21 ' A' ' 88' ' ' LEU . 12.2 p -127.78 155.91 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.273 0.629 . . . . 73.420000000000002 110.176 -176.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -149.46 142.32 24.72 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.373 1.069 . . . . 70.120000000000005 108.769 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.403 HG13 HD11 ' A' ' 73' ' ' LEU . 34.6 m -124.06 164.5 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.413 0.685 . . . . 65.299999999999997 110.817 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -87.29 150.96 23.52 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.492 -0.776 . . . . 72.319999999999993 108.943 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -119.84 98.26 6.01 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.804 0.442 . . . . 73.340000000000003 110.308 -170.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.409 ' H ' ' HG3' ' A' ' 12' ' ' GLN . 11.9 tp10 -132.38 104.94 6.98 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.435 -0.95 . . . . 73.400000000000006 108.435 170.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.85 153.47 39.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.074 0.95 . . . . 71.340000000000003 109.918 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.2 mt -110.95 124.84 52.92 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.34 0.656 . . . . 72.209999999999994 109.505 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.16 118.04 12.48 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.526 -0.546 . . . . 75.439999999999998 109.526 171.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -94.42 110.8 50.84 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 123.816 0.847 . . . . 74.329999999999998 109.556 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.12 -47.36 3.52 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.358 2.039 . . . . 74.329999999999998 111.949 176.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.2 m -141.07 157.75 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.236 1.014 . . . . 73.109999999999999 110.148 -178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.92 -55.81 1.68 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.217 1.007 . . . . 71.340000000000003 108.427 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.9 m -143.93 98.78 3.28 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.306 -0.998 . . . . 75.420000000000002 108.306 172.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.41 -39.36 25.06 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.007 0.432 . . . . 75.329999999999998 109.877 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -79.13 115.66 18.93 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.214 1.006 . . . . 75.420000000000002 108.652 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 58.61 71.06 1.05 Allowed Pre-proline 0 CA--C 1.551 0.986 0 O-C-N 124.573 1.17 . . . . 74.310000000000002 109.885 -176.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -83.36 36.4 0.61 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 123.722 2.948 . . . . 72.430000000000007 113.482 -170.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -76.7 86.52 3.34 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.321 0.648 . . . . 74.230000000000004 109.495 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.87 72.44 0.67 Allowed Glycine 0 C--N 1.348 1.201 0 CA-C-N 115.933 -0.576 . . . . 74.140000000000001 112.038 -177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.9 105.34 0.66 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.842 1.257 . . . . 74.540000000000006 111.846 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.3 m 64.69 5.08 2.59 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 114.141 1.163 . . . . 73.109999999999999 114.141 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -69.7 -36.72 76.19 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 118.173 0.442 . . . . 72.329999999999998 111.77 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.54 75.82 9.05 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.893 0.877 . . . . 72.409999999999997 109.381 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -162.61 146.2 11.42 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.823 -1.08 . . . . 73.530000000000001 110.009 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -79.89 87.46 5.34 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 106.808 -1.553 . . . . 75.129999999999995 106.808 171.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 24.5 p90 -67.82 161.68 25.68 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.827 -1.079 . . . . 70.019999999999996 111.78 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -73.91 100.21 3.45 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 109.417 -0.586 . . . . 74.400000000000006 109.417 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.5 t -79.48 168.86 18.88 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.186 -0.672 . . . . 65.519999999999996 109.186 168.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 166.07 22.87 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.105 0.479 . . . . 73.140000000000001 110.85 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -129.35 140.63 51.32 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.337 -0.847 . . . . 74.310000000000002 108.797 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -86.26 117.47 25.09 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.676 -0.861 . . . . 73.230000000000004 108.676 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.403 HD11 HG13 ' A' ' 43' ' ' VAL . 81.3 mt -79.39 -174.34 4.15 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.95 0.9 . . . . 73.209999999999994 111.123 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.31 82.87 0.37 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.647 0.779 . . . . 75.519999999999996 109.408 175.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -167.83 -179.49 4.26 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.326 1.051 . . . . 74.25 109.917 -172.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.89 82.19 0.04 OUTLIER Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.919 -0.934 . . . . 52.25 111.586 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.31 112.74 1.33 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.122 2.548 . . . . 74.239999999999995 111.838 177.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.0 m -83.38 102.04 11.75 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.841 0.856 . . . . 64.120000000000005 110.794 -176.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -149.13 123.55 9.66 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.367 -0.833 . . . . 75.439999999999998 108.769 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -78.84 111.04 14.59 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 123.838 0.711 . . . . 73.299999999999997 109.793 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -151.94 148.96 22.47 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.563 1.145 . . . . 74.040000000000006 108.659 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -40.28 -57.79 1.11 Allowed 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 123.875 3.05 . . . . 64.140000000000001 115.008 172.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.03 73.94 0.7 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.771 0.796 . . . . 73.319999999999993 111.232 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.1 tp -91.11 119.53 31.31 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.668 0.747 . . . . 74.230000000000004 110.939 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -111.96 173.86 6.16 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.293 1.437 . . . . 74.219999999999999 109.417 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.31 154.18 12.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.633 -1.247 . . . . 72.439999999999998 107.633 174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.457 ' HB1' HD11 ' A' ' 107' ' ' LEU . . . -94.85 132.89 39.17 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.334 -0.247 . . . . 74.030000000000001 110.334 173.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.488 HD21 HG23 ' A' ' 41' ' ' VAL . 79.3 mt -86.21 -20.94 27.78 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.479 0.711 . . . . 71.530000000000001 110.587 172.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -129.09 153.21 47.87 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.631 -0.713 . . . . 71.129999999999995 109.474 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.67 160.54 32.42 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.363 -0.835 . . . . 74.319999999999993 108.777 163.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' HB3' HG12 ' A' ' 101' ' ' ILE . 56.3 t80 -159.87 111.18 1.98 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.457 -0.942 . . . . 74.230000000000004 108.457 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.0 t -81.21 124.26 38.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 107.235 -1.394 . . . . 74.129999999999995 107.235 170.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.412 ' HB1' ' N ' ' A' ' 100' ' ' SER . . . -66.14 143.99 56.95 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.993 0.517 . . . . 74.519999999999996 110.799 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.5 m -76.59 -13.62 60.06 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.735 0.814 . . . . 60.240000000000002 110.655 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.68 -155.14 26.36 Favored Glycine 0 C--N 1.353 1.481 0 N-CA-C 111.823 -0.511 . . . . 71.140000000000001 111.823 176.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -65.91 -28.92 69.29 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.253 1.021 . . . . 72.120000000000005 111.416 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -69.38 -13.73 62.53 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.984 1.314 . . . . 74.329999999999998 112.419 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.0 p -128.82 162.8 26.62 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.348 1.059 . . . . 73.25 109.707 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.449 ' HB3' HG13 ' A' ' 130' ' ' VAL . 53.7 tp -111.39 121.61 45.67 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.198 0.599 . . . . 74.099999999999994 110.382 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.412 ' N ' ' HB1' ' A' ' 93' ' ' ALA . 16.0 p -72.12 116.08 12.12 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.524 -0.547 . . . . 72.319999999999993 109.524 173.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 91' ' ' PHE . 33.5 pt -122.18 161.51 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.145 0.578 . . . . 75.329999999999998 109.735 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 33.3 m -121.54 148.33 44.62 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.364 0.666 . . . . 75.010000000000005 110.172 -177.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -57.47 128.31 36.38 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.665 0.386 . . . . 72.030000000000001 110.255 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.06 -21.39 37.36 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 120.19 -0.228 . . . . 72.120000000000005 112.923 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -67.91 131.16 44.99 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.516 0.726 . . . . 74.099999999999994 110.282 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -78.71 121.21 24.44 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.146 0.578 . . . . 72.109999999999999 110.367 177.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.523 ' HA ' HG21 ' A' ' 123' ' ' THR . 14.7 mt -103.66 152.39 21.85 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.166 0.986 . . . . 74.349999999999994 108.424 -175.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 31' ' ' SER . 72.5 mtt-85 -123.25 104.74 9.34 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.809 -1.182 . . . . 75.5 107.809 172.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.596 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 53.9 t -96.01 114.22 32.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 108.449 -0.945 . . . . 54.25 108.449 -172.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.4 mt -79.74 -10.81 59.84 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.608 -1.178 . . . . 73.299999999999997 110.59 -174.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.89 157.19 9.2 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 110.521 -1.032 . . . . 64.409999999999997 110.521 173.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -94.11 168.01 11.21 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.601 -0.889 . . . . 74.430000000000007 108.601 174.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -77.63 147.46 35.56 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.578 -1.267 . . . . 62.549999999999997 107.578 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -70.04 -17.07 63.24 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.584 0.754 . . . . 75.310000000000002 112.371 -175.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.501 ' HB3' ' HG2' ' A' ' 117' ' ' GLU . 65.2 t30 -86.05 -11.49 52.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.79 0.436 . . . . 74.510000000000005 110.527 174.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.38 14.06 77.13 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.385 -0.37 . . . . 73.239999999999995 113.137 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 115' ' ' ASN . 7.9 pt-20 -75.38 -56.02 5.12 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.519 1.128 . . . . 75.239999999999995 110.629 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -124.59 179.09 5.1 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.796 1.238 . . . . 73.209999999999994 108.813 -176.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.3 133.88 16.59 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.243 0.617 . . . . 74.230000000000004 110.154 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -81.11 95.65 6.93 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 109.099 -0.704 . . . . 73.430000000000007 109.099 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.596 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -104.91 170.26 7.97 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.158 -0.928 . . . . 74.239999999999995 110.854 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -148.61 129.5 14.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.897 -1.047 . . . . 72.319999999999993 108.544 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.523 HG21 ' HA ' ' A' ' 107' ' ' LEU . 72.1 p -131.92 -171.13 2.55 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.526 1.13 . . . . 52.530000000000001 108.995 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -68.72 -8.55 43.78 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.607 0.763 . . . . 73.540000000000006 111.048 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.414 ' HB2' HD11 ' A' ' 99' ' ' LEU . 42.0 m-20 -83.16 -24.26 32.57 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.278 1.031 . . . . 75.400000000000006 110.144 173.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 127.99 -167.91 20.12 Favored Glycine 0 C--N 1.354 1.574 0 CA-C-O 119.668 -0.518 . . . . 72.430000000000007 112.183 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -100.14 157.76 16.34 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 117.699 0.749 . . . . 65.150000000000006 109.889 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.47 177.87 36.7 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 112.021 -0.432 . . . . 72.25 112.021 174.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.537 ' HE1' ' H ' ' A' ' 24' ' ' LYS . 84.3 m95 -91.08 134.67 34.33 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.367 0.603 . . . . 72.140000000000001 111.383 -176.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' A' ' 99' ' ' LEU . 5.4 m -136.47 140.4 32.31 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.726 1.61 . . . . 71.230000000000004 108.551 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.81 143.95 47.14 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.012 1.808 . . . . 64.450000000000003 111.679 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.1 m -60.32 -19.62 55.99 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 124.352 1.061 . . . . 74.25 113.12 -173.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.431 HD22 HD13 ' A' ' 9' ' ' LEU . 75.5 m-20 -79.38 -27.03 41.89 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 112.298 0.481 . . . . 74.109999999999999 112.298 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -79.37 -18.92 51.43 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.507 0.504 . . . . 62.43 110.509 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.494 HD11 HG23 ' A' ' 109' ' ' VAL . 18.7 pt -118.65 146.0 23.86 Favored 'Isoleucine or valine' 0 C--N 1.364 1.201 0 C-N-CA 123.463 0.705 . . . . 74.129999999999995 110.278 -165.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.485 ' OG1' ' HG ' ' A' ' 88' ' ' LEU . 9.6 m -149.66 112.14 3.41 Favored Pre-proline 0 CA--C 1.559 1.291 0 CA-C-O 119.196 -0.431 . . . . 52.009999999999998 112.145 -163.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.92 116.35 4.25 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.426 2.084 . . . . 75.109999999999999 112.608 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.5 m -84.99 -26.63 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.089 0.471 . . . . 72.109999999999999 110.04 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -86.74 16.81 4.42 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.947 -1.024 . . . . 75.230000000000004 110.54 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.0 t -49.54 125.9 12.32 Favored 'General case' 0 C--N 1.361 1.081 0 C-N-CA 123.938 0.895 . . . . 61.439999999999998 110.833 177.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.3 mt -60.85 -11.28 7.28 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.595 1.158 . . . . 75.019999999999996 112.0 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -53.6 -14.45 0.86 Allowed 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.527 1.531 . . . . 75.219999999999999 113.593 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -55.81 -35.04 65.91 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 109.483 -0.562 . . . . 75.329999999999998 109.483 172.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -89.37 123.24 33.35 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.283 -1.377 . . . . 73.319999999999993 107.283 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.4 m -67.04 -6.56 17.69 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 114.197 1.184 . . . . 54.420000000000002 114.197 -166.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.445 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 38.7 p-90 -69.2 -35.68 76.49 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.04 0.385 . . . . 75.400000000000006 112.04 174.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -93.25 145.69 24.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.469 0.708 . . . . 74.140000000000001 109.187 177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -135.38 7.16 3.32 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 112.986 0.735 . . . . 74.200000000000003 112.986 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 89.92 -167.57 33.42 Favored Glycine 0 N--CA 1.477 1.389 0 N-CA-C 115.091 0.797 . . . . 73.299999999999997 115.091 168.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.85 101.04 1.14 Allowed 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 123.399 2.733 . . . . 52.32 111.464 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.637 HG23 HH21 ' A' ' 171' ' ' ARG . 35.0 t -141.34 150.14 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 CA-C-N 116.065 -0.516 . . . . 73.349999999999994 110.027 -172.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.7 m -67.49 149.4 50.24 Favored 'General case' 0 C--O 1.252 1.205 0 C-N-CA 124.624 1.17 . . . . 74.230000000000004 111.965 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -57.72 -34.23 69.26 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.327 -0.851 . . . . 75.049999999999997 110.801 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -57.53 -55.15 38.6 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.379 0.672 . . . . 73.010000000000005 110.595 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.5 91.2 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.723 0.809 . . . . 63.310000000000002 111.005 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.18 -52.35 65.93 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.206 -0.907 . . . . 73.120000000000005 111.383 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -72.11 -27.72 62.82 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.953 0.901 . . . . 72.219999999999999 110.293 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -62.52 -47.65 82.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.043 0.537 . . . . 75.209999999999994 110.933 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.709 HD12 HH12 ' A' ' 171' ' ' ARG . 81.8 mt -66.88 -41.86 86.53 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.091 0.472 . . . . 73.420000000000002 110.746 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.428 HD22 HG13 ' A' ' 190' ' ' VAL . 31.5 tp -66.44 -24.29 66.42 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.273 -0.876 . . . . 75.519999999999996 111.984 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 36.5 t -63.97 -20.41 65.86 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.086 0.954 . . . . 72.109999999999999 112.432 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.8 p -105.73 15.83 26.22 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.337 0.655 . . . . 71.530000000000001 111.229 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -99.75 157.98 19.74 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 116.223 -0.444 . . . . 75.349999999999994 112.66 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 20.7 pt -107.14 -163.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.044 0.938 . . . . 74.129999999999995 110.172 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.764 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 26.7 p-10 -47.82 115.53 1.19 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.225 1.01 . . . . 75.430000000000007 113.125 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 86.04 13.65 68.57 Favored Glycine 0 C--O 1.255 1.419 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 112.581 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 22.2 t -72.66 133.72 44.76 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.623 -0.88 . . . . 74.340000000000003 108.623 176.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.527 ' HB3' HD22 ' A' ' 184' ' ' LEU . 14.5 p90 -142.25 162.55 35.18 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.405 0.52 . . . . 53.109999999999999 112.405 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.524 ' HB3' ' HD3' ' A' ' 171' ' ' ARG . 80.4 mt -141.93 133.15 26.31 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.253 -1.017 . . . . 75.319999999999993 108.253 172.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.43 110.9 32.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 107.543 -1.281 . . . . 71.450000000000003 107.543 174.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.709 HH12 HD12 ' A' ' 159' ' ' LEU . 4.4 mmm-85 -120.68 162.51 19.57 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.048 -1.093 . . . . 71.430000000000007 108.048 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.602 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 21.4 pt-20 -117.15 155.33 29.54 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.038 0.447 . . . . 75.239999999999995 110.099 165.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 37.2 m -86.02 127.73 34.71 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.95 -1.023 . . . . 74.319999999999993 110.424 -176.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -70.63 -34.71 72.39 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.103 1.361 . . . . 63.130000000000003 110.565 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 36.0 p -91.15 -14.76 30.54 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.577 1.151 . . . . 63.109999999999999 111.882 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 44.7 m -135.42 76.25 56.36 Favored Pre-proline 0 N--CA 1.477 0.924 0 N-CA-C 108.117 -1.068 . . . . 70.310000000000002 108.117 171.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.63 141.85 46.91 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.879 2.386 . . . . 72.019999999999996 112.968 -174.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.93 -22.65 27.65 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.726 -0.67 . . . . 75.040000000000006 111.903 -171.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -93.07 120.05 32.95 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.717 0.807 . . . . 74.230000000000004 109.104 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.602 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 52.1 mtt180 -110.52 169.57 8.66 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.205 -0.907 . . . . 74.420000000000002 109.724 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.7 t -152.18 137.3 17.36 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 123.731 0.812 . . . . 64.439999999999998 109.204 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.64 133.06 53.54 Favored 'Isoleucine or valine' 0 C--O 1.247 0.933 0 N-CA-C 107.601 -1.259 . . . . 75.299999999999997 107.601 171.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 19.8 m -111.49 117.28 32.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.661 -1.237 . . . . 75.400000000000006 107.661 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.527 HD22 ' HB3' ' A' ' 168' ' ' PHE . 43.5 mt -103.84 143.26 33.06 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.508 1.123 . . . . 70.519999999999996 110.863 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 29.7 ttt180 -132.27 129.87 40.15 Favored 'General case' 0 C--O 1.256 1.442 0 C-N-CA 124.059 0.944 . . . . 73.519999999999996 108.47 169.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.764 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 4.4 p90 -147.74 137.52 22.68 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.418 -0.956 . . . . 74.030000000000001 108.418 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 55.12 33.61 20.82 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.172 0.989 . . . . 65.420000000000002 111.864 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.47 -7.01 80.81 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.556 -0.747 . . . . 74.310000000000002 113.816 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 18.6 tpp180 -99.83 123.44 44.09 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.564 0.746 . . . . 75.439999999999998 110.281 -171.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.428 HG13 HD22 ' A' ' 160' ' ' LEU . 72.6 t -101.23 133.57 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.694 1.197 . . . . 74.319999999999993 109.602 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.571 ' HH ' HG22 ' A' ' 230' ' ' THR . 33.9 p90 -146.0 156.96 43.85 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.787 0.835 . . . . 63.350000000000001 109.532 169.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -127.74 140.39 52.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.825 0.85 . . . . 74.329999999999998 108.842 -172.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -141.47 140.09 33.47 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 110.135 -0.321 . . . . 51.43 110.135 174.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -79.18 137.67 37.54 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.405 -0.816 . . . . 71.540000000000006 111.183 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 91.1 mt -78.39 102.49 4.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 107.045 -1.465 . . . . 74.420000000000002 107.045 162.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -75.57 124.64 27.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.391 -1.337 . . . . 75.239999999999995 107.391 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 56.6 m -102.67 121.01 41.56 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.03 0.532 . . . . 72.230000000000004 109.86 -174.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -74.62 145.41 43.3 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.749 -1.204 . . . . 71.430000000000007 107.749 170.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.7 m -69.24 -9.78 54.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.197 0.599 . . . . 75.120000000000005 111.492 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -65.74 -18.96 65.7 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.751 1.22 . . . . 65.019999999999996 110.709 172.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 97.8 -1.17 59.6 Favored Glycine 0 C--N 1.355 1.627 0 C-N-CA 123.809 0.718 . . . . 54.009999999999998 111.622 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -90.83 137.85 32.05 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 123.571 0.749 . . . . 70.25 110.049 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 89.2 mt -96.58 157.83 15.71 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.412 0.685 . . . . 71.329999999999998 110.149 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -164.83 174.28 10.8 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 123.913 0.758 . . . . 70.310000000000002 110.595 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.6 t -138.86 -65.68 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.487 -1.301 . . . . 74.450000000000003 107.487 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.0 t -91.48 -175.98 4.38 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.326 1.05 . . . . 75.120000000000005 110.797 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 32.7 t -66.47 -48.11 70.93 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.535 0.734 . . . . 74.129999999999995 111.761 -174.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -87.04 -3.78 59.11 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.229 0.612 . . . . 72.510000000000005 111.684 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 74.4 m -69.18 116.57 9.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.692 0.797 . . . . 62.450000000000003 110.555 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -144.85 106.83 4.3 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.786 1.234 . . . . 75.340000000000003 108.389 172.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -127.37 140.38 52.22 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 122.926 0.49 . . . . 74.219999999999999 110.697 -173.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -74.84 -37.78 62.17 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.727 0.642 . . . . 74.319999999999993 110.364 173.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 66.9 p -133.43 165.01 25.85 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.983 0.897 . . . . 62.329999999999998 112.15 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 23.4 tp -70.57 -27.88 64.46 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 113.855 -1.52 . . . . 74.25 110.999 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.34 -41.84 98.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.079 0.552 . . . . 74.349999999999994 110.22 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -69.03 -42.08 76.85 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.798 -1.092 . . . . 64.209999999999994 110.662 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.04 -42.75 90.97 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.811 0.695 . . . . 75.099999999999994 110.935 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.6 t -76.75 -41.22 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.705 0.802 . . . . 65.340000000000003 110.9 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -59.63 -50.34 74.26 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.358 0.526 . . . . 73.400000000000006 110.161 173.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -53.42 -54.82 31.34 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.696 -1.138 . . . . 73.439999999999998 109.499 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -63.16 -26.22 68.71 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.643 -0.708 . . . . 74.420000000000002 112.012 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 26.8 t -77.77 -21.2 52.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.85 0.46 . . . . 73.209999999999994 111.711 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.9 t -115.43 -18.85 10.9 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.22 1.933 . . . . 74.549999999999997 116.22 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 35.0 m -92.77 143.65 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 120.745 1.611 . . . . 65.319999999999993 114.277 -166.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.38 -1.96 57.45 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.23 2.212 . . . . 73.430000000000007 112.393 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -78.56 13.66 1.54 Allowed 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 128.158 2.583 . . . . 72.439999999999998 114.087 -143.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.21 17.39 4.06 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 123.932 0.777 . . . . 62.219999999999999 111.242 -167.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 52.1 mt -91.3 135.39 33.84 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.093 0.557 . . . . 70.430000000000007 109.742 157.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.403 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 77.3 mt -65.74 -44.8 93.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 O-C-N 124.176 0.922 . . . . 64.129999999999995 109.273 174.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.571 HG22 ' HH ' ' A' ' 191' ' ' TYR . 11.6 t -138.44 149.32 45.36 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.807 0.443 . . . . 62.039999999999999 109.909 169.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 82.7 p -74.28 156.13 37.51 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 109.076 -0.712 . . . . 75.430000000000007 109.076 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.483 HD23 HD21 ' A' ' 184' ' ' LEU . 38.8 mt -68.6 101.7 1.34 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 108.878 -0.786 . . . . 74.209999999999994 108.878 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -80.05 -57.5 3.6 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.077 0.551 . . . . 73.219999999999999 110.095 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 167' ' ' SER . 7.9 p90 -155.64 152.29 23.99 Favored Pre-proline 0 N--CA 1.484 1.229 0 N-CA-C 109.131 -0.692 . . . . 72.329999999999998 109.131 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' ' 146' ' ' TRP . 58.8 Cg_endo -70.62 138.63 35.49 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 121.666 1.577 . . . . 75.239999999999995 111.438 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -57.99 146.91 66.69 Favored Pre-proline 0 C--O 1.245 0.844 0 CA-C-O 118.671 -0.68 . . . . 73.519999999999996 110.761 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -52.35 118.33 4.51 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.627 2.218 . . . . 72.340000000000003 112.132 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -58.95 159.66 6.81 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.733 -1.122 . . . . 73.329999999999998 110.929 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 62.5 ttt-85 -56.55 -34.55 67.2 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.781 0.832 . . . . 72.409999999999997 111.476 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -78.34 159.63 28.28 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.855 0.862 . . . . 74.340000000000003 109.438 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -64.08 145.01 98.19 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 123.827 0.851 . . . . 75.209999999999994 112.848 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.52 179.96 5.38 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.977 2.451 . . . . 72.299999999999997 110.819 167.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 12.3 t -146.16 -38.34 0.24 Allowed 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 112.645 0.609 . . . . 74.510000000000005 112.645 -175.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.3 p -151.78 145.77 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 118.406 0.548 . . . . 72.049999999999997 110.996 -177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -115.13 104.42 11.84 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.522 1.129 . . . . 74.400000000000006 108.166 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -77.06 110.66 3.08 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-O 119.488 -0.618 . . . . 75.450000000000003 111.67 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 63.7 t -61.29 122.82 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.541 0.736 . . . . 75.200000000000003 109.519 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 20.1 m -92.52 100.08 3.46 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.143 0.977 . . . . 61.340000000000003 109.983 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -70.77 135.2 27.51 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.254 1.969 . . . . 73.150000000000006 112.027 -175.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.4 169.57 17.42 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.392 0.677 . . . . 73.349999999999994 109.818 -178.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -111.67 167.97 9.93 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.923 0.889 . . . . 73.319999999999993 109.041 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.51 119.92 10.72 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 110.494 -0.188 . . . . 74.299999999999997 110.494 -176.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -98.37 -25.31 14.86 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.18 0.992 . . . . 74.129999999999995 109.936 -177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 -82.28 167.59 18.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.616 0.767 . . . . 73.409999999999997 111.902 -167.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 C--O 1.254 1.305 0 N-CA-C 108.962 -0.755 . . . . 71.140000000000001 108.962 -179.673 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.4 pmm? . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 109.639 -0.504 . . . . 74.430000000000007 109.639 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.489 ' HA3' ' HB3' ' A' ' 114' ' ' HIS . . . 143.2 70.59 0.02 OUTLIER Glycine 0 C--N 1.345 1.029 0 CA-C-N 116.384 -0.371 . . . . 65.409999999999997 112.735 176.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -133.98 70.09 1.46 Allowed 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 108.207 -1.035 . . . . 64.109999999999999 108.207 175.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.417 HE22 ' HA2' ' A' ' 2' ' ' GLY . 25.5 mp0 -89.37 160.81 41.57 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-N 114.222 -1.354 . . . . 75.409999999999997 109.616 177.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -58.86 -17.16 35.3 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 123.271 2.648 . . . . 75.040000000000006 114.468 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.18 119.55 3.04 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.779 -0.528 . . . . 62.340000000000003 111.779 176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -74.43 94.26 2.55 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.012 0.434 . . . . 74.439999999999998 109.999 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.4 m -92.15 131.96 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 115.378 -0.828 . . . . 73.120000000000005 109.524 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -108.68 147.4 31.97 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.663 -0.866 . . . . 73.519999999999996 108.663 173.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.91 71.87 0.41 Allowed Glycine 0 C--N 1.349 1.276 0 N-CA-C 111.694 -0.563 . . . . 63.350000000000001 111.694 -175.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -128.27 176.9 7.33 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.561 0.744 . . . . 62.509999999999998 110.734 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.3 -161.29 0.49 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.162 0.985 . . . . 74.120000000000005 111.119 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.4 ' HG3' ' HE2' ' A' ' 89' ' ' TYR . 26.8 ttm-85 -50.0 135.6 20.07 Favored 'General case' 0 C--N 1.362 1.127 0 C-N-CA 123.825 0.85 . . . . 73.430000000000007 110.151 172.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 57.25 71.64 1.08 Allowed Pre-proline 0 CA--C 1.554 1.103 0 O-C-N 124.193 0.933 . . . . 62.219999999999999 109.553 -167.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HG2' ' HB3' ' A' ' 133' ' ' ASN . 11.9 Cg_exo -66.39 162.7 35.25 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.211 1.941 . . . . 54.530000000000001 111.137 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.2 p -69.4 168.0 15.37 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.508 0.671 . . . . 74.030000000000001 111.069 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.1 mt -103.31 126.69 31.5 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 115.066 -0.97 . . . . 70.019999999999996 108.538 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.89 167.84 22.1 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.7 2.267 . . . . 63.130000000000003 112.147 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.83 145.2 32.9 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.961 0.41 . . . . 64.099999999999994 110.646 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.526 ' HB3' HD13 ' A' ' 23' ' ' ILE . 75.1 mt -87.6 92.57 9.15 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.465 -0.939 . . . . 75.430000000000007 108.465 177.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -91.14 -46.83 7.88 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.454 -0.943 . . . . 65.209999999999994 108.454 177.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -98.52 110.16 22.8 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.158 -1.383 . . . . 70.519999999999996 109.58 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.526 HD13 ' HB3' ' A' ' 20' ' ' LEU . 30.9 mm -116.62 112.12 38.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.673 -0.862 . . . . 75.540000000000006 108.673 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.488 ' HB3' ' HZ2' ' A' ' 129' ' ' TRP . 66.1 tttt -106.26 -23.52 12.54 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.768 -1.106 . . . . 74.420000000000002 109.187 173.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.52 -75.62 2.21 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 110.926 -0.869 . . . . 45.149999999999999 110.926 -176.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.42 141.9 3.76 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.938 0.895 . . . . 73.530000000000001 110.064 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.46 -110.35 1.65 Allowed Glycine 0 C--N 1.35 1.347 0 N-CA-C 111.968 -0.453 . . . . 54.439999999999998 111.968 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -88.4 153.0 21.53 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.623 0.769 . . . . 74.140000000000001 110.924 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -102.54 16.54 26.07 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.828 0.451 . . . . 74.120000000000005 110.228 171.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -117.83 144.16 45.63 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.62 0.768 . . . . 73.219999999999999 110.462 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.4 t -164.3 23.55 0.07 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.985 0.914 . . . . 70.319999999999993 109.265 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.8 m 62.63 23.42 13.93 Favored 'General case' 0 C--N 1.372 1.577 0 C-N-CA 124.441 1.096 . . . . 75.120000000000005 110.591 -169.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -68.96 161.48 28.77 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.478 1.111 . . . . 75.400000000000006 112.852 -170.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -165.3 178.57 6.8 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.279 -0.873 . . . . 74.439999999999998 109.955 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.28 -166.61 10.96 Favored Glycine 0 C--O 1.243 0.677 0 N-CA-C 110.526 -1.03 . . . . 74.530000000000001 110.526 173.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.92 -153.23 6.42 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-O 118.946 -0.919 . . . . 70.329999999999998 111.91 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.592 ' HG2' ' SG ' ' A' ' 39' ' ' CYS . 60.1 Cg_endo -68.55 174.68 8.04 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 123.103 2.535 . . . . 73.430000000000007 111.964 -176.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -86.65 57.01 4.26 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 121.465 0.65 . . . . 72.420000000000002 110.014 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.592 ' SG ' ' HG2' ' A' ' 37' ' ' PRO . 77.8 m -72.32 -31.41 65.66 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.33 0.652 . . . . 64.5 111.133 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -92.41 125.65 37.16 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.606 -0.516 . . . . 72.450000000000003 109.606 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.5 m -78.12 65.92 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-O 122.06 0.933 . . . . 71.040000000000006 110.132 173.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.412 ' HE2' ' HB2' ' A' ' 105' ' ' GLU . 66.7 t80 -70.2 116.86 11.05 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.696 -1.138 . . . . 73.340000000000003 109.98 -175.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.413 HG12 ' HB2' ' A' ' 71' ' ' GLU . 22.1 m -122.91 163.15 22.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 C-N-CA 124.359 1.063 . . . . 75.430000000000007 108.832 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.9 176.38 9.34 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.736 0.303 . . . . 74.230000000000004 110.692 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -153.14 113.24 3.95 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 109.723 -0.473 . . . . 70.319999999999993 109.723 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -80.84 155.56 26.54 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.733 0.413 . . . . 74.319999999999993 109.981 171.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.14 116.41 18.42 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.929 0.492 . . . . 73.030000000000001 110.342 -173.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.09 86.18 1.04 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.751 -0.833 . . . . 72.510000000000005 108.751 166.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -118.21 149.63 40.77 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.336 -0.987 . . . . 75.439999999999998 108.336 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.411 ' H ' ' HD2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -110.17 94.79 19.14 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.029 0.931 . . . . 75.120000000000005 108.904 177.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -88.37 -5.24 6.51 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.963 2.442 . . . . 74.540000000000006 112.674 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.5 p -145.53 14.77 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.053 0.941 . . . . 75.109999999999999 109.839 -173.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.11 165.75 26.95 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.754 0.422 . . . . 70.349999999999994 111.209 -172.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.5 p -137.48 144.32 42.17 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.869 0.868 . . . . 73.420000000000002 110.164 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -84.66 90.84 7.78 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.287 0.635 . . . . 71.420000000000002 111.087 -174.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -116.94 126.74 53.4 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.226 -1.027 . . . . 75.319999999999993 108.226 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 62.83 72.47 0.59 Allowed Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.552 1.141 . . . . 74.200000000000003 110.384 -171.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.58 65.7 4.69 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.659 2.906 . . . . 72.239999999999995 111.553 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -73.7 87.52 1.7 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.366 1.067 . . . . 74.230000000000004 111.025 -173.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.98 53.08 4.78 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.487 -0.645 . . . . 74.420000000000002 111.487 176.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.8 mt -56.35 -48.85 75.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.619 1.168 . . . . 75.200000000000003 110.767 -173.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.2 t -149.36 116.19 5.95 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.957 -1.127 . . . . 74.209999999999994 107.957 172.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -132.79 134.01 44.16 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 109.335 -0.617 . . . . 74.019999999999996 109.335 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.6 88.35 2.19 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.752 -1.203 . . . . 72.230000000000004 107.752 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.83 74.19 8.83 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.832 -0.803 . . . . 70.409999999999997 108.832 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -84.15 116.56 22.97 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 115.649 -0.705 . . . . 75.019999999999996 109.964 -175.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -98.32 159.82 14.7 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.353 0.661 . . . . 73.510000000000005 110.37 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -93.7 -58.64 2.21 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 106.955 -1.498 . . . . 73.129999999999995 106.955 165.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.3 m 60.59 26.19 15.89 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.652 1.581 . . . . 73.200000000000003 111.066 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -128.21 105.43 8.35 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.26 1.024 . . . . 74.409999999999997 108.37 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.413 ' HB2' HG12 ' A' ' 43' ' ' VAL . 42.9 mt-10 -150.34 -179.92 7.6 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.25 1.42 . . . . 75.049999999999997 108.505 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -136.99 80.43 1.81 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.89 -0.782 . . . . 74.219999999999999 108.89 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.3 mt -96.42 -160.47 0.8 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.229 0.612 . . . . 74.219999999999999 110.628 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.2 mt -69.62 152.58 44.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.444 0.697 . . . . 72.299999999999997 112.361 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.12 172.4 12.44 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.865 0.866 . . . . 74.140000000000001 111.512 -173.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 168.9 70.82 0.03 OUTLIER Glycine 0 CA--C 1.535 1.338 0 CA-C-N 115.245 -0.888 . . . . 43.149999999999999 111.574 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.81 -39.48 1.29 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.24 2.627 . . . . 73.299999999999997 111.633 176.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 p -96.19 75.97 3.02 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.516 1.126 . . . . 55.450000000000003 108.3 175.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -101.88 -44.44 5.51 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.747 -1.115 . . . . 73.540000000000006 108.841 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.0 m120 66.52 8.91 6.14 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.906 1.446 . . . . 74.329999999999998 114.906 162.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.24 146.88 69.03 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 112.758 0.651 . . . . 71.549999999999997 112.758 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 140' ' ' SER . 38.7 Cg_endo -64.21 -48.62 4.58 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.546 2.164 . . . . 64.329999999999998 111.58 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -96.65 56.2 1.48 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.927 -0.768 . . . . 75.230000000000004 108.927 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.697 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 24.8 tp -89.11 115.48 26.67 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.952 -0.758 . . . . 74.439999999999998 108.952 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -104.41 175.71 5.4 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.188 1.795 . . . . 71.329999999999998 109.327 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.96 146.52 33.83 Favored 'Isoleucine or valine' 0 C--O 1.256 1.447 0 N-CA-C 108.314 -0.995 . . . . 53.109999999999999 108.314 171.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.43 110.46 12.22 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 123.816 0.698 . . . . 60.109999999999999 110.048 173.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 90.3 mt -69.35 -28.55 66.31 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.481 1.112 . . . . 71.409999999999997 111.587 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.476 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 64.7 m-85 -135.43 152.66 51.6 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.054 -1.091 . . . . 72.219999999999999 108.054 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -71.37 146.02 49.02 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.167 -0.679 . . . . 72.319999999999993 109.167 169.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -149.37 108.25 3.87 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.165 -1.05 . . . . 71.519999999999996 108.165 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.47 133.93 28.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.133 -1.062 . . . . 71.030000000000001 108.133 170.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.86 128.9 37.72 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.837 0.455 . . . . 64.5 110.535 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.0 m -86.58 12.36 10.68 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.134 0.974 . . . . 75.400000000000006 111.215 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.58 179.34 37.9 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 110.586 -1.006 . . . . 74.129999999999995 110.586 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.81 -28.68 67.79 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.947 0.499 . . . . 72.329999999999998 110.689 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -68.09 -23.94 64.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.855 0.862 . . . . 73.310000000000002 111.798 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.2 p -103.98 158.51 16.37 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.36 0.664 . . . . 71.319999999999993 110.484 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.486 HD23 HG23 ' A' ' 123' ' ' THR . 49.8 tp -114.49 123.45 49.44 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.206 0.602 . . . . 73.310000000000002 110.488 -178.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.0 p -67.55 119.52 12.47 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.537 0.735 . . . . 74.400000000000006 109.807 173.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.453 HG23 HG22 ' A' ' 123' ' ' THR . 38.2 pt -128.53 129.27 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.483 -0.932 . . . . 75.519999999999996 108.483 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.7 m -95.64 137.85 34.13 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.457 -0.571 . . . . 71.400000000000006 109.457 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -51.16 119.25 3.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.54 0.736 . . . . 74.129999999999995 111.471 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.97 -3.46 48.47 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 116.015 -0.539 . . . . 72.140000000000001 113.198 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.412 ' HB2' ' HE2' ' A' ' 42' ' ' PHE . 59.0 tt0 -86.05 143.98 27.8 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 117.411 0.606 . . . . 73.109999999999999 110.101 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.506 ' HB2' ' HZ3' ' A' ' 124' ' ' LYS . 56.9 mttm -81.91 135.96 35.36 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.205 1.002 . . . . 71.430000000000007 109.157 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.452 ' HA ' HG21 ' A' ' 123' ' ' THR . 14.8 mt -126.98 135.41 50.82 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 107.99 -1.115 . . . . 74.450000000000003 107.99 -168.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -98.69 108.96 21.77 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.857 0.753 . . . . 74.329999999999998 109.141 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 88.0 t -98.24 113.91 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 118.77 0.714 . . . . 70.140000000000001 109.82 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.37 -37.88 68.66 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.835 0.854 . . . . 72.400000000000006 110.238 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.3 176.22 47.88 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.245 -0.889 . . . . 65.340000000000003 111.708 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 0.8 OUTLIER -98.98 174.42 6.36 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.515 -0.92 . . . . 73.150000000000006 108.515 176.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -74.61 165.71 24.76 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.801 0.44 . . . . 74.420000000000002 110.341 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.489 ' HB3' ' HA3' ' A' ' 2' ' ' GLY . 22.1 m-70 -58.9 -34.3 71.5 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.21 1.004 . . . . 74.299999999999997 111.632 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -107.21 7.33 29.38 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.87 0.868 . . . . 74.519999999999996 110.253 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 61.22 24.08 62.87 Favored Glycine 0 C--N 1.356 1.69 0 CA-C-N 115.66 -0.7 . . . . 50.409999999999997 114.407 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -69.66 -58.25 4.16 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.257 1.027 . . . . 72.219999999999999 108.689 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -112.4 -179.39 3.66 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.355 -1.748 . . . . 62.240000000000002 108.778 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -142.45 124.26 15.14 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.701 0.801 . . . . 54.439999999999998 108.854 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -72.39 100.91 2.78 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 109.403 -0.592 . . . . 74.230000000000004 109.403 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.7 170.11 8.56 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.316 -0.856 . . . . 61.420000000000002 111.246 -177.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.425 ' HG3' ' HB2' ' A' ' 127' ' ' GLN . 44.4 tt0 -148.03 125.13 11.4 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.342 -1.355 . . . . 74.200000000000003 107.342 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.486 HG23 HD23 ' A' ' 99' ' ' LEU . 67.7 p -128.27 -175.02 3.38 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.852 0.835 . . . . 62.109999999999999 111.585 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.506 ' HZ3' ' HB2' ' A' ' 106' ' ' LYS . 35.1 mttp -64.13 -23.83 67.46 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 113.85 -1.523 . . . . 75.109999999999999 109.722 174.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -85.79 -4.7 59.23 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.697 1.199 . . . . 65.400000000000006 111.931 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 131.19 -131.57 6.46 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-O 120.034 -0.314 . . . . 61.329999999999998 112.393 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.425 ' HB2' ' HG3' ' A' ' 122' ' ' GLN . 61.0 tt0 -152.21 153.18 33.29 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.444 0.698 . . . . 74.400000000000006 110.363 177.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.74 -170.0 38.14 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 112.187 -0.365 . . . . 71.319999999999993 112.187 176.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.488 ' HZ2' ' HB3' ' A' ' 24' ' ' LYS . 77.2 m95 -96.0 129.72 43.19 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.422 0.689 . . . . 74.450000000000003 110.494 -176.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.414 HG13 ' HB3' ' A' ' 99' ' ' LEU . 30.7 m -121.4 148.33 49.64 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 124.25 1.02 . . . . 73.510000000000005 109.915 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.27 132.67 19.75 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 121.868 1.712 . . . . 63.329999999999998 111.244 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.6 m -62.05 -18.59 61.1 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.987 0.915 . . . . 74.150000000000006 112.758 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.426 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 71.6 m-20 -72.91 -23.38 60.7 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.015 0.926 . . . . 73.019999999999996 111.742 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.476 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.2 m-85 -96.74 -0.42 48.21 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.541 0.736 . . . . 74.400000000000006 112.179 -174.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.1 pt -129.15 154.23 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 122.879 0.471 . . . . 75.319999999999993 110.552 -173.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.1 t -154.35 138.57 11.2 Favored Pre-proline 0 N--CA 1.491 1.611 0 CA-C-O 119.467 -0.301 . . . . 70.219999999999999 110.801 172.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.446 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 56.6 Cg_endo -69.47 130.92 20.57 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 122.594 2.196 . . . . 74.409999999999997 113.267 -175.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.3 m -108.37 -58.63 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.802 0.841 . . . . 74.129999999999995 110.733 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.697 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.6 t30 -93.49 1.13 56.9 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.205 0.602 . . . . 72.209999999999994 110.957 -174.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.446 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 25.5 t -73.84 -178.43 3.22 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.022 0.529 . . . . 74.439999999999998 109.883 173.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.0 mt -58.03 -18.66 25.74 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.886 0.874 . . . . 75.310000000000002 112.933 -174.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.571 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 29.7 tt0 -64.69 -14.49 58.62 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.298 1.039 . . . . 71.239999999999995 112.137 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.67 -21.86 55.51 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.81 0.844 . . . . 74.099999999999994 111.037 173.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -100.4 139.06 36.62 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.095 -0.705 . . . . 74.430000000000007 109.095 170.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.9 p -63.57 -12.41 32.52 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.182 1.178 . . . . 73.430000000000007 114.182 -171.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -75.93 -42.28 49.27 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 111.814 0.301 . . . . 74.430000000000007 111.814 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 29.0 t80 -89.74 139.31 30.7 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.434 -0.58 . . . . 74.109999999999999 109.434 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.571 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 72.3 m-70 -131.23 16.75 5.02 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.469 0.544 . . . . 75.099999999999994 112.469 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 72.44 -159.04 53.53 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-O 119.466 -0.63 . . . . 74.230000000000004 114.44 174.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.07 109.6 2.74 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.322 2.681 . . . . 73.25 111.848 176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.569 ' HB ' ' HD3' ' A' ' 171' ' ' ARG . 6.5 t -136.92 155.56 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.258 0.551 . . . . 72.129999999999995 111.076 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.2 m -68.26 148.56 50.63 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 124.909 1.283 . . . . 63.299999999999997 111.803 171.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -30.56 70.77 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.744 0.818 . . . . 74.530000000000001 111.09 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.89 -52.75 54.81 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.215 0.606 . . . . 71.129999999999995 109.934 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.83 87.09 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.55 0.74 . . . . 72.409999999999997 111.042 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.438 ' HB2' ' HD2' ' A' ' 171' ' ' ARG . . . -55.41 -59.6 4.59 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.166 -0.925 . . . . 75.400000000000006 111.337 173.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.572 ' HG3' HG12 ' A' ' 190' ' ' VAL . 33.0 tt0 -64.84 -28.19 69.39 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.31 -0.859 . . . . 61.140000000000001 111.29 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -66.43 -50.82 62.13 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.295 1.038 . . . . 75.120000000000005 110.964 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.78 -40.05 84.0 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.933 -0.576 . . . . 73.519999999999996 110.919 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.545 HD21 HG13 ' A' ' 190' ' ' VAL . 37.4 tp -68.53 -29.16 67.68 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.485 -0.779 . . . . 72.409999999999997 112.227 -177.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 13.2 t -62.63 -23.25 66.97 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.538 0.735 . . . . 72.019999999999996 110.856 177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.8 m -82.43 -20.5 36.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.046 0.938 . . . . 72.040000000000006 110.968 176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.73 -175.43 23.61 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.932 -0.576 . . . . 70.439999999999998 112.851 175.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.4 pt -141.04 -165.92 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 124.988 1.315 . . . . 73.299999999999997 111.159 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.708 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 14.6 p-10 -52.52 106.06 0.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.532 1.133 . . . . 64.549999999999997 113.487 -175.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.22 13.3 52.72 Favored Glycine 0 C--O 1.257 1.543 0 CA-C-N 116.132 -0.486 . . . . 74.209999999999994 113.497 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 74.1 m -80.56 140.12 35.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.971 0.386 . . . . 73.219999999999999 110.684 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 183' ' ' SER . 23.1 p90 -136.73 159.66 41.16 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.441 0.639 . . . . 64.239999999999995 112.584 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.577 HD22 HH21 ' A' ' 171' ' ' ARG . 91.5 mt -136.29 133.31 36.81 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.608 -1.178 . . . . 73.150000000000006 108.266 170.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 22.6 t -114.98 127.05 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 107.616 -1.253 . . . . 71.439999999999998 107.616 176.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.577 HH21 HD22 ' A' ' 169' ' ' LEU . 14.7 ptp180 -162.1 148.88 13.67 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.452 0.301 . . . . 72.140000000000001 111.041 -176.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 15.5 pt-20 -93.53 165.8 12.57 Favored 'General case' 0 C--O 1.253 1.248 0 CA-C-O 121.398 0.618 . . . . 72.25 111.693 -178.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.7 t -73.36 154.42 40.08 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.339 -1.3 . . . . 65.25 111.087 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -77.73 -40.02 42.54 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.39 -1.277 . . . . 74.439999999999998 110.653 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.644 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 72.5 p -100.62 -14.12 18.29 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.327 0.651 . . . . 72.230000000000004 112.446 -175.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 46.9 m -124.28 101.72 34.34 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.021 0.528 . . . . 73.549999999999997 110.439 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.74 131.65 28.22 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.226 2.618 . . . . 72.040000000000006 112.111 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.33 -24.04 8.91 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 116.237 -0.438 . . . . 62.340000000000003 113.882 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -75.19 118.2 17.85 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.207 -1.034 . . . . 71.219999999999999 108.207 172.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 82.9 mtt85 -123.29 172.86 8.32 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.274 0.63 . . . . 71.340000000000003 111.074 -169.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 15.9 m -147.51 144.45 28.56 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.039 0.936 . . . . 62.229999999999997 109.461 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.425 HG12 HG21 ' A' ' 170' ' ' VAL . 52.1 mt -119.06 139.58 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 107.967 -1.123 . . . . 74.25 107.967 167.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 17.5 m -119.82 122.78 42.11 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.196 -1.038 . . . . 74.420000000000002 108.196 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.486 HD21 HD22 ' A' ' 232' ' ' LEU . 59.6 mt -105.45 142.18 35.65 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.367 1.067 . . . . 63.310000000000002 111.593 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 20.4 ttt180 -128.56 131.47 48.21 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-N 115.05 -0.977 . . . . 75.299999999999997 109.473 169.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.708 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 3.4 p90 -150.83 142.08 23.25 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.215 -1.032 . . . . 71.310000000000002 108.215 171.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 58.44 18.89 5.99 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 124.164 0.986 . . . . 74.230000000000004 113.343 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.56 12.12 73.17 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 122.882 0.277 . . . . 65.120000000000005 113.157 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 4.0 tpm_? -105.14 124.01 48.8 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.37 1.068 . . . . 73.25 109.151 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.572 HG12 ' HG3' ' A' ' 157' ' ' GLU . 98.3 t -112.9 110.41 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.145 0.978 . . . . 71.150000000000006 110.177 -177.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.646 ' HH ' HG22 ' A' ' 230' ' ' THR . 30.6 p90 -125.85 156.63 39.3 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.533 0.733 . . . . 75.540000000000006 109.245 175.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -131.82 146.94 52.42 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.714 0.806 . . . . 73.450000000000003 109.044 -167.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -145.06 148.74 34.02 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.811 0.444 . . . . 75.450000000000003 110.429 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 15.4 tpp180 -89.94 138.36 31.57 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.525 0.73 . . . . 73.340000000000003 110.817 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 84.7 mt -88.99 120.47 37.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.217 -1.031 . . . . 71.420000000000002 108.217 165.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.1 m-20 -95.86 137.5 34.84 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.004 0.922 . . . . 72.129999999999995 109.358 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 25.8 m -105.24 110.46 22.83 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.339 0.656 . . . . 74.230000000000004 109.478 176.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.81 171.93 1.91 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.495 1.118 . . . . 73.310000000000002 112.041 173.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.4 p -67.07 -29.24 68.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.375 0.67 . . . . 74.140000000000001 111.966 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -71.21 -17.79 62.49 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.028 0.531 . . . . 63.520000000000003 111.282 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 103.5 -5.99 48.89 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 111.786 -0.526 . . . . 72.340000000000003 111.786 -171.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -64.16 130.7 44.96 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.728 0.811 . . . . 73.150000000000006 111.797 -177.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 89.4 mt -89.51 147.33 24.03 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.101 -0.703 . . . . 72.140000000000001 109.101 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -165.2 161.75 19.56 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.586 0.554 . . . . 75.349999999999994 110.724 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.75 -46.75 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.925 0.89 . . . . 74.0 109.844 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.53 ' H ' ' HB2' ' A' ' 209' ' ' SER . 27.1 t -139.12 -172.73 3.4 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.559 0.743 . . . . 73.430000000000007 110.397 -170.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.9 m -60.62 -49.05 79.09 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.706 1.202 . . . . 54.539999999999999 113.826 -167.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -85.81 -0.08 54.33 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.023 0.529 . . . . 74.549999999999997 110.832 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.53 ' HB2' ' H ' ' A' ' 206' ' ' SER . 72.4 m -97.84 106.62 18.95 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.6 0.76 . . . . 74.209999999999994 110.711 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -145.23 118.37 8.88 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 125.145 1.378 . . . . 74.150000000000006 107.759 170.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -136.85 145.67 44.7 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 118.095 0.407 . . . . 71.430000000000007 111.736 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -87.57 -21.65 25.27 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 123.743 0.652 . . . . 75.510000000000005 109.919 168.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 72.2 p -135.34 148.76 49.54 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-O 121.697 0.761 . . . . 71.140000000000001 112.02 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 38.1 tp -66.79 -27.68 67.77 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.334 -1.303 . . . . 71.400000000000006 111.105 176.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.98 -50.0 75.74 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.69 0.796 . . . . 75.319999999999993 110.781 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -69.93 -32.49 70.79 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.056 -0.975 . . . . 75.310000000000002 110.807 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.45 -48.78 78.25 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.315 0.384 . . . . 73.420000000000002 110.811 172.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 56.0 t -68.77 -42.43 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.751 0.821 . . . . 71.319999999999993 110.443 -176.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -58.81 -52.79 64.2 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.799 0.809 . . . . 65.430000000000007 111.594 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.41 ' O ' HG21 ' A' ' 224' ' ' VAL . 48.2 t60 -55.05 -50.07 70.04 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.408 -1.269 . . . . 73.129999999999995 109.783 177.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -65.16 -24.92 67.53 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.686 -0.688 . . . . 75.209999999999994 112.112 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.4 m -73.13 -27.87 61.93 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.034 -0.416 . . . . 64.209999999999994 110.983 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 15.2 t -110.12 -14.52 14.19 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.659 2.096 . . . . 64.319999999999993 116.659 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 220' ' ' HIS . 27.0 m -99.84 156.97 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 N-CA-C 115.925 1.824 . . . . 72.0 115.925 -166.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.47 -0.25 57.59 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 110.738 -2.937 . . . . 71.540000000000006 113.358 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -77.89 13.05 1.48 Allowed 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 128.436 2.694 . . . . 74.239999999999995 113.371 -144.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.16 17.99 4.33 Favored Glycine 0 N--CA 1.46 0.286 0 C-N-CA 124.802 1.191 . . . . 73.540000000000006 111.183 -169.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 91.4 mt -92.51 117.25 29.75 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 113.832 -1.184 . . . . 74.140000000000001 109.767 163.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.465 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 85.6 mt -63.01 -41.2 91.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.481 0.712 . . . . 75.420000000000002 109.322 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.646 HG22 ' HH ' ' A' ' 191' ' ' TYR . 10.0 t -129.66 142.66 50.69 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.46 -0.941 . . . . 73.219999999999999 108.46 165.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 63.5 p -71.28 156.42 39.55 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 109.359 -0.608 . . . . 73.540000000000006 109.359 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.486 HD22 HD21 ' A' ' 184' ' ' LEU . 25.0 mt -65.92 103.6 0.96 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.913 -0.773 . . . . 72.25 108.913 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.0 -49.53 7.28 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.159 0.583 . . . . 73.5 109.579 -176.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -161.66 144.44 9.11 Favored Pre-proline 0 N--CA 1.492 1.636 0 C-N-CA 123.177 0.591 . . . . 73.420000000000002 112.418 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.65 140.08 18.49 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.724 1.616 . . . . 72.140000000000001 112.461 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -66.96 120.72 73.87 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 108.847 -0.797 . . . . 73.319999999999993 108.847 172.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.07 145.0 59.65 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 121.952 1.768 . . . . 72.099999999999994 112.095 -175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -64.41 152.63 40.99 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 109.188 -0.671 . . . . 72.329999999999998 109.188 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -58.62 -28.31 65.52 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.09 0.556 . . . . 70.040000000000006 112.24 -173.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -96.94 75.87 2.69 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.079 -0.711 . . . . 75.310000000000002 109.079 170.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -173.9 133.11 0.57 Allowed Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 114.871 -1.059 . . . . 72.420000000000002 109.453 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -64.24 135.39 46.55 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.806 2.337 . . . . 74.319999999999993 112.063 169.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 9.1 t -75.63 162.67 28.06 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.274 0.629 . . . . 70.239999999999995 110.35 174.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.5 p -129.86 128.0 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.108 0.563 . . . . 74.010000000000005 109.958 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -110.35 98.64 7.82 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.202 1.001 . . . . 74.109999999999999 108.562 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -106.74 110.85 3.39 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 119.277 -0.735 . . . . 73.040000000000006 111.902 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.78 148.6 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 117.364 0.582 . . . . 72.340000000000003 109.565 170.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 21.5 m -146.94 139.36 14.04 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.159 0.584 . . . . 71.319999999999993 109.591 -175.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.04 132.07 28.93 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.404 2.069 . . . . 64.400000000000006 110.882 173.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -68.03 -64.73 0.8 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 119.117 -0.468 . . . . 75.340000000000003 111.007 -174.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 40.1 t80 45.54 36.53 2.57 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.872 1.269 . . . . 71.129999999999995 111.071 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -74.48 124.71 27.08 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.044 -0.98 . . . . 72.450000000000003 110.814 -173.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -71.84 147.45 47.16 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 123.413 0.685 . . . . 75.439999999999998 109.163 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -72.2 142.85 49.02 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.705 -0.85 . . . . 71.129999999999995 108.705 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 CA--C 1.553 1.07 0 C-N-CA 123.718 0.807 . . . . 65.200000000000003 111.408 -175.766 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 mmt . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 109.465 -0.569 . . . . 73.239999999999995 109.465 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.68 146.75 6.01 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 111.783 -0.527 . . . . 72.25 111.783 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -124.17 121.43 35.07 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.291 1.036 . . . . 74.530000000000001 109.513 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -95.26 127.05 43.83 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.675 0.79 . . . . 74.430000000000007 110.248 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -67.73 -21.76 44.53 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.924 2.416 . . . . 75.099999999999994 112.386 172.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.31 177.95 50.57 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.572 0.545 . . . . 74.219999999999999 112.607 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -81.05 121.29 25.88 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.626 -0.509 . . . . 70.439999999999998 109.626 175.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.4 m -63.78 131.46 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.1 0.56 . . . . 74.420000000000002 111.045 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -80.08 137.17 36.71 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.656 -0.498 . . . . 74.450000000000003 109.656 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.99 76.26 0.03 OUTLIER Glycine 0 C--N 1.342 0.877 0 N-CA-C 112.192 -0.363 . . . . 73.120000000000005 112.192 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -161.02 144.74 13.26 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.617 -0.512 . . . . 75.109999999999999 109.617 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -79.45 -28.56 41.61 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.412 0.685 . . . . 75.540000000000006 111.253 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -137.58 135.37 36.59 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.89 -0.782 . . . . 75.109999999999999 108.89 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.6 mmm-85 57.27 71.16 1.16 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.541 0.736 . . . . 73.120000000000005 109.715 -170.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -69.75 166.24 28.24 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.088 1.859 . . . . 60.43 110.72 177.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.9 m -65.1 166.36 9.67 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 120.864 0.364 . . . . 74.409999999999997 111.476 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.7 mt -103.46 126.57 31.73 Favored Pre-proline 0 C--O 1.239 0.518 0 N-CA-C 109.014 -0.735 . . . . 73.420000000000002 109.014 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.16 169.75 21.87 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.999 2.466 . . . . 65.120000000000005 111.954 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.54 149.94 32.96 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.903 0.481 . . . . 70.200000000000003 110.551 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.536 ' HB3' HD11 ' A' ' 23' ' ' ILE . 80.7 mt -86.14 94.52 9.3 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.686 -0.857 . . . . 73.140000000000001 108.686 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -97.34 -48.76 5.19 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.047 -0.979 . . . . 73.319999999999993 110.667 -177.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.608 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 60.4 m-85 -103.65 108.52 19.84 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.953 -0.758 . . . . 72.230000000000004 108.953 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' A' ' 20' ' ' LEU . 37.7 mm -118.6 112.94 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.863 0.865 . . . . 73.140000000000001 110.226 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.94 73.14 0.53 Allowed 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 124.229 1.012 . . . . 75.030000000000001 108.552 167.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.02 77.92 1.61 Allowed Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.704 -0.559 . . . . 73.129999999999995 111.704 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -170.5 134.17 1.1 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.95 0.9 . . . . 71.150000000000006 110.28 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.63 104.95 1.02 Allowed Glycine 0 C--N 1.349 1.293 0 N-CA-C 110.285 -1.126 . . . . 74.030000000000001 110.285 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -73.37 -60.63 2.15 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.048 0.539 . . . . 74.430000000000007 110.608 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -120.34 6.35 10.68 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.674 0.79 . . . . 73.329999999999998 110.989 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -72.09 170.31 14.2 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.912 0.885 . . . . 71.310000000000002 109.6 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.4 t -58.72 88.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.601 0.715 . . . . 61.329999999999998 111.785 -174.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.4 m -96.59 90.27 5.28 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.99 -1.005 . . . . 71.439999999999998 109.0 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -142.3 103.93 4.35 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.029 -0.987 . . . . 64.099999999999994 108.386 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -72.91 84.33 1.24 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.921 0.888 . . . . 72.420000000000002 110.895 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -93.28 -179.24 39.79 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 114.916 -1.038 . . . . 71.120000000000005 113.045 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.72 -157.01 53.54 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 123.988 0.464 . . . . 74.219999999999999 113.927 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -99.17 -157.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 123.662 2.908 . . . . 61.229999999999997 111.815 171.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -108.05 -174.49 2.54 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.532 0.733 . . . . 74.530000000000001 109.716 169.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.5 t -92.38 -163.06 0.99 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.569 1.147 . . . . 75.319999999999993 108.574 170.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -81.7 29.47 0.38 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.413 0.685 . . . . 73.340000000000003 111.111 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.2 75.78 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 CA-C-O 122.939 1.352 . . . . 72.400000000000006 110.283 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.588 ' HB3' HD12 ' A' ' 73' ' ' LEU . 5.2 p90 -118.36 4.69 11.83 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.949 -1.478 . . . . 64.200000000000003 108.971 167.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.5 m -96.81 135.61 30.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 124.173 0.989 . . . . 73.219999999999999 109.995 -177.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -72.43 149.76 43.94 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.578 0.751 . . . . 61.399999999999999 110.488 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -124.59 156.31 37.64 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.761 -0.829 . . . . 74.340000000000003 108.761 171.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -75.53 127.81 33.92 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 123.462 0.476 . . . . 73.030000000000001 110.288 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.61 113.67 20.09 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.738 0.815 . . . . 72.340000000000003 109.032 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.1 mt -94.57 175.71 6.57 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.611 0.719 . . . . 71.439999999999998 110.893 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -136.23 -167.5 2.06 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.653 -1.158 . . . . 73.420000000000002 108.753 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 63.22 78.85 0.27 Allowed Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 124.46 1.104 . . . . 74.129999999999995 112.294 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.01 167.43 12.6 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.588 2.192 . . . . 72.219999999999999 111.631 169.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.0 t -74.92 98.26 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 109.304 -0.628 . . . . 71.439999999999998 109.304 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.6 141.93 53.63 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.604 -0.725 . . . . 53.240000000000002 110.416 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.2 p -66.97 138.33 57.18 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.706 0.802 . . . . 75.150000000000006 111.166 -176.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -58.71 -60.83 3.21 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.732 0.813 . . . . 61.420000000000002 109.657 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -77.38 140.89 40.02 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.918 0.887 . . . . 72.329999999999998 108.858 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 59.75 71.43 0.91 Allowed Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.086 0.954 . . . . 71.439999999999998 111.195 -170.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -82.18 1.23 9.33 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.001 2.467 . . . . 74.409999999999997 112.816 174.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -61.86 98.2 0.09 Allowed 'General case' 0 C--N 1.349 0.564 0 C-N-CA 125.164 1.385 . . . . 62.210000000000001 110.779 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.73 144.46 10.77 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 111.494 -0.642 . . . . 63.530000000000001 111.494 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.5 mt -112.49 112.72 24.47 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.262 0.625 . . . . 75.310000000000002 109.726 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.4 m -90.16 71.38 7.28 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.834 -0.802 . . . . 75.129999999999995 108.834 173.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.78 151.39 40.63 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.0 -1.0 . . . . 71.239999999999995 110.253 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.6 163.94 23.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.099 0.559 . . . . 65.219999999999999 110.329 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -158.05 152.03 24.07 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.812 0.845 . . . . 70.400000000000006 109.758 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -84.8 99.05 10.63 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.347 -0.612 . . . . 73.420000000000002 109.347 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 45.2 t-105 -74.14 110.23 8.27 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.51 0.724 . . . . 74.239999999999995 110.07 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -120.73 94.2 4.28 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.632 0.729 . . . . 72.239999999999995 110.098 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 54.0 m -83.35 80.06 9.21 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.92 -0.77 . . . . 74.239999999999995 108.92 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -96.76 -179.17 4.49 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.474 -0.784 . . . . 73.109999999999999 111.259 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -65.91 -65.15 0.71 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.326 -0.852 . . . . 75.319999999999993 111.475 -173.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 59.77 20.25 9.04 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.51 1.124 . . . . 71.209999999999994 110.668 -173.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.588 HD12 ' HB3' ' A' ' 42' ' ' PHE . 91.5 mt -73.63 76.82 1.51 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.184 0.994 . . . . 75.230000000000004 110.005 -175.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.7 mt -119.11 154.76 32.72 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.772 0.829 . . . . 74.519999999999996 110.048 -173.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.36 165.35 27.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.26 1.024 . . . . 70.200000000000003 109.076 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.46 -70.57 0.31 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-O 118.884 -0.954 . . . . 61.210000000000001 112.088 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.84 90.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.391 2.773 0 C-N-CA 123.983 3.122 . . . . 70.239999999999995 113.995 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.7 p -106.41 48.48 0.84 Allowed 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.863 1.265 . . . . 74.340000000000003 107.986 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.45 140.52 58.05 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.525 -1.216 . . . . 71.450000000000003 109.929 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -65.28 -84.36 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 O-C-N 124.471 1.107 . . . . 75.049999999999997 111.539 -166.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 62.19 157.72 0.12 Allowed Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 124.476 1.11 . . . . 75.439999999999998 113.173 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.35 -25.44 56.58 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.09 1.86 . . . . 75.209999999999994 111.161 168.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -104.62 80.69 1.69 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.504 1.122 . . . . 62.229999999999997 110.252 -177.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 35.0 tp -128.06 112.77 14.97 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.114 -0.699 . . . . 73.420000000000002 109.114 167.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -116.1 173.91 6.32 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.379 1.472 . . . . 73.540000000000006 110.043 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.5 p -147.56 144.85 19.33 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 C-N-CA 124.281 1.033 . . . . 75.140000000000001 108.674 171.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.528 ' HB3' HD13 ' A' ' 107' ' ' LEU . . . -81.73 128.68 34.23 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.711 0.404 . . . . 71.109999999999999 110.161 175.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.8 mt -86.15 -20.57 28.43 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.513 0.725 . . . . 72.030000000000001 110.837 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.548 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 74.9 m-85 -130.59 158.38 40.16 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.782 0.833 . . . . 73.140000000000001 109.335 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -83.55 140.23 32.39 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.757 -0.831 . . . . 73.540000000000006 108.757 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -155.13 111.91 3.26 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.676 -0.861 . . . . 72.230000000000004 108.676 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.43 140.67 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 109.304 -0.628 . . . . 73.409999999999997 109.304 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.21 115.95 2.75 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.336 0.654 . . . . 75.5 110.623 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.0 p -72.21 -27.93 62.86 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.535 0.734 . . . . 73.400000000000006 110.392 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -152.91 -173.36 22.19 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 114.85 -1.068 . . . . 43.439999999999998 110.984 175.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.22 -28.89 65.63 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.306 0.643 . . . . 71.310000000000002 110.855 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -70.02 -22.42 63.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.567 1.147 . . . . 71.420000000000002 111.967 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 74.3 p -105.77 160.92 14.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.283 1.033 . . . . 71.329999999999998 110.271 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.0 tp -109.41 144.29 37.83 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.164 0.586 . . . . 71.140000000000001 110.44 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.2 p -83.09 111.61 19.05 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.513 -0.921 . . . . 75.549999999999997 108.513 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.7 pt -117.89 139.07 46.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 123.836 0.854 . . . . 74.209999999999994 109.014 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 20.5 m -101.34 150.24 23.2 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.731 -0.47 . . . . 55.109999999999999 109.731 176.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -56.74 112.04 1.19 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 122.622 0.369 . . . . 74.230000000000004 110.082 167.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.38 -4.31 43.95 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.328 -0.396 . . . . 70.040000000000006 112.916 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.92 134.03 36.89 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.555 0.742 . . . . 75.129999999999995 109.624 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -83.31 112.52 19.97 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.934 -0.765 . . . . 64.310000000000002 108.934 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.528 HD13 ' HB3' ' A' ' 87' ' ' ALA . 18.8 mt -101.37 156.72 17.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.005 0.522 . . . . 73.329999999999998 109.818 -171.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -124.72 108.64 12.2 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.601 -0.518 . . . . 73.140000000000001 109.601 167.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.521 HG23 HD12 ' A' ' 135' ' ' ILE . 85.4 t -96.81 106.92 19.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.152 -0.931 . . . . 74.540000000000006 109.843 -176.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.414 HD13 ' NE2' ' A' ' 127' ' ' GLN . 69.1 mt -73.57 -14.56 61.22 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.365 -0.834 . . . . 75.329999999999998 111.427 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.37 163.24 21.99 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 116.252 -0.431 . . . . 71.239999999999995 112.419 172.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 7.4 m-30 -95.29 173.31 7.6 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.845 -0.798 . . . . 74.430000000000007 108.845 173.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.608 ' ND2' ' HB2' ' A' ' 22' ' ' PHE . 10.1 m120 -64.01 150.94 44.2 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.584 -1.265 . . . . 74.340000000000003 107.584 161.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -65.19 -22.64 66.92 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.041 0.382 . . . . 65.099999999999994 110.526 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -86.15 -14.89 42.76 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 122.793 0.437 . . . . 71.129999999999995 110.441 174.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 174' ' ' GLU . . . 84.41 25.91 41.54 Favored Glycine 0 C--N 1.355 1.603 0 C-N-CA 123.452 0.549 . . . . 71.040000000000006 113.59 175.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -79.81 -71.33 0.46 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.391 0.677 . . . . 73.420000000000002 110.779 -175.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -104.77 175.56 5.45 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.336 1.054 . . . . 70.019999999999996 109.013 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -151.22 116.0 5.2 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.825 0.85 . . . . 42.439999999999998 109.445 -172.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 36.5 tt0 -67.91 97.38 0.66 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.677 0.391 . . . . 62.119999999999997 110.162 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.31 153.74 19.38 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.246 -0.65 . . . . 60.119999999999997 109.246 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -138.48 131.86 30.36 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.713 0.805 . . . . 75.530000000000001 109.681 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 63.9 p -140.38 -170.7 3.05 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.635 1.174 . . . . 74.299999999999997 109.423 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -64.67 -14.59 58.95 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.279 0.632 . . . . 74.109999999999999 112.098 170.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -80.14 -11.66 59.73 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.73 0.812 . . . . 73.430000000000007 111.304 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 121.09 -133.63 9.73 Favored Glycine 0 C--N 1.35 1.317 0 N-CA-C 111.415 -0.674 . . . . 62.539999999999999 111.415 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.414 ' NE2' HD13 ' A' ' 110' ' ' LEU . 58.2 tt0 -151.51 144.99 24.86 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 117.182 0.491 . . . . 74.420000000000002 111.103 -175.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 171.43 168.93 33.73 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.542 0.526 . . . . 72.519999999999996 112.709 174.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -82.48 117.48 22.53 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.527 1.131 . . . . 74.239999999999995 111.408 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.54 154.52 47.81 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.997 1.319 . . . . 75.439999999999998 109.136 177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.54 132.47 33.34 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 121.585 1.523 . . . . 74.430000000000007 111.326 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 31.6 m -62.22 -17.74 59.14 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.707 0.803 . . . . 75.120000000000005 112.489 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -82.18 -14.99 54.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.976 0.91 . . . . 73.109999999999999 111.619 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.548 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.7 m-85 -93.95 -3.84 50.84 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.854 0.862 . . . . 64.549999999999997 112.306 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.521 HD12 HG23 ' A' ' 109' ' ' VAL . 18.2 pt -125.95 169.93 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.251 0.62 . . . . 72.239999999999995 110.362 -172.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.5 t -158.04 141.03 10.8 Favored Pre-proline 0 CA--C 1.554 1.106 0 O-C-N 123.563 0.539 . . . . 72.540000000000006 109.963 171.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.14 136.78 14.81 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.573 2.182 . . . . 45.219999999999999 111.841 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.7 m -108.25 -45.53 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.668 0.387 . . . . 75.420000000000002 111.162 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 67.2 t30 -101.25 20.12 16.38 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.473 0.654 . . . . 73.239999999999995 110.699 -174.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.5 p -73.97 -171.24 1.06 Allowed 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 121.471 0.653 . . . . 75.140000000000001 110.746 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' A' ' 214' ' ' LEU . 67.1 mt -69.95 -13.81 62.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.916 0.886 . . . . 74.519999999999996 111.669 176.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.8 -6.73 17.21 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.86 1.264 . . . . 72.540000000000006 111.524 176.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -55.6 -35.69 66.1 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.214 1.005 . . . . 74.239999999999995 109.902 168.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -93.49 135.44 34.74 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.0 -1.0 . . . . 75.120000000000005 108.812 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.8 m -67.84 -12.07 59.87 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.526 0.935 . . . . 75.430000000000007 113.526 -171.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -75.19 -34.04 61.49 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 111.881 0.326 . . . . 73.319999999999993 111.881 175.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -94.24 134.33 36.82 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.396 -0.594 . . . . 70.150000000000006 109.396 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -125.17 5.12 7.84 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 111.793 0.294 . . . . 73.519999999999996 111.793 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.25 -159.48 50.33 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 119.462 -0.632 . . . . 72.040000000000006 114.446 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.27 104.85 0.93 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.369 2.713 . . . . 72.129999999999995 112.297 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.559 HG13 HH21 ' A' ' 171' ' ' ARG . 32.6 t -140.56 153.51 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.137 0.575 . . . . 71.140000000000001 110.545 -174.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.9 m -68.83 148.17 50.67 Favored 'General case' 0 C--O 1.249 1.027 0 C-N-CA 124.555 1.142 . . . . 73.219999999999999 112.028 173.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -62.62 -29.72 70.82 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.486 0.714 . . . . 75.150000000000006 110.616 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -57.05 -57.11 13.99 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.552 1.141 . . . . 71.409999999999997 110.453 175.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.16 -39.31 89.69 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.049 0.94 . . . . 75.310000000000002 111.189 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.48 -53.54 56.32 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.888 -1.051 . . . . 74.510000000000005 110.751 174.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -69.39 -26.88 64.86 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.378 1.071 . . . . 74.299999999999997 110.882 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -67.88 -49.95 59.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.371 0.668 . . . . 75.129999999999995 110.573 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.525 HD11 HH12 ' A' ' 171' ' ' ARG . 66.6 mt -66.31 -37.26 85.0 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 120.802 0.334 . . . . 73.230000000000004 110.265 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.56 HD21 ' HB3' ' A' ' 183' ' ' SER . 39.6 tp -65.54 -34.32 77.99 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.191 -0.913 . . . . 74.439999999999998 111.435 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.9 t -57.82 -24.79 59.01 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.905 1.282 . . . . 74.230000000000004 112.049 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.568 ' HB2' ' HG2' ' A' ' 237' ' ' PRO . 3.8 m -87.91 -4.82 58.8 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.028 0.931 . . . . 71.519999999999996 111.895 -175.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -94.09 175.97 35.5 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.197 0.427 . . . . 73.409999999999997 113.912 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.6 pt -118.42 -165.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 124.531 1.133 . . . . 71.129999999999995 109.726 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.639 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 16.8 p-10 -57.58 110.69 0.92 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 113.007 0.743 . . . . 72.310000000000002 113.007 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.89 12.11 35.5 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 115.001 -0.999 . . . . 65.340000000000003 112.493 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 23.4 t -74.25 130.13 39.13 Favored 'General case' 0 C--N 1.349 0.579 0 N-CA-C 109.01 -0.737 . . . . 72.420000000000002 109.01 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 183' ' ' SER . 19.0 p90 -136.78 155.96 49.14 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.29 0.848 . . . . 74.450000000000003 113.29 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.544 HD13 ' NH1' ' A' ' 171' ' ' ARG . 89.0 mt -142.29 135.64 28.95 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.114 0.966 . . . . 44.299999999999997 109.345 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.417 HG22 HG12 ' A' ' 182' ' ' ILE . 15.7 t -109.8 115.61 50.1 Favored 'Isoleucine or valine' 0 C--O 1.252 1.194 0 N-CA-C 108.29 -1.004 . . . . 74.450000000000003 108.29 176.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.559 HH21 HG13 ' A' ' 151' ' ' VAL . 1.4 mmm180 -126.7 159.99 32.08 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.592 -1.262 . . . . 72.319999999999993 107.592 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.654 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 16.9 pt-20 -116.99 163.31 16.41 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 109.482 -0.562 . . . . 74.150000000000006 109.482 167.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.5 t -78.78 138.0 38.0 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.712 -0.677 . . . . 73.430000000000007 110.287 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.4 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 27.1 mt-10 -75.94 -37.84 58.23 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.306 -0.861 . . . . 63.409999999999997 108.989 172.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 47.3 m -83.28 -3.78 57.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.288 1.035 . . . . 73.510000000000005 111.615 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.3 t -157.81 75.14 3.97 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 109.148 -0.686 . . . . 65.019999999999996 109.148 173.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.35 141.39 89.16 Favored 'Trans proline' 0 C--N 1.386 2.508 0 C-N-CA 122.987 2.458 . . . . 74.150000000000006 112.395 175.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 96.8 -25.19 27.66 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 115.098 -0.956 . . . . 62.030000000000001 112.009 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -91.69 117.59 29.88 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.486 -0.931 . . . . 74.439999999999998 108.486 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.654 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 56.0 mtt180 -115.64 170.21 8.61 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 123.77 0.828 . . . . 74.439999999999998 110.562 -172.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.5 t -153.97 143.29 21.44 Favored 'General case' 0 C--O 1.25 1.09 0 C-N-CA 123.956 0.902 . . . . 75.430000000000007 109.09 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.417 HG12 HG22 ' A' ' 170' ' ' VAL . 45.1 mt -110.72 132.82 58.09 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 N-CA-C 108.098 -1.075 . . . . 74.340000000000003 108.098 170.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.56 ' HB3' HD21 ' A' ' 160' ' ' LEU . 13.8 m -106.08 135.94 46.65 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 124.854 1.262 . . . . 75.099999999999994 108.082 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.416 HD22 HD23 ' A' ' 232' ' ' LEU . 36.4 mt -125.89 137.19 53.72 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.607 1.163 . . . . 74.519999999999996 110.335 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.459 ' HB2' ' HG ' ' A' ' 160' ' ' LEU . 71.4 ttt-85 -120.42 133.77 55.37 Favored 'General case' 0 C--O 1.263 1.804 0 O-C-N 124.472 1.108 . . . . 74.109999999999999 108.848 169.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.639 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 21.4 p90 -147.57 133.97 19.65 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.759 1.287 . . . . 74.140000000000001 108.295 167.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 37.76 59.77 1.25 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 126.378 1.871 . . . . 74.219999999999999 114.116 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.453 ' HA2' ' NH2' ' A' ' 185' ' ' ARG . . . 79.57 -2.52 72.37 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.823 -0.626 . . . . 53.340000000000003 114.6 173.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 42.0 ttm180 -109.78 125.51 52.78 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.501 0.72 . . . . 74.319999999999993 110.393 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 28.7 m -111.51 143.8 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.075 0.95 . . . . 74.040000000000006 110.42 172.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.551 ' HH ' ' HB ' ' A' ' 229' ' ' ILE . 24.3 p90 -147.27 150.1 34.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.948 0.899 . . . . 63.520000000000003 109.778 172.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -125.02 116.46 22.17 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.212 -1.032 . . . . 73.200000000000003 108.212 -173.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -115.07 145.81 41.94 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.31 0.576 . . . . 73.209999999999994 110.475 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.499 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 18.9 tpp180 -84.45 128.6 34.68 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 114.681 -1.145 . . . . 62.420000000000002 111.522 -169.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 79.2 mt -80.43 107.22 12.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 107.418 -1.327 . . . . 72.319999999999993 107.418 164.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -77.73 131.26 37.58 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.491 -0.929 . . . . 71.540000000000006 108.491 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.1 m -105.63 141.2 37.5 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.15 0.58 . . . . 74.530000000000001 109.529 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 202' ' ' LYS . . . -95.81 174.8 6.78 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.463 1.105 . . . . 63.450000000000003 109.757 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.0 m -59.79 -39.03 83.58 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.266 0.627 . . . . 74.030000000000001 111.762 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -83.54 12.67 5.34 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.658 0.783 . . . . 75.219999999999999 112.129 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 76.43 12.66 84.1 Favored Glycine 0 C--N 1.352 1.421 0 C-N-CA 122.828 0.252 . . . . 71.219999999999999 112.609 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 198' ' ' ALA . 28.9 mtpp -73.35 126.74 30.84 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 109.871 -0.418 . . . . 72.209999999999994 109.871 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.465 HD12 HH11 ' A' ' 180' ' ' ARG . 80.9 mt -94.72 145.37 24.91 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.457 -0.942 . . . . 74.109999999999999 108.457 -178.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -166.85 136.2 2.92 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.329 0.652 . . . . 73.030000000000001 109.611 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.7 t -92.93 -56.99 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 107.677 -1.231 . . . . 75.519999999999996 107.677 169.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 2.8 p -83.84 147.06 27.76 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.146 -1.388 . . . . 75.040000000000006 109.679 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 20.7 t -68.76 -46.21 69.38 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.848 0.859 . . . . 60.340000000000003 112.37 -165.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -77.09 -4.02 42.27 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.425 0.69 . . . . 75.420000000000002 111.601 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 70.2 m -91.32 140.37 29.84 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 123.587 0.755 . . . . 71.549999999999997 110.128 173.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -142.75 110.36 5.8 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.014 -1.106 . . . . 74.340000000000003 108.014 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 14.6 m-85 -117.0 141.91 47.64 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 109.674 -0.491 . . . . 63.509999999999998 109.674 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -91.2 -18.69 24.03 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.358 0.663 . . . . 74.510000000000005 109.958 168.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 29.5 p -128.64 138.29 52.1 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.956 0.884 . . . . 62.450000000000003 111.715 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.475 ' HB3' HD11 ' A' ' 141' ' ' LEU . 29.3 tp -67.59 -26.43 66.26 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.031 -1.441 . . . . 73.530000000000001 110.831 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.33 -45.79 92.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.533 0.733 . . . . 74.219999999999999 110.445 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -74.7 -30.54 61.59 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.707 -0.679 . . . . 74.150000000000006 111.932 177.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.73 -51.21 70.73 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 110.133 -0.321 . . . . 75.540000000000006 110.133 172.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.38 -42.48 93.68 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 C-N-CA 124.069 0.948 . . . . 74.349999999999994 110.717 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -60.79 -51.52 68.97 Favored 'General case' 0 C--O 1.262 1.734 0 C-N-CA 123.963 0.905 . . . . 74.25 111.033 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -55.23 -53.15 59.69 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.72 -1.127 . . . . 72.299999999999997 109.748 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -73.1 -12.24 60.83 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.245 -0.434 . . . . 61.420000000000002 112.134 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.0 t -78.44 -27.4 46.48 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.835 0.454 . . . . 63.240000000000002 110.472 172.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -109.84 -22.48 11.86 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.974 1.842 . . . . 71.310000000000002 115.974 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.69 152.64 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 120.552 1.523 . . . . 73.530000000000001 114.379 -165.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.09 -1.14 57.96 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 111.905 -2.407 . . . . 71.219999999999999 112.866 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -78.7 14.91 1.16 Allowed 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 128.132 2.573 . . . . 61.43 113.512 -140.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.89 17.36 4.63 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 110.773 -0.931 . . . . 75.239999999999995 110.773 -168.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.68 125.7 35.75 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.35 -0.925 . . . . 75.310000000000002 109.7 165.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.551 ' HB ' ' HH ' ' A' ' 191' ' ' TYR . 77.7 mt -61.67 -44.17 98.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 O-C-N 124.133 0.896 . . . . 73.310000000000002 109.427 172.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.4 t -137.16 144.91 43.2 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.19 -0.914 . . . . 64.310000000000002 108.582 169.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 60.4 p -73.99 151.11 40.37 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.228 -0.656 . . . . 73.420000000000002 109.228 172.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.433 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 33.5 mt -64.48 101.19 0.42 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.244 -0.65 . . . . 73.109999999999999 109.244 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -80.81 -55.72 4.62 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.845 0.458 . . . . 72.129999999999995 109.972 -174.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -155.24 149.87 20.11 Favored Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 109.824 -0.435 . . . . 44.130000000000003 109.824 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 32.8 Cg_endo -63.08 142.54 87.78 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.192 1.928 . . . . 74.549999999999997 111.628 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.02 140.37 95.98 Favored Pre-proline 0 C--O 1.244 0.785 0 CA-C-O 119.255 -0.402 . . . . 73.099999999999994 110.511 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 162' ' ' SER . 17.9 Cg_endo -57.52 118.61 5.51 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 123.012 2.475 . . . . 52.350000000000001 113.811 -174.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -76.42 155.89 33.61 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 108.055 -1.091 . . . . 74.049999999999997 108.055 166.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -59.03 -25.25 63.52 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.738 0.644 . . . . 73.510000000000005 112.738 -174.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -117.35 112.02 20.16 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.137 0.575 . . . . 75.349999999999994 109.861 174.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.442 ' N ' ' HD3' ' A' ' 242' ' ' PRO . 13.3 ptmm? -161.4 56.85 0.75 Allowed Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 124.133 0.973 . . . . 75.230000000000004 110.839 171.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 241' ' ' LYS . 12.9 Cg_exo -70.44 89.92 0.59 Allowed 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.739 2.293 . . . . 74.0 111.433 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 14.7 t -163.08 159.26 23.0 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.972 0.909 . . . . 74.329999999999998 109.935 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 30.6 m -116.31 144.21 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.197 0.599 . . . . 75.200000000000003 110.174 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -161.22 143.05 11.92 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.14 0.976 . . . . 75.040000000000006 110.079 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 122.01 128.19 3.44 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.759 -0.536 . . . . 72.019999999999996 111.759 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 62.0 t -112.68 -64.9 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.53 0.732 . . . . 74.519999999999996 109.799 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 35.9 t -169.81 127.84 0.83 Allowed Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.62 0.768 . . . . 63.100000000000001 109.594 -174.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -85.42 167.57 10.34 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.505 2.137 . . . . 51.530000000000001 111.563 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -140.23 90.83 2.4 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.643 -0.873 . . . . 64.530000000000001 108.643 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -95.36 121.58 37.18 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.419 -0.809 . . . . 75.319999999999993 109.063 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -93.56 166.45 12.24 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.169 0.988 . . . . 73.420000000000002 110.387 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -118.26 122.16 42.25 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.442 0.697 . . . . 74.310000000000002 110.409 -178.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -140.0 101.41 4.16 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.019 -1.475 . . . . 75.540000000000006 107.019 169.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 . . . . . 0 CA--C 1.561 1.39 0 C-N-CA 124.672 1.189 . . . . 73.040000000000006 111.965 -179.057 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 ptp . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 121.614 0.721 . . . . 74.430000000000007 110.912 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.55 17.03 0.03 OUTLIER Glycine 0 CA--C 1.526 0.741 0 CA-C-N 114.631 -1.168 . . . . 72.409999999999997 111.396 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -72.15 85.73 1.04 Allowed 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.413 1.085 . . . . 74.430000000000007 108.802 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -86.48 125.03 68.79 Favored Pre-proline 0 C--O 1.238 0.486 0 CA-C-N 114.936 -1.029 . . . . 74.230000000000004 108.862 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.99 -28.81 87.9 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.941 2.427 . . . . 70.099999999999994 112.217 173.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.25 -174.18 35.06 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.565 -0.743 . . . . 34.420000000000002 111.426 -174.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -176.75 135.61 0.23 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.568 0.747 . . . . 74.109999999999999 109.862 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.1 150.18 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 123.246 0.618 . . . . 71.409999999999997 111.652 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 pp -67.83 147.76 52.12 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.888 -0.596 . . . . 74.319999999999993 109.859 170.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 15' ' ' PRO . . . -66.34 -30.83 77.36 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-O 119.312 -0.716 . . . . 61.109999999999999 112.898 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.0 t70 73.75 -62.32 0.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.104 1.762 . . . . 73.049999999999997 111.567 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -79.03 -172.01 2.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.216 1.406 . . . . 74.439999999999998 111.883 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -56.38 139.1 49.79 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 124.689 1.196 . . . . 74.239999999999995 111.546 175.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 51.56 70.94 1.67 Allowed Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.837 0.855 . . . . 75.010000000000005 110.934 -169.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.412 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 91.7 Cg_endo -75.09 167.76 26.26 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.825 2.35 . . . . 75.409999999999997 112.132 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.0 p -66.91 167.52 11.45 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 121.304 0.573 . . . . 72.510000000000005 111.188 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.3 mt -108.3 134.68 20.11 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 123.981 0.912 . . . . 73.340000000000003 109.604 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -69.3 166.03 28.42 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.379 2.053 . . . . 71.430000000000007 110.908 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.8 142.87 29.47 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.727 0.299 . . . . 63.109999999999999 110.217 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.598 ' HB3' HD11 ' A' ' 23' ' ' ILE . 71.3 mt -87.01 95.54 9.97 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.934 0.893 . . . . 62.32 109.068 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -99.49 -49.66 4.35 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.49 0.662 . . . . 73.340000000000003 110.053 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -99.62 114.92 28.27 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.809 -1.087 . . . . 74.230000000000004 108.901 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.598 HD11 ' HB3' ' A' ' 20' ' ' LEU . 49.5 mm -116.29 117.84 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 108.609 -0.885 . . . . 71.329999999999998 108.609 -174.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.47 ' HB2' ' HE1' ' A' ' 129' ' ' TRP . 9.5 tmtt? -66.3 -38.17 87.13 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.115 -0.698 . . . . 74.239999999999995 109.115 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.18 175.19 49.81 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.775 -0.648 . . . . 60.210000000000001 113.476 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -92.44 107.92 19.58 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.198 -0.667 . . . . 74.230000000000004 109.198 173.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.26 66.9 0.11 Allowed Glycine 0 C--N 1.348 1.196 0 N-CA-C 110.589 -1.004 . . . . 45.399999999999999 110.589 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp 69.93 111.31 0.05 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.534 1.534 . . . . 74.219999999999999 110.731 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -93.93 145.86 24.33 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.28 0.632 . . . . 74.450000000000003 110.011 -177.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -82.49 167.22 18.63 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.829 0.852 . . . . 74.430000000000007 111.644 -170.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 78' ' ' SER . 19.9 m 57.6 23.65 9.55 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.733 1.213 . . . . 75.109999999999999 113.052 173.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.7 t -84.21 99.27 10.43 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 121.871 -0.518 . . . . 73.420000000000002 109.978 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.03 -70.47 0.8 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.612 0.765 . . . . 75.239999999999995 110.944 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -146.28 -41.66 0.2 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.458 0.703 . . . . 71.140000000000001 111.031 -171.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.473 ' HA3' ' HG2' ' A' ' 77' ' ' PRO . . . 79.38 60.18 2.56 Favored Glycine 0 C--N 1.343 0.934 0 O-C-N 123.341 0.401 . . . . 75.129999999999995 113.407 176.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.74 146.59 7.18 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.567 -0.574 . . . . 65.329999999999998 112.969 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.22 44.38 1.41 Allowed 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 123.748 2.965 . . . . 72.510000000000005 113.173 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -64.28 104.21 0.73 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.702 0.801 . . . . 71.329999999999998 111.119 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.3 t -157.28 142.85 17.4 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.143 0.977 . . . . 75.510000000000005 109.107 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -72.15 152.71 42.11 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 120.888 0.375 . . . . 71.239999999999995 111.415 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.24 173.67 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.55 0.74 . . . . 72.200000000000003 109.537 171.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.499 ' HB3' HD21 ' A' ' 61' ' ' LEU . 15.9 p90 -117.56 105.82 12.47 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.961 -1.126 . . . . 75.340000000000003 107.961 170.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' A' ' 62' ' ' SER . 3.6 p -72.69 89.39 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-O 122.75 1.262 . . . . 73.120000000000005 109.347 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.7 147.38 53.17 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 113.689 -1.596 . . . . 70.200000000000003 111.716 -177.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -84.95 133.37 34.28 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.751 0.821 . . . . 75.329999999999998 110.933 -172.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -73.21 97.72 2.48 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.194 0.598 . . . . 61.210000000000001 110.359 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.25 125.53 39.09 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.332 0.653 . . . . 53.439999999999998 109.965 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.9 -15.78 61.13 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.142 0.577 . . . . 75.439999999999998 110.144 170.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -79.05 141.09 37.7 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 108.98 -0.748 . . . . 75.230000000000004 108.98 168.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.17 149.66 67.41 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.915 1.286 . . . . 74.230000000000004 108.12 176.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.33 145.33 93.99 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.844 2.363 . . . . 75.439999999999998 113.145 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.48 -29.34 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.016 0.926 . . . . 74.329999999999998 110.564 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.75 148.61 38.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.97 0.908 . . . . 72.219999999999999 110.359 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.4 m -82.23 78.88 8.85 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.699 0.8 . . . . 65.239999999999995 109.869 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -86.94 177.59 7.21 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.403 -0.817 . . . . 74.239999999999995 110.269 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -131.74 171.93 12.9 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.816 0.846 . . . . 60.520000000000003 110.272 -176.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 69.07 76.05 0.25 Allowed Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 124.99 1.316 . . . . 73.430000000000007 111.602 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.19 82.24 0.5 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.501 2.134 . . . . 73.430000000000007 111.006 173.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -68.29 127.55 33.35 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.4 0.68 . . . . 74.510000000000005 110.498 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.28 70.31 0.09 OUTLIER Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.224 -1.15 . . . . 74.400000000000006 110.224 -173.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.499 HD21 ' HB3' ' A' ' 42' ' ' PHE . 88.4 mt -90.68 87.96 6.91 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.083 -0.71 . . . . 73.209999999999994 109.083 173.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.42 ' HB3' HG11 ' A' ' 43' ' ' VAL . 47.3 t -74.12 121.9 21.89 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 109.33 -0.619 . . . . 75.549999999999997 109.33 176.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.94 89.1 0.77 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.47 -0.786 . . . . 72.319999999999993 109.841 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.11 154.07 30.33 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.643 1.177 . . . . 72.120000000000005 108.591 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -153.0 118.2 5.18 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 122.982 0.513 . . . . 74.329999999999998 109.827 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -98.14 54.66 1.11 Allowed 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.796 -0.816 . . . . 71.409999999999997 108.796 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 43.07 65.22 1.0 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.912 1.685 . . . . 74.329999999999998 113.121 175.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -96.42 142.69 28.23 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.467 -0.788 . . . . 72.340000000000003 109.083 175.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.8 p -80.89 70.32 7.66 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.565 0.746 . . . . 64.319999999999993 110.973 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -84.31 80.09 9.33 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 107.699 -1.223 . . . . 74.230000000000004 107.699 172.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -67.84 82.24 0.2 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.757 -1.111 . . . . 64.409999999999997 111.531 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -72.46 132.07 43.39 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.079 -1.082 . . . . 75.230000000000004 108.079 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.4 mt -74.11 5.46 4.34 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.185 0.594 . . . . 74.540000000000006 112.264 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.23 131.77 49.5 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.561 1.144 . . . . 71.439999999999998 110.879 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.79 141.92 51.36 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.697 0.799 . . . . 73.319999999999993 111.003 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -172.9 -164.07 27.71 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-O 118.98 -0.9 . . . . 71.340000000000003 112.198 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.473 ' HG2' ' HA3' ' A' ' 35' ' ' GLY . 52.8 Cg_endo -69.42 -154.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.61 2.873 . . . . 70.150000000000006 113.527 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 31' ' ' SER . 2.8 p -84.47 139.4 32.2 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.74 1.385 . . . . 74.430000000000007 114.74 -166.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -77.52 -179.22 5.68 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-N 114.683 -1.144 . . . . 73.319999999999993 111.31 171.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -55.74 141.25 39.0 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.461 1.104 . . . . 71.510000000000005 111.877 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -148.4 152.25 38.33 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 123.816 0.846 . . . . 75.540000000000006 109.525 -174.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.45 -7.26 16.82 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.572 2.181 . . . . 72.420000000000002 112.627 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -96.71 33.32 1.87 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.674 0.79 . . . . 73.299999999999997 110.537 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 25.7 tp -80.83 113.6 19.14 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.919 -0.771 . . . . 73.310000000000002 108.919 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -103.5 176.42 5.15 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.927 1.691 . . . . 71.040000000000006 108.808 173.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.48 144.28 35.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 N-CA-C 108.721 -0.844 . . . . 74.129999999999995 108.721 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.91 113.3 12.06 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 123.532 0.52 . . . . 73.019999999999996 109.954 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.58 -26.2 62.51 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.006 0.922 . . . . 73.420000000000002 111.023 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.46 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 71.8 m-85 -134.95 155.46 50.69 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.85 -0.796 . . . . 74.209999999999994 108.85 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -74.41 141.68 45.05 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.88 -0.785 . . . . 73.340000000000003 108.88 170.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -143.44 112.59 6.72 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.94 -0.763 . . . . 72.25 108.94 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.6 t -79.47 129.64 37.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 107.877 -1.157 . . . . 63.299999999999997 107.877 172.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.58 146.68 54.24 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.397 0.679 . . . . 74.230000000000004 111.122 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.3 m -70.36 -25.31 63.21 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.858 0.863 . . . . 71.439999999999998 110.136 169.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.04 -140.55 6.21 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 115.723 -0.671 . . . . 64.519999999999996 112.245 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.17 -35.15 73.79 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.544 0.737 . . . . 71.319999999999993 111.013 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.563 ' HB2' HD13 ' A' ' 23' ' ' ILE . 28.7 p30 -70.08 -4.68 22.26 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.66 0.784 . . . . 74.129999999999995 112.676 -177.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.3 p -134.5 160.15 38.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.399 1.08 . . . . 72.329999999999998 109.047 177.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.5 tp -110.58 125.97 53.94 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.724 -0.473 . . . . 72.030000000000001 109.724 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.1 p -74.6 114.17 12.71 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 108.603 -0.888 . . . . 74.439999999999998 108.603 173.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.0 pt -117.23 155.23 18.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.971 -0.751 . . . . 70.200000000000003 108.971 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.8 m -120.71 145.71 47.2 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.151 -0.685 . . . . 72.099999999999994 109.151 175.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -53.3 114.84 1.63 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.552 0.741 . . . . 64.400000000000006 110.972 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.39 -14.34 33.06 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-O 119.87 -0.406 . . . . 74.310000000000002 112.828 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -76.33 132.41 39.77 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.209 0.604 . . . . 72.409999999999997 109.687 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.417 ' HB3' HD11 ' A' ' 84' ' ' LEU . 50.2 mtmt -84.7 119.69 25.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.685 0.794 . . . . 75.109999999999999 109.371 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.3 mt -104.29 139.48 39.22 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.523 1.129 . . . . 72.040000000000006 108.858 -170.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -101.39 106.93 18.14 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.416 -0.957 . . . . 75.510000000000005 108.416 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 93.9 t -93.07 109.18 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 109.235 -0.654 . . . . 75.310000000000002 109.235 -174.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.7 mt -68.02 -34.75 77.08 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.644 0.778 . . . . 72.230000000000004 110.376 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.66 173.6 38.65 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.337 -0.847 . . . . 60.119999999999997 111.887 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.686 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 14.2 m-85 -98.21 168.84 9.99 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.319 0.648 . . . . 72.439999999999998 109.536 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -71.38 152.15 43.42 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.059 -0.719 . . . . 75.219999999999999 109.059 172.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -58.11 -44.37 87.68 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.229 0.612 . . . . 74.329999999999998 111.472 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -79.13 -5.44 54.14 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 122.949 0.499 . . . . 72.430000000000007 110.315 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 72.6 34.31 60.09 Favored Glycine 0 C--N 1.352 1.44 0 C-N-CA 123.22 0.438 . . . . 72.109999999999999 113.349 174.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -85.44 -61.86 1.66 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.535 0.684 . . . . 72.239999999999995 109.498 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 129' ' ' TRP . 74.5 m95 -111.56 178.11 4.43 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.871 -1.059 . . . . 75.129999999999995 109.974 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -144.45 116.01 8.13 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.98 0.912 . . . . 73.230000000000004 108.658 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -76.58 110.83 11.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.89 0.376 . . . . 74.430000000000007 111.11 -174.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -105.5 165.35 11.2 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.223 -0.899 . . . . 51.439999999999998 110.195 177.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -142.61 125.27 15.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.34 0.656 . . . . 75.340000000000003 109.409 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.7 p -135.86 -164.31 1.53 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.315 1.046 . . . . 73.5 110.416 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -53.99 -33.28 56.64 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.487 1.515 . . . . 75.439999999999998 111.214 172.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -77.52 -1.85 32.59 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.88 1.272 . . . . 72.019999999999996 112.093 -177.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.09 -135.4 12.74 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.262 -0.735 . . . . 72.430000000000007 111.262 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -141.56 135.08 29.73 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.68 0.74 . . . . 73.140000000000001 110.63 -172.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -179.07 176.86 48.21 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 112.215 -0.354 . . . . 74.030000000000001 112.215 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.47 ' HE1' ' HB2' ' A' ' 24' ' ' LYS . 79.8 m95 -87.15 131.64 34.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.538 0.735 . . . . 72.549999999999997 111.309 -174.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.45 152.14 60.76 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.492 1.117 . . . . 73.530000000000001 109.294 175.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.71 131.52 17.34 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 121.819 1.68 . . . . 74.430000000000007 109.896 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.1 m -61.63 -18.73 60.64 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.988 0.915 . . . . 72.329999999999998 112.402 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -74.68 -18.73 60.48 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.322 1.049 . . . . 73.219999999999999 111.638 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.46 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 5.4 m-85 -97.93 1.24 47.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.595 0.758 . . . . 74.030000000000001 111.862 -177.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.3 pt -133.12 158.96 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 122.873 0.469 . . . . 74.25 110.435 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.3 t -150.61 140.86 14.23 Favored Pre-proline 0 N--CA 1.49 1.56 0 C-N-CA 122.527 0.331 . . . . 63.130000000000003 110.436 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.48 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 74.3 Cg_endo -72.85 132.37 18.4 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.91 2.407 . . . . 63.25 113.055 -177.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.7 m -113.86 -40.95 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 122.811 0.444 . . . . 74.019999999999996 111.693 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.426 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 62.8 t30 -100.97 0.42 38.21 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 122.859 0.464 . . . . 65.140000000000001 111.713 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.48 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 33.2 t -75.54 -178.94 4.34 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.11 0.564 . . . . 70.219999999999999 110.33 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 50.0 mt -56.86 -18.23 12.3 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.548 1.139 . . . . 74.25 112.708 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.572 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 28.2 tt0 -62.07 -19.13 62.6 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.89 0.876 . . . . 71.439999999999998 112.4 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -58.65 -23.73 59.71 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.419 0.688 . . . . 75.109999999999999 111.427 174.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -90.67 134.19 34.59 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.485 -0.931 . . . . 73.040000000000006 108.485 173.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.8 p -62.19 -20.56 64.29 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.013 0.745 . . . . 72.299999999999997 113.013 -172.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -73.51 -30.21 62.97 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.118 0.414 . . . . 63.530000000000001 112.118 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -103.33 135.02 45.74 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.553 -0.536 . . . . 74.450000000000003 109.553 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.572 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 16.6 m-70 -130.74 44.49 2.95 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.899 0.479 . . . . 74.329999999999998 110.667 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.45 -160.3 36.61 Favored Glycine 0 CA--C 1.541 1.669 0 N-CA-C 116.45 1.34 . . . . 64.409999999999997 116.45 164.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -83.37 108.97 1.56 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 124.178 3.252 . . . . 64.540000000000006 112.663 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 20.5 m -144.4 172.7 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 109.463 -0.569 . . . . 74.109999999999999 109.463 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.9 m -95.64 171.88 8.4 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 115.834 -0.621 . . . . 74.219999999999999 111.134 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -58.2 -25.29 61.41 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.002 0.921 . . . . 73.299999999999997 111.831 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -66.04 -56.45 11.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.068 0.947 . . . . 74.140000000000001 110.661 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.56 93.37 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.476 0.71 . . . . 73.209999999999994 110.614 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.465 ' HA ' ' NH2' ' A' ' 171' ' ' ARG . . . -56.59 -55.1 38.17 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-N 114.973 -1.012 . . . . 72.099999999999994 110.737 175.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.552 ' HG3' HG12 ' A' ' 190' ' ' VAL . 39.9 tt0 -68.59 -28.98 67.42 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.628 0.771 . . . . 71.230000000000004 110.927 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -61.17 -49.81 75.7 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.358 0.663 . . . . 74.420000000000002 110.5 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.537 HD13 HH22 ' A' ' 171' ' ' ARG . 38.4 mt -73.41 -32.98 64.73 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.85 -0.614 . . . . 72.109999999999999 111.811 177.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.498 HD23 ' HB3' ' A' ' 183' ' ' SER . 44.4 tp -69.88 -26.01 63.98 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.186 0.994 . . . . 74.409999999999997 111.326 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.7 t -69.52 -8.87 50.88 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.847 0.859 . . . . 75.450000000000003 111.594 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.9 t -95.94 12.03 31.79 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.588 0.755 . . . . 64.409999999999997 110.762 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.93 174.02 18.0 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 114.155 0.422 . . . . 73.040000000000006 114.155 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.6 pt -123.9 -165.55 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.512 1.125 . . . . 74.010000000000005 109.984 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.844 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 13.8 p-10 -52.64 108.65 0.32 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.08 0.952 . . . . 74.030000000000001 112.66 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 100.49 11.59 40.97 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.42 -0.809 . . . . 73.409999999999997 112.904 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.3 t -77.4 129.33 35.64 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.477 -0.934 . . . . 70.099999999999994 108.477 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -136.52 153.27 51.06 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.811 0.671 . . . . 74.340000000000003 112.811 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.721 HD11 HH21 ' A' ' 171' ' ' ARG . 88.9 mt -131.05 132.16 44.74 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.73 -1.211 . . . . 75.329999999999998 107.73 168.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.71 121.68 56.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 106.663 -1.606 . . . . 73.439999999999998 106.663 172.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.721 HH21 HD11 ' A' ' 169' ' ' LEU . 13.1 mmt180 -128.37 165.99 19.54 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.091 0.957 . . . . 74.340000000000003 108.781 -172.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 13.2 pt-20 -114.94 150.87 35.05 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 107.622 -1.251 . . . . 65.030000000000001 107.622 158.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.6 p -86.44 133.08 33.79 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.347 0.404 . . . . 75.150000000000006 109.915 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.76 -38.19 88.4 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.008 0.923 . . . . 64.439999999999998 110.869 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.42 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 32.9 p -81.31 -10.92 59.47 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.001 0.92 . . . . 70.549999999999997 112.418 -175.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 39.8 m -138.27 101.04 8.42 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 122.915 0.486 . . . . 74.049999999999997 110.477 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.686 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 56.5 Cg_endo -66.55 137.86 47.87 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.715 2.943 . . . . 74.329999999999998 112.462 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.36 -22.41 4.58 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 116.224 -0.443 . . . . 75.420000000000002 113.537 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -82.85 119.44 24.39 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.734 0.814 . . . . 70.019999999999996 109.335 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 77.8 mtt-85 -116.97 163.24 16.52 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 115.184 -0.916 . . . . 74.420000000000002 108.924 -176.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.2 m -147.92 148.0 30.33 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.143 0.577 . . . . 65.120000000000005 110.098 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 66.1 mt -110.58 137.74 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 108.864 -0.791 . . . . 72.420000000000002 108.864 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.498 ' HB3' HD23 ' A' ' 160' ' ' LEU . 29.1 m -114.01 115.51 27.73 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.665 1.186 . . . . 64.099999999999994 108.348 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.5 mt -105.0 144.95 31.11 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.808 0.843 . . . . 73.299999999999997 111.511 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.423 ' HB2' ' HG ' ' A' ' 160' ' ' LEU . 28.3 ttt180 -126.97 138.99 53.36 Favored 'General case' 0 C--O 1.256 1.405 0 N-CA-C 107.071 -1.455 . . . . 74.450000000000003 107.071 168.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.844 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 10.3 t80 -149.9 103.98 3.26 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.504 -1.225 . . . . 75.340000000000003 108.328 -168.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 56.02 35.66 25.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.682 1.193 . . . . 73.409999999999997 112.321 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.3 78.76 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.503 -0.771 . . . . 71.530000000000001 113.264 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -98.22 124.39 42.78 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.735 -0.839 . . . . 75.340000000000003 108.735 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.552 HG12 ' HG3' ' A' ' 157' ' ' GLU . 48.4 t -109.18 129.51 63.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.47 1.108 . . . . 73.310000000000002 108.78 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.459 ' HE2' ' HB3' ' A' ' 186' ' ' TYR . 13.1 p90 -146.85 143.85 28.88 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.231 1.013 . . . . 73.299999999999997 109.156 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -126.53 140.66 52.28 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.186 0.994 . . . . 64.239999999999995 108.814 -170.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -139.16 140.65 37.92 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.957 0.408 . . . . 75.349999999999994 111.056 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 23.1 tpp180 -77.04 131.2 38.29 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.903 -1.044 . . . . 74.540000000000006 110.705 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 96.3 mt -78.36 106.18 8.63 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 N-CA-C 107.555 -1.276 . . . . 63.119999999999997 107.555 164.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -75.5 124.94 28.04 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.531 -0.914 . . . . 64.549999999999997 108.531 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.3 m -99.7 115.46 29.53 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.931 0.893 . . . . 60.299999999999997 109.604 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.07 148.63 51.52 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.603 0.761 . . . . 64.340000000000003 109.033 167.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 75.1 p -66.71 -8.75 30.09 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.149 0.58 . . . . 71.430000000000007 112.382 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -83.58 -0.66 51.38 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.03 0.932 . . . . 74.519999999999996 111.14 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 86.83 -0.91 86.74 Favored Glycine 0 C--N 1.349 1.301 0 C-N-CA 123.12 0.39 . . . . 63.310000000000002 112.631 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -76.52 129.35 36.35 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 116.903 0.351 . . . . 74.319999999999993 110.105 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.5 mt -96.61 148.23 23.07 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.397 0.679 . . . . 72.519999999999996 109.261 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -164.61 167.49 19.18 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 123.747 0.655 . . . . 74.310000000000002 110.798 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.4 t -136.62 -63.47 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.815 -1.179 . . . . 73.530000000000001 107.815 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 30.2 t -86.38 167.49 14.68 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.179 0.992 . . . . 74.319999999999993 109.484 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 42.8 p -67.75 -39.79 84.15 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.585 0.754 . . . . 73.010000000000005 109.907 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -82.76 -2.52 54.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.841 0.856 . . . . 74.219999999999999 112.062 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.424 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 58.1 m -92.77 118.15 30.78 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.978 0.911 . . . . 75.299999999999997 109.581 171.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -144.87 118.19 9.0 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 124.684 1.193 . . . . 75.230000000000004 108.545 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 209' ' ' SER . 10.7 m-85 -135.39 150.43 49.9 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 118.295 0.498 . . . . 71.25 111.505 -172.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -92.03 -29.91 16.33 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.567 0.747 . . . . 62.520000000000003 110.47 171.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.1 p -124.4 147.42 48.27 Favored 'General case' 0 C--O 1.248 1.025 0 C-N-CA 123.527 0.731 . . . . 73.040000000000006 111.074 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 32.9 tp -65.56 -31.68 72.86 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 114.37 -1.287 . . . . 72.200000000000003 110.657 175.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.87 98.14 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.447 0.699 . . . . 71.310000000000002 111.154 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -73.7 -30.54 62.92 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 119.069 -0.491 . . . . 72.239999999999995 111.693 175.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.96 -47.54 84.73 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.514 0.509 . . . . 74.340000000000003 110.446 172.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.2 t -71.4 -37.32 64.51 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 C-N-CA 124.022 0.929 . . . . 74.010000000000005 110.808 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 14.4 t-160 -62.35 -56.14 21.23 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.719 0.807 . . . . 75.439999999999998 111.108 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -52.75 -53.53 46.65 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.641 -1.163 . . . . 70.209999999999994 109.393 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.411 ' HB3' ' HG ' ' A' ' 232' ' ' LEU . 8.0 m-70 -63.09 -27.72 69.59 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.979 -0.555 . . . . 74.329999999999998 112.388 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.5 t -71.23 -23.66 62.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.846 0.459 . . . . 74.329999999999998 110.841 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 15.4 t -119.07 -3.69 10.63 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 116.407 2.002 . . . . 72.299999999999997 116.407 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.406 ' O ' HG21 ' A' ' 231' ' ' THR . 27.0 m -106.03 154.67 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 116.422 2.008 . . . . 74.519999999999996 116.422 -172.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.7 -0.73 56.84 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 110.793 -2.912 . . . . 73.010000000000005 113.285 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -76.25 13.72 0.87 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 129.596 3.158 . . . . 71.150000000000006 113.56 -140.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.45 16.87 4.99 Favored Glycine 0 N--CA 1.464 0.545 0 C-N-CA 126.253 1.882 . . . . 73.230000000000004 111.629 -169.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.06 126.69 38.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.609 -1.295 . . . . 71.219999999999999 109.551 166.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 76.9 mt -58.36 -49.55 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.581 0.752 . . . . 73.010000000000005 109.428 170.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.8 t -134.24 148.13 50.79 Favored 'General case' 0 C--O 1.249 1.064 0 N-CA-C 107.826 -1.175 . . . . 71.329999999999998 107.826 169.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' THR . . . . . 0.406 HG21 ' O ' ' A' ' 224' ' ' VAL . 67.0 p -70.52 162.93 27.91 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 109.53 -0.544 . . . . 72.540000000000006 109.53 175.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.411 ' HG ' ' HB3' ' A' ' 221' ' ' HIS . 21.5 mt -68.58 100.52 1.13 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.154 -1.054 . . . . 62.240000000000002 108.154 176.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -90.89 -47.18 7.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.767 0.427 . . . . 64.409999999999997 111.253 -168.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -157.12 147.8 16.24 Favored Pre-proline 0 N--CA 1.485 1.319 0 N-CA-C 109.676 -0.49 . . . . 74.209999999999994 109.676 174.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.14 133.69 34.02 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.656 2.237 . . . . 72.209999999999994 112.626 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.71 150.25 97.9 Favored Pre-proline 0 C--O 1.246 0.882 0 C-N-CA 123.555 0.742 . . . . 72.219999999999999 110.414 174.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.437 ' O ' ' HB3' ' A' ' 159' ' ' LEU . 51.6 Cg_exo -56.95 132.57 52.44 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.341 2.694 . . . . 73.420000000000002 114.908 -172.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.422 ' HA ' HD12 ' A' ' 159' ' ' LEU . 54.3 tttp -73.35 157.18 37.46 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 106.721 -1.585 . . . . 60.439999999999998 106.721 158.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -62.77 -13.72 36.41 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 118.764 0.711 . . . . 74.439999999999998 112.691 -170.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -128.67 72.99 1.47 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.222 -1.399 . . . . 71.519999999999996 107.222 164.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.426 ' HD2' ' HB3' ' A' ' 237' ' ' PRO . 21.4 ptmt -64.51 143.75 98.58 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 115.838 -0.619 . . . . 73.230000000000004 112.181 -172.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 241' ' ' LYS . 1.2 Cg_endo -86.68 -164.74 0.22 Allowed 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 123.274 2.65 . . . . 71.349999999999994 110.87 166.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 9.7 t -119.64 144.65 47.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.065 0.546 . . . . 75.519999999999996 110.021 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.8 t -122.68 133.66 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.134 -1.061 . . . . 75.230000000000004 108.134 173.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -70.78 96.3 1.23 Allowed 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 109.069 -0.715 . . . . 71.099999999999994 109.069 173.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -93.28 -20.26 33.22 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.658 -0.701 . . . . 53.020000000000003 113.161 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.44 77.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-O 121.763 0.792 . . . . 74.209999999999994 110.472 -174.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.4 p -166.64 81.82 0.97 Allowed Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 115.117 -0.947 . . . . 73.400000000000006 110.323 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.56 129.67 12.05 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.555 2.17 . . . . 45.420000000000002 111.122 172.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -79.82 138.15 37.15 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.167 0.587 . . . . 75.510000000000005 109.935 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -113.32 114.23 26.37 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.613 -0.884 . . . . 73.010000000000005 108.613 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -165.18 151.37 10.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.665 -0.865 . . . . 75.219999999999999 108.665 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.544 ' HA ' ' HE2' ' A' ' 253' ' ' LYS . 10.2 mmpt? -81.84 124.18 29.46 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.937 0.399 . . . . 75.25 111.709 -176.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -95.33 -160.11 0.76 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.446 1.099 . . . . 72.329999999999998 108.704 165.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 123.057 0.543 . . . . 73.239999999999995 109.795 -175.391 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.656 -0.498 . . . . 75.519999999999996 109.656 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.21 82.38 1.66 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 110.669 -0.972 . . . . 74.219999999999999 110.669 -174.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -73.41 98.46 2.74 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.934 0.894 . . . . 64.219999999999999 110.511 -172.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -110.4 105.66 57.33 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 109.007 -0.738 . . . . 74.409999999999997 109.007 174.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -72.45 85.47 1.08 Allowed 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.063 2.509 . . . . 61.340000000000003 112.503 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.62 24.36 0.11 Allowed Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.423 -0.808 . . . . 71.030000000000001 113.168 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -105.17 116.34 31.79 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 109.362 -0.607 . . . . 72.0 109.362 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.9 m -118.26 163.07 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.387 0.675 . . . . 72.010000000000005 109.516 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.2 mt -126.61 120.82 30.5 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.417 0.687 . . . . 73.329999999999998 109.68 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.12 131.91 1.31 Allowed Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.494 -0.614 . . . . 63.030000000000001 113.141 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -172.39 158.62 4.39 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.614 0.766 . . . . 75.329999999999998 109.554 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -79.02 -10.23 59.77 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.696 0.798 . . . . 74.299999999999997 111.872 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -130.47 149.76 52.0 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.615 -1.254 . . . . 75.129999999999995 107.615 171.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 47.8 mmm-85 60.79 80.57 0.26 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.682 0.793 . . . . 72.299999999999997 110.508 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.73 159.48 28.44 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.419 2.079 . . . . 75.129999999999995 110.586 173.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.0 p -66.26 166.87 11.25 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.325 0.583 . . . . 74.409999999999997 110.861 -173.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.6 mt -107.9 123.71 36.97 Favored Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 108.405 -0.961 . . . . 71.120000000000005 108.405 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HG2' ' NE1' ' A' ' 118' ' ' TRP . 55.5 Cg_endo -71.73 173.77 12.13 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.812 2.341 . . . . 73.439999999999998 112.253 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.79 149.28 29.67 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.16 0.584 . . . . 64.439999999999998 111.32 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.517 HD22 HD12 ' A' ' 23' ' ' ILE . 89.2 mt -87.43 95.23 9.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.322 0.649 . . . . 73.540000000000006 109.767 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -97.44 -49.15 5.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.147 0.579 . . . . 70.349999999999994 110.485 175.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -99.87 107.78 19.87 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.91 -0.404 . . . . 74.409999999999997 109.91 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 97' ' ' ASN . 46.6 mm -124.26 121.04 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.103 0.961 . . . . 74.230000000000004 109.551 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -111.95 -50.31 2.92 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.376 -0.602 . . . . 75.420000000000002 109.376 174.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.82 -135.15 12.93 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 115.944 -0.571 . . . . 73.409999999999997 112.029 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.0 79.43 8.52 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.174 0.487 . . . . 72.219999999999999 110.048 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.24 -30.77 44.7 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 115.893 -0.594 . . . . 71.5 112.031 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -140.55 177.52 7.96 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.575 1.15 . . . . 75.310000000000002 110.484 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -147.1 -3.35 0.58 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.791 0.837 . . . . 74.319999999999993 110.766 171.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -109.62 122.11 46.71 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.248 0.619 . . . . 72.140000000000001 110.194 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.7 m -153.16 -70.84 0.15 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.987 0.915 . . . . 73.420000000000002 109.648 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 69.7 m -159.22 -166.06 1.73 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.137 0.975 . . . . 54.329999999999998 109.941 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -73.94 -87.21 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.62 0.768 . . . . 72.150000000000006 111.585 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 176.73 -6.38 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.651 1.18 . . . . 74.519999999999996 111.488 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.93 172.76 49.23 Favored Glycine 0 C--N 1.351 1.407 0 C-N-CA 123.033 0.349 . . . . 75.409999999999997 113.235 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.88 68.8 0.06 OUTLIER Glycine 0 CA--C 1.537 1.46 0 CA-C-O 119.626 -0.541 . . . . 53.25 112.922 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.483 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 26.2 Cg_endo -95.77 -159.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.939 3.093 . . . . 74.010000000000005 112.42 176.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -118.41 93.67 4.21 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.954 -1.128 . . . . 74.239999999999995 107.954 172.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.99 76.66 6.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.361 0.664 . . . . 71.219999999999999 110.645 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -164.13 140.71 6.54 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.158 0.983 . . . . 62.329999999999998 109.221 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.91 103.78 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 123.836 0.854 . . . . 74.409999999999997 108.829 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -112.65 90.87 3.46 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.949 0.9 . . . . 71.439999999999998 108.993 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.53 121.18 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.883 -0.598 . . . . 71.519999999999996 109.765 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -75.47 85.85 2.59 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.743 0.817 . . . . 75.019999999999996 109.313 175.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -72.18 -50.44 27.67 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.886 0.874 . . . . 73.099999999999994 109.276 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -139.17 152.41 47.38 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.973 0.909 . . . . 75.530000000000001 109.569 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.95 -57.58 0.19 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.852 0.861 . . . . 70.230000000000004 109.905 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.9 mt -57.91 -51.87 67.84 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.114 0.884 . . . . 73.099999999999994 110.869 -175.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -72.0 107.33 4.66 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 108.471 -0.937 . . . . 71.120000000000005 108.471 172.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -136.05 130.85 18.61 Favored Pre-proline 0 C--O 1.239 0.549 0 C-N-CA 123.631 0.772 . . . . 72.099999999999994 109.219 -175.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.79 155.98 7.44 Favored 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 122.64 2.227 . . . . 52.439999999999998 111.541 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.8 t -89.55 113.98 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 107.462 -1.31 . . . . 72.310000000000002 107.462 174.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.77 86.03 0.67 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 122.941 0.496 . . . . 75.409999999999997 110.656 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.9 t -107.36 133.7 51.5 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.589 1.155 . . . . 71.230000000000004 109.1 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.9 t70 65.74 29.15 10.82 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 122.142 0.973 . . . . 71.230000000000004 109.727 -173.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -74.96 157.13 35.47 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.227 1.011 . . . . 73.430000000000007 109.417 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 67.16 75.37 0.31 Allowed Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.101 0.96 . . . . 70.129999999999995 110.749 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.97 169.18 21.08 Favored 'Trans proline' 0 C--N 1.381 2.288 0 C-N-CA 123.884 3.056 . . . . 74.109999999999999 113.45 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -65.66 99.52 0.46 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.062 0.945 . . . . 72.540000000000006 109.963 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.63 151.91 18.28 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 123.497 0.498 . . . . 72.420000000000002 111.861 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.4 146.37 51.53 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.743 0.817 . . . . 75.299999999999997 110.279 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.4 m -117.3 35.88 4.48 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.832 0.853 . . . . 74.430000000000007 110.685 -170.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.16 -85.74 0.42 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.559 0.744 . . . . 73.430000000000007 110.537 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -171.73 123.3 0.53 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.28 1.032 . . . . 75.239999999999995 110.095 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -161.42 135.97 7.15 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.13 0.572 . . . . 53.140000000000001 111.094 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.2 128.84 47.12 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.589 -0.893 . . . . 74.049999999999997 108.589 172.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -89.22 134.94 33.84 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.281 0.632 . . . . 74.340000000000003 109.806 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -67.1 149.71 50.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.524 0.729 . . . . 74.420000000000002 110.297 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.6 p -147.05 -43.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.049 0.54 . . . . 62.219999999999999 109.697 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt 67.0 14.22 9.77 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 124.961 1.413 . . . . 74.439999999999998 111.379 -175.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -81.51 79.7 8.05 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-O 122.292 1.044 . . . . 62.210000000000001 108.8 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -105.09 -40.41 5.89 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 113.737 -1.574 . . . . 74.430000000000007 110.52 -169.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.62 120.91 10.34 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.383 1.052 . . . . 74.120000000000005 111.393 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.3 mt -130.22 153.01 49.02 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.756 1.223 . . . . 72.230000000000004 107.926 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.1 148.08 48.1 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.146 0.578 . . . . 73.400000000000006 109.628 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.02 70.46 0.1 Allowed Glycine 0 C--N 1.337 0.612 0 O-C-N 123.784 0.678 . . . . 72.0 112.855 177.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 139' ' ' ASN . 5.4 Cg_exo -80.04 133.7 10.14 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.821 2.347 . . . . 65.340000000000003 111.813 175.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 37' ' ' PRO . 64.6 p -147.0 133.21 19.4 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 122.738 0.415 . . . . 72.340000000000003 109.911 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.96 70.19 5.25 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 122.046 0.927 . . . . 74.430000000000007 110.598 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -142.48 -43.59 0.32 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.061 -1.427 . . . . 71.310000000000002 108.003 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.99 112.51 24.36 Favored Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 107.743 -1.206 . . . . 62.009999999999998 107.743 -177.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.0 -70.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.884 3.056 . . . . 70.150000000000006 113.647 -174.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -88.67 72.6 8.66 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.638 0.732 . . . . 73.319999999999993 109.062 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.547 HD13 ' HB3' ' A' ' 106' ' ' LYS . 29.8 tp -89.95 130.92 36.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.952 -1.022 . . . . 75.019999999999996 108.878 177.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -113.84 174.97 5.67 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.008 1.723 . . . . 73.409999999999997 109.015 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.96 149.1 19.95 Favored 'Isoleucine or valine' 0 C--O 1.256 1.395 0 N-CA-C 109.081 -0.711 . . . . 71.129999999999995 109.081 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.25 124.5 33.92 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.387 -0.824 . . . . 74.420000000000002 109.828 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.4 mt -83.13 -17.74 41.97 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.264 1.026 . . . . 74.25 111.619 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.491 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 57.8 m-85 -135.44 166.37 23.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.71 0.804 . . . . 64.019999999999996 109.336 -175.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -78.79 145.8 34.13 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.271 -0.877 . . . . 70.430000000000007 109.172 168.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -155.46 112.75 3.29 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.687 -0.486 . . . . 65.510000000000005 109.687 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.98 139.12 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.192 -0.67 . . . . 64.530000000000001 109.192 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.13 127.74 34.18 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.963 -0.384 . . . . 73.040000000000006 109.963 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.6 p -65.66 -24.37 67.01 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.648 0.779 . . . . 70.109999999999999 110.919 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.97 -149.78 8.47 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.53 -1.028 . . . . 72.120000000000005 110.53 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.24 -30.59 69.67 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.819 0.848 . . . . 72.209999999999994 111.578 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.592 ' HB2' HD11 ' A' ' 23' ' ' ILE . 20.1 p30 -71.24 -23.31 61.97 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.029 0.932 . . . . 74.310000000000002 113.51 -172.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.6 p -113.26 163.12 15.21 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.747 0.819 . . . . 61.539999999999999 110.217 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.404 ' HB3' HG11 ' A' ' 130' ' ' VAL . 59.3 tp -111.06 125.72 54.05 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.13 -0.693 . . . . 74.099999999999994 109.13 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -74.43 119.66 18.92 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.677 -0.86 . . . . 73.219999999999999 108.677 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.0 pt -123.87 138.71 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.273 0.629 . . . . 75.209999999999994 109.546 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.4 m -97.23 150.06 21.34 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.336 -0.847 . . . . 65.310000000000002 109.756 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -61.22 113.58 2.68 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 109.484 -0.562 . . . . 74.019999999999996 109.484 172.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.25 -11.11 47.69 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.198 -0.455 . . . . 73.310000000000002 113.697 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -72.68 134.56 45.13 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.537 0.735 . . . . 74.409999999999997 110.387 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.547 ' HB3' HD13 ' A' ' 84' ' ' LEU . 34.8 mtmm -85.75 123.27 30.94 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.877 0.871 . . . . 74.239999999999995 109.7 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.594 ' HA ' HG21 ' A' ' 123' ' ' THR . 13.0 mt -107.88 158.36 17.4 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.898 -0.779 . . . . 74.120000000000005 108.898 -170.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtm-85 -123.07 108.64 13.12 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.846 -0.798 . . . . 75.049999999999997 108.846 164.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.487 HG21 HD11 ' A' ' 135' ' ' ILE . 98.6 t -88.71 109.46 20.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.334 -0.617 . . . . 75.219999999999999 109.334 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.471 HD12 ' NE2' ' A' ' 127' ' ' GLN . 75.8 mt -81.68 -12.23 58.75 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.198 -0.91 . . . . 71.030000000000001 111.092 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.72 159.13 18.67 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.39 -0.684 . . . . 54.25 111.39 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 4.1 m-85 -96.93 173.61 7.2 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.686 0.794 . . . . 74.310000000000002 110.28 178.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.439 HD21 ' HB2' ' A' ' 118' ' ' TRP . 32.3 t-20 -77.76 147.19 35.45 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.176 0.991 . . . . 72.239999999999995 108.555 173.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.507 ' HD2' ' HG2' ' A' ' 177' ' ' PRO . 34.0 m170 -63.7 -26.28 68.58 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.117 0.567 . . . . 71.430000000000007 111.645 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -87.66 -16.85 33.21 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.389 1.075 . . . . 63.530000000000001 110.512 175.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.94 0.68 77.59 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 123.911 0.767 . . . . 75.299999999999997 113.68 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -78.0 -47.29 18.8 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.158 0.983 . . . . 71.239999999999995 112.098 -172.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.439 ' HB2' HD21 ' A' ' 113' ' ' ASN . 83.2 m95 -105.61 174.63 5.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.857 0.863 . . . . 62.420000000000002 109.637 177.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -153.49 127.14 8.75 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.175 -1.046 . . . . 74.230000000000004 108.175 175.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -74.28 106.63 6.01 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.232 0.469 . . . . 73.420000000000002 110.409 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.66 163.65 12.18 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.317 -0.856 . . . . 74.340000000000003 109.698 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -139.71 122.78 16.78 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.6 -1.259 . . . . 64.439999999999998 107.6 178.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.594 HG21 ' HA ' ' A' ' 107' ' ' LEU . 78.9 p -131.81 -169.56 2.23 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.379 0.672 . . . . 75.120000000000005 110.611 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -54.1 -28.52 39.87 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.098 -1.41 . . . . 65.420000000000002 111.708 170.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -84.64 -2.36 57.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.33 1.052 . . . . 64.010000000000005 111.84 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.51 -132.79 10.15 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 111.418 -0.673 . . . . 72.209999999999994 111.418 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.471 ' NE2' HD12 ' A' ' 110' ' ' LEU . 63.3 tt0 -142.99 143.74 32.04 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.243 0.617 . . . . 75.109999999999999 110.29 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 174.91 -178.13 46.76 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.843 -0.617 . . . . 54.409999999999997 111.58 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -95.97 123.87 39.74 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.017 0.527 . . . . 72.450000000000003 110.762 -173.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.404 HG11 ' HB3' ' A' ' 99' ' ' LEU . 35.1 m -117.64 149.02 44.24 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.978 1.311 . . . . 73.450000000000003 109.601 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.78 132.53 23.48 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 121.669 1.579 . . . . 74.310000000000002 111.234 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.6 m -60.74 -21.56 63.1 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.177 0.991 . . . . 75.040000000000006 112.364 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -68.55 -24.65 64.65 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.879 0.872 . . . . 73.530000000000001 111.741 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.491 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.2 m-85 -94.94 0.84 55.06 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.791 0.836 . . . . 72.140000000000001 112.78 -177.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.487 HD11 HG21 ' A' ' 109' ' ' VAL . 15.9 pt -127.72 160.88 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 118.98 0.809 . . . . 74.25 111.365 -171.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.1 t -157.89 145.09 13.39 Favored Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 119.108 -0.472 . . . . 71.349999999999994 110.599 169.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.37 139.27 37.73 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.714 2.276 . . . . 74.230000000000004 111.804 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.28 -50.01 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.001 0.52 . . . . 74.239999999999995 112.037 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.403 ' HB2' ' HA ' ' A' ' 77' ' ' PRO . 62.0 t30 -100.74 -6.04 25.56 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.397 0.544 . . . . 75.439999999999998 110.916 -177.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.5 t -60.32 177.75 0.25 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.27 1.028 . . . . 75.340000000000003 111.891 -176.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 84.7 mt -57.13 -17.66 11.75 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.981 0.912 . . . . 73.219999999999999 112.678 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -57.7 -24.7 58.18 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.506 1.122 . . . . 70.200000000000003 112.04 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -56.71 -36.19 69.39 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.409 1.083 . . . . 71.549999999999997 111.25 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 -74.33 141.71 45.2 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.369 -0.832 . . . . 75.230000000000004 109.342 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.1 t -62.69 -21.81 66.02 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.812 0.845 . . . . 75.120000000000005 112.075 -176.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.413 ' CE3' ' HB2' ' A' ' 147' ' ' TYR . 58.8 p-90 -80.05 -41.53 25.52 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.382 0.512 . . . . 73.510000000000005 112.382 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.413 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 29.5 t80 -99.98 138.04 37.6 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.375 0.534 . . . . 74.420000000000002 109.566 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -126.7 14.06 7.5 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 112.172 0.434 . . . . 64.109999999999999 112.172 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.15 -162.65 50.02 Favored Glycine 0 N--CA 1.474 1.23 0 CA-C-O 119.581 -0.566 . . . . 62.439999999999998 114.403 171.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.07 100.38 0.97 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.785 2.99 . . . . 61.439999999999998 111.558 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.537 HG11 ' NH2' ' A' ' 171' ' ' ARG . 84.1 t -138.93 150.92 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.818 0.447 . . . . 74.420000000000002 110.595 -172.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 18.4 m -59.2 139.34 57.04 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.598 1.159 . . . . 72.129999999999995 111.411 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -62.8 -27.59 69.41 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.736 0.814 . . . . 74.450000000000003 111.483 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -62.4 -50.3 72.07 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.529 0.732 . . . . 73.420000000000002 110.2 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.62 -33.83 76.81 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.461 0.705 . . . . 72.430000000000007 111.54 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.461 ' HB2' ' HG3' ' A' ' 171' ' ' ARG . . . -58.5 -52.36 65.97 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.256 -0.884 . . . . 60.539999999999999 110.573 173.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.461 ' HG3' HG12 ' A' ' 190' ' ' VAL . 35.0 tt0 -69.62 -27.41 65.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.537 0.735 . . . . 72.099999999999994 111.195 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -64.91 -49.42 70.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.856 0.862 . . . . 74.319999999999993 110.983 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.469 HD12 HH12 ' A' ' 171' ' ' ARG . 63.8 mt -70.77 -37.23 73.35 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 120.88 0.371 . . . . 74.25 110.739 175.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.7 tp -64.53 -25.38 67.96 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.547 -0.751 . . . . 75.349999999999994 112.094 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.6 t -59.96 -29.26 68.31 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.173 0.989 . . . . 62.119999999999997 111.228 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.2 t -77.17 -12.93 60.01 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.97 0.908 . . . . 74.340000000000003 111.969 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.59 165.61 32.43 Favored Glycine 0 C--N 1.344 1.001 0 N-CA-C 113.811 0.284 . . . . 61.539999999999999 113.811 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.0 pt -113.5 -164.28 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.58 1.152 . . . . 71.450000000000003 109.909 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.731 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 21.5 p-10 -52.99 115.18 1.72 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.725 0.81 . . . . 72.25 112.378 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.06 12.79 57.25 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 115.472 -0.785 . . . . 74.310000000000002 113.013 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 21.9 t -76.3 138.78 40.73 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.911 -0.774 . . . . 61.310000000000002 108.911 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.447 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 16.1 p90 -138.42 158.15 44.84 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.095 0.474 . . . . 72.25 111.979 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.496 HD12 ' NH1' ' A' ' 171' ' ' ARG . 84.9 mt -141.27 134.37 29.27 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.216 -1.031 . . . . 73.420000000000002 108.216 168.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.434 HG11 HD11 ' A' ' 214' ' ' LEU . 16.0 t -106.93 123.18 61.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.947 -1.131 . . . . 64.109999999999999 107.947 175.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.537 ' NH2' HG11 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -130.86 157.87 41.73 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.298 -1.371 . . . . 63.409999999999997 107.298 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 11.7 pt-20 -108.22 162.97 13.58 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 109.29 -0.633 . . . . 74.109999999999999 109.29 166.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' A' ' 176' ' ' SER . 48.1 t -82.67 136.94 34.62 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.22 -0.9 . . . . 71.230000000000004 111.038 -175.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.62 -22.35 63.5 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.139 -1.392 . . . . 70.430000000000007 111.567 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 30.1 t -111.24 -0.53 16.42 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.834 0.854 . . . . 74.019999999999996 111.384 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' A' ' 173' ' ' SER . 24.2 m -139.68 119.67 9.19 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 119.091 -0.481 . . . . 73.150000000000006 109.798 -178.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.507 ' HG2' ' HD2' ' A' ' 114' ' ' HIS . 21.4 Cg_exo -67.11 112.86 2.64 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 123.888 3.059 . . . . 74.319999999999993 113.401 -169.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.95 9.26 52.94 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.54 0.525 . . . . 62.43 114.024 175.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -85.05 114.55 22.28 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 107.71 -1.218 . . . . 72.120000000000005 107.71 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 57.2 mtt-85 -104.67 169.46 8.44 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.379 -0.6 . . . . 71.439999999999998 109.379 -169.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.0 m -155.0 136.42 14.15 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 123.875 0.87 . . . . 75.329999999999998 108.949 -173.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.426 HG12 HG23 ' A' ' 170' ' ' VAL . 54.7 mt -104.13 135.99 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 108.459 -0.941 . . . . 74.340000000000003 108.459 173.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.9 m -113.25 111.83 22.7 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.62 -1.173 . . . . 71.329999999999998 107.875 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.436 HD23 HD22 ' A' ' 232' ' ' LEU . 53.4 mt -105.0 139.81 39.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.753 0.821 . . . . 74.329999999999998 111.419 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -126.37 130.33 50.56 Favored 'General case' 0 C--O 1.261 1.685 0 O-C-N 124.056 0.848 . . . . 75.120000000000005 109.141 172.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.731 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 14.4 p90 -151.7 137.84 18.31 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 124.362 1.039 . . . . 75.5 108.492 172.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 55.36 28.94 12.18 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.044 1.338 . . . . 74.010000000000005 113.227 177.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.8 14.77 81.68 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 116.012 -0.54 . . . . 73.530000000000001 113.394 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -109.08 126.12 52.84 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.317 1.047 . . . . 74.409999999999997 108.698 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.461 HG12 ' HG3' ' A' ' 157' ' ' GLU . 91.5 t -109.81 135.58 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.509 0.724 . . . . 74.349999999999994 109.289 174.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.438 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 22.5 p90 -144.31 155.07 43.66 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.207 0.603 . . . . 74.019999999999996 109.538 171.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -129.17 136.34 50.03 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.156 -1.053 . . . . 72.150000000000006 108.156 -171.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -136.24 144.57 44.92 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 121.001 0.429 . . . . 75.530000000000001 110.738 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -76.91 131.71 38.71 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.73 -1.123 . . . . 72.230000000000004 110.365 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 77.8 mt -80.6 106.86 12.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 N-CA-C 108.298 -1.001 . . . . 72.530000000000001 108.298 164.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -69.74 123.72 22.12 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.436 -0.802 . . . . 70.209999999999994 109.558 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.3 m -104.88 107.99 19.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.427 0.691 . . . . 62.130000000000003 110.497 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.42 170.66 4.64 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.348 1.059 . . . . 71.209999999999994 111.293 173.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 41.2 p -59.21 -37.48 77.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.058 0.943 . . . . 75.540000000000006 112.191 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -76.1 -2.67 32.02 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.962 0.505 . . . . 75.340000000000003 111.862 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.92 6.89 84.65 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 111.811 -0.516 . . . . 74.530000000000001 111.811 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -69.83 128.29 35.88 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.74 -0.467 . . . . 73.219999999999999 109.74 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 80.8 mt -95.33 147.44 23.5 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.461 0.704 . . . . 74.329999999999998 109.784 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -163.6 164.88 23.96 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.425 0.69 . . . . 75.209999999999994 110.42 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 78.7 t -138.04 -52.64 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.11 0.964 . . . . 75.549999999999997 109.23 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 33.0 t -100.25 -178.28 3.78 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.774 0.83 . . . . 75.409999999999997 110.853 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.8 m -63.93 -46.23 85.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.641 1.177 . . . . 73.540000000000006 111.986 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.92 -14.42 41.91 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.263 0.625 . . . . 65.230000000000004 112.095 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 74.7 m -64.15 117.31 6.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.187 0.595 . . . . 63.130000000000003 111.186 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -146.53 112.73 5.83 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.654 1.182 . . . . 72.329999999999998 108.665 168.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -130.86 142.53 50.39 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.387 0.675 . . . . 74.439999999999998 109.417 -176.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -81.66 -34.81 30.55 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.661 0.384 . . . . 71.349999999999994 110.016 173.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 60.4 p -124.2 152.93 42.31 Favored 'General case' 0 C--O 1.255 1.363 0 CA-C-O 122.112 0.958 . . . . 72.109999999999999 111.287 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.434 HD11 HG11 ' A' ' 170' ' ' VAL . 35.9 tp -63.45 -31.14 72.21 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 113.671 -1.604 . . . . 64.299999999999997 111.266 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.96 95.65 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.497 0.719 . . . . 72.230000000000004 110.918 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -61.69 -44.13 97.54 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.478 0.711 . . . . 72.109999999999999 110.598 173.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.75 -41.08 85.67 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.709 0.631 . . . . 61.539999999999999 111.769 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.7 t -74.28 -41.99 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.645 0.778 . . . . 74.25 111.016 -175.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -58.81 -51.38 70.26 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.438 0.637 . . . . 70.129999999999995 110.1 174.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -54.14 -57.83 9.62 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.495 -1.229 . . . . 71.219999999999999 109.905 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -61.04 -26.7 67.81 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.337 0.655 . . . . 74.409999999999997 112.046 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 37.4 t -73.07 -27.76 61.92 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 122.913 0.485 . . . . 72.329999999999998 111.706 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.5 t -120.96 7.2 10.35 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 115.443 1.645 . . . . 71.010000000000005 115.443 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.74 156.14 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 121.069 1.759 . . . . 74.5 115.431 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.77 -2.47 58.25 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 129.986 3.314 . . . . 74.439999999999998 113.168 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -77.76 14.82 0.96 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 129.381 3.072 . . . . 73.439999999999998 113.51 -141.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.66 18.53 3.98 Favored Glycine 0 N--CA 1.47 0.921 0 C-N-CA 125.274 1.416 . . . . 75.409999999999997 111.377 -171.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 88.3 mt -91.26 134.49 34.53 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.206 1.002 . . . . 74.040000000000006 110.129 165.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.438 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 95.0 mt -67.83 -44.86 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 124.421 1.076 . . . . 72.420000000000002 108.695 170.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.5 t -135.04 142.13 46.3 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 114.992 -1.004 . . . . 71.299999999999997 108.866 173.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 67.4 p -70.38 155.98 39.95 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 108.606 -0.887 . . . . 75.129999999999995 108.606 171.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.447 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 32.1 mt -67.13 100.62 0.79 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.142 -1.058 . . . . 74.200000000000003 108.142 177.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -77.96 -50.29 12.46 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.066 0.547 . . . . 70.439999999999998 109.981 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 167' ' ' SER . 6.3 p90 -161.63 152.2 14.77 Favored Pre-proline 0 N--CA 1.488 1.455 0 C-N-CA 121.006 -0.278 . . . . 75.519999999999996 110.419 174.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.06 137.06 36.52 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.238 1.959 . . . . 74.129999999999995 111.538 173.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -57.99 130.7 83.12 Favored Pre-proline 0 C--O 1.246 0.9 0 O-C-N 123.558 0.536 . . . . 73.030000000000001 109.894 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.39 145.26 87.81 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.28 1.987 . . . . 72.209999999999994 112.143 -172.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -63.06 159.25 17.65 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.555 -0.748 . . . . 73.439999999999998 109.149 171.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -52.75 -35.07 55.58 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.469 0.707 . . . . 74.239999999999995 112.453 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -64.98 176.74 1.14 Allowed 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.865 -0.607 . . . . 74.439999999999998 111.387 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.563 ' HE2' ' HB ' ' A' ' 243' ' ' THR . 20.6 ptmt -55.62 127.57 67.01 Favored Pre-proline 0 CA--C 1.558 1.25 0 N-CA-C 112.462 0.541 . . . . 74.0 112.462 -176.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.15 78.09 3.02 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.95 2.433 . . . . 71.209999999999994 110.575 174.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' THR . . . . . 0.563 ' HB ' ' HE2' ' A' ' 241' ' ' LYS . 8.8 t -79.23 113.43 17.36 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.423 0.63 . . . . 74.329999999999998 109.871 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.49 122.87 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.429 0.691 . . . . 74.450000000000003 109.439 -175.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -136.36 122.53 20.39 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.157 -1.053 . . . . 70.120000000000005 108.157 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 177.1 115.69 0.44 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 112.325 -0.31 . . . . 75.430000000000007 112.325 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 39.5 t -109.18 117.44 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 107.676 -1.231 . . . . 62.5 107.676 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 62.5 m -137.04 139.21 27.84 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 123.009 0.524 . . . . 71.239999999999995 110.864 -175.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -79.24 131.63 9.83 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.792 2.328 . . . . 74.25 111.781 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -85.6 140.97 30.16 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 108.684 -0.858 . . . . 65.209999999999994 108.684 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -66.22 133.83 51.44 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.546 0.738 . . . . 72.340000000000003 110.011 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -67.43 105.26 1.75 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 121.552 0.691 . . . . 74.450000000000003 109.979 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -156.18 143.24 18.97 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.529 -0.76 . . . . 75.400000000000006 109.662 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 44.2 t-105 -74.4 108.82 7.42 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.005 -1.109 . . . . 74.120000000000005 108.005 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 C--O 1.249 1.037 0 CA-C-N 115.438 -0.801 . . . . 73.349999999999994 109.815 179.098 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.592 -0.522 . . . . 73.349999999999994 109.592 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.87 73.84 1.12 Allowed Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.371 -0.692 . . . . 74.310000000000002 111.371 -173.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -68.87 122.53 18.82 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.531 0.732 . . . . 71.239999999999995 109.791 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -138.58 77.56 33.71 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.426 0.69 . . . . 75.450000000000003 110.66 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.78 -29.61 77.1 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.063 1.842 . . . . 64.099999999999994 111.949 172.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.01 140.59 5.13 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.305 -0.407 . . . . 71.150000000000006 112.88 175.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.48 124.94 52.71 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.217 0.607 . . . . 75.209999999999994 109.694 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.0 m -84.62 141.65 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 123.539 0.736 . . . . 73.519999999999996 109.937 178.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.2 tp -82.29 -32.31 29.59 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.188 0.995 . . . . 74.0 109.942 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.43 163.41 25.38 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.566 -0.743 . . . . 64.540000000000006 111.69 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.608 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 28.8 t70 -70.42 98.59 1.45 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.263 0.625 . . . . 73.099999999999994 110.242 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -129.22 -171.06 2.4 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.653 1.181 . . . . 75.450000000000003 109.364 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -69.84 111.77 5.81 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.231 -2.137 . . . . 75.519999999999996 105.231 161.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 62.19 81.32 0.23 Allowed Pre-proline 0 CA--C 1.542 0.647 0 O-C-N 124.219 0.949 . . . . 75.420000000000002 111.015 -162.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.608 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 68.7 Cg_endo -74.08 165.87 30.97 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.555 2.17 . . . . 75.209999999999994 110.527 170.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 p -71.76 168.75 17.16 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.796 0.808 . . . . 73.129999999999995 112.428 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.9 mt -107.72 133.28 20.5 Favored Pre-proline 0 C--O 1.241 0.62 0 CA-C-N 114.636 -1.165 . . . . 74.140000000000001 108.545 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.92 170.22 14.67 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.511 2.14 . . . . 75.25 111.99 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.89 144.67 29.06 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.051 0.541 . . . . 73.450000000000003 110.499 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.547 ' HB3' HD11 ' A' ' 23' ' ' ILE . 74.1 mt -87.43 94.85 9.81 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.557 0.743 . . . . 75.140000000000001 109.175 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -96.22 -47.09 6.18 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.023 -0.732 . . . . 75.200000000000003 109.023 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -99.77 113.77 26.47 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.143 -0.935 . . . . 72.230000000000004 109.815 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.547 HD11 ' HB3' ' A' ' 20' ' ' LEU . 39.1 mm -116.51 114.11 45.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 107.904 -1.147 . . . . 74.299999999999997 107.904 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -123.57 126.52 46.81 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.202 0.601 . . . . 72.010000000000005 109.627 -175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.27 8.84 2.67 Favored Glycine 0 CA--C 1.527 0.836 0 O-C-N 124.246 0.966 . . . . 60.219999999999999 112.101 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.75 83.16 5.24 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.0 -0.741 . . . . 72.420000000000002 109.0 175.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.65 100.53 1.32 Allowed Glycine 0 C--N 1.348 1.217 0 CA-C-N 115.881 -0.6 . . . . 73.230000000000004 112.335 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -125.34 -73.2 0.64 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.74 0.816 . . . . 75.409999999999997 109.214 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -151.1 -178.1 6.42 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.881 0.872 . . . . 75.030000000000001 110.254 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 58.05 47.15 15.18 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.686 1.195 . . . . 72.109999999999999 110.698 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.9 p 50.32 87.29 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.605 1.162 . . . . 74.540000000000006 111.426 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.8 p -139.67 137.74 35.48 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.49 0.716 . . . . 72.230000000000004 109.59 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.425 ' HG3' ' HG2' ' A' ' 127' ' ' GLN . 64.2 ttt-85 -64.97 106.97 1.36 Allowed 'General case' 0 C--N 1.347 0.47 0 C-N-CA 123.568 0.747 . . . . 74.209999999999994 112.318 -172.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -74.39 132.42 41.97 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.867 -0.79 . . . . 70.099999999999994 108.867 168.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.53 71.64 2.8 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 116.132 -0.485 . . . . 64.400000000000006 113.078 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.6 88.59 0.41 Allowed Glycine 0 C--N 1.344 0.975 0 CA-C-O 119.218 -0.768 . . . . 74.420000000000002 111.407 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -83.38 163.0 14.95 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 123.065 2.51 . . . . 64.430000000000007 112.211 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -76.02 148.48 38.0 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.1 0.56 . . . . 61.520000000000003 110.857 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 55.7 m -98.46 132.44 43.91 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.767 -0.651 . . . . 72.209999999999994 110.001 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -113.54 133.31 55.32 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.889 0.876 . . . . 64.030000000000001 109.046 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -124.0 146.66 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.491 0.716 . . . . 74.239999999999995 110.038 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -117.75 167.3 11.49 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.366 1.066 . . . . 75.430000000000007 109.718 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -145.52 151.05 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.658 0.783 . . . . 74.329999999999998 109.447 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -67.61 148.01 51.97 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.928 0.891 . . . . 75.340000000000003 111.417 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -84.72 176.58 8.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.94 0.496 . . . . 74.209999999999994 110.229 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -134.69 139.87 45.56 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.367 0.667 . . . . 64.439999999999998 109.644 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.26 82.92 2.0 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.29 -1.004 . . . . 73.010000000000005 108.29 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.3 mt -67.2 -24.48 65.85 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.732 0.813 . . . . 74.030000000000001 112.167 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -80.33 168.25 19.26 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.863 0.465 . . . . 75.230000000000004 111.447 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -62.24 148.7 88.83 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 115.427 -0.806 . . . . 74.439999999999998 110.628 171.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.62 72.53 0.66 Allowed 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.919 2.413 . . . . 54.399999999999999 111.245 171.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 p -97.69 98.76 7.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.893 -1.151 . . . . 72.310000000000002 107.893 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.19 75.52 1.11 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.332 0.653 . . . . 74.409999999999997 109.747 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.2 m -88.12 -16.54 33.2 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.55 -0.75 . . . . 71.420000000000002 109.96 169.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -78.45 169.28 18.51 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.714 0.806 . . . . 74.319999999999993 110.597 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -101.68 153.92 19.35 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.889 -1.05 . . . . 74.040000000000006 108.932 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 61.49 71.11 0.81 Allowed Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 124.774 1.229 . . . . 72.319999999999993 111.641 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.83 -38.06 5.9 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.39 2.06 . . . . 71.430000000000007 112.675 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -85.83 101.29 12.7 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.8 0.84 . . . . 74.329999999999998 109.765 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.03 39.25 0.24 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.196 -0.761 . . . . 71.109999999999999 111.196 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.8 mt -89.47 71.18 8.03 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.162 0.985 . . . . 75.120000000000005 110.18 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.3 m -137.48 127.33 25.59 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.478 -0.783 . . . . 64.109999999999999 109.577 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -157.11 146.08 20.0 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.98 1.312 . . . . 74.340000000000003 108.374 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.69 67.82 6.71 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.511 0.725 . . . . 74.239999999999995 109.257 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.47 101.03 3.4 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-N 114.936 -1.029 . . . . 74.450000000000003 109.756 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -103.55 146.72 28.12 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.508 0.723 . . . . 73.209999999999994 109.447 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 52.7 t90 -76.19 139.44 41.23 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.569 0.748 . . . . 71.420000000000002 110.263 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -111.51 122.61 48.3 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.69 0.796 . . . . 70.219999999999999 108.989 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.3 p -75.12 83.58 2.32 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.332 -0.618 . . . . 71.299999999999997 109.332 176.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -83.76 -69.78 0.61 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.821 -1.178 . . . . 73.140000000000001 107.821 176.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.26 -50.34 60.88 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.215 0.606 . . . . 74.450000000000003 110.406 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -63.12 108.27 1.21 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.222 -0.899 . . . . 72.409999999999997 109.071 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.7 mt -73.54 80.27 1.46 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.758 0.823 . . . . 71.430000000000007 109.551 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.9 mt -110.37 18.22 20.07 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.614 1.166 . . . . 75.510000000000005 110.421 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.52 75.94 7.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.629 0.771 . . . . 74.420000000000002 110.185 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 147.69 60.16 0.01 OUTLIER Glycine 0 CA--C 1.53 0.99 0 CA-C-N 115.391 -0.822 . . . . 75.129999999999995 111.14 178.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -84.33 90.26 0.88 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.836 2.358 . . . . 75.349999999999994 110.529 -175.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 p -110.48 114.25 27.52 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.901 0.881 . . . . 72.409999999999997 109.183 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' HB2' HD13 ' A' ' 84' ' ' LEU . 1.3 mp0 -72.31 148.54 45.29 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.612 0.765 . . . . 75.540000000000006 112.076 -174.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -87.5 75.74 9.1 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.959 0.903 . . . . 61.539999999999999 110.519 -172.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -175.19 148.47 1.08 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 124.579 1.151 . . . . 74.400000000000006 109.052 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -81.25 -5.68 12.8 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.389 2.06 . . . . 72.329999999999998 112.183 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -96.12 33.7 1.69 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.938 0.895 . . . . 73.209999999999994 110.368 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 33.9 tp -81.03 112.47 18.45 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.815 -0.809 . . . . 65.540000000000006 108.815 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.6 m-85 -104.45 177.73 4.76 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.918 1.687 . . . . 75.430000000000007 109.505 175.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 11.3 p -144.28 138.93 24.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.47 0.708 . . . . 74.299999999999997 109.161 171.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 102' ' ' THR . . . -78.23 112.8 15.58 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.98 0.912 . . . . 65.209999999999994 109.431 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.4 mt -74.72 -22.2 58.95 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.193 0.997 . . . . 73.239999999999995 111.925 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -130.88 152.55 50.08 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.103 0.961 . . . . 75.299999999999997 109.214 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -77.84 130.85 37.17 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.226 -1.027 . . . . 72.540000000000006 108.226 173.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.474 ' HB3' HG12 ' A' ' 101' ' ' ILE . 74.7 t80 -133.21 114.83 14.27 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 108.916 -0.772 . . . . 74.239999999999995 108.916 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.3 136.76 22.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 108.904 -0.776 . . . . 73.409999999999997 108.904 171.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.8 137.96 57.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.762 0.425 . . . . 75.329999999999998 110.537 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.1 t -75.73 -9.93 59.01 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.064 0.546 . . . . 75.010000000000005 110.152 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.12 -154.63 25.12 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 115.866 -0.606 . . . . 75.450000000000003 111.759 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.99 -40.25 95.0 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.258 1.023 . . . . 70.540000000000006 111.789 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -67.86 -25.06 65.34 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.769 0.828 . . . . 72.109999999999999 112.467 -172.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.9 p -106.29 158.49 16.83 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.626 0.77 . . . . 71.109999999999999 109.702 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.8 tp -109.66 124.94 52.05 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 122.999 0.52 . . . . 73.200000000000003 109.991 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 p -70.57 114.88 9.11 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.279 -0.873 . . . . 74.010000000000005 109.356 170.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.474 HG12 ' HB3' ' A' ' 91' ' ' PHE . 24.8 pt -119.7 156.98 22.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.023 -0.732 . . . . 75.140000000000001 109.023 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.451 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 1.9 m -117.35 143.65 45.74 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.318 -0.623 . . . . 53.109999999999999 109.318 -174.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -57.56 120.22 7.91 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 122.807 0.443 . . . . 74.219999999999999 110.367 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.53 -13.84 63.82 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.323 0.389 . . . . 73.349999999999994 113.455 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -85.74 130.98 34.41 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.846 0.858 . . . . 71.040000000000006 110.235 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.633 ' HB2' ' HZ3' ' A' ' 106' ' ' LYS . 9.1 mtmp? -83.7 142.72 30.53 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.813 0.845 . . . . 74.120000000000005 110.886 -177.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.1 mt -120.46 150.96 39.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.519 1.128 . . . . 72.230000000000004 108.282 -171.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -113.89 107.37 15.61 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.941 -1.133 . . . . 72.430000000000007 107.941 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.08 121.94 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 109.935 -0.394 . . . . 72.439999999999998 109.935 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 72.3 mt -83.38 -41.57 18.02 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.098 0.475 . . . . 75.409999999999997 109.95 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.52 172.34 44.07 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.58 -0.736 . . . . 70.140000000000001 111.828 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.477 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 13.3 m-85 -99.28 169.13 9.58 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.046 -0.724 . . . . 71.349999999999994 109.046 175.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -66.39 146.53 54.47 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.877 -1.156 . . . . 75.219999999999999 107.877 172.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.685 ' HA ' ' HG3' ' A' ' 177' ' ' PRO . 31.0 m170 -68.59 -21.27 64.52 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.939 0.496 . . . . 72.099999999999994 112.217 -174.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -94.57 -12.23 27.92 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.17 0.588 . . . . 71.510000000000005 110.673 174.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.594 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 82.33 35.23 21.07 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 116.453 -0.339 . . . . 44.539999999999999 112.794 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -85.59 -65.68 0.98 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.518 0.727 . . . . 74.230000000000004 110.256 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -115.83 179.46 3.97 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.654 1.181 . . . . 71.439999999999998 109.5 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -135.31 127.45 29.91 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.91 0.884 . . . . 41.409999999999997 108.664 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -83.46 113.84 21.05 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.199 0.523 . . . . 73.310000000000002 110.668 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.76 163.49 18.04 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 114.966 -1.016 . . . . 72.239999999999995 110.47 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -133.16 141.64 48.23 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.103 0.961 . . . . 74.310000000000002 109.596 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.3 p -137.33 179.77 6.2 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.54 1.536 . . . . 74.420000000000002 108.053 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -73.96 -6.51 47.78 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.437 0.295 . . . . 54.420000000000002 110.753 172.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -76.88 -22.93 52.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.061 0.945 . . . . 75.049999999999997 110.177 169.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 130.13 -171.1 20.59 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 111.109 -0.796 . . . . 52.43 111.109 -174.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.425 ' HG2' ' HG3' ' A' ' 33' ' ' ARG . 57.2 tt0 -115.96 147.05 41.58 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.642 0.777 . . . . 62.109999999999999 110.245 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 175.45 -176.81 47.4 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 123.442 0.464 . . . . 75.219999999999999 112.767 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -89.42 136.01 33.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.833 0.853 . . . . 70.230000000000004 110.631 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.76 154.95 80.78 Favored Pre-proline 0 N--CA 1.482 1.163 0 C-N-CA 124.465 1.106 . . . . 75.299999999999997 110.206 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.68 130.1 11.36 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.481 2.12 . . . . 53.0 111.236 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.49 ' HA ' HG12 ' A' ' 135' ' ' ILE . 13.6 p -63.43 -20.93 65.98 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.61 0.764 . . . . 74.420000000000002 111.897 178.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -70.73 -27.02 63.65 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.872 0.869 . . . . 73.340000000000003 111.537 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -95.39 2.25 54.53 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.554 0.742 . . . . 63.210000000000001 111.955 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.49 HG12 ' HA ' ' A' ' 132' ' ' SER . 14.4 pt -134.92 152.33 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 118.029 0.377 . . . . 73.439999999999998 110.544 -173.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.4 t -143.3 139.56 16.71 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.455 0.702 . . . . 60.119999999999997 109.117 171.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.541 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 56.0 Cg_endo -71.05 140.36 37.69 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 122.26 1.974 . . . . 71.549999999999997 112.058 175.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.4 m -111.1 -45.05 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.152 0.981 . . . . 74.310000000000002 110.613 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.523 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.5 t30 -100.04 6.8 45.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.964 0.506 . . . . 53.340000000000003 111.22 -174.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.541 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 31.0 t -86.42 176.19 8.0 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.241 0.543 . . . . 74.450000000000003 110.127 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.449 ' O ' ' HB3' ' A' ' 147' ' ' TYR . 80.7 mt -66.21 -13.93 61.08 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.129 0.971 . . . . 75.430000000000007 112.585 -176.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.87 -28.79 64.47 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.521 0.728 . . . . 74.019999999999996 111.785 176.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -64.18 -25.37 68.05 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.088 -0.505 . . . . 74.099999999999994 110.853 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -78.54 134.29 37.27 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.57 -0.9 . . . . 74.439999999999998 108.57 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.1 t -67.89 -18.87 64.93 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.167 0.803 . . . . 74.319999999999993 113.167 -171.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -78.99 -26.46 43.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.073 0.549 . . . . 75.400000000000006 111.849 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 46.7 t80 -109.72 125.62 52.86 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.244 0.618 . . . . 64.409999999999997 109.389 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -113.11 25.89 10.97 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.669 0.388 . . . . 63.509999999999998 111.482 -172.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 64.61 -156.6 46.05 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.769 -0.65 . . . . 63.240000000000002 114.323 172.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.41 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 56.6 Cg_endo -70.52 101.58 1.04 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 123.009 2.473 . . . . 70.439999999999998 111.008 173.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.3 p -143.19 145.1 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 120.911 0.386 . . . . 75.120000000000005 110.289 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 70.5 m -73.62 166.73 22.74 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.449 1.1 . . . . 75.540000000000006 112.747 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 44.6 mtt85 -65.35 -40.94 94.24 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.52 -1.218 . . . . 72.319999999999993 111.359 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -70.13 -42.93 71.95 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.059 0.849 . . . . 75.439999999999998 111.186 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.64 -42.72 86.25 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.127 0.971 . . . . 72.140000000000001 110.135 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.35 -52.71 64.46 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.728 -1.124 . . . . 73.140000000000001 110.02 173.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.509 ' HG3' HG11 ' A' ' 190' ' ' VAL . 37.9 tt0 -61.07 -29.17 69.58 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.322 0.649 . . . . 75.409999999999997 111.272 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -63.68 -52.71 59.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.664 0.785 . . . . 55.049999999999997 110.277 173.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.62 -33.85 75.86 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.806 -0.634 . . . . 73.019999999999996 111.162 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.506 HD21 HG12 ' A' ' 190' ' ' VAL . 28.9 tp -78.55 -23.39 46.18 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.092 -0.958 . . . . 74.329999999999998 111.595 -177.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 t -64.28 -23.6 67.36 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.66 0.784 . . . . 72.310000000000002 111.374 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.0 m -82.88 -7.97 59.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.016 0.926 . . . . 65.030000000000001 112.091 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.15 174.03 41.67 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 114.26 0.464 . . . . 50.210000000000001 114.26 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.0 pt -121.29 -164.24 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.027 0.931 . . . . 70.120000000000005 109.91 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.75 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 22.7 p-10 -49.56 117.18 2.08 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.163 0.985 . . . . 72.140000000000001 112.236 177.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.97 13.99 68.06 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-N 115.562 -0.744 . . . . 71.519999999999996 113.617 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 23.3 t -73.54 132.96 43.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.569 -0.901 . . . . 75.540000000000006 108.569 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.488 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 19.4 p90 -134.87 161.32 35.55 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.176 0.806 . . . . 75.430000000000007 113.176 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 76.9 mt -137.87 135.47 36.19 Favored 'General case' 0 C--O 1.215 -0.754 0 C-N-CA 124.901 1.281 . . . . 73.340000000000003 108.978 172.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 14.3 t -114.83 140.06 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 106.467 -1.679 . . . . 75.040000000000006 106.467 167.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.2 ptt85 -158.72 168.85 25.77 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.955 0.502 . . . . 73.310000000000002 110.474 -172.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.456 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 12.2 pt-20 -115.46 153.44 31.1 Favored 'General case' 0 C--O 1.257 1.448 0 C-N-CA 123.09 0.556 . . . . 64.319999999999993 109.543 167.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 176' ' ' SER . 17.1 m -88.43 123.76 33.29 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.072 -0.967 . . . . 74.099999999999994 109.291 -178.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.41 ' HG2' ' HB2' ' A' ' 150' ' ' PRO . 38.3 mt-10 -57.56 -39.36 76.51 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.421 1.089 . . . . 72.329999999999998 111.674 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.594 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 8.5 t -87.41 -6.26 58.51 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 115.167 -0.924 . . . . 74.439999999999998 111.969 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 173' ' ' SER . 14.9 m -131.72 100.21 16.38 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.425 0.69 . . . . 73.109999999999999 109.324 -176.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.685 ' HG3' ' HA ' ' A' ' 114' ' ' HIS . 36.3 Cg_endo -60.35 113.55 1.73 Allowed 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.745 2.963 . . . . 74.209999999999994 112.061 -174.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.72 -20.38 19.56 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 116.101 -0.5 . . . . 44.43 113.666 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -73.79 116.84 14.87 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.648 0.724 . . . . 75.340000000000003 109.305 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.456 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 66.9 mtt85 -113.23 160.23 18.5 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 124.186 0.995 . . . . 74.230000000000004 110.279 -171.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 44.4 t -143.92 151.58 40.0 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.093 0.957 . . . . 74.430000000000007 110.48 -174.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 52.1 mt -119.06 145.85 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.214 1.006 . . . . 74.010000000000005 108.519 169.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 14.5 m -125.18 127.34 46.65 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.629 1.172 . . . . 73.439999999999998 108.148 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.44 HD21 HD23 ' A' ' 232' ' ' LEU . 57.9 mt -113.67 147.78 37.53 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.624 0.77 . . . . 75.420000000000002 111.891 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 19.7 ttt180 -133.86 131.01 38.68 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-N 114.536 -1.211 . . . . 74.340000000000003 109.651 172.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.75 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 9.5 p90 -149.38 141.03 23.49 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.562 1.145 . . . . 74.049999999999997 108.022 173.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 54.07 31.67 14.18 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.224 1.01 . . . . 71.420000000000002 113.232 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.19 3.68 90.62 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 116.343 -0.389 . . . . 64.230000000000004 112.782 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 10.3 tpp180 -102.13 124.21 47.33 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.151 0.98 . . . . 74.129999999999995 109.72 -176.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.509 HG11 ' HG3' ' A' ' 157' ' ' GLU . 81.0 t -107.45 135.89 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.265 1.026 . . . . 74.019999999999996 109.578 177.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.478 ' HH ' HG22 ' A' ' 230' ' ' THR . 26.7 p90 -145.87 163.11 36.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.202 1.001 . . . . 74.439999999999998 109.744 171.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -133.45 141.98 48.07 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.194 0.997 . . . . 75.140000000000001 108.477 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -143.17 152.62 41.97 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.43 0.692 . . . . 75.219999999999999 109.57 175.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -95.85 138.01 34.1 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.452 0.701 . . . . 72.200000000000003 111.62 -170.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 69.4 mt -83.58 113.8 23.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 124.229 1.012 . . . . 71.230000000000004 108.347 165.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -88.38 134.87 33.71 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.194 0.598 . . . . 73.519999999999996 109.686 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.2 m -104.35 120.34 40.97 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.13 0.972 . . . . 55.210000000000001 109.518 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -72.48 164.82 25.77 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.304 1.042 . . . . 72.299999999999997 111.697 175.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 52.6 p -68.94 -17.05 63.89 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.645 0.778 . . . . 75.349999999999994 111.068 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.57 -19.19 65.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.407 1.083 . . . . 64.319999999999993 111.577 173.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 91.93 -6.06 79.18 Favored Glycine 0 C--N 1.353 1.517 0 CA-C-N 115.848 -0.615 . . . . 70.230000000000004 111.921 -168.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -76.25 144.23 40.49 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.351 0.66 . . . . 73.310000000000002 110.934 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 47.1 mt -95.65 152.48 18.41 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.598 1.159 . . . . 73.099999999999994 108.518 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -166.5 172.28 10.98 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.661 0.6 . . . . 74.540000000000006 111.084 174.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.4 t -131.84 -41.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.377 1.071 . . . . 74.140000000000001 108.758 174.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.6 t -92.39 153.83 18.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.331 -0.618 . . . . 71.530000000000001 109.331 173.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.4 p -66.48 -29.35 69.45 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.122 0.569 . . . . 72.109999999999999 110.957 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -92.56 2.92 56.43 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.4 0.68 . . . . 71.310000000000002 112.144 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 211' ' ' PHE . 86.7 p -105.67 137.9 42.76 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.913 -0.773 . . . . 73.510000000000005 108.913 176.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -143.43 126.83 16.76 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.302 1.041 . . . . 74.430000000000007 108.194 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 209' ' ' SER . 14.4 m-85 -133.74 133.94 42.38 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.175 0.59 . . . . 74.310000000000002 109.422 -178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -74.88 -35.54 62.29 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.08 0.552 . . . . 72.510000000000005 110.403 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 61.9 p -123.22 147.44 46.89 Favored 'General case' 0 C--O 1.256 1.41 0 CA-C-O 122.267 1.032 . . . . 63.420000000000002 111.637 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.421 ' O ' HG21 ' A' ' 218' ' ' VAL . 25.1 tp -64.32 -28.62 69.84 Favored 'General case' 0 C--O 1.213 -0.832 0 CA-C-N 113.655 -1.611 . . . . 73.200000000000003 111.205 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.68 -42.53 95.28 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.316 0.646 . . . . 73.140000000000001 111.452 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -71.7 -35.03 70.11 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.975 0.51 . . . . 70.0 110.347 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.411 HD22 HD12 ' A' ' 182' ' ' ILE . 9.5 tt -56.54 -46.58 80.58 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.901 0.751 . . . . 73.540000000000006 110.384 170.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 214' ' ' LEU . 44.4 t -66.27 -44.97 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.738 0.815 . . . . 73.230000000000004 110.586 -177.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -61.78 -45.45 93.81 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.91 0.484 . . . . 64.140000000000001 110.145 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -52.35 -61.67 2.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.244 -0.889 . . . . 64.120000000000005 108.855 175.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -59.71 -23.45 63.16 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.88 -0.6 . . . . 71.230000000000004 111.92 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.412 ' O ' ' HB ' ' A' ' 231' ' ' THR . 35.6 t -75.21 -28.04 59.81 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.109 0.563 . . . . 74.120000000000005 111.713 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.8 t -118.17 -9.83 10.41 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.447 1.647 . . . . 51.310000000000002 115.447 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 27.6 m -92.71 148.45 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 123.632 1.682 . . . . 62.32 115.058 -167.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.6 0.16 54.99 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 110.96 -2.836 . . . . 74.25 111.359 173.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -78.9 15.46 1.08 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 128.959 2.904 . . . . 72.439999999999998 112.478 -143.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.05 18.39 4.67 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 124.525 1.059 . . . . 71.140000000000001 111.794 -170.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 56.0 mt -93.06 145.59 24.27 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.763 0.825 . . . . 75.409999999999997 111.47 162.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.461 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 63.9 mt -75.34 -43.42 43.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.644 -0.873 . . . . 71.25 108.644 170.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.478 HG22 ' HH ' ' A' ' 191' ' ' TYR . 11.9 t -139.02 144.62 38.94 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.323 -0.853 . . . . 75.010000000000005 109.217 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 222' ' ' SER . 40.8 p -75.49 155.17 36.45 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.597 0.759 . . . . 71.450000000000003 109.73 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.488 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 21.2 mt -67.72 101.78 1.1 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.554 -0.906 . . . . 74.319999999999993 108.554 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -83.1 -47.43 11.66 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.49 0.716 . . . . 75.409999999999997 110.075 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -163.3 152.3 12.29 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 109.572 -0.529 . . . . 74.430000000000007 109.572 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.51 144.39 60.83 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 121.932 1.755 . . . . 75.329999999999998 111.973 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -60.54 137.71 92.56 Favored Pre-proline 0 C--O 1.248 0.992 0 C-N-CA 123.359 0.664 . . . . 73.209999999999994 109.981 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.06 116.4 3.15 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.914 2.409 . . . . 61.439999999999998 111.742 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.456 ' HE2' ' HB2' ' A' ' 240' ' ' ASN . 6.1 ttpm? -80.91 145.56 31.23 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.85 -1.166 . . . . 75.109999999999999 107.85 174.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -58.77 -39.65 81.61 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 123.624 0.578 . . . . 74.329999999999998 109.982 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.456 ' HB2' ' HE2' ' A' ' 238' ' ' LYS . 14.5 m120 -79.8 83.92 5.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 106.873 -1.528 . . . . 75.319999999999993 106.873 162.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 143.05 44.89 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 123.023 0.529 . . . . 73.420000000000002 110.833 -172.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -92.27 -174.2 0.51 Allowed 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.088 2.525 . . . . 72.049999999999997 110.817 165.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 17.9 p -87.72 103.35 15.52 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.021 -1.103 . . . . 72.019999999999996 108.021 168.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 62.5 t -68.62 105.16 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.04 0.536 . . . . 75.510000000000005 110.227 -175.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -104.14 95.09 5.74 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.145 -1.058 . . . . 75.349999999999994 108.145 174.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -117.96 31.07 5.83 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.353 -0.699 . . . . 42.439999999999998 111.353 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.93 93.34 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.962 0.905 . . . . 74.010000000000005 109.591 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 11.5 p -168.0 82.91 0.78 Allowed Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.87 1.268 . . . . 73.010000000000005 108.971 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -77.08 -71.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.107 2.538 . . . . 71.329999999999998 110.708 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 30.8 p30 -177.15 167.98 2.39 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 125.036 1.334 . . . . 75.140000000000001 108.955 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -89.22 163.3 15.46 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 108.259 -1.015 . . . . 64.319999999999993 108.259 166.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -55.92 -43.03 76.96 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.279 0.562 . . . . 75.430000000000007 111.368 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.462 ' HA ' ' HE2' ' A' ' 253' ' ' LYS . 11.4 mmpt? -93.49 1.02 56.93 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.154 -0.93 . . . . 72.409999999999997 111.983 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.417 ' HB3' ' HB2' ' A' ' 250' ' ' ASN . 29.4 t-105 -72.64 -54.86 7.9 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.283 -1.006 . . . . 73.209999999999994 108.283 173.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 . . . . . 0 CA--C 1.552 1.056 0 C-N-CA 123.882 0.873 . . . . 72.319999999999993 109.097 176.706 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.419 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.8 mpp? . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 108.93 -0.767 . . . . 72.120000000000005 108.93 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.34 88.23 0.91 Allowed Glycine 0 C--N 1.346 1.136 0 O-C-N 123.324 0.39 . . . . 71.310000000000002 112.987 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -102.64 107.64 18.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.351 0.66 . . . . 64.420000000000002 109.222 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -130.57 103.61 16.19 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.21 0.604 . . . . 71.439999999999998 109.43 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.91 4.62 6.33 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 123.197 2.598 . . . . 71.129999999999995 112.302 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.99 152.42 40.08 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.741 0.651 . . . . 62.340000000000003 114.471 -174.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -135.15 143.58 46.59 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.046 0.938 . . . . 73.109999999999999 109.314 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 m -90.82 130.19 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-O 120.989 0.424 . . . . 74.319999999999993 109.866 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.5 tp -93.54 -37.59 11.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.248 0.619 . . . . 73.239999999999995 111.119 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.83 73.91 1.25 Allowed Glycine 0 C--N 1.341 0.832 0 N-CA-C 108.882 -1.687 . . . . 54.210000000000001 108.882 -164.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.94 -69.67 0.38 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.873 0.869 . . . . 70.239999999999995 112.274 -165.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -175.55 -153.54 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.517 1.127 . . . . 73.129999999999995 108.638 -173.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.4 133.34 56.01 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.739 -0.467 . . . . 73.409999999999997 109.739 168.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.4 mmm-85 51.29 73.74 0.92 Allowed Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.999 0.92 . . . . 73.239999999999995 110.172 -166.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.02 168.9 19.26 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.263 1.975 . . . . 74.519999999999996 110.544 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.2 m -64.45 165.21 10.19 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.095 0.474 . . . . 74.409999999999997 110.75 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.7 mt -104.27 133.5 20.19 Favored Pre-proline 0 C--O 1.238 0.449 0 N-CA-C 108.092 -1.077 . . . . 75.340000000000003 108.092 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.22 169.36 13.92 Favored 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 122.493 2.129 . . . . 72.140000000000001 112.025 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.3 147.03 27.43 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.933 -0.766 . . . . 75.439999999999998 108.933 170.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.419 HD21 HD11 ' A' ' 23' ' ' ILE . 83.4 mt -88.04 93.57 9.52 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.228 -0.656 . . . . 74.209999999999994 109.228 -177.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -98.23 -53.0 3.49 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.576 0.35 . . . . 75.030000000000001 110.281 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.427 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 61.0 m-85 -106.3 108.97 20.75 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.051 0.541 . . . . 75.430000000000007 110.124 -175.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.419 HD11 HD21 ' A' ' 20' ' ' LEU . 49.8 mm -123.79 120.76 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.754 0.822 . . . . 71.129999999999995 111.003 -175.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -79.5 132.21 36.26 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.486 0.714 . . . . 74.329999999999998 110.531 169.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.08 -13.98 1.31 Allowed Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.603 -0.726 . . . . 71.430000000000007 111.884 173.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.25 150.62 37.0 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.79 0.836 . . . . 52.109999999999999 109.28 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.94 48.27 84.63 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 111.209 -0.756 . . . . 65.510000000000005 111.209 -175.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.552 ' HB2' HE22 ' A' ' 127' ' ' GLN . 19.6 pttp -61.35 -23.0 65.44 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.158 0.983 . . . . 71.209999999999994 112.98 -172.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? 56.11 39.24 30.41 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.445 1.098 . . . . 74.120000000000005 110.501 171.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.63 164.77 25.29 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.66 -1.154 . . . . 63.340000000000003 113.18 -169.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.505 ' H ' HD21 ' A' ' 110' ' ' LEU . 30.7 t -77.28 105.32 8.32 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.457 -1.247 . . . . 75.0 108.357 172.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.4 t -54.04 99.03 0.02 OUTLIER 'General case' 0 C--N 1.353 0.72 0 O-C-N 124.34 1.025 . . . . 72.329999999999998 110.418 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -67.97 106.09 2.22 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 116.037 -0.529 . . . . 75.120000000000005 109.705 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -136.4 115.6 12.52 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.634 0.774 . . . . 74.319999999999993 109.039 -174.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.603 ' HA3' ' HA ' ' A' ' 79' ' ' GLU . . . 136.69 -148.16 19.59 Favored Glycine 0 C--N 1.341 0.811 0 O-C-N 123.597 0.56 . . . . 62.130000000000003 111.876 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.09 151.76 19.5 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 119.776 -0.458 . . . . 54.130000000000003 112.454 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.92 -2.74 12.97 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.21 2.607 . . . . 73.109999999999999 113.234 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.6 t60 66.23 102.77 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.389 1.476 . . . . 73.329999999999998 111.714 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.5 p -140.33 -177.61 5.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.744 0.818 . . . . 75.400000000000006 109.225 173.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -63.13 143.24 57.96 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.735 0.414 . . . . 74.319999999999993 110.551 173.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.5 p -79.77 166.74 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 109.262 -0.644 . . . . 75.340000000000003 109.262 177.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -53.93 139.54 33.64 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.537 0.735 . . . . 72.409999999999997 111.842 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.4 m -75.53 109.87 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-O 121.514 0.673 . . . . 65.230000000000004 109.54 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -96.02 146.13 24.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.401 0.68 . . . . 75.430000000000007 110.338 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -73.57 89.0 1.69 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.844 -0.798 . . . . 63.329999999999998 108.844 173.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -98.6 157.98 15.9 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.254 -0.885 . . . . 72.349999999999994 110.196 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.86 171.04 9.12 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.194 0.598 . . . . 72.319999999999993 110.701 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.3 mt -70.87 93.74 1.0 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.984 -0.553 . . . . 74.219999999999999 110.719 -176.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.482 ' HG3' ' HG2' ' A' ' 50' ' ' ARG . 6.7 tp-100 -78.4 132.37 37.32 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.96 -0.756 . . . . 70.299999999999997 108.96 174.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.482 ' HG2' ' HG3' ' A' ' 49' ' ' GLN . 15.7 mmt180 53.9 58.24 12.86 Favored Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 124.601 1.16 . . . . 75.409999999999997 112.126 -177.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.3 -10.18 16.26 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.772 2.315 . . . . 64.129999999999995 112.941 -173.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -70.01 -25.53 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.319 0.648 . . . . 64.319999999999993 111.122 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.44 82.59 1.9 Allowed 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.609 0.764 . . . . 72.409999999999997 109.179 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.2 m -85.13 113.68 21.7 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.096 -0.956 . . . . 65.230000000000004 109.851 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 64.01 10.63 5.49 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.694 1.198 . . . . 74.129999999999995 112.911 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -86.83 150.77 23.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.254 0.622 . . . . 74.010000000000005 109.55 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 60.11 70.87 0.95 Allowed Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 124.353 1.033 . . . . 71.099999999999994 109.617 -170.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -56.12 143.59 83.47 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.844 2.362 . . . . 72.239999999999995 112.77 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -90.27 -1.87 57.97 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.298 0.639 . . . . 74.340000000000003 110.525 175.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.94 122.96 1.44 Allowed Glycine 0 C--N 1.347 1.17 0 N-CA-C 111.388 -0.685 . . . . 72.310000000000002 111.388 174.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.8 mt -129.02 111.47 13.02 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 107.755 -1.202 . . . . 74.439999999999998 107.755 170.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.1 t 60.29 40.1 18.15 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 124.255 0.972 . . . . 75.099999999999994 110.283 -175.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.15 1.22 9.63 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.457 1.103 . . . . 70.439999999999998 112.228 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -45.9 116.79 1.3 Allowed 'General case' 0 C--N 1.359 0.988 0 C-N-CA 124.828 1.251 . . . . 74.239999999999995 111.09 173.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.72 89.67 0.07 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.327 1.051 . . . . 62.329999999999998 111.968 -172.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -111.77 116.88 31.43 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.841 -1.17 . . . . 75.030000000000001 107.841 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 47.55 20.68 0.2 Allowed 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 125.555 1.542 . . . . 73.439999999999998 113.687 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -70.5 114.78 8.95 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 123.905 0.882 . . . . 71.400000000000006 109.494 -173.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.9 t -57.21 132.91 54.41 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.355 1.062 . . . . 73.25 111.569 -175.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.573 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -68.45 97.57 0.77 Allowed 'General case' 0 C--N 1.354 0.764 0 O-C-N 124.101 0.876 . . . . 74.319999999999993 111.797 -173.606 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -91.66 143.9 26.08 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.26 -1.015 . . . . 71.219999999999999 108.26 171.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -86.19 49.61 1.82 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.31 0.644 . . . . 64.230000000000004 111.576 -172.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.9 mt 62.75 8.12 2.88 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.681 1.192 . . . . 71.409999999999997 113.265 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.0 mt 59.09 34.65 23.49 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.644 1.178 . . . . 74.209999999999994 111.311 -172.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.53 158.49 24.44 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.397 0.679 . . . . 75.450000000000003 111.207 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -136.81 -165.39 10.46 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.488 -0.618 . . . . 63.229999999999997 112.135 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.24 80.98 2.09 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.137 2.558 . . . . 64.450000000000003 112.572 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.8 m -75.94 -20.57 57.85 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.604 -0.725 . . . . 51.109999999999999 110.444 173.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.603 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 18.5 tt0 -116.11 -166.79 1.18 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.483 1.113 . . . . 73.129999999999995 108.531 -177.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.497 ' H ' ' HG2' ' A' ' 79' ' ' GLU . 5.2 p-10 -71.16 -155.63 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 124.51 1.124 . . . . 64.400000000000006 112.385 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -49.12 137.34 14.44 Favored Pre-proline 0 N--CA 1.487 1.396 0 C-N-CA 123.665 0.786 . . . . 62.109999999999999 112.079 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.37 23.64 0.74 Allowed 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.227 2.618 . . . . 74.409999999999997 114.045 -168.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -64.96 83.48 0.04 OUTLIER 'General case' 0 C--N 1.353 0.719 0 CA-C-O 121.766 0.793 . . . . 75.530000000000001 109.85 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 33.6 tp -125.07 119.01 27.44 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.363 -1.29 . . . . 74.409999999999997 107.904 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -105.14 176.23 5.23 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.646 1.579 . . . . 64.129999999999995 109.226 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.62 144.73 25.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 N-CA-C 108.641 -0.874 . . . . 72.099999999999994 108.641 172.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.28 118.52 19.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.433 0.693 . . . . 74.209999999999994 109.748 174.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.29 -21.29 39.43 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.91 0.884 . . . . 71.129999999999995 111.073 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.566 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 93.1 m-85 -134.46 169.28 17.5 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.405 0.682 . . . . 74.099999999999994 110.15 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.39 145.76 27.32 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.177 -0.919 . . . . 63.329999999999998 109.133 170.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.43 ' HB3' HG12 ' A' ' 101' ' ' ILE . 86.2 t80 -151.93 104.81 3.03 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.457 -0.942 . . . . 65.430000000000007 108.457 176.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.6 t -80.37 133.92 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 107.878 -1.156 . . . . 72.519999999999996 107.878 172.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.41 114.77 10.89 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.595 -0.52 . . . . 75.140000000000001 109.595 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.1 m -77.03 -23.19 52.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.009 0.524 . . . . 74.120000000000005 110.663 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.75 168.28 19.8 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 123.796 0.685 . . . . 52.030000000000001 111.734 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.52 -29.88 63.99 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.529 0.732 . . . . 62.43 110.29 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -71.43 -19.92 62.18 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.993 1.317 . . . . 72.010000000000005 112.235 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.3 p -98.47 154.87 17.57 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.256 0.622 . . . . 74.409999999999997 109.998 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.6 tp -107.08 128.35 54.3 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.877 -0.786 . . . . 74.0 108.877 -177.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.1 t -82.56 118.15 23.07 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 109.782 -0.451 . . . . 73.510000000000005 109.782 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.43 HG12 ' HB3' ' A' ' 91' ' ' PHE . 28.6 pt -119.6 165.42 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.075 0.95 . . . . 75.109999999999999 110.066 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.5 m -138.59 145.64 40.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.465 0.706 . . . . 75.140000000000001 109.214 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -54.54 118.67 4.36 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.813 0.845 . . . . 74.129999999999995 111.778 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.85 -14.87 29.08 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.032 -0.531 . . . . 64.409999999999997 112.842 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -78.49 124.36 28.05 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.596 0.758 . . . . 73.150000000000006 110.258 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.435 ' HB3' HD11 ' A' ' 84' ' ' LEU . 31.8 mtmm -75.01 116.9 16.27 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.364 0.666 . . . . 72.310000000000002 109.574 176.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.9 mt -101.14 163.61 12.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.694 -0.854 . . . . 71.129999999999995 108.694 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -126.38 110.12 12.99 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.56 -0.904 . . . . 74.049999999999997 108.56 163.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 99.1 t -90.23 124.35 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.127 -0.694 . . . . 72.430000000000007 109.127 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.505 HD21 ' H ' ' A' ' 31' ' ' SER . 27.4 mt -81.78 -37.83 26.55 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.567 1.147 . . . . 72.409999999999997 109.273 -174.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.81 176.28 47.88 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 113.936 -1.484 . . . . 61.310000000000002 110.51 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.518 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 56.7 m-85 -103.95 175.05 5.61 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 109.386 -0.598 . . . . 75.109999999999999 109.386 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 22' ' ' PHE . 43.7 t-20 -68.98 148.74 49.69 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.428 -0.953 . . . . 73.530000000000001 108.428 169.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -66.09 -17.81 64.94 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.758 0.823 . . . . 70.120000000000005 112.578 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -95.84 -5.28 42.07 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.493 0.717 . . . . 65.319999999999993 111.062 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.3 34.69 63.95 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.378 -0.689 . . . . 60.409999999999997 111.378 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.463 ' HG2' ' CD1' ' A' ' 118' ' ' TRP . 36.8 tt0 -89.03 -58.36 2.57 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.202 1.401 . . . . 73.420000000000002 109.282 -170.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.463 ' CD1' ' HG2' ' A' ' 117' ' ' GLU . 87.5 m95 -126.24 -176.96 3.8 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.587 1.155 . . . . 74.409999999999997 110.086 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -132.28 116.54 17.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.338 1.055 . . . . 64.510000000000005 109.698 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.46 107.53 14.3 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.795 -0.817 . . . . 74.129999999999995 108.795 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -121.12 165.42 15.37 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.939 0.896 . . . . 65.530000000000001 111.58 -172.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -143.42 131.31 21.56 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.101 0.96 . . . . 74.219999999999999 110.138 -175.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 45.1 p -141.06 -176.99 4.89 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.634 1.174 . . . . 64.329999999999998 110.973 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -60.79 -21.58 63.24 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.229 1.012 . . . . 71.120000000000005 111.41 171.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -72.71 -26.87 61.75 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.759 0.824 . . . . 73.430000000000007 110.127 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.22 -135.1 6.88 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.203 -0.759 . . . . 42.130000000000003 111.203 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.552 HE22 ' HB2' ' A' ' 28' ' ' LYS . 53.4 tt0 -152.88 148.55 27.29 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 122.924 0.489 . . . . 75.25 110.116 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 161.49 -177.7 37.68 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 121.088 0.271 . . . . 62.549999999999997 113.137 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -84.34 134.78 34.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.528 0.731 . . . . 63.439999999999998 111.781 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.66 155.23 80.65 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.085 1.354 . . . . 74.200000000000003 108.766 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -69.66 129.65 18.08 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 121.789 1.659 . . . . 75.409999999999997 110.846 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.4 m -60.25 -20.55 59.45 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.773 0.829 . . . . 75.510000000000005 112.539 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -84.66 -19.02 33.55 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.635 0.774 . . . . 74.530000000000001 111.615 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.566 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.4 m-85 -89.66 5.05 47.49 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.548 0.739 . . . . 73.310000000000002 112.107 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.456 HD13 HG22 ' A' ' 109' ' ' VAL . 21.3 pt -134.32 167.43 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.442 0.697 . . . . 70.319999999999993 110.695 -174.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.3 t -160.88 141.9 8.73 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 122.781 0.432 . . . . 73.319999999999993 111.11 168.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.04 133.21 22.76 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.978 2.452 . . . . 73.120000000000005 112.285 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.6 m -113.89 -49.15 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.109 0.564 . . . . 72.25 111.459 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.2 t30 -100.97 -11.7 19.5 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.92 0.488 . . . . 73.430000000000007 111.058 -176.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.1 t -65.39 177.62 1.1 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.549 0.74 . . . . 73.120000000000005 111.044 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.72 -21.95 21.22 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.194 1.183 . . . . 74.420000000000002 114.194 -171.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.59 -13.29 60.88 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.004 0.922 . . . . 75.5 112.028 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -63.33 -22.46 66.89 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.979 0.912 . . . . 73.450000000000003 110.692 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -85.07 145.22 27.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.612 0.765 . . . . 75.430000000000007 110.431 171.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.7 t -66.51 -20.76 66.11 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.861 0.865 . . . . 73.200000000000003 112.261 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -83.61 -34.87 25.02 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.097 0.406 . . . . 63.210000000000001 112.097 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 33.7 t80 -93.8 138.71 31.69 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 109.494 -0.558 . . . . 74.219999999999999 109.494 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.649 ' HB3' HH21 ' A' ' 171' ' ' ARG . 75.9 m-70 -134.27 26.39 3.83 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.448 0.536 . . . . 73.420000000000002 112.448 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 67.86 -163.5 47.31 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 115.585 0.994 . . . . 65.549999999999997 115.585 170.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.21 102.68 1.59 Allowed 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.499 2.799 . . . . 74.430000000000007 112.874 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.404 ' HB ' ' HD3' ' A' ' 171' ' ' ARG . 38.9 t -138.05 157.58 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 123.247 0.619 . . . . 75.439999999999998 110.363 -176.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.0 m -75.24 153.67 37.92 Favored 'General case' 0 C--O 1.256 1.435 0 C-N-CA 124.581 1.152 . . . . 75.030000000000001 112.09 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -62.81 -31.92 73.01 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.523 -0.762 . . . . 73.450000000000003 111.085 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -54.93 -53.6 53.51 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.022 0.929 . . . . 73.239999999999995 110.264 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.04 77.56 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.409 -0.814 . . . . 74.5 110.848 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.516 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.08 -50.53 73.13 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.345 0.593 . . . . 74.319999999999993 111.69 176.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.46 ' HG3' HG12 ' A' ' 190' ' ' VAL . 33.0 tt0 -78.2 -25.05 46.89 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.106 -0.952 . . . . 73.430000000000007 110.263 -175.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -60.25 -53.46 57.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.112 0.565 . . . . 64.340000000000003 110.269 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 64.8 mt -65.23 -39.33 92.58 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 116.237 -0.438 . . . . 73.040000000000006 110.854 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.543 HD21 ' HB3' ' A' ' 183' ' ' SER . 36.4 tp -73.08 -24.21 60.63 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.878 -0.601 . . . . 75.329999999999998 112.105 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 35.4 t -65.77 -23.81 66.8 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.109 0.564 . . . . 72.120000000000005 111.322 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 80.6 p -91.8 -0.64 57.54 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.155 0.582 . . . . 74.200000000000003 111.129 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -83.96 163.23 39.7 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.941 -0.572 . . . . 70.140000000000001 112.89 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.1 pt -120.15 -166.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.317 1.047 . . . . 72.209999999999994 111.095 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -58.58 107.36 0.5 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.899 0.879 . . . . 75.510000000000005 112.777 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 98.2 13.53 42.0 Favored Glycine 0 C--O 1.259 1.658 0 CA-C-N 116.03 -0.532 . . . . 75.299999999999997 112.617 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 31.5 t -74.35 134.79 42.49 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 119.126 -0.464 . . . . 52.149999999999999 109.961 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 183' ' ' SER . 22.3 p90 -135.25 153.7 51.82 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 121.51 0.671 . . . . 73.299999999999997 112.669 177.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 236' ' ' ALA . 97.5 mt -134.49 133.81 40.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.908 -1.042 . . . . 71.109999999999999 108.302 169.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 20.0 t -112.87 120.5 63.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.394 -1.336 . . . . 74.099999999999994 107.394 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.649 HH21 ' HB3' ' A' ' 148' ' ' HIS . 0.6 OUTLIER -159.37 148.89 18.5 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.469 -0.567 . . . . 73.530000000000001 109.469 177.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.79 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 15.0 pt-20 -92.3 157.77 16.47 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-O 121.224 0.535 . . . . 73.510000000000005 111.258 -176.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 p -76.72 115.97 16.97 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.975 -1.011 . . . . 71.439999999999998 108.53 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.21 -31.33 67.23 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.796 0.838 . . . . 70.340000000000003 112.429 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.8 t -95.67 8.46 43.37 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.81 0.844 . . . . 72.319999999999993 111.4 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 57.0 m -149.86 83.21 6.33 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 108.434 -0.95 . . . . 55.149999999999999 108.434 172.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.518 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 42.8 Cg_endo -63.57 140.55 75.85 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.47 2.78 . . . . 73.430000000000007 112.491 -173.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.65 -23.54 10.14 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.924 -0.58 . . . . 74.340000000000003 112.9 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -86.65 115.87 24.39 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 108.818 -0.808 . . . . 74.140000000000001 108.818 174.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.79 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 42.8 mtt85 -114.57 153.15 30.6 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.025 -0.989 . . . . 75.340000000000003 108.957 -173.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.1 m -134.18 142.72 47.53 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 109.945 -0.391 . . . . 63.119999999999997 109.945 -177.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.418 HG12 HG23 ' A' ' 170' ' ' VAL . 50.6 mt -106.48 136.25 41.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.365 -0.976 . . . . 70.040000000000006 108.365 169.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.543 ' HB3' HD21 ' A' ' 160' ' ' LEU . 20.4 m -115.77 113.95 24.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.99 -1.115 . . . . 72.25 107.99 -177.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 52.7 mt -104.58 141.09 37.03 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.5 0.72 . . . . 73.310000000000002 111.167 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 26.7 ttt180 -124.2 120.91 33.64 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 107.361 -1.348 . . . . 75.310000000000002 107.361 165.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.79 127.38 28.87 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.588 -1.264 . . . . 74.420000000000002 107.588 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 54.85 28.86 10.99 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.039 0.936 . . . . 64.329999999999998 112.282 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 89.31 1.25 78.88 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.155 0.407 . . . . 73.129999999999995 113.433 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 8.7 tpm_? -100.57 123.26 44.54 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.035 0.934 . . . . 74.400000000000006 109.455 -174.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.471 HG13 HD23 ' A' ' 160' ' ' LEU . 95.0 t -98.58 124.3 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.135 0.974 . . . . 74.450000000000003 109.978 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.473 ' HH ' ' HB ' ' A' ' 229' ' ' ILE . 14.3 p90 -145.95 149.99 35.21 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.062 0.945 . . . . 60.240000000000002 109.75 176.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -125.86 148.78 49.07 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.961 0.904 . . . . 74.129999999999995 109.361 -171.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -145.39 148.4 33.3 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.215 0.531 . . . . 74.049999999999997 111.106 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -93.77 125.88 38.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.932 -1.031 . . . . 74.140000000000001 111.785 -171.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 68.9 mt -77.65 111.0 13.97 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 124.397 1.079 . . . . 75.540000000000006 108.536 162.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -87.46 139.27 30.71 Favored 'General case' 0 C--O 1.249 1.051 0 N-CA-C 109.417 -0.586 . . . . 74.010000000000005 109.417 173.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 46.5 m -110.6 132.16 54.43 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.974 0.796 . . . . 65.200000000000003 110.1 -176.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.58 169.19 18.74 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.059 0.944 . . . . 75.310000000000002 111.1 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 72.1 p -75.92 -8.59 57.29 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.841 0.456 . . . . 74.549999999999997 111.461 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -93.33 -7.55 44.49 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.062 0.945 . . . . 73.219999999999999 110.821 170.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 91.8 -1.27 74.63 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-O 119.501 -0.61 . . . . 54.420000000000002 113.324 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -70.61 128.85 37.52 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.538 0.669 . . . . 73.450000000000003 111.164 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 29.0 mt -91.77 148.59 22.13 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.925 0.89 . . . . 65.299999999999997 110.535 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -160.74 148.74 16.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.301 0.572 . . . . 74.030000000000001 111.149 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.7 t -112.7 -45.32 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 114.721 -1.127 . . . . 73.010000000000005 109.371 176.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 22.2 t -121.75 178.94 4.65 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.009 0.524 . . . . 74.310000000000002 109.976 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.2 t -68.05 -26.72 66.0 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.577 0.751 . . . . 71.150000000000006 112.04 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -86.48 -3.97 59.1 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.604 0.761 . . . . 74.239999999999995 110.663 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.476 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 19.9 m -94.72 121.76 36.62 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.893 0.877 . . . . 71.439999999999998 110.976 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -143.49 109.29 5.2 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 107.869 -1.16 . . . . 74.310000000000002 107.869 168.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 209' ' ' SER . 17.7 m-85 -123.42 136.26 54.53 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.291 -0.633 . . . . 73.430000000000007 109.291 -178.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.24 -10.17 45.29 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 122.625 0.37 . . . . 71.420000000000002 110.182 175.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 57.7 p -141.36 152.55 44.47 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.587 0.708 . . . . 74.019999999999996 111.141 173.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.26 -25.4 63.35 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.483 -1.235 . . . . 73.140000000000001 110.474 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.61 -50.14 73.76 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 123.723 0.809 . . . . 73.140000000000001 110.382 174.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -72.11 -29.22 63.87 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.416 -0.811 . . . . 73.409999999999997 111.62 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.49 -52.7 64.55 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.354 0.409 . . . . 74.319999999999993 110.065 171.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.69 -40.5 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.273 0.629 . . . . 73.329999999999998 111.221 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -64.06 -47.5 79.9 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.091 0.472 . . . . 73.430000000000007 110.949 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -63.26 -46.69 85.65 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.151 -0.685 . . . . 74.040000000000006 109.151 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.435 ' HA ' HG21 ' A' ' 224' ' ' VAL . 46.1 m80 -66.24 -25.22 66.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.969 0.508 . . . . 74.439999999999998 111.489 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' A' ' 231' ' ' THR . 45.9 t -71.07 -28.65 64.51 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.658 0.383 . . . . 62.439999999999998 111.114 174.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -106.72 -18.02 14.06 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 115.433 1.642 . . . . 75.420000000000002 115.433 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 221' ' ' HIS . 23.9 m -87.34 122.41 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-N 120.251 1.387 . . . . 74.209999999999994 114.232 -169.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.55 -1.54 19.05 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.315 2.246 . . . . 74.420000000000002 113.17 170.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -79.5 15.51 1.28 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 127.986 2.514 . . . . 75.099999999999994 112.914 -144.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.07 16.84 4.26 Favored Glycine 0 C--O 1.25 1.129 0 C-N-CA 123.507 0.575 . . . . 70.430000000000007 112.133 -168.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 46.9 mt -88.78 131.51 35.03 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.978 -0.611 . . . . 75.349999999999994 109.59 158.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.473 ' HB ' ' HH ' ' A' ' 191' ' ' TYR . 77.5 mt -59.24 -41.2 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 O-C-N 124.03 0.832 . . . . 65.109999999999999 109.694 172.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.7 t -141.17 144.43 34.8 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.969 -1.014 . . . . 63.399999999999999 109.536 168.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 222' ' ' SER . 67.3 p -71.84 151.33 43.52 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.791 -0.818 . . . . 74.530000000000001 108.791 168.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.22 100.23 0.33 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.543 -0.91 . . . . 71.510000000000005 108.543 178.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -85.86 -50.73 6.89 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.21 -0.663 . . . . 72.319999999999993 109.21 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.1 OUTLIER -163.24 148.08 9.19 Favored Pre-proline 0 N--CA 1.482 1.151 0 CA-C-N 115.376 -0.829 . . . . 70.420000000000002 110.922 179.308 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 52.3 Cg_endo -67.47 155.86 68.52 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 121.738 1.625 . . . . 71.219999999999999 112.293 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . 0.5 ' HB2' HD21 ' A' ' 169' ' ' LEU . . . -63.41 134.56 95.89 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-O 118.779 -0.629 . . . . 71.549999999999997 109.779 173.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.11 120.47 7.29 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.967 2.445 . . . . 62.130000000000003 111.689 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -53.83 134.82 42.53 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 123.931 0.769 . . . . 75.420000000000002 110.477 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -57.67 -25.09 59.75 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.723 0.809 . . . . 75.010000000000005 111.687 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -121.26 133.33 55.15 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.266 1.026 . . . . 75.239999999999995 108.483 172.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt 43.3 67.94 3.32 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 126.013 1.725 . . . . 64.25 113.156 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.05 104.63 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.858 2.372 . . . . 75.310000000000002 112.262 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 86.1 m -70.28 108.93 4.42 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.293 0.637 . . . . 73.340000000000003 110.348 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 39.9 t -93.22 94.53 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.752 -0.833 . . . . 74.140000000000001 108.752 176.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -88.55 118.08 27.95 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.924 -0.769 . . . . 74.129999999999995 108.924 174.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -66.64 137.93 35.12 Favored Glycine 0 C--N 1.343 0.963 0 N-CA-C 111.086 -0.806 . . . . 53.229999999999997 111.086 171.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 22.6 m -60.76 -22.77 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.515 0.726 . . . . 74.430000000000007 112.558 -173.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 28.5 t 63.71 84.91 0.18 Allowed Pre-proline 0 C--N 1.359 1.009 0 C-N-CA 125.063 1.345 . . . . 75.230000000000004 109.965 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.24 171.72 16.56 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.915 2.41 . . . . 55.140000000000001 112.788 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -136.19 165.24 26.19 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.753 0.821 . . . . 75.299999999999997 110.312 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -74.88 -58.89 3.0 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.033 0.933 . . . . 73.409999999999997 110.752 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.18 169.56 24.23 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 121.146 0.498 . . . . 73.239999999999995 111.121 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.49 43.46 0.75 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.761 1.224 . . . . 74.099999999999994 108.772 171.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 59.61 93.05 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.013 1.325 . . . . 75.420000000000002 111.642 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 C--O 1.255 1.375 0 N-CA-C 108.816 -0.809 . . . . 74.349999999999994 108.816 175.228 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 108.837 -0.801 . . . . 71.140000000000001 108.837 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.26 177.39 9.65 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.551 0.532 . . . . 72.310000000000002 113.349 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -129.24 -36.4 1.73 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.968 -0.753 . . . . 64.109999999999999 108.968 175.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 54.63 73.39 0.9 Allowed Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.752 1.221 . . . . 73.219999999999999 108.232 -169.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.57 -58.79 0.36 Allowed 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.005 1.803 . . . . 62.340000000000003 111.585 -174.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.49 175.95 5.73 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 116.064 -0.516 . . . . 74.319999999999993 113.286 -176.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -157.98 93.09 1.23 Allowed 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.742 -0.836 . . . . 75.219999999999999 108.742 177.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.428 ' HB ' ' OG ' ' A' ' 16' ' ' SER . 18.7 m -83.45 159.74 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 115.404 -0.816 . . . . 71.230000000000004 110.557 174.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.5 tp -158.83 152.76 23.46 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.208 -0.664 . . . . 75.530000000000001 109.208 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.665 ' HA3' ' HB3' ' A' ' 15' ' ' PRO . . . -134.65 71.97 0.48 Allowed Glycine 0 C--N 1.347 1.14 0 N-CA-C 111.523 -0.631 . . . . 33.549999999999997 111.523 -177.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -76.54 -33.39 58.56 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.3 -0.63 . . . . 72.310000000000002 109.3 172.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -93.59 153.36 18.45 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.167 -0.924 . . . . 62.25 109.715 173.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.477 ' HD3' ' H ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -56.96 153.12 11.71 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.42 0.688 . . . . 75.319999999999993 111.33 175.232 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 56.5 73.94 0.75 Allowed Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 124.158 0.983 . . . . 73.120000000000005 109.258 -169.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.665 ' HB3' ' HA3' ' A' ' 10' ' ' GLY . 26.7 Cg_endo -63.83 166.11 16.93 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.963 2.442 . . . . 73.120000000000005 112.563 -178.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.428 ' OG ' ' HB ' ' A' ' 8' ' ' VAL . 6.2 p -72.19 168.37 18.37 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.415 0.626 . . . . 72.219999999999999 111.322 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.6 mt -107.24 126.84 29.14 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 107.975 -1.12 . . . . 75.239999999999995 107.975 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.51 171.95 11.06 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.391 2.061 . . . . 64.299999999999997 111.632 173.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.23 144.35 32.99 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.847 0.459 . . . . 65.409999999999997 111.085 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.552 ' HB3' HD11 ' A' ' 23' ' ' ILE . 56.4 mt -86.1 93.89 9.12 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.073 0.949 . . . . 73.129999999999995 108.699 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -98.25 -42.15 7.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.815 -1.084 . . . . 75.420000000000002 109.285 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -96.85 111.86 23.87 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 114.583 -1.189 . . . . 75.030000000000001 108.547 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.552 HD11 ' HB3' ' A' ' 20' ' ' LEU . 44.1 mm -116.08 120.88 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.991 -1.114 . . . . 74.239999999999995 107.991 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -147.61 149.44 32.53 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.45 -0.945 . . . . 75.310000000000002 108.45 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -160.28 -127.33 0.89 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.226 -1.15 . . . . 65.430000000000007 110.226 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 62.24 92.44 0.06 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.723 1.209 . . . . 63.43 110.657 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.81 73.9 2.05 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.272 -0.876 . . . . 54.200000000000003 112.489 -175.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.574 ' HB2' ' HZ2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -132.0 10.15 4.58 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.395 1.078 . . . . 74.400000000000006 110.099 178.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -136.67 159.75 40.9 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 124.215 1.006 . . . . 73.329999999999998 108.665 -174.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.494 ' HA ' HE22 ' A' ' 122' ' ' GLN . 0.0 OUTLIER -149.45 178.43 8.81 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.994 -0.548 . . . . 74.450000000000003 110.693 -177.383 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 56.6 p -79.02 -158.03 0.14 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.313 1.045 . . . . 63.310000000000002 110.61 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.1 t -63.71 175.42 1.11 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 122.8 0.44 . . . . 71.219999999999999 111.238 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -64.69 -172.01 0.07 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.315 1.046 . . . . 73.530000000000001 113.503 -170.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -72.32 153.37 41.54 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.183 0.593 . . . . 74.120000000000005 111.359 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.04 -142.47 3.71 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 115.743 -0.662 . . . . 74.230000000000004 111.605 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -107.55 97.42 1.16 Allowed Glycine 0 C--N 1.344 0.979 0 N-CA-C 110.777 -0.929 . . . . 72.409999999999997 110.777 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.72 ' HG3' ' HA2' ' A' ' 76' ' ' GLY . 18.0 Cg_endo -86.89 50.11 2.15 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 123.457 2.772 . . . . 64.049999999999997 112.389 -171.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.431 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 19.9 p-80 -55.49 -23.56 26.59 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 124.792 1.237 . . . . 65.329999999999998 113.681 -174.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.8 m -66.25 111.58 3.54 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 107.305 -1.368 . . . . 71.549999999999997 107.305 170.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -51.98 -79.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.356 1.063 . . . . 72.230000000000004 112.939 -162.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 p -179.42 158.4 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.663 0.785 . . . . 73.439999999999998 109.717 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -134.49 95.5 3.39 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.569 -0.9 . . . . 64.409999999999997 108.569 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.7 m -112.37 176.71 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.064 0.545 . . . . 63.200000000000003 110.579 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -148.35 135.53 20.29 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.222 -1.029 . . . . 74.329999999999998 108.222 174.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -71.54 92.22 1.11 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.151 0.581 . . . . 74.329999999999998 110.039 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -76.84 139.75 40.4 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.324 -0.853 . . . . 74.129999999999995 108.984 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.73 112.96 23.65 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.5 -0.926 . . . . 72.239999999999995 108.5 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.43 90.2 0.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.351 0.66 . . . . 73.010000000000005 110.121 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -155.68 136.08 13.2 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.976 0.91 . . . . 75.430000000000007 108.775 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -61.92 136.32 95.0 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 123.645 0.59 . . . . 75.400000000000006 110.082 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.09 93.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.984 2.456 . . . . 71.010000000000005 113.538 175.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.03 -57.84 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 108.253 -1.017 . . . . 70.420000000000002 108.253 172.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.79 97.86 0.86 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.729 0.812 . . . . 70.140000000000001 109.449 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.4 m -82.86 167.37 18.12 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.185 0.594 . . . . 74.519999999999996 111.578 -176.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.19 145.29 44.31 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.118 0.967 . . . . 65.340000000000003 110.977 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -148.97 166.8 27.55 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.083 0.953 . . . . 75.030000000000001 109.38 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 65.75 71.63 0.49 Allowed Pre-proline 0 N--CA 1.485 1.315 0 C-N-CA 124.93 1.292 . . . . 75.450000000000003 111.862 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.06 160.16 36.89 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.206 1.937 . . . . 62.439999999999998 112.112 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -65.0 -42.62 94.34 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.629 0.772 . . . . 72.430000000000007 110.436 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 144.22 92.12 0.14 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.171 -0.772 . . . . 64.439999999999998 111.171 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.44 98.48 1.82 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.422 0.689 . . . . 64.310000000000002 110.768 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.2 t -152.98 145.95 24.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.21 -0.905 . . . . 74.310000000000002 108.934 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.79 159.99 15.54 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.328 0.651 . . . . 74.0 111.003 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.77 -38.51 8.25 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.104 0.962 . . . . 73.120000000000005 109.712 172.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -158.18 134.27 9.28 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.376 1.07 . . . . 74.400000000000006 109.509 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -109.45 85.69 2.15 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.195 0.598 . . . . 72.420000000000002 109.599 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -109.27 85.57 2.12 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 107.295 -1.372 . . . . 64.450000000000003 107.295 166.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -81.43 134.34 35.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 114.453 -1.249 . . . . 71.340000000000003 110.128 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.1 t -71.59 97.51 1.72 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 109.701 -0.481 . . . . 71.439999999999998 109.701 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.431 ' HD3' ' HB2' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -64.72 110.59 2.43 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.386 -0.824 . . . . 74.209999999999994 109.475 179.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -176.45 121.68 0.15 Allowed 'General case' 0 N--CA 1.48 1.03 0 O-C-N 124.347 1.029 . . . . 74.150000000000006 110.151 160.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -154.88 93.79 1.59 Allowed 'General case' 0 C--O 1.244 0.801 0 N-CA-C 109.066 -0.716 . . . . 74.150000000000006 109.066 170.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 99.4 mt -123.85 -178.1 3.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.141 0.977 . . . . 74.219999999999999 109.555 175.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.3 mt 62.81 18.05 10.4 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.982 1.313 . . . . 74.400000000000006 111.172 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.68 163.96 38.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.948 1.299 . . . . 71.200000000000003 109.3 -175.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.72 ' HA2' ' HG3' ' A' ' 37' ' ' PRO . . . 175.46 99.78 0.12 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.084 -0.842 . . . . 63.399999999999999 113.098 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.6 170.65 13.34 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.836 2.357 . . . . 74.409999999999997 111.591 163.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.6 m -74.73 85.42 2.15 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.128 0.489 . . . . 71.340000000000003 109.853 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HB3' ' NE ' ' A' ' 108' ' ' ARG . 11.1 pt-20 -146.32 92.3 2.16 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-O 122.785 1.279 . . . . 75.540000000000006 110.228 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -147.94 44.01 1.07 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 105.569 -2.011 . . . . 73.109999999999999 105.569 171.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -82.89 133.15 49.2 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 114.118 -1.401 . . . . 74.150000000000006 110.373 -170.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -59.01 -32.29 97.28 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.274 2.649 . . . . 75.409999999999997 112.774 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -93.05 66.7 4.17 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-O 121.792 0.806 . . . . 72.430000000000007 109.543 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.511 HD13 ' HB3' ' A' ' 106' ' ' LYS . 42.5 tp -85.78 117.63 24.77 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.797 -1.092 . . . . 73.420000000000002 109.007 175.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -109.09 176.51 5.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.694 1.598 . . . . 70.230000000000004 109.373 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.82 146.24 24.29 Favored 'Isoleucine or valine' 0 C--O 1.25 1.103 0 N-CA-C 108.722 -0.844 . . . . 75.140000000000001 108.722 170.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.03 120.64 25.06 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.282 0.633 . . . . 74.25 109.776 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.1 mt -77.05 -20.48 55.8 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.872 0.869 . . . . 74.439999999999998 111.446 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -141.78 149.11 39.98 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.831 -0.804 . . . . 72.25 108.831 -174.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.76 146.54 46.31 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.02 -0.733 . . . . 71.439999999999998 109.02 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -151.87 108.46 3.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.691 -1.226 . . . . 65.310000000000002 107.691 -176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.7 t -79.17 138.63 19.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 107.263 -1.384 . . . . 61.140000000000001 107.263 173.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.85 125.86 25.3 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.928 0.491 . . . . 73.010000000000005 110.867 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.2 t -72.52 -17.74 61.71 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.937 0.895 . . . . 74.349999999999994 110.283 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.36 -166.72 37.39 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 115.698 -0.683 . . . . 75.219999999999999 112.129 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -64.58 -32.33 73.94 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.635 1.174 . . . . 51.229999999999997 112.059 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -69.79 -25.7 63.91 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.866 0.866 . . . . 74.349999999999994 112.05 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.1 p -103.35 160.31 14.8 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.59 0.756 . . . . 73.129999999999995 110.777 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.1 tp -109.22 130.5 55.49 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.384 0.673 . . . . 74.329999999999998 109.21 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -77.02 117.44 18.61 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 108.345 -0.984 . . . . 74.200000000000003 108.345 172.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.8 pt -119.68 138.26 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.538 0.735 . . . . 75.409999999999997 109.194 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.1 m -94.07 145.82 24.4 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.507 -0.553 . . . . 73.129999999999995 109.507 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.625 ' HZ2' ' HB3' ' A' ' 103' ' ' LYS . 7.1 ttpm? -58.2 111.86 1.34 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.619 0.368 . . . . 74.200000000000003 110.705 171.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.71 5.93 50.47 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.122 0.391 . . . . 74.010000000000005 112.627 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -87.25 137.83 32.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.24 1.016 . . . . 75.349999999999994 109.83 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.511 ' HB3' HD13 ' A' ' 84' ' ' LEU . 63.0 mttm -88.33 123.77 33.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.288 0.635 . . . . 74.420000000000002 109.825 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 21.4 mt -108.64 139.96 42.69 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.053 0.941 . . . . 74.219999999999999 110.299 -168.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.512 ' NE ' ' HB3' ' A' ' 79' ' ' GLU . 30.4 mtt180 -95.26 107.15 19.24 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 106.002 -1.851 . . . . 71.5 106.002 172.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 68.7 t -100.19 111.56 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 119.364 0.984 . . . . 72.430000000000007 109.571 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.11 -25.62 64.5 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.484 -1.235 . . . . 74.120000000000005 111.018 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.51 173.05 22.98 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.675 -0.693 . . . . 24.140000000000001 112.104 173.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 1.8 m-30 -95.23 148.93 21.88 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 106.668 -1.605 . . . . 74.099999999999994 106.668 172.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.434 HD22 ' HB2' ' A' ' 117' ' ' GLU . 29.5 p30 -66.44 167.5 10.56 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 110.25 -0.278 . . . . 74.400000000000006 110.25 173.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -56.5 -32.04 64.66 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.508 0.929 . . . . 74.349999999999994 113.508 -167.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -96.93 -2.59 43.42 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.562 0.345 . . . . 75.239999999999995 111.617 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.77 18.58 79.57 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 123.157 0.408 . . . . 62.32 113.397 174.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.434 ' HB2' HD22 ' A' ' 113' ' ' ASN . 6.0 mm-40 -65.72 -65.65 0.65 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.522 1.129 . . . . 72.510000000000005 110.136 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -122.97 152.53 40.79 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.227 -1.351 . . . . 70.299999999999997 108.291 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -115.87 127.38 54.98 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.326 1.051 . . . . 74.019999999999996 109.379 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -76.72 101.44 5.8 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.04 -0.726 . . . . 70.209999999999994 109.04 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -104.87 169.02 8.68 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.315 -0.857 . . . . 75.420000000000002 110.298 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.494 HE22 ' HA ' ' A' ' 30' ' ' GLU . 35.1 tt0 -148.08 138.24 22.7 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.219 1.008 . . . . 72.239999999999995 108.953 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 37.5 p -144.23 -171.02 3.49 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.403 1.081 . . . . 71.510000000000005 108.901 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -64.95 -16.48 63.39 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 122.971 0.508 . . . . 74.349999999999994 111.098 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -76.39 -14.11 60.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.712 0.805 . . . . 73.439999999999998 111.722 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 129.64 -137.06 9.3 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 111.866 -0.493 . . . . 74.420000000000002 111.866 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -149.91 144.21 25.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.355 0.662 . . . . 75.349999999999994 109.755 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 166.43 179.61 39.85 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-O 121.245 0.358 . . . . 61.32 113.235 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -79.85 130.79 35.6 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.09 0.956 . . . . 74.430000000000007 110.695 -176.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.7 m -124.36 146.86 53.32 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.75 1.22 . . . . 75.329999999999998 108.22 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.98 131.64 26.0 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 121.599 1.533 . . . . 71.430000000000007 110.889 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.7 m -59.22 -21.38 59.44 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.791 0.836 . . . . 75.239999999999995 111.898 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -73.16 -18.95 61.22 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.485 1.114 . . . . 63.119999999999997 112.184 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -102.18 -3.63 27.09 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.419 0.688 . . . . 75.219999999999999 112.603 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.0 pt -122.05 155.88 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 118.478 0.581 . . . . 74.230000000000004 111.134 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.1 t -153.58 136.12 9.53 Favored Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 123.309 0.381 . . . . 61.43 110.708 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -76.44 132.7 13.78 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.805 2.337 . . . . 63.350000000000001 113.163 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.1 m -109.36 -31.34 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.891 0.876 . . . . 74.109999999999999 111.741 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -97.64 0.07 46.55 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.24 0.616 . . . . 55.149999999999999 111.594 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 97.7 p -80.12 -171.0 2.74 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.835 0.826 . . . . 74.540000000000006 111.318 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.14 -9.77 12.22 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.569 1.148 . . . . 75.129999999999995 113.298 171.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -59.35 -20.57 55.72 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.252 0.834 . . . . 62.520000000000003 113.252 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.96 -8.14 52.74 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.253 0.621 . . . . 65.120000000000005 111.959 175.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -88.37 135.51 33.43 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 107.886 -1.153 . . . . 75.430000000000007 107.886 170.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.5 m -64.44 -28.0 69.37 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.584 0.754 . . . . 74.340000000000003 112.322 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -73.49 -32.15 64.12 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.117 0.414 . . . . 72.519999999999996 112.117 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -91.51 128.18 37.24 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.084 0.554 . . . . 74.239999999999995 109.572 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -121.03 2.16 10.43 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 112.303 0.483 . . . . 73.109999999999999 112.303 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.06 -155.56 33.13 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 119.584 -0.565 . . . . 75.109999999999999 114.11 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.12 101.43 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.988 2.459 . . . . 71.140000000000001 111.159 173.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.563 ' HB ' ' HD2' ' A' ' 171' ' ' ARG . 15.9 t -118.79 142.81 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 110.231 -0.285 . . . . 74.200000000000003 110.231 -173.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.6 m -73.94 161.99 29.54 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.967 0.907 . . . . 64.019999999999996 110.772 172.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -63.38 -44.59 94.31 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.234 0.614 . . . . 75.549999999999997 111.361 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -58.87 -51.89 68.1 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.071 0.948 . . . . 74.329999999999998 110.192 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.06 86.73 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.946 0.898 . . . . 44.229999999999997 111.59 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.97 -53.86 53.63 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.077 -0.965 . . . . 72.420000000000002 111.588 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.528 ' HG3' HG11 ' A' ' 190' ' ' VAL . 30.4 tt0 -70.87 -24.87 62.59 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.945 -1.025 . . . . 63.039999999999999 110.52 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -66.52 -43.22 85.83 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.143 0.577 . . . . 71.439999999999998 111.098 173.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' A' ' 238' ' ' LYS . 44.8 mt -72.85 -36.78 67.51 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.473 0.654 . . . . 72.25 110.789 175.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 183' ' ' SER . 39.5 tp -77.76 -19.81 54.48 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.223 -0.899 . . . . 72.0 112.28 -174.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 81.0 p -64.94 -26.06 68.14 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 120.861 0.362 . . . . 72.439999999999998 110.184 174.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.4 t -82.02 -5.85 58.68 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.416 1.086 . . . . 63.210000000000001 111.076 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.77 171.81 55.16 Favored Glycine 0 C--N 1.346 1.118 0 C-N-CA 122.917 0.294 . . . . 72.230000000000004 113.436 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.6 pt -133.95 -169.58 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.598 1.159 . . . . 73.120000000000005 110.09 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 18.1 p-10 -59.75 103.26 0.19 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.442 0.697 . . . . 72.409999999999997 112.435 -172.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 102.73 12.88 31.31 Favored Glycine 0 C--O 1.261 1.816 0 CA-C-N 116.184 -0.462 . . . . 71.329999999999998 113.082 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 78.7 p -79.75 137.78 37.11 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 109.991 -0.374 . . . . 72.25 109.991 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -137.01 155.91 49.1 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.282 0.563 . . . . 75.299999999999997 112.264 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.0 mt -131.74 134.22 45.64 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.994 -1.113 . . . . 74.329999999999998 107.994 170.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.409 HG22 HG21 ' A' ' 218' ' ' VAL . 52.2 t -114.0 126.25 71.45 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 108.354 -0.98 . . . . 74.310000000000002 108.354 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.563 ' HD2' ' HB ' ' A' ' 151' ' ' VAL . 17.9 mtm180 -140.32 170.19 16.27 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.741 -1.118 . . . . 64.310000000000002 109.005 -167.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 9.0 pm0 -117.4 163.5 16.28 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 108.695 -0.854 . . . . 74.340000000000003 108.695 153.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 176' ' ' SER . 48.8 m -82.68 131.92 35.19 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.434 -0.803 . . . . 75.420000000000002 110.308 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -53.6 -40.09 65.42 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.087 1.355 . . . . 73.340000000000003 112.205 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.8 t -98.49 6.25 47.33 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.558 0.743 . . . . 62.439999999999998 111.376 -174.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 173' ' ' SER . 28.8 m -147.08 86.97 6.31 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.32 0.648 . . . . 72.230000000000004 109.489 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.437 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 34.9 Cg_endo -62.58 136.73 60.17 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 123.327 2.684 . . . . 75.340000000000003 111.331 177.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.85 -24.92 5.57 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.901 -0.59 . . . . 74.439999999999998 113.306 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -84.11 116.35 22.85 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.002 -1.11 . . . . 72.239999999999995 108.002 175.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.636 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 58.2 mtt-85 -109.17 168.56 9.29 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.308 -0.86 . . . . 71.140000000000001 110.633 -170.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.4 t -155.91 145.91 21.4 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.323 0.649 . . . . 63.32 110.063 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 65.9 mt -115.94 147.91 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.587 0.755 . . . . 72.120000000000005 109.081 173.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.544 ' HB3' HD22 ' A' ' 160' ' ' LEU . 24.5 m -125.89 114.2 18.22 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.869 1.268 . . . . 73.120000000000005 108.602 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 76.7 mt -105.01 139.1 40.19 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.629 1.171 . . . . 74.5 111.448 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -120.79 132.18 54.88 Favored 'General case' 0 C--O 1.257 1.475 0 N-CA-C 107.24 -1.393 . . . . 74.140000000000001 107.24 161.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 28.5 t80 -151.94 123.6 7.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.736 -1.12 . . . . 74.400000000000006 108.678 -171.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 51.29 36.13 15.42 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.435 1.494 . . . . 74.129999999999995 112.359 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 89.23 3.34 75.83 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 114.995 -1.002 . . . . 64.349999999999994 114.088 173.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -115.02 127.73 55.83 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 117.722 0.761 . . . . 75.010000000000005 111.224 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.528 HG11 ' HG3' ' A' ' 157' ' ' GLU . 46.3 t -88.26 132.79 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 124.636 1.174 . . . . 74.409999999999997 109.854 171.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.475 ' HH ' ' HB ' ' A' ' 229' ' ' ILE . 17.4 p90 -146.39 153.35 40.38 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.118 1.367 . . . . 71.200000000000003 109.174 171.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -131.21 149.31 52.63 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.083 0.953 . . . . 75.400000000000006 109.335 -170.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -146.3 154.58 41.86 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.285 0.564 . . . . 75.099999999999994 111.713 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.496 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 20.8 tpp180 -85.75 135.26 33.82 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.761 1.224 . . . . 75.230000000000004 111.001 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.447 ' HA ' HG23 ' A' ' 205' ' ' VAL . 90.9 mt -85.69 110.27 19.45 Favored 'Isoleucine or valine' 0 C--O 1.245 0.858 0 N-CA-C 107.888 -1.153 . . . . 75.219999999999999 107.888 163.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -75.72 119.03 19.17 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.515 -0.766 . . . . 72.209999999999994 109.5 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 25.9 m -99.43 114.3 27.15 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.165 0.586 . . . . 74.450000000000003 109.892 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.02 163.18 12.72 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.198 0.999 . . . . 75.0 111.405 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 82.1 p -62.0 -24.72 67.21 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.384 0.674 . . . . 74.340000000000003 111.514 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.0 -5.79 50.1 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.145 0.978 . . . . 63.210000000000001 111.778 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 88.34 -3.97 85.35 Favored Glycine 0 C--N 1.352 1.465 0 C-N-CA 123.057 0.36 . . . . 62.219999999999999 112.56 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -74.42 142.46 44.97 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.578 0.751 . . . . 75.239999999999995 109.657 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 80.4 mt -98.05 153.57 18.31 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.672 0.789 . . . . 74.120000000000005 109.762 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -167.56 163.73 14.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.737 0.815 . . . . 64.310000000000002 109.648 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.447 HG23 ' HA ' ' A' ' 195' ' ' ILE . 71.5 t -131.92 -56.98 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 107.699 -1.223 . . . . 74.299999999999997 107.699 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 40.0 t -83.65 155.18 23.31 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.541 -0.754 . . . . 70.299999999999997 109.478 171.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.3 m -68.66 -33.63 74.32 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.309 0.643 . . . . 74.140000000000001 110.327 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -75.06 -19.11 60.15 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.302 -0.863 . . . . 72.310000000000002 111.408 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 48.0 m -104.58 127.36 52.29 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.245 1.018 . . . . 72.409999999999997 110.17 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -138.59 133.94 33.16 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.569 1.147 . . . . 75.209999999999994 108.721 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 11.2 m-85 -133.76 135.84 44.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.255 0.622 . . . . 74.019999999999996 110.639 -172.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -83.15 -30.35 27.93 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.622 0.769 . . . . 63.329999999999998 110.261 169.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 40.1 p -128.84 150.36 50.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.579 0.752 . . . . 61.420000000000002 111.502 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 38.2 tp -70.17 -31.31 68.73 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.57 -1.195 . . . . 72.349999999999994 110.824 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.87 -41.73 87.79 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.404 0.682 . . . . 74.239999999999995 110.435 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -80.85 -24.63 38.26 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.842 -0.617 . . . . 74.349999999999994 111.536 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.65 -49.06 79.04 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.728 -0.471 . . . . 74.310000000000002 109.728 168.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.409 HG21 HG22 ' A' ' 170' ' ' VAL . 76.3 t -67.29 -40.13 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.125 0.97 . . . . 64.219999999999999 110.588 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -63.94 -52.93 57.48 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.984 0.914 . . . . 71.310000000000002 111.312 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.43 ' CE1' HG11 ' A' ' 224' ' ' VAL . 26.9 t-80 -60.18 -47.79 84.47 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 115.054 -0.975 . . . . 75.310000000000002 109.086 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.466 ' HB3' ' HG ' ' A' ' 232' ' ' LEU . 7.9 m-70 -62.19 -29.6 70.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.337 0.655 . . . . 74.439999999999998 111.932 175.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 33.7 t -69.9 -26.15 64.03 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.157 0.583 . . . . 70.230000000000004 111.316 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.3 t -112.93 -11.3 13.43 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 115.902 1.815 . . . . 71.319999999999993 115.902 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 221' ' ' HIS . 24.1 m -92.47 139.4 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 120.982 1.719 . . . . 70.450000000000003 114.143 -171.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.38 -1.0 57.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.021 2.528 . . . . 65.409999999999997 112.295 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -79.22 15.87 1.1 Allowed 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 127.621 2.368 . . . . 74.219999999999999 112.009 -145.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 117.58 19.62 4.91 Favored Glycine 0 C--O 1.245 0.825 0 C-N-CA 125.028 1.299 . . . . 71.239999999999995 112.403 -172.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 52.0 mt -90.87 121.67 32.92 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.145 -1.028 . . . . 75.329999999999998 109.124 158.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.475 ' HB ' ' HH ' ' A' ' 191' ' ' TYR . 59.4 mt -53.0 -43.09 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 124.357 1.035 . . . . 73.230000000000004 110.307 173.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.1 t -133.14 142.77 48.84 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.428 -0.805 . . . . 73.219999999999999 109.172 171.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 41.6 p -70.14 145.39 51.59 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.684 -0.858 . . . . 61.140000000000001 108.684 166.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.466 ' HG ' ' HB3' ' A' ' 221' ' ' HIS . 21.2 mt -61.76 102.67 0.28 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.049 -0.723 . . . . 74.329999999999998 109.049 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 -87.1 -54.34 4.38 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.29 -0.633 . . . . 72.519999999999996 109.29 -171.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.582 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -157.58 150.12 17.97 Favored Pre-proline 0 N--CA 1.487 1.385 0 C-N-CA 123.503 0.721 . . . . 61.310000000000002 111.443 -177.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.99 145.55 45.2 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 121.903 1.735 . . . . 73.109999999999999 112.402 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.19 131.79 82.91 Favored Pre-proline 0 C--O 1.243 0.751 0 N-CA-C 109.199 -0.667 . . . . 72.540000000000006 109.199 173.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.1 147.45 54.37 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 121.874 1.716 . . . . 72.340000000000003 111.63 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HA ' HD21 ' A' ' 159' ' ' LEU . 38.6 ttpt -69.69 158.45 35.34 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.296 -0.865 . . . . 75.319999999999993 109.344 171.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -38.43 -47.36 1.25 Allowed 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 125.275 1.43 . . . . 74.329999999999998 113.081 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -124.9 111.81 15.89 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 107.409 -1.33 . . . . 62.100000000000001 107.409 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -170.5 110.13 0.44 Allowed Pre-proline 0 N--CA 1.476 0.858 0 N-CA-C 108.558 -0.904 . . . . 73.329999999999998 108.558 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.51 137.27 18.28 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.444 2.096 . . . . 70.109999999999999 111.851 176.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 9.5 t -145.27 159.41 43.06 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.923 0.889 . . . . 74.209999999999994 110.305 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.8 p -143.75 117.65 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.173 0.989 . . . . 73.450000000000003 109.291 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -149.05 132.89 17.01 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.776 1.23 . . . . 72.430000000000007 108.745 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -148.0 147.42 18.05 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 111.334 -0.706 . . . . 73.340000000000003 111.334 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.89 146.91 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.633 0.773 . . . . 74.209999999999994 109.186 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 42.0 p -121.42 84.28 41.45 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.174 0.99 . . . . 72.129999999999995 108.634 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.79 95.27 1.07 Allowed 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.185 2.59 . . . . 75.450000000000003 112.137 -175.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.9 116.54 23.39 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.484 0.714 . . . . 75.340000000000003 110.392 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -134.37 141.95 47.03 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.723 0.809 . . . . 65.129999999999995 109.57 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.48 -61.68 1.82 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.996 -0.742 . . . . 62.409999999999997 108.996 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -177.63 79.29 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.446 1.098 . . . . 72.230000000000004 109.071 171.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -71.86 122.19 20.32 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.755 -0.657 . . . . 71.129999999999995 110.016 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--O 1.254 1.293 0 CA-C-O 118.748 -0.644 . . . . 74.540000000000006 109.432 -174.833 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.6 mmm . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.01 -0.737 . . . . 61.009999999999998 109.01 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.94 -130.01 1.25 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-O 118.791 -1.005 . . . . 71.129999999999995 110.646 -176.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 56.94 -1.76 0.05 Allowed 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 126.864 2.066 . . . . 75.400000000000006 115.692 176.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.74 115.07 65.77 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.485 0.714 . . . . 74.530000000000001 109.459 -175.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.4 -39.58 45.36 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 121.958 1.772 . . . . 73.420000000000002 110.83 169.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.6 -67.68 3.68 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 115.487 -0.779 . . . . 64.530000000000001 113.443 169.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -123.45 159.84 28.15 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.466 0.651 . . . . 71.530000000000001 112.235 -170.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.91 146.0 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 106.719 -1.585 . . . . 72.230000000000004 106.719 164.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.42 -173.11 4.1 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.578 0.351 . . . . 74.319999999999993 110.918 -172.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.88 24.57 29.63 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.995 -0.548 . . . . 53.229999999999997 111.773 -172.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -91.86 -167.9 1.89 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.391 1.076 . . . . 63.329999999999998 110.688 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -80.09 -161.05 0.32 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.003 0.921 . . . . 75.239999999999995 112.715 -170.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -44.96 133.33 6.4 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 124.545 1.138 . . . . 75.329999999999998 111.671 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 60.91 80.89 0.25 Allowed Pre-proline 0 N--CA 1.479 0.979 0 O-C-N 124.197 0.936 . . . . 73.209999999999994 109.037 -169.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.74 165.42 16.06 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.22 1.947 . . . . 64.040000000000006 111.828 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 54.3 m -68.24 168.04 13.14 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 121.547 0.689 . . . . 72.519999999999996 112.612 -171.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.4 mt -103.05 125.83 34.13 Favored Pre-proline 0 C--O 1.239 0.511 0 N-CA-C 108.041 -1.096 . . . . 74.310000000000002 108.041 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.52 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 39.2 Cg_endo -69.57 171.58 14.01 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.367 2.045 . . . . 64.430000000000007 113.602 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.29 140.07 31.11 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.178 0.591 . . . . 74.140000000000001 111.39 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.449 HD23 HD13 ' A' ' 23' ' ' ILE . 78.4 mt -88.65 91.99 9.02 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.078 -1.082 . . . . 74.209999999999994 108.078 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -98.99 -43.5 6.67 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.383 -0.826 . . . . 73.120000000000005 109.81 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -103.34 108.61 19.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.474 -0.785 . . . . 55.020000000000003 109.714 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.449 HD13 HD23 ' A' ' 20' ' ' LEU . 41.7 mm -118.05 121.32 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 107.566 -1.272 . . . . 74.200000000000003 107.566 172.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -132.05 159.08 39.85 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.592 0.757 . . . . 75.319999999999993 110.988 -176.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.71 -172.9 13.5 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 114.599 -1.182 . . . . 51.149999999999999 111.001 173.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 64.02 11.83 6.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.395 1.078 . . . . 73.209999999999994 113.204 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.62 124.57 7.62 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 109.953 -1.259 . . . . 51.530000000000001 109.953 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -169.4 -46.46 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 117.82 0.81 . . . . 75.140000000000001 111.158 -170.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 65.44 21.8 11.88 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.81 1.244 . . . . 75.310000000000002 110.475 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 50.89 28.26 3.63 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.126 0.97 . . . . 72.109999999999999 112.232 -172.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.9 t -75.07 -11.84 60.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.711 0.404 . . . . 65.409999999999997 110.652 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.5 p -64.66 82.56 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.853 0.861 . . . . 73.430000000000007 110.782 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -91.98 124.05 35.8 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 108.365 -0.976 . . . . 72.200000000000003 108.365 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -52.24 139.2 24.49 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 124.473 1.108 . . . . 71.230000000000004 112.883 -168.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.521 ' HA2' ' HE3' ' A' ' 124' ' ' LYS . . . -67.77 -86.21 0.09 OUTLIER Glycine 0 C--N 1.346 1.132 0 O-C-N 123.878 0.736 . . . . 62.350000000000001 113.331 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.69 175.98 23.19 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.426 -0.652 . . . . 75.409999999999997 112.273 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.85 97.63 0.4 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 123.523 2.815 . . . . 64.530000000000001 112.793 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -169.21 20.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.233 1.413 . . . . 72.430000000000007 109.075 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 61.7 m -72.12 110.64 6.73 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.428 1.091 . . . . 71.239999999999995 112.158 -167.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -79.21 75.41 5.76 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.761 0.791 . . . . 72.409999999999997 109.485 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.7 m -78.07 128.0 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 115.409 -0.814 . . . . 73.239999999999995 110.774 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -130.83 90.22 2.87 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.833 0.853 . . . . 72.510000000000005 108.993 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.7 m -99.45 123.44 52.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 109.42 -0.585 . . . . 71.439999999999998 109.42 172.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.59 141.86 32.87 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.768 -0.826 . . . . 75.120000000000005 108.768 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -92.22 7.76 41.16 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 122.886 0.474 . . . . 73.5 112.069 -171.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -75.54 83.49 2.59 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.289 -0.634 . . . . 75.430000000000007 109.289 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.68 96.48 2.25 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.933 0.893 . . . . 73.329999999999998 109.504 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.8 mt -99.21 108.9 21.6 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.104 -0.702 . . . . 75.120000000000005 109.104 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -73.73 89.06 1.77 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.448 0.699 . . . . 73.219999999999999 111.562 -174.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -72.98 -49.4 7.43 Favored Pre-proline 0 CA--C 1.562 1.442 0 CA-C-N 115.507 -0.769 . . . . 73.129999999999995 111.037 173.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.27 71.99 6.76 Favored 'Trans proline' 0 C--N 1.392 2.839 0 C-N-CA 121.763 1.642 . . . . 73.329999999999998 112.026 176.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.13 136.78 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 115.372 -0.831 . . . . 74.530000000000001 108.981 175.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.86 145.89 49.57 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.763 0.825 . . . . 72.430000000000007 110.191 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -103.46 90.96 3.85 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.071 -0.714 . . . . 72.209999999999994 109.071 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.85 110.61 15.38 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.164 -0.925 . . . . 54.229999999999997 111.237 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -68.06 145.6 54.29 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.606 0.762 . . . . 72.530000000000001 109.813 173.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 59.72 69.27 1.29 Allowed Pre-proline 0 CA--C 1.564 1.512 0 C-N-CA 123.829 0.851 . . . . 74.540000000000006 110.425 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -85.79 49.52 2.36 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 123.493 2.796 . . . . 64.219999999999999 112.413 -176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -60.85 135.01 57.65 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.63 0.772 . . . . 72.420000000000002 111.554 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.04 141.41 8.04 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.688 -0.965 . . . . 70.230000000000004 110.688 -172.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.9 mt -97.16 73.07 2.48 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.142 -0.688 . . . . 74.140000000000001 109.142 -177.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.3 t -74.28 141.19 45.32 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.752 -1.113 . . . . 74.420000000000002 110.956 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -154.72 154.09 32.32 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.893 0.877 . . . . 74.430000000000007 110.523 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.08 140.72 31.02 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.118 0.967 . . . . 71.349999999999994 109.66 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -117.71 113.73 22.3 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.41 0.684 . . . . 73.109999999999999 110.666 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.6 74.33 2.77 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.989 0.916 . . . . 74.409999999999997 108.561 175.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -90.96 116.2 28.57 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.485 -0.78 . . . . 62.130000000000003 110.329 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -98.81 89.76 4.44 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.022 0.929 . . . . 71.420000000000002 109.202 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.0 p -142.85 95.22 2.74 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.013 -0.736 . . . . 64.200000000000003 109.013 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.0 tttm -79.18 140.53 37.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.254 1.021 . . . . 75.010000000000005 110.747 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -97.75 151.48 20.11 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 122.935 0.494 . . . . 74.120000000000005 110.104 172.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -73.11 144.86 46.82 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.774 -0.824 . . . . 71.150000000000006 108.774 174.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.08 88.65 0.17 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.367 0.667 . . . . 75.299999999999997 110.314 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.5 mt -80.57 138.44 36.48 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.545 0.738 . . . . 74.510000000000005 110.187 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.26 167.54 20.18 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 123.804 0.69 . . . . 73.319999999999993 110.45 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.61 120.31 0.97 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-O 118.077 -1.402 . . . . 51.020000000000003 110.615 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.36 111.14 0.73 Allowed 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.081 2.521 . . . . 74.510000000000005 111.68 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.0 p -126.98 113.14 16.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.467 0.707 . . . . 74.230000000000004 111.51 -170.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -164.38 103.36 0.84 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.556 -0.905 . . . . 75.209999999999994 108.556 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -128.0 -51.38 1.33 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.615 0.766 . . . . 75.230000000000004 110.283 -177.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.2 142.74 41.36 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 124.165 0.986 . . . . 65.209999999999994 110.195 -170.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.03 -46.27 10.82 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.673 2.249 . . . . 64.019999999999996 111.322 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.449 ' HA ' ' HB2' ' A' ' 140' ' ' SER . 82.3 m-20 -87.76 66.67 8.91 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.686 0.755 . . . . 75.510000000000005 109.461 176.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.408 HD21 ' HD2' ' A' ' 106' ' ' LYS . 40.1 tp -92.32 125.84 37.15 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 108.168 -1.049 . . . . 74.439999999999998 108.168 175.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 4.5 m-85 -104.0 175.46 5.48 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.583 1.153 . . . . 74.530000000000001 109.556 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 p -145.04 141.34 22.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 108.779 -0.823 . . . . 72.219999999999999 108.779 171.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -77.93 108.7 11.38 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.082 -0.711 . . . . 72.329999999999998 109.082 173.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.54 -26.51 66.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.901 0.881 . . . . 74.010000000000005 111.212 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -126.98 155.89 42.44 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.961 0.904 . . . . 74.25 109.127 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -69.81 145.46 52.12 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.37 -0.832 . . . . 73.230000000000004 109.485 169.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -153.3 108.47 3.21 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.497 -0.927 . . . . 63.240000000000002 108.497 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 52.8 t -81.56 131.95 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.952 -1.129 . . . . 70.310000000000002 107.952 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.84 136.62 57.95 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.454 0.472 . . . . 72.109999999999999 110.896 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.5 t -62.31 -25.06 67.66 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.696 0.798 . . . . 75.340000000000003 109.824 172.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.51 -133.42 3.75 Favored Glycine 0 C--N 1.353 1.513 0 CA-C-N 115.557 -0.747 . . . . 43.32 112.305 172.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.06 -25.86 66.46 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.785 1.234 . . . . 74.430000000000007 111.926 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -79.87 -11.28 59.82 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.381 1.072 . . . . 75.329999999999998 112.511 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.8 p -137.74 169.7 17.34 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.574 0.75 . . . . 44.420000000000002 111.441 -171.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.9 tp -115.65 134.72 54.76 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.933 0.893 . . . . 74.019999999999996 109.781 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.0 t -85.59 117.33 24.42 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.829 -0.804 . . . . 65.239999999999995 108.829 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.4 pt -119.51 131.94 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.648 0.779 . . . . 74.230000000000004 109.52 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.436 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 50.3 m -90.34 146.42 24.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.375 0.67 . . . . 72.209999999999994 110.111 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -52.94 112.95 0.94 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 122.84 0.456 . . . . 64.230000000000004 110.408 164.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 106.27 -13.12 44.17 Favored Glycine 0 N--CA 1.472 1.082 0 CA-C-N 116.701 -0.227 . . . . 44.119999999999997 112.901 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -76.67 126.96 31.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.183 0.993 . . . . 72.409999999999997 109.462 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HD2' HD21 ' A' ' 84' ' ' LEU . 31.8 mtmm -90.2 133.03 35.16 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.157 0.583 . . . . 71.140000000000001 110.733 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.8 mt -116.71 150.0 38.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.911 0.884 . . . . 75.409999999999997 110.731 -161.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -102.58 109.02 20.5 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.642 -0.873 . . . . 71.430000000000007 108.642 169.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.6 t -87.66 106.25 16.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 108.571 -0.9 . . . . 65.129999999999995 108.571 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 76.2 mt -72.4 -31.49 65.58 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 115.375 -0.83 . . . . 72.430000000000007 109.441 176.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.31 -174.61 42.96 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.093 -0.958 . . . . 73.420000000000002 111.259 172.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.3 m-30 -113.31 174.08 6.09 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.539 0.736 . . . . 74.209999999999994 109.427 167.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -64.95 145.99 55.57 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.066 -1.087 . . . . 74.540000000000006 108.066 166.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -65.22 -29.91 70.76 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.355 0.662 . . . . 73.450000000000003 111.62 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -85.95 -5.98 59.14 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.633 0.773 . . . . 73.310000000000002 111.253 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.17 33.07 41.51 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.805 -0.634 . . . . 63.100000000000001 113.274 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . 29.8 mt-10 -89.34 -73.09 0.52 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.129 0.572 . . . . 64.439999999999998 110.117 -177.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -100.53 -178.87 3.93 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.69 0.796 . . . . 75.310000000000002 109.64 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.28 117.91 22.33 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.165 0.986 . . . . 73.540000000000006 108.854 -177.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.62 92.72 1.17 Allowed 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.555 -1.276 . . . . 72.450000000000003 107.555 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -112.24 164.08 13.62 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.873 0.844 . . . . 74.239999999999995 111.111 -171.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -151.67 138.74 19.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.522 -1.217 . . . . 74.25 108.254 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 43.4 p -132.21 175.93 8.83 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.633 0.773 . . . . 64.340000000000003 109.638 171.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.521 ' HE3' ' HA2' ' A' ' 35' ' ' GLY . 25.7 mtpp -70.53 -6.66 37.96 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 121.212 0.53 . . . . 74.230000000000004 110.168 174.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -89.33 -18.93 25.95 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.823 1.249 . . . . 75.239999999999995 111.217 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 154.91 -148.14 18.14 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 118.041 0.382 . . . . 75.420000000000002 113.034 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -151.15 157.25 42.47 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.44 0.62 . . . . 74.129999999999995 110.295 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 153.25 -171.17 32.18 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 122.966 0.317 . . . . 75.530000000000001 112.494 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -91.34 133.7 35.22 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.065 0.546 . . . . 65.299999999999997 110.53 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.31 156.19 72.9 Favored Pre-proline 0 N--CA 1.479 1.025 0 C-N-CA 124.484 1.114 . . . . 74.439999999999998 109.43 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.36 123.91 11.07 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.063 1.842 . . . . 42.439999999999998 110.92 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.4 m -59.41 -22.09 60.92 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.679 0.792 . . . . 75.310000000000002 111.47 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -73.33 -23.26 60.22 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.571 1.148 . . . . 75.030000000000001 111.719 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -94.58 -4.17 48.36 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.671 0.788 . . . . 72.420000000000002 112.393 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.4 pt -123.08 151.74 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 118.363 0.529 . . . . 73.420000000000002 110.397 -172.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.0 t -145.16 135.45 11.93 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.019 0.528 . . . . 55.229999999999997 109.639 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.543 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 59.3 Cg_endo -74.18 115.17 4.23 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.334 2.023 . . . . 72.530000000000001 111.938 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.1 m -87.64 -54.62 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.023 0.529 . . . . 74.420000000000002 111.028 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -80.97 -18.29 47.47 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.329 0.651 . . . . 73.519999999999996 111.308 -171.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.543 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 32.8 t -71.34 -179.87 2.63 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.609 0.763 . . . . 73.209999999999994 111.228 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.51 -14.6 43.63 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.406 1.082 . . . . 64.549999999999997 113.266 -174.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.86 -25.55 67.6 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.979 0.512 . . . . 73.340000000000003 111.63 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.14 -26.53 62.79 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.286 1.034 . . . . 73.430000000000007 111.337 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -78.86 169.6 17.97 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.918 0.887 . . . . 71.140000000000001 111.764 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.5 p -84.58 -26.18 28.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.364 0.666 . . . . 75.329999999999998 112.097 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . 0.446 ' CE3' HG23 ' A' ' 218' ' ' VAL . 55.3 p-90 -83.89 -42.36 16.43 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.066 -0.515 . . . . 72.099999999999994 111.485 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -95.42 126.36 40.67 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.847 -0.797 . . . . 75.329999999999998 108.847 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -110.57 5.3 21.03 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.8 -0.637 . . . . 75.120000000000005 111.259 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.82 -155.09 36.58 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.475 -0.625 . . . . 74.040000000000006 113.418 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.75 106.07 1.77 Allowed 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 123.196 2.597 . . . . 53.310000000000002 110.408 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.3 t -128.39 150.54 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 123.631 0.773 . . . . 63.32 109.154 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.2 t -86.3 167.27 14.95 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.849 0.86 . . . . 52.439999999999998 110.066 173.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -63.71 -33.33 75.41 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.33 0.652 . . . . 73.420000000000002 111.903 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -67.52 -55.21 14.42 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.291 0.636 . . . . 72.150000000000006 110.284 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.42 -37.37 80.66 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.965 0.79 . . . . 74.519999999999996 111.226 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.54 -57.54 12.24 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.66 -0.7 . . . . 71.420000000000002 110.849 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.51 -21.12 63.69 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.359 -0.837 . . . . 74.310000000000002 111.118 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -68.22 -53.25 26.08 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.687 0.795 . . . . 75.420000000000002 110.591 174.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.429 ' HB2' HD13 ' A' ' 169' ' ' LEU . 74.6 mt -68.06 -37.33 81.18 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.946 -0.57 . . . . 75.430000000000007 110.957 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.8 tp -73.51 -22.48 60.11 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.381 -0.827 . . . . 74.230000000000004 111.349 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.9 t -59.76 -26.84 66.03 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.48 0.712 . . . . 61.030000000000001 111.787 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.8 m -79.16 9.66 4.3 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.363 1.065 . . . . 62.539999999999999 112.246 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.04 159.24 14.46 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 122.98 0.324 . . . . 73.329999999999998 113.53 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.1 pt -115.57 -164.47 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.347 1.059 . . . . 75.219999999999999 109.859 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.661 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 17.4 p-10 -52.65 99.62 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.516 1.126 . . . . 63.020000000000003 113.142 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 107.85 13.71 19.31 Favored Glycine 0 C--N 1.355 1.632 0 CA-C-N 116.174 -0.466 . . . . 44.399999999999999 113.538 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.452 ' OG ' ' HB3' ' A' ' 185' ' ' ARG . 37.9 p -79.0 137.45 37.59 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.998 -0.707 . . . . 74.400000000000006 109.98 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.482 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 27.1 p90 -134.08 160.7 36.97 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 112.452 0.538 . . . . 74.209999999999994 112.452 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.451 HD21 ' HB1' ' A' ' 236' ' ' ALA . 82.4 mt -134.65 134.15 40.85 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.337 1.055 . . . . 72.219999999999999 108.292 166.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 32.3 t -106.14 128.45 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.113 -1.44 . . . . 70.120000000000005 107.113 171.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -158.43 161.11 37.45 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.908 0.483 . . . . 74.129999999999995 110.07 -174.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.68 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 12.5 pt-20 -109.21 161.62 15.06 Favored 'General case' 0 C--O 1.244 0.812 0 O-C-N 123.409 0.443 . . . . 64.040000000000006 109.806 169.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.2 m -83.41 135.53 34.66 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.627 -0.715 . . . . 70.319999999999993 109.395 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -71.19 -41.86 69.74 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.388 0.675 . . . . 64.340000000000003 110.213 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 25.0 m -78.57 -17.16 56.55 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.115 -0.948 . . . . 72.329999999999998 111.431 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 28.3 t -130.49 80.9 69.33 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.423 -0.954 . . . . 73.010000000000005 108.423 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.24 141.44 93.19 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.621 2.881 . . . . 53.140000000000001 112.837 -173.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 77.66 -23.07 2.55 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 116.208 -0.451 . . . . 72.010000000000005 114.071 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -84.25 116.38 22.94 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 108.177 -1.045 . . . . 72.129999999999995 108.177 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.68 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 44.5 mtt180 -110.88 169.78 8.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.168 -0.923 . . . . 75.329999999999998 111.209 -168.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.401 ' HB2' ' HD3' ' A' ' 194' ' ' ARG . 47.8 t -154.59 144.38 21.63 Favored 'General case' 0 C--O 1.253 1.244 0 C-N-CA 124.982 1.313 . . . . 74.409999999999997 108.722 -176.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.461 HD13 HD22 ' A' ' 217' ' ' LEU . 58.6 mt -109.33 135.38 48.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 107.221 -1.4 . . . . 74.450000000000003 107.221 166.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 19.3 m -112.26 114.06 26.63 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.229 -1.026 . . . . 75.420000000000002 108.229 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.3 mt -105.14 144.31 32.11 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.107 0.963 . . . . 74.310000000000002 111.035 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.452 ' HB3' ' OG ' ' A' ' 167' ' ' SER . 27.1 ttt85 -132.74 133.27 43.26 Favored 'General case' 0 C--O 1.259 1.579 0 CA-C-N 114.357 -1.292 . . . . 74.010000000000005 108.895 175.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.661 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 28.2 p90 -148.1 138.83 23.06 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 124.616 1.198 . . . . 71.209999999999994 108.804 171.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 58.58 19.1 6.34 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.934 1.293 . . . . 75.310000000000002 113.534 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.62 21.1 69.95 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 116.626 -0.261 . . . . 71.420000000000002 112.814 -175.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -118.16 126.9 53.14 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.511 1.125 . . . . 70.420000000000002 108.553 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 51.4 t -119.04 141.88 36.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 124.13 0.972 . . . . 72.200000000000003 110.722 -168.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.566 ' HH ' HG23 ' A' ' 230' ' ' THR . 18.2 p90 -145.19 151.13 37.94 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.507 1.123 . . . . 74.140000000000001 109.403 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -126.36 115.39 19.58 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 107.918 -1.141 . . . . 71.409999999999997 107.918 -173.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -117.46 132.63 56.52 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.637 -0.505 . . . . 64.409999999999997 109.637 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.401 ' HD3' ' HB2' ' A' ' 181' ' ' SER . 10.8 mmt85 -72.68 131.5 42.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.777 0.831 . . . . 75.340000000000003 112.07 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 82.0 mt -71.45 110.63 4.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 108.107 -1.071 . . . . 74.239999999999995 108.107 163.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -69.33 120.92 15.88 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.274 -0.875 . . . . 62.100000000000001 108.641 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.4 m -103.47 110.64 22.75 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 122.969 0.508 . . . . 64.420000000000002 109.804 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.404 ' HB1' ' HE1' ' A' ' 204' ' ' TYR . . . -61.38 156.53 18.82 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.959 0.904 . . . . 65.409999999999997 111.606 172.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.1 m -71.22 -12.47 61.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.707 0.803 . . . . 73.099999999999994 112.196 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -86.55 12.38 10.59 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.468 0.707 . . . . 72.019999999999996 111.16 171.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 75.05 4.91 74.1 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 123.179 0.419 . . . . 73.239999999999995 113.266 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -81.64 140.06 34.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.605 0.762 . . . . 73.409999999999997 109.991 -175.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.497 HD11 HD11 ' A' ' 214' ' ' LEU . 85.8 mt -103.13 147.29 27.19 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.515 0.726 . . . . 65.0 109.481 -175.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.404 ' HE1' ' HB1' ' A' ' 198' ' ' ALA . 28.7 p90 -167.49 177.39 5.99 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.118 0.967 . . . . 74.420000000000002 110.819 173.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 74.9 t -131.3 -54.89 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 107.452 -1.314 . . . . 75.049999999999997 107.452 174.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 12.1 t -86.08 153.55 22.03 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.916 -1.038 . . . . 62.149999999999999 108.961 172.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.1 t -68.88 -25.58 64.68 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.728 0.411 . . . . 71.109999999999999 110.424 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.75 -34.13 62.45 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.568 -0.742 . . . . 73.540000000000006 110.492 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.446 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 74.8 m -64.32 126.32 27.4 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.528 0.731 . . . . 62.350000000000001 109.28 172.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -144.65 112.56 6.32 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.202 1.001 . . . . 74.349999999999994 108.645 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.446 ' CE2' ' HB3' ' A' ' 209' ' ' SER . 17.4 m-85 -129.66 142.76 50.67 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 118.683 0.674 . . . . 74.519999999999996 111.315 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -90.58 -22.51 21.22 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.382 0.673 . . . . 74.409999999999997 109.66 172.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.0 p -129.87 147.02 51.59 Favored 'General case' 0 C--O 1.253 1.272 0 CA-C-O 122.182 0.992 . . . . 71.109999999999999 111.459 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.497 HD11 HD11 ' A' ' 203' ' ' LEU . 27.1 tp -67.23 -29.02 68.56 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 114.047 -1.433 . . . . 73.140000000000001 110.841 177.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.46 90.51 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.487 0.715 . . . . 72.540000000000006 111.029 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -66.53 -37.98 86.19 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.545 -0.752 . . . . 74.239999999999995 110.762 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.461 HD22 HD13 ' A' ' 182' ' ' ILE . 9.2 tt -55.64 -47.53 76.5 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.885 0.74 . . . . 74.109999999999999 111.486 174.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.446 HG23 ' CE3' ' A' ' 146' ' ' TRP . 70.4 t -70.53 -44.04 77.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 123.262 0.625 . . . . 73.329999999999998 111.263 -175.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -59.72 -49.63 76.98 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.632 0.73 . . . . 74.129999999999995 110.577 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -56.6 -56.47 20.88 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.961 -1.018 . . . . 72.439999999999998 109.684 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.456 ' HA ' HG21 ' A' ' 224' ' ' VAL . 36.0 m80 -67.32 -16.74 64.43 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.168 0.433 . . . . 73.340000000000003 112.168 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.442 ' HA ' ' HB2' ' A' ' 232' ' ' LEU . 35.9 t -73.59 -31.57 63.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.555 0.342 . . . . 74.510000000000005 111.047 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.6 t -112.04 -6.62 14.17 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.27 1.952 . . . . 64.430000000000007 116.27 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 221' ' ' HIS . 33.8 m -104.21 158.4 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 116.199 1.925 . . . . 75.099999999999994 116.199 -171.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -90.89 -0.99 57.88 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 129.25 3.02 . . . . 54.0 113.543 -175.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -77.9 14.98 0.95 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 128.734 2.814 . . . . 71.409999999999997 113.766 -141.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.77 18.78 3.87 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 124.571 1.081 . . . . 43.420000000000002 111.817 -168.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.91 135.37 33.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.957 0.903 . . . . 73.239999999999995 110.555 167.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.48 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 85.8 mt -72.96 -34.86 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 109.321 -0.622 . . . . 75.120000000000005 109.321 171.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.566 HG23 ' HH ' ' A' ' 191' ' ' TYR . 7.8 t -143.25 142.24 31.31 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.59 -0.893 . . . . 73.219999999999999 108.59 168.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 67.8 p -67.92 147.48 52.43 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.802 -0.814 . . . . 73.209999999999994 108.802 171.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.482 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 28.6 mt -62.68 99.91 0.17 Allowed 'General case' 0 CA--C 1.555 1.147 0 N-CA-C 108.89 -0.781 . . . . 64.129999999999995 108.89 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -81.8 -50.93 8.66 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.702 0.401 . . . . 72.209999999999994 110.277 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -156.76 148.37 17.1 Favored Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 120.689 -0.405 . . . . 74.010000000000005 110.191 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.05 138.78 20.96 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 121.843 1.696 . . . . 64.310000000000002 111.97 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . 0.451 ' HB1' HD21 ' A' ' 169' ' ' LEU . . . -67.67 140.63 94.53 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 108.793 -0.817 . . . . 74.400000000000006 108.793 171.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.77 156.4 64.23 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.833 2.356 . . . . 64.439999999999998 114.67 -164.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -72.18 159.9 33.34 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.567 -1.197 . . . . 72.310000000000002 109.898 170.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -53.46 -39.6 64.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 123.674 0.609 . . . . 72.510000000000005 111.058 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -120.25 119.82 34.3 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.366 -0.976 . . . . 74.400000000000006 108.366 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -87.09 107.77 15.96 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.646 -0.872 . . . . 74.530000000000001 108.646 171.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -88.57 14.57 2.26 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.727 2.284 . . . . 74.129999999999995 112.674 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 9.1 t -154.02 151.04 28.89 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.729 0.812 . . . . 74.400000000000006 110.561 -176.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.83 105.66 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 125.291 1.436 . . . . 74.510000000000005 107.853 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -159.84 145.58 15.64 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.275 0.63 . . . . 73.5 110.036 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -169.53 116.75 0.67 Allowed Glycine 0 C--N 1.348 1.209 0 N-CA-C 112.151 -0.38 . . . . 62.229999999999997 112.151 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 80.6 t -117.58 132.36 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.613 1.165 . . . . 71.209999999999994 108.322 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.1 t -103.71 95.82 8.06 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 123.511 0.724 . . . . 64.329999999999998 109.931 176.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.03 122.15 2.17 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.069 2.512 . . . . 62.399999999999999 111.594 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.65 139.35 34.48 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.25 0.62 . . . . 74.400000000000006 109.432 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -137.39 103.06 4.97 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.858 0.863 . . . . 75.239999999999995 109.538 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -81.88 166.46 19.91 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.999 0.52 . . . . 73.420000000000002 109.753 170.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -156.69 141.75 17.21 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.743 0.417 . . . . 75.099999999999994 110.158 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -84.35 167.21 16.74 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.095 0.958 . . . . 73.129999999999995 111.527 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.247 0.965 0 N-CA-C 107.587 -1.264 . . . . 75.219999999999999 107.587 177.95 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mmm . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 109.19 -0.67 . . . . 70.310000000000002 109.19 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.13 120.57 6.57 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 116.004 -0.544 . . . . 70.310000000000002 112.443 -174.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.576 ' HB2' ' HG3' ' A' ' 194' ' ' ARG . 63.0 mt-30 -132.32 152.9 51.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.525 0.73 . . . . 72.129999999999995 109.078 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -132.2 91.31 32.16 Favored Pre-proline 0 N--CA 1.482 1.125 0 N-CA-C 108.704 -0.85 . . . . 73.430000000000007 108.704 173.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.64 -37.71 86.21 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 123.029 2.486 . . . . 64.25 112.549 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.5 138.75 2.53 Favored Glycine 0 C--O 1.245 0.813 0 CA-C-N 115.039 -0.982 . . . . 74.5 111.374 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.539 ' HZ3' ' HB3' ' A' ' 7' ' ' LYS . 6.0 ttpm? -69.76 119.27 13.74 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 109.159 -0.682 . . . . 71.129999999999995 109.159 174.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.573 HG11 ' HB3' ' A' ' 152' ' ' SER . 8.3 p -138.93 160.78 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 N-CA-C 108.427 -0.953 . . . . 75.329999999999998 108.427 -173.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 tt -163.21 101.64 0.96 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 107.565 -1.272 . . . . 74.439999999999998 107.565 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.35 -2.16 26.22 Favored Glycine 0 N--CA 1.473 1.127 0 O-C-N 123.457 0.473 . . . . 64.5 113.671 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -82.66 91.97 7.08 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.865 0.84 . . . . 71.299999999999997 110.228 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -141.78 163.56 32.56 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.12 0.968 . . . . 75.310000000000002 108.747 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.487 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 40.7 ttm180 -80.61 108.47 14.28 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.61 -1.256 . . . . 74.230000000000004 107.61 167.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 53.06 78.63 0.38 Allowed Pre-proline 0 CA--C 1.545 0.754 0 O-C-N 124.001 0.813 . . . . 75.239999999999995 111.739 -167.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.68 ' HG2' ' HB3' ' A' ' 133' ' ' ASN . 4.7 Cg_exo -75.76 165.39 30.27 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 122.764 2.31 . . . . 74.109999999999999 110.369 172.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.7 p -70.98 169.16 15.48 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.312 0.577 . . . . 72.049999999999997 111.116 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 94.6 mt -104.98 131.65 21.59 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.884 -0.598 . . . . 75.120000000000005 109.432 -176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 17' ' ' LEU . 8.2 Cg_exo -69.13 171.83 13.08 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.102 2.535 . . . . 62.340000000000003 112.267 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.56 149.15 25.56 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.867 0.467 . . . . 74.099999999999994 110.401 170.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.442 HD13 ' ND2' ' A' ' 97' ' ' ASN . 84.8 mt -86.05 94.2 9.18 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.938 -1.134 . . . . 75.140000000000001 107.938 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -97.31 -52.9 3.65 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.632 0.373 . . . . 75.319999999999993 110.948 -176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -105.16 102.87 12.33 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.925 -1.139 . . . . 74.040000000000006 107.925 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.441 HD11 HD23 ' A' ' 20' ' ' LEU . 48.0 mm -126.1 111.57 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.923 -0.769 . . . . 73.209999999999994 108.923 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.82 -54.17 0.01 OUTLIER 'General case' 0 C--O 1.247 0.934 0 O-C-N 124.352 1.033 . . . . 71.540000000000006 108.714 173.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.93 -159.59 3.39 Favored Glycine 0 C--N 1.355 1.605 0 CA-C-O 118.852 -0.971 . . . . 53.240000000000002 113.423 -173.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 42.76 81.32 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.7 1.2 . . . . 73.439999999999998 113.252 171.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.4 -35.83 0.02 OUTLIER Glycine 0 N--CA 1.467 0.732 0 O-C-N 123.161 0.288 . . . . 61.210000000000001 112.604 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.41 175.37 10.67 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.918 0.487 . . . . 72.519999999999996 110.725 177.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.2 ptt85 -52.7 122.16 8.55 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.725 0.81 . . . . 75.409999999999997 111.723 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.84 127.79 33.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.858 0.863 . . . . 72.030000000000001 110.404 -174.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.3 p -56.41 -52.53 64.27 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.345 1.058 . . . . 72.430000000000007 111.889 -174.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.2 t -120.99 109.48 15.11 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.92 -1.141 . . . . 74.400000000000006 107.92 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.555 ' HD2' ' HA ' ' A' ' 72' ' ' ASN . 26.3 ptt180 -117.82 -179.6 3.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.336 0.654 . . . . 72.219999999999999 109.942 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -89.99 163.27 15.0 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.02 0.528 . . . . 75.329999999999998 110.886 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.41 153.51 6.88 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.061 -0.816 . . . . 75.5 111.061 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.6 -55.66 0.46 Allowed Glycine 0 CA--C 1.537 1.451 0 CA-C-O 118.16 -1.356 . . . . 75.340000000000003 113.588 -175.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.84 102.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 123.69 2.927 . . . . 72.340000000000003 113.644 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -139.72 166.01 25.75 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.549 1.14 . . . . 74.530000000000001 109.963 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 63.2 m -122.04 93.67 4.06 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.041 0.936 . . . . 74.129999999999995 109.869 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -164.64 160.36 19.96 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.333 0.653 . . . . 72.519999999999996 110.271 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.3 137.71 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.089 0.956 . . . . 73.25 109.102 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -118.51 100.13 7.25 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.157 -1.053 . . . . 75.040000000000006 108.157 173.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m -64.08 136.22 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.434 0.693 . . . . 73.540000000000006 111.238 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -80.01 132.61 36.04 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 115.545 -0.752 . . . . 74.239999999999995 110.201 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -124.8 77.31 1.59 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.796 -1.187 . . . . 74.010000000000005 107.796 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -72.83 142.75 48.0 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.989 -0.551 . . . . 72.120000000000005 112.044 -176.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.94 -49.36 10.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.935 -0.575 . . . . 74.510000000000005 109.645 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.5 mt 59.29 -71.82 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.326 1.851 . . . . 74.109999999999999 112.005 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -66.79 170.35 6.65 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.673 1.189 . . . . 75.540000000000006 111.059 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -120.0 90.74 44.65 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.177 0.591 . . . . 73.340000000000003 110.54 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -87.14 130.43 2.95 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.343 2.028 . . . . 73.450000000000003 111.608 168.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.06 -40.55 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 N-CA-C 109.187 -0.671 . . . . 74.109999999999999 109.187 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.54 89.91 0.53 Allowed 'General case' 0 C--N 1.351 0.641 0 CA-C-N 115.131 -0.94 . . . . 65.450000000000003 109.863 172.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.2 t -134.82 -1.85 2.69 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.095 1.358 . . . . 55.530000000000001 108.663 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -86.3 -10.67 54.05 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.655 1.582 . . . . 74.099999999999994 111.784 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -71.64 75.36 0.82 Allowed 'General case' 0 CA--C 1.555 1.145 0 CA-C-O 121.914 0.864 . . . . 75.319999999999993 111.608 -175.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 56.63 69.39 1.77 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 125.265 1.426 . . . . 72.230000000000004 111.136 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.61 -14.58 27.42 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.348 2.032 . . . . 64.519999999999996 113.344 -175.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -116.63 106.59 13.71 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.12 0.968 . . . . 61.439999999999998 108.931 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.26 13.75 0.07 OUTLIER Glycine 0 C--N 1.349 1.273 0 O-C-N 123.447 0.467 . . . . 73.340000000000003 113.733 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.7 mt -129.55 137.55 50.83 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.022 0.929 . . . . 73.030000000000001 109.749 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.2 t -147.03 169.23 19.66 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.898 0.879 . . . . 73.329999999999998 108.997 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.45 170.88 19.65 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.306 0.642 . . . . 73.230000000000004 110.82 -178.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -163.53 123.75 2.2 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.531 0.732 . . . . 50.25 110.686 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -166.95 146.82 5.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.183 0.993 . . . . 75.140000000000001 109.454 172.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -139.29 119.38 13.54 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.517 -0.92 . . . . 73.230000000000004 108.517 177.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -133.06 93.6 3.21 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.328 -1.36 . . . . 71.430000000000007 107.328 170.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -81.1 153.9 27.08 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.707 -0.679 . . . . 75.129999999999995 110.773 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.4 p -68.2 135.23 51.72 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.154 -0.684 . . . . 74.230000000000004 109.154 170.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -59.04 -63.39 1.32 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.389 0.676 . . . . 71.519999999999996 110.531 -177.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -173.68 176.17 2.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.616 0.766 . . . . 65.209999999999994 109.031 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.555 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 3.2 p-10 -63.89 145.9 54.98 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.009 0.523 . . . . 75.040000000000006 110.472 172.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.3 mt -121.77 -66.94 1.0 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.303 -0.999 . . . . 64.030000000000001 108.303 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.4 mt -139.73 140.94 36.9 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.947 0.899 . . . . 74.010000000000005 109.716 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.0 -178.97 6.75 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.318 1.047 . . . . 70.209999999999994 111.781 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.09 145.17 16.32 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.773 -1.015 . . . . 62.409999999999997 111.094 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.97 81.09 0.9 Allowed 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.061 2.508 . . . . 71.450000000000003 112.083 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.434 ' O ' ' HD3' ' A' ' 108' ' ' ARG . 29.2 t -65.84 109.23 2.41 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.597 1.159 . . . . 70.450000000000003 110.325 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 80' ' ' ASN . 9.2 pt-20 -63.18 -56.31 17.73 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.667 0.787 . . . . 73.319999999999993 112.313 -176.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.446 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 60.8 m-80 -141.94 131.28 23.61 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.794 0.837 . . . . 70.409999999999997 109.039 -171.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -164.4 145.38 6.62 Favored Pre-proline 0 N--CA 1.475 0.823 0 N-CA-C 107.641 -1.244 . . . . 72.099999999999994 107.641 -173.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -56.72 75.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.594 2.863 . . . . 63.530000000000001 114.32 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.69 22.2 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.287 1.835 . . . . 74.319999999999993 109.24 176.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.5 tp -85.3 132.84 34.19 Favored 'General case' 0 C--N 1.359 1.007 0 CA-C-O 121.017 0.437 . . . . 75.129999999999995 109.894 -178.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -106.65 173.9 6.12 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.191 1.396 . . . . 72.430000000000007 110.086 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.49 145.96 25.06 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 107.925 -1.139 . . . . 72.109999999999999 107.925 171.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -74.95 117.93 17.34 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 123.039 0.212 . . . . 70.439999999999998 110.606 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.3 mt -65.41 -33.69 76.53 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.222 1.009 . . . . 64.010000000000005 111.556 171.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.487 ' OH ' ' HA ' ' A' ' 13' ' ' ARG . 75.6 m-85 -140.35 159.0 43.16 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.172 0.589 . . . . 75.5 109.418 -175.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -74.7 152.19 39.15 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.107 -0.701 . . . . 75.230000000000004 109.107 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -156.04 115.93 3.63 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.602 0.761 . . . . 72.439999999999998 109.1 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.72 133.21 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.339 -0.985 . . . . 71.109999999999999 108.339 170.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.69 134.63 52.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.811 0.444 . . . . 73.150000000000006 110.91 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.9 m -67.59 -20.94 65.43 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.943 0.897 . . . . 73.219999999999999 111.391 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.35 -165.65 38.27 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.69 -0.686 . . . . 62.450000000000003 112.008 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -52.3 -38.77 59.34 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.7 1.2 . . . . 75.219999999999999 112.852 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.442 ' ND2' HD13 ' A' ' 20' ' ' LEU . 31.3 p-10 -72.19 -24.71 61.46 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.178 0.991 . . . . 74.049999999999997 112.69 -175.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 p -104.23 157.75 16.92 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.301 0.641 . . . . 53.509999999999998 110.022 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.466 ' HB3' HG11 ' A' ' 130' ' ' VAL . 64.2 tp -110.55 132.74 53.93 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.797 -0.638 . . . . 72.129999999999995 109.808 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.2 t -80.16 136.54 36.53 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.36 -0.608 . . . . 74.140000000000001 109.36 173.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 28.6 pt -137.89 144.55 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.484 0.713 . . . . 64.140000000000001 109.652 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 9.3 m -105.65 143.91 33.13 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.231 -0.655 . . . . 74.400000000000006 109.231 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -56.38 111.91 1.11 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 118.536 0.607 . . . . 75.5 111.046 174.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.13 1.8 35.91 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 116.707 -0.224 . . . . 74.319999999999993 113.254 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.538 ' HG3' ' HE2' ' A' ' 124' ' ' LYS . 36.5 tt0 -85.66 137.64 32.7 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.029 0.931 . . . . 74.319999999999993 110.511 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -76.4 119.14 19.85 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.603 0.761 . . . . 75.420000000000002 110.338 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.649 ' HA ' HG22 ' A' ' 123' ' ' THR . 11.4 mt -112.43 123.68 50.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.405 -0.961 . . . . 72.329999999999998 108.405 -173.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 78' ' ' SER . 71.8 mtt180 -95.6 106.76 18.89 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 107.769 -1.197 . . . . 74.409999999999997 107.769 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 67.1 t -99.66 114.55 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 109.229 -0.656 . . . . 73.409999999999997 109.229 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.38 -34.77 68.18 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.62 0.768 . . . . 71.540000000000006 109.934 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.35 167.09 35.69 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 114.783 -1.098 . . . . 74.150000000000006 111.422 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 3.0 m-30 -97.5 175.0 6.38 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.781 0.8 . . . . 74.239999999999995 110.063 177.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -75.13 147.1 40.8 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 114.411 -1.268 . . . . 73.319999999999993 108.304 169.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -60.08 -37.17 79.12 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.7 0.8 . . . . 75.319999999999993 112.328 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -92.92 7.52 43.6 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 121.07 0.462 . . . . 73.209999999999994 110.94 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 174' ' ' GLU . . . 70.91 27.96 71.4 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 116.079 -0.51 . . . . 72.019999999999996 113.898 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -68.41 -70.72 0.25 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 122.126 0.965 . . . . 75.430000000000007 110.245 178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -131.04 -178.58 4.88 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.57 1.148 . . . . 73.010000000000005 108.859 -172.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -138.48 122.22 17.56 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.973 0.509 . . . . 70.150000000000006 109.99 -175.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -72.23 96.84 1.87 Allowed 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.648 0.737 . . . . 70.120000000000005 109.816 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -109.68 165.69 11.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.709 -1.132 . . . . 73.340000000000003 111.097 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -140.75 118.65 11.8 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.608 -1.256 . . . . 74.120000000000005 107.608 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.649 HG22 ' HA ' ' A' ' 107' ' ' LEU . 71.7 p -132.05 -172.28 2.84 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.58 0.705 . . . . 73.530000000000001 111.123 -176.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.538 ' HE2' ' HG3' ' A' ' 105' ' ' GLU . 40.0 mtmt -57.44 -30.52 65.07 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 114.242 -1.344 . . . . 74.409999999999997 110.862 170.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -85.51 3.25 41.28 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.07 0.948 . . . . 75.430000000000007 111.759 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 118.97 -127.38 7.2 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 122.21 -0.306 . . . . 73.129999999999995 112.835 173.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -151.97 140.99 21.18 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.57 0.748 . . . . 73.019999999999996 110.384 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 167.72 -171.77 42.33 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.143 0.277 . . . . 51.100000000000001 112.446 176.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -88.57 125.24 34.7 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.113 0.565 . . . . 74.299999999999997 111.216 -175.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.466 HG11 ' HB3' ' A' ' 99' ' ' LEU . 30.8 m -120.62 152.26 55.36 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.724 1.21 . . . . 71.510000000000005 110.098 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 134' ' ' TYR . 56.9 Cg_endo -73.64 129.14 13.28 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 121.654 1.569 . . . . 75.310000000000002 111.347 -177.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 43.8 t -57.74 -27.14 62.74 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.648 0.779 . . . . 54.140000000000001 111.799 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.68 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 47.3 m-20 -67.87 -21.25 65.17 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.312 1.045 . . . . 72.120000000000005 112.191 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.41 ' HB2' ' HG2' ' A' ' 131' ' ' PRO . 2.0 m-85 -107.06 8.52 30.34 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.613 0.765 . . . . 75.420000000000002 111.681 -176.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.5 pt -128.26 155.2 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-N 118.545 0.611 . . . . 75.219999999999999 109.958 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.3 t -150.36 134.97 9.53 Favored Pre-proline 0 N--CA 1.495 1.779 0 C-N-CA 122.849 0.459 . . . . 73.25 110.175 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.558 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 74.4 Cg_endo -76.21 117.46 4.64 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.879 2.386 . . . . 72.430000000000007 114.282 -176.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.7 m -90.29 -49.7 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 122.841 0.457 . . . . 74.129999999999995 111.618 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -94.36 6.36 48.94 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.114 0.483 . . . . 75.319999999999993 111.405 -173.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.558 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 25.0 t -83.59 -178.69 7.11 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.126 0.489 . . . . 70.140000000000001 109.807 173.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 62.4 mt -63.16 -13.79 41.13 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.235 1.014 . . . . 71.329999999999998 112.644 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.554 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 36.5 tt0 -58.75 -24.59 61.88 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.856 0.862 . . . . 72.310000000000002 112.519 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.2 -25.3 66.95 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 123.469 0.708 . . . . 71.109999999999999 110.837 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -79.57 148.33 31.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.718 0.807 . . . . 74.219999999999999 110.705 170.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.6 p -65.72 -22.65 66.63 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.924 0.713 . . . . 74.099999999999994 112.924 -175.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 59.5 p-90 -81.6 -46.48 14.35 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.965 0.506 . . . . 65.340000000000003 112.32 -178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 30.5 t80 -88.37 137.37 32.39 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.441 -0.578 . . . . 72.040000000000006 109.441 -177.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.554 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 25.0 m-70 -130.45 26.82 5.07 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 111.97 0.359 . . . . 73.239999999999995 111.97 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.93 -154.63 46.39 Favored Glycine 0 CA--C 1.54 1.644 0 N-CA-C 114.766 0.667 . . . . 71.530000000000001 114.766 171.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.452 ' HG3' ' OH ' ' A' ' 112' ' ' TYR . 72.2 Cg_endo -75.03 108.62 2.76 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 123.478 2.785 . . . . 64.230000000000004 111.901 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.495 HG13 ' HD3' ' A' ' 171' ' ' ARG . 1.6 p -155.23 138.5 7.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 115.493 -0.776 . . . . 71.450000000000003 109.659 -177.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.573 ' HB3' HG11 ' A' ' 8' ' ' VAL . 10.3 p -80.83 170.74 15.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.999 0.74 . . . . 74.140000000000001 112.999 -174.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -63.41 -27.62 69.42 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 114.94 -1.027 . . . . 73.209999999999994 112.694 -169.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -68.54 -57.33 5.94 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.552 0.741 . . . . 74.540000000000006 110.072 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.12 -36.62 84.85 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.338 0.655 . . . . 70.510000000000005 110.695 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.446 ' HA ' ' NH1' ' A' ' 171' ' ' ARG . . . -53.26 -52.25 59.61 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.824 -1.08 . . . . 73.239999999999995 112.03 171.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.549 ' HG3' HG13 ' A' ' 190' ' ' VAL . 29.7 tt0 -76.9 -19.65 57.17 Favored 'General case' 0 C--O 1.212 -0.871 0 CA-C-N 114.856 -1.065 . . . . 74.140000000000001 110.71 -175.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -67.53 -51.16 54.19 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.873 0.469 . . . . 72.239999999999995 109.974 172.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.62 HD22 ' HG3' ' A' ' 239' ' ' ARG . 82.7 mt -64.93 -42.16 94.91 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.864 -0.607 . . . . 73.219999999999999 110.965 178.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.529 HD22 HG11 ' A' ' 190' ' ' VAL . 32.4 tp -71.77 -28.8 63.88 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.214 -0.903 . . . . 75.530000000000001 112.024 -177.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.5 t -57.03 -40.13 76.14 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.641 0.776 . . . . 61.130000000000003 110.327 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.404 ' HB2' ' HG2' ' A' ' 237' ' ' PRO . 10.5 m -81.93 -0.21 42.83 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 114.636 -1.166 . . . . 64.310000000000002 111.585 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -93.23 154.53 21.89 Favored Glycine 0 C--N 1.349 1.271 0 C-N-CA 123.068 0.366 . . . . 74.420000000000002 113.055 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 20.5 pt -103.76 -167.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 123.798 0.839 . . . . 72.040000000000006 112.13 -173.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.638 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 16.3 p-10 -59.52 103.94 0.23 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.008 0.923 . . . . 72.010000000000005 113.486 -171.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 103.82 13.25 28.08 Favored Glycine 0 C--O 1.26 1.768 0 CA-C-N 116.288 -0.414 . . . . 74.140000000000001 112.847 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 22.6 t -71.72 136.73 47.31 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-O 119.227 -0.416 . . . . 74.230000000000004 110.132 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 183' ' ' SER . 21.6 p90 -135.22 156.35 49.13 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.932 0.716 . . . . 71.120000000000005 112.932 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.566 HD23 HH21 ' A' ' 171' ' ' ARG . 84.0 mt -140.01 132.84 29.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.419 -1.264 . . . . 74.420000000000002 108.184 171.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 23.0 t -110.07 130.73 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 107.613 -1.255 . . . . 73.150000000000006 107.613 172.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.596 HH22 HD11 ' A' ' 159' ' ' LEU . 11.9 ptp180 -163.38 164.66 24.59 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.165 0.586 . . . . 74.219999999999999 110.206 -174.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 16.1 pt-20 -111.48 156.93 20.93 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.568 0.347 . . . . 75.329999999999998 110.068 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.2 t -75.06 139.1 42.59 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 116.065 -0.516 . . . . 75.040000000000006 110.582 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.42 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 94.4 mt-10 -65.51 -42.43 92.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.941 0.497 . . . . 74.420000000000002 110.01 172.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 54.7 p -77.75 -21.97 51.0 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.106 0.962 . . . . 75.239999999999995 111.852 -176.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 36.9 t -140.03 79.89 21.53 Favored Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 109.33 -0.618 . . . . 75.25 109.33 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -71.43 148.08 53.71 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 123.028 2.485 . . . . 74.349999999999994 111.675 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 88.43 -25.03 9.83 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 115.414 -0.812 . . . . 62.210000000000001 111.843 -170.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -90.46 118.07 29.65 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 108.687 -0.857 . . . . 75.329999999999998 108.687 168.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 61.2 mtt180 -103.44 172.41 6.82 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 114.7 -1.136 . . . . 65.299999999999997 110.252 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.5 m -155.96 140.18 16.56 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.512 1.125 . . . . 71.230000000000004 108.462 -169.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.424 HD12 ' CD2' ' A' ' 217' ' ' LEU . 53.1 mt -112.78 137.98 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.243 -1.021 . . . . 71.409999999999997 108.243 167.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.529 ' HB3' HD23 ' A' ' 160' ' ' LEU . 17.0 m -117.19 112.58 21.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.283 1.433 . . . . 72.329999999999998 107.735 -175.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 42.1 mt -110.62 139.46 45.87 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.138 0.975 . . . . 74.319999999999993 111.459 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 45.4 ttt-85 -129.0 134.92 48.34 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 115.649 -0.705 . . . . 75.510000000000005 109.726 171.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 12.2 p90 -153.19 139.85 18.88 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 124.67 1.231 . . . . 72.129999999999995 107.823 175.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 54.66 23.11 4.48 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 125.026 1.33 . . . . 74.129999999999995 114.233 176.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.56 6.22 73.82 Favored Glycine 0 N--CA 1.475 1.282 0 O-C-N 122.206 -0.309 . . . . 75.319999999999993 113.189 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 15.7 tpp180 -101.03 124.47 46.81 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.218 1.007 . . . . 74.239999999999995 108.746 177.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.549 HG13 ' HG3' ' A' ' 157' ' ' GLU . 97.0 t -106.85 133.52 51.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.64 1.176 . . . . 75.439999999999998 108.624 174.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . 0.527 ' HH ' HG23 ' A' ' 230' ' ' THR . 27.4 p90 -146.3 155.7 42.83 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.238 0.615 . . . . 74.329999999999998 109.986 169.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -134.66 122.22 21.95 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.842 -1.17 . . . . 75.140000000000001 107.842 -174.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -119.19 155.11 32.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.026 0.53 . . . . 71.420000000000002 109.917 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.576 ' HG3' ' HB2' ' A' ' 3' ' ' GLN . 35.0 mmt180 -99.72 135.0 41.8 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.15 0.5 . . . . 75.25 111.381 -169.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 71.3 mt -82.74 111.79 19.58 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 CA-C-N 114.932 -1.031 . . . . 74.129999999999995 108.607 167.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -81.04 130.99 35.28 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.49 0.716 . . . . 74.030000000000001 109.185 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 48.1 m -97.31 125.55 41.96 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.323 0.649 . . . . 52.310000000000002 110.202 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.56 178.54 6.58 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.48 1.112 . . . . 74.209999999999994 111.727 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 45.3 t -60.7 -36.0 77.71 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.122 0.969 . . . . 73.219999999999999 112.059 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -74.07 -14.17 60.95 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.691 -0.686 . . . . 71.439999999999998 112.318 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 93.66 3.38 64.49 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.513 -0.635 . . . . 74.420000000000002 111.513 -170.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -72.27 160.61 32.1 Favored 'General case' 0 C--N 1.346 0.455 0 C-N-CA 124.123 0.969 . . . . 75.239999999999995 110.404 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 214' ' ' LEU . 72.7 mt -113.84 147.19 38.83 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.006 0.923 . . . . 70.129999999999995 110.359 -173.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -163.19 153.77 16.35 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.715 0.635 . . . . 72.519999999999996 109.977 175.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 71.7 t -125.26 -62.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.999 -1.112 . . . . 73.150000000000006 107.999 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.0 t -102.4 -178.4 3.68 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.253 1.021 . . . . 75.340000000000003 111.071 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.6 t -61.5 -47.41 85.75 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.333 1.053 . . . . 74.049999999999997 112.044 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -90.34 12.81 17.18 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.486 0.714 . . . . 71.430000000000007 111.643 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 66.8 m -98.51 111.54 23.87 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.373 0.669 . . . . 74.329999999999998 109.782 173.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -146.71 115.13 6.71 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.257 1.023 . . . . 73.420000000000002 109.304 171.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -135.8 142.26 44.85 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 117.843 0.292 . . . . 72.209999999999994 111.105 -171.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -83.85 -34.78 24.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.264 -0.643 . . . . 71.319999999999993 109.264 169.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 66.8 p -121.13 145.47 47.78 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-O 122.039 0.923 . . . . 74.209999999999994 111.72 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 203' ' ' LEU . 30.2 tp -68.3 -24.68 64.88 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.472 -1.24 . . . . 74.439999999999998 110.811 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.44 85.96 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.457 0.703 . . . . 73.510000000000005 110.542 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -67.89 -34.39 76.56 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 116.053 -0.521 . . . . 75.129999999999995 111.382 175.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.424 ' CD2' HD12 ' A' ' 182' ' ' ILE . 10.0 tt -58.6 -46.22 87.47 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.42 0.45 . . . . 74.209999999999994 110.981 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.94 -39.11 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.166 0.587 . . . . 63.549999999999997 110.828 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -61.66 -55.1 34.11 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.318 0.58 . . . . 74.549999999999997 111.328 176.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.41 ' O ' HG23 ' A' ' 224' ' ' VAL . 46.9 t60 -51.14 -54.77 22.19 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 114.589 -1.187 . . . . 74.310000000000002 109.662 177.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -65.23 -24.94 67.48 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.608 -0.724 . . . . 54.149999999999999 112.709 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.6 t -72.51 -25.41 61.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.854 0.462 . . . . 73.400000000000006 111.064 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.3 t -122.47 -2.9 8.9 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 116.408 2.003 . . . . 61.409999999999997 116.408 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 220' ' ' HIS . 27.8 m -101.61 154.17 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-N 121.123 1.783 . . . . 61.219999999999999 115.421 -172.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.66 -0.73 57.29 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 129.248 3.019 . . . . 71.140000000000001 113.487 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.23 14.56 0.89 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 129.027 2.931 . . . . 72.230000000000004 113.677 -145.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.4 16.42 4.7 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 122.225 0.903 . . . . 51.109999999999999 111.725 -170.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.14 120.02 32.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.257 -0.972 . . . . 75.409999999999997 110.927 169.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.476 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 92.7 mt -59.23 -43.26 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 123.97 0.794 . . . . 74.209999999999994 109.39 172.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' THR . . . . . 0.527 HG23 ' HH ' ' A' ' 191' ' ' TYR . 8.8 t -136.09 148.74 48.42 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.694 -0.854 . . . . 73.450000000000003 108.694 165.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 80.7 p -72.4 159.71 33.54 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.566 -0.531 . . . . 65.430000000000007 109.566 171.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 20.4 mt -69.33 102.31 1.71 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.202 -1.036 . . . . 71.519999999999996 108.202 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -87.83 -50.52 6.4 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.461 -0.57 . . . . 74.430000000000007 109.461 -174.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -161.43 147.14 10.81 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 112.444 0.535 . . . . 73.439999999999998 112.444 -177.784 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.36 152.4 71.4 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.122 1.882 . . . . 74.239999999999995 112.736 -176.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.56 155.61 89.22 Favored Pre-proline 0 C--O 1.244 0.81 0 CA-C-N 115.774 -0.648 . . . . 72.319999999999993 110.667 175.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.404 ' HG2' ' HB2' ' A' ' 162' ' ' SER . 17.7 Cg_endo -56.85 140.02 90.58 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.801 2.334 . . . . 74.040000000000006 113.309 177.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -77.77 158.83 29.4 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.834 -1.075 . . . . 74.099999999999994 108.657 169.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . 0.62 ' HG3' HD22 ' A' ' 159' ' ' LEU . 98.0 mtt180 -53.72 -27.86 30.72 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 122.935 0.494 . . . . 72.120000000000005 111.778 176.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -69.04 -67.71 0.45 Allowed 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.584 -0.735 . . . . 73.329999999999998 109.522 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -174.75 161.42 2.52 Favored Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 123.777 0.831 . . . . 74.530000000000001 111.035 177.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.21 156.77 61.41 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.743 2.295 . . . . 62.549999999999997 112.412 170.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 20.5 m -148.71 90.16 1.75 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.519 0.727 . . . . 73.329999999999998 109.68 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.5 p -171.89 137.01 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.825 0.85 . . . . 73.25 110.466 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -161.33 56.86 0.29 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.908 0.861 . . . . 74.239999999999995 110.017 173.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -69.74 114.46 5.63 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 115.171 -0.922 . . . . 72.319999999999993 112.954 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.81 126.82 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.701 0.801 . . . . 73.239999999999995 109.549 174.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 51.3 m -149.94 139.16 12.95 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.598 1.159 . . . . 74.319999999999993 108.119 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -56.96 -32.34 92.52 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.466 2.111 . . . . 72.209999999999994 112.722 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 57.63 94.71 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.793 1.237 . . . . 72.299999999999997 112.691 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -151.02 166.9 29.28 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.614 -0.721 . . . . 64.5 110.594 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -162.3 147.48 12.61 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.948 -1.024 . . . . 62.229999999999997 108.608 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -83.62 -23.81 31.7 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.514 0.325 . . . . 73.299999999999997 111.753 -172.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -74.28 143.02 45.2 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.313 -0.625 . . . . 73.530000000000001 109.313 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 CA--C 1.555 1.16 0 CA-C-O 118.107 -0.949 . . . . 74.129999999999995 108.973 -179.808 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.2 p . . . . . 0 C--O 1.243 0.763 0 CA-C-O 121.352 0.596 . . . . 33.409999999999997 111.639 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.9 mt -106.56 130.56 22.73 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 108.542 -0.91 . . . . 72.230000000000004 108.542 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -66.58 165.46 25.18 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 121.982 1.788 . . . . 62.43 110.618 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.18 147.2 31.39 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.601 0.239 . . . . 55.020000000000003 110.407 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.568 ' HB3' HD11 ' A' ' 23' ' ' ILE . 63.5 mt -85.85 94.07 9.07 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.249 -1.019 . . . . 64.129999999999995 108.249 176.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -98.15 -47.73 5.37 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.878 -1.055 . . . . 75.109999999999999 109.057 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -101.79 113.59 26.92 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 114.345 -1.298 . . . . 74.400000000000006 109.9 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.568 HD11 ' HB3' ' A' ' 20' ' ' LEU . 46.5 mm -115.75 120.18 64.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 106.083 -1.821 . . . . 72.409999999999997 106.083 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HB2' ' HE1' ' A' ' 129' ' ' TRP . 16.8 tptm . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 121.478 0.656 . . . . 75.150000000000006 109.84 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 N--CA 1.492 1.438 0 N-CA-C 113.144 0.402 . . . . 74.319999999999993 113.144 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -56.36 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.951 0.782 . . . . 70.310000000000002 111.987 -175.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.66 ' H ' ' HB3' ' A' ' 139' ' ' ASN . 50.3 tp -81.55 135.77 35.59 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.538 -1.21 . . . . 74.409999999999997 109.165 177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -105.49 176.08 5.28 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.948 1.299 . . . . 75.299999999999997 109.359 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.35 143.13 23.52 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 N-CA-C 108.503 -0.925 . . . . 61.539999999999999 108.503 171.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -76.05 121.67 23.12 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.627 -0.508 . . . . 63.539999999999999 109.627 173.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 74.4 mt -82.42 -21.63 35.65 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.703 0.801 . . . . 74.239999999999995 111.252 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.574 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 84.5 m-85 -136.16 158.14 45.14 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.114 0.565 . . . . 74.319999999999993 109.585 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.51 145.58 39.04 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.689 -0.687 . . . . 73.219999999999999 109.835 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -153.23 111.16 3.59 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.236 -1.024 . . . . 74.019999999999996 108.236 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.4 t -82.54 138.71 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 109.074 -0.713 . . . . 65.099999999999994 109.074 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.65 116.25 4.61 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.087 0.555 . . . . 71.230000000000004 110.194 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.5 m -78.79 -11.05 59.97 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.718 0.807 . . . . 73.430000000000007 110.717 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.74 -172.68 41.62 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.587 -0.733 . . . . 63.310000000000002 111.28 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.53 -25.68 66.78 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.436 0.694 . . . . 72.030000000000001 110.719 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -70.2 -22.99 62.88 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.588 0.755 . . . . 71.340000000000003 112.456 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.7 p -113.71 157.74 21.81 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.408 0.683 . . . . 64.219999999999999 110.915 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.2 tp -109.93 131.15 55.32 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.734 0.814 . . . . 62.0 109.927 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.8 t -74.05 120.01 19.04 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 108.892 -0.781 . . . . 34.119999999999997 108.892 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.32 159.53 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.244 1.018 . . . . 41.210000000000001 108.775 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 60.0 m -135.78 148.15 48.64 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.265 -0.643 . . . . 74.310000000000002 109.265 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -54.84 123.38 13.21 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.095 0.558 . . . . 74.230000000000004 111.646 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.29 -9.54 49.81 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.388 -0.369 . . . . 54.210000000000001 113.095 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -85.01 131.89 34.41 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.557 0.743 . . . . 72.019999999999996 110.445 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.45 ' HB3' HD11 ' A' ' 84' ' ' LEU . 8.7 mtmp? -83.52 115.48 22.11 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.773 0.829 . . . . 71.299999999999997 110.302 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.505 ' HA ' HG22 ' A' ' 123' ' ' THR . 15.7 mt -103.14 145.74 29.45 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.956 0.903 . . . . 73.510000000000005 109.965 -169.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.472 ' NH2' ' HG2' ' A' ' 122' ' ' GLN . 84.5 mtm180 -108.65 108.95 20.02 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.605 -0.887 . . . . 70.129999999999995 108.605 173.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 71.6 t -95.56 117.28 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 121.298 0.571 . . . . 73.299999999999997 110.249 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.5 mt -77.16 -28.73 54.25 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.251 1.421 . . . . 73.109999999999999 111.207 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.3 177.51 39.46 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.127 -0.488 . . . . 41.310000000000002 113.016 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.484 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 2.8 m-85 -107.15 168.41 9.23 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.833 0.853 . . . . 72.340000000000003 109.398 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -85.9 151.77 23.51 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 110.018 -0.364 . . . . 72.239999999999995 110.018 170.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -57.87 -32.29 67.53 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 113.185 0.809 . . . . 73.439999999999998 113.185 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -90.16 3.88 52.1 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.129 0.572 . . . . 72.150000000000006 110.465 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 61.59 31.16 76.77 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 111.03 -0.828 . . . . 73.549999999999997 111.03 -174.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -67.65 -70.45 0.26 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 107.934 -1.136 . . . . 64.319999999999993 107.934 -174.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -135.54 178.46 7.02 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 108.337 -0.986 . . . . 72.540000000000006 108.337 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.16 117.81 24.71 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.67 0.788 . . . . 63.310000000000002 109.058 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.92 108.65 3.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.279 0.632 . . . . 62.340000000000003 109.711 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.37 168.23 10.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.634 0.773 . . . . 53.310000000000002 110.784 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.472 ' HG2' ' NH2' ' A' ' 108' ' ' ARG . 61.6 tt0 -149.09 128.09 12.69 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.149 -1.056 . . . . 72.109999999999999 108.149 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.505 HG22 ' HA ' ' A' ' 107' ' ' LEU . 81.6 p -139.31 -174.46 3.87 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.701 0.801 . . . . 72.219999999999999 110.701 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -55.53 -28.87 57.31 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.6 0.76 . . . . 72.530000000000001 111.336 169.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -76.1 -13.3 60.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.547 0.739 . . . . 61.219999999999999 111.573 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 132.02 -130.95 6.09 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 111.905 -0.478 . . . . 70.450000000000003 111.905 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -150.73 146.58 26.53 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.338 0.655 . . . . 71.209999999999994 110.072 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 166.94 177.79 38.93 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 112.1 -0.4 . . . . 71.519999999999996 112.1 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.438 ' HE1' ' HB2' ' A' ' 24' ' ' LYS . 90.9 m95 -80.62 130.3 35.03 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.589 0.756 . . . . 72.409999999999997 110.887 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.03 151.54 61.65 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 124.286 1.034 . . . . 74.209999999999994 109.767 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.54 132.02 14.28 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 121.748 1.632 . . . . 62.310000000000002 111.636 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.501 ' HA ' HG12 ' A' ' 135' ' ' ILE . 41.8 p -61.58 -22.01 64.82 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.703 0.801 . . . . 71.510000000000005 111.901 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -68.36 -24.5 64.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.429 1.092 . . . . 61.439999999999998 111.926 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.574 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.1 m-85 -101.7 2.19 38.34 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.593 0.757 . . . . 74.329999999999998 112.153 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.501 HG12 ' HA ' ' A' ' 132' ' ' SER . 16.4 pt -131.21 161.92 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.66 0.384 . . . . 75.340000000000003 110.056 -173.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 11.0 t -151.16 147.92 21.55 Favored Pre-proline 0 N--CA 1.481 1.113 0 N-CA-C 108.593 -0.891 . . . . 75.400000000000006 108.593 170.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.94 150.59 38.68 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 121.971 1.781 . . . . 64.140000000000001 111.564 172.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.1 m -131.13 -44.52 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.155 0.582 . . . . 74.010000000000005 111.185 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.66 ' HB3' ' H ' ' A' ' 84' ' ' LEU . 58.2 t30 -95.5 17.96 13.66 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.411 1.101 . . . . 75.329999999999998 110.491 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.6 p -76.24 168.86 19.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.483 -0.78 . . . . 74.109999999999999 110.677 172.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 63.2 mt -62.98 -15.84 57.48 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 114.957 -1.019 . . . . 73.340000000000003 111.166 172.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.4 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 82.4 tt0 -61.74 -26.77 68.27 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.269 1.428 . . . . 73.310000000000002 112.999 -176.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -67.78 -18.11 64.76 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 122.768 0.427 . . . . 64.140000000000001 110.819 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -82.0 145.05 30.46 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.02 -0.733 . . . . 72.430000000000007 109.02 168.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.3 p -64.3 -19.91 65.73 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 112.884 0.698 . . . . 75.329999999999998 112.884 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.435 ' CE3' HG21 ' A' ' 218' ' ' VAL . 65.3 p-90 -77.72 -37.81 48.59 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 112.445 0.535 . . . . 64.120000000000005 112.445 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.408 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 22.7 t80 -102.22 138.6 38.94 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.143 -0.688 . . . . 71.129999999999995 109.143 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.4 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 22.3 m-70 -129.56 22.37 5.51 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.682 0.393 . . . . 71.439999999999998 111.446 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 62.81 -156.19 40.57 Favored Glycine 0 CA--C 1.536 1.385 0 N-CA-C 115.092 0.797 . . . . 72.209999999999994 115.092 169.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 6.3 Cg_exo -76.37 104.59 1.93 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.391 2.727 . . . . 62.229999999999997 111.044 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.55 160.98 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.293 0.568 . . . . 75.140000000000001 112.02 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 18.2 m -71.26 161.73 30.6 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 114.924 -1.035 . . . . 60.530000000000001 110.916 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -64.02 -32.65 74.28 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.109 0.564 . . . . 73.549999999999997 110.114 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -65.11 -49.72 68.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.524 1.129 . . . . 60.509999999999998 110.416 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.02 -43.51 87.45 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.597 0.759 . . . . 73.310000000000002 110.406 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.46 -59.9 4.46 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.387 -1.279 . . . . 53.229999999999997 110.944 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.595 ' HG3' HG11 ' A' ' 190' ' ' VAL . 31.7 tt0 -67.73 -22.73 65.22 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.835 -0.62 . . . . 54.329999999999998 111.281 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -65.42 -56.38 12.83 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.996 0.519 . . . . 75.239999999999995 109.706 173.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.27 -35.91 80.44 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 116.431 -0.349 . . . . 75.209999999999994 111.148 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.657 HD23 HG13 ' A' ' 190' ' ' VAL . 34.4 tp -72.25 -26.72 62.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.013 0.525 . . . . 73.120000000000005 111.66 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.5 t -70.06 -16.28 63.12 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.976 0.51 . . . . 74.409999999999997 111.162 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.3 m -83.07 -17.79 41.94 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.263 0.625 . . . . 72.310000000000002 111.052 170.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.36 -179.64 51.02 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 116.154 -0.475 . . . . 64.420000000000002 113.431 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.1 pt -133.37 -166.45 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 125.864 1.666 . . . . 74.109999999999999 110.503 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 24.3 p-10 -60.15 129.95 44.24 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.62 0.368 . . . . 73.219999999999999 111.229 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.88 10.03 84.61 Favored Glycine 0 C--O 1.264 1.982 0 CA-C-O 119.997 -0.335 . . . . 51.409999999999997 113.061 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 75.2 m -82.58 141.2 32.76 Favored 'General case' 0 C--N 1.371 1.532 0 N-CA-C 110.086 -0.338 . . . . 74.209999999999994 110.086 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 183' ' ' SER . 16.4 p90 -136.68 161.48 35.8 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.756 0.789 . . . . 64.319999999999993 112.918 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 79.6 mt -135.13 131.96 37.48 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 114.213 -1.358 . . . . 74.420000000000002 108.04 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.461 HG21 HG22 ' A' ' 218' ' ' VAL . 32.5 t -108.02 130.05 61.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 106.053 -1.832 . . . . 70.129999999999995 106.053 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.55 163.48 39.92 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.999 0.52 . . . . 71.0 110.261 -171.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 15.7 pt-20 -117.91 164.49 14.99 Favored 'General case' 0 C--O 1.26 1.625 0 C-N-CA 123.263 0.625 . . . . 64.239999999999995 110.368 172.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.1 m -80.29 146.93 31.37 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.73 -1.123 . . . . 44.32 110.209 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -78.74 -43.46 25.66 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.694 1.197 . . . . 73.319999999999993 110.293 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.476 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 27.3 m -99.29 9.48 43.29 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.531 -1.213 . . . . 74.299999999999997 112.032 -173.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.4 t -147.61 108.73 3.82 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 122.521 0.328 . . . . 63.109999999999999 110.709 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.484 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 68.4 Cg_endo -74.5 135.21 19.78 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.003 2.469 . . . . 74.420000000000002 111.551 173.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.71 -25.74 12.67 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 116.172 -0.467 . . . . 52.350000000000001 113.509 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.404 ' OE1' ' HD2' ' A' ' 194' ' ' ARG . 83.3 mm-40 -81.3 116.54 21.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.03 0.915 . . . . 75.239999999999995 109.192 174.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 41.1 mtt-85 -129.41 157.14 42.8 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.099 -1.075 . . . . 72.430000000000007 108.099 -177.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.6 m -140.08 144.89 37.05 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 123.225 0.61 . . . . 72.340000000000003 109.825 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 55.3 mt -109.67 143.88 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.021 -1.103 . . . . 70.420000000000002 108.021 165.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.447 ' HB3' HD22 ' A' ' 160' ' ' LEU . 16.8 m -125.37 112.31 16.16 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.375 1.07 . . . . 64.140000000000001 108.349 -174.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.463 HD21 HD23 ' A' ' 232' ' ' LEU . 47.1 mt -102.81 143.38 32.51 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.362 0.665 . . . . 74.150000000000006 111.341 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -122.16 128.11 50.84 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 107.224 -1.398 . . . . 72.230000000000004 107.224 167.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 1.3 t80 -152.48 123.94 7.74 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.066 1.346 . . . . 75.019999999999996 107.991 -171.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 62.49 18.98 10.86 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.905 1.282 . . . . 65.439999999999998 112.33 -172.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.66 1.63 85.27 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-O 120.019 -0.323 . . . . 73.230000000000004 113.099 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -97.34 125.43 41.94 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.071 -0.714 . . . . 75.420000000000002 109.071 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.657 HG13 HD23 ' A' ' 160' ' ' LEU . 73.1 t -98.43 118.77 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.328 1.051 . . . . 74.430000000000007 109.506 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -138.73 140.23 38.64 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.972 0.909 . . . . 55.32 109.389 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -120.19 146.32 46.12 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.779 0.832 . . . . 73.25 109.059 -171.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -139.68 150.03 44.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.974 0.509 . . . . 73.409999999999997 110.478 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 12.4 tpp85 -88.37 132.44 34.43 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.108 -0.951 . . . . 72.439999999999998 111.308 -171.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 68.4 mt -81.45 113.51 20.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 108.159 -1.052 . . . . 74.120000000000005 108.159 164.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -83.78 132.05 34.86 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.375 -0.602 . . . . 65.200000000000003 109.375 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.0 m -110.79 116.96 32.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.505 0.722 . . . . 74.049999999999997 109.714 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.5 178.42 2.03 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.363 1.065 . . . . 41.32 112.035 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 79.8 p -58.56 -41.48 85.76 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.9 0.88 . . . . 71.439999999999998 113.035 -170.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -79.46 -20.12 48.17 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 116.24 -0.436 . . . . 73.329999999999998 110.67 -175.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 113.37 5.5 22.81 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.013 -0.54 . . . . 53.420000000000002 113.53 -174.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -66.26 142.12 57.79 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.625 0.713 . . . . 53.149999999999999 110.502 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 78.3 mt -103.46 146.13 28.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.427 0.691 . . . . 64.310000000000002 109.501 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -165.76 140.61 4.78 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.149 0.579 . . . . 74.230000000000004 110.531 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.4 t -97.91 -38.68 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.316 0.646 . . . . 63.210000000000001 109.722 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 40.7 t -109.05 154.69 21.87 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.614 0.766 . . . . 74.340000000000003 110.96 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.1 m -69.96 -21.13 63.28 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.143 -0.935 . . . . 71.409999999999997 111.04 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -84.64 -6.9 59.39 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.538 0.735 . . . . 72.120000000000005 111.497 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 59.1 m -136.69 147.9 47.06 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.888 0.475 . . . . 64.239999999999995 112.044 -168.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -140.65 134.05 29.86 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.791 1.236 . . . . 75.329999999999998 108.326 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -127.82 132.62 49.43 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.916 0.486 . . . . 74.299999999999997 110.117 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -83.8 -25.02 30.77 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.323 0.649 . . . . 73.439999999999998 110.236 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.0 p -128.99 150.31 50.45 Favored 'General case' 0 C--O 1.253 1.263 0 C-N-CA 123.185 0.594 . . . . 75.409999999999997 110.973 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 31.3 tp -69.71 -27.73 65.23 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.407 -0.815 . . . . 63.25 110.047 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.25 -44.92 92.36 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.345 0.658 . . . . 50.340000000000003 110.847 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -75.78 -29.63 58.83 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 116.191 -0.459 . . . . 62.210000000000001 111.377 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tt -58.17 -51.3 70.32 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 123.301 0.375 . . . . 41.030000000000001 110.51 172.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.461 HG22 HG21 ' A' ' 170' ' ' VAL . 94.9 t -69.47 -42.9 81.03 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 CA-C-N 115.41 -0.814 . . . . 73.129999999999995 111.097 -176.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -57.71 -53.93 52.57 Favored 'General case' 0 C--O 1.259 1.568 0 C-N-CA 123.386 0.674 . . . . 74.200000000000003 111.151 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.497 ' O ' HG22 ' A' ' 224' ' ' VAL . 35.9 t-80 -55.65 -54.75 40.31 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 114.846 -1.07 . . . . 75.450000000000003 109.585 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.402 ' HA ' HG22 ' A' ' 224' ' ' VAL . 4.5 m-70 -68.15 -16.54 64.04 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.758 0.651 . . . . 64.140000000000001 112.758 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.451 ' HA ' ' HB2' ' A' ' 232' ' ' LEU . 44.4 t -74.56 -31.32 62.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.564 0.345 . . . . 54.229999999999997 110.243 173.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.4 t -107.56 -12.34 15.29 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 116.501 2.037 . . . . 71.239999999999995 116.501 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 220' ' ' HIS . 27.7 m -105.86 167.2 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 N-CA-C 117.512 2.412 . . . . 71.530000000000001 117.512 -166.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.02 -1.49 58.02 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 130.075 3.35 . . . . 52.439999999999998 113.663 -173.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -77.58 12.77 1.48 Allowed 'General case' 0 CA--C 1.567 1.619 0 C-N-CA 130.532 3.533 . . . . 70.099999999999994 114.031 -136.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.48 16.5 4.63 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 124.95 1.262 . . . . 61.140000000000001 110.58 -170.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 90.6 mt -90.79 123.38 34.31 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.122 1.369 . . . . 70.150000000000006 110.8 173.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 68.5 mt -62.5 -39.54 84.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.795 -0.639 . . . . 73.329999999999998 109.384 170.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.9 t -138.44 144.46 40.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.431 -0.951 . . . . 70.299999999999997 108.431 166.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 224' ' ' VAL . 59.6 p -65.68 150.68 48.08 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 109.22 -0.659 . . . . 74.209999999999994 109.22 170.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.463 HD23 HD21 ' A' ' 184' ' ' LEU . 31.4 mt -64.36 100.16 0.34 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 108.044 -1.095 . . . . 74.239999999999995 108.044 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -90.23 -53.42 4.47 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 109.619 -0.511 . . . . 65.430000000000007 109.619 -169.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 167' ' ' SER . 1.0 OUTLIER -151.8 145.33 17.65 Favored Pre-proline 0 N--CA 1.479 0.983 0 CA-C-N 115.495 -0.775 . . . . 72.209999999999994 110.451 177.652 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -85.3 158.07 11.09 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 121.626 1.551 . . . . 73.409999999999997 113.809 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.39 128.29 87.59 Favored Pre-proline 0 C--O 1.245 0.842 0 N-CA-C 108.923 -0.769 . . . . 51.200000000000003 108.923 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.93 171.15 18.06 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.482 2.121 . . . . 64.450000000000003 114.185 -167.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 59.9 tttm . . . . . 0 CA--C 1.554 1.126 0 CA-C-N 114.265 -1.334 . . . . 62.520000000000003 108.664 172.786 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.9 p . . . . . 0 CA--C 1.547 0.836 0 CA-C-O 121.143 0.497 . . . . 74.230000000000004 111.743 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.0 mt -105.76 129.35 24.78 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 123.183 0.593 . . . . 73.519999999999996 109.455 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.63 171.62 17.42 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.477 2.118 . . . . 75.040000000000006 111.902 172.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.14 148.87 26.54 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.992 0.517 . . . . 71.329999999999998 111.236 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.647 HD22 HD11 ' A' ' 23' ' ' ILE . 83.6 mt -85.84 95.72 9.53 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.278 -1.008 . . . . 60.210000000000001 108.278 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -97.6 -53.42 3.44 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 120.762 0.315 . . . . 72.129999999999995 110.779 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -106.87 108.39 19.88 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.624 -0.717 . . . . 72.150000000000006 109.378 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.647 HD11 HD22 ' A' ' 20' ' ' LEU . 46.9 mm -124.3 114.07 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.291 0.636 . . . . 72.329999999999998 109.573 176.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.448 ' HG2' ' HZ2' ' A' ' 129' ' ' TRP . 20.0 pttp . . . . . 0 CA--C 1.544 0.734 0 CA-C-O 122.514 1.149 . . . . 64.109999999999999 108.509 169.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 CA--C 1.564 1.99 0 N-CA-C 113.3 0.461 . . . . 71.239999999999995 113.3 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -142.74 99.07 3.4 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.628 0.771 . . . . 62.219999999999999 110.687 -172.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.583 ' H ' ' HB3' ' A' ' 139' ' ' ASN . 24.1 tp -102.62 137.6 40.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.412 0.685 . . . . 63.43 109.483 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 8.8 m-85 -120.02 176.52 5.39 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.826 1.651 . . . . 70.439999999999998 108.54 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.12 143.75 21.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 109.057 -0.72 . . . . 75.209999999999994 109.057 169.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.28 113.31 11.35 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.494 0.718 . . . . 64.409999999999997 109.112 172.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.2 mt -79.26 -20.14 48.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.516 0.726 . . . . 62.530000000000001 110.006 171.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.562 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 71.5 m-85 -136.1 151.61 49.98 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.06 0.544 . . . . 74.150000000000006 109.548 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -70.52 141.8 51.9 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.5 -0.773 . . . . 70.239999999999995 110.304 174.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.527 ' HB3' HG12 ' A' ' 101' ' ' ILE . 87.8 t80 -138.67 115.58 10.83 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.461 -0.57 . . . . 75.420000000000002 109.461 174.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.3 t -81.0 134.34 27.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 107.986 -1.116 . . . . 74.5 107.986 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.23 116.64 8.24 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.763 -0.458 . . . . 75.239999999999995 109.763 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.2 p -71.45 -23.87 61.91 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.465 0.706 . . . . 71.400000000000006 110.501 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.75 -172.01 29.67 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.273 -0.876 . . . . 75.510000000000005 112.097 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.44 -28.8 68.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.325 1.05 . . . . 75.439999999999998 110.72 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -75.25 -16.85 60.43 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.292 1.037 . . . . 71.150000000000006 113.019 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.5 p -109.3 158.6 17.71 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.679 0.792 . . . . 72.409999999999997 110.607 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 125' ' ' ASN . 66.8 tp -107.88 130.72 54.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.33 0.652 . . . . 74.230000000000004 109.701 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 p -78.12 113.38 16.01 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.308 -0.627 . . . . 62.130000000000003 109.308 172.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 91' ' ' PHE . 34.2 pt -122.22 161.7 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.68 -0.859 . . . . 74.400000000000006 108.68 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.7 m -135.4 151.66 50.66 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 109.304 -0.628 . . . . 75.409999999999997 109.304 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -53.37 117.22 2.9 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.224 0.61 . . . . 71.450000000000003 111.089 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.59 -27.5 7.94 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.973 -0.558 . . . . 70.099999999999994 113.218 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -72.25 122.57 21.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.31 0.644 . . . . 72.430000000000007 110.323 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -84.31 124.61 31.44 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.935 0.494 . . . . 75.239999999999995 110.27 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 19.7 mt -105.55 135.28 47.23 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.702 0.801 . . . . 73.329999999999998 110.365 -168.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -95.35 107.53 19.67 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.111 -1.44 . . . . 72.450000000000003 107.111 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.7 t -97.51 124.47 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.987 -0.746 . . . . 72.239999999999995 108.987 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.4 mt -70.56 -36.27 73.55 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.529 0.681 . . . . 74.120000000000005 109.58 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.13 178.63 41.76 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 114.66 -1.155 . . . . 51.420000000000002 111.357 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 2.4 m-30 -94.99 174.33 7.14 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.785 -0.82 . . . . 72.349999999999994 108.785 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -72.33 159.12 34.56 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.612 -0.722 . . . . 71.219999999999999 109.795 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -58.07 -24.81 59.95 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.526 1.13 . . . . 65.430000000000007 111.76 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.434 ' HB3' ' HG2' ' A' ' 117' ' ' GLU . 56.5 t30 -95.98 -21.97 17.68 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.924 0.49 . . . . 74.049999999999997 111.144 174.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.04 -0.18 83.8 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 122.7 0.191 . . . . 63.210000000000001 113.025 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.434 ' HG2' ' HB3' ' A' ' 115' ' ' ASN . 8.4 pt-20 -57.68 -52.42 65.5 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.008 1.323 . . . . 71.409999999999997 112.081 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -118.58 177.28 4.89 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.28 1.032 . . . . 75.319999999999993 110.12 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -146.93 124.46 11.72 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.649 0.78 . . . . 65.310000000000002 109.411 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -85.24 105.8 16.19 Favored 'General case' 0 C--O 1.249 1.064 0 CA-C-O 121.071 0.462 . . . . 63.420000000000002 110.537 -173.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.11 153.21 20.53 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 115.102 -0.953 . . . . 53.100000000000001 110.086 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -141.8 124.72 16.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.789 0.836 . . . . 71.409999999999997 110.081 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 59.6 p -133.7 -167.3 1.92 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.563 0.745 . . . . 52.340000000000003 110.47 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -58.48 -22.5 55.09 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.539 1.135 . . . . 55.520000000000003 111.116 170.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.457 ' HB2' HD11 ' A' ' 99' ' ' LEU . 53.5 m-20 -84.99 6.11 26.47 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.894 1.278 . . . . 42.299999999999997 111.754 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.77 -128.98 9.75 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 111.001 -0.84 . . . . 72.400000000000006 111.001 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -151.53 162.17 41.42 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.53 0.665 . . . . 63.240000000000002 111.736 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 165.23 171.51 31.55 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.777 -0.647 . . . . 35.509999999999998 112.9 170.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.448 ' HZ2' ' HG2' ' A' ' 24' ' ' LYS . 94.7 m95 -79.29 117.55 20.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.549 0.74 . . . . 70.209999999999994 110.92 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.2 m -117.58 154.88 50.84 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.373 1.069 . . . . 73.239999999999995 108.564 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.38 131.57 15.24 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 121.557 1.505 . . . . 64.310000000000002 111.152 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.569 ' HA ' HG12 ' A' ' 135' ' ' ILE . 23.9 t -63.53 -14.97 56.46 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.921 0.488 . . . . 63.210000000000001 111.547 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -69.89 -25.46 63.71 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.22 1.008 . . . . 70.530000000000001 111.016 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.562 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 6.5 m-30 -95.58 -3.09 47.07 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.577 0.751 . . . . 74.120000000000005 112.739 -177.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.569 HG12 ' HA ' ' A' ' 132' ' ' SER . 12.6 pt -129.42 161.06 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 118.113 0.415 . . . . 74.219999999999999 110.847 -171.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 10.0 t -145.72 139.24 14.58 Favored Pre-proline 0 N--CA 1.483 1.218 0 C-N-CA 123.075 0.55 . . . . 72.310000000000002 110.045 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.501 ' HB2' ' HB2' ' A' ' 140' ' ' SER . 74.1 Cg_endo -74.52 116.64 4.68 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.3 2.0 . . . . 53.149999999999999 111.889 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.9 m -89.51 -25.76 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.069 0.547 . . . . 63.200000000000003 111.492 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.583 ' HB3' ' H ' ' A' ' 84' ' ' LEU . 65.6 t30 -94.17 18.67 10.45 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 122.01 0.91 . . . . 75.310000000000002 110.142 173.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.501 ' HB2' ' HB2' ' A' ' 137' ' ' PRO . 32.3 t -64.84 162.84 15.41 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.445 0.698 . . . . 72.129999999999995 110.515 170.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.6 mt -73.6 -12.11 60.65 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 123.568 0.747 . . . . 75.400000000000006 109.828 173.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.69 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 39.2 tt0 -49.51 -27.65 4.57 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 127.38 2.272 . . . . 75.409999999999997 115.68 -175.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.408 ' H ' ' HD3' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -60.65 -31.04 70.27 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 118.625 0.648 . . . . 71.299999999999997 110.314 177.257 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -79.63 123.59 27.77 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.047 -1.094 . . . . 61.140000000000001 108.047 166.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.0 p -61.11 -10.74 6.76 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.96 1.096 . . . . 73.219999999999999 113.96 -168.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.471 ' CE3' HG21 ' A' ' 218' ' ' VAL . 61.7 p-90 -71.17 -40.58 71.19 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 111.885 0.328 . . . . 72.209999999999994 111.885 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 142' ' ' GLU . 36.1 t80 -97.62 146.78 24.97 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 110.172 -0.307 . . . . 74.129999999999995 110.172 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.69 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 61.6 m-70 -146.06 60.97 1.25 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.001 0.52 . . . . 73.329999999999998 110.687 175.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 57.53 -165.58 6.21 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 116.97 1.548 . . . . 55.509999999999998 116.97 164.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 71.6 Cg_endo -80.09 102.86 1.48 Allowed 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.433 2.756 . . . . 45.539999999999999 112.263 168.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.434 HG21 HH21 ' A' ' 171' ' ' ARG . 21.3 t -139.31 155.36 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.132 0.973 . . . . 72.109999999999999 110.24 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.3 m -89.52 173.03 8.55 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.245 1.018 . . . . 53.439999999999998 113.425 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -62.96 -34.17 76.93 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.646 -1.161 . . . . 53.130000000000003 113.16 -173.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -61.64 -57.93 10.08 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 123.607 0.567 . . . . 75.420000000000002 110.595 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.91 -31.34 71.86 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.4 0.68 . . . . 60.039999999999999 111.017 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.75 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.1 -56.99 14.92 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.365 0.603 . . . . 75.109999999999999 111.255 173.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -71.75 -23.98 61.69 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.249 -0.887 . . . . 74.150000000000006 110.797 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -63.98 -51.79 62.63 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.981 0.912 . . . . 65.409999999999997 110.33 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.56 HD12 HH12 ' A' ' 171' ' ' ARG . 79.2 mt -68.9 -40.89 78.91 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.024 0.44 . . . . 53.43 110.931 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.47 HD23 HG13 ' A' ' 190' ' ' VAL . 34.2 tp -67.09 -22.65 65.82 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.479 -0.782 . . . . 72.040000000000006 112.272 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.9 t -58.26 -30.09 66.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.979 0.911 . . . . 63.240000000000002 111.447 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.8 t -88.11 8.5 26.53 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.419 0.687 . . . . 62.229999999999997 111.571 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -100.49 150.6 18.87 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 122.324 -0.235 . . . . 44.030000000000001 113.481 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.6 pt -97.43 -166.32 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.044 0.938 . . . . 74.420000000000002 109.47 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 25.4 p-10 -51.21 118.65 3.38 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.798 0.839 . . . . 53.25 112.619 -176.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.73 14.01 68.63 Favored Glycine 0 C--O 1.257 1.542 0 CA-C-N 116.253 -0.43 . . . . 42.549999999999997 113.768 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 63.2 p -70.94 138.78 50.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.316 -0.624 . . . . 65.209999999999994 109.316 174.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.415 ' HB3' HD23 ' A' ' 184' ' ' LEU . 18.5 p90 -139.28 156.24 47.19 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.231 0.826 . . . . 71.420000000000002 113.231 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 236' ' ' ALA . 96.8 mt -134.16 134.5 42.22 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.428 -1.26 . . . . 62.420000000000002 108.581 169.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.41 HG22 HG12 ' A' ' 182' ' ' ILE . 25.8 t -114.63 126.98 72.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 107.057 -1.46 . . . . 54.100000000000001 107.057 174.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.75 HH11 ' HA ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -159.84 150.04 18.65 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.226 0.61 . . . . 65.439999999999998 110.019 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 14.1 pt-20 -94.77 163.96 13.14 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.973 -0.751 . . . . 52.030000000000001 108.973 177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 176' ' ' SER . 35.4 m -87.03 141.12 28.9 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.645 0.26 . . . . 65.439999999999998 111.532 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.55 -37.46 86.2 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.849 0.859 . . . . 73.349999999999994 110.416 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 63.0 p -86.07 -10.2 55.37 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.207 -1.36 . . . . 61.340000000000003 112.471 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 173' ' ' SER . 12.0 m -139.28 88.31 13.04 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.338 0.655 . . . . 72.439999999999998 109.533 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.39 124.25 13.48 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.96 2.44 . . . . 75.530000000000001 112.11 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.84 -22.25 29.42 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.868 -0.606 . . . . 71.140000000000001 113.744 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -82.8 117.67 22.85 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 108.878 -0.786 . . . . 75.140000000000001 108.878 176.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 70.1 mtt-85 -111.15 169.07 9.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.137 -0.938 . . . . 73.340000000000003 110.842 -170.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.5 m -152.0 149.75 29.22 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.722 0.809 . . . . 54.240000000000002 110.136 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.41 HG12 HG22 ' A' ' 170' ' ' VAL . 48.7 mt -116.95 139.96 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 108.732 -0.84 . . . . 52.520000000000003 108.732 169.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.417 ' HB3' HD22 ' A' ' 160' ' ' LEU . 18.6 m -118.75 111.64 18.74 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.13 1.372 . . . . 75.120000000000005 107.908 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.467 HD21 HD23 ' A' ' 232' ' ' LEU . 29.9 mt -106.14 137.94 43.2 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.317 1.047 . . . . 75.439999999999998 111.256 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -126.92 126.15 42.76 Favored 'General case' 0 C--O 1.256 1.401 0 N-CA-C 108.656 -0.868 . . . . 74.340000000000003 108.656 170.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.79 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 6.2 p90 -138.35 141.69 39.7 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.143 -1.058 . . . . 73.409999999999997 108.143 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 52.38 23.61 2.55 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.104 0.961 . . . . 74.510000000000005 113.547 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 96.82 -11.18 66.34 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 123.05 0.357 . . . . 74.109999999999999 113.576 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -101.98 126.76 48.97 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.751 0.82 . . . . 61.329999999999998 111.149 -173.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.47 HG13 HD23 ' A' ' 160' ' ' LEU . 80.0 t -95.14 142.42 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.199 1.0 . . . . 75.430000000000007 110.461 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.402 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 23.2 p90 -146.41 154.5 41.69 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.325 1.05 . . . . 74.329999999999998 109.431 165.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -128.05 142.39 51.23 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.829 0.852 . . . . 74.549999999999997 108.732 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -141.76 151.55 42.98 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 120.985 0.421 . . . . 71.239999999999995 110.341 174.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -78.95 145.29 34.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.29 -0.868 . . . . 74.5 111.304 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 79.8 mt -89.49 104.23 14.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 106.754 -1.573 . . . . 62.520000000000003 106.754 161.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -71.22 127.06 31.33 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.193 -0.912 . . . . 74.319999999999993 108.668 -177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 31.8 m -99.52 116.58 31.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.168 0.587 . . . . 73.400000000000006 109.862 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.09 166.61 4.59 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.557 1.143 . . . . 74.549999999999997 111.575 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 55.9 p -62.29 -35.72 79.9 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.153 -0.476 . . . . 74.310000000000002 110.487 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -69.05 -12.77 61.98 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.533 0.733 . . . . 34.420000000000002 111.775 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 96.27 -5.49 65.42 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 116.458 -0.337 . . . . 62.32 112.313 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -62.49 141.93 58.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.561 0.744 . . . . 64.109999999999999 110.798 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 81.4 mt -93.87 144.36 25.51 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.195 -0.669 . . . . 74.150000000000006 109.195 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -162.78 161.49 26.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.094 0.558 . . . . 73.010000000000005 109.891 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 70.7 t -135.54 -55.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.375 -0.972 . . . . 74.120000000000005 108.375 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 9.9 m -90.96 169.86 10.54 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.379 0.671 . . . . 63.329999999999998 109.699 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 61.3 m -69.66 -48.22 60.55 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.509 0.559 . . . . 43.119999999999997 112.509 -171.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -73.62 -26.41 60.77 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.271 0.629 . . . . 63.530000000000001 110.795 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 58.0 m -67.91 118.19 10.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.234 1.014 . . . . 65.299999999999997 110.684 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -142.48 126.9 17.74 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.432 1.093 . . . . 75.219999999999999 108.324 175.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -135.64 141.26 45.02 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.033 0.379 . . . . 62.439999999999998 111.056 -173.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -91.58 -21.72 20.69 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.471 -0.786 . . . . 75.120000000000005 109.94 169.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 48.4 p -127.7 142.46 51.32 Favored 'General case' 0 C--N 1.363 1.185 0 CA-C-O 121.674 0.749 . . . . 74.099999999999994 111.88 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.4 HD11 HG11 ' A' ' 170' ' ' VAL . 30.1 tp -65.57 -28.7 69.34 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.404 -1.271 . . . . 74.200000000000003 110.764 175.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.89 97.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.408 0.683 . . . . 64.25 110.521 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.9 -30.27 63.8 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.474 0.31 . . . . 74.510000000000005 111.518 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.0 tt -61.04 -44.0 98.05 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.271 0.357 . . . . 75.310000000000002 110.555 170.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.471 HG21 ' CE3' ' A' ' 146' ' ' TRP . 42.5 t -70.18 -40.07 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.334 0.653 . . . . 53.109999999999999 111.006 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -60.42 -50.81 72.1 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.784 0.802 . . . . 74.439999999999998 110.486 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.415 ' O ' HG22 ' A' ' 224' ' ' VAL . 49.6 t60 -56.32 -54.65 42.95 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.285 -1.325 . . . . 73.340000000000003 110.335 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -63.52 -25.18 68.14 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.137 0.575 . . . . 75.409999999999997 112.141 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 23.0 t -74.61 -28.2 60.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.272 0.229 . . . . 44.539999999999999 110.994 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.8 t -103.9 -22.49 13.49 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.021 1.86 . . . . 63.100000000000001 116.021 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 220' ' ' HIS . 29.0 m -90.83 120.42 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 120.495 1.498 . . . . 74.439999999999998 114.344 -165.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.2 -1.32 9.87 Favored 'General case' 0 CA--C 1.57 1.715 0 C-N-CA 127.783 2.433 . . . . 73.340000000000003 112.745 171.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.19 14.72 1.1 Allowed 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 128.142 2.577 . . . . 65.409999999999997 114.311 -145.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.76 17.23 4.28 Favored Glycine 0 N--CA 1.467 0.755 0 O-C-N 121.805 -0.559 . . . . 64.530000000000001 111.926 -166.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 64.2 mt -91.36 133.73 35.2 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.045 -0.724 . . . . 74.209999999999994 109.045 156.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.402 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 93.4 mt -57.91 -52.48 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 109.233 -0.655 . . . . 74.540000000000006 109.233 172.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.3 t -130.52 150.35 51.77 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.944 -1.026 . . . . 72.439999999999998 108.282 167.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 69.8 p -80.02 170.6 16.24 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 109.05 -0.722 . . . . 75.019999999999996 109.05 171.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.467 HD23 HD21 ' A' ' 184' ' ' LEU . 26.2 mt -74.88 102.59 4.8 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 108.896 -0.779 . . . . 64.299999999999997 108.896 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -78.64 -57.62 3.67 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.16 -0.682 . . . . 75.510000000000005 109.16 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 167' ' ' SER . 7.3 p90 -154.8 151.17 22.8 Favored Pre-proline 0 N--CA 1.483 1.184 0 N-CA-C 109.832 -0.433 . . . . 72.329999999999998 109.832 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.82 138.52 44.98 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.105 1.87 . . . . 72.310000000000002 111.578 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.472 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -58.83 127.06 82.45 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 109.231 -0.655 . . . . 64.549999999999997 109.231 173.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.06 158.69 28.82 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.853 2.368 . . . . 64.219999999999999 113.281 -172.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt . . . . . 0 C--N 1.348 0.511 0 N-CA-C 109.052 -0.722 . . . . 61.229999999999997 109.052 174.281 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 121.29 0.566 . . . . 64.230000000000004 111.801 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.9 mt -103.32 124.63 37.57 Favored Pre-proline 0 C--O 1.242 0.658 0 N-CA-C 108.1 -1.074 . . . . 64.25 108.1 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.02 168.62 21.37 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.289 1.993 . . . . 62.020000000000003 111.244 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' HB3' ' NE2' ' A' ' 21' ' ' HIS . . . -83.03 148.22 27.68 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.773 0.32 . . . . 74.140000000000001 110.446 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.559 HD22 HD11 ' A' ' 23' ' ' ILE . 73.6 mt -84.58 94.77 8.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.86 -1.163 . . . . 63.43 107.86 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.423 ' NE2' ' HB3' ' A' ' 19' ' ' ALA . 34.1 m170 -96.24 -50.12 4.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.684 -0.689 . . . . 73.409999999999997 110.522 -174.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.488 ' HB2' ' OD1' ' A' ' 113' ' ' ASN . 73.8 m-85 -102.76 107.35 18.19 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.875 -0.787 . . . . 75.010000000000005 108.875 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.559 HD11 HD22 ' A' ' 20' ' ' LEU . 45.4 mm -122.6 114.05 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.034 -1.098 . . . . 73.209999999999994 108.034 175.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 123.346 0.658 . . . . 75.310000000000002 110.161 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.499 1.843 0 N-CA-C 114.025 0.74 . . . . 73.099999999999994 114.025 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -135.48 67.07 1.49 Allowed 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.086 -1.079 . . . . 62.240000000000002 108.086 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.547 HD11 ' HB3' ' A' ' 106' ' ' LYS . 18.0 tp -85.83 114.53 22.84 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 121.275 0.559 . . . . 75.510000000000005 109.526 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 5.1 m-85 -104.8 175.09 5.61 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.777 1.631 . . . . 70.0 109.401 173.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.93 142.73 31.51 Favored 'Isoleucine or valine' 0 C--O 1.251 1.133 0 N-CA-C 108.073 -1.084 . . . . 65.140000000000001 108.073 169.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.466 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -77.42 117.65 19.1 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.548 0.53 . . . . 71.340000000000003 109.814 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.2 mt -80.67 -11.11 59.68 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.269 0.628 . . . . 63.43 111.284 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.434 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 54.1 m-85 -138.79 156.64 47.18 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.911 0.884 . . . . 74.25 109.025 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.84 130.88 35.29 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.066 -1.087 . . . . 65.340000000000003 108.066 168.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -141.0 124.1 16.41 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.563 -0.902 . . . . 74.409999999999997 108.563 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.31 138.95 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.037 -0.727 . . . . 75.340000000000003 109.037 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.02 133.89 56.49 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.297 0.639 . . . . 52.509999999999998 111.743 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.5 t -81.01 -6.17 58.47 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.355 1.062 . . . . 61.43 110.855 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.33 -162.11 35.91 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.649 -0.58 . . . . 54.310000000000002 111.649 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.52 -34.21 76.65 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.302 1.041 . . . . 51.310000000000002 111.084 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.474 ' ND2' HD13 ' A' ' 20' ' ' LEU . 30.0 p-10 -82.53 9.96 8.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.047 0.939 . . . . 74.349999999999994 112.59 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.1 p -135.49 153.96 51.56 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.335 1.054 . . . . 75.099999999999994 108.833 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.0 tp -110.25 135.7 50.59 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.869 0.468 . . . . 73.439999999999998 110.463 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.4 m -78.54 114.56 17.56 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.404 -0.962 . . . . 72.129999999999995 108.404 169.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.5 pt -118.87 144.72 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.611 0.765 . . . . 71.430000000000007 109.3 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 4.8 m -107.78 146.29 32.39 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.351 -0.611 . . . . 74.329999999999998 109.351 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -63.42 109.11 1.5 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.735 0.414 . . . . 53.450000000000003 110.995 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.73 1.69 34.56 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 116.064 -0.516 . . . . 31.120000000000001 112.748 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.62 136.36 33.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.326 1.05 . . . . 43.0 110.181 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.547 ' HB3' HD11 ' A' ' 84' ' ' LEU . 66.4 mttm -82.8 112.99 20.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.832 0.853 . . . . 65.5 109.55 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 87' ' ' ALA . 16.8 mt -100.72 138.05 38.3 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.781 0.832 . . . . 71.230000000000004 108.925 -173.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -108.59 107.32 17.77 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.139 -1.06 . . . . 70.109999999999999 108.139 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 88.1 t -100.14 129.88 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.422 0.689 . . . . 54.210000000000001 109.221 -173.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.4 mt -85.1 -22.82 28.74 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.7 0.4 . . . . 65.519999999999996 110.844 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.73 174.88 37.1 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.779 -0.646 . . . . 73.129999999999995 111.839 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 13.4 m-30 -94.84 174.92 6.86 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.267 0.627 . . . . 75.200000000000003 109.633 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.488 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 57.4 t30 -62.03 159.5 14.27 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.494 1.118 . . . . 71.150000000000006 109.572 173.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -65.91 -18.26 65.22 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 122.487 0.315 . . . . 73.099999999999994 110.696 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -111.44 5.89 19.91 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.555 0.742 . . . . 72.019999999999996 111.398 171.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.87 2.87 53.6 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 115.427 0.931 . . . . 72.310000000000002 115.427 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -60.67 -59.05 6.01 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.345 1.058 . . . . 65.409999999999997 110.907 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -104.49 179.34 4.3 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.142 -1.39 . . . . 73.340000000000003 109.55 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -150.89 121.46 7.44 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.996 0.918 . . . . 70.5 109.376 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.406 ' HG2' HE21 ' A' ' 127' ' ' GLN . 36.4 tt0 -75.75 100.33 4.68 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 120.985 0.421 . . . . 73.019999999999996 110.207 -176.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -103.86 157.41 17.11 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.944 0.898 . . . . 73.340000000000003 110.242 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -142.92 126.78 17.17 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.86 0.864 . . . . 74.530000000000001 109.471 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.2 p -136.1 -171.61 2.92 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.49 1.116 . . . . 62.130000000000003 109.686 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -70.01 -7.3 39.79 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.363 0.665 . . . . 73.129999999999995 111.504 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -84.61 -13.19 52.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.116 0.967 . . . . 75.5 111.316 173.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 128.07 -142.36 13.45 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.853 -0.499 . . . . 52.229999999999997 111.853 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.406 HE21 ' HG2' ' A' ' 120' ' ' GLU . 55.2 tt0 -151.69 145.68 25.22 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.376 0.67 . . . . 72.329999999999998 110.833 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 173.58 179.01 43.96 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.442 -0.799 . . . . 73.120000000000005 111.717 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -82.07 123.37 28.88 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.693 0.797 . . . . 73.349999999999994 110.433 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.88 148.32 41.87 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 124.738 1.215 . . . . 71.010000000000005 109.025 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.95 130.69 25.08 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 121.871 1.714 . . . . 54.25 111.008 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.1 m -61.42 -19.37 61.86 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.942 0.897 . . . . 63.43 112.698 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -72.97 -21.39 60.86 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.941 0.896 . . . . 61.240000000000002 111.537 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.434 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.1 m-85 -94.36 -3.99 49.33 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.566 0.746 . . . . 64.310000000000002 112.608 -175.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.4 pt -128.36 151.74 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.039 0.536 . . . . 75.129999999999995 110.525 -171.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 8.2 t -141.28 133.54 13.97 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 122.602 0.361 . . . . 44.25 110.637 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 59.2 Cg_endo -72.43 117.78 5.29 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.522 2.148 . . . . 70.120000000000005 112.116 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 22.9 m -80.22 -36.92 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.158 0.583 . . . . 73.409999999999997 110.11 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -73.43 -9.76 59.02 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.365 0.666 . . . . 72.239999999999995 111.295 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 143' ' ' LYS . 28.6 t -39.16 129.28 1.69 Allowed 'General case' 0 C--N 1.363 1.174 0 C-N-CA 125.281 1.433 . . . . 73.200000000000003 112.447 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 72.0 mt -60.82 -10.07 5.01 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.482 0.713 . . . . 61.0 111.591 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -57.1 -19.59 20.52 Favored 'General case' 0 C--N 1.365 1.246 0 C-N-CA 124.732 1.213 . . . . 74.420000000000002 112.634 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 140' ' ' SER . 2.4 mmmp? -61.09 -24.99 66.64 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.164 0.506 . . . . 73.099999999999994 110.243 171.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -94.0 120.74 34.68 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 106.371 -1.714 . . . . 74.25 106.371 163.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.5 t -57.32 -17.42 12.15 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.257 1.206 . . . . 73.019999999999996 114.257 -166.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.503 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 51.2 p-90 -66.74 -50.43 62.8 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.689 0.626 . . . . 62.539999999999999 112.689 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.427 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 75.7 t80 -79.42 148.0 32.11 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.898 0.479 . . . . 75.200000000000003 110.426 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.45 ' CD2' HD22 ' A' ' 169' ' ' LEU . 87.9 m-70 -135.85 -27.16 1.15 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.203 0.601 . . . . 73.120000000000005 110.47 171.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 100.15 -151.28 19.11 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.139 -0.812 . . . . 73.400000000000006 114.609 171.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 33.6 Cg_endo -63.04 89.47 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.273 2.649 . . . . 72.049999999999997 110.781 175.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 86.9 t -130.43 149.56 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 115.708 -0.678 . . . . 71.400000000000006 110.244 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.6 m -60.91 148.63 39.02 Favored 'General case' 0 C--O 1.246 0.921 0 C-N-CA 124.744 1.217 . . . . 71.400000000000006 112.333 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 41.0 ttt-85 -57.16 -39.35 75.1 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.451 -0.795 . . . . 55.020000000000003 110.033 172.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -60.27 -58.59 7.87 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.735 -1.121 . . . . 41.520000000000003 110.554 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -56.72 -39.08 73.26 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.035 0.835 . . . . 63.210000000000001 111.328 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.06 -61.54 2.56 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.362 -0.835 . . . . 63.299999999999997 111.776 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -70.5 -20.0 62.88 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.245 -0.889 . . . . 75.0 110.805 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -74.11 -51.29 16.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.701 0.8 . . . . 74.540000000000006 110.691 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 71.1 mt -63.8 -39.44 94.25 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.111 0.482 . . . . 74.340000000000003 109.892 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.435 HD23 HG13 ' A' ' 190' ' ' VAL . 27.4 tp -72.34 -18.61 61.75 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.142 -0.936 . . . . 63.409999999999997 111.197 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.492 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 17.3 t -67.17 -23.13 65.74 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.934 0.494 . . . . 73.430000000000007 110.902 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.1 t -91.12 8.63 34.64 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.89 0.876 . . . . 75.209999999999994 110.52 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.21 159.64 30.07 Favored Glycine 0 C--N 1.343 0.958 0 C-N-CA 123.088 0.375 . . . . 73.409999999999997 112.67 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 18.9 pt -126.09 -165.24 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 C-N-CA 124.184 0.994 . . . . 74.219999999999999 110.424 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 14.0 p-10 -56.86 99.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.815 1.043 . . . . 71.120000000000005 113.815 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 103.65 13.54 27.67 Favored Glycine 0 C--O 1.259 1.696 0 CA-C-N 116.162 -0.472 . . . . 63.530000000000001 112.818 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 23.0 t -77.65 136.47 38.22 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.854 -0.424 . . . . 63.509999999999998 109.854 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.472 ' HB3' HD23 ' A' ' 184' ' ' LEU . 17.1 p90 -139.49 159.87 41.16 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.125 0.787 . . . . 75.219999999999999 113.125 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 236' ' ' ALA . 95.4 mt -137.61 134.4 35.5 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.33 1.052 . . . . 71.109999999999999 108.578 170.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 43.9 t -109.68 124.62 66.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 108.685 -0.857 . . . . 71.040000000000006 108.685 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.8 mtp-105 -142.81 168.38 19.86 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.936 0.894 . . . . 71.030000000000001 111.03 -174.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.794 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 2.9 pt-20 -120.46 166.1 14.05 Favored 'General case' 0 C--O 1.26 1.645 0 C-N-CA 124.547 1.139 . . . . 65.329999999999998 110.679 159.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.2 m -74.61 146.3 42.59 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.339 -1.3 . . . . 52.109999999999999 110.505 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.9 -43.16 75.8 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.67 0.788 . . . . 71.519999999999996 111.105 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.2 m -84.66 -43.91 13.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.483 -0.78 . . . . 62.32 111.709 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.6 t -112.56 97.09 39.25 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 109.289 -0.634 . . . . 44.420000000000002 109.289 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -69.18 147.17 65.98 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.074 2.516 . . . . 71.319999999999993 111.593 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.52 -23.85 8.14 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 116.329 -0.396 . . . . 41.32 112.996 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -80.69 116.12 20.54 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 107.127 -1.434 . . . . 73.109999999999999 107.127 170.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.794 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 83.7 mtt85 -122.45 166.48 14.69 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.13 0.572 . . . . 64.019999999999996 111.228 -168.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 65.4 m -151.84 138.03 18.35 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.235 1.014 . . . . 71.409999999999997 109.838 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 63.0 mt -105.17 140.37 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 107.849 -1.167 . . . . 71.120000000000005 107.849 165.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 15.5 m -116.29 113.6 23.2 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.384 1.074 . . . . 73.329999999999998 108.388 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.489 HD21 HD23 ' A' ' 232' ' ' LEU . 39.5 mt -104.3 144.01 32.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.153 0.981 . . . . 63.439999999999998 111.301 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.492 ' NH1' ' HA ' ' A' ' 161' ' ' SER . 21.1 ttt180 -134.48 138.16 44.5 Favored 'General case' 0 C--O 1.25 1.132 0 CA-C-N 114.637 -1.165 . . . . 74.310000000000002 110.03 172.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 10.2 p90 -157.71 139.18 13.73 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.838 -1.074 . . . . 71.219999999999999 108.108 171.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 54.49 31.37 14.65 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.583 1.153 . . . . 74.439999999999998 113.537 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.73 9.53 86.26 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.343 -0.39 . . . . 74.420000000000002 113.817 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 28.7 tpt180 -102.9 127.09 50.24 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.501 1.12 . . . . 73.099999999999994 109.411 175.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.435 HG13 HD23 ' A' ' 160' ' ' LEU . 94.9 t -114.08 129.85 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.78 1.232 . . . . 73.010000000000005 108.971 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.407 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 22.5 p90 -145.36 160.73 41.09 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.051 0.941 . . . . 74.329999999999998 109.061 174.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -134.42 148.27 50.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.104 0.962 . . . . 75.219999999999999 108.506 -171.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -145.29 145.67 31.34 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.68 0.392 . . . . 71.25 110.867 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -76.82 146.31 37.87 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.375 1.07 . . . . 75.450000000000003 112.149 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.763 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 64.3 mt -104.52 119.18 53.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 N-CA-C 107.393 -1.336 . . . . 74.409999999999997 107.393 163.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -91.02 145.04 25.03 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 109.637 -0.505 . . . . 70.540000000000006 109.637 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 18.1 m -106.02 128.07 53.59 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.969 0.908 . . . . 72.340000000000003 109.449 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 202' ' ' LYS . . . -85.37 158.66 20.19 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.709 0.803 . . . . 73.340000000000003 109.432 170.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 15.8 t -65.6 -9.64 28.59 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.842 1.053 . . . . 63.210000000000001 113.842 -169.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.42 ' HB2' ' HG3' ' A' ' 202' ' ' LYS . 80.9 m-20 -87.46 11.73 13.99 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.117 0.567 . . . . 73.450000000000003 111.833 175.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 75.2 12.48 83.47 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 111.954 -0.458 . . . . 71.409999999999997 111.954 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.639 ' HB2' ' HB3' ' A' ' 198' ' ' ALA . 98.4 mttt -79.65 153.33 29.44 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 123.88 0.872 . . . . 65.109999999999999 110.441 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 90.5 mt -118.37 148.14 42.82 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.342 0.657 . . . . 73.219999999999999 109.41 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -162.91 154.99 18.33 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.193 0.597 . . . . 72.040000000000006 109.981 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 79.2 t -125.01 -63.59 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.09 -1.078 . . . . 51.43 108.09 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.4 t -113.02 -175.54 2.69 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.15 -0.932 . . . . 74.129999999999995 110.035 -174.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 49.9 m -62.33 -47.8 82.62 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.45 1.1 . . . . 64.310000000000002 112.979 -170.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -85.57 3.17 41.85 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 122.182 0.193 . . . . 70.129999999999995 111.124 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 73.0 m -98.81 106.41 18.67 Favored 'General case' 0 C--O 1.215 -0.732 0 C-N-CA 123.608 0.763 . . . . 74.120000000000005 109.97 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -143.31 118.37 10.07 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.842 1.257 . . . . 64.239999999999995 107.685 171.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -134.99 154.93 51.56 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.073 0.549 . . . . 74.049999999999997 110.659 -170.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -91.53 -31.39 15.96 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 123.677 0.611 . . . . 65.310000000000002 109.907 169.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' THR . . . . . 0.413 ' OG1' ' HG2' ' A' ' 216' ' ' GLU . 48.5 p -131.14 157.92 41.86 Favored 'General case' 0 C--O 1.253 1.289 0 CA-C-O 122.324 1.059 . . . . 64.109999999999999 112.104 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.419 ' O ' HG23 ' A' ' 218' ' ' VAL . 23.1 tp -72.78 -27.92 62.29 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 113.765 -1.561 . . . . 72.140000000000001 111.396 -176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.84 -43.27 93.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.878 0.471 . . . . 74.439999999999998 110.521 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.413 ' HG2' ' OG1' ' A' ' 213' ' ' THR . 21.0 mm-40 -68.9 -35.04 76.38 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 115.768 -0.651 . . . . 72.230000000000004 110.146 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tt -55.78 -50.01 71.6 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.951 0.782 . . . . 64.150000000000006 110.91 171.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 214' ' ' LEU . 55.4 t -63.8 -45.75 96.3 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 O-C-N 123.956 0.785 . . . . 63.299999999999997 111.055 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -58.01 -53.32 59.59 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.581 0.705 . . . . 71.409999999999997 111.14 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.435 ' CE1' HG11 ' A' ' 224' ' ' VAL . 61.5 t60 -54.48 -51.68 64.29 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.016 -0.993 . . . . 73.340000000000003 109.425 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -66.54 -22.77 66.16 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.265 -0.88 . . . . 73.319999999999993 112.077 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.2 m -72.98 -27.05 61.57 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.745 0.418 . . . . 71.120000000000005 110.583 173.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.8 t -120.25 4.22 10.81 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 116.206 1.928 . . . . 63.219999999999999 116.206 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.435 HG11 ' CE1' ' A' ' 220' ' ' HIS . 26.8 m -107.92 156.44 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 116.085 1.883 . . . . 73.510000000000005 116.085 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -92.56 -0.49 57.32 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 111.111 -2.768 . . . . 63.420000000000002 113.274 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -77.62 14.3 1.06 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 128.169 2.588 . . . . 72.25 113.999 -143.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.46 17.52 4.77 Favored Glycine 0 N--CA 1.467 0.751 0 O-C-N 120.724 -1.235 . . . . 72.420000000000002 111.321 -169.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.1 mt -92.17 118.08 30.5 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.731 -1.234 . . . . 63.329999999999998 108.605 165.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.407 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 76.8 mt -59.74 -46.42 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 123.868 0.73 . . . . 43.340000000000003 109.478 173.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.1 t -130.77 142.7 50.42 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.109 -1.071 . . . . 71.349999999999994 108.109 167.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 55.6 p -69.02 157.35 36.97 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.777 0.431 . . . . 75.129999999999995 110.524 174.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.489 HD23 HD21 ' A' ' 184' ' ' LEU . 23.1 mt -66.96 101.37 0.84 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 108.729 -0.841 . . . . 72.219999999999999 108.729 177.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -88.26 -53.64 4.6 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.838 -0.801 . . . . 73.310000000000002 108.838 -173.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -158.91 145.43 12.63 Favored Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 115.083 -0.962 . . . . 63.210000000000001 110.793 -177.734 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.503 ' HB3' ' HA ' ' A' ' 146' ' ' TRP . 51.6 Cg_endo -68.59 163.43 36.91 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 121.781 1.654 . . . . 73.010000000000005 113.096 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.537 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -73.42 125.57 90.61 Favored Pre-proline 0 C--O 1.244 0.812 0 N-CA-C 108.861 -0.792 . . . . 73.120000000000005 108.861 170.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.36 132.43 27.48 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.058 1.839 . . . . 73.420000000000002 111.642 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 21.3 pttp . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 123.62 0.768 . . . . 61.32 109.976 175.066 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.6 p . . . . . 0 CA--C 1.551 1.001 0 CA-C-O 121.143 0.497 . . . . 60.310000000000002 111.397 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.7 mt -103.89 133.28 20.34 Favored Pre-proline 0 N--CA 1.476 0.86 0 N-CA-C 108.77 -0.826 . . . . 62.439999999999998 108.77 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.26 169.8 19.84 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.387 2.058 . . . . 72.120000000000005 112.688 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.64 142.19 30.98 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.098 0.559 . . . . 74.010000000000005 110.63 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HB3' HD11 ' A' ' 23' ' ' ILE . 75.6 mt -88.35 96.93 10.77 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.636 0.774 . . . . 73.219999999999999 109.035 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -97.04 -47.79 5.65 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.57 -0.741 . . . . 74.540000000000006 109.75 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -103.46 109.95 21.79 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.507 -0.77 . . . . 74.299999999999997 109.289 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 20' ' ' LEU . 25.7 mm -117.29 120.01 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.387 1.075 . . . . 74.120000000000005 109.892 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.4 pttp . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 107.574 -1.269 . . . . 73.120000000000005 107.574 167.121 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.559 1.762 0 N-CA-C 113.922 0.701 . . . . 64.109999999999999 113.922 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -90.46 40.16 1.0 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.824 0.85 . . . . 71.510000000000005 111.672 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 57.4 tp -83.72 112.55 20.17 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.512 0.672 . . . . 74.25 110.553 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.41 173.33 6.37 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.813 1.645 . . . . 65.140000000000001 108.766 170.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.6 p -144.96 143.16 22.63 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 N-CA-C 108.706 -0.85 . . . . 74.25 108.706 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.588 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -80.26 135.84 36.32 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.858 0.463 . . . . 73.329999999999998 110.201 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.3 mt -95.12 -16.56 22.52 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.315 1.046 . . . . 61.299999999999997 110.767 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -138.98 145.96 40.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.838 0.855 . . . . 72.549999999999997 108.915 -177.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -79.43 117.82 20.74 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.07 -0.715 . . . . 51.140000000000001 109.07 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -121.18 117.74 27.89 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.024 0.93 . . . . 72.040000000000006 109.247 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.8 t -79.96 138.74 19.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 C-N-CA 123.659 0.784 . . . . 51.100000000000001 109.262 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.71 115.09 3.69 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.818 -0.808 . . . . 73.019999999999996 108.818 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.4 m -74.59 -11.92 60.32 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.926 0.891 . . . . 71.25 110.753 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.79 -163.34 28.9 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 110.554 -1.018 . . . . 75.329999999999998 110.554 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -73.6 -23.92 59.98 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.219 0.608 . . . . 52.119999999999997 111.043 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -72.67 -24.19 60.99 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.438 1.095 . . . . 63.340000000000003 112.282 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.1 p -110.41 158.63 18.26 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.836 0.854 . . . . 74.299999999999997 110.013 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.9 tp -109.17 132.73 53.84 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.223 -0.898 . . . . 73.019999999999996 109.226 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.2 t -82.0 124.84 30.14 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.767 -0.827 . . . . 50.450000000000003 108.767 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.1 pt -128.86 140.59 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 108.094 -1.076 . . . . 72.5 108.094 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 16.0 m -98.31 151.96 19.94 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.024 0.375 . . . . 72.120000000000005 110.211 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -60.12 111.4 1.5 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.199 0.6 . . . . 70.120000000000005 110.799 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.82 3.7 55.93 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 115.405 -0.816 . . . . 50.020000000000003 113.183 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -83.41 145.97 28.7 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.481 0.712 . . . . 61.539999999999999 110.346 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -87.92 113.32 23.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.398 1.079 . . . . 73.329999999999998 109.306 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.588 HD11 ' HB2' ' A' ' 87' ' ' ALA . 15.2 mt -108.07 133.84 51.8 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.464 -0.939 . . . . 53.240000000000002 108.464 -170.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -104.17 106.93 17.61 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.337 -0.616 . . . . 72.109999999999999 109.337 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 92.8 t -98.73 119.4 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 109.07 -0.715 . . . . 73.109999999999999 109.07 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.9 mt -67.83 -37.49 81.97 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.762 0.825 . . . . 73.239999999999995 109.924 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.05 -178.6 44.17 Favored Glycine 0 C--O 1.244 0.727 0 CA-C-N 114.431 -1.259 . . . . 44.219999999999999 111.167 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 14.4 m-30 -95.99 169.81 9.72 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.256 -0.646 . . . . 74.140000000000001 109.256 177.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -60.28 145.82 46.11 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.631 -1.248 . . . . 74.430000000000007 107.631 168.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -65.53 -25.59 67.52 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.46 0.304 . . . . 74.120000000000005 110.896 -176.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -81.76 -18.51 43.94 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.694 0.797 . . . . 74.219999999999999 110.56 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 174' ' ' GLU . . . 85.93 34.25 13.5 Favored Glycine 0 C--N 1.35 1.353 0 C-N-CA 123.484 0.564 . . . . 74.420000000000002 113.607 174.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -96.27 -64.14 1.08 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.577 0.703 . . . . 73.230000000000004 110.583 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -103.49 -179.0 3.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.589 1.156 . . . . 74.319999999999993 109.633 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -142.18 122.19 13.69 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.668 0.787 . . . . 72.349999999999994 109.477 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -79.98 101.77 8.84 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.179 0.514 . . . . 74.0 109.623 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -103.88 167.65 9.64 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.139 -0.937 . . . . 61.310000000000002 109.998 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -141.4 125.62 17.45 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 124.449 1.1 . . . . 74.530000000000001 108.502 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.8 p -138.15 -168.6 2.39 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.029 0.932 . . . . 73.420000000000002 110.661 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 124' ' ' LYS . 31.6 mtmt -54.41 -35.14 62.59 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.895 1.278 . . . . 73.409999999999997 111.159 175.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -83.92 8.01 16.44 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.556 -1.202 . . . . 61.420000000000002 111.424 -175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.55 -126.14 7.42 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 111.499 -0.64 . . . . 75.409999999999997 111.499 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -151.02 139.8 20.8 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.305 0.642 . . . . 75.439999999999998 109.324 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 179.2 -178.76 48.86 Favored Glycine 0 C--N 1.344 1.0 0 O-C-N 123.263 0.352 . . . . 71.310000000000002 112.338 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -89.66 131.97 35.38 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.255 0.622 . . . . 63.340000000000003 110.835 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.67 152.08 76.29 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 125.322 1.449 . . . . 75.150000000000006 109.095 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.08 132.98 23.93 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.272 1.982 . . . . 74.430000000000007 111.462 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.506 ' HA ' HG12 ' A' ' 135' ' ' ILE . 20.0 m -62.3 -17.81 59.66 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.11 0.964 . . . . 65.150000000000006 112.724 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -74.65 -20.81 59.74 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.03 0.932 . . . . 75.420000000000002 111.526 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -95.17 -6.51 41.56 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.828 0.851 . . . . 74.310000000000002 112.023 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.506 HG12 ' HA ' ' A' ' 132' ' ' SER . 14.8 pt -125.06 156.68 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.158 0.583 . . . . 72.310000000000002 110.059 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 11.3 t -149.86 136.38 10.75 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 122.701 0.4 . . . . 65.340000000000003 110.375 172.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.534 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 73.6 Cg_endo -75.38 140.19 24.17 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.487 2.125 . . . . 75.540000000000006 111.765 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.85 -36.54 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.002 0.521 . . . . 71.040000000000006 111.414 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 59.2 t30 -98.74 -9.39 24.58 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.71 0.404 . . . . 71.409999999999997 111.149 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 32.5 t -73.34 177.04 5.46 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.919 0.488 . . . . 64.420000000000002 109.902 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 64.4 mt -61.15 -16.24 42.37 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.698 0.999 . . . . 73.329999999999998 113.698 -172.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -59.37 -24.13 63.14 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.574 1.15 . . . . 71.109999999999999 112.666 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -67.19 -8.37 30.9 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.438 0.695 . . . . 74.310000000000002 112.135 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -89.1 151.76 22.04 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.765 0.826 . . . . 75.340000000000003 110.549 170.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 56.8 p -69.24 -36.21 76.95 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 123.625 0.77 . . . . 72.530000000000001 111.13 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -72.44 -31.35 65.4 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.607 -0.724 . . . . 73.420000000000002 112.638 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -97.27 120.95 38.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.873 -0.788 . . . . 74.349999999999994 108.873 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -103.13 5.05 37.65 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.87 -0.605 . . . . 75.209999999999994 111.663 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.81 -154.5 35.86 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.67 -0.517 . . . . 63.329999999999998 112.948 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.4 106.39 1.59 Allowed 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 123.152 2.568 . . . . 45.329999999999998 111.028 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.6 t -140.34 143.86 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.405 0.682 . . . . 73.030000000000001 109.404 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.2 t -64.54 161.88 16.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.061 0.944 . . . . 61.329999999999998 112.121 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -69.58 -31.86 70.26 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.673 0.789 . . . . 73.140000000000001 110.739 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -76.17 -43.89 40.6 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.23 0.612 . . . . 72.099999999999994 109.527 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.07 79.14 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.396 -0.82 . . . . 72.109999999999999 110.387 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.75 -56.23 24.64 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.715 -0.675 . . . . 75.040000000000006 110.214 171.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -60.49 -32.33 71.33 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.618 -0.719 . . . . 71.209999999999994 110.968 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -65.73 -52.22 52.94 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.222 1.009 . . . . 55.240000000000002 110.975 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.5 ' HB2' HD11 ' A' ' 169' ' ' LEU . 81.5 mt -67.03 -39.37 87.0 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.439 0.637 . . . . 71.450000000000003 110.788 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.452 HD23 HG13 ' A' ' 190' ' ' VAL . 27.2 tp -73.73 -20.14 60.6 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.682 -1.145 . . . . 72.329999999999998 111.604 -174.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.6 t -61.62 -27.22 68.5 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.842 0.857 . . . . 34.439999999999998 111.83 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.4 p -86.45 8.53 21.43 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.918 0.887 . . . . 74.299999999999997 111.719 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -97.39 170.16 25.51 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 116.374 -0.375 . . . . 72.340000000000003 112.605 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 32.4 pt -121.92 -163.59 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.95 0.9 . . . . 71.319999999999993 109.66 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.736 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 27.1 p-10 -49.48 118.15 2.6 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.729 0.811 . . . . 71.239999999999995 112.412 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.18 14.0 72.83 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.297 -0.41 . . . . 44.439999999999998 113.288 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 20.2 t -75.23 136.02 40.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.035 -0.728 . . . . 60.130000000000003 109.035 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.488 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 22.2 p90 -135.65 164.97 26.65 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.948 0.721 . . . . 74.340000000000003 112.948 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 159' ' ' LEU . 86.0 mt -137.41 135.48 36.97 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.549 1.139 . . . . 74.439999999999998 108.353 169.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.401 HG22 HG12 ' A' ' 182' ' ' ILE . 39.0 t -114.55 128.46 71.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 107.851 -1.166 . . . . 74.450000000000003 107.851 171.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 12.9 mtm105 -143.05 172.34 12.85 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.769 0.828 . . . . 73.310000000000002 109.483 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 13.9 pt-20 -116.25 163.06 16.54 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.642 -0.873 . . . . 74.400000000000006 108.642 160.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.5 m -88.58 134.85 33.75 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.155 0.582 . . . . 62.299999999999997 110.141 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.418 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 27.9 mt-10 -78.68 -26.27 44.95 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.115 0.966 . . . . 75.420000000000002 109.224 174.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.1 p -70.61 -37.24 73.81 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.619 -1.173 . . . . 54.229999999999997 110.584 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.9 m -140.48 94.38 8.45 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.056 0.942 . . . . 74.150000000000006 109.433 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.34 135.25 52.85 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.969 2.446 . . . . 70.219999999999999 111.501 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 91.33 -23.51 24.3 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 115.97 -0.559 . . . . 64.200000000000003 113.46 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -82.83 115.62 21.8 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.727 -1.212 . . . . 73.430000000000007 107.727 172.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 82.9 mtt-85 -112.31 159.87 18.23 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.066 0.546 . . . . 74.530000000000001 109.698 -171.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.9 t -152.44 146.67 25.48 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 122.837 0.455 . . . . 72.239999999999995 110.775 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 170' ' ' VAL . 52.9 mt -113.94 150.9 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.112 0.965 . . . . 73.049999999999997 108.476 173.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.2 m -132.36 128.42 37.61 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.721 -0.844 . . . . 75.540000000000006 108.721 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.462 HD21 HD23 ' A' ' 232' ' ' LEU . 38.8 mt -110.66 147.44 34.31 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.328 1.451 . . . . 75.129999999999995 111.382 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -133.5 130.88 39.15 Favored 'General case' 0 C--O 1.253 1.255 0 C-N-CA 124.429 1.092 . . . . 64.209999999999994 108.434 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.736 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 3.7 p90 -154.66 143.55 20.92 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 124.146 0.904 . . . . 73.230000000000004 108.646 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 58.13 19.28 5.94 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 124.389 1.075 . . . . 71.319999999999993 112.941 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 76.65 30.06 56.83 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.984 -0.553 . . . . 61.240000000000002 112.663 -175.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -128.52 123.24 33.03 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.115 0.966 . . . . 52.539999999999999 108.569 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.452 HG13 HD23 ' A' ' 160' ' ' LEU . 48.8 t -104.13 138.2 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.257 1.023 . . . . 63.140000000000001 109.79 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.467 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 28.7 p90 -143.15 157.94 44.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.939 0.895 . . . . 54.210000000000001 109.215 171.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -128.09 144.16 51.1 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.125 -1.065 . . . . 73.010000000000005 108.125 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -145.67 147.57 32.13 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.062 0.458 . . . . 73.409999999999997 110.644 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 20.9 tpp180 -82.35 133.43 35.23 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.056 -0.975 . . . . 73.25 110.431 -174.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 93.5 mt -75.1 102.68 2.51 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 N-CA-C 106.979 -1.489 . . . . 73.310000000000002 106.979 165.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -68.15 111.62 4.61 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.531 -1.213 . . . . 71.420000000000002 108.063 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 37.7 m -97.28 113.45 25.07 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.873 -0.603 . . . . 62.530000000000001 109.527 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.1 160.03 10.81 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.197 0.999 . . . . 71.420000000000002 111.862 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.3 m -62.09 -23.62 66.63 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.2 -0.909 . . . . 72.200000000000003 111.47 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.405 ' HB2' ' HE2' ' A' ' 202' ' ' LYS . 15.7 m-20 -87.28 3.56 46.26 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.182 0.993 . . . . 74.409999999999997 111.104 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 83.83 -1.76 88.34 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 122.933 0.302 . . . . 61.43 113.35 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' A' ' 200' ' ' ASP . 54.1 mtmt -77.19 131.19 38.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.518 0.727 . . . . 74.349999999999994 110.274 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.72 147.45 22.98 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.836 -0.802 . . . . 54.549999999999997 108.836 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -166.14 176.24 7.81 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.406 0.682 . . . . 75.349999999999994 110.143 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 75.7 t -140.38 -50.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 107.004 -1.48 . . . . 51.43 107.004 172.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 22.0 m -74.83 145.99 42.37 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.347 -0.842 . . . . 74.25 109.933 171.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.8 m -70.83 -26.15 63.16 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.521 0.728 . . . . 73.549999999999997 110.922 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -71.85 -41.75 67.72 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.319 -0.623 . . . . 55.539999999999999 109.319 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 m -91.67 135.13 34.11 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.284 -0.871 . . . . 61.210000000000001 110.865 -165.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -137.26 118.38 14.43 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 107.956 -1.128 . . . . 71.239999999999995 107.956 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 9.0 m-85 -120.85 142.88 49.24 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 109.484 -0.561 . . . . 71.099999999999994 109.484 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -89.46 -24.18 21.91 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.778 -0.453 . . . . 73.019999999999996 109.778 171.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.8 p -124.53 144.81 49.91 Favored 'General case' 0 C--O 1.253 1.246 0 CA-C-O 121.87 0.843 . . . . 72.540000000000006 111.696 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 18.1 tp -69.57 -29.18 66.68 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 113.992 -1.458 . . . . 74.129999999999995 110.961 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.86 -37.12 85.33 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.324 0.649 . . . . 61.039999999999999 111.373 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -76.48 -31.93 58.06 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.884 0.474 . . . . 74.439999999999998 111.344 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.45 -45.88 90.34 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 110.118 -0.327 . . . . 74.209999999999994 110.118 170.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.9 t -70.8 -40.51 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.094 0.958 . . . . 74.239999999999995 110.971 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -59.74 -53.94 52.13 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.7 0.8 . . . . 64.420000000000002 109.583 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.571 ' CE1' HG11 ' A' ' 224' ' ' VAL . 59.1 t60 -53.69 -54.24 40.64 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.966 -1.015 . . . . 65.430000000000007 109.349 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -61.39 -26.33 67.77 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.609 -0.723 . . . . 72.409999999999997 112.286 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 32.4 t -75.17 -28.24 59.98 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 122.756 0.422 . . . . 61.030000000000001 111.236 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 15.4 t -117.56 1.43 12.27 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 116.094 1.887 . . . . 74.120000000000005 116.094 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.571 HG11 ' CE1' ' A' ' 220' ' ' HIS . 35.8 m -107.14 144.27 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.524 0 CA-C-N 121.465 1.938 . . . . 72.420000000000002 116.19 -175.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -82.11 -2.65 52.7 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 129.07 2.948 . . . . 73.010000000000005 112.187 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -79.34 14.25 1.62 Allowed 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 129.202 3.001 . . . . 53.299999999999997 113.354 -140.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.63 18.16 4.09 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 110.947 -0.861 . . . . 44.420000000000002 110.947 -169.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 86.0 mt -93.63 132.94 37.47 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.993 0.917 . . . . 62.240000000000002 109.951 160.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.467 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 85.3 mt -60.42 -60.06 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 108.749 -0.834 . . . . 75.109999999999999 108.749 170.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.5 t -119.65 141.63 49.17 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.149 -0.932 . . . . 72.409999999999997 108.668 173.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 224' ' ' VAL . 82.1 p -73.19 158.84 34.47 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 108.834 -0.802 . . . . 72.420000000000002 108.834 170.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.488 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 26.2 mt -69.47 99.54 1.26 Allowed 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 108.828 -0.805 . . . . 73.409999999999997 108.828 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -77.9 -45.76 23.22 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.28 0.632 . . . . 65.420000000000002 110.056 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 167' ' ' SER . 12.9 p90 -164.01 153.1 11.91 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 109.541 -0.54 . . . . 61.140000000000001 109.541 172.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.22 139.04 14.6 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 121.698 1.599 . . . . 61.229999999999997 112.273 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.98 118.17 39.93 Favored Pre-proline 0 C--N 1.352 0.689 0 N-CA-C 108.155 -1.054 . . . . 51.450000000000003 108.155 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -66.07 142.1 66.6 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.131 1.887 . . . . 51.310000000000002 112.188 -169.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt . . . . . 0 N--CA 1.477 0.901 0 C-N-CA 123.842 0.857 . . . . 72.219999999999999 110.745 176.333 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.8 m . . . . . 0 C--O 1.247 0.948 0 CA-C-O 121.308 0.575 . . . . 63.109999999999999 111.0 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.1 mt -103.45 125.26 35.43 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 107.88 -1.155 . . . . 62.439999999999998 107.88 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 67.0 Cg_endo -72.08 176.61 8.21 Favored 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 123.114 2.543 . . . . 74.530000000000001 112.437 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.08 141.69 38.64 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 116.395 -0.366 . . . . 71.230000000000004 111.073 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.57 ' HB3' HD11 ' A' ' 23' ' ' ILE . 66.7 mt -87.93 91.49 8.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.109 -0.7 . . . . 65.230000000000004 109.109 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -97.0 -48.49 5.39 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.676 0.79 . . . . 74.540000000000006 110.22 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -100.75 109.46 21.47 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.857 -1.065 . . . . 73.0 108.732 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.57 HD11 ' HB3' ' A' ' 20' ' ' LEU . 48.3 mm -118.69 119.35 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.697 0.799 . . . . 73.409999999999997 109.325 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.578 ' H ' ' HE1' ' A' ' 129' ' ' TRP . 75.0 mmtt . . . . . 0 C--O 1.241 0.633 0 N-CA-C 108.634 -0.876 . . . . 72.239999999999995 108.634 169.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 N--CA 1.493 1.473 0 N-CA-C 114.104 0.771 . . . . 62.409999999999997 114.104 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -92.35 41.96 1.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.531 0.732 . . . . 74.310000000000002 111.098 -174.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.1 tp -91.58 112.36 24.24 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.445 -0.798 . . . . 71.209999999999994 110.308 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -107.43 176.28 5.21 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.65 1.58 . . . . 63.100000000000001 109.549 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 9.9 p -147.73 149.34 15.5 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 C-N-CA 123.014 0.526 . . . . 73.409999999999997 109.868 171.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.58 113.66 20.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.624 0.77 . . . . 72.329999999999998 109.345 171.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.65 -12.59 53.62 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.058 0.543 . . . . 73.239999999999995 110.568 174.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -135.01 146.49 49.08 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.33 0.652 . . . . 70.430000000000007 110.091 -173.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -60.28 137.73 58.07 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.138 -0.937 . . . . 61.240000000000002 110.439 168.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -152.27 116.24 4.89 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.923 -0.399 . . . . 73.040000000000006 109.923 174.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.94 139.03 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 108.002 -1.11 . . . . 64.519999999999996 108.002 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.79 116.13 8.12 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 110.07 -0.345 . . . . 62.210000000000001 110.07 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.1 m -74.99 -17.66 60.5 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.313 0.645 . . . . 75.099999999999994 110.743 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -156.3 -177.54 29.57 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.611 -0.722 . . . . 42.329999999999998 111.747 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -73.57 -27.55 61.38 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.331 0.652 . . . . 71.519999999999996 110.575 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.431 HD21 HD13 ' A' ' 20' ' ' LEU . 25.2 p-10 -69.7 -23.64 63.46 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.863 0.865 . . . . 74.109999999999999 111.922 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.4 p -99.83 157.14 16.72 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.284 0.634 . . . . 61.549999999999997 110.754 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.5 tp -110.32 117.16 32.88 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.531 0.733 . . . . 75.0 109.87 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -66.89 117.59 9.2 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.031 -0.729 . . . . 63.140000000000001 109.031 172.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.4 pt -122.39 130.76 74.28 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 N-CA-C 109.244 -0.65 . . . . 52.229999999999997 109.244 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.0 m -90.53 141.26 28.94 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.503 -0.554 . . . . 72.439999999999998 109.503 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -57.51 116.64 3.49 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.012 0.525 . . . . 60.100000000000001 110.794 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.16 -20.13 21.81 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 115.417 -0.81 . . . . 63.439999999999998 112.38 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -72.55 128.54 35.9 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.017 -0.735 . . . . 71.319999999999993 109.017 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 54.5 mtmt -84.0 126.99 33.56 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.165 0.507 . . . . 72.140000000000001 109.909 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.41 ' HA ' HG22 ' A' ' 123' ' ' THR . 14.5 mt -102.1 166.76 10.43 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.981 -1.008 . . . . 73.430000000000007 108.592 -169.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -128.34 107.4 9.73 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.728 -1.212 . . . . 71.310000000000002 107.728 168.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 98.3 t -96.46 116.52 38.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.625 -0.88 . . . . 43.109999999999999 108.625 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.5 mt -78.46 -25.42 45.85 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.065 -0.971 . . . . 52.030000000000001 110.116 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.03 161.02 25.9 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.458 -0.792 . . . . 74.219999999999999 111.421 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 3.8 m-30 -95.4 171.84 8.45 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.473 0.654 . . . . 73.219999999999999 109.424 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -66.84 144.87 56.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.668 1.187 . . . . 71.430000000000007 107.979 164.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -60.89 -38.09 84.47 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.43 0.692 . . . . 73.340000000000003 112.158 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -79.35 -11.94 59.93 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.75 0.82 . . . . 52.409999999999997 110.98 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.35 23.17 48.92 Favored Glycine 0 C--N 1.349 1.281 0 C-N-CA 123.529 0.585 . . . . 72.019999999999996 113.281 177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . 46.5 mt-10 -78.28 -72.21 0.38 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.722 0.772 . . . . 64.109999999999999 110.729 -177.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -104.33 -177.43 3.36 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.534 1.133 . . . . 73.150000000000006 109.439 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -149.23 126.82 11.65 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.338 0.655 . . . . 63.329999999999998 110.07 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -71.03 94.26 1.08 Allowed 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.078 -0.712 . . . . 72.239999999999995 109.078 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -104.88 162.57 13.21 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 124.005 0.922 . . . . 72.109999999999999 110.402 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -144.06 133.72 23.63 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.555 0.742 . . . . 64.409999999999997 109.241 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 107' ' ' LEU . 62.9 p -139.67 -171.37 3.13 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.556 1.143 . . . . 75.439999999999998 110.454 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -61.6 -19.77 62.59 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.382 -0.827 . . . . 72.120000000000005 111.196 170.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -85.69 1.93 47.36 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.882 0.873 . . . . 73.420000000000002 111.353 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.5 -130.4 9.54 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.619 -0.593 . . . . 61.409999999999997 111.619 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -145.76 154.38 41.98 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.458 0.703 . . . . 74.219999999999999 109.837 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 166.54 -178.89 40.78 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 112.685 -0.166 . . . . 74.420000000000002 112.685 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.578 ' HE1' ' H ' ' A' ' 24' ' ' LYS . 86.4 m95 -89.85 127.07 35.92 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.767 0.827 . . . . 73.420000000000002 110.688 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.6 m -125.34 146.19 53.4 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.797 1.239 . . . . 54.229999999999997 108.68 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.41 141.5 42.73 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 121.937 1.758 . . . . 72.519999999999996 111.616 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.6 m -60.64 -19.94 59.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.931 0.892 . . . . 75.340000000000003 112.108 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -72.27 -27.49 62.52 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.503 0.721 . . . . 53.229999999999997 111.705 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -88.85 -11.75 43.85 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.661 0.784 . . . . 73.409999999999997 112.073 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.483 HD12 HG21 ' A' ' 109' ' ' VAL . 18.2 pt -122.64 161.43 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.002 0.521 . . . . 72.409999999999997 110.928 -170.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.0 t -155.9 143.05 13.7 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 122.727 0.411 . . . . 65.409999999999997 110.291 168.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.548 ' HB2' ' HB2' ' A' ' 140' ' ' SER . 5.7 Cg_exo -75.63 126.45 9.57 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.579 2.186 . . . . 52.219999999999999 111.217 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.0 m -94.28 -51.26 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 111.945 0.35 . . . . 53.109999999999999 111.945 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -92.52 18.91 7.88 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.175 0.512 . . . . 74.239999999999995 111.305 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.548 ' HB2' ' HB2' ' A' ' 137' ' ' PRO . 22.7 t -64.45 177.51 0.87 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.818 0.847 . . . . 32.329999999999998 112.691 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 49.5 mt -65.31 -13.49 58.59 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.055 1.342 . . . . 52.200000000000003 111.98 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 42.6 tt0 -63.87 -8.9 12.4 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.856 0.863 . . . . 74.420000000000002 111.491 174.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -55.16 -23.76 23.05 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.921 1.289 . . . . 72.140000000000001 110.515 167.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -99.36 143.64 29.38 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.974 0.909 . . . . 74.019999999999996 109.824 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.0 p -66.25 -15.41 63.17 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.369 0.668 . . . . 71.420000000000002 112.771 -175.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.409 ' CZ3' ' HB2' ' A' ' 147' ' ' TYR . 44.3 p-90 -80.29 -38.16 31.33 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 112.592 0.59 . . . . 74.219999999999999 112.592 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.409 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 28.8 t80 -91.67 140.47 29.69 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.81 -0.441 . . . . 71.549999999999997 109.81 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.489 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 63.3 m-70 -137.97 29.55 2.54 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.136 0.421 . . . . 70.140000000000001 112.136 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.63 -170.88 54.49 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 115.652 1.021 . . . . 51.020000000000003 115.652 165.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.04 102.77 1.49 Allowed 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.276 2.651 . . . . 61.43 111.341 172.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.414 HG21 ' NH2' ' A' ' 171' ' ' ARG . 60.4 t -140.02 156.9 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.458 0.703 . . . . 71.329999999999998 110.023 -175.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.6 t -61.62 145.15 53.09 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.965 1.306 . . . . 41.409999999999997 112.717 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -55.19 -32.87 62.54 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.506 -1.225 . . . . 72.510000000000005 112.019 171.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -66.3 -52.08 50.95 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.442 0.697 . . . . 65.209999999999994 110.553 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.84 75.69 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.228 0.611 . . . . 61.539999999999999 111.262 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.557 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.28 -53.44 58.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.141 -0.936 . . . . 72.019999999999996 110.416 173.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.575 ' HG3' HG11 ' A' ' 190' ' ' VAL . 34.6 tt0 -68.67 -27.46 66.0 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.661 -0.699 . . . . 64.439999999999998 111.079 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -67.62 -45.99 73.79 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.877 0.471 . . . . 72.409999999999997 111.45 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.2 mt -67.76 -38.4 83.39 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 110.146 -0.316 . . . . 64.430000000000007 110.146 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 183' ' ' SER . 29.3 tp -68.15 -21.29 64.92 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.292 0.637 . . . . 73.230000000000004 111.658 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.464 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 33.2 t -64.93 -24.35 67.5 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.505 0.722 . . . . 72.450000000000003 110.603 176.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.8 t -85.62 -2.54 58.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.903 0.881 . . . . 54.420000000000002 111.604 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -86.2 170.91 43.61 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 114.073 0.389 . . . . 61.420000000000002 114.073 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.4 pt -132.31 -165.05 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 124.568 1.147 . . . . 64.129999999999995 111.023 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.666 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 14.3 p-10 -58.09 102.81 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.03 0.932 . . . . 65.109999999999999 113.362 -172.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 104.06 11.79 31.19 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 115.977 -0.556 . . . . 54.119999999999997 112.776 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 23.0 t -75.76 142.35 42.38 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 109.853 -0.425 . . . . 42.25 109.853 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 235' ' ' PRO . 14.9 p90 -144.07 161.47 38.71 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.84 0.682 . . . . 73.430000000000007 112.84 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' A' ' 236' ' ' ALA . 95.7 mt -142.45 135.51 28.53 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.489 1.116 . . . . 74.239999999999995 108.358 170.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.5 t -110.91 113.52 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.327 -1.36 . . . . 74.200000000000003 107.327 174.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.557 HH11 ' HA ' ' A' ' 156' ' ' ALA . 17.2 mtp180 -141.12 143.28 34.21 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 107.602 -1.258 . . . . 73.230000000000004 107.602 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.701 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 15.3 pt-20 -95.14 161.29 14.18 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.074 0.397 . . . . 60.399999999999999 110.506 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 37.4 m -82.81 134.47 35.11 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 116.308 -0.406 . . . . 74.040000000000006 110.284 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -70.16 -41.67 73.53 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.214 1.006 . . . . 73.120000000000005 109.975 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 72.0 p -84.26 -9.17 58.72 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.366 1.066 . . . . 71.510000000000005 111.864 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.2 m -141.64 67.45 24.07 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.499 1.12 . . . . 75.409999999999997 108.812 173.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.71 149.11 42.71 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.655 2.237 . . . . 63.32 112.817 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.66 -26.01 6.17 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 114.665 -1.152 . . . . 74.329999999999998 112.049 -168.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -90.84 119.17 30.83 Favored 'General case' 0 C--O 1.259 1.574 0 N-CA-C 108.151 -1.055 . . . . 63.520000000000003 108.151 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.701 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 26.0 mtt85 -105.95 170.24 8.02 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.36 -0.836 . . . . 72.120000000000005 110.77 -173.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.8 m -144.11 144.14 31.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.699 0.8 . . . . 75.450000000000003 110.22 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 56.7 mt -112.91 139.25 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.18 -1.045 . . . . 71.230000000000004 108.18 168.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.575 ' HB3' HD22 ' A' ' 160' ' ' LEU . 23.6 m -116.04 115.09 25.5 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 124.661 1.184 . . . . 55.100000000000001 107.981 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.462 HD21 HD23 ' A' ' 232' ' ' LEU . 57.2 mt -104.77 142.99 33.73 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.474 0.71 . . . . 71.209999999999994 111.088 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.464 ' NH1' ' HA ' ' A' ' 161' ' ' SER . 20.3 ttt180 -131.99 126.55 34.25 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.61 -1.177 . . . . 72.230000000000004 108.773 170.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -150.21 141.46 23.19 Favored 'General case' 0 C--O 1.211 -0.945 0 N-CA-C 107.154 -1.424 . . . . 74.510000000000005 107.154 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 54.29 18.61 1.91 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 125.759 1.624 . . . . 74.519999999999996 113.442 -174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.49 14.01 80.74 Favored Glycine 0 N--CA 1.475 1.294 0 O-C-N 122.284 -0.26 . . . . 45.100000000000001 113.049 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -103.21 127.73 50.42 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 125.4 1.48 . . . . 73.340000000000003 108.763 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.575 HG11 ' HG3' ' A' ' 157' ' ' GLU . 86.2 t -107.79 116.82 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.887 0.875 . . . . 73.129999999999995 110.304 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -139.55 141.13 37.26 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.44 1.096 . . . . 65.040000000000006 109.275 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -124.57 151.19 45.07 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.139 0.975 . . . . 73.349999999999994 108.963 -170.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -142.94 141.49 31.47 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.213 0.53 . . . . 70.109999999999999 110.752 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -77.68 131.28 37.65 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.815 -1.084 . . . . 71.319999999999993 110.828 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 80.4 mt -75.2 108.52 7.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 107.48 -1.304 . . . . 71.349999999999994 107.48 165.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -73.17 106.76 5.15 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.799 -1.185 . . . . 75.349999999999994 107.799 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' THR . . . . . 0.511 HG23 HD23 ' A' ' 203' ' ' LEU . 30.9 m -92.37 121.65 34.06 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.255 0.622 . . . . 74.140000000000001 109.717 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.21 153.52 34.28 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.454 0.702 . . . . 72.430000000000007 110.236 172.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 51.3 p -61.37 -22.36 64.88 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.405 0.682 . . . . 61.310000000000002 112.005 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.401 ' HB2' ' HE2' ' A' ' 202' ' ' LYS . 67.8 m-20 -71.54 -14.99 62.27 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.883 1.273 . . . . 75.0 112.373 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 101.77 -2.68 52.56 Favored Glycine 0 C--N 1.348 1.223 0 C-N-CA 122.901 0.286 . . . . 63.140000000000001 112.671 -176.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 200' ' ' ASP . 48.5 mtmt -82.65 156.07 24.05 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.652 0.781 . . . . 70.409999999999997 109.79 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.511 HD23 HG23 ' A' ' 197' ' ' THR . 79.0 mt -113.69 151.2 32.18 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.581 0.752 . . . . 75.329999999999998 110.73 -171.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -163.78 171.97 14.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.888 0.875 . . . . 62.520000000000003 110.413 170.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.3 t -131.46 -56.34 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.414 -1.328 . . . . 72.340000000000003 107.414 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 8.9 m -76.25 153.12 36.27 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.508 -0.769 . . . . 62.140000000000001 108.932 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.9 m -61.32 -36.82 81.19 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.131 0.573 . . . . 72.299999999999997 111.067 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -82.67 -20.67 35.75 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.451 0.7 . . . . 71.200000000000003 111.461 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 68.7 m -63.49 135.91 57.21 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 122.707 0.403 . . . . 52.219999999999999 110.764 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -141.13 108.52 5.55 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.368 -0.975 . . . . 71.319999999999993 108.368 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -121.39 135.76 55.04 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.285 -0.635 . . . . 74.430000000000007 109.285 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -84.25 -30.5 25.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.956 0.502 . . . . 72.530000000000001 110.04 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 216' ' ' GLU . 81.5 p -132.36 161.49 33.45 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-O 122.209 1.004 . . . . 75.420000000000002 111.609 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 37.6 tp -71.24 -24.5 62.2 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 114.159 -1.382 . . . . 42.039999999999999 110.992 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.18 -42.03 89.45 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.434 0.693 . . . . 71.129999999999995 109.93 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.4 ' HG2' ' OG1' ' A' ' 213' ' ' THR . 31.7 mm-40 -65.02 -43.8 91.24 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.341 -0.845 . . . . 71.310000000000002 109.637 174.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.22 -46.25 86.23 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 124.077 0.861 . . . . 71.010000000000005 111.686 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 42.2 t -74.41 -40.55 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.084 0.553 . . . . 74.450000000000003 111.236 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -62.59 -47.07 85.4 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.107 0.479 . . . . 74.230000000000004 110.591 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.428 ' O ' HG22 ' A' ' 224' ' ' VAL . 52.9 t-80 -54.98 -54.46 42.6 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.066 -0.97 . . . . 70.439999999999998 109.961 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.485 ' HD2' HD21 ' A' ' 228' ' ' LEU . 40.3 m80 -65.85 -23.86 66.76 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.676 -0.693 . . . . 63.25 111.65 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 44.2 t -74.4 -24.44 59.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.019 0.528 . . . . 61.32 111.298 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.7 t -110.44 -21.73 12.03 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 116.336 1.976 . . . . 72.310000000000002 116.336 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 220' ' ' HIS . 26.9 m -93.84 157.35 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 115.435 1.643 . . . . 61.219999999999999 115.435 -164.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.16 -1.44 57.73 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.378 2.671 . . . . 73.349999999999994 112.666 -175.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -78.92 15.86 1.01 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 128.357 2.663 . . . . 70.150000000000006 113.751 -140.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.93 18.11 4.4 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 124.819 1.2 . . . . 54.530000000000001 110.529 -170.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.485 HD21 ' HD2' ' A' ' 221' ' ' HIS . 95.2 mt -93.19 126.73 38.45 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.989 1.315 . . . . 65.239999999999995 109.713 164.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 81.0 mt -67.01 -39.9 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 109.21 -0.663 . . . . 71.329999999999998 109.21 173.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.8 t -133.28 141.98 48.26 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 115.08 -0.964 . . . . 71.310000000000002 108.803 168.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 65.1 p -66.3 151.84 46.21 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 108.791 -0.818 . . . . 71.099999999999994 108.791 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.462 HD23 HD21 ' A' ' 184' ' ' LEU . 28.5 mt -62.11 102.69 0.31 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 108.126 -1.064 . . . . 73.310000000000002 108.126 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -89.43 -58.18 2.62 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.818 -0.808 . . . . 74.099999999999994 108.818 -173.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.583 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -151.95 141.34 14.24 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 123.058 0.543 . . . . 75.230000000000004 111.82 -178.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 65.5 Cg_endo -71.76 156.76 56.66 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 121.494 1.463 . . . . 71.239999999999995 112.45 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.474 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -70.72 133.31 86.62 Favored Pre-proline 0 C--O 1.244 0.81 0 CA-C-N 115.935 -0.575 . . . . 63.039999999999999 109.752 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 236' ' ' ALA . 31.3 Cg_exo -61.45 132.1 39.24 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.22 2.614 . . . . 60.140000000000001 113.602 -175.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt . . . . . 0 N--CA 1.476 0.85 0 C-N-CA 123.761 0.825 . . . . 65.349999999999994 110.829 171.989 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.7 p . . . . . 0 C--O 1.244 0.802 0 CA-C-O 121.169 0.509 . . . . 73.109999999999999 111.006 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.6 mt -108.31 130.62 22.53 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 109.064 -0.717 . . . . 74.409999999999997 109.064 -176.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.27 172.7 9.7 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.301 2.001 . . . . 74.530000000000001 111.206 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.86 144.45 36.97 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 122.329 -0.232 . . . . 62.420000000000002 110.439 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.629 ' HB3' HD11 ' A' ' 23' ' ' ILE . 72.6 mt -84.84 92.38 8.25 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.486 -0.931 . . . . 62.43 108.486 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -96.27 -49.07 5.36 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.203 -0.908 . . . . 74.430000000000007 109.379 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -103.2 110.96 23.11 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.561 -1.2 . . . . 63.25 109.228 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 20' ' ' LEU . 37.2 mm -116.99 113.01 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.954 0.902 . . . . 64.439999999999998 109.491 -177.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.681 ' HA ' ' HE1' ' A' ' 129' ' ' TRP . 2.2 tppp? . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 125.166 1.386 . . . . 73.25 112.739 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo . . . . . 0 CA--C 1.555 1.539 0 N-CA-C 112.817 0.276 . . . . 72.019999999999996 112.817 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -88.61 38.14 0.86 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.464 1.105 . . . . 75.430000000000007 110.738 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.587 HD21 ' HD2' ' A' ' 106' ' ' LYS . 20.8 tp -89.53 113.63 25.06 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-N 115.378 -0.828 . . . . 71.129999999999995 110.184 -173.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 3.0 m-85 -103.83 176.56 5.11 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.877 1.271 . . . . 72.099999999999994 108.78 174.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.1 p -141.58 148.46 20.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 108.624 -0.88 . . . . 65.510000000000005 108.624 170.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.88 127.96 33.14 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.162 0.585 . . . . 74.439999999999998 109.55 173.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.25 -22.78 24.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.45 1.1 . . . . 71.040000000000006 111.067 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -136.79 160.25 39.41 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.377 0.671 . . . . 74.409999999999997 109.924 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -81.53 123.09 28.34 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.415 -0.957 . . . . 72.439999999999998 108.415 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.441 ' HB3' HG12 ' A' ' 101' ' ' ILE . 91.8 t80 -125.8 116.68 21.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.417 -0.957 . . . . 72.430000000000007 108.417 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.6 p -80.67 139.03 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.072 0.549 . . . . 74.239999999999995 110.211 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.06 132.27 42.15 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.934 0.494 . . . . 45.149999999999999 110.917 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 t -74.36 -27.53 60.71 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.377 0.671 . . . . 50.219999999999999 109.737 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.48 -144.51 7.25 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.516 -0.634 . . . . 73.150000000000006 111.516 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -71.24 -24.23 62.15 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.692 0.797 . . . . 72.530000000000001 110.952 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.424 ' HB2' HD12 ' A' ' 23' ' ' ILE . 27.4 p-10 -67.93 -22.61 65.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.04 0.936 . . . . 75.409999999999997 111.238 -177.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.5 p -129.87 158.54 39.21 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.298 1.039 . . . . 62.229999999999997 110.226 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.2 tp -110.08 136.46 49.29 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.131 -0.692 . . . . 74.129999999999995 109.131 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.4 t -81.73 112.9 19.32 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 107.503 -1.295 . . . . 50.530000000000001 107.503 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.441 HG12 ' HB3' ' A' ' 91' ' ' PHE . 37.1 pt -119.95 157.8 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.569 0.748 . . . . 71.209999999999994 109.452 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.5 m -131.32 143.84 50.82 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.545 -0.539 . . . . 63.210000000000001 109.545 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -52.07 123.84 11.47 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.778 0.831 . . . . 64.310000000000002 111.533 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.92 -22.69 34.5 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.054 -0.521 . . . . 62.32 112.935 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -76.9 132.33 39.05 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 117.119 0.46 . . . . 31.129999999999999 110.26 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.587 ' HD2' HD21 ' A' ' 84' ' ' LEU . 41.2 mtmt -82.25 127.9 33.65 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 124.11 0.881 . . . . 61.240000000000002 109.661 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.9 mt -108.21 130.98 55.12 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.829 0.852 . . . . 74.400000000000006 109.241 -171.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -91.82 106.23 18.31 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.777 -0.823 . . . . 72.230000000000004 108.777 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 89.7 t -96.89 117.03 40.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.871 -0.789 . . . . 75.209999999999994 108.871 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.4 mt -71.38 -27.46 63.35 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.328 0.651 . . . . 72.329999999999998 110.418 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.79 175.61 34.87 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.482 -0.781 . . . . 71.129999999999995 111.792 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.59 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 2.1 m-30 -95.2 171.17 8.89 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.006 -1.109 . . . . 74.010000000000005 108.006 173.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.525 HD21 ' HB2' ' A' ' 117' ' ' GLU . 32.0 p30 -76.05 178.58 6.22 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.923 -0.399 . . . . 73.430000000000007 109.923 172.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -65.03 -16.65 63.69 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.331 0.493 . . . . 72.230000000000004 112.331 -172.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -109.7 -8.27 14.97 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-O 120.859 0.361 . . . . 54.340000000000003 111.564 176.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 74.18 21.92 78.4 Favored Glycine 0 N--CA 1.469 0.838 0 N-CA-C 114.185 0.434 . . . . 73.019999999999996 114.185 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.525 ' HB2' HD21 ' A' ' 113' ' ' ASN . 25.5 mt-10 -74.67 -55.52 5.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.993 0.902 . . . . 71.420000000000002 110.118 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -118.72 133.01 56.16 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 113.998 -1.455 . . . . 73.420000000000002 108.513 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -110.97 127.52 55.53 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.917 1.287 . . . . 71.129999999999995 110.401 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -77.58 106.43 9.37 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.033 0.444 . . . . 71.519999999999996 110.325 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.48 163.48 12.83 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.336 -0.847 . . . . 74.019999999999996 110.61 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -142.78 131.53 22.7 Favored 'General case' 0 C--O 1.249 1.051 0 C-N-CA 124.24 1.016 . . . . 73.329999999999998 108.581 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 81.4 p -143.66 -167.86 2.69 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.697 1.199 . . . . 74.049999999999997 109.463 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -57.93 -18.79 25.49 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.671 1.188 . . . . 72.310000000000002 112.028 173.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -89.62 -6.51 56.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.598 1.159 . . . . 65.439999999999998 111.692 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.38 -141.85 16.86 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 111.392 -0.683 . . . . 64.209999999999994 111.392 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -142.77 138.92 30.79 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.421 0.688 . . . . 72.200000000000003 110.63 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 176.32 -177.02 47.91 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 111.622 -0.591 . . . . 44.25 111.622 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.681 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 33.9 m95 -100.4 136.91 39.55 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.349 0.66 . . . . 64.230000000000004 110.816 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.23 149.85 74.83 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.331 1.053 . . . . 73.439999999999998 109.27 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.95 137.02 33.94 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 121.74 1.627 . . . . 75.5 110.94 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.471 ' HA ' HG12 ' A' ' 135' ' ' ILE . 26.3 m -61.4 -17.1 52.55 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.729 0.812 . . . . 55.200000000000003 112.64 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -71.1 -26.75 63.17 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.024 0.93 . . . . 63.32 111.175 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -98.94 3.94 47.22 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.923 0.889 . . . . 73.099999999999994 111.658 -173.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 132' ' ' SER . 16.2 pt -130.63 157.62 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.779 0.432 . . . . 74.340000000000003 110.047 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.426 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 14.2 t -155.76 135.07 7.88 Favored Pre-proline 0 CA--C 1.555 1.159 0 O-C-N 123.349 0.406 . . . . 74.439999999999998 110.005 172.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 3.0 Cg_exo -74.94 117.03 4.77 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.955 2.437 . . . . 64.219999999999999 111.953 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.2 m -91.89 -34.37 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 122.988 0.515 . . . . 71.299999999999997 112.137 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -99.84 16.75 22.72 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.641 0.734 . . . . 64.310000000000002 110.077 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.1 t -92.74 -176.8 4.35 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.736 0.779 . . . . 62.229999999999997 110.649 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.428 HD13 HD23 ' A' ' 214' ' ' LEU . 51.7 mt -64.91 -12.59 50.96 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.441 1.496 . . . . 63.340000000000003 112.151 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -55.86 -23.36 30.45 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.65 1.18 . . . . 72.310000000000002 112.524 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -58.58 -19.66 40.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.538 0.735 . . . . 74.319999999999993 111.368 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -95.74 131.99 41.43 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.254 1.022 . . . . 73.349999999999994 108.332 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.2 m -70.8 -6.9 41.28 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.081 0.771 . . . . 71.430000000000007 113.081 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 33.4 p-90 -81.05 -27.6 35.69 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.258 0.223 . . . . 73.219999999999999 111.498 173.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -94.91 120.49 35.21 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.126 -0.694 . . . . 63.100000000000001 109.126 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -112.81 6.88 18.24 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 116.346 -0.388 . . . . 64.340000000000003 111.368 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 151' ' ' VAL . . . 70.73 -150.8 48.52 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 119.032 -0.871 . . . . 63.119999999999997 113.461 177.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.55 104.28 0.92 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.279 2.652 . . . . 73.129999999999995 111.6 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 149' ' ' GLY . 40.4 t -124.32 140.1 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 120.761 0.315 . . . . 63.420000000000002 110.838 -173.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.0 t -71.1 160.14 33.42 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.875 0.87 . . . . 74.400000000000006 111.088 172.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -62.91 -36.89 84.85 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.66 -0.7 . . . . 71.299999999999997 110.874 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -66.51 -51.62 54.7 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 123.714 0.634 . . . . 73.549999999999997 109.991 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.33 -42.27 81.57 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 124.002 0.814 . . . . 74.140000000000001 110.734 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.9 -59.63 4.77 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.694 -1.139 . . . . 60.030000000000001 111.257 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -67.11 -29.26 68.95 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 116.065 -0.516 . . . . 73.549999999999997 111.317 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -61.82 -53.78 51.25 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.453 0.701 . . . . 61.119999999999997 110.113 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.492 ' HB2' HD11 ' A' ' 169' ' ' LEU . 77.8 mt -67.35 -38.05 84.23 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.044 -0.526 . . . . 73.439999999999998 110.848 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.508 HD23 HG13 ' A' ' 190' ' ' VAL . 25.4 tp -71.22 -30.65 66.61 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.359 -0.837 . . . . 75.019999999999996 112.184 -172.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.4 m -68.35 -16.72 64.04 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.368 0.667 . . . . 72.340000000000003 111.963 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.3 m -82.23 3.86 25.78 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.703 0.801 . . . . 74.329999999999998 111.027 172.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -101.82 -178.89 28.04 Favored Glycine 0 C--N 1.344 0.978 0 C-N-CA 123.244 0.449 . . . . 70.329999999999998 113.228 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.4 pt -132.05 -163.89 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.508 1.123 . . . . 74.109999999999999 108.884 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.677 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 26.8 p-10 -50.75 112.09 0.65 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.452 0.701 . . . . 73.010000000000005 112.424 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 92.76 14.26 55.43 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.749 -0.659 . . . . 42.340000000000003 113.36 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 60.8 p -77.95 135.52 37.85 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.993 -0.743 . . . . 62.310000000000002 108.993 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.439 ' CE2' ' HB3' ' A' ' 232' ' ' LEU . 21.3 p90 -136.62 162.2 33.79 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.019 0.748 . . . . 62.439999999999998 113.019 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' A' ' 159' ' ' LEU . 84.3 mt -137.78 133.99 34.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.179 0.991 . . . . 72.010000000000005 108.582 169.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.93 118.27 56.13 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 107.698 -1.223 . . . . 72.530000000000001 107.698 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -128.99 165.6 20.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.899 -1.046 . . . . 72.5 108.988 -171.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 17.0 pt-20 -117.06 161.89 18.68 Favored 'General case' 0 C--O 1.261 1.674 0 N-CA-C 108.214 -1.032 . . . . 73.200000000000003 108.214 161.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.8 t -77.68 144.61 37.19 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.415 0.686 . . . . 71.230000000000004 110.263 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.417 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 29.3 mt-10 -71.03 -44.0 66.73 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.609 -1.178 . . . . 71.239999999999995 109.701 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 18.8 m -91.46 3.14 55.68 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.23 -0.896 . . . . 54.420000000000002 111.702 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.4 t -155.89 77.86 4.5 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 109.256 -0.646 . . . . 71.040000000000006 109.256 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.49 ' HG2' ' HB2' ' A' ' 112' ' ' TYR . 36.1 Cg_exo -62.18 138.16 70.6 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.173 2.582 . . . . 73.409999999999997 112.559 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.07 -24.34 27.19 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.808 -0.633 . . . . 62.299999999999997 112.335 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -88.9 118.58 28.71 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.428 -1.323 . . . . 74.540000000000006 107.428 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 82.0 mtt85 -115.7 165.4 13.09 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 123.067 0.547 . . . . 74.420000000000002 112.298 -165.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 40.3 t -151.91 136.98 17.34 Favored 'General case' 0 C--O 1.247 0.972 0 C-N-CA 124.478 1.111 . . . . 35.409999999999997 109.437 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 58.1 mt -105.43 141.92 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 109.016 -0.735 . . . . 64.439999999999998 109.016 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 12.9 m -117.94 115.73 25.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.575 1.15 . . . . 61.229999999999997 108.508 -177.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.427 HD21 ' CD2' ' A' ' 232' ' ' LEU . 58.6 mt -105.31 143.96 32.75 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.909 0.883 . . . . 73.030000000000001 111.219 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 46.3 ttt-85 -133.64 131.12 39.19 Favored 'General case' 0 C--O 1.26 1.621 0 CA-C-N 114.818 -1.083 . . . . 74.129999999999995 109.564 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.677 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 9.2 p90 -152.44 139.7 19.4 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 124.503 1.127 . . . . 75.140000000000001 108.733 173.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 56.73 24.86 9.5 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 124.766 1.226 . . . . 71.239999999999995 112.937 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.85 8.04 80.16 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 116.651 -0.249 . . . . 71.319999999999993 112.973 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 26.5 tpt180 -102.35 123.35 45.98 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.394 1.078 . . . . 71.439999999999998 109.359 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.508 HG13 HD23 ' A' ' 160' ' ' LEU . 77.1 t -110.76 128.49 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.723 1.209 . . . . 63.530000000000001 109.149 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.434 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 31.2 p90 -145.43 158.28 43.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.46 0.704 . . . . 71.030000000000001 109.135 173.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -130.9 141.53 50.3 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.509 -1.293 . . . . 73.230000000000004 107.509 -173.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -138.45 149.43 45.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.691 0.396 . . . . 74.209999999999994 110.002 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 13.3 tpp85 -84.38 137.2 33.53 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.262 -0.881 . . . . 75.519999999999996 111.088 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 65.0 mt -83.07 110.09 17.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 N-CA-C 108.321 -0.992 . . . . 70.349999999999994 108.321 166.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -68.04 119.43 12.65 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.341 1.056 . . . . 71.219999999999999 109.117 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.1 m -102.89 116.68 33.03 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.685 0.394 . . . . 65.420000000000002 109.971 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 202' ' ' LYS . . . -67.16 167.08 12.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.462 1.105 . . . . 64.120000000000005 111.986 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.2 m -61.71 -30.15 70.57 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.685 0.794 . . . . 74.409999999999997 110.883 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.403 ' HB2' ' HG3' ' A' ' 202' ' ' LYS . 29.0 m-20 -70.76 -12.66 61.68 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.705 1.202 . . . . 71.540000000000006 111.783 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 87.77 2.73 81.24 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 111.818 -0.513 . . . . 45.310000000000002 111.818 -169.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 198' ' ' ALA . 64.6 mttp -68.27 159.38 31.39 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 123.073 0.549 . . . . 62.450000000000003 110.111 175.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 79.6 mt -121.38 145.61 47.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.447 -0.945 . . . . 71.200000000000003 108.447 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -165.87 174.83 9.18 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.628 0.771 . . . . 72.219999999999999 110.018 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 78.2 t -138.47 -53.84 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 107.715 -1.217 . . . . 72.340000000000003 107.715 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 17.3 m -73.19 148.75 43.48 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.414 -0.812 . . . . 71.409999999999997 110.026 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.3 m -61.22 -42.2 98.19 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.239 1.016 . . . . 63.109999999999999 112.312 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -84.52 -36.52 22.14 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 122.742 0.417 . . . . 54.439999999999998 111.333 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.9 m -67.65 138.68 56.55 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.659 0.784 . . . . 75.019999999999996 111.665 -177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -142.37 119.85 11.68 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.555 1.142 . . . . 73.200000000000003 109.067 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -117.94 136.61 53.38 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 109.634 -0.506 . . . . 73.019999999999996 109.634 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -84.29 -26.25 28.71 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.347 0.659 . . . . 62.32 109.943 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 81.8 p -130.47 147.64 52.19 Favored 'General case' 0 C--O 1.256 1.411 0 CA-C-O 121.694 0.759 . . . . 73.239999999999995 111.115 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.428 HD23 HD13 ' A' ' 141' ' ' LEU . 35.2 tp -67.65 -29.27 68.53 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 114.529 -1.214 . . . . 72.040000000000006 111.08 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.74 92.02 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.609 0.363 . . . . 75.140000000000001 110.836 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -75.19 -32.38 61.22 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 116.522 -0.308 . . . . 54.439999999999998 110.763 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.53 -47.17 85.07 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 110.16 -0.311 . . . . 72.239999999999995 110.16 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 43.0 t -69.42 -44.65 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.061 0.945 . . . . 71.140000000000001 110.359 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -61.78 -45.43 93.92 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.249 0.547 . . . . 55.229999999999997 110.869 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.459 ' O ' HG22 ' A' ' 224' ' ' VAL . 49.7 t-80 -53.03 -54.48 34.77 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.843 -1.072 . . . . 74.430000000000007 108.727 175.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -61.99 -26.08 68.01 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.544 -0.753 . . . . 74.430000000000007 112.426 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 50.5 m -72.44 -30.15 64.34 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.8 0.44 . . . . 74.109999999999999 111.188 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -108.74 -17.04 14.04 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 115.578 1.696 . . . . 64.409999999999997 115.578 -176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 220' ' ' HIS . 30.8 m -98.38 148.02 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 115.936 1.828 . . . . 72.340000000000003 115.936 -165.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -83.51 -2.44 55.95 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 129.337 3.055 . . . . 60.030000000000001 112.635 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -79.11 13.41 1.82 Allowed 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 129.252 3.021 . . . . 52.439999999999998 113.331 -138.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.76 16.19 4.18 Favored Glycine 0 N--CA 1.466 0.687 0 N-CA-C 110.091 -1.204 . . . . 63.109999999999999 110.091 -169.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 69.1 mt -90.72 135.05 33.97 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.83 0.852 . . . . 73.019999999999996 109.766 163.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.434 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 84.2 mt -67.66 -44.38 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.868 -0.79 . . . . 53.329999999999998 108.868 172.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.3 t -137.7 142.86 41.04 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.327 -0.851 . . . . 50.530000000000001 109.491 174.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 73.5 p -74.77 157.55 35.0 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.24 0.616 . . . . 62.420000000000002 109.565 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.439 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . 23.5 mt -70.85 101.74 2.2 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 109.567 -0.531 . . . . 61.140000000000001 109.567 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -79.0 -49.7 12.29 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.46 0.704 . . . . 62.049999999999997 110.224 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 167' ' ' SER . 4.3 p90 -164.76 152.72 10.45 Favored Pre-proline 0 N--CA 1.494 1.741 0 CA-C-O 119.61 -0.233 . . . . 70.150000000000006 110.511 173.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.18 146.63 32.25 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 121.936 1.757 . . . . 74.540000000000006 112.505 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -76.25 144.91 75.66 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.242 0.617 . . . . 61.240000000000002 109.409 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -84.7 170.34 10.2 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.548 2.165 . . . . 71.430000000000007 113.733 -171.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? . . . . . 0 N--CA 1.48 1.026 0 C-N-CA 124.254 1.022 . . . . 72.129999999999995 109.204 169.443 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.548 0.88 0 CA-C-O 121.201 0.524 . . . . 75.140000000000001 111.936 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.4 mt -102.66 127.22 30.73 Favored Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 108.764 -0.828 . . . . 54.340000000000003 108.764 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.13 171.16 17.35 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.187 1.925 . . . . 71.400000000000006 111.31 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.68 146.87 27.99 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 122.409 0.283 . . . . 73.329999999999998 110.642 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.531 ' HB3' HD11 ' A' ' 23' ' ' ILE . 70.5 mt -85.54 92.51 8.55 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 107.89 -1.152 . . . . 74.209999999999994 107.89 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -97.71 -48.42 5.23 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.725 -0.472 . . . . 75.340000000000003 109.725 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -101.56 114.18 27.97 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.354 -0.839 . . . . 71.310000000000002 109.451 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 20' ' ' LEU . 41.8 mm -117.65 113.62 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.588 -0.893 . . . . 63.310000000000002 108.588 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.553 ' HB3' ' HZ2' ' A' ' 129' ' ' TRP . 49.0 tttm . . . . . 0 C--O 1.243 0.747 0 CA-C-N 114.881 -1.054 . . . . 54.130000000000003 109.453 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 N--CA 1.488 1.173 0 CA-C-O 121.059 0.358 . . . . 74.450000000000003 111.786 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -82.36 27.01 0.52 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.415 1.086 . . . . 72.109999999999999 111.182 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 28.3 tp -86.09 116.24 24.18 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.391 0.676 . . . . 71.219999999999999 109.702 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 3.6 m-85 -104.62 177.18 4.92 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.816 1.646 . . . . 73.450000000000003 109.202 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.8 p -140.82 142.85 29.59 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 108.277 -1.008 . . . . 74.219999999999999 108.277 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.99 116.62 16.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.997 0.519 . . . . 74.239999999999995 109.825 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.52 -24.11 50.08 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.859 0.864 . . . . 73.450000000000003 110.689 172.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -130.83 158.75 39.33 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.983 0.513 . . . . 71.209999999999994 110.17 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.02 151.64 37.11 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.911 -0.586 . . . . 72.209999999999994 109.459 172.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.531 ' HB3' HG12 ' A' ' 101' ' ' ILE . 81.1 t80 -155.8 116.58 3.82 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.298 -0.63 . . . . 74.230000000000004 109.298 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.56 138.78 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 108.988 -0.745 . . . . 73.239999999999995 108.988 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.408 ' HB2' ' N ' ' A' ' 100' ' ' SER . . . -75.53 129.51 37.36 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 122.178 -0.326 . . . . 63.020000000000003 110.862 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 m -66.07 -23.95 66.62 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.385 0.674 . . . . 75.319999999999993 110.607 173.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.96 -153.33 12.93 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.42 -0.809 . . . . 73.549999999999997 111.261 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.6 -26.14 60.66 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.219 0.608 . . . . 74.510000000000005 110.58 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -69.73 -21.68 63.44 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.756 0.822 . . . . 70.219999999999999 112.014 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.0 p -117.02 155.0 29.94 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.407 1.083 . . . . 72.040000000000006 109.036 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.2 tp -108.93 123.93 49.86 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.242 -0.651 . . . . 74.310000000000002 109.242 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.408 ' N ' ' HB2' ' A' ' 93' ' ' ALA . 31.2 p -69.46 115.38 8.66 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.653 -0.869 . . . . 75.25 108.653 171.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.531 HG12 ' HB3' ' A' ' 91' ' ' PHE . 34.5 pt -119.59 143.68 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.271 -0.64 . . . . 50.439999999999998 109.271 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 m -112.38 144.73 41.33 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.977 -0.749 . . . . 62.240000000000002 108.977 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -56.07 119.65 6.23 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.668 0.387 . . . . 74.409999999999997 110.148 173.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.13 -17.29 44.63 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.301 -0.409 . . . . 73.209999999999994 113.219 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -78.8 129.51 34.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.143 0.577 . . . . 64.010000000000005 110.226 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.401 ' HD2' HD21 ' A' ' 84' ' ' LEU . 48.0 mtmt -87.48 130.14 34.81 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.024 0.529 . . . . 65.530000000000001 110.566 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.47 ' HB3' ' HB1' ' A' ' 121' ' ' ALA . 18.8 mt -107.3 148.1 29.43 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.232 1.013 . . . . 54.299999999999997 108.937 -172.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -111.04 107.92 17.47 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.386 -0.968 . . . . 63.329999999999998 108.386 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.2 t -99.78 123.44 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.243 0.617 . . . . 54.340000000000003 110.078 -171.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.5 mt -94.86 -4.45 47.0 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.506 0.722 . . . . 74.230000000000004 111.457 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.48 165.33 18.11 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 112.5 -0.24 . . . . 54.539999999999999 112.5 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.45 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 2.4 m-85 -97.06 174.53 6.71 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.665 0.786 . . . . 63.329999999999998 109.993 172.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -72.5 150.33 43.34 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.131 -0.94 . . . . 64.120000000000005 108.687 171.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -63.0 -27.17 69.24 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.237 0.458 . . . . 64.340000000000003 112.237 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.418 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 64.0 t30 -92.22 -10.96 36.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.041 0.536 . . . . 73.230000000000004 110.689 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 81.61 22.32 60.3 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 116.199 -0.455 . . . . 73.019999999999996 113.419 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.418 ' HG3' ' HB3' ' A' ' 115' ' ' ASN . 78.8 mt-10 -67.42 -62.38 1.45 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.836 0.854 . . . . 73.409999999999997 110.332 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -120.17 -179.12 3.84 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.928 -1.033 . . . . 53.020000000000003 109.781 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -144.36 123.45 12.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.574 0.75 . . . . 60.439999999999998 109.703 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -70.94 95.04 1.12 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.499 0.72 . . . . 70.239999999999995 110.693 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' A' ' 107' ' ' LEU . . . -105.45 145.21 31.16 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.444 0.698 . . . . 55.219999999999999 110.263 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.9 130.77 45.58 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.397 0.679 . . . . 64.329999999999998 110.195 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.9 p -133.93 -173.49 3.27 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.12 0.968 . . . . 73.439999999999998 109.643 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -61.94 -21.53 64.85 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.21 0.604 . . . . 63.039999999999999 111.339 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -76.07 -5.86 48.47 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.158 0.983 . . . . 73.040000000000006 111.836 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 116.41 -135.65 12.23 Favored Glycine 0 C--N 1.342 0.903 0 N-CA-C 110.316 -1.114 . . . . 53.219999999999999 110.316 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -151.13 156.63 41.39 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.541 0.67 . . . . 65.319999999999993 111.493 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 174.32 176.47 42.73 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.726 -0.67 . . . . 52.329999999999998 112.727 170.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.553 ' HZ2' ' HB3' ' A' ' 24' ' ' LYS . 86.9 m95 -84.54 118.7 24.49 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.495 -0.853 . . . . 74.549999999999997 110.037 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.91 153.93 47.01 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.742 1.217 . . . . 63.399999999999999 109.265 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -69.93 131.14 20.39 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 121.529 1.486 . . . . 73.430000000000007 111.059 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 27.4 p -59.63 -25.48 64.71 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.832 0.853 . . . . 75.120000000000005 111.828 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -74.91 -17.81 60.51 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.544 1.138 . . . . 72.150000000000006 112.094 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -95.34 -4.68 44.98 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.694 0.798 . . . . 65.430000000000007 112.386 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.7 pt -128.33 156.93 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.51 0.324 . . . . 63.350000000000001 110.721 -170.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.3 t -148.81 134.28 9.54 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 122.792 0.437 . . . . 62.509999999999998 109.957 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 74.3 Cg_endo -75.59 123.1 7.32 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.457 2.105 . . . . 64.209999999999994 112.918 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.9 m -98.3 -40.38 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.283 0.633 . . . . 65.040000000000006 111.825 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.468 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.0 t30 -99.01 5.39 47.15 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.104 0.562 . . . . 75.299999999999997 111.832 -172.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.8 p -83.9 -166.29 1.37 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.981 0.513 . . . . 64.340000000000003 110.655 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.408 HD13 ' HB3' ' A' ' 214' ' ' LEU . 71.7 mt -77.38 -12.16 59.92 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.804 0.841 . . . . 73.409999999999997 111.998 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.21 -21.12 66.45 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.497 0.719 . . . . 64.25 111.56 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.68 -29.4 64.62 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.994 0.918 . . . . 54.530000000000001 110.604 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -79.57 137.71 37.24 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.66 0.784 . . . . 73.310000000000002 109.633 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.0 m -63.39 -17.96 63.19 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.59 0.756 . . . . 71.430000000000007 112.778 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 51.9 p-90 -77.42 -35.55 54.04 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.324 0.49 . . . . 64.129999999999995 112.324 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -97.64 130.1 44.68 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.531 -0.544 . . . . 71.340000000000003 109.531 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -122.64 19.92 10.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.789 0.436 . . . . 75.040000000000006 111.574 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.5 -155.32 49.94 Favored Glycine 0 CA--C 1.536 1.366 0 N-CA-C 114.839 0.696 . . . . 72.349999999999994 114.839 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.26 99.06 1.24 Allowed 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 123.587 2.858 . . . . 73.430000000000007 112.049 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.5 t -142.7 145.92 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.188 0.995 . . . . 64.209999999999994 109.298 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.9 m -82.64 169.28 16.43 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.843 0.683 . . . . 72.010000000000005 112.843 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -53.71 -37.99 63.84 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 124.014 0.926 . . . . 72.299999999999997 112.488 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -56.04 -50.17 71.67 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.858 0.463 . . . . 73.219999999999999 111.746 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.89 -30.23 40.09 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 123.478 0.711 . . . . 62.450000000000003 110.465 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.716 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -59.57 -48.22 82.5 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.915 -0.584 . . . . 42.420000000000002 111.212 172.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.526 ' HG3' HG11 ' A' ' 190' ' ' VAL . 28.5 tt0 -78.85 -25.95 44.04 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.618 0.767 . . . . 73.109999999999999 109.574 -176.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.71 -52.78 63.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.665 0.786 . . . . 73.030000000000001 111.645 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.446 ' HB2' HD11 ' A' ' 169' ' ' LEU . 48.5 mt -72.22 -34.57 68.44 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 120.728 0.299 . . . . 75.439999999999998 111.042 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.453 HD22 ' HB3' ' A' ' 183' ' ' SER . 33.2 tp -66.72 -26.72 67.14 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.145 0.578 . . . . 62.450000000000003 111.898 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.3 t -64.28 -17.53 63.72 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.855 0.862 . . . . 75.420000000000002 111.715 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.0 m -89.26 -6.51 56.75 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.72 0.808 . . . . 73.109999999999999 111.565 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -97.62 161.11 21.18 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 114.616 0.606 . . . . 73.319999999999993 114.616 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.7 pt -102.59 -164.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.904 0.882 . . . . 63.140000000000001 110.221 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.862 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 13.3 p-10 -51.34 118.56 3.36 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.766 0.827 . . . . 74.319999999999993 113.124 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.59 14.37 68.2 Favored Glycine 0 C--O 1.256 1.499 0 CA-C-N 115.574 -0.739 . . . . 63.420000000000002 113.227 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.6 t -69.49 134.04 48.42 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.075 -0.713 . . . . 73.519999999999996 109.075 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.547 ' HA ' ' O ' ' A' ' 183' ' ' SER . 20.1 p90 -139.97 154.13 47.09 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.879 0.696 . . . . 72.439999999999998 112.879 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 159' ' ' LEU . 97.8 mt -133.08 133.73 43.36 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.708 -0.849 . . . . 44.32 108.708 169.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.416 HG22 HG12 ' A' ' 182' ' ' ILE . 22.7 t -106.55 118.0 53.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 107.363 -1.347 . . . . 71.209999999999994 107.363 174.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.716 HH11 ' HA ' ' A' ' 156' ' ' ALA . 28.9 mtt180 -147.42 152.03 37.44 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.198 0.999 . . . . 74.239999999999995 109.527 -174.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 16.1 pt-20 -106.76 162.6 13.64 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.8 -0.815 . . . . 62.530000000000001 108.8 172.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.5 t -77.27 134.54 38.53 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.657 0.383 . . . . 65.519999999999996 110.262 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -60.76 -43.78 97.56 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.404 0.682 . . . . 73.439999999999998 109.962 175.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 62.5 p -90.6 5.73 46.69 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.67 -1.15 . . . . 70.040000000000006 112.188 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.0 m -150.69 87.96 4.68 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.443 0.697 . . . . 73.129999999999995 109.333 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.45 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 27.1 Cg_endo -60.84 138.98 82.75 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.827 2.351 . . . . 61.140000000000001 111.89 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.83 -23.07 11.19 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 116.066 -0.516 . . . . 70.129999999999995 113.652 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -83.52 113.76 21.02 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.141 -0.689 . . . . 63.109999999999999 109.141 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.692 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 67.6 mtt-85 -114.77 170.71 8.13 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.088 -0.505 . . . . 74.230000000000004 110.124 -170.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.472 ' HB2' ' HD3' ' A' ' 194' ' ' ARG . 33.0 t -161.02 148.56 15.48 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.397 0.679 . . . . 60.340000000000003 110.048 -177.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.416 HG12 HG22 ' A' ' 170' ' ' VAL . 55.3 mt -112.78 141.06 29.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 107.955 -1.128 . . . . 51.329999999999998 107.955 166.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 20.0 m -118.12 112.29 19.99 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 124.287 1.035 . . . . 74.209999999999994 108.849 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.465 HD21 HD23 ' A' ' 232' ' ' LEU . 38.2 mt -104.78 142.25 35.04 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.486 0.585 . . . . 75.299999999999997 112.424 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -129.99 125.65 35.87 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 114.565 -1.198 . . . . 74.409999999999997 108.182 168.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.862 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 6.3 p90 -140.65 134.97 31.2 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 109.162 -0.681 . . . . 74.530000000000001 109.162 174.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 58.15 22.95 9.64 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.664 1.186 . . . . 73.400000000000006 112.48 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 84.07 7.99 84.56 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.203 -0.453 . . . . 45.200000000000003 113.654 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -102.49 124.99 49.04 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.422 0.689 . . . . 74.209999999999994 109.543 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.526 HG11 ' HG3' ' A' ' 157' ' ' GLU . 98.1 t -104.96 134.77 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.236 1.014 . . . . 63.340000000000003 110.478 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.461 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 32.4 p90 -147.0 151.84 37.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.34 1.056 . . . . 63.219999999999999 108.811 168.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -121.47 150.94 40.83 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.588 -0.893 . . . . 72.099999999999994 108.588 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -146.19 139.62 26.01 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.631 0.373 . . . . 74.109999999999999 110.464 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.472 ' HD3' ' HB2' ' A' ' 181' ' ' SER . 32.5 mmt180 -82.76 140.6 32.92 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.75 0.786 . . . . 74.109999999999999 112.913 -172.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 84.9 mt -93.04 111.2 24.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-N 114.284 -1.325 . . . . 73.129999999999995 107.539 165.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -87.98 133.35 33.96 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 109.395 -0.594 . . . . 74.120000000000005 109.395 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.7 m -94.19 116.46 28.87 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.265 0.626 . . . . 72.0 109.717 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.51 160.36 27.78 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.433 0.693 . . . . 75.140000000000001 110.997 171.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.3 t -66.4 -10.16 40.96 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.796 0.839 . . . . 74.129999999999995 111.957 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -90.61 5.19 48.98 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.79 0.836 . . . . 64.230000000000004 111.8 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 81.08 -3.5 76.26 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 122.796 0.236 . . . . 72.030000000000001 113.097 -175.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -83.5 135.19 34.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.692 0.797 . . . . 64.230000000000004 110.136 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.9 mt -92.97 157.32 16.39 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.508 0.723 . . . . 73.530000000000001 110.052 -177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -164.4 156.95 16.92 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.161 0.505 . . . . 64.140000000000001 111.29 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.3 t -117.04 -67.03 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 106.904 -1.517 . . . . 71.340000000000003 106.904 170.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.8 m -68.44 140.81 55.77 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.07 0.948 . . . . 51.530000000000001 110.257 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 54.7 p -62.86 -31.49 72.53 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.329 0.652 . . . . 45.149999999999999 111.666 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -88.08 3.31 49.46 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.513 0.725 . . . . 74.439999999999998 112.084 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.5 m -123.1 144.12 49.52 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.762 0.425 . . . . 61.450000000000003 111.453 -174.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 81.0 mmt-85 -143.03 135.43 27.39 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 107.609 -1.256 . . . . 74.310000000000002 107.609 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -131.33 135.73 47.51 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.708 -1.219 . . . . 75.219999999999999 107.708 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -75.07 -35.91 61.81 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 122.551 0.34 . . . . 72.319999999999993 110.122 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 77.4 p -124.26 150.51 45.26 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.479 0.712 . . . . 62.210000000000001 111.848 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.408 ' HB3' HD13 ' A' ' 141' ' ' LEU . 33.2 tp -69.64 -28.15 65.66 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.974 -1.012 . . . . 71.019999999999996 110.523 174.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.87 -44.58 91.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.042 0.537 . . . . 73.420000000000002 110.486 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -77.56 -29.32 52.13 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.815 -0.63 . . . . 74.129999999999995 112.273 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.3 tt -61.27 -46.34 90.74 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 118.363 0.529 . . . . 74.319999999999993 109.898 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 67.0 t -74.1 -42.09 51.99 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 C-N-CA 123.891 0.876 . . . . 64.200000000000003 111.129 -176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -58.77 -52.4 65.86 Favored 'General case' 0 C--O 1.262 1.74 0 CA-C-O 121.289 0.566 . . . . 63.229999999999997 111.223 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.483 ' O ' HG22 ' A' ' 224' ' ' VAL . 37.9 t-80 -54.67 -56.99 13.33 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 114.646 -1.161 . . . . 55.299999999999997 108.377 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.405 ' HA ' HG22 ' A' ' 224' ' ' VAL . 10.4 m170 -68.05 -14.65 63.14 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.17 0.804 . . . . 70.040000000000006 113.17 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.493 ' HA ' ' HB2' ' A' ' 232' ' ' LEU . 42.0 t -73.77 -34.65 64.77 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 110.169 -0.308 . . . . 71.310000000000002 110.169 171.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.9 t -108.5 -13.42 14.84 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 116.144 1.905 . . . . 72.329999999999998 116.144 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 220' ' ' HIS . 34.1 m -103.63 165.84 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 116.316 1.969 . . . . 72.510000000000005 116.316 -165.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.85 -1.71 58.05 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.829 3.252 . . . . 62.140000000000001 113.854 -172.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -78.67 14.36 1.34 Allowed 'General case' 0 CA--C 1.576 1.955 0 C-N-CA 130.322 3.449 . . . . 63.420000000000002 113.519 -138.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.11 17.61 4.46 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 110.856 -0.897 . . . . 42.200000000000003 110.856 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 92.8 mt -92.36 124.03 36.12 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.828 1.251 . . . . 62.200000000000003 110.34 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.461 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 89.5 mt -61.73 -40.78 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 109.303 -0.628 . . . . 65.140000000000001 109.303 172.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.5 t -138.19 142.61 40.02 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.275 -0.875 . . . . 75.329999999999998 109.392 166.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 224' ' ' VAL . 82.3 p -66.65 149.59 50.28 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.989 -0.55 . . . . 72.010000000000005 109.547 169.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 222' ' ' SER . 40.9 mt -65.48 103.32 0.82 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.001 0.521 . . . . 74.420000000000002 109.956 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -75.62 -59.42 2.76 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.518 0.727 . . . . 65.540000000000006 109.809 -176.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -156.44 150.67 19.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 CA-C-O 119.326 -0.368 . . . . 73.349999999999994 110.212 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 31.2 Cg_endo -62.81 137.3 62.31 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.116 1.877 . . . . 63.520000000000003 111.855 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -59.59 135.74 89.29 Favored Pre-proline 0 C--O 1.243 0.747 0 C-N-CA 123.333 0.653 . . . . 63.530000000000001 111.045 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.01 117.21 3.88 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.387 2.058 . . . . 73.310000000000002 112.617 -174.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt . . . . . 0 CA--C 1.547 0.837 0 CA-C-N 114.542 -1.208 . . . . 73.420000000000002 109.843 170.308 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 121.073 0.463 . . . . 71.0 111.355 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.9 mt -104.79 128.46 26.75 Favored Pre-proline 0 C--O 1.241 0.644 0 N-CA-C 109.205 -0.665 . . . . 52.030000000000001 109.205 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -66.32 165.95 22.99 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.566 2.177 . . . . 63.020000000000003 111.865 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.98 146.71 31.9 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 120.809 0.337 . . . . 63.530000000000001 110.53 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.611 ' HB3' HD11 ' A' ' 23' ' ' ILE . 75.6 mt -87.02 93.17 9.28 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.524 -0.917 . . . . 75.299999999999997 108.524 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -95.26 -45.24 7.24 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.942 -1.026 . . . . 54.43 109.389 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -105.85 115.36 30.1 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.144 -0.935 . . . . 72.0 110.084 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.611 HD11 ' HB3' ' A' ' 20' ' ' LEU . 45.9 mm -116.47 113.84 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.298 -1.001 . . . . 50.399999999999999 108.298 175.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt . . . . . 0 N--CA 1.472 0.667 0 C-N-CA 123.81 0.844 . . . . 74.209999999999994 109.185 175.528 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.482 ' HG3' ' NH1' ' A' ' 108' ' ' ARG . 74.2 Cg_endo . . . . . 0 N--CA 1.502 1.979 0 N-CA-C 111.587 -0.197 . . . . 73.540000000000006 111.587 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.633 ' HA ' ' HA ' ' A' ' 140' ' ' SER . 48.8 m-80 -66.14 85.99 0.1 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.898 0.856 . . . . 53.049999999999997 108.751 167.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 30.2 tp -87.4 122.91 31.77 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.306 -1.315 . . . . 54.329999999999998 109.865 -173.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -107.22 174.7 5.77 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.556 1.142 . . . . 74.439999999999998 109.225 174.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.24 142.55 19.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 108.464 -0.939 . . . . 72.040000000000006 108.464 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.449 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -78.39 123.28 26.83 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.513 0.508 . . . . 70.219999999999999 110.398 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.08 -22.92 41.7 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.34 0.656 . . . . 60.240000000000002 110.499 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.496 ' CD1' ' HA ' ' A' ' 134' ' ' TYR . 22.0 m-85 -127.15 162.0 27.15 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.939 0.896 . . . . 74.409999999999997 109.012 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.11 150.39 25.58 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.054 -1.091 . . . . 74.219999999999999 108.054 166.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -156.26 108.58 2.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.83 -1.174 . . . . 74.420000000000002 107.83 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 p -80.44 135.77 24.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.779 -0.823 . . . . 53.520000000000003 108.779 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.83 123.27 16.49 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.169 0.588 . . . . 21.440000000000001 110.687 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.2 t -84.39 8.26 16.82 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.554 0.742 . . . . 72.310000000000002 110.778 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.51 -171.64 44.14 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.789 -0.524 . . . . 74.530000000000001 111.789 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.5 -27.59 62.36 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.683 0.793 . . . . 45.439999999999998 110.682 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -74.84 -24.3 58.58 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.794 0.838 . . . . 55.219999999999999 112.74 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.9 p -102.03 157.58 16.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.603 0.761 . . . . 60.0 110.731 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.8 tp -110.0 131.83 54.71 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.516 0.727 . . . . 70.319999999999993 110.319 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.0 m -71.28 118.69 14.4 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.08 -0.711 . . . . 74.230000000000004 109.08 168.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.7 pt -124.03 147.18 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.566 0.746 . . . . 72.329999999999998 109.016 173.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.3 m -115.46 145.02 42.98 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.67 -0.493 . . . . 74.340000000000003 109.67 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -55.25 114.8 1.94 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.747 0.819 . . . . 63.130000000000003 110.856 174.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.78 -16.16 37.0 Favored Glycine 0 C--N 1.35 1.361 0 O-C-N 123.167 0.292 . . . . 73.400000000000006 112.763 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -78.38 137.24 37.92 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 124.153 0.981 . . . . 71.409999999999997 110.973 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.59 ' HB3' HD11 ' A' ' 84' ' ' LEU . 29.8 mtmt -77.44 134.72 38.31 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 124.044 0.84 . . . . 70.430000000000007 109.777 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 87' ' ' ALA . 19.0 mt -120.3 135.87 54.87 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.38 0.672 . . . . 73.129999999999995 109.255 -173.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.482 ' NH1' ' HG3' ' A' ' 82' ' ' PRO . 50.9 mtp85 -93.56 108.14 19.89 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.718 -0.845 . . . . 74.209999999999994 108.718 167.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.459 HG21 HD12 ' A' ' 135' ' ' ILE . 95.6 t -95.27 108.94 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.565 -0.902 . . . . 41.219999999999999 108.565 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.86 -28.97 64.97 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.025 0.93 . . . . 74.200000000000003 110.224 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.85 173.12 37.05 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-N 114.648 -1.16 . . . . 71.010000000000005 111.013 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 51.3 m-85 -96.8 175.02 6.51 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.648 -0.871 . . . . 55.229999999999997 108.648 176.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.496 ' HB3' ' H ' ' A' ' 117' ' ' GLU . 49.8 t-20 -63.4 144.39 57.01 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.69 -1.226 . . . . 72.340000000000003 107.69 173.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -54.37 -32.65 57.47 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.688 0.795 . . . . 72.230000000000004 110.905 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.53 -19.83 28.89 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.441 1.097 . . . . 74.299999999999997 111.797 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.07 34.46 7.18 Favored Glycine 0 N--CA 1.477 1.418 0 C-N-CA 123.121 0.391 . . . . 63.32 113.854 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.496 ' H ' ' HB3' ' A' ' 113' ' ' ASN . 28.5 mt-10 -99.4 -65.86 0.94 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.466 0.706 . . . . 64.349999999999994 111.043 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -103.01 -176.77 3.18 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.668 1.187 . . . . 73.219999999999999 110.207 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -143.66 117.16 9.14 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.563 0.745 . . . . 63.240000000000002 110.032 -177.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -73.81 97.96 2.85 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.615 -0.513 . . . . 54.25 109.615 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.78 168.14 9.33 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.145 -0.934 . . . . 74.030000000000001 110.718 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -147.48 127.81 13.94 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 108.57 -0.9 . . . . 72.120000000000005 108.57 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.6 p -139.71 -172.57 3.41 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.025 0.93 . . . . 75.519999999999996 109.785 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -63.02 -20.68 65.55 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.509 -0.768 . . . . 74.329999999999998 111.307 171.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -81.72 -4.11 55.43 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.056 0.943 . . . . 71.219999999999999 111.269 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 125.47 -135.07 9.07 Favored Glycine 0 C--N 1.355 1.589 0 N-CA-C 112.354 -0.298 . . . . 72.120000000000005 112.354 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -150.65 133.88 16.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.997 0.919 . . . . 70.010000000000005 109.155 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 176.18 -177.91 47.68 Favored Glycine 0 C--N 1.348 1.25 0 O-C-N 123.214 0.321 . . . . 41.43 112.867 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -88.37 126.53 35.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.374 1.07 . . . . 75.430000000000007 111.149 -174.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.05 154.7 55.79 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.914 1.286 . . . . 72.230000000000004 109.138 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.95 132.82 23.81 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 121.744 1.63 . . . . 71.430000000000007 110.398 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.3 m -63.8 -19.33 64.93 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.571 0.748 . . . . 74.340000000000003 112.108 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -72.22 -22.05 61.31 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.977 0.911 . . . . 73.319999999999993 111.302 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.496 ' HA ' ' CD1' ' A' ' 89' ' ' TYR . 2.5 m-85 -90.61 -7.4 52.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.763 0.825 . . . . 72.5 113.024 -175.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.459 HD12 HG21 ' A' ' 109' ' ' VAL . 16.1 pt -121.57 157.35 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 122.808 0.443 . . . . 74.420000000000002 110.409 -171.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.5 t -147.35 141.55 15.94 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 122.917 0.487 . . . . 55.340000000000003 110.248 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.81 147.15 43.93 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.632 2.221 . . . . 74.140000000000001 112.111 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 m -130.94 -59.96 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.55 0.74 . . . . 73.430000000000007 110.666 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.629 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.1 t30 -103.06 16.08 27.6 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 122.945 0.498 . . . . 74.25 111.06 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 41.3 m -60.62 170.78 1.31 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.028 0.531 . . . . 72.140000000000001 111.034 172.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 69.7 mt -55.65 -16.09 3.76 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.921 1.082 . . . . 74.299999999999997 113.921 -173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.532 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 31.4 tt0 -65.97 -6.29 12.15 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.536 1.134 . . . . 73.219999999999999 111.478 175.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -56.53 -31.11 63.83 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.271 1.428 . . . . 72.200000000000003 110.496 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -100.29 141.77 32.68 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.566 -0.743 . . . . 72.5 109.262 173.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.3 p -70.42 -5.81 31.14 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.242 0.83 . . . . 74.439999999999998 113.242 -170.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.402 ' CE3' HG21 ' A' ' 218' ' ' VAL . 42.5 p-90 -77.94 -33.64 51.55 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 111.806 0.299 . . . . 72.319999999999993 111.806 174.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.4 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 37.3 t80 -99.27 139.25 35.19 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.281 -0.637 . . . . 74.530000000000001 109.281 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.532 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 25.1 m-70 -134.12 38.51 3.15 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.894 0.478 . . . . 72.200000000000003 110.372 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 68.59 -171.16 38.04 Favored Glycine 0 CA--C 1.542 1.732 0 N-CA-C 116.305 1.282 . . . . 70.109999999999999 116.305 165.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.11 100.65 0.88 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.635 2.89 . . . . 73.200000000000003 111.553 171.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.464 ' HB ' ' HD2' ' A' ' 171' ' ' ARG . 78.0 t -142.66 148.47 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.772 0.829 . . . . 73.329999999999998 109.352 -174.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.5 m -70.83 151.34 44.89 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 123.93 0.892 . . . . 70.530000000000001 111.288 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -20.59 55.26 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.228 -0.896 . . . . 72.049999999999997 112.186 176.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.83 -59.13 5.6 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.303 1.041 . . . . 75.140000000000001 109.822 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 158' ' ' TYR . . . -70.12 -31.72 69.39 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.842 0.857 . . . . 71.239999999999995 110.81 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.497 ' HA ' HH21 ' A' ' 171' ' ' ARG . . . -57.25 -54.06 51.08 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.43 -0.804 . . . . 70.439999999999998 110.738 171.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -73.1 -23.34 60.51 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.862 -0.608 . . . . 54.539999999999999 110.762 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.411 ' HB3' ' HA ' ' A' ' 155' ' ' ALA . 71.1 t80 -63.58 -49.37 73.66 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.743 0.817 . . . . 72.310000000000002 110.398 175.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.495 HD12 ' NH2' ' A' ' 171' ' ' ARG . 67.3 mt -71.32 -37.52 71.76 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.058 0.456 . . . . 72.299999999999997 110.79 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.438 HD23 HG13 ' A' ' 190' ' ' VAL . 29.1 tp -73.98 -17.27 61.02 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.854 -0.612 . . . . 73.310000000000002 112.269 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 38.9 t -68.86 -19.84 64.26 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.371 0.669 . . . . 63.43 110.651 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.9 t -99.82 6.82 45.34 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.472 0.709 . . . . 70.120000000000005 110.6 174.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.15 163.27 43.11 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 116.089 -0.505 . . . . 62.229999999999997 113.068 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.2 pt -126.35 -166.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.442 1.497 . . . . 64.010000000000005 110.396 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.698 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 24.7 p-10 -58.78 110.12 0.95 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.63 0.604 . . . . 73.129999999999995 112.63 -169.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 91.91 13.37 57.92 Favored Glycine 0 C--O 1.256 1.477 0 CA-C-N 115.91 -0.587 . . . . 53.32 113.168 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 67.4 m -77.69 131.35 37.67 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.023 -0.362 . . . . 74.150000000000006 110.023 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.477 ' HB3' HD23 ' A' ' 184' ' ' LEU . 16.2 p90 -133.13 154.88 50.18 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.834 0.679 . . . . 64.209999999999994 112.834 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.6 mt -135.46 133.82 38.94 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.931 -1.032 . . . . 74.230000000000004 108.459 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.74 118.07 54.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 107.838 -1.171 . . . . 73.420000000000002 107.838 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.497 HH21 ' HA ' ' A' ' 156' ' ' ALA . 18.7 mmt180 -118.62 167.58 11.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.059 0.944 . . . . 60.219999999999999 108.798 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.581 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 15.7 pt-20 -117.89 160.76 20.87 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 109.575 -0.528 . . . . 74.319999999999993 109.575 158.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 59.3 m -87.33 135.24 33.4 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.749 -0.66 . . . . 44.340000000000003 110.326 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -74.44 -36.42 63.38 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.007 0.923 . . . . 74.239999999999995 110.872 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 26.5 t -89.37 -16.26 31.41 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.551 0.741 . . . . 61.340000000000003 111.031 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 32.7 t -127.19 85.25 61.43 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 108.387 -0.968 . . . . 61.240000000000002 108.387 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.47 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 51.6 Cg_endo -65.64 140.38 62.09 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.161 2.574 . . . . 72.019999999999996 112.289 -176.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.6 -25.37 5.16 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 115.771 -0.649 . . . . 74.150000000000006 113.102 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -79.95 119.11 22.35 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 108.741 -0.837 . . . . 73.310000000000002 108.741 173.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.581 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 47.9 mtt85 -114.21 165.46 12.65 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 115.019 -0.991 . . . . 75.209999999999994 109.167 -176.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.3 m -146.71 139.01 24.87 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.495 -0.557 . . . . 72.150000000000006 109.495 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 47.4 mt -103.84 140.99 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.1 -1.074 . . . . 73.540000000000006 108.1 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 18.1 m -121.21 111.86 17.92 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.103 -0.953 . . . . 64.25 108.505 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 168' ' ' PHE . 33.9 mt -103.79 143.91 32.19 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.17 0.988 . . . . 53.509999999999998 111.212 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -131.71 133.6 45.01 Favored 'General case' 0 C--O 1.257 1.496 0 CA-C-N 114.825 -1.08 . . . . 75.239999999999995 108.536 168.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.698 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 24.3 p90 -143.73 133.52 23.85 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.862 -1.063 . . . . 74.420000000000002 108.21 173.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 47.64 37.47 6.81 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.674 1.19 . . . . 63.520000000000003 113.817 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 92.18 -5.41 78.3 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.621 -0.718 . . . . 55.020000000000003 113.779 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -102.93 123.99 47.59 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.1 0.56 . . . . 72.340000000000003 109.738 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.438 HG13 HD23 ' A' ' 160' ' ' LEU . 84.7 t -106.27 137.55 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.238 1.015 . . . . 61.219999999999999 109.547 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.402 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 24.3 p90 -145.73 151.33 37.82 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.751 0.821 . . . . 72.200000000000003 109.572 169.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -128.38 134.13 48.77 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.544 -1.28 . . . . 75.409999999999997 107.544 -173.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -136.8 139.36 41.72 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.242 0.544 . . . . 70.219999999999999 110.436 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.544 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 22.2 tpp180 -81.76 122.46 27.7 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.588 -1.187 . . . . 72.140000000000001 111.58 -171.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.491 ' HA ' HG22 ' A' ' 205' ' ' VAL . 73.4 mt -72.69 115.56 13.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 108.308 -0.997 . . . . 75.109999999999999 108.308 162.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -93.46 132.47 37.7 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 109.016 -0.735 . . . . 75.230000000000004 109.016 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.7 m -95.6 116.45 28.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.407 -0.815 . . . . 73.049999999999997 108.909 172.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.35 161.27 22.82 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.138 0.975 . . . . 72.430000000000007 111.693 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.3 t -70.06 -10.76 59.77 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.654 0.782 . . . . 64.109999999999999 110.803 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -71.77 -17.12 62.2 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.463 1.105 . . . . 70.340000000000003 111.206 172.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 88.25 2.28 80.41 Favored Glycine 0 C--N 1.355 1.62 0 C-N-CA 123.169 0.414 . . . . 62.100000000000001 112.081 -171.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -90.47 145.33 24.99 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.913 0.885 . . . . 74.140000000000001 110.773 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 86.8 mt -94.23 149.2 21.46 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 123.195 0.598 . . . . 74.299999999999997 109.621 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -162.43 166.94 24.37 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.668 0.605 . . . . 74.230000000000004 111.182 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 195' ' ' ILE . 92.8 t -140.88 -62.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.301 1.041 . . . . 71.319999999999993 108.632 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 12.7 m -98.79 -169.96 1.86 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.628 1.171 . . . . 74.329999999999998 111.196 -172.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.8 m -69.99 -47.68 61.22 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.532 0.733 . . . . 65.230000000000004 112.859 -169.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -84.36 -16.77 41.68 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.455 0.702 . . . . 73.140000000000001 109.257 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 71.6 m -64.41 106.59 1.16 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.32 0.648 . . . . 74.150000000000006 111.376 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 210' ' ' ARG . 8.7 mmt180 -146.1 117.57 8.0 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.393 1.077 . . . . 75.120000000000005 109.18 169.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -136.54 152.71 50.8 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.145 0.578 . . . . 75.430000000000007 110.616 -171.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -82.07 -36.28 27.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.197 -0.668 . . . . 75.450000000000003 109.197 168.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 82.8 p -130.73 160.13 35.23 Favored 'General case' 0 C--O 1.252 1.2 0 CA-C-O 122.247 1.022 . . . . 71.5 112.598 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 21.4 tp -74.14 -22.04 59.61 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.15 -1.386 . . . . 72.239999999999995 110.807 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.23 -49.64 76.29 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.44 0.638 . . . . 51.329999999999998 110.41 171.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -62.23 -41.96 98.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.521 -1.218 . . . . 72.040000000000006 110.504 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.9 tt -57.88 -48.92 78.41 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.02 0.825 . . . . 64.129999999999995 111.612 177.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.402 HG21 ' CE3' ' A' ' 146' ' ' TRP . 55.7 t -72.08 -38.47 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.083 0.553 . . . . 62.409999999999997 111.19 -174.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -65.43 -46.75 78.69 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.128 0.49 . . . . 73.310000000000002 110.938 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.478 ' O ' HG22 ' A' ' 224' ' ' VAL . 40.6 t-80 -56.07 -52.35 64.58 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.672 -0.695 . . . . 74.540000000000006 109.322 176.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.557 ' HD1' HD21 ' A' ' 228' ' ' LEU . 18.1 m-70 -70.19 -19.15 63.19 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.531 -0.759 . . . . 74.030000000000001 112.535 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.2 p -81.29 -20.2 41.36 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.127 0.421 . . . . 70.040000000000006 110.715 172.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 7.0 t -111.53 -12.99 13.9 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.251 1.945 . . . . 75.0 116.251 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 220' ' ' HIS . 30.3 m -105.59 158.34 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 121.145 1.793 . . . . 74.219999999999999 115.733 -167.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -90.7 0.61 57.35 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.855 2.862 . . . . 74.129999999999995 113.523 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -81.16 15.03 2.06 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 128.191 2.596 . . . . 64.510000000000005 113.157 -139.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.02 19.88 3.87 Favored Glycine 0 N--CA 1.464 0.563 0 N-CA-C 110.35 -1.1 . . . . 40.420000000000002 110.35 -170.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.557 HD21 ' HD1' ' A' ' 221' ' ' HIS . 95.7 mt -93.59 128.4 39.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.626 -1.287 . . . . 74.219999999999999 109.102 163.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.402 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 95.3 mt -64.04 -49.0 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.871 -0.788 . . . . 71.010000000000005 108.871 170.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.2 t -130.97 147.83 52.65 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.104 -1.072 . . . . 73.329999999999998 108.104 170.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.0 p -75.29 155.75 36.32 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.913 -0.403 . . . . 72.209999999999994 109.913 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.406 HD23 HD21 ' A' ' 184' ' ' LEU . 27.5 mt -64.58 103.32 0.66 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.397 -0.964 . . . . 74.239999999999995 108.397 176.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -88.28 -58.29 2.61 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.047 -0.723 . . . . 74.400000000000006 109.047 -172.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.563 ' O ' ' HA ' ' A' ' 167' ' ' SER . 14.5 p90 -152.3 149.14 22.29 Favored Pre-proline 0 N--CA 1.484 1.257 0 CA-C-N 116.017 -0.538 . . . . 74.439999999999998 110.272 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 26.8 Cg_exo -63.31 148.88 92.53 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.116 1.877 . . . . 74.340000000000003 112.958 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.72 134.22 78.92 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 108.378 -0.971 . . . . 73.209999999999994 108.378 169.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.07 137.99 59.88 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.417 2.078 . . . . 74.430000000000007 113.379 -171.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 65.3 tttm . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 108.284 -1.006 . . . . 74.019999999999996 108.284 170.149 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.546 0.806 0 CA-C-O 121.563 0.697 . . . . 75.299999999999997 111.297 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.4 mt -106.48 135.16 19.53 Favored Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 115.478 -0.783 . . . . 73.010000000000005 109.946 -173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.72 173.72 13.91 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.602 2.201 . . . . 63.020000000000003 111.874 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.06 148.85 26.6 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.957 0.503 . . . . 74.329999999999998 110.776 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.489 HD22 HD11 ' A' ' 23' ' ' ILE . 79.2 mt -86.3 93.48 9.09 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.79 -0.818 . . . . 72.209999999999994 108.79 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -97.17 -48.83 5.21 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.977 0.511 . . . . 74.209999999999994 110.427 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.473 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 64.1 m-85 -104.16 114.83 29.35 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.313 -0.625 . . . . 51.109999999999999 109.313 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.489 HD11 HD22 ' A' ' 20' ' ' LEU . 47.1 mm -121.77 120.99 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 109.4 -0.593 . . . . 50.329999999999998 109.4 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.5 ' H ' ' HE1' ' A' ' 129' ' ' TRP . 63.8 mttm . . . . . 0 N--CA 1.481 1.084 0 C-N-CA 123.917 0.887 . . . . 73.450000000000003 109.763 172.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 N--CA 1.5 1.888 0 N-CA-C 114.17 0.796 . . . . 63.130000000000003 114.17 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -91.21 17.03 8.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.795 0.838 . . . . 44.240000000000002 111.484 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.91 109.66 18.3 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 108.701 -0.852 . . . . 72.319999999999993 108.701 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 4.4 m-85 -105.69 175.79 5.38 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.49 1.516 . . . . 71.299999999999997 110.421 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.97 148.07 27.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.798 -1.186 . . . . 73.040000000000006 107.798 169.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.52 107.77 14.56 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.754 -0.832 . . . . 53.32 108.754 170.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.4 mt -62.52 -27.4 69.13 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.058 0.943 . . . . 64.109999999999999 111.198 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -141.17 166.35 25.01 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.699 0.8 . . . . 62.409999999999997 109.728 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.52 147.47 29.65 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.518 -0.764 . . . . 52.329999999999998 109.812 175.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -155.93 118.09 4.07 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.347 1.059 . . . . 75.140000000000001 108.496 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.44 140.73 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.79 -0.819 . . . . 51.140000000000001 108.79 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.92 117.46 3.98 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.073 0.549 . . . . 63.340000000000003 110.526 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 m -59.46 -44.17 93.06 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.313 1.045 . . . . 73.310000000000002 110.386 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -160.26 -147.6 4.97 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 114.712 -1.131 . . . . 62.049999999999997 111.752 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -69.56 -34.87 74.8 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.312 1.045 . . . . 74.140000000000001 111.775 -175.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -84.91 8.69 16.66 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 113.252 0.834 . . . . 74.319999999999993 113.252 -175.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.6 p -127.26 156.84 41.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.299 0.64 . . . . 73.400000000000006 110.552 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.4 tp -109.97 137.13 48.18 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.571 0.749 . . . . 64.200000000000003 109.579 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.4 t -82.86 115.22 21.65 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.369 -0.975 . . . . 74.230000000000004 108.369 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.6 pt -123.48 144.29 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.256 1.022 . . . . 43.329999999999998 109.966 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.2 m -110.73 151.39 27.8 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 109.732 -0.469 . . . . 72.530000000000001 109.732 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -54.82 111.17 0.77 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.353 0.661 . . . . 72.019999999999996 111.682 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.55 -14.69 24.87 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 123.291 0.472 . . . . 55.399999999999999 112.765 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.48 120.91 14.71 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.971 0.908 . . . . 74.129999999999995 109.467 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 106' ' ' LYS . 8.0 mtmp? -80.87 118.19 22.16 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.665 -0.865 . . . . 73.25 108.665 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 21.7 mt -99.42 160.59 14.17 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.394 -0.965 . . . . 74.340000000000003 108.394 -174.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -121.12 107.3 12.43 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.206 -1.035 . . . . 75.439999999999998 108.206 164.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 74.1 t -94.6 115.18 32.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 108.573 -0.899 . . . . 75.120000000000005 108.573 -176.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.46 -35.34 80.04 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 123.588 0.555 . . . . 74.310000000000002 109.691 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.66 174.57 46.2 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.735 -0.666 . . . . 75.329999999999998 112.209 173.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.54 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 21.5 m-85 -92.91 174.88 7.02 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 108.808 -0.812 . . . . 71.409999999999997 108.808 176.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.473 ' ND2' ' HB2' ' A' ' 22' ' ' PHE . 12.8 m120 -64.07 167.85 5.98 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.945 -0.57 . . . . 74.400000000000006 110.13 164.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -72.31 -4.48 30.02 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 120.707 0.289 . . . . 62.539999999999999 110.324 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -105.21 -19.88 13.68 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.775 0.83 . . . . 74.530000000000001 110.754 170.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 80.15 12.93 82.71 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-N 116.633 -0.258 . . . . 71.219999999999999 113.603 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.406 ' HG3' ' OD1' ' A' ' 113' ' ' ASN . 9.5 pt-20 -68.4 -54.58 16.26 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.948 1.299 . . . . 71.430000000000007 111.794 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -116.18 173.19 6.72 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.796 0.838 . . . . 72.129999999999995 109.331 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.28 120.66 10.96 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.494 0.717 . . . . 64.530000000000001 110.735 -170.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -75.93 97.14 3.9 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.554 -0.536 . . . . 75.129999999999995 109.554 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -102.14 150.59 23.11 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.507 -0.77 . . . . 62.240000000000002 110.156 -174.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -132.22 122.54 25.39 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 124.047 0.939 . . . . 72.209999999999994 109.105 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 58.3 p -133.88 -176.73 4.27 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.275 1.43 . . . . 72.120000000000005 108.874 171.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -72.67 -3.19 23.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.982 0.513 . . . . 71.510000000000005 111.759 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -89.22 -1.18 57.97 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.786 0.834 . . . . 73.530000000000001 110.785 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.66 -156.23 15.89 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 111.759 -0.537 . . . . 63.420000000000002 111.759 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -144.6 131.53 20.32 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.173 0.589 . . . . 71.310000000000002 110.191 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -179.42 173.48 45.41 Favored Glycine 0 C--N 1.346 1.129 0 O-C-N 123.329 0.393 . . . . 62.539999999999999 112.694 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.5 ' HE1' ' H ' ' A' ' 24' ' ' LYS . 91.0 m95 -76.77 121.24 23.05 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.344 1.058 . . . . 64.319999999999993 111.517 -176.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.19 150.7 44.8 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 124.717 1.207 . . . . 70.239999999999995 108.904 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.51 126.08 14.94 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 121.799 1.666 . . . . 72.239999999999995 109.772 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 m -57.62 -26.79 62.08 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.723 0.809 . . . . 63.310000000000002 111.539 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -63.22 -28.68 70.2 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.657 1.183 . . . . 73.349999999999994 111.879 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -93.67 1.3 56.64 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.97 0.908 . . . . 74.299999999999997 112.774 -175.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 25.2 pt -133.75 164.68 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.347 0.521 . . . . 62.030000000000001 111.022 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.7 t -159.28 140.94 9.69 Favored Pre-proline 0 N--CA 1.484 1.241 0 O-C-N 123.455 0.472 . . . . 62.420000000000002 110.145 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 62.8 Cg_endo -71.68 114.54 3.98 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.269 1.98 . . . . 62.219999999999999 112.172 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.11 -36.04 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.757 0.823 . . . . 62.340000000000003 112.117 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -93.06 16.84 11.91 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.662 0.785 . . . . 72.540000000000006 110.111 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 137' ' ' PRO . 22.5 t -63.23 165.3 7.55 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.742 0.817 . . . . 75.219999999999999 110.808 175.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.4 mt -66.99 -10.24 47.46 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.35 1.06 . . . . 54.109999999999999 111.878 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.596 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 29.4 tt0 -66.0 -12.21 53.46 Favored 'General case' 0 C--N 1.369 1.439 0 C-N-CA 123.391 0.676 . . . . 72.25 111.922 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -61.25 -12.29 12.69 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 123.582 0.753 . . . . 74.109999999999999 110.428 167.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -105.85 150.12 25.89 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.979 1.711 . . . . 61.219999999999999 109.222 167.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.4 p -69.33 -20.49 63.87 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.61 0.967 . . . . 73.25 113.61 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.468 ' CE3' HG21 ' A' ' 218' ' ' VAL . 53.0 p-90 -77.38 -43.38 32.98 Favored 'General case' 0 C--O 1.25 1.108 0 N-CA-C 112.681 0.623 . . . . 73.040000000000006 112.681 -175.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -87.56 146.94 25.55 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.703 -0.48 . . . . 74.040000000000006 109.703 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.596 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 65.3 m-70 -143.21 39.59 1.45 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.12 0.968 . . . . 75.439999999999998 111.352 -174.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.25 -169.05 54.77 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 115.919 1.128 . . . . 73.549999999999997 115.919 163.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.464 ' HB2' ' HB2' ' A' ' 174' ' ' GLU . 8.3 Cg_endo -89.09 95.66 0.34 Allowed 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 124.083 3.188 . . . . 74.409999999999997 111.23 171.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.08 153.04 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.389 1.076 . . . . 75.140000000000001 110.82 -170.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.7 m -75.68 156.87 34.35 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.437 1.095 . . . . 64.510000000000005 112.069 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -62.39 -33.51 74.89 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.769 0.828 . . . . 70.420000000000002 112.162 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -66.75 -45.18 79.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.686 0.795 . . . . 75.540000000000006 110.026 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.23 -31.97 70.89 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.571 0.748 . . . . 61.340000000000003 111.043 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.78 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.39 -51.09 71.29 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.699 -0.682 . . . . 51.009999999999998 110.31 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.47 -31.27 71.9 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.994 0.918 . . . . 74.150000000000006 111.562 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -63.99 -45.75 87.61 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.482 0.713 . . . . 73.340000000000003 111.319 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.477 HD12 HH12 ' A' ' 171' ' ' ARG . 66.5 mt -77.43 -39.08 48.17 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 120.867 0.365 . . . . 74.140000000000001 111.375 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.61 HD23 HG13 ' A' ' 190' ' ' VAL . 34.0 tp -74.85 -20.95 59.53 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.732 -0.667 . . . . 72.409999999999997 112.194 -171.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.1 p -60.21 -28.28 67.85 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.052 0.541 . . . . 71.519999999999996 111.456 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.8 m -75.31 -15.26 60.51 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.039 0.935 . . . . 60.310000000000002 112.353 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.15 165.31 50.54 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 113.785 0.274 . . . . 74.219999999999999 113.785 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.3 pt -113.35 -164.74 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.23 1.012 . . . . 74.299999999999997 109.465 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.749 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 25.3 p-10 -49.32 114.12 0.96 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.909 0.884 . . . . 72.349999999999994 112.375 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.39 14.22 60.45 Favored Glycine 0 C--O 1.258 1.605 0 CA-C-N 116.46 -0.337 . . . . 64.519999999999996 113.498 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 70.4 p -74.85 139.49 43.23 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 108.989 -0.745 . . . . 73.409999999999997 108.989 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 232' ' ' LEU . 28.9 p90 -138.32 160.35 39.7 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.215 0.82 . . . . 75.450000000000003 113.215 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.443 HD13 ' NH1' ' A' ' 171' ' ' ARG . 96.4 mt -132.62 132.82 42.89 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.137 -1.431 . . . . 61.32 107.137 166.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 56.6 t -107.72 115.4 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 106.949 -1.501 . . . . 74.450000000000003 106.949 171.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.78 HH11 ' HA ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -159.1 152.34 22.44 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.204 0.602 . . . . 75.420000000000002 110.236 -175.384 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.657 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 10.9 pt-20 -107.7 156.55 18.96 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.942 0.401 . . . . 64.409999999999997 111.238 -177.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.9 m -90.71 113.45 25.55 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.065 -0.717 . . . . 62.539999999999999 109.065 173.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 33.0 tt0 -70.44 -26.47 63.67 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.427 0.691 . . . . 74.310000000000002 110.626 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.1 p -79.24 5.51 12.09 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.764 1.225 . . . . 62.43 112.183 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 37.5 m -142.93 123.22 7.99 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.668 0.787 . . . . 74.340000000000003 109.88 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.23 111.47 1.28 Allowed 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.298 2.665 . . . . 65.040000000000006 113.528 -171.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.58 9.83 52.25 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-N 115.774 -0.648 . . . . 75.129999999999995 114.552 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -87.53 115.31 24.87 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 109.175 -0.676 . . . . 72.430000000000007 109.175 -176.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.781 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 50.6 mtt85 -110.12 165.71 11.53 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.963 0.905 . . . . 72.019999999999996 108.825 176.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 65.9 m -149.85 142.71 24.76 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.754 0.421 . . . . 63.310000000000002 110.951 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 60.8 mt -111.93 130.77 64.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 N-CA-C 107.409 -1.33 . . . . 73.310000000000002 107.409 161.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 11.4 m -107.92 118.96 38.11 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.498 -1.228 . . . . 60.240000000000002 107.92 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.429 HD21 HD23 ' A' ' 232' ' ' LEU . 47.3 mt -110.03 135.78 50.32 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.334 1.054 . . . . 75.129999999999995 111.289 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 37.3 ttt-85 -121.18 130.78 53.88 Favored 'General case' 0 C--O 1.257 1.453 0 O-C-N 123.766 0.666 . . . . 75.25 109.276 169.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.749 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 15.6 p90 -147.65 136.85 22.34 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.366 1.041 . . . . 73.219999999999999 108.827 173.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 56.28 26.26 10.29 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 124.514 1.126 . . . . 74.540000000000006 113.263 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 97.04 -9.57 65.6 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.168 0.413 . . . . 43.119999999999997 113.222 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 18.9 ttm180 -98.89 124.28 43.72 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.275 0.63 . . . . 75.439999999999998 109.961 -171.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.61 HG13 HD23 ' A' ' 160' ' ' LEU . 59.1 t -104.87 132.96 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.494 1.117 . . . . 65.540000000000006 108.873 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.48 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 40.8 p90 -145.29 163.08 35.58 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.551 0.741 . . . . 74.230000000000004 109.423 171.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -128.62 151.77 49.11 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.006 0.923 . . . . 73.219999999999999 108.784 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.423 ' HE2' HD12 ' A' ' 184' ' ' LEU . 32.9 p90 -143.13 140.48 30.86 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 122.689 0.396 . . . . 74.420000000000002 110.056 168.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -73.72 134.19 43.47 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.257 -0.883 . . . . 73.219999999999999 111.504 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.781 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 80.5 mt -84.68 109.05 17.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 107.224 -1.399 . . . . 63.399999999999999 107.224 163.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -80.2 125.96 30.5 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.435 -0.802 . . . . 73.230000000000004 109.181 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 27.2 m -90.43 113.55 25.5 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.894 -0.78 . . . . 71.150000000000006 108.894 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -58.6 157.98 8.41 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.91 0.884 . . . . 71.400000000000006 111.082 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 23.3 t -68.27 -11.99 60.29 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.361 0.664 . . . . 74.540000000000006 111.569 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -71.46 -13.21 61.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.455 0.702 . . . . 73.219999999999999 111.436 170.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.9 5.47 86.19 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.984 -0.446 . . . . 64.129999999999995 111.984 -170.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -87.72 153.48 21.33 Favored 'General case' 0 C--N 1.346 0.444 0 C-N-CA 124.219 1.008 . . . . 74.140000000000001 109.29 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.427 HD21 HH11 ' A' ' 180' ' ' ARG . 97.3 mt -99.87 153.71 18.93 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.59 0.756 . . . . 71.430000000000007 110.19 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -166.4 169.53 13.89 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.953 0.783 . . . . 75.349999999999994 110.11 172.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 195' ' ' ILE . 73.2 t -132.52 -58.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 105.996 -1.853 . . . . 63.43 105.996 172.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 37.8 t -81.61 131.98 35.29 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.374 -1.285 . . . . 71.219999999999999 107.587 168.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 74.2 p -65.28 -32.59 74.33 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.407 0.683 . . . . 60.43 112.4 -171.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -74.12 -23.92 59.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.721 0.809 . . . . 72.329999999999998 111.219 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 68.6 m -97.37 104.45 16.47 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.153 0.981 . . . . 75.530000000000001 110.104 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 20.2 mmt85 -114.51 137.49 51.79 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.749 0.819 . . . . 63.439999999999998 109.192 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 8.3 m-85 -132.89 133.58 43.45 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.652 0.595 . . . . 64.540000000000006 109.639 -173.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -72.29 -40.71 67.34 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.217 0.607 . . . . 71.230000000000004 110.037 169.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.0 p -123.02 153.87 39.25 Favored 'General case' 0 C--N 1.368 1.371 0 CA-C-O 121.903 0.859 . . . . 70.120000000000005 112.201 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 24.9 tp -70.19 -28.75 65.55 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.118 -1.401 . . . . 71.230000000000004 111.002 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.92 99.57 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.236 0.614 . . . . 43.5 110.852 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -75.82 -31.69 59.49 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.424 -0.807 . . . . 63.5 111.33 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tt -56.95 -46.83 81.83 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 123.856 0.722 . . . . 73.349999999999994 110.544 169.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.468 HG21 ' CE3' ' A' ' 146' ' ' TRP . 51.3 t -72.47 -37.63 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.892 0.877 . . . . 74.510000000000005 111.444 -175.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -60.14 -50.59 73.07 Favored 'General case' 0 C--O 1.258 1.528 0 CA-C-O 121.622 0.725 . . . . 75.109999999999999 110.033 173.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.43 ' CE1' HG11 ' A' ' 224' ' ' VAL . 50.0 t60 -52.51 -54.72 28.79 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.136 -1.393 . . . . 74.140000000000001 109.787 177.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -64.29 -25.42 68.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.866 -1.061 . . . . 63.109999999999999 112.051 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.2 t -74.0 -28.54 61.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.743 0.417 . . . . 63.240000000000002 111.793 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.7 t -109.86 -17.44 13.64 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.299 1.962 . . . . 73.420000000000002 116.299 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.43 HG11 ' CE1' ' A' ' 220' ' ' HIS . 36.0 m -96.04 152.47 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 115.371 1.619 . . . . 60.140000000000001 115.371 -166.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -90.98 -1.76 57.78 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.409 2.683 . . . . 71.439999999999998 112.523 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.17 13.94 1.33 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 128.326 2.65 . . . . 63.439999999999998 112.751 -141.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.1 18.0 3.94 Favored Glycine 0 C--N 1.346 1.139 0 C-N-CA 125.443 1.497 . . . . 73.530000000000001 110.933 -171.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.11 120.75 33.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.214 1.006 . . . . 72.030000000000001 109.84 165.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.48 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 80.1 mt -60.15 -40.36 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.391 1.077 . . . . 74.450000000000003 109.497 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.9 t -137.58 140.38 40.96 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 114.835 -1.075 . . . . 74.140000000000001 108.756 170.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 80.6 p -71.77 155.77 40.08 Favored 'General case' 0 C--O 1.247 0.93 0 N-CA-C 108.567 -0.901 . . . . 65.510000000000005 108.567 170.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.453 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . 27.8 mt -67.82 100.8 0.98 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 108.661 -0.866 . . . . 61.439999999999998 108.661 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -80.28 -49.99 10.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.309 0.644 . . . . 72.430000000000007 109.886 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 167' ' ' SER . 9.6 p90 -160.57 150.41 14.49 Favored Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 109.675 -0.491 . . . . 75.329999999999998 109.675 173.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.89 138.95 17.09 Favored 'Trans proline' 0 C--N 1.365 1.436 0 C-N-CA 121.964 1.776 . . . . 71.219999999999999 112.495 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.31 142.94 97.1 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 108.68 -0.859 . . . . 62.520000000000003 108.68 168.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -69.09 169.55 17.79 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.795 2.33 . . . . 64.099999999999994 114.452 -170.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.483 ' NZ ' ' HG2' ' A' ' 142' ' ' GLU . 67.1 mttm . . . . . 0 N--CA 1.475 0.79 0 CA-C-N 114.536 -1.211 . . . . 44.130000000000003 109.678 165.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.6 p . . . . . 0 N--CA 1.475 0.798 0 CA-C-O 121.006 0.431 . . . . 34.43 111.299 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.8 mt -102.58 126.56 32.6 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 109.13 -0.693 . . . . 41.340000000000003 109.13 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.561 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 75.8 Cg_endo -74.03 174.49 12.32 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.785 2.323 . . . . 71.549999999999997 112.371 177.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.71 147.66 28.34 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.836 0.455 . . . . 64.310000000000002 111.491 -174.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HB3' HD11 ' A' ' 23' ' ' ILE . 85.1 mt -88.19 93.69 9.58 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.366 -0.976 . . . . 72.340000000000003 108.366 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -96.84 -48.68 5.36 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.109 0.564 . . . . 54.450000000000003 110.876 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.518 ' HE1' ' HB2' ' A' ' 115' ' ' ASN . 84.0 m-85 -105.93 111.04 23.53 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.092 0.557 . . . . 73.430000000000007 110.183 178.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' A' ' 20' ' ' LEU . 47.2 mm -118.08 110.44 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.006 0.523 . . . . 51.149999999999999 109.614 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' NZ ' ' HB2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.827 0 C-N-CA 124.868 1.267 . . . . 63.340000000000003 108.724 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 CA--C 1.548 1.219 0 N-CA-C 113.139 0.399 . . . . 60.340000000000003 113.139 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.498 ' HA ' ' HB3' ' A' ' 140' ' ' SER . 59.8 t30 -94.15 78.96 4.02 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 109.408 -0.59 . . . . 71.209999999999994 109.408 -176.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.658 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 33.5 tp -107.96 123.15 48.21 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.306 -0.861 . . . . 65.409999999999997 111.203 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.71 176.08 5.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.126 1.771 . . . . 75.040000000000006 108.879 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.43 148.88 24.34 Favored 'Isoleucine or valine' 0 C--O 1.252 1.234 0 N-CA-C 108.507 -0.923 . . . . 73.5 108.507 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.16 118.44 20.4 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 123.67 0.606 . . . . 61.299999999999997 109.654 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.2 mt -82.01 -25.23 34.87 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.969 0.908 . . . . 64.420000000000002 110.611 173.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -132.47 155.92 47.68 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.226 0.61 . . . . 73.209999999999994 110.614 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -72.61 146.05 46.9 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.012 -0.995 . . . . 63.299999999999997 110.542 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -160.65 112.31 1.9 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.693 0.797 . . . . 61.450000000000003 109.238 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.4 t -85.45 137.97 19.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.671 -0.863 . . . . 61.520000000000003 108.671 172.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.56 119.58 7.3 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.399 0.68 . . . . 75.530000000000001 110.576 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.6 m -70.69 -22.62 62.44 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.474 0.709 . . . . 75.340000000000003 110.626 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -159.11 -173.67 27.83 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.94 -0.864 . . . . 61.039999999999999 110.94 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.17 -32.42 73.99 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.938 0.895 . . . . 64.049999999999997 111.312 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.417 HD22 HD12 ' A' ' 23' ' ' ILE . 23.2 p-10 -68.63 -24.47 64.56 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.125 0.97 . . . . 53.340000000000003 112.367 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.4 p -101.43 162.94 12.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.18 0.592 . . . . 62.119999999999997 110.065 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.443 HD21 HG23 ' A' ' 123' ' ' THR . 64.7 tp -114.75 137.94 51.33 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.555 0.342 . . . . 74.239999999999995 110.875 -177.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.7 m -78.11 116.11 18.33 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.885 -0.598 . . . . 74.310000000000002 110.051 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 pt -123.69 140.82 46.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.638 0.775 . . . . 73.109999999999999 110.334 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.7 m -115.88 148.14 40.31 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.498 -0.926 . . . . 65.340000000000003 108.498 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -53.89 130.99 39.17 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.954 0.502 . . . . 73.040000000000006 111.284 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.47 -21.61 45.11 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.584 -0.28 . . . . 63.329999999999998 112.806 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -76.84 130.26 37.36 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.309 -0.997 . . . . 71.219999999999999 108.309 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.492 ' HB3' HD11 ' A' ' 84' ' ' LEU . 43.7 mttp -89.87 130.58 36.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.779 0.432 . . . . 71.519999999999996 109.885 -175.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.02 133.82 53.11 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.97 0.908 . . . . 71.25 109.174 -166.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.7 mtm-85 -94.9 108.03 20.06 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 118.736 0.698 . . . . 62.399999999999999 109.429 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 76.8 t -95.11 129.52 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 117.948 0.34 . . . . 72.430000000000007 110.111 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -105.23 -3.77 22.49 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.079 0.952 . . . . 73.420000000000002 111.321 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.31 164.79 16.86 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.919 -0.872 . . . . 63.030000000000001 110.919 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -95.44 171.79 8.48 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.065 -0.717 . . . . 73.239999999999995 109.065 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -63.5 150.11 44.6 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.831 -0.803 . . . . 63.119999999999997 108.831 175.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -70.61 -11.04 60.69 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 122.872 0.469 . . . . 74.109999999999999 110.845 -176.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.518 ' HB2' ' HE1' ' A' ' 22' ' ' PHE . 62.9 t30 -109.44 -2.98 17.36 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.342 1.057 . . . . 45.039999999999999 110.567 169.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.23 -16.32 59.07 Favored Glycine 0 N--CA 1.48 1.616 0 C-N-CA 123.775 0.703 . . . . 35.240000000000002 114.375 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . 33.7 mt-10 -54.17 -59.9 4.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.847 1.259 . . . . 71.129999999999995 112.955 -172.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -102.8 -179.88 4.09 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.814 -1.085 . . . . 75.340000000000003 109.026 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.63 129.6 12.56 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.52 0.728 . . . . 64.140000000000001 109.226 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -74.96 107.19 6.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.844 0.458 . . . . 73.310000000000002 110.555 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -110.58 160.14 16.93 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.547 0.739 . . . . 73.25 110.386 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -133.88 117.94 17.37 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.592 0.757 . . . . 75.120000000000005 109.732 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.443 HG23 HD21 ' A' ' 99' ' ' LEU . 68.4 p -113.46 -177.36 3.11 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.786 0.834 . . . . 74.129999999999995 110.273 175.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -70.73 -8.89 55.52 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.117 0.567 . . . . 64.530000000000001 110.849 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -79.77 -27.36 40.43 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.86 1.264 . . . . 60.200000000000003 110.598 173.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.3 -150.73 21.78 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.164 -0.774 . . . . 50.450000000000003 111.164 -173.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -128.25 154.1 46.24 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 117.724 0.762 . . . . 75.109999999999999 109.701 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 171.66 178.68 42.19 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 123.41 0.444 . . . . 72.040000000000006 112.018 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -89.94 120.57 31.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.383 0.673 . . . . 73.219999999999999 110.712 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.8 m -113.99 154.09 46.08 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 124.106 0.962 . . . . 73.200000000000003 109.475 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.24 127.98 17.63 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 121.502 1.468 . . . . 55.409999999999997 111.058 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.4 m -58.63 -19.52 39.64 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.822 0.849 . . . . 74.25 111.956 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -70.73 -24.63 62.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.585 1.154 . . . . 65.219999999999999 111.604 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -98.99 -0.7 41.54 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.09 0.956 . . . . 74.230000000000004 112.639 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.3 pt -126.92 153.21 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 118.231 0.468 . . . . 75.010000000000005 110.83 -171.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.5 t -148.73 134.4 9.64 Favored Pre-proline 0 N--CA 1.484 1.259 0 CA-C-O 119.613 -0.232 . . . . 61.219999999999999 110.717 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.97 131.82 32.23 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.434 2.09 . . . . 72.230000000000004 112.404 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.8 m -119.6 -61.1 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.613 0.765 . . . . 73.409999999999997 112.089 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.658 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 66.1 t30 -89.96 -16.85 29.03 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.508 0.723 . . . . 74.5 109.732 -175.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.498 ' HB3' ' HA ' ' A' ' 83' ' ' ASN . 4.6 p -72.42 -157.75 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.382 1.473 . . . . 72.109999999999999 111.563 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.498 HD13 HD23 ' A' ' 214' ' ' LEU . 76.5 mt -57.35 -25.54 59.59 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.145 1.165 . . . . 73.510000000000005 114.145 -175.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -71.41 -14.2 62.08 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 119.054 0.843 . . . . 73.409999999999997 111.187 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -62.35 -22.36 66.03 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.424 0.69 . . . . 75.219999999999999 109.997 168.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -75.37 131.35 40.18 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 108.542 -0.91 . . . . 74.420000000000002 108.542 163.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.1 m -66.36 -15.51 63.33 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 112.55 0.574 . . . . 41.140000000000001 112.55 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.607 ' HB3' ' HG3' ' A' ' 235' ' ' PRO . 29.7 p-90 -85.31 -26.8 26.36 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 113.204 0.816 . . . . 73.420000000000002 113.204 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 42.2 t80 -94.01 132.22 38.71 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.311 -0.625 . . . . 73.349999999999994 109.311 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -126.25 13.42 7.72 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.944 0.72 . . . . 71.109999999999999 112.944 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.26 -159.25 53.53 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-O 119.548 -0.585 . . . . 40.100000000000001 114.54 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.21 104.22 1.75 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.302 2.668 . . . . 64.439999999999998 112.951 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.458 ' HB ' ' HD3' ' A' ' 171' ' ' ARG . 17.3 t -139.86 152.64 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 122.936 0.494 . . . . 64.430000000000007 109.782 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.7 m -73.87 158.48 34.42 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 123.831 0.852 . . . . 71.200000000000003 112.397 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 157' ' ' GLU . 52.7 ptt85 -65.97 -32.48 73.99 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.506 -1.225 . . . . 71.219999999999999 112.088 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -72.44 -42.17 65.34 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.106 0.562 . . . . 54.409999999999997 110.365 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.64 -39.58 93.96 Favored 'General case' 0 C--O 1.251 1.167 0 C-N-CA 123.242 0.617 . . . . 34.299999999999997 110.484 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.518 ' HB2' ' HD2' ' A' ' 171' ' ' ARG . . . -55.45 -47.96 75.24 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.087 -0.961 . . . . 63.439999999999998 111.105 172.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 43.8 mt-10 -71.99 -26.96 62.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.958 0.503 . . . . 65.230000000000004 112.064 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -62.52 -43.52 98.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.772 0.429 . . . . 73.439999999999998 110.343 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.605 HD12 HH22 ' A' ' 171' ' ' ARG . 66.8 mt -78.12 -30.1 49.25 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.955 -0.566 . . . . 73.329999999999998 112.258 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.531 HD23 HG13 ' A' ' 190' ' ' VAL . 37.4 tp -78.93 -31.07 45.02 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.916 0.486 . . . . 64.310000000000002 111.487 -174.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 67.8 p -63.53 -19.88 65.15 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.663 0.785 . . . . 52.509999999999998 111.158 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.4 m -80.59 20.65 0.71 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.124 1.37 . . . . 62.5 111.781 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.63 177.81 16.88 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 114.613 0.605 . . . . 75.239999999999995 114.613 -174.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.7 pt -123.58 -164.55 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 124.819 1.248 . . . . 73.409999999999997 108.757 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.76 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 26.5 p-10 -48.19 120.41 3.55 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.6 0.76 . . . . 72.329999999999998 112.566 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.42 13.81 75.38 Favored Glycine 0 C--O 1.258 1.633 0 CA-C-N 116.621 -0.263 . . . . 70.239999999999995 113.335 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.1 t -73.14 127.79 33.6 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.368 -0.975 . . . . 73.239999999999995 108.368 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' ' 232' ' ' LEU . 23.9 p90 -137.95 152.76 49.27 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.706 0.684 . . . . 75.299999999999997 112.575 -174.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.569 HD22 HH21 ' A' ' 171' ' ' ARG . 87.6 mt -131.2 131.72 44.18 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.91 -1.041 . . . . 74.530000000000001 108.59 171.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.501 HG22 HG12 ' A' ' 182' ' ' ILE . 38.9 t -109.09 120.53 60.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.199 -1.408 . . . . 72.409999999999997 107.199 174.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.605 HH22 HD12 ' A' ' 159' ' ' LEU . 16.9 ptp180 -159.17 153.32 23.65 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.707 -0.479 . . . . 63.009999999999998 109.707 -176.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 13.1 pt-20 -97.42 157.41 16.01 Favored 'General case' 0 C--O 1.25 1.096 0 O-C-N 123.704 0.628 . . . . 75.209999999999994 109.862 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.618 ' HB3' ' HB2' ' A' ' 176' ' ' SER . 34.0 t -79.93 144.86 32.99 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.479 -0.782 . . . . 54.409999999999997 109.337 174.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -71.55 -42.79 67.43 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.63 -0.714 . . . . 72.25 110.805 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.8 t -89.52 -1.87 58.17 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.291 0.636 . . . . 62.219999999999999 112.03 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.618 ' HB2' ' HB3' ' A' ' 173' ' ' SER . 15.0 m -116.85 104.24 51.27 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 109.344 -0.613 . . . . 73.219999999999999 109.344 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.24 113.37 1.32 Allowed 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 123.402 2.735 . . . . 60.229999999999997 112.635 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.27 14.28 46.98 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 114.646 0.618 . . . . 62.109999999999999 114.646 173.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -89.55 112.93 24.26 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.25 -1.019 . . . . 72.439999999999998 108.25 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 78.2 mtt85 -104.3 161.23 14.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.904 -1.044 . . . . 73.530000000000001 108.807 -168.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.3 m -151.77 152.91 33.32 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 123.278 0.631 . . . . 75.409999999999997 109.763 -175.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.501 HG12 HG22 ' A' ' 170' ' ' VAL . 28.4 mt -118.8 137.68 51.97 Favored 'Isoleucine or valine' 0 C--O 1.25 1.123 0 N-CA-C 108.226 -1.027 . . . . 63.439999999999998 108.226 173.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.8 m -119.47 120.7 37.59 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.198 -1.038 . . . . 71.340000000000003 108.198 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.438 HD21 HD23 ' A' ' 232' ' ' LEU . 62.1 mt -103.61 141.3 36.28 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.528 0.731 . . . . 71.299999999999997 111.246 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -117.93 134.36 55.03 Favored 'General case' 0 C--O 1.26 1.636 0 N-CA-C 107.253 -1.388 . . . . 71.439999999999998 107.253 166.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.76 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 34.7 t80 -157.81 111.71 2.55 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.719 -1.128 . . . . 72.040000000000006 109.503 -172.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 50.96 44.17 28.54 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.881 1.272 . . . . 72.340000000000003 112.718 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.55 -1.5 87.23 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 114.717 0.647 . . . . 61.240000000000002 114.717 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -102.65 125.95 49.56 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.271 0.629 . . . . 71.439999999999998 109.448 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.531 HG13 HD23 ' A' ' 160' ' ' LEU . 72.1 t -115.1 117.35 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.961 0.904 . . . . 71.200000000000003 108.711 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -136.58 144.52 44.2 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.413 0.625 . . . . 53.119999999999997 110.637 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -122.92 136.36 54.83 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.231 1.012 . . . . 72.040000000000006 109.766 -167.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -145.34 141.95 28.97 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.842 0.353 . . . . 71.540000000000006 111.343 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -80.03 134.39 36.22 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.756 0.822 . . . . 72.299999999999997 111.081 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 91.3 mt -77.24 101.99 3.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 N-CA-C 107.58 -1.267 . . . . 71.510000000000005 107.58 161.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -72.7 122.9 22.23 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.177 -0.92 . . . . 74.519999999999996 109.152 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 21.6 m -100.34 111.14 23.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.143 0.577 . . . . 71.319999999999993 109.77 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.16 157.97 27.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.893 0.877 . . . . 63.520000000000003 111.499 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 77.9 p -62.74 -18.8 63.18 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.315 -0.857 . . . . 72.219999999999999 111.413 174.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -69.05 -15.85 63.56 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.894 1.678 . . . . 72.420000000000002 111.803 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 86.5 2.52 84.91 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 111.605 -0.598 . . . . 55.509999999999998 111.605 -170.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -89.93 143.12 27.06 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.082 0.553 . . . . 72.030000000000001 111.036 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 83.3 mt -95.57 150.15 20.65 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.196 0.998 . . . . 73.409999999999997 110.059 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -164.87 158.37 17.21 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.214 0.606 . . . . 74.510000000000005 111.01 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 94.9 t -127.18 -56.67 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 124.564 1.146 . . . . 71.420000000000002 108.985 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.3 t -100.75 -169.08 1.66 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.902 1.281 . . . . 63.310000000000002 110.433 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 50.9 m -76.81 -43.34 36.96 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.475 0.71 . . . . 75.420000000000002 112.153 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.56 -29.86 63.91 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.242 0.544 . . . . 75.310000000000002 111.368 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.523 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 83.6 p -68.65 118.17 11.31 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.411 -0.813 . . . . 53.240000000000002 111.813 -173.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -147.16 114.48 6.28 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.983 1.313 . . . . 65.230000000000004 107.653 170.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.523 ' CE2' ' HB2' ' A' ' 209' ' ' SER . 21.3 m-85 -130.53 138.83 50.4 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 118.449 0.568 . . . . 65.230000000000004 111.805 -171.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -79.95 -31.11 40.0 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.963 0.505 . . . . 73.129999999999995 109.968 169.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 60.1 p -126.59 148.09 49.81 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.734 0.778 . . . . 72.0 111.966 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.498 HD23 HD13 ' A' ' 141' ' ' LEU . 24.9 tp -69.87 -21.67 63.31 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.22 -1.355 . . . . 63.439999999999998 111.194 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.87 -47.49 77.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.394 0.678 . . . . 72.129999999999995 110.515 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -70.14 -31.74 69.4 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 115.705 -0.68 . . . . 74.329999999999998 111.008 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 10.1 tt -55.47 -56.28 22.06 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 123.699 0.625 . . . . 72.439999999999998 109.859 172.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.58 -39.15 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.736 0.814 . . . . 64.430000000000007 111.622 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -59.83 -57.04 14.61 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.692 0.758 . . . . 73.230000000000004 111.222 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.436 ' CE1' HG11 ' A' ' 224' ' ' VAL . 40.4 t-80 -56.52 -44.16 80.53 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.771 -1.104 . . . . 74.510000000000005 109.854 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 217' ' ' LEU . 1.9 t60 -72.28 -19.96 61.6 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.535 1.134 . . . . 73.109999999999999 110.417 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 29.1 t -82.76 -20.26 36.26 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.016 0.926 . . . . 74.239999999999995 110.895 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.8 t -115.92 -8.52 11.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.401 2.0 . . . . 72.150000000000006 116.401 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.436 HG11 ' CE1' ' A' ' 220' ' ' HIS . 15.3 m -89.54 143.11 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 120.95 1.705 . . . . 72.299999999999997 114.505 -171.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.58 -0.53 57.58 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 128.713 2.805 . . . . 64.049999999999997 111.883 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -78.23 13.85 1.37 Allowed 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 130.066 3.347 . . . . 61.109999999999999 112.621 -146.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.83 18.68 3.51 Favored Glycine 0 C--N 1.343 0.928 0 C-N-CA 124.038 0.828 . . . . 51.32 111.43 -172.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 71.4 mt -92.06 121.47 33.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.627 0.771 . . . . 72.319999999999993 110.617 163.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 76.6 mt -53.76 -42.58 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.779 0.832 . . . . 61.509999999999998 109.546 169.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -140.87 140.42 34.57 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.673 -1.149 . . . . 53.439999999999998 108.446 173.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.1 p -69.45 162.98 26.32 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.933 -0.576 . . . . 74.310000000000002 109.565 171.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.438 HD23 HD21 ' A' ' 184' ' ' LEU . 57.2 mt -65.55 103.84 0.91 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 110.073 -0.343 . . . . 71.209999999999994 110.073 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -77.99 -60.91 2.18 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.194 -0.669 . . . . 71.549999999999997 109.194 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -158.36 149.53 16.49 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 120.492 -0.483 . . . . 74.400000000000006 112.143 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.607 ' HG3' ' HB3' ' A' ' 146' ' ' TRP . 46.5 Cg_exo -58.33 123.01 12.64 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.882 2.388 . . . . 53.109999999999999 112.195 172.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -58.27 135.21 84.86 Favored Pre-proline 0 C--O 1.246 0.893 0 O-C-N 123.665 0.603 . . . . 53.130000000000003 109.981 175.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.96 135.74 42.13 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.887 1.725 . . . . 75.25 113.979 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.524 ' HA ' HD22 ' A' ' 159' ' ' LEU . 18.3 ptpt . . . . . 0 CA--C 1.548 0.887 0 CA-C-N 114.71 -1.132 . . . . 70.209999999999994 109.235 162.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.1 m . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 121.218 0.532 . . . . 71.5 110.303 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.3 mt -107.23 125.15 33.14 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.103 -1.073 . . . . 72.549999999999997 108.103 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.17 174.51 8.89 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.786 2.324 . . . . 75.349999999999994 112.158 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.43 145.67 39.14 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.54 0.336 . . . . 64.299999999999997 110.124 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.487 ' HB3' HD11 ' A' ' 23' ' ' ILE . 64.6 mt -89.46 101.96 14.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.373 1.069 . . . . 72.040000000000006 109.684 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -96.05 -50.92 4.65 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.419 0.688 . . . . 71.120000000000005 110.074 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -104.45 116.54 32.29 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.197 0.999 . . . . 74.329999999999998 110.077 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 20' ' ' LEU . 37.3 mm -118.38 114.05 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.617 0.767 . . . . 54.329999999999998 111.124 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.63 ' H ' ' HE1' ' A' ' 129' ' ' TRP . 75.5 mmtt . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 125.07 1.348 . . . . 74.219999999999999 109.085 166.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 CA--C 1.556 1.614 0 N-CA-C 115.008 1.118 . . . . 64.140000000000001 115.008 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.03 73.94 0.7 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.771 0.796 . . . . 73.319999999999993 111.232 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.1 tp -91.11 119.53 31.31 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.668 0.747 . . . . 73.409999999999997 110.939 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -111.96 173.86 6.16 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.293 1.437 . . . . 74.219999999999999 109.417 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.31 154.18 12.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.633 -1.247 . . . . 71.129999999999995 107.633 174.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.475 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -94.85 132.89 39.17 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.334 -0.247 . . . . 72.109999999999999 110.334 173.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.472 ' HG ' ' OG1' ' A' ' 136' ' ' THR . 79.3 mt -86.21 -20.94 27.78 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.479 0.711 . . . . 71.530000000000001 110.587 172.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -129.09 153.21 47.87 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.631 -0.713 . . . . 71.129999999999995 109.474 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.67 160.54 32.42 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.363 -0.835 . . . . 74.319999999999993 108.777 163.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.496 ' HB3' HG12 ' A' ' 101' ' ' ILE . 56.3 t80 -159.87 111.18 1.98 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.457 -0.942 . . . . 74.230000000000004 108.457 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.0 t -81.21 124.26 38.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 107.235 -1.394 . . . . 54.409999999999997 107.235 170.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB2' ' N ' ' A' ' 100' ' ' SER . . . -66.14 143.99 56.95 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.993 0.517 . . . . 74.519999999999996 110.799 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.5 m -76.59 -13.62 60.06 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.735 0.814 . . . . 52.130000000000003 110.655 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.68 -155.14 26.36 Favored Glycine 0 C--N 1.353 1.481 0 N-CA-C 111.823 -0.511 . . . . 71.019999999999996 111.823 176.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -65.91 -28.92 69.29 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.253 1.021 . . . . 54.240000000000002 111.416 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -69.38 -13.73 62.53 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.984 1.314 . . . . 55.130000000000003 112.419 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.0 p -128.82 162.8 26.62 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.348 1.059 . . . . 60.32 109.707 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.456 ' HB3' HG13 ' A' ' 130' ' ' VAL . 53.7 tp -111.39 121.61 45.67 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.198 0.599 . . . . 74.099999999999994 110.382 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.419 ' N ' ' HB2' ' A' ' 93' ' ' ALA . 16.0 p -72.12 116.08 12.12 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.524 -0.547 . . . . 60.43 109.524 173.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.496 HG12 ' HB3' ' A' ' 91' ' ' PHE . 33.5 pt -122.18 161.51 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.145 0.578 . . . . 75.329999999999998 109.735 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 33.3 m -121.54 148.33 44.62 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.364 0.666 . . . . 75.010000000000005 110.172 -177.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -57.47 128.31 36.38 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.665 0.386 . . . . 72.030000000000001 110.255 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.06 -21.39 37.36 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 120.19 -0.228 . . . . 72.120000000000005 112.923 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -67.91 131.16 44.99 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.516 0.726 . . . . 72.109999999999999 110.282 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -78.71 121.21 24.44 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.146 0.578 . . . . 64.530000000000001 110.367 177.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.518 ' HA ' HG22 ' A' ' 123' ' ' THR . 14.7 mt -103.66 152.39 21.85 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.166 0.986 . . . . 54.119999999999997 108.424 -175.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 72.5 mtt-85 -123.25 104.74 9.34 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.809 -1.182 . . . . 72.430000000000007 107.809 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 53.9 t -96.01 114.22 32.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 108.449 -0.945 . . . . 54.25 108.449 -172.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.4 mt -79.74 -10.81 59.84 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.608 -1.178 . . . . 62.140000000000001 110.59 -174.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.89 157.19 9.2 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 110.521 -1.032 . . . . 62.229999999999997 110.521 173.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -94.11 168.01 11.21 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.601 -0.889 . . . . 74.430000000000007 108.601 174.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -77.63 147.46 35.56 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.578 -1.267 . . . . 53.350000000000001 107.578 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -70.04 -17.07 63.24 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.584 0.754 . . . . 74.040000000000006 112.371 -175.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.505 ' HB3' ' HG2' ' A' ' 117' ' ' GLU . 65.2 t30 -86.05 -11.49 52.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.79 0.436 . . . . 72.430000000000007 110.527 174.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.38 14.06 77.13 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.385 -0.37 . . . . 42.240000000000002 113.137 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.505 ' HG2' ' HB3' ' A' ' 115' ' ' ASN . 7.9 pt-20 -75.38 -56.02 5.12 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.519 1.128 . . . . 75.239999999999995 110.629 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -124.59 179.09 5.1 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.796 1.238 . . . . 73.209999999999994 108.813 -176.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.3 133.88 16.59 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.243 0.617 . . . . 74.230000000000004 110.154 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -81.11 95.65 6.93 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 109.099 -0.704 . . . . 73.430000000000007 109.099 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -104.91 170.26 7.97 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.158 -0.928 . . . . 74.239999999999995 110.854 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -148.61 129.5 14.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.897 -1.047 . . . . 72.319999999999993 108.544 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 107' ' ' LEU . 72.1 p -131.92 -171.13 2.55 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.526 1.13 . . . . 52.530000000000001 108.995 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -68.72 -8.55 43.78 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.607 0.763 . . . . 65.530000000000001 111.048 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.437 ' HB2' HD11 ' A' ' 99' ' ' LEU . 42.0 m-20 -83.16 -24.26 32.57 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.278 1.031 . . . . 75.400000000000006 110.144 173.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 127.99 -167.91 20.12 Favored Glycine 0 C--N 1.354 1.574 0 CA-C-O 119.668 -0.518 . . . . 72.430000000000007 112.183 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -100.14 157.76 16.34 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 117.699 0.749 . . . . 61.32 109.889 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.47 177.87 36.7 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 112.021 -0.432 . . . . 62.520000000000003 112.021 174.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.63 ' HE1' ' H ' ' A' ' 24' ' ' LYS . 84.3 m95 -91.08 134.67 34.33 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.367 0.603 . . . . 72.140000000000001 111.383 -176.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 99' ' ' LEU . 5.4 m -136.47 140.4 32.31 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.726 1.61 . . . . 62.329999999999998 108.551 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.81 143.95 47.14 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.012 1.808 . . . . 64.450000000000003 111.679 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.412 ' HA ' HG12 ' A' ' 135' ' ' ILE . 23.1 m -60.32 -19.62 55.99 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 124.352 1.061 . . . . 74.25 113.12 -173.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -79.38 -27.03 41.89 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 112.298 0.481 . . . . 71.25 112.298 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -79.37 -18.92 51.43 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.507 0.504 . . . . 61.119999999999997 110.509 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.551 HD12 HG21 ' A' ' 109' ' ' VAL . 18.7 pt -118.65 146.0 23.86 Favored 'Isoleucine or valine' 0 C--N 1.364 1.201 0 C-N-CA 123.463 0.705 . . . . 74.129999999999995 110.278 -165.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.472 ' OG1' ' HG ' ' A' ' 88' ' ' LEU . 9.6 m -149.66 112.14 3.41 Favored Pre-proline 0 CA--C 1.559 1.291 0 CA-C-O 119.196 -0.431 . . . . 52.009999999999998 112.145 -163.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.92 116.35 4.25 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.426 2.084 . . . . 75.109999999999999 112.608 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.5 m -84.99 -26.63 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.089 0.471 . . . . 63.210000000000001 110.04 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -86.74 16.81 4.42 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.947 -1.024 . . . . 75.219999999999999 110.54 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.0 t -49.54 125.9 12.32 Favored 'General case' 0 C--N 1.361 1.081 0 C-N-CA 123.938 0.895 . . . . 61.439999999999998 110.833 177.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.3 mt -60.85 -11.28 7.28 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.595 1.158 . . . . 70.349999999999994 112.0 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -53.6 -14.45 0.86 Allowed 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.527 1.531 . . . . 71.439999999999998 113.593 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -55.81 -35.04 65.91 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 109.483 -0.562 . . . . 75.329999999999998 109.483 172.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -89.37 123.24 33.35 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.283 -1.377 . . . . 72.219999999999999 107.283 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.4 m -67.04 -6.56 17.69 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 114.197 1.184 . . . . 54.310000000000002 114.197 -166.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 38.7 p-90 -69.2 -35.68 76.49 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.04 0.385 . . . . 75.400000000000006 112.04 174.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.401 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 52.2 t80 -93.25 145.69 24.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.469 0.708 . . . . 62.329999999999998 109.187 177.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -135.38 7.16 3.32 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 112.986 0.735 . . . . 74.200000000000003 112.986 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 89.92 -167.57 33.42 Favored Glycine 0 N--CA 1.477 1.389 0 N-CA-C 115.091 0.797 . . . . 73.299999999999997 115.091 168.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.85 101.04 1.14 Allowed 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 123.399 2.733 . . . . 52.32 111.464 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.671 HG21 HH21 ' A' ' 171' ' ' ARG . 35.0 t -141.34 150.14 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 CA-C-N 116.065 -0.516 . . . . 72.340000000000003 110.027 -172.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.7 m -67.49 149.4 50.24 Favored 'General case' 0 C--O 1.252 1.205 0 C-N-CA 124.624 1.17 . . . . 71.049999999999997 111.965 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -57.72 -34.23 69.26 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.327 -0.851 . . . . 75.049999999999997 110.801 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -57.53 -55.15 38.6 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.379 0.672 . . . . 54.350000000000001 110.595 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.5 91.2 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.723 0.809 . . . . 54.25 111.005 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.18 -52.35 65.93 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.206 -0.907 . . . . 73.120000000000005 111.383 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -72.11 -27.72 62.82 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.953 0.901 . . . . 52.43 110.293 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -62.52 -47.65 82.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.043 0.537 . . . . 75.209999999999994 110.933 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.737 HD12 HH12 ' A' ' 171' ' ' ARG . 81.8 mt -66.88 -41.86 86.53 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.091 0.472 . . . . 73.420000000000002 110.746 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.473 HD23 HG13 ' A' ' 190' ' ' VAL . 31.5 tp -66.44 -24.29 66.42 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.273 -0.876 . . . . 64.319999999999993 111.984 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 36.5 t -63.97 -20.41 65.86 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.086 0.954 . . . . 64.430000000000007 112.432 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.8 p -105.73 15.83 26.22 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.337 0.655 . . . . 61.340000000000003 111.229 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -99.75 157.98 19.74 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 116.223 -0.444 . . . . 75.349999999999994 112.66 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 20.7 pt -107.14 -163.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.044 0.938 . . . . 54.329999999999998 110.172 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.808 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 26.7 p-10 -47.82 115.53 1.19 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.225 1.01 . . . . 75.430000000000007 113.125 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 86.04 13.65 68.57 Favored Glycine 0 C--O 1.255 1.419 0 CA-C-N 116.168 -0.469 . . . . 51.0 112.581 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 22.2 t -72.66 133.72 44.76 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.623 -0.88 . . . . 73.310000000000002 108.623 176.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.555 ' HB3' HD23 ' A' ' 184' ' ' LEU . 14.5 p90 -142.25 162.55 35.18 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.405 0.52 . . . . 52.119999999999997 112.405 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.532 ' HB3' ' HD3' ' A' ' 171' ' ' ARG . 80.4 mt -141.93 133.15 26.31 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.253 -1.017 . . . . 43.149999999999999 108.253 172.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.43 110.9 32.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 107.543 -1.281 . . . . 71.450000000000003 107.543 174.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.737 HH12 HD12 ' A' ' 159' ' ' LEU . 4.4 mmm-85 -120.68 162.51 19.57 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.048 -1.093 . . . . 63.329999999999998 108.048 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.616 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 21.4 pt-20 -117.15 155.33 29.54 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.038 0.447 . . . . 75.239999999999995 110.099 165.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 37.2 m -86.02 127.73 34.71 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.95 -1.023 . . . . 74.319999999999993 110.424 -176.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -70.63 -34.71 72.39 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.103 1.361 . . . . 63.130000000000003 110.565 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 36.0 p -91.15 -14.76 30.54 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.577 1.151 . . . . 55.509999999999998 111.882 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 44.7 m -135.42 76.25 56.36 Favored Pre-proline 0 N--CA 1.477 0.924 0 N-CA-C 108.117 -1.068 . . . . 63.119999999999997 108.117 171.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.63 141.85 46.91 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.879 2.386 . . . . 72.019999999999996 112.968 -174.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.93 -22.65 27.65 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.726 -0.67 . . . . 75.040000000000006 111.903 -171.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -93.07 120.05 32.95 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.717 0.807 . . . . 73.409999999999997 109.104 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.616 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 52.1 mtt180 -110.52 169.57 8.66 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.205 -0.907 . . . . 73.5 109.724 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.7 t -152.18 137.3 17.36 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 123.731 0.812 . . . . 62.420000000000002 109.204 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.64 133.06 53.54 Favored 'Isoleucine or valine' 0 C--O 1.247 0.933 0 N-CA-C 107.601 -1.259 . . . . 75.120000000000005 107.601 171.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 19.8 m -111.49 117.28 32.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.661 -1.237 . . . . 75.400000000000006 107.661 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.555 HD23 ' HB3' ' A' ' 168' ' ' PHE . 43.5 mt -103.84 143.26 33.06 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.508 1.123 . . . . 65.420000000000002 110.863 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 29.7 ttt180 -132.27 129.87 40.15 Favored 'General case' 0 C--O 1.256 1.442 0 C-N-CA 124.059 0.944 . . . . 73.519999999999996 108.47 169.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.808 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 4.4 p90 -147.74 137.52 22.68 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.418 -0.956 . . . . 74.030000000000001 108.418 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 55.12 33.61 20.82 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.172 0.989 . . . . 54.340000000000003 111.864 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.47 -7.01 80.81 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.556 -0.747 . . . . 74.310000000000002 113.816 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 18.6 tpp180 -99.83 123.44 44.09 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.564 0.746 . . . . 75.439999999999998 110.281 -171.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.473 HG13 HD23 ' A' ' 160' ' ' LEU . 72.6 t -101.23 133.57 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.694 1.197 . . . . 74.319999999999993 109.602 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.401 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 33.9 p90 -146.0 156.96 43.85 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.787 0.835 . . . . 63.350000000000001 109.532 169.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -127.74 140.39 52.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.825 0.85 . . . . 74.329999999999998 108.842 -172.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -141.47 140.09 33.47 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 110.135 -0.321 . . . . 51.43 110.135 174.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -79.18 137.67 37.54 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.405 -0.816 . . . . 71.540000000000006 111.183 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 91.1 mt -78.39 102.49 4.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 107.045 -1.465 . . . . 74.420000000000002 107.045 162.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -75.57 124.64 27.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.391 -1.337 . . . . 75.239999999999995 107.391 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 56.6 m -102.67 121.01 41.56 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.03 0.532 . . . . 72.230000000000004 109.86 -174.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -74.62 145.41 43.3 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.749 -1.204 . . . . 64.329999999999998 107.749 170.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.7 m -69.24 -9.78 54.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.197 0.599 . . . . 75.120000000000005 111.492 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -65.74 -18.96 65.7 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.751 1.22 . . . . 65.019999999999996 110.709 172.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 97.8 -1.17 59.6 Favored Glycine 0 C--N 1.355 1.627 0 C-N-CA 123.809 0.718 . . . . 40.409999999999997 111.622 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -90.83 137.85 32.05 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 123.571 0.749 . . . . 63.130000000000003 110.049 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 89.2 mt -96.58 157.83 15.71 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.412 0.685 . . . . 71.010000000000005 110.149 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -164.83 174.28 10.8 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 123.913 0.758 . . . . 70.310000000000002 110.595 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.6 t -138.86 -65.68 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.487 -1.301 . . . . 74.450000000000003 107.487 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.0 t -91.48 -175.98 4.38 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.326 1.05 . . . . 75.120000000000005 110.797 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 32.7 t -66.47 -48.11 70.93 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.535 0.734 . . . . 74.129999999999995 111.761 -174.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -87.04 -3.78 59.11 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.229 0.612 . . . . 71.340000000000003 111.684 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 74.4 m -69.18 116.57 9.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.692 0.797 . . . . 62.32 110.555 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -144.85 106.83 4.3 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.786 1.234 . . . . 75.340000000000003 108.389 172.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -127.37 140.38 52.22 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 122.926 0.49 . . . . 74.219999999999999 110.697 -173.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -74.84 -37.78 62.17 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.727 0.642 . . . . 74.319999999999993 110.364 173.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 66.9 p -133.43 165.01 25.85 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.983 0.897 . . . . 44.420000000000002 112.15 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 23.4 tp -70.57 -27.88 64.46 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 113.855 -1.52 . . . . 72.439999999999998 110.999 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.34 -41.84 98.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.079 0.552 . . . . 74.349999999999994 110.22 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -69.03 -42.08 76.85 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.798 -1.092 . . . . 61.310000000000002 110.662 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.04 -42.75 90.97 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.811 0.695 . . . . 72.299999999999997 110.935 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.6 t -76.75 -41.22 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.705 0.802 . . . . 65.340000000000003 110.9 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -59.63 -50.34 74.26 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.358 0.526 . . . . 73.400000000000006 110.161 173.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -53.42 -54.82 31.34 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.696 -1.138 . . . . 73.439999999999998 109.499 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -63.16 -26.22 68.71 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.643 -0.708 . . . . 72.319999999999993 112.012 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 26.8 t -77.77 -21.2 52.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.85 0.46 . . . . 73.209999999999994 111.711 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.9 t -115.43 -18.85 10.9 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.22 1.933 . . . . 74.549999999999997 116.22 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 35.0 m -92.77 143.65 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 120.745 1.611 . . . . 65.319999999999993 114.277 -166.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.38 -1.96 57.45 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.23 2.212 . . . . 73.430000000000007 112.393 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -78.56 13.66 1.54 Allowed 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 128.158 2.583 . . . . 72.439999999999998 114.087 -143.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.21 17.39 4.06 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 123.932 0.777 . . . . 62.219999999999999 111.242 -167.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 52.1 mt -91.3 135.39 33.84 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.093 0.557 . . . . 70.430000000000007 109.742 157.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.401 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 77.3 mt -65.74 -44.8 93.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 O-C-N 124.176 0.922 . . . . 62.520000000000003 109.273 174.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.6 t -138.44 149.32 45.36 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.807 0.443 . . . . 62.039999999999999 109.909 169.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 82.7 p -74.28 156.13 37.51 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 109.076 -0.712 . . . . 75.430000000000007 109.076 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.502 HD23 HD21 ' A' ' 184' ' ' LEU . 38.8 mt -68.6 101.7 1.34 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 108.878 -0.786 . . . . 74.209999999999994 108.878 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -80.05 -57.5 3.6 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.077 0.551 . . . . 72.510000000000005 110.095 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 167' ' ' SER . 7.9 p90 -155.64 152.29 23.99 Favored Pre-proline 0 N--CA 1.484 1.229 0 N-CA-C 109.131 -0.692 . . . . 72.329999999999998 109.131 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.471 ' HB3' ' HA ' ' A' ' 146' ' ' TRP . 58.8 Cg_endo -70.62 138.63 35.49 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 121.666 1.577 . . . . 73.319999999999993 111.438 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -57.99 146.91 66.69 Favored Pre-proline 0 C--O 1.245 0.844 0 CA-C-O 118.671 -0.68 . . . . 73.519999999999996 110.761 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -52.35 118.33 4.51 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.627 2.218 . . . . 72.340000000000003 112.132 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.9 pttt . . . . . 0 CA--C 1.542 0.646 0 CA-C-N 114.733 -1.122 . . . . 73.329999999999998 110.929 174.877 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 C--O 1.246 0.869 0 CA-C-O 121.508 0.671 . . . . 65.129999999999995 111.069 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.1 mt -103.31 126.69 31.5 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 115.066 -0.97 . . . . 70.019999999999996 108.538 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.89 167.84 22.1 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.7 2.267 . . . . 63.130000000000003 112.147 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.83 145.2 32.9 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.961 0.41 . . . . 54.039999999999999 110.646 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.657 ' HB3' HD11 ' A' ' 23' ' ' ILE . 75.1 mt -87.6 92.57 9.15 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.465 -0.939 . . . . 75.430000000000007 108.465 177.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -91.14 -46.83 7.88 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.454 -0.943 . . . . 64.219999999999999 108.454 177.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -98.52 110.16 22.8 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.158 -1.383 . . . . 70.019999999999996 109.58 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 20' ' ' LEU . 30.9 mm -116.62 112.12 38.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.673 -0.862 . . . . 75.540000000000006 108.673 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.499 ' HB3' ' HZ2' ' A' ' 129' ' ' TRP . 66.1 tttt . . . . . 0 CA--C 1.541 0.632 0 CA-C-N 114.768 -1.106 . . . . 72.519999999999996 109.187 173.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo . . . . . 0 CA--C 1.543 0.928 0 N-CA-C 111.58 -0.2 . . . . 64.329999999999998 111.58 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -96.65 56.2 1.48 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.927 -0.768 . . . . 75.230000000000004 108.927 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.723 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 24.8 tp -89.11 115.48 26.67 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.952 -0.758 . . . . 74.439999999999998 108.952 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -104.41 175.71 5.4 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.188 1.795 . . . . 71.329999999999998 109.327 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.96 146.52 33.83 Favored 'Isoleucine or valine' 0 C--O 1.256 1.447 0 N-CA-C 108.314 -0.995 . . . . 53.109999999999999 108.314 171.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.43 110.46 12.22 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 123.816 0.698 . . . . 60.109999999999999 110.048 173.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 90.3 mt -69.35 -28.55 66.31 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.481 1.112 . . . . 70.329999999999998 111.587 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.472 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 64.7 m-85 -135.43 152.66 51.6 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.054 -1.091 . . . . 64.0 108.054 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -71.37 146.02 49.02 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.167 -0.679 . . . . 72.319999999999993 109.167 169.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -149.37 108.25 3.87 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.165 -1.05 . . . . 71.519999999999996 108.165 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.47 133.93 28.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.133 -1.062 . . . . 70.109999999999999 108.133 170.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.401 ' HB2' ' N ' ' A' ' 100' ' ' SER . . . -64.86 128.9 37.72 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.837 0.455 . . . . 63.329999999999998 110.535 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.0 m -86.58 12.36 10.68 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.134 0.974 . . . . 75.400000000000006 111.215 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.58 179.34 37.9 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 110.586 -1.006 . . . . 74.129999999999995 110.586 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.81 -28.68 67.79 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.947 0.499 . . . . 72.329999999999998 110.689 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -68.09 -23.94 64.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.855 0.862 . . . . 73.310000000000002 111.798 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.2 p -103.98 158.51 16.37 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.36 0.664 . . . . 71.319999999999993 110.484 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.507 HD21 HG23 ' A' ' 123' ' ' THR . 49.8 tp -114.49 123.45 49.44 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.206 0.602 . . . . 65.319999999999993 110.488 -178.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.401 ' N ' ' HB2' ' A' ' 93' ' ' ALA . 27.0 p -67.55 119.52 12.47 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.537 0.735 . . . . 74.400000000000006 109.807 173.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.482 HG22 HG21 ' A' ' 123' ' ' THR . 38.2 pt -128.53 129.27 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.483 -0.932 . . . . 64.329999999999998 108.483 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.7 m -95.64 137.85 34.13 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.457 -0.571 . . . . 71.400000000000006 109.457 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -51.16 119.25 3.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.54 0.736 . . . . 70.019999999999996 111.471 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.97 -3.46 48.47 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 116.015 -0.539 . . . . 71.310000000000002 113.198 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -86.05 143.98 27.8 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 117.411 0.606 . . . . 73.109999999999999 110.101 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.537 ' HB3' HD11 ' A' ' 84' ' ' LEU . 56.9 mttm -81.91 135.96 35.36 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.205 1.002 . . . . 63.049999999999997 109.157 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.466 ' HA ' HG22 ' A' ' 123' ' ' THR . 14.8 mt -126.98 135.41 50.82 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 107.99 -1.115 . . . . 74.450000000000003 107.99 -168.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -98.69 108.96 21.77 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.857 0.753 . . . . 74.329999999999998 109.141 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 88.0 t -98.24 113.91 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 118.77 0.714 . . . . 70.140000000000001 109.82 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.37 -37.88 68.66 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.835 0.854 . . . . 71.030000000000001 110.238 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.3 176.22 47.88 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.245 -0.889 . . . . 43.100000000000001 111.708 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 0.8 OUTLIER -98.98 174.42 6.36 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.515 -0.92 . . . . 61.030000000000001 108.515 176.892 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -74.61 165.71 24.76 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.801 0.44 . . . . 71.230000000000004 110.341 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -58.9 -34.3 71.5 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.21 1.004 . . . . 70.409999999999997 111.632 177.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.402 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 55.0 t30 -107.21 7.33 29.38 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.87 0.868 . . . . 74.519999999999996 110.253 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.654 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 61.22 24.08 62.87 Favored Glycine 0 C--N 1.356 1.69 0 CA-C-N 115.66 -0.7 . . . . 50.409999999999997 114.407 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.402 ' HG3' ' HB3' ' A' ' 115' ' ' ASN . 15.6 mt-10 -69.66 -58.25 4.16 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.257 1.027 . . . . 64.430000000000007 108.689 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -112.4 -179.39 3.66 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.355 -1.748 . . . . 62.240000000000002 108.778 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -142.45 124.26 15.14 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.701 0.801 . . . . 40.210000000000001 108.854 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -72.39 100.91 2.78 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 109.403 -0.592 . . . . 70.430000000000007 109.403 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.7 170.11 8.56 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.316 -0.856 . . . . 61.420000000000002 111.246 -177.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.426 ' HG3' ' HB2' ' A' ' 127' ' ' GLN . 44.4 tt0 -148.03 125.13 11.4 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.342 -1.355 . . . . 72.310000000000002 107.342 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.507 HG23 HD21 ' A' ' 99' ' ' LEU . 67.7 p -128.27 -175.02 3.38 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.852 0.835 . . . . 62.109999999999999 111.585 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -64.13 -23.83 67.46 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 113.85 -1.523 . . . . 75.109999999999999 109.722 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -85.79 -4.7 59.23 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.697 1.199 . . . . 63.32 111.931 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 131.19 -131.57 6.46 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-O 120.034 -0.314 . . . . 61.329999999999998 112.393 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.426 ' HB2' ' HG3' ' A' ' 122' ' ' GLN . 61.0 tt0 -152.21 153.18 33.29 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.444 0.698 . . . . 74.400000000000006 110.363 177.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.74 -170.0 38.14 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 112.187 -0.365 . . . . 71.319999999999993 112.187 176.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.499 ' HZ2' ' HB3' ' A' ' 24' ' ' LYS . 77.2 m95 -96.0 129.72 43.19 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.422 0.689 . . . . 74.450000000000003 110.494 -176.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 99' ' ' LEU . 30.7 m -121.4 148.33 49.64 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 124.25 1.02 . . . . 63.439999999999998 109.915 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.27 132.67 19.75 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 121.868 1.712 . . . . 63.329999999999998 111.244 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.6 m -62.05 -18.59 61.1 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.987 0.915 . . . . 74.150000000000006 112.758 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -72.91 -23.38 60.7 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.015 0.926 . . . . 73.019999999999996 111.742 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.472 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.2 m-85 -96.74 -0.42 48.21 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.541 0.736 . . . . 74.400000000000006 112.179 -174.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.1 pt -129.15 154.23 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 122.879 0.471 . . . . 75.319999999999993 110.552 -173.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.1 t -154.35 138.57 11.2 Favored Pre-proline 0 N--CA 1.491 1.611 0 CA-C-O 119.467 -0.301 . . . . 70.219999999999999 110.801 172.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.461 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 56.6 Cg_endo -69.47 130.92 20.57 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 122.594 2.196 . . . . 74.409999999999997 113.267 -175.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.3 m -108.37 -58.63 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.802 0.841 . . . . 74.129999999999995 110.733 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.723 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.6 t30 -93.49 1.13 56.9 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.205 0.602 . . . . 72.209999999999994 110.957 -174.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 25.5 t -73.84 -178.43 3.22 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.022 0.529 . . . . 74.439999999999998 109.883 173.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.0 mt -58.03 -18.66 25.74 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.886 0.874 . . . . 62.030000000000001 112.933 -174.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.589 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 29.7 tt0 -64.69 -14.49 58.62 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.298 1.039 . . . . 71.239999999999995 112.137 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.67 -21.86 55.51 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.81 0.844 . . . . 73.430000000000007 111.037 173.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -100.4 139.06 36.62 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.095 -0.705 . . . . 73.239999999999995 109.095 170.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.9 p -63.57 -12.41 32.52 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.182 1.178 . . . . 54.219999999999999 114.182 -171.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -75.93 -42.28 49.27 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 111.814 0.301 . . . . 74.430000000000007 111.814 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 29.0 t80 -89.74 139.31 30.7 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.434 -0.58 . . . . 74.109999999999999 109.434 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.589 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 72.3 m-70 -131.23 16.75 5.02 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.469 0.544 . . . . 75.099999999999994 112.469 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 72.44 -159.04 53.53 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-O 119.466 -0.63 . . . . 62.200000000000003 114.44 174.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 68.5 Cg_endo -72.07 109.6 2.74 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.322 2.681 . . . . 73.25 111.848 176.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.562 ' HB ' ' HD3' ' A' ' 171' ' ' ARG . 6.5 t -136.92 155.56 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.258 0.551 . . . . 64.329999999999998 111.076 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.2 m -68.26 148.56 50.63 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 124.909 1.283 . . . . 60.229999999999997 111.803 171.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -30.56 70.77 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.744 0.818 . . . . 62.240000000000002 111.09 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.89 -52.75 54.81 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.215 0.606 . . . . 71.129999999999995 109.934 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.83 87.09 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.55 0.74 . . . . 63.130000000000003 111.042 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.53 ' HB2' ' HD2' ' A' ' 171' ' ' ARG . . . -55.41 -59.6 4.59 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.166 -0.925 . . . . 75.109999999999999 111.337 173.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.631 ' HG3' HG11 ' A' ' 190' ' ' VAL . 33.0 tt0 -64.84 -28.19 69.39 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.31 -0.859 . . . . 61.140000000000001 111.29 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -66.43 -50.82 62.13 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.295 1.038 . . . . 75.120000000000005 110.964 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.78 -40.05 84.0 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.933 -0.576 . . . . 71.0 110.919 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.667 HD23 HG13 ' A' ' 190' ' ' VAL . 37.4 tp -68.53 -29.16 67.68 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.485 -0.779 . . . . 72.409999999999997 112.227 -177.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 13.2 t -62.63 -23.25 66.97 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.538 0.735 . . . . 71.430000000000007 110.856 177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.8 m -82.43 -20.5 36.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.046 0.938 . . . . 72.040000000000006 110.968 176.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.73 -175.43 23.61 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.932 -0.576 . . . . 70.439999999999998 112.851 175.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.4 pt -141.04 -165.92 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 124.988 1.315 . . . . 54.200000000000003 111.159 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.731 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 14.6 p-10 -52.52 106.06 0.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.532 1.133 . . . . 64.549999999999997 113.487 -175.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.22 13.3 52.72 Favored Glycine 0 C--O 1.257 1.543 0 CA-C-N 116.132 -0.486 . . . . 74.209999999999994 113.497 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 74.1 m -80.56 140.12 35.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.971 0.386 . . . . 72.120000000000005 110.684 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 183' ' ' SER . 23.1 p90 -136.73 159.66 41.16 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.441 0.639 . . . . 64.239999999999995 112.584 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.592 HD22 HH21 ' A' ' 171' ' ' ARG . 91.5 mt -136.29 133.31 36.81 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.608 -1.178 . . . . 73.150000000000006 108.266 170.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 22.6 t -114.98 127.05 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 107.616 -1.253 . . . . 71.409999999999997 107.616 176.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.592 HH21 HD22 ' A' ' 169' ' ' LEU . 14.7 ptp180 -162.1 148.88 13.67 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.452 0.301 . . . . 72.140000000000001 111.041 -176.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 15.5 pt-20 -93.53 165.8 12.57 Favored 'General case' 0 C--O 1.253 1.248 0 CA-C-O 121.398 0.618 . . . . 72.25 111.693 -178.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.7 t -73.36 154.42 40.08 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.339 -1.3 . . . . 53.310000000000002 111.087 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -77.73 -40.02 42.54 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.39 -1.277 . . . . 73.439999999999998 110.653 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.654 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 72.5 p -100.62 -14.12 18.29 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.327 0.651 . . . . 72.010000000000005 112.446 -175.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 46.9 m -124.28 101.72 34.34 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.021 0.528 . . . . 73.310000000000002 110.439 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.74 131.65 28.22 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.226 2.618 . . . . 72.040000000000006 112.111 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.33 -24.04 8.91 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 116.237 -0.438 . . . . 53.43 113.882 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -75.19 118.2 17.85 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.207 -1.034 . . . . 64.129999999999995 108.207 172.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.576 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 82.9 mtt85 -123.29 172.86 8.32 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.274 0.63 . . . . 63.420000000000002 111.074 -169.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 15.9 m -147.51 144.45 28.56 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.039 0.936 . . . . 62.229999999999997 109.461 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.424 HG12 HG22 ' A' ' 170' ' ' VAL . 52.1 mt -119.06 139.58 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 107.967 -1.123 . . . . 74.25 107.967 167.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 17.5 m -119.82 122.78 42.11 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.196 -1.038 . . . . 44.32 108.196 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.511 HD21 HD23 ' A' ' 232' ' ' LEU . 59.6 mt -105.45 142.18 35.65 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.367 1.067 . . . . 62.5 111.593 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 20.4 ttt180 -128.56 131.47 48.21 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-N 115.05 -0.977 . . . . 75.299999999999997 109.473 169.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.731 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 3.4 p90 -150.83 142.08 23.25 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.215 -1.032 . . . . 71.310000000000002 108.215 171.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 58.44 18.89 5.99 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 124.164 0.986 . . . . 74.230000000000004 113.343 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.56 12.12 73.17 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 122.882 0.277 . . . . 45.32 113.157 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 4.0 tpm_? -105.14 124.01 48.8 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.37 1.068 . . . . 72.439999999999998 109.151 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.667 HG13 HD23 ' A' ' 160' ' ' LEU . 98.3 t -112.9 110.41 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.145 0.978 . . . . 34.43 110.177 -177.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.466 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 30.6 p90 -125.85 156.63 39.3 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.533 0.733 . . . . 75.540000000000006 109.245 175.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -131.82 146.94 52.42 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.714 0.806 . . . . 63.420000000000002 109.044 -167.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -145.06 148.74 34.02 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.811 0.444 . . . . 75.450000000000003 110.429 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 15.4 tpp180 -89.94 138.36 31.57 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.525 0.73 . . . . 73.340000000000003 110.817 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.4 HD11 HG13 ' A' ' 182' ' ' ILE . 84.7 mt -88.99 120.47 37.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.217 -1.031 . . . . 71.420000000000002 108.217 165.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.1 m-20 -95.86 137.5 34.84 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.004 0.922 . . . . 55.109999999999999 109.358 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 25.8 m -105.24 110.46 22.83 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.339 0.656 . . . . 43.140000000000001 109.478 176.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.81 171.93 1.91 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.495 1.118 . . . . 73.310000000000002 112.041 173.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.4 p -67.07 -29.24 68.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.375 0.67 . . . . 74.140000000000001 111.966 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -71.21 -17.79 62.49 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.028 0.531 . . . . 63.520000000000003 111.282 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 103.5 -5.99 48.89 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 111.786 -0.526 . . . . 72.340000000000003 111.786 -171.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -64.16 130.7 44.96 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.728 0.811 . . . . 73.150000000000006 111.797 -177.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 89.4 mt -89.51 147.33 24.03 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.101 -0.703 . . . . 72.140000000000001 109.101 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -165.2 161.75 19.56 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.586 0.554 . . . . 75.349999999999994 110.724 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.75 -46.75 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.925 0.89 . . . . 74.0 109.844 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' SER . . . . . 0.622 ' H ' ' HB2' ' A' ' 209' ' ' SER . 27.1 t -139.12 -172.73 3.4 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.559 0.743 . . . . 73.430000000000007 110.397 -170.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.9 m -60.62 -49.05 79.09 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.706 1.202 . . . . 54.539999999999999 113.826 -167.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -85.81 -0.08 54.33 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.023 0.529 . . . . 74.549999999999997 110.832 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.622 ' HB2' ' H ' ' A' ' 206' ' ' SER . 72.4 m -97.84 106.62 18.95 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.6 0.76 . . . . 74.209999999999994 110.711 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -145.23 118.37 8.88 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 125.145 1.378 . . . . 74.150000000000006 107.759 170.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -136.85 145.67 44.7 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 118.095 0.407 . . . . 71.430000000000007 111.736 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -87.57 -21.65 25.27 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 123.743 0.652 . . . . 75.510000000000005 109.919 168.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 72.2 p -135.34 148.76 49.54 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-O 121.697 0.761 . . . . 71.140000000000001 112.02 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 38.1 tp -66.79 -27.68 67.77 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.334 -1.303 . . . . 65.450000000000003 111.105 176.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.98 -50.0 75.74 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.69 0.796 . . . . 75.319999999999993 110.781 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -69.93 -32.49 70.79 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.056 -0.975 . . . . 75.310000000000002 110.807 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.45 -48.78 78.25 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.315 0.384 . . . . 73.420000000000002 110.811 172.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 56.0 t -68.77 -42.43 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.751 0.821 . . . . 71.319999999999993 110.443 -176.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -58.81 -52.79 64.2 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.799 0.809 . . . . 65.430000000000007 111.594 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.431 ' O ' HG22 ' A' ' 224' ' ' VAL . 48.2 t60 -55.05 -50.07 70.04 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.408 -1.269 . . . . 73.129999999999995 109.783 177.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -65.16 -24.92 67.53 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.686 -0.688 . . . . 75.209999999999994 112.112 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.4 m -73.13 -27.87 61.93 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.034 -0.416 . . . . 64.209999999999994 110.983 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 15.2 t -110.12 -14.52 14.19 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.659 2.096 . . . . 64.319999999999993 116.659 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 220' ' ' HIS . 27.0 m -99.84 156.97 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 N-CA-C 115.925 1.824 . . . . 72.0 115.925 -166.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.47 -0.25 57.59 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 110.738 -2.937 . . . . 71.540000000000006 113.358 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -77.89 13.05 1.48 Allowed 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 128.436 2.694 . . . . 74.239999999999995 113.371 -144.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.16 17.99 4.33 Favored Glycine 0 N--CA 1.46 0.286 0 C-N-CA 124.802 1.191 . . . . 62.409999999999997 111.183 -169.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 91.4 mt -92.51 117.25 29.75 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 113.832 -1.184 . . . . 43.32 109.767 163.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.466 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 85.6 mt -63.01 -41.2 91.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.481 0.712 . . . . 75.420000000000002 109.322 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.0 t -129.66 142.66 50.69 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.46 -0.941 . . . . 73.219999999999999 108.46 165.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 63.5 p -71.28 156.42 39.55 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 109.359 -0.608 . . . . 73.540000000000006 109.359 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.511 HD23 HD21 ' A' ' 184' ' ' LEU . 25.0 mt -65.92 103.6 0.96 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.913 -0.773 . . . . 62.020000000000003 108.913 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.0 -49.53 7.28 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.159 0.583 . . . . 72.329999999999998 109.579 -176.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.602 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -161.66 144.44 9.11 Favored Pre-proline 0 N--CA 1.492 1.636 0 C-N-CA 123.177 0.591 . . . . 71.230000000000004 112.418 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.65 140.08 18.49 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.724 1.616 . . . . 72.140000000000001 112.461 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -66.96 120.72 73.87 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 108.847 -0.797 . . . . 73.319999999999993 108.847 172.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.07 145.0 59.65 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 121.952 1.768 . . . . 72.099999999999994 112.095 -175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 109.188 -0.671 . . . . 72.329999999999998 109.188 169.639 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.242 0.669 0 CA-C-O 120.864 0.364 . . . . 74.409999999999997 111.476 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.7 mt -103.46 126.57 31.73 Favored Pre-proline 0 C--O 1.239 0.518 0 N-CA-C 109.014 -0.735 . . . . 72.439999999999998 109.014 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.16 169.75 21.87 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.999 2.466 . . . . 65.120000000000005 111.954 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.54 149.94 32.96 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.903 0.481 . . . . 60.32 110.551 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.57 ' HB3' HD11 ' A' ' 23' ' ' ILE . 80.7 mt -86.14 94.52 9.3 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.686 -0.857 . . . . 71.420000000000002 108.686 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -97.34 -48.76 5.19 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.047 -0.979 . . . . 72.409999999999997 110.667 -177.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.611 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 60.4 m-85 -103.65 108.52 19.84 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.953 -0.758 . . . . 72.230000000000004 108.953 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.57 HD11 ' HB3' ' A' ' 20' ' ' LEU . 37.7 mm -118.6 112.94 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.863 0.865 . . . . 73.140000000000001 110.226 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.211 -0.962 0 C-N-CA 124.229 1.012 . . . . 75.030000000000001 108.552 167.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo . . . . . 0 CA--C 1.553 1.453 0 CA-C-O 121.39 0.496 . . . . 75.209999999999994 111.161 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -104.62 80.69 1.69 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.504 1.122 . . . . 62.210000000000001 110.252 -177.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 35.0 tp -128.06 112.77 14.97 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.114 -0.699 . . . . 61.149999999999999 109.114 167.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -116.1 173.91 6.32 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.379 1.472 . . . . 73.540000000000006 110.043 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.5 p -147.56 144.85 19.33 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 C-N-CA 124.281 1.033 . . . . 74.230000000000004 108.674 171.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.544 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -81.73 128.68 34.23 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.711 0.404 . . . . 71.109999999999999 110.161 175.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.8 mt -86.15 -20.57 28.43 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.513 0.725 . . . . 72.030000000000001 110.837 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.554 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 74.9 m-85 -130.59 158.38 40.16 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.782 0.833 . . . . 60.25 109.335 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -83.55 140.23 32.39 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.757 -0.831 . . . . 63.25 108.757 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -155.13 111.91 3.26 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.676 -0.861 . . . . 72.230000000000004 108.676 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.43 140.67 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 109.304 -0.628 . . . . 73.409999999999997 109.304 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.21 115.95 2.75 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.336 0.654 . . . . 74.150000000000006 110.623 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.0 p -72.21 -27.93 62.86 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.535 0.734 . . . . 73.150000000000006 110.392 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -152.91 -173.36 22.19 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 114.85 -1.068 . . . . 43.439999999999998 110.984 175.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.22 -28.89 65.63 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.306 0.643 . . . . 64.340000000000003 110.855 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.477 HD22 HD12 ' A' ' 23' ' ' ILE . 26.1 p-10 -70.02 -22.42 63.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.567 1.147 . . . . 71.420000000000002 111.967 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 74.3 p -105.77 160.92 14.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.283 1.033 . . . . 71.329999999999998 110.271 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.0 tp -109.41 144.29 37.83 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.164 0.586 . . . . 71.140000000000001 110.44 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.2 p -83.09 111.61 19.05 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.513 -0.921 . . . . 55.119999999999997 108.513 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.7 pt -117.89 139.07 46.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 123.836 0.854 . . . . 61.509999999999998 109.014 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 20.5 m -101.34 150.24 23.2 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.731 -0.47 . . . . 42.310000000000002 109.731 176.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -56.74 112.04 1.19 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 122.622 0.369 . . . . 65.340000000000003 110.082 167.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.38 -4.31 43.95 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.328 -0.396 . . . . 51.0 112.916 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.92 134.03 36.89 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.555 0.742 . . . . 75.129999999999995 109.624 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -83.31 112.52 19.97 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.934 -0.765 . . . . 64.310000000000002 108.934 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 87' ' ' ALA . 18.8 mt -101.37 156.72 17.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.005 0.522 . . . . 73.329999999999998 109.818 -171.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -124.72 108.64 12.2 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.601 -0.518 . . . . 65.530000000000001 109.601 167.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 135' ' ' ILE . 85.4 t -96.81 106.92 19.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.152 -0.931 . . . . 64.530000000000001 109.843 -176.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.413 HD12 ' NE2' ' A' ' 127' ' ' GLN . 69.1 mt -73.57 -14.56 61.22 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.365 -0.834 . . . . 75.319999999999993 111.427 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.37 163.24 21.99 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 116.252 -0.431 . . . . 71.239999999999995 112.419 172.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 7.4 m-30 -95.29 173.31 7.6 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.845 -0.798 . . . . 74.430000000000007 108.845 173.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.611 ' ND2' ' HB2' ' A' ' 22' ' ' PHE . 10.1 m120 -64.01 150.94 44.2 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.584 -1.265 . . . . 74.340000000000003 107.584 161.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -65.19 -22.64 66.92 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.041 0.382 . . . . 62.140000000000001 110.526 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -86.15 -14.89 42.76 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 122.793 0.437 . . . . 71.129999999999995 110.441 174.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 174' ' ' GLU . . . 84.41 25.91 41.54 Favored Glycine 0 C--N 1.355 1.603 0 C-N-CA 123.452 0.549 . . . . 62.329999999999998 113.59 175.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -79.81 -71.33 0.46 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.391 0.677 . . . . 73.420000000000002 110.779 -175.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -104.77 175.56 5.45 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.336 1.054 . . . . 70.019999999999996 109.013 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -151.22 116.0 5.2 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.825 0.85 . . . . 33.229999999999997 109.445 -172.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 36.5 tt0 -67.91 97.38 0.66 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.677 0.391 . . . . 62.119999999999997 110.162 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.31 153.74 19.38 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.246 -0.65 . . . . 53.340000000000003 109.246 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -138.48 131.86 30.36 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.713 0.805 . . . . 63.450000000000003 109.681 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 63.9 p -140.38 -170.7 3.05 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.635 1.174 . . . . 74.299999999999997 109.423 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -64.67 -14.59 58.95 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.279 0.632 . . . . 64.109999999999999 112.098 170.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -80.14 -11.66 59.73 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.73 0.812 . . . . 43.229999999999997 111.304 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 121.09 -133.63 9.73 Favored Glycine 0 C--N 1.35 1.317 0 N-CA-C 111.415 -0.674 . . . . 52.32 111.415 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.413 ' NE2' HD12 ' A' ' 110' ' ' LEU . 58.2 tt0 -151.51 144.99 24.86 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 117.182 0.491 . . . . 74.420000000000002 111.103 -175.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 171.43 168.93 33.73 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.542 0.526 . . . . 72.519999999999996 112.709 174.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -82.48 117.48 22.53 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.527 1.131 . . . . 74.239999999999995 111.408 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.54 154.52 47.81 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.997 1.319 . . . . 53.240000000000002 109.136 177.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.54 132.47 33.34 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 121.585 1.523 . . . . 74.430000000000007 111.326 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 31.6 m -62.22 -17.74 59.14 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.707 0.803 . . . . 75.120000000000005 112.489 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -82.18 -14.99 54.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.976 0.91 . . . . 60.420000000000002 111.619 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.554 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.7 m-85 -93.95 -3.84 50.84 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.854 0.862 . . . . 64.549999999999997 112.306 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.56 HD12 HG21 ' A' ' 109' ' ' VAL . 18.2 pt -125.95 169.93 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.251 0.62 . . . . 70.409999999999997 110.362 -172.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.5 t -158.04 141.03 10.8 Favored Pre-proline 0 CA--C 1.554 1.106 0 O-C-N 123.563 0.539 . . . . 72.540000000000006 109.963 171.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.14 136.78 14.81 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.573 2.182 . . . . 45.219999999999999 111.841 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.7 m -108.25 -45.53 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.668 0.387 . . . . 75.420000000000002 111.162 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.577 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 67.2 t30 -101.25 20.12 16.38 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.473 0.654 . . . . 63.32 110.699 -174.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.5 p -73.97 -171.24 1.06 Allowed 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 121.471 0.653 . . . . 74.430000000000007 110.746 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.483 HD13 ' HB3' ' A' ' 214' ' ' LEU . 67.1 mt -69.95 -13.81 62.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.916 0.886 . . . . 74.519999999999996 111.669 176.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.8 -6.73 17.21 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.86 1.264 . . . . 72.540000000000006 111.524 176.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -55.6 -35.69 66.1 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.214 1.005 . . . . 52.420000000000002 109.902 168.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -93.49 135.44 34.74 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.0 -1.0 . . . . 75.120000000000005 108.812 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.8 m -67.84 -12.07 59.87 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.526 0.935 . . . . 75.430000000000007 113.526 -171.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -75.19 -34.04 61.49 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 111.881 0.326 . . . . 73.319999999999993 111.881 175.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -94.24 134.33 36.82 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.396 -0.594 . . . . 70.150000000000006 109.396 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -125.17 5.12 7.84 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 111.793 0.294 . . . . 71.049999999999997 111.793 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.25 -159.48 50.33 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 119.462 -0.632 . . . . 72.040000000000006 114.446 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 38.1 Cg_endo -67.27 104.85 0.93 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.369 2.713 . . . . 63.299999999999997 112.297 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.587 HG11 HH21 ' A' ' 171' ' ' ARG . 32.6 t -140.56 153.51 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.137 0.575 . . . . 54.340000000000003 110.545 -174.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.9 m -68.83 148.17 50.67 Favored 'General case' 0 C--O 1.249 1.027 0 C-N-CA 124.555 1.142 . . . . 73.219999999999999 112.028 173.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -62.62 -29.72 70.82 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.486 0.714 . . . . 74.400000000000006 110.616 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -57.05 -57.11 13.99 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.552 1.141 . . . . 51.020000000000003 110.453 175.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.16 -39.31 89.69 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.049 0.94 . . . . 75.310000000000002 111.189 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.48 -53.54 56.32 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.888 -1.051 . . . . 74.510000000000005 110.751 174.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -69.39 -26.88 64.86 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.378 1.071 . . . . 52.119999999999997 110.882 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -67.88 -49.95 59.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.371 0.668 . . . . 75.129999999999995 110.573 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.55 HD12 HH12 ' A' ' 171' ' ' ARG . 66.6 mt -66.31 -37.26 85.0 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 120.802 0.334 . . . . 62.43 110.265 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 183' ' ' SER . 39.6 tp -65.54 -34.32 77.99 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.191 -0.913 . . . . 63.530000000000001 111.435 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.9 t -57.82 -24.79 59.01 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.905 1.282 . . . . 74.230000000000004 112.049 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.612 ' HB2' ' HG2' ' A' ' 237' ' ' PRO . 3.8 m -87.91 -4.82 58.8 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.028 0.931 . . . . 64.209999999999994 111.895 -175.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -94.09 175.97 35.5 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.197 0.427 . . . . 73.409999999999997 113.912 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.6 pt -118.42 -165.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 124.531 1.133 . . . . 60.399999999999999 109.726 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.677 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 16.8 p-10 -57.58 110.69 0.92 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 113.007 0.743 . . . . 72.310000000000002 113.007 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.89 12.11 35.5 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 115.001 -0.999 . . . . 65.340000000000003 112.493 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 23.4 t -74.25 130.13 39.13 Favored 'General case' 0 C--N 1.349 0.579 0 N-CA-C 109.01 -0.737 . . . . 72.420000000000002 109.01 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 235' ' ' PRO . 19.0 p90 -136.78 155.96 49.14 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.29 0.848 . . . . 74.450000000000003 113.29 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.557 HD13 ' NH1' ' A' ' 171' ' ' ARG . 89.0 mt -142.29 135.64 28.95 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.114 0.966 . . . . 43.310000000000002 109.345 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.423 HG22 HG12 ' A' ' 182' ' ' ILE . 15.7 t -109.8 115.61 50.1 Favored 'Isoleucine or valine' 0 C--O 1.252 1.194 0 N-CA-C 108.29 -1.004 . . . . 74.239999999999995 108.29 176.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.587 HH21 HG11 ' A' ' 151' ' ' VAL . 1.4 mmm180 -126.7 159.99 32.08 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.592 -1.262 . . . . 64.239999999999995 107.592 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.674 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 16.9 pt-20 -116.99 163.31 16.41 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 109.482 -0.562 . . . . 74.150000000000006 109.482 167.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.5 t -78.78 138.0 38.0 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.712 -0.677 . . . . 73.430000000000007 110.287 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.407 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 27.1 mt-10 -75.94 -37.84 58.23 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.306 -0.861 . . . . 63.409999999999997 108.989 172.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 47.3 m -83.28 -3.78 57.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.288 1.035 . . . . 61.409999999999997 111.615 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.3 t -157.81 75.14 3.97 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 109.148 -0.686 . . . . 65.019999999999996 109.148 173.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.35 141.39 89.16 Favored 'Trans proline' 0 C--N 1.386 2.508 0 C-N-CA 122.987 2.458 . . . . 74.150000000000006 112.395 175.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 96.8 -25.19 27.66 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 115.098 -0.956 . . . . 53.520000000000003 112.009 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -91.69 117.59 29.88 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.486 -0.931 . . . . 63.229999999999997 108.486 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.674 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 56.0 mtt180 -115.64 170.21 8.61 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 123.77 0.828 . . . . 74.439999999999998 110.562 -172.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.5 t -153.97 143.29 21.44 Favored 'General case' 0 C--O 1.25 1.09 0 C-N-CA 123.956 0.902 . . . . 75.430000000000007 109.09 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 170' ' ' VAL . 45.1 mt -110.72 132.82 58.09 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 N-CA-C 108.098 -1.075 . . . . 73.340000000000003 108.098 170.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.596 ' HB3' HD22 ' A' ' 160' ' ' LEU . 13.8 m -106.08 135.94 46.65 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 124.854 1.262 . . . . 63.310000000000002 108.082 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.429 HD21 HD23 ' A' ' 232' ' ' LEU . 36.4 mt -125.89 137.19 53.72 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.607 1.163 . . . . 74.099999999999994 110.335 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.476 ' HB2' ' HG ' ' A' ' 160' ' ' LEU . 71.4 ttt-85 -120.42 133.77 55.37 Favored 'General case' 0 C--O 1.263 1.804 0 O-C-N 124.472 1.108 . . . . 73.340000000000003 108.848 169.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.677 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 21.4 p90 -147.57 133.97 19.65 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.759 1.287 . . . . 74.140000000000001 108.295 167.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 37.76 59.77 1.25 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 126.378 1.871 . . . . 74.219999999999999 114.116 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.458 ' HA2' ' NH2' ' A' ' 185' ' ' ARG . . . 79.57 -2.52 72.37 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.823 -0.626 . . . . 53.340000000000003 114.6 173.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 42.0 ttm180 -109.78 125.51 52.78 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.501 0.72 . . . . 74.319999999999993 110.393 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 28.7 m -111.51 143.8 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.075 0.95 . . . . 74.040000000000006 110.42 172.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -147.27 150.1 34.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.948 0.899 . . . . 63.520000000000003 109.778 172.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -125.02 116.46 22.17 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.212 -1.032 . . . . 73.200000000000003 108.212 -173.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -115.07 145.81 41.94 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.31 0.576 . . . . 73.209999999999994 110.475 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.511 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 18.9 tpp180 -84.45 128.6 34.68 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 114.681 -1.145 . . . . 62.420000000000002 111.522 -169.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 79.2 mt -80.43 107.22 12.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 107.418 -1.327 . . . . 72.319999999999993 107.418 164.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -77.73 131.26 37.58 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.491 -0.929 . . . . 44.130000000000003 108.491 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.1 m -105.63 141.2 37.5 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.15 0.58 . . . . 74.530000000000001 109.529 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 202' ' ' LYS . . . -95.81 174.8 6.78 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.463 1.105 . . . . 63.450000000000003 109.757 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.0 m -59.79 -39.03 83.58 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.266 0.627 . . . . 64.400000000000006 111.762 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -83.54 12.67 5.34 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.658 0.783 . . . . 75.219999999999999 112.129 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 76.43 12.66 84.1 Favored Glycine 0 C--N 1.352 1.421 0 C-N-CA 122.828 0.252 . . . . 71.219999999999999 112.609 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 198' ' ' ALA . 28.9 mtpp -73.35 126.74 30.84 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 109.871 -0.418 . . . . 72.209999999999994 109.871 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.498 HD11 HH11 ' A' ' 180' ' ' ARG . 80.9 mt -94.72 145.37 24.91 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.457 -0.942 . . . . 73.319999999999993 108.457 -178.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -166.85 136.2 2.92 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.329 0.652 . . . . 73.030000000000001 109.611 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.7 t -92.93 -56.99 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 107.677 -1.231 . . . . 63.200000000000003 107.677 169.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 2.8 p -83.84 147.06 27.76 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.146 -1.388 . . . . 74.430000000000007 109.679 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 20.7 t -68.76 -46.21 69.38 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.848 0.859 . . . . 60.340000000000003 112.37 -165.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -77.09 -4.02 42.27 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.425 0.69 . . . . 75.420000000000002 111.601 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 70.2 m -91.32 140.37 29.84 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 123.587 0.755 . . . . 71.549999999999997 110.128 173.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -142.75 110.36 5.8 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.014 -1.106 . . . . 74.340000000000003 108.014 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 14.6 m-85 -117.0 141.91 47.64 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 109.674 -0.491 . . . . 63.509999999999998 109.674 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -91.2 -18.69 24.03 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.358 0.663 . . . . 74.510000000000005 109.958 168.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 29.5 p -128.64 138.29 52.1 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.956 0.884 . . . . 55.350000000000001 111.715 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.483 ' HB3' HD13 ' A' ' 141' ' ' LEU . 29.3 tp -67.59 -26.43 66.26 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.031 -1.441 . . . . 72.129999999999995 110.831 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.33 -45.79 92.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.533 0.733 . . . . 74.219999999999999 110.445 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -74.7 -30.54 61.59 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.707 -0.679 . . . . 74.150000000000006 111.932 177.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.73 -51.21 70.73 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 110.133 -0.321 . . . . 75.540000000000006 110.133 172.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.38 -42.48 93.68 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 C-N-CA 124.069 0.948 . . . . 74.349999999999994 110.717 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -60.79 -51.52 68.97 Favored 'General case' 0 C--O 1.262 1.734 0 C-N-CA 123.963 0.905 . . . . 74.25 111.033 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.401 ' O ' HG22 ' A' ' 224' ' ' VAL . 47.0 t-80 -55.23 -53.15 59.69 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.72 -1.127 . . . . 72.299999999999997 109.748 177.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -73.1 -12.24 60.83 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.245 -0.434 . . . . 61.420000000000002 112.134 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.0 t -78.44 -27.4 46.48 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.835 0.454 . . . . 63.240000000000002 110.472 172.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -109.84 -22.48 11.86 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.974 1.842 . . . . 71.310000000000002 115.974 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 220' ' ' HIS . 30.9 m -88.69 152.64 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 120.552 1.523 . . . . 73.530000000000001 114.379 -165.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.09 -1.14 57.96 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 111.905 -2.407 . . . . 70.030000000000001 112.866 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -78.7 14.91 1.16 Allowed 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 128.132 2.573 . . . . 54.530000000000001 113.512 -140.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.89 17.36 4.63 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 110.773 -0.931 . . . . 74.219999999999999 110.773 -168.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.68 125.7 35.75 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.35 -0.925 . . . . 75.140000000000001 109.7 165.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 77.7 mt -61.67 -44.17 98.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 O-C-N 124.133 0.896 . . . . 71.439999999999998 109.427 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.4 t -137.16 144.91 43.2 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.19 -0.914 . . . . 64.310000000000002 108.582 169.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 60.4 p -73.99 151.11 40.37 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.228 -0.656 . . . . 73.420000000000002 109.228 172.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.438 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 33.5 mt -64.48 101.19 0.42 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.244 -0.65 . . . . 51.520000000000003 109.244 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -80.81 -55.72 4.62 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.845 0.458 . . . . 63.210000000000001 109.972 -174.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -155.24 149.87 20.11 Favored Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 109.824 -0.435 . . . . 44.130000000000003 109.824 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 32.8 Cg_endo -63.08 142.54 87.78 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.192 1.928 . . . . 53.530000000000001 111.628 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.02 140.37 95.98 Favored Pre-proline 0 C--O 1.244 0.785 0 CA-C-O 119.255 -0.402 . . . . 73.099999999999994 110.511 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.612 ' HG2' ' HB2' ' A' ' 162' ' ' SER . 17.9 Cg_endo -57.52 118.61 5.51 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 123.012 2.475 . . . . 52.350000000000001 113.811 -174.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 108.055 -1.091 . . . . 71.049999999999997 108.055 166.073 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.0 p . . . . . 0 CA--C 1.55 0.979 0 CA-C-O 121.304 0.573 . . . . 71.140000000000001 111.188 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.3 mt -108.3 134.68 20.11 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 123.981 0.912 . . . . 65.129999999999995 109.604 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -69.3 166.03 28.42 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.379 2.053 . . . . 71.430000000000007 110.908 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.8 142.87 29.47 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.727 0.299 . . . . 63.109999999999999 110.217 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.659 ' HB3' HD11 ' A' ' 23' ' ' ILE . 71.3 mt -87.01 95.54 9.97 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.934 0.893 . . . . 62.32 109.068 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -99.49 -49.66 4.35 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.49 0.662 . . . . 73.340000000000003 110.053 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -99.62 114.92 28.27 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.809 -1.087 . . . . 74.230000000000004 108.901 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 20' ' ' LEU . 49.5 mm -116.29 117.84 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 108.609 -0.885 . . . . 63.119999999999997 108.609 -174.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.531 ' HB2' ' HE1' ' A' ' 129' ' ' TRP . 9.5 tmtt? . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.115 -0.698 . . . . 53.329999999999998 109.115 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo . . . . . 0 CA--C 1.55 1.303 0 N-CA-C 112.627 0.203 . . . . 71.209999999999994 112.627 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -96.71 33.32 1.87 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.674 0.79 . . . . 71.230000000000004 110.537 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 25.7 tp -80.83 113.6 19.14 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.919 -0.771 . . . . 72.209999999999994 108.919 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -103.5 176.42 5.15 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.927 1.691 . . . . 71.040000000000006 108.808 173.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.48 144.28 35.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 N-CA-C 108.721 -0.844 . . . . 74.129999999999995 108.721 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.91 113.3 12.06 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 123.532 0.52 . . . . 73.019999999999996 109.954 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.58 -26.2 62.51 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.006 0.922 . . . . 72.040000000000006 111.023 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.465 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 71.8 m-85 -134.95 155.46 50.69 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.85 -0.796 . . . . 74.209999999999994 108.85 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -74.41 141.68 45.05 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.88 -0.785 . . . . 73.340000000000003 108.88 170.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -143.44 112.59 6.72 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.94 -0.763 . . . . 72.25 108.94 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.6 t -79.47 129.64 37.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 107.877 -1.157 . . . . 62.219999999999999 107.877 172.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.58 146.68 54.24 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.397 0.679 . . . . 74.230000000000004 111.122 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.3 m -70.36 -25.31 63.21 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.858 0.863 . . . . 71.439999999999998 110.136 169.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.04 -140.55 6.21 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 115.723 -0.671 . . . . 41.119999999999997 112.245 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.17 -35.15 73.79 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.544 0.737 . . . . 71.319999999999993 111.013 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.535 ' HB2' HD12 ' A' ' 23' ' ' ILE . 28.7 p30 -70.08 -4.68 22.26 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.66 0.784 . . . . 74.129999999999995 112.676 -177.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.3 p -134.5 160.15 38.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.399 1.08 . . . . 72.329999999999998 109.047 177.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.5 tp -110.58 125.97 53.94 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.724 -0.473 . . . . 72.030000000000001 109.724 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.1 p -74.6 114.17 12.71 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 108.603 -0.888 . . . . 74.439999999999998 108.603 173.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.0 pt -117.23 155.23 18.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.971 -0.751 . . . . 64.239999999999995 108.971 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.8 m -120.71 145.71 47.2 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.151 -0.685 . . . . 72.099999999999994 109.151 175.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -53.3 114.84 1.63 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.552 0.741 . . . . 62.420000000000002 110.972 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.39 -14.34 33.06 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-O 119.87 -0.406 . . . . 74.310000000000002 112.828 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -76.33 132.41 39.77 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.209 0.604 . . . . 72.409999999999997 109.687 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HB3' HD11 ' A' ' 84' ' ' LEU . 50.2 mtmt -84.7 119.69 25.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.685 0.794 . . . . 75.109999999999999 109.371 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.3 mt -104.29 139.48 39.22 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.523 1.129 . . . . 72.040000000000006 108.858 -170.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -101.39 106.93 18.14 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.416 -0.957 . . . . 75.510000000000005 108.416 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 93.9 t -93.07 109.18 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 109.235 -0.654 . . . . 72.109999999999999 109.235 -174.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.7 mt -68.02 -34.75 77.08 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.644 0.778 . . . . 72.230000000000004 110.376 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.66 173.6 38.65 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.337 -0.847 . . . . 60.119999999999997 111.887 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.687 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 14.2 m-85 -98.21 168.84 9.99 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.319 0.648 . . . . 72.439999999999998 109.536 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -71.38 152.15 43.42 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.059 -0.719 . . . . 74.109999999999999 109.059 172.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -58.11 -44.37 87.68 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.229 0.612 . . . . 74.329999999999998 111.472 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -79.13 -5.44 54.14 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 122.949 0.499 . . . . 72.430000000000007 110.315 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 72.6 34.31 60.09 Favored Glycine 0 C--N 1.352 1.44 0 C-N-CA 123.22 0.438 . . . . 72.109999999999999 113.349 174.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -85.44 -61.86 1.66 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.535 0.684 . . . . 71.439999999999998 109.498 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.408 ' HB3' ' HB3' ' A' ' 129' ' ' TRP . 74.5 m95 -111.56 178.11 4.43 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.871 -1.059 . . . . 75.129999999999995 109.974 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -144.45 116.01 8.13 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.98 0.912 . . . . 73.230000000000004 108.658 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -76.58 110.83 11.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.89 0.376 . . . . 74.430000000000007 111.11 -174.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -105.5 165.35 11.2 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.223 -0.899 . . . . 51.439999999999998 110.195 177.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -142.61 125.27 15.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.34 0.656 . . . . 75.340000000000003 109.409 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.7 p -135.86 -164.31 1.53 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.315 1.046 . . . . 44.0 110.416 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -53.99 -33.28 56.64 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.487 1.515 . . . . 73.129999999999995 111.214 172.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -77.52 -1.85 32.59 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.88 1.272 . . . . 72.019999999999996 112.093 -177.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.09 -135.4 12.74 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.262 -0.735 . . . . 72.430000000000007 111.262 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -141.56 135.08 29.73 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.68 0.74 . . . . 73.140000000000001 110.63 -172.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -179.07 176.86 48.21 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 112.215 -0.354 . . . . 74.030000000000001 112.215 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.531 ' HE1' ' HB2' ' A' ' 24' ' ' LYS . 79.8 m95 -87.15 131.64 34.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.538 0.735 . . . . 71.239999999999995 111.309 -174.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.45 152.14 60.76 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.492 1.117 . . . . 73.230000000000004 109.294 175.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.71 131.52 17.34 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 121.819 1.68 . . . . 74.430000000000007 109.896 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.1 m -61.63 -18.73 60.64 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.988 0.915 . . . . 72.329999999999998 112.402 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -74.68 -18.73 60.48 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.322 1.049 . . . . 73.219999999999999 111.638 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.465 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 5.4 m-85 -97.93 1.24 47.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.595 0.758 . . . . 74.030000000000001 111.862 -177.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.3 pt -133.12 158.96 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 122.873 0.469 . . . . 62.5 110.435 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.3 t -150.61 140.86 14.23 Favored Pre-proline 0 N--CA 1.49 1.56 0 C-N-CA 122.527 0.331 . . . . 61.299999999999997 110.436 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.499 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 74.3 Cg_endo -72.85 132.37 18.4 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.91 2.407 . . . . 63.240000000000002 113.055 -177.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.7 m -113.86 -40.95 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 122.811 0.444 . . . . 74.019999999999996 111.693 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 62.8 t30 -100.97 0.42 38.21 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 122.859 0.464 . . . . 60.020000000000003 111.713 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.499 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 33.2 t -75.54 -178.94 4.34 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.11 0.564 . . . . 54.439999999999998 110.33 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 50.0 mt -56.86 -18.23 12.3 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.548 1.139 . . . . 72.329999999999998 112.708 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.562 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 28.2 tt0 -62.07 -19.13 62.6 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.89 0.876 . . . . 71.099999999999994 112.4 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -58.65 -23.73 59.71 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.419 0.688 . . . . 61.509999999999998 111.427 174.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -90.67 134.19 34.59 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.485 -0.931 . . . . 63.25 108.485 173.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.8 p -62.19 -20.56 64.29 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.013 0.745 . . . . 64.409999999999997 113.013 -172.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -73.51 -30.21 62.97 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.118 0.414 . . . . 63.530000000000001 112.118 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -103.33 135.02 45.74 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.553 -0.536 . . . . 74.450000000000003 109.553 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.562 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 16.6 m-70 -130.74 44.49 2.95 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.899 0.479 . . . . 74.329999999999998 110.667 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.45 -160.3 36.61 Favored Glycine 0 CA--C 1.541 1.669 0 N-CA-C 116.45 1.34 . . . . 64.409999999999997 116.45 164.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -83.37 108.97 1.56 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 124.178 3.252 . . . . 64.540000000000006 112.663 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 20.5 m -144.4 172.7 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 109.463 -0.569 . . . . 74.030000000000001 109.463 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.9 m -95.64 171.88 8.4 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 115.834 -0.621 . . . . 70.400000000000006 111.134 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -58.2 -25.29 61.41 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.002 0.921 . . . . 72.040000000000006 111.831 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -66.04 -56.45 11.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.068 0.947 . . . . 74.140000000000001 110.661 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.56 93.37 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.476 0.71 . . . . 72.120000000000005 110.614 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.459 ' HA ' ' NH2' ' A' ' 171' ' ' ARG . . . -56.59 -55.1 38.17 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-N 114.973 -1.012 . . . . 72.099999999999994 110.737 175.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.565 ' HG3' HG11 ' A' ' 190' ' ' VAL . 39.9 tt0 -68.59 -28.98 67.42 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.628 0.771 . . . . 71.129999999999995 110.927 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -61.17 -49.81 75.7 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.358 0.663 . . . . 74.420000000000002 110.5 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.591 HD12 HH22 ' A' ' 171' ' ' ARG . 38.4 mt -73.41 -32.98 64.73 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.85 -0.614 . . . . 72.109999999999999 111.811 177.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 183' ' ' SER . 44.4 tp -69.88 -26.01 63.98 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.186 0.994 . . . . 74.409999999999997 111.326 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.7 t -69.52 -8.87 50.88 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.847 0.859 . . . . 75.450000000000003 111.594 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.9 t -95.94 12.03 31.79 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.588 0.755 . . . . 64.409999999999997 110.762 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.93 174.02 18.0 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 114.155 0.422 . . . . 64.25 114.155 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.6 pt -123.9 -165.55 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.512 1.125 . . . . 73.349999999999994 109.984 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.875 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 13.8 p-10 -52.64 108.65 0.32 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.08 0.952 . . . . 72.540000000000006 112.66 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 100.49 11.59 40.97 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.42 -0.809 . . . . 71.219999999999999 112.904 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.3 t -77.4 129.33 35.64 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.477 -0.934 . . . . 63.509999999999998 108.477 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -136.52 153.27 51.06 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.811 0.671 . . . . 74.340000000000003 112.811 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.744 HD13 HH21 ' A' ' 171' ' ' ARG . 88.9 mt -131.05 132.16 44.74 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.73 -1.211 . . . . 75.329999999999998 107.73 168.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.71 121.68 56.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 106.663 -1.606 . . . . 73.439999999999998 106.663 172.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.744 HH21 HD13 ' A' ' 169' ' ' LEU . 13.1 mmt180 -128.37 165.99 19.54 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.091 0.957 . . . . 64.129999999999995 108.781 -172.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 13.2 pt-20 -114.94 150.87 35.05 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 107.622 -1.251 . . . . 65.030000000000001 107.622 158.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.6 p -86.44 133.08 33.79 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.347 0.404 . . . . 75.150000000000006 109.915 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.76 -38.19 88.4 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.008 0.923 . . . . 52.530000000000001 110.869 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.454 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 32.9 p -81.31 -10.92 59.47 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.001 0.92 . . . . 70.549999999999997 112.418 -175.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 39.8 m -138.27 101.04 8.42 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 122.915 0.486 . . . . 74.049999999999997 110.477 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.687 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 56.5 Cg_endo -66.55 137.86 47.87 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.715 2.943 . . . . 74.329999999999998 112.462 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.36 -22.41 4.58 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 116.224 -0.443 . . . . 75.420000000000002 113.537 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -82.85 119.44 24.39 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.734 0.814 . . . . 61.229999999999997 109.335 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.575 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 77.8 mtt-85 -116.97 163.24 16.52 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 115.184 -0.916 . . . . 74.420000000000002 108.924 -176.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.2 m -147.92 148.0 30.33 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.143 0.577 . . . . 65.120000000000005 110.098 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 66.1 mt -110.58 137.74 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 108.864 -0.791 . . . . 70.109999999999999 108.864 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.529 ' HB3' HD22 ' A' ' 160' ' ' LEU . 29.1 m -114.01 115.51 27.73 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.665 1.186 . . . . 52.399999999999999 108.348 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.5 mt -105.0 144.95 31.11 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.808 0.843 . . . . 72.109999999999999 111.511 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.44 ' HB2' ' HG ' ' A' ' 160' ' ' LEU . 28.3 ttt180 -126.97 138.99 53.36 Favored 'General case' 0 C--O 1.256 1.405 0 N-CA-C 107.071 -1.455 . . . . 63.43 107.071 168.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.875 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 10.3 t80 -149.9 103.98 3.26 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.504 -1.225 . . . . 75.340000000000003 108.328 -168.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 56.02 35.66 25.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.682 1.193 . . . . 73.140000000000001 112.321 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.3 78.76 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.503 -0.771 . . . . 34.439999999999998 113.264 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -98.22 124.39 42.78 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.735 -0.839 . . . . 75.340000000000003 108.735 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.565 HG11 ' HG3' ' A' ' 157' ' ' GLU . 48.4 t -109.18 129.51 63.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.47 1.108 . . . . 73.310000000000002 108.78 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.456 ' HE2' ' HB3' ' A' ' 186' ' ' TYR . 13.1 p90 -146.85 143.85 28.88 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.231 1.013 . . . . 73.299999999999997 109.156 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -126.53 140.66 52.28 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.186 0.994 . . . . 62.409999999999997 108.814 -170.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -139.16 140.65 37.92 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.957 0.408 . . . . 75.349999999999994 111.056 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.442 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 23.1 tpp180 -77.04 131.2 38.29 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.903 -1.044 . . . . 72.25 110.705 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 96.3 mt -78.36 106.18 8.63 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 N-CA-C 107.555 -1.276 . . . . 63.119999999999997 107.555 164.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -75.5 124.94 28.04 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.531 -0.914 . . . . 62.119999999999997 108.531 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.3 m -99.7 115.46 29.53 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.931 0.893 . . . . 60.299999999999997 109.604 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.07 148.63 51.52 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.603 0.761 . . . . 64.340000000000003 109.033 167.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 75.1 p -66.71 -8.75 30.09 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.149 0.58 . . . . 71.430000000000007 112.382 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -83.58 -0.66 51.38 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.03 0.932 . . . . 74.519999999999996 111.14 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 86.83 -0.91 86.74 Favored Glycine 0 C--N 1.349 1.301 0 C-N-CA 123.12 0.39 . . . . 54.25 112.631 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -76.52 129.35 36.35 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 116.903 0.351 . . . . 72.200000000000003 110.105 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.5 mt -96.61 148.23 23.07 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.397 0.679 . . . . 72.519999999999996 109.261 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -164.61 167.49 19.18 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 123.747 0.655 . . . . 74.310000000000002 110.798 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.4 t -136.62 -63.47 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.815 -1.179 . . . . 64.519999999999996 107.815 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 30.2 t -86.38 167.49 14.68 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.179 0.992 . . . . 74.0 109.484 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 42.8 p -67.75 -39.79 84.15 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.585 0.754 . . . . 73.010000000000005 109.907 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -82.76 -2.52 54.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.841 0.856 . . . . 74.219999999999999 112.062 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 58.1 m -92.77 118.15 30.78 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.978 0.911 . . . . 75.299999999999997 109.581 171.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -144.87 118.19 9.0 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 124.684 1.193 . . . . 73.430000000000007 108.545 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 209' ' ' SER . 10.7 m-85 -135.39 150.43 49.9 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 118.295 0.498 . . . . 71.25 111.505 -172.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -92.03 -29.91 16.33 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.567 0.747 . . . . 61.409999999999997 110.47 171.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.1 p -124.4 147.42 48.27 Favored 'General case' 0 C--O 1.248 1.025 0 C-N-CA 123.527 0.731 . . . . 53.0 111.074 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 32.9 tp -65.56 -31.68 72.86 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 114.37 -1.287 . . . . 72.200000000000003 110.657 175.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.87 98.14 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.447 0.699 . . . . 71.310000000000002 111.154 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -73.7 -30.54 62.92 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 119.069 -0.491 . . . . 71.310000000000002 111.693 175.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.96 -47.54 84.73 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.514 0.509 . . . . 74.340000000000003 110.446 172.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.2 t -71.4 -37.32 64.51 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 C-N-CA 124.022 0.929 . . . . 74.010000000000005 110.808 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 14.4 t-160 -62.35 -56.14 21.23 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.719 0.807 . . . . 72.219999999999999 111.108 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.428 ' O ' HG22 ' A' ' 224' ' ' VAL . 49.8 t-80 -52.75 -53.53 46.65 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.641 -1.163 . . . . 70.209999999999994 109.393 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.41 ' HB3' ' HG ' ' A' ' 232' ' ' LEU . 8.0 m-70 -63.09 -27.72 69.59 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.979 -0.555 . . . . 65.430000000000007 112.388 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.5 t -71.23 -23.66 62.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.846 0.459 . . . . 64.200000000000003 110.841 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 15.4 t -119.07 -3.69 10.63 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 116.407 2.002 . . . . 71.030000000000001 116.407 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 220' ' ' HIS . 27.0 m -106.03 154.67 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 116.422 2.008 . . . . 74.519999999999996 116.422 -172.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.7 -0.73 56.84 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 110.793 -2.912 . . . . 53.109999999999999 113.285 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -76.25 13.72 0.87 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 129.596 3.158 . . . . 71.150000000000006 113.56 -140.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.45 16.87 4.99 Favored Glycine 0 N--CA 1.464 0.545 0 C-N-CA 126.253 1.882 . . . . 63.240000000000002 111.629 -169.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.06 126.69 38.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.609 -1.295 . . . . 43.119999999999997 109.551 166.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 76.9 mt -58.36 -49.55 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.581 0.752 . . . . 72.439999999999998 109.428 170.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' THR . . . . . 0.405 HG22 ' OH ' ' A' ' 191' ' ' TYR . 12.8 t -134.24 148.13 50.79 Favored 'General case' 0 C--O 1.249 1.064 0 N-CA-C 107.826 -1.175 . . . . 71.329999999999998 107.826 169.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 224' ' ' VAL . 67.0 p -70.52 162.93 27.91 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 109.53 -0.544 . . . . 61.219999999999999 109.53 175.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.41 ' HG ' ' HB3' ' A' ' 221' ' ' HIS . 21.5 mt -68.58 100.52 1.13 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.154 -1.054 . . . . 51.049999999999997 108.154 176.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -90.89 -47.18 7.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.767 0.427 . . . . 64.340000000000003 111.253 -168.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -157.12 147.8 16.24 Favored Pre-proline 0 N--CA 1.485 1.319 0 N-CA-C 109.676 -0.49 . . . . 74.209999999999994 109.676 174.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.14 133.69 34.02 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.656 2.237 . . . . 62.240000000000002 112.626 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.409 ' HB3' ' HG ' ' A' ' 169' ' ' LEU . . . -67.71 150.25 97.9 Favored Pre-proline 0 C--O 1.246 0.882 0 C-N-CA 123.555 0.742 . . . . 72.219999999999999 110.414 174.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.441 ' O ' ' HB3' ' A' ' 159' ' ' LEU . 51.6 Cg_exo -56.95 132.57 52.44 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.341 2.694 . . . . 73.420000000000002 114.908 -172.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.3 tttp . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 106.721 -1.585 . . . . 60.439999999999998 106.721 158.238 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.0 p . . . . . 0 C--O 1.247 0.932 0 CA-C-O 121.325 0.583 . . . . 53.140000000000001 110.861 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.6 mt -107.9 123.71 36.97 Favored Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 108.405 -0.961 . . . . 42.329999999999998 108.405 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HG3' ' HB3' ' A' ' 117' ' ' GLU . 55.5 Cg_endo -71.73 173.77 12.13 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.812 2.341 . . . . 73.439999999999998 112.253 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.79 149.28 29.67 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.16 0.584 . . . . 53.140000000000001 111.32 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.573 HD22 HD11 ' A' ' 23' ' ' ILE . 89.2 mt -87.43 95.23 9.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.322 0.649 . . . . 64.049999999999997 109.767 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -97.44 -49.15 5.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.147 0.579 . . . . 70.349999999999994 110.485 175.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -99.87 107.78 19.87 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.91 -0.404 . . . . 74.409999999999997 109.91 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.638 HD12 ' HB2' ' A' ' 97' ' ' ASN . 46.6 mm -124.26 121.04 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.103 0.961 . . . . 74.230000000000004 109.551 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 109.376 -0.602 . . . . 75.420000000000002 109.376 174.076 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo . . . . . 0 N--CA 1.499 1.837 0 N-CA-C 113.647 0.595 . . . . 70.150000000000006 113.647 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -88.67 72.6 8.66 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.638 0.732 . . . . 63.439999999999998 109.062 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.58 HD11 ' HB3' ' A' ' 106' ' ' LYS . 29.8 tp -89.95 130.92 36.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.952 -1.022 . . . . 75.019999999999996 108.878 177.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 13.0 m-85 -113.84 174.97 5.67 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.008 1.723 . . . . 73.409999999999997 109.015 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.96 149.1 19.95 Favored 'Isoleucine or valine' 0 C--O 1.256 1.395 0 N-CA-C 109.081 -0.711 . . . . 71.129999999999995 109.081 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.25 124.5 33.92 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.387 -0.824 . . . . 74.420000000000002 109.828 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.4 mt -83.13 -17.74 41.97 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.264 1.026 . . . . 74.25 111.619 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.479 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 57.8 m-85 -135.44 166.37 23.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.71 0.804 . . . . 64.019999999999996 109.336 -175.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -78.79 145.8 34.13 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.271 -0.877 . . . . 70.430000000000007 109.172 168.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -155.46 112.75 3.29 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.687 -0.486 . . . . 65.510000000000005 109.687 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.98 139.12 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.192 -0.67 . . . . 60.009999999999998 109.192 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.13 127.74 34.18 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.963 -0.384 . . . . 73.040000000000006 109.963 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.6 p -65.66 -24.37 67.01 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.648 0.779 . . . . 64.049999999999997 110.919 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.97 -149.78 8.47 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.53 -1.028 . . . . 61.32 110.53 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.24 -30.59 69.67 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.819 0.848 . . . . 72.209999999999994 111.578 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.638 ' HB2' HD12 ' A' ' 23' ' ' ILE . 20.1 p30 -71.24 -23.31 61.97 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.029 0.932 . . . . 63.530000000000001 113.51 -172.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.6 p -113.26 163.12 15.21 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.747 0.819 . . . . 61.539999999999999 110.217 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.402 ' HB3' HG13 ' A' ' 130' ' ' VAL . 59.3 tp -111.06 125.72 54.05 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.13 -0.693 . . . . 61.32 109.13 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -74.43 119.66 18.92 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.677 -0.86 . . . . 65.310000000000002 108.677 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.0 pt -123.87 138.71 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.273 0.629 . . . . 52.409999999999997 109.546 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.4 m -97.23 150.06 21.34 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.336 -0.847 . . . . 65.310000000000002 109.756 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -61.22 113.58 2.68 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 109.484 -0.562 . . . . 71.329999999999998 109.484 172.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.25 -11.11 47.69 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.198 -0.455 . . . . 44.439999999999998 113.697 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -72.68 134.56 45.13 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.537 0.735 . . . . 72.030000000000001 110.387 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.58 ' HB3' HD11 ' A' ' 84' ' ' LEU . 34.8 mtmm -85.75 123.27 30.94 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.877 0.871 . . . . 74.239999999999995 109.7 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.601 ' HA ' HG22 ' A' ' 123' ' ' THR . 13.0 mt -107.88 158.36 17.4 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.898 -0.779 . . . . 74.120000000000005 108.898 -170.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtm-85 -123.07 108.64 13.12 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.846 -0.798 . . . . 75.049999999999997 108.846 164.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.505 HG21 HD12 ' A' ' 135' ' ' ILE . 98.6 t -88.71 109.46 20.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.334 -0.617 . . . . 61.210000000000001 109.334 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.8 mt -81.68 -12.23 58.75 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.198 -0.91 . . . . 65.409999999999997 111.092 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.72 159.13 18.67 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.39 -0.684 . . . . 54.25 111.39 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 4.1 m-85 -96.93 173.61 7.2 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.686 0.794 . . . . 74.310000000000002 110.28 178.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.468 HD22 ' HB2' ' A' ' 118' ' ' TRP . 32.3 t-20 -77.76 147.19 35.45 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.176 0.991 . . . . 72.239999999999995 108.555 173.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.52 ' HD2' ' HG2' ' A' ' 177' ' ' PRO . 34.0 m170 -63.7 -26.28 68.58 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.117 0.567 . . . . 71.430000000000007 111.645 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -87.66 -16.85 33.21 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.389 1.075 . . . . 52.310000000000002 110.512 175.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.94 0.68 77.59 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 123.911 0.767 . . . . 75.299999999999997 113.68 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.403 ' HB3' ' HG3' ' A' ' 18' ' ' PRO . 17.2 mm-40 -78.0 -47.29 18.8 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.158 0.983 . . . . 71.239999999999995 112.098 -172.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.468 ' HB2' HD22 ' A' ' 113' ' ' ASN . 83.2 m95 -105.61 174.63 5.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.857 0.863 . . . . 62.420000000000002 109.637 177.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -153.49 127.14 8.75 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.175 -1.046 . . . . 74.230000000000004 108.175 175.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -74.28 106.63 6.01 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.232 0.469 . . . . 73.420000000000002 110.409 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.66 163.65 12.18 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.317 -0.856 . . . . 74.340000000000003 109.698 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -139.71 122.78 16.78 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.6 -1.259 . . . . 54.210000000000001 107.6 178.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 107' ' ' LEU . 78.9 p -131.81 -169.56 2.23 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.379 0.672 . . . . 75.120000000000005 110.611 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -54.1 -28.52 39.87 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.098 -1.41 . . . . 53.32 111.708 170.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -84.64 -2.36 57.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.33 1.052 . . . . 64.010000000000005 111.84 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.51 -132.79 10.15 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 111.418 -0.673 . . . . 72.209999999999994 111.418 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -142.99 143.74 32.04 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.243 0.617 . . . . 52.329999999999998 110.29 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 174.91 -178.13 46.76 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.843 -0.617 . . . . 54.409999999999997 111.58 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -95.97 123.87 39.74 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.017 0.527 . . . . 72.439999999999998 110.762 -173.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 99' ' ' LEU . 35.1 m -117.64 149.02 44.24 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.978 1.311 . . . . 41.229999999999997 109.601 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.78 132.53 23.48 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 121.669 1.579 . . . . 74.310000000000002 111.234 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.6 m -60.74 -21.56 63.1 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.177 0.991 . . . . 75.040000000000006 112.364 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -68.55 -24.65 64.65 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.879 0.872 . . . . 73.209999999999994 111.741 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.479 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.2 m-85 -94.94 0.84 55.06 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.791 0.836 . . . . 63.420000000000002 112.78 -177.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.505 HD12 HG21 ' A' ' 109' ' ' VAL . 15.9 pt -127.72 160.88 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 118.98 0.809 . . . . 74.25 111.365 -171.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.1 t -157.89 145.09 13.39 Favored Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 119.108 -0.472 . . . . 71.349999999999994 110.599 169.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.37 139.27 37.73 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.714 2.276 . . . . 44.43 111.804 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.28 -50.01 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.001 0.52 . . . . 74.239999999999995 112.037 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -100.74 -6.04 25.56 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.397 0.544 . . . . 75.439999999999998 110.916 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.5 t -60.32 177.75 0.25 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.27 1.028 . . . . 75.030000000000001 111.891 -176.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 84.7 mt -57.13 -17.66 11.75 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.981 0.912 . . . . 73.140000000000001 112.678 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -57.7 -24.7 58.18 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.506 1.122 . . . . 55.340000000000003 112.04 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -56.71 -36.19 69.39 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.409 1.083 . . . . 70.109999999999999 111.25 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 -74.33 141.71 45.2 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.369 -0.832 . . . . 75.230000000000004 109.342 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.1 t -62.69 -21.81 66.02 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.812 0.845 . . . . 75.010000000000005 112.075 -176.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.425 ' CE3' ' HB2' ' A' ' 147' ' ' TYR . 58.8 p-90 -80.05 -41.53 25.52 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.382 0.512 . . . . 73.510000000000005 112.382 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.425 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 29.5 t80 -99.98 138.04 37.6 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.375 0.534 . . . . 74.420000000000002 109.566 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.404 ' HB2' ' NE ' ' A' ' 171' ' ' ARG . 22.1 m-70 -126.7 14.06 7.5 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 112.172 0.434 . . . . 64.109999999999999 112.172 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.15 -162.65 50.02 Favored Glycine 0 N--CA 1.474 1.23 0 CA-C-O 119.581 -0.566 . . . . 62.439999999999998 114.403 171.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.07 100.38 0.97 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.785 2.99 . . . . 61.439999999999998 111.558 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.55 HG11 ' NH2' ' A' ' 171' ' ' ARG . 84.1 t -138.93 150.92 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.818 0.447 . . . . 74.420000000000002 110.595 -172.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 18.4 m -59.2 139.34 57.04 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.598 1.159 . . . . 71.230000000000004 111.411 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -62.8 -27.59 69.41 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.736 0.814 . . . . 74.450000000000003 111.483 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -62.4 -50.3 72.07 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.529 0.732 . . . . 73.420000000000002 110.2 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.62 -33.83 76.81 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.461 0.705 . . . . 64.409999999999997 111.54 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 171' ' ' ARG . . . -58.5 -52.36 65.97 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.256 -0.884 . . . . 60.539999999999999 110.573 173.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.462 ' HG3' HG11 ' A' ' 190' ' ' VAL . 35.0 tt0 -69.62 -27.41 65.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.537 0.735 . . . . 65.540000000000006 111.195 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -64.91 -49.42 70.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.856 0.862 . . . . 74.319999999999993 110.983 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.498 HD12 HH12 ' A' ' 171' ' ' ARG . 63.8 mt -70.77 -37.23 73.35 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 120.88 0.371 . . . . 71.040000000000006 110.739 175.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.7 tp -64.53 -25.38 67.96 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.547 -0.751 . . . . 75.349999999999994 112.094 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.6 t -59.96 -29.26 68.31 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.173 0.989 . . . . 62.119999999999997 111.228 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.2 t -77.17 -12.93 60.01 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.97 0.908 . . . . 74.340000000000003 111.969 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.59 165.61 32.43 Favored Glycine 0 C--N 1.344 1.001 0 N-CA-C 113.811 0.284 . . . . 61.539999999999999 113.811 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.0 pt -113.5 -164.28 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.58 1.152 . . . . 71.450000000000003 109.909 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.763 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 21.5 p-10 -52.99 115.18 1.72 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.725 0.81 . . . . 72.25 112.378 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.06 12.79 57.25 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 115.472 -0.785 . . . . 74.310000000000002 113.013 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 21.9 t -76.3 138.78 40.73 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.911 -0.774 . . . . 60.310000000000002 108.911 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 16.1 p90 -138.42 158.15 44.84 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.095 0.474 . . . . 72.25 111.979 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.506 HD13 ' NH1' ' A' ' 171' ' ' ARG . 84.9 mt -141.27 134.37 29.27 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.216 -1.031 . . . . 73.420000000000002 108.216 168.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 214' ' ' LEU . 16.0 t -106.93 123.18 61.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.947 -1.131 . . . . 61.030000000000001 107.947 175.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.55 ' NH2' HG11 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -130.86 157.87 41.73 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.298 -1.371 . . . . 63.119999999999997 107.298 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 11.7 pt-20 -108.22 162.97 13.58 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 109.29 -0.633 . . . . 74.109999999999999 109.29 166.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 176' ' ' SER . 48.1 t -82.67 136.94 34.62 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.22 -0.9 . . . . 63.420000000000002 111.038 -175.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.62 -22.35 63.5 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.139 -1.392 . . . . 50.229999999999997 111.567 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 30.1 t -111.24 -0.53 16.42 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.834 0.854 . . . . 73.230000000000004 111.384 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 173' ' ' SER . 24.2 m -139.68 119.67 9.19 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 119.091 -0.481 . . . . 73.150000000000006 109.798 -178.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.52 ' HG2' ' HD2' ' A' ' 114' ' ' HIS . 21.4 Cg_exo -67.11 112.86 2.64 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 123.888 3.059 . . . . 74.319999999999993 113.401 -169.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.95 9.26 52.94 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.54 0.525 . . . . 62.43 114.024 175.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -85.05 114.55 22.28 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 107.71 -1.218 . . . . 63.109999999999999 107.71 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 57.2 mtt-85 -104.67 169.46 8.44 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.379 -0.6 . . . . 71.439999999999998 109.379 -169.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.0 m -155.0 136.42 14.15 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 123.875 0.87 . . . . 75.329999999999998 108.949 -173.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.428 HG12 HG22 ' A' ' 170' ' ' VAL . 54.7 mt -104.13 135.99 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 108.459 -0.941 . . . . 74.340000000000003 108.459 173.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.9 m -113.25 111.83 22.7 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.62 -1.173 . . . . 64.239999999999995 107.875 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.444 HD21 HD23 ' A' ' 232' ' ' LEU . 53.4 mt -105.0 139.81 39.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.753 0.821 . . . . 74.329999999999998 111.419 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -126.37 130.33 50.56 Favored 'General case' 0 C--O 1.261 1.685 0 O-C-N 124.056 0.848 . . . . 74.420000000000002 109.141 172.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.763 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 14.4 p90 -151.7 137.84 18.31 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 124.362 1.039 . . . . 75.5 108.492 172.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 55.36 28.94 12.18 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.044 1.338 . . . . 74.010000000000005 113.227 177.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.8 14.77 81.68 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 116.012 -0.54 . . . . 73.530000000000001 113.394 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -109.08 126.12 52.84 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.317 1.047 . . . . 74.409999999999997 108.698 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.462 HG11 ' HG3' ' A' ' 157' ' ' GLU . 91.5 t -109.81 135.58 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.509 0.724 . . . . 74.25 109.289 174.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.442 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 22.5 p90 -144.31 155.07 43.66 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.207 0.603 . . . . 74.019999999999996 109.538 171.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -129.17 136.34 50.03 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.156 -1.053 . . . . 72.150000000000006 108.156 -171.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -136.24 144.57 44.92 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 121.001 0.429 . . . . 75.530000000000001 110.738 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -76.91 131.71 38.71 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.73 -1.123 . . . . 71.129999999999995 110.365 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 77.8 mt -80.6 106.86 12.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 N-CA-C 108.298 -1.001 . . . . 72.530000000000001 108.298 164.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -69.74 123.72 22.12 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.436 -0.802 . . . . 70.209999999999994 109.558 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.3 m -104.88 107.99 19.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.427 0.691 . . . . 62.130000000000003 110.497 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.42 170.66 4.64 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.348 1.059 . . . . 62.43 111.293 173.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 41.2 p -59.21 -37.48 77.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.058 0.943 . . . . 75.540000000000006 112.191 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -76.1 -2.67 32.02 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.962 0.505 . . . . 75.340000000000003 111.862 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.92 6.89 84.65 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 111.811 -0.516 . . . . 74.530000000000001 111.811 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -69.83 128.29 35.88 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.74 -0.467 . . . . 62.549999999999997 109.74 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 80.8 mt -95.33 147.44 23.5 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.461 0.704 . . . . 62.200000000000003 109.784 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -163.6 164.88 23.96 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.425 0.69 . . . . 75.209999999999994 110.42 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 78.7 t -138.04 -52.64 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.11 0.964 . . . . 75.230000000000004 109.23 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 33.0 t -100.25 -178.28 3.78 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.774 0.83 . . . . 75.409999999999997 110.853 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.8 m -63.93 -46.23 85.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.641 1.177 . . . . 72.319999999999993 111.986 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.92 -14.42 41.91 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.263 0.625 . . . . 65.230000000000004 112.095 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 74.7 m -64.15 117.31 6.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.187 0.595 . . . . 63.130000000000003 111.186 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -146.53 112.73 5.83 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.654 1.182 . . . . 63.240000000000002 108.665 168.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -130.86 142.53 50.39 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.387 0.675 . . . . 74.439999999999998 109.417 -176.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -81.66 -34.81 30.55 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.661 0.384 . . . . 71.349999999999994 110.016 173.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 60.4 p -124.2 152.93 42.31 Favored 'General case' 0 C--O 1.255 1.363 0 CA-C-O 122.112 0.958 . . . . 72.109999999999999 111.287 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 170' ' ' VAL . 35.9 tp -63.45 -31.14 72.21 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 113.671 -1.604 . . . . 61.539999999999999 111.266 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.96 95.65 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.497 0.719 . . . . 72.230000000000004 110.918 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -61.69 -44.13 97.54 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.478 0.711 . . . . 53.439999999999998 110.598 173.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.75 -41.08 85.67 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.709 0.631 . . . . 61.539999999999999 111.769 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.7 t -74.28 -41.99 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.645 0.778 . . . . 74.25 111.016 -175.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -58.81 -51.38 70.26 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.438 0.637 . . . . 70.129999999999995 110.1 174.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.422 ' O ' HG22 ' A' ' 224' ' ' VAL . 48.3 t-80 -54.14 -57.83 9.62 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.495 -1.229 . . . . 50.109999999999999 109.905 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -61.04 -26.7 67.81 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.337 0.655 . . . . 74.409999999999997 112.046 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 37.4 t -73.07 -27.76 61.92 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 122.913 0.485 . . . . 65.400000000000006 111.706 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.5 t -120.96 7.2 10.35 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 115.443 1.645 . . . . 71.010000000000005 115.443 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 220' ' ' HIS . 34.1 m -113.74 156.14 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 121.069 1.759 . . . . 53.130000000000003 115.431 -176.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.77 -2.47 58.25 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 129.986 3.314 . . . . 74.439999999999998 113.168 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -77.76 14.82 0.96 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 129.381 3.072 . . . . 73.439999999999998 113.51 -141.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.66 18.53 3.98 Favored Glycine 0 N--CA 1.47 0.921 0 C-N-CA 125.274 1.416 . . . . 75.409999999999997 111.377 -171.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 88.3 mt -91.26 134.49 34.53 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.206 1.002 . . . . 71.239999999999995 110.129 165.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.442 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 95.0 mt -67.83 -44.86 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 124.421 1.076 . . . . 65.420000000000002 108.695 170.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.5 t -135.04 142.13 46.3 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 114.992 -1.004 . . . . 71.299999999999997 108.866 173.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 67.4 p -70.38 155.98 39.95 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 108.606 -0.887 . . . . 75.129999999999995 108.606 171.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.446 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 32.1 mt -67.13 100.62 0.79 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.142 -1.058 . . . . 74.200000000000003 108.142 177.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -77.96 -50.29 12.46 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.066 0.547 . . . . 63.420000000000002 109.981 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 167' ' ' SER . 6.3 p90 -161.63 152.2 14.77 Favored Pre-proline 0 N--CA 1.488 1.455 0 C-N-CA 121.006 -0.278 . . . . 75.519999999999996 110.419 174.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 53.4 Cg_endo -69.06 137.06 36.52 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.238 1.959 . . . . 74.129999999999995 111.538 173.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -57.99 130.7 83.12 Favored Pre-proline 0 C--O 1.246 0.9 0 O-C-N 123.558 0.536 . . . . 73.030000000000001 109.894 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.39 145.26 87.81 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.28 1.987 . . . . 72.209999999999994 112.143 -172.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt . . . . . 0 CA--C 1.545 0.766 0 CA-C-N 115.555 -0.748 . . . . 60.420000000000002 109.149 171.033 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.24 0.599 0 CA-C-O 121.796 0.808 . . . . 64.209999999999994 112.428 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.9 mt -107.72 133.28 20.5 Favored Pre-proline 0 C--O 1.241 0.62 0 CA-C-N 114.636 -1.165 . . . . 74.140000000000001 108.545 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.92 170.22 14.67 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.511 2.14 . . . . 75.25 111.99 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.89 144.67 29.06 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.051 0.541 . . . . 63.539999999999999 110.499 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.63 ' HB3' HD11 ' A' ' 23' ' ' ILE . 74.1 mt -87.43 94.85 9.81 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.557 0.743 . . . . 75.140000000000001 109.175 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -96.22 -47.09 6.18 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.023 -0.732 . . . . 64.319999999999993 109.023 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -99.77 113.77 26.47 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.143 -0.935 . . . . 72.230000000000004 109.815 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.63 HD11 ' HB3' ' A' ' 20' ' ' LEU . 39.1 mm -116.51 114.11 45.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 107.904 -1.147 . . . . 70.010000000000005 107.904 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.1 mttm . . . . . 0 N--CA 1.471 0.59 0 C-N-CA 123.202 0.601 . . . . 63.439999999999998 109.627 -175.861 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo . . . . . 0 CA--C 1.549 1.269 0 CA-C-O 120.608 0.17 . . . . 72.329999999999998 112.183 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -96.12 33.7 1.69 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.938 0.895 . . . . 73.209999999999994 110.368 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 33.9 tp -81.03 112.47 18.45 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.815 -0.809 . . . . 65.540000000000006 108.815 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.6 m-85 -104.45 177.73 4.76 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.918 1.687 . . . . 75.430000000000007 109.505 175.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 11.3 p -144.28 138.93 24.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.47 0.708 . . . . 73.340000000000003 109.161 171.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -78.23 112.8 15.58 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.98 0.912 . . . . 62.340000000000003 109.431 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.4 mt -74.72 -22.2 58.95 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.193 0.997 . . . . 64.230000000000004 111.925 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -130.88 152.55 50.08 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.103 0.961 . . . . 75.299999999999997 109.214 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -77.84 130.85 37.17 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.226 -1.027 . . . . 72.450000000000003 108.226 173.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.49 ' HB3' HG12 ' A' ' 101' ' ' ILE . 74.7 t80 -133.21 114.83 14.27 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 108.916 -0.772 . . . . 74.239999999999995 108.916 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.3 136.76 22.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 108.904 -0.776 . . . . 65.319999999999993 108.904 171.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.8 137.96 57.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.762 0.425 . . . . 62.399999999999999 110.537 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.1 t -75.73 -9.93 59.01 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.064 0.546 . . . . 75.010000000000005 110.152 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.12 -154.63 25.12 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 115.866 -0.606 . . . . 55.340000000000003 111.759 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.99 -40.25 95.0 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.258 1.023 . . . . 70.540000000000006 111.789 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -67.86 -25.06 65.34 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.769 0.828 . . . . 72.109999999999999 112.467 -172.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.9 p -106.29 158.49 16.83 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.626 0.77 . . . . 71.109999999999999 109.702 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.8 tp -109.66 124.94 52.05 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 122.999 0.52 . . . . 73.200000000000003 109.991 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 p -70.57 114.88 9.11 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.279 -0.873 . . . . 74.010000000000005 109.356 170.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 91' ' ' PHE . 24.8 pt -119.7 156.98 22.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.023 -0.732 . . . . 60.420000000000002 109.023 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 1.9 m -117.35 143.65 45.74 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.318 -0.623 . . . . 53.109999999999999 109.318 -174.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -57.56 120.22 7.91 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 122.807 0.443 . . . . 74.219999999999999 110.367 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.53 -13.84 63.82 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.323 0.389 . . . . 73.349999999999994 113.455 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -85.74 130.98 34.41 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.846 0.858 . . . . 71.040000000000006 110.235 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HB3' HD11 ' A' ' 84' ' ' LEU . 9.1 mtmp? -83.7 142.72 30.53 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.813 0.845 . . . . 74.120000000000005 110.886 -177.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.1 mt -120.46 150.96 39.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.519 1.128 . . . . 71.129999999999995 108.282 -171.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -113.89 107.37 15.61 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.941 -1.133 . . . . 64.030000000000001 107.941 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.08 121.94 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 109.935 -0.394 . . . . 53.340000000000003 109.935 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 72.3 mt -83.38 -41.57 18.02 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.098 0.475 . . . . 74.450000000000003 109.95 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.52 172.34 44.07 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.58 -0.736 . . . . 70.140000000000001 111.828 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.483 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 13.3 m-85 -99.28 169.13 9.58 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.046 -0.724 . . . . 71.349999999999994 109.046 175.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -66.39 146.53 54.47 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.877 -1.156 . . . . 75.219999999999999 107.877 172.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' HIS . . . . . 0.689 ' HA ' ' HG3' ' A' ' 177' ' ' PRO . 31.0 m170 -68.59 -21.27 64.52 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.939 0.496 . . . . 62.100000000000001 112.217 -174.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -94.57 -12.23 27.92 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.17 0.588 . . . . 71.299999999999997 110.673 174.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 82.33 35.23 21.07 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 116.453 -0.339 . . . . 41.439999999999998 112.794 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -85.59 -65.68 0.98 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.518 0.727 . . . . 65.239999999999995 110.256 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -115.83 179.46 3.97 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.654 1.181 . . . . 71.439999999999998 109.5 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -135.31 127.45 29.91 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.91 0.884 . . . . 34.119999999999997 108.664 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -83.46 113.84 21.05 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.199 0.523 . . . . 73.310000000000002 110.668 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.76 163.49 18.04 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 114.966 -1.016 . . . . 63.020000000000003 110.47 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -133.16 141.64 48.23 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.103 0.961 . . . . 73.120000000000005 109.596 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.3 p -137.33 179.77 6.2 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.54 1.536 . . . . 74.420000000000002 108.053 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -73.96 -6.51 47.78 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.437 0.295 . . . . 54.420000000000002 110.753 172.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -76.88 -22.93 52.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.061 0.945 . . . . 75.049999999999997 110.177 169.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 130.13 -171.1 20.59 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 111.109 -0.796 . . . . 44.329999999999998 111.109 -174.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -115.96 147.05 41.58 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.642 0.777 . . . . 60.509999999999998 110.245 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 175.45 -176.81 47.4 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 123.442 0.464 . . . . 75.219999999999999 112.767 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -89.42 136.01 33.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.833 0.853 . . . . 70.230000000000004 110.631 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.76 154.95 80.78 Favored Pre-proline 0 N--CA 1.482 1.163 0 C-N-CA 124.465 1.106 . . . . 54.310000000000002 110.206 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.68 130.1 11.36 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.481 2.12 . . . . 42.009999999999998 111.236 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.512 ' HA ' HG12 ' A' ' 135' ' ' ILE . 13.6 p -63.43 -20.93 65.98 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.61 0.764 . . . . 71.219999999999999 111.897 178.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -70.73 -27.02 63.65 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.872 0.869 . . . . 70.420000000000002 111.537 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -95.39 2.25 54.53 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.554 0.742 . . . . 63.210000000000001 111.955 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.512 HG12 ' HA ' ' A' ' 132' ' ' SER . 14.4 pt -134.92 152.33 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 118.029 0.377 . . . . 52.329999999999998 110.544 -173.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.4 t -143.3 139.56 16.71 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.455 0.702 . . . . 51.149999999999999 109.117 171.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.567 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 56.0 Cg_endo -71.05 140.36 37.69 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 122.26 1.974 . . . . 71.549999999999997 112.058 175.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.4 m -111.1 -45.05 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.152 0.981 . . . . 74.310000000000002 110.613 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.551 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.5 t30 -100.04 6.8 45.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.964 0.506 . . . . 53.340000000000003 111.22 -174.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 31.0 t -86.42 176.19 8.0 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.241 0.543 . . . . 65.25 110.127 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.456 ' O ' ' HB3' ' A' ' 147' ' ' TYR . 80.7 mt -66.21 -13.93 61.08 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.129 0.971 . . . . 74.409999999999997 112.585 -176.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.87 -28.79 64.47 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.521 0.728 . . . . 74.019999999999996 111.785 176.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -64.18 -25.37 68.05 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.088 -0.505 . . . . 54.399999999999999 110.853 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -78.54 134.29 37.27 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.57 -0.9 . . . . 74.439999999999998 108.57 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.1 t -67.89 -18.87 64.93 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.167 0.803 . . . . 74.319999999999993 113.167 -171.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 61.4 p-90 -78.99 -26.46 43.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.073 0.549 . . . . 75.400000000000006 111.849 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 46.7 t80 -109.72 125.62 52.86 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.244 0.618 . . . . 64.409999999999997 109.389 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -113.11 25.89 10.97 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.669 0.388 . . . . 63.509999999999998 111.482 -172.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 64.61 -156.6 46.05 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.769 -0.65 . . . . 63.240000000000002 114.323 172.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.425 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 56.6 Cg_endo -70.52 101.58 1.04 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 123.009 2.473 . . . . 70.439999999999998 111.008 173.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.3 p -143.19 145.1 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 120.911 0.386 . . . . 73.219999999999999 110.289 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 70.5 m -73.62 166.73 22.74 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.449 1.1 . . . . 75.540000000000006 112.747 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 44.6 mtt85 -65.35 -40.94 94.24 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.52 -1.218 . . . . 72.319999999999993 111.359 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -70.13 -42.93 71.95 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.059 0.849 . . . . 72.200000000000003 111.186 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.64 -42.72 86.25 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.127 0.971 . . . . 72.140000000000001 110.135 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.35 -52.71 64.46 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.728 -1.124 . . . . 73.140000000000001 110.02 173.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.534 ' HG3' HG11 ' A' ' 190' ' ' VAL . 37.9 tt0 -61.07 -29.17 69.58 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.322 0.649 . . . . 75.409999999999997 111.272 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -63.68 -52.71 59.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.664 0.785 . . . . 55.049999999999997 110.277 173.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.62 -33.85 75.86 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.806 -0.634 . . . . 73.019999999999996 111.162 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.662 HD23 HG13 ' A' ' 190' ' ' VAL . 28.9 tp -78.55 -23.39 46.18 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.092 -0.958 . . . . 74.329999999999998 111.595 -177.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 t -64.28 -23.6 67.36 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.66 0.784 . . . . 42.549999999999997 111.374 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.0 m -82.88 -7.97 59.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.016 0.926 . . . . 65.030000000000001 112.091 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.15 174.03 41.67 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 114.26 0.464 . . . . 43.229999999999997 114.26 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.0 pt -121.29 -164.24 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.027 0.931 . . . . 52.109999999999999 109.91 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.769 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 22.7 p-10 -49.56 117.18 2.08 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.163 0.985 . . . . 72.140000000000001 112.236 177.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.97 13.99 68.06 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-N 115.562 -0.744 . . . . 71.519999999999996 113.617 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 23.3 t -73.54 132.96 43.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.569 -0.901 . . . . 72.209999999999994 108.569 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.495 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 19.4 p90 -134.87 161.32 35.55 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.176 0.806 . . . . 75.430000000000007 113.176 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 76.9 mt -137.87 135.47 36.19 Favored 'General case' 0 C--O 1.215 -0.754 0 C-N-CA 124.901 1.281 . . . . 73.340000000000003 108.978 172.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 14.3 t -114.83 140.06 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 106.467 -1.679 . . . . 75.040000000000006 106.467 167.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.2 ptt85 -158.72 168.85 25.77 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.955 0.502 . . . . 73.310000000000002 110.474 -172.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.473 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 12.2 pt-20 -115.46 153.44 31.1 Favored 'General case' 0 C--O 1.257 1.448 0 C-N-CA 123.09 0.556 . . . . 63.520000000000003 109.543 167.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 176' ' ' SER . 17.1 m -88.43 123.76 33.29 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.072 -0.967 . . . . 72.200000000000003 109.291 -178.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' A' ' 150' ' ' PRO . 38.3 mt-10 -57.56 -39.36 76.51 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.421 1.089 . . . . 71.5 111.674 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.614 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 8.5 t -87.41 -6.26 58.51 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 115.167 -0.924 . . . . 74.219999999999999 111.969 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 173' ' ' SER . 14.9 m -131.72 100.21 16.38 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.425 0.69 . . . . 73.109999999999999 109.324 -176.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.689 ' HG3' ' HA ' ' A' ' 114' ' ' HIS . 36.3 Cg_endo -60.35 113.55 1.73 Allowed 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.745 2.963 . . . . 74.209999999999994 112.061 -174.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.72 -20.38 19.56 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 116.101 -0.5 . . . . 44.43 113.666 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -73.79 116.84 14.87 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.648 0.724 . . . . 75.340000000000003 109.305 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.473 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 66.9 mtt85 -113.23 160.23 18.5 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 124.186 0.995 . . . . 71.129999999999995 110.279 -171.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 44.4 t -143.92 151.58 40.0 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.093 0.957 . . . . 74.430000000000007 110.48 -174.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.432 HD11 HD21 ' A' ' 217' ' ' LEU . 52.1 mt -119.06 145.85 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.214 1.006 . . . . 71.319999999999993 108.519 169.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.5 m -125.18 127.34 46.65 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.629 1.172 . . . . 61.340000000000003 108.148 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.449 HD21 HD23 ' A' ' 232' ' ' LEU . 57.9 mt -113.67 147.78 37.53 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.624 0.77 . . . . 75.420000000000002 111.891 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 19.7 ttt180 -133.86 131.01 38.68 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-N 114.536 -1.211 . . . . 74.299999999999997 109.651 172.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.769 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 9.5 p90 -149.38 141.03 23.49 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.562 1.145 . . . . 74.049999999999997 108.022 173.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 54.07 31.67 14.18 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.224 1.01 . . . . 53.200000000000003 113.232 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.19 3.68 90.62 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 116.343 -0.389 . . . . 64.230000000000004 112.782 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 10.3 tpp180 -102.13 124.21 47.33 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.151 0.98 . . . . 74.030000000000001 109.72 -176.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.662 HG13 HD23 ' A' ' 160' ' ' LEU . 81.0 t -107.45 135.89 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.265 1.026 . . . . 72.120000000000005 109.578 177.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.472 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 26.7 p90 -145.87 163.11 36.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.202 1.001 . . . . 74.439999999999998 109.744 171.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -133.45 141.98 48.07 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.194 0.997 . . . . 75.140000000000001 108.477 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -143.17 152.62 41.97 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.43 0.692 . . . . 75.219999999999999 109.57 175.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -95.85 138.01 34.1 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.452 0.701 . . . . 72.200000000000003 111.62 -170.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 69.4 mt -83.58 113.8 23.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 124.229 1.012 . . . . 61.130000000000003 108.347 165.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -88.38 134.87 33.71 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.194 0.598 . . . . 73.329999999999998 109.686 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.2 m -104.35 120.34 40.97 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.13 0.972 . . . . 55.210000000000001 109.518 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -72.48 164.82 25.77 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.304 1.042 . . . . 62.119999999999997 111.697 175.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 52.6 p -68.94 -17.05 63.89 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.645 0.778 . . . . 71.510000000000005 111.068 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.57 -19.19 65.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.407 1.083 . . . . 63.32 111.577 173.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 91.93 -6.06 79.18 Favored Glycine 0 C--N 1.353 1.517 0 CA-C-N 115.848 -0.615 . . . . 70.230000000000004 111.921 -168.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -76.25 144.23 40.49 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.351 0.66 . . . . 72.129999999999995 110.934 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 47.1 mt -95.65 152.48 18.41 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.598 1.159 . . . . 73.030000000000001 108.518 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -166.5 172.28 10.98 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.661 0.6 . . . . 74.540000000000006 111.084 174.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.4 t -131.84 -41.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.377 1.071 . . . . 51.32 108.758 174.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.6 t -92.39 153.83 18.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.331 -0.618 . . . . 71.530000000000001 109.331 173.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.4 p -66.48 -29.35 69.45 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.122 0.569 . . . . 65.409999999999997 110.957 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -92.56 2.92 56.43 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.4 0.68 . . . . 71.310000000000002 112.144 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 211' ' ' PHE . 86.7 p -105.67 137.9 42.76 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.913 -0.773 . . . . 72.129999999999995 108.913 176.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -143.43 126.83 16.76 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.302 1.041 . . . . 74.430000000000007 108.194 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 209' ' ' SER . 14.4 m-85 -133.74 133.94 42.38 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.175 0.59 . . . . 74.310000000000002 109.422 -178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -74.88 -35.54 62.29 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.08 0.552 . . . . 72.510000000000005 110.403 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 61.9 p -123.22 147.44 46.89 Favored 'General case' 0 C--O 1.256 1.41 0 CA-C-O 122.267 1.032 . . . . 63.420000000000002 111.637 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.444 ' O ' HG23 ' A' ' 218' ' ' VAL . 25.1 tp -64.32 -28.62 69.84 Favored 'General case' 0 C--O 1.213 -0.832 0 CA-C-N 113.655 -1.611 . . . . 73.200000000000003 111.205 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.68 -42.53 95.28 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.316 0.646 . . . . 54.109999999999999 111.452 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -71.7 -35.03 70.11 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.975 0.51 . . . . 70.0 110.347 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.432 HD21 HD11 ' A' ' 182' ' ' ILE . 9.5 tt -56.54 -46.58 80.58 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.901 0.751 . . . . 72.150000000000006 110.384 170.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 214' ' ' LEU . 44.4 t -66.27 -44.97 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.738 0.815 . . . . 73.040000000000006 110.586 -177.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -61.78 -45.45 93.81 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.91 0.484 . . . . 63.530000000000001 110.145 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -52.35 -61.67 2.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.244 -0.889 . . . . 63.420000000000002 108.855 175.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -59.71 -23.45 63.16 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.88 -0.6 . . . . 61.350000000000001 111.92 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.406 ' O ' ' HB ' ' A' ' 231' ' ' THR . 35.6 t -75.21 -28.04 59.81 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.109 0.563 . . . . 72.549999999999997 111.713 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.8 t -118.17 -9.83 10.41 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.447 1.647 . . . . 51.310000000000002 115.447 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 27.6 m -92.71 148.45 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 123.632 1.682 . . . . 62.32 115.058 -167.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.6 0.16 54.99 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 110.96 -2.836 . . . . 74.25 111.359 173.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -78.9 15.46 1.08 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 128.959 2.904 . . . . 72.439999999999998 112.478 -143.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.05 18.39 4.67 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 124.525 1.059 . . . . 71.140000000000001 111.794 -170.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 56.0 mt -93.06 145.59 24.27 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.763 0.825 . . . . 75.409999999999997 111.47 162.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.472 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 63.9 mt -75.34 -43.42 43.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.644 -0.873 . . . . 62.439999999999998 108.644 170.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t -139.02 144.62 38.94 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.323 -0.853 . . . . 75.010000000000005 109.217 177.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 222' ' ' SER . 40.8 p -75.49 155.17 36.45 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.597 0.759 . . . . 71.450000000000003 109.73 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.495 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 21.2 mt -67.72 101.78 1.1 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.554 -0.906 . . . . 74.319999999999993 108.554 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -83.1 -47.43 11.66 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.49 0.716 . . . . 62.399999999999999 110.075 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -163.3 152.3 12.29 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 109.572 -0.529 . . . . 74.430000000000007 109.572 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.404 ' HB3' ' HA ' ' A' ' 146' ' ' TRP . 53.0 Cg_endo -68.51 144.39 60.83 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 121.932 1.755 . . . . 75.329999999999998 111.973 175.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -60.54 137.71 92.56 Favored Pre-proline 0 C--O 1.248 0.992 0 C-N-CA 123.359 0.664 . . . . 73.209999999999994 109.981 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.06 116.4 3.15 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.914 2.409 . . . . 61.439999999999998 111.742 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? . . . . . 0 C--O 1.241 0.617 0 N-CA-C 107.85 -1.166 . . . . 64.420000000000002 107.85 174.085 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.2 m . . . . . 0 C--O 1.246 0.905 0 CA-C-O 121.095 0.474 . . . . 71.129999999999995 110.75 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.7 mt -104.27 133.5 20.19 Favored Pre-proline 0 C--O 1.238 0.449 0 N-CA-C 108.092 -1.077 . . . . 75.340000000000003 108.092 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.22 169.36 13.92 Favored 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 122.493 2.129 . . . . 72.140000000000001 112.025 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.3 147.03 27.43 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.933 -0.766 . . . . 65.200000000000003 108.933 170.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 23' ' ' ILE . 83.4 mt -88.04 93.57 9.52 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.228 -0.656 . . . . 41.140000000000001 109.228 -177.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -98.23 -53.0 3.49 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.576 0.35 . . . . 71.519999999999996 110.281 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.428 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 61.0 m-85 -106.3 108.97 20.75 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.051 0.541 . . . . 75.430000000000007 110.124 -175.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.469 HD11 HD22 ' A' ' 20' ' ' LEU . 49.8 mm -123.79 120.76 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.754 0.822 . . . . 71.129999999999995 111.003 -175.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt . . . . . 0 CA--C 1.542 0.64 0 C-N-CA 123.486 0.714 . . . . 74.329999999999998 110.531 169.301 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 CA--C 1.542 0.883 0 N-CA-C 114.045 0.748 . . . . 74.409999999999997 114.045 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -64.96 83.48 0.04 OUTLIER 'General case' 0 C--N 1.353 0.719 0 CA-C-O 121.766 0.793 . . . . 75.530000000000001 109.85 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.62 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 33.6 tp -125.07 119.01 27.44 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.363 -1.29 . . . . 74.329999999999998 107.904 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -105.14 176.23 5.23 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.646 1.579 . . . . 52.329999999999998 109.226 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.62 144.73 25.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 N-CA-C 108.641 -0.874 . . . . 71.239999999999995 108.641 172.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.28 118.52 19.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.433 0.693 . . . . 74.209999999999994 109.748 174.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.29 -21.29 39.43 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.91 0.884 . . . . 71.129999999999995 111.073 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.572 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 93.1 m-85 -134.46 169.28 17.5 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.405 0.682 . . . . 74.099999999999994 110.15 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.39 145.76 27.32 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.177 -0.919 . . . . 63.240000000000002 109.133 170.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.444 ' HB3' HG12 ' A' ' 101' ' ' ILE . 86.2 t80 -151.93 104.81 3.03 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.457 -0.942 . . . . 65.430000000000007 108.457 176.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.6 t -80.37 133.92 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 107.878 -1.156 . . . . 72.519999999999996 107.878 172.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.41 114.77 10.89 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.595 -0.52 . . . . 75.140000000000001 109.595 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.1 m -77.03 -23.19 52.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.009 0.524 . . . . 63.009999999999998 110.663 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.75 168.28 19.8 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 123.796 0.685 . . . . 51.020000000000003 111.734 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.52 -29.88 63.99 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.529 0.732 . . . . 62.43 110.29 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -71.43 -19.92 62.18 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.993 1.317 . . . . 72.010000000000005 112.235 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.3 p -98.47 154.87 17.57 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.256 0.622 . . . . 74.409999999999997 109.998 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.6 tp -107.08 128.35 54.3 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.877 -0.786 . . . . 74.0 108.877 -177.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.1 t -82.56 118.15 23.07 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 109.782 -0.451 . . . . 62.350000000000001 109.782 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.444 HG12 ' HB3' ' A' ' 91' ' ' PHE . 28.6 pt -119.6 165.42 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.075 0.95 . . . . 75.109999999999999 110.066 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.5 m -138.59 145.64 40.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.465 0.706 . . . . 75.140000000000001 109.214 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -54.54 118.67 4.36 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.813 0.845 . . . . 74.120000000000005 111.778 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.85 -14.87 29.08 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.032 -0.531 . . . . 64.409999999999997 112.842 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -78.49 124.36 28.05 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.596 0.758 . . . . 73.150000000000006 110.258 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.456 ' HB3' HD11 ' A' ' 84' ' ' LEU . 31.8 mtmm -75.01 116.9 16.27 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.364 0.666 . . . . 72.310000000000002 109.574 176.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.9 mt -101.14 163.61 12.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.694 -0.854 . . . . 64.430000000000007 108.694 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -126.38 110.12 12.99 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.56 -0.904 . . . . 74.049999999999997 108.56 163.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.485 HG21 HD12 ' A' ' 135' ' ' ILE . 99.1 t -90.23 124.35 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.127 -0.694 . . . . 72.430000000000007 109.127 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.4 mt -81.78 -37.83 26.55 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.567 1.147 . . . . 71.209999999999994 109.273 -174.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.81 176.28 47.88 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 113.936 -1.484 . . . . 43.340000000000003 110.51 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 56.7 m-85 -103.95 175.05 5.61 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 109.386 -0.598 . . . . 75.109999999999999 109.386 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 22' ' ' PHE . 43.7 t-20 -68.98 148.74 49.69 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.428 -0.953 . . . . 73.530000000000001 108.428 169.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -66.09 -17.81 64.94 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.758 0.823 . . . . 70.120000000000005 112.578 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -95.84 -5.28 42.07 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.493 0.717 . . . . 65.319999999999993 111.062 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.3 34.69 63.95 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.378 -0.689 . . . . 60.409999999999997 111.378 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.463 ' HG2' ' CD1' ' A' ' 118' ' ' TRP . 36.8 tt0 -89.03 -58.36 2.57 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.202 1.401 . . . . 73.420000000000002 109.282 -170.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.463 ' CD1' ' HG2' ' A' ' 117' ' ' GLU . 87.5 m95 -126.24 -176.96 3.8 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.587 1.155 . . . . 74.409999999999997 110.086 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -132.28 116.54 17.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.338 1.055 . . . . 64.510000000000005 109.698 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.46 107.53 14.3 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.795 -0.817 . . . . 74.129999999999995 108.795 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.464 ' HB2' HG22 ' A' ' 109' ' ' VAL . . . -121.12 165.42 15.37 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.939 0.896 . . . . 60.219999999999999 111.58 -172.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -143.42 131.31 21.56 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.101 0.96 . . . . 72.400000000000006 110.138 -175.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 45.1 p -141.06 -176.99 4.89 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.634 1.174 . . . . 54.439999999999998 110.973 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -60.79 -21.58 63.24 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.229 1.012 . . . . 71.120000000000005 111.41 171.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -72.71 -26.87 61.75 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.759 0.824 . . . . 72.439999999999998 110.127 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.22 -135.1 6.88 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.203 -0.759 . . . . 42.130000000000003 111.203 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -152.88 148.55 27.29 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 122.924 0.489 . . . . 73.230000000000004 110.116 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 161.49 -177.7 37.68 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 121.088 0.271 . . . . 62.549999999999997 113.137 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -84.34 134.78 34.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.528 0.731 . . . . 50.210000000000001 111.781 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.66 155.23 80.65 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.085 1.354 . . . . 74.200000000000003 108.766 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -69.66 129.65 18.08 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 121.789 1.659 . . . . 75.129999999999995 110.846 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.4 m -60.25 -20.55 59.45 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.773 0.829 . . . . 32.329999999999998 112.539 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -84.66 -19.02 33.55 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.635 0.774 . . . . 64.439999999999998 111.615 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.572 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.4 m-85 -89.66 5.05 47.49 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.548 0.739 . . . . 73.310000000000002 112.107 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.485 HD12 HG21 ' A' ' 109' ' ' VAL . 21.3 pt -134.32 167.43 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.442 0.697 . . . . 63.329999999999998 110.695 -174.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.3 t -160.88 141.9 8.73 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 122.781 0.432 . . . . 73.319999999999993 111.11 168.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.04 133.21 22.76 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.978 2.452 . . . . 73.120000000000005 112.285 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.6 m -113.89 -49.15 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.109 0.564 . . . . 72.25 111.459 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.62 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.2 t30 -100.97 -11.7 19.5 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.92 0.488 . . . . 55.350000000000001 111.058 -176.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.1 t -65.39 177.62 1.1 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.549 0.74 . . . . 73.120000000000005 111.044 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.72 -21.95 21.22 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.194 1.183 . . . . 55.409999999999997 114.194 -171.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.59 -13.29 60.88 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.004 0.922 . . . . 74.510000000000005 112.028 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -63.33 -22.46 66.89 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.979 0.912 . . . . 73.450000000000003 110.692 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -85.07 145.22 27.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.612 0.765 . . . . 75.430000000000007 110.431 171.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.7 t -66.51 -20.76 66.11 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.861 0.865 . . . . 64.319999999999993 112.261 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -83.61 -34.87 25.02 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.097 0.406 . . . . 63.210000000000001 112.097 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 33.7 t80 -93.8 138.71 31.69 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 109.494 -0.558 . . . . 74.219999999999999 109.494 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.671 ' HB3' HH21 ' A' ' 171' ' ' ARG . 75.9 m-70 -134.27 26.39 3.83 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.448 0.536 . . . . 73.209999999999994 112.448 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 67.86 -163.5 47.31 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 115.585 0.994 . . . . 65.549999999999997 115.585 170.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.21 102.68 1.59 Allowed 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.499 2.799 . . . . 74.430000000000007 112.874 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.9 t -138.05 157.58 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 123.247 0.619 . . . . 64.349999999999994 110.363 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.0 m -75.24 153.67 37.92 Favored 'General case' 0 C--O 1.256 1.435 0 C-N-CA 124.581 1.152 . . . . 75.030000000000001 112.09 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -62.81 -31.92 73.01 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.523 -0.762 . . . . 53.43 111.085 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -54.93 -53.6 53.51 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.022 0.929 . . . . 72.219999999999999 110.264 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.04 77.56 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.409 -0.814 . . . . 74.5 110.848 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.498 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.08 -50.53 73.13 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.345 0.593 . . . . 74.319999999999993 111.69 176.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.467 ' HG3' HG11 ' A' ' 190' ' ' VAL . 33.0 tt0 -78.2 -25.05 46.89 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.106 -0.952 . . . . 64.040000000000006 110.263 -175.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -60.25 -53.46 57.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.112 0.565 . . . . 64.120000000000005 110.269 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 64.8 mt -65.23 -39.33 92.58 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 116.237 -0.438 . . . . 72.420000000000002 110.854 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.58 HD23 HG13 ' A' ' 190' ' ' VAL . 36.4 tp -73.08 -24.21 60.63 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.878 -0.601 . . . . 75.329999999999998 112.105 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 35.4 t -65.77 -23.81 66.8 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.109 0.564 . . . . 54.409999999999997 111.322 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 80.6 p -91.8 -0.64 57.54 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.155 0.582 . . . . 72.519999999999996 111.129 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -83.96 163.23 39.7 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.941 -0.572 . . . . 64.400000000000006 112.89 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.1 pt -120.15 -166.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.317 1.047 . . . . 72.209999999999994 111.095 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -58.58 107.36 0.5 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.899 0.879 . . . . 75.510000000000005 112.777 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 98.2 13.53 42.0 Favored Glycine 0 C--O 1.259 1.658 0 CA-C-N 116.03 -0.532 . . . . 75.299999999999997 112.617 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 31.5 t -74.35 134.79 42.49 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 119.126 -0.464 . . . . 52.149999999999999 109.961 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 183' ' ' SER . 22.3 p90 -135.25 153.7 51.82 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 121.51 0.671 . . . . 73.299999999999997 112.669 177.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' A' ' 236' ' ' ALA . 97.5 mt -134.49 133.81 40.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.908 -1.042 . . . . 61.32 108.302 169.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 20.0 t -112.87 120.5 63.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.394 -1.336 . . . . 74.019999999999996 107.394 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.671 HH21 ' HB3' ' A' ' 148' ' ' HIS . 0.6 OUTLIER -159.37 148.89 18.5 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.469 -0.567 . . . . 72.150000000000006 109.469 177.586 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.808 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 15.0 pt-20 -92.3 157.77 16.47 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-O 121.224 0.535 . . . . 72.310000000000002 111.258 -176.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 p -76.72 115.97 16.97 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.975 -1.011 . . . . 71.439999999999998 108.53 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.21 -31.33 67.23 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.796 0.838 . . . . 65.430000000000007 112.429 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.8 t -95.67 8.46 43.37 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.81 0.844 . . . . 72.319999999999993 111.4 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 57.0 m -149.86 83.21 6.33 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 108.434 -0.95 . . . . 55.149999999999999 108.434 172.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.517 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 42.8 Cg_endo -63.57 140.55 75.85 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.47 2.78 . . . . 73.430000000000007 112.491 -173.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.65 -23.54 10.14 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.924 -0.58 . . . . 74.340000000000003 112.9 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -86.65 115.87 24.39 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 108.818 -0.808 . . . . 74.140000000000001 108.818 174.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.808 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 42.8 mtt85 -114.57 153.15 30.6 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.025 -0.989 . . . . 75.129999999999995 108.957 -173.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.1 m -134.18 142.72 47.53 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 109.945 -0.391 . . . . 63.119999999999997 109.945 -177.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.411 HG12 HG22 ' A' ' 170' ' ' VAL . 50.6 mt -106.48 136.25 41.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.365 -0.976 . . . . 70.040000000000006 108.365 169.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.576 ' HB3' HD22 ' A' ' 160' ' ' LEU . 20.4 m -115.77 113.95 24.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.99 -1.115 . . . . 72.25 107.99 -177.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 52.7 mt -104.58 141.09 37.03 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.5 0.72 . . . . 73.310000000000002 111.167 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 26.7 ttt180 -124.2 120.91 33.64 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 107.361 -1.348 . . . . 75.310000000000002 107.361 165.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.79 127.38 28.87 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.588 -1.264 . . . . 74.420000000000002 107.588 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 54.85 28.86 10.99 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.039 0.936 . . . . 64.329999999999998 112.282 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 89.31 1.25 78.88 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.155 0.407 . . . . 73.129999999999995 113.433 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 8.7 tpm_? -100.57 123.26 44.54 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.035 0.934 . . . . 65.230000000000004 109.455 -174.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.58 HG13 HD23 ' A' ' 160' ' ' LEU . 95.0 t -98.58 124.3 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.135 0.974 . . . . 44.030000000000001 109.978 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -145.95 149.99 35.21 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.062 0.945 . . . . 60.240000000000002 109.75 176.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -125.86 148.78 49.07 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.961 0.904 . . . . 74.129999999999995 109.361 -171.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -145.39 148.4 33.3 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.215 0.531 . . . . 74.049999999999997 111.106 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -93.77 125.88 38.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.932 -1.031 . . . . 73.329999999999998 111.785 -171.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 68.9 mt -77.65 111.0 13.97 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 124.397 1.079 . . . . 75.540000000000006 108.536 162.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -87.46 139.27 30.71 Favored 'General case' 0 C--O 1.249 1.051 0 N-CA-C 109.417 -0.586 . . . . 73.219999999999999 109.417 173.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 46.5 m -110.6 132.16 54.43 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.974 0.796 . . . . 65.200000000000003 110.1 -176.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.58 169.19 18.74 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.059 0.944 . . . . 75.310000000000002 111.1 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 72.1 p -75.92 -8.59 57.29 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.841 0.456 . . . . 74.120000000000005 111.461 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -93.33 -7.55 44.49 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.062 0.945 . . . . 73.219999999999999 110.821 170.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 91.8 -1.27 74.63 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-O 119.501 -0.61 . . . . 31.030000000000001 113.324 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -70.61 128.85 37.52 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.538 0.669 . . . . 73.450000000000003 111.164 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 29.0 mt -91.77 148.59 22.13 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.925 0.89 . . . . 52.420000000000002 110.535 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -160.74 148.74 16.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.301 0.572 . . . . 74.030000000000001 111.149 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.7 t -112.7 -45.32 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 114.721 -1.127 . . . . 63.130000000000003 109.371 176.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 22.2 t -121.75 178.94 4.65 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.009 0.524 . . . . 61.210000000000001 109.976 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.2 t -68.05 -26.72 66.0 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.577 0.751 . . . . 71.150000000000006 112.04 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -86.48 -3.97 59.1 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.604 0.761 . . . . 74.239999999999995 110.663 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.484 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 19.9 m -94.72 121.76 36.62 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.893 0.877 . . . . 71.439999999999998 110.976 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -143.49 109.29 5.2 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 107.869 -1.16 . . . . 72.219999999999999 107.869 168.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.484 ' CE2' ' HB3' ' A' ' 209' ' ' SER . 17.7 m-85 -123.42 136.26 54.53 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.291 -0.633 . . . . 73.430000000000007 109.291 -178.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.24 -10.17 45.29 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 122.625 0.37 . . . . 71.420000000000002 110.182 175.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 57.7 p -141.36 152.55 44.47 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.587 0.708 . . . . 65.200000000000003 111.141 173.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.26 -25.4 63.35 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.483 -1.235 . . . . 63.039999999999999 110.474 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.61 -50.14 73.76 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 123.723 0.809 . . . . 72.109999999999999 110.382 174.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -72.11 -29.22 63.87 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.416 -0.811 . . . . 72.230000000000004 111.62 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.49 -52.7 64.55 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.354 0.409 . . . . 73.430000000000007 110.065 171.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.69 -40.5 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.273 0.629 . . . . 73.329999999999998 111.221 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -64.06 -47.5 79.9 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.091 0.472 . . . . 63.329999999999998 110.949 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -63.26 -46.69 85.65 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.151 -0.685 . . . . 74.040000000000006 109.151 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.434 ' HA ' HG22 ' A' ' 224' ' ' VAL . 46.1 m80 -66.24 -25.22 66.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.969 0.508 . . . . 72.319999999999993 111.489 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.407 ' O ' ' HB ' ' A' ' 231' ' ' THR . 45.9 t -71.07 -28.65 64.51 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.658 0.383 . . . . 62.439999999999998 111.114 174.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -106.72 -18.02 14.06 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 115.433 1.642 . . . . 75.420000000000002 115.433 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 221' ' ' HIS . 23.9 m -87.34 122.41 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-N 120.251 1.387 . . . . 74.209999999999994 114.232 -169.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.55 -1.54 19.05 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.315 2.246 . . . . 74.420000000000002 113.17 170.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -79.5 15.51 1.28 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 127.986 2.514 . . . . 75.099999999999994 112.914 -144.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.07 16.84 4.26 Favored Glycine 0 C--O 1.25 1.129 0 C-N-CA 123.507 0.575 . . . . 70.430000000000007 112.133 -168.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 46.9 mt -88.78 131.51 35.03 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.978 -0.611 . . . . 75.349999999999994 109.59 158.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 77.5 mt -59.24 -41.2 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 O-C-N 124.03 0.832 . . . . 65.109999999999999 109.694 172.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.7 t -141.17 144.43 34.8 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.969 -1.014 . . . . 63.399999999999999 109.536 168.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 222' ' ' SER . 67.3 p -71.84 151.33 43.52 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.791 -0.818 . . . . 74.530000000000001 108.791 168.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.22 100.23 0.33 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.543 -0.91 . . . . 61.43 108.543 178.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -85.86 -50.73 6.89 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.21 -0.663 . . . . 53.409999999999997 109.21 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.1 OUTLIER -163.24 148.08 9.19 Favored Pre-proline 0 N--CA 1.482 1.151 0 CA-C-N 115.376 -0.829 . . . . 70.420000000000002 110.922 179.308 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 52.3 Cg_endo -67.47 155.86 68.52 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 121.738 1.625 . . . . 71.219999999999999 112.293 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.523 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -63.41 134.56 95.89 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-O 118.779 -0.629 . . . . 71.549999999999997 109.779 173.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.11 120.47 7.29 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.967 2.445 . . . . 62.130000000000003 111.689 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' A' ' 238' ' ' LYS . 46.9 mtmt . . . . . 0 N--CA 1.472 0.657 0 O-C-N 123.931 0.769 . . . . 75.420000000000002 110.477 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.245 0.867 0 CA-C-O 121.415 0.626 . . . . 72.200000000000003 111.322 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.6 mt -107.24 126.84 29.14 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 107.975 -1.12 . . . . 64.109999999999999 107.975 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.51 171.95 11.06 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.391 2.061 . . . . 64.299999999999997 111.632 173.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.23 144.35 32.99 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.847 0.459 . . . . 54.310000000000002 111.085 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.638 ' HB3' HD11 ' A' ' 23' ' ' ILE . 56.4 mt -86.1 93.89 9.12 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.073 0.949 . . . . 64.239999999999995 108.699 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -98.25 -42.15 7.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.815 -1.084 . . . . 75.420000000000002 109.285 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -96.85 111.86 23.87 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 114.583 -1.189 . . . . 72.209999999999994 108.547 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.638 HD11 ' HB3' ' A' ' 20' ' ' LEU . 44.1 mm -116.08 120.88 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.991 -1.114 . . . . 74.239999999999995 107.991 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? . . . . . 0 C--O 1.24 0.573 0 N-CA-C 108.45 -0.945 . . . . 75.310000000000002 108.45 -177.795 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo . . . . . 0 N--CA 1.489 1.22 0 CA-C-O 120.868 0.278 . . . . 75.409999999999997 112.774 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -93.05 66.7 4.17 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-O 121.792 0.806 . . . . 60.43 109.543 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.542 HD11 ' HB3' ' A' ' 106' ' ' LYS . 42.5 tp -85.78 117.63 24.77 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.797 -1.092 . . . . 73.420000000000002 109.007 175.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -109.09 176.51 5.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.694 1.598 . . . . 70.230000000000004 109.373 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.82 146.24 24.29 Favored 'Isoleucine or valine' 0 C--O 1.25 1.103 0 N-CA-C 108.722 -0.844 . . . . 64.010000000000005 108.722 170.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.03 120.64 25.06 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.282 0.633 . . . . 62.25 109.776 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.1 mt -77.05 -20.48 55.8 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.872 0.869 . . . . 74.219999999999999 111.446 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -141.78 149.11 39.98 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.831 -0.804 . . . . 71.239999999999995 108.831 -174.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.76 146.54 46.31 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.02 -0.733 . . . . 71.439999999999998 109.02 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -151.87 108.46 3.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.691 -1.226 . . . . 65.310000000000002 107.691 -176.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.7 t -79.17 138.63 19.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 107.263 -1.384 . . . . 51.43 107.263 173.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.85 125.86 25.3 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.928 0.491 . . . . 64.409999999999997 110.867 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.2 t -72.52 -17.74 61.71 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.937 0.895 . . . . 74.349999999999994 110.283 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.36 -166.72 37.39 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 115.698 -0.683 . . . . 44.329999999999998 112.129 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -64.58 -32.33 73.94 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.635 1.174 . . . . 51.229999999999997 112.059 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -69.79 -25.7 63.91 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.866 0.866 . . . . 74.349999999999994 112.05 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.1 p -103.35 160.31 14.8 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.59 0.756 . . . . 73.129999999999995 110.777 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.1 tp -109.22 130.5 55.49 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.384 0.673 . . . . 74.329999999999998 109.21 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -77.02 117.44 18.61 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 108.345 -0.984 . . . . 71.129999999999995 108.345 172.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.8 pt -119.68 138.26 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.538 0.735 . . . . 51.43 109.194 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.1 m -94.07 145.82 24.4 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.507 -0.553 . . . . 73.129999999999995 109.507 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -58.2 111.86 1.34 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.619 0.368 . . . . 74.200000000000003 110.705 171.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.71 5.93 50.47 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.122 0.391 . . . . 74.010000000000005 112.627 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -87.25 137.83 32.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.24 1.016 . . . . 75.349999999999994 109.83 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HB3' HD11 ' A' ' 84' ' ' LEU . 63.0 mttm -88.33 123.77 33.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.288 0.635 . . . . 74.219999999999999 109.825 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 21.4 mt -108.64 139.96 42.69 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.053 0.941 . . . . 74.219999999999999 110.299 -168.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -95.26 107.15 19.24 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 106.002 -1.851 . . . . 61.5 106.002 172.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 68.7 t -100.19 111.56 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 119.364 0.984 . . . . 72.430000000000007 109.571 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.11 -25.62 64.5 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.484 -1.235 . . . . 74.120000000000005 111.018 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.51 173.05 22.98 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.675 -0.693 . . . . 24.140000000000001 112.104 173.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.457 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 1.8 m-30 -95.23 148.93 21.88 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 106.668 -1.605 . . . . 74.099999999999994 106.668 172.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.459 HD21 ' HB2' ' A' ' 117' ' ' GLU . 29.5 p30 -66.44 167.5 10.56 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 110.25 -0.278 . . . . 74.400000000000006 110.25 173.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -56.5 -32.04 64.66 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.508 0.929 . . . . 70.299999999999997 113.508 -167.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -96.93 -2.59 43.42 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.562 0.345 . . . . 64.310000000000002 111.617 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.77 18.58 79.57 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 123.157 0.408 . . . . 62.32 113.397 174.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.459 ' HB2' HD21 ' A' ' 113' ' ' ASN . 6.0 mm-40 -65.72 -65.65 0.65 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.522 1.129 . . . . 72.510000000000005 110.136 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -122.97 152.53 40.79 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.227 -1.351 . . . . 70.299999999999997 108.291 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -115.87 127.38 54.98 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.326 1.051 . . . . 74.019999999999996 109.379 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -76.72 101.44 5.8 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.04 -0.726 . . . . 53.439999999999998 109.04 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -104.87 169.02 8.68 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.315 -0.857 . . . . 74.239999999999995 110.298 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -148.08 138.24 22.7 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.219 1.008 . . . . 72.239999999999995 108.953 178.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 37.5 p -144.23 -171.02 3.49 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.403 1.081 . . . . 63.210000000000001 108.901 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -64.95 -16.48 63.39 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 122.971 0.508 . . . . 73.340000000000003 111.098 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -76.39 -14.11 60.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.712 0.805 . . . . 73.439999999999998 111.722 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 129.64 -137.06 9.3 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 111.866 -0.493 . . . . 74.420000000000002 111.866 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -149.91 144.21 25.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.355 0.662 . . . . 75.349999999999994 109.755 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 166.43 179.61 39.85 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-O 121.245 0.358 . . . . 34.310000000000002 113.235 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -79.85 130.79 35.6 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.09 0.956 . . . . 74.430000000000007 110.695 -176.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.7 m -124.36 146.86 53.32 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.75 1.22 . . . . 75.329999999999998 108.22 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.98 131.64 26.0 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 121.599 1.533 . . . . 71.430000000000007 110.889 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.7 m -59.22 -21.38 59.44 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.791 0.836 . . . . 75.239999999999995 111.898 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -73.16 -18.95 61.22 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.485 1.114 . . . . 61.140000000000001 112.184 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -102.18 -3.63 27.09 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.419 0.688 . . . . 75.219999999999999 112.603 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.0 pt -122.05 155.88 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 118.478 0.581 . . . . 71.319999999999993 111.134 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.1 t -153.58 136.12 9.53 Favored Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 123.309 0.381 . . . . 61.43 110.708 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -76.44 132.7 13.78 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.805 2.337 . . . . 63.350000000000001 113.163 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.1 m -109.36 -31.34 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.891 0.876 . . . . 71.040000000000006 111.741 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 84' ' ' LEU . 63.9 t30 -97.64 0.07 46.55 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.24 0.616 . . . . 55.149999999999999 111.594 -175.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 97.7 p -80.12 -171.0 2.74 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.835 0.826 . . . . 74.540000000000006 111.318 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.14 -9.77 12.22 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.569 1.148 . . . . 64.530000000000001 113.298 171.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -59.35 -20.57 55.72 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.252 0.834 . . . . 62.520000000000003 113.252 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.96 -8.14 52.74 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.253 0.621 . . . . 65.120000000000005 111.959 175.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -88.37 135.51 33.43 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 107.886 -1.153 . . . . 75.430000000000007 107.886 170.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.5 m -64.44 -28.0 69.37 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.584 0.754 . . . . 74.340000000000003 112.322 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -73.49 -32.15 64.12 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.117 0.414 . . . . 72.519999999999996 112.117 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -91.51 128.18 37.24 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.084 0.554 . . . . 74.239999999999995 109.572 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -121.03 2.16 10.43 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 112.303 0.483 . . . . 73.109999999999999 112.303 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.06 -155.56 33.13 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 119.584 -0.565 . . . . 63.229999999999997 114.11 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.12 101.43 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.988 2.459 . . . . 71.140000000000001 111.159 173.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.554 ' HB ' ' HD2' ' A' ' 171' ' ' ARG . 15.9 t -118.79 142.81 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 110.231 -0.285 . . . . 74.200000000000003 110.231 -173.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.6 m -73.94 161.99 29.54 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.967 0.907 . . . . 64.019999999999996 110.772 172.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -63.38 -44.59 94.31 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.234 0.614 . . . . 75.549999999999997 111.361 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -58.87 -51.89 68.1 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.071 0.948 . . . . 74.329999999999998 110.192 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.06 86.73 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.946 0.898 . . . . 44.229999999999997 111.59 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.97 -53.86 53.63 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.077 -0.965 . . . . 41.520000000000003 111.588 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.55 ' HG3' HG11 ' A' ' 190' ' ' VAL . 30.4 tt0 -70.87 -24.87 62.59 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.945 -1.025 . . . . 63.039999999999999 110.52 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -66.52 -43.22 85.83 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.143 0.577 . . . . 71.439999999999998 111.098 173.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 238' ' ' LYS . 44.8 mt -72.85 -36.78 67.51 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.473 0.654 . . . . 65.129999999999995 110.789 175.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.576 HD22 ' HB3' ' A' ' 183' ' ' SER . 39.5 tp -77.76 -19.81 54.48 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.223 -0.899 . . . . 60.039999999999999 112.28 -174.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 81.0 p -64.94 -26.06 68.14 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 120.861 0.362 . . . . 72.219999999999999 110.184 174.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.4 t -82.02 -5.85 58.68 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.416 1.086 . . . . 60.520000000000003 111.076 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.77 171.81 55.16 Favored Glycine 0 C--N 1.346 1.118 0 C-N-CA 122.917 0.294 . . . . 72.230000000000004 113.436 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.6 pt -133.95 -169.58 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.598 1.159 . . . . 73.120000000000005 110.09 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 18.1 p-10 -59.75 103.26 0.19 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.442 0.697 . . . . 64.329999999999998 112.435 -172.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 102.73 12.88 31.31 Favored Glycine 0 C--O 1.261 1.816 0 CA-C-N 116.184 -0.462 . . . . 63.030000000000001 113.082 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 78.7 p -79.75 137.78 37.11 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 109.991 -0.374 . . . . 72.25 109.991 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -137.01 155.91 49.1 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.282 0.563 . . . . 74.420000000000002 112.264 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.0 mt -131.74 134.22 45.64 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.994 -1.113 . . . . 74.329999999999998 107.994 170.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.404 HG21 HG22 ' A' ' 218' ' ' VAL . 52.2 t -114.0 126.25 71.45 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 108.354 -0.98 . . . . 74.310000000000002 108.354 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.554 ' HD2' ' HB ' ' A' ' 151' ' ' VAL . 17.9 mtm180 -140.32 170.19 16.27 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.741 -1.118 . . . . 62.009999999999998 109.005 -167.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 9.0 pm0 -117.4 163.5 16.28 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 108.695 -0.854 . . . . 74.340000000000003 108.695 153.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 176' ' ' SER . 48.8 m -82.68 131.92 35.19 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.434 -0.803 . . . . 71.319999999999993 110.308 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -53.6 -40.09 65.42 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.087 1.355 . . . . 72.400000000000006 112.205 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.8 t -98.49 6.25 47.33 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.558 0.743 . . . . 62.439999999999998 111.376 -174.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 173' ' ' SER . 28.8 m -147.08 86.97 6.31 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.32 0.648 . . . . 72.230000000000004 109.489 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.457 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 34.9 Cg_endo -62.58 136.73 60.17 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 123.327 2.684 . . . . 75.340000000000003 111.331 177.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.85 -24.92 5.57 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.901 -0.59 . . . . 74.439999999999998 113.306 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -84.11 116.35 22.85 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.002 -1.11 . . . . 72.239999999999995 108.002 175.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.654 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 58.2 mtt-85 -109.17 168.56 9.29 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.308 -0.86 . . . . 61.130000000000003 110.633 -170.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.4 t -155.91 145.91 21.4 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.323 0.649 . . . . 63.32 110.063 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 65.9 mt -115.94 147.91 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.587 0.755 . . . . 72.120000000000005 109.081 173.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.576 ' HB3' HD22 ' A' ' 160' ' ' LEU . 24.5 m -125.89 114.2 18.22 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.869 1.268 . . . . 73.120000000000005 108.602 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.403 HD21 ' CD2' ' A' ' 232' ' ' LEU . 76.7 mt -105.01 139.1 40.19 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.629 1.171 . . . . 74.5 111.448 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -120.79 132.18 54.88 Favored 'General case' 0 C--O 1.257 1.475 0 N-CA-C 107.24 -1.393 . . . . 74.140000000000001 107.24 161.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 28.5 t80 -151.94 123.6 7.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.736 -1.12 . . . . 74.400000000000006 108.678 -171.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 51.29 36.13 15.42 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.435 1.494 . . . . 73.239999999999995 112.359 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 89.23 3.34 75.83 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 114.995 -1.002 . . . . 64.349999999999994 114.088 173.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -115.02 127.73 55.83 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 117.722 0.761 . . . . 75.010000000000005 111.224 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.55 HG11 ' HG3' ' A' ' 157' ' ' GLU . 46.3 t -88.26 132.79 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 124.636 1.174 . . . . 72.129999999999995 109.854 171.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -146.39 153.35 40.38 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.118 1.367 . . . . 71.200000000000003 109.174 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -131.21 149.31 52.63 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.083 0.953 . . . . 75.400000000000006 109.335 -170.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -146.3 154.58 41.86 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.285 0.564 . . . . 70.219999999999999 111.713 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.505 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 20.8 tpp180 -85.75 135.26 33.82 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.761 1.224 . . . . 74.030000000000001 111.001 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.461 ' HA ' HG22 ' A' ' 205' ' ' VAL . 90.9 mt -85.69 110.27 19.45 Favored 'Isoleucine or valine' 0 C--O 1.245 0.858 0 N-CA-C 107.888 -1.153 . . . . 75.219999999999999 107.888 163.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -75.72 119.03 19.17 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.515 -0.766 . . . . 72.209999999999994 109.5 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 25.9 m -99.43 114.3 27.15 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.165 0.586 . . . . 74.450000000000003 109.892 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.02 163.18 12.72 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.198 0.999 . . . . 75.0 111.405 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 82.1 p -62.0 -24.72 67.21 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.384 0.674 . . . . 74.340000000000003 111.514 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.0 -5.79 50.1 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.145 0.978 . . . . 63.210000000000001 111.778 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 88.34 -3.97 85.35 Favored Glycine 0 C--N 1.352 1.465 0 C-N-CA 123.057 0.36 . . . . 21.300000000000001 112.56 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -74.42 142.46 44.97 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.578 0.751 . . . . 75.239999999999995 109.657 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 80.4 mt -98.05 153.57 18.31 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.672 0.789 . . . . 73.25 109.762 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -167.56 163.73 14.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.737 0.815 . . . . 64.310000000000002 109.648 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 195' ' ' ILE . 71.5 t -131.92 -56.98 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 107.699 -1.223 . . . . 74.299999999999997 107.699 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 40.0 t -83.65 155.18 23.31 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.541 -0.754 . . . . 70.299999999999997 109.478 171.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.3 m -68.66 -33.63 74.32 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.309 0.643 . . . . 74.099999999999994 110.327 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -75.06 -19.11 60.15 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.302 -0.863 . . . . 72.310000000000002 111.408 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 48.0 m -104.58 127.36 52.29 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.245 1.018 . . . . 65.010000000000005 110.17 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -138.59 133.94 33.16 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.569 1.147 . . . . 63.549999999999997 108.721 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.505 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 11.2 m-85 -133.76 135.84 44.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.255 0.622 . . . . 74.019999999999996 110.639 -172.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -83.15 -30.35 27.93 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.622 0.769 . . . . 63.329999999999998 110.261 169.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 40.1 p -128.84 150.36 50.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.579 0.752 . . . . 52.32 111.502 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 38.2 tp -70.17 -31.31 68.73 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.57 -1.195 . . . . 72.349999999999994 110.824 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.87 -41.73 87.79 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.404 0.682 . . . . 62.25 110.435 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -80.85 -24.63 38.26 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.842 -0.617 . . . . 53.219999999999999 111.536 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.65 -49.06 79.04 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.728 -0.471 . . . . 70.230000000000004 109.728 168.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.404 HG22 HG21 ' A' ' 170' ' ' VAL . 76.3 t -67.29 -40.13 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.125 0.97 . . . . 64.219999999999999 110.588 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -63.94 -52.93 57.48 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.984 0.914 . . . . 71.310000000000002 111.312 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.453 ' CE1' HG11 ' A' ' 224' ' ' VAL . 26.9 t-80 -60.18 -47.79 84.47 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 115.054 -0.975 . . . . 63.229999999999997 109.086 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.464 ' HB3' ' HG ' ' A' ' 232' ' ' LEU . 7.9 m-70 -62.19 -29.6 70.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.337 0.655 . . . . 74.439999999999998 111.932 175.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 33.7 t -69.9 -26.15 64.03 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.157 0.583 . . . . 45.009999999999998 111.316 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.3 t -112.93 -11.3 13.43 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 115.902 1.815 . . . . 71.319999999999993 115.902 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 221' ' ' HIS . 24.1 m -92.47 139.4 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 120.982 1.719 . . . . 70.420000000000002 114.143 -171.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.38 -1.0 57.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.021 2.528 . . . . 65.409999999999997 112.295 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -79.22 15.87 1.1 Allowed 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 127.621 2.368 . . . . 74.219999999999999 112.009 -145.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 117.58 19.62 4.91 Favored Glycine 0 C--O 1.245 0.825 0 C-N-CA 125.028 1.299 . . . . 71.239999999999995 112.403 -172.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 52.0 mt -90.87 121.67 32.92 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.145 -1.028 . . . . 62.329999999999998 109.124 158.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 59.4 mt -53.0 -43.09 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 124.357 1.035 . . . . 71.129999999999995 110.307 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.1 t -133.14 142.77 48.84 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.428 -0.805 . . . . 73.219999999999999 109.172 171.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 41.6 p -70.14 145.39 51.59 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.684 -0.858 . . . . 61.100000000000001 108.684 166.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' A' ' 221' ' ' HIS . 21.2 mt -61.76 102.67 0.28 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.049 -0.723 . . . . 41.549999999999997 109.049 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 -87.1 -54.34 4.38 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.29 -0.633 . . . . 72.519999999999996 109.29 -171.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -157.58 150.12 17.97 Favored Pre-proline 0 N--CA 1.487 1.385 0 C-N-CA 123.503 0.721 . . . . 61.310000000000002 111.443 -177.368 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.99 145.55 45.2 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 121.903 1.735 . . . . 73.109999999999999 112.402 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.19 131.79 82.91 Favored Pre-proline 0 C--O 1.243 0.751 0 N-CA-C 109.199 -0.667 . . . . 72.540000000000006 109.199 173.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.1 147.45 54.37 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 121.874 1.716 . . . . 72.340000000000003 111.63 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.47 ' HA ' HD22 ' A' ' 159' ' ' LEU . 38.6 ttpt . . . . . 0 CA--C 1.553 1.075 0 CA-C-N 115.296 -0.865 . . . . 75.319999999999993 109.344 171.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 121.547 0.689 . . . . 72.519999999999996 112.612 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.4 mt -103.05 125.83 34.13 Favored Pre-proline 0 C--O 1.239 0.511 0 N-CA-C 108.041 -1.096 . . . . 73.319999999999993 108.041 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.525 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 39.2 Cg_endo -69.57 171.58 14.01 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.367 2.045 . . . . 64.430000000000007 113.602 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.29 140.07 31.11 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.178 0.591 . . . . 34.229999999999997 111.39 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.491 HD22 HD11 ' A' ' 23' ' ' ILE . 78.4 mt -88.65 91.99 9.02 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.078 -1.082 . . . . 74.209999999999994 108.078 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -98.99 -43.5 6.67 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.383 -0.826 . . . . 71.319999999999993 109.81 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -103.34 108.61 19.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.474 -0.785 . . . . 55.020000000000003 109.714 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.491 HD11 HD22 ' A' ' 20' ' ' LEU . 41.7 mm -118.05 121.32 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 107.566 -1.272 . . . . 73.420000000000002 107.566 172.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt . . . . . 0 N--CA 1.471 0.588 0 C-N-CA 123.592 0.757 . . . . 75.319999999999993 110.988 -176.893 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo . . . . . 0 CA--C 1.547 1.135 0 N-CA-C 111.322 -0.299 . . . . 64.019999999999996 111.322 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 140' ' ' SER . 82.3 m-20 -87.76 66.67 8.91 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.686 0.755 . . . . 75.510000000000005 109.461 176.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.1 tp -92.32 125.84 37.15 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 108.168 -1.049 . . . . 74.439999999999998 108.168 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 4.5 m-85 -104.0 175.46 5.48 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.583 1.153 . . . . 74.530000000000001 109.556 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 p -145.04 141.34 22.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 108.779 -0.823 . . . . 61.219999999999999 108.779 171.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -77.93 108.7 11.38 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.082 -0.711 . . . . 64.329999999999998 109.082 173.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.54 -26.51 66.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.901 0.881 . . . . 71.420000000000002 111.212 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -126.98 155.89 42.44 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.961 0.904 . . . . 74.25 109.127 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -69.81 145.46 52.12 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.37 -0.832 . . . . 73.230000000000004 109.485 169.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -153.3 108.47 3.21 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.497 -0.927 . . . . 63.240000000000002 108.497 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 52.8 t -81.56 131.95 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.952 -1.129 . . . . 70.310000000000002 107.952 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.84 136.62 57.95 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.454 0.472 . . . . 72.109999999999999 110.896 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.5 t -62.31 -25.06 67.66 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.696 0.798 . . . . 52.409999999999997 109.824 172.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.51 -133.42 3.75 Favored Glycine 0 C--N 1.353 1.513 0 CA-C-N 115.557 -0.747 . . . . 34.229999999999997 112.305 172.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.06 -25.86 66.46 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.785 1.234 . . . . 65.230000000000004 111.926 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -79.87 -11.28 59.82 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.381 1.072 . . . . 75.329999999999998 112.511 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.8 p -137.74 169.7 17.34 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.574 0.75 . . . . 31.210000000000001 111.441 -171.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.9 tp -115.65 134.72 54.76 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.933 0.893 . . . . 74.019999999999996 109.781 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.0 t -85.59 117.33 24.42 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.829 -0.804 . . . . 62.119999999999997 108.829 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.4 pt -119.51 131.94 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.648 0.779 . . . . 71.319999999999993 109.52 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.438 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 50.3 m -90.34 146.42 24.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.375 0.67 . . . . 72.209999999999994 110.111 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -52.94 112.95 0.94 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 122.84 0.456 . . . . 64.230000000000004 110.408 164.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 106.27 -13.12 44.17 Favored Glycine 0 N--CA 1.472 1.082 0 CA-C-N 116.701 -0.227 . . . . 32.409999999999997 112.901 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -76.67 126.96 31.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.183 0.993 . . . . 72.409999999999997 109.462 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -90.2 133.03 35.16 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.157 0.583 . . . . 71.140000000000001 110.733 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.8 mt -116.71 150.0 38.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.911 0.884 . . . . 73.049999999999997 110.731 -161.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -102.58 109.02 20.5 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.642 -0.873 . . . . 54.32 108.642 169.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.6 t -87.66 106.25 16.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 108.571 -0.9 . . . . 55.219999999999999 108.571 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 76.2 mt -72.4 -31.49 65.58 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 115.375 -0.83 . . . . 55.310000000000002 109.441 176.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.31 -174.61 42.96 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.093 -0.958 . . . . 73.420000000000002 111.259 172.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.3 m-30 -113.31 174.08 6.09 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.539 0.736 . . . . 74.209999999999994 109.427 167.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -64.95 145.99 55.57 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.066 -1.087 . . . . 72.200000000000003 108.066 166.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -65.22 -29.91 70.76 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.355 0.662 . . . . 71.430000000000007 111.62 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -85.95 -5.98 59.14 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.633 0.773 . . . . 73.310000000000002 111.253 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.17 33.07 41.51 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.805 -0.634 . . . . 43.43 113.274 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . 29.8 mt-10 -89.34 -73.09 0.52 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.129 0.572 . . . . 64.439999999999998 110.117 -177.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -100.53 -178.87 3.93 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.69 0.796 . . . . 75.310000000000002 109.64 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.28 117.91 22.33 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.165 0.986 . . . . 73.540000000000006 108.854 -177.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.62 92.72 1.17 Allowed 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.555 -1.276 . . . . 72.450000000000003 107.555 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -112.24 164.08 13.62 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.873 0.844 . . . . 74.209999999999994 111.111 -171.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -151.67 138.74 19.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.522 -1.217 . . . . 74.25 108.254 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 43.4 p -132.21 175.93 8.83 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.633 0.773 . . . . 64.340000000000003 109.638 171.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -70.53 -6.66 37.96 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 121.212 0.53 . . . . 74.230000000000004 110.168 174.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -89.33 -18.93 25.95 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.823 1.249 . . . . 73.230000000000004 111.217 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 154.91 -148.14 18.14 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 118.041 0.382 . . . . 75.420000000000002 113.034 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -151.15 157.25 42.47 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.44 0.62 . . . . 74.129999999999995 110.295 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 153.25 -171.17 32.18 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 122.966 0.317 . . . . 52.0 112.494 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -91.34 133.7 35.22 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.065 0.546 . . . . 51.210000000000001 110.53 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.31 156.19 72.9 Favored Pre-proline 0 N--CA 1.479 1.025 0 C-N-CA 124.484 1.114 . . . . 73.319999999999993 109.43 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.36 123.91 11.07 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.063 1.842 . . . . 42.439999999999998 110.92 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.4 m -59.41 -22.09 60.92 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.679 0.792 . . . . 75.310000000000002 111.47 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -73.33 -23.26 60.22 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.571 1.148 . . . . 72.219999999999999 111.719 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -94.58 -4.17 48.36 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.671 0.788 . . . . 71.219999999999999 112.393 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.4 pt -123.08 151.74 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 118.363 0.529 . . . . 73.420000000000002 110.397 -172.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.0 t -145.16 135.45 11.93 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.019 0.528 . . . . 53.219999999999999 109.639 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.567 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 59.3 Cg_endo -74.18 115.17 4.23 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.334 2.023 . . . . 72.530000000000001 111.938 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.1 m -87.64 -54.62 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.023 0.529 . . . . 74.420000000000002 111.028 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -80.97 -18.29 47.47 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.329 0.651 . . . . 73.519999999999996 111.308 -171.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 32.8 t -71.34 -179.87 2.63 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.609 0.763 . . . . 73.209999999999994 111.228 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.51 -14.6 43.63 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.406 1.082 . . . . 63.020000000000003 113.266 -174.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.86 -25.55 67.6 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.979 0.512 . . . . 71.420000000000002 111.63 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.14 -26.53 62.79 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.286 1.034 . . . . 73.430000000000007 111.337 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -78.86 169.6 17.97 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.918 0.887 . . . . 71.140000000000001 111.764 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.5 p -84.58 -26.18 28.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.364 0.666 . . . . 43.43 112.097 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' TRP . . . . . 0.453 ' CE3' HG21 ' A' ' 218' ' ' VAL . 55.3 p-90 -83.89 -42.36 16.43 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.066 -0.515 . . . . 72.099999999999994 111.485 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -95.42 126.36 40.67 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.847 -0.797 . . . . 75.329999999999998 108.847 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -110.57 5.3 21.03 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.8 -0.637 . . . . 72.239999999999995 111.259 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.82 -155.09 36.58 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.475 -0.625 . . . . 74.040000000000006 113.418 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.75 106.07 1.77 Allowed 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 123.196 2.597 . . . . 53.310000000000002 110.408 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.3 t -128.39 150.54 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 123.631 0.773 . . . . 60.32 109.154 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.2 t -86.3 167.27 14.95 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.849 0.86 . . . . 52.439999999999998 110.066 173.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -63.71 -33.33 75.41 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.33 0.652 . . . . 73.420000000000002 111.903 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -67.52 -55.21 14.42 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.291 0.636 . . . . 44.140000000000001 110.284 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.42 -37.37 80.66 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.965 0.79 . . . . 74.519999999999996 111.226 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.54 -57.54 12.24 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.66 -0.7 . . . . 54.32 110.849 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.51 -21.12 63.69 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.359 -0.837 . . . . 70.239999999999995 111.118 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -68.22 -53.25 26.08 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.687 0.795 . . . . 75.420000000000002 110.591 174.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.439 ' HB2' HD11 ' A' ' 169' ' ' LEU . 74.6 mt -68.06 -37.33 81.18 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.946 -0.57 . . . . 75.349999999999994 110.957 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.8 tp -73.51 -22.48 60.11 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.381 -0.827 . . . . 71.329999999999998 111.349 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.9 t -59.76 -26.84 66.03 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.48 0.712 . . . . 61.030000000000001 111.787 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.8 m -79.16 9.66 4.3 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.363 1.065 . . . . 62.539999999999999 112.246 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.04 159.24 14.46 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 122.98 0.324 . . . . 73.329999999999998 113.53 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.1 pt -115.57 -164.47 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.347 1.059 . . . . 65.329999999999998 109.859 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.699 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 17.4 p-10 -52.65 99.62 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.516 1.126 . . . . 52.530000000000001 113.142 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 107.85 13.71 19.31 Favored Glycine 0 C--N 1.355 1.632 0 CA-C-N 116.174 -0.466 . . . . 44.399999999999999 113.538 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 185' ' ' ARG . 37.9 p -79.0 137.45 37.59 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.998 -0.707 . . . . 74.400000000000006 109.98 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.492 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 27.1 p90 -134.08 160.7 36.97 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 112.452 0.538 . . . . 74.209999999999994 112.452 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 159' ' ' LEU . 82.4 mt -134.65 134.15 40.85 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.337 1.055 . . . . 32.539999999999999 108.292 166.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.401 HG21 HG22 ' A' ' 218' ' ' VAL . 32.3 t -106.14 128.45 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.113 -1.44 . . . . 64.319999999999993 107.113 171.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -158.43 161.11 37.45 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.908 0.483 . . . . 73.030000000000001 110.07 -174.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.701 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 12.5 pt-20 -109.21 161.62 15.06 Favored 'General case' 0 C--O 1.244 0.812 0 O-C-N 123.409 0.443 . . . . 62.130000000000003 109.806 169.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 176' ' ' SER . 16.2 m -83.41 135.53 34.66 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.627 -0.715 . . . . 70.319999999999993 109.395 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -71.19 -41.86 69.74 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.388 0.675 . . . . 50.420000000000002 110.213 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 25.0 m -78.57 -17.16 56.55 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.115 -0.948 . . . . 72.329999999999998 111.431 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 28.3 t -130.49 80.9 69.33 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.423 -0.954 . . . . 72.030000000000001 108.423 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.24 141.44 93.19 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.621 2.881 . . . . 53.140000000000001 112.837 -173.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 77.66 -23.07 2.55 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 116.208 -0.451 . . . . 31.41 114.071 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -84.25 116.38 22.94 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 108.177 -1.045 . . . . 72.129999999999995 108.177 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.701 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 44.5 mtt180 -110.88 169.78 8.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.168 -0.923 . . . . 75.329999999999998 111.209 -168.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.401 ' HB2' ' HD3' ' A' ' 194' ' ' ARG . 47.8 t -154.59 144.38 21.63 Favored 'General case' 0 C--O 1.253 1.244 0 C-N-CA 124.982 1.313 . . . . 74.409999999999997 108.722 -176.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.475 HD11 HD21 ' A' ' 217' ' ' LEU . 58.6 mt -109.33 135.38 48.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 107.221 -1.4 . . . . 74.450000000000003 107.221 166.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 19.3 m -112.26 114.06 26.63 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.229 -1.026 . . . . 75.420000000000002 108.229 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.3 mt -105.14 144.31 32.11 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.107 0.963 . . . . 63.200000000000003 111.035 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.455 ' HB3' ' OG ' ' A' ' 167' ' ' SER . 27.1 ttt85 -132.74 133.27 43.26 Favored 'General case' 0 C--O 1.259 1.579 0 CA-C-N 114.357 -1.292 . . . . 74.010000000000005 108.895 175.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 28.2 p90 -148.1 138.83 23.06 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 124.616 1.198 . . . . 71.209999999999994 108.804 171.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 58.58 19.1 6.34 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.934 1.293 . . . . 75.310000000000002 113.534 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.62 21.1 69.95 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 116.626 -0.261 . . . . 71.420000000000002 112.814 -175.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -118.16 126.9 53.14 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.511 1.125 . . . . 64.439999999999998 108.553 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 51.4 t -119.04 141.88 36.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 124.13 0.972 . . . . 71.530000000000001 110.722 -168.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.485 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 18.2 p90 -145.19 151.13 37.94 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.507 1.123 . . . . 74.140000000000001 109.403 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -126.36 115.39 19.58 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 107.918 -1.141 . . . . 71.409999999999997 107.918 -173.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -117.46 132.63 56.52 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.637 -0.505 . . . . 64.409999999999997 109.637 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.401 ' HD3' ' HB2' ' A' ' 181' ' ' SER . 10.8 mmt85 -72.68 131.5 42.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.777 0.831 . . . . 73.310000000000002 112.07 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 82.0 mt -71.45 110.63 4.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 108.107 -1.071 . . . . 74.239999999999995 108.107 163.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -69.33 120.92 15.88 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.274 -0.875 . . . . 43.32 108.641 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.4 m -103.47 110.64 22.75 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 122.969 0.508 . . . . 63.329999999999998 109.804 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.402 ' HB2' ' HE1' ' A' ' 204' ' ' TYR . . . -61.38 156.53 18.82 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.959 0.904 . . . . 62.5 111.606 172.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.1 m -71.22 -12.47 61.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.707 0.803 . . . . 71.120000000000005 112.196 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -86.55 12.38 10.59 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.468 0.707 . . . . 72.019999999999996 111.16 171.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 75.05 4.91 74.1 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 123.179 0.419 . . . . 72.409999999999997 113.266 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -81.64 140.06 34.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.605 0.762 . . . . 73.409999999999997 109.991 -175.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.519 HD13 HD13 ' A' ' 214' ' ' LEU . 85.8 mt -103.13 147.29 27.19 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.515 0.726 . . . . 65.0 109.481 -175.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.402 ' HE1' ' HB2' ' A' ' 198' ' ' ALA . 28.7 p90 -167.49 177.39 5.99 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.118 0.967 . . . . 73.400000000000006 110.819 173.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 74.9 t -131.3 -54.89 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 107.452 -1.314 . . . . 75.049999999999997 107.452 174.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 12.1 t -86.08 153.55 22.03 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.916 -1.038 . . . . 62.149999999999999 108.961 172.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.1 t -68.88 -25.58 64.68 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.728 0.411 . . . . 71.109999999999999 110.424 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.75 -34.13 62.45 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.568 -0.742 . . . . 73.540000000000006 110.492 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.455 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 74.8 m -64.32 126.32 27.4 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.528 0.731 . . . . 62.350000000000001 109.28 172.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -144.65 112.56 6.32 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.202 1.001 . . . . 74.150000000000006 108.645 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 209' ' ' SER . 17.4 m-85 -129.66 142.76 50.67 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 118.683 0.674 . . . . 74.519999999999996 111.315 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -90.58 -22.51 21.22 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.382 0.673 . . . . 74.409999999999997 109.66 172.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.0 p -129.87 147.02 51.59 Favored 'General case' 0 C--O 1.253 1.272 0 CA-C-O 122.182 0.992 . . . . 71.109999999999999 111.459 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.519 HD13 HD13 ' A' ' 203' ' ' LEU . 27.1 tp -67.23 -29.02 68.56 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 114.047 -1.433 . . . . 54.420000000000002 110.841 177.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.46 90.51 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.487 0.715 . . . . 72.540000000000006 111.029 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -66.53 -37.98 86.19 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.545 -0.752 . . . . 64.230000000000004 110.762 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.475 HD21 HD11 ' A' ' 182' ' ' ILE . 9.2 tt -55.64 -47.53 76.5 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.885 0.74 . . . . 74.109999999999999 111.486 174.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.453 HG21 ' CE3' ' A' ' 146' ' ' TRP . 70.4 t -70.53 -44.04 77.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 123.262 0.625 . . . . 53.439999999999998 111.263 -175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -59.72 -49.63 76.98 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.632 0.73 . . . . 71.099999999999994 110.577 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -56.6 -56.47 20.88 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.961 -1.018 . . . . 72.439999999999998 109.684 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' HIS . . . . . 0.446 ' HA ' HG22 ' A' ' 224' ' ' VAL . 36.0 m80 -67.32 -16.74 64.43 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.168 0.433 . . . . 73.340000000000003 112.168 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' SER . . . . . 0.434 ' HA ' ' HB2' ' A' ' 232' ' ' LEU . 35.9 t -73.59 -31.57 63.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.555 0.342 . . . . 73.430000000000007 111.047 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.6 t -112.04 -6.62 14.17 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.27 1.952 . . . . 64.430000000000007 116.27 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.446 HG22 ' HA ' ' A' ' 221' ' ' HIS . 33.8 m -104.21 158.4 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 116.199 1.925 . . . . 64.450000000000003 116.199 -171.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -90.89 -0.99 57.88 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 129.25 3.02 . . . . 54.0 113.543 -175.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -77.9 14.98 0.95 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 128.734 2.814 . . . . 71.409999999999997 113.766 -141.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.77 18.78 3.87 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 124.571 1.081 . . . . 42.32 111.817 -168.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.91 135.37 33.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.957 0.903 . . . . 73.239999999999995 110.555 167.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.485 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 85.8 mt -72.96 -34.86 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 109.321 -0.622 . . . . 72.420000000000002 109.321 171.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.8 t -143.25 142.24 31.31 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.59 -0.893 . . . . 73.219999999999999 108.59 168.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 224' ' ' VAL . 67.8 p -67.92 147.48 52.43 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.802 -0.814 . . . . 73.209999999999994 108.802 171.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.492 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 28.6 mt -62.68 99.91 0.17 Allowed 'General case' 0 CA--C 1.555 1.147 0 N-CA-C 108.89 -0.781 . . . . 64.129999999999995 108.89 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -81.8 -50.93 8.66 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.702 0.401 . . . . 72.209999999999994 110.277 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -156.76 148.37 17.1 Favored Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 120.689 -0.405 . . . . 74.010000000000005 110.191 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.05 138.78 20.96 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 121.843 1.696 . . . . 64.310000000000002 111.97 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ALA . . . . . 0.426 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -67.67 140.63 94.53 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 108.793 -0.817 . . . . 72.5 108.793 171.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.77 156.4 64.23 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.833 2.356 . . . . 64.439999999999998 114.67 -164.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp . . . . . 0 N--CA 1.477 0.905 0 CA-C-N 114.567 -1.197 . . . . 72.099999999999994 109.898 170.618 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.7 p . . . . . 0 CA--C 1.545 0.756 0 CA-C-O 121.312 0.577 . . . . 65.430000000000007 111.116 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 94.6 mt -104.98 131.65 21.59 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.884 -0.598 . . . . 64.140000000000001 109.432 -176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 17' ' ' LEU . 8.2 Cg_exo -69.13 171.83 13.08 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.102 2.535 . . . . 52.039999999999999 112.267 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HB3' ' NE2' ' A' ' 21' ' ' HIS . . . -85.56 149.15 25.56 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.867 0.467 . . . . 74.099999999999994 110.401 170.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.576 HD22 HD11 ' A' ' 23' ' ' ILE . 84.8 mt -86.05 94.2 9.18 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.938 -1.134 . . . . 53.409999999999997 107.938 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.406 ' NE2' ' HB3' ' A' ' 19' ' ' ALA . 29.3 m170 -97.31 -52.9 3.65 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.632 0.373 . . . . 64.019999999999996 110.948 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -105.16 102.87 12.33 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.925 -1.139 . . . . 74.040000000000006 107.925 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.576 HD11 HD22 ' A' ' 20' ' ' LEU . 48.0 mm -126.1 111.57 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.923 -0.769 . . . . 60.25 108.923 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.934 0 O-C-N 124.352 1.033 . . . . 54.439999999999998 108.714 173.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo . . . . . 0 N--CA 1.498 1.739 0 N-CA-C 114.32 0.854 . . . . 63.530000000000001 114.32 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 179.69 22.2 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.287 1.835 . . . . 74.319999999999993 109.24 176.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.5 tp -85.3 132.84 34.19 Favored 'General case' 0 C--N 1.359 1.007 0 CA-C-O 121.017 0.437 . . . . 75.129999999999995 109.894 -178.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 14.3 m-85 -106.65 173.9 6.12 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.191 1.396 . . . . 64.120000000000005 110.086 177.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.49 145.96 25.06 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 107.925 -1.139 . . . . 71.400000000000006 107.925 171.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -74.95 117.93 17.34 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 123.039 0.212 . . . . 70.439999999999998 110.606 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.3 mt -65.41 -33.69 76.53 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.222 1.009 . . . . 55.0 111.556 171.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -140.35 159.0 43.16 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.172 0.589 . . . . 74.439999999999998 109.418 -175.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -74.7 152.19 39.15 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.107 -0.701 . . . . 75.230000000000004 109.107 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -156.04 115.93 3.63 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.602 0.761 . . . . 72.439999999999998 109.1 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.72 133.21 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.339 -0.985 . . . . 71.109999999999999 108.339 170.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.69 134.63 52.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.811 0.444 . . . . 73.150000000000006 110.91 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.9 m -67.59 -20.94 65.43 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.943 0.897 . . . . 73.219999999999999 111.391 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.35 -165.65 38.27 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.69 -0.686 . . . . 34.340000000000003 112.008 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -52.3 -38.77 59.34 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.7 1.2 . . . . 51.340000000000003 112.852 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.457 HD21 HD13 ' A' ' 20' ' ' LEU . 31.3 p-10 -72.19 -24.71 61.46 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.178 0.991 . . . . 74.049999999999997 112.69 -175.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 p -104.23 157.75 16.92 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.301 0.641 . . . . 53.509999999999998 110.022 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.468 ' HB3' HG13 ' A' ' 130' ' ' VAL . 64.2 tp -110.55 132.74 53.93 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.797 -0.638 . . . . 71.430000000000007 109.808 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.2 t -80.16 136.54 36.53 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.36 -0.608 . . . . 74.140000000000001 109.36 173.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 28.6 pt -137.89 144.55 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.484 0.713 . . . . 62.219999999999999 109.652 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 9.3 m -105.65 143.91 33.13 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.231 -0.655 . . . . 74.400000000000006 109.231 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -56.38 111.91 1.11 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 118.536 0.607 . . . . 62.450000000000003 111.046 174.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.13 1.8 35.91 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 116.707 -0.224 . . . . 41.409999999999997 113.254 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.552 ' HG3' ' HE2' ' A' ' 124' ' ' LYS . 36.5 tt0 -85.66 137.64 32.7 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.029 0.931 . . . . 64.340000000000003 110.511 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -76.4 119.14 19.85 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.603 0.761 . . . . 75.420000000000002 110.338 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.658 ' HA ' HG22 ' A' ' 123' ' ' THR . 11.4 mt -112.43 123.68 50.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.405 -0.961 . . . . 72.329999999999998 108.405 -173.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -95.6 106.76 18.89 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 107.769 -1.197 . . . . 73.040000000000006 107.769 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 67.1 t -99.66 114.55 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 109.229 -0.656 . . . . 61.130000000000003 109.229 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.38 -34.77 68.18 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.62 0.768 . . . . 71.540000000000006 109.934 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.35 167.09 35.69 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 114.783 -1.098 . . . . 54.210000000000001 111.422 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 3.0 m-30 -97.5 175.0 6.38 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.781 0.8 . . . . 74.239999999999995 110.063 177.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -75.13 147.1 40.8 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 114.411 -1.268 . . . . 73.319999999999993 108.304 169.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -60.08 -37.17 79.12 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.7 0.8 . . . . 75.319999999999993 112.328 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -92.92 7.52 43.6 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 121.07 0.462 . . . . 72.239999999999995 110.94 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 174' ' ' GLU . . . 70.91 27.96 71.4 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 116.079 -0.51 . . . . 72.019999999999996 113.898 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -68.41 -70.72 0.25 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 122.126 0.965 . . . . 74.329999999999998 110.245 178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -131.04 -178.58 4.88 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.57 1.148 . . . . 73.010000000000005 108.859 -172.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -138.48 122.22 17.56 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.973 0.509 . . . . 64.439999999999998 109.99 -175.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -72.23 96.84 1.87 Allowed 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.648 0.737 . . . . 70.120000000000005 109.816 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -109.68 165.69 11.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.709 -1.132 . . . . 65.5 111.097 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -140.75 118.65 11.8 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.608 -1.256 . . . . 74.120000000000005 107.608 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.658 HG22 ' HA ' ' A' ' 107' ' ' LEU . 71.7 p -132.05 -172.28 2.84 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.58 0.705 . . . . 73.530000000000001 111.123 -176.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.552 ' HE2' ' HG3' ' A' ' 105' ' ' GLU . 40.0 mtmt -57.44 -30.52 65.07 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 114.242 -1.344 . . . . 74.409999999999997 110.862 170.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -85.51 3.25 41.28 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.07 0.948 . . . . 75.430000000000007 111.759 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 118.97 -127.38 7.2 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 122.21 -0.306 . . . . 73.129999999999995 112.835 173.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -151.97 140.99 21.18 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.57 0.748 . . . . 54.130000000000003 110.384 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 167.72 -171.77 42.33 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.143 0.277 . . . . 51.100000000000001 112.446 176.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -88.57 125.24 34.7 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.113 0.565 . . . . 74.299999999999997 111.216 -175.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 99' ' ' LEU . 30.8 m -120.62 152.26 55.36 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.724 1.21 . . . . 52.310000000000002 110.098 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.64 129.14 13.28 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 121.654 1.569 . . . . 75.310000000000002 111.347 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 43.8 t -57.74 -27.14 62.74 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.648 0.779 . . . . 53.5 111.799 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -67.87 -21.25 65.17 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.312 1.045 . . . . 72.120000000000005 112.191 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -107.06 8.52 30.34 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.613 0.765 . . . . 75.420000000000002 111.681 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.5 pt -128.26 155.2 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-N 118.545 0.611 . . . . 75.219999999999999 109.958 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.3 t -150.36 134.97 9.53 Favored Pre-proline 0 N--CA 1.495 1.779 0 C-N-CA 122.849 0.459 . . . . 73.25 110.175 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.587 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 74.4 Cg_endo -76.21 117.46 4.64 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.879 2.386 . . . . 64.510000000000005 114.282 -176.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.7 m -90.29 -49.7 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 122.841 0.457 . . . . 51.43 111.618 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -94.36 6.36 48.94 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.114 0.483 . . . . 75.319999999999993 111.405 -173.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.587 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 25.0 t -83.59 -178.69 7.11 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.126 0.489 . . . . 65.340000000000003 109.807 173.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 62.4 mt -63.16 -13.79 41.13 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.235 1.014 . . . . 44.219999999999999 112.644 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.555 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 36.5 tt0 -58.75 -24.59 61.88 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.856 0.862 . . . . 72.310000000000002 112.519 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.2 -25.3 66.95 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 123.469 0.708 . . . . 71.109999999999999 110.837 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -79.57 148.33 31.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.718 0.807 . . . . 74.219999999999999 110.705 170.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.6 p -65.72 -22.65 66.63 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.924 0.713 . . . . 74.099999999999994 112.924 -175.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 59.5 p-90 -81.6 -46.48 14.35 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.965 0.506 . . . . 65.340000000000003 112.32 -178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 30.5 t80 -88.37 137.37 32.39 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.441 -0.578 . . . . 72.040000000000006 109.441 -177.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' HIS . . . . . 0.555 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 25.0 m-70 -130.45 26.82 5.07 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 111.97 0.359 . . . . 72.099999999999994 111.97 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.93 -154.63 46.39 Favored Glycine 0 CA--C 1.54 1.644 0 N-CA-C 114.766 0.667 . . . . 71.530000000000001 114.766 171.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.469 ' HG3' ' OH ' ' A' ' 112' ' ' TYR . 72.2 Cg_endo -75.03 108.62 2.76 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 123.478 2.785 . . . . 64.230000000000004 111.901 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.481 HG13 ' HD3' ' A' ' 171' ' ' ARG . 1.6 p -155.23 138.5 7.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 115.493 -0.776 . . . . 43.130000000000003 109.659 -177.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.3 p -80.83 170.74 15.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.999 0.74 . . . . 51.43 112.999 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -63.41 -27.62 69.42 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 114.94 -1.027 . . . . 65.400000000000006 112.694 -169.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -68.54 -57.33 5.94 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.552 0.741 . . . . 74.540000000000006 110.072 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.12 -36.62 84.85 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.338 0.655 . . . . 64.239999999999995 110.695 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.432 ' HA ' ' NH1' ' A' ' 171' ' ' ARG . . . -53.26 -52.25 59.61 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.824 -1.08 . . . . 73.239999999999995 112.03 171.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.547 ' HG3' HG11 ' A' ' 190' ' ' VAL . 29.7 tt0 -76.9 -19.65 57.17 Favored 'General case' 0 C--O 1.212 -0.871 0 CA-C-N 114.856 -1.065 . . . . 74.140000000000001 110.71 -175.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -67.53 -51.16 54.19 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.873 0.469 . . . . 55.310000000000002 109.974 172.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.593 HD12 HH22 ' A' ' 171' ' ' ARG . 82.7 mt -64.93 -42.16 94.91 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.864 -0.607 . . . . 70.450000000000003 110.965 178.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.653 HD23 HG13 ' A' ' 190' ' ' VAL . 32.4 tp -71.77 -28.8 63.88 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.214 -0.903 . . . . 62.229999999999997 112.024 -177.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.5 t -57.03 -40.13 76.14 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.641 0.776 . . . . 61.109999999999999 110.327 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.45 ' HB2' ' HG2' ' A' ' 237' ' ' PRO . 10.5 m -81.93 -0.21 42.83 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 114.636 -1.166 . . . . 64.310000000000002 111.585 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -93.23 154.53 21.89 Favored Glycine 0 C--N 1.349 1.271 0 C-N-CA 123.068 0.366 . . . . 74.420000000000002 113.055 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 20.5 pt -103.76 -167.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 123.798 0.839 . . . . 72.040000000000006 112.13 -173.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.664 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 16.3 p-10 -59.52 103.94 0.23 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.008 0.923 . . . . 72.010000000000005 113.486 -171.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 103.82 13.25 28.08 Favored Glycine 0 C--O 1.26 1.768 0 CA-C-N 116.288 -0.414 . . . . 73.120000000000005 112.847 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 22.6 t -71.72 136.73 47.31 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-O 119.227 -0.416 . . . . 74.230000000000004 110.132 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 183' ' ' SER . 21.6 p90 -135.22 156.35 49.13 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.932 0.716 . . . . 71.120000000000005 112.932 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.581 HD22 HH21 ' A' ' 171' ' ' ARG . 84.0 mt -140.01 132.84 29.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.419 -1.264 . . . . 74.420000000000002 108.184 171.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 23.0 t -110.07 130.73 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 107.613 -1.255 . . . . 73.150000000000006 107.613 172.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.593 HH22 HD12 ' A' ' 159' ' ' LEU . 11.9 ptp180 -163.38 164.66 24.59 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.165 0.586 . . . . 74.219999999999999 110.206 -174.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 16.1 pt-20 -111.48 156.93 20.93 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.568 0.347 . . . . 75.329999999999998 110.068 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.2 t -75.06 139.1 42.59 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 116.065 -0.516 . . . . 72.25 110.582 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.418 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 94.4 mt-10 -65.51 -42.43 92.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.941 0.497 . . . . 72.319999999999993 110.01 172.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 54.7 p -77.75 -21.97 51.0 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.106 0.962 . . . . 74.209999999999994 111.852 -176.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 36.9 t -140.03 79.89 21.53 Favored Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 109.33 -0.618 . . . . 51.140000000000001 109.33 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -71.43 148.08 53.71 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 123.028 2.485 . . . . 74.349999999999994 111.675 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 88.43 -25.03 9.83 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 115.414 -0.812 . . . . 51.210000000000001 111.843 -170.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -90.46 118.07 29.65 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 108.687 -0.857 . . . . 63.439999999999998 108.687 168.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 61.2 mtt180 -103.44 172.41 6.82 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 114.7 -1.136 . . . . 44.109999999999999 110.252 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.5 m -155.96 140.18 16.56 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.512 1.125 . . . . 70.409999999999997 108.462 -169.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.446 HD11 ' CD2' ' A' ' 217' ' ' LEU . 53.1 mt -112.78 137.98 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.243 -1.021 . . . . 71.409999999999997 108.243 167.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.599 ' HB3' HD22 ' A' ' 160' ' ' LEU . 17.0 m -117.19 112.58 21.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.283 1.433 . . . . 72.329999999999998 107.735 -175.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.414 HD12 ' HE2' ' A' ' 193' ' ' TYR . 42.1 mt -110.62 139.46 45.87 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.138 0.975 . . . . 74.319999999999993 111.459 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 45.4 ttt-85 -129.0 134.92 48.34 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 115.649 -0.705 . . . . 75.510000000000005 109.726 171.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 12.2 p90 -153.19 139.85 18.88 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 124.67 1.231 . . . . 72.129999999999995 107.823 175.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 54.66 23.11 4.48 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 125.026 1.33 . . . . 73.510000000000005 114.233 176.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.56 6.22 73.82 Favored Glycine 0 N--CA 1.475 1.282 0 O-C-N 122.206 -0.309 . . . . 75.319999999999993 113.189 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 15.7 tpp180 -101.03 124.47 46.81 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.218 1.007 . . . . 72.310000000000002 108.746 177.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.653 HG13 HD23 ' A' ' 160' ' ' LEU . 97.0 t -106.85 133.52 51.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.64 1.176 . . . . 73.420000000000002 108.624 174.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.478 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 27.4 p90 -146.3 155.7 42.83 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.238 0.615 . . . . 74.329999999999998 109.986 169.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -134.66 122.22 21.95 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.842 -1.17 . . . . 74.510000000000005 107.842 -174.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.414 ' HE2' HD12 ' A' ' 184' ' ' LEU . 37.1 p90 -119.19 155.11 32.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.026 0.53 . . . . 71.420000000000002 109.917 176.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -99.72 135.0 41.8 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.15 0.5 . . . . 75.25 111.381 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 71.3 mt -82.74 111.79 19.58 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 CA-C-N 114.932 -1.031 . . . . 74.129999999999995 108.607 167.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -81.04 130.99 35.28 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.49 0.716 . . . . 73.409999999999997 109.185 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 48.1 m -97.31 125.55 41.96 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.323 0.649 . . . . 44.240000000000002 110.202 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.56 178.54 6.58 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.48 1.112 . . . . 74.209999999999994 111.727 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 45.3 t -60.7 -36.0 77.71 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.122 0.969 . . . . 73.219999999999999 112.059 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -74.07 -14.17 60.95 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.691 -0.686 . . . . 71.439999999999998 112.318 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 93.66 3.38 64.49 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.513 -0.635 . . . . 64.120000000000005 111.513 -170.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -72.27 160.61 32.1 Favored 'General case' 0 C--N 1.346 0.455 0 C-N-CA 124.123 0.969 . . . . 63.240000000000002 110.404 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.42 HD13 HD13 ' A' ' 214' ' ' LEU . 72.7 mt -113.84 147.19 38.83 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.006 0.923 . . . . 64.310000000000002 110.359 -173.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -163.19 153.77 16.35 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.715 0.635 . . . . 72.519999999999996 109.977 175.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 195' ' ' ILE . 71.7 t -125.26 -62.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.999 -1.112 . . . . 73.150000000000006 107.999 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.0 t -102.4 -178.4 3.68 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.253 1.021 . . . . 64.310000000000002 111.071 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.6 t -61.5 -47.41 85.75 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.333 1.053 . . . . 74.049999999999997 112.044 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -90.34 12.81 17.18 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.486 0.714 . . . . 71.430000000000007 111.643 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 66.8 m -98.51 111.54 23.87 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.373 0.669 . . . . 74.329999999999998 109.782 173.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -146.71 115.13 6.71 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.257 1.023 . . . . 73.420000000000002 109.304 171.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -135.8 142.26 44.85 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 117.843 0.292 . . . . 72.209999999999994 111.105 -171.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -83.85 -34.78 24.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.264 -0.643 . . . . 71.319999999999993 109.264 169.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 66.8 p -121.13 145.47 47.78 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-O 122.039 0.923 . . . . 51.43 111.72 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.42 HD13 HD13 ' A' ' 203' ' ' LEU . 30.2 tp -68.3 -24.68 64.88 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.472 -1.24 . . . . 73.230000000000004 110.811 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.44 85.96 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.457 0.703 . . . . 73.510000000000005 110.542 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -67.89 -34.39 76.56 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 116.053 -0.521 . . . . 75.129999999999995 111.382 175.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.446 ' CD2' HD11 ' A' ' 182' ' ' ILE . 10.0 tt -58.6 -46.22 87.47 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.42 0.45 . . . . 74.209999999999994 110.981 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.94 -39.11 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.166 0.587 . . . . 61.350000000000001 110.828 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -61.66 -55.1 34.11 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.318 0.58 . . . . 74.549999999999997 111.328 176.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.422 ' O ' HG22 ' A' ' 224' ' ' VAL . 46.9 t60 -51.14 -54.77 22.19 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 114.589 -1.187 . . . . 64.329999999999998 109.662 177.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -65.23 -24.94 67.48 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.608 -0.724 . . . . 54.149999999999999 112.709 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.6 t -72.51 -25.41 61.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.854 0.462 . . . . 63.130000000000003 111.064 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.3 t -122.47 -2.9 8.9 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 116.408 2.003 . . . . 61.409999999999997 116.408 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 220' ' ' HIS . 27.8 m -101.61 154.17 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-N 121.123 1.783 . . . . 61.219999999999999 115.421 -172.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.66 -0.73 57.29 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 129.248 3.019 . . . . 63.140000000000001 113.487 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.23 14.56 0.89 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 129.027 2.931 . . . . 72.230000000000004 113.677 -145.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.4 16.42 4.7 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 122.225 0.903 . . . . 42.43 111.725 -170.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.14 120.02 32.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.257 -0.972 . . . . 73.430000000000007 110.927 169.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.478 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 92.7 mt -59.23 -43.26 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 123.97 0.794 . . . . 61.530000000000001 109.39 172.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.8 t -136.09 148.74 48.42 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.694 -0.854 . . . . 73.450000000000003 108.694 165.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 80.7 p -72.4 159.71 33.54 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.566 -0.531 . . . . 65.430000000000007 109.566 171.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 20.4 mt -69.33 102.31 1.71 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.202 -1.036 . . . . 71.299999999999997 108.202 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -87.83 -50.52 6.4 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.461 -0.57 . . . . 73.019999999999996 109.461 -174.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -161.43 147.14 10.81 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 112.444 0.535 . . . . 73.439999999999998 112.444 -177.784 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.36 152.4 71.4 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.122 1.882 . . . . 74.239999999999995 112.736 -176.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.56 155.61 89.22 Favored Pre-proline 0 C--O 1.244 0.81 0 CA-C-N 115.774 -0.648 . . . . 64.409999999999997 110.667 175.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.45 ' HG2' ' HB2' ' A' ' 162' ' ' SER . 17.7 Cg_endo -56.85 140.02 90.58 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.801 2.334 . . . . 74.040000000000006 113.309 177.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt . . . . . 0 CA--C 1.543 0.709 0 CA-C-N 114.834 -1.075 . . . . 64.219999999999999 108.657 169.145 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.856 -0.424 . . . . 75.099999999999994 109.856 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.64 38.29 61.45 Favored Glycine 0 C--N 1.35 1.35 0 O-C-N 123.167 0.292 . . . . 73.329999999999998 113.198 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -85.24 129.52 34.79 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.836 0.455 . . . . 71.439999999999998 110.351 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.86 68.7 3.42 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 123.914 0.886 . . . . 72.549999999999997 110.94 172.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.45 -12.18 22.69 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.723 2.282 . . . . 65.230000000000004 112.272 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.31 148.49 51.35 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-N 115.843 -0.617 . . . . 23.219999999999999 113.034 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -77.14 81.82 3.64 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.324 0.65 . . . . 73.120000000000005 110.886 -173.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.9 m -79.02 169.94 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 115.824 -0.626 . . . . 70.140000000000001 109.71 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.5 tp 63.25 93.58 0.05 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.886 0.875 . . . . 74.030000000000001 110.886 -175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.27 167.57 13.75 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.626 -0.716 . . . . 53.350000000000001 111.611 176.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.62 95.14 4.51 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 122.779 0.431 . . . . 72.430000000000007 110.045 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -164.31 153.86 13.94 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.041 0.537 . . . . 72.549999999999997 110.446 -175.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -66.06 143.44 57.33 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.917 -0.583 . . . . 72.010000000000005 109.474 167.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 52.05 71.71 1.4 Allowed Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 123.105 0.562 . . . . 72.310000000000002 109.864 -168.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.446 ' HG2' ' HB3' ' A' ' 133' ' ' ASN . 9.8 Cg_exo -68.29 168.78 18.45 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.284 1.989 . . . . 73.340000000000003 111.063 174.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.2 p -67.41 165.81 15.83 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 121.352 0.596 . . . . 33.409999999999997 111.639 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.9 mt -106.56 130.56 22.73 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 108.542 -0.91 . . . . 72.230000000000004 108.542 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -66.58 165.46 25.18 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 121.982 1.788 . . . . 62.43 110.618 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.18 147.2 31.39 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.601 0.239 . . . . 55.020000000000003 110.407 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.568 ' HB3' HD11 ' A' ' 23' ' ' ILE . 63.5 mt -85.85 94.07 9.07 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.249 -1.019 . . . . 64.129999999999995 108.249 176.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -98.15 -47.73 5.37 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.878 -1.055 . . . . 75.109999999999999 109.057 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -101.79 113.59 26.92 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 114.345 -1.298 . . . . 74.400000000000006 109.9 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.568 HD11 ' HB3' ' A' ' 20' ' ' LEU . 46.5 mm -115.75 120.18 64.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 106.083 -1.821 . . . . 72.409999999999997 106.083 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HB2' ' HE1' ' A' ' 129' ' ' TRP . 16.8 tptm -63.83 -47.43 80.81 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.478 0.656 . . . . 75.150000000000006 109.84 -177.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.39 -48.66 0.92 Allowed Glycine 0 C--N 1.342 0.911 0 CA-C-N 115.008 -0.996 . . . . 75.109999999999999 111.278 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -138.36 -59.62 0.63 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.204 0.602 . . . . 75.340000000000003 110.001 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.417 ' HA2' ' HG2' ' A' ' 24' ' ' LYS . . . 91.49 -156.88 24.31 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 115.792 -0.64 . . . . 72.349999999999994 112.205 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.695 ' HB2' HD13 ' A' ' 110' ' ' LEU . 88.9 mttt -86.92 -166.33 1.54 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.996 0.518 . . . . 74.299999999999997 110.198 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.73 161.45 6.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.927 0.891 . . . . 43.200000000000003 109.948 171.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 61.62 80.38 0.22 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.52 1.128 . . . . 74.439999999999998 111.972 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 p -92.35 -60.6 1.8 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.266 -0.879 . . . . 53.439999999999998 110.255 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.1 t -178.82 138.04 0.15 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.754 1.222 . . . . 72.030000000000001 109.234 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -100.18 85.2 2.97 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 109.164 -0.68 . . . . 71.530000000000001 109.164 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -159.53 150.44 19.54 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.475 -0.784 . . . . 64.129999999999995 109.451 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.92 -108.25 1.82 Allowed Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.851 -0.9 . . . . 60.119999999999997 110.851 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.64 162.35 10.87 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-O 119.332 -0.705 . . . . 64.019999999999996 111.7 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.53 146.71 31.12 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.798 2.332 . . . . 73.329999999999998 111.792 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -96.76 43.14 1.08 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 122.123 0.963 . . . . 75.540000000000006 109.59 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.1 p -84.13 134.13 34.6 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.766 -1.198 . . . . 63.409999999999997 107.766 169.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -75.55 -22.77 56.75 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.394 0.278 . . . . 65.430000000000007 111.62 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.2 t -113.98 112.53 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.696 0.798 . . . . 61.200000000000003 109.532 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.57 140.96 1.08 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.981 0.912 . . . . 74.329999999999998 110.189 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.3 m -105.46 178.05 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.403 0.681 . . . . 73.040000000000006 111.107 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -89.82 161.9 15.76 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.204 0.602 . . . . 70.340000000000003 111.304 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.4 ' ND1' ' HG2' ' A' ' 46' ' ' GLU . 42.2 t-80 -106.31 -50.17 3.2 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.941 -0.572 . . . . 60.420000000000002 109.983 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.4 ' HG2' ' ND1' ' A' ' 45' ' ' HIS . 60.7 mm-40 -126.9 -168.77 1.92 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.399 1.08 . . . . 73.219999999999999 109.709 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.17 149.57 50.1 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.049 0.54 . . . . 51.539999999999999 110.58 172.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.5 mt -96.73 122.72 39.98 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.071 -1.085 . . . . 60.530000000000001 108.071 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -73.32 107.49 5.66 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 113.951 1.093 . . . . 74.310000000000002 113.951 -164.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.407 ' HB2' ' OD1' ' A' ' 83' ' ' ASN . 20.5 ttm180 -129.72 89.75 45.51 Favored Pre-proline 0 C--O 1.245 0.842 0 N-CA-C 107.018 -1.475 . . . . 74.010000000000005 107.018 155.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.613 ' HA ' HG22 ' A' ' 213' ' ' THR . 52.8 Cg_endo -82.51 -139.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.629 2.219 . . . . 73.140000000000001 111.15 174.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.4 t -54.71 117.1 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 C-N-CA 123.615 0.766 . . . . 65.010000000000005 109.626 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.21 121.44 7.52 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.238 1.415 . . . . 73.409999999999997 113.74 -166.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.9 t -77.1 -29.64 54.94 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.983 0.913 . . . . 74.549999999999997 110.015 175.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -81.89 107.08 14.33 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.707 0.803 . . . . 70.450000000000003 110.145 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -124.46 -174.18 2.95 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.986 1.314 . . . . 72.530000000000001 108.331 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.709 ' HG2' ' HB3' ' A' ' 114' ' ' HIS . 29.4 tt0 71.12 73.02 0.27 Allowed Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.42 1.088 . . . . 74.510000000000005 109.588 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -95.55 139.33 0.87 Allowed 'Trans proline' 0 CA--C 1.558 1.688 0 C-N-CA 123.538 2.825 . . . . 73.219999999999999 114.885 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -135.9 114.22 11.59 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.822 0.849 . . . . 74.040000000000006 109.588 171.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.89 78.05 1.25 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.924 -0.471 . . . . 75.200000000000003 111.924 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.722 HD11 ' HA ' ' A' ' 115' ' ' ASN . 75.9 mt -73.1 143.06 47.52 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.701 0.801 . . . . 73.140000000000001 111.003 -177.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.7 p -66.16 94.05 0.23 Allowed 'General case' 0 CA--C 1.553 1.087 0 O-C-N 123.712 0.632 . . . . 52.229999999999997 110.717 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.85 130.61 41.47 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.213 -0.662 . . . . 73.049999999999997 109.213 176.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.79 -89.27 0.12 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.977 0.511 . . . . 55.329999999999998 111.69 -168.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.89 75.88 0.13 Allowed 'General case' 0 C--N 1.348 0.538 0 C-N-CA 123.132 0.573 . . . . 73.420000000000002 109.853 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -80.04 75.53 6.79 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.637 -0.875 . . . . 72.140000000000001 108.637 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -75.13 97.43 3.47 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 114.911 -1.04 . . . . 74.010000000000005 110.016 -177.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -173.49 155.8 2.88 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.601 -1.181 . . . . 73.230000000000004 108.309 174.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.2 m -149.64 85.98 1.45 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.027 0.531 . . . . 35.439999999999998 109.901 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -84.77 163.32 19.19 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.713 -0.847 . . . . 65.409999999999997 108.713 164.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -79.06 139.66 38.08 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.149 0.5 . . . . 64.310000000000002 111.772 -174.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -63.94 109.29 1.73 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.931 -1.031 . . . . 53.210000000000001 109.494 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.447 HD12 HD13 ' A' ' 88' ' ' LEU . 92.5 mt -82.54 63.85 6.9 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.634 0.731 . . . . 60.119999999999997 110.764 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.6 mt -84.87 108.73 17.66 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.333 -0.988 . . . . 74.209999999999994 108.333 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.513 ' H ' HG12 ' A' ' 138' ' ' VAL . . . -75.47 -57.31 3.96 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.036 0.535 . . . . 72.409999999999997 111.047 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.75 178.74 36.84 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 115.733 -0.667 . . . . 71.120000000000005 112.52 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -95.86 -153.86 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 123.343 2.696 . . . . 62.439999999999998 113.999 -166.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.0 t -137.85 -167.51 2.16 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 106.904 -1.517 . . . . 73.439999999999998 106.904 167.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -74.45 -53.96 8.5 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.737 0.698 . . . . 74.409999999999997 111.567 -168.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -160.48 26.9 0.16 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.069 0.948 . . . . 62.549999999999997 109.426 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.04 158.96 33.26 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 115.158 -0.928 . . . . 74.230000000000004 110.989 -165.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.65 159.0 14.77 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 123.174 2.583 . . . . 74.319999999999993 113.144 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 50' ' ' ARG . 9.6 m120 -56.36 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.951 0.782 . . . . 70.310000000000002 111.987 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.66 ' H ' ' HB3' ' A' ' 139' ' ' ASN . 50.3 tp -81.55 135.77 35.59 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.538 -1.21 . . . . 74.409999999999997 109.165 177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -105.49 176.08 5.28 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.948 1.299 . . . . 75.299999999999997 109.359 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.35 143.13 23.52 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 N-CA-C 108.503 -0.925 . . . . 61.539999999999999 108.503 171.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -76.05 121.67 23.12 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.627 -0.508 . . . . 63.539999999999999 109.627 173.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.447 HD13 HD12 ' A' ' 73' ' ' LEU . 74.4 mt -82.42 -21.63 35.65 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.703 0.801 . . . . 74.239999999999995 111.252 173.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.574 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 84.5 m-85 -136.16 158.14 45.14 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.114 0.565 . . . . 74.319999999999993 109.585 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.51 145.58 39.04 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.689 -0.687 . . . . 73.219999999999999 109.835 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -153.23 111.16 3.59 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.236 -1.024 . . . . 74.019999999999996 108.236 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.4 t -82.54 138.71 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 109.074 -0.713 . . . . 65.099999999999994 109.074 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.65 116.25 4.61 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.087 0.555 . . . . 71.230000000000004 110.194 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.5 m -78.79 -11.05 59.97 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.718 0.807 . . . . 73.430000000000007 110.717 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.74 -172.68 41.62 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.587 -0.733 . . . . 63.310000000000002 111.28 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.53 -25.68 66.78 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.436 0.694 . . . . 72.030000000000001 110.719 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -70.2 -22.99 62.88 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.588 0.755 . . . . 71.340000000000003 112.456 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.7 p -113.71 157.74 21.81 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.408 0.683 . . . . 64.219999999999999 110.915 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.2 tp -109.93 131.15 55.32 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.734 0.814 . . . . 62.0 109.927 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.8 t -74.05 120.01 19.04 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 108.892 -0.781 . . . . 34.119999999999997 108.892 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.32 159.53 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.244 1.018 . . . . 41.210000000000001 108.775 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 60.0 m -135.78 148.15 48.64 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.265 -0.643 . . . . 74.310000000000002 109.265 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -54.84 123.38 13.21 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.095 0.558 . . . . 74.230000000000004 111.646 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.29 -9.54 49.81 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.388 -0.369 . . . . 54.210000000000001 113.095 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -85.01 131.89 34.41 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.557 0.743 . . . . 72.019999999999996 110.445 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.45 ' HB3' HD11 ' A' ' 84' ' ' LEU . 8.7 mtmp? -83.52 115.48 22.11 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.773 0.829 . . . . 71.299999999999997 110.302 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.505 ' HA ' HG22 ' A' ' 123' ' ' THR . 15.7 mt -103.14 145.74 29.45 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.956 0.903 . . . . 73.510000000000005 109.965 -169.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.472 ' NH2' ' HG2' ' A' ' 122' ' ' GLN . 84.5 mtm180 -108.65 108.95 20.02 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.605 -0.887 . . . . 70.129999999999995 108.605 173.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 71.6 t -95.56 117.28 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 121.298 0.571 . . . . 73.299999999999997 110.249 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.695 HD13 ' HB2' ' A' ' 28' ' ' LYS . 48.5 mt -77.16 -28.73 54.25 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.251 1.421 . . . . 73.109999999999999 111.207 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.3 177.51 39.46 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.127 -0.488 . . . . 41.310000000000002 113.016 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.484 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 2.8 m-85 -107.15 168.41 9.23 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.833 0.853 . . . . 72.340000000000003 109.398 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -85.9 151.77 23.51 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 110.018 -0.364 . . . . 72.239999999999995 110.018 170.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.709 ' HB3' ' HG2' ' A' ' 57' ' ' GLU . 18.1 p-80 -57.87 -32.29 67.53 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 113.185 0.809 . . . . 73.439999999999998 113.185 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.722 ' HA ' HD11 ' A' ' 61' ' ' LEU . 67.3 t30 -90.16 3.88 52.1 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.129 0.572 . . . . 72.150000000000006 110.465 -176.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 61.59 31.16 76.77 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 111.03 -0.828 . . . . 73.549999999999997 111.03 -174.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -67.65 -70.45 0.26 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 107.934 -1.136 . . . . 64.319999999999993 107.934 -174.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -135.54 178.46 7.02 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 108.337 -0.986 . . . . 72.540000000000006 108.337 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.16 117.81 24.71 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.67 0.788 . . . . 63.310000000000002 109.058 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.92 108.65 3.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.279 0.632 . . . . 62.340000000000003 109.711 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.37 168.23 10.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.634 0.773 . . . . 53.310000000000002 110.784 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.472 ' HG2' ' NH2' ' A' ' 108' ' ' ARG . 61.6 tt0 -149.09 128.09 12.69 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.149 -1.056 . . . . 72.109999999999999 108.149 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.505 HG22 ' HA ' ' A' ' 107' ' ' LEU . 81.6 p -139.31 -174.46 3.87 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.701 0.801 . . . . 72.219999999999999 110.701 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -55.53 -28.87 57.31 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.6 0.76 . . . . 72.530000000000001 111.336 169.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -76.1 -13.3 60.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.547 0.739 . . . . 61.219999999999999 111.573 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 132.02 -130.95 6.09 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 111.905 -0.478 . . . . 70.450000000000003 111.905 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -150.73 146.58 26.53 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.338 0.655 . . . . 71.209999999999994 110.072 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 166.94 177.79 38.93 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 112.1 -0.4 . . . . 71.519999999999996 112.1 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.438 ' HE1' ' HB2' ' A' ' 24' ' ' LYS . 90.9 m95 -80.62 130.3 35.03 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.589 0.756 . . . . 72.409999999999997 110.887 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.03 151.54 61.65 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 124.286 1.034 . . . . 74.209999999999994 109.767 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.54 132.02 14.28 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 121.748 1.632 . . . . 62.310000000000002 111.636 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.501 ' HA ' HG12 ' A' ' 135' ' ' ILE . 41.8 p -61.58 -22.01 64.82 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.703 0.801 . . . . 71.510000000000005 111.901 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.446 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 43.6 m-20 -68.36 -24.5 64.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.429 1.092 . . . . 61.439999999999998 111.926 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.574 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.1 m-85 -101.7 2.19 38.34 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.593 0.757 . . . . 74.329999999999998 112.153 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.501 HG12 ' HA ' ' A' ' 132' ' ' SER . 16.4 pt -131.21 161.92 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.66 0.384 . . . . 75.340000000000003 110.056 -173.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 11.0 t -151.16 147.92 21.55 Favored Pre-proline 0 N--CA 1.481 1.113 0 N-CA-C 108.593 -0.891 . . . . 75.400000000000006 108.593 170.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.94 150.59 38.68 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 121.971 1.781 . . . . 64.140000000000001 111.564 172.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.513 HG12 ' H ' ' A' ' 75' ' ' ALA . 15.1 m -131.13 -44.52 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.155 0.582 . . . . 74.010000000000005 111.185 176.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.66 ' HB3' ' H ' ' A' ' 84' ' ' LEU . 58.2 t30 -95.5 17.96 13.66 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.411 1.101 . . . . 75.329999999999998 110.491 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.406 ' HA ' ' ND2' ' A' ' 83' ' ' ASN . 75.6 p -76.24 168.86 19.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.483 -0.78 . . . . 74.109999999999999 110.677 172.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 63.2 mt -62.98 -15.84 57.48 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 114.957 -1.019 . . . . 73.340000000000003 111.166 172.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.4 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 82.4 tt0 -61.74 -26.77 68.27 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.269 1.428 . . . . 73.310000000000002 112.999 -176.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -67.78 -18.11 64.76 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 122.768 0.427 . . . . 64.140000000000001 110.819 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -82.0 145.05 30.46 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.02 -0.733 . . . . 72.430000000000007 109.02 168.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.3 p -64.3 -19.91 65.73 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 112.884 0.698 . . . . 75.329999999999998 112.884 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.435 ' CE3' HG21 ' A' ' 218' ' ' VAL . 65.3 p-90 -77.72 -37.81 48.59 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 112.445 0.535 . . . . 64.120000000000005 112.445 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.408 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 22.7 t80 -102.22 138.6 38.94 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.143 -0.688 . . . . 71.129999999999995 109.143 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.4 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 22.3 m-70 -129.56 22.37 5.51 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.682 0.393 . . . . 71.439999999999998 111.446 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 62.81 -156.19 40.57 Favored Glycine 0 CA--C 1.536 1.385 0 N-CA-C 115.092 0.797 . . . . 72.209999999999994 115.092 169.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 6.3 Cg_exo -76.37 104.59 1.93 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.391 2.727 . . . . 62.229999999999997 111.044 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.55 160.98 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.293 0.568 . . . . 75.140000000000001 112.02 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 18.2 m -71.26 161.73 30.6 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 114.924 -1.035 . . . . 60.530000000000001 110.916 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -64.02 -32.65 74.28 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.109 0.564 . . . . 73.549999999999997 110.114 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -65.11 -49.72 68.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.524 1.129 . . . . 60.509999999999998 110.416 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.02 -43.51 87.45 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.597 0.759 . . . . 73.310000000000002 110.406 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.46 -59.9 4.46 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.387 -1.279 . . . . 53.229999999999997 110.944 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.595 ' HG3' HG11 ' A' ' 190' ' ' VAL . 31.7 tt0 -67.73 -22.73 65.22 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.835 -0.62 . . . . 54.329999999999998 111.281 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -65.42 -56.38 12.83 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.996 0.519 . . . . 75.239999999999995 109.706 173.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.27 -35.91 80.44 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 116.431 -0.349 . . . . 75.209999999999994 111.148 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.657 HD23 HG13 ' A' ' 190' ' ' VAL . 34.4 tp -72.25 -26.72 62.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.013 0.525 . . . . 73.120000000000005 111.66 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.5 t -70.06 -16.28 63.12 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.976 0.51 . . . . 74.409999999999997 111.162 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.3 m -83.07 -17.79 41.94 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.263 0.625 . . . . 72.310000000000002 111.052 170.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.36 -179.64 51.02 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 116.154 -0.475 . . . . 64.420000000000002 113.431 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.1 pt -133.37 -166.45 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 125.864 1.666 . . . . 74.109999999999999 110.503 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 24.3 p-10 -60.15 129.95 44.24 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.62 0.368 . . . . 73.219999999999999 111.229 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.88 10.03 84.61 Favored Glycine 0 C--O 1.264 1.982 0 CA-C-O 119.997 -0.335 . . . . 51.409999999999997 113.061 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 75.2 m -82.58 141.2 32.76 Favored 'General case' 0 C--N 1.371 1.532 0 N-CA-C 110.086 -0.338 . . . . 74.209999999999994 110.086 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 183' ' ' SER . 16.4 p90 -136.68 161.48 35.8 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.756 0.789 . . . . 64.319999999999993 112.918 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 79.6 mt -135.13 131.96 37.48 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 114.213 -1.358 . . . . 74.420000000000002 108.04 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.461 HG21 HG22 ' A' ' 218' ' ' VAL . 32.5 t -108.02 130.05 61.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 106.053 -1.832 . . . . 70.129999999999995 106.053 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.55 163.48 39.92 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.999 0.52 . . . . 71.0 110.261 -171.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 15.7 pt-20 -117.91 164.49 14.99 Favored 'General case' 0 C--O 1.26 1.625 0 C-N-CA 123.263 0.625 . . . . 64.239999999999995 110.368 172.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.1 m -80.29 146.93 31.37 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.73 -1.123 . . . . 44.32 110.209 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -78.74 -43.46 25.66 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.694 1.197 . . . . 73.319999999999993 110.293 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.476 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 27.3 m -99.29 9.48 43.29 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.531 -1.213 . . . . 74.299999999999997 112.032 -173.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.4 t -147.61 108.73 3.82 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 122.521 0.328 . . . . 63.109999999999999 110.709 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.484 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 68.4 Cg_endo -74.5 135.21 19.78 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.003 2.469 . . . . 74.420000000000002 111.551 173.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.71 -25.74 12.67 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 116.172 -0.467 . . . . 52.350000000000001 113.509 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.404 ' OE1' ' HD2' ' A' ' 194' ' ' ARG . 83.3 mm-40 -81.3 116.54 21.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.03 0.915 . . . . 75.239999999999995 109.192 174.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 41.1 mtt-85 -129.41 157.14 42.8 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.099 -1.075 . . . . 72.430000000000007 108.099 -177.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.6 m -140.08 144.89 37.05 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 123.225 0.61 . . . . 72.340000000000003 109.825 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 55.3 mt -109.67 143.88 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.021 -1.103 . . . . 70.420000000000002 108.021 165.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.447 ' HB3' HD22 ' A' ' 160' ' ' LEU . 16.8 m -125.37 112.31 16.16 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.375 1.07 . . . . 64.140000000000001 108.349 -174.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.463 HD21 HD23 ' A' ' 232' ' ' LEU . 47.1 mt -102.81 143.38 32.51 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.362 0.665 . . . . 74.150000000000006 111.341 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -122.16 128.11 50.84 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 107.224 -1.398 . . . . 72.230000000000004 107.224 167.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 1.3 t80 -152.48 123.94 7.74 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.066 1.346 . . . . 75.019999999999996 107.991 -171.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 62.49 18.98 10.86 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.905 1.282 . . . . 65.439999999999998 112.33 -172.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.66 1.63 85.27 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-O 120.019 -0.323 . . . . 73.230000000000004 113.099 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -97.34 125.43 41.94 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.071 -0.714 . . . . 75.420000000000002 109.071 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.657 HG13 HD23 ' A' ' 160' ' ' LEU . 73.1 t -98.43 118.77 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.328 1.051 . . . . 74.430000000000007 109.506 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -138.73 140.23 38.64 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.972 0.909 . . . . 55.32 109.389 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -120.19 146.32 46.12 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.779 0.832 . . . . 73.25 109.059 -171.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -139.68 150.03 44.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.974 0.509 . . . . 73.409999999999997 110.478 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 12.4 tpp85 -88.37 132.44 34.43 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.108 -0.951 . . . . 72.439999999999998 111.308 -171.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 68.4 mt -81.45 113.51 20.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 108.159 -1.052 . . . . 74.120000000000005 108.159 164.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -83.78 132.05 34.86 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.375 -0.602 . . . . 65.200000000000003 109.375 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.0 m -110.79 116.96 32.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.505 0.722 . . . . 74.049999999999997 109.714 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.5 178.42 2.03 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.363 1.065 . . . . 41.32 112.035 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 79.8 p -58.56 -41.48 85.76 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.9 0.88 . . . . 71.439999999999998 113.035 -170.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -79.46 -20.12 48.17 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 116.24 -0.436 . . . . 73.329999999999998 110.67 -175.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 113.37 5.5 22.81 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.013 -0.54 . . . . 53.420000000000002 113.53 -174.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -66.26 142.12 57.79 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.625 0.713 . . . . 53.149999999999999 110.502 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 78.3 mt -103.46 146.13 28.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.427 0.691 . . . . 64.310000000000002 109.501 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -165.76 140.61 4.78 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.149 0.579 . . . . 74.230000000000004 110.531 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.4 t -97.91 -38.68 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.316 0.646 . . . . 63.210000000000001 109.722 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 40.7 t -109.05 154.69 21.87 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.614 0.766 . . . . 74.340000000000003 110.96 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.1 m -69.96 -21.13 63.28 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.143 -0.935 . . . . 71.409999999999997 111.04 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -84.64 -6.9 59.39 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.538 0.735 . . . . 72.120000000000005 111.497 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 59.1 m -136.69 147.9 47.06 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.888 0.475 . . . . 64.239999999999995 112.044 -168.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -140.65 134.05 29.86 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.791 1.236 . . . . 75.329999999999998 108.326 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -127.82 132.62 49.43 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.916 0.486 . . . . 74.299999999999997 110.117 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -83.8 -25.02 30.77 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.323 0.649 . . . . 73.439999999999998 110.236 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.613 HG22 ' HA ' ' A' ' 51' ' ' PRO . 71.0 p -128.99 150.31 50.45 Favored 'General case' 0 C--O 1.253 1.263 0 C-N-CA 123.185 0.594 . . . . 75.409999999999997 110.973 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 31.3 tp -69.71 -27.73 65.23 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.407 -0.815 . . . . 63.25 110.047 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.25 -44.92 92.36 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.345 0.658 . . . . 50.340000000000003 110.847 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -75.78 -29.63 58.83 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 116.191 -0.459 . . . . 62.210000000000001 111.377 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tt -58.17 -51.3 70.32 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 123.301 0.375 . . . . 41.030000000000001 110.51 172.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.461 HG22 HG21 ' A' ' 170' ' ' VAL . 94.9 t -69.47 -42.9 81.03 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 CA-C-N 115.41 -0.814 . . . . 73.129999999999995 111.097 -176.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -57.71 -53.93 52.57 Favored 'General case' 0 C--O 1.259 1.568 0 C-N-CA 123.386 0.674 . . . . 74.200000000000003 111.151 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.497 ' O ' HG22 ' A' ' 224' ' ' VAL . 35.9 t-80 -55.65 -54.75 40.31 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 114.846 -1.07 . . . . 75.450000000000003 109.585 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.402 ' HA ' HG22 ' A' ' 224' ' ' VAL . 4.5 m-70 -68.15 -16.54 64.04 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.758 0.651 . . . . 64.140000000000001 112.758 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.451 ' HA ' ' HB2' ' A' ' 232' ' ' LEU . 44.4 t -74.56 -31.32 62.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.564 0.345 . . . . 54.229999999999997 110.243 173.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.4 t -107.56 -12.34 15.29 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 116.501 2.037 . . . . 71.239999999999995 116.501 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 220' ' ' HIS . 27.7 m -105.86 167.2 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 N-CA-C 117.512 2.412 . . . . 71.530000000000001 117.512 -166.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.02 -1.49 58.02 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 130.075 3.35 . . . . 52.439999999999998 113.663 -173.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -77.58 12.77 1.48 Allowed 'General case' 0 CA--C 1.567 1.619 0 C-N-CA 130.532 3.533 . . . . 70.099999999999994 114.031 -136.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.48 16.5 4.63 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 124.95 1.262 . . . . 61.140000000000001 110.58 -170.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 90.6 mt -90.79 123.38 34.31 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.122 1.369 . . . . 70.150000000000006 110.8 173.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 68.5 mt -62.5 -39.54 84.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.795 -0.639 . . . . 73.329999999999998 109.384 170.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.9 t -138.44 144.46 40.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.431 -0.951 . . . . 70.299999999999997 108.431 166.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 224' ' ' VAL . 59.6 p -65.68 150.68 48.08 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 109.22 -0.659 . . . . 74.209999999999994 109.22 170.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.463 HD23 HD21 ' A' ' 184' ' ' LEU . 31.4 mt -64.36 100.16 0.34 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 108.044 -1.095 . . . . 74.239999999999995 108.044 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -90.23 -53.42 4.47 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 109.619 -0.511 . . . . 65.430000000000007 109.619 -169.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 167' ' ' SER . 1.0 OUTLIER -151.8 145.33 17.65 Favored Pre-proline 0 N--CA 1.479 0.983 0 CA-C-N 115.495 -0.775 . . . . 72.209999999999994 110.451 177.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -85.3 158.07 11.09 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 121.626 1.551 . . . . 73.409999999999997 113.809 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.39 128.29 87.59 Favored Pre-proline 0 C--O 1.245 0.842 0 N-CA-C 108.923 -0.769 . . . . 51.200000000000003 108.923 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.93 171.15 18.06 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.482 2.121 . . . . 64.450000000000003 114.185 -167.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -79.02 152.99 30.61 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.265 -1.334 . . . . 62.520000000000003 108.664 172.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -49.69 -44.62 48.15 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 123.234 0.614 . . . . 73.049999999999997 111.642 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -86.93 124.06 32.72 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.01 -1.107 . . . . 74.239999999999995 108.01 169.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -67.33 116.65 38.86 Favored Pre-proline 0 CA--C 1.554 1.122 0 O-C-N 123.905 0.753 . . . . 73.140000000000001 110.257 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -89.68 165.6 5.11 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.919 2.413 . . . . 74.310000000000002 112.703 174.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 29.5 m -124.7 93.89 4.03 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.353 0.596 . . . . 74.239999999999995 110.454 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.51 146.66 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.274 1.03 . . . . 74.340000000000003 108.284 171.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -146.93 178.88 8.0 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.863 0.465 . . . . 71.019999999999996 110.575 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 164.19 142.94 3.55 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 111.201 -0.76 . . . . 72.340000000000003 111.201 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 60.1 t -129.58 -67.47 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.373 -0.973 . . . . 73.530000000000001 108.373 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 18.3 t 58.25 80.31 0.29 Allowed Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 124.163 0.985 . . . . 70.540000000000006 109.704 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -59.62 133.92 54.57 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.499 2.799 . . . . 73.129999999999995 113.106 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -74.52 112.38 10.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.734 0.814 . . . . 63.030000000000001 111.134 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -103.49 106.03 16.44 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.03 -1.1 . . . . 74.239999999999995 108.03 168.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.08 151.42 43.13 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.692 0.797 . . . . 64.409999999999997 112.668 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -157.15 118.57 3.71 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.553 -0.906 . . . . 71.510000000000005 108.553 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -86.08 -77.5 0.3 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.651 -0.87 . . . . 71.299999999999997 108.651 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 CA--C 1.552 1.052 0 C-N-CA 124.576 1.151 . . . . 74.230000000000004 108.103 177.583 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptm . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 110.337 -0.246 . . . . 71.409999999999997 110.337 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.86 -152.99 35.76 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.973 -0.558 . . . . 74.209999999999994 112.599 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -149.35 134.98 18.61 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.473 0.709 . . . . 63.109999999999999 109.658 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -73.06 124.19 90.4 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-O 118.791 -0.623 . . . . 75.349999999999994 109.653 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.82 -15.46 42.81 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.112 2.541 . . . . 73.25 113.755 174.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.52 -118.54 5.94 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 111.038 -0.825 . . . . 55.340000000000003 111.038 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -128.93 137.5 51.44 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.627 0.771 . . . . 54.439999999999998 109.476 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.6 154.21 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.104 0.961 . . . . 43.119999999999997 108.558 174.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -68.91 -10.52 57.62 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.864 0.465 . . . . 75.230000000000004 111.512 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.11 -162.84 20.09 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 115.913 -0.585 . . . . 73.5 111.676 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.43 91.57 2.26 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.736 0.779 . . . . 72.120000000000005 109.811 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -145.81 68.58 1.21 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.946 1.298 . . . . 73.040000000000006 109.072 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 64.43 125.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.684 1.194 . . . . 63.109999999999999 110.804 -174.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 59.07 66.22 2.43 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.137 0.975 . . . . 64.109999999999999 110.198 -171.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -60.36 162.05 18.51 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.375 2.05 . . . . 71.129999999999995 111.825 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.9 p -68.1 167.23 14.46 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.143 0.497 . . . . 74.230000000000004 111.743 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.0 mt -105.76 129.35 24.78 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 123.183 0.593 . . . . 73.519999999999996 109.455 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.63 171.62 17.42 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.477 2.118 . . . . 75.040000000000006 111.902 172.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.14 148.87 26.54 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.992 0.517 . . . . 71.329999999999998 111.236 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.647 HD22 HD11 ' A' ' 23' ' ' ILE . 83.6 mt -85.84 95.72 9.53 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.278 -1.008 . . . . 60.210000000000001 108.278 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -97.6 -53.42 3.44 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 120.762 0.315 . . . . 72.129999999999995 110.779 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -106.87 108.39 19.88 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.624 -0.717 . . . . 72.150000000000006 109.378 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.647 HD11 HD22 ' A' ' 20' ' ' LEU . 46.9 mm -124.3 114.07 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.291 0.636 . . . . 72.329999999999998 109.573 176.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.51 ' HE2' ' HG3' ' A' ' 58' ' ' PRO . 20.0 pttp -94.26 70.82 3.81 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 122.514 1.149 . . . . 64.109999999999999 108.509 169.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.45 -17.57 66.66 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 114.592 -1.186 . . . . 43.310000000000002 113.079 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.15 -12.73 20.2 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.048 0.939 . . . . 64.120000000000005 111.322 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.61 52.97 4.52 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-O 121.345 0.414 . . . . 34.140000000000001 112.685 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -111.97 22.97 14.29 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.354 1.062 . . . . 74.510000000000005 110.348 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -89.45 -11.08 44.09 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.218 0.607 . . . . 63.409999999999997 109.949 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 56' ' ' PHE . 25.8 mt-10 -80.05 -13.82 59.01 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.855 1.262 . . . . 55.399999999999999 110.163 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 m -78.3 139.96 38.84 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 124.284 1.034 . . . . 65.439999999999998 111.526 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.9 p -99.67 124.11 44.59 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 107.665 -1.235 . . . . 70.299999999999997 107.665 169.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 74.56 96.94 0.07 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.774 1.23 . . . . 72.209999999999994 108.378 -161.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -153.27 137.93 16.93 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.617 -0.72 . . . . 75.0 109.828 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.51 -59.96 0.01 OUTLIER Glycine 0 C--N 1.34 0.768 0 N-CA-C 110.75 -0.94 . . . . 74.540000000000006 110.75 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.97 -112.5 3.95 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 118.739 -1.034 . . . . 70.340000000000003 112.181 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.77 135.48 38.55 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.922 2.414 . . . . 72.400000000000006 112.503 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -136.29 115.17 12.19 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.484 0.713 . . . . 64.099999999999994 109.396 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.7 p -84.17 178.52 7.78 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.908 0.883 . . . . 75.530000000000001 110.447 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -64.73 104.25 0.8 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.362 0.665 . . . . 64.209999999999994 109.948 175.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.0 t -127.82 125.35 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.718 -1.216 . . . . 73.239999999999995 107.718 175.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -69.81 90.31 0.6 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.6 0.714 . . . . 71.019999999999996 109.571 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -140.49 119.76 11.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 107.305 -1.368 . . . . 72.230000000000004 107.305 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -63.99 -48.91 74.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.535 0.734 . . . . 61.229999999999997 111.01 -171.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -145.68 137.76 25.43 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.017 0.927 . . . . 75.129999999999995 109.007 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -107.6 152.53 24.15 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.603 0.761 . . . . 73.329999999999998 110.65 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.48 72.79 1.5 Allowed 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.757 -1.201 . . . . 65.219999999999999 107.757 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.0 mt -72.63 122.86 22.11 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.75 -0.659 . . . . 61.130000000000003 111.685 -171.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -143.82 -63.14 0.39 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.645 1.178 . . . . 75.340000000000003 108.028 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 59.06 105.1 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 125.386 1.475 . . . . 72.420000000000002 110.883 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.62 122.98 9.7 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.517 2.811 . . . . 60.240000000000002 113.339 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.7 t -58.28 117.9 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.309 0.643 . . . . 75.349999999999994 109.63 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.54 -51.12 68.62 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.39 0.676 . . . . 63.399999999999999 110.125 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.1 p -178.28 160.47 1.34 Allowed 'General case' 0 C--O 1.245 0.868 0 C-N-CA 124.839 1.256 . . . . 63.109999999999999 109.242 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.66 138.5 39.12 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.9 -0.591 . . . . 64.129999999999995 109.963 172.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.42 ' H ' ' HG2' ' A' ' 30' ' ' GLU . 37.5 m-85 -76.46 -8.27 56.81 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.217 0.607 . . . . 73.209999999999994 109.885 169.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 67.17 76.93 0.26 Allowed Pre-proline 0 C--N 1.363 1.171 0 C-N-CA 123.812 0.845 . . . . 75.430000000000007 111.052 165.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.51 ' HG3' ' HE2' ' A' ' 24' ' ' LYS . 32.0 Cg_exo -58.28 96.86 0.08 OUTLIER 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.945 2.43 . . . . 40.130000000000003 111.969 -177.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 39.5 mm-40 -70.07 153.33 43.31 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.754 -0.657 . . . . 72.329999999999998 110.756 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.24 147.92 19.44 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 123.452 0.47 . . . . 64.200000000000003 112.844 -175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.68 -172.83 2.11 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.215 1.006 . . . . 70.329999999999998 109.472 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.8 p -106.52 129.31 54.49 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.597 0.759 . . . . 62.549999999999997 109.543 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.06 160.43 32.49 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.817 0.447 . . . . 62.409999999999997 111.116 174.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.55 151.04 40.78 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.903 0.881 . . . . 51.439999999999998 109.621 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 63.83 26.47 14.35 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.262 1.025 . . . . 63.200000000000003 111.991 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.455 ' HG3' ' HB3' ' A' ' 175' ' ' SER . 0.0 OUTLIER -66.95 98.1 0.53 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.277 1.031 . . . . 74.329999999999998 110.967 -173.226 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 25.5 t90 -117.7 157.26 26.8 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.021 0.929 . . . . 65.099999999999994 109.66 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 62.46 78.77 0.28 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.704 1.201 . . . . 55.030000000000001 109.957 -173.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.1 m -145.55 86.75 1.76 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-N 115.032 -0.985 . . . . 73.329999999999998 109.607 -173.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -170.13 127.15 0.84 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.84 0.856 . . . . 55.329999999999998 109.461 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -161.27 148.52 15.0 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.078 -0.712 . . . . 74.420000000000002 109.078 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -80.75 96.2 6.87 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.116 0.566 . . . . 70.140000000000001 109.843 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.3 mt -72.84 139.63 47.08 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.038 0.535 . . . . 73.129999999999995 110.043 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 98.3 mt -126.7 87.91 2.74 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.822 0.849 . . . . 72.230000000000004 109.695 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . . . -90.81 137.77 32.11 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.149 0.58 . . . . 65.040000000000006 110.273 173.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -166.11 -83.65 0.05 OUTLIER Glycine 0 C--N 1.346 1.111 0 CA-C-O 119.178 -0.79 . . . . 74.209999999999994 112.251 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.2 122.75 12.08 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.518 2.812 . . . . 74.310000000000002 112.999 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.4 m -144.82 125.44 14.11 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.027 0.931 . . . . 74.409999999999997 109.494 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -100.1 -76.13 0.56 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.651 0.38 . . . . 74.120000000000005 111.092 -173.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -171.47 5.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.642 0.777 . . . . 72.340000000000003 110.902 -171.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.408 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 6.4 p-10 -83.86 173.45 7.34 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 125.385 1.474 . . . . 62.229999999999997 110.456 -174.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 81' ' ' ASP . 55.9 Cg_endo -71.12 -63.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.008 1.806 . . . . 71.239999999999995 113.3 172.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -142.74 99.07 3.4 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.628 0.771 . . . . 62.219999999999999 110.687 -172.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.583 ' H ' ' HB3' ' A' ' 139' ' ' ASN . 24.1 tp -102.62 137.6 40.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.412 0.685 . . . . 63.43 109.483 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 8.8 m-85 -120.02 176.52 5.39 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.826 1.651 . . . . 70.439999999999998 108.54 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.12 143.75 21.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 109.057 -0.72 . . . . 75.209999999999994 109.057 169.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.28 113.31 11.35 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.494 0.718 . . . . 64.409999999999997 109.112 172.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.2 mt -79.26 -20.14 48.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.516 0.726 . . . . 62.530000000000001 110.006 171.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.562 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 71.5 m-85 -136.1 151.61 49.98 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.06 0.544 . . . . 74.150000000000006 109.548 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -70.52 141.8 51.9 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.5 -0.773 . . . . 70.239999999999995 110.304 174.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.527 ' HB3' HG12 ' A' ' 101' ' ' ILE . 87.8 t80 -138.67 115.58 10.83 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.461 -0.57 . . . . 75.420000000000002 109.461 174.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.3 t -81.0 134.34 27.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 107.986 -1.116 . . . . 74.5 107.986 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.23 116.64 8.24 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.763 -0.458 . . . . 75.239999999999995 109.763 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.2 p -71.45 -23.87 61.91 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.465 0.706 . . . . 71.400000000000006 110.501 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.75 -172.01 29.67 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.273 -0.876 . . . . 75.510000000000005 112.097 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.44 -28.8 68.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.325 1.05 . . . . 75.439999999999998 110.72 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -75.25 -16.85 60.43 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.292 1.037 . . . . 71.150000000000006 113.019 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.5 p -109.3 158.6 17.71 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.679 0.792 . . . . 72.409999999999997 110.607 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 125' ' ' ASN . 66.8 tp -107.88 130.72 54.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.33 0.652 . . . . 74.230000000000004 109.701 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 p -78.12 113.38 16.01 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.308 -0.627 . . . . 62.130000000000003 109.308 172.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 91' ' ' PHE . 34.2 pt -122.22 161.7 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.68 -0.859 . . . . 74.400000000000006 108.68 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.7 m -135.4 151.66 50.66 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 109.304 -0.628 . . . . 75.409999999999997 109.304 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -53.37 117.22 2.9 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.224 0.61 . . . . 71.450000000000003 111.089 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.59 -27.5 7.94 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.973 -0.558 . . . . 70.099999999999994 113.218 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -72.25 122.57 21.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.31 0.644 . . . . 72.430000000000007 110.323 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -84.31 124.61 31.44 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.935 0.494 . . . . 75.239999999999995 110.27 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 19.7 mt -105.55 135.28 47.23 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.702 0.801 . . . . 73.329999999999998 110.365 -168.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -95.35 107.53 19.67 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.111 -1.44 . . . . 72.450000000000003 107.111 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.7 t -97.51 124.47 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.987 -0.746 . . . . 72.239999999999995 108.987 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 30' ' ' GLU . 64.4 mt -70.56 -36.27 73.55 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.529 0.681 . . . . 74.120000000000005 109.58 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.13 178.63 41.76 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 114.66 -1.155 . . . . 51.420000000000002 111.357 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 2.4 m-30 -94.99 174.33 7.14 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.785 -0.82 . . . . 72.349999999999994 108.785 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -72.33 159.12 34.56 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.612 -0.722 . . . . 71.219999999999999 109.795 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.436 ' HA ' ' O ' ' A' ' 59' ' ' GLN . 47.6 t60 -58.07 -24.81 59.95 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.526 1.13 . . . . 65.430000000000007 111.76 175.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.434 ' HB3' ' HG2' ' A' ' 117' ' ' GLU . 56.5 t30 -95.98 -21.97 17.68 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.924 0.49 . . . . 74.049999999999997 111.144 174.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.04 -0.18 83.8 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 122.7 0.191 . . . . 63.210000000000001 113.025 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.434 ' HG2' ' HB3' ' A' ' 115' ' ' ASN . 8.4 pt-20 -57.68 -52.42 65.5 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.008 1.323 . . . . 71.409999999999997 112.081 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -118.58 177.28 4.89 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.28 1.032 . . . . 75.319999999999993 110.12 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -146.93 124.46 11.72 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.649 0.78 . . . . 65.310000000000002 109.411 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -85.24 105.8 16.19 Favored 'General case' 0 C--O 1.249 1.064 0 CA-C-O 121.071 0.462 . . . . 63.420000000000002 110.537 -173.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.11 153.21 20.53 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 115.102 -0.953 . . . . 53.100000000000001 110.086 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -141.8 124.72 16.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.789 0.836 . . . . 71.409999999999997 110.081 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 59.6 p -133.7 -167.3 1.92 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.563 0.745 . . . . 52.340000000000003 110.47 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -58.48 -22.5 55.09 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.539 1.135 . . . . 55.520000000000003 111.116 170.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.457 ' HB2' HD11 ' A' ' 99' ' ' LEU . 53.5 m-20 -84.99 6.11 26.47 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.894 1.278 . . . . 42.299999999999997 111.754 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.77 -128.98 9.75 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 111.001 -0.84 . . . . 72.400000000000006 111.001 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -151.53 162.17 41.42 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.53 0.665 . . . . 63.240000000000002 111.736 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 165.23 171.51 31.55 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.777 -0.647 . . . . 35.509999999999998 112.9 170.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.448 ' HZ2' ' HG2' ' A' ' 24' ' ' LYS . 94.7 m95 -79.29 117.55 20.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.549 0.74 . . . . 70.209999999999994 110.92 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.2 m -117.58 154.88 50.84 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.373 1.069 . . . . 73.239999999999995 108.564 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.38 131.57 15.24 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 121.557 1.505 . . . . 64.310000000000002 111.152 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.569 ' HA ' HG12 ' A' ' 135' ' ' ILE . 23.9 t -63.53 -14.97 56.46 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.921 0.488 . . . . 63.210000000000001 111.547 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -69.89 -25.46 63.71 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.22 1.008 . . . . 70.530000000000001 111.016 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.562 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 6.5 m-30 -95.58 -3.09 47.07 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.577 0.751 . . . . 74.120000000000005 112.739 -177.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.569 HG12 ' HA ' ' A' ' 132' ' ' SER . 12.6 pt -129.42 161.06 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 118.113 0.415 . . . . 74.219999999999999 110.847 -171.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 10.0 t -145.72 139.24 14.58 Favored Pre-proline 0 N--CA 1.483 1.218 0 C-N-CA 123.075 0.55 . . . . 72.310000000000002 110.045 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.501 ' HB2' ' HB2' ' A' ' 140' ' ' SER . 74.1 Cg_endo -74.52 116.64 4.68 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.3 2.0 . . . . 53.149999999999999 111.889 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 17.9 m -89.51 -25.76 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.069 0.547 . . . . 63.200000000000003 111.492 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.583 ' HB3' ' H ' ' A' ' 84' ' ' LEU . 65.6 t30 -94.17 18.67 10.45 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 122.01 0.91 . . . . 75.310000000000002 110.142 173.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.501 ' HB2' ' HB2' ' A' ' 137' ' ' PRO . 32.3 t -64.84 162.84 15.41 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.445 0.698 . . . . 72.129999999999995 110.515 170.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.6 mt -73.6 -12.11 60.65 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 123.568 0.747 . . . . 75.400000000000006 109.828 173.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.69 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 39.2 tt0 -49.51 -27.65 4.57 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 127.38 2.272 . . . . 75.409999999999997 115.68 -175.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.408 ' H ' ' HD3' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -60.65 -31.04 70.27 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 118.625 0.648 . . . . 71.299999999999997 110.314 177.257 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -79.63 123.59 27.77 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.047 -1.094 . . . . 61.140000000000001 108.047 166.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.0 p -61.11 -10.74 6.76 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.96 1.096 . . . . 73.219999999999999 113.96 -168.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.471 ' CE3' HG21 ' A' ' 218' ' ' VAL . 61.7 p-90 -71.17 -40.58 71.19 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 111.885 0.328 . . . . 72.209999999999994 111.885 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 142' ' ' GLU . 36.1 t80 -97.62 146.78 24.97 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 110.172 -0.307 . . . . 74.129999999999995 110.172 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.69 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 61.6 m-70 -146.06 60.97 1.25 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.001 0.52 . . . . 73.329999999999998 110.687 175.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 57.53 -165.58 6.21 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 116.97 1.548 . . . . 55.509999999999998 116.97 164.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 71.6 Cg_endo -80.09 102.86 1.48 Allowed 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.433 2.756 . . . . 45.539999999999999 112.263 168.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.434 HG21 HH21 ' A' ' 171' ' ' ARG . 21.3 t -139.31 155.36 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.132 0.973 . . . . 72.109999999999999 110.24 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.3 m -89.52 173.03 8.55 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.245 1.018 . . . . 53.439999999999998 113.425 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -62.96 -34.17 76.93 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.646 -1.161 . . . . 53.130000000000003 113.16 -173.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -61.64 -57.93 10.08 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 123.607 0.567 . . . . 75.420000000000002 110.595 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.91 -31.34 71.86 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.4 0.68 . . . . 60.039999999999999 111.017 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.75 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.1 -56.99 14.92 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.365 0.603 . . . . 75.109999999999999 111.255 173.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -71.75 -23.98 61.69 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.249 -0.887 . . . . 74.150000000000006 110.797 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -63.98 -51.79 62.63 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.981 0.912 . . . . 65.409999999999997 110.33 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.56 HD12 HH12 ' A' ' 171' ' ' ARG . 79.2 mt -68.9 -40.89 78.91 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.024 0.44 . . . . 53.43 110.931 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.47 HD23 HG13 ' A' ' 190' ' ' VAL . 34.2 tp -67.09 -22.65 65.82 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.479 -0.782 . . . . 72.040000000000006 112.272 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.9 t -58.26 -30.09 66.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.979 0.911 . . . . 63.240000000000002 111.447 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.8 t -88.11 8.5 26.53 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.419 0.687 . . . . 62.229999999999997 111.571 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -100.49 150.6 18.87 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 122.324 -0.235 . . . . 44.030000000000001 113.481 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.6 pt -97.43 -166.32 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.044 0.938 . . . . 74.420000000000002 109.47 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 25.4 p-10 -51.21 118.65 3.38 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.798 0.839 . . . . 53.25 112.619 -176.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.73 14.01 68.63 Favored Glycine 0 C--O 1.257 1.542 0 CA-C-N 116.253 -0.43 . . . . 42.549999999999997 113.768 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 63.2 p -70.94 138.78 50.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.316 -0.624 . . . . 65.209999999999994 109.316 174.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.415 ' HB3' HD23 ' A' ' 184' ' ' LEU . 18.5 p90 -139.28 156.24 47.19 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.231 0.826 . . . . 71.420000000000002 113.231 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 236' ' ' ALA . 96.8 mt -134.16 134.5 42.22 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.428 -1.26 . . . . 62.420000000000002 108.581 169.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.41 HG22 HG12 ' A' ' 182' ' ' ILE . 25.8 t -114.63 126.98 72.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 107.057 -1.46 . . . . 54.100000000000001 107.057 174.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.75 HH11 ' HA ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -159.84 150.04 18.65 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.226 0.61 . . . . 65.439999999999998 110.019 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 14.1 pt-20 -94.77 163.96 13.14 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.973 -0.751 . . . . 52.030000000000001 108.973 177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 176' ' ' SER . 35.4 m -87.03 141.12 28.9 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.645 0.26 . . . . 65.439999999999998 111.532 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.55 -37.46 86.2 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.849 0.859 . . . . 73.349999999999994 110.416 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.455 ' HB3' ' HG3' ' A' ' 66' ' ' ARG . 63.0 p -86.07 -10.2 55.37 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.207 -1.36 . . . . 61.340000000000003 112.471 -176.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 173' ' ' SER . 12.0 m -139.28 88.31 13.04 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.338 0.655 . . . . 72.439999999999998 109.533 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.39 124.25 13.48 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.96 2.44 . . . . 75.530000000000001 112.11 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.84 -22.25 29.42 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.868 -0.606 . . . . 71.140000000000001 113.744 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -82.8 117.67 22.85 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 108.878 -0.786 . . . . 75.140000000000001 108.878 176.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 70.1 mtt-85 -111.15 169.07 9.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.137 -0.938 . . . . 73.340000000000003 110.842 -170.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.5 m -152.0 149.75 29.22 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.722 0.809 . . . . 54.240000000000002 110.136 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.41 HG12 HG22 ' A' ' 170' ' ' VAL . 48.7 mt -116.95 139.96 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 108.732 -0.84 . . . . 52.520000000000003 108.732 169.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.417 ' HB3' HD22 ' A' ' 160' ' ' LEU . 18.6 m -118.75 111.64 18.74 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.13 1.372 . . . . 75.120000000000005 107.908 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.467 HD21 HD23 ' A' ' 232' ' ' LEU . 29.9 mt -106.14 137.94 43.2 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.317 1.047 . . . . 75.439999999999998 111.256 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -126.92 126.15 42.76 Favored 'General case' 0 C--O 1.256 1.401 0 N-CA-C 108.656 -0.868 . . . . 74.340000000000003 108.656 170.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.79 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 6.2 p90 -138.35 141.69 39.7 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.143 -1.058 . . . . 73.409999999999997 108.143 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 52.38 23.61 2.55 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.104 0.961 . . . . 74.510000000000005 113.547 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 96.82 -11.18 66.34 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 123.05 0.357 . . . . 74.109999999999999 113.576 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -101.98 126.76 48.97 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.751 0.82 . . . . 61.329999999999998 111.149 -173.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.47 HG13 HD23 ' A' ' 160' ' ' LEU . 80.0 t -95.14 142.42 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.199 1.0 . . . . 75.430000000000007 110.461 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.402 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 23.2 p90 -146.41 154.5 41.69 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.325 1.05 . . . . 74.329999999999998 109.431 165.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -128.05 142.39 51.23 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.829 0.852 . . . . 74.549999999999997 108.732 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -141.76 151.55 42.98 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 120.985 0.421 . . . . 71.239999999999995 110.341 174.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -78.95 145.29 34.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.29 -0.868 . . . . 74.5 111.304 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 79.8 mt -89.49 104.23 14.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 106.754 -1.573 . . . . 62.520000000000003 106.754 161.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -71.22 127.06 31.33 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.193 -0.912 . . . . 74.319999999999993 108.668 -177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 31.8 m -99.52 116.58 31.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.168 0.587 . . . . 73.400000000000006 109.862 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.09 166.61 4.59 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.557 1.143 . . . . 74.549999999999997 111.575 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 55.9 p -62.29 -35.72 79.9 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.153 -0.476 . . . . 74.310000000000002 110.487 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -69.05 -12.77 61.98 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.533 0.733 . . . . 34.420000000000002 111.775 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 96.27 -5.49 65.42 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 116.458 -0.337 . . . . 62.32 112.313 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -62.49 141.93 58.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.561 0.744 . . . . 64.109999999999999 110.798 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 81.4 mt -93.87 144.36 25.51 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.195 -0.669 . . . . 74.150000000000006 109.195 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -162.78 161.49 26.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.094 0.558 . . . . 73.010000000000005 109.891 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 70.7 t -135.54 -55.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.375 -0.972 . . . . 74.120000000000005 108.375 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 9.9 m -90.96 169.86 10.54 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.379 0.671 . . . . 63.329999999999998 109.699 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 61.3 m -69.66 -48.22 60.55 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.509 0.559 . . . . 43.119999999999997 112.509 -171.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -73.62 -26.41 60.77 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.271 0.629 . . . . 63.530000000000001 110.795 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 58.0 m -67.91 118.19 10.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.234 1.014 . . . . 65.299999999999997 110.684 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -142.48 126.9 17.74 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.432 1.093 . . . . 75.219999999999999 108.324 175.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -135.64 141.26 45.02 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.033 0.379 . . . . 62.439999999999998 111.056 -173.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -91.58 -21.72 20.69 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.471 -0.786 . . . . 75.120000000000005 109.94 169.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 48.4 p -127.7 142.46 51.32 Favored 'General case' 0 C--N 1.363 1.185 0 CA-C-O 121.674 0.749 . . . . 74.099999999999994 111.88 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.4 HD11 HG11 ' A' ' 170' ' ' VAL . 30.1 tp -65.57 -28.7 69.34 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.404 -1.271 . . . . 74.200000000000003 110.764 175.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.89 97.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.408 0.683 . . . . 64.25 110.521 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.9 -30.27 63.8 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.474 0.31 . . . . 74.510000000000005 111.518 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.0 tt -61.04 -44.0 98.05 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.271 0.357 . . . . 75.310000000000002 110.555 170.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.471 HG21 ' CE3' ' A' ' 146' ' ' TRP . 42.5 t -70.18 -40.07 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.334 0.653 . . . . 53.109999999999999 111.006 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -60.42 -50.81 72.1 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.784 0.802 . . . . 74.439999999999998 110.486 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.415 ' O ' HG22 ' A' ' 224' ' ' VAL . 49.6 t60 -56.32 -54.65 42.95 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.285 -1.325 . . . . 73.340000000000003 110.335 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -63.52 -25.18 68.14 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.137 0.575 . . . . 75.409999999999997 112.141 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 23.0 t -74.61 -28.2 60.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.272 0.229 . . . . 44.539999999999999 110.994 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.8 t -103.9 -22.49 13.49 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.021 1.86 . . . . 63.100000000000001 116.021 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 220' ' ' HIS . 29.0 m -90.83 120.42 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 120.495 1.498 . . . . 74.439999999999998 114.344 -165.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.2 -1.32 9.87 Favored 'General case' 0 CA--C 1.57 1.715 0 C-N-CA 127.783 2.433 . . . . 73.340000000000003 112.745 171.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.19 14.72 1.1 Allowed 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 128.142 2.577 . . . . 65.409999999999997 114.311 -145.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.76 17.23 4.28 Favored Glycine 0 N--CA 1.467 0.755 0 O-C-N 121.805 -0.559 . . . . 64.530000000000001 111.926 -166.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 64.2 mt -91.36 133.73 35.2 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.045 -0.724 . . . . 74.209999999999994 109.045 156.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.402 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 93.4 mt -57.91 -52.48 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 109.233 -0.655 . . . . 74.540000000000006 109.233 172.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.3 t -130.52 150.35 51.77 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.944 -1.026 . . . . 72.439999999999998 108.282 167.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 69.8 p -80.02 170.6 16.24 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 109.05 -0.722 . . . . 75.019999999999996 109.05 171.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.467 HD23 HD21 ' A' ' 184' ' ' LEU . 26.2 mt -74.88 102.59 4.8 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 108.896 -0.779 . . . . 64.299999999999997 108.896 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -78.64 -57.62 3.67 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.16 -0.682 . . . . 75.510000000000005 109.16 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 167' ' ' SER . 7.3 p90 -154.8 151.17 22.8 Favored Pre-proline 0 N--CA 1.483 1.184 0 N-CA-C 109.832 -0.433 . . . . 72.329999999999998 109.832 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.82 138.52 44.98 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.105 1.87 . . . . 72.310000000000002 111.578 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.472 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -58.83 127.06 82.45 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 109.231 -0.655 . . . . 64.549999999999997 109.231 173.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.06 158.69 28.82 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.853 2.368 . . . . 64.219999999999999 113.281 -172.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.49 141.6 58.7 Favored 'General case' 0 C--N 1.348 0.511 0 N-CA-C 109.052 -0.722 . . . . 61.229999999999997 109.052 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -46.3 -33.93 4.12 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.975 1.31 . . . . 74.019999999999996 112.748 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -56.49 -66.12 0.49 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 124.119 0.968 . . . . 71.129999999999995 110.371 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -175.67 160.34 2.05 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 123.73 0.812 . . . . 63.329999999999998 111.168 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.95 -178.81 4.79 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.925 2.416 . . . . 71.530000000000001 112.811 167.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 41.4 p -105.29 -72.81 0.7 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.552 0.741 . . . . 52.409999999999997 109.76 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 18.4 m -138.77 152.8 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 124.504 1.122 . . . . 52.119999999999997 110.204 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -99.54 -57.21 2.2 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.997 0.519 . . . . 64.420000000000002 109.993 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 144.94 -178.16 22.92 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-O 119.973 -0.348 . . . . 74.239999999999995 113.116 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.9 m -130.74 143.49 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 117.348 0.574 . . . . 73.019999999999996 111.622 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.0 m -88.47 120.35 70.34 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.003 0.921 . . . . 71.230000000000004 109.452 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.93 132.68 46.17 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.931 2.42 . . . . 75.129999999999995 112.803 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -80.85 162.66 23.89 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.932 0.493 . . . . 74.040000000000006 110.79 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -157.47 159.15 36.97 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.68 0.792 . . . . 71.200000000000003 110.479 -173.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -90.23 118.08 29.47 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.786 -0.82 . . . . 63.530000000000001 108.786 171.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.82 141.31 56.52 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.699 0.4 . . . . 61.130000000000003 110.858 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -70.8 164.77 24.53 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.191 0.596 . . . . 70.140000000000001 110.942 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 . . . . . 0 CA--C 1.561 1.394 0 C-N-CA 125.158 1.383 . . . . 72.019999999999996 111.848 174.343 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtm . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 109.348 -0.612 . . . . 72.420000000000002 109.348 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.24 68.72 1.1 Allowed Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.323 -0.711 . . . . 54.409999999999997 111.323 -177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -70.64 -68.68 0.41 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.264 0.626 . . . . 74.409999999999997 109.812 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 65.48 129.43 0.03 OUTLIER Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 125.161 1.384 . . . . 52.310000000000002 110.896 -171.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -61.46 -31.46 87.96 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.701 2.268 . . . . 50.210000000000001 111.878 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.33 -175.86 50.69 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.552 -0.749 . . . . 74.120000000000005 113.168 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' HD2' ' HA ' ' A' ' 68' ' ' ASN . 23.1 ttpp -88.89 148.88 23.61 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.921 -0.77 . . . . 74.310000000000002 108.921 173.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.7 m -70.93 158.42 6.21 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 CA-C-O 121.011 0.434 . . . . 61.420000000000002 110.682 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.1 tp -63.17 131.47 48.57 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.063 -0.972 . . . . 72.409999999999997 111.175 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.544 ' HA2' HD21 ' A' ' 68' ' ' ASN . . . -100.84 49.81 1.06 Allowed Glycine 0 C--N 1.345 1.044 0 CA-C-N 115.999 -0.546 . . . . 71.209999999999994 111.746 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -136.89 174.45 10.6 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.706 0.802 . . . . 55.109999999999999 111.146 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -79.73 179.78 7.34 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.611 -1.177 . . . . 73.25 111.603 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.3 ttm105 61.84 83.59 0.15 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.887 1.275 . . . . 73.329999999999998 110.721 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 46.25 77.96 0.43 Allowed Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 114.435 1.272 . . . . 74.120000000000005 114.435 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.64 165.81 31.39 Favored 'Trans proline' 0 C--N 1.365 1.411 0 C-N-CA 121.752 1.634 . . . . 64.420000000000002 109.689 161.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -66.13 169.23 7.27 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.29 0.566 . . . . 64.230000000000004 111.801 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.9 mt -103.32 124.63 37.57 Favored Pre-proline 0 C--O 1.242 0.658 0 N-CA-C 108.1 -1.074 . . . . 64.25 108.1 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.02 168.62 21.37 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.289 1.993 . . . . 62.020000000000003 111.244 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' HB3' ' NE2' ' A' ' 21' ' ' HIS . . . -83.03 148.22 27.68 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.773 0.32 . . . . 74.140000000000001 110.446 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.559 HD22 HD11 ' A' ' 23' ' ' ILE . 73.6 mt -84.58 94.77 8.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.86 -1.163 . . . . 63.43 107.86 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.423 ' NE2' ' HB3' ' A' ' 19' ' ' ALA . 34.1 m170 -96.24 -50.12 4.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.684 -0.689 . . . . 73.409999999999997 110.522 -174.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.488 ' HB2' ' OD1' ' A' ' 113' ' ' ASN . 73.8 m-85 -102.76 107.35 18.19 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.875 -0.787 . . . . 75.010000000000005 108.875 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.559 HD11 HD22 ' A' ' 20' ' ' LEU . 45.4 mm -122.6 114.05 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.034 -1.098 . . . . 73.209999999999994 108.034 175.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 21.09 15.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.346 0.658 . . . . 75.310000000000002 110.161 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.85 -91.6 0.27 Allowed Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.21 -0.905 . . . . 64.340000000000003 111.32 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -166.44 -23.21 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.22 1.008 . . . . 74.439999999999998 111.073 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.45 -168.14 53.6 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.379 0.425 . . . . 74.540000000000006 112.682 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -96.85 104.49 16.5 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.465 -0.939 . . . . 61.310000000000002 108.465 170.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.54 ' HD3' ' H ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -135.07 160.0 39.74 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.271 1.028 . . . . 71.340000000000003 109.505 -172.555 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -151.04 149.1 29.14 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.547 0.739 . . . . 71.430000000000007 109.554 174.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.0 t -153.73 93.56 1.68 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.349 -0.982 . . . . 61.25 108.349 176.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 p -90.04 79.85 6.46 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.821 0.848 . . . . 71.310000000000002 110.384 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.419 ' HG2' ' HD2' ' A' ' 82' ' ' PRO . 5.4 mpt_? -119.46 -156.88 0.68 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.112 0.965 . . . . 70.439999999999998 109.796 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.404 ' H ' ' HB3' ' A' ' 33' ' ' ARG . 11.5 p80 -61.39 124.62 21.12 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.2 0.6 . . . . 65.319999999999993 111.255 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.47 163.61 19.18 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.832 -0.907 . . . . 71.049999999999997 110.832 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.67 -75.76 0.41 Allowed Glycine 0 C--N 1.344 0.998 0 CA-C-O 118.643 -1.087 . . . . 40.25 112.688 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HD3' HG11 ' A' ' 43' ' ' VAL . 11.8 Cg_endo -51.93 108.96 0.28 Allowed 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 123.992 3.128 . . . . 55.409999999999997 114.473 -172.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.485 ' HB2' ' HE2' ' A' ' 124' ' ' LYS . 14.4 t-160 -158.81 10.35 0.14 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.104 1.361 . . . . 74.439999999999998 109.304 174.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.9 t -158.51 156.52 30.38 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.834 0.854 . . . . 72.239999999999995 109.05 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -75.84 87.84 2.85 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.249 0.547 . . . . 54.130000000000003 110.005 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.5 p -153.37 148.88 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.114 0.966 . . . . 71.099999999999994 109.199 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -58.97 110.96 1.14 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.65 0.78 . . . . 65.109999999999999 110.777 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.429 HG11 ' HD3' ' A' ' 37' ' ' PRO . 41.8 t -89.86 116.07 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.916 -0.772 . . . . 75.430000000000007 108.916 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -94.3 -37.71 11.37 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.101 0.56 . . . . 63.329999999999998 111.772 -175.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 29.8 m170 59.83 22.12 11.04 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.073 0.949 . . . . 70.400000000000006 111.572 -172.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.45 139.65 47.84 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.765 -0.652 . . . . 62.420000000000002 110.253 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.22 148.44 11.46 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.77 0.828 . . . . 44.409999999999997 109.568 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.6 mt -116.61 111.45 19.9 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.289 -1.004 . . . . 33.32 108.289 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -65.59 135.67 55.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.008 0.523 . . . . 74.25 110.245 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -78.18 120.72 82.26 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.589 0.756 . . . . 72.439999999999998 109.132 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.37 -21.12 12.89 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 123.967 3.111 . . . . 65.25 115.031 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.41 -56.06 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 109.156 -0.683 . . . . 72.439999999999998 109.156 172.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 52.25 31.14 8.81 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.527 1.131 . . . . 71.420000000000002 112.198 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.3 t -155.46 162.7 40.68 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.353 1.061 . . . . 65.010000000000005 109.036 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -144.85 160.42 41.31 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.262 0.625 . . . . 75.030000000000001 109.595 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -59.65 -36.01 75.56 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.025 0.93 . . . . 73.310000000000002 111.429 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.253 5.0 pt-20 53.59 73.38 0.93 Allowed Pre-proline 0 N--CA 1.485 1.295 0 C-N-CA 125.883 1.673 . . . . 74.239999999999995 112.27 175.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.39 86.57 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.932 2.422 . . . . 65.329999999999998 111.979 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -86.85 175.9 7.96 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.166 -0.924 . . . . 73.519999999999996 111.605 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.56 157.46 30.11 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 115.695 -0.684 . . . . 75.010000000000005 113.566 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.6 mt -116.38 -50.5 2.64 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.863 0.865 . . . . 73.040000000000006 109.953 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.8 p -172.74 71.46 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.632 0.773 . . . . 72.450000000000003 109.808 -174.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.21 140.1 26.34 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.885 0.874 . . . . 75.140000000000001 109.826 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -169.73 73.51 0.08 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.172 0.989 . . . . 70.200000000000003 109.401 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.22 95.88 5.08 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.862 -1.162 . . . . 71.430000000000007 107.862 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -72.55 81.04 1.08 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.656 0.782 . . . . 75.400000000000006 111.031 -165.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.454 ' H ' ' HE3' ' A' ' 67' ' ' TRP . 4.1 p90 -59.45 -38.17 80.05 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.692 1.197 . . . . 75.040000000000006 111.197 -177.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.553 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 56.9 t30 -168.87 137.07 2.03 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.753 0.821 . . . . 74.530000000000001 109.65 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.4 t -159.61 125.67 4.32 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 108.029 -1.1 . . . . 75.310000000000002 108.029 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.407 ' HB3' ' HA3' ' A' ' 10' ' ' GLY . 61.5 tttm -161.47 -59.03 0.05 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.365 0.666 . . . . 70.040000000000006 110.39 -176.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -167.78 164.22 14.2 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.458 0.703 . . . . 63.240000000000002 110.443 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -156.26 147.87 22.76 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.686 0.794 . . . . 60.310000000000002 109.977 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.9 mt -124.24 92.36 3.65 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.01 0.924 . . . . 70.299999999999997 108.706 176.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 79.1 mt -93.46 125.34 38.02 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.183 0.593 . . . . 72.140000000000001 109.676 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.85 169.68 19.97 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.795 0.838 . . . . 52.130000000000003 111.016 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.468 ' HA3' HG12 ' A' ' 138' ' ' VAL . . . 142.28 160.38 8.32 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.524 -0.762 . . . . 75.439999999999998 112.418 175.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.96 137.29 17.37 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 123.022 2.481 . . . . 71.019999999999996 111.46 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.689 ' HB2' ' HG3' ' A' ' 143' ' ' LYS . 7.9 t -68.0 95.31 0.54 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.057 0.543 . . . . 74.219999999999999 109.861 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.59 ' HB2' HD23 ' A' ' 84' ' ' LEU . 41.3 mt-10 -102.71 170.24 8.13 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.791 0.837 . . . . 65.209999999999994 110.985 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -94.67 96.08 9.18 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.245 0.618 . . . . 74.439999999999998 111.44 -169.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.828 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 13.9 t70 179.08 129.96 0.23 Allowed Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 125.572 1.549 . . . . 61.450000000000003 107.552 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.419 ' HD2' ' HG2' ' A' ' 33' ' ' ARG . 9.6 Cg_endo -46.03 -47.56 14.22 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 124.239 3.293 . . . . 73.099999999999994 114.025 -168.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -135.48 67.07 1.49 Allowed 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.086 -1.079 . . . . 62.240000000000002 108.086 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.828 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 18.0 tp -85.83 114.53 22.84 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 121.275 0.559 . . . . 75.510000000000005 109.526 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 5.1 m-85 -104.8 175.09 5.61 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.777 1.631 . . . . 70.0 109.401 173.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.93 142.73 31.51 Favored 'Isoleucine or valine' 0 C--O 1.251 1.133 0 N-CA-C 108.073 -1.084 . . . . 65.140000000000001 108.073 169.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.466 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -77.42 117.65 19.1 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.548 0.53 . . . . 71.340000000000003 109.814 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.2 mt -80.67 -11.11 59.68 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.269 0.628 . . . . 63.43 111.284 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.434 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 54.1 m-85 -138.79 156.64 47.18 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.911 0.884 . . . . 74.25 109.025 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.84 130.88 35.29 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.066 -1.087 . . . . 65.340000000000003 108.066 168.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -141.0 124.1 16.41 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.563 -0.902 . . . . 74.409999999999997 108.563 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.31 138.95 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.037 -0.727 . . . . 75.340000000000003 109.037 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.02 133.89 56.49 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.297 0.639 . . . . 52.509999999999998 111.743 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.5 t -81.01 -6.17 58.47 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.355 1.062 . . . . 61.43 110.855 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.33 -162.11 35.91 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.649 -0.58 . . . . 54.310000000000002 111.649 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.52 -34.21 76.65 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.302 1.041 . . . . 51.310000000000002 111.084 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.474 ' ND2' HD13 ' A' ' 20' ' ' LEU . 30.0 p-10 -82.53 9.96 8.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.047 0.939 . . . . 74.349999999999994 112.59 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.1 p -135.49 153.96 51.56 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.335 1.054 . . . . 75.099999999999994 108.833 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.0 tp -110.25 135.7 50.59 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.869 0.468 . . . . 73.439999999999998 110.463 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.4 m -78.54 114.56 17.56 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.404 -0.962 . . . . 72.129999999999995 108.404 169.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.5 pt -118.87 144.72 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.611 0.765 . . . . 71.430000000000007 109.3 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 4.8 m -107.78 146.29 32.39 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.351 -0.611 . . . . 74.329999999999998 109.351 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -63.42 109.11 1.5 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.735 0.414 . . . . 53.450000000000003 110.995 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.73 1.69 34.56 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 116.064 -0.516 . . . . 31.120000000000001 112.748 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.62 136.36 33.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.326 1.05 . . . . 43.0 110.181 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.547 ' HB3' HD11 ' A' ' 84' ' ' LEU . 66.4 mttm -82.8 112.99 20.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.832 0.853 . . . . 65.5 109.55 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 87' ' ' ALA . 16.8 mt -100.72 138.05 38.3 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.781 0.832 . . . . 71.230000000000004 108.925 -173.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -108.59 107.32 17.77 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.139 -1.06 . . . . 70.109999999999999 108.139 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 88.1 t -100.14 129.88 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.422 0.689 . . . . 54.210000000000001 109.221 -173.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.4 mt -85.1 -22.82 28.74 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.7 0.4 . . . . 65.519999999999996 110.844 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.73 174.88 37.1 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.779 -0.646 . . . . 73.129999999999995 111.839 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 13.4 m-30 -94.84 174.92 6.86 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.267 0.627 . . . . 75.200000000000003 109.633 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.488 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 57.4 t30 -62.03 159.5 14.27 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.494 1.118 . . . . 71.150000000000006 109.572 173.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -65.91 -18.26 65.22 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 122.487 0.315 . . . . 73.099999999999994 110.696 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -111.44 5.89 19.91 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.555 0.742 . . . . 72.019999999999996 111.398 171.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.87 2.87 53.6 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 115.427 0.931 . . . . 72.310000000000002 115.427 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -60.67 -59.05 6.01 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.345 1.058 . . . . 65.409999999999997 110.907 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -104.49 179.34 4.3 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.142 -1.39 . . . . 73.340000000000003 109.55 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -150.89 121.46 7.44 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.996 0.918 . . . . 70.5 109.376 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.406 ' HG2' HE21 ' A' ' 127' ' ' GLN . 36.4 tt0 -75.75 100.33 4.68 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 120.985 0.421 . . . . 73.019999999999996 110.207 -176.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -103.86 157.41 17.11 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.944 0.898 . . . . 73.340000000000003 110.242 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -142.92 126.78 17.17 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.86 0.864 . . . . 74.530000000000001 109.471 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.2 p -136.1 -171.61 2.92 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.49 1.116 . . . . 62.130000000000003 109.686 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.485 ' HE2' ' HB2' ' A' ' 38' ' ' HIS . 27.3 mtpp -70.01 -7.3 39.79 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.363 0.665 . . . . 73.129999999999995 111.504 175.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -84.61 -13.19 52.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.116 0.967 . . . . 75.5 111.316 173.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 128.07 -142.36 13.45 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.853 -0.499 . . . . 52.229999999999997 111.853 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.406 HE21 ' HG2' ' A' ' 120' ' ' GLU . 55.2 tt0 -151.69 145.68 25.22 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.376 0.67 . . . . 72.329999999999998 110.833 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 173.58 179.01 43.96 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.442 -0.799 . . . . 73.120000000000005 111.717 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -82.07 123.37 28.88 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.693 0.797 . . . . 73.349999999999994 110.433 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.88 148.32 41.87 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 124.738 1.215 . . . . 71.010000000000005 109.025 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.95 130.69 25.08 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 121.871 1.714 . . . . 54.25 111.008 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.1 m -61.42 -19.37 61.86 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.942 0.897 . . . . 63.43 112.698 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -72.97 -21.39 60.86 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.941 0.896 . . . . 61.240000000000002 111.537 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.434 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.1 m-85 -94.36 -3.99 49.33 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.566 0.746 . . . . 64.310000000000002 112.608 -175.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.4 pt -128.36 151.74 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.039 0.536 . . . . 75.129999999999995 110.525 -171.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 8.2 t -141.28 133.54 13.97 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 122.602 0.361 . . . . 44.25 110.637 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 59.2 Cg_endo -72.43 117.78 5.29 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.522 2.148 . . . . 70.120000000000005 112.116 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.468 HG12 ' HA3' ' A' ' 76' ' ' GLY . 22.9 m -80.22 -36.92 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.158 0.583 . . . . 73.409999999999997 110.11 176.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -73.43 -9.76 59.02 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.365 0.666 . . . . 72.239999999999995 111.295 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 143' ' ' LYS . 28.6 t -39.16 129.28 1.69 Allowed 'General case' 0 C--N 1.363 1.174 0 C-N-CA 125.281 1.433 . . . . 73.200000000000003 112.447 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 72.0 mt -60.82 -10.07 5.01 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.482 0.713 . . . . 61.0 111.591 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -57.1 -19.59 20.52 Favored 'General case' 0 C--N 1.365 1.246 0 C-N-CA 124.732 1.213 . . . . 74.420000000000002 112.634 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.689 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 2.4 mmmp? -61.09 -24.99 66.64 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.164 0.506 . . . . 73.099999999999994 110.243 171.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -94.0 120.74 34.68 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 106.371 -1.714 . . . . 74.25 106.371 163.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.5 t -57.32 -17.42 12.15 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.257 1.206 . . . . 73.019999999999996 114.257 -166.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.503 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 51.2 p-90 -66.74 -50.43 62.8 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.689 0.626 . . . . 62.539999999999999 112.689 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.427 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 75.7 t80 -79.42 148.0 32.11 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.898 0.479 . . . . 75.200000000000003 110.426 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.45 ' CD2' HD22 ' A' ' 169' ' ' LEU . 87.9 m-70 -135.85 -27.16 1.15 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.203 0.601 . . . . 73.120000000000005 110.47 171.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 100.15 -151.28 19.11 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.139 -0.812 . . . . 73.400000000000006 114.609 171.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 33.6 Cg_endo -63.04 89.47 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.273 2.649 . . . . 72.049999999999997 110.781 175.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 86.9 t -130.43 149.56 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 115.708 -0.678 . . . . 71.400000000000006 110.244 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.6 m -60.91 148.63 39.02 Favored 'General case' 0 C--O 1.246 0.921 0 C-N-CA 124.744 1.217 . . . . 71.400000000000006 112.333 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 41.0 ttt-85 -57.16 -39.35 75.1 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.451 -0.795 . . . . 55.020000000000003 110.033 172.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -60.27 -58.59 7.87 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.735 -1.121 . . . . 41.520000000000003 110.554 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -56.72 -39.08 73.26 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.035 0.835 . . . . 63.210000000000001 111.328 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.06 -61.54 2.56 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.362 -0.835 . . . . 63.299999999999997 111.776 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -70.5 -20.0 62.88 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.245 -0.889 . . . . 75.0 110.805 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.481 ' HE2' HH21 ' A' ' 239' ' ' ARG . 50.6 t80 -74.11 -51.29 16.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.701 0.8 . . . . 74.540000000000006 110.691 176.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 71.1 mt -63.8 -39.44 94.25 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.111 0.482 . . . . 74.340000000000003 109.892 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.435 HD23 HG13 ' A' ' 190' ' ' VAL . 27.4 tp -72.34 -18.61 61.75 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.142 -0.936 . . . . 63.409999999999997 111.197 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.492 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 17.3 t -67.17 -23.13 65.74 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.934 0.494 . . . . 73.430000000000007 110.902 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.1 t -91.12 8.63 34.64 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.89 0.876 . . . . 75.209999999999994 110.52 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.21 159.64 30.07 Favored Glycine 0 C--N 1.343 0.958 0 C-N-CA 123.088 0.375 . . . . 73.409999999999997 112.67 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 18.9 pt -126.09 -165.24 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 C-N-CA 124.184 0.994 . . . . 74.219999999999999 110.424 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 14.0 p-10 -56.86 99.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.815 1.043 . . . . 71.120000000000005 113.815 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 103.65 13.54 27.67 Favored Glycine 0 C--O 1.259 1.696 0 CA-C-N 116.162 -0.472 . . . . 63.530000000000001 112.818 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 23.0 t -77.65 136.47 38.22 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.854 -0.424 . . . . 63.509999999999998 109.854 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.472 ' HB3' HD23 ' A' ' 184' ' ' LEU . 17.1 p90 -139.49 159.87 41.16 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.125 0.787 . . . . 75.219999999999999 113.125 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 236' ' ' ALA . 95.4 mt -137.61 134.4 35.5 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.33 1.052 . . . . 71.109999999999999 108.578 170.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 43.9 t -109.68 124.62 66.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 108.685 -0.857 . . . . 71.040000000000006 108.685 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.8 mtp-105 -142.81 168.38 19.86 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.936 0.894 . . . . 71.030000000000001 111.03 -174.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.794 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 2.9 pt-20 -120.46 166.1 14.05 Favored 'General case' 0 C--O 1.26 1.645 0 C-N-CA 124.547 1.139 . . . . 65.329999999999998 110.679 159.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.2 m -74.61 146.3 42.59 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.339 -1.3 . . . . 52.109999999999999 110.505 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.9 -43.16 75.8 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.67 0.788 . . . . 71.519999999999996 111.105 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.2 m -84.66 -43.91 13.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.483 -0.78 . . . . 62.32 111.709 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.6 t -112.56 97.09 39.25 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 109.289 -0.634 . . . . 44.420000000000002 109.289 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -69.18 147.17 65.98 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.074 2.516 . . . . 71.319999999999993 111.593 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.52 -23.85 8.14 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 116.329 -0.396 . . . . 41.32 112.996 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -80.69 116.12 20.54 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 107.127 -1.434 . . . . 73.109999999999999 107.127 170.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.794 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 83.7 mtt85 -122.45 166.48 14.69 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.13 0.572 . . . . 64.019999999999996 111.228 -168.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 65.4 m -151.84 138.03 18.35 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.235 1.014 . . . . 71.409999999999997 109.838 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 63.0 mt -105.17 140.37 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 107.849 -1.167 . . . . 71.120000000000005 107.849 165.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 15.5 m -116.29 113.6 23.2 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.384 1.074 . . . . 73.329999999999998 108.388 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.489 HD21 HD23 ' A' ' 232' ' ' LEU . 39.5 mt -104.3 144.01 32.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.153 0.981 . . . . 63.439999999999998 111.301 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.492 ' NH1' ' HA ' ' A' ' 161' ' ' SER . 21.1 ttt180 -134.48 138.16 44.5 Favored 'General case' 0 C--O 1.25 1.132 0 CA-C-N 114.637 -1.165 . . . . 74.310000000000002 110.03 172.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 10.2 p90 -157.71 139.18 13.73 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.838 -1.074 . . . . 71.219999999999999 108.108 171.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 54.49 31.37 14.65 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.583 1.153 . . . . 74.439999999999998 113.537 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.73 9.53 86.26 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.343 -0.39 . . . . 74.420000000000002 113.817 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 28.7 tpt180 -102.9 127.09 50.24 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.501 1.12 . . . . 73.099999999999994 109.411 175.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.435 HG13 HD23 ' A' ' 160' ' ' LEU . 94.9 t -114.08 129.85 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.78 1.232 . . . . 73.010000000000005 108.971 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.407 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 22.5 p90 -145.36 160.73 41.09 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.051 0.941 . . . . 74.329999999999998 109.061 174.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -134.42 148.27 50.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.104 0.962 . . . . 75.219999999999999 108.506 -171.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -145.29 145.67 31.34 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.68 0.392 . . . . 71.25 110.867 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -76.82 146.31 37.87 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.375 1.07 . . . . 75.450000000000003 112.149 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.763 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 64.3 mt -104.52 119.18 53.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 N-CA-C 107.393 -1.336 . . . . 74.409999999999997 107.393 163.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -91.02 145.04 25.03 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 109.637 -0.505 . . . . 70.540000000000006 109.637 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 18.1 m -106.02 128.07 53.59 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.969 0.908 . . . . 72.340000000000003 109.449 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 202' ' ' LYS . . . -85.37 158.66 20.19 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.709 0.803 . . . . 73.340000000000003 109.432 170.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 15.8 t -65.6 -9.64 28.59 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.842 1.053 . . . . 63.210000000000001 113.842 -169.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.42 ' HB2' ' HG3' ' A' ' 202' ' ' LYS . 80.9 m-20 -87.46 11.73 13.99 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.117 0.567 . . . . 73.450000000000003 111.833 175.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 75.2 12.48 83.47 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 111.954 -0.458 . . . . 71.409999999999997 111.954 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.639 ' HB2' ' HB3' ' A' ' 198' ' ' ALA . 98.4 mttt -79.65 153.33 29.44 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 123.88 0.872 . . . . 65.109999999999999 110.441 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 90.5 mt -118.37 148.14 42.82 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.342 0.657 . . . . 73.219999999999999 109.41 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -162.91 154.99 18.33 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.193 0.597 . . . . 72.040000000000006 109.981 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 79.2 t -125.01 -63.59 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.09 -1.078 . . . . 51.43 108.09 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.4 t -113.02 -175.54 2.69 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.15 -0.932 . . . . 74.129999999999995 110.035 -174.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 49.9 m -62.33 -47.8 82.62 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.45 1.1 . . . . 64.310000000000002 112.979 -170.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -85.57 3.17 41.85 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 122.182 0.193 . . . . 70.129999999999995 111.124 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 73.0 m -98.81 106.41 18.67 Favored 'General case' 0 C--O 1.215 -0.732 0 C-N-CA 123.608 0.763 . . . . 74.120000000000005 109.97 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -143.31 118.37 10.07 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.842 1.257 . . . . 64.239999999999995 107.685 171.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -134.99 154.93 51.56 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.073 0.549 . . . . 74.049999999999997 110.659 -170.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -91.53 -31.39 15.96 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 123.677 0.611 . . . . 65.310000000000002 109.907 169.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.413 ' OG1' ' HG2' ' A' ' 216' ' ' GLU . 48.5 p -131.14 157.92 41.86 Favored 'General case' 0 C--O 1.253 1.289 0 CA-C-O 122.324 1.059 . . . . 64.109999999999999 112.104 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.419 ' O ' HG23 ' A' ' 218' ' ' VAL . 23.1 tp -72.78 -27.92 62.29 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 113.765 -1.561 . . . . 72.140000000000001 111.396 -176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.84 -43.27 93.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.878 0.471 . . . . 74.439999999999998 110.521 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.413 ' HG2' ' OG1' ' A' ' 213' ' ' THR . 21.0 mm-40 -68.9 -35.04 76.38 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 115.768 -0.651 . . . . 72.230000000000004 110.146 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tt -55.78 -50.01 71.6 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.951 0.782 . . . . 64.150000000000006 110.91 171.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 214' ' ' LEU . 55.4 t -63.8 -45.75 96.3 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 O-C-N 123.956 0.785 . . . . 63.299999999999997 111.055 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -58.01 -53.32 59.59 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.581 0.705 . . . . 71.409999999999997 111.14 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.435 ' CE1' HG11 ' A' ' 224' ' ' VAL . 61.5 t60 -54.48 -51.68 64.29 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.016 -0.993 . . . . 73.340000000000003 109.425 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -66.54 -22.77 66.16 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.265 -0.88 . . . . 73.319999999999993 112.077 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.2 m -72.98 -27.05 61.57 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.745 0.418 . . . . 71.120000000000005 110.583 173.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.8 t -120.25 4.22 10.81 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 116.206 1.928 . . . . 63.219999999999999 116.206 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.435 HG11 ' CE1' ' A' ' 220' ' ' HIS . 26.8 m -107.92 156.44 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 116.085 1.883 . . . . 73.510000000000005 116.085 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -92.56 -0.49 57.32 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 111.111 -2.768 . . . . 63.420000000000002 113.274 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -77.62 14.3 1.06 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 128.169 2.588 . . . . 72.25 113.999 -143.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.46 17.52 4.77 Favored Glycine 0 N--CA 1.467 0.751 0 O-C-N 120.724 -1.235 . . . . 72.420000000000002 111.321 -169.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.1 mt -92.17 118.08 30.5 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.731 -1.234 . . . . 63.329999999999998 108.605 165.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.407 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 76.8 mt -59.74 -46.42 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 123.868 0.73 . . . . 43.340000000000003 109.478 173.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.1 t -130.77 142.7 50.42 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.109 -1.071 . . . . 71.349999999999994 108.109 167.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 55.6 p -69.02 157.35 36.97 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.777 0.431 . . . . 75.129999999999995 110.524 174.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.489 HD23 HD21 ' A' ' 184' ' ' LEU . 23.1 mt -66.96 101.37 0.84 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 108.729 -0.841 . . . . 72.219999999999999 108.729 177.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -88.26 -53.64 4.6 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.838 -0.801 . . . . 73.310000000000002 108.838 -173.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -158.91 145.43 12.63 Favored Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 115.083 -0.962 . . . . 63.210000000000001 110.793 -177.734 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.503 ' HB3' ' HA ' ' A' ' 146' ' ' TRP . 51.6 Cg_endo -68.59 163.43 36.91 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 121.781 1.654 . . . . 73.010000000000005 113.096 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.537 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -73.42 125.57 90.61 Favored Pre-proline 0 C--O 1.244 0.812 0 N-CA-C 108.861 -0.792 . . . . 73.120000000000005 108.861 170.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.36 132.43 27.48 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.058 1.839 . . . . 73.420000000000002 111.642 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -63.32 149.57 45.38 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.62 0.768 . . . . 61.32 109.976 175.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.481 HH21 ' HE2' ' A' ' 158' ' ' TYR . 4.5 ptp180 -50.85 -46.66 60.24 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.249 1.019 . . . . 62.310000000000002 113.603 -171.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -82.82 139.57 33.43 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.553 -0.906 . . . . 63.140000000000001 108.553 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.68 143.78 86.21 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 122.364 0.266 . . . . 74.430000000000007 111.454 -174.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -85.17 -144.87 0.03 OUTLIER 'Trans proline' 0 CA--C 1.555 1.57 0 C-N-CA 122.816 2.344 . . . . 62.5 110.128 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 77.6 m -67.94 126.92 30.97 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 109.283 -0.636 . . . . 62.350000000000001 109.283 170.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.54 -43.45 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.152 0.581 . . . . 71.319999999999993 111.273 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -94.85 136.53 35.06 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.098 0.559 . . . . 73.439999999999998 109.909 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -155.51 36.36 0.64 Allowed Glycine 0 N--CA 1.464 0.563 0 N-CA-C 110.367 -1.093 . . . . 52.539999999999999 110.367 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.4 m -107.59 164.92 4.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 124.272 1.029 . . . . 72.040000000000006 110.144 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 249' ' ' PRO . 71.9 p -143.43 134.51 12.55 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.321 0.648 . . . . 71.329999999999998 109.884 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 248' ' ' SER . 19.7 Cg_exo -67.33 154.05 75.16 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.202 2.601 . . . . 70.340000000000003 112.528 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -143.85 154.44 43.38 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.376 0.607 . . . . 75.340000000000003 110.897 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -134.08 140.64 46.76 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.892 -1.521 . . . . 72.120000000000005 106.892 169.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -137.28 129.31 29.2 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.653 0.381 . . . . 53.140000000000001 110.079 -172.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -150.65 130.79 13.54 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.601 0.76 . . . . 63.32 110.034 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -135.4 -179.01 5.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.57 1.148 . . . . 72.319999999999993 109.891 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 123.989 0.916 . . . . 71.439999999999998 108.769 173.545 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 109.198 -0.667 . . . . 63.140000000000001 109.198 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -88.88 167.04 34.39 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.507 0.505 . . . . 64.030000000000001 111.945 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -91.77 65.21 4.97 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.591 0.71 . . . . 73.329999999999998 110.726 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.84 67.23 7.1 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 115.196 -0.911 . . . . 70.120000000000005 109.404 171.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.61 -13.84 35.66 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.53 2.153 . . . . 63.409999999999997 111.663 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.43 -173.92 55.15 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 115.349 -0.841 . . . . 70.329999999999998 112.899 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -150.03 96.29 2.41 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.907 -1.146 . . . . 65.049999999999997 107.907 172.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 m -117.75 -176.94 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.824 0 C-N-CA 124.498 1.119 . . . . 75.219999999999999 109.615 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.472 HD11 ' HA ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -91.34 41.82 1.08 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.968 0.907 . . . . 72.099999999999994 110.588 -175.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.21 37.15 0.17 Allowed Glycine 0 C--N 1.347 1.151 0 C-N-CA 121.303 -0.475 . . . . 73.099999999999994 113.074 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -97.86 -178.11 3.99 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.949 0.5 . . . . 75.099999999999994 111.083 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.05 -144.83 0.11 Allowed 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 107.436 -1.32 . . . . 75.150000000000006 107.436 164.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 49.64 38.05 14.16 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 125.24 1.416 . . . . 74.430000000000007 113.479 163.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 61.56 80.63 0.25 Allowed Pre-proline 0 C--N 1.365 1.275 0 C-N-CA 124.205 1.002 . . . . 75.5 109.643 -173.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.04 166.88 21.46 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.83 2.353 . . . . 73.430000000000007 112.203 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.6 p -67.84 168.65 11.17 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 121.143 0.497 . . . . 60.310000000000002 111.397 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.7 mt -103.89 133.28 20.34 Favored Pre-proline 0 N--CA 1.476 0.86 0 N-CA-C 108.77 -0.826 . . . . 62.439999999999998 108.77 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.472 ' HA ' HD11 ' A' ' 9' ' ' LEU . 36.8 Cg_endo -71.26 169.8 19.84 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.387 2.058 . . . . 72.120000000000005 112.688 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.64 142.19 30.98 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.098 0.559 . . . . 74.010000000000005 110.63 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HB3' HD11 ' A' ' 23' ' ' ILE . 75.6 mt -88.35 96.93 10.77 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.636 0.774 . . . . 73.219999999999999 109.035 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -97.04 -47.79 5.65 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.57 -0.741 . . . . 74.540000000000006 109.75 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -103.46 109.95 21.79 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.507 -0.77 . . . . 74.299999999999997 109.289 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 20' ' ' LEU . 25.7 mm -117.29 120.01 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.387 1.075 . . . . 74.120000000000005 109.892 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -142.15 127.33 18.58 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.574 -1.269 . . . . 73.120000000000005 107.574 167.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -130.73 -159.12 9.51 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 111.961 -0.455 . . . . 43.100000000000001 111.961 -172.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 59.25 26.06 14.78 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.22 1.008 . . . . 63.119999999999997 111.414 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' HA3' HE21 ' A' ' 127' ' ' GLN . . . -78.09 117.37 4.67 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 115.236 -0.893 . . . . 71.540000000000006 112.256 -175.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -145.23 -47.48 0.23 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.152 0.981 . . . . 72.239999999999995 109.685 -170.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -78.66 -3.01 41.88 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 114.797 -1.092 . . . . 65.319999999999993 112.513 -170.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -72.01 2.32 5.89 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.935 0.894 . . . . 71.319999999999993 112.166 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.9 p -143.71 172.33 12.97 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.617 0.767 . . . . 72.299999999999997 110.762 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.3 p -70.31 -67.94 0.46 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.06 0.944 . . . . 73.450000000000003 111.144 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -158.7 110.96 2.23 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.415 0.686 . . . . 73.209999999999994 109.176 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -140.8 147.0 38.36 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.749 0.819 . . . . 75.299999999999997 110.076 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.75 -161.06 29.69 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 124.085 0.865 . . . . 75.510000000000005 111.04 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.12 171.53 43.97 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 119.477 -0.624 . . . . 72.439999999999998 112.512 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.28 144.09 55.41 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.361 2.708 . . . . 74.120000000000005 111.44 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -84.0 99.76 10.63 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.322 -0.621 . . . . 62.43 109.322 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.1 t -68.68 148.35 50.53 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.027 0.531 . . . . 74.230000000000004 109.912 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -84.32 82.79 8.23 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.379 0.609 . . . . 62.539999999999999 109.532 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.59 95.16 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.31 -0.859 . . . . 65.430000000000007 109.046 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -114.98 100.64 8.34 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.618 -0.882 . . . . 74.040000000000006 108.618 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.3 t -104.44 137.43 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.5 -1.296 . . . . 65.150000000000006 107.5 169.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.22 174.16 11.05 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.345 0.658 . . . . 74.310000000000002 111.494 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -114.99 154.92 27.92 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.313 -0.858 . . . . 75.140000000000001 110.189 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -151.08 145.9 25.8 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.5 -0.926 . . . . 70.530000000000001 108.5 170.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.4 104.76 0.14 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.717 0.807 . . . . 60.409999999999997 110.096 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 75.3 mt -68.18 79.8 0.24 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.614 0.766 . . . . 54.32 110.123 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.473 ' HG2' ' HG3' ' A' ' 50' ' ' ARG . 34.6 tt0 -98.43 142.07 30.51 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.517 -1.29 . . . . 71.219999999999999 107.517 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.473 ' HG3' ' HG2' ' A' ' 49' ' ' GLN . 66.8 mtm180 57.56 55.11 7.05 Favored Pre-proline 0 CA--C 1.564 1.515 0 O-C-N 123.878 0.737 . . . . 61.219999999999999 110.803 -177.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 50' ' ' ARG . 24.2 Cg_exo -64.13 -25.89 65.42 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.596 2.197 . . . . 73.239999999999995 112.578 -175.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 t -91.16 50.14 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 CA-C-O 122.428 1.109 . . . . 52.229999999999997 108.956 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.44 11.95 34.97 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.098 0.959 . . . . 51.219999999999999 110.314 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.8 p -66.23 -46.53 76.86 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.996 0.918 . . . . 74.430000000000007 110.251 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -161.25 164.45 30.3 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.854 -1.066 . . . . 72.400000000000006 109.386 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -141.03 141.44 34.33 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.434 1.094 . . . . 74.099999999999994 108.647 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 60.76 72.7 0.69 Allowed Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 124.425 1.09 . . . . 65.430000000000007 111.166 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.39 98.13 0.22 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.727 2.285 . . . . 73.409999999999997 112.504 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -102.31 87.9 3.16 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.85 -1.167 . . . . 75.329999999999998 107.85 172.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.94 -159.79 25.75 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.009 -0.996 . . . . 71.530000000000001 112.226 -174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.8 mt -122.28 151.64 40.89 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.422 0.689 . . . . 55.450000000000003 110.397 -176.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.9 t -61.72 -37.53 84.53 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.469 1.108 . . . . 65.219999999999999 110.637 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -98.21 33.82 2.1 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.593 -0.731 . . . . 73.129999999999995 111.392 -174.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.4 123.96 21.84 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 108.455 -0.943 . . . . 73.549999999999997 108.455 167.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.65 104.46 0.66 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.347 0.659 . . . . 70.430000000000007 110.771 -175.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -81.52 94.16 6.81 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.23 -1.026 . . . . 74.510000000000005 108.23 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -76.79 136.44 38.97 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.632 -0.713 . . . . 75.239999999999995 111.423 -173.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -77.15 141.48 40.12 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.667 -0.697 . . . . 61.409999999999997 109.766 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.3 p -160.86 161.75 31.95 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.356 1.062 . . . . 73.409999999999997 109.066 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.7 tttp 75.06 -4.4 2.39 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.997 1.319 . . . . 72.140000000000001 112.435 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -75.63 90.98 2.82 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-O 121.575 0.702 . . . . 73.299999999999997 110.136 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -106.07 106.08 16.42 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.48 -1.304 . . . . 64.349999999999994 107.48 172.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.9 mt -79.69 136.4 36.78 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.31 0.644 . . . . 64.430000000000007 111.19 -173.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.6 mt -78.96 165.86 23.0 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.005 0.922 . . . . 74.019999999999996 110.21 174.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.53 84.42 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.684 0.794 . . . . 72.439999999999998 110.559 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 64.43 -151.43 50.42 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 115.377 -0.829 . . . . 44.310000000000002 113.157 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.9 120.71 7.03 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.593 2.195 . . . . 75.409999999999997 111.1 171.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.4 p -60.88 117.39 5.37 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.404 0.682 . . . . 73.109999999999999 110.518 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.463 ' HA ' HH21 ' A' ' 108' ' ' ARG . 1.8 mp0 -83.09 131.08 35.17 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.904 0.882 . . . . 61.240000000000002 110.651 -169.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -155.83 32.37 0.35 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.726 1.21 . . . . 63.5 108.215 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -145.76 144.15 21.59 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 114.19 -1.368 . . . . 62.140000000000001 109.287 -170.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.48 -19.8 18.82 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.103 2.535 . . . . 64.109999999999999 113.922 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -90.46 40.16 1.0 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.824 0.85 . . . . 71.510000000000005 111.672 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 57.4 tp -83.72 112.55 20.17 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.512 0.672 . . . . 74.25 110.553 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.41 173.33 6.37 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.813 1.645 . . . . 65.140000000000001 108.766 170.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.6 p -144.96 143.16 22.63 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 N-CA-C 108.706 -0.85 . . . . 74.25 108.706 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.588 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -80.26 135.84 36.32 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.858 0.463 . . . . 73.329999999999998 110.201 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.3 mt -95.12 -16.56 22.52 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.315 1.046 . . . . 61.299999999999997 110.767 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -138.98 145.96 40.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.838 0.855 . . . . 72.549999999999997 108.915 -177.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -79.43 117.82 20.74 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.07 -0.715 . . . . 51.140000000000001 109.07 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -121.18 117.74 27.89 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.024 0.93 . . . . 72.040000000000006 109.247 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.8 t -79.96 138.74 19.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 C-N-CA 123.659 0.784 . . . . 51.100000000000001 109.262 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.71 115.09 3.69 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.818 -0.808 . . . . 73.019999999999996 108.818 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.4 m -74.59 -11.92 60.32 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.926 0.891 . . . . 71.25 110.753 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.79 -163.34 28.9 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 110.554 -1.018 . . . . 75.329999999999998 110.554 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -73.6 -23.92 59.98 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.219 0.608 . . . . 52.119999999999997 111.043 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -72.67 -24.19 60.99 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.438 1.095 . . . . 63.340000000000003 112.282 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.1 p -110.41 158.63 18.26 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.836 0.854 . . . . 74.299999999999997 110.013 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.9 tp -109.17 132.73 53.84 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.223 -0.898 . . . . 73.019999999999996 109.226 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.2 t -82.0 124.84 30.14 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.767 -0.827 . . . . 50.450000000000003 108.767 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.1 pt -128.86 140.59 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 108.094 -1.076 . . . . 72.5 108.094 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 16.0 m -98.31 151.96 19.94 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.024 0.375 . . . . 72.120000000000005 110.211 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -60.12 111.4 1.5 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.199 0.6 . . . . 70.120000000000005 110.799 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.82 3.7 55.93 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 115.405 -0.816 . . . . 50.020000000000003 113.183 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -83.41 145.97 28.7 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.481 0.712 . . . . 61.539999999999999 110.346 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -87.92 113.32 23.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.398 1.079 . . . . 73.329999999999998 109.306 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.588 HD11 ' HB2' ' A' ' 87' ' ' ALA . 15.2 mt -108.07 133.84 51.8 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.464 -0.939 . . . . 53.240000000000002 108.464 -170.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.463 HH21 ' HA ' ' A' ' 79' ' ' GLU . 65.9 mtt180 -104.17 106.93 17.61 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.337 -0.616 . . . . 72.109999999999999 109.337 175.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 92.8 t -98.73 119.4 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 109.07 -0.715 . . . . 73.109999999999999 109.07 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.9 mt -67.83 -37.49 81.97 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.762 0.825 . . . . 73.239999999999995 109.924 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.05 -178.6 44.17 Favored Glycine 0 C--O 1.244 0.727 0 CA-C-N 114.431 -1.259 . . . . 44.219999999999999 111.167 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 14.4 m-30 -95.99 169.81 9.72 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.256 -0.646 . . . . 74.140000000000001 109.256 177.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -60.28 145.82 46.11 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.631 -1.248 . . . . 74.430000000000007 107.631 168.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -65.53 -25.59 67.52 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.46 0.304 . . . . 74.120000000000005 110.896 -176.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -81.76 -18.51 43.94 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.694 0.797 . . . . 74.219999999999999 110.56 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 174' ' ' GLU . . . 85.93 34.25 13.5 Favored Glycine 0 C--N 1.35 1.353 0 C-N-CA 123.484 0.564 . . . . 74.420000000000002 113.607 174.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -96.27 -64.14 1.08 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.577 0.703 . . . . 73.230000000000004 110.583 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -103.49 -179.0 3.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.589 1.156 . . . . 74.319999999999993 109.633 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -142.18 122.19 13.69 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.668 0.787 . . . . 72.349999999999994 109.477 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -79.98 101.77 8.84 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.179 0.514 . . . . 74.0 109.623 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -103.88 167.65 9.64 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.139 -0.937 . . . . 61.310000000000002 109.998 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -141.4 125.62 17.45 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 124.449 1.1 . . . . 74.530000000000001 108.502 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.8 p -138.15 -168.6 2.39 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.029 0.932 . . . . 73.420000000000002 110.661 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 124' ' ' LYS . 31.6 mtmt -54.41 -35.14 62.59 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.895 1.278 . . . . 73.409999999999997 111.159 175.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -83.92 8.01 16.44 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.556 -1.202 . . . . 61.420000000000002 111.424 -175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.55 -126.14 7.42 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 111.499 -0.64 . . . . 75.409999999999997 111.499 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.44 HE21 ' HA3' ' A' ' 27' ' ' GLY . 29.9 tt0 -151.02 139.8 20.8 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.305 0.642 . . . . 75.439999999999998 109.324 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 179.2 -178.76 48.86 Favored Glycine 0 C--N 1.344 1.0 0 O-C-N 123.263 0.352 . . . . 71.310000000000002 112.338 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -89.66 131.97 35.38 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.255 0.622 . . . . 63.340000000000003 110.835 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.67 152.08 76.29 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 125.322 1.449 . . . . 75.150000000000006 109.095 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.08 132.98 23.93 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.272 1.982 . . . . 74.430000000000007 111.462 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.506 ' HA ' HG12 ' A' ' 135' ' ' ILE . 20.0 m -62.3 -17.81 59.66 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.11 0.964 . . . . 65.150000000000006 112.724 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -74.65 -20.81 59.74 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.03 0.932 . . . . 75.420000000000002 111.526 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -95.17 -6.51 41.56 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.828 0.851 . . . . 74.310000000000002 112.023 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.506 HG12 ' HA ' ' A' ' 132' ' ' SER . 14.8 pt -125.06 156.68 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.158 0.583 . . . . 72.310000000000002 110.059 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 11.3 t -149.86 136.38 10.75 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 122.701 0.4 . . . . 65.340000000000003 110.375 172.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.534 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 73.6 Cg_endo -75.38 140.19 24.17 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.487 2.125 . . . . 75.540000000000006 111.765 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.85 -36.54 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.002 0.521 . . . . 71.040000000000006 111.414 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 59.2 t30 -98.74 -9.39 24.58 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.71 0.404 . . . . 71.409999999999997 111.149 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 32.5 t -73.34 177.04 5.46 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.919 0.488 . . . . 64.420000000000002 109.902 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 64.4 mt -61.15 -16.24 42.37 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.698 0.999 . . . . 73.329999999999998 113.698 -172.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -59.37 -24.13 63.14 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.574 1.15 . . . . 71.109999999999999 112.666 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -67.19 -8.37 30.9 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.438 0.695 . . . . 74.310000000000002 112.135 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -89.1 151.76 22.04 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.765 0.826 . . . . 75.340000000000003 110.549 170.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 56.8 p -69.24 -36.21 76.95 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 123.625 0.77 . . . . 72.530000000000001 111.13 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -72.44 -31.35 65.4 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.607 -0.724 . . . . 73.420000000000002 112.638 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -97.27 120.95 38.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.873 -0.788 . . . . 74.349999999999994 108.873 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -103.13 5.05 37.65 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.87 -0.605 . . . . 75.209999999999994 111.663 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.81 -154.5 35.86 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.67 -0.517 . . . . 63.329999999999998 112.948 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.4 106.39 1.59 Allowed 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 123.152 2.568 . . . . 45.329999999999998 111.028 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.6 t -140.34 143.86 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.405 0.682 . . . . 73.030000000000001 109.404 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.2 t -64.54 161.88 16.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.061 0.944 . . . . 61.329999999999998 112.121 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -69.58 -31.86 70.26 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.673 0.789 . . . . 73.140000000000001 110.739 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -76.17 -43.89 40.6 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.23 0.612 . . . . 72.099999999999994 109.527 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.07 79.14 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.396 -0.82 . . . . 72.109999999999999 110.387 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.75 -56.23 24.64 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.715 -0.675 . . . . 75.040000000000006 110.214 171.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -60.49 -32.33 71.33 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.618 -0.719 . . . . 71.209999999999994 110.968 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -65.73 -52.22 52.94 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.222 1.009 . . . . 55.240000000000002 110.975 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.5 ' HB2' HD11 ' A' ' 169' ' ' LEU . 81.5 mt -67.03 -39.37 87.0 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.439 0.637 . . . . 71.450000000000003 110.788 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.452 HD23 HG13 ' A' ' 190' ' ' VAL . 27.2 tp -73.73 -20.14 60.6 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.682 -1.145 . . . . 72.329999999999998 111.604 -174.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.6 t -61.62 -27.22 68.5 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.842 0.857 . . . . 34.439999999999998 111.83 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.4 p -86.45 8.53 21.43 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.918 0.887 . . . . 74.299999999999997 111.719 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -97.39 170.16 25.51 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 116.374 -0.375 . . . . 72.340000000000003 112.605 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 32.4 pt -121.92 -163.59 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.95 0.9 . . . . 71.319999999999993 109.66 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.736 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 27.1 p-10 -49.48 118.15 2.6 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.729 0.811 . . . . 71.239999999999995 112.412 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.18 14.0 72.83 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.297 -0.41 . . . . 44.439999999999998 113.288 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 20.2 t -75.23 136.02 40.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.035 -0.728 . . . . 60.130000000000003 109.035 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.488 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 22.2 p90 -135.65 164.97 26.65 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.948 0.721 . . . . 74.340000000000003 112.948 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 159' ' ' LEU . 86.0 mt -137.41 135.48 36.97 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.549 1.139 . . . . 74.439999999999998 108.353 169.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.401 HG22 HG12 ' A' ' 182' ' ' ILE . 39.0 t -114.55 128.46 71.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 107.851 -1.166 . . . . 74.450000000000003 107.851 171.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 12.9 mtm105 -143.05 172.34 12.85 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.769 0.828 . . . . 73.310000000000002 109.483 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 13.9 pt-20 -116.25 163.06 16.54 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.642 -0.873 . . . . 74.400000000000006 108.642 160.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.5 m -88.58 134.85 33.75 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.155 0.582 . . . . 62.299999999999997 110.141 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.418 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 27.9 mt-10 -78.68 -26.27 44.95 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.115 0.966 . . . . 75.420000000000002 109.224 174.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.1 p -70.61 -37.24 73.81 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.619 -1.173 . . . . 54.229999999999997 110.584 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.9 m -140.48 94.38 8.45 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.056 0.942 . . . . 74.150000000000006 109.433 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.34 135.25 52.85 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.969 2.446 . . . . 70.219999999999999 111.501 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 91.33 -23.51 24.3 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 115.97 -0.559 . . . . 64.200000000000003 113.46 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -82.83 115.62 21.8 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.727 -1.212 . . . . 73.430000000000007 107.727 172.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 82.9 mtt-85 -112.31 159.87 18.23 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.066 0.546 . . . . 74.530000000000001 109.698 -171.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.9 t -152.44 146.67 25.48 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 122.837 0.455 . . . . 72.239999999999995 110.775 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 170' ' ' VAL . 52.9 mt -113.94 150.9 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.112 0.965 . . . . 73.049999999999997 108.476 173.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.2 m -132.36 128.42 37.61 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.721 -0.844 . . . . 75.540000000000006 108.721 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.462 HD21 HD23 ' A' ' 232' ' ' LEU . 38.8 mt -110.66 147.44 34.31 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.328 1.451 . . . . 75.129999999999995 111.382 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -133.5 130.88 39.15 Favored 'General case' 0 C--O 1.253 1.255 0 C-N-CA 124.429 1.092 . . . . 64.209999999999994 108.434 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.736 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 3.7 p90 -154.66 143.55 20.92 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 124.146 0.904 . . . . 73.230000000000004 108.646 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 58.13 19.28 5.94 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 124.389 1.075 . . . . 71.319999999999993 112.941 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 76.65 30.06 56.83 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.984 -0.553 . . . . 61.240000000000002 112.663 -175.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -128.52 123.24 33.03 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.115 0.966 . . . . 52.539999999999999 108.569 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.452 HG13 HD23 ' A' ' 160' ' ' LEU . 48.8 t -104.13 138.2 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.257 1.023 . . . . 63.140000000000001 109.79 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.467 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 28.7 p90 -143.15 157.94 44.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.939 0.895 . . . . 54.210000000000001 109.215 171.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -128.09 144.16 51.1 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.125 -1.065 . . . . 73.010000000000005 108.125 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -145.67 147.57 32.13 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.062 0.458 . . . . 73.409999999999997 110.644 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 20.9 tpp180 -82.35 133.43 35.23 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.056 -0.975 . . . . 73.25 110.431 -174.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 93.5 mt -75.1 102.68 2.51 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 N-CA-C 106.979 -1.489 . . . . 73.310000000000002 106.979 165.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -68.15 111.62 4.61 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.531 -1.213 . . . . 71.420000000000002 108.063 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 37.7 m -97.28 113.45 25.07 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.873 -0.603 . . . . 62.530000000000001 109.527 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.1 160.03 10.81 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.197 0.999 . . . . 71.420000000000002 111.862 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.3 m -62.09 -23.62 66.63 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.2 -0.909 . . . . 72.200000000000003 111.47 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.405 ' HB2' ' HE2' ' A' ' 202' ' ' LYS . 15.7 m-20 -87.28 3.56 46.26 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.182 0.993 . . . . 74.409999999999997 111.104 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 83.83 -1.76 88.34 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 122.933 0.302 . . . . 61.43 113.35 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' A' ' 200' ' ' ASP . 54.1 mtmt -77.19 131.19 38.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.518 0.727 . . . . 74.349999999999994 110.274 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.72 147.45 22.98 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.836 -0.802 . . . . 54.549999999999997 108.836 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -166.14 176.24 7.81 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.406 0.682 . . . . 75.349999999999994 110.143 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 75.7 t -140.38 -50.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 107.004 -1.48 . . . . 51.43 107.004 172.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 22.0 m -74.83 145.99 42.37 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.347 -0.842 . . . . 74.25 109.933 171.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.8 m -70.83 -26.15 63.16 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.521 0.728 . . . . 73.549999999999997 110.922 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -71.85 -41.75 67.72 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.319 -0.623 . . . . 55.539999999999999 109.319 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 m -91.67 135.13 34.11 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.284 -0.871 . . . . 61.210000000000001 110.865 -165.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -137.26 118.38 14.43 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 107.956 -1.128 . . . . 71.239999999999995 107.956 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 9.0 m-85 -120.85 142.88 49.24 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 109.484 -0.561 . . . . 71.099999999999994 109.484 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -89.46 -24.18 21.91 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.778 -0.453 . . . . 73.019999999999996 109.778 171.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.8 p -124.53 144.81 49.91 Favored 'General case' 0 C--O 1.253 1.246 0 CA-C-O 121.87 0.843 . . . . 72.540000000000006 111.696 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 18.1 tp -69.57 -29.18 66.68 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 113.992 -1.458 . . . . 74.129999999999995 110.961 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.86 -37.12 85.33 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.324 0.649 . . . . 61.039999999999999 111.373 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -76.48 -31.93 58.06 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.884 0.474 . . . . 74.439999999999998 111.344 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.45 -45.88 90.34 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 110.118 -0.327 . . . . 74.209999999999994 110.118 170.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.9 t -70.8 -40.51 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.094 0.958 . . . . 74.239999999999995 110.971 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -59.74 -53.94 52.13 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.7 0.8 . . . . 64.420000000000002 109.583 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.571 ' CE1' HG11 ' A' ' 224' ' ' VAL . 59.1 t60 -53.69 -54.24 40.64 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.966 -1.015 . . . . 65.430000000000007 109.349 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -61.39 -26.33 67.77 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.609 -0.723 . . . . 72.409999999999997 112.286 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 32.4 t -75.17 -28.24 59.98 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 122.756 0.422 . . . . 61.030000000000001 111.236 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 15.4 t -117.56 1.43 12.27 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 116.094 1.887 . . . . 74.120000000000005 116.094 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.571 HG11 ' CE1' ' A' ' 220' ' ' HIS . 35.8 m -107.14 144.27 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.524 0 CA-C-N 121.465 1.938 . . . . 72.420000000000002 116.19 -175.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -82.11 -2.65 52.7 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 129.07 2.948 . . . . 73.010000000000005 112.187 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -79.34 14.25 1.62 Allowed 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 129.202 3.001 . . . . 53.299999999999997 113.354 -140.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.63 18.16 4.09 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 110.947 -0.861 . . . . 44.420000000000002 110.947 -169.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 86.0 mt -93.63 132.94 37.47 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.993 0.917 . . . . 62.240000000000002 109.951 160.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.467 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 85.3 mt -60.42 -60.06 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 108.749 -0.834 . . . . 75.109999999999999 108.749 170.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.5 t -119.65 141.63 49.17 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.149 -0.932 . . . . 72.409999999999997 108.668 173.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 224' ' ' VAL . 82.1 p -73.19 158.84 34.47 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 108.834 -0.802 . . . . 72.420000000000002 108.834 170.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.488 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 26.2 mt -69.47 99.54 1.26 Allowed 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 108.828 -0.805 . . . . 73.409999999999997 108.828 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -77.9 -45.76 23.22 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.28 0.632 . . . . 65.420000000000002 110.056 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 167' ' ' SER . 12.9 p90 -164.01 153.1 11.91 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 109.541 -0.54 . . . . 61.140000000000001 109.541 172.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.22 139.04 14.6 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 121.698 1.599 . . . . 61.229999999999997 112.273 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.98 118.17 39.93 Favored Pre-proline 0 C--N 1.352 0.689 0 N-CA-C 108.155 -1.054 . . . . 51.450000000000003 108.155 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.411 ' HB2' ' HG2' ' A' ' 241' ' ' LYS . 54.1 Cg_endo -66.07 142.1 66.6 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.131 1.887 . . . . 51.310000000000002 112.188 -169.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -65.23 157.45 28.86 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.842 0.857 . . . . 72.219999999999999 110.745 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -46.76 -32.95 3.97 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.344 1.058 . . . . 75.430000000000007 113.171 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -94.24 75.46 3.98 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 108.289 -1.004 . . . . 54.299999999999997 108.289 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.411 ' HG2' ' HB2' ' A' ' 237' ' ' PRO . 10.3 mtmp? -70.48 148.8 95.5 Favored Pre-proline 0 N--CA 1.478 0.952 0 CA-C-N 114.714 -1.13 . . . . 75.319999999999993 111.26 -174.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.32 155.23 71.36 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.84 2.36 . . . . 73.420000000000002 111.958 173.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 17.0 m -62.54 -36.42 82.56 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.476 0.71 . . . . 61.140000000000001 111.445 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.71 131.33 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.047 0.539 . . . . 71.409999999999997 110.022 176.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -163.57 121.54 1.9 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.984 0.913 . . . . 74.200000000000003 109.212 168.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 162.67 94.36 0.1 OUTLIER Glycine 0 C--N 1.344 0.973 0 O-C-N 123.441 0.463 . . . . 72.430000000000007 111.954 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 3.5 m -118.14 125.15 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.395 0.678 . . . . 73.420000000000002 109.371 173.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 34.1 p -135.86 75.27 55.75 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 107.937 -1.134 . . . . 73.140000000000001 107.937 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.73 -8.41 19.2 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.913 2.409 . . . . 72.200000000000003 113.501 -172.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.76 95.39 3.44 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 122.853 0.461 . . . . 75.349999999999994 110.154 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -76.22 117.12 17.58 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.267 1.027 . . . . 73.019999999999996 109.194 171.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -89.18 123.55 33.53 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.871 0.693 . . . . 71.120000000000005 112.871 -168.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.48 115.73 4.07 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 106.75 -1.574 . . . . 72.450000000000003 106.75 170.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -111.09 -49.8 2.99 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.65 0.78 . . . . 74.430000000000007 110.054 -172.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--O 1.249 1.032 0 N-CA-C 106.398 -1.704 . . . . 53.210000000000001 106.398 -179.555 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 mmt . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 109.501 -0.555 . . . . 73.549999999999997 109.501 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.37 179.88 46.6 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 116.377 -0.374 . . . . 43.240000000000002 113.05 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -166.02 -62.55 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.196 0.998 . . . . 62.420000000000002 109.513 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 54.87 83.03 0.23 Allowed Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 124.608 1.163 . . . . 74.439999999999998 110.238 -167.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.04 111.18 3.27 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.56 2.173 . . . . 53.520000000000003 111.621 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.99 -130.59 0.19 Allowed Glycine 0 C--N 1.341 0.843 0 CA-C-N 116.309 -0.405 . . . . 73.200000000000003 113.104 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -121.26 166.28 14.24 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.719 0.808 . . . . 74.519999999999996 109.415 174.544 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.0 t -72.87 96.33 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.73 -1.211 . . . . 74.400000000000006 107.73 171.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.06 130.82 48.33 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.448 -0.796 . . . . 74.420000000000002 110.87 178.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' H ' ' HB2' ' A' ' 16' ' ' SER . . . -60.46 144.49 47.56 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.473 -0.651 . . . . 62.229999999999997 111.473 173.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -117.35 23.61 11.69 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.709 0.804 . . . . 74.219999999999999 110.851 -174.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -74.9 -169.72 0.95 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.385 0.674 . . . . 73.129999999999995 111.508 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.61 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 3.7 tmm_? -65.48 130.67 44.14 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.811 -0.811 . . . . 74.450000000000003 108.811 171.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 50.42 68.42 3.43 Favored Pre-proline 0 C--O 1.243 0.762 0 O-C-N 124.177 0.923 . . . . 52.240000000000002 108.608 -165.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.05 158.81 20.2 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.104 2.536 . . . . 63.32 111.815 -170.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.415 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 28.8 m -65.92 165.35 13.29 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 121.308 0.575 . . . . 63.109999999999999 111.0 -171.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.1 mt -103.45 125.26 35.43 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 107.88 -1.155 . . . . 62.439999999999998 107.88 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 67.0 Cg_endo -72.08 176.61 8.21 Favored 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 123.114 2.543 . . . . 74.530000000000001 112.437 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.08 141.69 38.64 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 116.395 -0.366 . . . . 71.230000000000004 111.073 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.57 ' HB3' HD11 ' A' ' 23' ' ' ILE . 66.7 mt -87.93 91.49 8.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.109 -0.7 . . . . 65.230000000000004 109.109 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -97.0 -48.49 5.39 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.676 0.79 . . . . 74.540000000000006 110.22 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -100.75 109.46 21.47 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.857 -1.065 . . . . 73.0 108.732 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.57 HD11 ' HB3' ' A' ' 20' ' ' LEU . 48.3 mm -118.69 119.35 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.697 0.799 . . . . 73.409999999999997 109.325 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.578 ' H ' ' HE1' ' A' ' 129' ' ' TRP . 75.0 mmtt -110.42 142.02 42.7 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.634 -0.876 . . . . 72.239999999999995 108.634 169.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.27 143.54 42.99 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.445 0.466 . . . . 71.329999999999998 112.493 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.56 80.34 2.57 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.372 0.606 . . . . 72.209999999999994 110.706 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.36 -42.18 28.65 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.179 -0.919 . . . . 53.229999999999997 112.423 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 71.3 142.09 0.05 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.916 1.686 . . . . 64.409999999999997 111.974 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -132.36 163.71 28.08 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.714 0.806 . . . . 74.530000000000001 110.859 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -80.38 83.22 6.25 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.679 -1.23 . . . . 75.299999999999997 107.679 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.3 p -111.09 124.6 52.5 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.629 0.772 . . . . 53.109999999999999 110.35 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.2 m 68.34 -177.04 0.21 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.778 1.231 . . . . 74.430000000000007 112.938 173.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 -101.96 149.8 23.86 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.278 1.031 . . . . 74.120000000000005 109.403 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -64.37 155.65 31.73 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.983 0.513 . . . . 75.349999999999994 111.517 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.52 148.72 16.69 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.185 0.303 . . . . 72.310000000000002 112.685 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.94 110.69 3.08 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-O 119.126 -0.819 . . . . 70.450000000000003 112.724 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.578 ' HB2' ' HA ' ' A' ' 105' ' ' GLU . 20.6 Cg_endo -84.57 -159.55 0.1 Allowed 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.91 2.407 . . . . 65.209999999999994 112.828 -173.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -120.43 149.25 42.66 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.795 -0.817 . . . . 73.530000000000001 108.795 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.8 m -143.78 10.98 1.61 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.002 0.921 . . . . 72.150000000000006 109.492 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -69.72 166.59 18.9 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 123.816 0.847 . . . . 73.0 111.526 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 m -77.78 71.38 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.059 0.933 . . . . 71.549999999999997 111.224 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -74.26 158.6 33.77 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.982 -1.008 . . . . 65.129999999999995 110.229 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.519 HG11 ' HB3' ' A' ' 71' ' ' GLU . 30.7 m -75.74 168.8 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 123.623 0.769 . . . . 44.210000000000001 113.038 -175.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -156.78 158.21 36.42 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.482 1.113 . . . . 73.299999999999997 108.4 167.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.98 90.15 0.44 Allowed 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.05 0.452 . . . . 53.420000000000002 111.969 -173.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.61 ' HA ' ' HB2' ' A' ' 13' ' ' ARG . 12.5 tp10 -63.92 120.09 11.29 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.228 0.537 . . . . 72.140000000000001 111.438 -176.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -161.97 138.41 7.99 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.011 -0.995 . . . . 63.439999999999998 109.601 -170.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.459 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 92.9 mt -113.6 94.92 5.08 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.052 -0.721 . . . . 44.109999999999999 109.052 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -62.26 -56.08 22.05 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.331 -0.989 . . . . 61.240000000000002 108.331 170.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -161.3 110.2 1.24 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 114.734 -1.121 . . . . 60.350000000000001 108.621 168.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 48' ' ' LEU . 84.1 Cg_endo -77.19 -156.98 0.07 OUTLIER 'Trans proline' 0 CA--C 1.554 1.522 0 C-N-CA 122.671 2.247 . . . . 63.240000000000002 112.249 173.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 p 47.58 56.95 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 126.023 1.729 . . . . 64.5 112.403 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.68 105.12 2.2 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.487 -1.233 . . . . 71.310000000000002 110.054 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -144.1 80.07 1.64 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.95 0.9 . . . . 70.129999999999995 108.778 173.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -75.69 -67.21 0.69 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.071 -0.715 . . . . 72.540000000000006 109.071 173.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -74.28 131.26 41.02 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.91 -1.144 . . . . 74.349999999999994 107.91 171.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 59.57 66.37 2.19 Favored Pre-proline 0 CA--C 1.556 1.184 0 O-C-N 124.445 1.091 . . . . 75.349999999999994 109.179 -164.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.44 -8.19 22.2 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.238 2.625 . . . . 64.209999999999994 112.758 -173.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -63.21 -37.42 87.15 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.101 0.961 . . . . 73.129999999999995 109.706 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.4 49.44 72.97 Favored Glycine 0 C--N 1.359 1.808 0 O-C-N 124.399 1.062 . . . . 74.129999999999995 112.674 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.4 mt -81.07 100.91 9.26 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.312 0.577 . . . . 54.32 110.651 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.2 m -103.34 77.58 1.53 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.237 -0.892 . . . . 74.540000000000006 109.575 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.74 -24.99 64.52 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.327 -0.851 . . . . 64.409999999999997 110.51 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.95 130.77 38.98 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.946 0.899 . . . . 71.010000000000005 110.321 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.82 167.95 20.71 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.222 0.609 . . . . 64.129999999999995 111.372 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -83.88 77.61 9.87 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.753 0.787 . . . . 63.240000000000002 110.068 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -90.03 96.06 10.5 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.083 -1.08 . . . . 72.230000000000004 108.083 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.533 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . 33.8 m-80 -71.43 87.85 0.88 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.102 -0.954 . . . . 71.019999999999996 109.562 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.5 p -93.24 134.05 35.83 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.188 0.995 . . . . 61.200000000000003 110.866 -175.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -139.25 96.1 3.05 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.198 0.999 . . . . 72.530000000000001 109.247 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.519 ' HB3' HG11 ' A' ' 43' ' ' VAL . 10.5 tp10 -168.64 151.39 5.2 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.479 1.512 . . . . 73.010000000000005 107.434 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -147.18 150.1 34.25 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.313 -0.995 . . . . 63.140000000000001 108.313 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.8 mt -126.1 149.5 48.87 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.424 -0.584 . . . . 61.439999999999998 109.424 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.6 mt -69.57 159.76 32.78 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.47 0.481 . . . . 53.409999999999997 111.025 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.597 ' HB1' ' HA ' ' A' ' 138' ' ' VAL . . . -67.07 152.44 45.77 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.753 0.821 . . . . 62.43 111.496 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -53.48 113.86 3.38 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-O 118.446 -1.197 . . . . 64.420000000000002 112.574 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -50.29 -59.59 1.14 Allowed 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 123.833 3.022 . . . . 71.340000000000003 114.207 -170.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 62.8 m -152.25 139.33 19.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.179 0.592 . . . . 71.439999999999998 111.556 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -159.99 174.22 14.69 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.618 0.767 . . . . 72.219999999999999 109.352 175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -92.1 35.28 0.99 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.97 0.908 . . . . 73.109999999999999 112.644 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -141.94 107.17 5.82 Favored Pre-proline 0 N--CA 1.484 1.265 0 CA-C-O 119.257 -0.401 . . . . 75.430000000000007 111.421 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.77 -48.8 9.91 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.695 2.93 . . . . 62.409999999999997 114.104 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -92.35 41.96 1.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.531 0.732 . . . . 74.310000000000002 111.098 -174.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.1 tp -91.58 112.36 24.24 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.445 -0.798 . . . . 71.209999999999994 110.308 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -107.43 176.28 5.21 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.65 1.58 . . . . 63.100000000000001 109.549 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 9.9 p -147.73 149.34 15.5 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 C-N-CA 123.014 0.526 . . . . 73.409999999999997 109.868 171.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.58 113.66 20.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.624 0.77 . . . . 72.329999999999998 109.345 171.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.65 -12.59 53.62 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.058 0.543 . . . . 73.239999999999995 110.568 174.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -135.01 146.49 49.08 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.33 0.652 . . . . 70.430000000000007 110.091 -173.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -60.28 137.73 58.07 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.138 -0.937 . . . . 61.240000000000002 110.439 168.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -152.27 116.24 4.89 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.923 -0.399 . . . . 73.040000000000006 109.923 174.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.94 139.03 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 108.002 -1.11 . . . . 64.519999999999996 108.002 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.79 116.13 8.12 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 110.07 -0.345 . . . . 62.210000000000001 110.07 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.1 m -74.99 -17.66 60.5 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.313 0.645 . . . . 75.099999999999994 110.743 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -156.3 -177.54 29.57 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.611 -0.722 . . . . 42.329999999999998 111.747 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -73.57 -27.55 61.38 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.331 0.652 . . . . 71.519999999999996 110.575 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.431 HD21 HD13 ' A' ' 20' ' ' LEU . 25.2 p-10 -69.7 -23.64 63.46 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.863 0.865 . . . . 74.109999999999999 111.922 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.4 p -99.83 157.14 16.72 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.284 0.634 . . . . 61.549999999999997 110.754 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.5 tp -110.32 117.16 32.88 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.531 0.733 . . . . 75.0 109.87 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -66.89 117.59 9.2 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.031 -0.729 . . . . 63.140000000000001 109.031 172.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.4 pt -122.39 130.76 74.28 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 N-CA-C 109.244 -0.65 . . . . 52.229999999999997 109.244 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.0 m -90.53 141.26 28.94 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.503 -0.554 . . . . 72.439999999999998 109.503 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -57.51 116.64 3.49 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.012 0.525 . . . . 60.100000000000001 110.794 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.16 -20.13 21.81 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 115.417 -0.81 . . . . 63.439999999999998 112.38 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.578 ' HA ' ' HB2' ' A' ' 37' ' ' PRO . 69.9 tt0 -72.55 128.54 35.9 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.017 -0.735 . . . . 71.319999999999993 109.017 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 54.5 mtmt -84.0 126.99 33.56 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.165 0.507 . . . . 72.140000000000001 109.909 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.41 ' HA ' HG22 ' A' ' 123' ' ' THR . 14.5 mt -102.1 166.76 10.43 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.981 -1.008 . . . . 73.430000000000007 108.592 -169.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -128.34 107.4 9.73 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.728 -1.212 . . . . 71.310000000000002 107.728 168.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 98.3 t -96.46 116.52 38.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.625 -0.88 . . . . 43.109999999999999 108.625 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.423 HD12 ' NE2' ' A' ' 127' ' ' GLN . 47.5 mt -78.46 -25.42 45.85 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.065 -0.971 . . . . 52.030000000000001 110.116 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.03 161.02 25.9 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.458 -0.792 . . . . 74.219999999999999 111.421 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 3.8 m-30 -95.4 171.84 8.45 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.473 0.654 . . . . 73.219999999999999 109.424 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -66.84 144.87 56.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.668 1.187 . . . . 71.430000000000007 107.979 164.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -60.89 -38.09 84.47 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.43 0.692 . . . . 73.340000000000003 112.158 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -79.35 -11.94 59.93 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.75 0.82 . . . . 52.409999999999997 110.98 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.35 23.17 48.92 Favored Glycine 0 C--N 1.349 1.281 0 C-N-CA 123.529 0.585 . . . . 72.019999999999996 113.281 177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . 46.5 mt-10 -78.28 -72.21 0.38 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.722 0.772 . . . . 64.109999999999999 110.729 -177.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -104.33 -177.43 3.36 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.534 1.133 . . . . 73.150000000000006 109.439 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -149.23 126.82 11.65 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.338 0.655 . . . . 63.329999999999998 110.07 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -71.03 94.26 1.08 Allowed 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.078 -0.712 . . . . 72.239999999999995 109.078 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -104.88 162.57 13.21 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 124.005 0.922 . . . . 72.109999999999999 110.402 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -144.06 133.72 23.63 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.555 0.742 . . . . 64.409999999999997 109.241 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 107' ' ' LEU . 62.9 p -139.67 -171.37 3.13 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.556 1.143 . . . . 75.439999999999998 110.454 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -61.6 -19.77 62.59 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.382 -0.827 . . . . 72.120000000000005 111.196 170.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -85.69 1.93 47.36 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.882 0.873 . . . . 73.420000000000002 111.353 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.5 -130.4 9.54 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.619 -0.593 . . . . 61.409999999999997 111.619 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.423 ' NE2' HD12 ' A' ' 110' ' ' LEU . 57.2 tt0 -145.76 154.38 41.98 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.458 0.703 . . . . 74.219999999999999 109.837 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 166.54 -178.89 40.78 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 112.685 -0.166 . . . . 74.420000000000002 112.685 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.578 ' HE1' ' H ' ' A' ' 24' ' ' LYS . 86.4 m95 -89.85 127.07 35.92 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.767 0.827 . . . . 73.420000000000002 110.688 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.6 m -125.34 146.19 53.4 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.797 1.239 . . . . 54.229999999999997 108.68 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.41 141.5 42.73 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 121.937 1.758 . . . . 72.519999999999996 111.616 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.6 m -60.64 -19.94 59.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.931 0.892 . . . . 75.340000000000003 112.108 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -72.27 -27.49 62.52 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.503 0.721 . . . . 53.229999999999997 111.705 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -88.85 -11.75 43.85 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.661 0.784 . . . . 73.409999999999997 112.073 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.483 HD12 HG21 ' A' ' 109' ' ' VAL . 18.2 pt -122.64 161.43 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.002 0.521 . . . . 72.409999999999997 110.928 -170.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.0 t -155.9 143.05 13.7 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 122.727 0.411 . . . . 65.409999999999997 110.291 168.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.548 ' HB2' ' HB2' ' A' ' 140' ' ' SER . 5.7 Cg_exo -75.63 126.45 9.57 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.579 2.186 . . . . 52.219999999999999 111.217 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.597 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 12.0 m -94.28 -51.26 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 111.945 0.35 . . . . 53.109999999999999 111.945 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -92.52 18.91 7.88 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.175 0.512 . . . . 74.239999999999995 111.305 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.548 ' HB2' ' HB2' ' A' ' 137' ' ' PRO . 22.7 t -64.45 177.51 0.87 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.818 0.847 . . . . 32.329999999999998 112.691 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 49.5 mt -65.31 -13.49 58.59 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.055 1.342 . . . . 52.200000000000003 111.98 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 42.6 tt0 -63.87 -8.9 12.4 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.856 0.863 . . . . 74.420000000000002 111.491 174.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -55.16 -23.76 23.05 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.921 1.289 . . . . 72.140000000000001 110.515 167.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -99.36 143.64 29.38 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.974 0.909 . . . . 74.019999999999996 109.824 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.0 p -66.25 -15.41 63.17 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.369 0.668 . . . . 71.420000000000002 112.771 -175.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.409 ' CZ3' ' HB2' ' A' ' 147' ' ' TYR . 44.3 p-90 -80.29 -38.16 31.33 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 112.592 0.59 . . . . 74.219999999999999 112.592 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.409 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 28.8 t80 -91.67 140.47 29.69 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.81 -0.441 . . . . 71.549999999999997 109.81 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.489 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 63.3 m-70 -137.97 29.55 2.54 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.136 0.421 . . . . 70.140000000000001 112.136 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.63 -170.88 54.49 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 115.652 1.021 . . . . 51.020000000000003 115.652 165.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.04 102.77 1.49 Allowed 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.276 2.651 . . . . 61.43 111.341 172.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.414 HG21 ' NH2' ' A' ' 171' ' ' ARG . 60.4 t -140.02 156.9 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.458 0.703 . . . . 71.329999999999998 110.023 -175.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.6 t -61.62 145.15 53.09 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.965 1.306 . . . . 41.409999999999997 112.717 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -55.19 -32.87 62.54 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.506 -1.225 . . . . 72.510000000000005 112.019 171.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -66.3 -52.08 50.95 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.442 0.697 . . . . 65.209999999999994 110.553 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.84 75.69 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.228 0.611 . . . . 61.539999999999999 111.262 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.557 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.28 -53.44 58.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.141 -0.936 . . . . 72.019999999999996 110.416 173.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.575 ' HG3' HG11 ' A' ' 190' ' ' VAL . 34.6 tt0 -68.67 -27.46 66.0 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.661 -0.699 . . . . 64.439999999999998 111.079 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -67.62 -45.99 73.79 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.877 0.471 . . . . 72.409999999999997 111.45 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.2 mt -67.76 -38.4 83.39 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 110.146 -0.316 . . . . 64.430000000000007 110.146 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 183' ' ' SER . 29.3 tp -68.15 -21.29 64.92 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.292 0.637 . . . . 73.230000000000004 111.658 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.464 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 33.2 t -64.93 -24.35 67.5 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.505 0.722 . . . . 72.450000000000003 110.603 176.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.8 t -85.62 -2.54 58.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.903 0.881 . . . . 54.420000000000002 111.604 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -86.2 170.91 43.61 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 114.073 0.389 . . . . 61.420000000000002 114.073 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.4 pt -132.31 -165.05 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 124.568 1.147 . . . . 64.129999999999995 111.023 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.666 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 14.3 p-10 -58.09 102.81 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.03 0.932 . . . . 65.109999999999999 113.362 -172.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 104.06 11.79 31.19 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 115.977 -0.556 . . . . 54.119999999999997 112.776 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 23.0 t -75.76 142.35 42.38 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 109.853 -0.425 . . . . 42.25 109.853 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 235' ' ' PRO . 14.9 p90 -144.07 161.47 38.71 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.84 0.682 . . . . 73.430000000000007 112.84 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' A' ' 236' ' ' ALA . 95.7 mt -142.45 135.51 28.53 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.489 1.116 . . . . 74.239999999999995 108.358 170.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.5 t -110.91 113.52 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.327 -1.36 . . . . 74.200000000000003 107.327 174.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.557 HH11 ' HA ' ' A' ' 156' ' ' ALA . 17.2 mtp180 -141.12 143.28 34.21 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 107.602 -1.258 . . . . 73.230000000000004 107.602 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.701 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 15.3 pt-20 -95.14 161.29 14.18 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.074 0.397 . . . . 60.399999999999999 110.506 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 37.4 m -82.81 134.47 35.11 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 116.308 -0.406 . . . . 74.040000000000006 110.284 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -70.16 -41.67 73.53 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.214 1.006 . . . . 73.120000000000005 109.975 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 72.0 p -84.26 -9.17 58.72 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.366 1.066 . . . . 71.510000000000005 111.864 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.2 m -141.64 67.45 24.07 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.499 1.12 . . . . 75.409999999999997 108.812 173.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.71 149.11 42.71 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.655 2.237 . . . . 63.32 112.817 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.66 -26.01 6.17 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 114.665 -1.152 . . . . 74.329999999999998 112.049 -168.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -90.84 119.17 30.83 Favored 'General case' 0 C--O 1.259 1.574 0 N-CA-C 108.151 -1.055 . . . . 63.520000000000003 108.151 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.701 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 26.0 mtt85 -105.95 170.24 8.02 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.36 -0.836 . . . . 72.120000000000005 110.77 -173.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.8 m -144.11 144.14 31.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.699 0.8 . . . . 75.450000000000003 110.22 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 56.7 mt -112.91 139.25 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.18 -1.045 . . . . 71.230000000000004 108.18 168.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.575 ' HB3' HD22 ' A' ' 160' ' ' LEU . 23.6 m -116.04 115.09 25.5 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 124.661 1.184 . . . . 55.100000000000001 107.981 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.462 HD21 HD23 ' A' ' 232' ' ' LEU . 57.2 mt -104.77 142.99 33.73 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.474 0.71 . . . . 71.209999999999994 111.088 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.464 ' NH1' ' HA ' ' A' ' 161' ' ' SER . 20.3 ttt180 -131.99 126.55 34.25 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.61 -1.177 . . . . 72.230000000000004 108.773 170.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -150.21 141.46 23.19 Favored 'General case' 0 C--O 1.211 -0.945 0 N-CA-C 107.154 -1.424 . . . . 74.510000000000005 107.154 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 54.29 18.61 1.91 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 125.759 1.624 . . . . 74.519999999999996 113.442 -174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.49 14.01 80.74 Favored Glycine 0 N--CA 1.475 1.294 0 O-C-N 122.284 -0.26 . . . . 45.100000000000001 113.049 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -103.21 127.73 50.42 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 125.4 1.48 . . . . 73.340000000000003 108.763 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.575 HG11 ' HG3' ' A' ' 157' ' ' GLU . 86.2 t -107.79 116.82 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.887 0.875 . . . . 73.129999999999995 110.304 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -139.55 141.13 37.26 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.44 1.096 . . . . 65.040000000000006 109.275 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -124.57 151.19 45.07 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.139 0.975 . . . . 73.349999999999994 108.963 -170.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -142.94 141.49 31.47 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.213 0.53 . . . . 70.109999999999999 110.752 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -77.68 131.28 37.65 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.815 -1.084 . . . . 71.319999999999993 110.828 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 80.4 mt -75.2 108.52 7.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 107.48 -1.304 . . . . 71.349999999999994 107.48 165.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -73.17 106.76 5.15 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.799 -1.185 . . . . 75.349999999999994 107.799 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.511 HG23 HD23 ' A' ' 203' ' ' LEU . 30.9 m -92.37 121.65 34.06 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.255 0.622 . . . . 74.140000000000001 109.717 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.21 153.52 34.28 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.454 0.702 . . . . 72.430000000000007 110.236 172.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 51.3 p -61.37 -22.36 64.88 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.405 0.682 . . . . 61.310000000000002 112.005 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.401 ' HB2' ' HE2' ' A' ' 202' ' ' LYS . 67.8 m-20 -71.54 -14.99 62.27 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.883 1.273 . . . . 75.0 112.373 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 101.77 -2.68 52.56 Favored Glycine 0 C--N 1.348 1.223 0 C-N-CA 122.901 0.286 . . . . 63.140000000000001 112.671 -176.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 200' ' ' ASP . 48.5 mtmt -82.65 156.07 24.05 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.652 0.781 . . . . 70.409999999999997 109.79 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.511 HD23 HG23 ' A' ' 197' ' ' THR . 79.0 mt -113.69 151.2 32.18 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.581 0.752 . . . . 75.329999999999998 110.73 -171.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -163.78 171.97 14.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.888 0.875 . . . . 62.520000000000003 110.413 170.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.3 t -131.46 -56.34 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.414 -1.328 . . . . 72.340000000000003 107.414 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 8.9 m -76.25 153.12 36.27 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.508 -0.769 . . . . 62.140000000000001 108.932 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.9 m -61.32 -36.82 81.19 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.131 0.573 . . . . 72.299999999999997 111.067 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -82.67 -20.67 35.75 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.451 0.7 . . . . 71.200000000000003 111.461 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 68.7 m -63.49 135.91 57.21 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 122.707 0.403 . . . . 52.219999999999999 110.764 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -141.13 108.52 5.55 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.368 -0.975 . . . . 71.319999999999993 108.368 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -121.39 135.76 55.04 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.285 -0.635 . . . . 74.430000000000007 109.285 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -84.25 -30.5 25.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.956 0.502 . . . . 72.530000000000001 110.04 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 216' ' ' GLU . 81.5 p -132.36 161.49 33.45 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-O 122.209 1.004 . . . . 75.420000000000002 111.609 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 37.6 tp -71.24 -24.5 62.2 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 114.159 -1.382 . . . . 42.039999999999999 110.992 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.18 -42.03 89.45 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.434 0.693 . . . . 71.129999999999995 109.93 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.4 ' HG2' ' OG1' ' A' ' 213' ' ' THR . 31.7 mm-40 -65.02 -43.8 91.24 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.341 -0.845 . . . . 71.310000000000002 109.637 174.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.22 -46.25 86.23 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 124.077 0.861 . . . . 71.010000000000005 111.686 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 42.2 t -74.41 -40.55 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.084 0.553 . . . . 74.450000000000003 111.236 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -62.59 -47.07 85.4 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.107 0.479 . . . . 74.230000000000004 110.591 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.428 ' O ' HG22 ' A' ' 224' ' ' VAL . 52.9 t-80 -54.98 -54.46 42.6 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.066 -0.97 . . . . 70.439999999999998 109.961 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.485 ' HD2' HD21 ' A' ' 228' ' ' LEU . 40.3 m80 -65.85 -23.86 66.76 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.676 -0.693 . . . . 63.25 111.65 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 44.2 t -74.4 -24.44 59.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.019 0.528 . . . . 61.32 111.298 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.7 t -110.44 -21.73 12.03 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 116.336 1.976 . . . . 72.310000000000002 116.336 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 220' ' ' HIS . 26.9 m -93.84 157.35 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 115.435 1.643 . . . . 61.219999999999999 115.435 -164.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.16 -1.44 57.73 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.378 2.671 . . . . 73.349999999999994 112.666 -175.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -78.92 15.86 1.01 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 128.357 2.663 . . . . 70.150000000000006 113.751 -140.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.93 18.11 4.4 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 124.819 1.2 . . . . 54.530000000000001 110.529 -170.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.485 HD21 ' HD2' ' A' ' 221' ' ' HIS . 95.2 mt -93.19 126.73 38.45 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.989 1.315 . . . . 65.239999999999995 109.713 164.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 81.0 mt -67.01 -39.9 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 109.21 -0.663 . . . . 71.329999999999998 109.21 173.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.8 t -133.28 141.98 48.26 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 115.08 -0.964 . . . . 71.310000000000002 108.803 168.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 65.1 p -66.3 151.84 46.21 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 108.791 -0.818 . . . . 71.099999999999994 108.791 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.462 HD23 HD21 ' A' ' 184' ' ' LEU . 28.5 mt -62.11 102.69 0.31 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 108.126 -1.064 . . . . 73.310000000000002 108.126 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -89.43 -58.18 2.62 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.818 -0.808 . . . . 74.099999999999994 108.818 -173.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.583 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -151.95 141.34 14.24 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 123.058 0.543 . . . . 75.230000000000004 111.82 -178.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 65.5 Cg_endo -71.76 156.76 56.66 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 121.494 1.463 . . . . 71.239999999999995 112.45 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.474 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -70.72 133.31 86.62 Favored Pre-proline 0 C--O 1.244 0.81 0 CA-C-N 115.935 -0.575 . . . . 63.039999999999999 109.752 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.495 ' HB3' ' HD2' ' A' ' 242' ' ' PRO . 31.3 Cg_exo -61.45 132.1 39.24 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.22 2.614 . . . . 60.140000000000001 113.602 -175.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.462 ' HG2' ' HG3' ' A' ' 242' ' ' PRO . 19.3 ptpt -69.02 161.31 29.25 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.761 0.825 . . . . 65.349999999999994 110.829 171.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -53.38 -32.19 48.26 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.588 0.755 . . . . 74.040000000000006 112.284 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -79.28 83.85 5.27 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.917 -1.142 . . . . 74.150000000000006 107.917 170.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -44.23 103.91 0.35 Allowed Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 126.261 1.825 . . . . 55.420000000000002 114.519 -168.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 237' ' ' PRO . 93.2 Cg_endo -107.44 105.07 0.02 OUTLIER 'Trans proline' 0 CA--C 1.563 1.973 0 C-N-CA 123.886 3.057 . . . . 75.530000000000001 113.934 175.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 13.8 t -93.89 156.93 16.37 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.75 -0.594 . . . . 75.25 110.011 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 13.5 p -159.62 143.44 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.811 0.844 . . . . 65.329999999999998 109.642 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -104.98 104.59 14.36 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.21 1.004 . . . . 75.439999999999998 110.439 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -82.24 76.96 2.14 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.662 -0.699 . . . . 73.409999999999997 112.577 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.5 m -65.52 149.7 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.499 0.72 . . . . 74.25 111.234 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 48.4 t -151.33 140.1 13.39 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.265 0.626 . . . . 53.420000000000002 110.676 -172.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.63 146.63 67.85 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.286 1.99 . . . . 54.329999999999998 111.231 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -61.83 99.06 0.11 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.769 0.428 . . . . 50.439999999999998 110.177 175.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -146.57 17.93 1.31 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.581 0.752 . . . . 71.409999999999997 109.303 174.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -76.67 155.51 33.32 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.146 0.498 . . . . 72.019999999999996 111.121 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -115.7 166.31 12.07 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.818 0.847 . . . . 64.109999999999999 109.315 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -70.1 -55.99 8.03 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.79 -0.819 . . . . 72.510000000000005 108.79 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 . . . . . 0 C--O 1.248 0.991 0 C-N-CA 125.584 1.554 . . . . 73.239999999999995 107.676 174.203 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.3 mtt . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.339 -0.615 . . . . 74.319999999999993 109.339 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.22 79.46 0.52 Allowed Glycine 0 C--N 1.35 1.319 0 N-CA-C 110.758 -0.937 . . . . 74.510000000000005 110.758 173.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.435 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . 30.0 pt20 -74.39 -14.38 60.85 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.723 0.809 . . . . 64.530000000000001 112.0 -173.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 66.23 160.25 0.13 Allowed Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 124.777 1.231 . . . . 72.140000000000001 111.783 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.24 -28.24 84.61 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.359 2.039 . . . . 60.200000000000003 111.637 166.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.08 -69.42 3.38 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.199 -0.91 . . . . 31.23 111.007 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt 58.0 52.69 7.5 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.728 1.211 . . . . 72.439999999999998 109.896 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.57 107.48 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 114.186 -1.37 . . . . 73.040000000000006 109.322 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 79.7 mt -86.87 80.33 8.5 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.505 -0.77 . . . . 73.209999999999994 109.436 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.51 -34.23 88.83 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 114.727 -1.124 . . . . 60.109999999999999 114.335 -171.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -89.12 50.51 1.96 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.376 0.608 . . . . 63.020000000000003 111.366 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -134.84 153.8 51.89 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.538 1.135 . . . . 74.510000000000005 108.799 170.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -68.68 117.09 9.96 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.742 -1.207 . . . . 73.319999999999993 107.742 170.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.431 ' HB3' HH11 ' A' ' 14' ' ' ARG . 1.5 mmm180 61.01 73.38 0.61 Allowed Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 124.462 1.105 . . . . 74.230000000000004 109.311 -170.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.9 161.48 12.9 Favored 'Trans proline' 0 C--N 1.387 2.581 0 C-N-CA 123.344 2.696 . . . . 71.299999999999997 112.553 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.7 p -66.05 165.15 13.94 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 121.169 0.509 . . . . 73.109999999999999 111.006 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.6 mt -108.31 130.62 22.53 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 109.064 -0.717 . . . . 74.409999999999997 109.064 -176.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.27 172.7 9.7 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.301 2.001 . . . . 74.530000000000001 111.206 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.86 144.45 36.97 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 122.329 -0.232 . . . . 62.420000000000002 110.439 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.629 ' HB3' HD11 ' A' ' 23' ' ' ILE . 72.6 mt -84.84 92.38 8.25 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.486 -0.931 . . . . 62.43 108.486 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -96.27 -49.07 5.36 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.203 -0.908 . . . . 74.430000000000007 109.379 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -103.2 110.96 23.11 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.561 -1.2 . . . . 63.25 109.228 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 20' ' ' LEU . 37.2 mm -116.99 113.01 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.954 0.902 . . . . 64.439999999999998 109.491 -177.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.681 ' HA ' ' HE1' ' A' ' 129' ' ' TRP . 2.2 tppp? 49.66 53.46 12.71 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.166 1.386 . . . . 73.25 112.739 175.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.18 53.47 4.79 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 114.78 -1.1 . . . . 65.450000000000003 110.817 173.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.35 85.58 5.82 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.536 0.734 . . . . 61.109999999999999 109.796 -176.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.19 -10.41 85.38 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.503 -0.771 . . . . 62.329999999999998 111.925 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -100.5 108.5 20.48 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.178 0.991 . . . . 72.120000000000005 109.382 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -92.17 17.56 9.4 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.762 0.825 . . . . 74.310000000000002 110.629 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -96.35 19.1 12.52 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.582 1.153 . . . . 71.439999999999998 111.016 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.9 p -70.35 143.44 51.95 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.985 0.914 . . . . 70.030000000000001 110.047 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.1 m -65.22 103.67 0.81 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.768 0.427 . . . . 74.349999999999994 110.841 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -110.17 167.11 10.43 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.075 0.95 . . . . 72.209999999999994 110.642 -177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -73.03 127.8 33.61 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.209 0.604 . . . . 73.310000000000002 111.195 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.9 95.14 0.1 Allowed Glycine 0 C--N 1.341 0.857 0 N-CA-C 110.495 -1.042 . . . . 72.010000000000005 110.495 175.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.29 78.11 0.35 Allowed Glycine 0 C--N 1.35 1.315 0 CA-C-O 119.676 -0.514 . . . . 62.219999999999999 111.99 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.81 132.65 15.93 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.166 2.577 . . . . 62.329999999999998 111.232 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -72.81 159.91 33.01 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.007 0.432 . . . . 72.540000000000006 111.674 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.1 t -158.82 152.59 23.28 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.361 -0.836 . . . . 23.329999999999998 110.244 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -65.15 95.88 0.19 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.61 0.764 . . . . 60.299999999999997 109.462 172.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -76.35 88.25 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.454 0.702 . . . . 71.239999999999995 109.58 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -125.33 126.96 45.89 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.5 1.12 . . . . 74.299999999999997 108.269 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 p -102.39 153.49 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 123.265 0.626 . . . . 70.230000000000004 109.918 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.65 158.9 39.07 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 107.168 -1.419 . . . . 74.049999999999997 107.168 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -74.12 -17.7 60.9 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.657 0.662 . . . . 64.109999999999999 111.26 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -137.89 162.25 34.51 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.083 0.953 . . . . 63.409999999999997 110.079 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 70.54 24.77 4.4 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.63 1.172 . . . . 51.149999999999999 111.969 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.0 mt -86.25 75.66 9.82 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.068 0.461 . . . . 62.229999999999997 111.115 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -89.16 123.35 33.33 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.413 -0.958 . . . . 71.120000000000005 108.413 167.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -90.36 102.49 5.05 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.016 1.326 . . . . 70.019999999999996 109.83 -174.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -82.63 119.66 3.01 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.667 2.245 . . . . 63.109999999999999 111.917 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.4 t -89.58 118.56 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.396 -0.594 . . . . 63.450000000000003 109.396 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.77 143.42 54.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.277 0.631 . . . . 61.200000000000003 110.764 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.3 m -59.1 124.59 20.45 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.398 0.679 . . . . 41.439999999999998 110.695 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.85 97.06 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.854 0.862 . . . . 62.240000000000002 109.969 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -58.53 -36.95 74.65 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.843 0.857 . . . . 74.239999999999995 110.135 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 60.4 73.69 0.61 Allowed Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 114.492 -1.231 . . . . 53.009999999999998 109.934 -177.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.34 118.65 4.83 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.648 2.232 . . . . 71.0 111.279 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -62.78 -30.5 71.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.982 0.913 . . . . 74.409999999999997 111.045 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.84 130.33 2.13 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.701 -0.681 . . . . 73.340000000000003 112.657 174.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 73.2 mt -103.85 109.36 21.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.541 0.736 . . . . 54.420000000000002 109.124 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.5 p -72.3 99.37 2.39 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.538 0.735 . . . . 72.230000000000004 110.718 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -123.27 122.43 38.34 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.066 0.946 . . . . 70.420000000000002 109.71 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' A' ' 96' ' ' ASP . . . -94.43 70.56 3.68 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.6 0.714 . . . . 73.439999999999998 110.353 -175.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.84 121.92 21.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.029 -0.987 . . . . 51.020000000000003 110.846 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -120.34 -0.55 10.38 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.156 0.582 . . . . 72.430000000000007 110.977 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 30.5 t90 -73.92 88.75 1.85 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.346 -0.613 . . . . 63.439999999999998 109.346 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -85.77 64.32 8.54 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.194 -0.912 . . . . 64.349999999999994 110.809 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.2 p -61.25 -33.31 73.31 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.737 0.78 . . . . 62.020000000000003 110.175 172.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -106.63 131.03 54.24 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.254 -1.339 . . . . 74.310000000000002 109.032 173.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -122.17 163.44 19.54 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.389 0.676 . . . . 73.310000000000002 110.094 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -93.93 128.89 40.49 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.146 0.578 . . . . 74.310000000000002 110.554 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.6 mt -137.65 -45.56 0.54 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.579 1.152 . . . . 72.140000000000001 108.888 173.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 78.4 mt -74.24 104.42 5.01 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 114.933 -1.031 . . . . 65.319999999999993 109.48 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.62 81.63 2.05 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.354 1.062 . . . . 71.040000000000006 110.794 -172.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.04 66.42 0.26 Allowed Glycine 0 CA--C 1.534 1.246 0 CA-C-O 119.523 -0.598 . . . . 53.530000000000001 112.9 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.85 160.92 36.92 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.55 2.166 . . . . 55.0 112.435 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 62.1 m -72.82 125.7 28.17 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.415 0.686 . . . . 73.329999999999998 111.305 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.749 ' HG3' HD22 ' A' ' 84' ' ' LEU . 1.1 tm-20 -102.13 145.45 29.34 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.429 0.692 . . . . 72.140000000000001 109.682 176.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -164.92 30.13 0.06 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 107.327 -1.36 . . . . 74.319999999999993 107.327 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -147.96 142.89 17.02 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-N 115.47 -0.786 . . . . 45.049999999999997 111.057 -164.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.69 -12.88 12.15 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.157 2.572 . . . . 72.019999999999996 112.817 173.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -88.61 38.14 0.86 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.464 1.105 . . . . 75.430000000000007 110.738 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.749 HD22 ' HG3' ' A' ' 79' ' ' GLU . 20.8 tp -89.53 113.63 25.06 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-N 115.378 -0.828 . . . . 71.129999999999995 110.184 -173.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 3.0 m-85 -103.83 176.56 5.11 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.877 1.271 . . . . 72.099999999999994 108.78 174.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.1 p -141.58 148.46 20.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 108.624 -0.88 . . . . 65.510000000000005 108.624 170.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.88 127.96 33.14 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.162 0.585 . . . . 74.439999999999998 109.55 173.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.25 -22.78 24.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.45 1.1 . . . . 71.040000000000006 111.067 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -136.79 160.25 39.41 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.377 0.671 . . . . 74.409999999999997 109.924 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -81.53 123.09 28.34 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.415 -0.957 . . . . 72.439999999999998 108.415 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.441 ' HB3' HG12 ' A' ' 101' ' ' ILE . 91.8 t80 -125.8 116.68 21.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.417 -0.957 . . . . 72.430000000000007 108.417 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.6 p -80.67 139.03 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.072 0.549 . . . . 74.239999999999995 110.211 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.06 132.27 42.15 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.934 0.494 . . . . 45.149999999999999 110.917 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 t -74.36 -27.53 60.71 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.377 0.671 . . . . 50.219999999999999 109.737 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.48 -144.51 7.25 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.516 -0.634 . . . . 73.150000000000006 111.516 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.485 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 31.2 t70 -71.24 -24.23 62.15 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.692 0.797 . . . . 72.530000000000001 110.952 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.424 ' HB2' HD12 ' A' ' 23' ' ' ILE . 27.4 p-10 -67.93 -22.61 65.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.04 0.936 . . . . 75.409999999999997 111.238 -177.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.5 p -129.87 158.54 39.21 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.298 1.039 . . . . 62.229999999999997 110.226 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.2 tp -110.08 136.46 49.29 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.131 -0.692 . . . . 74.129999999999995 109.131 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.4 t -81.73 112.9 19.32 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 107.503 -1.295 . . . . 50.530000000000001 107.503 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.441 HG12 ' HB3' ' A' ' 91' ' ' PHE . 37.1 pt -119.95 157.8 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.569 0.748 . . . . 71.209999999999994 109.452 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.5 m -131.32 143.84 50.82 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.545 -0.539 . . . . 63.210000000000001 109.545 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -52.07 123.84 11.47 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.778 0.831 . . . . 64.310000000000002 111.533 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.92 -22.69 34.5 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.054 -0.521 . . . . 62.32 112.935 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -76.9 132.33 39.05 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 117.119 0.46 . . . . 31.129999999999999 110.26 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.587 ' HD2' HD21 ' A' ' 84' ' ' LEU . 41.2 mtmt -82.25 127.9 33.65 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 124.11 0.881 . . . . 61.240000000000002 109.661 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.9 mt -108.21 130.98 55.12 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.829 0.852 . . . . 74.400000000000006 109.241 -171.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -91.82 106.23 18.31 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.777 -0.823 . . . . 72.230000000000004 108.777 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 89.7 t -96.89 117.03 40.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.871 -0.789 . . . . 75.209999999999994 108.871 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.4 mt -71.38 -27.46 63.35 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.328 0.651 . . . . 72.329999999999998 110.418 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.79 175.61 34.87 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.482 -0.781 . . . . 71.129999999999995 111.792 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.59 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 2.1 m-30 -95.2 171.17 8.89 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.006 -1.109 . . . . 74.010000000000005 108.006 173.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.525 HD21 ' HB2' ' A' ' 117' ' ' GLU . 32.0 p30 -76.05 178.58 6.22 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.923 -0.399 . . . . 73.430000000000007 109.923 172.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -65.03 -16.65 63.69 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.331 0.493 . . . . 72.230000000000004 112.331 -172.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.435 ' OD1' ' HA ' ' A' ' 3' ' ' GLN . 63.1 t30 -109.7 -8.27 14.97 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-O 120.859 0.361 . . . . 54.340000000000003 111.564 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 74.18 21.92 78.4 Favored Glycine 0 N--CA 1.469 0.838 0 N-CA-C 114.185 0.434 . . . . 73.019999999999996 114.185 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.525 ' HB2' HD21 ' A' ' 113' ' ' ASN . 25.5 mt-10 -74.67 -55.52 5.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.993 0.902 . . . . 71.420000000000002 110.118 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -118.72 133.01 56.16 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 113.998 -1.455 . . . . 73.420000000000002 108.513 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -110.97 127.52 55.53 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.917 1.287 . . . . 71.129999999999995 110.401 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -77.58 106.43 9.37 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.033 0.444 . . . . 71.519999999999996 110.325 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.48 163.48 12.83 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.336 -0.847 . . . . 74.019999999999996 110.61 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -142.78 131.53 22.7 Favored 'General case' 0 C--O 1.249 1.051 0 C-N-CA 124.24 1.016 . . . . 73.329999999999998 108.581 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 81.4 p -143.66 -167.86 2.69 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.697 1.199 . . . . 74.049999999999997 109.463 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -57.93 -18.79 25.49 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.671 1.188 . . . . 72.310000000000002 112.028 173.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -89.62 -6.51 56.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.598 1.159 . . . . 65.439999999999998 111.692 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.38 -141.85 16.86 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 111.392 -0.683 . . . . 64.209999999999994 111.392 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -142.77 138.92 30.79 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.421 0.688 . . . . 72.200000000000003 110.63 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 176.32 -177.02 47.91 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 111.622 -0.591 . . . . 44.25 111.622 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.681 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 33.9 m95 -100.4 136.91 39.55 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.349 0.66 . . . . 64.230000000000004 110.816 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.23 149.85 74.83 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.331 1.053 . . . . 73.439999999999998 109.27 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.95 137.02 33.94 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 121.74 1.627 . . . . 75.5 110.94 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.471 ' HA ' HG12 ' A' ' 135' ' ' ILE . 26.3 m -61.4 -17.1 52.55 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.729 0.812 . . . . 55.200000000000003 112.64 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -71.1 -26.75 63.17 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.024 0.93 . . . . 63.32 111.175 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -98.94 3.94 47.22 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.923 0.889 . . . . 73.099999999999994 111.658 -173.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 132' ' ' SER . 16.2 pt -130.63 157.62 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.779 0.432 . . . . 74.340000000000003 110.047 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.426 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 14.2 t -155.76 135.07 7.88 Favored Pre-proline 0 CA--C 1.555 1.159 0 O-C-N 123.349 0.406 . . . . 74.439999999999998 110.005 172.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 3.0 Cg_exo -74.94 117.03 4.77 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.955 2.437 . . . . 64.219999999999999 111.953 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.2 m -91.89 -34.37 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 122.988 0.515 . . . . 71.299999999999997 112.137 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -99.84 16.75 22.72 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.641 0.734 . . . . 64.310000000000002 110.077 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.1 t -92.74 -176.8 4.35 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.736 0.779 . . . . 62.229999999999997 110.649 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.428 HD13 HD23 ' A' ' 214' ' ' LEU . 51.7 mt -64.91 -12.59 50.96 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.441 1.496 . . . . 63.340000000000003 112.151 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -55.86 -23.36 30.45 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.65 1.18 . . . . 72.310000000000002 112.524 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -58.58 -19.66 40.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.538 0.735 . . . . 74.319999999999993 111.368 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -95.74 131.99 41.43 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.254 1.022 . . . . 73.349999999999994 108.332 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.2 m -70.8 -6.9 41.28 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.081 0.771 . . . . 71.430000000000007 113.081 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 33.4 p-90 -81.05 -27.6 35.69 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.258 0.223 . . . . 73.219999999999999 111.498 173.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -94.91 120.49 35.21 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.126 -0.694 . . . . 63.100000000000001 109.126 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -112.81 6.88 18.24 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 116.346 -0.388 . . . . 64.340000000000003 111.368 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 151' ' ' VAL . . . 70.73 -150.8 48.52 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 119.032 -0.871 . . . . 63.119999999999997 113.461 177.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.55 104.28 0.92 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.279 2.652 . . . . 73.129999999999995 111.6 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 149' ' ' GLY . 40.4 t -124.32 140.1 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 120.761 0.315 . . . . 63.420000000000002 110.838 -173.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.0 t -71.1 160.14 33.42 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.875 0.87 . . . . 74.400000000000006 111.088 172.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -62.91 -36.89 84.85 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.66 -0.7 . . . . 71.299999999999997 110.874 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -66.51 -51.62 54.7 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 123.714 0.634 . . . . 73.549999999999997 109.991 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.33 -42.27 81.57 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 124.002 0.814 . . . . 74.140000000000001 110.734 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.9 -59.63 4.77 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.694 -1.139 . . . . 60.030000000000001 111.257 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -67.11 -29.26 68.95 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 116.065 -0.516 . . . . 73.549999999999997 111.317 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -61.82 -53.78 51.25 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.453 0.701 . . . . 61.119999999999997 110.113 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.492 ' HB2' HD11 ' A' ' 169' ' ' LEU . 77.8 mt -67.35 -38.05 84.23 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.044 -0.526 . . . . 73.439999999999998 110.848 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.508 HD23 HG13 ' A' ' 190' ' ' VAL . 25.4 tp -71.22 -30.65 66.61 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.359 -0.837 . . . . 75.019999999999996 112.184 -172.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.4 m -68.35 -16.72 64.04 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.368 0.667 . . . . 72.340000000000003 111.963 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.3 m -82.23 3.86 25.78 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.703 0.801 . . . . 74.329999999999998 111.027 172.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -101.82 -178.89 28.04 Favored Glycine 0 C--N 1.344 0.978 0 C-N-CA 123.244 0.449 . . . . 70.329999999999998 113.228 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.4 pt -132.05 -163.89 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.508 1.123 . . . . 74.109999999999999 108.884 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.677 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 26.8 p-10 -50.75 112.09 0.65 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.452 0.701 . . . . 73.010000000000005 112.424 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 92.76 14.26 55.43 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.749 -0.659 . . . . 42.340000000000003 113.36 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 60.8 p -77.95 135.52 37.85 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.993 -0.743 . . . . 62.310000000000002 108.993 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.439 ' CE2' ' HB3' ' A' ' 232' ' ' LEU . 21.3 p90 -136.62 162.2 33.79 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.019 0.748 . . . . 62.439999999999998 113.019 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' A' ' 159' ' ' LEU . 84.3 mt -137.78 133.99 34.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.179 0.991 . . . . 72.010000000000005 108.582 169.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.93 118.27 56.13 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 107.698 -1.223 . . . . 72.530000000000001 107.698 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -128.99 165.6 20.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.899 -1.046 . . . . 72.5 108.988 -171.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 17.0 pt-20 -117.06 161.89 18.68 Favored 'General case' 0 C--O 1.261 1.674 0 N-CA-C 108.214 -1.032 . . . . 73.200000000000003 108.214 161.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.8 t -77.68 144.61 37.19 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.415 0.686 . . . . 71.230000000000004 110.263 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.417 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 29.3 mt-10 -71.03 -44.0 66.73 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.609 -1.178 . . . . 71.239999999999995 109.701 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 18.8 m -91.46 3.14 55.68 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.23 -0.896 . . . . 54.420000000000002 111.702 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.4 t -155.89 77.86 4.5 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 109.256 -0.646 . . . . 71.040000000000006 109.256 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.49 ' HG2' ' HB2' ' A' ' 112' ' ' TYR . 36.1 Cg_exo -62.18 138.16 70.6 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.173 2.582 . . . . 73.409999999999997 112.559 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.07 -24.34 27.19 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.808 -0.633 . . . . 62.299999999999997 112.335 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -88.9 118.58 28.71 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.428 -1.323 . . . . 74.540000000000006 107.428 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 82.0 mtt85 -115.7 165.4 13.09 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 123.067 0.547 . . . . 74.420000000000002 112.298 -165.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 40.3 t -151.91 136.98 17.34 Favored 'General case' 0 C--O 1.247 0.972 0 C-N-CA 124.478 1.111 . . . . 35.409999999999997 109.437 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 58.1 mt -105.43 141.92 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 109.016 -0.735 . . . . 64.439999999999998 109.016 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 12.9 m -117.94 115.73 25.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.575 1.15 . . . . 61.229999999999997 108.508 -177.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.427 HD21 ' CD2' ' A' ' 232' ' ' LEU . 58.6 mt -105.31 143.96 32.75 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.909 0.883 . . . . 73.030000000000001 111.219 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 46.3 ttt-85 -133.64 131.12 39.19 Favored 'General case' 0 C--O 1.26 1.621 0 CA-C-N 114.818 -1.083 . . . . 74.129999999999995 109.564 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.677 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 9.2 p90 -152.44 139.7 19.4 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 124.503 1.127 . . . . 75.140000000000001 108.733 173.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 56.73 24.86 9.5 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 124.766 1.226 . . . . 71.239999999999995 112.937 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.85 8.04 80.16 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 116.651 -0.249 . . . . 71.319999999999993 112.973 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 26.5 tpt180 -102.35 123.35 45.98 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.394 1.078 . . . . 71.439999999999998 109.359 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.508 HG13 HD23 ' A' ' 160' ' ' LEU . 77.1 t -110.76 128.49 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.723 1.209 . . . . 63.530000000000001 109.149 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.434 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 31.2 p90 -145.43 158.28 43.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.46 0.704 . . . . 71.030000000000001 109.135 173.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -130.9 141.53 50.3 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.509 -1.293 . . . . 73.230000000000004 107.509 -173.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -138.45 149.43 45.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.691 0.396 . . . . 74.209999999999994 110.002 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 13.3 tpp85 -84.38 137.2 33.53 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.262 -0.881 . . . . 75.519999999999996 111.088 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 65.0 mt -83.07 110.09 17.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 N-CA-C 108.321 -0.992 . . . . 70.349999999999994 108.321 166.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -68.04 119.43 12.65 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.341 1.056 . . . . 71.219999999999999 109.117 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.1 m -102.89 116.68 33.03 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.685 0.394 . . . . 65.420000000000002 109.971 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 202' ' ' LYS . . . -67.16 167.08 12.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.462 1.105 . . . . 64.120000000000005 111.986 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.2 m -61.71 -30.15 70.57 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.685 0.794 . . . . 74.409999999999997 110.883 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.403 ' HB2' ' HG3' ' A' ' 202' ' ' LYS . 29.0 m-20 -70.76 -12.66 61.68 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.705 1.202 . . . . 71.540000000000006 111.783 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 87.77 2.73 81.24 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 111.818 -0.513 . . . . 45.310000000000002 111.818 -169.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 198' ' ' ALA . 64.6 mttp -68.27 159.38 31.39 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 123.073 0.549 . . . . 62.450000000000003 110.111 175.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 79.6 mt -121.38 145.61 47.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.447 -0.945 . . . . 71.200000000000003 108.447 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -165.87 174.83 9.18 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.628 0.771 . . . . 72.219999999999999 110.018 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 78.2 t -138.47 -53.84 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 107.715 -1.217 . . . . 72.340000000000003 107.715 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 17.3 m -73.19 148.75 43.48 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.414 -0.812 . . . . 71.409999999999997 110.026 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.3 m -61.22 -42.2 98.19 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.239 1.016 . . . . 63.109999999999999 112.312 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -84.52 -36.52 22.14 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 122.742 0.417 . . . . 54.439999999999998 111.333 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.9 m -67.65 138.68 56.55 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.659 0.784 . . . . 75.019999999999996 111.665 -177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -142.37 119.85 11.68 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.555 1.142 . . . . 73.200000000000003 109.067 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -117.94 136.61 53.38 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 109.634 -0.506 . . . . 73.019999999999996 109.634 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -84.29 -26.25 28.71 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.347 0.659 . . . . 62.32 109.943 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 81.8 p -130.47 147.64 52.19 Favored 'General case' 0 C--O 1.256 1.411 0 CA-C-O 121.694 0.759 . . . . 73.239999999999995 111.115 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.428 HD23 HD13 ' A' ' 141' ' ' LEU . 35.2 tp -67.65 -29.27 68.53 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 114.529 -1.214 . . . . 72.040000000000006 111.08 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.74 92.02 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.609 0.363 . . . . 75.140000000000001 110.836 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -75.19 -32.38 61.22 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 116.522 -0.308 . . . . 54.439999999999998 110.763 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.53 -47.17 85.07 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 110.16 -0.311 . . . . 72.239999999999995 110.16 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 43.0 t -69.42 -44.65 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.061 0.945 . . . . 71.140000000000001 110.359 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -61.78 -45.43 93.92 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.249 0.547 . . . . 55.229999999999997 110.869 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.459 ' O ' HG22 ' A' ' 224' ' ' VAL . 49.7 t-80 -53.03 -54.48 34.77 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.843 -1.072 . . . . 74.430000000000007 108.727 175.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -61.99 -26.08 68.01 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.544 -0.753 . . . . 74.430000000000007 112.426 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 50.5 m -72.44 -30.15 64.34 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.8 0.44 . . . . 74.109999999999999 111.188 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -108.74 -17.04 14.04 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 115.578 1.696 . . . . 64.409999999999997 115.578 -176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 220' ' ' HIS . 30.8 m -98.38 148.02 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 115.936 1.828 . . . . 72.340000000000003 115.936 -165.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -83.51 -2.44 55.95 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 129.337 3.055 . . . . 60.030000000000001 112.635 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -79.11 13.41 1.82 Allowed 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 129.252 3.021 . . . . 52.439999999999998 113.331 -138.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.76 16.19 4.18 Favored Glycine 0 N--CA 1.466 0.687 0 N-CA-C 110.091 -1.204 . . . . 63.109999999999999 110.091 -169.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 69.1 mt -90.72 135.05 33.97 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.83 0.852 . . . . 73.019999999999996 109.766 163.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.434 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 84.2 mt -67.66 -44.38 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.868 -0.79 . . . . 53.329999999999998 108.868 172.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.3 t -137.7 142.86 41.04 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.327 -0.851 . . . . 50.530000000000001 109.491 174.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 73.5 p -74.77 157.55 35.0 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.24 0.616 . . . . 62.420000000000002 109.565 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.439 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . 23.5 mt -70.85 101.74 2.2 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 109.567 -0.531 . . . . 61.140000000000001 109.567 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -79.0 -49.7 12.29 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.46 0.704 . . . . 62.049999999999997 110.224 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 167' ' ' SER . 4.3 p90 -164.76 152.72 10.45 Favored Pre-proline 0 N--CA 1.494 1.741 0 CA-C-O 119.61 -0.233 . . . . 70.150000000000006 110.511 173.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.18 146.63 32.25 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 121.936 1.757 . . . . 74.540000000000006 112.505 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -76.25 144.91 75.66 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.242 0.617 . . . . 61.240000000000002 109.409 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -84.7 170.34 10.2 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.548 2.165 . . . . 71.430000000000007 113.733 -171.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -86.02 162.86 18.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.254 1.022 . . . . 72.129999999999995 109.204 169.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 38.6 ttm105 -52.53 -30.22 29.39 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.69 0.757 . . . . 74.349999999999994 111.075 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -62.62 179.25 0.36 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 114.805 -1.089 . . . . 74.019999999999996 110.361 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -103.67 94.68 6.43 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.979 -0.748 . . . . 72.140000000000001 108.979 172.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.31 157.45 22.73 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.193 1.929 . . . . 63.310000000000002 111.327 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 5.1 t -124.43 107.34 11.0 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.204 -0.665 . . . . 74.430000000000007 109.204 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 11.2 m -134.46 142.73 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.142 0.977 . . . . 61.310000000000002 109.239 175.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -154.81 139.55 17.09 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.354 -0.98 . . . . 73.5 108.354 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 118.99 127.66 3.68 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 110.933 -0.867 . . . . 74.219999999999999 110.933 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.6 139.91 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.013 -1.106 . . . . 63.409999999999997 108.013 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 46.3 m -131.16 83.8 59.18 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.517 0.727 . . . . 75.129999999999995 109.607 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.16 130.76 7.42 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.825 2.35 . . . . 55.140000000000001 111.214 174.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -80.86 135.44 35.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.122 0.569 . . . . 74.400000000000006 110.218 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -142.49 100.88 3.78 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.112 0.965 . . . . 74.349999999999994 109.644 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -161.69 161.49 29.46 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.958 -0.756 . . . . 74.109999999999999 108.958 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.67 -35.18 78.37 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.919 0.487 . . . . 64.010000000000005 110.663 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -144.15 159.02 43.36 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.884 0.873 . . . . 73.219999999999999 109.887 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 CA--C 1.553 1.083 0 C-N-CA 124.05 0.94 . . . . 63.020000000000003 109.725 -179.12 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 tmm? . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 108.794 -0.817 . . . . 72.349999999999994 108.794 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.41 123.02 0.63 Allowed Glycine 0 C--N 1.338 0.668 0 N-CA-C 111.271 -0.731 . . . . 65.219999999999999 111.271 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -62.04 -56.3 20.35 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.213 0.506 . . . . 64.420000000000002 109.686 174.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 34.46 55.12 1.78 Allowed Pre-proline 0 CA--C 1.57 1.724 0 C-N-CA 126.563 1.945 . . . . 73.230000000000004 115.211 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.51 -33.32 3.25 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 121.842 1.695 . . . . 51.009999999999998 112.427 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.93 -84.8 0.07 OUTLIER Glycine 0 C--N 1.351 1.368 0 O-C-N 123.435 0.459 . . . . 73.230000000000004 113.608 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -159.56 27.51 0.19 Allowed 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.678 0.791 . . . . 72.219999999999999 110.193 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.816 ' HA ' ' HB2' ' A' ' 16' ' ' SER . 27.9 m -61.28 -31.33 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 122.449 0.3 . . . . 73.150000000000006 111.448 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.2 tp -108.07 137.43 46.08 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.996 0.918 . . . . 73.040000000000006 109.184 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.11 -176.15 43.16 Favored Glycine 0 C--O 1.24 0.512 0 N-CA-C 111.077 -0.809 . . . . 64.099999999999994 111.077 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -75.99 -15.35 60.16 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.037 0.535 . . . . 54.439999999999998 111.062 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -57.75 129.21 40.86 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.094 0.958 . . . . 53.200000000000003 111.94 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 137.73 58.34 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.962 -0.755 . . . . 72.319999999999993 108.962 172.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 54.85 69.59 1.99 Allowed Pre-proline 0 CA--C 1.555 1.151 0 O-C-N 123.859 0.725 . . . . 72.120000000000005 109.918 -168.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.5 160.72 22.93 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.674 2.249 . . . . 75.530000000000001 110.909 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.816 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 14.5 m -68.76 166.59 17.17 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 121.201 0.524 . . . . 75.140000000000001 111.936 -168.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.4 mt -102.66 127.22 30.73 Favored Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 108.764 -0.828 . . . . 54.340000000000003 108.764 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.13 171.16 17.35 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.187 1.925 . . . . 71.400000000000006 111.31 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.68 146.87 27.99 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 122.409 0.283 . . . . 73.329999999999998 110.642 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.531 ' HB3' HD11 ' A' ' 23' ' ' ILE . 70.5 mt -85.54 92.51 8.55 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 107.89 -1.152 . . . . 74.209999999999994 107.89 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -97.71 -48.42 5.23 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.725 -0.472 . . . . 75.340000000000003 109.725 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -101.56 114.18 27.97 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.354 -0.839 . . . . 71.310000000000002 109.451 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 20' ' ' LEU . 41.8 mm -117.65 113.62 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.588 -0.893 . . . . 63.310000000000002 108.588 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.553 ' HB3' ' HZ2' ' A' ' 129' ' ' TRP . 49.0 tttm -100.24 120.37 39.81 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 114.881 -1.054 . . . . 54.130000000000003 109.453 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.91 118.18 6.84 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.648 0.592 . . . . 54.329999999999998 112.139 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.52 ' HB1' ' HD2' ' A' ' 29' ' ' ARG . . . -77.45 -43.83 31.05 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.153 0.581 . . . . 73.409999999999997 112.001 -175.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.01 -99.15 0.29 Allowed Glycine 0 C--N 1.347 1.171 0 O-C-N 123.491 0.495 . . . . 31.120000000000001 112.25 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -121.57 155.63 34.63 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.276 -1.009 . . . . 74.349999999999994 108.276 169.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -128.0 156.95 41.9 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.558 0.343 . . . . 75.019999999999996 111.146 -172.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -91.74 10.78 26.97 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.16 0.584 . . . . 60.009999999999998 110.893 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 m -63.13 109.32 1.48 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.086 0.555 . . . . 43.5 109.591 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.4 p -57.38 118.11 4.81 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.288 1.035 . . . . 70.209999999999994 111.941 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -112.33 169.29 8.97 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.316 0.646 . . . . 62.0 110.83 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -154.79 168.71 25.96 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.45 -0.796 . . . . 72.420000000000002 110.01 173.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.37 168.65 54.6 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 123.737 0.648 . . . . 71.219999999999999 112.911 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.57 -169.13 37.58 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-O 118.836 -0.98 . . . . 60.340000000000003 112.568 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -42.67 131.09 5.44 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 124.524 3.483 . . . . 42.109999999999999 114.709 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -56.43 106.13 0.26 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.193 0.997 . . . . 72.200000000000003 111.811 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.2 t -83.38 143.97 29.96 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.082 -1.081 . . . . 74.129999999999995 108.082 166.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -76.2 76.56 3.01 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.406 0.622 . . . . 64.519999999999996 110.407 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.39 145.47 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.134 -0.939 . . . . 72.329999999999998 108.911 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.48 138.03 31.88 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 109.625 -0.509 . . . . 73.040000000000006 109.625 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.519 HG22 ' H ' ' A' ' 46' ' ' GLU . 4.2 p -70.73 111.21 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 123.255 0.622 . . . . 63.310000000000002 110.58 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -80.53 -34.16 35.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.473 0.709 . . . . 71.25 110.777 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -68.08 -22.67 64.91 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.84 0.456 . . . . 75.219999999999999 111.484 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.519 ' H ' HG22 ' A' ' 43' ' ' VAL . 10.6 tp10 -72.94 125.11 26.83 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 109.275 -0.639 . . . . 54.009999999999998 109.275 173.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.41 -97.2 0.08 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.72 -0.844 . . . . 64.200000000000003 108.72 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.0 mt 46.78 -78.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 125.927 1.691 . . . . 61.450000000000003 113.453 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -55.72 -39.54 71.22 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 125.058 1.343 . . . . 64.099999999999994 111.546 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 58.95 87.22 0.14 Allowed Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 124.244 1.018 . . . . 74.420000000000002 109.824 -171.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -63.08 89.07 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.642 2.228 . . . . 71.409999999999997 111.466 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.9 t -83.43 74.32 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.784 0 N-CA-C 108.303 -0.999 . . . . 63.229999999999997 108.303 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.52 115.43 16.26 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.921 -1.036 . . . . 42.329999999999998 108.785 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.0 p -67.53 92.07 0.3 Allowed 'General case' 0 CA--C 1.547 0.85 0 O-C-N 123.892 0.745 . . . . 34.32 109.809 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.33 96.06 1.81 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-N 114.705 -1.134 . . . . 73.510000000000005 110.631 -173.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -120.71 103.47 9.14 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.751 -0.659 . . . . 74.420000000000002 109.629 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 61.6 75.84 0.42 Allowed Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.592 1.157 . . . . 41.329999999999998 112.267 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.23 95.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.384 2.723 . . . . 64.129999999999995 113.157 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -118.79 107.99 14.31 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.49 1.116 . . . . 71.129999999999995 108.78 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.97 171.02 33.81 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.38 -0.688 . . . . 64.329999999999998 111.38 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 74.6 mt -99.13 135.66 40.21 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.131 0.572 . . . . 72.299999999999997 110.153 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.2 m -78.24 79.42 4.68 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.413 0.625 . . . . 51.310000000000002 109.441 171.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -76.39 136.1 39.48 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.757 -1.11 . . . . 74.109999999999999 111.028 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.8 82.6 7.78 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.488 0.715 . . . . 71.219999999999999 110.184 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.93 104.82 3.07 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.918 -0.583 . . . . 53.109999999999999 109.456 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -82.5 50.25 1.61 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.271 1.028 . . . . 74.120000000000005 111.3 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -110.62 100.71 9.45 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.025 0.93 . . . . 73.319999999999993 109.938 -176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -124.46 93.2 3.84 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.337 -1.357 . . . . 62.229999999999997 107.337 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.3 t -90.71 108.67 19.97 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.827 0.451 . . . . 53.219999999999999 109.915 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.77 -18.28 64.18 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.156 0.583 . . . . 70.310000000000002 112.104 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -89.1 56.72 3.79 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.8 0.84 . . . . 60.450000000000003 110.949 -171.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -167.44 153.69 7.91 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.463 0.705 . . . . 65.129999999999995 109.443 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.1 mt -122.16 82.41 1.96 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.111 0.564 . . . . 64.540000000000006 110.287 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.3 mt -96.84 -73.96 0.58 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 109.615 -0.513 . . . . 72.209999999999994 109.615 169.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.16 123.02 11.29 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.05 0.54 . . . . 53.229999999999997 109.686 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -118.97 167.54 13.17 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-O 119.37 -0.683 . . . . 63.539999999999999 112.446 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.09 95.98 0.14 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 123.588 2.859 . . . . 71.019999999999996 111.786 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.7 m -77.5 98.28 5.29 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.372 -0.831 . . . . 75.219999999999999 110.511 -174.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -96.61 108.6 21.22 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.408 1.083 . . . . 74.329999999999998 110.408 -175.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -173.26 165.7 4.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 123.642 0.589 . . . . 74.510000000000005 110.892 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 79.85 137.36 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 126.245 1.818 . . . . 75.340000000000003 112.649 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -70.43 -7.89 22.31 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.311 2.674 . . . . 74.450000000000003 111.786 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -82.36 27.01 0.52 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.415 1.086 . . . . 72.109999999999999 111.182 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 28.3 tp -86.09 116.24 24.18 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.391 0.676 . . . . 71.219999999999999 109.702 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 3.6 m-85 -104.62 177.18 4.92 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.816 1.646 . . . . 73.450000000000003 109.202 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.8 p -140.82 142.85 29.59 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 108.277 -1.008 . . . . 74.219999999999999 108.277 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.99 116.62 16.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.997 0.519 . . . . 74.239999999999995 109.825 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.52 -24.11 50.08 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.859 0.864 . . . . 73.450000000000003 110.689 172.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -130.83 158.75 39.33 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.983 0.513 . . . . 71.209999999999994 110.17 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.02 151.64 37.11 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.911 -0.586 . . . . 72.209999999999994 109.459 172.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.531 ' HB3' HG12 ' A' ' 101' ' ' ILE . 81.1 t80 -155.8 116.58 3.82 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.298 -0.63 . . . . 74.230000000000004 109.298 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.56 138.78 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 108.988 -0.745 . . . . 73.239999999999995 108.988 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.408 ' HB2' ' N ' ' A' ' 100' ' ' SER . . . -75.53 129.51 37.36 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 122.178 -0.326 . . . . 63.020000000000003 110.862 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 m -66.07 -23.95 66.62 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.385 0.674 . . . . 75.319999999999993 110.607 173.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.96 -153.33 12.93 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.42 -0.809 . . . . 73.549999999999997 111.261 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.6 -26.14 60.66 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.219 0.608 . . . . 74.510000000000005 110.58 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -69.73 -21.68 63.44 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.756 0.822 . . . . 70.219999999999999 112.014 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.0 p -117.02 155.0 29.94 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.407 1.083 . . . . 72.040000000000006 109.036 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.2 tp -108.93 123.93 49.86 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.242 -0.651 . . . . 74.310000000000002 109.242 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.408 ' N ' ' HB2' ' A' ' 93' ' ' ALA . 31.2 p -69.46 115.38 8.66 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.653 -0.869 . . . . 75.25 108.653 171.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.531 HG12 ' HB3' ' A' ' 91' ' ' PHE . 34.5 pt -119.59 143.68 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.271 -0.64 . . . . 50.439999999999998 109.271 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 m -112.38 144.73 41.33 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.977 -0.749 . . . . 62.240000000000002 108.977 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -56.07 119.65 6.23 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.668 0.387 . . . . 74.409999999999997 110.148 173.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.13 -17.29 44.63 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.301 -0.409 . . . . 73.209999999999994 113.219 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -78.8 129.51 34.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.143 0.577 . . . . 64.010000000000005 110.226 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.401 ' HD2' HD21 ' A' ' 84' ' ' LEU . 48.0 mtmt -87.48 130.14 34.81 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.024 0.529 . . . . 65.530000000000001 110.566 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.47 ' HB3' ' HB1' ' A' ' 121' ' ' ALA . 18.8 mt -107.3 148.1 29.43 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.232 1.013 . . . . 54.299999999999997 108.937 -172.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -111.04 107.92 17.47 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.386 -0.968 . . . . 63.329999999999998 108.386 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.2 t -99.78 123.44 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.243 0.617 . . . . 54.340000000000003 110.078 -171.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.429 HD12 ' HD3' ' A' ' 29' ' ' ARG . 91.5 mt -94.86 -4.45 47.0 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.506 0.722 . . . . 74.230000000000004 111.457 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.48 165.33 18.11 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 112.5 -0.24 . . . . 54.539999999999999 112.5 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.45 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 2.4 m-85 -97.06 174.53 6.71 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.665 0.786 . . . . 63.329999999999998 109.993 172.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -72.5 150.33 43.34 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.131 -0.94 . . . . 64.120000000000005 108.687 171.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -63.0 -27.17 69.24 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.237 0.458 . . . . 64.340000000000003 112.237 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.418 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 64.0 t30 -92.22 -10.96 36.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.041 0.536 . . . . 73.230000000000004 110.689 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 81.61 22.32 60.3 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 116.199 -0.455 . . . . 73.019999999999996 113.419 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.418 ' HG3' ' HB3' ' A' ' 115' ' ' ASN . 78.8 mt-10 -67.42 -62.38 1.45 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.836 0.854 . . . . 73.409999999999997 110.332 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -120.17 -179.12 3.84 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.928 -1.033 . . . . 53.020000000000003 109.781 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -144.36 123.45 12.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.574 0.75 . . . . 60.439999999999998 109.703 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -70.94 95.04 1.12 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.499 0.72 . . . . 70.239999999999995 110.693 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' A' ' 107' ' ' LEU . . . -105.45 145.21 31.16 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.444 0.698 . . . . 55.219999999999999 110.263 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.9 130.77 45.58 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.397 0.679 . . . . 64.329999999999998 110.195 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.9 p -133.93 -173.49 3.27 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.12 0.968 . . . . 73.439999999999998 109.643 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -61.94 -21.53 64.85 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.21 0.604 . . . . 63.039999999999999 111.339 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -76.07 -5.86 48.47 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.158 0.983 . . . . 73.040000000000006 111.836 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 116.41 -135.65 12.23 Favored Glycine 0 C--N 1.342 0.903 0 N-CA-C 110.316 -1.114 . . . . 53.219999999999999 110.316 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -151.13 156.63 41.39 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.541 0.67 . . . . 65.319999999999993 111.493 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 174.32 176.47 42.73 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.726 -0.67 . . . . 52.329999999999998 112.727 170.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.553 ' HZ2' ' HB3' ' A' ' 24' ' ' LYS . 86.9 m95 -84.54 118.7 24.49 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.495 -0.853 . . . . 74.549999999999997 110.037 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.91 153.93 47.01 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.742 1.217 . . . . 63.399999999999999 109.265 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -69.93 131.14 20.39 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 121.529 1.486 . . . . 73.430000000000007 111.059 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 27.4 p -59.63 -25.48 64.71 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.832 0.853 . . . . 75.120000000000005 111.828 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -74.91 -17.81 60.51 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.544 1.138 . . . . 72.150000000000006 112.094 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -95.34 -4.68 44.98 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.694 0.798 . . . . 65.430000000000007 112.386 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.7 pt -128.33 156.93 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.51 0.324 . . . . 63.350000000000001 110.721 -170.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.3 t -148.81 134.28 9.54 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 122.792 0.437 . . . . 62.509999999999998 109.957 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 74.3 Cg_endo -75.59 123.1 7.32 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.457 2.105 . . . . 64.209999999999994 112.918 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.9 m -98.3 -40.38 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.283 0.633 . . . . 65.040000000000006 111.825 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.468 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.0 t30 -99.01 5.39 47.15 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.104 0.562 . . . . 75.299999999999997 111.832 -172.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.8 p -83.9 -166.29 1.37 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.981 0.513 . . . . 64.340000000000003 110.655 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.408 HD13 ' HB3' ' A' ' 214' ' ' LEU . 71.7 mt -77.38 -12.16 59.92 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.804 0.841 . . . . 73.409999999999997 111.998 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.21 -21.12 66.45 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.497 0.719 . . . . 64.25 111.56 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.68 -29.4 64.62 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.994 0.918 . . . . 54.530000000000001 110.604 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -79.57 137.71 37.24 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.66 0.784 . . . . 73.310000000000002 109.633 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.0 m -63.39 -17.96 63.19 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.59 0.756 . . . . 71.430000000000007 112.778 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 51.9 p-90 -77.42 -35.55 54.04 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.324 0.49 . . . . 64.129999999999995 112.324 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -97.64 130.1 44.68 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.531 -0.544 . . . . 71.340000000000003 109.531 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -122.64 19.92 10.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.789 0.436 . . . . 75.040000000000006 111.574 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.5 -155.32 49.94 Favored Glycine 0 CA--C 1.536 1.366 0 N-CA-C 114.839 0.696 . . . . 72.349999999999994 114.839 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.26 99.06 1.24 Allowed 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 123.587 2.858 . . . . 73.430000000000007 112.049 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.5 t -142.7 145.92 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.188 0.995 . . . . 64.209999999999994 109.298 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.9 m -82.64 169.28 16.43 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.843 0.683 . . . . 72.010000000000005 112.843 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -53.71 -37.99 63.84 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 124.014 0.926 . . . . 72.299999999999997 112.488 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -56.04 -50.17 71.67 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.858 0.463 . . . . 73.219999999999999 111.746 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.89 -30.23 40.09 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 123.478 0.711 . . . . 62.450000000000003 110.465 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.716 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -59.57 -48.22 82.5 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.915 -0.584 . . . . 42.420000000000002 111.212 172.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.526 ' HG3' HG11 ' A' ' 190' ' ' VAL . 28.5 tt0 -78.85 -25.95 44.04 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.618 0.767 . . . . 73.109999999999999 109.574 -176.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.71 -52.78 63.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.665 0.786 . . . . 73.030000000000001 111.645 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.446 ' HB2' HD11 ' A' ' 169' ' ' LEU . 48.5 mt -72.22 -34.57 68.44 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 120.728 0.299 . . . . 75.439999999999998 111.042 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.453 HD22 ' HB3' ' A' ' 183' ' ' SER . 33.2 tp -66.72 -26.72 67.14 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.145 0.578 . . . . 62.450000000000003 111.898 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.3 t -64.28 -17.53 63.72 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.855 0.862 . . . . 75.420000000000002 111.715 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.0 m -89.26 -6.51 56.75 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.72 0.808 . . . . 73.109999999999999 111.565 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -97.62 161.11 21.18 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 114.616 0.606 . . . . 73.319999999999993 114.616 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.7 pt -102.59 -164.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.904 0.882 . . . . 63.140000000000001 110.221 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.862 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 13.3 p-10 -51.34 118.56 3.36 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.766 0.827 . . . . 74.319999999999993 113.124 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.59 14.37 68.2 Favored Glycine 0 C--O 1.256 1.499 0 CA-C-N 115.574 -0.739 . . . . 63.420000000000002 113.227 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.6 t -69.49 134.04 48.42 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.075 -0.713 . . . . 73.519999999999996 109.075 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.547 ' HA ' ' O ' ' A' ' 183' ' ' SER . 20.1 p90 -139.97 154.13 47.09 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.879 0.696 . . . . 72.439999999999998 112.879 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 159' ' ' LEU . 97.8 mt -133.08 133.73 43.36 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.708 -0.849 . . . . 44.32 108.708 169.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.416 HG22 HG12 ' A' ' 182' ' ' ILE . 22.7 t -106.55 118.0 53.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 107.363 -1.347 . . . . 71.209999999999994 107.363 174.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.716 HH11 ' HA ' ' A' ' 156' ' ' ALA . 28.9 mtt180 -147.42 152.03 37.44 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.198 0.999 . . . . 74.239999999999995 109.527 -174.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 16.1 pt-20 -106.76 162.6 13.64 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.8 -0.815 . . . . 62.530000000000001 108.8 172.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.5 t -77.27 134.54 38.53 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.657 0.383 . . . . 65.519999999999996 110.262 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -60.76 -43.78 97.56 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.404 0.682 . . . . 73.439999999999998 109.962 175.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 62.5 p -90.6 5.73 46.69 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.67 -1.15 . . . . 70.040000000000006 112.188 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.0 m -150.69 87.96 4.68 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.443 0.697 . . . . 73.129999999999995 109.333 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.45 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 27.1 Cg_endo -60.84 138.98 82.75 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.827 2.351 . . . . 61.140000000000001 111.89 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.83 -23.07 11.19 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 116.066 -0.516 . . . . 70.129999999999995 113.652 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -83.52 113.76 21.02 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.141 -0.689 . . . . 63.109999999999999 109.141 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.692 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 67.6 mtt-85 -114.77 170.71 8.13 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.088 -0.505 . . . . 74.230000000000004 110.124 -170.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.472 ' HB2' ' HD3' ' A' ' 194' ' ' ARG . 33.0 t -161.02 148.56 15.48 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.397 0.679 . . . . 60.340000000000003 110.048 -177.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.416 HG12 HG22 ' A' ' 170' ' ' VAL . 55.3 mt -112.78 141.06 29.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 107.955 -1.128 . . . . 51.329999999999998 107.955 166.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 20.0 m -118.12 112.29 19.99 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 124.287 1.035 . . . . 74.209999999999994 108.849 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.465 HD21 HD23 ' A' ' 232' ' ' LEU . 38.2 mt -104.78 142.25 35.04 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.486 0.585 . . . . 75.299999999999997 112.424 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -129.99 125.65 35.87 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 114.565 -1.198 . . . . 74.409999999999997 108.182 168.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.862 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 6.3 p90 -140.65 134.97 31.2 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 109.162 -0.681 . . . . 74.530000000000001 109.162 174.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 58.15 22.95 9.64 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.664 1.186 . . . . 73.400000000000006 112.48 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 84.07 7.99 84.56 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.203 -0.453 . . . . 45.200000000000003 113.654 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -102.49 124.99 49.04 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.422 0.689 . . . . 74.209999999999994 109.543 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.526 HG11 ' HG3' ' A' ' 157' ' ' GLU . 98.1 t -104.96 134.77 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.236 1.014 . . . . 63.340000000000003 110.478 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.461 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 32.4 p90 -147.0 151.84 37.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.34 1.056 . . . . 63.219999999999999 108.811 168.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -121.47 150.94 40.83 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.588 -0.893 . . . . 72.099999999999994 108.588 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -146.19 139.62 26.01 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.631 0.373 . . . . 74.109999999999999 110.464 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.472 ' HD3' ' HB2' ' A' ' 181' ' ' SER . 32.5 mmt180 -82.76 140.6 32.92 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.75 0.786 . . . . 74.109999999999999 112.913 -172.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 84.9 mt -93.04 111.2 24.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-N 114.284 -1.325 . . . . 73.129999999999995 107.539 165.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -87.98 133.35 33.96 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 109.395 -0.594 . . . . 74.120000000000005 109.395 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.7 m -94.19 116.46 28.87 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.265 0.626 . . . . 72.0 109.717 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.51 160.36 27.78 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.433 0.693 . . . . 75.140000000000001 110.997 171.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.3 t -66.4 -10.16 40.96 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.796 0.839 . . . . 74.129999999999995 111.957 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -90.61 5.19 48.98 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.79 0.836 . . . . 64.230000000000004 111.8 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 81.08 -3.5 76.26 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 122.796 0.236 . . . . 72.030000000000001 113.097 -175.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -83.5 135.19 34.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.692 0.797 . . . . 64.230000000000004 110.136 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.9 mt -92.97 157.32 16.39 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.508 0.723 . . . . 73.530000000000001 110.052 -177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -164.4 156.95 16.92 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.161 0.505 . . . . 64.140000000000001 111.29 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.3 t -117.04 -67.03 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 106.904 -1.517 . . . . 71.340000000000003 106.904 170.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.8 m -68.44 140.81 55.77 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.07 0.948 . . . . 51.530000000000001 110.257 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 54.7 p -62.86 -31.49 72.53 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.329 0.652 . . . . 45.149999999999999 111.666 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -88.08 3.31 49.46 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.513 0.725 . . . . 74.439999999999998 112.084 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.5 m -123.1 144.12 49.52 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.762 0.425 . . . . 61.450000000000003 111.453 -174.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 81.0 mmt-85 -143.03 135.43 27.39 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 107.609 -1.256 . . . . 74.310000000000002 107.609 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -131.33 135.73 47.51 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.708 -1.219 . . . . 75.219999999999999 107.708 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -75.07 -35.91 61.81 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 122.551 0.34 . . . . 72.319999999999993 110.122 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 77.4 p -124.26 150.51 45.26 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.479 0.712 . . . . 62.210000000000001 111.848 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.408 ' HB3' HD13 ' A' ' 141' ' ' LEU . 33.2 tp -69.64 -28.15 65.66 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.974 -1.012 . . . . 71.019999999999996 110.523 174.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.87 -44.58 91.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.042 0.537 . . . . 73.420000000000002 110.486 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -77.56 -29.32 52.13 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.815 -0.63 . . . . 74.129999999999995 112.273 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.3 tt -61.27 -46.34 90.74 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 118.363 0.529 . . . . 74.319999999999993 109.898 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 67.0 t -74.1 -42.09 51.99 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 C-N-CA 123.891 0.876 . . . . 64.200000000000003 111.129 -176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -58.77 -52.4 65.86 Favored 'General case' 0 C--O 1.262 1.74 0 CA-C-O 121.289 0.566 . . . . 63.229999999999997 111.223 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.483 ' O ' HG22 ' A' ' 224' ' ' VAL . 37.9 t-80 -54.67 -56.99 13.33 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 114.646 -1.161 . . . . 55.299999999999997 108.377 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.405 ' HA ' HG22 ' A' ' 224' ' ' VAL . 10.4 m170 -68.05 -14.65 63.14 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.17 0.804 . . . . 70.040000000000006 113.17 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.493 ' HA ' ' HB2' ' A' ' 232' ' ' LEU . 42.0 t -73.77 -34.65 64.77 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 110.169 -0.308 . . . . 71.310000000000002 110.169 171.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.9 t -108.5 -13.42 14.84 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 116.144 1.905 . . . . 72.329999999999998 116.144 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 220' ' ' HIS . 34.1 m -103.63 165.84 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 116.316 1.969 . . . . 72.510000000000005 116.316 -165.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.85 -1.71 58.05 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.829 3.252 . . . . 62.140000000000001 113.854 -172.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -78.67 14.36 1.34 Allowed 'General case' 0 CA--C 1.576 1.955 0 C-N-CA 130.322 3.449 . . . . 63.420000000000002 113.519 -138.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.11 17.61 4.46 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 110.856 -0.897 . . . . 42.200000000000003 110.856 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 92.8 mt -92.36 124.03 36.12 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.828 1.251 . . . . 62.200000000000003 110.34 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.461 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 89.5 mt -61.73 -40.78 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 109.303 -0.628 . . . . 65.140000000000001 109.303 172.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.5 t -138.19 142.61 40.02 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.275 -0.875 . . . . 75.329999999999998 109.392 166.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 224' ' ' VAL . 82.3 p -66.65 149.59 50.28 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.989 -0.55 . . . . 72.010000000000005 109.547 169.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 222' ' ' SER . 40.9 mt -65.48 103.32 0.82 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.001 0.521 . . . . 74.420000000000002 109.956 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -75.62 -59.42 2.76 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.518 0.727 . . . . 65.540000000000006 109.809 -176.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -156.44 150.67 19.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 CA-C-O 119.326 -0.368 . . . . 73.349999999999994 110.212 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 31.2 Cg_endo -62.81 137.3 62.31 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.116 1.877 . . . . 63.520000000000003 111.855 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -59.59 135.74 89.29 Favored Pre-proline 0 C--O 1.243 0.747 0 C-N-CA 123.333 0.653 . . . . 63.530000000000001 111.045 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.01 117.21 3.88 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.387 2.058 . . . . 73.310000000000002 112.617 -174.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.602 ' HE2' ' HB3' ' A' ' 240' ' ' ASN . 19.9 ptmt -63.71 158.27 22.02 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.542 -1.208 . . . . 73.420000000000002 109.843 170.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -61.51 -29.65 70.12 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.369 0.507 . . . . 73.409999999999997 112.369 -172.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.602 ' HB3' ' HE2' ' A' ' 238' ' ' LYS . 27.7 t-20 -82.83 137.24 34.38 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.426 -0.954 . . . . 62.420000000000002 108.426 169.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -56.94 108.83 1.36 Allowed Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 124.574 1.15 . . . . 74.120000000000005 113.099 -168.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -94.89 151.82 1.76 Allowed 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.045 2.496 . . . . 72.019999999999996 112.191 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 57.5 m -145.49 111.96 5.8 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.479 0.712 . . . . 73.319999999999993 109.547 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.7 t -89.03 93.82 4.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 108.612 -0.885 . . . . 74.340000000000003 108.612 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -102.72 131.45 49.54 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.548 -0.751 . . . . 73.420000000000002 108.988 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -167.84 -74.61 0.03 OUTLIER Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.786 -0.452 . . . . 75.540000000000006 112.281 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 92.2 t 63.71 100.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 125.0 1.32 . . . . 53.299999999999997 111.341 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 33.3 t -135.93 83.93 33.1 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.636 0.774 . . . . 44.310000000000002 109.16 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -82.16 76.66 4.13 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.853 2.369 . . . . 73.299999999999997 112.542 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -96.12 127.77 42.42 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.186 -0.672 . . . . 73.420000000000002 109.186 174.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -125.96 86.68 2.56 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.612 -0.884 . . . . 72.319999999999993 108.612 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -98.98 -177.9 3.77 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.392 -1.276 . . . . 65.329999999999998 110.045 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -159.29 -178.72 7.38 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.242 -0.89 . . . . 74.340000000000003 109.25 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -154.94 -68.55 0.13 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.43 -0.952 . . . . 61.140000000000001 108.43 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 124.174 0.99 . . . . 73.439999999999998 108.384 -179.01 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.9 tpp . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.892 -0.41 . . . . 54.32 109.892 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.69 178.97 19.27 Favored Glycine 0 C--N 1.342 0.916 0 O-C-N 123.405 0.441 . . . . 70.510000000000005 113.171 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.493 HE22 ' HG3' ' A' ' 5' ' ' PRO . 8.5 tm0? -168.71 109.19 0.5 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.223 -1.399 . . . . 71.430000000000007 107.223 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -159.95 86.83 1.99 Allowed Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.733 1.213 . . . . 74.209999999999994 108.276 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.493 ' HG3' HE22 ' A' ' 3' ' ' GLN . 13.2 Cg_exo -68.59 114.41 3.49 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.962 2.442 . . . . 73.239999999999995 112.186 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.468 ' O ' ' HG2' ' A' ' 7' ' ' LYS . . . 147.15 -146.74 16.91 Favored Glycine 0 C--N 1.341 0.826 0 O-C-N 123.93 0.769 . . . . 54.340000000000003 112.1 173.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 6' ' ' GLY . 3.4 ptpp? 61.73 15.02 6.6 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 126.318 1.847 . . . . 71.310000000000002 112.205 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.5 m -121.38 52.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.955 1.302 . . . . 72.219999999999999 109.599 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.06 124.48 24.19 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.741 -1.118 . . . . 61.240000000000002 110.078 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.76 62.53 4.59 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.557 -1.017 . . . . 75.549999999999997 110.557 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.75 -58.3 3.6 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.768 0.827 . . . . 71.400000000000006 110.579 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.52 ' HB3' ' HA ' ' A' ' 66' ' ' ARG . 12.1 pt20 -141.62 -177.35 5.13 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.64 -0.709 . . . . 75.230000000000004 110.801 -176.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.514 ' HG3' ' HE2' ' A' ' 89' ' ' TYR . 13.5 ttt85 -75.5 127.01 32.16 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.208 -1.034 . . . . 74.329999999999998 108.208 170.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 61.64 76.82 0.38 Allowed Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.871 1.269 . . . . 62.140000000000001 110.655 -158.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -79.93 169.86 17.37 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.991 2.461 . . . . 71.239999999999995 110.439 167.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m -65.08 167.03 8.53 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.073 0.463 . . . . 71.0 111.355 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.9 mt -104.79 128.46 26.75 Favored Pre-proline 0 C--O 1.241 0.644 0 N-CA-C 109.205 -0.665 . . . . 52.030000000000001 109.205 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -66.32 165.95 22.99 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.566 2.177 . . . . 63.020000000000003 111.865 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.98 146.71 31.9 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 120.809 0.337 . . . . 63.530000000000001 110.53 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.611 ' HB3' HD11 ' A' ' 23' ' ' ILE . 75.6 mt -87.02 93.17 9.28 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.524 -0.917 . . . . 75.299999999999997 108.524 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -95.26 -45.24 7.24 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.942 -1.026 . . . . 54.43 109.389 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -105.85 115.36 30.1 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.144 -0.935 . . . . 72.0 110.084 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.611 HD11 ' HB3' ' A' ' 20' ' ' LEU . 45.9 mm -116.47 113.84 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.298 -1.001 . . . . 50.399999999999999 108.298 175.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -117.37 150.17 39.3 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.81 0.844 . . . . 74.209999999999994 109.185 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.18 58.46 0.18 Allowed Glycine 0 C--O 1.241 0.588 0 N-CA-C 110.161 -1.176 . . . . 70.209999999999994 110.161 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.06 -46.69 84.98 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.785 0.834 . . . . 65.430000000000007 110.787 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.97 171.31 13.97 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 115.753 -0.658 . . . . 63.399999999999999 112.176 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -77.38 73.44 3.95 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.102 0.561 . . . . 71.239999999999995 109.863 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -93.97 -28.05 16.0 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.375 0.67 . . . . 73.310000000000002 109.646 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.93 -162.05 1.2 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.526 1.131 . . . . 73.219999999999999 109.048 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.4 m 71.81 99.29 0.07 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.413 1.085 . . . . 64.230000000000004 111.71 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -69.87 144.78 52.42 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.774 -0.648 . . . . 73.340000000000003 111.145 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 -98.72 95.8 7.48 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.035 0.934 . . . . 43.130000000000003 109.735 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -73.39 -38.19 65.72 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.663 -0.699 . . . . 63.310000000000002 110.738 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.13 -164.97 23.84 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 115.76 -0.655 . . . . 44.549999999999997 112.41 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.23 159.19 7.91 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-O 119.384 -0.676 . . . . 62.340000000000003 111.79 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -78.92 136.63 13.35 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.779 2.32 . . . . 73.239999999999995 111.919 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -76.25 112.82 13.14 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.784 -1.191 . . . . 71.239999999999995 107.784 167.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 63.8 m -63.65 108.59 1.44 Allowed 'General case' 0 C--O 1.243 0.74 0 O-C-N 123.615 0.572 . . . . 73.230000000000004 110.443 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -69.22 128.29 36.08 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.971 -0.751 . . . . 75.040000000000006 108.971 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.6 t -88.21 127.39 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 116.357 -0.383 . . . . 64.420000000000002 111.0 -168.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -94.17 -47.28 6.72 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.097 0.959 . . . . 74.010000000000005 108.925 173.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.0 m -68.59 78.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 124.058 0.943 . . . . 62.32 112.337 -174.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -137.61 127.71 25.96 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.974 -0.557 . . . . 73.140000000000001 110.774 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -165.13 134.13 3.42 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.074 0.95 . . . . 75.25 108.444 171.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -84.12 130.56 34.84 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.507 -0.553 . . . . 73.25 109.507 174.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.98 107.48 9.12 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.15 -1.056 . . . . 75.310000000000002 108.15 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.5 mt 61.76 84.21 0.14 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.199 1.0 . . . . 71.209999999999994 110.3 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -72.29 131.58 42.89 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.416 -0.587 . . . . 60.299999999999997 109.416 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -101.42 94.65 4.28 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 108.577 -0.897 . . . . 72.349999999999994 108.577 172.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -94.4 179.15 0.85 Allowed 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.533 2.155 . . . . 75.310000000000002 112.863 172.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.1 t -124.25 85.97 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 107.149 -1.426 . . . . 53.329999999999998 107.149 175.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.63 104.17 3.72 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.793 0.837 . . . . 65.299999999999997 110.144 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.1 m 62.74 19.31 11.32 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.656 1.182 . . . . 72.109999999999999 112.893 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -70.14 100.57 1.68 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.103 0.561 . . . . 62.409999999999997 110.588 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -79.13 79.8 5.52 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.483 -0.932 . . . . 73.019999999999996 108.483 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 60.09 72.57 0.74 Allowed Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.983 0.913 . . . . 73.439999999999998 111.04 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -76.65 21.07 0.58 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.423 2.748 . . . . 34.299999999999997 114.138 -170.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -73.08 89.85 1.5 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.567 -0.531 . . . . 54.140000000000001 109.567 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -144.3 28.6 1.94 Allowed Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.915 -0.874 . . . . 20.030000000000001 110.915 176.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.0 mt -74.8 96.11 3.03 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.034 0.934 . . . . 51.009999999999998 109.962 -174.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 t -123.79 13.41 9.24 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.002 0.921 . . . . 54.039999999999999 110.453 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -70.3 -64.38 0.9 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.425 0.69 . . . . 62.119999999999997 110.361 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 55.53 40.86 31.19 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.91 1.284 . . . . 61.219999999999999 111.227 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.0 105.4 17.12 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.644 -0.707 . . . . 45.439999999999998 110.349 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.52 ' HA ' ' HB3' ' A' ' 12' ' ' GLN . 7.0 mpt_? -80.88 82.55 6.83 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.151 0.58 . . . . 64.439999999999998 109.985 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -76.55 135.29 39.26 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.665 -0.865 . . . . 63.329999999999998 108.665 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -97.09 162.79 13.21 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.998 0.428 . . . . 54.509999999999998 110.913 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.7 m -125.49 137.16 53.95 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.986 0.914 . . . . 74.129999999999995 109.703 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -71.8 115.31 10.85 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.571 0.749 . . . . 74.340000000000003 111.004 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -75.92 -55.16 5.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.85 0.86 . . . . 73.310000000000002 111.513 -172.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -78.99 75.88 5.48 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.111 0.565 . . . . 74.200000000000003 111.373 -174.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.5 mt -92.63 54.22 2.21 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.146 -1.057 . . . . 70.230000000000004 108.146 167.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.8 mt -74.79 82.73 2.13 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.635 -1.166 . . . . 70.430000000000007 109.663 -175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.67 95.95 4.62 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.885 -1.154 . . . . 73.230000000000004 107.885 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.73 81.82 0.35 Allowed Glycine 0 C--N 1.346 1.115 0 CA-C-O 119.488 -0.618 . . . . 53.450000000000003 112.498 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.92 -25.8 44.67 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.282 1.988 . . . . 64.439999999999998 111.106 169.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 t -107.03 96.98 6.82 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.759 -1.109 . . . . 53.149999999999999 109.759 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -87.82 -9.97 52.27 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.962 0.505 . . . . 62.530000000000001 111.945 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -89.51 9.43 26.6 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.624 0.37 . . . . 64.25 111.611 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.552 ' HB2' HD22 ' A' ' 139' ' ' ASN . 17.0 m-20 -69.73 155.73 92.98 Favored Pre-proline 0 N--CA 1.48 1.054 0 N-CA-C 109.454 -0.572 . . . . 75.420000000000002 109.454 166.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.482 ' HG3' ' NH1' ' A' ' 108' ' ' ARG . 74.2 Cg_endo -69.12 -145.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.377 2.718 . . . . 73.540000000000006 111.587 173.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.633 ' HA ' ' HA ' ' A' ' 140' ' ' SER . 48.8 m-80 -66.14 85.99 0.1 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.898 0.856 . . . . 53.049999999999997 108.751 167.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 30.2 tp -87.4 122.91 31.77 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.306 -1.315 . . . . 54.329999999999998 109.865 -173.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -107.22 174.7 5.77 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.556 1.142 . . . . 74.439999999999998 109.225 174.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.24 142.55 19.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 108.464 -0.939 . . . . 72.040000000000006 108.464 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.449 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -78.39 123.28 26.83 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.513 0.508 . . . . 70.219999999999999 110.398 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.08 -22.92 41.7 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.34 0.656 . . . . 60.240000000000002 110.499 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.514 ' HE2' ' HG3' ' A' ' 13' ' ' ARG . 22.0 m-85 -127.15 162.0 27.15 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.939 0.896 . . . . 74.409999999999997 109.012 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.11 150.39 25.58 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.054 -1.091 . . . . 74.219999999999999 108.054 166.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -156.26 108.58 2.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.83 -1.174 . . . . 74.420000000000002 107.83 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 p -80.44 135.77 24.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.779 -0.823 . . . . 53.520000000000003 108.779 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.83 123.27 16.49 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.169 0.588 . . . . 21.440000000000001 110.687 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.2 t -84.39 8.26 16.82 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.554 0.742 . . . . 72.310000000000002 110.778 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.51 -171.64 44.14 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.789 -0.524 . . . . 74.530000000000001 111.789 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.5 -27.59 62.36 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.683 0.793 . . . . 45.439999999999998 110.682 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -74.84 -24.3 58.58 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.794 0.838 . . . . 55.219999999999999 112.74 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.9 p -102.03 157.58 16.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.603 0.761 . . . . 60.0 110.731 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.8 tp -110.0 131.83 54.71 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.516 0.727 . . . . 70.319999999999993 110.319 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.0 m -71.28 118.69 14.4 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.08 -0.711 . . . . 74.230000000000004 109.08 168.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.7 pt -124.03 147.18 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.566 0.746 . . . . 72.329999999999998 109.016 173.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.3 m -115.46 145.02 42.98 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.67 -0.493 . . . . 74.340000000000003 109.67 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -55.25 114.8 1.94 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.747 0.819 . . . . 63.130000000000003 110.856 174.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.78 -16.16 37.0 Favored Glycine 0 C--N 1.35 1.361 0 O-C-N 123.167 0.292 . . . . 73.400000000000006 112.763 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -78.38 137.24 37.92 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 124.153 0.981 . . . . 71.409999999999997 110.973 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.59 ' HB3' HD11 ' A' ' 84' ' ' LEU . 29.8 mtmt -77.44 134.72 38.31 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 124.044 0.84 . . . . 70.430000000000007 109.777 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 87' ' ' ALA . 19.0 mt -120.3 135.87 54.87 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.38 0.672 . . . . 73.129999999999995 109.255 -173.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.482 ' NH1' ' HG3' ' A' ' 82' ' ' PRO . 50.9 mtp85 -93.56 108.14 19.89 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.718 -0.845 . . . . 74.209999999999994 108.718 167.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.459 HG21 HD12 ' A' ' 135' ' ' ILE . 95.6 t -95.27 108.94 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.565 -0.902 . . . . 41.219999999999999 108.565 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.86 -28.97 64.97 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.025 0.93 . . . . 74.200000000000003 110.224 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.85 173.12 37.05 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-N 114.648 -1.16 . . . . 71.010000000000005 111.013 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 51.3 m-85 -96.8 175.02 6.51 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.648 -0.871 . . . . 55.229999999999997 108.648 176.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.496 ' HB3' ' H ' ' A' ' 117' ' ' GLU . 49.8 t-20 -63.4 144.39 57.01 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.69 -1.226 . . . . 72.340000000000003 107.69 173.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -54.37 -32.65 57.47 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.688 0.795 . . . . 72.230000000000004 110.905 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.53 -19.83 28.89 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.441 1.097 . . . . 74.299999999999997 111.797 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.07 34.46 7.18 Favored Glycine 0 N--CA 1.477 1.418 0 C-N-CA 123.121 0.391 . . . . 63.32 113.854 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.496 ' H ' ' HB3' ' A' ' 113' ' ' ASN . 28.5 mt-10 -99.4 -65.86 0.94 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.466 0.706 . . . . 64.349999999999994 111.043 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -103.01 -176.77 3.18 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.668 1.187 . . . . 73.219999999999999 110.207 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -143.66 117.16 9.14 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.563 0.745 . . . . 63.240000000000002 110.032 -177.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -73.81 97.96 2.85 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.615 -0.513 . . . . 54.25 109.615 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.78 168.14 9.33 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.145 -0.934 . . . . 74.030000000000001 110.718 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -147.48 127.81 13.94 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 108.57 -0.9 . . . . 72.120000000000005 108.57 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.6 p -139.71 -172.57 3.41 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.025 0.93 . . . . 75.519999999999996 109.785 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -63.02 -20.68 65.55 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.509 -0.768 . . . . 74.329999999999998 111.307 171.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -81.72 -4.11 55.43 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.056 0.943 . . . . 71.219999999999999 111.269 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 125.47 -135.07 9.07 Favored Glycine 0 C--N 1.355 1.589 0 N-CA-C 112.354 -0.298 . . . . 72.120000000000005 112.354 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -150.65 133.88 16.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.997 0.919 . . . . 70.010000000000005 109.155 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 176.18 -177.91 47.68 Favored Glycine 0 C--N 1.348 1.25 0 O-C-N 123.214 0.321 . . . . 41.43 112.867 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -88.37 126.53 35.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.374 1.07 . . . . 75.430000000000007 111.149 -174.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.05 154.7 55.79 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.914 1.286 . . . . 72.230000000000004 109.138 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.95 132.82 23.81 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 121.744 1.63 . . . . 71.430000000000007 110.398 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.3 m -63.8 -19.33 64.93 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.571 0.748 . . . . 74.340000000000003 112.108 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -72.22 -22.05 61.31 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.977 0.911 . . . . 73.319999999999993 111.302 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.496 ' HA ' ' CD1' ' A' ' 89' ' ' TYR . 2.5 m-85 -90.61 -7.4 52.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.763 0.825 . . . . 72.5 113.024 -175.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.459 HD12 HG21 ' A' ' 109' ' ' VAL . 16.1 pt -121.57 157.35 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 122.808 0.443 . . . . 74.420000000000002 110.409 -171.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.5 t -147.35 141.55 15.94 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 122.917 0.487 . . . . 55.340000000000003 110.248 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.81 147.15 43.93 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.632 2.221 . . . . 74.140000000000001 112.111 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 m -130.94 -59.96 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.55 0.74 . . . . 73.430000000000007 110.666 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.629 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.1 t30 -103.06 16.08 27.6 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 122.945 0.498 . . . . 74.25 111.06 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 41.3 m -60.62 170.78 1.31 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.028 0.531 . . . . 72.140000000000001 111.034 172.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 69.7 mt -55.65 -16.09 3.76 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.921 1.082 . . . . 74.299999999999997 113.921 -173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.532 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 31.4 tt0 -65.97 -6.29 12.15 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.536 1.134 . . . . 73.219999999999999 111.478 175.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -56.53 -31.11 63.83 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.271 1.428 . . . . 72.200000000000003 110.496 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -100.29 141.77 32.68 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.566 -0.743 . . . . 72.5 109.262 173.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.3 p -70.42 -5.81 31.14 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.242 0.83 . . . . 74.439999999999998 113.242 -170.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.402 ' CE3' HG21 ' A' ' 218' ' ' VAL . 42.5 p-90 -77.94 -33.64 51.55 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 111.806 0.299 . . . . 72.319999999999993 111.806 174.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.4 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 37.3 t80 -99.27 139.25 35.19 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.281 -0.637 . . . . 74.530000000000001 109.281 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.532 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 25.1 m-70 -134.12 38.51 3.15 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.894 0.478 . . . . 72.200000000000003 110.372 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 68.59 -171.16 38.04 Favored Glycine 0 CA--C 1.542 1.732 0 N-CA-C 116.305 1.282 . . . . 70.109999999999999 116.305 165.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.11 100.65 0.88 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.635 2.89 . . . . 73.200000000000003 111.553 171.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.464 ' HB ' ' HD2' ' A' ' 171' ' ' ARG . 78.0 t -142.66 148.47 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.772 0.829 . . . . 73.329999999999998 109.352 -174.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.5 m -70.83 151.34 44.89 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 123.93 0.892 . . . . 70.530000000000001 111.288 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -20.59 55.26 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.228 -0.896 . . . . 72.049999999999997 112.186 176.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.83 -59.13 5.6 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.303 1.041 . . . . 75.140000000000001 109.822 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 158' ' ' TYR . . . -70.12 -31.72 69.39 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.842 0.857 . . . . 71.239999999999995 110.81 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.497 ' HA ' HH21 ' A' ' 171' ' ' ARG . . . -57.25 -54.06 51.08 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.43 -0.804 . . . . 70.439999999999998 110.738 171.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -73.1 -23.34 60.51 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.862 -0.608 . . . . 54.539999999999999 110.762 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.411 ' HB3' ' HA ' ' A' ' 155' ' ' ALA . 71.1 t80 -63.58 -49.37 73.66 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.743 0.817 . . . . 72.310000000000002 110.398 175.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.495 HD12 ' NH2' ' A' ' 171' ' ' ARG . 67.3 mt -71.32 -37.52 71.76 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.058 0.456 . . . . 72.299999999999997 110.79 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.438 HD23 HG13 ' A' ' 190' ' ' VAL . 29.1 tp -73.98 -17.27 61.02 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.854 -0.612 . . . . 73.310000000000002 112.269 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 38.9 t -68.86 -19.84 64.26 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.371 0.669 . . . . 63.43 110.651 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.9 t -99.82 6.82 45.34 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.472 0.709 . . . . 70.120000000000005 110.6 174.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.15 163.27 43.11 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 116.089 -0.505 . . . . 62.229999999999997 113.068 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.2 pt -126.35 -166.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.442 1.497 . . . . 64.010000000000005 110.396 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.698 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 24.7 p-10 -58.78 110.12 0.95 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.63 0.604 . . . . 73.129999999999995 112.63 -169.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 91.91 13.37 57.92 Favored Glycine 0 C--O 1.256 1.477 0 CA-C-N 115.91 -0.587 . . . . 53.32 113.168 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 67.4 m -77.69 131.35 37.67 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.023 -0.362 . . . . 74.150000000000006 110.023 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.477 ' HB3' HD23 ' A' ' 184' ' ' LEU . 16.2 p90 -133.13 154.88 50.18 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.834 0.679 . . . . 64.209999999999994 112.834 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.6 mt -135.46 133.82 38.94 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.931 -1.032 . . . . 74.230000000000004 108.459 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.74 118.07 54.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 107.838 -1.171 . . . . 73.420000000000002 107.838 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.497 HH21 ' HA ' ' A' ' 156' ' ' ALA . 18.7 mmt180 -118.62 167.58 11.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.059 0.944 . . . . 60.219999999999999 108.798 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.581 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 15.7 pt-20 -117.89 160.76 20.87 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 109.575 -0.528 . . . . 74.319999999999993 109.575 158.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 59.3 m -87.33 135.24 33.4 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.749 -0.66 . . . . 44.340000000000003 110.326 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -74.44 -36.42 63.38 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.007 0.923 . . . . 74.239999999999995 110.872 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 26.5 t -89.37 -16.26 31.41 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.551 0.741 . . . . 61.340000000000003 111.031 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 32.7 t -127.19 85.25 61.43 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 108.387 -0.968 . . . . 61.240000000000002 108.387 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.47 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 51.6 Cg_endo -65.64 140.38 62.09 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.161 2.574 . . . . 72.019999999999996 112.289 -176.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.6 -25.37 5.16 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 115.771 -0.649 . . . . 74.150000000000006 113.102 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -79.95 119.11 22.35 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 108.741 -0.837 . . . . 73.310000000000002 108.741 173.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.581 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 47.9 mtt85 -114.21 165.46 12.65 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 115.019 -0.991 . . . . 75.209999999999994 109.167 -176.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.3 m -146.71 139.01 24.87 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.495 -0.557 . . . . 72.150000000000006 109.495 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 47.4 mt -103.84 140.99 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.1 -1.074 . . . . 73.540000000000006 108.1 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 18.1 m -121.21 111.86 17.92 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.103 -0.953 . . . . 64.25 108.505 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 168' ' ' PHE . 33.9 mt -103.79 143.91 32.19 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.17 0.988 . . . . 53.509999999999998 111.212 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -131.71 133.6 45.01 Favored 'General case' 0 C--O 1.257 1.496 0 CA-C-N 114.825 -1.08 . . . . 75.239999999999995 108.536 168.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.698 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 24.3 p90 -143.73 133.52 23.85 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.862 -1.063 . . . . 74.420000000000002 108.21 173.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 47.64 37.47 6.81 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.674 1.19 . . . . 63.520000000000003 113.817 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 92.18 -5.41 78.3 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.621 -0.718 . . . . 55.020000000000003 113.779 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -102.93 123.99 47.59 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.1 0.56 . . . . 72.340000000000003 109.738 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.438 HG13 HD23 ' A' ' 160' ' ' LEU . 84.7 t -106.27 137.55 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.238 1.015 . . . . 61.219999999999999 109.547 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.402 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 24.3 p90 -145.73 151.33 37.82 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.751 0.821 . . . . 72.200000000000003 109.572 169.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -128.38 134.13 48.77 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.544 -1.28 . . . . 75.409999999999997 107.544 -173.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -136.8 139.36 41.72 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.242 0.544 . . . . 70.219999999999999 110.436 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.544 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 22.2 tpp180 -81.76 122.46 27.7 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.588 -1.187 . . . . 72.140000000000001 111.58 -171.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.491 ' HA ' HG22 ' A' ' 205' ' ' VAL . 73.4 mt -72.69 115.56 13.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 108.308 -0.997 . . . . 75.109999999999999 108.308 162.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -93.46 132.47 37.7 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 109.016 -0.735 . . . . 75.230000000000004 109.016 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.7 m -95.6 116.45 28.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.407 -0.815 . . . . 73.049999999999997 108.909 172.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.35 161.27 22.82 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.138 0.975 . . . . 72.430000000000007 111.693 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.3 t -70.06 -10.76 59.77 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.654 0.782 . . . . 64.109999999999999 110.803 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -71.77 -17.12 62.2 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.463 1.105 . . . . 70.340000000000003 111.206 172.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 88.25 2.28 80.41 Favored Glycine 0 C--N 1.355 1.62 0 C-N-CA 123.169 0.414 . . . . 62.100000000000001 112.081 -171.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -90.47 145.33 24.99 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.913 0.885 . . . . 74.140000000000001 110.773 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 86.8 mt -94.23 149.2 21.46 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 123.195 0.598 . . . . 74.299999999999997 109.621 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -162.43 166.94 24.37 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.668 0.605 . . . . 74.230000000000004 111.182 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 195' ' ' ILE . 92.8 t -140.88 -62.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.301 1.041 . . . . 71.319999999999993 108.632 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 12.7 m -98.79 -169.96 1.86 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.628 1.171 . . . . 74.329999999999998 111.196 -172.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.8 m -69.99 -47.68 61.22 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.532 0.733 . . . . 65.230000000000004 112.859 -169.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -84.36 -16.77 41.68 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.455 0.702 . . . . 73.140000000000001 109.257 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 71.6 m -64.41 106.59 1.16 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.32 0.648 . . . . 74.150000000000006 111.376 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 210' ' ' ARG . 8.7 mmt180 -146.1 117.57 8.0 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.393 1.077 . . . . 75.120000000000005 109.18 169.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -136.54 152.71 50.8 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.145 0.578 . . . . 75.430000000000007 110.616 -171.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -82.07 -36.28 27.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.197 -0.668 . . . . 75.450000000000003 109.197 168.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 82.8 p -130.73 160.13 35.23 Favored 'General case' 0 C--O 1.252 1.2 0 CA-C-O 122.247 1.022 . . . . 71.5 112.598 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 21.4 tp -74.14 -22.04 59.61 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.15 -1.386 . . . . 72.239999999999995 110.807 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.23 -49.64 76.29 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.44 0.638 . . . . 51.329999999999998 110.41 171.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -62.23 -41.96 98.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.521 -1.218 . . . . 72.040000000000006 110.504 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.9 tt -57.88 -48.92 78.41 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.02 0.825 . . . . 64.129999999999995 111.612 177.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.402 HG21 ' CE3' ' A' ' 146' ' ' TRP . 55.7 t -72.08 -38.47 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.083 0.553 . . . . 62.409999999999997 111.19 -174.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -65.43 -46.75 78.69 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.128 0.49 . . . . 73.310000000000002 110.938 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.478 ' O ' HG22 ' A' ' 224' ' ' VAL . 40.6 t-80 -56.07 -52.35 64.58 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.672 -0.695 . . . . 74.540000000000006 109.322 176.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.557 ' HD1' HD21 ' A' ' 228' ' ' LEU . 18.1 m-70 -70.19 -19.15 63.19 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.531 -0.759 . . . . 74.030000000000001 112.535 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.2 p -81.29 -20.2 41.36 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.127 0.421 . . . . 70.040000000000006 110.715 172.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 7.0 t -111.53 -12.99 13.9 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.251 1.945 . . . . 75.0 116.251 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 220' ' ' HIS . 30.3 m -105.59 158.34 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 121.145 1.793 . . . . 74.219999999999999 115.733 -167.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -90.7 0.61 57.35 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.855 2.862 . . . . 74.129999999999995 113.523 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -81.16 15.03 2.06 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 128.191 2.596 . . . . 64.510000000000005 113.157 -139.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.02 19.88 3.87 Favored Glycine 0 N--CA 1.464 0.563 0 N-CA-C 110.35 -1.1 . . . . 40.420000000000002 110.35 -170.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.557 HD21 ' HD1' ' A' ' 221' ' ' HIS . 95.7 mt -93.59 128.4 39.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.626 -1.287 . . . . 74.219999999999999 109.102 163.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.402 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 95.3 mt -64.04 -49.0 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.871 -0.788 . . . . 71.010000000000005 108.871 170.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.2 t -130.97 147.83 52.65 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.104 -1.072 . . . . 73.329999999999998 108.104 170.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.0 p -75.29 155.75 36.32 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.913 -0.403 . . . . 72.209999999999994 109.913 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.406 HD23 HD21 ' A' ' 184' ' ' LEU . 27.5 mt -64.58 103.32 0.66 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.397 -0.964 . . . . 74.239999999999995 108.397 176.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -88.28 -58.29 2.61 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.047 -0.723 . . . . 74.400000000000006 109.047 -172.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.563 ' O ' ' HA ' ' A' ' 167' ' ' SER . 14.5 p90 -152.3 149.14 22.29 Favored Pre-proline 0 N--CA 1.484 1.257 0 CA-C-N 116.017 -0.538 . . . . 74.439999999999998 110.272 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 26.8 Cg_exo -63.31 148.88 92.53 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.116 1.877 . . . . 74.340000000000003 112.958 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.72 134.22 78.92 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 108.378 -0.971 . . . . 73.209999999999994 108.378 169.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.07 137.99 59.88 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.417 2.078 . . . . 74.430000000000007 113.379 -171.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -70.26 156.77 38.81 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.284 -1.006 . . . . 74.019999999999996 108.284 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -53.8 -32.89 54.23 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.787 0.835 . . . . 72.420000000000002 112.321 -172.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -98.62 122.91 42.42 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 108.262 -1.014 . . . . 63.520000000000003 108.262 166.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -150.08 113.88 3.36 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 122.477 0.311 . . . . 72.120000000000005 111.661 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.9 159.02 38.46 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.794 2.329 . . . . 63.539999999999999 112.187 166.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 15.1 t -113.12 147.35 37.51 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.643 0.777 . . . . 73.329999999999998 110.162 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 95.7 t -122.62 135.1 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.17 0.988 . . . . 54.420000000000002 108.567 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -90.98 -39.91 11.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.481 0.712 . . . . 61.350000000000001 110.059 -176.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 97.42 172.49 33.68 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.189 -0.914 . . . . 72.430000000000007 112.057 -174.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 16.8 m -139.96 155.78 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.725 0.81 . . . . 72.540000000000006 110.694 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 20.0 m 64.77 119.9 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 125.045 1.338 . . . . 65.209999999999994 113.529 171.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.48 179.02 6.73 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.418 2.079 . . . . 71.519999999999996 111.503 171.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -118.72 138.69 52.47 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.341 -0.614 . . . . 70.519999999999996 109.341 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -100.59 105.66 17.08 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.599 0.76 . . . . 71.439999999999998 109.021 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.72 -47.53 85.3 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.938 0.495 . . . . 72.409999999999997 110.184 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -88.19 168.1 13.04 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.296 0.638 . . . . 64.319999999999993 110.291 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 82.4 m95 59.08 90.08 0.05 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.221 1.008 . . . . 70.140000000000001 111.05 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 C--O 1.248 1.023 0 N-CA-C 107.153 -1.425 . . . . 74.299999999999997 107.153 179.164 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.599 -0.519 . . . . 64.439999999999998 109.599 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 125.27 -53.59 0.77 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 110.99 -0.844 . . . . 53.340000000000003 110.99 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -105.31 134.43 48.44 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.729 0.812 . . . . 74.510000000000005 109.534 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -102.61 104.54 39.08 Favored Pre-proline 0 C--O 1.241 0.643 0 N-CA-C 108.092 -1.077 . . . . 74.319999999999993 108.092 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.592 ' HG3' ' HB2' ' A' ' 62' ' ' SER . 97.1 Cg_endo -74.09 79.82 2.29 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 122.411 2.074 . . . . 73.049999999999997 111.511 -177.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.76 81.33 0.02 OUTLIER Glycine 0 C--N 1.36 1.867 0 O-C-N 124.02 0.825 . . . . 73.420000000000002 112.676 -175.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -131.73 90.32 2.82 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.827 1.251 . . . . 32.149999999999999 109.212 -170.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.5 m -120.12 159.44 21.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 CA-C-N 115.174 -0.921 . . . . 61.200000000000003 109.575 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -112.09 164.87 12.66 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.922 -1.035 . . . . 42.149999999999999 109.256 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.01 53.74 0.1 OUTLIER Glycine 0 C--N 1.34 0.751 0 N-CA-C 111.144 -0.782 . . . . 44.130000000000003 111.144 -175.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.09 -160.21 0.23 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.209 1.004 . . . . 74.219999999999999 109.145 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -69.08 -157.77 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.272 0.629 . . . . 74.219999999999999 110.387 170.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -61.96 141.35 58.08 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.588 -0.695 . . . . 71.120000000000005 109.979 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 59.16 65.21 2.81 Favored Pre-proline 0 CA--C 1.558 1.285 0 O-C-N 124.327 1.017 . . . . 72.409999999999997 110.783 -170.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.7 166.93 16.53 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.329 2.019 . . . . 70.230000000000004 111.671 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.6 p -70.93 168.97 15.78 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.563 0.697 . . . . 75.299999999999997 111.297 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.4 mt -106.48 135.16 19.53 Favored Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 115.478 -0.783 . . . . 73.010000000000005 109.946 -173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.72 173.72 13.91 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.602 2.201 . . . . 63.020000000000003 111.874 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.06 148.85 26.6 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.957 0.503 . . . . 74.329999999999998 110.776 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.489 HD22 HD11 ' A' ' 23' ' ' ILE . 79.2 mt -86.3 93.48 9.09 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.79 -0.818 . . . . 72.209999999999994 108.79 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -97.17 -48.83 5.21 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.977 0.511 . . . . 74.209999999999994 110.427 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.473 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 64.1 m-85 -104.16 114.83 29.35 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.313 -0.625 . . . . 51.109999999999999 109.313 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.489 HD11 HD22 ' A' ' 20' ' ' LEU . 47.1 mm -121.77 120.99 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 109.4 -0.593 . . . . 50.329999999999998 109.4 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.5 ' H ' ' HE1' ' A' ' 129' ' ' TRP . 63.8 mttm -115.76 165.55 12.93 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.917 0.887 . . . . 73.450000000000003 109.763 172.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 179.83 44.35 0.08 OUTLIER Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.961 -0.855 . . . . 42.049999999999997 110.961 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -138.64 127.7 24.0 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.144 0.978 . . . . 72.450000000000003 110.045 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.75 111.77 1.11 Allowed Glycine 0 C--N 1.347 1.174 0 N-CA-C 111.736 -0.546 . . . . 71.530000000000001 111.736 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -79.55 -21.81 44.67 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.711 0.805 . . . . 74.209999999999994 111.582 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -73.46 84.05 1.49 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.622 1.201 . . . . 63.200000000000003 110.2 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 32' ' ' SER . 15.2 pt-20 -78.8 -175.91 4.69 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 113.605 -1.634 . . . . 64.439999999999998 110.448 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.2 m -98.62 10.33 41.28 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.993 0.517 . . . . 72.129999999999995 111.294 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.409 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 56.4 m -140.3 -148.67 0.25 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.064 1.346 . . . . 63.340000000000003 108.884 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -156.07 93.87 1.47 Allowed 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.067 -0.716 . . . . 72.439999999999998 109.067 168.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -77.1 122.06 24.45 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.625 -0.509 . . . . 74.340000000000003 109.625 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.14 171.86 55.14 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 116.556 -0.293 . . . . 63.25 113.423 -174.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.71 -171.28 47.54 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-O 119.567 -0.574 . . . . 42.509999999999998 113.204 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.14 152.82 56.85 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.925 2.417 . . . . 74.239999999999995 112.182 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -69.24 -50.93 42.56 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.855 -0.611 . . . . 70.230000000000004 109.547 174.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 57.6 m -90.37 112.39 23.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.242 1.017 . . . . 74.319999999999993 110.073 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -85.0 112.0 20.21 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.486 0.714 . . . . 73.319999999999993 109.821 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.5 m -74.94 -179.08 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 123.818 0.847 . . . . 42.310000000000002 111.703 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -62.49 143.7 56.84 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.107 0.563 . . . . 70.349999999999994 110.966 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.8 p -154.49 150.63 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.708 -0.849 . . . . 64.030000000000001 108.708 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -138.99 138.21 37.06 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.305 1.042 . . . . 70.329999999999998 108.191 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -81.86 87.84 6.36 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.432 0.634 . . . . 44.530000000000001 109.925 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -114.89 100.54 8.29 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.847 -1.07 . . . . 64.400000000000006 109.1 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.36 76.03 0.95 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.614 0.766 . . . . 51.130000000000003 110.585 -175.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 92.8 mt -89.12 77.64 7.53 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.168 0.987 . . . . 71.040000000000006 110.207 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -101.83 37.03 1.92 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.675 0.79 . . . . 45.409999999999997 110.322 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -59.16 -46.18 99.31 Favored Pre-proline 0 CA--C 1.564 1.491 0 CA-C-O 118.429 -0.796 . . . . 75.420000000000002 110.925 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.14 118.42 5.37 Favored 'Trans proline' 0 C--N 1.394 2.945 0 C-N-CA 121.457 1.438 . . . . 62.109999999999999 110.741 168.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.29 -11.02 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.169 0.587 . . . . 72.129999999999995 112.166 -176.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.9 176.36 9.88 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.254 0.621 . . . . 62.240000000000002 111.487 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.4 t -150.99 -171.7 4.01 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.181 0.992 . . . . 75.120000000000005 108.799 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -142.63 136.55 29.25 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.94 -0.763 . . . . 74.140000000000001 108.94 173.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -124.26 -170.92 2.23 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.889 0.876 . . . . 75.299999999999997 109.721 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 63.84 74.14 0.44 Allowed Pre-proline 0 N--CA 1.49 1.551 0 C-N-CA 124.09 0.956 . . . . 74.530000000000001 112.172 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.63 -161.15 0.12 Allowed 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 123.024 2.483 . . . . 61.299999999999997 112.155 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -148.35 169.76 19.45 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.168 0.587 . . . . 73.420000000000002 110.743 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.5 86.63 0.06 OUTLIER Glycine 0 C--N 1.348 1.24 0 N-CA-C 111.498 -0.641 . . . . 31.309999999999999 111.498 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.5 mt -118.68 145.84 45.18 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.886 0.875 . . . . 73.450000000000003 110.58 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.592 ' HB2' ' HG3' ' A' ' 5' ' ' PRO . 38.1 m -153.87 148.27 26.06 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.594 1.158 . . . . 63.520000000000003 108.433 170.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -114.45 93.89 4.54 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.737 0.815 . . . . 63.439999999999998 109.229 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.63 133.37 13.04 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 123.959 0.903 . . . . 64.319999999999993 108.868 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.16 90.27 1.51 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.306 0.503 . . . . 61.119999999999997 111.539 -175.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -164.66 145.31 7.74 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.284 -1.006 . . . . 73.120000000000005 108.284 166.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -127.16 172.18 10.78 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.382 0.673 . . . . 72.439999999999998 109.771 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -139.66 168.81 18.98 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.412 1.085 . . . . 74.030000000000001 108.722 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 62.0 p -78.11 122.17 25.26 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.209 -1.034 . . . . 74.400000000000006 108.209 169.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -84.61 135.11 34.32 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.304 0.642 . . . . 74.230000000000004 110.221 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -74.18 137.89 43.42 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.49 -0.559 . . . . 74.099999999999994 109.49 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -135.42 112.4 10.29 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 123.871 0.868 . . . . 64.219999999999999 110.055 -174.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.5 mt -132.52 102.5 5.74 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.36 1.064 . . . . 64.340000000000003 108.42 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.5 mt -76.59 106.37 8.2 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.806 0.442 . . . . 60.399999999999999 110.342 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.14 69.05 6.47 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.667 -0.864 . . . . 40.340000000000003 108.667 169.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.25 116.41 8.8 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 114.861 -1.063 . . . . 54.240000000000002 113.555 -168.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -87.41 -147.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.676 2.917 . . . . 74.120000000000005 110.028 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -66.31 -85.72 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 108.75 -0.833 . . . . 65.25 108.75 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 169.22 150.36 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.079 1.352 . . . . 75.209999999999994 110.069 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -133.72 -77.28 0.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.61 0.764 . . . . 62.109999999999999 109.63 171.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -143.88 158.78 55.4 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.566 1.146 . . . . 75.310000000000002 108.835 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.27 -19.3 33.99 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.092 2.528 . . . . 63.130000000000003 114.17 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -91.21 17.03 8.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.795 0.838 . . . . 44.240000000000002 111.484 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.91 109.66 18.3 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 108.701 -0.852 . . . . 72.319999999999993 108.701 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 4.4 m-85 -105.69 175.79 5.38 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.49 1.516 . . . . 71.299999999999997 110.421 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.97 148.07 27.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.798 -1.186 . . . . 73.040000000000006 107.798 169.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.52 107.77 14.56 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.754 -0.832 . . . . 53.32 108.754 170.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.4 mt -62.52 -27.4 69.13 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.058 0.943 . . . . 64.109999999999999 111.198 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -141.17 166.35 25.01 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.699 0.8 . . . . 62.409999999999997 109.728 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.52 147.47 29.65 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.518 -0.764 . . . . 52.329999999999998 109.812 175.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -155.93 118.09 4.07 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.347 1.059 . . . . 75.140000000000001 108.496 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.44 140.73 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.79 -0.819 . . . . 51.140000000000001 108.79 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.92 117.46 3.98 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.073 0.549 . . . . 63.340000000000003 110.526 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 m -59.46 -44.17 93.06 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.313 1.045 . . . . 73.310000000000002 110.386 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -160.26 -147.6 4.97 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 114.712 -1.131 . . . . 62.049999999999997 111.752 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -69.56 -34.87 74.8 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.312 1.045 . . . . 74.140000000000001 111.775 -175.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -84.91 8.69 16.66 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 113.252 0.834 . . . . 74.319999999999993 113.252 -175.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.6 p -127.26 156.84 41.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.299 0.64 . . . . 73.400000000000006 110.552 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.4 tp -109.97 137.13 48.18 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.571 0.749 . . . . 64.200000000000003 109.579 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.4 t -82.86 115.22 21.65 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.369 -0.975 . . . . 74.230000000000004 108.369 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.6 pt -123.48 144.29 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.256 1.022 . . . . 43.329999999999998 109.966 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.2 m -110.73 151.39 27.8 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 109.732 -0.469 . . . . 72.530000000000001 109.732 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -54.82 111.17 0.77 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.353 0.661 . . . . 72.019999999999996 111.682 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.55 -14.69 24.87 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 123.291 0.472 . . . . 55.399999999999999 112.765 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.48 120.91 14.71 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.971 0.908 . . . . 74.129999999999995 109.467 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 106' ' ' LYS . 8.0 mtmp? -80.87 118.19 22.16 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.665 -0.865 . . . . 73.25 108.665 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 21.7 mt -99.42 160.59 14.17 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.394 -0.965 . . . . 74.340000000000003 108.394 -174.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -121.12 107.3 12.43 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.206 -1.035 . . . . 75.439999999999998 108.206 164.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 74.1 t -94.6 115.18 32.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 108.573 -0.899 . . . . 75.120000000000005 108.573 -176.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.46 -35.34 80.04 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 123.588 0.555 . . . . 74.310000000000002 109.691 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.66 174.57 46.2 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.735 -0.666 . . . . 75.329999999999998 112.209 173.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.54 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 21.5 m-85 -92.91 174.88 7.02 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 108.808 -0.812 . . . . 71.409999999999997 108.808 176.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.473 ' ND2' ' HB2' ' A' ' 22' ' ' PHE . 12.8 m120 -64.07 167.85 5.98 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.945 -0.57 . . . . 74.400000000000006 110.13 164.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -72.31 -4.48 30.02 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 120.707 0.289 . . . . 62.539999999999999 110.324 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -105.21 -19.88 13.68 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.775 0.83 . . . . 74.530000000000001 110.754 170.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 80.15 12.93 82.71 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-N 116.633 -0.258 . . . . 71.219999999999999 113.603 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.406 ' HG3' ' OD1' ' A' ' 113' ' ' ASN . 9.5 pt-20 -68.4 -54.58 16.26 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.948 1.299 . . . . 71.430000000000007 111.794 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -116.18 173.19 6.72 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.796 0.838 . . . . 72.129999999999995 109.331 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.28 120.66 10.96 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.494 0.717 . . . . 64.530000000000001 110.735 -170.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -75.93 97.14 3.9 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.554 -0.536 . . . . 75.129999999999995 109.554 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -102.14 150.59 23.11 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.507 -0.77 . . . . 62.240000000000002 110.156 -174.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -132.22 122.54 25.39 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 124.047 0.939 . . . . 72.209999999999994 109.105 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 58.3 p -133.88 -176.73 4.27 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.275 1.43 . . . . 72.120000000000005 108.874 171.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -72.67 -3.19 23.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.982 0.513 . . . . 71.510000000000005 111.759 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -89.22 -1.18 57.97 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.786 0.834 . . . . 73.530000000000001 110.785 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.66 -156.23 15.89 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 111.759 -0.537 . . . . 63.420000000000002 111.759 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -144.6 131.53 20.32 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.173 0.589 . . . . 71.310000000000002 110.191 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -179.42 173.48 45.41 Favored Glycine 0 C--N 1.346 1.129 0 O-C-N 123.329 0.393 . . . . 62.539999999999999 112.694 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.5 ' HE1' ' H ' ' A' ' 24' ' ' LYS . 91.0 m95 -76.77 121.24 23.05 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.344 1.058 . . . . 64.319999999999993 111.517 -176.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.19 150.7 44.8 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 124.717 1.207 . . . . 70.239999999999995 108.904 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.51 126.08 14.94 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 121.799 1.666 . . . . 72.239999999999995 109.772 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 m -57.62 -26.79 62.08 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.723 0.809 . . . . 63.310000000000002 111.539 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -63.22 -28.68 70.2 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.657 1.183 . . . . 73.349999999999994 111.879 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -93.67 1.3 56.64 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.97 0.908 . . . . 74.299999999999997 112.774 -175.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 25.2 pt -133.75 164.68 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.347 0.521 . . . . 62.030000000000001 111.022 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.7 t -159.28 140.94 9.69 Favored Pre-proline 0 N--CA 1.484 1.241 0 O-C-N 123.455 0.472 . . . . 62.420000000000002 110.145 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 62.8 Cg_endo -71.68 114.54 3.98 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.269 1.98 . . . . 62.219999999999999 112.172 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.11 -36.04 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.757 0.823 . . . . 62.340000000000003 112.117 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -93.06 16.84 11.91 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.662 0.785 . . . . 72.540000000000006 110.111 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 137' ' ' PRO . 22.5 t -63.23 165.3 7.55 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.742 0.817 . . . . 75.219999999999999 110.808 175.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.4 mt -66.99 -10.24 47.46 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.35 1.06 . . . . 54.109999999999999 111.878 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.596 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 29.4 tt0 -66.0 -12.21 53.46 Favored 'General case' 0 C--N 1.369 1.439 0 C-N-CA 123.391 0.676 . . . . 72.25 111.922 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -61.25 -12.29 12.69 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 123.582 0.753 . . . . 74.109999999999999 110.428 167.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -105.85 150.12 25.89 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.979 1.711 . . . . 61.219999999999999 109.222 167.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.4 p -69.33 -20.49 63.87 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.61 0.967 . . . . 73.25 113.61 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.468 ' CE3' HG21 ' A' ' 218' ' ' VAL . 53.0 p-90 -77.38 -43.38 32.98 Favored 'General case' 0 C--O 1.25 1.108 0 N-CA-C 112.681 0.623 . . . . 73.040000000000006 112.681 -175.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -87.56 146.94 25.55 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.703 -0.48 . . . . 74.040000000000006 109.703 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.596 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 65.3 m-70 -143.21 39.59 1.45 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.12 0.968 . . . . 75.439999999999998 111.352 -174.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.25 -169.05 54.77 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 115.919 1.128 . . . . 73.549999999999997 115.919 163.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.464 ' HB2' ' HB2' ' A' ' 174' ' ' GLU . 8.3 Cg_endo -89.09 95.66 0.34 Allowed 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 124.083 3.188 . . . . 74.409999999999997 111.23 171.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.08 153.04 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.389 1.076 . . . . 75.140000000000001 110.82 -170.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.7 m -75.68 156.87 34.35 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.437 1.095 . . . . 64.510000000000005 112.069 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -62.39 -33.51 74.89 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.769 0.828 . . . . 70.420000000000002 112.162 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -66.75 -45.18 79.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.686 0.795 . . . . 75.540000000000006 110.026 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.23 -31.97 70.89 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.571 0.748 . . . . 61.340000000000003 111.043 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.78 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.39 -51.09 71.29 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.699 -0.682 . . . . 51.009999999999998 110.31 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.47 -31.27 71.9 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.994 0.918 . . . . 74.150000000000006 111.562 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -63.99 -45.75 87.61 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.482 0.713 . . . . 73.340000000000003 111.319 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.477 HD12 HH12 ' A' ' 171' ' ' ARG . 66.5 mt -77.43 -39.08 48.17 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 120.867 0.365 . . . . 74.140000000000001 111.375 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.61 HD23 HG13 ' A' ' 190' ' ' VAL . 34.0 tp -74.85 -20.95 59.53 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.732 -0.667 . . . . 72.409999999999997 112.194 -171.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.1 p -60.21 -28.28 67.85 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.052 0.541 . . . . 71.519999999999996 111.456 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.8 m -75.31 -15.26 60.51 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.039 0.935 . . . . 60.310000000000002 112.353 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.15 165.31 50.54 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 113.785 0.274 . . . . 74.219999999999999 113.785 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.3 pt -113.35 -164.74 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.23 1.012 . . . . 74.299999999999997 109.465 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.749 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 25.3 p-10 -49.32 114.12 0.96 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.909 0.884 . . . . 72.349999999999994 112.375 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.39 14.22 60.45 Favored Glycine 0 C--O 1.258 1.605 0 CA-C-N 116.46 -0.337 . . . . 64.519999999999996 113.498 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 70.4 p -74.85 139.49 43.23 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 108.989 -0.745 . . . . 73.409999999999997 108.989 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 232' ' ' LEU . 28.9 p90 -138.32 160.35 39.7 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.215 0.82 . . . . 75.450000000000003 113.215 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.443 HD13 ' NH1' ' A' ' 171' ' ' ARG . 96.4 mt -132.62 132.82 42.89 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.137 -1.431 . . . . 61.32 107.137 166.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 56.6 t -107.72 115.4 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 106.949 -1.501 . . . . 74.450000000000003 106.949 171.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.78 HH11 ' HA ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -159.1 152.34 22.44 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.204 0.602 . . . . 75.420000000000002 110.236 -175.384 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.657 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 10.9 pt-20 -107.7 156.55 18.96 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.942 0.401 . . . . 64.409999999999997 111.238 -177.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.9 m -90.71 113.45 25.55 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.065 -0.717 . . . . 62.539999999999999 109.065 173.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 33.0 tt0 -70.44 -26.47 63.67 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.427 0.691 . . . . 74.310000000000002 110.626 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.1 p -79.24 5.51 12.09 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.764 1.225 . . . . 62.43 112.183 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 37.5 m -142.93 123.22 7.99 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.668 0.787 . . . . 74.340000000000003 109.88 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.23 111.47 1.28 Allowed 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.298 2.665 . . . . 65.040000000000006 113.528 -171.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.58 9.83 52.25 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-N 115.774 -0.648 . . . . 75.129999999999995 114.552 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -87.53 115.31 24.87 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 109.175 -0.676 . . . . 72.430000000000007 109.175 -176.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.781 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 50.6 mtt85 -110.12 165.71 11.53 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.963 0.905 . . . . 72.019999999999996 108.825 176.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 65.9 m -149.85 142.71 24.76 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.754 0.421 . . . . 63.310000000000002 110.951 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 60.8 mt -111.93 130.77 64.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 N-CA-C 107.409 -1.33 . . . . 73.310000000000002 107.409 161.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 11.4 m -107.92 118.96 38.11 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.498 -1.228 . . . . 60.240000000000002 107.92 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.429 HD21 HD23 ' A' ' 232' ' ' LEU . 47.3 mt -110.03 135.78 50.32 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.334 1.054 . . . . 75.129999999999995 111.289 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 37.3 ttt-85 -121.18 130.78 53.88 Favored 'General case' 0 C--O 1.257 1.453 0 O-C-N 123.766 0.666 . . . . 75.25 109.276 169.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.749 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 15.6 p90 -147.65 136.85 22.34 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.366 1.041 . . . . 73.219999999999999 108.827 173.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 56.28 26.26 10.29 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 124.514 1.126 . . . . 74.540000000000006 113.263 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 97.04 -9.57 65.6 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.168 0.413 . . . . 43.119999999999997 113.222 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 18.9 ttm180 -98.89 124.28 43.72 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.275 0.63 . . . . 75.439999999999998 109.961 -171.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.61 HG13 HD23 ' A' ' 160' ' ' LEU . 59.1 t -104.87 132.96 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.494 1.117 . . . . 65.540000000000006 108.873 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.48 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 40.8 p90 -145.29 163.08 35.58 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.551 0.741 . . . . 74.230000000000004 109.423 171.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -128.62 151.77 49.11 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.006 0.923 . . . . 73.219999999999999 108.784 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.423 ' HE2' HD12 ' A' ' 184' ' ' LEU . 32.9 p90 -143.13 140.48 30.86 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 122.689 0.396 . . . . 74.420000000000002 110.056 168.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -73.72 134.19 43.47 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.257 -0.883 . . . . 73.219999999999999 111.504 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.781 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 80.5 mt -84.68 109.05 17.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 107.224 -1.399 . . . . 63.399999999999999 107.224 163.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -80.2 125.96 30.5 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.435 -0.802 . . . . 73.230000000000004 109.181 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 27.2 m -90.43 113.55 25.5 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.894 -0.78 . . . . 71.150000000000006 108.894 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -58.6 157.98 8.41 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.91 0.884 . . . . 71.400000000000006 111.082 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 23.3 t -68.27 -11.99 60.29 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.361 0.664 . . . . 74.540000000000006 111.569 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -71.46 -13.21 61.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.455 0.702 . . . . 73.219999999999999 111.436 170.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.9 5.47 86.19 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.984 -0.446 . . . . 64.129999999999995 111.984 -170.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -87.72 153.48 21.33 Favored 'General case' 0 C--N 1.346 0.444 0 C-N-CA 124.219 1.008 . . . . 74.140000000000001 109.29 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.427 HD21 HH11 ' A' ' 180' ' ' ARG . 97.3 mt -99.87 153.71 18.93 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.59 0.756 . . . . 71.430000000000007 110.19 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -166.4 169.53 13.89 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.953 0.783 . . . . 75.349999999999994 110.11 172.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 195' ' ' ILE . 73.2 t -132.52 -58.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 105.996 -1.853 . . . . 63.43 105.996 172.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 37.8 t -81.61 131.98 35.29 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.374 -1.285 . . . . 71.219999999999999 107.587 168.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 74.2 p -65.28 -32.59 74.33 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.407 0.683 . . . . 60.43 112.4 -171.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -74.12 -23.92 59.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.721 0.809 . . . . 72.329999999999998 111.219 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 68.6 m -97.37 104.45 16.47 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.153 0.981 . . . . 75.530000000000001 110.104 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 20.2 mmt85 -114.51 137.49 51.79 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.749 0.819 . . . . 63.439999999999998 109.192 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 8.3 m-85 -132.89 133.58 43.45 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.652 0.595 . . . . 64.540000000000006 109.639 -173.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -72.29 -40.71 67.34 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.217 0.607 . . . . 71.230000000000004 110.037 169.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.0 p -123.02 153.87 39.25 Favored 'General case' 0 C--N 1.368 1.371 0 CA-C-O 121.903 0.859 . . . . 70.120000000000005 112.201 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 24.9 tp -70.19 -28.75 65.55 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.118 -1.401 . . . . 71.230000000000004 111.002 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.92 99.57 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.236 0.614 . . . . 43.5 110.852 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -75.82 -31.69 59.49 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.424 -0.807 . . . . 63.5 111.33 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tt -56.95 -46.83 81.83 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 123.856 0.722 . . . . 73.349999999999994 110.544 169.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.468 HG21 ' CE3' ' A' ' 146' ' ' TRP . 51.3 t -72.47 -37.63 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.892 0.877 . . . . 74.510000000000005 111.444 -175.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -60.14 -50.59 73.07 Favored 'General case' 0 C--O 1.258 1.528 0 CA-C-O 121.622 0.725 . . . . 75.109999999999999 110.033 173.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.43 ' CE1' HG11 ' A' ' 224' ' ' VAL . 50.0 t60 -52.51 -54.72 28.79 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.136 -1.393 . . . . 74.140000000000001 109.787 177.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -64.29 -25.42 68.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.866 -1.061 . . . . 63.109999999999999 112.051 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.2 t -74.0 -28.54 61.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.743 0.417 . . . . 63.240000000000002 111.793 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.7 t -109.86 -17.44 13.64 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.299 1.962 . . . . 73.420000000000002 116.299 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.43 HG11 ' CE1' ' A' ' 220' ' ' HIS . 36.0 m -96.04 152.47 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 115.371 1.619 . . . . 60.140000000000001 115.371 -166.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -90.98 -1.76 57.78 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.409 2.683 . . . . 71.439999999999998 112.523 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.17 13.94 1.33 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 128.326 2.65 . . . . 63.439999999999998 112.751 -141.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.1 18.0 3.94 Favored Glycine 0 C--N 1.346 1.139 0 C-N-CA 125.443 1.497 . . . . 73.530000000000001 110.933 -171.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.11 120.75 33.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.214 1.006 . . . . 72.030000000000001 109.84 165.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.48 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 80.1 mt -60.15 -40.36 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.391 1.077 . . . . 74.450000000000003 109.497 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.9 t -137.58 140.38 40.96 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 114.835 -1.075 . . . . 74.140000000000001 108.756 170.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 80.6 p -71.77 155.77 40.08 Favored 'General case' 0 C--O 1.247 0.93 0 N-CA-C 108.567 -0.901 . . . . 65.510000000000005 108.567 170.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.453 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . 27.8 mt -67.82 100.8 0.98 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 108.661 -0.866 . . . . 61.439999999999998 108.661 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -80.28 -49.99 10.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.309 0.644 . . . . 72.430000000000007 109.886 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 167' ' ' SER . 9.6 p90 -160.57 150.41 14.49 Favored Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 109.675 -0.491 . . . . 75.329999999999998 109.675 173.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.89 138.95 17.09 Favored 'Trans proline' 0 C--N 1.365 1.436 0 C-N-CA 121.964 1.776 . . . . 71.219999999999999 112.495 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.31 142.94 97.1 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 108.68 -0.859 . . . . 62.520000000000003 108.68 168.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -69.09 169.55 17.79 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.795 2.33 . . . . 64.099999999999994 114.452 -170.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.483 ' NZ ' ' HG2' ' A' ' 142' ' ' GLU . 67.1 mttm -65.0 161.13 19.32 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.536 -1.211 . . . . 44.130000000000003 109.678 165.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -61.97 -37.55 85.2 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 109.173 -0.677 . . . . 71.25 109.173 166.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -73.34 172.0 12.04 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.36 1.064 . . . . 71.519999999999996 109.858 170.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -57.73 130.14 81.82 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 123.215 0.606 . . . . 54.43 111.527 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -86.77 -160.62 0.11 Allowed 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 123.034 2.489 . . . . 60.340000000000003 112.088 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 45.9 m -135.16 124.18 24.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.812 0.845 . . . . 73.049999999999997 108.99 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 29.4 m -75.62 150.43 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.237 0.615 . . . . 71.140000000000001 109.795 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -129.57 155.7 45.37 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.015 -0.735 . . . . 73.420000000000002 109.015 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -140.79 -107.41 0.68 Allowed Glycine 0 N--CA 1.468 0.777 0 CA-C-O 119.28 -0.733 . . . . 51.009999999999998 111.754 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 65.0 t 56.38 88.9 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.703 1.201 . . . . 74.239999999999995 110.169 -174.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.2 t -89.45 111.31 44.87 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.863 0.865 . . . . 75.209999999999994 110.09 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -55.63 140.27 83.74 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.281 2.654 . . . . 64.140000000000001 112.157 171.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -141.0 -62.38 0.48 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.207 0.603 . . . . 75.340000000000003 109.696 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -94.84 71.17 3.46 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.301 0.64 . . . . 62.219999999999999 110.008 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.08 88.11 2.66 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.527 0.731 . . . . 72.010000000000005 109.33 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -168.84 119.83 0.75 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.942 0.897 . . . . 72.430000000000007 109.175 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -77.11 -61.96 1.81 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.79 -1.189 . . . . 44.119999999999997 107.79 170.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 N--CA 1.483 1.189 0 C-N-CA 124.359 1.063 . . . . 73.129999999999995 109.923 172.817 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 109.197 -0.668 . . . . 73.400000000000006 109.197 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 170.03 154.56 9.45 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 112.053 -0.419 . . . . 74.109999999999999 112.053 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -127.68 122.03 31.92 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.624 0.77 . . . . 75.010000000000005 111.361 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -100.42 117.2 63.41 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 108.091 -1.077 . . . . 71.519999999999996 108.091 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -48.56 -46.31 24.3 Favored 'Trans proline' 0 C--N 1.386 2.527 0 C-N-CA 124.011 3.14 . . . . 64.430000000000007 114.752 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.19 129.66 2.95 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-O 119.653 -0.526 . . . . 64.310000000000002 113.248 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -82.99 102.08 11.51 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.647 0.779 . . . . 51.119999999999997 109.67 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.2 t -76.37 135.47 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.563 0.745 . . . . 72.219999999999999 111.342 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -87.69 -178.35 6.06 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.595 1.158 . . . . 64.530000000000001 110.247 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.17 147.34 4.88 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.088 -0.405 . . . . 72.439999999999998 112.088 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -78.21 146.73 34.8 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.222 0.609 . . . . 75.450000000000003 109.561 177.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -169.53 141.75 2.46 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.654 0.382 . . . . 75.349999999999994 111.092 -172.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.85 147.99 48.47 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.845 -0.616 . . . . 74.349999999999994 109.952 171.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.6 mmm-85 56.87 76.72 0.46 Allowed Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 123.256 0.622 . . . . 71.310000000000002 109.324 -162.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.5 161.17 28.77 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.318 2.012 . . . . 72.25 111.443 176.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.6 p -69.65 169.72 12.22 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.006 0.431 . . . . 34.43 111.299 -174.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.8 mt -102.58 126.56 32.6 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 109.13 -0.693 . . . . 41.340000000000003 109.13 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.561 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 75.8 Cg_endo -74.03 174.49 12.32 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.785 2.323 . . . . 71.549999999999997 112.371 177.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.71 147.66 28.34 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.836 0.455 . . . . 64.310000000000002 111.491 -174.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HB3' HD11 ' A' ' 23' ' ' ILE . 85.1 mt -88.19 93.69 9.58 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.366 -0.976 . . . . 72.340000000000003 108.366 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -96.84 -48.68 5.36 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.109 0.564 . . . . 54.450000000000003 110.876 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.518 ' HE1' ' HB2' ' A' ' 115' ' ' ASN . 84.0 m-85 -105.93 111.04 23.53 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.092 0.557 . . . . 73.430000000000007 110.183 178.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' A' ' 20' ' ' LEU . 47.2 mm -118.08 110.44 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.006 0.523 . . . . 51.149999999999999 109.614 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' NZ ' ' HB2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -175.37 150.72 1.15 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.868 1.267 . . . . 63.340000000000003 108.724 179.05 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.27 69.88 2.93 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-O 119.886 -0.397 . . . . 64.040000000000006 113.396 -173.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -177.96 104.18 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.432 1.093 . . . . 70.299999999999997 109.537 172.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.16 -64.04 3.92 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.85 -0.5 . . . . 52.130000000000003 111.85 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.488 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . 32.8 ttmt -167.5 -6.43 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.315 0.646 . . . . 74.299999999999997 111.029 173.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.438 ' H ' ' H ' ' A' ' 28' ' ' LYS . 30.3 mmm180 73.61 29.45 1.54 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.034 1.333 . . . . 70.150000000000006 111.122 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.488 ' HG3' ' HB3' ' A' ' 28' ' ' LYS . 41.9 mt-10 -77.58 149.04 34.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.076 0.55 . . . . 62.130000000000003 111.058 175.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.9 p -147.34 87.89 1.68 Allowed 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.1 -0.954 . . . . 62.340000000000003 109.546 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.8 m -66.07 93.5 0.2 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.122 -0.945 . . . . 63.409999999999997 108.513 170.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.461 ' H ' ' HG2' ' A' ' 33' ' ' ARG . 11.1 ptp180 -78.73 -168.64 1.47 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.664 0.987 . . . . 73.230000000000004 113.664 -164.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -49.82 133.57 21.75 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.644 1.177 . . . . 64.319999999999993 112.576 -169.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.775 ' HA3' ' HB3' ' A' ' 143' ' ' LYS . . . -88.1 -151.84 23.12 Favored Glycine 0 C--N 1.347 1.178 0 O-C-N 123.463 0.477 . . . . 73.409999999999997 113.719 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 168.6 113.08 0.28 Allowed Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.914 -0.937 . . . . 62.32 111.006 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -71.62 155.25 59.31 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.83 2.353 . . . . 74.040000000000006 113.345 -171.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -154.67 106.86 2.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.489 0.716 . . . . 75.409999999999997 109.508 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.663 ' SG ' ' HA ' ' A' ' 69' ' ' SER . 66.5 m -86.5 144.45 27.25 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.59 0.709 . . . . 74.430000000000007 112.508 -176.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.529 ' H ' ' HE2' ' A' ' 241' ' ' LYS . 17.4 m120 -143.92 157.56 44.27 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.79 -1.55 . . . . 65.019999999999996 107.21 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.741 HG12 ' H ' ' A' ' 43' ' ' VAL . 26.3 t -61.82 145.62 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 110.017 -0.364 . . . . 72.299999999999997 110.017 174.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.447 ' H ' ' HD1' ' A' ' 42' ' ' PHE . 2.4 p90 -75.72 3.11 10.39 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.484 0.714 . . . . 62.32 111.811 174.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.741 ' H ' HG12 ' A' ' 41' ' ' VAL . 2.2 m 64.42 -1.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 128.408 2.683 . . . . 63.039999999999999 113.662 175.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 58.42 76.47 0.34 Allowed 'General case' 0 C--N 1.354 0.772 0 C-N-CA 124.587 1.155 . . . . 60.130000000000003 109.363 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -109.48 169.27 8.81 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 115.044 -0.98 . . . . 63.530000000000001 111.361 -169.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -100.2 149.8 23.18 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.976 -0.557 . . . . 73.099999999999994 109.871 168.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.05 125.37 30.75 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.024 -0.732 . . . . 72.549999999999997 109.024 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.3 mt -71.21 116.44 11.53 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.08 0.4 . . . . 72.030000000000001 112.08 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -86.85 171.51 10.79 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.904 -0.776 . . . . 73.420000000000002 108.904 167.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -120.76 89.51 45.27 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 109.365 -0.605 . . . . 73.519999999999996 109.365 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -92.41 -178.63 0.98 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.748 2.299 . . . . 75.310000000000002 112.566 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.1 p -74.4 -28.76 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.979 0.511 . . . . 73.219999999999999 110.111 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.28 165.91 21.88 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.794 0.838 . . . . 65.310000000000002 109.993 171.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.0 t -136.01 104.73 5.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.406 0.682 . . . . 70.329999999999998 109.7 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -107.08 -175.32 2.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.148 0.979 . . . . 61.310000000000002 109.809 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -121.45 -54.07 1.99 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.062 0.393 . . . . 72.519999999999996 112.062 -168.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 58.45 71.08 1.06 Allowed Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 124.294 1.038 . . . . 74.319999999999993 110.535 -169.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.02 70.21 7.16 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.953 2.435 . . . . 75.319999999999993 110.235 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -123.01 150.76 42.62 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.059 -0.973 . . . . 54.229999999999997 109.616 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 167.05 167.52 27.86 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 114.951 -1.022 . . . . 63.43 111.746 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.46 ' H ' ' HB ' ' A' ' 43' ' ' VAL . 95.7 mt -135.27 141.5 45.74 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.721 0.808 . . . . 70.420000000000002 109.735 -174.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.6 t -70.35 114.73 8.77 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.906 -0.776 . . . . 50.119999999999997 108.906 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.01 -167.25 1.82 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.803 0.841 . . . . 61.439999999999998 111.314 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -160.13 -169.59 2.55 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.778 0.831 . . . . 52.399999999999999 109.646 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.15 98.19 3.13 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.573 -0.528 . . . . 74.230000000000004 109.573 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.469 ' HG3' ' HA3' ' A' ' 246' ' ' GLY . 3.3 mmp_? -139.35 -45.57 0.46 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.393 0.677 . . . . 64.140000000000001 110.099 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -80.29 150.95 29.79 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 115.919 -0.582 . . . . 72.329999999999998 111.356 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -79.21 161.76 26.17 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.373 -0.831 . . . . 73.150000000000006 109.533 169.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.663 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 61.0 m -69.68 -6.86 34.44 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 112.477 0.547 . . . . 53.520000000000003 112.477 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? 60.63 49.64 6.28 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.747 1.219 . . . . 73.540000000000006 110.857 172.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -82.1 157.29 24.14 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 113.517 -1.674 . . . . 61.409999999999997 111.491 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -160.38 179.46 8.63 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.214 1.005 . . . . 74.310000000000002 111.053 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.3 mt 66.79 20.66 10.6 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 125.254 1.422 . . . . 72.010000000000005 112.944 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 70.8 mt -82.83 93.4 7.45 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.198 -0.667 . . . . 71.420000000000002 109.198 177.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.39 158.52 43.71 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.33 0.652 . . . . 71.25 110.963 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.28 -166.75 29.04 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.979 -0.9 . . . . 73.230000000000004 110.905 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.98 164.1 36.49 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.364 2.043 . . . . 72.519999999999996 112.265 171.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.4 p -70.1 82.91 0.51 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.111 0.564 . . . . 42.149999999999999 110.235 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -163.24 106.41 1.02 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.168 -1.049 . . . . 72.319999999999993 108.168 -173.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -119.55 -72.04 0.71 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.931 0.493 . . . . 61.219999999999999 111.654 -173.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 71.24 158.5 0.16 Allowed Pre-proline 0 N--CA 1.498 1.962 0 C-N-CA 124.106 0.962 . . . . 70.420000000000002 111.854 -174.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -66.55 -55.62 0.34 Allowed 'Trans proline' 0 C--N 1.39 2.711 0 C-N-CA 122.467 2.111 . . . . 60.340000000000003 113.139 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.498 ' HA ' ' HB3' ' A' ' 140' ' ' SER . 59.8 t30 -94.15 78.96 4.02 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 109.408 -0.59 . . . . 71.209999999999994 109.408 -176.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.658 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 33.5 tp -107.96 123.15 48.21 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.306 -0.861 . . . . 65.409999999999997 111.203 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.71 176.08 5.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.126 1.771 . . . . 75.040000000000006 108.879 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.43 148.88 24.34 Favored 'Isoleucine or valine' 0 C--O 1.252 1.234 0 N-CA-C 108.507 -0.923 . . . . 73.5 108.507 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.16 118.44 20.4 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 123.67 0.606 . . . . 61.299999999999997 109.654 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.2 mt -82.01 -25.23 34.87 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.969 0.908 . . . . 64.420000000000002 110.611 173.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -132.47 155.92 47.68 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.226 0.61 . . . . 73.209999999999994 110.614 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -72.61 146.05 46.9 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.012 -0.995 . . . . 63.299999999999997 110.542 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -160.65 112.31 1.9 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.693 0.797 . . . . 61.450000000000003 109.238 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.4 t -85.45 137.97 19.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.671 -0.863 . . . . 61.520000000000003 108.671 172.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.56 119.58 7.3 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.399 0.68 . . . . 75.530000000000001 110.576 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.6 m -70.69 -22.62 62.44 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.474 0.709 . . . . 75.340000000000003 110.626 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -159.11 -173.67 27.83 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.94 -0.864 . . . . 61.039999999999999 110.94 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.17 -32.42 73.99 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.938 0.895 . . . . 64.049999999999997 111.312 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.417 HD22 HD12 ' A' ' 23' ' ' ILE . 23.2 p-10 -68.63 -24.47 64.56 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.125 0.97 . . . . 53.340000000000003 112.367 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.4 p -101.43 162.94 12.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.18 0.592 . . . . 62.119999999999997 110.065 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.443 HD21 HG23 ' A' ' 123' ' ' THR . 64.7 tp -114.75 137.94 51.33 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.555 0.342 . . . . 74.239999999999995 110.875 -177.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.7 m -78.11 116.11 18.33 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.885 -0.598 . . . . 74.310000000000002 110.051 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 pt -123.69 140.82 46.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.638 0.775 . . . . 73.109999999999999 110.334 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.7 m -115.88 148.14 40.31 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.498 -0.926 . . . . 65.340000000000003 108.498 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -53.89 130.99 39.17 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.954 0.502 . . . . 73.040000000000006 111.284 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.47 -21.61 45.11 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.584 -0.28 . . . . 63.329999999999998 112.806 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -76.84 130.26 37.36 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.309 -0.997 . . . . 71.219999999999999 108.309 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.492 ' HB3' HD11 ' A' ' 84' ' ' LEU . 43.7 mttp -89.87 130.58 36.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.779 0.432 . . . . 71.519999999999996 109.885 -175.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.02 133.82 53.11 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.97 0.908 . . . . 71.25 109.174 -166.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.7 mtm-85 -94.9 108.03 20.06 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 118.736 0.698 . . . . 62.399999999999999 109.429 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 76.8 t -95.11 129.52 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 117.948 0.34 . . . . 72.430000000000007 110.111 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -105.23 -3.77 22.49 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.079 0.952 . . . . 73.420000000000002 111.321 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.31 164.79 16.86 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.919 -0.872 . . . . 63.030000000000001 110.919 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -95.44 171.79 8.48 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.065 -0.717 . . . . 73.239999999999995 109.065 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -63.5 150.11 44.6 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.831 -0.803 . . . . 63.119999999999997 108.831 175.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -70.61 -11.04 60.69 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 122.872 0.469 . . . . 74.109999999999999 110.845 -176.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.518 ' HB2' ' HE1' ' A' ' 22' ' ' PHE . 62.9 t30 -109.44 -2.98 17.36 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.342 1.057 . . . . 45.039999999999999 110.567 169.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.23 -16.32 59.07 Favored Glycine 0 N--CA 1.48 1.616 0 C-N-CA 123.775 0.703 . . . . 35.240000000000002 114.375 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . 33.7 mt-10 -54.17 -59.9 4.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.847 1.259 . . . . 71.129999999999995 112.955 -172.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -102.8 -179.88 4.09 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.814 -1.085 . . . . 75.340000000000003 109.026 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.63 129.6 12.56 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.52 0.728 . . . . 64.140000000000001 109.226 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -74.96 107.19 6.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.844 0.458 . . . . 73.310000000000002 110.555 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -110.58 160.14 16.93 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.547 0.739 . . . . 73.25 110.386 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -133.88 117.94 17.37 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.592 0.757 . . . . 75.120000000000005 109.732 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.443 HG23 HD21 ' A' ' 99' ' ' LEU . 68.4 p -113.46 -177.36 3.11 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.786 0.834 . . . . 74.129999999999995 110.273 175.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -70.73 -8.89 55.52 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.117 0.567 . . . . 64.530000000000001 110.849 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -79.77 -27.36 40.43 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.86 1.264 . . . . 60.200000000000003 110.598 173.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.3 -150.73 21.78 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.164 -0.774 . . . . 50.450000000000003 111.164 -173.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -128.25 154.1 46.24 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 117.724 0.762 . . . . 75.109999999999999 109.701 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 171.66 178.68 42.19 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 123.41 0.444 . . . . 72.040000000000006 112.018 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -89.94 120.57 31.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.383 0.673 . . . . 73.219999999999999 110.712 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.8 m -113.99 154.09 46.08 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 124.106 0.962 . . . . 73.200000000000003 109.475 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.24 127.98 17.63 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 121.502 1.468 . . . . 55.409999999999997 111.058 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.4 m -58.63 -19.52 39.64 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.822 0.849 . . . . 74.25 111.956 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -70.73 -24.63 62.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.585 1.154 . . . . 65.219999999999999 111.604 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -98.99 -0.7 41.54 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.09 0.956 . . . . 74.230000000000004 112.639 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.3 pt -126.92 153.21 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 118.231 0.468 . . . . 75.010000000000005 110.83 -171.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.5 t -148.73 134.4 9.64 Favored Pre-proline 0 N--CA 1.484 1.259 0 CA-C-O 119.613 -0.232 . . . . 61.219999999999999 110.717 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.97 131.82 32.23 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.434 2.09 . . . . 72.230000000000004 112.404 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.8 m -119.6 -61.1 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.613 0.765 . . . . 73.409999999999997 112.089 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.658 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 66.1 t30 -89.96 -16.85 29.03 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.508 0.723 . . . . 74.5 109.732 -175.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.498 ' HB3' ' HA ' ' A' ' 83' ' ' ASN . 4.6 p -72.42 -157.75 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.382 1.473 . . . . 72.109999999999999 111.563 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.498 HD13 HD23 ' A' ' 214' ' ' LEU . 76.5 mt -57.35 -25.54 59.59 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.145 1.165 . . . . 73.510000000000005 114.145 -175.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -71.41 -14.2 62.08 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 119.054 0.843 . . . . 73.409999999999997 111.187 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.775 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 26.3 tptp -62.35 -22.36 66.03 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.424 0.69 . . . . 75.219999999999999 109.997 168.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -75.37 131.35 40.18 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 108.542 -0.91 . . . . 74.420000000000002 108.542 163.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.1 m -66.36 -15.51 63.33 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 112.55 0.574 . . . . 41.140000000000001 112.55 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.607 ' HB3' ' HG3' ' A' ' 235' ' ' PRO . 29.7 p-90 -85.31 -26.8 26.36 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 113.204 0.816 . . . . 73.420000000000002 113.204 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 42.2 t80 -94.01 132.22 38.71 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.311 -0.625 . . . . 73.349999999999994 109.311 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -126.25 13.42 7.72 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.944 0.72 . . . . 71.109999999999999 112.944 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.26 -159.25 53.53 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-O 119.548 -0.585 . . . . 40.100000000000001 114.54 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.21 104.22 1.75 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.302 2.668 . . . . 64.439999999999998 112.951 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.458 ' HB ' ' HD3' ' A' ' 171' ' ' ARG . 17.3 t -139.86 152.64 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 122.936 0.494 . . . . 64.430000000000007 109.782 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.7 m -73.87 158.48 34.42 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 123.831 0.852 . . . . 71.200000000000003 112.397 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 157' ' ' GLU . 52.7 ptt85 -65.97 -32.48 73.99 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.506 -1.225 . . . . 71.219999999999999 112.088 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -72.44 -42.17 65.34 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.106 0.562 . . . . 54.409999999999997 110.365 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.64 -39.58 93.96 Favored 'General case' 0 C--O 1.251 1.167 0 C-N-CA 123.242 0.617 . . . . 34.299999999999997 110.484 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.518 ' HB2' ' HD2' ' A' ' 171' ' ' ARG . . . -55.45 -47.96 75.24 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.087 -0.961 . . . . 63.439999999999998 111.105 172.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 43.8 mt-10 -71.99 -26.96 62.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.958 0.503 . . . . 65.230000000000004 112.064 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -62.52 -43.52 98.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.772 0.429 . . . . 73.439999999999998 110.343 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.605 HD12 HH22 ' A' ' 171' ' ' ARG . 66.8 mt -78.12 -30.1 49.25 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.955 -0.566 . . . . 73.329999999999998 112.258 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.531 HD23 HG13 ' A' ' 190' ' ' VAL . 37.4 tp -78.93 -31.07 45.02 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.916 0.486 . . . . 64.310000000000002 111.487 -174.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 67.8 p -63.53 -19.88 65.15 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.663 0.785 . . . . 52.509999999999998 111.158 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.4 m -80.59 20.65 0.71 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.124 1.37 . . . . 62.5 111.781 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.63 177.81 16.88 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 114.613 0.605 . . . . 75.239999999999995 114.613 -174.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.7 pt -123.58 -164.55 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 124.819 1.248 . . . . 73.409999999999997 108.757 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.76 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 26.5 p-10 -48.19 120.41 3.55 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.6 0.76 . . . . 72.329999999999998 112.566 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.42 13.81 75.38 Favored Glycine 0 C--O 1.258 1.633 0 CA-C-N 116.621 -0.263 . . . . 70.239999999999995 113.335 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.1 t -73.14 127.79 33.6 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.368 -0.975 . . . . 73.239999999999995 108.368 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' ' 232' ' ' LEU . 23.9 p90 -137.95 152.76 49.27 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.706 0.684 . . . . 75.299999999999997 112.575 -174.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.569 HD22 HH21 ' A' ' 171' ' ' ARG . 87.6 mt -131.2 131.72 44.18 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.91 -1.041 . . . . 74.530000000000001 108.59 171.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.501 HG22 HG12 ' A' ' 182' ' ' ILE . 38.9 t -109.09 120.53 60.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.199 -1.408 . . . . 72.409999999999997 107.199 174.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.605 HH22 HD12 ' A' ' 159' ' ' LEU . 16.9 ptp180 -159.17 153.32 23.65 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.707 -0.479 . . . . 63.009999999999998 109.707 -176.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 13.1 pt-20 -97.42 157.41 16.01 Favored 'General case' 0 C--O 1.25 1.096 0 O-C-N 123.704 0.628 . . . . 75.209999999999994 109.862 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.618 ' HB3' ' HB2' ' A' ' 176' ' ' SER . 34.0 t -79.93 144.86 32.99 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.479 -0.782 . . . . 54.409999999999997 109.337 174.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -71.55 -42.79 67.43 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.63 -0.714 . . . . 72.25 110.805 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.8 t -89.52 -1.87 58.17 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.291 0.636 . . . . 62.219999999999999 112.03 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.618 ' HB2' ' HB3' ' A' ' 173' ' ' SER . 15.0 m -116.85 104.24 51.27 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 109.344 -0.613 . . . . 73.219999999999999 109.344 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.24 113.37 1.32 Allowed 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 123.402 2.735 . . . . 60.229999999999997 112.635 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.27 14.28 46.98 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 114.646 0.618 . . . . 62.109999999999999 114.646 173.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -89.55 112.93 24.26 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.25 -1.019 . . . . 72.439999999999998 108.25 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 78.2 mtt85 -104.3 161.23 14.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.904 -1.044 . . . . 73.530000000000001 108.807 -168.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.3 m -151.77 152.91 33.32 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 123.278 0.631 . . . . 75.409999999999997 109.763 -175.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.501 HG12 HG22 ' A' ' 170' ' ' VAL . 28.4 mt -118.8 137.68 51.97 Favored 'Isoleucine or valine' 0 C--O 1.25 1.123 0 N-CA-C 108.226 -1.027 . . . . 63.439999999999998 108.226 173.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.8 m -119.47 120.7 37.59 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.198 -1.038 . . . . 71.340000000000003 108.198 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.438 HD21 HD23 ' A' ' 232' ' ' LEU . 62.1 mt -103.61 141.3 36.28 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.528 0.731 . . . . 71.299999999999997 111.246 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -117.93 134.36 55.03 Favored 'General case' 0 C--O 1.26 1.636 0 N-CA-C 107.253 -1.388 . . . . 71.439999999999998 107.253 166.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.76 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 34.7 t80 -157.81 111.71 2.55 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.719 -1.128 . . . . 72.040000000000006 109.503 -172.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 50.96 44.17 28.54 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.881 1.272 . . . . 72.340000000000003 112.718 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.55 -1.5 87.23 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 114.717 0.647 . . . . 61.240000000000002 114.717 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -102.65 125.95 49.56 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.271 0.629 . . . . 71.439999999999998 109.448 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.531 HG13 HD23 ' A' ' 160' ' ' LEU . 72.1 t -115.1 117.35 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.961 0.904 . . . . 71.200000000000003 108.711 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -136.58 144.52 44.2 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.413 0.625 . . . . 53.119999999999997 110.637 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -122.92 136.36 54.83 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.231 1.012 . . . . 72.040000000000006 109.766 -167.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -145.34 141.95 28.97 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.842 0.353 . . . . 71.540000000000006 111.343 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -80.03 134.39 36.22 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.756 0.822 . . . . 72.299999999999997 111.081 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 91.3 mt -77.24 101.99 3.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 N-CA-C 107.58 -1.267 . . . . 71.510000000000005 107.58 161.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -72.7 122.9 22.23 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.177 -0.92 . . . . 74.519999999999996 109.152 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 21.6 m -100.34 111.14 23.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.143 0.577 . . . . 71.319999999999993 109.77 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.16 157.97 27.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.893 0.877 . . . . 63.520000000000003 111.499 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 77.9 p -62.74 -18.8 63.18 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.315 -0.857 . . . . 72.219999999999999 111.413 174.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -69.05 -15.85 63.56 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.894 1.678 . . . . 72.420000000000002 111.803 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 86.5 2.52 84.91 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 111.605 -0.598 . . . . 55.509999999999998 111.605 -170.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -89.93 143.12 27.06 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.082 0.553 . . . . 72.030000000000001 111.036 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 83.3 mt -95.57 150.15 20.65 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.196 0.998 . . . . 73.409999999999997 110.059 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -164.87 158.37 17.21 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.214 0.606 . . . . 74.510000000000005 111.01 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 94.9 t -127.18 -56.67 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 124.564 1.146 . . . . 71.420000000000002 108.985 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.3 t -100.75 -169.08 1.66 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.902 1.281 . . . . 63.310000000000002 110.433 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 50.9 m -76.81 -43.34 36.96 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.475 0.71 . . . . 75.420000000000002 112.153 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.56 -29.86 63.91 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.242 0.544 . . . . 75.310000000000002 111.368 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.523 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 83.6 p -68.65 118.17 11.31 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.411 -0.813 . . . . 53.240000000000002 111.813 -173.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -147.16 114.48 6.28 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.983 1.313 . . . . 65.230000000000004 107.653 170.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.523 ' CE2' ' HB2' ' A' ' 209' ' ' SER . 21.3 m-85 -130.53 138.83 50.4 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 118.449 0.568 . . . . 65.230000000000004 111.805 -171.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -79.95 -31.11 40.0 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.963 0.505 . . . . 73.129999999999995 109.968 169.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 60.1 p -126.59 148.09 49.81 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.734 0.778 . . . . 72.0 111.966 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.498 HD23 HD13 ' A' ' 141' ' ' LEU . 24.9 tp -69.87 -21.67 63.31 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.22 -1.355 . . . . 63.439999999999998 111.194 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.87 -47.49 77.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.394 0.678 . . . . 72.129999999999995 110.515 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -70.14 -31.74 69.4 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 115.705 -0.68 . . . . 74.329999999999998 111.008 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 10.1 tt -55.47 -56.28 22.06 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 123.699 0.625 . . . . 72.439999999999998 109.859 172.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.58 -39.15 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.736 0.814 . . . . 64.430000000000007 111.622 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -59.83 -57.04 14.61 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.692 0.758 . . . . 73.230000000000004 111.222 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.436 ' CE1' HG11 ' A' ' 224' ' ' VAL . 40.4 t-80 -56.52 -44.16 80.53 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.771 -1.104 . . . . 74.510000000000005 109.854 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 217' ' ' LEU . 1.9 t60 -72.28 -19.96 61.6 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.535 1.134 . . . . 73.109999999999999 110.417 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 29.1 t -82.76 -20.26 36.26 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.016 0.926 . . . . 74.239999999999995 110.895 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.8 t -115.92 -8.52 11.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.401 2.0 . . . . 72.150000000000006 116.401 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.436 HG11 ' CE1' ' A' ' 220' ' ' HIS . 15.3 m -89.54 143.11 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 120.95 1.705 . . . . 72.299999999999997 114.505 -171.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.58 -0.53 57.58 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 128.713 2.805 . . . . 64.049999999999997 111.883 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -78.23 13.85 1.37 Allowed 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 130.066 3.347 . . . . 61.109999999999999 112.621 -146.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.83 18.68 3.51 Favored Glycine 0 C--N 1.343 0.928 0 C-N-CA 124.038 0.828 . . . . 51.32 111.43 -172.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 71.4 mt -92.06 121.47 33.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.627 0.771 . . . . 72.319999999999993 110.617 163.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 76.6 mt -53.76 -42.58 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.779 0.832 . . . . 61.509999999999998 109.546 169.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -140.87 140.42 34.57 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.673 -1.149 . . . . 53.439999999999998 108.446 173.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.1 p -69.45 162.98 26.32 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.933 -0.576 . . . . 74.310000000000002 109.565 171.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.438 HD23 HD21 ' A' ' 184' ' ' LEU . 57.2 mt -65.55 103.84 0.91 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 110.073 -0.343 . . . . 71.209999999999994 110.073 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -77.99 -60.91 2.18 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.194 -0.669 . . . . 71.549999999999997 109.194 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -158.36 149.53 16.49 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 120.492 -0.483 . . . . 74.400000000000006 112.143 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.607 ' HG3' ' HB3' ' A' ' 146' ' ' TRP . 46.5 Cg_exo -58.33 123.01 12.64 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.882 2.388 . . . . 53.109999999999999 112.195 172.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -58.27 135.21 84.86 Favored Pre-proline 0 C--O 1.246 0.893 0 O-C-N 123.665 0.603 . . . . 53.130000000000003 109.981 175.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.448 ' HA ' ' HD2' ' A' ' 241' ' ' LYS . 36.1 Cg_endo -65.96 135.74 42.13 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.887 1.725 . . . . 75.25 113.979 -175.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.524 ' HA ' HD22 ' A' ' 159' ' ' LEU . 18.3 ptpt -66.85 161.34 24.1 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.71 -1.132 . . . . 70.209999999999994 109.235 162.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -36.69 -39.26 0.2 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.575 1.55 . . . . 72.530000000000001 114.005 -173.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -133.89 126.7 31.0 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 108.697 -0.853 . . . . 74.109999999999999 108.697 171.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.529 ' HE2' ' H ' ' A' ' 40' ' ' ASN . 85.7 tttt -149.28 135.76 10.43 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 123.808 0.843 . . . . 62.140000000000001 108.753 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.99 154.26 68.15 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.902 2.402 . . . . 70.109999999999999 114.174 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 87.6 m -88.75 130.38 35.36 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.726 0.81 . . . . 55.420000000000002 109.661 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.463 ' H ' HG22 ' A' ' 41' ' ' VAL . 21.8 m -126.06 160.44 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.383 0.673 . . . . 63.329999999999998 109.908 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -141.43 -171.64 3.35 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.578 -0.897 . . . . 75.010000000000005 108.578 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.469 ' HA3' ' HG3' ' A' ' 66' ' ' ARG . . . 103.98 54.73 0.8 Allowed Glycine 0 C--N 1.342 0.894 0 O-C-N 123.43 0.457 . . . . 32.310000000000002 113.591 175.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.6 m -78.55 149.92 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.131 -1.063 . . . . 63.229999999999997 108.131 166.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.3 p -150.09 108.74 3.23 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 122.662 0.385 . . . . 72.209999999999994 110.861 -169.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.15 162.67 39.18 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.368 2.712 . . . . 73.200000000000003 112.968 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -140.94 -179.57 6.15 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.692 0.797 . . . . 73.239999999999995 109.7 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -123.31 145.74 48.47 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.141 0.576 . . . . 75.540000000000006 110.037 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -135.75 159.76 40.64 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.562 0.745 . . . . 72.329999999999998 110.032 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -110.29 129.7 55.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.236 -0.893 . . . . 65.420000000000002 109.337 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -80.29 150.7 29.88 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.347 -0.612 . . . . 74.140000000000001 109.347 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 123.56 0.744 . . . . 74.430000000000007 110.932 -172.496 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 109.533 -0.543 . . . . 75.430000000000007 109.533 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.29 29.99 0.58 Allowed Glycine 0 C--N 1.346 1.137 0 O-C-N 123.246 0.341 . . . . 62.539999999999999 112.524 -177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -73.21 112.79 9.59 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.385 -0.598 . . . . 72.310000000000002 109.385 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -129.51 70.36 81.81 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 123.808 0.843 . . . . 73.140000000000001 109.263 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -81.73 -5.41 12.37 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.175 1.917 . . . . 51.200000000000003 112.633 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.75 132.65 5.7 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-O 119.315 -0.714 . . . . 72.219999999999999 111.58 -174.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -178.47 136.88 0.16 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.928 0.891 . . . . 63.210000000000001 108.783 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.31 -168.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 123.664 0.786 . . . . 74.200000000000003 110.245 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.417 HD13 HD21 ' A' ' 133' ' ' ASN . 0.3 OUTLIER -125.7 149.25 48.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.759 1.224 . . . . 73.340000000000003 109.617 176.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.06 36.23 0.66 Allowed Glycine 0 C--N 1.342 0.882 0 N-CA-C 111.539 -0.625 . . . . 75.120000000000005 111.539 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.743 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 1.2 m-20 -123.36 178.1 5.3 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.791 0.836 . . . . 75.530000000000001 109.309 -174.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 20.3 mm-40 -115.03 -74.43 0.61 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.507 0.723 . . . . 71.120000000000005 109.731 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -69.77 104.72 2.52 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.172 0.989 . . . . 72.219999999999999 109.479 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.1 mmm-85 54.17 77.13 0.46 Allowed Pre-proline 0 CA--C 1.553 1.08 0 O-C-N 124.269 0.981 . . . . 74.450000000000003 109.667 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.743 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 33.6 Cg_endo -63.86 166.53 15.91 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.252 1.968 . . . . 64.140000000000001 112.488 -177.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.1 m -65.23 170.54 4.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.218 0.532 . . . . 71.5 110.303 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.3 mt -107.23 125.15 33.14 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.103 -1.073 . . . . 72.549999999999997 108.103 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.17 174.51 8.89 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.786 2.324 . . . . 75.349999999999994 112.158 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.43 145.67 39.14 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.54 0.336 . . . . 64.299999999999997 110.124 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.487 ' HB3' HD11 ' A' ' 23' ' ' ILE . 64.6 mt -89.46 101.96 14.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.373 1.069 . . . . 72.040000000000006 109.684 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -96.05 -50.92 4.65 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.419 0.688 . . . . 71.120000000000005 110.074 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -104.45 116.54 32.29 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.197 0.999 . . . . 74.329999999999998 110.077 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 20' ' ' LEU . 37.3 mm -118.38 114.05 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.617 0.767 . . . . 54.329999999999998 111.124 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.63 ' H ' ' HE1' ' A' ' 129' ' ' TRP . 75.5 mmtt -115.62 157.55 24.01 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.07 1.348 . . . . 74.219999999999999 109.085 166.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.83 14.17 1.96 Allowed Glycine 0 C--N 1.343 0.932 0 CA-C-N 116.272 -0.422 . . . . 73.530000000000001 112.456 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.73 146.38 27.18 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.696 0.799 . . . . 43.130000000000003 110.564 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 146.25 86.1 0.06 OUTLIER Glycine 0 C--N 1.35 1.325 0 N-CA-C 111.889 -0.485 . . . . 74.109999999999999 111.889 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -78.46 84.73 4.59 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.337 0.655 . . . . 53.509999999999998 111.363 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -85.48 -59.43 2.32 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.489 1.116 . . . . 63.100000000000001 110.833 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.74 159.93 39.9 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 120.911 0.386 . . . . 64.239999999999995 110.632 168.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.462 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 22.4 p -165.08 94.23 0.64 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.027 -0.988 . . . . 71.120000000000005 108.769 166.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.439 ' HB2' ' NH2' ' A' ' 108' ' ' ARG . 16.2 m -64.49 143.99 57.52 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 108.987 -0.746 . . . . 63.210000000000001 108.987 173.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 45.5 mmm-85 -74.03 -26.38 60.39 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.734 0.642 . . . . 63.109999999999999 112.734 -171.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -81.25 147.11 30.11 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 120.864 0.364 . . . . 74.230000000000004 111.769 -172.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.91 -100.61 0.5 Allowed Glycine 0 C--N 1.343 0.924 0 N-CA-C 109.006 -1.638 . . . . 64.310000000000002 109.006 172.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 37' ' ' PRO . . . 82.03 -115.55 4.04 Favored Glycine 0 CA--C 1.541 1.659 0 CA-C-O 118.469 -1.184 . . . . 24.039999999999999 115.252 166.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 36' ' ' GLY . 20.4 Cg_exo -65.19 126.59 16.67 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 123.994 3.13 . . . . 75.310000000000002 114.027 -170.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -148.39 167.17 25.97 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.939 0.895 . . . . 71.109999999999999 109.945 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.84 145.86 50.8 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.538 0.735 . . . . 70.540000000000006 111.478 -173.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -74.58 146.76 42.28 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.875 0.87 . . . . 75.420000000000002 110.217 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.502 HG21 HD22 ' A' ' 88' ' ' LEU . 12.2 p -127.78 155.91 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.273 0.629 . . . . 73.420000000000002 110.176 -176.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -149.46 142.32 24.72 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.373 1.069 . . . . 54.329999999999998 108.769 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.401 HG12 HD11 ' A' ' 73' ' ' LEU . 34.6 m -124.06 164.5 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.413 0.685 . . . . 52.200000000000003 110.817 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -87.29 150.96 23.52 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.492 -0.776 . . . . 55.100000000000001 108.943 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -119.84 98.26 6.01 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.804 0.442 . . . . 73.109999999999999 110.308 -170.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.417 ' H ' ' HG3' ' A' ' 12' ' ' GLN . 11.9 tp10 -132.38 104.94 6.98 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.435 -0.95 . . . . 54.229999999999997 108.435 170.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.85 153.47 39.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.074 0.95 . . . . 71.340000000000003 109.918 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.2 mt -110.95 124.84 52.92 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.34 0.656 . . . . 72.209999999999994 109.505 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.16 118.04 12.48 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.526 -0.546 . . . . 70.540000000000006 109.526 171.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -94.42 110.8 50.84 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 123.816 0.847 . . . . 74.140000000000001 109.556 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.12 -47.36 3.52 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.358 2.039 . . . . 74.329999999999998 111.949 176.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.2 m -141.07 157.75 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.236 1.014 . . . . 73.109999999999999 110.148 -178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.92 -55.81 1.68 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.217 1.007 . . . . 65.120000000000005 108.427 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.9 m -143.93 98.78 3.28 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.306 -0.998 . . . . 75.200000000000003 108.306 172.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.41 -39.36 25.06 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.007 0.432 . . . . 73.430000000000007 109.877 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -79.13 115.66 18.93 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.214 1.006 . . . . 75.420000000000002 108.652 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 58.61 71.06 1.05 Allowed Pre-proline 0 CA--C 1.551 0.986 0 O-C-N 124.573 1.17 . . . . 74.310000000000002 109.885 -176.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -83.36 36.4 0.61 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 123.722 2.948 . . . . 72.430000000000007 113.482 -170.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -76.7 86.52 3.34 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.321 0.648 . . . . 74.150000000000006 109.495 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.87 72.44 0.67 Allowed Glycine 0 C--N 1.348 1.201 0 CA-C-N 115.933 -0.576 . . . . 71.140000000000001 112.038 -177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.9 105.34 0.66 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.842 1.257 . . . . 64.409999999999997 111.846 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.3 m 64.69 5.08 2.59 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 114.141 1.163 . . . . 51.130000000000003 114.141 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -69.7 -36.72 76.19 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 118.173 0.442 . . . . 71.450000000000003 111.77 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.54 75.82 9.05 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.893 0.877 . . . . 70.319999999999993 109.381 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -162.61 146.2 11.42 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.823 -1.08 . . . . 73.530000000000001 110.009 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -79.89 87.46 5.34 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 106.808 -1.553 . . . . 61.130000000000003 106.808 171.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.406 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 24.5 p90 -67.82 161.68 25.68 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.827 -1.079 . . . . 70.019999999999996 111.78 -177.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -73.91 100.21 3.45 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 109.417 -0.586 . . . . 63.119999999999997 109.417 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.5 t -79.48 168.86 18.88 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.186 -0.672 . . . . 52.310000000000002 109.186 168.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 166.07 22.87 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.105 0.479 . . . . 73.129999999999995 110.85 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -129.35 140.63 51.32 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.337 -0.847 . . . . 74.310000000000002 108.797 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -86.26 117.47 25.09 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.676 -0.861 . . . . 73.230000000000004 108.676 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.401 HD11 HG12 ' A' ' 43' ' ' VAL . 81.3 mt -79.39 -174.34 4.15 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.95 0.9 . . . . 41.020000000000003 111.123 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.31 82.87 0.37 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.647 0.779 . . . . 75.519999999999996 109.408 175.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -167.83 -179.49 4.26 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.326 1.051 . . . . 74.25 109.917 -172.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.89 82.19 0.04 OUTLIER Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.919 -0.934 . . . . 44.439999999999998 111.586 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.31 112.74 1.33 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.122 2.548 . . . . 74.239999999999995 111.838 177.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.0 m -83.38 102.04 11.75 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.841 0.856 . . . . 53.539999999999999 110.794 -176.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -149.13 123.55 9.66 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.367 -0.833 . . . . 42.299999999999997 108.769 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -78.84 111.04 14.59 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 123.838 0.711 . . . . 73.299999999999997 109.793 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -151.94 148.96 22.47 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.563 1.145 . . . . 74.040000000000006 108.659 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -40.28 -57.79 1.11 Allowed 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 123.875 3.05 . . . . 64.140000000000001 115.008 172.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.03 73.94 0.7 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.771 0.796 . . . . 73.319999999999993 111.232 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.1 tp -91.11 119.53 31.31 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.668 0.747 . . . . 73.409999999999997 110.939 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -111.96 173.86 6.16 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.293 1.437 . . . . 74.219999999999999 109.417 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.31 154.18 12.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.633 -1.247 . . . . 71.129999999999995 107.633 174.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.475 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -94.85 132.89 39.17 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.334 -0.247 . . . . 72.109999999999999 110.334 173.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.502 HD22 HG21 ' A' ' 41' ' ' VAL . 79.3 mt -86.21 -20.94 27.78 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.479 0.711 . . . . 71.530000000000001 110.587 172.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -129.09 153.21 47.87 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.631 -0.713 . . . . 71.129999999999995 109.474 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.67 160.54 32.42 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.363 -0.835 . . . . 74.319999999999993 108.777 163.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.496 ' HB3' HG12 ' A' ' 101' ' ' ILE . 56.3 t80 -159.87 111.18 1.98 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.457 -0.942 . . . . 74.230000000000004 108.457 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.0 t -81.21 124.26 38.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 107.235 -1.394 . . . . 54.409999999999997 107.235 170.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB2' ' N ' ' A' ' 100' ' ' SER . . . -66.14 143.99 56.95 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.993 0.517 . . . . 74.519999999999996 110.799 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.5 m -76.59 -13.62 60.06 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.735 0.814 . . . . 52.130000000000003 110.655 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.68 -155.14 26.36 Favored Glycine 0 C--N 1.353 1.481 0 N-CA-C 111.823 -0.511 . . . . 71.019999999999996 111.823 176.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -65.91 -28.92 69.29 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.253 1.021 . . . . 54.240000000000002 111.416 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -69.38 -13.73 62.53 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.984 1.314 . . . . 55.130000000000003 112.419 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.0 p -128.82 162.8 26.62 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.348 1.059 . . . . 60.32 109.707 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.456 ' HB3' HG13 ' A' ' 130' ' ' VAL . 53.7 tp -111.39 121.61 45.67 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.198 0.599 . . . . 74.099999999999994 110.382 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.419 ' N ' ' HB2' ' A' ' 93' ' ' ALA . 16.0 p -72.12 116.08 12.12 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.524 -0.547 . . . . 60.43 109.524 173.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.496 HG12 ' HB3' ' A' ' 91' ' ' PHE . 33.5 pt -122.18 161.51 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.145 0.578 . . . . 75.329999999999998 109.735 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 33.3 m -121.54 148.33 44.62 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.364 0.666 . . . . 75.010000000000005 110.172 -177.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -57.47 128.31 36.38 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.665 0.386 . . . . 72.030000000000001 110.255 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.06 -21.39 37.36 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 120.19 -0.228 . . . . 72.120000000000005 112.923 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -67.91 131.16 44.99 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.516 0.726 . . . . 72.109999999999999 110.282 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -78.71 121.21 24.44 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.146 0.578 . . . . 64.530000000000001 110.367 177.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.518 ' HA ' HG22 ' A' ' 123' ' ' THR . 14.7 mt -103.66 152.39 21.85 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.166 0.986 . . . . 54.119999999999997 108.424 -175.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.462 ' HD3' ' HA ' ' A' ' 31' ' ' SER . 72.5 mtt-85 -123.25 104.74 9.34 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.809 -1.182 . . . . 72.430000000000007 107.809 172.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 53.9 t -96.01 114.22 32.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 108.449 -0.945 . . . . 54.25 108.449 -172.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.4 mt -79.74 -10.81 59.84 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.608 -1.178 . . . . 62.140000000000001 110.59 -174.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.89 157.19 9.2 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 110.521 -1.032 . . . . 62.229999999999997 110.521 173.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -94.11 168.01 11.21 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.601 -0.889 . . . . 74.430000000000007 108.601 174.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -77.63 147.46 35.56 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.578 -1.267 . . . . 53.350000000000001 107.578 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -70.04 -17.07 63.24 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.584 0.754 . . . . 74.040000000000006 112.371 -175.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.505 ' HB3' ' HG2' ' A' ' 117' ' ' GLU . 65.2 t30 -86.05 -11.49 52.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.79 0.436 . . . . 72.430000000000007 110.527 174.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.38 14.06 77.13 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.385 -0.37 . . . . 42.240000000000002 113.137 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.505 ' HG2' ' HB3' ' A' ' 115' ' ' ASN . 7.9 pt-20 -75.38 -56.02 5.12 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.519 1.128 . . . . 75.239999999999995 110.629 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -124.59 179.09 5.1 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.796 1.238 . . . . 73.209999999999994 108.813 -176.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.3 133.88 16.59 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.243 0.617 . . . . 74.230000000000004 110.154 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -81.11 95.65 6.93 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 109.099 -0.704 . . . . 73.430000000000007 109.099 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -104.91 170.26 7.97 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.158 -0.928 . . . . 74.239999999999995 110.854 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -148.61 129.5 14.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.897 -1.047 . . . . 72.319999999999993 108.544 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 107' ' ' LEU . 72.1 p -131.92 -171.13 2.55 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.526 1.13 . . . . 52.530000000000001 108.995 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -68.72 -8.55 43.78 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.607 0.763 . . . . 65.530000000000001 111.048 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.437 ' HB2' HD11 ' A' ' 99' ' ' LEU . 42.0 m-20 -83.16 -24.26 32.57 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.278 1.031 . . . . 75.400000000000006 110.144 173.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 127.99 -167.91 20.12 Favored Glycine 0 C--N 1.354 1.574 0 CA-C-O 119.668 -0.518 . . . . 72.430000000000007 112.183 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -100.14 157.76 16.34 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 117.699 0.749 . . . . 61.32 109.889 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.47 177.87 36.7 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 112.021 -0.432 . . . . 62.520000000000003 112.021 174.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.63 ' HE1' ' H ' ' A' ' 24' ' ' LYS . 84.3 m95 -91.08 134.67 34.33 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.367 0.603 . . . . 72.140000000000001 111.383 -176.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 99' ' ' LEU . 5.4 m -136.47 140.4 32.31 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.726 1.61 . . . . 62.329999999999998 108.551 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.81 143.95 47.14 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.012 1.808 . . . . 64.450000000000003 111.679 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.412 ' HA ' HG12 ' A' ' 135' ' ' ILE . 23.1 m -60.32 -19.62 55.99 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 124.352 1.061 . . . . 74.25 113.12 -173.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.417 HD21 HD13 ' A' ' 9' ' ' LEU . 75.5 m-20 -79.38 -27.03 41.89 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 112.298 0.481 . . . . 71.25 112.298 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -79.37 -18.92 51.43 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.507 0.504 . . . . 61.119999999999997 110.509 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.551 HD12 HG21 ' A' ' 109' ' ' VAL . 18.7 pt -118.65 146.0 23.86 Favored 'Isoleucine or valine' 0 C--N 1.364 1.201 0 C-N-CA 123.463 0.705 . . . . 74.129999999999995 110.278 -165.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.472 ' OG1' ' HG ' ' A' ' 88' ' ' LEU . 9.6 m -149.66 112.14 3.41 Favored Pre-proline 0 CA--C 1.559 1.291 0 CA-C-O 119.196 -0.431 . . . . 52.009999999999998 112.145 -163.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.92 116.35 4.25 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.426 2.084 . . . . 75.109999999999999 112.608 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.5 m -84.99 -26.63 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.089 0.471 . . . . 63.210000000000001 110.04 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -86.74 16.81 4.42 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.947 -1.024 . . . . 75.219999999999999 110.54 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.0 t -49.54 125.9 12.32 Favored 'General case' 0 C--N 1.361 1.081 0 C-N-CA 123.938 0.895 . . . . 61.439999999999998 110.833 177.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.3 mt -60.85 -11.28 7.28 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.595 1.158 . . . . 70.349999999999994 112.0 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -53.6 -14.45 0.86 Allowed 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.527 1.531 . . . . 71.439999999999998 113.593 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -55.81 -35.04 65.91 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 109.483 -0.562 . . . . 75.329999999999998 109.483 172.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -89.37 123.24 33.35 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.283 -1.377 . . . . 72.219999999999999 107.283 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.4 m -67.04 -6.56 17.69 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 114.197 1.184 . . . . 54.310000000000002 114.197 -166.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 38.7 p-90 -69.2 -35.68 76.49 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.04 0.385 . . . . 75.400000000000006 112.04 174.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.401 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 52.2 t80 -93.25 145.69 24.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.469 0.708 . . . . 62.329999999999998 109.187 177.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -135.38 7.16 3.32 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 112.986 0.735 . . . . 74.200000000000003 112.986 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 89.92 -167.57 33.42 Favored Glycine 0 N--CA 1.477 1.389 0 N-CA-C 115.091 0.797 . . . . 73.299999999999997 115.091 168.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.85 101.04 1.14 Allowed 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 123.399 2.733 . . . . 52.32 111.464 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.671 HG21 HH21 ' A' ' 171' ' ' ARG . 35.0 t -141.34 150.14 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 CA-C-N 116.065 -0.516 . . . . 72.340000000000003 110.027 -172.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.7 m -67.49 149.4 50.24 Favored 'General case' 0 C--O 1.252 1.205 0 C-N-CA 124.624 1.17 . . . . 71.049999999999997 111.965 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -57.72 -34.23 69.26 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.327 -0.851 . . . . 75.049999999999997 110.801 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -57.53 -55.15 38.6 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.379 0.672 . . . . 54.350000000000001 110.595 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.5 91.2 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.723 0.809 . . . . 54.25 111.005 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.18 -52.35 65.93 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.206 -0.907 . . . . 73.120000000000005 111.383 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -72.11 -27.72 62.82 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.953 0.901 . . . . 52.43 110.293 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -62.52 -47.65 82.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.043 0.537 . . . . 75.209999999999994 110.933 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.737 HD12 HH12 ' A' ' 171' ' ' ARG . 81.8 mt -66.88 -41.86 86.53 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.091 0.472 . . . . 73.420000000000002 110.746 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.473 HD23 HG13 ' A' ' 190' ' ' VAL . 31.5 tp -66.44 -24.29 66.42 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.273 -0.876 . . . . 64.319999999999993 111.984 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 36.5 t -63.97 -20.41 65.86 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.086 0.954 . . . . 64.430000000000007 112.432 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.8 p -105.73 15.83 26.22 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.337 0.655 . . . . 61.340000000000003 111.229 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -99.75 157.98 19.74 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 116.223 -0.444 . . . . 75.349999999999994 112.66 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 20.7 pt -107.14 -163.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.044 0.938 . . . . 54.329999999999998 110.172 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.808 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 26.7 p-10 -47.82 115.53 1.19 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.225 1.01 . . . . 75.430000000000007 113.125 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 86.04 13.65 68.57 Favored Glycine 0 C--O 1.255 1.419 0 CA-C-N 116.168 -0.469 . . . . 51.0 112.581 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 22.2 t -72.66 133.72 44.76 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.623 -0.88 . . . . 73.310000000000002 108.623 176.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.555 ' HB3' HD23 ' A' ' 184' ' ' LEU . 14.5 p90 -142.25 162.55 35.18 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.405 0.52 . . . . 52.119999999999997 112.405 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.532 ' HB3' ' HD3' ' A' ' 171' ' ' ARG . 80.4 mt -141.93 133.15 26.31 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.253 -1.017 . . . . 43.149999999999999 108.253 172.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.43 110.9 32.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 107.543 -1.281 . . . . 71.450000000000003 107.543 174.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.737 HH12 HD12 ' A' ' 159' ' ' LEU . 4.4 mmm-85 -120.68 162.51 19.57 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.048 -1.093 . . . . 63.329999999999998 108.048 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.616 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 21.4 pt-20 -117.15 155.33 29.54 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.038 0.447 . . . . 75.239999999999995 110.099 165.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 37.2 m -86.02 127.73 34.71 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.95 -1.023 . . . . 74.319999999999993 110.424 -176.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -70.63 -34.71 72.39 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.103 1.361 . . . . 63.130000000000003 110.565 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 36.0 p -91.15 -14.76 30.54 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.577 1.151 . . . . 55.509999999999998 111.882 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 44.7 m -135.42 76.25 56.36 Favored Pre-proline 0 N--CA 1.477 0.924 0 N-CA-C 108.117 -1.068 . . . . 63.119999999999997 108.117 171.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.63 141.85 46.91 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.879 2.386 . . . . 72.019999999999996 112.968 -174.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.93 -22.65 27.65 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.726 -0.67 . . . . 75.040000000000006 111.903 -171.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -93.07 120.05 32.95 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.717 0.807 . . . . 73.409999999999997 109.104 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.616 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 52.1 mtt180 -110.52 169.57 8.66 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.205 -0.907 . . . . 73.5 109.724 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.7 t -152.18 137.3 17.36 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 123.731 0.812 . . . . 62.420000000000002 109.204 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.64 133.06 53.54 Favored 'Isoleucine or valine' 0 C--O 1.247 0.933 0 N-CA-C 107.601 -1.259 . . . . 75.120000000000005 107.601 171.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 19.8 m -111.49 117.28 32.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.661 -1.237 . . . . 75.400000000000006 107.661 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.555 HD23 ' HB3' ' A' ' 168' ' ' PHE . 43.5 mt -103.84 143.26 33.06 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.508 1.123 . . . . 65.420000000000002 110.863 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 29.7 ttt180 -132.27 129.87 40.15 Favored 'General case' 0 C--O 1.256 1.442 0 C-N-CA 124.059 0.944 . . . . 73.519999999999996 108.47 169.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.808 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 4.4 p90 -147.74 137.52 22.68 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.418 -0.956 . . . . 74.030000000000001 108.418 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 55.12 33.61 20.82 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.172 0.989 . . . . 54.340000000000003 111.864 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.47 -7.01 80.81 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.556 -0.747 . . . . 74.310000000000002 113.816 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 18.6 tpp180 -99.83 123.44 44.09 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.564 0.746 . . . . 75.439999999999998 110.281 -171.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.473 HG13 HD23 ' A' ' 160' ' ' LEU . 72.6 t -101.23 133.57 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.694 1.197 . . . . 74.319999999999993 109.602 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.401 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 33.9 p90 -146.0 156.96 43.85 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.787 0.835 . . . . 63.350000000000001 109.532 169.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -127.74 140.39 52.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.825 0.85 . . . . 74.329999999999998 108.842 -172.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -141.47 140.09 33.47 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 110.135 -0.321 . . . . 51.43 110.135 174.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -79.18 137.67 37.54 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.405 -0.816 . . . . 71.540000000000006 111.183 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 91.1 mt -78.39 102.49 4.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 107.045 -1.465 . . . . 74.420000000000002 107.045 162.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -75.57 124.64 27.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.391 -1.337 . . . . 75.239999999999995 107.391 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 56.6 m -102.67 121.01 41.56 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.03 0.532 . . . . 72.230000000000004 109.86 -174.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -74.62 145.41 43.3 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.749 -1.204 . . . . 64.329999999999998 107.749 170.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.7 m -69.24 -9.78 54.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.197 0.599 . . . . 75.120000000000005 111.492 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -65.74 -18.96 65.7 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.751 1.22 . . . . 65.019999999999996 110.709 172.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 97.8 -1.17 59.6 Favored Glycine 0 C--N 1.355 1.627 0 C-N-CA 123.809 0.718 . . . . 40.409999999999997 111.622 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -90.83 137.85 32.05 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 123.571 0.749 . . . . 63.130000000000003 110.049 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 89.2 mt -96.58 157.83 15.71 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.412 0.685 . . . . 71.010000000000005 110.149 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -164.83 174.28 10.8 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 123.913 0.758 . . . . 70.310000000000002 110.595 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.6 t -138.86 -65.68 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.487 -1.301 . . . . 74.450000000000003 107.487 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.0 t -91.48 -175.98 4.38 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.326 1.05 . . . . 75.120000000000005 110.797 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 32.7 t -66.47 -48.11 70.93 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.535 0.734 . . . . 74.129999999999995 111.761 -174.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -87.04 -3.78 59.11 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.229 0.612 . . . . 71.340000000000003 111.684 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 74.4 m -69.18 116.57 9.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.692 0.797 . . . . 62.32 110.555 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -144.85 106.83 4.3 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.786 1.234 . . . . 75.340000000000003 108.389 172.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -127.37 140.38 52.22 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 122.926 0.49 . . . . 74.219999999999999 110.697 -173.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -74.84 -37.78 62.17 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.727 0.642 . . . . 74.319999999999993 110.364 173.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 66.9 p -133.43 165.01 25.85 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.983 0.897 . . . . 44.420000000000002 112.15 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 23.4 tp -70.57 -27.88 64.46 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 113.855 -1.52 . . . . 72.439999999999998 110.999 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.34 -41.84 98.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.079 0.552 . . . . 74.349999999999994 110.22 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -69.03 -42.08 76.85 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.798 -1.092 . . . . 61.310000000000002 110.662 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.04 -42.75 90.97 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.811 0.695 . . . . 72.299999999999997 110.935 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.6 t -76.75 -41.22 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.705 0.802 . . . . 65.340000000000003 110.9 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -59.63 -50.34 74.26 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.358 0.526 . . . . 73.400000000000006 110.161 173.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -53.42 -54.82 31.34 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.696 -1.138 . . . . 73.439999999999998 109.499 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -63.16 -26.22 68.71 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.643 -0.708 . . . . 72.319999999999993 112.012 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 26.8 t -77.77 -21.2 52.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.85 0.46 . . . . 73.209999999999994 111.711 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.9 t -115.43 -18.85 10.9 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.22 1.933 . . . . 74.549999999999997 116.22 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 35.0 m -92.77 143.65 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 120.745 1.611 . . . . 65.319999999999993 114.277 -166.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.38 -1.96 57.45 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.23 2.212 . . . . 73.430000000000007 112.393 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -78.56 13.66 1.54 Allowed 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 128.158 2.583 . . . . 72.439999999999998 114.087 -143.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.21 17.39 4.06 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 123.932 0.777 . . . . 62.219999999999999 111.242 -167.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 52.1 mt -91.3 135.39 33.84 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.093 0.557 . . . . 70.430000000000007 109.742 157.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.401 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 77.3 mt -65.74 -44.8 93.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 O-C-N 124.176 0.922 . . . . 62.520000000000003 109.273 174.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.6 t -138.44 149.32 45.36 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.807 0.443 . . . . 62.039999999999999 109.909 169.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 82.7 p -74.28 156.13 37.51 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 109.076 -0.712 . . . . 75.430000000000007 109.076 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.502 HD23 HD21 ' A' ' 184' ' ' LEU . 38.8 mt -68.6 101.7 1.34 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 108.878 -0.786 . . . . 74.209999999999994 108.878 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -80.05 -57.5 3.6 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.077 0.551 . . . . 72.510000000000005 110.095 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 167' ' ' SER . 7.9 p90 -155.64 152.29 23.99 Favored Pre-proline 0 N--CA 1.484 1.229 0 N-CA-C 109.131 -0.692 . . . . 72.329999999999998 109.131 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.471 ' HB3' ' HA ' ' A' ' 146' ' ' TRP . 58.8 Cg_endo -70.62 138.63 35.49 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 121.666 1.577 . . . . 73.319999999999993 111.438 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -57.99 146.91 66.69 Favored Pre-proline 0 C--O 1.245 0.844 0 CA-C-O 118.671 -0.68 . . . . 73.519999999999996 110.761 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -52.35 118.33 4.51 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.627 2.218 . . . . 72.340000000000003 112.132 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -58.95 159.66 6.81 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.733 -1.122 . . . . 73.329999999999998 110.929 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 62.5 ttt-85 -56.55 -34.55 67.2 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.781 0.832 . . . . 72.409999999999997 111.476 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -78.34 159.63 28.28 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.855 0.862 . . . . 74.340000000000003 109.438 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -64.08 145.01 98.19 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 123.827 0.851 . . . . 75.209999999999994 112.848 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.52 179.96 5.38 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.977 2.451 . . . . 72.299999999999997 110.819 167.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 12.3 t -146.16 -38.34 0.24 Allowed 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 112.645 0.609 . . . . 74.510000000000005 112.645 -175.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.3 p -151.78 145.77 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 118.406 0.548 . . . . 64.030000000000001 110.996 -177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -115.13 104.42 11.84 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.522 1.129 . . . . 74.400000000000006 108.166 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -77.06 110.66 3.08 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-O 119.488 -0.618 . . . . 64.239999999999995 111.67 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 63.7 t -61.29 122.82 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.541 0.736 . . . . 74.109999999999999 109.519 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 20.1 m -92.52 100.08 3.46 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.143 0.977 . . . . 61.340000000000003 109.983 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -70.77 135.2 27.51 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.254 1.969 . . . . 73.150000000000006 112.027 -175.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -140.4 169.57 17.42 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.392 0.677 . . . . 70.140000000000001 109.818 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -111.67 167.97 9.93 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.923 0.889 . . . . 73.319999999999993 109.041 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.51 119.92 10.72 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 110.494 -0.188 . . . . 74.299999999999997 110.494 -176.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -98.37 -25.31 14.86 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.18 0.992 . . . . 74.129999999999995 109.936 -177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 -82.28 167.59 18.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.616 0.767 . . . . 73.409999999999997 111.902 -167.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 C--O 1.254 1.305 0 N-CA-C 108.962 -0.755 . . . . 62.539999999999999 108.962 -179.673 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 109.639 -0.504 . . . . 74.430000000000007 109.639 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 114' ' ' HIS . . . 143.2 70.59 0.02 OUTLIER Glycine 0 C--N 1.345 1.029 0 CA-C-N 116.384 -0.371 . . . . 65.409999999999997 112.735 176.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -133.98 70.09 1.46 Allowed 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 108.207 -1.035 . . . . 54.409999999999997 108.207 175.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.429 HE22 ' HA2' ' A' ' 2' ' ' GLY . 25.5 mp0 -89.37 160.81 41.57 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-N 114.222 -1.354 . . . . 75.409999999999997 109.616 177.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -58.86 -17.16 35.3 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 123.271 2.648 . . . . 75.040000000000006 114.468 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.18 119.55 3.04 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.779 -0.528 . . . . 60.210000000000001 111.779 176.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -74.43 94.26 2.55 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.012 0.434 . . . . 64.310000000000002 109.999 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.4 m -92.15 131.96 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 115.378 -0.828 . . . . 72.329999999999998 109.524 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -108.68 147.4 31.97 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.663 -0.866 . . . . 73.519999999999996 108.663 173.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.91 71.87 0.41 Allowed Glycine 0 C--N 1.349 1.276 0 N-CA-C 111.694 -0.563 . . . . 63.350000000000001 111.694 -175.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -128.27 176.9 7.33 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.561 0.744 . . . . 62.509999999999998 110.734 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.3 -161.29 0.49 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.162 0.985 . . . . 74.120000000000005 111.119 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.404 ' HG3' ' HE2' ' A' ' 89' ' ' TYR . 26.8 ttm-85 -50.0 135.6 20.07 Favored 'General case' 0 C--N 1.362 1.127 0 C-N-CA 123.825 0.85 . . . . 73.430000000000007 110.151 172.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 57.25 71.64 1.08 Allowed Pre-proline 0 CA--C 1.554 1.103 0 O-C-N 124.193 0.933 . . . . 60.219999999999999 109.553 -167.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.444 ' HG2' ' HB3' ' A' ' 133' ' ' ASN . 11.9 Cg_exo -66.39 162.7 35.25 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.211 1.941 . . . . 54.530000000000001 111.137 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.2 p -69.4 168.0 15.37 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.508 0.671 . . . . 65.129999999999995 111.069 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.1 mt -103.31 126.69 31.5 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 115.066 -0.97 . . . . 70.019999999999996 108.538 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.89 167.84 22.1 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.7 2.267 . . . . 63.130000000000003 112.147 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.83 145.2 32.9 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.961 0.41 . . . . 54.039999999999999 110.646 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.657 ' HB3' HD11 ' A' ' 23' ' ' ILE . 75.1 mt -87.6 92.57 9.15 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.465 -0.939 . . . . 75.430000000000007 108.465 177.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -91.14 -46.83 7.88 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.454 -0.943 . . . . 64.219999999999999 108.454 177.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -98.52 110.16 22.8 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.158 -1.383 . . . . 70.019999999999996 109.58 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 20' ' ' LEU . 30.9 mm -116.62 112.12 38.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.673 -0.862 . . . . 75.540000000000006 108.673 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.499 ' HB3' ' HZ2' ' A' ' 129' ' ' TRP . 66.1 tttt -106.26 -23.52 12.54 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.768 -1.106 . . . . 72.519999999999996 109.187 173.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.52 -75.62 2.21 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 110.926 -0.869 . . . . 44.149999999999999 110.926 -176.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.42 141.9 3.76 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.938 0.895 . . . . 72.450000000000003 110.064 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.46 -110.35 1.65 Allowed Glycine 0 C--N 1.35 1.347 0 N-CA-C 111.968 -0.453 . . . . 54.439999999999998 111.968 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -88.4 153.0 21.53 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.623 0.769 . . . . 74.140000000000001 110.924 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -102.54 16.54 26.07 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.828 0.451 . . . . 74.120000000000005 110.228 171.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -117.83 144.16 45.63 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.62 0.768 . . . . 73.219999999999999 110.462 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.4 t -164.3 23.55 0.07 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.985 0.914 . . . . 53.149999999999999 109.265 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.8 m 62.63 23.42 13.93 Favored 'General case' 0 C--N 1.372 1.577 0 C-N-CA 124.441 1.096 . . . . 54.420000000000002 110.591 -169.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -68.96 161.48 28.77 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.478 1.111 . . . . 64.319999999999993 112.852 -170.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -165.3 178.57 6.8 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.279 -0.873 . . . . 74.439999999999998 109.955 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.28 -166.61 10.96 Favored Glycine 0 C--O 1.243 0.677 0 N-CA-C 110.526 -1.03 . . . . 74.530000000000001 110.526 173.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.92 -153.23 6.42 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-O 118.946 -0.919 . . . . 65.019999999999996 111.91 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.6 ' HG2' ' SG ' ' A' ' 39' ' ' CYS . 60.1 Cg_endo -68.55 174.68 8.04 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 123.103 2.535 . . . . 73.430000000000007 111.964 -176.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -86.65 57.01 4.26 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 121.465 0.65 . . . . 72.420000000000002 110.014 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.6 ' SG ' ' HG2' ' A' ' 37' ' ' PRO . 77.8 m -72.32 -31.41 65.66 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.33 0.652 . . . . 64.5 111.133 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -92.41 125.65 37.16 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.606 -0.516 . . . . 72.450000000000003 109.606 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.5 m -78.12 65.92 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-O 122.06 0.933 . . . . 71.040000000000006 110.132 173.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' A' ' 105' ' ' GLU . 66.7 t80 -70.2 116.86 11.05 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.696 -1.138 . . . . 44.43 109.98 -175.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' A' ' 71' ' ' GLU . 22.1 m -122.91 163.15 22.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 C-N-CA 124.359 1.063 . . . . 64.120000000000005 108.832 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.9 176.38 9.34 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.736 0.303 . . . . 74.230000000000004 110.692 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -153.14 113.24 3.95 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 109.723 -0.473 . . . . 70.319999999999993 109.723 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -80.84 155.56 26.54 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.733 0.413 . . . . 74.319999999999993 109.981 171.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.14 116.41 18.42 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.929 0.492 . . . . 62.039999999999999 110.342 -173.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.09 86.18 1.04 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.751 -0.833 . . . . 65.150000000000006 108.751 166.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -118.21 149.63 40.77 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.336 -0.987 . . . . 53.43 108.336 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.481 ' H ' ' HD2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -110.17 94.79 19.14 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.029 0.931 . . . . 75.120000000000005 108.904 177.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -88.37 -5.24 6.51 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.963 2.442 . . . . 74.540000000000006 112.674 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.5 p -145.53 14.77 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.053 0.941 . . . . 73.329999999999998 109.839 -173.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.11 165.75 26.95 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.754 0.422 . . . . 42.100000000000001 111.209 -172.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.5 p -137.48 144.32 42.17 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.869 0.868 . . . . 73.420000000000002 110.164 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -84.66 90.84 7.78 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.287 0.635 . . . . 52.43 111.087 -174.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -116.94 126.74 53.4 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.226 -1.027 . . . . 72.329999999999998 108.226 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 62.83 72.47 0.59 Allowed Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.552 1.141 . . . . 74.200000000000003 110.384 -171.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.58 65.7 4.69 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.659 2.906 . . . . 72.239999999999995 111.553 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -73.7 87.52 1.7 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.366 1.067 . . . . 74.230000000000004 111.025 -173.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.98 53.08 4.78 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.487 -0.645 . . . . 72.450000000000003 111.487 176.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.8 mt -56.35 -48.85 75.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.619 1.168 . . . . 64.219999999999999 110.767 -173.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.2 t -149.36 116.19 5.95 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.957 -1.127 . . . . 74.209999999999994 107.957 172.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -132.79 134.01 44.16 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 109.335 -0.617 . . . . 73.409999999999997 109.335 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.6 88.35 2.19 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.752 -1.203 . . . . 72.230000000000004 107.752 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.83 74.19 8.83 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.832 -0.803 . . . . 70.409999999999997 108.832 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -84.15 116.56 22.97 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 115.649 -0.705 . . . . 75.019999999999996 109.964 -175.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -98.32 159.82 14.7 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.353 0.661 . . . . 73.510000000000005 110.37 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -93.7 -58.64 2.21 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 106.955 -1.498 . . . . 73.129999999999995 106.955 165.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.3 m 60.59 26.19 15.89 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.652 1.581 . . . . 73.200000000000003 111.066 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -128.21 105.43 8.35 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.26 1.024 . . . . 74.409999999999997 108.37 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.434 ' HB2' HG12 ' A' ' 43' ' ' VAL . 42.9 mt-10 -150.34 -179.92 7.6 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.25 1.42 . . . . 75.049999999999997 108.505 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -136.99 80.43 1.81 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.89 -0.782 . . . . 65.310000000000002 108.89 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.3 mt -96.42 -160.47 0.8 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.229 0.612 . . . . 60.219999999999999 110.628 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.2 mt -69.62 152.58 44.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.444 0.697 . . . . 71.109999999999999 112.361 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.12 172.4 12.44 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.865 0.866 . . . . 53.420000000000002 111.512 -173.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 168.9 70.82 0.03 OUTLIER Glycine 0 CA--C 1.535 1.338 0 CA-C-N 115.245 -0.888 . . . . 43.149999999999999 111.574 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.81 -39.48 1.29 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.24 2.627 . . . . 73.299999999999997 111.633 176.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 p -96.19 75.97 3.02 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.516 1.126 . . . . 55.450000000000003 108.3 175.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -101.88 -44.44 5.51 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.747 -1.115 . . . . 70.329999999999998 108.841 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.0 m120 66.52 8.91 6.14 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.906 1.446 . . . . 71.129999999999995 114.906 162.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.24 146.88 69.03 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 112.758 0.651 . . . . 65.019999999999996 112.758 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.21 -48.62 4.58 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.546 2.164 . . . . 64.329999999999998 111.58 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -96.65 56.2 1.48 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.927 -0.768 . . . . 75.230000000000004 108.927 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.723 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 24.8 tp -89.11 115.48 26.67 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.952 -0.758 . . . . 74.439999999999998 108.952 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -104.41 175.71 5.4 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.188 1.795 . . . . 71.329999999999998 109.327 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.96 146.52 33.83 Favored 'Isoleucine or valine' 0 C--O 1.256 1.447 0 N-CA-C 108.314 -0.995 . . . . 53.109999999999999 108.314 171.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.43 110.46 12.22 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 123.816 0.698 . . . . 60.109999999999999 110.048 173.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 90.3 mt -69.35 -28.55 66.31 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.481 1.112 . . . . 70.329999999999998 111.587 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.472 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 64.7 m-85 -135.43 152.66 51.6 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.054 -1.091 . . . . 64.0 108.054 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -71.37 146.02 49.02 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.167 -0.679 . . . . 72.319999999999993 109.167 169.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -149.37 108.25 3.87 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.165 -1.05 . . . . 71.519999999999996 108.165 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.47 133.93 28.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.133 -1.062 . . . . 70.109999999999999 108.133 170.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.401 ' HB2' ' N ' ' A' ' 100' ' ' SER . . . -64.86 128.9 37.72 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.837 0.455 . . . . 63.329999999999998 110.535 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.0 m -86.58 12.36 10.68 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.134 0.974 . . . . 75.400000000000006 111.215 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.58 179.34 37.9 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 110.586 -1.006 . . . . 74.129999999999995 110.586 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.81 -28.68 67.79 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.947 0.499 . . . . 72.329999999999998 110.689 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -68.09 -23.94 64.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.855 0.862 . . . . 73.310000000000002 111.798 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.2 p -103.98 158.51 16.37 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.36 0.664 . . . . 71.319999999999993 110.484 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.507 HD21 HG23 ' A' ' 123' ' ' THR . 49.8 tp -114.49 123.45 49.44 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.206 0.602 . . . . 65.319999999999993 110.488 -178.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.401 ' N ' ' HB2' ' A' ' 93' ' ' ALA . 27.0 p -67.55 119.52 12.47 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.537 0.735 . . . . 74.400000000000006 109.807 173.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.482 HG22 HG21 ' A' ' 123' ' ' THR . 38.2 pt -128.53 129.27 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.483 -0.932 . . . . 64.329999999999998 108.483 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.7 m -95.64 137.85 34.13 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.457 -0.571 . . . . 71.400000000000006 109.457 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -51.16 119.25 3.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.54 0.736 . . . . 70.019999999999996 111.471 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.97 -3.46 48.47 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 116.015 -0.539 . . . . 71.310000000000002 113.198 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.413 ' HB2' ' HE2' ' A' ' 42' ' ' PHE . 59.0 tt0 -86.05 143.98 27.8 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 117.411 0.606 . . . . 73.109999999999999 110.101 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.537 ' HB3' HD11 ' A' ' 84' ' ' LEU . 56.9 mttm -81.91 135.96 35.36 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.205 1.002 . . . . 63.049999999999997 109.157 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.466 ' HA ' HG22 ' A' ' 123' ' ' THR . 14.8 mt -126.98 135.41 50.82 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 107.99 -1.115 . . . . 74.450000000000003 107.99 -168.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -98.69 108.96 21.77 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.857 0.753 . . . . 74.329999999999998 109.141 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 88.0 t -98.24 113.91 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 118.77 0.714 . . . . 70.140000000000001 109.82 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.37 -37.88 68.66 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.835 0.854 . . . . 71.030000000000001 110.238 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.3 176.22 47.88 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.245 -0.889 . . . . 43.100000000000001 111.708 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 0.8 OUTLIER -98.98 174.42 6.36 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.515 -0.92 . . . . 61.030000000000001 108.515 176.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -74.61 165.71 24.76 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.801 0.44 . . . . 71.230000000000004 110.341 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.495 ' HB3' ' HA3' ' A' ' 2' ' ' GLY . 22.1 m-70 -58.9 -34.3 71.5 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.21 1.004 . . . . 70.409999999999997 111.632 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.402 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 55.0 t30 -107.21 7.33 29.38 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.87 0.868 . . . . 74.519999999999996 110.253 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.654 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 61.22 24.08 62.87 Favored Glycine 0 C--N 1.356 1.69 0 CA-C-N 115.66 -0.7 . . . . 50.409999999999997 114.407 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.402 ' HG3' ' HB3' ' A' ' 115' ' ' ASN . 15.6 mt-10 -69.66 -58.25 4.16 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.257 1.027 . . . . 64.430000000000007 108.689 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -112.4 -179.39 3.66 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.355 -1.748 . . . . 62.240000000000002 108.778 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -142.45 124.26 15.14 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.701 0.801 . . . . 40.210000000000001 108.854 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -72.39 100.91 2.78 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 109.403 -0.592 . . . . 70.430000000000007 109.403 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.7 170.11 8.56 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.316 -0.856 . . . . 61.420000000000002 111.246 -177.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.426 ' HG3' ' HB2' ' A' ' 127' ' ' GLN . 44.4 tt0 -148.03 125.13 11.4 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.342 -1.355 . . . . 72.310000000000002 107.342 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.507 HG23 HD21 ' A' ' 99' ' ' LEU . 67.7 p -128.27 -175.02 3.38 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.852 0.835 . . . . 62.109999999999999 111.585 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -64.13 -23.83 67.46 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 113.85 -1.523 . . . . 75.109999999999999 109.722 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -85.79 -4.7 59.23 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.697 1.199 . . . . 63.32 111.931 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 131.19 -131.57 6.46 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-O 120.034 -0.314 . . . . 61.329999999999998 112.393 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.426 ' HB2' ' HG3' ' A' ' 122' ' ' GLN . 61.0 tt0 -152.21 153.18 33.29 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.444 0.698 . . . . 74.400000000000006 110.363 177.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.74 -170.0 38.14 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 112.187 -0.365 . . . . 71.319999999999993 112.187 176.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.499 ' HZ2' ' HB3' ' A' ' 24' ' ' LYS . 77.2 m95 -96.0 129.72 43.19 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.422 0.689 . . . . 74.450000000000003 110.494 -176.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 99' ' ' LEU . 30.7 m -121.4 148.33 49.64 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 124.25 1.02 . . . . 63.439999999999998 109.915 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.27 132.67 19.75 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 121.868 1.712 . . . . 63.329999999999998 111.244 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.6 m -62.05 -18.59 61.1 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.987 0.915 . . . . 74.150000000000006 112.758 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.444 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 71.6 m-20 -72.91 -23.38 60.7 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.015 0.926 . . . . 73.019999999999996 111.742 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.472 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.2 m-85 -96.74 -0.42 48.21 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.541 0.736 . . . . 74.400000000000006 112.179 -174.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.1 pt -129.15 154.23 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 122.879 0.471 . . . . 75.319999999999993 110.552 -173.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.1 t -154.35 138.57 11.2 Favored Pre-proline 0 N--CA 1.491 1.611 0 CA-C-O 119.467 -0.301 . . . . 70.219999999999999 110.801 172.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.461 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 56.6 Cg_endo -69.47 130.92 20.57 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 122.594 2.196 . . . . 74.409999999999997 113.267 -175.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.3 m -108.37 -58.63 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.802 0.841 . . . . 74.129999999999995 110.733 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.723 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.6 t30 -93.49 1.13 56.9 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.205 0.602 . . . . 72.209999999999994 110.957 -174.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 25.5 t -73.84 -178.43 3.22 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.022 0.529 . . . . 74.439999999999998 109.883 173.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.0 mt -58.03 -18.66 25.74 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.886 0.874 . . . . 62.030000000000001 112.933 -174.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.589 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 29.7 tt0 -64.69 -14.49 58.62 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.298 1.039 . . . . 71.239999999999995 112.137 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.67 -21.86 55.51 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.81 0.844 . . . . 73.430000000000007 111.037 173.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -100.4 139.06 36.62 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.095 -0.705 . . . . 73.239999999999995 109.095 170.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.9 p -63.57 -12.41 32.52 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.182 1.178 . . . . 54.219999999999999 114.182 -171.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -75.93 -42.28 49.27 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 111.814 0.301 . . . . 74.430000000000007 111.814 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 29.0 t80 -89.74 139.31 30.7 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.434 -0.58 . . . . 74.109999999999999 109.434 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.589 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 72.3 m-70 -131.23 16.75 5.02 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.469 0.544 . . . . 75.099999999999994 112.469 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 72.44 -159.04 53.53 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-O 119.466 -0.63 . . . . 62.200000000000003 114.44 174.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 68.5 Cg_endo -72.07 109.6 2.74 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.322 2.681 . . . . 73.25 111.848 176.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.562 ' HB ' ' HD3' ' A' ' 171' ' ' ARG . 6.5 t -136.92 155.56 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.258 0.551 . . . . 64.329999999999998 111.076 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.2 m -68.26 148.56 50.63 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 124.909 1.283 . . . . 60.229999999999997 111.803 171.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -30.56 70.77 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.744 0.818 . . . . 62.240000000000002 111.09 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.89 -52.75 54.81 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.215 0.606 . . . . 71.129999999999995 109.934 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.83 87.09 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.55 0.74 . . . . 63.130000000000003 111.042 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.53 ' HB2' ' HD2' ' A' ' 171' ' ' ARG . . . -55.41 -59.6 4.59 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.166 -0.925 . . . . 75.109999999999999 111.337 173.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.631 ' HG3' HG11 ' A' ' 190' ' ' VAL . 33.0 tt0 -64.84 -28.19 69.39 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.31 -0.859 . . . . 61.140000000000001 111.29 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -66.43 -50.82 62.13 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.295 1.038 . . . . 75.120000000000005 110.964 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.78 -40.05 84.0 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.933 -0.576 . . . . 71.0 110.919 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.667 HD23 HG13 ' A' ' 190' ' ' VAL . 37.4 tp -68.53 -29.16 67.68 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.485 -0.779 . . . . 72.409999999999997 112.227 -177.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 13.2 t -62.63 -23.25 66.97 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.538 0.735 . . . . 71.430000000000007 110.856 177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.8 m -82.43 -20.5 36.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.046 0.938 . . . . 72.040000000000006 110.968 176.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.73 -175.43 23.61 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.932 -0.576 . . . . 70.439999999999998 112.851 175.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.4 pt -141.04 -165.92 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 124.988 1.315 . . . . 54.200000000000003 111.159 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.731 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 14.6 p-10 -52.52 106.06 0.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.532 1.133 . . . . 64.549999999999997 113.487 -175.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.22 13.3 52.72 Favored Glycine 0 C--O 1.257 1.543 0 CA-C-N 116.132 -0.486 . . . . 74.209999999999994 113.497 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 74.1 m -80.56 140.12 35.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.971 0.386 . . . . 72.120000000000005 110.684 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 183' ' ' SER . 23.1 p90 -136.73 159.66 41.16 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.441 0.639 . . . . 64.239999999999995 112.584 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.592 HD22 HH21 ' A' ' 171' ' ' ARG . 91.5 mt -136.29 133.31 36.81 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.608 -1.178 . . . . 73.150000000000006 108.266 170.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 22.6 t -114.98 127.05 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 107.616 -1.253 . . . . 71.409999999999997 107.616 176.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.592 HH21 HD22 ' A' ' 169' ' ' LEU . 14.7 ptp180 -162.1 148.88 13.67 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.452 0.301 . . . . 72.140000000000001 111.041 -176.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 15.5 pt-20 -93.53 165.8 12.57 Favored 'General case' 0 C--O 1.253 1.248 0 CA-C-O 121.398 0.618 . . . . 72.25 111.693 -178.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.7 t -73.36 154.42 40.08 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.339 -1.3 . . . . 53.310000000000002 111.087 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -77.73 -40.02 42.54 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.39 -1.277 . . . . 73.439999999999998 110.653 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.654 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 72.5 p -100.62 -14.12 18.29 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.327 0.651 . . . . 72.010000000000005 112.446 -175.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 46.9 m -124.28 101.72 34.34 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.021 0.528 . . . . 73.310000000000002 110.439 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.74 131.65 28.22 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.226 2.618 . . . . 72.040000000000006 112.111 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.33 -24.04 8.91 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 116.237 -0.438 . . . . 53.43 113.882 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -75.19 118.2 17.85 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.207 -1.034 . . . . 64.129999999999995 108.207 172.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.576 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 82.9 mtt85 -123.29 172.86 8.32 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.274 0.63 . . . . 63.420000000000002 111.074 -169.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 15.9 m -147.51 144.45 28.56 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.039 0.936 . . . . 62.229999999999997 109.461 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.424 HG12 HG22 ' A' ' 170' ' ' VAL . 52.1 mt -119.06 139.58 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 107.967 -1.123 . . . . 74.25 107.967 167.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 17.5 m -119.82 122.78 42.11 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.196 -1.038 . . . . 44.32 108.196 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.511 HD21 HD23 ' A' ' 232' ' ' LEU . 59.6 mt -105.45 142.18 35.65 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.367 1.067 . . . . 62.5 111.593 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 20.4 ttt180 -128.56 131.47 48.21 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-N 115.05 -0.977 . . . . 75.299999999999997 109.473 169.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.731 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 3.4 p90 -150.83 142.08 23.25 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.215 -1.032 . . . . 71.310000000000002 108.215 171.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 58.44 18.89 5.99 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 124.164 0.986 . . . . 74.230000000000004 113.343 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.56 12.12 73.17 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 122.882 0.277 . . . . 45.32 113.157 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 4.0 tpm_? -105.14 124.01 48.8 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.37 1.068 . . . . 72.439999999999998 109.151 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.667 HG13 HD23 ' A' ' 160' ' ' LEU . 98.3 t -112.9 110.41 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.145 0.978 . . . . 34.43 110.177 -177.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.466 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 30.6 p90 -125.85 156.63 39.3 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.533 0.733 . . . . 75.540000000000006 109.245 175.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -131.82 146.94 52.42 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.714 0.806 . . . . 63.420000000000002 109.044 -167.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -145.06 148.74 34.02 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.811 0.444 . . . . 75.450000000000003 110.429 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 15.4 tpp180 -89.94 138.36 31.57 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.525 0.73 . . . . 73.340000000000003 110.817 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.4 HD11 HG13 ' A' ' 182' ' ' ILE . 84.7 mt -88.99 120.47 37.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.217 -1.031 . . . . 71.420000000000002 108.217 165.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.1 m-20 -95.86 137.5 34.84 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.004 0.922 . . . . 55.109999999999999 109.358 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 25.8 m -105.24 110.46 22.83 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.339 0.656 . . . . 43.140000000000001 109.478 176.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.81 171.93 1.91 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.495 1.118 . . . . 73.310000000000002 112.041 173.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.4 p -67.07 -29.24 68.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.375 0.67 . . . . 74.140000000000001 111.966 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -71.21 -17.79 62.49 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.028 0.531 . . . . 63.520000000000003 111.282 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 103.5 -5.99 48.89 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 111.786 -0.526 . . . . 72.340000000000003 111.786 -171.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -64.16 130.7 44.96 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.728 0.811 . . . . 73.150000000000006 111.797 -177.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 89.4 mt -89.51 147.33 24.03 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.101 -0.703 . . . . 72.140000000000001 109.101 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -165.2 161.75 19.56 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.586 0.554 . . . . 75.349999999999994 110.724 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.75 -46.75 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.925 0.89 . . . . 74.0 109.844 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.622 ' H ' ' HB2' ' A' ' 209' ' ' SER . 27.1 t -139.12 -172.73 3.4 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.559 0.743 . . . . 73.430000000000007 110.397 -170.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.9 m -60.62 -49.05 79.09 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.706 1.202 . . . . 54.539999999999999 113.826 -167.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -85.81 -0.08 54.33 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.023 0.529 . . . . 74.549999999999997 110.832 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.622 ' HB2' ' H ' ' A' ' 206' ' ' SER . 72.4 m -97.84 106.62 18.95 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.6 0.76 . . . . 74.209999999999994 110.711 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -145.23 118.37 8.88 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 125.145 1.378 . . . . 74.150000000000006 107.759 170.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -136.85 145.67 44.7 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 118.095 0.407 . . . . 71.430000000000007 111.736 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -87.57 -21.65 25.27 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 123.743 0.652 . . . . 75.510000000000005 109.919 168.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 72.2 p -135.34 148.76 49.54 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-O 121.697 0.761 . . . . 71.140000000000001 112.02 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 38.1 tp -66.79 -27.68 67.77 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.334 -1.303 . . . . 65.450000000000003 111.105 176.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.98 -50.0 75.74 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.69 0.796 . . . . 75.319999999999993 110.781 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -69.93 -32.49 70.79 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.056 -0.975 . . . . 75.310000000000002 110.807 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.45 -48.78 78.25 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.315 0.384 . . . . 73.420000000000002 110.811 172.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 56.0 t -68.77 -42.43 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.751 0.821 . . . . 71.319999999999993 110.443 -176.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -58.81 -52.79 64.2 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.799 0.809 . . . . 65.430000000000007 111.594 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.431 ' O ' HG22 ' A' ' 224' ' ' VAL . 48.2 t60 -55.05 -50.07 70.04 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.408 -1.269 . . . . 73.129999999999995 109.783 177.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -65.16 -24.92 67.53 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.686 -0.688 . . . . 75.209999999999994 112.112 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.4 m -73.13 -27.87 61.93 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.034 -0.416 . . . . 64.209999999999994 110.983 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 15.2 t -110.12 -14.52 14.19 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.659 2.096 . . . . 64.319999999999993 116.659 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 220' ' ' HIS . 27.0 m -99.84 156.97 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 N-CA-C 115.925 1.824 . . . . 72.0 115.925 -166.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.47 -0.25 57.59 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 110.738 -2.937 . . . . 71.540000000000006 113.358 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -77.89 13.05 1.48 Allowed 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 128.436 2.694 . . . . 74.239999999999995 113.371 -144.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.16 17.99 4.33 Favored Glycine 0 N--CA 1.46 0.286 0 C-N-CA 124.802 1.191 . . . . 62.409999999999997 111.183 -169.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 91.4 mt -92.51 117.25 29.75 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 113.832 -1.184 . . . . 43.32 109.767 163.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.466 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 85.6 mt -63.01 -41.2 91.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.481 0.712 . . . . 75.420000000000002 109.322 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.0 t -129.66 142.66 50.69 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.46 -0.941 . . . . 73.219999999999999 108.46 165.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 63.5 p -71.28 156.42 39.55 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 109.359 -0.608 . . . . 73.540000000000006 109.359 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.511 HD23 HD21 ' A' ' 184' ' ' LEU . 25.0 mt -65.92 103.6 0.96 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.913 -0.773 . . . . 62.020000000000003 108.913 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.0 -49.53 7.28 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.159 0.583 . . . . 72.329999999999998 109.579 -176.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.602 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -161.66 144.44 9.11 Favored Pre-proline 0 N--CA 1.492 1.636 0 C-N-CA 123.177 0.591 . . . . 71.230000000000004 112.418 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.65 140.08 18.49 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.724 1.616 . . . . 72.140000000000001 112.461 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -66.96 120.72 73.87 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 108.847 -0.797 . . . . 73.319999999999993 108.847 172.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.07 145.0 59.65 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 121.952 1.768 . . . . 72.099999999999994 112.095 -175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -64.41 152.63 40.99 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 109.188 -0.671 . . . . 72.329999999999998 109.188 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -58.62 -28.31 65.52 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.09 0.556 . . . . 70.040000000000006 112.24 -173.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -96.94 75.87 2.69 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.079 -0.711 . . . . 62.310000000000002 109.079 170.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -173.9 133.11 0.57 Allowed Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 114.871 -1.059 . . . . 64.030000000000001 109.453 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -64.24 135.39 46.55 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.806 2.337 . . . . 74.319999999999993 112.063 169.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 9.1 t -75.63 162.67 28.06 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.274 0.629 . . . . 70.239999999999995 110.35 174.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.5 p -129.86 128.0 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.108 0.563 . . . . 61.439999999999998 109.958 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -110.35 98.64 7.82 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.202 1.001 . . . . 74.109999999999999 108.562 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -106.74 110.85 3.39 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 119.277 -0.735 . . . . 53.140000000000001 111.902 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.78 148.6 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 117.364 0.582 . . . . 44.219999999999999 109.565 170.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 21.5 m -146.94 139.36 14.04 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.159 0.584 . . . . 61.439999999999998 109.591 -175.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.04 132.07 28.93 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.404 2.069 . . . . 64.400000000000006 110.882 173.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -68.03 -64.73 0.8 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 119.117 -0.468 . . . . 54.100000000000001 111.007 -174.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 40.1 t80 45.54 36.53 2.57 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.872 1.269 . . . . 71.129999999999995 111.071 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -74.48 124.71 27.08 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.044 -0.98 . . . . 63.009999999999998 110.814 -173.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -71.84 147.45 47.16 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 123.413 0.685 . . . . 75.439999999999998 109.163 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -72.2 142.85 49.02 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.705 -0.85 . . . . 64.420000000000002 108.705 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 CA--C 1.553 1.07 0 C-N-CA 123.718 0.807 . . . . 65.200000000000003 111.408 -175.766 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 mmt . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 109.465 -0.569 . . . . 73.239999999999995 109.465 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.68 146.75 6.01 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 111.783 -0.527 . . . . 53.340000000000003 111.783 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -124.17 121.43 35.07 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.291 1.036 . . . . 74.530000000000001 109.513 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -95.26 127.05 43.83 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.675 0.79 . . . . 63.149999999999999 110.248 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -67.73 -21.76 44.53 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.924 2.416 . . . . 75.099999999999994 112.386 172.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.31 177.95 50.57 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.572 0.545 . . . . 74.219999999999999 112.607 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -81.05 121.29 25.88 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.626 -0.509 . . . . 70.420000000000002 109.626 175.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.4 m -63.78 131.46 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.1 0.56 . . . . 74.420000000000002 111.045 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -80.08 137.17 36.71 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.656 -0.498 . . . . 74.450000000000003 109.656 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.99 76.26 0.03 OUTLIER Glycine 0 C--N 1.342 0.877 0 N-CA-C 112.192 -0.363 . . . . 61.409999999999997 112.192 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -161.02 144.74 13.26 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.617 -0.512 . . . . 75.109999999999999 109.617 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -79.45 -28.56 41.61 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.412 0.685 . . . . 75.540000000000006 111.253 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -137.58 135.37 36.59 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.89 -0.782 . . . . 74.209999999999994 108.89 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.6 mmm-85 57.27 71.16 1.16 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.541 0.736 . . . . 70.5 109.715 -170.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -69.75 166.24 28.24 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.088 1.859 . . . . 60.43 110.72 177.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.9 m -65.1 166.36 9.67 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 120.864 0.364 . . . . 74.409999999999997 111.476 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.7 mt -103.46 126.57 31.73 Favored Pre-proline 0 C--O 1.239 0.518 0 N-CA-C 109.014 -0.735 . . . . 72.439999999999998 109.014 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.16 169.75 21.87 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.999 2.466 . . . . 65.120000000000005 111.954 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.54 149.94 32.96 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.903 0.481 . . . . 60.32 110.551 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.57 ' HB3' HD11 ' A' ' 23' ' ' ILE . 80.7 mt -86.14 94.52 9.3 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.686 -0.857 . . . . 71.420000000000002 108.686 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -97.34 -48.76 5.19 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.047 -0.979 . . . . 72.409999999999997 110.667 -177.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.611 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 60.4 m-85 -103.65 108.52 19.84 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.953 -0.758 . . . . 72.230000000000004 108.953 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.57 HD11 ' HB3' ' A' ' 20' ' ' LEU . 37.7 mm -118.6 112.94 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.863 0.865 . . . . 73.140000000000001 110.226 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.94 73.14 0.53 Allowed 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 124.229 1.012 . . . . 75.030000000000001 108.552 167.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.02 77.92 1.61 Allowed Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.704 -0.559 . . . . 72.420000000000002 111.704 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -170.5 134.17 1.1 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.95 0.9 . . . . 64.310000000000002 110.28 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.63 104.95 1.02 Allowed Glycine 0 C--N 1.349 1.293 0 N-CA-C 110.285 -1.126 . . . . 74.030000000000001 110.285 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -73.37 -60.63 2.15 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.048 0.539 . . . . 64.510000000000005 110.608 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -120.34 6.35 10.68 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.674 0.79 . . . . 73.329999999999998 110.989 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -72.09 170.31 14.2 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.912 0.885 . . . . 71.310000000000002 109.6 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.4 t -58.72 88.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.601 0.715 . . . . 55.210000000000001 111.785 -174.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.4 m -96.59 90.27 5.28 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.99 -1.005 . . . . 71.439999999999998 109.0 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -142.3 103.93 4.35 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.029 -0.987 . . . . 63.140000000000001 108.386 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -72.91 84.33 1.24 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.921 0.888 . . . . 72.420000000000002 110.895 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -93.28 -179.24 39.79 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 114.916 -1.038 . . . . 71.120000000000005 113.045 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.72 -157.01 53.54 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 123.988 0.464 . . . . 64.129999999999995 113.927 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -99.17 -157.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 123.662 2.908 . . . . 61.229999999999997 111.815 171.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -108.05 -174.49 2.54 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.532 0.733 . . . . 74.530000000000001 109.716 169.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.5 t -92.38 -163.06 0.99 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.569 1.147 . . . . 75.319999999999993 108.574 170.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -81.7 29.47 0.38 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.413 0.685 . . . . 73.340000000000003 111.111 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.2 75.78 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 CA-C-O 122.939 1.352 . . . . 72.400000000000006 110.283 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.585 ' HB3' HD11 ' A' ' 73' ' ' LEU . 5.2 p90 -118.36 4.69 11.83 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.949 -1.478 . . . . 64.200000000000003 108.971 167.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.5 m -96.81 135.61 30.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 124.173 0.989 . . . . 64.439999999999998 109.995 -177.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -72.43 149.76 43.94 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.578 0.751 . . . . 61.399999999999999 110.488 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -124.59 156.31 37.64 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.761 -0.829 . . . . 74.340000000000003 108.761 171.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -75.53 127.81 33.92 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 123.462 0.476 . . . . 73.030000000000001 110.288 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.61 113.67 20.09 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.738 0.815 . . . . 70.310000000000002 109.032 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.1 mt -94.57 175.71 6.57 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.611 0.719 . . . . 63.509999999999998 110.893 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -136.23 -167.5 2.06 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.653 -1.158 . . . . 73.420000000000002 108.753 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 63.22 78.85 0.27 Allowed Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 124.46 1.104 . . . . 74.129999999999995 112.294 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.01 167.43 12.6 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.588 2.192 . . . . 72.030000000000001 111.631 169.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.0 t -74.92 98.26 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 109.304 -0.628 . . . . 71.439999999999998 109.304 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.6 141.93 53.63 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.604 -0.725 . . . . 53.240000000000002 110.416 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.2 p -66.97 138.33 57.18 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.706 0.802 . . . . 73.010000000000005 111.166 -176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -58.71 -60.83 3.21 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.732 0.813 . . . . 53.399999999999999 109.657 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -77.38 140.89 40.02 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.918 0.887 . . . . 72.329999999999998 108.858 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 59.75 71.43 0.91 Allowed Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.086 0.954 . . . . 71.439999999999998 111.195 -170.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -82.18 1.23 9.33 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.001 2.467 . . . . 74.409999999999997 112.816 174.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -61.86 98.2 0.09 Allowed 'General case' 0 C--N 1.349 0.564 0 C-N-CA 125.164 1.385 . . . . 62.210000000000001 110.779 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.73 144.46 10.77 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 111.494 -0.642 . . . . 63.530000000000001 111.494 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.5 mt -112.49 112.72 24.47 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.262 0.625 . . . . 65.409999999999997 109.726 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.4 m -90.16 71.38 7.28 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.834 -0.802 . . . . 75.129999999999995 108.834 173.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.78 151.39 40.63 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.0 -1.0 . . . . 71.239999999999995 110.253 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.6 163.94 23.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.099 0.559 . . . . 62.229999999999997 110.329 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -158.05 152.03 24.07 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.812 0.845 . . . . 70.200000000000003 109.758 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -84.8 99.05 10.63 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.347 -0.612 . . . . 63.439999999999998 109.347 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 45.2 t-105 -74.14 110.23 8.27 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.51 0.724 . . . . 74.239999999999995 110.07 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -120.73 94.2 4.28 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.632 0.729 . . . . 64.540000000000006 110.098 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 54.0 m -83.35 80.06 9.21 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.92 -0.77 . . . . 74.239999999999995 108.92 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -96.76 -179.17 4.49 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.474 -0.784 . . . . 62.219999999999999 111.259 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -65.91 -65.15 0.71 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.326 -0.852 . . . . 65.140000000000001 111.475 -173.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 59.77 20.25 9.04 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.51 1.124 . . . . 63.409999999999997 110.668 -173.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.585 HD11 ' HB3' ' A' ' 42' ' ' PHE . 91.5 mt -73.63 76.82 1.51 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.184 0.994 . . . . 65.040000000000006 110.005 -175.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.7 mt -119.11 154.76 32.72 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.772 0.829 . . . . 64.299999999999997 110.048 -173.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.36 165.35 27.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.26 1.024 . . . . 42.43 109.076 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.46 -70.57 0.31 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-O 118.884 -0.954 . . . . 50.310000000000002 112.088 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.84 90.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.391 2.773 0 C-N-CA 123.983 3.122 . . . . 70.239999999999995 113.995 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.7 p -106.41 48.48 0.84 Allowed 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.863 1.265 . . . . 74.340000000000003 107.986 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.45 140.52 58.05 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.525 -1.216 . . . . 71.450000000000003 109.929 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -65.28 -84.36 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 O-C-N 124.471 1.107 . . . . 72.340000000000003 111.539 -166.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 62.19 157.72 0.12 Allowed Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 124.476 1.11 . . . . 73.310000000000002 113.173 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.35 -25.44 56.58 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.09 1.86 . . . . 75.209999999999994 111.161 168.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -104.62 80.69 1.69 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.504 1.122 . . . . 62.210000000000001 110.252 -177.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 35.0 tp -128.06 112.77 14.97 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.114 -0.699 . . . . 61.149999999999999 109.114 167.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -116.1 173.91 6.32 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.379 1.472 . . . . 73.540000000000006 110.043 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.5 p -147.56 144.85 19.33 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 C-N-CA 124.281 1.033 . . . . 74.230000000000004 108.674 171.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.544 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -81.73 128.68 34.23 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.711 0.404 . . . . 71.109999999999999 110.161 175.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.8 mt -86.15 -20.57 28.43 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.513 0.725 . . . . 72.030000000000001 110.837 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.554 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 74.9 m-85 -130.59 158.38 40.16 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.782 0.833 . . . . 60.25 109.335 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -83.55 140.23 32.39 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.757 -0.831 . . . . 63.25 108.757 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -155.13 111.91 3.26 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.676 -0.861 . . . . 72.230000000000004 108.676 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.43 140.67 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 109.304 -0.628 . . . . 73.409999999999997 109.304 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.21 115.95 2.75 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.336 0.654 . . . . 74.150000000000006 110.623 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.0 p -72.21 -27.93 62.86 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.535 0.734 . . . . 73.150000000000006 110.392 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -152.91 -173.36 22.19 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 114.85 -1.068 . . . . 43.439999999999998 110.984 175.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.22 -28.89 65.63 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.306 0.643 . . . . 64.340000000000003 110.855 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.477 HD22 HD12 ' A' ' 23' ' ' ILE . 26.1 p-10 -70.02 -22.42 63.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.567 1.147 . . . . 71.420000000000002 111.967 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 74.3 p -105.77 160.92 14.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.283 1.033 . . . . 71.329999999999998 110.271 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.0 tp -109.41 144.29 37.83 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.164 0.586 . . . . 71.140000000000001 110.44 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.2 p -83.09 111.61 19.05 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.513 -0.921 . . . . 55.119999999999997 108.513 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.7 pt -117.89 139.07 46.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 123.836 0.854 . . . . 61.509999999999998 109.014 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 20.5 m -101.34 150.24 23.2 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.731 -0.47 . . . . 42.310000000000002 109.731 176.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -56.74 112.04 1.19 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 122.622 0.369 . . . . 65.340000000000003 110.082 167.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.38 -4.31 43.95 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.328 -0.396 . . . . 51.0 112.916 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.92 134.03 36.89 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.555 0.742 . . . . 75.129999999999995 109.624 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -83.31 112.52 19.97 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.934 -0.765 . . . . 64.310000000000002 108.934 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 87' ' ' ALA . 18.8 mt -101.37 156.72 17.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.005 0.522 . . . . 73.329999999999998 109.818 -171.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -124.72 108.64 12.2 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.601 -0.518 . . . . 65.530000000000001 109.601 167.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 135' ' ' ILE . 85.4 t -96.81 106.92 19.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.152 -0.931 . . . . 64.530000000000001 109.843 -176.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.413 HD12 ' NE2' ' A' ' 127' ' ' GLN . 69.1 mt -73.57 -14.56 61.22 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.365 -0.834 . . . . 75.319999999999993 111.427 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.37 163.24 21.99 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 116.252 -0.431 . . . . 71.239999999999995 112.419 172.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 7.4 m-30 -95.29 173.31 7.6 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.845 -0.798 . . . . 74.430000000000007 108.845 173.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.611 ' ND2' ' HB2' ' A' ' 22' ' ' PHE . 10.1 m120 -64.01 150.94 44.2 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.584 -1.265 . . . . 74.340000000000003 107.584 161.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -65.19 -22.64 66.92 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.041 0.382 . . . . 62.140000000000001 110.526 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -86.15 -14.89 42.76 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 122.793 0.437 . . . . 71.129999999999995 110.441 174.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 174' ' ' GLU . . . 84.41 25.91 41.54 Favored Glycine 0 C--N 1.355 1.603 0 C-N-CA 123.452 0.549 . . . . 62.329999999999998 113.59 175.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -79.81 -71.33 0.46 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.391 0.677 . . . . 73.420000000000002 110.779 -175.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -104.77 175.56 5.45 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.336 1.054 . . . . 70.019999999999996 109.013 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -151.22 116.0 5.2 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.825 0.85 . . . . 33.229999999999997 109.445 -172.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 36.5 tt0 -67.91 97.38 0.66 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.677 0.391 . . . . 62.119999999999997 110.162 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.31 153.74 19.38 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.246 -0.65 . . . . 53.340000000000003 109.246 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -138.48 131.86 30.36 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.713 0.805 . . . . 63.450000000000003 109.681 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 63.9 p -140.38 -170.7 3.05 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.635 1.174 . . . . 74.299999999999997 109.423 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -64.67 -14.59 58.95 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.279 0.632 . . . . 64.109999999999999 112.098 170.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -80.14 -11.66 59.73 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.73 0.812 . . . . 43.229999999999997 111.304 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 121.09 -133.63 9.73 Favored Glycine 0 C--N 1.35 1.317 0 N-CA-C 111.415 -0.674 . . . . 52.32 111.415 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.413 ' NE2' HD12 ' A' ' 110' ' ' LEU . 58.2 tt0 -151.51 144.99 24.86 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 117.182 0.491 . . . . 74.420000000000002 111.103 -175.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 171.43 168.93 33.73 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.542 0.526 . . . . 72.519999999999996 112.709 174.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -82.48 117.48 22.53 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.527 1.131 . . . . 74.239999999999995 111.408 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.54 154.52 47.81 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.997 1.319 . . . . 53.240000000000002 109.136 177.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.54 132.47 33.34 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 121.585 1.523 . . . . 74.430000000000007 111.326 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 31.6 m -62.22 -17.74 59.14 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.707 0.803 . . . . 75.120000000000005 112.489 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -82.18 -14.99 54.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.976 0.91 . . . . 60.420000000000002 111.619 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.554 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.7 m-85 -93.95 -3.84 50.84 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.854 0.862 . . . . 64.549999999999997 112.306 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.56 HD12 HG21 ' A' ' 109' ' ' VAL . 18.2 pt -125.95 169.93 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.251 0.62 . . . . 70.409999999999997 110.362 -172.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.5 t -158.04 141.03 10.8 Favored Pre-proline 0 CA--C 1.554 1.106 0 O-C-N 123.563 0.539 . . . . 72.540000000000006 109.963 171.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.14 136.78 14.81 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.573 2.182 . . . . 45.219999999999999 111.841 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.7 m -108.25 -45.53 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.668 0.387 . . . . 75.420000000000002 111.162 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.577 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 67.2 t30 -101.25 20.12 16.38 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.473 0.654 . . . . 63.32 110.699 -174.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.5 p -73.97 -171.24 1.06 Allowed 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 121.471 0.653 . . . . 74.430000000000007 110.746 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.483 HD13 ' HB3' ' A' ' 214' ' ' LEU . 67.1 mt -69.95 -13.81 62.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.916 0.886 . . . . 74.519999999999996 111.669 176.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.8 -6.73 17.21 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.86 1.264 . . . . 72.540000000000006 111.524 176.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -55.6 -35.69 66.1 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.214 1.005 . . . . 52.420000000000002 109.902 168.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -93.49 135.44 34.74 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.0 -1.0 . . . . 75.120000000000005 108.812 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.8 m -67.84 -12.07 59.87 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.526 0.935 . . . . 75.430000000000007 113.526 -171.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -75.19 -34.04 61.49 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 111.881 0.326 . . . . 73.319999999999993 111.881 175.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -94.24 134.33 36.82 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.396 -0.594 . . . . 70.150000000000006 109.396 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -125.17 5.12 7.84 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 111.793 0.294 . . . . 71.049999999999997 111.793 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.25 -159.48 50.33 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 119.462 -0.632 . . . . 72.040000000000006 114.446 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 38.1 Cg_endo -67.27 104.85 0.93 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.369 2.713 . . . . 63.299999999999997 112.297 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.587 HG11 HH21 ' A' ' 171' ' ' ARG . 32.6 t -140.56 153.51 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.137 0.575 . . . . 54.340000000000003 110.545 -174.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.9 m -68.83 148.17 50.67 Favored 'General case' 0 C--O 1.249 1.027 0 C-N-CA 124.555 1.142 . . . . 73.219999999999999 112.028 173.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -62.62 -29.72 70.82 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.486 0.714 . . . . 74.400000000000006 110.616 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -57.05 -57.11 13.99 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.552 1.141 . . . . 51.020000000000003 110.453 175.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.16 -39.31 89.69 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.049 0.94 . . . . 75.310000000000002 111.189 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.48 -53.54 56.32 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.888 -1.051 . . . . 74.510000000000005 110.751 174.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -69.39 -26.88 64.86 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.378 1.071 . . . . 52.119999999999997 110.882 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -67.88 -49.95 59.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.371 0.668 . . . . 75.129999999999995 110.573 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.55 HD12 HH12 ' A' ' 171' ' ' ARG . 66.6 mt -66.31 -37.26 85.0 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 120.802 0.334 . . . . 62.43 110.265 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 183' ' ' SER . 39.6 tp -65.54 -34.32 77.99 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.191 -0.913 . . . . 63.530000000000001 111.435 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.9 t -57.82 -24.79 59.01 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.905 1.282 . . . . 74.230000000000004 112.049 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.612 ' HB2' ' HG2' ' A' ' 237' ' ' PRO . 3.8 m -87.91 -4.82 58.8 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.028 0.931 . . . . 64.209999999999994 111.895 -175.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -94.09 175.97 35.5 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.197 0.427 . . . . 73.409999999999997 113.912 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.6 pt -118.42 -165.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 124.531 1.133 . . . . 60.399999999999999 109.726 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.677 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 16.8 p-10 -57.58 110.69 0.92 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 113.007 0.743 . . . . 72.310000000000002 113.007 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.89 12.11 35.5 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 115.001 -0.999 . . . . 65.340000000000003 112.493 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 23.4 t -74.25 130.13 39.13 Favored 'General case' 0 C--N 1.349 0.579 0 N-CA-C 109.01 -0.737 . . . . 72.420000000000002 109.01 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 235' ' ' PRO . 19.0 p90 -136.78 155.96 49.14 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.29 0.848 . . . . 74.450000000000003 113.29 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.557 HD13 ' NH1' ' A' ' 171' ' ' ARG . 89.0 mt -142.29 135.64 28.95 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.114 0.966 . . . . 43.310000000000002 109.345 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.423 HG22 HG12 ' A' ' 182' ' ' ILE . 15.7 t -109.8 115.61 50.1 Favored 'Isoleucine or valine' 0 C--O 1.252 1.194 0 N-CA-C 108.29 -1.004 . . . . 74.239999999999995 108.29 176.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.587 HH21 HG11 ' A' ' 151' ' ' VAL . 1.4 mmm180 -126.7 159.99 32.08 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.592 -1.262 . . . . 64.239999999999995 107.592 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.674 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 16.9 pt-20 -116.99 163.31 16.41 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 109.482 -0.562 . . . . 74.150000000000006 109.482 167.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.5 t -78.78 138.0 38.0 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.712 -0.677 . . . . 73.430000000000007 110.287 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.407 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 27.1 mt-10 -75.94 -37.84 58.23 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.306 -0.861 . . . . 63.409999999999997 108.989 172.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 47.3 m -83.28 -3.78 57.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.288 1.035 . . . . 61.409999999999997 111.615 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.3 t -157.81 75.14 3.97 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 109.148 -0.686 . . . . 65.019999999999996 109.148 173.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.35 141.39 89.16 Favored 'Trans proline' 0 C--N 1.386 2.508 0 C-N-CA 122.987 2.458 . . . . 74.150000000000006 112.395 175.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 96.8 -25.19 27.66 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 115.098 -0.956 . . . . 53.520000000000003 112.009 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -91.69 117.59 29.88 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.486 -0.931 . . . . 63.229999999999997 108.486 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.674 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 56.0 mtt180 -115.64 170.21 8.61 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 123.77 0.828 . . . . 74.439999999999998 110.562 -172.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.5 t -153.97 143.29 21.44 Favored 'General case' 0 C--O 1.25 1.09 0 C-N-CA 123.956 0.902 . . . . 75.430000000000007 109.09 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 170' ' ' VAL . 45.1 mt -110.72 132.82 58.09 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 N-CA-C 108.098 -1.075 . . . . 73.340000000000003 108.098 170.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.596 ' HB3' HD22 ' A' ' 160' ' ' LEU . 13.8 m -106.08 135.94 46.65 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 124.854 1.262 . . . . 63.310000000000002 108.082 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.429 HD21 HD23 ' A' ' 232' ' ' LEU . 36.4 mt -125.89 137.19 53.72 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.607 1.163 . . . . 74.099999999999994 110.335 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.476 ' HB2' ' HG ' ' A' ' 160' ' ' LEU . 71.4 ttt-85 -120.42 133.77 55.37 Favored 'General case' 0 C--O 1.263 1.804 0 O-C-N 124.472 1.108 . . . . 73.340000000000003 108.848 169.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.677 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 21.4 p90 -147.57 133.97 19.65 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.759 1.287 . . . . 74.140000000000001 108.295 167.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 37.76 59.77 1.25 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 126.378 1.871 . . . . 74.219999999999999 114.116 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.458 ' HA2' ' NH2' ' A' ' 185' ' ' ARG . . . 79.57 -2.52 72.37 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.823 -0.626 . . . . 53.340000000000003 114.6 173.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 42.0 ttm180 -109.78 125.51 52.78 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.501 0.72 . . . . 74.319999999999993 110.393 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 28.7 m -111.51 143.8 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.075 0.95 . . . . 74.040000000000006 110.42 172.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -147.27 150.1 34.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.948 0.899 . . . . 63.520000000000003 109.778 172.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -125.02 116.46 22.17 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.212 -1.032 . . . . 73.200000000000003 108.212 -173.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -115.07 145.81 41.94 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.31 0.576 . . . . 73.209999999999994 110.475 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.511 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 18.9 tpp180 -84.45 128.6 34.68 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 114.681 -1.145 . . . . 62.420000000000002 111.522 -169.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 79.2 mt -80.43 107.22 12.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 107.418 -1.327 . . . . 72.319999999999993 107.418 164.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -77.73 131.26 37.58 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.491 -0.929 . . . . 44.130000000000003 108.491 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.1 m -105.63 141.2 37.5 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.15 0.58 . . . . 74.530000000000001 109.529 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 202' ' ' LYS . . . -95.81 174.8 6.78 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.463 1.105 . . . . 63.450000000000003 109.757 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.0 m -59.79 -39.03 83.58 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.266 0.627 . . . . 64.400000000000006 111.762 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -83.54 12.67 5.34 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.658 0.783 . . . . 75.219999999999999 112.129 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 76.43 12.66 84.1 Favored Glycine 0 C--N 1.352 1.421 0 C-N-CA 122.828 0.252 . . . . 71.219999999999999 112.609 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 198' ' ' ALA . 28.9 mtpp -73.35 126.74 30.84 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 109.871 -0.418 . . . . 72.209999999999994 109.871 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.498 HD11 HH11 ' A' ' 180' ' ' ARG . 80.9 mt -94.72 145.37 24.91 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.457 -0.942 . . . . 73.319999999999993 108.457 -178.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -166.85 136.2 2.92 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.329 0.652 . . . . 73.030000000000001 109.611 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.7 t -92.93 -56.99 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 107.677 -1.231 . . . . 63.200000000000003 107.677 169.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 2.8 p -83.84 147.06 27.76 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.146 -1.388 . . . . 74.430000000000007 109.679 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 20.7 t -68.76 -46.21 69.38 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.848 0.859 . . . . 60.340000000000003 112.37 -165.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -77.09 -4.02 42.27 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.425 0.69 . . . . 75.420000000000002 111.601 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 70.2 m -91.32 140.37 29.84 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 123.587 0.755 . . . . 71.549999999999997 110.128 173.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -142.75 110.36 5.8 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.014 -1.106 . . . . 74.340000000000003 108.014 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 14.6 m-85 -117.0 141.91 47.64 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 109.674 -0.491 . . . . 63.509999999999998 109.674 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -91.2 -18.69 24.03 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.358 0.663 . . . . 74.510000000000005 109.958 168.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 29.5 p -128.64 138.29 52.1 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.956 0.884 . . . . 55.350000000000001 111.715 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.483 ' HB3' HD13 ' A' ' 141' ' ' LEU . 29.3 tp -67.59 -26.43 66.26 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.031 -1.441 . . . . 72.129999999999995 110.831 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.33 -45.79 92.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.533 0.733 . . . . 74.219999999999999 110.445 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -74.7 -30.54 61.59 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.707 -0.679 . . . . 74.150000000000006 111.932 177.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.73 -51.21 70.73 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 110.133 -0.321 . . . . 75.540000000000006 110.133 172.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.38 -42.48 93.68 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 C-N-CA 124.069 0.948 . . . . 74.349999999999994 110.717 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -60.79 -51.52 68.97 Favored 'General case' 0 C--O 1.262 1.734 0 C-N-CA 123.963 0.905 . . . . 74.25 111.033 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.401 ' O ' HG22 ' A' ' 224' ' ' VAL . 47.0 t-80 -55.23 -53.15 59.69 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.72 -1.127 . . . . 72.299999999999997 109.748 177.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -73.1 -12.24 60.83 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.245 -0.434 . . . . 61.420000000000002 112.134 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.0 t -78.44 -27.4 46.48 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.835 0.454 . . . . 63.240000000000002 110.472 172.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -109.84 -22.48 11.86 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.974 1.842 . . . . 71.310000000000002 115.974 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 220' ' ' HIS . 30.9 m -88.69 152.64 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 120.552 1.523 . . . . 73.530000000000001 114.379 -165.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.09 -1.14 57.96 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 111.905 -2.407 . . . . 70.030000000000001 112.866 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -78.7 14.91 1.16 Allowed 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 128.132 2.573 . . . . 54.530000000000001 113.512 -140.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.89 17.36 4.63 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 110.773 -0.931 . . . . 74.219999999999999 110.773 -168.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.68 125.7 35.75 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.35 -0.925 . . . . 75.140000000000001 109.7 165.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 77.7 mt -61.67 -44.17 98.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 O-C-N 124.133 0.896 . . . . 71.439999999999998 109.427 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.4 t -137.16 144.91 43.2 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.19 -0.914 . . . . 64.310000000000002 108.582 169.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 60.4 p -73.99 151.11 40.37 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.228 -0.656 . . . . 73.420000000000002 109.228 172.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.438 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 33.5 mt -64.48 101.19 0.42 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.244 -0.65 . . . . 51.520000000000003 109.244 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -80.81 -55.72 4.62 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.845 0.458 . . . . 63.210000000000001 109.972 -174.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -155.24 149.87 20.11 Favored Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 109.824 -0.435 . . . . 44.130000000000003 109.824 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 32.8 Cg_endo -63.08 142.54 87.78 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.192 1.928 . . . . 53.530000000000001 111.628 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.02 140.37 95.98 Favored Pre-proline 0 C--O 1.244 0.785 0 CA-C-O 119.255 -0.402 . . . . 73.099999999999994 110.511 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.612 ' HG2' ' HB2' ' A' ' 162' ' ' SER . 17.9 Cg_endo -57.52 118.61 5.51 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 123.012 2.475 . . . . 52.350000000000001 113.811 -174.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -76.42 155.89 33.61 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 108.055 -1.091 . . . . 71.049999999999997 108.055 166.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -59.03 -25.25 63.52 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.738 0.644 . . . . 73.510000000000005 112.738 -174.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -117.35 112.02 20.16 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.137 0.575 . . . . 75.349999999999994 109.861 174.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.447 ' N ' ' HD3' ' A' ' 242' ' ' PRO . 13.3 ptmm? -161.4 56.85 0.75 Allowed Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 124.133 0.973 . . . . 75.230000000000004 110.839 171.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.447 ' HD3' ' N ' ' A' ' 241' ' ' LYS . 12.9 Cg_exo -70.44 89.92 0.59 Allowed 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.739 2.293 . . . . 74.0 111.433 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 14.7 t -163.08 159.26 23.0 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.972 0.909 . . . . 74.329999999999998 109.935 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 30.6 m -116.31 144.21 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.197 0.599 . . . . 74.420000000000002 110.174 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -161.22 143.05 11.92 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.14 0.976 . . . . 62.329999999999998 110.079 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 122.01 128.19 3.44 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.759 -0.536 . . . . 72.019999999999996 111.759 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 62.0 t -112.68 -64.9 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.53 0.732 . . . . 64.430000000000007 109.799 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 35.9 t -169.81 127.84 0.83 Allowed Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.62 0.768 . . . . 63.100000000000001 109.594 -174.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -85.42 167.57 10.34 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.505 2.137 . . . . 51.530000000000001 111.563 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -140.23 90.83 2.4 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.643 -0.873 . . . . 64.150000000000006 108.643 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -95.36 121.58 37.18 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.419 -0.809 . . . . 75.319999999999993 109.063 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -93.56 166.45 12.24 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.169 0.988 . . . . 73.420000000000002 110.387 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -118.26 122.16 42.25 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.442 0.697 . . . . 72.099999999999994 110.409 -178.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -140.0 101.41 4.16 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.019 -1.475 . . . . 75.540000000000006 107.019 169.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 . . . . . 0 CA--C 1.561 1.39 0 C-N-CA 124.672 1.189 . . . . 73.040000000000006 111.965 -179.057 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 ptp . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 121.614 0.721 . . . . 74.430000000000007 110.912 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.55 17.03 0.03 OUTLIER Glycine 0 CA--C 1.526 0.741 0 CA-C-N 114.631 -1.168 . . . . 64.409999999999997 111.396 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -72.15 85.73 1.04 Allowed 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.413 1.085 . . . . 53.329999999999998 108.802 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.462 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 64.0 tt0 -86.48 125.03 68.79 Favored Pre-proline 0 C--O 1.238 0.486 0 CA-C-N 114.936 -1.029 . . . . 71.310000000000002 108.862 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.99 -28.81 87.9 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.941 2.427 . . . . 70.099999999999994 112.217 173.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.462 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . 93.25 -174.18 35.06 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.565 -0.743 . . . . 34.420000000000002 111.426 -174.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -176.75 135.61 0.23 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.568 0.747 . . . . 74.109999999999999 109.862 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.1 150.18 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 123.246 0.618 . . . . 71.409999999999997 111.652 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 pp -67.83 147.76 52.12 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.888 -0.596 . . . . 73.420000000000002 109.859 170.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 15' ' ' PRO . . . -66.34 -30.83 77.36 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-O 119.312 -0.716 . . . . 43.109999999999999 112.898 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.0 t70 73.75 -62.32 0.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.104 1.762 . . . . 60.219999999999999 111.567 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -79.03 -172.01 2.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.216 1.406 . . . . 74.439999999999998 111.883 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -56.38 139.1 49.79 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 124.689 1.196 . . . . 74.239999999999995 111.546 175.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 51.56 70.94 1.67 Allowed Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.837 0.855 . . . . 75.010000000000005 110.934 -169.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.424 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 91.7 Cg_endo -75.09 167.76 26.26 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.825 2.35 . . . . 75.409999999999997 112.132 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.0 p -66.91 167.52 11.45 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 121.304 0.573 . . . . 71.140000000000001 111.188 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.3 mt -108.3 134.68 20.11 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 123.981 0.912 . . . . 65.129999999999995 109.604 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -69.3 166.03 28.42 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.379 2.053 . . . . 71.430000000000007 110.908 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.8 142.87 29.47 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.727 0.299 . . . . 63.109999999999999 110.217 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.659 ' HB3' HD11 ' A' ' 23' ' ' ILE . 71.3 mt -87.01 95.54 9.97 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.934 0.893 . . . . 62.32 109.068 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -99.49 -49.66 4.35 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.49 0.662 . . . . 73.340000000000003 110.053 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -99.62 114.92 28.27 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.809 -1.087 . . . . 74.230000000000004 108.901 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 20' ' ' LEU . 49.5 mm -116.29 117.84 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 108.609 -0.885 . . . . 63.119999999999997 108.609 -174.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.531 ' HB2' ' HE1' ' A' ' 129' ' ' TRP . 9.5 tmtt? -66.3 -38.17 87.13 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.115 -0.698 . . . . 53.329999999999998 109.115 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.18 175.19 49.81 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.775 -0.648 . . . . 55.439999999999998 113.476 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -92.44 107.92 19.58 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.198 -0.667 . . . . 62.32 109.198 173.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.26 66.9 0.11 Allowed Glycine 0 C--N 1.348 1.196 0 N-CA-C 110.589 -1.004 . . . . 45.399999999999999 110.589 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp 69.93 111.31 0.05 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.534 1.534 . . . . 65.329999999999998 110.731 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -93.93 145.86 24.33 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.28 0.632 . . . . 74.450000000000003 110.011 -177.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -82.49 167.22 18.63 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.829 0.852 . . . . 71.230000000000004 111.644 -170.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.9 m 57.6 23.65 9.55 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.733 1.213 . . . . 75.109999999999999 113.052 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.7 t -84.21 99.27 10.43 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 121.871 -0.518 . . . . 64.400000000000006 109.978 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.03 -70.47 0.8 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.612 0.765 . . . . 75.239999999999995 110.944 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -146.28 -41.66 0.2 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.458 0.703 . . . . 65.530000000000001 111.031 -171.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.466 ' HA3' ' HG2' ' A' ' 77' ' ' PRO . . . 79.38 60.18 2.56 Favored Glycine 0 C--N 1.343 0.934 0 O-C-N 123.341 0.401 . . . . 75.129999999999995 113.407 176.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.74 146.59 7.18 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.567 -0.574 . . . . 65.329999999999998 112.969 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.22 44.38 1.41 Allowed 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 123.748 2.965 . . . . 72.510000000000005 113.173 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -64.28 104.21 0.73 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.702 0.801 . . . . 71.329999999999998 111.119 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.3 t -157.28 142.85 17.4 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.143 0.977 . . . . 74.109999999999999 109.107 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -72.15 152.71 42.11 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 120.888 0.375 . . . . 71.239999999999995 111.415 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.24 173.67 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.55 0.74 . . . . 71.140000000000001 109.537 171.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.514 ' HB3' HD23 ' A' ' 61' ' ' LEU . 15.9 p90 -117.56 105.82 12.47 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.961 -1.126 . . . . 75.040000000000006 107.961 170.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.428 HG12 ' HB3' ' A' ' 62' ' ' SER . 3.6 p -72.69 89.39 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-O 122.75 1.262 . . . . 54.009999999999998 109.347 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.7 147.38 53.17 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 113.689 -1.596 . . . . 65.219999999999999 111.716 -177.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -84.95 133.37 34.28 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.751 0.821 . . . . 54.43 110.933 -172.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -73.21 97.72 2.48 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.194 0.598 . . . . 51.119999999999997 110.359 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.25 125.53 39.09 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.332 0.653 . . . . 53.439999999999998 109.965 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.9 -15.78 61.13 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.142 0.577 . . . . 71.299999999999997 110.144 170.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -79.05 141.09 37.7 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 108.98 -0.748 . . . . 61.409999999999997 108.98 168.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.17 149.66 67.41 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.915 1.286 . . . . 74.230000000000004 108.12 176.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.33 145.33 93.99 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.844 2.363 . . . . 75.439999999999998 113.145 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.48 -29.34 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.016 0.926 . . . . 74.329999999999998 110.564 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.75 148.61 38.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.97 0.908 . . . . 72.219999999999999 110.359 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.4 m -82.23 78.88 8.85 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.699 0.8 . . . . 65.239999999999995 109.869 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -86.94 177.59 7.21 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.403 -0.817 . . . . 74.239999999999995 110.269 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -131.74 171.93 12.9 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.816 0.846 . . . . 60.520000000000003 110.272 -176.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 69.07 76.05 0.25 Allowed Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 124.99 1.316 . . . . 70.430000000000007 111.602 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.19 82.24 0.5 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.501 2.134 . . . . 73.430000000000007 111.006 173.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -68.29 127.55 33.35 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.4 0.68 . . . . 72.519999999999996 110.498 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.28 70.31 0.09 OUTLIER Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.224 -1.15 . . . . 74.400000000000006 110.224 -173.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 42' ' ' PHE . 88.4 mt -90.68 87.96 6.91 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.083 -0.71 . . . . 70.310000000000002 109.083 173.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.428 ' HB3' HG12 ' A' ' 43' ' ' VAL . 47.3 t -74.12 121.9 21.89 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 109.33 -0.619 . . . . 75.549999999999997 109.33 176.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.94 89.1 0.77 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.47 -0.786 . . . . 72.120000000000005 109.841 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.11 154.07 30.33 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.643 1.177 . . . . 50.409999999999997 108.591 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -153.0 118.2 5.18 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 122.982 0.513 . . . . 74.329999999999998 109.827 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -98.14 54.66 1.11 Allowed 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.796 -0.816 . . . . 71.319999999999993 108.796 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 43.07 65.22 1.0 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.912 1.685 . . . . 74.329999999999998 113.121 175.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -96.42 142.69 28.23 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.467 -0.788 . . . . 72.340000000000003 109.083 175.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.8 p -80.89 70.32 7.66 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.565 0.746 . . . . 61.539999999999999 110.973 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -84.31 80.09 9.33 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 107.699 -1.223 . . . . 74.230000000000004 107.699 172.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -67.84 82.24 0.2 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.757 -1.111 . . . . 64.409999999999997 111.531 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -72.46 132.07 43.39 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.079 -1.082 . . . . 64.209999999999994 108.079 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.4 mt -74.11 5.46 4.34 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.185 0.594 . . . . 74.239999999999995 112.264 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.23 131.77 49.5 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.561 1.144 . . . . 60.119999999999997 110.879 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.79 141.92 51.36 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.697 0.799 . . . . 72.430000000000007 111.003 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -172.9 -164.07 27.71 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-O 118.98 -0.9 . . . . 65.099999999999994 112.198 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.466 ' HG2' ' HA3' ' A' ' 35' ' ' GLY . 52.8 Cg_endo -69.42 -154.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.61 2.873 . . . . 70.150000000000006 113.527 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -84.47 139.4 32.2 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.74 1.385 . . . . 74.430000000000007 114.74 -166.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -77.52 -179.22 5.68 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-N 114.683 -1.144 . . . . 73.319999999999993 111.31 171.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -55.74 141.25 39.0 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.461 1.104 . . . . 71.510000000000005 111.877 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -148.4 152.25 38.33 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 123.816 0.846 . . . . 75.540000000000006 109.525 -174.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.45 -7.26 16.82 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.572 2.181 . . . . 71.209999999999994 112.627 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -96.71 33.32 1.87 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.674 0.79 . . . . 71.230000000000004 110.537 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 25.7 tp -80.83 113.6 19.14 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.919 -0.771 . . . . 72.209999999999994 108.919 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -103.5 176.42 5.15 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.927 1.691 . . . . 71.040000000000006 108.808 173.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.48 144.28 35.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 N-CA-C 108.721 -0.844 . . . . 74.129999999999995 108.721 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.91 113.3 12.06 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 123.532 0.52 . . . . 73.019999999999996 109.954 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.58 -26.2 62.51 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.006 0.922 . . . . 72.040000000000006 111.023 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.465 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 71.8 m-85 -134.95 155.46 50.69 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.85 -0.796 . . . . 74.209999999999994 108.85 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -74.41 141.68 45.05 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.88 -0.785 . . . . 73.340000000000003 108.88 170.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -143.44 112.59 6.72 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.94 -0.763 . . . . 72.25 108.94 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.6 t -79.47 129.64 37.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 107.877 -1.157 . . . . 62.219999999999999 107.877 172.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.58 146.68 54.24 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.397 0.679 . . . . 74.230000000000004 111.122 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.3 m -70.36 -25.31 63.21 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.858 0.863 . . . . 71.439999999999998 110.136 169.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.04 -140.55 6.21 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 115.723 -0.671 . . . . 41.119999999999997 112.245 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.17 -35.15 73.79 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.544 0.737 . . . . 71.319999999999993 111.013 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.535 ' HB2' HD12 ' A' ' 23' ' ' ILE . 28.7 p30 -70.08 -4.68 22.26 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.66 0.784 . . . . 74.129999999999995 112.676 -177.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.3 p -134.5 160.15 38.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.399 1.08 . . . . 72.329999999999998 109.047 177.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.5 tp -110.58 125.97 53.94 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.724 -0.473 . . . . 72.030000000000001 109.724 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.1 p -74.6 114.17 12.71 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 108.603 -0.888 . . . . 74.439999999999998 108.603 173.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.0 pt -117.23 155.23 18.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.971 -0.751 . . . . 64.239999999999995 108.971 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.8 m -120.71 145.71 47.2 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.151 -0.685 . . . . 72.099999999999994 109.151 175.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -53.3 114.84 1.63 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.552 0.741 . . . . 62.420000000000002 110.972 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.39 -14.34 33.06 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-O 119.87 -0.406 . . . . 74.310000000000002 112.828 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -76.33 132.41 39.77 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.209 0.604 . . . . 72.409999999999997 109.687 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HB3' HD11 ' A' ' 84' ' ' LEU . 50.2 mtmt -84.7 119.69 25.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.685 0.794 . . . . 75.109999999999999 109.371 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.3 mt -104.29 139.48 39.22 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.523 1.129 . . . . 72.040000000000006 108.858 -170.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -101.39 106.93 18.14 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.416 -0.957 . . . . 75.510000000000005 108.416 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 93.9 t -93.07 109.18 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 109.235 -0.654 . . . . 72.109999999999999 109.235 -174.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.7 mt -68.02 -34.75 77.08 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.644 0.778 . . . . 72.230000000000004 110.376 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.66 173.6 38.65 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.337 -0.847 . . . . 60.119999999999997 111.887 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.687 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 14.2 m-85 -98.21 168.84 9.99 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.319 0.648 . . . . 72.439999999999998 109.536 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -71.38 152.15 43.42 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.059 -0.719 . . . . 74.109999999999999 109.059 172.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -58.11 -44.37 87.68 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.229 0.612 . . . . 74.329999999999998 111.472 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -79.13 -5.44 54.14 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 122.949 0.499 . . . . 72.430000000000007 110.315 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 72.6 34.31 60.09 Favored Glycine 0 C--N 1.352 1.44 0 C-N-CA 123.22 0.438 . . . . 72.109999999999999 113.349 174.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -85.44 -61.86 1.66 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.535 0.684 . . . . 71.439999999999998 109.498 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.408 ' HB3' ' HB3' ' A' ' 129' ' ' TRP . 74.5 m95 -111.56 178.11 4.43 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.871 -1.059 . . . . 75.129999999999995 109.974 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -144.45 116.01 8.13 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.98 0.912 . . . . 73.230000000000004 108.658 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -76.58 110.83 11.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.89 0.376 . . . . 74.430000000000007 111.11 -174.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -105.5 165.35 11.2 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.223 -0.899 . . . . 51.439999999999998 110.195 177.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -142.61 125.27 15.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.34 0.656 . . . . 75.340000000000003 109.409 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.7 p -135.86 -164.31 1.53 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.315 1.046 . . . . 44.0 110.416 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -53.99 -33.28 56.64 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.487 1.515 . . . . 73.129999999999995 111.214 172.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -77.52 -1.85 32.59 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.88 1.272 . . . . 72.019999999999996 112.093 -177.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.09 -135.4 12.74 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.262 -0.735 . . . . 72.430000000000007 111.262 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -141.56 135.08 29.73 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.68 0.74 . . . . 73.140000000000001 110.63 -172.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -179.07 176.86 48.21 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 112.215 -0.354 . . . . 74.030000000000001 112.215 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.531 ' HE1' ' HB2' ' A' ' 24' ' ' LYS . 79.8 m95 -87.15 131.64 34.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.538 0.735 . . . . 71.239999999999995 111.309 -174.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.45 152.14 60.76 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.492 1.117 . . . . 73.230000000000004 109.294 175.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.71 131.52 17.34 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 121.819 1.68 . . . . 74.430000000000007 109.896 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.1 m -61.63 -18.73 60.64 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.988 0.915 . . . . 72.329999999999998 112.402 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -74.68 -18.73 60.48 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.322 1.049 . . . . 73.219999999999999 111.638 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.465 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 5.4 m-85 -97.93 1.24 47.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.595 0.758 . . . . 74.030000000000001 111.862 -177.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.3 pt -133.12 158.96 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 122.873 0.469 . . . . 62.5 110.435 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.3 t -150.61 140.86 14.23 Favored Pre-proline 0 N--CA 1.49 1.56 0 C-N-CA 122.527 0.331 . . . . 61.299999999999997 110.436 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.499 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 74.3 Cg_endo -72.85 132.37 18.4 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.91 2.407 . . . . 63.240000000000002 113.055 -177.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.7 m -113.86 -40.95 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 122.811 0.444 . . . . 74.019999999999996 111.693 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 62.8 t30 -100.97 0.42 38.21 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 122.859 0.464 . . . . 60.020000000000003 111.713 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.499 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 33.2 t -75.54 -178.94 4.34 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.11 0.564 . . . . 54.439999999999998 110.33 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 50.0 mt -56.86 -18.23 12.3 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.548 1.139 . . . . 72.329999999999998 112.708 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.562 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 28.2 tt0 -62.07 -19.13 62.6 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.89 0.876 . . . . 71.099999999999994 112.4 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -58.65 -23.73 59.71 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.419 0.688 . . . . 61.509999999999998 111.427 174.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -90.67 134.19 34.59 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.485 -0.931 . . . . 63.25 108.485 173.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.8 p -62.19 -20.56 64.29 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.013 0.745 . . . . 64.409999999999997 113.013 -172.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -73.51 -30.21 62.97 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.118 0.414 . . . . 63.530000000000001 112.118 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -103.33 135.02 45.74 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.553 -0.536 . . . . 74.450000000000003 109.553 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.562 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 16.6 m-70 -130.74 44.49 2.95 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.899 0.479 . . . . 74.329999999999998 110.667 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.45 -160.3 36.61 Favored Glycine 0 CA--C 1.541 1.669 0 N-CA-C 116.45 1.34 . . . . 64.409999999999997 116.45 164.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -83.37 108.97 1.56 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 124.178 3.252 . . . . 64.540000000000006 112.663 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 20.5 m -144.4 172.7 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 109.463 -0.569 . . . . 74.030000000000001 109.463 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.9 m -95.64 171.88 8.4 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 115.834 -0.621 . . . . 70.400000000000006 111.134 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -58.2 -25.29 61.41 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.002 0.921 . . . . 72.040000000000006 111.831 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -66.04 -56.45 11.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.068 0.947 . . . . 74.140000000000001 110.661 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.56 93.37 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.476 0.71 . . . . 72.120000000000005 110.614 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.459 ' HA ' ' NH2' ' A' ' 171' ' ' ARG . . . -56.59 -55.1 38.17 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-N 114.973 -1.012 . . . . 72.099999999999994 110.737 175.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.565 ' HG3' HG11 ' A' ' 190' ' ' VAL . 39.9 tt0 -68.59 -28.98 67.42 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.628 0.771 . . . . 71.129999999999995 110.927 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -61.17 -49.81 75.7 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.358 0.663 . . . . 74.420000000000002 110.5 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.591 HD12 HH22 ' A' ' 171' ' ' ARG . 38.4 mt -73.41 -32.98 64.73 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.85 -0.614 . . . . 72.109999999999999 111.811 177.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 183' ' ' SER . 44.4 tp -69.88 -26.01 63.98 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.186 0.994 . . . . 74.409999999999997 111.326 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.7 t -69.52 -8.87 50.88 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.847 0.859 . . . . 75.450000000000003 111.594 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.9 t -95.94 12.03 31.79 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.588 0.755 . . . . 64.409999999999997 110.762 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.93 174.02 18.0 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 114.155 0.422 . . . . 64.25 114.155 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.6 pt -123.9 -165.55 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.512 1.125 . . . . 73.349999999999994 109.984 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.875 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 13.8 p-10 -52.64 108.65 0.32 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.08 0.952 . . . . 72.540000000000006 112.66 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 100.49 11.59 40.97 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.42 -0.809 . . . . 71.219999999999999 112.904 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.3 t -77.4 129.33 35.64 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.477 -0.934 . . . . 63.509999999999998 108.477 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -136.52 153.27 51.06 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.811 0.671 . . . . 74.340000000000003 112.811 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.744 HD13 HH21 ' A' ' 171' ' ' ARG . 88.9 mt -131.05 132.16 44.74 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.73 -1.211 . . . . 75.329999999999998 107.73 168.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.71 121.68 56.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 106.663 -1.606 . . . . 73.439999999999998 106.663 172.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.744 HH21 HD13 ' A' ' 169' ' ' LEU . 13.1 mmt180 -128.37 165.99 19.54 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.091 0.957 . . . . 64.129999999999995 108.781 -172.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 13.2 pt-20 -114.94 150.87 35.05 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 107.622 -1.251 . . . . 65.030000000000001 107.622 158.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.6 p -86.44 133.08 33.79 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.347 0.404 . . . . 75.150000000000006 109.915 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.76 -38.19 88.4 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.008 0.923 . . . . 52.530000000000001 110.869 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.454 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 32.9 p -81.31 -10.92 59.47 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.001 0.92 . . . . 70.549999999999997 112.418 -175.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 39.8 m -138.27 101.04 8.42 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 122.915 0.486 . . . . 74.049999999999997 110.477 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.687 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 56.5 Cg_endo -66.55 137.86 47.87 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.715 2.943 . . . . 74.329999999999998 112.462 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.36 -22.41 4.58 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 116.224 -0.443 . . . . 75.420000000000002 113.537 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -82.85 119.44 24.39 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.734 0.814 . . . . 61.229999999999997 109.335 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.575 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 77.8 mtt-85 -116.97 163.24 16.52 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 115.184 -0.916 . . . . 74.420000000000002 108.924 -176.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.2 m -147.92 148.0 30.33 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.143 0.577 . . . . 65.120000000000005 110.098 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 66.1 mt -110.58 137.74 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 108.864 -0.791 . . . . 70.109999999999999 108.864 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.529 ' HB3' HD22 ' A' ' 160' ' ' LEU . 29.1 m -114.01 115.51 27.73 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.665 1.186 . . . . 52.399999999999999 108.348 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.5 mt -105.0 144.95 31.11 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.808 0.843 . . . . 72.109999999999999 111.511 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.44 ' HB2' ' HG ' ' A' ' 160' ' ' LEU . 28.3 ttt180 -126.97 138.99 53.36 Favored 'General case' 0 C--O 1.256 1.405 0 N-CA-C 107.071 -1.455 . . . . 63.43 107.071 168.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.875 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 10.3 t80 -149.9 103.98 3.26 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.504 -1.225 . . . . 75.340000000000003 108.328 -168.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 56.02 35.66 25.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.682 1.193 . . . . 73.140000000000001 112.321 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.3 78.76 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.503 -0.771 . . . . 34.439999999999998 113.264 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -98.22 124.39 42.78 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.735 -0.839 . . . . 75.340000000000003 108.735 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.565 HG11 ' HG3' ' A' ' 157' ' ' GLU . 48.4 t -109.18 129.51 63.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.47 1.108 . . . . 73.310000000000002 108.78 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.456 ' HE2' ' HB3' ' A' ' 186' ' ' TYR . 13.1 p90 -146.85 143.85 28.88 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.231 1.013 . . . . 73.299999999999997 109.156 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -126.53 140.66 52.28 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.186 0.994 . . . . 62.409999999999997 108.814 -170.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -139.16 140.65 37.92 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.957 0.408 . . . . 75.349999999999994 111.056 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.442 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 23.1 tpp180 -77.04 131.2 38.29 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.903 -1.044 . . . . 72.25 110.705 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 96.3 mt -78.36 106.18 8.63 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 N-CA-C 107.555 -1.276 . . . . 63.119999999999997 107.555 164.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -75.5 124.94 28.04 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.531 -0.914 . . . . 62.119999999999997 108.531 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.3 m -99.7 115.46 29.53 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.931 0.893 . . . . 60.299999999999997 109.604 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.07 148.63 51.52 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.603 0.761 . . . . 64.340000000000003 109.033 167.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 75.1 p -66.71 -8.75 30.09 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.149 0.58 . . . . 71.430000000000007 112.382 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -83.58 -0.66 51.38 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.03 0.932 . . . . 74.519999999999996 111.14 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 86.83 -0.91 86.74 Favored Glycine 0 C--N 1.349 1.301 0 C-N-CA 123.12 0.39 . . . . 54.25 112.631 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -76.52 129.35 36.35 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 116.903 0.351 . . . . 72.200000000000003 110.105 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.5 mt -96.61 148.23 23.07 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.397 0.679 . . . . 72.519999999999996 109.261 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -164.61 167.49 19.18 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 123.747 0.655 . . . . 74.310000000000002 110.798 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.4 t -136.62 -63.47 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.815 -1.179 . . . . 64.519999999999996 107.815 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 30.2 t -86.38 167.49 14.68 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.179 0.992 . . . . 74.0 109.484 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 42.8 p -67.75 -39.79 84.15 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.585 0.754 . . . . 73.010000000000005 109.907 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -82.76 -2.52 54.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.841 0.856 . . . . 74.219999999999999 112.062 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 58.1 m -92.77 118.15 30.78 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.978 0.911 . . . . 75.299999999999997 109.581 171.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -144.87 118.19 9.0 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 124.684 1.193 . . . . 73.430000000000007 108.545 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 209' ' ' SER . 10.7 m-85 -135.39 150.43 49.9 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 118.295 0.498 . . . . 71.25 111.505 -172.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -92.03 -29.91 16.33 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.567 0.747 . . . . 61.409999999999997 110.47 171.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.1 p -124.4 147.42 48.27 Favored 'General case' 0 C--O 1.248 1.025 0 C-N-CA 123.527 0.731 . . . . 53.0 111.074 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 32.9 tp -65.56 -31.68 72.86 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 114.37 -1.287 . . . . 72.200000000000003 110.657 175.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.87 98.14 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.447 0.699 . . . . 71.310000000000002 111.154 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -73.7 -30.54 62.92 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 119.069 -0.491 . . . . 71.310000000000002 111.693 175.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.96 -47.54 84.73 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.514 0.509 . . . . 74.340000000000003 110.446 172.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.2 t -71.4 -37.32 64.51 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 C-N-CA 124.022 0.929 . . . . 74.010000000000005 110.808 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 14.4 t-160 -62.35 -56.14 21.23 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.719 0.807 . . . . 72.219999999999999 111.108 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.428 ' O ' HG22 ' A' ' 224' ' ' VAL . 49.8 t-80 -52.75 -53.53 46.65 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.641 -1.163 . . . . 70.209999999999994 109.393 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.41 ' HB3' ' HG ' ' A' ' 232' ' ' LEU . 8.0 m-70 -63.09 -27.72 69.59 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.979 -0.555 . . . . 65.430000000000007 112.388 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.5 t -71.23 -23.66 62.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.846 0.459 . . . . 64.200000000000003 110.841 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 15.4 t -119.07 -3.69 10.63 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 116.407 2.002 . . . . 71.030000000000001 116.407 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 220' ' ' HIS . 27.0 m -106.03 154.67 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 116.422 2.008 . . . . 74.519999999999996 116.422 -172.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.7 -0.73 56.84 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 110.793 -2.912 . . . . 53.109999999999999 113.285 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -76.25 13.72 0.87 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 129.596 3.158 . . . . 71.150000000000006 113.56 -140.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.45 16.87 4.99 Favored Glycine 0 N--CA 1.464 0.545 0 C-N-CA 126.253 1.882 . . . . 63.240000000000002 111.629 -169.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.06 126.69 38.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.609 -1.295 . . . . 43.119999999999997 109.551 166.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 76.9 mt -58.36 -49.55 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.581 0.752 . . . . 72.439999999999998 109.428 170.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' THR . . . . . 0.405 HG22 ' OH ' ' A' ' 191' ' ' TYR . 12.8 t -134.24 148.13 50.79 Favored 'General case' 0 C--O 1.249 1.064 0 N-CA-C 107.826 -1.175 . . . . 71.329999999999998 107.826 169.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 224' ' ' VAL . 67.0 p -70.52 162.93 27.91 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 109.53 -0.544 . . . . 61.219999999999999 109.53 175.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.41 ' HG ' ' HB3' ' A' ' 221' ' ' HIS . 21.5 mt -68.58 100.52 1.13 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.154 -1.054 . . . . 51.049999999999997 108.154 176.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -90.89 -47.18 7.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.767 0.427 . . . . 64.340000000000003 111.253 -168.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -157.12 147.8 16.24 Favored Pre-proline 0 N--CA 1.485 1.319 0 N-CA-C 109.676 -0.49 . . . . 74.209999999999994 109.676 174.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.14 133.69 34.02 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.656 2.237 . . . . 62.240000000000002 112.626 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.409 ' HB3' ' HG ' ' A' ' 169' ' ' LEU . . . -67.71 150.25 97.9 Favored Pre-proline 0 C--O 1.246 0.882 0 C-N-CA 123.555 0.742 . . . . 72.219999999999999 110.414 174.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.441 ' O ' ' HB3' ' A' ' 159' ' ' LEU . 51.6 Cg_exo -56.95 132.57 52.44 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.341 2.694 . . . . 73.420000000000002 114.908 -172.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -73.35 157.18 37.46 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 106.721 -1.585 . . . . 60.439999999999998 106.721 158.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -62.77 -13.72 36.41 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 118.764 0.711 . . . . 73.519999999999996 112.691 -170.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -128.67 72.99 1.47 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.222 -1.399 . . . . 62.140000000000001 107.222 164.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 21.4 ptmt -64.51 143.75 98.58 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 115.838 -0.619 . . . . 73.230000000000004 112.181 -172.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 241' ' ' LYS . 1.2 Cg_endo -86.68 -164.74 0.22 Allowed 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 123.274 2.65 . . . . 71.349999999999994 110.87 166.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 9.7 t -119.64 144.65 47.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.065 0.546 . . . . 75.519999999999996 110.021 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.8 t -122.68 133.66 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.134 -1.061 . . . . 75.209999999999994 108.134 173.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -70.78 96.3 1.23 Allowed 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 109.069 -0.715 . . . . 71.099999999999994 109.069 173.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -93.28 -20.26 33.22 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.658 -0.701 . . . . 51.340000000000003 113.161 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.44 77.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-O 121.763 0.792 . . . . 73.319999999999993 110.472 -174.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.4 p -166.64 81.82 0.97 Allowed Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 115.117 -0.947 . . . . 73.400000000000006 110.323 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.56 129.67 12.05 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.555 2.17 . . . . 45.149999999999999 111.122 172.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -79.82 138.15 37.15 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.167 0.587 . . . . 75.409999999999997 109.935 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -113.32 114.23 26.37 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.613 -0.884 . . . . 73.010000000000005 108.613 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -165.18 151.37 10.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.665 -0.865 . . . . 64.030000000000001 108.665 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.561 ' HA ' ' HE2' ' A' ' 253' ' ' LYS . 10.2 mmpt? -81.84 124.18 29.46 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.937 0.399 . . . . 75.25 111.709 -176.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -95.33 -160.11 0.76 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.446 1.099 . . . . 72.329999999999998 108.704 165.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 123.057 0.543 . . . . 73.239999999999995 109.795 -175.391 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.656 -0.498 . . . . 75.519999999999996 109.656 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.21 82.38 1.66 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 110.669 -0.972 . . . . 74.219999999999999 110.669 -174.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -73.41 98.46 2.74 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.934 0.894 . . . . 53.229999999999997 110.511 -172.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -110.4 105.66 57.33 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 109.007 -0.738 . . . . 61.140000000000001 109.007 174.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -72.45 85.47 1.08 Allowed 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.063 2.509 . . . . 61.340000000000003 112.503 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.62 24.36 0.11 Allowed Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.423 -0.808 . . . . 55.520000000000003 113.168 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -105.17 116.34 31.79 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 109.362 -0.607 . . . . 62.530000000000001 109.362 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.9 m -118.26 163.07 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.387 0.675 . . . . 72.010000000000005 109.516 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.2 mt -126.61 120.82 30.5 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.417 0.687 . . . . 51.509999999999998 109.68 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.12 131.91 1.31 Allowed Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.494 -0.614 . . . . 63.030000000000001 113.141 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -172.39 158.62 4.39 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.614 0.766 . . . . 75.329999999999998 109.554 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -79.02 -10.23 59.77 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.696 0.798 . . . . 74.299999999999997 111.872 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -130.47 149.76 52.0 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.615 -1.254 . . . . 75.129999999999995 107.615 171.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 47.8 mmm-85 60.79 80.57 0.26 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.682 0.793 . . . . 72.299999999999997 110.508 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.73 159.48 28.44 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.419 2.079 . . . . 75.129999999999995 110.586 173.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.0 p -66.26 166.87 11.25 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.325 0.583 . . . . 53.140000000000001 110.861 -173.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.6 mt -107.9 123.71 36.97 Favored Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 108.405 -0.961 . . . . 42.329999999999998 108.405 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HG3' ' HB3' ' A' ' 117' ' ' GLU . 55.5 Cg_endo -71.73 173.77 12.13 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.812 2.341 . . . . 73.439999999999998 112.253 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.79 149.28 29.67 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.16 0.584 . . . . 53.140000000000001 111.32 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.573 HD22 HD11 ' A' ' 23' ' ' ILE . 89.2 mt -87.43 95.23 9.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.322 0.649 . . . . 64.049999999999997 109.767 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -97.44 -49.15 5.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.147 0.579 . . . . 70.349999999999994 110.485 175.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -99.87 107.78 19.87 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.91 -0.404 . . . . 74.409999999999997 109.91 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.638 HD12 ' HB2' ' A' ' 97' ' ' ASN . 46.6 mm -124.26 121.04 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.103 0.961 . . . . 74.230000000000004 109.551 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -111.95 -50.31 2.92 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.376 -0.602 . . . . 75.420000000000002 109.376 174.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.82 -135.15 12.93 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 115.944 -0.571 . . . . 73.409999999999997 112.029 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.0 79.43 8.52 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.174 0.487 . . . . 65.219999999999999 110.048 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.24 -30.77 44.7 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 115.893 -0.594 . . . . 71.5 112.031 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -140.55 177.52 7.96 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.575 1.15 . . . . 75.310000000000002 110.484 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -147.1 -3.35 0.58 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.791 0.837 . . . . 72.109999999999999 110.766 171.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -109.62 122.11 46.71 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.248 0.619 . . . . 65.439999999999998 110.194 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.7 m -153.16 -70.84 0.15 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.987 0.915 . . . . 60.200000000000003 109.648 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 69.7 m -159.22 -166.06 1.73 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.137 0.975 . . . . 52.509999999999998 109.941 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -73.94 -87.21 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.62 0.768 . . . . 60.140000000000001 111.585 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 176.73 -6.38 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.651 1.18 . . . . 70.120000000000005 111.488 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.93 172.76 49.23 Favored Glycine 0 C--N 1.351 1.407 0 C-N-CA 123.033 0.349 . . . . 75.409999999999997 113.235 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.88 68.8 0.06 OUTLIER Glycine 0 CA--C 1.537 1.46 0 CA-C-O 119.626 -0.541 . . . . 51.310000000000002 112.922 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.459 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 26.2 Cg_endo -95.77 -159.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.939 3.093 . . . . 72.409999999999997 112.42 176.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -118.41 93.67 4.21 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.954 -1.128 . . . . 70.530000000000001 107.954 172.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.99 76.66 6.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.361 0.664 . . . . 64.150000000000006 110.645 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -164.13 140.71 6.54 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.158 0.983 . . . . 45.100000000000001 109.221 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.91 103.78 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 123.836 0.854 . . . . 63.520000000000003 108.829 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -112.65 90.87 3.46 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.949 0.9 . . . . 61.310000000000002 108.993 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.53 121.18 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.883 -0.598 . . . . 60.450000000000003 109.765 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -75.47 85.85 2.59 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.743 0.817 . . . . 75.019999999999996 109.313 175.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -72.18 -50.44 27.67 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.886 0.874 . . . . 73.099999999999994 109.276 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -139.17 152.41 47.38 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.973 0.909 . . . . 74.409999999999997 109.569 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.95 -57.58 0.19 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.852 0.861 . . . . 70.230000000000004 109.905 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.9 mt -57.91 -51.87 67.84 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.114 0.884 . . . . 73.099999999999994 110.869 -175.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -72.0 107.33 4.66 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 108.471 -0.937 . . . . 60.32 108.471 172.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -136.05 130.85 18.61 Favored Pre-proline 0 C--O 1.239 0.549 0 C-N-CA 123.631 0.772 . . . . 65.120000000000005 109.219 -175.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.79 155.98 7.44 Favored 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 122.64 2.227 . . . . 52.439999999999998 111.541 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.8 t -89.55 113.98 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 107.462 -1.31 . . . . 71.519999999999996 107.462 174.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.77 86.03 0.67 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 122.941 0.496 . . . . 75.409999999999997 110.656 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.9 t -107.36 133.7 51.5 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.589 1.155 . . . . 65.310000000000002 109.1 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.9 t70 65.74 29.15 10.82 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 122.142 0.973 . . . . 71.230000000000004 109.727 -173.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -74.96 157.13 35.47 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.227 1.011 . . . . 73.430000000000007 109.417 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 67.16 75.37 0.31 Allowed Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.101 0.96 . . . . 70.129999999999995 110.749 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.97 169.18 21.08 Favored 'Trans proline' 0 C--N 1.381 2.288 0 C-N-CA 123.884 3.056 . . . . 74.109999999999999 113.45 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -65.66 99.52 0.46 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.062 0.945 . . . . 60.030000000000001 109.963 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.63 151.91 18.28 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 123.497 0.498 . . . . 72.420000000000002 111.861 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.4 146.37 51.53 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.743 0.817 . . . . 75.299999999999997 110.279 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.4 m -117.3 35.88 4.48 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.832 0.853 . . . . 43.539999999999999 110.685 -170.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.16 -85.74 0.42 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.559 0.744 . . . . 64.329999999999998 110.537 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -171.73 123.3 0.53 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.28 1.032 . . . . 75.239999999999995 110.095 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -161.42 135.97 7.15 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.13 0.572 . . . . 33.25 111.094 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HD3' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -101.2 128.84 47.12 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.589 -0.893 . . . . 74.049999999999997 108.589 172.877 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -89.22 134.94 33.84 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.281 0.632 . . . . 74.340000000000003 109.806 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -67.1 149.71 50.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.524 0.729 . . . . 74.420000000000002 110.297 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.6 p -147.05 -43.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.049 0.54 . . . . 34.219999999999999 109.697 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt 67.0 14.22 9.77 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 124.961 1.413 . . . . 73.109999999999999 111.379 -175.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -81.51 79.7 8.05 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-O 122.292 1.044 . . . . 62.210000000000001 108.8 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.414 ' HA ' ' HZ3' ' A' ' 103' ' ' LYS . 11.0 m120 -105.09 -40.41 5.89 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 113.737 -1.574 . . . . 70.510000000000005 110.52 -169.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.62 120.91 10.34 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.383 1.052 . . . . 73.030000000000001 111.393 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.3 mt -130.22 153.01 49.02 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.756 1.223 . . . . 72.230000000000004 107.926 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.1 148.08 48.1 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.146 0.578 . . . . 73.400000000000006 109.628 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.02 70.46 0.1 Allowed Glycine 0 C--N 1.337 0.612 0 O-C-N 123.784 0.678 . . . . 53.43 112.855 177.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -80.04 133.7 10.14 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.821 2.347 . . . . 65.340000000000003 111.813 175.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 37' ' ' PRO . 64.6 p -147.0 133.21 19.4 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 122.738 0.415 . . . . 72.340000000000003 109.911 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.96 70.19 5.25 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 122.046 0.927 . . . . 74.430000000000007 110.598 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -142.48 -43.59 0.32 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.061 -1.427 . . . . 71.310000000000002 108.003 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.99 112.51 24.36 Favored Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 107.743 -1.206 . . . . 51.43 107.743 -177.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.0 -70.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.884 3.056 . . . . 70.150000000000006 113.647 -174.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -88.67 72.6 8.66 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.638 0.732 . . . . 63.439999999999998 109.062 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.58 HD11 ' HB3' ' A' ' 106' ' ' LYS . 29.8 tp -89.95 130.92 36.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.952 -1.022 . . . . 75.019999999999996 108.878 177.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 13.0 m-85 -113.84 174.97 5.67 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.008 1.723 . . . . 73.409999999999997 109.015 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.96 149.1 19.95 Favored 'Isoleucine or valine' 0 C--O 1.256 1.395 0 N-CA-C 109.081 -0.711 . . . . 71.129999999999995 109.081 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.25 124.5 33.92 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.387 -0.824 . . . . 74.420000000000002 109.828 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.4 mt -83.13 -17.74 41.97 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.264 1.026 . . . . 74.25 111.619 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.479 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 57.8 m-85 -135.44 166.37 23.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.71 0.804 . . . . 64.019999999999996 109.336 -175.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -78.79 145.8 34.13 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.271 -0.877 . . . . 70.430000000000007 109.172 168.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -155.46 112.75 3.29 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.687 -0.486 . . . . 65.510000000000005 109.687 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.98 139.12 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.192 -0.67 . . . . 60.009999999999998 109.192 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.13 127.74 34.18 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.963 -0.384 . . . . 73.040000000000006 109.963 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.6 p -65.66 -24.37 67.01 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.648 0.779 . . . . 64.049999999999997 110.919 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.97 -149.78 8.47 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.53 -1.028 . . . . 61.32 110.53 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.24 -30.59 69.67 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.819 0.848 . . . . 72.209999999999994 111.578 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.638 ' HB2' HD12 ' A' ' 23' ' ' ILE . 20.1 p30 -71.24 -23.31 61.97 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.029 0.932 . . . . 63.530000000000001 113.51 -172.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.6 p -113.26 163.12 15.21 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.747 0.819 . . . . 61.539999999999999 110.217 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.402 ' HB3' HG13 ' A' ' 130' ' ' VAL . 59.3 tp -111.06 125.72 54.05 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.13 -0.693 . . . . 61.32 109.13 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -74.43 119.66 18.92 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.677 -0.86 . . . . 65.310000000000002 108.677 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.0 pt -123.87 138.71 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.273 0.629 . . . . 52.409999999999997 109.546 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.4 m -97.23 150.06 21.34 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.336 -0.847 . . . . 65.310000000000002 109.756 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.414 ' HZ3' ' HA ' ' A' ' 72' ' ' ASN . 66.3 tttp -61.22 113.58 2.68 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 109.484 -0.562 . . . . 71.329999999999998 109.484 172.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.25 -11.11 47.69 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.198 -0.455 . . . . 44.439999999999998 113.697 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -72.68 134.56 45.13 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.537 0.735 . . . . 72.030000000000001 110.387 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.58 ' HB3' HD11 ' A' ' 84' ' ' LEU . 34.8 mtmm -85.75 123.27 30.94 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.877 0.871 . . . . 74.239999999999995 109.7 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.601 ' HA ' HG22 ' A' ' 123' ' ' THR . 13.0 mt -107.88 158.36 17.4 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.898 -0.779 . . . . 74.120000000000005 108.898 -170.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtm-85 -123.07 108.64 13.12 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.846 -0.798 . . . . 75.049999999999997 108.846 164.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.505 HG21 HD12 ' A' ' 135' ' ' ILE . 98.6 t -88.71 109.46 20.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.334 -0.617 . . . . 61.210000000000001 109.334 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.476 HD12 ' NE2' ' A' ' 127' ' ' GLN . 75.8 mt -81.68 -12.23 58.75 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.198 -0.91 . . . . 65.409999999999997 111.092 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.72 159.13 18.67 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.39 -0.684 . . . . 54.25 111.39 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 4.1 m-85 -96.93 173.61 7.2 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.686 0.794 . . . . 74.310000000000002 110.28 178.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.468 HD22 ' HB2' ' A' ' 118' ' ' TRP . 32.3 t-20 -77.76 147.19 35.45 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.176 0.991 . . . . 72.239999999999995 108.555 173.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.52 ' HD2' ' HG2' ' A' ' 177' ' ' PRO . 34.0 m170 -63.7 -26.28 68.58 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.117 0.567 . . . . 71.430000000000007 111.645 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -87.66 -16.85 33.21 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.389 1.075 . . . . 52.310000000000002 110.512 175.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.94 0.68 77.59 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 123.911 0.767 . . . . 75.299999999999997 113.68 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.403 ' HB3' ' HG3' ' A' ' 18' ' ' PRO . 17.2 mm-40 -78.0 -47.29 18.8 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.158 0.983 . . . . 71.239999999999995 112.098 -172.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.468 ' HB2' HD22 ' A' ' 113' ' ' ASN . 83.2 m95 -105.61 174.63 5.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.857 0.863 . . . . 62.420000000000002 109.637 177.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -153.49 127.14 8.75 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.175 -1.046 . . . . 74.230000000000004 108.175 175.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -74.28 106.63 6.01 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.232 0.469 . . . . 73.420000000000002 110.409 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.66 163.65 12.18 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.317 -0.856 . . . . 74.340000000000003 109.698 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -139.71 122.78 16.78 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.6 -1.259 . . . . 54.210000000000001 107.6 178.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 107' ' ' LEU . 78.9 p -131.81 -169.56 2.23 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.379 0.672 . . . . 75.120000000000005 110.611 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -54.1 -28.52 39.87 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.098 -1.41 . . . . 53.32 111.708 170.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -84.64 -2.36 57.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.33 1.052 . . . . 64.010000000000005 111.84 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.51 -132.79 10.15 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 111.418 -0.673 . . . . 72.209999999999994 111.418 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.476 ' NE2' HD12 ' A' ' 110' ' ' LEU . 63.3 tt0 -142.99 143.74 32.04 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.243 0.617 . . . . 52.329999999999998 110.29 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 174.91 -178.13 46.76 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.843 -0.617 . . . . 54.409999999999997 111.58 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -95.97 123.87 39.74 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.017 0.527 . . . . 72.439999999999998 110.762 -173.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 99' ' ' LEU . 35.1 m -117.64 149.02 44.24 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.978 1.311 . . . . 41.229999999999997 109.601 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.78 132.53 23.48 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 121.669 1.579 . . . . 74.310000000000002 111.234 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.6 m -60.74 -21.56 63.1 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.177 0.991 . . . . 75.040000000000006 112.364 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -68.55 -24.65 64.65 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.879 0.872 . . . . 73.209999999999994 111.741 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.479 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.2 m-85 -94.94 0.84 55.06 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.791 0.836 . . . . 63.420000000000002 112.78 -177.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.505 HD12 HG21 ' A' ' 109' ' ' VAL . 15.9 pt -127.72 160.88 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 118.98 0.809 . . . . 74.25 111.365 -171.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.1 t -157.89 145.09 13.39 Favored Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 119.108 -0.472 . . . . 71.349999999999994 110.599 169.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.37 139.27 37.73 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.714 2.276 . . . . 44.43 111.804 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.28 -50.01 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.001 0.52 . . . . 74.239999999999995 112.037 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -100.74 -6.04 25.56 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.397 0.544 . . . . 75.439999999999998 110.916 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.5 t -60.32 177.75 0.25 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.27 1.028 . . . . 75.030000000000001 111.891 -176.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 84.7 mt -57.13 -17.66 11.75 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.981 0.912 . . . . 73.140000000000001 112.678 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -57.7 -24.7 58.18 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.506 1.122 . . . . 55.340000000000003 112.04 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -56.71 -36.19 69.39 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.409 1.083 . . . . 70.109999999999999 111.25 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 -74.33 141.71 45.2 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.369 -0.832 . . . . 75.230000000000004 109.342 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.1 t -62.69 -21.81 66.02 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.812 0.845 . . . . 75.010000000000005 112.075 -176.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.425 ' CE3' ' HB2' ' A' ' 147' ' ' TYR . 58.8 p-90 -80.05 -41.53 25.52 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.382 0.512 . . . . 73.510000000000005 112.382 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.425 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 29.5 t80 -99.98 138.04 37.6 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.375 0.534 . . . . 74.420000000000002 109.566 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.404 ' HB2' ' NE ' ' A' ' 171' ' ' ARG . 22.1 m-70 -126.7 14.06 7.5 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 112.172 0.434 . . . . 64.109999999999999 112.172 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.15 -162.65 50.02 Favored Glycine 0 N--CA 1.474 1.23 0 CA-C-O 119.581 -0.566 . . . . 62.439999999999998 114.403 171.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.07 100.38 0.97 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.785 2.99 . . . . 61.439999999999998 111.558 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.55 HG11 ' NH2' ' A' ' 171' ' ' ARG . 84.1 t -138.93 150.92 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.818 0.447 . . . . 74.420000000000002 110.595 -172.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 18.4 m -59.2 139.34 57.04 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.598 1.159 . . . . 71.230000000000004 111.411 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -62.8 -27.59 69.41 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.736 0.814 . . . . 74.450000000000003 111.483 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -62.4 -50.3 72.07 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.529 0.732 . . . . 73.420000000000002 110.2 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.62 -33.83 76.81 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.461 0.705 . . . . 64.409999999999997 111.54 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 171' ' ' ARG . . . -58.5 -52.36 65.97 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.256 -0.884 . . . . 60.539999999999999 110.573 173.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.462 ' HG3' HG11 ' A' ' 190' ' ' VAL . 35.0 tt0 -69.62 -27.41 65.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.537 0.735 . . . . 65.540000000000006 111.195 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -64.91 -49.42 70.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.856 0.862 . . . . 74.319999999999993 110.983 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.498 HD12 HH12 ' A' ' 171' ' ' ARG . 63.8 mt -70.77 -37.23 73.35 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 120.88 0.371 . . . . 71.040000000000006 110.739 175.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.7 tp -64.53 -25.38 67.96 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.547 -0.751 . . . . 75.349999999999994 112.094 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.6 t -59.96 -29.26 68.31 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.173 0.989 . . . . 62.119999999999997 111.228 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.2 t -77.17 -12.93 60.01 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.97 0.908 . . . . 74.340000000000003 111.969 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.59 165.61 32.43 Favored Glycine 0 C--N 1.344 1.001 0 N-CA-C 113.811 0.284 . . . . 61.539999999999999 113.811 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.0 pt -113.5 -164.28 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.58 1.152 . . . . 71.450000000000003 109.909 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.763 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 21.5 p-10 -52.99 115.18 1.72 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.725 0.81 . . . . 72.25 112.378 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.06 12.79 57.25 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 115.472 -0.785 . . . . 74.310000000000002 113.013 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 21.9 t -76.3 138.78 40.73 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.911 -0.774 . . . . 60.310000000000002 108.911 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 16.1 p90 -138.42 158.15 44.84 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.095 0.474 . . . . 72.25 111.979 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.506 HD13 ' NH1' ' A' ' 171' ' ' ARG . 84.9 mt -141.27 134.37 29.27 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.216 -1.031 . . . . 73.420000000000002 108.216 168.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 214' ' ' LEU . 16.0 t -106.93 123.18 61.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.947 -1.131 . . . . 61.030000000000001 107.947 175.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.55 ' NH2' HG11 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -130.86 157.87 41.73 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.298 -1.371 . . . . 63.119999999999997 107.298 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 11.7 pt-20 -108.22 162.97 13.58 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 109.29 -0.633 . . . . 74.109999999999999 109.29 166.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 176' ' ' SER . 48.1 t -82.67 136.94 34.62 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.22 -0.9 . . . . 63.420000000000002 111.038 -175.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.62 -22.35 63.5 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.139 -1.392 . . . . 50.229999999999997 111.567 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 30.1 t -111.24 -0.53 16.42 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.834 0.854 . . . . 73.230000000000004 111.384 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 173' ' ' SER . 24.2 m -139.68 119.67 9.19 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 119.091 -0.481 . . . . 73.150000000000006 109.798 -178.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.52 ' HG2' ' HD2' ' A' ' 114' ' ' HIS . 21.4 Cg_exo -67.11 112.86 2.64 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 123.888 3.059 . . . . 74.319999999999993 113.401 -169.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.95 9.26 52.94 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.54 0.525 . . . . 62.43 114.024 175.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -85.05 114.55 22.28 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 107.71 -1.218 . . . . 63.109999999999999 107.71 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 57.2 mtt-85 -104.67 169.46 8.44 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.379 -0.6 . . . . 71.439999999999998 109.379 -169.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.0 m -155.0 136.42 14.15 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 123.875 0.87 . . . . 75.329999999999998 108.949 -173.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.428 HG12 HG22 ' A' ' 170' ' ' VAL . 54.7 mt -104.13 135.99 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 108.459 -0.941 . . . . 74.340000000000003 108.459 173.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.9 m -113.25 111.83 22.7 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.62 -1.173 . . . . 64.239999999999995 107.875 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.444 HD21 HD23 ' A' ' 232' ' ' LEU . 53.4 mt -105.0 139.81 39.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.753 0.821 . . . . 74.329999999999998 111.419 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -126.37 130.33 50.56 Favored 'General case' 0 C--O 1.261 1.685 0 O-C-N 124.056 0.848 . . . . 74.420000000000002 109.141 172.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.763 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 14.4 p90 -151.7 137.84 18.31 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 124.362 1.039 . . . . 75.5 108.492 172.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 55.36 28.94 12.18 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.044 1.338 . . . . 74.010000000000005 113.227 177.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.8 14.77 81.68 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 116.012 -0.54 . . . . 73.530000000000001 113.394 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -109.08 126.12 52.84 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.317 1.047 . . . . 74.409999999999997 108.698 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.462 HG11 ' HG3' ' A' ' 157' ' ' GLU . 91.5 t -109.81 135.58 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.509 0.724 . . . . 74.25 109.289 174.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.442 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 22.5 p90 -144.31 155.07 43.66 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.207 0.603 . . . . 74.019999999999996 109.538 171.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -129.17 136.34 50.03 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.156 -1.053 . . . . 72.150000000000006 108.156 -171.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -136.24 144.57 44.92 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 121.001 0.429 . . . . 75.530000000000001 110.738 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -76.91 131.71 38.71 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.73 -1.123 . . . . 71.129999999999995 110.365 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 77.8 mt -80.6 106.86 12.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 N-CA-C 108.298 -1.001 . . . . 72.530000000000001 108.298 164.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -69.74 123.72 22.12 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.436 -0.802 . . . . 70.209999999999994 109.558 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.3 m -104.88 107.99 19.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.427 0.691 . . . . 62.130000000000003 110.497 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.42 170.66 4.64 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.348 1.059 . . . . 62.43 111.293 173.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 41.2 p -59.21 -37.48 77.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.058 0.943 . . . . 75.540000000000006 112.191 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -76.1 -2.67 32.02 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.962 0.505 . . . . 75.340000000000003 111.862 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.92 6.89 84.65 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 111.811 -0.516 . . . . 74.530000000000001 111.811 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -69.83 128.29 35.88 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.74 -0.467 . . . . 62.549999999999997 109.74 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 80.8 mt -95.33 147.44 23.5 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.461 0.704 . . . . 62.200000000000003 109.784 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -163.6 164.88 23.96 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.425 0.69 . . . . 75.209999999999994 110.42 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 78.7 t -138.04 -52.64 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.11 0.964 . . . . 75.230000000000004 109.23 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 33.0 t -100.25 -178.28 3.78 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.774 0.83 . . . . 75.409999999999997 110.853 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.8 m -63.93 -46.23 85.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.641 1.177 . . . . 72.319999999999993 111.986 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.92 -14.42 41.91 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.263 0.625 . . . . 65.230000000000004 112.095 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 74.7 m -64.15 117.31 6.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.187 0.595 . . . . 63.130000000000003 111.186 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -146.53 112.73 5.83 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.654 1.182 . . . . 63.240000000000002 108.665 168.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -130.86 142.53 50.39 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.387 0.675 . . . . 74.439999999999998 109.417 -176.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -81.66 -34.81 30.55 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.661 0.384 . . . . 71.349999999999994 110.016 173.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 60.4 p -124.2 152.93 42.31 Favored 'General case' 0 C--O 1.255 1.363 0 CA-C-O 122.112 0.958 . . . . 72.109999999999999 111.287 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 170' ' ' VAL . 35.9 tp -63.45 -31.14 72.21 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 113.671 -1.604 . . . . 61.539999999999999 111.266 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.96 95.65 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.497 0.719 . . . . 72.230000000000004 110.918 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -61.69 -44.13 97.54 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.478 0.711 . . . . 53.439999999999998 110.598 173.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.75 -41.08 85.67 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.709 0.631 . . . . 61.539999999999999 111.769 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.7 t -74.28 -41.99 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.645 0.778 . . . . 74.25 111.016 -175.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -58.81 -51.38 70.26 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.438 0.637 . . . . 70.129999999999995 110.1 174.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.422 ' O ' HG22 ' A' ' 224' ' ' VAL . 48.3 t-80 -54.14 -57.83 9.62 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.495 -1.229 . . . . 50.109999999999999 109.905 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -61.04 -26.7 67.81 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.337 0.655 . . . . 74.409999999999997 112.046 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 37.4 t -73.07 -27.76 61.92 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 122.913 0.485 . . . . 65.400000000000006 111.706 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.5 t -120.96 7.2 10.35 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 115.443 1.645 . . . . 71.010000000000005 115.443 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 220' ' ' HIS . 34.1 m -113.74 156.14 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 121.069 1.759 . . . . 53.130000000000003 115.431 -176.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.77 -2.47 58.25 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 129.986 3.314 . . . . 74.439999999999998 113.168 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -77.76 14.82 0.96 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 129.381 3.072 . . . . 73.439999999999998 113.51 -141.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.66 18.53 3.98 Favored Glycine 0 N--CA 1.47 0.921 0 C-N-CA 125.274 1.416 . . . . 75.409999999999997 111.377 -171.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 88.3 mt -91.26 134.49 34.53 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.206 1.002 . . . . 71.239999999999995 110.129 165.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.442 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 95.0 mt -67.83 -44.86 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 124.421 1.076 . . . . 65.420000000000002 108.695 170.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.5 t -135.04 142.13 46.3 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 114.992 -1.004 . . . . 71.299999999999997 108.866 173.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 67.4 p -70.38 155.98 39.95 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 108.606 -0.887 . . . . 75.129999999999995 108.606 171.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.446 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 32.1 mt -67.13 100.62 0.79 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.142 -1.058 . . . . 74.200000000000003 108.142 177.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -77.96 -50.29 12.46 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.066 0.547 . . . . 63.420000000000002 109.981 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 167' ' ' SER . 6.3 p90 -161.63 152.2 14.77 Favored Pre-proline 0 N--CA 1.488 1.455 0 C-N-CA 121.006 -0.278 . . . . 75.519999999999996 110.419 174.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 53.4 Cg_endo -69.06 137.06 36.52 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.238 1.959 . . . . 74.129999999999995 111.538 173.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -57.99 130.7 83.12 Favored Pre-proline 0 C--O 1.246 0.9 0 O-C-N 123.558 0.536 . . . . 73.030000000000001 109.894 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.39 145.26 87.81 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.28 1.987 . . . . 72.209999999999994 112.143 -172.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -63.06 159.25 17.65 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.555 -0.748 . . . . 60.420000000000002 109.149 171.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -52.75 -35.07 55.58 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.469 0.707 . . . . 74.239999999999995 112.453 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -64.98 176.74 1.14 Allowed 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.865 -0.607 . . . . 74.439999999999998 111.387 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.556 ' HE2' ' HB ' ' A' ' 243' ' ' THR . 20.6 ptmt -55.62 127.57 67.01 Favored Pre-proline 0 CA--C 1.558 1.25 0 N-CA-C 112.462 0.541 . . . . 74.0 112.462 -176.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.15 78.09 3.02 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.95 2.433 . . . . 60.43 110.575 174.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.556 ' HB ' ' HE2' ' A' ' 241' ' ' LYS . 8.8 t -79.23 113.43 17.36 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.423 0.63 . . . . 74.329999999999998 109.871 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.49 122.87 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.429 0.691 . . . . 74.450000000000003 109.439 -175.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -136.36 122.53 20.39 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.157 -1.053 . . . . 64.549999999999997 108.157 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 177.1 115.69 0.44 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 112.325 -0.31 . . . . 74.150000000000006 112.325 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 39.5 t -109.18 117.44 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 107.676 -1.231 . . . . 62.5 107.676 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 62.5 m -137.04 139.21 27.84 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 123.009 0.524 . . . . 71.239999999999995 110.864 -175.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -79.24 131.63 9.83 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.792 2.328 . . . . 74.25 111.781 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -85.6 140.97 30.16 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 108.684 -0.858 . . . . 65.209999999999994 108.684 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -66.22 133.83 51.44 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.546 0.738 . . . . 72.340000000000003 110.011 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -67.43 105.26 1.75 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 121.552 0.691 . . . . 74.450000000000003 109.979 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -156.18 143.24 18.97 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.529 -0.76 . . . . 74.439999999999998 109.662 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 44.2 t-105 -74.4 108.82 7.42 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.005 -1.109 . . . . 71.140000000000001 108.005 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 C--O 1.249 1.037 0 CA-C-N 115.438 -0.801 . . . . 52.219999999999999 109.815 179.098 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.592 -0.522 . . . . 70.530000000000001 109.592 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.87 73.84 1.12 Allowed Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.371 -0.692 . . . . 74.310000000000002 111.371 -173.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -68.87 122.53 18.82 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.531 0.732 . . . . 71.239999999999995 109.791 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -138.58 77.56 33.71 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.426 0.69 . . . . 75.450000000000003 110.66 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.78 -29.61 77.1 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.063 1.842 . . . . 64.099999999999994 111.949 172.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.01 140.59 5.13 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.305 -0.407 . . . . 61.32 112.88 175.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.48 124.94 52.71 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.217 0.607 . . . . 73.349999999999994 109.694 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.0 m -84.62 141.65 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 123.539 0.736 . . . . 62.109999999999999 109.937 178.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.2 tp -82.29 -32.31 29.59 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.188 0.995 . . . . 64.120000000000005 109.942 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.43 163.41 25.38 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.566 -0.743 . . . . 64.540000000000006 111.69 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.633 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 28.8 t70 -70.42 98.59 1.45 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.263 0.625 . . . . 53.0 110.242 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -129.22 -171.06 2.4 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.653 1.181 . . . . 74.540000000000006 109.364 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -69.84 111.77 5.81 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.231 -2.137 . . . . 75.519999999999996 105.231 161.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 62.19 81.32 0.23 Allowed Pre-proline 0 CA--C 1.542 0.647 0 O-C-N 124.219 0.949 . . . . 74.329999999999998 111.015 -162.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.633 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 68.7 Cg_endo -74.08 165.87 30.97 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.555 2.17 . . . . 75.209999999999994 110.527 170.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 p -71.76 168.75 17.16 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.796 0.808 . . . . 64.209999999999994 112.428 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.9 mt -107.72 133.28 20.5 Favored Pre-proline 0 C--O 1.241 0.62 0 CA-C-N 114.636 -1.165 . . . . 74.140000000000001 108.545 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.92 170.22 14.67 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.511 2.14 . . . . 75.25 111.99 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.89 144.67 29.06 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.051 0.541 . . . . 63.539999999999999 110.499 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.63 ' HB3' HD11 ' A' ' 23' ' ' ILE . 74.1 mt -87.43 94.85 9.81 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.557 0.743 . . . . 75.140000000000001 109.175 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -96.22 -47.09 6.18 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.023 -0.732 . . . . 64.319999999999993 109.023 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -99.77 113.77 26.47 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.143 -0.935 . . . . 72.230000000000004 109.815 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.63 HD11 ' HB3' ' A' ' 20' ' ' LEU . 39.1 mm -116.51 114.11 45.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 107.904 -1.147 . . . . 70.010000000000005 107.904 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -123.57 126.52 46.81 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.202 0.601 . . . . 63.439999999999998 109.627 -175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.27 8.84 2.67 Favored Glycine 0 CA--C 1.527 0.836 0 O-C-N 124.246 0.966 . . . . 60.219999999999999 112.101 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.75 83.16 5.24 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.0 -0.741 . . . . 71.209999999999994 109.0 175.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.65 100.53 1.32 Allowed Glycine 0 C--N 1.348 1.217 0 CA-C-N 115.881 -0.6 . . . . 73.230000000000004 112.335 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -125.34 -73.2 0.64 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.74 0.816 . . . . 75.409999999999997 109.214 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -151.1 -178.1 6.42 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.881 0.872 . . . . 71.230000000000004 110.254 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 58.05 47.15 15.18 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.686 1.195 . . . . 60.119999999999997 110.698 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.9 p 50.32 87.29 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.605 1.162 . . . . 74.540000000000006 111.426 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.8 p -139.67 137.74 35.48 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.49 0.716 . . . . 70.120000000000005 109.59 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.417 ' HG3' ' HG2' ' A' ' 127' ' ' GLN . 64.2 ttt-85 -64.97 106.97 1.36 Allowed 'General case' 0 C--N 1.347 0.47 0 C-N-CA 123.568 0.747 . . . . 64.340000000000003 112.318 -172.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -74.39 132.42 41.97 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.867 -0.79 . . . . 64.209999999999994 108.867 168.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.53 71.64 2.8 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 116.132 -0.485 . . . . 53.329999999999998 113.078 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.6 88.59 0.41 Allowed Glycine 0 C--N 1.344 0.975 0 CA-C-O 119.218 -0.768 . . . . 74.420000000000002 111.407 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -83.38 163.0 14.95 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 123.065 2.51 . . . . 64.430000000000007 112.211 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -76.02 148.48 38.0 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.1 0.56 . . . . 61.520000000000003 110.857 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 55.7 m -98.46 132.44 43.91 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.767 -0.651 . . . . 72.209999999999994 110.001 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -113.54 133.31 55.32 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.889 0.876 . . . . 62.420000000000002 109.046 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -124.0 146.66 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.491 0.716 . . . . 70.439999999999998 110.038 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -117.75 167.3 11.49 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.366 1.066 . . . . 75.430000000000007 109.718 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -145.52 151.05 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.658 0.783 . . . . 63.130000000000003 109.447 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -67.61 148.01 51.97 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.928 0.891 . . . . 75.340000000000003 111.417 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -84.72 176.58 8.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.94 0.496 . . . . 74.209999999999994 110.229 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -134.69 139.87 45.56 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.367 0.667 . . . . 64.439999999999998 109.644 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.26 82.92 2.0 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.29 -1.004 . . . . 52.509999999999998 108.29 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.3 mt -67.2 -24.48 65.85 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.732 0.813 . . . . 74.030000000000001 112.167 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -80.33 168.25 19.26 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.863 0.465 . . . . 75.230000000000004 111.447 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -62.24 148.7 88.83 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 115.427 -0.806 . . . . 74.439999999999998 110.628 171.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.62 72.53 0.66 Allowed 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.919 2.413 . . . . 54.399999999999999 111.245 171.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 p -97.69 98.76 7.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.893 -1.151 . . . . 61.149999999999999 107.893 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.19 75.52 1.11 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.332 0.653 . . . . 74.409999999999997 109.747 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.2 m -88.12 -16.54 33.2 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.55 -0.75 . . . . 64.430000000000007 109.96 169.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -78.45 169.28 18.51 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.714 0.806 . . . . 74.319999999999993 110.597 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -101.68 153.92 19.35 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.889 -1.05 . . . . 74.040000000000006 108.932 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 61.49 71.11 0.81 Allowed Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 124.774 1.229 . . . . 61.43 111.641 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.83 -38.06 5.9 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.39 2.06 . . . . 71.430000000000007 112.675 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -85.83 101.29 12.7 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.8 0.84 . . . . 74.329999999999998 109.765 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.03 39.25 0.24 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.196 -0.761 . . . . 52.119999999999997 111.196 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.8 mt -89.47 71.18 8.03 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.162 0.985 . . . . 73.010000000000005 110.18 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.3 m -137.48 127.33 25.59 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.478 -0.783 . . . . 60.140000000000001 109.577 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -157.11 146.08 20.0 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.98 1.312 . . . . 72.239999999999995 108.374 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.69 67.82 6.71 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.511 0.725 . . . . 74.239999999999995 109.257 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.47 101.03 3.4 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-N 114.936 -1.029 . . . . 74.450000000000003 109.756 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -103.55 146.72 28.12 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.508 0.723 . . . . 62.5 109.447 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 52.7 t90 -76.19 139.44 41.23 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.569 0.748 . . . . 71.420000000000002 110.263 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -111.51 122.61 48.3 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.69 0.796 . . . . 61.109999999999999 108.989 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.3 p -75.12 83.58 2.32 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.332 -0.618 . . . . 60.43 109.332 176.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -83.76 -69.78 0.61 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.821 -1.178 . . . . 73.120000000000005 107.821 176.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.26 -50.34 60.88 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.215 0.606 . . . . 72.230000000000004 110.406 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -63.12 108.27 1.21 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.222 -0.899 . . . . 72.409999999999997 109.071 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.7 mt -73.54 80.27 1.46 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.758 0.823 . . . . 64.340000000000003 109.551 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.9 mt -110.37 18.22 20.07 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.614 1.166 . . . . 75.510000000000005 110.421 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.52 75.94 7.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.629 0.771 . . . . 62.450000000000003 110.185 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 147.69 60.16 0.01 OUTLIER Glycine 0 CA--C 1.53 0.99 0 CA-C-N 115.391 -0.822 . . . . 75.129999999999995 111.14 178.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -84.33 90.26 0.88 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.836 2.358 . . . . 75.349999999999994 110.529 -175.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 p -110.48 114.25 27.52 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.901 0.881 . . . . 64.150000000000006 109.183 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.446 ' HB2' HD13 ' A' ' 84' ' ' LEU . 1.3 mp0 -72.31 148.54 45.29 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.612 0.765 . . . . 75.540000000000006 112.076 -174.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -87.5 75.74 9.1 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.959 0.903 . . . . 61.539999999999999 110.519 -172.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -175.19 148.47 1.08 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 124.579 1.151 . . . . 63.530000000000001 109.052 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -81.25 -5.68 12.8 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.389 2.06 . . . . 72.329999999999998 112.183 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -96.12 33.7 1.69 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.938 0.895 . . . . 73.209999999999994 110.368 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 33.9 tp -81.03 112.47 18.45 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.815 -0.809 . . . . 65.540000000000006 108.815 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.6 m-85 -104.45 177.73 4.76 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.918 1.687 . . . . 75.430000000000007 109.505 175.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 11.3 p -144.28 138.93 24.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.47 0.708 . . . . 73.340000000000003 109.161 171.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -78.23 112.8 15.58 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.98 0.912 . . . . 62.340000000000003 109.431 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.4 mt -74.72 -22.2 58.95 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.193 0.997 . . . . 64.230000000000004 111.925 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -130.88 152.55 50.08 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.103 0.961 . . . . 75.299999999999997 109.214 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -77.84 130.85 37.17 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.226 -1.027 . . . . 72.450000000000003 108.226 173.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.49 ' HB3' HG12 ' A' ' 101' ' ' ILE . 74.7 t80 -133.21 114.83 14.27 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 108.916 -0.772 . . . . 74.239999999999995 108.916 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.3 136.76 22.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 108.904 -0.776 . . . . 65.319999999999993 108.904 171.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.8 137.96 57.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.762 0.425 . . . . 62.399999999999999 110.537 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.1 t -75.73 -9.93 59.01 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.064 0.546 . . . . 75.010000000000005 110.152 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.12 -154.63 25.12 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 115.866 -0.606 . . . . 55.340000000000003 111.759 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.99 -40.25 95.0 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.258 1.023 . . . . 70.540000000000006 111.789 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -67.86 -25.06 65.34 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.769 0.828 . . . . 72.109999999999999 112.467 -172.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.9 p -106.29 158.49 16.83 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.626 0.77 . . . . 71.109999999999999 109.702 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.8 tp -109.66 124.94 52.05 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 122.999 0.52 . . . . 73.200000000000003 109.991 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 p -70.57 114.88 9.11 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.279 -0.873 . . . . 74.010000000000005 109.356 170.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 91' ' ' PHE . 24.8 pt -119.7 156.98 22.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.023 -0.732 . . . . 60.420000000000002 109.023 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 1.9 m -117.35 143.65 45.74 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.318 -0.623 . . . . 53.109999999999999 109.318 -174.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -57.56 120.22 7.91 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 122.807 0.443 . . . . 74.219999999999999 110.367 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.53 -13.84 63.82 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.323 0.389 . . . . 73.349999999999994 113.455 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -85.74 130.98 34.41 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.846 0.858 . . . . 71.040000000000006 110.235 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HB3' HD11 ' A' ' 84' ' ' LEU . 9.1 mtmp? -83.7 142.72 30.53 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.813 0.845 . . . . 74.120000000000005 110.886 -177.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.1 mt -120.46 150.96 39.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.519 1.128 . . . . 71.129999999999995 108.282 -171.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -113.89 107.37 15.61 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.941 -1.133 . . . . 64.030000000000001 107.941 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.08 121.94 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 109.935 -0.394 . . . . 53.340000000000003 109.935 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 72.3 mt -83.38 -41.57 18.02 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.098 0.475 . . . . 74.450000000000003 109.95 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.52 172.34 44.07 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.58 -0.736 . . . . 70.140000000000001 111.828 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.483 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 13.3 m-85 -99.28 169.13 9.58 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.046 -0.724 . . . . 71.349999999999994 109.046 175.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -66.39 146.53 54.47 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.877 -1.156 . . . . 75.219999999999999 107.877 172.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.689 ' HA ' ' HG3' ' A' ' 177' ' ' PRO . 31.0 m170 -68.59 -21.27 64.52 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.939 0.496 . . . . 62.100000000000001 112.217 -174.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -94.57 -12.23 27.92 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.17 0.588 . . . . 71.299999999999997 110.673 174.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 82.33 35.23 21.07 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 116.453 -0.339 . . . . 41.439999999999998 112.794 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -85.59 -65.68 0.98 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.518 0.727 . . . . 65.239999999999995 110.256 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -115.83 179.46 3.97 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.654 1.181 . . . . 71.439999999999998 109.5 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -135.31 127.45 29.91 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.91 0.884 . . . . 34.119999999999997 108.664 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -83.46 113.84 21.05 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.199 0.523 . . . . 73.310000000000002 110.668 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.76 163.49 18.04 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 114.966 -1.016 . . . . 63.020000000000003 110.47 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -133.16 141.64 48.23 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.103 0.961 . . . . 73.120000000000005 109.596 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.3 p -137.33 179.77 6.2 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.54 1.536 . . . . 74.420000000000002 108.053 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -73.96 -6.51 47.78 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.437 0.295 . . . . 54.420000000000002 110.753 172.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -76.88 -22.93 52.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.061 0.945 . . . . 75.049999999999997 110.177 169.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 130.13 -171.1 20.59 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 111.109 -0.796 . . . . 44.329999999999998 111.109 -174.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.417 ' HG2' ' HG3' ' A' ' 33' ' ' ARG . 57.2 tt0 -115.96 147.05 41.58 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.642 0.777 . . . . 60.509999999999998 110.245 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 175.45 -176.81 47.4 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 123.442 0.464 . . . . 75.219999999999999 112.767 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -89.42 136.01 33.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.833 0.853 . . . . 70.230000000000004 110.631 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.76 154.95 80.78 Favored Pre-proline 0 N--CA 1.482 1.163 0 C-N-CA 124.465 1.106 . . . . 54.310000000000002 110.206 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.68 130.1 11.36 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.481 2.12 . . . . 42.009999999999998 111.236 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.512 ' HA ' HG12 ' A' ' 135' ' ' ILE . 13.6 p -63.43 -20.93 65.98 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.61 0.764 . . . . 71.219999999999999 111.897 178.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -70.73 -27.02 63.65 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.872 0.869 . . . . 70.420000000000002 111.537 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -95.39 2.25 54.53 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.554 0.742 . . . . 63.210000000000001 111.955 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.512 HG12 ' HA ' ' A' ' 132' ' ' SER . 14.4 pt -134.92 152.33 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 118.029 0.377 . . . . 52.329999999999998 110.544 -173.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.4 t -143.3 139.56 16.71 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.455 0.702 . . . . 51.149999999999999 109.117 171.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.567 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 56.0 Cg_endo -71.05 140.36 37.69 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 122.26 1.974 . . . . 71.549999999999997 112.058 175.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.4 m -111.1 -45.05 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.152 0.981 . . . . 74.310000000000002 110.613 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.551 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.5 t30 -100.04 6.8 45.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.964 0.506 . . . . 53.340000000000003 111.22 -174.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 31.0 t -86.42 176.19 8.0 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.241 0.543 . . . . 65.25 110.127 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.456 ' O ' ' HB3' ' A' ' 147' ' ' TYR . 80.7 mt -66.21 -13.93 61.08 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.129 0.971 . . . . 74.409999999999997 112.585 -176.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.87 -28.79 64.47 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.521 0.728 . . . . 74.019999999999996 111.785 176.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -64.18 -25.37 68.05 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.088 -0.505 . . . . 54.399999999999999 110.853 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -78.54 134.29 37.27 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.57 -0.9 . . . . 74.439999999999998 108.57 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.1 t -67.89 -18.87 64.93 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.167 0.803 . . . . 74.319999999999993 113.167 -171.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 61.4 p-90 -78.99 -26.46 43.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.073 0.549 . . . . 75.400000000000006 111.849 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 46.7 t80 -109.72 125.62 52.86 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.244 0.618 . . . . 64.409999999999997 109.389 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -113.11 25.89 10.97 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.669 0.388 . . . . 63.509999999999998 111.482 -172.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 64.61 -156.6 46.05 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.769 -0.65 . . . . 63.240000000000002 114.323 172.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.425 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 56.6 Cg_endo -70.52 101.58 1.04 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 123.009 2.473 . . . . 70.439999999999998 111.008 173.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.3 p -143.19 145.1 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 120.911 0.386 . . . . 73.219999999999999 110.289 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 70.5 m -73.62 166.73 22.74 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.449 1.1 . . . . 75.540000000000006 112.747 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 44.6 mtt85 -65.35 -40.94 94.24 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.52 -1.218 . . . . 72.319999999999993 111.359 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -70.13 -42.93 71.95 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.059 0.849 . . . . 72.200000000000003 111.186 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.64 -42.72 86.25 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.127 0.971 . . . . 72.140000000000001 110.135 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.35 -52.71 64.46 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.728 -1.124 . . . . 73.140000000000001 110.02 173.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.534 ' HG3' HG11 ' A' ' 190' ' ' VAL . 37.9 tt0 -61.07 -29.17 69.58 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.322 0.649 . . . . 75.409999999999997 111.272 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -63.68 -52.71 59.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.664 0.785 . . . . 55.049999999999997 110.277 173.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.62 -33.85 75.86 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.806 -0.634 . . . . 73.019999999999996 111.162 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.662 HD23 HG13 ' A' ' 190' ' ' VAL . 28.9 tp -78.55 -23.39 46.18 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.092 -0.958 . . . . 74.329999999999998 111.595 -177.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 t -64.28 -23.6 67.36 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.66 0.784 . . . . 42.549999999999997 111.374 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.0 m -82.88 -7.97 59.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.016 0.926 . . . . 65.030000000000001 112.091 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.15 174.03 41.67 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 114.26 0.464 . . . . 43.229999999999997 114.26 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.0 pt -121.29 -164.24 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.027 0.931 . . . . 52.109999999999999 109.91 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.769 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 22.7 p-10 -49.56 117.18 2.08 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.163 0.985 . . . . 72.140000000000001 112.236 177.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.97 13.99 68.06 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-N 115.562 -0.744 . . . . 71.519999999999996 113.617 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 23.3 t -73.54 132.96 43.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.569 -0.901 . . . . 72.209999999999994 108.569 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.495 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 19.4 p90 -134.87 161.32 35.55 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.176 0.806 . . . . 75.430000000000007 113.176 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 76.9 mt -137.87 135.47 36.19 Favored 'General case' 0 C--O 1.215 -0.754 0 C-N-CA 124.901 1.281 . . . . 73.340000000000003 108.978 172.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 14.3 t -114.83 140.06 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 106.467 -1.679 . . . . 75.040000000000006 106.467 167.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.2 ptt85 -158.72 168.85 25.77 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.955 0.502 . . . . 73.310000000000002 110.474 -172.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.473 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 12.2 pt-20 -115.46 153.44 31.1 Favored 'General case' 0 C--O 1.257 1.448 0 C-N-CA 123.09 0.556 . . . . 63.520000000000003 109.543 167.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 176' ' ' SER . 17.1 m -88.43 123.76 33.29 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.072 -0.967 . . . . 72.200000000000003 109.291 -178.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' A' ' 150' ' ' PRO . 38.3 mt-10 -57.56 -39.36 76.51 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.421 1.089 . . . . 71.5 111.674 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.614 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 8.5 t -87.41 -6.26 58.51 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 115.167 -0.924 . . . . 74.219999999999999 111.969 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 173' ' ' SER . 14.9 m -131.72 100.21 16.38 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.425 0.69 . . . . 73.109999999999999 109.324 -176.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.689 ' HG3' ' HA ' ' A' ' 114' ' ' HIS . 36.3 Cg_endo -60.35 113.55 1.73 Allowed 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.745 2.963 . . . . 74.209999999999994 112.061 -174.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.72 -20.38 19.56 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 116.101 -0.5 . . . . 44.43 113.666 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -73.79 116.84 14.87 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.648 0.724 . . . . 75.340000000000003 109.305 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.473 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 66.9 mtt85 -113.23 160.23 18.5 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 124.186 0.995 . . . . 71.129999999999995 110.279 -171.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 44.4 t -143.92 151.58 40.0 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.093 0.957 . . . . 74.430000000000007 110.48 -174.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.432 HD11 HD21 ' A' ' 217' ' ' LEU . 52.1 mt -119.06 145.85 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.214 1.006 . . . . 71.319999999999993 108.519 169.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.5 m -125.18 127.34 46.65 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.629 1.172 . . . . 61.340000000000003 108.148 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.449 HD21 HD23 ' A' ' 232' ' ' LEU . 57.9 mt -113.67 147.78 37.53 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.624 0.77 . . . . 75.420000000000002 111.891 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 19.7 ttt180 -133.86 131.01 38.68 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-N 114.536 -1.211 . . . . 74.299999999999997 109.651 172.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.769 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 9.5 p90 -149.38 141.03 23.49 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.562 1.145 . . . . 74.049999999999997 108.022 173.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 54.07 31.67 14.18 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.224 1.01 . . . . 53.200000000000003 113.232 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.19 3.68 90.62 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 116.343 -0.389 . . . . 64.230000000000004 112.782 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 10.3 tpp180 -102.13 124.21 47.33 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.151 0.98 . . . . 74.030000000000001 109.72 -176.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.662 HG13 HD23 ' A' ' 160' ' ' LEU . 81.0 t -107.45 135.89 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.265 1.026 . . . . 72.120000000000005 109.578 177.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.472 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 26.7 p90 -145.87 163.11 36.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.202 1.001 . . . . 74.439999999999998 109.744 171.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -133.45 141.98 48.07 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.194 0.997 . . . . 75.140000000000001 108.477 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -143.17 152.62 41.97 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.43 0.692 . . . . 75.219999999999999 109.57 175.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -95.85 138.01 34.1 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.452 0.701 . . . . 72.200000000000003 111.62 -170.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 69.4 mt -83.58 113.8 23.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 124.229 1.012 . . . . 61.130000000000003 108.347 165.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -88.38 134.87 33.71 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.194 0.598 . . . . 73.329999999999998 109.686 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.2 m -104.35 120.34 40.97 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.13 0.972 . . . . 55.210000000000001 109.518 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -72.48 164.82 25.77 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.304 1.042 . . . . 62.119999999999997 111.697 175.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 52.6 p -68.94 -17.05 63.89 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.645 0.778 . . . . 71.510000000000005 111.068 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.57 -19.19 65.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.407 1.083 . . . . 63.32 111.577 173.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 91.93 -6.06 79.18 Favored Glycine 0 C--N 1.353 1.517 0 CA-C-N 115.848 -0.615 . . . . 70.230000000000004 111.921 -168.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -76.25 144.23 40.49 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.351 0.66 . . . . 72.129999999999995 110.934 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 47.1 mt -95.65 152.48 18.41 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.598 1.159 . . . . 73.030000000000001 108.518 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -166.5 172.28 10.98 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.661 0.6 . . . . 74.540000000000006 111.084 174.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.4 t -131.84 -41.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.377 1.071 . . . . 51.32 108.758 174.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.6 t -92.39 153.83 18.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.331 -0.618 . . . . 71.530000000000001 109.331 173.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.4 p -66.48 -29.35 69.45 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.122 0.569 . . . . 65.409999999999997 110.957 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -92.56 2.92 56.43 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.4 0.68 . . . . 71.310000000000002 112.144 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 211' ' ' PHE . 86.7 p -105.67 137.9 42.76 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.913 -0.773 . . . . 72.129999999999995 108.913 176.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -143.43 126.83 16.76 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.302 1.041 . . . . 74.430000000000007 108.194 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 209' ' ' SER . 14.4 m-85 -133.74 133.94 42.38 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.175 0.59 . . . . 74.310000000000002 109.422 -178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -74.88 -35.54 62.29 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.08 0.552 . . . . 72.510000000000005 110.403 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 61.9 p -123.22 147.44 46.89 Favored 'General case' 0 C--O 1.256 1.41 0 CA-C-O 122.267 1.032 . . . . 63.420000000000002 111.637 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.444 ' O ' HG23 ' A' ' 218' ' ' VAL . 25.1 tp -64.32 -28.62 69.84 Favored 'General case' 0 C--O 1.213 -0.832 0 CA-C-N 113.655 -1.611 . . . . 73.200000000000003 111.205 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.68 -42.53 95.28 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.316 0.646 . . . . 54.109999999999999 111.452 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -71.7 -35.03 70.11 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.975 0.51 . . . . 70.0 110.347 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.432 HD21 HD11 ' A' ' 182' ' ' ILE . 9.5 tt -56.54 -46.58 80.58 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.901 0.751 . . . . 72.150000000000006 110.384 170.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 214' ' ' LEU . 44.4 t -66.27 -44.97 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.738 0.815 . . . . 73.040000000000006 110.586 -177.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -61.78 -45.45 93.81 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.91 0.484 . . . . 63.530000000000001 110.145 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -52.35 -61.67 2.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.244 -0.889 . . . . 63.420000000000002 108.855 175.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -59.71 -23.45 63.16 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.88 -0.6 . . . . 61.350000000000001 111.92 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.406 ' O ' ' HB ' ' A' ' 231' ' ' THR . 35.6 t -75.21 -28.04 59.81 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.109 0.563 . . . . 72.549999999999997 111.713 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.8 t -118.17 -9.83 10.41 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.447 1.647 . . . . 51.310000000000002 115.447 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 27.6 m -92.71 148.45 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 123.632 1.682 . . . . 62.32 115.058 -167.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.6 0.16 54.99 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 110.96 -2.836 . . . . 74.25 111.359 173.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -78.9 15.46 1.08 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 128.959 2.904 . . . . 72.439999999999998 112.478 -143.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.05 18.39 4.67 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 124.525 1.059 . . . . 71.140000000000001 111.794 -170.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 56.0 mt -93.06 145.59 24.27 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.763 0.825 . . . . 75.409999999999997 111.47 162.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.472 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 63.9 mt -75.34 -43.42 43.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.644 -0.873 . . . . 62.439999999999998 108.644 170.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t -139.02 144.62 38.94 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.323 -0.853 . . . . 75.010000000000005 109.217 177.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 222' ' ' SER . 40.8 p -75.49 155.17 36.45 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.597 0.759 . . . . 71.450000000000003 109.73 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.495 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 21.2 mt -67.72 101.78 1.1 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.554 -0.906 . . . . 74.319999999999993 108.554 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -83.1 -47.43 11.66 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.49 0.716 . . . . 62.399999999999999 110.075 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -163.3 152.3 12.29 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 109.572 -0.529 . . . . 74.430000000000007 109.572 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.404 ' HB3' ' HA ' ' A' ' 146' ' ' TRP . 53.0 Cg_endo -68.51 144.39 60.83 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 121.932 1.755 . . . . 75.329999999999998 111.973 175.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -60.54 137.71 92.56 Favored Pre-proline 0 C--O 1.248 0.992 0 C-N-CA 123.359 0.664 . . . . 73.209999999999994 109.981 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.06 116.4 3.15 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.914 2.409 . . . . 61.439999999999998 111.742 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 240' ' ' ASN . 6.1 ttpm? -80.91 145.56 31.23 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.85 -1.166 . . . . 64.420000000000002 107.85 174.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -58.77 -39.65 81.61 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 123.624 0.578 . . . . 74.329999999999998 109.982 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.472 ' HB2' ' HE2' ' A' ' 238' ' ' LYS . 14.5 m120 -79.8 83.92 5.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 106.873 -1.528 . . . . 75.319999999999993 106.873 162.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 143.05 44.89 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 123.023 0.529 . . . . 71.430000000000007 110.833 -172.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -92.27 -174.2 0.51 Allowed 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.088 2.525 . . . . 72.049999999999997 110.817 165.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 17.9 p -87.72 103.35 15.52 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.021 -1.103 . . . . 72.019999999999996 108.021 168.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 62.5 t -68.62 105.16 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.04 0.536 . . . . 74.010000000000005 110.227 -175.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -104.14 95.09 5.74 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.145 -1.058 . . . . 75.349999999999994 108.145 174.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -117.96 31.07 5.83 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.353 -0.699 . . . . 42.439999999999998 111.353 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.93 93.34 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.962 0.905 . . . . 74.010000000000005 109.591 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 11.5 p -168.0 82.91 0.78 Allowed Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.87 1.268 . . . . 64.340000000000003 108.971 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -77.08 -71.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.107 2.538 . . . . 71.329999999999998 110.708 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 30.8 p30 -177.15 167.98 2.39 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 125.036 1.334 . . . . 75.140000000000001 108.955 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -89.22 163.3 15.46 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 108.259 -1.015 . . . . 53.399999999999999 108.259 166.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -55.92 -43.03 76.96 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.279 0.562 . . . . 75.230000000000004 111.368 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.459 ' HA ' ' HE2' ' A' ' 253' ' ' LYS . 11.4 mmpt? -93.49 1.02 56.93 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.154 -0.93 . . . . 72.409999999999997 111.983 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.426 ' HB3' ' HB2' ' A' ' 250' ' ' ASN . 29.4 t-105 -72.64 -54.86 7.9 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.283 -1.006 . . . . 73.209999999999994 108.283 173.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 . . . . . 0 CA--C 1.552 1.056 0 C-N-CA 123.882 0.873 . . . . 72.019999999999996 109.097 176.706 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mpp? . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 108.93 -0.767 . . . . 52.420000000000002 108.93 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.34 88.23 0.91 Allowed Glycine 0 C--N 1.346 1.136 0 O-C-N 123.324 0.39 . . . . 71.310000000000002 112.987 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -102.64 107.64 18.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.351 0.66 . . . . 63.539999999999999 109.222 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -130.57 103.61 16.19 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.21 0.604 . . . . 54.229999999999997 109.43 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.91 4.62 6.33 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 123.197 2.598 . . . . 71.129999999999995 112.302 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.99 152.42 40.08 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.741 0.651 . . . . 62.340000000000003 114.471 -174.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -135.15 143.58 46.59 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.046 0.938 . . . . 63.539999999999999 109.314 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 m -90.82 130.19 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-O 120.989 0.424 . . . . 74.319999999999993 109.866 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.5 tp -93.54 -37.59 11.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.248 0.619 . . . . 72.319999999999993 111.119 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.83 73.91 1.25 Allowed Glycine 0 C--N 1.341 0.832 0 N-CA-C 108.882 -1.687 . . . . 54.210000000000001 108.882 -164.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.94 -69.67 0.38 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.873 0.869 . . . . 70.239999999999995 112.274 -165.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -175.55 -153.54 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.517 1.127 . . . . 73.129999999999995 108.638 -173.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.4 133.34 56.01 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.739 -0.467 . . . . 64.129999999999995 109.739 168.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.4 mmm-85 51.29 73.74 0.92 Allowed Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.999 0.92 . . . . 73.239999999999995 110.172 -166.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.02 168.9 19.26 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.263 1.975 . . . . 74.519999999999996 110.544 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.2 m -64.45 165.21 10.19 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.095 0.474 . . . . 71.129999999999995 110.75 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.7 mt -104.27 133.5 20.19 Favored Pre-proline 0 C--O 1.238 0.449 0 N-CA-C 108.092 -1.077 . . . . 75.340000000000003 108.092 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.22 169.36 13.92 Favored 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 122.493 2.129 . . . . 72.140000000000001 112.025 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.3 147.03 27.43 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.933 -0.766 . . . . 65.200000000000003 108.933 170.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 23' ' ' ILE . 83.4 mt -88.04 93.57 9.52 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.228 -0.656 . . . . 41.140000000000001 109.228 -177.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -98.23 -53.0 3.49 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.576 0.35 . . . . 71.519999999999996 110.281 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.428 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 61.0 m-85 -106.3 108.97 20.75 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.051 0.541 . . . . 75.430000000000007 110.124 -175.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.469 HD11 HD22 ' A' ' 20' ' ' LEU . 49.8 mm -123.79 120.76 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.754 0.822 . . . . 71.129999999999995 111.003 -175.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -79.5 132.21 36.26 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.486 0.714 . . . . 74.329999999999998 110.531 169.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.08 -13.98 1.31 Allowed Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.603 -0.726 . . . . 24.039999999999999 111.884 173.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.25 150.62 37.0 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.79 0.836 . . . . 44.030000000000001 109.28 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.94 48.27 84.63 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 111.209 -0.756 . . . . 61.240000000000002 111.209 -175.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.603 ' HB2' HE22 ' A' ' 127' ' ' GLN . 19.6 pttp -61.35 -23.0 65.44 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.158 0.983 . . . . 71.010000000000005 112.98 -172.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.456 ' HE ' ' HA ' ' A' ' 29' ' ' ARG . 1.4 tpm_? 56.11 39.24 30.41 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.445 1.098 . . . . 74.120000000000005 110.501 171.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.63 164.77 25.29 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.66 -1.154 . . . . 54.409999999999997 113.18 -169.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.563 ' H ' HD22 ' A' ' 110' ' ' LEU . 30.7 t -77.28 105.32 8.32 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.457 -1.247 . . . . 75.0 108.357 172.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.4 t -54.04 99.03 0.02 OUTLIER 'General case' 0 C--N 1.353 0.72 0 O-C-N 124.34 1.025 . . . . 72.329999999999998 110.418 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.4 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 36.7 ttt180 -67.97 106.09 2.22 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 116.037 -0.529 . . . . 75.120000000000005 109.705 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -136.4 115.6 12.52 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.634 0.774 . . . . 74.319999999999993 109.039 -174.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.616 ' HA3' ' HA ' ' A' ' 79' ' ' GLU . . . 136.69 -148.16 19.59 Favored Glycine 0 C--N 1.341 0.811 0 O-C-N 123.597 0.56 . . . . 43.450000000000003 111.876 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.09 151.76 19.5 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 119.776 -0.458 . . . . 54.130000000000003 112.454 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.92 -2.74 12.97 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.21 2.607 . . . . 73.109999999999999 113.234 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.6 t60 66.23 102.77 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.389 1.476 . . . . 73.329999999999998 111.714 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.5 p -140.33 -177.61 5.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.744 0.818 . . . . 74.099999999999994 109.225 173.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -63.13 143.24 57.96 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.735 0.414 . . . . 74.319999999999993 110.551 173.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.5 p -79.77 166.74 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 109.262 -0.644 . . . . 75.340000000000003 109.262 177.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -53.93 139.54 33.64 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.537 0.735 . . . . 72.409999999999997 111.842 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.4 m -75.53 109.87 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-O 121.514 0.673 . . . . 52.140000000000001 109.54 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -96.02 146.13 24.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.401 0.68 . . . . 75.430000000000007 110.338 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -73.57 89.0 1.69 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.844 -0.798 . . . . 63.329999999999998 108.844 173.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -98.6 157.98 15.9 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.254 -0.885 . . . . 72.349999999999994 110.196 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.86 171.04 9.12 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.194 0.598 . . . . 63.350000000000001 110.701 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.3 mt -70.87 93.74 1.0 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.984 -0.553 . . . . 41.340000000000003 110.719 -176.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.487 ' HG3' ' HG2' ' A' ' 50' ' ' ARG . 6.7 tp-100 -78.4 132.37 37.32 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.96 -0.756 . . . . 70.299999999999997 108.96 174.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.487 ' HG2' ' HG3' ' A' ' 49' ' ' GLN . 15.7 mmt180 53.9 58.24 12.86 Favored Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 124.601 1.16 . . . . 75.409999999999997 112.126 -177.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.3 -10.18 16.26 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.772 2.315 . . . . 64.129999999999995 112.941 -173.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -70.01 -25.53 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.319 0.648 . . . . 64.319999999999993 111.122 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.44 82.59 1.9 Allowed 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.609 0.764 . . . . 55.409999999999997 109.179 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.2 m -85.13 113.68 21.7 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.096 -0.956 . . . . 65.019999999999996 109.851 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 64.01 10.63 5.49 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.694 1.198 . . . . 74.129999999999995 112.911 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -86.83 150.77 23.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.254 0.622 . . . . 72.400000000000006 109.55 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 60.11 70.87 0.95 Allowed Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 124.353 1.033 . . . . 53.210000000000001 109.617 -170.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -56.12 143.59 83.47 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.844 2.362 . . . . 72.239999999999995 112.77 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -90.27 -1.87 57.97 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.298 0.639 . . . . 74.340000000000003 110.525 175.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.94 122.96 1.44 Allowed Glycine 0 C--N 1.347 1.17 0 N-CA-C 111.388 -0.685 . . . . 72.310000000000002 111.388 174.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.8 mt -129.02 111.47 13.02 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 107.755 -1.202 . . . . 74.439999999999998 107.755 170.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.1 t 60.29 40.1 18.15 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 124.255 0.972 . . . . 75.099999999999994 110.283 -175.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.15 1.22 9.63 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.457 1.103 . . . . 70.439999999999998 112.228 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -45.9 116.79 1.3 Allowed 'General case' 0 C--N 1.359 0.988 0 C-N-CA 124.828 1.251 . . . . 74.239999999999995 111.09 173.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.72 89.67 0.07 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.327 1.051 . . . . 62.329999999999998 111.968 -172.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -111.77 116.88 31.43 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.841 -1.17 . . . . 75.030000000000001 107.841 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 47.55 20.68 0.2 Allowed 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 125.555 1.542 . . . . 73.439999999999998 113.687 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -70.5 114.78 8.95 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 123.905 0.882 . . . . 64.319999999999993 109.494 -173.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.9 t -57.21 132.91 54.41 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.355 1.062 . . . . 73.109999999999999 111.569 -175.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.58 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -68.45 97.57 0.77 Allowed 'General case' 0 C--N 1.354 0.764 0 O-C-N 124.101 0.876 . . . . 73.450000000000003 111.797 -173.606 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -91.66 143.9 26.08 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.26 -1.015 . . . . 71.219999999999999 108.26 171.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -86.19 49.61 1.82 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.31 0.644 . . . . 64.230000000000004 111.576 -172.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.9 mt 62.75 8.12 2.88 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.681 1.192 . . . . 71.409999999999997 113.265 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.0 mt 59.09 34.65 23.49 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.644 1.178 . . . . 74.209999999999994 111.311 -172.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.53 158.49 24.44 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.397 0.679 . . . . 35.030000000000001 111.207 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -136.81 -165.39 10.46 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.488 -0.618 . . . . 63.229999999999997 112.135 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.24 80.98 2.09 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.137 2.558 . . . . 62.310000000000002 112.572 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.8 m -75.94 -20.57 57.85 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.604 -0.725 . . . . 51.109999999999999 110.444 173.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.616 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 18.5 tt0 -116.11 -166.79 1.18 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.483 1.113 . . . . 73.129999999999995 108.531 -177.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.499 ' H ' ' HG2' ' A' ' 79' ' ' GLU . 5.2 p-10 -71.16 -155.63 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 124.51 1.124 . . . . 64.400000000000006 112.385 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -49.12 137.34 14.44 Favored Pre-proline 0 N--CA 1.487 1.396 0 C-N-CA 123.665 0.786 . . . . 54.409999999999997 112.079 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.37 23.64 0.74 Allowed 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.227 2.618 . . . . 74.409999999999997 114.045 -168.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -64.96 83.48 0.04 OUTLIER 'General case' 0 C--N 1.353 0.719 0 CA-C-O 121.766 0.793 . . . . 75.530000000000001 109.85 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.62 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 33.6 tp -125.07 119.01 27.44 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.363 -1.29 . . . . 74.329999999999998 107.904 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -105.14 176.23 5.23 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.646 1.579 . . . . 52.329999999999998 109.226 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.62 144.73 25.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 N-CA-C 108.641 -0.874 . . . . 71.239999999999995 108.641 172.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.28 118.52 19.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.433 0.693 . . . . 74.209999999999994 109.748 174.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.29 -21.29 39.43 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.91 0.884 . . . . 71.129999999999995 111.073 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.572 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 93.1 m-85 -134.46 169.28 17.5 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.405 0.682 . . . . 74.099999999999994 110.15 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.39 145.76 27.32 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.177 -0.919 . . . . 63.240000000000002 109.133 170.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.444 ' HB3' HG12 ' A' ' 101' ' ' ILE . 86.2 t80 -151.93 104.81 3.03 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.457 -0.942 . . . . 65.430000000000007 108.457 176.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.6 t -80.37 133.92 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 107.878 -1.156 . . . . 72.519999999999996 107.878 172.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.41 114.77 10.89 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.595 -0.52 . . . . 75.140000000000001 109.595 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.1 m -77.03 -23.19 52.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.009 0.524 . . . . 63.009999999999998 110.663 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.75 168.28 19.8 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 123.796 0.685 . . . . 51.020000000000003 111.734 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.52 -29.88 63.99 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.529 0.732 . . . . 62.43 110.29 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -71.43 -19.92 62.18 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.993 1.317 . . . . 72.010000000000005 112.235 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.3 p -98.47 154.87 17.57 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.256 0.622 . . . . 74.409999999999997 109.998 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.6 tp -107.08 128.35 54.3 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.877 -0.786 . . . . 74.0 108.877 -177.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.1 t -82.56 118.15 23.07 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 109.782 -0.451 . . . . 62.350000000000001 109.782 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.444 HG12 ' HB3' ' A' ' 91' ' ' PHE . 28.6 pt -119.6 165.42 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.075 0.95 . . . . 75.109999999999999 110.066 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.5 m -138.59 145.64 40.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.465 0.706 . . . . 75.140000000000001 109.214 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -54.54 118.67 4.36 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.813 0.845 . . . . 74.120000000000005 111.778 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.85 -14.87 29.08 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.032 -0.531 . . . . 64.409999999999997 112.842 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -78.49 124.36 28.05 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.596 0.758 . . . . 73.150000000000006 110.258 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.456 ' HB3' HD11 ' A' ' 84' ' ' LEU . 31.8 mtmm -75.01 116.9 16.27 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.364 0.666 . . . . 72.310000000000002 109.574 176.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.9 mt -101.14 163.61 12.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.694 -0.854 . . . . 64.430000000000007 108.694 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -126.38 110.12 12.99 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.56 -0.904 . . . . 74.049999999999997 108.56 163.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.485 HG21 HD12 ' A' ' 135' ' ' ILE . 99.1 t -90.23 124.35 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.127 -0.694 . . . . 72.430000000000007 109.127 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.563 HD22 ' H ' ' A' ' 31' ' ' SER . 27.4 mt -81.78 -37.83 26.55 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.567 1.147 . . . . 71.209999999999994 109.273 -174.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.81 176.28 47.88 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 113.936 -1.484 . . . . 43.340000000000003 110.51 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 56.7 m-85 -103.95 175.05 5.61 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 109.386 -0.598 . . . . 75.109999999999999 109.386 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 22' ' ' PHE . 43.7 t-20 -68.98 148.74 49.69 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.428 -0.953 . . . . 73.530000000000001 108.428 169.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -66.09 -17.81 64.94 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.758 0.823 . . . . 70.120000000000005 112.578 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -95.84 -5.28 42.07 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.493 0.717 . . . . 65.319999999999993 111.062 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.3 34.69 63.95 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.378 -0.689 . . . . 60.409999999999997 111.378 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.463 ' HG2' ' CD1' ' A' ' 118' ' ' TRP . 36.8 tt0 -89.03 -58.36 2.57 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.202 1.401 . . . . 73.420000000000002 109.282 -170.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.463 ' CD1' ' HG2' ' A' ' 117' ' ' GLU . 87.5 m95 -126.24 -176.96 3.8 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.587 1.155 . . . . 74.409999999999997 110.086 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -132.28 116.54 17.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.338 1.055 . . . . 64.510000000000005 109.698 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.46 107.53 14.3 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.795 -0.817 . . . . 74.129999999999995 108.795 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.464 ' HB2' HG22 ' A' ' 109' ' ' VAL . . . -121.12 165.42 15.37 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.939 0.896 . . . . 60.219999999999999 111.58 -172.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -143.42 131.31 21.56 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.101 0.96 . . . . 72.400000000000006 110.138 -175.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 45.1 p -141.06 -176.99 4.89 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.634 1.174 . . . . 54.439999999999998 110.973 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -60.79 -21.58 63.24 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.229 1.012 . . . . 71.120000000000005 111.41 171.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -72.71 -26.87 61.75 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.759 0.824 . . . . 72.439999999999998 110.127 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.22 -135.1 6.88 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.203 -0.759 . . . . 42.130000000000003 111.203 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.603 HE22 ' HB2' ' A' ' 28' ' ' LYS . 53.4 tt0 -152.88 148.55 27.29 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 122.924 0.489 . . . . 73.230000000000004 110.116 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 161.49 -177.7 37.68 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 121.088 0.271 . . . . 62.549999999999997 113.137 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -84.34 134.78 34.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.528 0.731 . . . . 50.210000000000001 111.781 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.66 155.23 80.65 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.085 1.354 . . . . 74.200000000000003 108.766 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -69.66 129.65 18.08 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 121.789 1.659 . . . . 75.129999999999995 110.846 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.4 m -60.25 -20.55 59.45 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.773 0.829 . . . . 32.329999999999998 112.539 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -84.66 -19.02 33.55 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.635 0.774 . . . . 64.439999999999998 111.615 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.572 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.4 m-85 -89.66 5.05 47.49 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.548 0.739 . . . . 73.310000000000002 112.107 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.485 HD12 HG21 ' A' ' 109' ' ' VAL . 21.3 pt -134.32 167.43 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.442 0.697 . . . . 63.329999999999998 110.695 -174.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.3 t -160.88 141.9 8.73 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 122.781 0.432 . . . . 73.319999999999993 111.11 168.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.04 133.21 22.76 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.978 2.452 . . . . 73.120000000000005 112.285 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.6 m -113.89 -49.15 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.109 0.564 . . . . 72.25 111.459 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.62 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.2 t30 -100.97 -11.7 19.5 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.92 0.488 . . . . 55.350000000000001 111.058 -176.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.1 t -65.39 177.62 1.1 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.549 0.74 . . . . 73.120000000000005 111.044 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.72 -21.95 21.22 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.194 1.183 . . . . 55.409999999999997 114.194 -171.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.59 -13.29 60.88 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.004 0.922 . . . . 74.510000000000005 112.028 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -63.33 -22.46 66.89 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.979 0.912 . . . . 73.450000000000003 110.692 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -85.07 145.22 27.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.612 0.765 . . . . 75.430000000000007 110.431 171.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.7 t -66.51 -20.76 66.11 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.861 0.865 . . . . 64.319999999999993 112.261 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -83.61 -34.87 25.02 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.097 0.406 . . . . 63.210000000000001 112.097 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 33.7 t80 -93.8 138.71 31.69 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 109.494 -0.558 . . . . 74.219999999999999 109.494 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.671 ' HB3' HH21 ' A' ' 171' ' ' ARG . 75.9 m-70 -134.27 26.39 3.83 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.448 0.536 . . . . 73.209999999999994 112.448 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 67.86 -163.5 47.31 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 115.585 0.994 . . . . 65.549999999999997 115.585 170.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.21 102.68 1.59 Allowed 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.499 2.799 . . . . 74.430000000000007 112.874 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.9 t -138.05 157.58 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 123.247 0.619 . . . . 64.349999999999994 110.363 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.0 m -75.24 153.67 37.92 Favored 'General case' 0 C--O 1.256 1.435 0 C-N-CA 124.581 1.152 . . . . 75.030000000000001 112.09 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -62.81 -31.92 73.01 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.523 -0.762 . . . . 53.43 111.085 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -54.93 -53.6 53.51 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.022 0.929 . . . . 72.219999999999999 110.264 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.04 77.56 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.409 -0.814 . . . . 74.5 110.848 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.498 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.08 -50.53 73.13 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.345 0.593 . . . . 74.319999999999993 111.69 176.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.467 ' HG3' HG11 ' A' ' 190' ' ' VAL . 33.0 tt0 -78.2 -25.05 46.89 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.106 -0.952 . . . . 64.040000000000006 110.263 -175.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -60.25 -53.46 57.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.112 0.565 . . . . 64.120000000000005 110.269 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 64.8 mt -65.23 -39.33 92.58 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 116.237 -0.438 . . . . 72.420000000000002 110.854 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.58 HD23 HG13 ' A' ' 190' ' ' VAL . 36.4 tp -73.08 -24.21 60.63 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.878 -0.601 . . . . 75.329999999999998 112.105 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 35.4 t -65.77 -23.81 66.8 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.109 0.564 . . . . 54.409999999999997 111.322 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 80.6 p -91.8 -0.64 57.54 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.155 0.582 . . . . 72.519999999999996 111.129 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -83.96 163.23 39.7 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.941 -0.572 . . . . 64.400000000000006 112.89 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.1 pt -120.15 -166.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.317 1.047 . . . . 72.209999999999994 111.095 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -58.58 107.36 0.5 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.899 0.879 . . . . 75.510000000000005 112.777 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 98.2 13.53 42.0 Favored Glycine 0 C--O 1.259 1.658 0 CA-C-N 116.03 -0.532 . . . . 75.299999999999997 112.617 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 31.5 t -74.35 134.79 42.49 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 119.126 -0.464 . . . . 52.149999999999999 109.961 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 183' ' ' SER . 22.3 p90 -135.25 153.7 51.82 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 121.51 0.671 . . . . 73.299999999999997 112.669 177.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' A' ' 236' ' ' ALA . 97.5 mt -134.49 133.81 40.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.908 -1.042 . . . . 61.32 108.302 169.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 20.0 t -112.87 120.5 63.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.394 -1.336 . . . . 74.019999999999996 107.394 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.671 HH21 ' HB3' ' A' ' 148' ' ' HIS . 0.6 OUTLIER -159.37 148.89 18.5 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.469 -0.567 . . . . 72.150000000000006 109.469 177.586 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.808 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 15.0 pt-20 -92.3 157.77 16.47 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-O 121.224 0.535 . . . . 72.310000000000002 111.258 -176.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 p -76.72 115.97 16.97 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.975 -1.011 . . . . 71.439999999999998 108.53 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.21 -31.33 67.23 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.796 0.838 . . . . 65.430000000000007 112.429 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.8 t -95.67 8.46 43.37 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.81 0.844 . . . . 72.319999999999993 111.4 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 57.0 m -149.86 83.21 6.33 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 108.434 -0.95 . . . . 55.149999999999999 108.434 172.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.517 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 42.8 Cg_endo -63.57 140.55 75.85 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.47 2.78 . . . . 73.430000000000007 112.491 -173.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.65 -23.54 10.14 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.924 -0.58 . . . . 74.340000000000003 112.9 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -86.65 115.87 24.39 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 108.818 -0.808 . . . . 74.140000000000001 108.818 174.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.808 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 42.8 mtt85 -114.57 153.15 30.6 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.025 -0.989 . . . . 75.129999999999995 108.957 -173.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.1 m -134.18 142.72 47.53 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 109.945 -0.391 . . . . 63.119999999999997 109.945 -177.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.411 HG12 HG22 ' A' ' 170' ' ' VAL . 50.6 mt -106.48 136.25 41.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.365 -0.976 . . . . 70.040000000000006 108.365 169.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.576 ' HB3' HD22 ' A' ' 160' ' ' LEU . 20.4 m -115.77 113.95 24.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.99 -1.115 . . . . 72.25 107.99 -177.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 52.7 mt -104.58 141.09 37.03 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.5 0.72 . . . . 73.310000000000002 111.167 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 26.7 ttt180 -124.2 120.91 33.64 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 107.361 -1.348 . . . . 75.310000000000002 107.361 165.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.79 127.38 28.87 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.588 -1.264 . . . . 74.420000000000002 107.588 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 54.85 28.86 10.99 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.039 0.936 . . . . 64.329999999999998 112.282 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 89.31 1.25 78.88 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.155 0.407 . . . . 73.129999999999995 113.433 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 8.7 tpm_? -100.57 123.26 44.54 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.035 0.934 . . . . 65.230000000000004 109.455 -174.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.58 HG13 HD23 ' A' ' 160' ' ' LEU . 95.0 t -98.58 124.3 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.135 0.974 . . . . 44.030000000000001 109.978 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -145.95 149.99 35.21 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.062 0.945 . . . . 60.240000000000002 109.75 176.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -125.86 148.78 49.07 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.961 0.904 . . . . 74.129999999999995 109.361 -171.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -145.39 148.4 33.3 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.215 0.531 . . . . 74.049999999999997 111.106 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -93.77 125.88 38.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.932 -1.031 . . . . 73.329999999999998 111.785 -171.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 68.9 mt -77.65 111.0 13.97 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 124.397 1.079 . . . . 75.540000000000006 108.536 162.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -87.46 139.27 30.71 Favored 'General case' 0 C--O 1.249 1.051 0 N-CA-C 109.417 -0.586 . . . . 73.219999999999999 109.417 173.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 46.5 m -110.6 132.16 54.43 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.974 0.796 . . . . 65.200000000000003 110.1 -176.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.58 169.19 18.74 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.059 0.944 . . . . 75.310000000000002 111.1 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 72.1 p -75.92 -8.59 57.29 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.841 0.456 . . . . 74.120000000000005 111.461 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -93.33 -7.55 44.49 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.062 0.945 . . . . 73.219999999999999 110.821 170.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 91.8 -1.27 74.63 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-O 119.501 -0.61 . . . . 31.030000000000001 113.324 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -70.61 128.85 37.52 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.538 0.669 . . . . 73.450000000000003 111.164 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 29.0 mt -91.77 148.59 22.13 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.925 0.89 . . . . 52.420000000000002 110.535 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -160.74 148.74 16.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.301 0.572 . . . . 74.030000000000001 111.149 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.7 t -112.7 -45.32 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 114.721 -1.127 . . . . 63.130000000000003 109.371 176.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 22.2 t -121.75 178.94 4.65 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.009 0.524 . . . . 61.210000000000001 109.976 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.2 t -68.05 -26.72 66.0 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.577 0.751 . . . . 71.150000000000006 112.04 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -86.48 -3.97 59.1 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.604 0.761 . . . . 74.239999999999995 110.663 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.484 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 19.9 m -94.72 121.76 36.62 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.893 0.877 . . . . 71.439999999999998 110.976 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -143.49 109.29 5.2 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 107.869 -1.16 . . . . 72.219999999999999 107.869 168.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.484 ' CE2' ' HB3' ' A' ' 209' ' ' SER . 17.7 m-85 -123.42 136.26 54.53 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.291 -0.633 . . . . 73.430000000000007 109.291 -178.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.24 -10.17 45.29 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 122.625 0.37 . . . . 71.420000000000002 110.182 175.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 57.7 p -141.36 152.55 44.47 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.587 0.708 . . . . 65.200000000000003 111.141 173.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.26 -25.4 63.35 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.483 -1.235 . . . . 63.039999999999999 110.474 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.61 -50.14 73.76 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 123.723 0.809 . . . . 72.109999999999999 110.382 174.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -72.11 -29.22 63.87 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.416 -0.811 . . . . 72.230000000000004 111.62 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.49 -52.7 64.55 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.354 0.409 . . . . 73.430000000000007 110.065 171.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.69 -40.5 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.273 0.629 . . . . 73.329999999999998 111.221 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -64.06 -47.5 79.9 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.091 0.472 . . . . 63.329999999999998 110.949 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -63.26 -46.69 85.65 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.151 -0.685 . . . . 74.040000000000006 109.151 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.434 ' HA ' HG22 ' A' ' 224' ' ' VAL . 46.1 m80 -66.24 -25.22 66.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.969 0.508 . . . . 72.319999999999993 111.489 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.407 ' O ' ' HB ' ' A' ' 231' ' ' THR . 45.9 t -71.07 -28.65 64.51 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.658 0.383 . . . . 62.439999999999998 111.114 174.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -106.72 -18.02 14.06 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 115.433 1.642 . . . . 75.420000000000002 115.433 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 221' ' ' HIS . 23.9 m -87.34 122.41 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-N 120.251 1.387 . . . . 74.209999999999994 114.232 -169.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.55 -1.54 19.05 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.315 2.246 . . . . 74.420000000000002 113.17 170.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -79.5 15.51 1.28 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 127.986 2.514 . . . . 75.099999999999994 112.914 -144.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.07 16.84 4.26 Favored Glycine 0 C--O 1.25 1.129 0 C-N-CA 123.507 0.575 . . . . 70.430000000000007 112.133 -168.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 46.9 mt -88.78 131.51 35.03 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.978 -0.611 . . . . 75.349999999999994 109.59 158.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 77.5 mt -59.24 -41.2 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 O-C-N 124.03 0.832 . . . . 65.109999999999999 109.694 172.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.7 t -141.17 144.43 34.8 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.969 -1.014 . . . . 63.399999999999999 109.536 168.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 222' ' ' SER . 67.3 p -71.84 151.33 43.52 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.791 -0.818 . . . . 74.530000000000001 108.791 168.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.22 100.23 0.33 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.543 -0.91 . . . . 61.43 108.543 178.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -85.86 -50.73 6.89 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.21 -0.663 . . . . 53.409999999999997 109.21 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.1 OUTLIER -163.24 148.08 9.19 Favored Pre-proline 0 N--CA 1.482 1.151 0 CA-C-N 115.376 -0.829 . . . . 70.420000000000002 110.922 179.308 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 52.3 Cg_endo -67.47 155.86 68.52 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 121.738 1.625 . . . . 71.219999999999999 112.293 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.523 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -63.41 134.56 95.89 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-O 118.779 -0.629 . . . . 71.549999999999997 109.779 173.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.11 120.47 7.29 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.967 2.445 . . . . 62.130000000000003 111.689 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' A' ' 238' ' ' LYS . 46.9 mtmt -53.83 134.82 42.53 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 123.931 0.769 . . . . 75.420000000000002 110.477 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -57.67 -25.09 59.75 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.723 0.809 . . . . 75.010000000000005 111.687 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -121.26 133.33 55.15 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.266 1.026 . . . . 75.239999999999995 108.483 172.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt 43.3 67.94 3.32 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 126.013 1.725 . . . . 64.230000000000004 113.156 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.05 104.63 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.858 2.372 . . . . 75.310000000000002 112.262 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 86.1 m -70.28 108.93 4.42 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.293 0.637 . . . . 64.230000000000004 110.348 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 39.9 t -93.22 94.53 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.752 -0.833 . . . . 74.140000000000001 108.752 176.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -88.55 118.08 27.95 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.924 -0.769 . . . . 74.129999999999995 108.924 174.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -66.64 137.93 35.12 Favored Glycine 0 C--N 1.343 0.963 0 N-CA-C 111.086 -0.806 . . . . 53.229999999999997 111.086 171.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 22.6 m -60.76 -22.77 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.515 0.726 . . . . 74.430000000000007 112.558 -173.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 28.5 t 63.71 84.91 0.18 Allowed Pre-proline 0 C--N 1.359 1.009 0 C-N-CA 125.063 1.345 . . . . 54.539999999999999 109.965 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.24 171.72 16.56 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.915 2.41 . . . . 55.140000000000001 112.788 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -136.19 165.24 26.19 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.753 0.821 . . . . 65.349999999999994 110.312 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -74.88 -58.89 3.0 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.033 0.933 . . . . 73.409999999999997 110.752 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.18 169.56 24.23 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 121.146 0.498 . . . . 73.239999999999995 111.121 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.49 43.46 0.75 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.761 1.224 . . . . 70.109999999999999 108.772 171.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 59.61 93.05 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.013 1.325 . . . . 75.420000000000002 111.642 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 C--O 1.255 1.375 0 N-CA-C 108.816 -0.809 . . . . 74.349999999999994 108.816 175.228 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 108.837 -0.801 . . . . 62.399999999999999 108.837 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.26 177.39 9.65 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.551 0.532 . . . . 55.119999999999997 113.349 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -129.24 -36.4 1.73 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.968 -0.753 . . . . 64.109999999999999 108.968 175.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 54.63 73.39 0.9 Allowed Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.752 1.221 . . . . 73.219999999999999 108.232 -169.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.57 -58.79 0.36 Allowed 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.005 1.803 . . . . 62.340000000000003 111.585 -174.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.49 175.95 5.73 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 116.064 -0.516 . . . . 74.319999999999993 113.286 -176.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -157.98 93.09 1.23 Allowed 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.742 -0.836 . . . . 71.230000000000004 108.742 177.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.422 ' HB ' ' OG ' ' A' ' 16' ' ' SER . 18.7 m -83.45 159.74 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 115.404 -0.816 . . . . 63.420000000000002 110.557 174.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.5 tp -158.83 152.76 23.46 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.208 -0.664 . . . . 74.430000000000007 109.208 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.715 ' HA3' ' HB3' ' A' ' 15' ' ' PRO . . . -134.65 71.97 0.48 Allowed Glycine 0 C--N 1.347 1.14 0 N-CA-C 111.523 -0.631 . . . . 21.109999999999999 111.523 -177.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -76.54 -33.39 58.56 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.3 -0.63 . . . . 72.310000000000002 109.3 172.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -93.59 153.36 18.45 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.167 -0.924 . . . . 40.32 109.715 173.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.549 ' HD3' ' H ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -56.96 153.12 11.71 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.42 0.688 . . . . 75.310000000000002 111.33 175.232 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 56.5 73.94 0.75 Allowed Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 124.158 0.983 . . . . 72.140000000000001 109.258 -169.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.715 ' HB3' ' HA3' ' A' ' 10' ' ' GLY . 26.7 Cg_endo -63.83 166.11 16.93 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.963 2.442 . . . . 73.120000000000005 112.563 -178.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.422 ' OG ' ' HB ' ' A' ' 8' ' ' VAL . 6.2 p -72.19 168.37 18.37 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.415 0.626 . . . . 72.200000000000003 111.322 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.6 mt -107.24 126.84 29.14 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 107.975 -1.12 . . . . 64.109999999999999 107.975 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.51 171.95 11.06 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.391 2.061 . . . . 64.299999999999997 111.632 173.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.23 144.35 32.99 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.847 0.459 . . . . 54.310000000000002 111.085 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.638 ' HB3' HD11 ' A' ' 23' ' ' ILE . 56.4 mt -86.1 93.89 9.12 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.073 0.949 . . . . 64.239999999999995 108.699 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -98.25 -42.15 7.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.815 -1.084 . . . . 75.420000000000002 109.285 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -96.85 111.86 23.87 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 114.583 -1.189 . . . . 72.209999999999994 108.547 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.638 HD11 ' HB3' ' A' ' 20' ' ' LEU . 44.1 mm -116.08 120.88 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.991 -1.114 . . . . 74.239999999999995 107.991 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -147.61 149.44 32.53 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.45 -0.945 . . . . 75.310000000000002 108.45 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -160.28 -127.33 0.89 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.226 -1.15 . . . . 65.430000000000007 110.226 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 62.24 92.44 0.06 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.723 1.209 . . . . 63.43 110.657 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.81 73.9 2.05 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.272 -0.876 . . . . 32.329999999999998 112.489 -175.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.0 10.15 4.58 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.395 1.078 . . . . 62.049999999999997 110.099 178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -136.67 159.75 40.9 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 124.215 1.006 . . . . 63.329999999999998 108.665 -174.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.513 ' HA ' HE22 ' A' ' 122' ' ' GLN . 0.0 OUTLIER -149.45 178.43 8.81 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.994 -0.548 . . . . 74.450000000000003 110.693 -177.383 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 56.6 p -79.02 -158.03 0.14 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.313 1.045 . . . . 63.119999999999997 110.61 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.1 t -63.71 175.42 1.11 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 122.8 0.44 . . . . 71.219999999999999 111.238 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -64.69 -172.01 0.07 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.315 1.046 . . . . 73.530000000000001 113.503 -170.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -72.32 153.37 41.54 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.183 0.593 . . . . 73.150000000000006 111.359 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.04 -142.47 3.71 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 115.743 -0.662 . . . . 70.310000000000002 111.605 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -107.55 97.42 1.16 Allowed Glycine 0 C--N 1.344 0.979 0 N-CA-C 110.777 -0.929 . . . . 41.119999999999997 110.777 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.734 ' HG3' ' HA2' ' A' ' 76' ' ' GLY . 18.0 Cg_endo -86.89 50.11 2.15 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 123.457 2.772 . . . . 63.140000000000001 112.389 -171.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.434 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 19.9 p-80 -55.49 -23.56 26.59 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 124.792 1.237 . . . . 53.130000000000003 113.681 -174.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.8 m -66.25 111.58 3.54 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 107.305 -1.368 . . . . 71.549999999999997 107.305 170.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -51.98 -79.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.356 1.063 . . . . 72.120000000000005 112.939 -162.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 p -179.42 158.4 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.663 0.785 . . . . 64.010000000000005 109.717 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -134.49 95.5 3.39 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.569 -0.9 . . . . 64.409999999999997 108.569 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.7 m -112.37 176.71 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.064 0.545 . . . . 63.200000000000003 110.579 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -148.35 135.53 20.29 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.222 -1.029 . . . . 74.329999999999998 108.222 174.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -71.54 92.22 1.11 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.151 0.581 . . . . 64.430000000000007 110.039 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -76.84 139.75 40.4 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.324 -0.853 . . . . 73.430000000000007 108.984 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.73 112.96 23.65 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.5 -0.926 . . . . 72.239999999999995 108.5 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.43 90.2 0.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.351 0.66 . . . . 73.010000000000005 110.121 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -155.68 136.08 13.2 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.976 0.91 . . . . 74.030000000000001 108.775 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -61.92 136.32 95.0 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 123.645 0.59 . . . . 74.010000000000005 110.082 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.09 93.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.984 2.456 . . . . 64.120000000000005 113.538 175.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.03 -57.84 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 108.253 -1.017 . . . . 54.119999999999997 108.253 172.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.79 97.86 0.86 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.729 0.812 . . . . 61.399999999999999 109.449 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.4 m -82.86 167.37 18.12 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.185 0.594 . . . . 64.530000000000001 111.578 -176.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.19 145.29 44.31 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.118 0.967 . . . . 60.240000000000002 110.977 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -148.97 166.8 27.55 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.083 0.953 . . . . 75.030000000000001 109.38 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 65.75 71.63 0.49 Allowed Pre-proline 0 N--CA 1.485 1.315 0 C-N-CA 124.93 1.292 . . . . 71.439999999999998 111.862 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.06 160.16 36.89 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.206 1.937 . . . . 62.439999999999998 112.112 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -65.0 -42.62 94.34 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.629 0.772 . . . . 72.040000000000006 110.436 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 144.22 92.12 0.14 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.171 -0.772 . . . . 64.439999999999998 111.171 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.44 98.48 1.82 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.422 0.689 . . . . 64.310000000000002 110.768 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.2 t -152.98 145.95 24.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.21 -0.905 . . . . 74.310000000000002 108.934 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.79 159.99 15.54 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.328 0.651 . . . . 74.0 111.003 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.77 -38.51 8.25 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.104 0.962 . . . . 71.140000000000001 109.712 172.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -158.18 134.27 9.28 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.376 1.07 . . . . 74.400000000000006 109.509 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -109.45 85.69 2.15 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.195 0.598 . . . . 70.439999999999998 109.599 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -109.27 85.57 2.12 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 107.295 -1.372 . . . . 64.450000000000003 107.295 166.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -81.43 134.34 35.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 114.453 -1.249 . . . . 71.340000000000003 110.128 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.1 t -71.59 97.51 1.72 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 109.701 -0.481 . . . . 71.430000000000007 109.701 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HD3' ' HB2' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -64.72 110.59 2.43 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.386 -0.824 . . . . 73.239999999999995 109.475 179.414 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -176.45 121.68 0.15 Allowed 'General case' 0 N--CA 1.48 1.03 0 O-C-N 124.347 1.029 . . . . 74.150000000000006 110.151 160.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -154.88 93.79 1.59 Allowed 'General case' 0 C--O 1.244 0.801 0 N-CA-C 109.066 -0.716 . . . . 74.150000000000006 109.066 170.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 99.4 mt -123.85 -178.1 3.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.141 0.977 . . . . 74.099999999999994 109.555 175.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.3 mt 62.81 18.05 10.4 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.982 1.313 . . . . 74.219999999999999 111.172 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.68 163.96 38.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.948 1.299 . . . . 71.200000000000003 109.3 -175.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.734 ' HA2' ' HG3' ' A' ' 37' ' ' PRO . . . 175.46 99.78 0.12 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.084 -0.842 . . . . 63.399999999999999 113.098 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.6 170.65 13.34 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.836 2.357 . . . . 74.409999999999997 111.591 163.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.6 m -74.73 85.42 2.15 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.128 0.489 . . . . 61.219999999999999 109.853 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.523 ' HB3' ' NE ' ' A' ' 108' ' ' ARG . 11.1 pt-20 -146.32 92.3 2.16 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-O 122.785 1.279 . . . . 75.540000000000006 110.228 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -147.94 44.01 1.07 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 105.569 -2.011 . . . . 73.109999999999999 105.569 171.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -82.89 133.15 49.2 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 114.118 -1.401 . . . . 74.150000000000006 110.373 -170.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -59.01 -32.29 97.28 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.274 2.649 . . . . 75.409999999999997 112.774 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -93.05 66.7 4.17 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-O 121.792 0.806 . . . . 60.43 109.543 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.542 HD11 ' HB3' ' A' ' 106' ' ' LYS . 42.5 tp -85.78 117.63 24.77 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.797 -1.092 . . . . 73.420000000000002 109.007 175.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -109.09 176.51 5.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.694 1.598 . . . . 70.230000000000004 109.373 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.82 146.24 24.29 Favored 'Isoleucine or valine' 0 C--O 1.25 1.103 0 N-CA-C 108.722 -0.844 . . . . 64.010000000000005 108.722 170.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.03 120.64 25.06 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.282 0.633 . . . . 62.25 109.776 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.1 mt -77.05 -20.48 55.8 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.872 0.869 . . . . 74.219999999999999 111.446 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -141.78 149.11 39.98 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.831 -0.804 . . . . 71.239999999999995 108.831 -174.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.76 146.54 46.31 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.02 -0.733 . . . . 71.439999999999998 109.02 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -151.87 108.46 3.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.691 -1.226 . . . . 65.310000000000002 107.691 -176.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.7 t -79.17 138.63 19.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 107.263 -1.384 . . . . 51.43 107.263 173.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.85 125.86 25.3 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.928 0.491 . . . . 64.409999999999997 110.867 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.2 t -72.52 -17.74 61.71 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.937 0.895 . . . . 74.349999999999994 110.283 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.36 -166.72 37.39 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 115.698 -0.683 . . . . 44.329999999999998 112.129 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -64.58 -32.33 73.94 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.635 1.174 . . . . 51.229999999999997 112.059 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -69.79 -25.7 63.91 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.866 0.866 . . . . 74.349999999999994 112.05 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.1 p -103.35 160.31 14.8 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.59 0.756 . . . . 73.129999999999995 110.777 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.1 tp -109.22 130.5 55.49 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.384 0.673 . . . . 74.329999999999998 109.21 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -77.02 117.44 18.61 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 108.345 -0.984 . . . . 71.129999999999995 108.345 172.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.8 pt -119.68 138.26 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.538 0.735 . . . . 51.43 109.194 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.1 m -94.07 145.82 24.4 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.507 -0.553 . . . . 73.129999999999995 109.507 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -58.2 111.86 1.34 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.619 0.368 . . . . 74.200000000000003 110.705 171.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.71 5.93 50.47 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.122 0.391 . . . . 74.010000000000005 112.627 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -87.25 137.83 32.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.24 1.016 . . . . 75.349999999999994 109.83 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HB3' HD11 ' A' ' 84' ' ' LEU . 63.0 mttm -88.33 123.77 33.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.288 0.635 . . . . 74.219999999999999 109.825 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 21.4 mt -108.64 139.96 42.69 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.053 0.941 . . . . 74.219999999999999 110.299 -168.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.523 ' NE ' ' HB3' ' A' ' 79' ' ' GLU . 30.4 mtt180 -95.26 107.15 19.24 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 106.002 -1.851 . . . . 61.5 106.002 172.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 68.7 t -100.19 111.56 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 119.364 0.984 . . . . 72.430000000000007 109.571 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.11 -25.62 64.5 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.484 -1.235 . . . . 74.120000000000005 111.018 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.51 173.05 22.98 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.675 -0.693 . . . . 24.140000000000001 112.104 173.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.457 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 1.8 m-30 -95.23 148.93 21.88 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 106.668 -1.605 . . . . 74.099999999999994 106.668 172.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.459 HD21 ' HB2' ' A' ' 117' ' ' GLU . 29.5 p30 -66.44 167.5 10.56 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 110.25 -0.278 . . . . 74.400000000000006 110.25 173.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -56.5 -32.04 64.66 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.508 0.929 . . . . 70.299999999999997 113.508 -167.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -96.93 -2.59 43.42 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.562 0.345 . . . . 64.310000000000002 111.617 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.77 18.58 79.57 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 123.157 0.408 . . . . 62.32 113.397 174.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.459 ' HB2' HD21 ' A' ' 113' ' ' ASN . 6.0 mm-40 -65.72 -65.65 0.65 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.522 1.129 . . . . 72.510000000000005 110.136 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -122.97 152.53 40.79 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.227 -1.351 . . . . 70.299999999999997 108.291 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -115.87 127.38 54.98 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.326 1.051 . . . . 74.019999999999996 109.379 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -76.72 101.44 5.8 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.04 -0.726 . . . . 53.439999999999998 109.04 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -104.87 169.02 8.68 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.315 -0.857 . . . . 74.239999999999995 110.298 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.513 HE22 ' HA ' ' A' ' 30' ' ' GLU . 35.1 tt0 -148.08 138.24 22.7 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.219 1.008 . . . . 72.239999999999995 108.953 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 37.5 p -144.23 -171.02 3.49 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.403 1.081 . . . . 63.210000000000001 108.901 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -64.95 -16.48 63.39 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 122.971 0.508 . . . . 73.340000000000003 111.098 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -76.39 -14.11 60.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.712 0.805 . . . . 73.439999999999998 111.722 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 129.64 -137.06 9.3 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 111.866 -0.493 . . . . 74.420000000000002 111.866 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -149.91 144.21 25.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.355 0.662 . . . . 75.349999999999994 109.755 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 166.43 179.61 39.85 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-O 121.245 0.358 . . . . 34.310000000000002 113.235 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -79.85 130.79 35.6 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.09 0.956 . . . . 74.430000000000007 110.695 -176.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.7 m -124.36 146.86 53.32 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.75 1.22 . . . . 75.329999999999998 108.22 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.98 131.64 26.0 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 121.599 1.533 . . . . 71.430000000000007 110.889 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.7 m -59.22 -21.38 59.44 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.791 0.836 . . . . 75.239999999999995 111.898 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -73.16 -18.95 61.22 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.485 1.114 . . . . 61.140000000000001 112.184 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -102.18 -3.63 27.09 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.419 0.688 . . . . 75.219999999999999 112.603 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.0 pt -122.05 155.88 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 118.478 0.581 . . . . 71.319999999999993 111.134 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.1 t -153.58 136.12 9.53 Favored Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 123.309 0.381 . . . . 61.43 110.708 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -76.44 132.7 13.78 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.805 2.337 . . . . 63.350000000000001 113.163 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.1 m -109.36 -31.34 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.891 0.876 . . . . 71.040000000000006 111.741 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 84' ' ' LEU . 63.9 t30 -97.64 0.07 46.55 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.24 0.616 . . . . 55.149999999999999 111.594 -175.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 97.7 p -80.12 -171.0 2.74 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.835 0.826 . . . . 74.540000000000006 111.318 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.14 -9.77 12.22 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.569 1.148 . . . . 64.530000000000001 113.298 171.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -59.35 -20.57 55.72 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.252 0.834 . . . . 62.520000000000003 113.252 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.96 -8.14 52.74 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.253 0.621 . . . . 65.120000000000005 111.959 175.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -88.37 135.51 33.43 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 107.886 -1.153 . . . . 75.430000000000007 107.886 170.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.5 m -64.44 -28.0 69.37 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.584 0.754 . . . . 74.340000000000003 112.322 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -73.49 -32.15 64.12 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.117 0.414 . . . . 72.519999999999996 112.117 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -91.51 128.18 37.24 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.084 0.554 . . . . 74.239999999999995 109.572 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -121.03 2.16 10.43 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 112.303 0.483 . . . . 73.109999999999999 112.303 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.06 -155.56 33.13 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 119.584 -0.565 . . . . 63.229999999999997 114.11 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.12 101.43 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.988 2.459 . . . . 71.140000000000001 111.159 173.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.554 ' HB ' ' HD2' ' A' ' 171' ' ' ARG . 15.9 t -118.79 142.81 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 110.231 -0.285 . . . . 74.200000000000003 110.231 -173.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.6 m -73.94 161.99 29.54 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.967 0.907 . . . . 64.019999999999996 110.772 172.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -63.38 -44.59 94.31 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.234 0.614 . . . . 75.549999999999997 111.361 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -58.87 -51.89 68.1 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.071 0.948 . . . . 74.329999999999998 110.192 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.06 86.73 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.946 0.898 . . . . 44.229999999999997 111.59 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.97 -53.86 53.63 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.077 -0.965 . . . . 41.520000000000003 111.588 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.55 ' HG3' HG11 ' A' ' 190' ' ' VAL . 30.4 tt0 -70.87 -24.87 62.59 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.945 -1.025 . . . . 63.039999999999999 110.52 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -66.52 -43.22 85.83 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.143 0.577 . . . . 71.439999999999998 111.098 173.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 238' ' ' LYS . 44.8 mt -72.85 -36.78 67.51 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.473 0.654 . . . . 65.129999999999995 110.789 175.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.576 HD22 ' HB3' ' A' ' 183' ' ' SER . 39.5 tp -77.76 -19.81 54.48 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.223 -0.899 . . . . 60.039999999999999 112.28 -174.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 81.0 p -64.94 -26.06 68.14 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 120.861 0.362 . . . . 72.219999999999999 110.184 174.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.4 t -82.02 -5.85 58.68 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.416 1.086 . . . . 60.520000000000003 111.076 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.77 171.81 55.16 Favored Glycine 0 C--N 1.346 1.118 0 C-N-CA 122.917 0.294 . . . . 72.230000000000004 113.436 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.6 pt -133.95 -169.58 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.598 1.159 . . . . 73.120000000000005 110.09 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 18.1 p-10 -59.75 103.26 0.19 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.442 0.697 . . . . 64.329999999999998 112.435 -172.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 102.73 12.88 31.31 Favored Glycine 0 C--O 1.261 1.816 0 CA-C-N 116.184 -0.462 . . . . 63.030000000000001 113.082 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 78.7 p -79.75 137.78 37.11 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 109.991 -0.374 . . . . 72.25 109.991 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -137.01 155.91 49.1 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.282 0.563 . . . . 74.420000000000002 112.264 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.0 mt -131.74 134.22 45.64 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.994 -1.113 . . . . 74.329999999999998 107.994 170.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.404 HG21 HG22 ' A' ' 218' ' ' VAL . 52.2 t -114.0 126.25 71.45 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 108.354 -0.98 . . . . 74.310000000000002 108.354 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.554 ' HD2' ' HB ' ' A' ' 151' ' ' VAL . 17.9 mtm180 -140.32 170.19 16.27 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.741 -1.118 . . . . 62.009999999999998 109.005 -167.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 9.0 pm0 -117.4 163.5 16.28 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 108.695 -0.854 . . . . 74.340000000000003 108.695 153.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 176' ' ' SER . 48.8 m -82.68 131.92 35.19 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.434 -0.803 . . . . 71.319999999999993 110.308 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -53.6 -40.09 65.42 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.087 1.355 . . . . 72.400000000000006 112.205 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.8 t -98.49 6.25 47.33 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.558 0.743 . . . . 62.439999999999998 111.376 -174.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 173' ' ' SER . 28.8 m -147.08 86.97 6.31 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.32 0.648 . . . . 72.230000000000004 109.489 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.457 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 34.9 Cg_endo -62.58 136.73 60.17 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 123.327 2.684 . . . . 75.340000000000003 111.331 177.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.85 -24.92 5.57 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.901 -0.59 . . . . 74.439999999999998 113.306 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -84.11 116.35 22.85 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.002 -1.11 . . . . 72.239999999999995 108.002 175.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.654 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 58.2 mtt-85 -109.17 168.56 9.29 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.308 -0.86 . . . . 61.130000000000003 110.633 -170.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.4 t -155.91 145.91 21.4 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.323 0.649 . . . . 63.32 110.063 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 65.9 mt -115.94 147.91 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.587 0.755 . . . . 72.120000000000005 109.081 173.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.576 ' HB3' HD22 ' A' ' 160' ' ' LEU . 24.5 m -125.89 114.2 18.22 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.869 1.268 . . . . 73.120000000000005 108.602 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.403 HD21 ' CD2' ' A' ' 232' ' ' LEU . 76.7 mt -105.01 139.1 40.19 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.629 1.171 . . . . 74.5 111.448 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -120.79 132.18 54.88 Favored 'General case' 0 C--O 1.257 1.475 0 N-CA-C 107.24 -1.393 . . . . 74.140000000000001 107.24 161.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 28.5 t80 -151.94 123.6 7.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.736 -1.12 . . . . 74.400000000000006 108.678 -171.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 51.29 36.13 15.42 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.435 1.494 . . . . 73.239999999999995 112.359 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 89.23 3.34 75.83 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 114.995 -1.002 . . . . 64.349999999999994 114.088 173.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -115.02 127.73 55.83 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 117.722 0.761 . . . . 75.010000000000005 111.224 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.55 HG11 ' HG3' ' A' ' 157' ' ' GLU . 46.3 t -88.26 132.79 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 124.636 1.174 . . . . 72.129999999999995 109.854 171.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -146.39 153.35 40.38 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.118 1.367 . . . . 71.200000000000003 109.174 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -131.21 149.31 52.63 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.083 0.953 . . . . 75.400000000000006 109.335 -170.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -146.3 154.58 41.86 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.285 0.564 . . . . 70.219999999999999 111.713 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.505 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 20.8 tpp180 -85.75 135.26 33.82 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.761 1.224 . . . . 74.030000000000001 111.001 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.461 ' HA ' HG22 ' A' ' 205' ' ' VAL . 90.9 mt -85.69 110.27 19.45 Favored 'Isoleucine or valine' 0 C--O 1.245 0.858 0 N-CA-C 107.888 -1.153 . . . . 75.219999999999999 107.888 163.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -75.72 119.03 19.17 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.515 -0.766 . . . . 72.209999999999994 109.5 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 25.9 m -99.43 114.3 27.15 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.165 0.586 . . . . 74.450000000000003 109.892 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.02 163.18 12.72 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.198 0.999 . . . . 75.0 111.405 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 82.1 p -62.0 -24.72 67.21 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.384 0.674 . . . . 74.340000000000003 111.514 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.0 -5.79 50.1 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.145 0.978 . . . . 63.210000000000001 111.778 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 88.34 -3.97 85.35 Favored Glycine 0 C--N 1.352 1.465 0 C-N-CA 123.057 0.36 . . . . 21.300000000000001 112.56 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -74.42 142.46 44.97 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.578 0.751 . . . . 75.239999999999995 109.657 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 80.4 mt -98.05 153.57 18.31 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.672 0.789 . . . . 73.25 109.762 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -167.56 163.73 14.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.737 0.815 . . . . 64.310000000000002 109.648 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 195' ' ' ILE . 71.5 t -131.92 -56.98 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 107.699 -1.223 . . . . 74.299999999999997 107.699 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 40.0 t -83.65 155.18 23.31 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.541 -0.754 . . . . 70.299999999999997 109.478 171.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.3 m -68.66 -33.63 74.32 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.309 0.643 . . . . 74.099999999999994 110.327 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -75.06 -19.11 60.15 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.302 -0.863 . . . . 72.310000000000002 111.408 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 48.0 m -104.58 127.36 52.29 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.245 1.018 . . . . 65.010000000000005 110.17 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -138.59 133.94 33.16 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.569 1.147 . . . . 63.549999999999997 108.721 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.505 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 11.2 m-85 -133.76 135.84 44.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.255 0.622 . . . . 74.019999999999996 110.639 -172.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -83.15 -30.35 27.93 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.622 0.769 . . . . 63.329999999999998 110.261 169.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 40.1 p -128.84 150.36 50.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.579 0.752 . . . . 52.32 111.502 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 38.2 tp -70.17 -31.31 68.73 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.57 -1.195 . . . . 72.349999999999994 110.824 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.87 -41.73 87.79 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.404 0.682 . . . . 62.25 110.435 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -80.85 -24.63 38.26 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.842 -0.617 . . . . 53.219999999999999 111.536 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.65 -49.06 79.04 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.728 -0.471 . . . . 70.230000000000004 109.728 168.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.404 HG22 HG21 ' A' ' 170' ' ' VAL . 76.3 t -67.29 -40.13 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.125 0.97 . . . . 64.219999999999999 110.588 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -63.94 -52.93 57.48 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.984 0.914 . . . . 71.310000000000002 111.312 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.453 ' CE1' HG11 ' A' ' 224' ' ' VAL . 26.9 t-80 -60.18 -47.79 84.47 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 115.054 -0.975 . . . . 63.229999999999997 109.086 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.464 ' HB3' ' HG ' ' A' ' 232' ' ' LEU . 7.9 m-70 -62.19 -29.6 70.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.337 0.655 . . . . 74.439999999999998 111.932 175.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 33.7 t -69.9 -26.15 64.03 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.157 0.583 . . . . 45.009999999999998 111.316 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.3 t -112.93 -11.3 13.43 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 115.902 1.815 . . . . 71.319999999999993 115.902 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 221' ' ' HIS . 24.1 m -92.47 139.4 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 120.982 1.719 . . . . 70.420000000000002 114.143 -171.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.38 -1.0 57.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.021 2.528 . . . . 65.409999999999997 112.295 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -79.22 15.87 1.1 Allowed 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 127.621 2.368 . . . . 74.219999999999999 112.009 -145.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 117.58 19.62 4.91 Favored Glycine 0 C--O 1.245 0.825 0 C-N-CA 125.028 1.299 . . . . 71.239999999999995 112.403 -172.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 52.0 mt -90.87 121.67 32.92 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.145 -1.028 . . . . 62.329999999999998 109.124 158.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 59.4 mt -53.0 -43.09 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 124.357 1.035 . . . . 71.129999999999995 110.307 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.1 t -133.14 142.77 48.84 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.428 -0.805 . . . . 73.219999999999999 109.172 171.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 41.6 p -70.14 145.39 51.59 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.684 -0.858 . . . . 61.100000000000001 108.684 166.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' A' ' 221' ' ' HIS . 21.2 mt -61.76 102.67 0.28 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.049 -0.723 . . . . 41.549999999999997 109.049 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 -87.1 -54.34 4.38 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.29 -0.633 . . . . 72.519999999999996 109.29 -171.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -157.58 150.12 17.97 Favored Pre-proline 0 N--CA 1.487 1.385 0 C-N-CA 123.503 0.721 . . . . 61.310000000000002 111.443 -177.368 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.99 145.55 45.2 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 121.903 1.735 . . . . 73.109999999999999 112.402 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.19 131.79 82.91 Favored Pre-proline 0 C--O 1.243 0.751 0 N-CA-C 109.199 -0.667 . . . . 72.540000000000006 109.199 173.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.1 147.45 54.37 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 121.874 1.716 . . . . 72.340000000000003 111.63 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.47 ' HA ' HD22 ' A' ' 159' ' ' LEU . 38.6 ttpt -69.69 158.45 35.34 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.296 -0.865 . . . . 75.319999999999993 109.344 171.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -38.43 -47.36 1.25 Allowed 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 125.275 1.43 . . . . 71.430000000000007 113.081 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -124.9 111.81 15.89 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 107.409 -1.33 . . . . 62.100000000000001 107.409 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -170.5 110.13 0.44 Allowed Pre-proline 0 N--CA 1.476 0.858 0 N-CA-C 108.558 -0.904 . . . . 73.329999999999998 108.558 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.51 137.27 18.28 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.444 2.096 . . . . 70.109999999999999 111.851 176.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 9.5 t -145.27 159.41 43.06 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.923 0.889 . . . . 74.209999999999994 110.305 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.8 p -143.75 117.65 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.173 0.989 . . . . 73.450000000000003 109.291 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -149.05 132.89 17.01 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.776 1.23 . . . . 72.430000000000007 108.745 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -148.0 147.42 18.05 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 111.334 -0.706 . . . . 70.0 111.334 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.89 146.91 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.633 0.773 . . . . 74.209999999999994 109.186 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 42.0 p -121.42 84.28 41.45 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.174 0.99 . . . . 72.129999999999995 108.634 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.79 95.27 1.07 Allowed 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.185 2.59 . . . . 75.340000000000003 112.137 -175.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -84.9 116.54 23.39 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.484 0.714 . . . . 75.340000000000003 110.392 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -134.37 141.95 47.03 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.723 0.809 . . . . 50.520000000000003 109.57 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.48 -61.68 1.82 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.996 -0.742 . . . . 62.409999999999997 108.996 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -177.63 79.29 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.446 1.098 . . . . 72.230000000000004 109.071 171.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -71.86 122.19 20.32 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.755 -0.657 . . . . 71.129999999999995 110.016 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--O 1.254 1.293 0 CA-C-O 118.748 -0.644 . . . . 74.540000000000006 109.432 -174.833 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.6 mmm . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.01 -0.737 . . . . 45.219999999999999 109.01 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.94 -130.01 1.25 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-O 118.791 -1.005 . . . . 71.129999999999995 110.646 -176.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 56.94 -1.76 0.05 Allowed 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 126.864 2.066 . . . . 75.109999999999999 115.692 176.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.74 115.07 65.77 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.485 0.714 . . . . 52.509999999999998 109.459 -175.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.4 -39.58 45.36 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 121.958 1.772 . . . . 71.230000000000004 110.83 169.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.6 -67.68 3.68 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 115.487 -0.779 . . . . 63.240000000000002 113.443 169.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.506 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -123.45 159.84 28.15 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.466 0.651 . . . . 71.530000000000001 112.235 -170.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.91 146.0 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 106.719 -1.585 . . . . 72.230000000000004 106.719 164.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.42 -173.11 4.1 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.578 0.351 . . . . 74.319999999999993 110.918 -172.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.88 24.57 29.63 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.995 -0.548 . . . . 53.229999999999997 111.773 -172.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -91.86 -167.9 1.89 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.391 1.076 . . . . 62.229999999999997 110.688 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -80.09 -161.05 0.32 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.003 0.921 . . . . 62.299999999999997 112.715 -170.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -44.96 133.33 6.4 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 124.545 1.138 . . . . 75.329999999999998 111.671 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 60.91 80.89 0.25 Allowed Pre-proline 0 N--CA 1.479 0.979 0 O-C-N 124.197 0.936 . . . . 64.409999999999997 109.037 -169.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.74 165.42 16.06 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.22 1.947 . . . . 64.040000000000006 111.828 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 54.3 m -68.24 168.04 13.14 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 121.547 0.689 . . . . 72.519999999999996 112.612 -171.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.4 mt -103.05 125.83 34.13 Favored Pre-proline 0 C--O 1.239 0.511 0 N-CA-C 108.041 -1.096 . . . . 73.319999999999993 108.041 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.525 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 39.2 Cg_endo -69.57 171.58 14.01 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.367 2.045 . . . . 64.430000000000007 113.602 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.29 140.07 31.11 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.178 0.591 . . . . 34.229999999999997 111.39 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.491 HD22 HD11 ' A' ' 23' ' ' ILE . 78.4 mt -88.65 91.99 9.02 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.078 -1.082 . . . . 74.209999999999994 108.078 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -98.99 -43.5 6.67 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.383 -0.826 . . . . 71.319999999999993 109.81 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -103.34 108.61 19.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.474 -0.785 . . . . 55.020000000000003 109.714 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.491 HD11 HD22 ' A' ' 20' ' ' LEU . 41.7 mm -118.05 121.32 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 107.566 -1.272 . . . . 73.420000000000002 107.566 172.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -132.05 159.08 39.85 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.592 0.757 . . . . 75.319999999999993 110.988 -176.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.71 -172.9 13.5 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 114.599 -1.182 . . . . 51.149999999999999 111.001 173.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 64.02 11.83 6.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.395 1.078 . . . . 73.209999999999994 113.204 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.62 124.57 7.62 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 109.953 -1.259 . . . . 51.530000000000001 109.953 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -169.4 -46.46 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 117.82 0.81 . . . . 73.140000000000001 111.158 -170.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 65.44 21.8 11.88 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.81 1.244 . . . . 75.310000000000002 110.475 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 50.89 28.26 3.63 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.126 0.97 . . . . 72.109999999999999 112.232 -172.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.9 t -75.07 -11.84 60.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.711 0.404 . . . . 63.399999999999999 110.652 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.5 p -64.66 82.56 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.853 0.861 . . . . 55.119999999999997 110.782 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -91.98 124.05 35.8 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 108.365 -0.976 . . . . 65.099999999999994 108.365 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -52.24 139.2 24.49 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 124.473 1.108 . . . . 71.230000000000004 112.883 -168.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.525 ' HA2' ' HE3' ' A' ' 124' ' ' LYS . . . -67.77 -86.21 0.09 OUTLIER Glycine 0 C--N 1.346 1.132 0 O-C-N 123.878 0.736 . . . . 62.350000000000001 113.331 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.69 175.98 23.19 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.426 -0.652 . . . . 75.409999999999997 112.273 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.85 97.63 0.4 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 123.523 2.815 . . . . 63.039999999999999 112.793 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -169.21 20.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.233 1.413 . . . . 72.430000000000007 109.075 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 61.7 m -72.12 110.64 6.73 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.428 1.091 . . . . 71.239999999999995 112.158 -167.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -79.21 75.41 5.76 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.761 0.791 . . . . 72.409999999999997 109.485 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.7 m -78.07 128.0 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 115.409 -0.814 . . . . 73.239999999999995 110.774 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -130.83 90.22 2.87 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.833 0.853 . . . . 72.510000000000005 108.993 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.7 m -99.45 123.44 52.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 109.42 -0.585 . . . . 70.439999999999998 109.42 172.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.59 141.86 32.87 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.768 -0.826 . . . . 75.120000000000005 108.768 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -92.22 7.76 41.16 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 122.886 0.474 . . . . 72.230000000000004 112.069 -171.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -75.54 83.49 2.59 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.289 -0.634 . . . . 61.119999999999997 109.289 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.68 96.48 2.25 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.933 0.893 . . . . 73.329999999999998 109.504 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.8 mt -99.21 108.9 21.6 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.104 -0.702 . . . . 74.310000000000002 109.104 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -73.73 89.06 1.77 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.448 0.699 . . . . 72.140000000000001 111.562 -174.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -72.98 -49.4 7.43 Favored Pre-proline 0 CA--C 1.562 1.442 0 CA-C-N 115.507 -0.769 . . . . 73.129999999999995 111.037 173.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.27 71.99 6.76 Favored 'Trans proline' 0 C--N 1.392 2.839 0 C-N-CA 121.763 1.642 . . . . 73.329999999999998 112.026 176.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.13 136.78 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 115.372 -0.831 . . . . 74.530000000000001 108.981 175.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.86 145.89 49.57 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.763 0.825 . . . . 72.430000000000007 110.191 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -103.46 90.96 3.85 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.071 -0.714 . . . . 72.209999999999994 109.071 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.85 110.61 15.38 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.164 -0.925 . . . . 53.219999999999999 111.237 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -68.06 145.6 54.29 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.606 0.762 . . . . 60.399999999999999 109.813 173.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 59.72 69.27 1.29 Allowed Pre-proline 0 CA--C 1.564 1.512 0 C-N-CA 123.829 0.851 . . . . 74.540000000000006 110.425 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -85.79 49.52 2.36 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 123.493 2.796 . . . . 64.219999999999999 112.413 -176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -60.85 135.01 57.65 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.63 0.772 . . . . 65.409999999999997 111.554 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.04 141.41 8.04 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.688 -0.965 . . . . 62.409999999999997 110.688 -172.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.9 mt -97.16 73.07 2.48 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.142 -0.688 . . . . 70.439999999999998 109.142 -177.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.3 t -74.28 141.19 45.32 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.752 -1.113 . . . . 72.129999999999995 110.956 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -154.72 154.09 32.32 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.893 0.877 . . . . 50.509999999999998 110.523 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.08 140.72 31.02 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.118 0.967 . . . . 71.349999999999994 109.66 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -117.71 113.73 22.3 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.41 0.684 . . . . 64.230000000000004 110.666 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.6 74.33 2.77 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.989 0.916 . . . . 74.409999999999997 108.561 175.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -90.96 116.2 28.57 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.485 -0.78 . . . . 62.130000000000003 110.329 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -98.81 89.76 4.44 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.022 0.929 . . . . 71.420000000000002 109.202 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.0 p -142.85 95.22 2.74 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.013 -0.736 . . . . 64.200000000000003 109.013 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.0 tttm -79.18 140.53 37.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.254 1.021 . . . . 75.010000000000005 110.747 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -97.75 151.48 20.11 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 122.935 0.494 . . . . 74.120000000000005 110.104 172.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -73.11 144.86 46.82 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.774 -0.824 . . . . 71.150000000000006 108.774 174.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.08 88.65 0.17 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.367 0.667 . . . . 75.299999999999997 110.314 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.5 mt -80.57 138.44 36.48 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.545 0.738 . . . . 62.009999999999998 110.187 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.26 167.54 20.18 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 123.804 0.69 . . . . 34.240000000000002 110.45 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.61 120.31 0.97 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-O 118.077 -1.402 . . . . 35.229999999999997 110.615 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.36 111.14 0.73 Allowed 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.081 2.521 . . . . 74.510000000000005 111.68 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.0 p -126.98 113.14 16.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.467 0.707 . . . . 72.510000000000005 111.51 -170.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -164.38 103.36 0.84 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.556 -0.905 . . . . 75.209999999999994 108.556 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -128.0 -51.38 1.33 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.615 0.766 . . . . 75.230000000000004 110.283 -177.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.2 142.74 41.36 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 124.165 0.986 . . . . 65.209999999999994 110.195 -170.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.03 -46.27 10.82 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.673 2.249 . . . . 64.019999999999996 111.322 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 140' ' ' SER . 82.3 m-20 -87.76 66.67 8.91 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.686 0.755 . . . . 75.510000000000005 109.461 176.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.1 tp -92.32 125.84 37.15 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 108.168 -1.049 . . . . 74.439999999999998 108.168 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 4.5 m-85 -104.0 175.46 5.48 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.583 1.153 . . . . 74.530000000000001 109.556 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 p -145.04 141.34 22.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 108.779 -0.823 . . . . 61.219999999999999 108.779 171.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -77.93 108.7 11.38 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.082 -0.711 . . . . 64.329999999999998 109.082 173.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.54 -26.51 66.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.901 0.881 . . . . 71.420000000000002 111.212 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -126.98 155.89 42.44 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.961 0.904 . . . . 74.25 109.127 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -69.81 145.46 52.12 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.37 -0.832 . . . . 73.230000000000004 109.485 169.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -153.3 108.47 3.21 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.497 -0.927 . . . . 63.240000000000002 108.497 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 52.8 t -81.56 131.95 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.952 -1.129 . . . . 70.310000000000002 107.952 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.84 136.62 57.95 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.454 0.472 . . . . 72.109999999999999 110.896 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.5 t -62.31 -25.06 67.66 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.696 0.798 . . . . 52.409999999999997 109.824 172.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.51 -133.42 3.75 Favored Glycine 0 C--N 1.353 1.513 0 CA-C-N 115.557 -0.747 . . . . 34.229999999999997 112.305 172.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.06 -25.86 66.46 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.785 1.234 . . . . 65.230000000000004 111.926 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -79.87 -11.28 59.82 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.381 1.072 . . . . 75.329999999999998 112.511 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.8 p -137.74 169.7 17.34 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.574 0.75 . . . . 31.210000000000001 111.441 -171.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.9 tp -115.65 134.72 54.76 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.933 0.893 . . . . 74.019999999999996 109.781 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.0 t -85.59 117.33 24.42 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.829 -0.804 . . . . 62.119999999999997 108.829 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.4 pt -119.51 131.94 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.648 0.779 . . . . 71.319999999999993 109.52 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.438 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 50.3 m -90.34 146.42 24.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.375 0.67 . . . . 72.209999999999994 110.111 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -52.94 112.95 0.94 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 122.84 0.456 . . . . 64.230000000000004 110.408 164.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 106.27 -13.12 44.17 Favored Glycine 0 N--CA 1.472 1.082 0 CA-C-N 116.701 -0.227 . . . . 32.409999999999997 112.901 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -76.67 126.96 31.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.183 0.993 . . . . 72.409999999999997 109.462 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -90.2 133.03 35.16 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.157 0.583 . . . . 71.140000000000001 110.733 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.8 mt -116.71 150.0 38.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.911 0.884 . . . . 73.049999999999997 110.731 -161.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -102.58 109.02 20.5 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.642 -0.873 . . . . 54.32 108.642 169.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.6 t -87.66 106.25 16.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 108.571 -0.9 . . . . 55.219999999999999 108.571 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 76.2 mt -72.4 -31.49 65.58 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 115.375 -0.83 . . . . 55.310000000000002 109.441 176.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.31 -174.61 42.96 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.093 -0.958 . . . . 73.420000000000002 111.259 172.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.3 m-30 -113.31 174.08 6.09 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.539 0.736 . . . . 74.209999999999994 109.427 167.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -64.95 145.99 55.57 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.066 -1.087 . . . . 72.200000000000003 108.066 166.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -65.22 -29.91 70.76 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.355 0.662 . . . . 71.430000000000007 111.62 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -85.95 -5.98 59.14 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.633 0.773 . . . . 73.310000000000002 111.253 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.17 33.07 41.51 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.805 -0.634 . . . . 43.43 113.274 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . 29.8 mt-10 -89.34 -73.09 0.52 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.129 0.572 . . . . 64.439999999999998 110.117 -177.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -100.53 -178.87 3.93 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.69 0.796 . . . . 75.310000000000002 109.64 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.28 117.91 22.33 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.165 0.986 . . . . 73.540000000000006 108.854 -177.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.62 92.72 1.17 Allowed 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.555 -1.276 . . . . 72.450000000000003 107.555 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -112.24 164.08 13.62 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.873 0.844 . . . . 74.209999999999994 111.111 -171.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -151.67 138.74 19.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.522 -1.217 . . . . 74.25 108.254 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 43.4 p -132.21 175.93 8.83 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.633 0.773 . . . . 64.340000000000003 109.638 171.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.525 ' HE3' ' HA2' ' A' ' 35' ' ' GLY . 25.7 mtpp -70.53 -6.66 37.96 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 121.212 0.53 . . . . 74.230000000000004 110.168 174.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -89.33 -18.93 25.95 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.823 1.249 . . . . 73.230000000000004 111.217 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 154.91 -148.14 18.14 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 118.041 0.382 . . . . 75.420000000000002 113.034 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -151.15 157.25 42.47 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.44 0.62 . . . . 74.129999999999995 110.295 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 153.25 -171.17 32.18 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 122.966 0.317 . . . . 52.0 112.494 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -91.34 133.7 35.22 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.065 0.546 . . . . 51.210000000000001 110.53 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.31 156.19 72.9 Favored Pre-proline 0 N--CA 1.479 1.025 0 C-N-CA 124.484 1.114 . . . . 73.319999999999993 109.43 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.36 123.91 11.07 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.063 1.842 . . . . 42.439999999999998 110.92 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.4 m -59.41 -22.09 60.92 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.679 0.792 . . . . 75.310000000000002 111.47 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -73.33 -23.26 60.22 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.571 1.148 . . . . 72.219999999999999 111.719 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -94.58 -4.17 48.36 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.671 0.788 . . . . 71.219999999999999 112.393 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.4 pt -123.08 151.74 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 118.363 0.529 . . . . 73.420000000000002 110.397 -172.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.0 t -145.16 135.45 11.93 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.019 0.528 . . . . 53.219999999999999 109.639 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.567 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 59.3 Cg_endo -74.18 115.17 4.23 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.334 2.023 . . . . 72.530000000000001 111.938 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.1 m -87.64 -54.62 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.023 0.529 . . . . 74.420000000000002 111.028 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -80.97 -18.29 47.47 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.329 0.651 . . . . 73.519999999999996 111.308 -171.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 32.8 t -71.34 -179.87 2.63 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.609 0.763 . . . . 73.209999999999994 111.228 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.51 -14.6 43.63 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.406 1.082 . . . . 63.020000000000003 113.266 -174.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.86 -25.55 67.6 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.979 0.512 . . . . 71.420000000000002 111.63 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.14 -26.53 62.79 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.286 1.034 . . . . 73.430000000000007 111.337 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -78.86 169.6 17.97 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.918 0.887 . . . . 71.140000000000001 111.764 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.5 p -84.58 -26.18 28.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.364 0.666 . . . . 43.43 112.097 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' TRP . . . . . 0.453 ' CE3' HG21 ' A' ' 218' ' ' VAL . 55.3 p-90 -83.89 -42.36 16.43 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.066 -0.515 . . . . 72.099999999999994 111.485 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -95.42 126.36 40.67 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.847 -0.797 . . . . 75.329999999999998 108.847 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -110.57 5.3 21.03 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.8 -0.637 . . . . 72.239999999999995 111.259 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.82 -155.09 36.58 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.475 -0.625 . . . . 74.040000000000006 113.418 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.75 106.07 1.77 Allowed 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 123.196 2.597 . . . . 53.310000000000002 110.408 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.3 t -128.39 150.54 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 123.631 0.773 . . . . 60.32 109.154 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.2 t -86.3 167.27 14.95 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.849 0.86 . . . . 52.439999999999998 110.066 173.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -63.71 -33.33 75.41 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.33 0.652 . . . . 73.420000000000002 111.903 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -67.52 -55.21 14.42 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.291 0.636 . . . . 44.140000000000001 110.284 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.42 -37.37 80.66 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.965 0.79 . . . . 74.519999999999996 111.226 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.54 -57.54 12.24 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.66 -0.7 . . . . 54.32 110.849 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.51 -21.12 63.69 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.359 -0.837 . . . . 70.239999999999995 111.118 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -68.22 -53.25 26.08 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.687 0.795 . . . . 75.420000000000002 110.591 174.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.439 ' HB2' HD11 ' A' ' 169' ' ' LEU . 74.6 mt -68.06 -37.33 81.18 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.946 -0.57 . . . . 75.349999999999994 110.957 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.8 tp -73.51 -22.48 60.11 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.381 -0.827 . . . . 71.329999999999998 111.349 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.9 t -59.76 -26.84 66.03 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.48 0.712 . . . . 61.030000000000001 111.787 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.8 m -79.16 9.66 4.3 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.363 1.065 . . . . 62.539999999999999 112.246 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.04 159.24 14.46 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 122.98 0.324 . . . . 73.329999999999998 113.53 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.1 pt -115.57 -164.47 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.347 1.059 . . . . 65.329999999999998 109.859 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.699 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 17.4 p-10 -52.65 99.62 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.516 1.126 . . . . 52.530000000000001 113.142 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 107.85 13.71 19.31 Favored Glycine 0 C--N 1.355 1.632 0 CA-C-N 116.174 -0.466 . . . . 44.399999999999999 113.538 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 185' ' ' ARG . 37.9 p -79.0 137.45 37.59 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.998 -0.707 . . . . 74.400000000000006 109.98 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.492 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 27.1 p90 -134.08 160.7 36.97 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 112.452 0.538 . . . . 74.209999999999994 112.452 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 159' ' ' LEU . 82.4 mt -134.65 134.15 40.85 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.337 1.055 . . . . 32.539999999999999 108.292 166.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.401 HG21 HG22 ' A' ' 218' ' ' VAL . 32.3 t -106.14 128.45 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.113 -1.44 . . . . 64.319999999999993 107.113 171.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -158.43 161.11 37.45 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.908 0.483 . . . . 73.030000000000001 110.07 -174.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.701 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 12.5 pt-20 -109.21 161.62 15.06 Favored 'General case' 0 C--O 1.244 0.812 0 O-C-N 123.409 0.443 . . . . 62.130000000000003 109.806 169.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 176' ' ' SER . 16.2 m -83.41 135.53 34.66 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.627 -0.715 . . . . 70.319999999999993 109.395 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -71.19 -41.86 69.74 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.388 0.675 . . . . 50.420000000000002 110.213 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 25.0 m -78.57 -17.16 56.55 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.115 -0.948 . . . . 72.329999999999998 111.431 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 28.3 t -130.49 80.9 69.33 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.423 -0.954 . . . . 72.030000000000001 108.423 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.24 141.44 93.19 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.621 2.881 . . . . 53.140000000000001 112.837 -173.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 77.66 -23.07 2.55 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 116.208 -0.451 . . . . 31.41 114.071 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -84.25 116.38 22.94 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 108.177 -1.045 . . . . 72.129999999999995 108.177 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.701 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 44.5 mtt180 -110.88 169.78 8.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.168 -0.923 . . . . 75.329999999999998 111.209 -168.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.401 ' HB2' ' HD3' ' A' ' 194' ' ' ARG . 47.8 t -154.59 144.38 21.63 Favored 'General case' 0 C--O 1.253 1.244 0 C-N-CA 124.982 1.313 . . . . 74.409999999999997 108.722 -176.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.475 HD11 HD21 ' A' ' 217' ' ' LEU . 58.6 mt -109.33 135.38 48.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 107.221 -1.4 . . . . 74.450000000000003 107.221 166.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 19.3 m -112.26 114.06 26.63 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.229 -1.026 . . . . 75.420000000000002 108.229 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.3 mt -105.14 144.31 32.11 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.107 0.963 . . . . 63.200000000000003 111.035 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.455 ' HB3' ' OG ' ' A' ' 167' ' ' SER . 27.1 ttt85 -132.74 133.27 43.26 Favored 'General case' 0 C--O 1.259 1.579 0 CA-C-N 114.357 -1.292 . . . . 74.010000000000005 108.895 175.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 28.2 p90 -148.1 138.83 23.06 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 124.616 1.198 . . . . 71.209999999999994 108.804 171.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 58.58 19.1 6.34 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.934 1.293 . . . . 75.310000000000002 113.534 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.62 21.1 69.95 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 116.626 -0.261 . . . . 71.420000000000002 112.814 -175.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -118.16 126.9 53.14 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.511 1.125 . . . . 64.439999999999998 108.553 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 51.4 t -119.04 141.88 36.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 124.13 0.972 . . . . 71.530000000000001 110.722 -168.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.485 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 18.2 p90 -145.19 151.13 37.94 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.507 1.123 . . . . 74.140000000000001 109.403 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -126.36 115.39 19.58 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 107.918 -1.141 . . . . 71.409999999999997 107.918 -173.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -117.46 132.63 56.52 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.637 -0.505 . . . . 64.409999999999997 109.637 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.401 ' HD3' ' HB2' ' A' ' 181' ' ' SER . 10.8 mmt85 -72.68 131.5 42.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.777 0.831 . . . . 73.310000000000002 112.07 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 82.0 mt -71.45 110.63 4.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 108.107 -1.071 . . . . 74.239999999999995 108.107 163.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -69.33 120.92 15.88 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.274 -0.875 . . . . 43.32 108.641 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.4 m -103.47 110.64 22.75 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 122.969 0.508 . . . . 63.329999999999998 109.804 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.402 ' HB2' ' HE1' ' A' ' 204' ' ' TYR . . . -61.38 156.53 18.82 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.959 0.904 . . . . 62.5 111.606 172.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.1 m -71.22 -12.47 61.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.707 0.803 . . . . 71.120000000000005 112.196 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -86.55 12.38 10.59 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.468 0.707 . . . . 72.019999999999996 111.16 171.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 75.05 4.91 74.1 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 123.179 0.419 . . . . 72.409999999999997 113.266 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -81.64 140.06 34.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.605 0.762 . . . . 73.409999999999997 109.991 -175.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.519 HD13 HD13 ' A' ' 214' ' ' LEU . 85.8 mt -103.13 147.29 27.19 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.515 0.726 . . . . 65.0 109.481 -175.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.402 ' HE1' ' HB2' ' A' ' 198' ' ' ALA . 28.7 p90 -167.49 177.39 5.99 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.118 0.967 . . . . 73.400000000000006 110.819 173.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 74.9 t -131.3 -54.89 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 107.452 -1.314 . . . . 75.049999999999997 107.452 174.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 12.1 t -86.08 153.55 22.03 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.916 -1.038 . . . . 62.149999999999999 108.961 172.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.1 t -68.88 -25.58 64.68 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.728 0.411 . . . . 71.109999999999999 110.424 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.75 -34.13 62.45 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.568 -0.742 . . . . 73.540000000000006 110.492 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.455 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 74.8 m -64.32 126.32 27.4 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.528 0.731 . . . . 62.350000000000001 109.28 172.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -144.65 112.56 6.32 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.202 1.001 . . . . 74.150000000000006 108.645 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 209' ' ' SER . 17.4 m-85 -129.66 142.76 50.67 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 118.683 0.674 . . . . 74.519999999999996 111.315 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -90.58 -22.51 21.22 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.382 0.673 . . . . 74.409999999999997 109.66 172.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.0 p -129.87 147.02 51.59 Favored 'General case' 0 C--O 1.253 1.272 0 CA-C-O 122.182 0.992 . . . . 71.109999999999999 111.459 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.519 HD13 HD13 ' A' ' 203' ' ' LEU . 27.1 tp -67.23 -29.02 68.56 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 114.047 -1.433 . . . . 54.420000000000002 110.841 177.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.46 90.51 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.487 0.715 . . . . 72.540000000000006 111.029 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -66.53 -37.98 86.19 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.545 -0.752 . . . . 64.230000000000004 110.762 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.475 HD21 HD11 ' A' ' 182' ' ' ILE . 9.2 tt -55.64 -47.53 76.5 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.885 0.74 . . . . 74.109999999999999 111.486 174.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.453 HG21 ' CE3' ' A' ' 146' ' ' TRP . 70.4 t -70.53 -44.04 77.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 123.262 0.625 . . . . 53.439999999999998 111.263 -175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -59.72 -49.63 76.98 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.632 0.73 . . . . 71.099999999999994 110.577 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -56.6 -56.47 20.88 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.961 -1.018 . . . . 72.439999999999998 109.684 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.446 ' HA ' HG22 ' A' ' 224' ' ' VAL . 36.0 m80 -67.32 -16.74 64.43 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.168 0.433 . . . . 73.340000000000003 112.168 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.434 ' HA ' ' HB2' ' A' ' 232' ' ' LEU . 35.9 t -73.59 -31.57 63.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.555 0.342 . . . . 73.430000000000007 111.047 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.6 t -112.04 -6.62 14.17 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.27 1.952 . . . . 64.430000000000007 116.27 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.446 HG22 ' HA ' ' A' ' 221' ' ' HIS . 33.8 m -104.21 158.4 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 116.199 1.925 . . . . 64.450000000000003 116.199 -171.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -90.89 -0.99 57.88 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 129.25 3.02 . . . . 54.0 113.543 -175.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -77.9 14.98 0.95 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 128.734 2.814 . . . . 71.409999999999997 113.766 -141.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.77 18.78 3.87 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 124.571 1.081 . . . . 42.32 111.817 -168.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.91 135.37 33.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.957 0.903 . . . . 73.239999999999995 110.555 167.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.485 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 85.8 mt -72.96 -34.86 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 109.321 -0.622 . . . . 72.420000000000002 109.321 171.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.8 t -143.25 142.24 31.31 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.59 -0.893 . . . . 73.219999999999999 108.59 168.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 224' ' ' VAL . 67.8 p -67.92 147.48 52.43 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.802 -0.814 . . . . 73.209999999999994 108.802 171.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.492 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 28.6 mt -62.68 99.91 0.17 Allowed 'General case' 0 CA--C 1.555 1.147 0 N-CA-C 108.89 -0.781 . . . . 64.129999999999995 108.89 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -81.8 -50.93 8.66 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.702 0.401 . . . . 72.209999999999994 110.277 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -156.76 148.37 17.1 Favored Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 120.689 -0.405 . . . . 74.010000000000005 110.191 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.05 138.78 20.96 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 121.843 1.696 . . . . 64.310000000000002 111.97 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ALA . . . . . 0.426 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -67.67 140.63 94.53 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 108.793 -0.817 . . . . 72.5 108.793 171.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.77 156.4 64.23 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.833 2.356 . . . . 64.439999999999998 114.67 -164.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -72.18 159.9 33.34 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.567 -1.197 . . . . 72.099999999999994 109.898 170.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -53.46 -39.6 64.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 123.674 0.609 . . . . 71.329999999999998 111.058 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -120.25 119.82 34.3 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.366 -0.976 . . . . 73.230000000000004 108.366 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -87.09 107.77 15.96 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.646 -0.872 . . . . 74.319999999999993 108.646 171.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -88.57 14.57 2.26 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.727 2.284 . . . . 74.129999999999995 112.674 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 9.1 t -154.02 151.04 28.89 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.729 0.812 . . . . 74.400000000000006 110.561 -176.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.83 105.66 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 125.291 1.436 . . . . 74.510000000000005 107.853 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -159.84 145.58 15.64 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.275 0.63 . . . . 73.5 110.036 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -169.53 116.75 0.67 Allowed Glycine 0 C--N 1.348 1.209 0 N-CA-C 112.151 -0.38 . . . . 62.229999999999997 112.151 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 80.6 t -117.58 132.36 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.613 1.165 . . . . 64.049999999999997 108.322 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.1 t -103.71 95.82 8.06 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 123.511 0.724 . . . . 64.329999999999998 109.931 176.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.03 122.15 2.17 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.069 2.512 . . . . 62.399999999999999 111.594 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -98.65 139.35 34.48 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.25 0.62 . . . . 72.200000000000003 109.432 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -137.39 103.06 4.97 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.858 0.863 . . . . 74.219999999999999 109.538 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -81.88 166.46 19.91 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.999 0.52 . . . . 73.420000000000002 109.753 170.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -156.69 141.75 17.21 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.743 0.417 . . . . 72.349999999999994 110.158 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -84.35 167.21 16.74 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.095 0.958 . . . . 73.129999999999995 111.527 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.247 0.965 0 N-CA-C 107.587 -1.264 . . . . 75.219999999999999 107.587 177.95 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mmm . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 109.19 -0.67 . . . . 70.310000000000002 109.19 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.13 120.57 6.57 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 116.004 -0.544 . . . . 70.310000000000002 112.443 -174.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.576 ' HB2' ' HG3' ' A' ' 194' ' ' ARG . 22.0 mt-30 -132.32 152.9 51.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.525 0.73 . . . . 72.129999999999995 109.078 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -132.2 91.31 32.16 Favored Pre-proline 0 N--CA 1.482 1.125 0 N-CA-C 108.704 -0.85 . . . . 73.430000000000007 108.704 173.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.64 -37.71 86.21 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 123.029 2.486 . . . . 64.25 112.549 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.5 138.75 2.53 Favored Glycine 0 C--O 1.245 0.813 0 CA-C-N 115.039 -0.982 . . . . 40.539999999999999 111.374 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -69.76 119.27 13.74 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 109.159 -0.682 . . . . 71.129999999999995 109.159 174.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.614 HG13 ' HB3' ' A' ' 152' ' ' SER . 8.3 p -138.93 160.78 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 N-CA-C 108.427 -0.953 . . . . 72.510000000000005 108.427 -173.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 tt -163.21 101.64 0.96 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 107.565 -1.272 . . . . 74.439999999999998 107.565 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.35 -2.16 26.22 Favored Glycine 0 N--CA 1.473 1.127 0 O-C-N 123.457 0.473 . . . . 44.130000000000003 113.671 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -82.66 91.97 7.08 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.865 0.84 . . . . 71.299999999999997 110.228 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -141.78 163.56 32.56 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.12 0.968 . . . . 75.310000000000002 108.747 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.499 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 40.7 ttm180 -80.61 108.47 14.28 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.61 -1.256 . . . . 73.010000000000005 107.61 167.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 53.06 78.63 0.38 Allowed Pre-proline 0 CA--C 1.545 0.754 0 O-C-N 124.001 0.813 . . . . 73.329999999999998 111.739 -167.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.692 ' HG2' ' HB3' ' A' ' 133' ' ' ASN . 4.7 Cg_exo -75.76 165.39 30.27 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 122.764 2.31 . . . . 73.420000000000002 110.369 172.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.7 p -70.98 169.16 15.48 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.312 0.577 . . . . 65.430000000000007 111.116 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 94.6 mt -104.98 131.65 21.59 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.884 -0.598 . . . . 64.140000000000001 109.432 -176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 17' ' ' LEU . 8.2 Cg_exo -69.13 171.83 13.08 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.102 2.535 . . . . 52.039999999999999 112.267 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HB3' ' NE2' ' A' ' 21' ' ' HIS . . . -85.56 149.15 25.56 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.867 0.467 . . . . 74.099999999999994 110.401 170.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.576 HD22 HD11 ' A' ' 23' ' ' ILE . 84.8 mt -86.05 94.2 9.18 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.938 -1.134 . . . . 53.409999999999997 107.938 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.406 ' NE2' ' HB3' ' A' ' 19' ' ' ALA . 29.3 m170 -97.31 -52.9 3.65 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.632 0.373 . . . . 64.019999999999996 110.948 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -105.16 102.87 12.33 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.925 -1.139 . . . . 74.040000000000006 107.925 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.576 HD11 HD22 ' A' ' 20' ' ' LEU . 48.0 mm -126.1 111.57 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.923 -0.769 . . . . 60.25 108.923 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.82 -54.17 0.01 OUTLIER 'General case' 0 C--O 1.247 0.934 0 O-C-N 124.352 1.033 . . . . 54.439999999999998 108.714 173.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.93 -159.59 3.39 Favored Glycine 0 C--N 1.355 1.605 0 CA-C-O 118.852 -0.971 . . . . 51.340000000000003 113.423 -173.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 42.76 81.32 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.7 1.2 . . . . 52.409999999999997 113.252 171.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.4 -35.83 0.02 OUTLIER Glycine 0 N--CA 1.467 0.732 0 O-C-N 123.161 0.288 . . . . 61.210000000000001 112.604 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.41 175.37 10.67 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.918 0.487 . . . . 61.539999999999999 110.725 177.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.2 ptt85 -52.7 122.16 8.55 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.725 0.81 . . . . 64.409999999999997 111.723 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.84 127.79 33.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.858 0.863 . . . . 72.030000000000001 110.404 -174.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.3 p -56.41 -52.53 64.27 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.345 1.058 . . . . 72.430000000000007 111.889 -174.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.2 t -120.99 109.48 15.11 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.92 -1.141 . . . . 74.400000000000006 107.92 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.57 ' HD2' ' HA ' ' A' ' 72' ' ' ASN . 26.3 ptt180 -117.82 -179.6 3.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.336 0.654 . . . . 60.149999999999999 109.942 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -89.99 163.27 15.0 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.02 0.528 . . . . 75.329999999999998 110.886 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.41 153.51 6.88 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.061 -0.816 . . . . 73.540000000000006 111.061 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.6 -55.66 0.46 Allowed Glycine 0 CA--C 1.537 1.451 0 CA-C-O 118.16 -1.356 . . . . 75.340000000000003 113.588 -175.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.84 102.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 123.69 2.927 . . . . 72.340000000000003 113.644 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -139.72 166.01 25.75 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.549 1.14 . . . . 74.530000000000001 109.963 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 63.2 m -122.04 93.67 4.06 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.041 0.936 . . . . 74.129999999999995 109.869 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -164.64 160.36 19.96 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.333 0.653 . . . . 72.519999999999996 110.271 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.3 137.71 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.089 0.956 . . . . 73.25 109.102 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -118.51 100.13 7.25 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.157 -1.053 . . . . 75.040000000000006 108.157 173.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m -64.08 136.22 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.434 0.693 . . . . 62.530000000000001 111.238 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -80.01 132.61 36.04 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 115.545 -0.752 . . . . 74.239999999999995 110.201 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -124.8 77.31 1.59 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.796 -1.187 . . . . 74.010000000000005 107.796 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -72.83 142.75 48.0 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.989 -0.551 . . . . 72.120000000000005 112.044 -176.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.94 -49.36 10.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.935 -0.575 . . . . 73.129999999999995 109.645 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.5 mt 59.29 -71.82 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.326 1.851 . . . . 72.310000000000002 112.005 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -66.79 170.35 6.65 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.673 1.189 . . . . 75.540000000000006 111.059 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -120.0 90.74 44.65 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.177 0.591 . . . . 73.340000000000003 110.54 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -87.14 130.43 2.95 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.343 2.028 . . . . 73.450000000000003 111.608 168.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.06 -40.55 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 N-CA-C 109.187 -0.671 . . . . 64.310000000000002 109.187 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.54 89.91 0.53 Allowed 'General case' 0 C--N 1.351 0.641 0 CA-C-N 115.131 -0.94 . . . . 61.539999999999999 109.863 172.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.2 t -134.82 -1.85 2.69 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.095 1.358 . . . . 53.439999999999998 108.663 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -86.3 -10.67 54.05 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.655 1.582 . . . . 74.099999999999994 111.784 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -71.64 75.36 0.82 Allowed 'General case' 0 CA--C 1.555 1.145 0 CA-C-O 121.914 0.864 . . . . 75.319999999999993 111.608 -175.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 56.63 69.39 1.77 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 125.265 1.426 . . . . 50.119999999999997 111.136 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.61 -14.58 27.42 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.348 2.032 . . . . 64.519999999999996 113.344 -175.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -116.63 106.59 13.71 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.12 0.968 . . . . 61.439999999999998 108.931 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.26 13.75 0.07 OUTLIER Glycine 0 C--N 1.349 1.273 0 O-C-N 123.447 0.467 . . . . 54.350000000000001 113.733 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.7 mt -129.55 137.55 50.83 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.022 0.929 . . . . 73.030000000000001 109.749 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.2 t -147.03 169.23 19.66 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.898 0.879 . . . . 73.329999999999998 108.997 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.45 170.88 19.65 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.306 0.642 . . . . 73.230000000000004 110.82 -178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -163.53 123.75 2.2 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.531 0.732 . . . . 43.229999999999997 110.686 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -166.95 146.82 5.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.183 0.993 . . . . 72.349999999999994 109.454 172.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -139.29 119.38 13.54 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.517 -0.92 . . . . 71.299999999999997 108.517 177.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -133.06 93.6 3.21 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.328 -1.36 . . . . 71.430000000000007 107.328 170.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -81.1 153.9 27.08 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.707 -0.679 . . . . 75.129999999999995 110.773 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.4 p -68.2 135.23 51.72 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.154 -0.684 . . . . 74.230000000000004 109.154 170.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -59.04 -63.39 1.32 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.389 0.676 . . . . 62.240000000000002 110.531 -177.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -173.68 176.17 2.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.616 0.766 . . . . 65.209999999999994 109.031 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.57 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 3.2 p-10 -63.89 145.9 54.98 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.009 0.523 . . . . 74.549999999999997 110.472 172.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.3 mt -121.77 -66.94 1.0 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.303 -0.999 . . . . 62.140000000000001 108.303 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.4 mt -139.73 140.94 36.9 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.947 0.899 . . . . 74.010000000000005 109.716 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.0 -178.97 6.75 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.318 1.047 . . . . 34.520000000000003 111.781 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.09 145.17 16.32 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.773 -1.015 . . . . 52.329999999999998 111.094 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.97 81.09 0.9 Allowed 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.061 2.508 . . . . 71.450000000000003 112.083 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.437 ' O ' ' HD3' ' A' ' 108' ' ' ARG . 29.2 t -65.84 109.23 2.41 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.597 1.159 . . . . 70.450000000000003 110.325 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 80' ' ' ASN . 9.2 pt-20 -63.18 -56.31 17.73 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.667 0.787 . . . . 62.219999999999999 112.313 -176.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.444 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 60.8 m-80 -141.94 131.28 23.61 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.794 0.837 . . . . 51.310000000000002 109.039 -171.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -164.4 145.38 6.62 Favored Pre-proline 0 N--CA 1.475 0.823 0 N-CA-C 107.641 -1.244 . . . . 72.099999999999994 107.641 -173.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -56.72 75.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.594 2.863 . . . . 63.530000000000001 114.32 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 179.69 22.2 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.287 1.835 . . . . 74.319999999999993 109.24 176.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.5 tp -85.3 132.84 34.19 Favored 'General case' 0 C--N 1.359 1.007 0 CA-C-O 121.017 0.437 . . . . 75.129999999999995 109.894 -178.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 14.3 m-85 -106.65 173.9 6.12 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.191 1.396 . . . . 64.120000000000005 110.086 177.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.49 145.96 25.06 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 107.925 -1.139 . . . . 71.400000000000006 107.925 171.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -74.95 117.93 17.34 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 123.039 0.212 . . . . 70.439999999999998 110.606 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.3 mt -65.41 -33.69 76.53 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.222 1.009 . . . . 55.0 111.556 171.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.499 ' OH ' ' HA ' ' A' ' 13' ' ' ARG . 75.6 m-85 -140.35 159.0 43.16 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.172 0.589 . . . . 74.439999999999998 109.418 -175.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -74.7 152.19 39.15 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.107 -0.701 . . . . 75.230000000000004 109.107 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -156.04 115.93 3.63 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.602 0.761 . . . . 72.439999999999998 109.1 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.72 133.21 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.339 -0.985 . . . . 71.109999999999999 108.339 170.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.69 134.63 52.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.811 0.444 . . . . 73.150000000000006 110.91 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.9 m -67.59 -20.94 65.43 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.943 0.897 . . . . 73.219999999999999 111.391 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.35 -165.65 38.27 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.69 -0.686 . . . . 34.340000000000003 112.008 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -52.3 -38.77 59.34 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.7 1.2 . . . . 51.340000000000003 112.852 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.457 HD21 HD13 ' A' ' 20' ' ' LEU . 31.3 p-10 -72.19 -24.71 61.46 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.178 0.991 . . . . 74.049999999999997 112.69 -175.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 p -104.23 157.75 16.92 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.301 0.641 . . . . 53.509999999999998 110.022 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.468 ' HB3' HG13 ' A' ' 130' ' ' VAL . 64.2 tp -110.55 132.74 53.93 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.797 -0.638 . . . . 71.430000000000007 109.808 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.2 t -80.16 136.54 36.53 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.36 -0.608 . . . . 74.140000000000001 109.36 173.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 28.6 pt -137.89 144.55 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.484 0.713 . . . . 62.219999999999999 109.652 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 9.3 m -105.65 143.91 33.13 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.231 -0.655 . . . . 74.400000000000006 109.231 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -56.38 111.91 1.11 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 118.536 0.607 . . . . 62.450000000000003 111.046 174.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.13 1.8 35.91 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 116.707 -0.224 . . . . 41.409999999999997 113.254 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.552 ' HG3' ' HE2' ' A' ' 124' ' ' LYS . 36.5 tt0 -85.66 137.64 32.7 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.029 0.931 . . . . 64.340000000000003 110.511 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -76.4 119.14 19.85 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.603 0.761 . . . . 75.420000000000002 110.338 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.658 ' HA ' HG22 ' A' ' 123' ' ' THR . 11.4 mt -112.43 123.68 50.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.405 -0.961 . . . . 72.329999999999998 108.405 -173.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 78' ' ' SER . 71.8 mtt180 -95.6 106.76 18.89 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 107.769 -1.197 . . . . 73.040000000000006 107.769 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 67.1 t -99.66 114.55 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 109.229 -0.656 . . . . 61.130000000000003 109.229 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.38 -34.77 68.18 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.62 0.768 . . . . 71.540000000000006 109.934 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.35 167.09 35.69 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 114.783 -1.098 . . . . 54.210000000000001 111.422 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 3.0 m-30 -97.5 175.0 6.38 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.781 0.8 . . . . 74.239999999999995 110.063 177.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -75.13 147.1 40.8 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 114.411 -1.268 . . . . 73.319999999999993 108.304 169.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -60.08 -37.17 79.12 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.7 0.8 . . . . 75.319999999999993 112.328 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -92.92 7.52 43.6 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 121.07 0.462 . . . . 72.239999999999995 110.94 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 174' ' ' GLU . . . 70.91 27.96 71.4 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 116.079 -0.51 . . . . 72.019999999999996 113.898 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -68.41 -70.72 0.25 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 122.126 0.965 . . . . 74.329999999999998 110.245 178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -131.04 -178.58 4.88 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.57 1.148 . . . . 73.010000000000005 108.859 -172.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -138.48 122.22 17.56 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.973 0.509 . . . . 64.439999999999998 109.99 -175.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -72.23 96.84 1.87 Allowed 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.648 0.737 . . . . 70.120000000000005 109.816 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -109.68 165.69 11.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.709 -1.132 . . . . 65.5 111.097 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -140.75 118.65 11.8 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.608 -1.256 . . . . 74.120000000000005 107.608 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.658 HG22 ' HA ' ' A' ' 107' ' ' LEU . 71.7 p -132.05 -172.28 2.84 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.58 0.705 . . . . 73.530000000000001 111.123 -176.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.552 ' HE2' ' HG3' ' A' ' 105' ' ' GLU . 40.0 mtmt -57.44 -30.52 65.07 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 114.242 -1.344 . . . . 74.409999999999997 110.862 170.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -85.51 3.25 41.28 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.07 0.948 . . . . 75.430000000000007 111.759 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 118.97 -127.38 7.2 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 122.21 -0.306 . . . . 73.129999999999995 112.835 173.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -151.97 140.99 21.18 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.57 0.748 . . . . 54.130000000000003 110.384 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 167.72 -171.77 42.33 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.143 0.277 . . . . 51.100000000000001 112.446 176.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -88.57 125.24 34.7 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.113 0.565 . . . . 74.299999999999997 111.216 -175.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 99' ' ' LEU . 30.8 m -120.62 152.26 55.36 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.724 1.21 . . . . 52.310000000000002 110.098 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.64 129.14 13.28 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 121.654 1.569 . . . . 75.310000000000002 111.347 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 43.8 t -57.74 -27.14 62.74 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.648 0.779 . . . . 53.5 111.799 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.692 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 47.3 m-20 -67.87 -21.25 65.17 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.312 1.045 . . . . 72.120000000000005 112.191 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -107.06 8.52 30.34 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.613 0.765 . . . . 75.420000000000002 111.681 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.5 pt -128.26 155.2 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-N 118.545 0.611 . . . . 75.219999999999999 109.958 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.3 t -150.36 134.97 9.53 Favored Pre-proline 0 N--CA 1.495 1.779 0 C-N-CA 122.849 0.459 . . . . 73.25 110.175 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.587 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 74.4 Cg_endo -76.21 117.46 4.64 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.879 2.386 . . . . 64.510000000000005 114.282 -176.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.7 m -90.29 -49.7 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 122.841 0.457 . . . . 51.43 111.618 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -94.36 6.36 48.94 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.114 0.483 . . . . 75.319999999999993 111.405 -173.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.587 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 25.0 t -83.59 -178.69 7.11 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.126 0.489 . . . . 65.340000000000003 109.807 173.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 62.4 mt -63.16 -13.79 41.13 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.235 1.014 . . . . 44.219999999999999 112.644 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.555 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 36.5 tt0 -58.75 -24.59 61.88 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.856 0.862 . . . . 72.310000000000002 112.519 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.2 -25.3 66.95 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 123.469 0.708 . . . . 71.109999999999999 110.837 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -79.57 148.33 31.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.718 0.807 . . . . 74.219999999999999 110.705 170.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.6 p -65.72 -22.65 66.63 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.924 0.713 . . . . 74.099999999999994 112.924 -175.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 59.5 p-90 -81.6 -46.48 14.35 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.965 0.506 . . . . 65.340000000000003 112.32 -178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 30.5 t80 -88.37 137.37 32.39 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.441 -0.578 . . . . 72.040000000000006 109.441 -177.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.555 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 25.0 m-70 -130.45 26.82 5.07 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 111.97 0.359 . . . . 72.099999999999994 111.97 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.93 -154.63 46.39 Favored Glycine 0 CA--C 1.54 1.644 0 N-CA-C 114.766 0.667 . . . . 71.530000000000001 114.766 171.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.469 ' HG3' ' OH ' ' A' ' 112' ' ' TYR . 72.2 Cg_endo -75.03 108.62 2.76 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 123.478 2.785 . . . . 64.230000000000004 111.901 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.481 HG13 ' HD3' ' A' ' 171' ' ' ARG . 1.6 p -155.23 138.5 7.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 115.493 -0.776 . . . . 43.130000000000003 109.659 -177.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.614 ' HB3' HG13 ' A' ' 8' ' ' VAL . 10.3 p -80.83 170.74 15.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.999 0.74 . . . . 51.43 112.999 -174.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -63.41 -27.62 69.42 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 114.94 -1.027 . . . . 65.400000000000006 112.694 -169.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -68.54 -57.33 5.94 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.552 0.741 . . . . 74.540000000000006 110.072 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.12 -36.62 84.85 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.338 0.655 . . . . 64.239999999999995 110.695 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.432 ' HA ' ' NH1' ' A' ' 171' ' ' ARG . . . -53.26 -52.25 59.61 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.824 -1.08 . . . . 73.239999999999995 112.03 171.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.547 ' HG3' HG11 ' A' ' 190' ' ' VAL . 29.7 tt0 -76.9 -19.65 57.17 Favored 'General case' 0 C--O 1.212 -0.871 0 CA-C-N 114.856 -1.065 . . . . 74.140000000000001 110.71 -175.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -67.53 -51.16 54.19 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.873 0.469 . . . . 55.310000000000002 109.974 172.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.641 HD21 ' HG3' ' A' ' 239' ' ' ARG . 82.7 mt -64.93 -42.16 94.91 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.864 -0.607 . . . . 70.450000000000003 110.965 178.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.653 HD23 HG13 ' A' ' 190' ' ' VAL . 32.4 tp -71.77 -28.8 63.88 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.214 -0.903 . . . . 62.229999999999997 112.024 -177.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.5 t -57.03 -40.13 76.14 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.641 0.776 . . . . 61.109999999999999 110.327 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.45 ' HB2' ' HG2' ' A' ' 237' ' ' PRO . 10.5 m -81.93 -0.21 42.83 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 114.636 -1.166 . . . . 64.310000000000002 111.585 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -93.23 154.53 21.89 Favored Glycine 0 C--N 1.349 1.271 0 C-N-CA 123.068 0.366 . . . . 74.420000000000002 113.055 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 20.5 pt -103.76 -167.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 123.798 0.839 . . . . 72.040000000000006 112.13 -173.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.664 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 16.3 p-10 -59.52 103.94 0.23 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.008 0.923 . . . . 72.010000000000005 113.486 -171.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 103.82 13.25 28.08 Favored Glycine 0 C--O 1.26 1.768 0 CA-C-N 116.288 -0.414 . . . . 73.120000000000005 112.847 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 22.6 t -71.72 136.73 47.31 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-O 119.227 -0.416 . . . . 74.230000000000004 110.132 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 183' ' ' SER . 21.6 p90 -135.22 156.35 49.13 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.932 0.716 . . . . 71.120000000000005 112.932 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.581 HD22 HH21 ' A' ' 171' ' ' ARG . 84.0 mt -140.01 132.84 29.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.419 -1.264 . . . . 74.420000000000002 108.184 171.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 23.0 t -110.07 130.73 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 107.613 -1.255 . . . . 73.150000000000006 107.613 172.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.593 HH22 HD12 ' A' ' 159' ' ' LEU . 11.9 ptp180 -163.38 164.66 24.59 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.165 0.586 . . . . 74.219999999999999 110.206 -174.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 16.1 pt-20 -111.48 156.93 20.93 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.568 0.347 . . . . 75.329999999999998 110.068 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.2 t -75.06 139.1 42.59 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 116.065 -0.516 . . . . 72.25 110.582 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.418 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 94.4 mt-10 -65.51 -42.43 92.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.941 0.497 . . . . 72.319999999999993 110.01 172.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 54.7 p -77.75 -21.97 51.0 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.106 0.962 . . . . 74.209999999999994 111.852 -176.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 36.9 t -140.03 79.89 21.53 Favored Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 109.33 -0.618 . . . . 51.140000000000001 109.33 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -71.43 148.08 53.71 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 123.028 2.485 . . . . 74.349999999999994 111.675 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 88.43 -25.03 9.83 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 115.414 -0.812 . . . . 51.210000000000001 111.843 -170.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -90.46 118.07 29.65 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 108.687 -0.857 . . . . 63.439999999999998 108.687 168.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 61.2 mtt180 -103.44 172.41 6.82 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 114.7 -1.136 . . . . 44.109999999999999 110.252 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.5 m -155.96 140.18 16.56 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.512 1.125 . . . . 70.409999999999997 108.462 -169.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.446 HD11 ' CD2' ' A' ' 217' ' ' LEU . 53.1 mt -112.78 137.98 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.243 -1.021 . . . . 71.409999999999997 108.243 167.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.599 ' HB3' HD22 ' A' ' 160' ' ' LEU . 17.0 m -117.19 112.58 21.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.283 1.433 . . . . 72.329999999999998 107.735 -175.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.414 HD12 ' HE2' ' A' ' 193' ' ' TYR . 42.1 mt -110.62 139.46 45.87 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.138 0.975 . . . . 74.319999999999993 111.459 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 45.4 ttt-85 -129.0 134.92 48.34 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 115.649 -0.705 . . . . 75.510000000000005 109.726 171.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 12.2 p90 -153.19 139.85 18.88 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 124.67 1.231 . . . . 72.129999999999995 107.823 175.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 54.66 23.11 4.48 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 125.026 1.33 . . . . 73.510000000000005 114.233 176.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.56 6.22 73.82 Favored Glycine 0 N--CA 1.475 1.282 0 O-C-N 122.206 -0.309 . . . . 75.319999999999993 113.189 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 15.7 tpp180 -101.03 124.47 46.81 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.218 1.007 . . . . 72.310000000000002 108.746 177.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.653 HG13 HD23 ' A' ' 160' ' ' LEU . 97.0 t -106.85 133.52 51.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.64 1.176 . . . . 73.420000000000002 108.624 174.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.478 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 27.4 p90 -146.3 155.7 42.83 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.238 0.615 . . . . 74.329999999999998 109.986 169.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -134.66 122.22 21.95 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.842 -1.17 . . . . 74.510000000000005 107.842 -174.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.414 ' HE2' HD12 ' A' ' 184' ' ' LEU . 37.1 p90 -119.19 155.11 32.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.026 0.53 . . . . 71.420000000000002 109.917 176.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.576 ' HG3' ' HB2' ' A' ' 3' ' ' GLN . 35.0 mmt180 -99.72 135.0 41.8 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.15 0.5 . . . . 75.25 111.381 -169.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 71.3 mt -82.74 111.79 19.58 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 CA-C-N 114.932 -1.031 . . . . 74.129999999999995 108.607 167.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -81.04 130.99 35.28 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.49 0.716 . . . . 73.409999999999997 109.185 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 48.1 m -97.31 125.55 41.96 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.323 0.649 . . . . 44.240000000000002 110.202 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.56 178.54 6.58 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.48 1.112 . . . . 74.209999999999994 111.727 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 45.3 t -60.7 -36.0 77.71 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.122 0.969 . . . . 73.219999999999999 112.059 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -74.07 -14.17 60.95 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.691 -0.686 . . . . 71.439999999999998 112.318 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 93.66 3.38 64.49 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.513 -0.635 . . . . 64.120000000000005 111.513 -170.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -72.27 160.61 32.1 Favored 'General case' 0 C--N 1.346 0.455 0 C-N-CA 124.123 0.969 . . . . 63.240000000000002 110.404 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.42 HD13 HD13 ' A' ' 214' ' ' LEU . 72.7 mt -113.84 147.19 38.83 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.006 0.923 . . . . 64.310000000000002 110.359 -173.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -163.19 153.77 16.35 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.715 0.635 . . . . 72.519999999999996 109.977 175.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 195' ' ' ILE . 71.7 t -125.26 -62.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.999 -1.112 . . . . 73.150000000000006 107.999 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.0 t -102.4 -178.4 3.68 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.253 1.021 . . . . 64.310000000000002 111.071 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.6 t -61.5 -47.41 85.75 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.333 1.053 . . . . 74.049999999999997 112.044 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -90.34 12.81 17.18 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.486 0.714 . . . . 71.430000000000007 111.643 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 66.8 m -98.51 111.54 23.87 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.373 0.669 . . . . 74.329999999999998 109.782 173.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -146.71 115.13 6.71 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.257 1.023 . . . . 73.420000000000002 109.304 171.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -135.8 142.26 44.85 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 117.843 0.292 . . . . 72.209999999999994 111.105 -171.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -83.85 -34.78 24.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.264 -0.643 . . . . 71.319999999999993 109.264 169.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 66.8 p -121.13 145.47 47.78 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-O 122.039 0.923 . . . . 51.43 111.72 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.42 HD13 HD13 ' A' ' 203' ' ' LEU . 30.2 tp -68.3 -24.68 64.88 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.472 -1.24 . . . . 73.230000000000004 110.811 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.44 85.96 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.457 0.703 . . . . 73.510000000000005 110.542 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -67.89 -34.39 76.56 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 116.053 -0.521 . . . . 75.129999999999995 111.382 175.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.446 ' CD2' HD11 ' A' ' 182' ' ' ILE . 10.0 tt -58.6 -46.22 87.47 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.42 0.45 . . . . 74.209999999999994 110.981 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.94 -39.11 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.166 0.587 . . . . 61.350000000000001 110.828 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -61.66 -55.1 34.11 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.318 0.58 . . . . 74.549999999999997 111.328 176.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.422 ' O ' HG22 ' A' ' 224' ' ' VAL . 46.9 t60 -51.14 -54.77 22.19 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 114.589 -1.187 . . . . 64.329999999999998 109.662 177.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -65.23 -24.94 67.48 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.608 -0.724 . . . . 54.149999999999999 112.709 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.6 t -72.51 -25.41 61.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.854 0.462 . . . . 63.130000000000003 111.064 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.3 t -122.47 -2.9 8.9 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 116.408 2.003 . . . . 61.409999999999997 116.408 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 220' ' ' HIS . 27.8 m -101.61 154.17 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-N 121.123 1.783 . . . . 61.219999999999999 115.421 -172.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.66 -0.73 57.29 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 129.248 3.019 . . . . 63.140000000000001 113.487 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.23 14.56 0.89 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 129.027 2.931 . . . . 72.230000000000004 113.677 -145.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.4 16.42 4.7 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 122.225 0.903 . . . . 42.43 111.725 -170.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.14 120.02 32.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.257 -0.972 . . . . 73.430000000000007 110.927 169.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.478 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 92.7 mt -59.23 -43.26 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 123.97 0.794 . . . . 61.530000000000001 109.39 172.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.8 t -136.09 148.74 48.42 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.694 -0.854 . . . . 73.450000000000003 108.694 165.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 80.7 p -72.4 159.71 33.54 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.566 -0.531 . . . . 65.430000000000007 109.566 171.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 20.4 mt -69.33 102.31 1.71 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.202 -1.036 . . . . 71.299999999999997 108.202 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -87.83 -50.52 6.4 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.461 -0.57 . . . . 73.019999999999996 109.461 -174.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -161.43 147.14 10.81 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 112.444 0.535 . . . . 73.439999999999998 112.444 -177.784 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.36 152.4 71.4 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.122 1.882 . . . . 74.239999999999995 112.736 -176.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.56 155.61 89.22 Favored Pre-proline 0 C--O 1.244 0.81 0 CA-C-N 115.774 -0.648 . . . . 64.409999999999997 110.667 175.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.45 ' HG2' ' HB2' ' A' ' 162' ' ' SER . 17.7 Cg_endo -56.85 140.02 90.58 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.801 2.334 . . . . 74.040000000000006 113.309 177.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -77.77 158.83 29.4 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.834 -1.075 . . . . 64.219999999999999 108.657 169.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.641 ' HG3' HD21 ' A' ' 159' ' ' LEU . 98.0 mtt180 -53.72 -27.86 30.72 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 122.935 0.494 . . . . 72.120000000000005 111.778 176.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -69.04 -67.71 0.45 Allowed 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.584 -0.735 . . . . 73.209999999999994 109.522 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -174.75 161.42 2.52 Favored Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 123.777 0.831 . . . . 74.230000000000004 111.035 177.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.21 156.77 61.41 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.743 2.295 . . . . 62.549999999999997 112.412 170.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 20.5 m -148.71 90.16 1.75 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.519 0.727 . . . . 73.329999999999998 109.68 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.5 p -171.89 137.01 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.825 0.85 . . . . 64.120000000000005 110.466 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -161.33 56.86 0.29 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.908 0.861 . . . . 74.239999999999995 110.017 173.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -69.74 114.46 5.63 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 115.171 -0.922 . . . . 72.319999999999993 112.954 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.81 126.82 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.701 0.801 . . . . 63.020000000000003 109.549 174.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 51.3 m -149.94 139.16 12.95 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.598 1.159 . . . . 74.319999999999993 108.119 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -56.96 -32.34 92.52 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.466 2.111 . . . . 72.209999999999994 112.722 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 57.63 94.71 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.793 1.237 . . . . 72.299999999999997 112.691 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -151.02 166.9 29.28 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.614 -0.721 . . . . 64.5 110.594 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -162.3 147.48 12.61 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.948 -1.024 . . . . 62.229999999999997 108.608 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -83.62 -23.81 31.7 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.514 0.325 . . . . 70.430000000000007 111.753 -172.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -74.28 143.02 45.2 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.313 -0.625 . . . . 73.530000000000001 109.313 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 CA--C 1.555 1.16 0 CA-C-O 118.107 -0.949 . . . . 73.319999999999993 108.973 -179.808 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.2 p . . . . . 0 C--O 1.243 0.763 0 CA-C-O 121.352 0.596 . . . . 33.409999999999997 111.639 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.9 mt -106.56 130.56 22.73 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 108.542 -0.91 . . . . 72.230000000000004 108.542 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -66.58 165.46 25.18 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 121.982 1.788 . . . . 62.43 110.618 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.18 147.2 31.39 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.601 0.239 . . . . 55.020000000000003 110.407 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.568 ' HB3' HD11 ' A' ' 23' ' ' ILE . 63.5 mt -85.85 94.07 9.07 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.249 -1.019 . . . . 64.129999999999995 108.249 176.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -98.15 -47.73 5.37 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.878 -1.055 . . . . 75.109999999999999 109.057 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -101.79 113.59 26.92 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 114.345 -1.298 . . . . 74.400000000000006 109.9 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.568 HD11 ' HB3' ' A' ' 20' ' ' LEU . 46.5 mm -115.75 120.18 64.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 106.083 -1.821 . . . . 72.409999999999997 106.083 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HB2' ' HE1' ' A' ' 129' ' ' TRP . 16.8 tptm . . . . . 0 N--CA 1.476 0.826 0 CA-C-O 121.478 0.656 . . . . 75.150000000000006 109.84 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 N--CA 1.492 1.438 0 N-CA-C 113.144 0.402 . . . . 74.319999999999993 113.144 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.406 ' ND2' ' HA ' ' A' ' 140' ' ' SER . 9.6 m120 -56.36 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.951 0.782 . . . . 70.310000000000002 111.987 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.66 ' H ' ' HB3' ' A' ' 139' ' ' ASN . 50.3 tp -81.55 135.77 35.59 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.538 -1.21 . . . . 74.409999999999997 109.165 177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -105.49 176.08 5.28 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.948 1.299 . . . . 75.299999999999997 109.359 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.35 143.13 23.52 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 N-CA-C 108.503 -0.925 . . . . 61.539999999999999 108.503 171.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -76.05 121.67 23.12 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.627 -0.508 . . . . 63.539999999999999 109.627 173.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 74.4 mt -82.42 -21.63 35.65 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.703 0.801 . . . . 74.239999999999995 111.252 173.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.574 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 84.5 m-85 -136.16 158.14 45.14 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.114 0.565 . . . . 74.319999999999993 109.585 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.51 145.58 39.04 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.689 -0.687 . . . . 73.219999999999999 109.835 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -153.23 111.16 3.59 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.236 -1.024 . . . . 74.019999999999996 108.236 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.4 t -82.54 138.71 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 109.074 -0.713 . . . . 65.099999999999994 109.074 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.65 116.25 4.61 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.087 0.555 . . . . 71.230000000000004 110.194 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.5 m -78.79 -11.05 59.97 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.718 0.807 . . . . 73.430000000000007 110.717 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.74 -172.68 41.62 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.587 -0.733 . . . . 63.310000000000002 111.28 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.53 -25.68 66.78 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.436 0.694 . . . . 72.030000000000001 110.719 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -70.2 -22.99 62.88 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.588 0.755 . . . . 71.340000000000003 112.456 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.7 p -113.71 157.74 21.81 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.408 0.683 . . . . 64.219999999999999 110.915 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.2 tp -109.93 131.15 55.32 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.734 0.814 . . . . 62.0 109.927 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.8 t -74.05 120.01 19.04 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 108.892 -0.781 . . . . 34.119999999999997 108.892 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.32 159.53 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.244 1.018 . . . . 41.210000000000001 108.775 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 60.0 m -135.78 148.15 48.64 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.265 -0.643 . . . . 74.310000000000002 109.265 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -54.84 123.38 13.21 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.095 0.558 . . . . 74.230000000000004 111.646 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.29 -9.54 49.81 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.388 -0.369 . . . . 54.210000000000001 113.095 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -85.01 131.89 34.41 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.557 0.743 . . . . 72.019999999999996 110.445 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.45 ' HB3' HD11 ' A' ' 84' ' ' LEU . 8.7 mtmp? -83.52 115.48 22.11 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.773 0.829 . . . . 71.299999999999997 110.302 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.505 ' HA ' HG22 ' A' ' 123' ' ' THR . 15.7 mt -103.14 145.74 29.45 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.956 0.903 . . . . 73.510000000000005 109.965 -169.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.472 ' NH2' ' HG2' ' A' ' 122' ' ' GLN . 84.5 mtm180 -108.65 108.95 20.02 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.605 -0.887 . . . . 70.129999999999995 108.605 173.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 71.6 t -95.56 117.28 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 121.298 0.571 . . . . 73.299999999999997 110.249 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.5 mt -77.16 -28.73 54.25 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.251 1.421 . . . . 73.109999999999999 111.207 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.3 177.51 39.46 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.127 -0.488 . . . . 41.310000000000002 113.016 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.484 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 2.8 m-85 -107.15 168.41 9.23 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.833 0.853 . . . . 72.340000000000003 109.398 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -85.9 151.77 23.51 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 110.018 -0.364 . . . . 72.239999999999995 110.018 170.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -57.87 -32.29 67.53 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 113.185 0.809 . . . . 73.439999999999998 113.185 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.3 t30 -90.16 3.88 52.1 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.129 0.572 . . . . 72.150000000000006 110.465 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 61.59 31.16 76.77 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 111.03 -0.828 . . . . 73.549999999999997 111.03 -174.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -67.65 -70.45 0.26 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 107.934 -1.136 . . . . 64.319999999999993 107.934 -174.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -135.54 178.46 7.02 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 108.337 -0.986 . . . . 72.540000000000006 108.337 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.16 117.81 24.71 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.67 0.788 . . . . 63.310000000000002 109.058 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.92 108.65 3.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.279 0.632 . . . . 62.340000000000003 109.711 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.37 168.23 10.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.634 0.773 . . . . 53.310000000000002 110.784 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.472 ' HG2' ' NH2' ' A' ' 108' ' ' ARG . 61.6 tt0 -149.09 128.09 12.69 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.149 -1.056 . . . . 72.109999999999999 108.149 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.505 HG22 ' HA ' ' A' ' 107' ' ' LEU . 81.6 p -139.31 -174.46 3.87 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.701 0.801 . . . . 72.219999999999999 110.701 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -55.53 -28.87 57.31 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.6 0.76 . . . . 72.530000000000001 111.336 169.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -76.1 -13.3 60.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.547 0.739 . . . . 61.219999999999999 111.573 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 132.02 -130.95 6.09 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 111.905 -0.478 . . . . 70.450000000000003 111.905 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -150.73 146.58 26.53 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.338 0.655 . . . . 71.209999999999994 110.072 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 166.94 177.79 38.93 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 112.1 -0.4 . . . . 71.519999999999996 112.1 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.438 ' HE1' ' HB2' ' A' ' 24' ' ' LYS . 90.9 m95 -80.62 130.3 35.03 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.589 0.756 . . . . 72.409999999999997 110.887 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.03 151.54 61.65 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 124.286 1.034 . . . . 74.209999999999994 109.767 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.54 132.02 14.28 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 121.748 1.632 . . . . 62.310000000000002 111.636 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.501 ' HA ' HG12 ' A' ' 135' ' ' ILE . 41.8 p -61.58 -22.01 64.82 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.703 0.801 . . . . 71.510000000000005 111.901 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 43.6 m-20 -68.36 -24.5 64.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.429 1.092 . . . . 61.439999999999998 111.926 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.574 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.1 m-85 -101.7 2.19 38.34 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.593 0.757 . . . . 74.329999999999998 112.153 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.501 HG12 ' HA ' ' A' ' 132' ' ' SER . 16.4 pt -131.21 161.92 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.66 0.384 . . . . 75.340000000000003 110.056 -173.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 11.0 t -151.16 147.92 21.55 Favored Pre-proline 0 N--CA 1.481 1.113 0 N-CA-C 108.593 -0.891 . . . . 75.400000000000006 108.593 170.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.94 150.59 38.68 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 121.971 1.781 . . . . 64.140000000000001 111.564 172.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.1 m -131.13 -44.52 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.155 0.582 . . . . 74.010000000000005 111.185 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.66 ' HB3' ' H ' ' A' ' 84' ' ' LEU . 58.2 t30 -95.5 17.96 13.66 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.411 1.101 . . . . 75.329999999999998 110.491 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.406 ' HA ' ' ND2' ' A' ' 83' ' ' ASN . 75.6 p -76.24 168.86 19.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.483 -0.78 . . . . 74.109999999999999 110.677 172.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 63.2 mt -62.98 -15.84 57.48 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 114.957 -1.019 . . . . 73.340000000000003 111.166 172.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.4 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 82.4 tt0 -61.74 -26.77 68.27 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.269 1.428 . . . . 73.310000000000002 112.999 -176.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -67.78 -18.11 64.76 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 122.768 0.427 . . . . 64.140000000000001 110.819 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -82.0 145.05 30.46 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.02 -0.733 . . . . 72.430000000000007 109.02 168.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.3 p -64.3 -19.91 65.73 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 112.884 0.698 . . . . 75.329999999999998 112.884 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.435 ' CE3' HG21 ' A' ' 218' ' ' VAL . 65.3 p-90 -77.72 -37.81 48.59 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 112.445 0.535 . . . . 64.120000000000005 112.445 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.408 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 22.7 t80 -102.22 138.6 38.94 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.143 -0.688 . . . . 71.129999999999995 109.143 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.4 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 22.3 m-70 -129.56 22.37 5.51 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.682 0.393 . . . . 71.439999999999998 111.446 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 62.81 -156.19 40.57 Favored Glycine 0 CA--C 1.536 1.385 0 N-CA-C 115.092 0.797 . . . . 72.209999999999994 115.092 169.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 6.3 Cg_exo -76.37 104.59 1.93 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.391 2.727 . . . . 62.229999999999997 111.044 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.55 160.98 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.293 0.568 . . . . 75.140000000000001 112.02 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 18.2 m -71.26 161.73 30.6 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 114.924 -1.035 . . . . 60.530000000000001 110.916 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -64.02 -32.65 74.28 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.109 0.564 . . . . 73.549999999999997 110.114 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -65.11 -49.72 68.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.524 1.129 . . . . 60.509999999999998 110.416 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.02 -43.51 87.45 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.597 0.759 . . . . 73.310000000000002 110.406 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.46 -59.9 4.46 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.387 -1.279 . . . . 53.229999999999997 110.944 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.595 ' HG3' HG11 ' A' ' 190' ' ' VAL . 31.7 tt0 -67.73 -22.73 65.22 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.835 -0.62 . . . . 54.329999999999998 111.281 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -65.42 -56.38 12.83 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.996 0.519 . . . . 75.239999999999995 109.706 173.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.27 -35.91 80.44 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 116.431 -0.349 . . . . 75.209999999999994 111.148 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.657 HD23 HG13 ' A' ' 190' ' ' VAL . 34.4 tp -72.25 -26.72 62.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.013 0.525 . . . . 73.120000000000005 111.66 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.5 t -70.06 -16.28 63.12 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.976 0.51 . . . . 74.409999999999997 111.162 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.3 m -83.07 -17.79 41.94 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.263 0.625 . . . . 72.310000000000002 111.052 170.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.36 -179.64 51.02 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 116.154 -0.475 . . . . 64.420000000000002 113.431 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.1 pt -133.37 -166.45 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 125.864 1.666 . . . . 74.109999999999999 110.503 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 24.3 p-10 -60.15 129.95 44.24 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.62 0.368 . . . . 73.219999999999999 111.229 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.88 10.03 84.61 Favored Glycine 0 C--O 1.264 1.982 0 CA-C-O 119.997 -0.335 . . . . 51.409999999999997 113.061 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 75.2 m -82.58 141.2 32.76 Favored 'General case' 0 C--N 1.371 1.532 0 N-CA-C 110.086 -0.338 . . . . 74.209999999999994 110.086 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 183' ' ' SER . 16.4 p90 -136.68 161.48 35.8 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.756 0.789 . . . . 64.319999999999993 112.918 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 79.6 mt -135.13 131.96 37.48 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 114.213 -1.358 . . . . 74.420000000000002 108.04 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.461 HG21 HG22 ' A' ' 218' ' ' VAL . 32.5 t -108.02 130.05 61.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 106.053 -1.832 . . . . 70.129999999999995 106.053 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.55 163.48 39.92 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.999 0.52 . . . . 71.0 110.261 -171.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 15.7 pt-20 -117.91 164.49 14.99 Favored 'General case' 0 C--O 1.26 1.625 0 C-N-CA 123.263 0.625 . . . . 64.239999999999995 110.368 172.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.1 m -80.29 146.93 31.37 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.73 -1.123 . . . . 44.32 110.209 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -78.74 -43.46 25.66 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.694 1.197 . . . . 73.319999999999993 110.293 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.476 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 27.3 m -99.29 9.48 43.29 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.531 -1.213 . . . . 74.299999999999997 112.032 -173.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.4 t -147.61 108.73 3.82 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 122.521 0.328 . . . . 63.109999999999999 110.709 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.484 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 68.4 Cg_endo -74.5 135.21 19.78 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.003 2.469 . . . . 74.420000000000002 111.551 173.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.71 -25.74 12.67 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 116.172 -0.467 . . . . 52.350000000000001 113.509 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.404 ' OE1' ' HD2' ' A' ' 194' ' ' ARG . 83.3 mm-40 -81.3 116.54 21.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.03 0.915 . . . . 75.239999999999995 109.192 174.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 41.1 mtt-85 -129.41 157.14 42.8 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.099 -1.075 . . . . 72.430000000000007 108.099 -177.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.6 m -140.08 144.89 37.05 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 123.225 0.61 . . . . 72.340000000000003 109.825 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 55.3 mt -109.67 143.88 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.021 -1.103 . . . . 70.420000000000002 108.021 165.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.447 ' HB3' HD22 ' A' ' 160' ' ' LEU . 16.8 m -125.37 112.31 16.16 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.375 1.07 . . . . 64.140000000000001 108.349 -174.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.463 HD21 HD23 ' A' ' 232' ' ' LEU . 47.1 mt -102.81 143.38 32.51 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.362 0.665 . . . . 74.150000000000006 111.341 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -122.16 128.11 50.84 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 107.224 -1.398 . . . . 72.230000000000004 107.224 167.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 1.3 t80 -152.48 123.94 7.74 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.066 1.346 . . . . 75.019999999999996 107.991 -171.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 62.49 18.98 10.86 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.905 1.282 . . . . 65.439999999999998 112.33 -172.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.66 1.63 85.27 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-O 120.019 -0.323 . . . . 73.230000000000004 113.099 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -97.34 125.43 41.94 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.071 -0.714 . . . . 75.420000000000002 109.071 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.657 HG13 HD23 ' A' ' 160' ' ' LEU . 73.1 t -98.43 118.77 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.328 1.051 . . . . 74.430000000000007 109.506 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -138.73 140.23 38.64 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.972 0.909 . . . . 55.32 109.389 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -120.19 146.32 46.12 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.779 0.832 . . . . 73.25 109.059 -171.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -139.68 150.03 44.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.974 0.509 . . . . 73.409999999999997 110.478 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 12.4 tpp85 -88.37 132.44 34.43 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.108 -0.951 . . . . 72.439999999999998 111.308 -171.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 68.4 mt -81.45 113.51 20.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 108.159 -1.052 . . . . 74.120000000000005 108.159 164.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -83.78 132.05 34.86 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.375 -0.602 . . . . 65.200000000000003 109.375 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.0 m -110.79 116.96 32.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.505 0.722 . . . . 74.049999999999997 109.714 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.5 178.42 2.03 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.363 1.065 . . . . 41.32 112.035 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 79.8 p -58.56 -41.48 85.76 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.9 0.88 . . . . 71.439999999999998 113.035 -170.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -79.46 -20.12 48.17 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 116.24 -0.436 . . . . 73.329999999999998 110.67 -175.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 113.37 5.5 22.81 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.013 -0.54 . . . . 53.420000000000002 113.53 -174.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -66.26 142.12 57.79 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.625 0.713 . . . . 53.149999999999999 110.502 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 78.3 mt -103.46 146.13 28.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.427 0.691 . . . . 64.310000000000002 109.501 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -165.76 140.61 4.78 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.149 0.579 . . . . 74.230000000000004 110.531 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.4 t -97.91 -38.68 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.316 0.646 . . . . 63.210000000000001 109.722 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 40.7 t -109.05 154.69 21.87 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.614 0.766 . . . . 74.340000000000003 110.96 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.1 m -69.96 -21.13 63.28 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.143 -0.935 . . . . 71.409999999999997 111.04 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -84.64 -6.9 59.39 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.538 0.735 . . . . 72.120000000000005 111.497 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 59.1 m -136.69 147.9 47.06 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.888 0.475 . . . . 64.239999999999995 112.044 -168.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -140.65 134.05 29.86 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.791 1.236 . . . . 75.329999999999998 108.326 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -127.82 132.62 49.43 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.916 0.486 . . . . 74.299999999999997 110.117 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -83.8 -25.02 30.77 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.323 0.649 . . . . 73.439999999999998 110.236 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.0 p -128.99 150.31 50.45 Favored 'General case' 0 C--O 1.253 1.263 0 C-N-CA 123.185 0.594 . . . . 75.409999999999997 110.973 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 31.3 tp -69.71 -27.73 65.23 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.407 -0.815 . . . . 63.25 110.047 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.25 -44.92 92.36 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.345 0.658 . . . . 50.340000000000003 110.847 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -75.78 -29.63 58.83 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 116.191 -0.459 . . . . 62.210000000000001 111.377 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tt -58.17 -51.3 70.32 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 123.301 0.375 . . . . 41.030000000000001 110.51 172.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.461 HG22 HG21 ' A' ' 170' ' ' VAL . 94.9 t -69.47 -42.9 81.03 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 CA-C-N 115.41 -0.814 . . . . 73.129999999999995 111.097 -176.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -57.71 -53.93 52.57 Favored 'General case' 0 C--O 1.259 1.568 0 C-N-CA 123.386 0.674 . . . . 74.200000000000003 111.151 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.497 ' O ' HG22 ' A' ' 224' ' ' VAL . 35.9 t-80 -55.65 -54.75 40.31 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 114.846 -1.07 . . . . 75.450000000000003 109.585 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.402 ' HA ' HG22 ' A' ' 224' ' ' VAL . 4.5 m-70 -68.15 -16.54 64.04 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.758 0.651 . . . . 64.140000000000001 112.758 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.451 ' HA ' ' HB2' ' A' ' 232' ' ' LEU . 44.4 t -74.56 -31.32 62.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.564 0.345 . . . . 54.229999999999997 110.243 173.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.4 t -107.56 -12.34 15.29 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 116.501 2.037 . . . . 71.239999999999995 116.501 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 220' ' ' HIS . 27.7 m -105.86 167.2 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 N-CA-C 117.512 2.412 . . . . 71.530000000000001 117.512 -166.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.02 -1.49 58.02 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 130.075 3.35 . . . . 52.439999999999998 113.663 -173.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -77.58 12.77 1.48 Allowed 'General case' 0 CA--C 1.567 1.619 0 C-N-CA 130.532 3.533 . . . . 70.099999999999994 114.031 -136.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.48 16.5 4.63 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 124.95 1.262 . . . . 61.140000000000001 110.58 -170.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 90.6 mt -90.79 123.38 34.31 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.122 1.369 . . . . 70.150000000000006 110.8 173.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 68.5 mt -62.5 -39.54 84.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.795 -0.639 . . . . 73.329999999999998 109.384 170.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.9 t -138.44 144.46 40.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.431 -0.951 . . . . 70.299999999999997 108.431 166.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 224' ' ' VAL . 59.6 p -65.68 150.68 48.08 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 109.22 -0.659 . . . . 74.209999999999994 109.22 170.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.463 HD23 HD21 ' A' ' 184' ' ' LEU . 31.4 mt -64.36 100.16 0.34 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 108.044 -1.095 . . . . 74.239999999999995 108.044 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -90.23 -53.42 4.47 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 109.619 -0.511 . . . . 65.430000000000007 109.619 -169.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 167' ' ' SER . 1.0 OUTLIER -151.8 145.33 17.65 Favored Pre-proline 0 N--CA 1.479 0.983 0 CA-C-N 115.495 -0.775 . . . . 72.209999999999994 110.451 177.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -85.3 158.07 11.09 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 121.626 1.551 . . . . 73.409999999999997 113.809 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.39 128.29 87.59 Favored Pre-proline 0 C--O 1.245 0.842 0 N-CA-C 108.923 -0.769 . . . . 51.200000000000003 108.923 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.93 171.15 18.06 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.482 2.121 . . . . 64.450000000000003 114.185 -167.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 59.9 tttm . . . . . 0 CA--C 1.554 1.126 0 CA-C-N 114.265 -1.334 . . . . 62.520000000000003 108.664 172.786 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.9 p . . . . . 0 CA--C 1.547 0.836 0 CA-C-O 121.143 0.497 . . . . 74.230000000000004 111.743 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.0 mt -105.76 129.35 24.78 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 123.183 0.593 . . . . 73.519999999999996 109.455 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.63 171.62 17.42 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.477 2.118 . . . . 75.040000000000006 111.902 172.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.14 148.87 26.54 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.992 0.517 . . . . 71.329999999999998 111.236 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.647 HD22 HD11 ' A' ' 23' ' ' ILE . 83.6 mt -85.84 95.72 9.53 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.278 -1.008 . . . . 60.210000000000001 108.278 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -97.6 -53.42 3.44 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 120.762 0.315 . . . . 72.129999999999995 110.779 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -106.87 108.39 19.88 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.624 -0.717 . . . . 72.150000000000006 109.378 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.647 HD11 HD22 ' A' ' 20' ' ' LEU . 46.9 mm -124.3 114.07 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.291 0.636 . . . . 72.329999999999998 109.573 176.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.448 ' HG2' ' HZ2' ' A' ' 129' ' ' TRP . 20.0 pttp . . . . . 0 CA--C 1.544 0.734 0 CA-C-O 122.514 1.149 . . . . 64.109999999999999 108.509 169.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 CA--C 1.564 1.99 0 N-CA-C 113.3 0.461 . . . . 71.239999999999995 113.3 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -142.74 99.07 3.4 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.628 0.771 . . . . 62.219999999999999 110.687 -172.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.583 ' H ' ' HB3' ' A' ' 139' ' ' ASN . 24.1 tp -102.62 137.6 40.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.412 0.685 . . . . 63.43 109.483 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 8.8 m-85 -120.02 176.52 5.39 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.826 1.651 . . . . 70.439999999999998 108.54 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.12 143.75 21.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 109.057 -0.72 . . . . 75.209999999999994 109.057 169.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.28 113.31 11.35 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.494 0.718 . . . . 64.409999999999997 109.112 172.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.2 mt -79.26 -20.14 48.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.516 0.726 . . . . 62.530000000000001 110.006 171.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.562 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 71.5 m-85 -136.1 151.61 49.98 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.06 0.544 . . . . 74.150000000000006 109.548 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -70.52 141.8 51.9 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.5 -0.773 . . . . 70.239999999999995 110.304 174.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.527 ' HB3' HG12 ' A' ' 101' ' ' ILE . 87.8 t80 -138.67 115.58 10.83 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.461 -0.57 . . . . 75.420000000000002 109.461 174.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.3 t -81.0 134.34 27.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 107.986 -1.116 . . . . 74.5 107.986 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.23 116.64 8.24 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.763 -0.458 . . . . 75.239999999999995 109.763 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.2 p -71.45 -23.87 61.91 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.465 0.706 . . . . 71.400000000000006 110.501 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.75 -172.01 29.67 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.273 -0.876 . . . . 75.510000000000005 112.097 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.44 -28.8 68.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.325 1.05 . . . . 75.439999999999998 110.72 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -75.25 -16.85 60.43 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.292 1.037 . . . . 71.150000000000006 113.019 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.5 p -109.3 158.6 17.71 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.679 0.792 . . . . 72.409999999999997 110.607 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 125' ' ' ASN . 66.8 tp -107.88 130.72 54.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.33 0.652 . . . . 74.230000000000004 109.701 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 p -78.12 113.38 16.01 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.308 -0.627 . . . . 62.130000000000003 109.308 172.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 91' ' ' PHE . 34.2 pt -122.22 161.7 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.68 -0.859 . . . . 74.400000000000006 108.68 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.7 m -135.4 151.66 50.66 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 109.304 -0.628 . . . . 75.409999999999997 109.304 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -53.37 117.22 2.9 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.224 0.61 . . . . 71.450000000000003 111.089 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.59 -27.5 7.94 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.973 -0.558 . . . . 70.099999999999994 113.218 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -72.25 122.57 21.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.31 0.644 . . . . 72.430000000000007 110.323 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -84.31 124.61 31.44 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.935 0.494 . . . . 75.239999999999995 110.27 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 19.7 mt -105.55 135.28 47.23 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.702 0.801 . . . . 73.329999999999998 110.365 -168.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -95.35 107.53 19.67 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.111 -1.44 . . . . 72.450000000000003 107.111 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.7 t -97.51 124.47 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.987 -0.746 . . . . 72.239999999999995 108.987 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 64.4 mt -70.56 -36.27 73.55 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.529 0.681 . . . . 74.120000000000005 109.58 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.13 178.63 41.76 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 114.66 -1.155 . . . . 51.420000000000002 111.357 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 2.4 m-30 -94.99 174.33 7.14 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.785 -0.82 . . . . 72.349999999999994 108.785 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -72.33 159.12 34.56 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.612 -0.722 . . . . 71.219999999999999 109.795 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -58.07 -24.81 59.95 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.526 1.13 . . . . 65.430000000000007 111.76 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.434 ' HB3' ' HG2' ' A' ' 117' ' ' GLU . 56.5 t30 -95.98 -21.97 17.68 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.924 0.49 . . . . 74.049999999999997 111.144 174.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.04 -0.18 83.8 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 122.7 0.191 . . . . 63.210000000000001 113.025 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.434 ' HG2' ' HB3' ' A' ' 115' ' ' ASN . 8.4 pt-20 -57.68 -52.42 65.5 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.008 1.323 . . . . 71.409999999999997 112.081 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -118.58 177.28 4.89 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.28 1.032 . . . . 75.319999999999993 110.12 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -146.93 124.46 11.72 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.649 0.78 . . . . 65.310000000000002 109.411 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -85.24 105.8 16.19 Favored 'General case' 0 C--O 1.249 1.064 0 CA-C-O 121.071 0.462 . . . . 63.420000000000002 110.537 -173.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.11 153.21 20.53 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 115.102 -0.953 . . . . 53.100000000000001 110.086 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -141.8 124.72 16.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.789 0.836 . . . . 71.409999999999997 110.081 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 59.6 p -133.7 -167.3 1.92 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.563 0.745 . . . . 52.340000000000003 110.47 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -58.48 -22.5 55.09 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.539 1.135 . . . . 55.520000000000003 111.116 170.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.457 ' HB2' HD11 ' A' ' 99' ' ' LEU . 53.5 m-20 -84.99 6.11 26.47 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.894 1.278 . . . . 42.299999999999997 111.754 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.77 -128.98 9.75 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 111.001 -0.84 . . . . 72.400000000000006 111.001 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -151.53 162.17 41.42 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.53 0.665 . . . . 63.240000000000002 111.736 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 165.23 171.51 31.55 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.777 -0.647 . . . . 35.509999999999998 112.9 170.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.448 ' HZ2' ' HG2' ' A' ' 24' ' ' LYS . 94.7 m95 -79.29 117.55 20.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.549 0.74 . . . . 70.209999999999994 110.92 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.2 m -117.58 154.88 50.84 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.373 1.069 . . . . 73.239999999999995 108.564 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.38 131.57 15.24 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 121.557 1.505 . . . . 64.310000000000002 111.152 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.569 ' HA ' HG12 ' A' ' 135' ' ' ILE . 23.9 t -63.53 -14.97 56.46 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.921 0.488 . . . . 63.210000000000001 111.547 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -69.89 -25.46 63.71 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.22 1.008 . . . . 70.530000000000001 111.016 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.562 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 6.5 m-30 -95.58 -3.09 47.07 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.577 0.751 . . . . 74.120000000000005 112.739 -177.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.569 HG12 ' HA ' ' A' ' 132' ' ' SER . 12.6 pt -129.42 161.06 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 118.113 0.415 . . . . 74.219999999999999 110.847 -171.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 10.0 t -145.72 139.24 14.58 Favored Pre-proline 0 N--CA 1.483 1.218 0 C-N-CA 123.075 0.55 . . . . 72.310000000000002 110.045 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.501 ' HB2' ' HB2' ' A' ' 140' ' ' SER . 74.1 Cg_endo -74.52 116.64 4.68 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.3 2.0 . . . . 53.149999999999999 111.889 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.9 m -89.51 -25.76 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.069 0.547 . . . . 63.200000000000003 111.492 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.583 ' HB3' ' H ' ' A' ' 84' ' ' LEU . 65.6 t30 -94.17 18.67 10.45 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 122.01 0.91 . . . . 75.310000000000002 110.142 173.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.501 ' HB2' ' HB2' ' A' ' 137' ' ' PRO . 32.3 t -64.84 162.84 15.41 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.445 0.698 . . . . 72.129999999999995 110.515 170.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.6 mt -73.6 -12.11 60.65 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 123.568 0.747 . . . . 75.400000000000006 109.828 173.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.69 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 39.2 tt0 -49.51 -27.65 4.57 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 127.38 2.272 . . . . 75.409999999999997 115.68 -175.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.408 ' H ' ' HD3' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -60.65 -31.04 70.27 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 118.625 0.648 . . . . 71.299999999999997 110.314 177.257 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -79.63 123.59 27.77 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.047 -1.094 . . . . 61.140000000000001 108.047 166.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.0 p -61.11 -10.74 6.76 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.96 1.096 . . . . 73.219999999999999 113.96 -168.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.471 ' CE3' HG21 ' A' ' 218' ' ' VAL . 61.7 p-90 -71.17 -40.58 71.19 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 111.885 0.328 . . . . 72.209999999999994 111.885 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 142' ' ' GLU . 36.1 t80 -97.62 146.78 24.97 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 110.172 -0.307 . . . . 74.129999999999995 110.172 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.69 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 61.6 m-70 -146.06 60.97 1.25 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.001 0.52 . . . . 73.329999999999998 110.687 175.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 57.53 -165.58 6.21 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 116.97 1.548 . . . . 55.509999999999998 116.97 164.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 71.6 Cg_endo -80.09 102.86 1.48 Allowed 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.433 2.756 . . . . 45.539999999999999 112.263 168.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.434 HG21 HH21 ' A' ' 171' ' ' ARG . 21.3 t -139.31 155.36 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.132 0.973 . . . . 72.109999999999999 110.24 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.3 m -89.52 173.03 8.55 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.245 1.018 . . . . 53.439999999999998 113.425 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -62.96 -34.17 76.93 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.646 -1.161 . . . . 53.130000000000003 113.16 -173.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -61.64 -57.93 10.08 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 123.607 0.567 . . . . 75.420000000000002 110.595 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.91 -31.34 71.86 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.4 0.68 . . . . 60.039999999999999 111.017 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.75 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.1 -56.99 14.92 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.365 0.603 . . . . 75.109999999999999 111.255 173.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -71.75 -23.98 61.69 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.249 -0.887 . . . . 74.150000000000006 110.797 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -63.98 -51.79 62.63 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.981 0.912 . . . . 65.409999999999997 110.33 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.56 HD12 HH12 ' A' ' 171' ' ' ARG . 79.2 mt -68.9 -40.89 78.91 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.024 0.44 . . . . 53.43 110.931 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.47 HD23 HG13 ' A' ' 190' ' ' VAL . 34.2 tp -67.09 -22.65 65.82 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.479 -0.782 . . . . 72.040000000000006 112.272 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.9 t -58.26 -30.09 66.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.979 0.911 . . . . 63.240000000000002 111.447 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.8 t -88.11 8.5 26.53 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.419 0.687 . . . . 62.229999999999997 111.571 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -100.49 150.6 18.87 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 122.324 -0.235 . . . . 44.030000000000001 113.481 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.6 pt -97.43 -166.32 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.044 0.938 . . . . 74.420000000000002 109.47 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 25.4 p-10 -51.21 118.65 3.38 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.798 0.839 . . . . 53.25 112.619 -176.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.73 14.01 68.63 Favored Glycine 0 C--O 1.257 1.542 0 CA-C-N 116.253 -0.43 . . . . 42.549999999999997 113.768 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 63.2 p -70.94 138.78 50.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.316 -0.624 . . . . 65.209999999999994 109.316 174.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.415 ' HB3' HD23 ' A' ' 184' ' ' LEU . 18.5 p90 -139.28 156.24 47.19 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.231 0.826 . . . . 71.420000000000002 113.231 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 236' ' ' ALA . 96.8 mt -134.16 134.5 42.22 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.428 -1.26 . . . . 62.420000000000002 108.581 169.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.41 HG22 HG12 ' A' ' 182' ' ' ILE . 25.8 t -114.63 126.98 72.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 107.057 -1.46 . . . . 54.100000000000001 107.057 174.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.75 HH11 ' HA ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -159.84 150.04 18.65 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.226 0.61 . . . . 65.439999999999998 110.019 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 14.1 pt-20 -94.77 163.96 13.14 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.973 -0.751 . . . . 52.030000000000001 108.973 177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 176' ' ' SER . 35.4 m -87.03 141.12 28.9 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.645 0.26 . . . . 65.439999999999998 111.532 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.55 -37.46 86.2 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.849 0.859 . . . . 73.349999999999994 110.416 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 63.0 p -86.07 -10.2 55.37 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.207 -1.36 . . . . 61.340000000000003 112.471 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 173' ' ' SER . 12.0 m -139.28 88.31 13.04 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.338 0.655 . . . . 72.439999999999998 109.533 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.39 124.25 13.48 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.96 2.44 . . . . 75.530000000000001 112.11 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.84 -22.25 29.42 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.868 -0.606 . . . . 71.140000000000001 113.744 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -82.8 117.67 22.85 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 108.878 -0.786 . . . . 75.140000000000001 108.878 176.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 70.1 mtt-85 -111.15 169.07 9.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.137 -0.938 . . . . 73.340000000000003 110.842 -170.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.5 m -152.0 149.75 29.22 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.722 0.809 . . . . 54.240000000000002 110.136 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.41 HG12 HG22 ' A' ' 170' ' ' VAL . 48.7 mt -116.95 139.96 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 108.732 -0.84 . . . . 52.520000000000003 108.732 169.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.417 ' HB3' HD22 ' A' ' 160' ' ' LEU . 18.6 m -118.75 111.64 18.74 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.13 1.372 . . . . 75.120000000000005 107.908 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.467 HD21 HD23 ' A' ' 232' ' ' LEU . 29.9 mt -106.14 137.94 43.2 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.317 1.047 . . . . 75.439999999999998 111.256 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -126.92 126.15 42.76 Favored 'General case' 0 C--O 1.256 1.401 0 N-CA-C 108.656 -0.868 . . . . 74.340000000000003 108.656 170.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.79 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 6.2 p90 -138.35 141.69 39.7 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.143 -1.058 . . . . 73.409999999999997 108.143 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 52.38 23.61 2.55 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.104 0.961 . . . . 74.510000000000005 113.547 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 96.82 -11.18 66.34 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 123.05 0.357 . . . . 74.109999999999999 113.576 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -101.98 126.76 48.97 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.751 0.82 . . . . 61.329999999999998 111.149 -173.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.47 HG13 HD23 ' A' ' 160' ' ' LEU . 80.0 t -95.14 142.42 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.199 1.0 . . . . 75.430000000000007 110.461 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.402 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 23.2 p90 -146.41 154.5 41.69 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.325 1.05 . . . . 74.329999999999998 109.431 165.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -128.05 142.39 51.23 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.829 0.852 . . . . 74.549999999999997 108.732 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -141.76 151.55 42.98 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 120.985 0.421 . . . . 71.239999999999995 110.341 174.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -78.95 145.29 34.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.29 -0.868 . . . . 74.5 111.304 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 79.8 mt -89.49 104.23 14.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 106.754 -1.573 . . . . 62.520000000000003 106.754 161.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -71.22 127.06 31.33 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.193 -0.912 . . . . 74.319999999999993 108.668 -177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 31.8 m -99.52 116.58 31.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.168 0.587 . . . . 73.400000000000006 109.862 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.09 166.61 4.59 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.557 1.143 . . . . 74.549999999999997 111.575 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 55.9 p -62.29 -35.72 79.9 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.153 -0.476 . . . . 74.310000000000002 110.487 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -69.05 -12.77 61.98 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.533 0.733 . . . . 34.420000000000002 111.775 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 96.27 -5.49 65.42 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 116.458 -0.337 . . . . 62.32 112.313 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -62.49 141.93 58.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.561 0.744 . . . . 64.109999999999999 110.798 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 81.4 mt -93.87 144.36 25.51 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.195 -0.669 . . . . 74.150000000000006 109.195 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -162.78 161.49 26.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.094 0.558 . . . . 73.010000000000005 109.891 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 70.7 t -135.54 -55.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.375 -0.972 . . . . 74.120000000000005 108.375 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 9.9 m -90.96 169.86 10.54 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.379 0.671 . . . . 63.329999999999998 109.699 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 61.3 m -69.66 -48.22 60.55 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.509 0.559 . . . . 43.119999999999997 112.509 -171.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -73.62 -26.41 60.77 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.271 0.629 . . . . 63.530000000000001 110.795 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 58.0 m -67.91 118.19 10.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.234 1.014 . . . . 65.299999999999997 110.684 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -142.48 126.9 17.74 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.432 1.093 . . . . 75.219999999999999 108.324 175.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -135.64 141.26 45.02 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.033 0.379 . . . . 62.439999999999998 111.056 -173.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -91.58 -21.72 20.69 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.471 -0.786 . . . . 75.120000000000005 109.94 169.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 48.4 p -127.7 142.46 51.32 Favored 'General case' 0 C--N 1.363 1.185 0 CA-C-O 121.674 0.749 . . . . 74.099999999999994 111.88 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.4 HD11 HG11 ' A' ' 170' ' ' VAL . 30.1 tp -65.57 -28.7 69.34 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.404 -1.271 . . . . 74.200000000000003 110.764 175.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.89 97.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.408 0.683 . . . . 64.25 110.521 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.9 -30.27 63.8 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.474 0.31 . . . . 74.510000000000005 111.518 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.0 tt -61.04 -44.0 98.05 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.271 0.357 . . . . 75.310000000000002 110.555 170.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.471 HG21 ' CE3' ' A' ' 146' ' ' TRP . 42.5 t -70.18 -40.07 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.334 0.653 . . . . 53.109999999999999 111.006 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -60.42 -50.81 72.1 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.784 0.802 . . . . 74.439999999999998 110.486 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.415 ' O ' HG22 ' A' ' 224' ' ' VAL . 49.6 t60 -56.32 -54.65 42.95 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.285 -1.325 . . . . 73.340000000000003 110.335 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -63.52 -25.18 68.14 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.137 0.575 . . . . 75.409999999999997 112.141 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 23.0 t -74.61 -28.2 60.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.272 0.229 . . . . 44.539999999999999 110.994 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.8 t -103.9 -22.49 13.49 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.021 1.86 . . . . 63.100000000000001 116.021 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 220' ' ' HIS . 29.0 m -90.83 120.42 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 120.495 1.498 . . . . 74.439999999999998 114.344 -165.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.2 -1.32 9.87 Favored 'General case' 0 CA--C 1.57 1.715 0 C-N-CA 127.783 2.433 . . . . 73.340000000000003 112.745 171.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.19 14.72 1.1 Allowed 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 128.142 2.577 . . . . 65.409999999999997 114.311 -145.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.76 17.23 4.28 Favored Glycine 0 N--CA 1.467 0.755 0 O-C-N 121.805 -0.559 . . . . 64.530000000000001 111.926 -166.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 64.2 mt -91.36 133.73 35.2 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.045 -0.724 . . . . 74.209999999999994 109.045 156.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.402 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 93.4 mt -57.91 -52.48 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 109.233 -0.655 . . . . 74.540000000000006 109.233 172.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.3 t -130.52 150.35 51.77 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.944 -1.026 . . . . 72.439999999999998 108.282 167.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 69.8 p -80.02 170.6 16.24 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 109.05 -0.722 . . . . 75.019999999999996 109.05 171.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.467 HD23 HD21 ' A' ' 184' ' ' LEU . 26.2 mt -74.88 102.59 4.8 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 108.896 -0.779 . . . . 64.299999999999997 108.896 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -78.64 -57.62 3.67 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.16 -0.682 . . . . 75.510000000000005 109.16 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 167' ' ' SER . 7.3 p90 -154.8 151.17 22.8 Favored Pre-proline 0 N--CA 1.483 1.184 0 N-CA-C 109.832 -0.433 . . . . 72.329999999999998 109.832 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.82 138.52 44.98 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.105 1.87 . . . . 72.310000000000002 111.578 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.472 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -58.83 127.06 82.45 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 109.231 -0.655 . . . . 64.549999999999997 109.231 173.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.06 158.69 28.82 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.853 2.368 . . . . 64.219999999999999 113.281 -172.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt . . . . . 0 C--N 1.348 0.511 0 N-CA-C 109.052 -0.722 . . . . 61.229999999999997 109.052 174.281 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 121.29 0.566 . . . . 64.230000000000004 111.801 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.9 mt -103.32 124.63 37.57 Favored Pre-proline 0 C--O 1.242 0.658 0 N-CA-C 108.1 -1.074 . . . . 64.25 108.1 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.02 168.62 21.37 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.289 1.993 . . . . 62.020000000000003 111.244 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' HB3' ' NE2' ' A' ' 21' ' ' HIS . . . -83.03 148.22 27.68 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.773 0.32 . . . . 74.140000000000001 110.446 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.559 HD22 HD11 ' A' ' 23' ' ' ILE . 73.6 mt -84.58 94.77 8.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.86 -1.163 . . . . 63.43 107.86 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.423 ' NE2' ' HB3' ' A' ' 19' ' ' ALA . 34.1 m170 -96.24 -50.12 4.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.684 -0.689 . . . . 73.409999999999997 110.522 -174.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.488 ' HB2' ' OD1' ' A' ' 113' ' ' ASN . 73.8 m-85 -102.76 107.35 18.19 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.875 -0.787 . . . . 75.010000000000005 108.875 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.559 HD11 HD22 ' A' ' 20' ' ' LEU . 45.4 mm -122.6 114.05 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.034 -1.098 . . . . 73.209999999999994 108.034 175.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 123.346 0.658 . . . . 75.310000000000002 110.161 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.499 1.843 0 N-CA-C 114.025 0.74 . . . . 73.099999999999994 114.025 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -135.48 67.07 1.49 Allowed 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.086 -1.079 . . . . 62.240000000000002 108.086 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.547 HD11 ' HB3' ' A' ' 106' ' ' LYS . 18.0 tp -85.83 114.53 22.84 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 121.275 0.559 . . . . 75.510000000000005 109.526 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 5.1 m-85 -104.8 175.09 5.61 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.777 1.631 . . . . 70.0 109.401 173.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.93 142.73 31.51 Favored 'Isoleucine or valine' 0 C--O 1.251 1.133 0 N-CA-C 108.073 -1.084 . . . . 65.140000000000001 108.073 169.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.466 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -77.42 117.65 19.1 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.548 0.53 . . . . 71.340000000000003 109.814 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.2 mt -80.67 -11.11 59.68 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.269 0.628 . . . . 63.43 111.284 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.434 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 54.1 m-85 -138.79 156.64 47.18 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.911 0.884 . . . . 74.25 109.025 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.84 130.88 35.29 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.066 -1.087 . . . . 65.340000000000003 108.066 168.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -141.0 124.1 16.41 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.563 -0.902 . . . . 74.409999999999997 108.563 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.31 138.95 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.037 -0.727 . . . . 75.340000000000003 109.037 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.02 133.89 56.49 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.297 0.639 . . . . 52.509999999999998 111.743 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.5 t -81.01 -6.17 58.47 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.355 1.062 . . . . 61.43 110.855 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.33 -162.11 35.91 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.649 -0.58 . . . . 54.310000000000002 111.649 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.52 -34.21 76.65 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.302 1.041 . . . . 51.310000000000002 111.084 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.474 ' ND2' HD13 ' A' ' 20' ' ' LEU . 30.0 p-10 -82.53 9.96 8.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.047 0.939 . . . . 74.349999999999994 112.59 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.1 p -135.49 153.96 51.56 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.335 1.054 . . . . 75.099999999999994 108.833 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.0 tp -110.25 135.7 50.59 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.869 0.468 . . . . 73.439999999999998 110.463 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.4 m -78.54 114.56 17.56 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.404 -0.962 . . . . 72.129999999999995 108.404 169.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.5 pt -118.87 144.72 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.611 0.765 . . . . 71.430000000000007 109.3 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 4.8 m -107.78 146.29 32.39 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.351 -0.611 . . . . 74.329999999999998 109.351 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -63.42 109.11 1.5 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.735 0.414 . . . . 53.450000000000003 110.995 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.73 1.69 34.56 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 116.064 -0.516 . . . . 31.120000000000001 112.748 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.62 136.36 33.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.326 1.05 . . . . 43.0 110.181 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.547 ' HB3' HD11 ' A' ' 84' ' ' LEU . 66.4 mttm -82.8 112.99 20.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.832 0.853 . . . . 65.5 109.55 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 87' ' ' ALA . 16.8 mt -100.72 138.05 38.3 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.781 0.832 . . . . 71.230000000000004 108.925 -173.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -108.59 107.32 17.77 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.139 -1.06 . . . . 70.109999999999999 108.139 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 88.1 t -100.14 129.88 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.422 0.689 . . . . 54.210000000000001 109.221 -173.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.4 mt -85.1 -22.82 28.74 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.7 0.4 . . . . 65.519999999999996 110.844 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.73 174.88 37.1 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.779 -0.646 . . . . 73.129999999999995 111.839 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 13.4 m-30 -94.84 174.92 6.86 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.267 0.627 . . . . 75.200000000000003 109.633 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.488 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 57.4 t30 -62.03 159.5 14.27 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.494 1.118 . . . . 71.150000000000006 109.572 173.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -65.91 -18.26 65.22 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 122.487 0.315 . . . . 73.099999999999994 110.696 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -111.44 5.89 19.91 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.555 0.742 . . . . 72.019999999999996 111.398 171.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.87 2.87 53.6 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 115.427 0.931 . . . . 72.310000000000002 115.427 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -60.67 -59.05 6.01 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.345 1.058 . . . . 65.409999999999997 110.907 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -104.49 179.34 4.3 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.142 -1.39 . . . . 73.340000000000003 109.55 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -150.89 121.46 7.44 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.996 0.918 . . . . 70.5 109.376 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.406 ' HG2' HE21 ' A' ' 127' ' ' GLN . 36.4 tt0 -75.75 100.33 4.68 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 120.985 0.421 . . . . 73.019999999999996 110.207 -176.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -103.86 157.41 17.11 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.944 0.898 . . . . 73.340000000000003 110.242 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -142.92 126.78 17.17 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.86 0.864 . . . . 74.530000000000001 109.471 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.2 p -136.1 -171.61 2.92 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.49 1.116 . . . . 62.130000000000003 109.686 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -70.01 -7.3 39.79 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.363 0.665 . . . . 73.129999999999995 111.504 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -84.61 -13.19 52.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.116 0.967 . . . . 75.5 111.316 173.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 128.07 -142.36 13.45 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.853 -0.499 . . . . 52.229999999999997 111.853 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.406 HE21 ' HG2' ' A' ' 120' ' ' GLU . 55.2 tt0 -151.69 145.68 25.22 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.376 0.67 . . . . 72.329999999999998 110.833 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 173.58 179.01 43.96 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.442 -0.799 . . . . 73.120000000000005 111.717 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -82.07 123.37 28.88 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.693 0.797 . . . . 73.349999999999994 110.433 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.88 148.32 41.87 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 124.738 1.215 . . . . 71.010000000000005 109.025 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.95 130.69 25.08 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 121.871 1.714 . . . . 54.25 111.008 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.1 m -61.42 -19.37 61.86 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.942 0.897 . . . . 63.43 112.698 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -72.97 -21.39 60.86 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.941 0.896 . . . . 61.240000000000002 111.537 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.434 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.1 m-85 -94.36 -3.99 49.33 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.566 0.746 . . . . 64.310000000000002 112.608 -175.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.4 pt -128.36 151.74 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.039 0.536 . . . . 75.129999999999995 110.525 -171.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 8.2 t -141.28 133.54 13.97 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 122.602 0.361 . . . . 44.25 110.637 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 59.2 Cg_endo -72.43 117.78 5.29 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.522 2.148 . . . . 70.120000000000005 112.116 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 22.9 m -80.22 -36.92 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.158 0.583 . . . . 73.409999999999997 110.11 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -73.43 -9.76 59.02 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.365 0.666 . . . . 72.239999999999995 111.295 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 143' ' ' LYS . 28.6 t -39.16 129.28 1.69 Allowed 'General case' 0 C--N 1.363 1.174 0 C-N-CA 125.281 1.433 . . . . 73.200000000000003 112.447 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 72.0 mt -60.82 -10.07 5.01 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.482 0.713 . . . . 61.0 111.591 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -57.1 -19.59 20.52 Favored 'General case' 0 C--N 1.365 1.246 0 C-N-CA 124.732 1.213 . . . . 74.420000000000002 112.634 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 140' ' ' SER . 2.4 mmmp? -61.09 -24.99 66.64 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.164 0.506 . . . . 73.099999999999994 110.243 171.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -94.0 120.74 34.68 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 106.371 -1.714 . . . . 74.25 106.371 163.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.5 t -57.32 -17.42 12.15 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.257 1.206 . . . . 73.019999999999996 114.257 -166.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.503 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 51.2 p-90 -66.74 -50.43 62.8 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.689 0.626 . . . . 62.539999999999999 112.689 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.427 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 75.7 t80 -79.42 148.0 32.11 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.898 0.479 . . . . 75.200000000000003 110.426 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.45 ' CD2' HD22 ' A' ' 169' ' ' LEU . 87.9 m-70 -135.85 -27.16 1.15 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.203 0.601 . . . . 73.120000000000005 110.47 171.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 100.15 -151.28 19.11 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.139 -0.812 . . . . 73.400000000000006 114.609 171.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 33.6 Cg_endo -63.04 89.47 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.273 2.649 . . . . 72.049999999999997 110.781 175.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 86.9 t -130.43 149.56 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 115.708 -0.678 . . . . 71.400000000000006 110.244 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.6 m -60.91 148.63 39.02 Favored 'General case' 0 C--O 1.246 0.921 0 C-N-CA 124.744 1.217 . . . . 71.400000000000006 112.333 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 41.0 ttt-85 -57.16 -39.35 75.1 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.451 -0.795 . . . . 55.020000000000003 110.033 172.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -60.27 -58.59 7.87 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.735 -1.121 . . . . 41.520000000000003 110.554 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -56.72 -39.08 73.26 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.035 0.835 . . . . 63.210000000000001 111.328 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.06 -61.54 2.56 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.362 -0.835 . . . . 63.299999999999997 111.776 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -70.5 -20.0 62.88 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.245 -0.889 . . . . 75.0 110.805 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -74.11 -51.29 16.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.701 0.8 . . . . 74.540000000000006 110.691 176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 71.1 mt -63.8 -39.44 94.25 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.111 0.482 . . . . 74.340000000000003 109.892 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.435 HD23 HG13 ' A' ' 190' ' ' VAL . 27.4 tp -72.34 -18.61 61.75 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.142 -0.936 . . . . 63.409999999999997 111.197 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.492 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 17.3 t -67.17 -23.13 65.74 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.934 0.494 . . . . 73.430000000000007 110.902 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.1 t -91.12 8.63 34.64 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.89 0.876 . . . . 75.209999999999994 110.52 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.21 159.64 30.07 Favored Glycine 0 C--N 1.343 0.958 0 C-N-CA 123.088 0.375 . . . . 73.409999999999997 112.67 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 18.9 pt -126.09 -165.24 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 C-N-CA 124.184 0.994 . . . . 74.219999999999999 110.424 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 14.0 p-10 -56.86 99.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.815 1.043 . . . . 71.120000000000005 113.815 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 103.65 13.54 27.67 Favored Glycine 0 C--O 1.259 1.696 0 CA-C-N 116.162 -0.472 . . . . 63.530000000000001 112.818 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 23.0 t -77.65 136.47 38.22 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.854 -0.424 . . . . 63.509999999999998 109.854 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.472 ' HB3' HD23 ' A' ' 184' ' ' LEU . 17.1 p90 -139.49 159.87 41.16 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.125 0.787 . . . . 75.219999999999999 113.125 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 236' ' ' ALA . 95.4 mt -137.61 134.4 35.5 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.33 1.052 . . . . 71.109999999999999 108.578 170.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 43.9 t -109.68 124.62 66.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 108.685 -0.857 . . . . 71.040000000000006 108.685 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.8 mtp-105 -142.81 168.38 19.86 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.936 0.894 . . . . 71.030000000000001 111.03 -174.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.794 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 2.9 pt-20 -120.46 166.1 14.05 Favored 'General case' 0 C--O 1.26 1.645 0 C-N-CA 124.547 1.139 . . . . 65.329999999999998 110.679 159.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.2 m -74.61 146.3 42.59 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.339 -1.3 . . . . 52.109999999999999 110.505 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.9 -43.16 75.8 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.67 0.788 . . . . 71.519999999999996 111.105 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.2 m -84.66 -43.91 13.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.483 -0.78 . . . . 62.32 111.709 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.6 t -112.56 97.09 39.25 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 109.289 -0.634 . . . . 44.420000000000002 109.289 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -69.18 147.17 65.98 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.074 2.516 . . . . 71.319999999999993 111.593 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.52 -23.85 8.14 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 116.329 -0.396 . . . . 41.32 112.996 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -80.69 116.12 20.54 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 107.127 -1.434 . . . . 73.109999999999999 107.127 170.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.794 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 83.7 mtt85 -122.45 166.48 14.69 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.13 0.572 . . . . 64.019999999999996 111.228 -168.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 65.4 m -151.84 138.03 18.35 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.235 1.014 . . . . 71.409999999999997 109.838 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 63.0 mt -105.17 140.37 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 107.849 -1.167 . . . . 71.120000000000005 107.849 165.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 15.5 m -116.29 113.6 23.2 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.384 1.074 . . . . 73.329999999999998 108.388 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.489 HD21 HD23 ' A' ' 232' ' ' LEU . 39.5 mt -104.3 144.01 32.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.153 0.981 . . . . 63.439999999999998 111.301 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.492 ' NH1' ' HA ' ' A' ' 161' ' ' SER . 21.1 ttt180 -134.48 138.16 44.5 Favored 'General case' 0 C--O 1.25 1.132 0 CA-C-N 114.637 -1.165 . . . . 74.310000000000002 110.03 172.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 10.2 p90 -157.71 139.18 13.73 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.838 -1.074 . . . . 71.219999999999999 108.108 171.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 54.49 31.37 14.65 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.583 1.153 . . . . 74.439999999999998 113.537 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.73 9.53 86.26 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.343 -0.39 . . . . 74.420000000000002 113.817 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 28.7 tpt180 -102.9 127.09 50.24 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.501 1.12 . . . . 73.099999999999994 109.411 175.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.435 HG13 HD23 ' A' ' 160' ' ' LEU . 94.9 t -114.08 129.85 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.78 1.232 . . . . 73.010000000000005 108.971 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.407 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 22.5 p90 -145.36 160.73 41.09 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.051 0.941 . . . . 74.329999999999998 109.061 174.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -134.42 148.27 50.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.104 0.962 . . . . 75.219999999999999 108.506 -171.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -145.29 145.67 31.34 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.68 0.392 . . . . 71.25 110.867 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -76.82 146.31 37.87 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.375 1.07 . . . . 75.450000000000003 112.149 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.763 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 64.3 mt -104.52 119.18 53.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 N-CA-C 107.393 -1.336 . . . . 74.409999999999997 107.393 163.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -91.02 145.04 25.03 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 109.637 -0.505 . . . . 70.540000000000006 109.637 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 18.1 m -106.02 128.07 53.59 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.969 0.908 . . . . 72.340000000000003 109.449 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 202' ' ' LYS . . . -85.37 158.66 20.19 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.709 0.803 . . . . 73.340000000000003 109.432 170.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 15.8 t -65.6 -9.64 28.59 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.842 1.053 . . . . 63.210000000000001 113.842 -169.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.42 ' HB2' ' HG3' ' A' ' 202' ' ' LYS . 80.9 m-20 -87.46 11.73 13.99 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.117 0.567 . . . . 73.450000000000003 111.833 175.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 75.2 12.48 83.47 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 111.954 -0.458 . . . . 71.409999999999997 111.954 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.639 ' HB2' ' HB3' ' A' ' 198' ' ' ALA . 98.4 mttt -79.65 153.33 29.44 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 123.88 0.872 . . . . 65.109999999999999 110.441 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 90.5 mt -118.37 148.14 42.82 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.342 0.657 . . . . 73.219999999999999 109.41 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -162.91 154.99 18.33 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.193 0.597 . . . . 72.040000000000006 109.981 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 79.2 t -125.01 -63.59 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.09 -1.078 . . . . 51.43 108.09 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.4 t -113.02 -175.54 2.69 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.15 -0.932 . . . . 74.129999999999995 110.035 -174.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 49.9 m -62.33 -47.8 82.62 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.45 1.1 . . . . 64.310000000000002 112.979 -170.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -85.57 3.17 41.85 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 122.182 0.193 . . . . 70.129999999999995 111.124 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 73.0 m -98.81 106.41 18.67 Favored 'General case' 0 C--O 1.215 -0.732 0 C-N-CA 123.608 0.763 . . . . 74.120000000000005 109.97 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -143.31 118.37 10.07 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.842 1.257 . . . . 64.239999999999995 107.685 171.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -134.99 154.93 51.56 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.073 0.549 . . . . 74.049999999999997 110.659 -170.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -91.53 -31.39 15.96 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 123.677 0.611 . . . . 65.310000000000002 109.907 169.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . 0.413 ' OG1' ' HG2' ' A' ' 216' ' ' GLU . 48.5 p -131.14 157.92 41.86 Favored 'General case' 0 C--O 1.253 1.289 0 CA-C-O 122.324 1.059 . . . . 64.109999999999999 112.104 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.419 ' O ' HG23 ' A' ' 218' ' ' VAL . 23.1 tp -72.78 -27.92 62.29 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 113.765 -1.561 . . . . 72.140000000000001 111.396 -176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.84 -43.27 93.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.878 0.471 . . . . 74.439999999999998 110.521 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.413 ' HG2' ' OG1' ' A' ' 213' ' ' THR . 21.0 mm-40 -68.9 -35.04 76.38 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 115.768 -0.651 . . . . 72.230000000000004 110.146 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tt -55.78 -50.01 71.6 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.951 0.782 . . . . 64.150000000000006 110.91 171.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 214' ' ' LEU . 55.4 t -63.8 -45.75 96.3 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 O-C-N 123.956 0.785 . . . . 63.299999999999997 111.055 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -58.01 -53.32 59.59 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.581 0.705 . . . . 71.409999999999997 111.14 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.435 ' CE1' HG11 ' A' ' 224' ' ' VAL . 61.5 t60 -54.48 -51.68 64.29 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.016 -0.993 . . . . 73.340000000000003 109.425 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -66.54 -22.77 66.16 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.265 -0.88 . . . . 73.319999999999993 112.077 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.2 m -72.98 -27.05 61.57 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.745 0.418 . . . . 71.120000000000005 110.583 173.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.8 t -120.25 4.22 10.81 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 116.206 1.928 . . . . 63.219999999999999 116.206 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.435 HG11 ' CE1' ' A' ' 220' ' ' HIS . 26.8 m -107.92 156.44 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 116.085 1.883 . . . . 73.510000000000005 116.085 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -92.56 -0.49 57.32 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 111.111 -2.768 . . . . 63.420000000000002 113.274 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -77.62 14.3 1.06 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 128.169 2.588 . . . . 72.25 113.999 -143.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.46 17.52 4.77 Favored Glycine 0 N--CA 1.467 0.751 0 O-C-N 120.724 -1.235 . . . . 72.420000000000002 111.321 -169.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.1 mt -92.17 118.08 30.5 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.731 -1.234 . . . . 63.329999999999998 108.605 165.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.407 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 76.8 mt -59.74 -46.42 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 123.868 0.73 . . . . 43.340000000000003 109.478 173.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.1 t -130.77 142.7 50.42 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.109 -1.071 . . . . 71.349999999999994 108.109 167.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 55.6 p -69.02 157.35 36.97 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.777 0.431 . . . . 75.129999999999995 110.524 174.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.489 HD23 HD21 ' A' ' 184' ' ' LEU . 23.1 mt -66.96 101.37 0.84 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 108.729 -0.841 . . . . 72.219999999999999 108.729 177.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -88.26 -53.64 4.6 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.838 -0.801 . . . . 73.310000000000002 108.838 -173.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -158.91 145.43 12.63 Favored Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 115.083 -0.962 . . . . 63.210000000000001 110.793 -177.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.503 ' HB3' ' HA ' ' A' ' 146' ' ' TRP . 51.6 Cg_endo -68.59 163.43 36.91 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 121.781 1.654 . . . . 73.010000000000005 113.096 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.537 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -73.42 125.57 90.61 Favored Pre-proline 0 C--O 1.244 0.812 0 N-CA-C 108.861 -0.792 . . . . 73.120000000000005 108.861 170.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.36 132.43 27.48 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.058 1.839 . . . . 73.420000000000002 111.642 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 21.3 pttp . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 123.62 0.768 . . . . 61.32 109.976 175.066 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.6 p . . . . . 0 CA--C 1.551 1.001 0 CA-C-O 121.143 0.497 . . . . 60.310000000000002 111.397 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.7 mt -103.89 133.28 20.34 Favored Pre-proline 0 N--CA 1.476 0.86 0 N-CA-C 108.77 -0.826 . . . . 62.439999999999998 108.77 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.26 169.8 19.84 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.387 2.058 . . . . 72.120000000000005 112.688 177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.64 142.19 30.98 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.098 0.559 . . . . 74.010000000000005 110.63 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HB3' HD11 ' A' ' 23' ' ' ILE . 75.6 mt -88.35 96.93 10.77 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.636 0.774 . . . . 73.219999999999999 109.035 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -97.04 -47.79 5.65 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.57 -0.741 . . . . 74.540000000000006 109.75 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -103.46 109.95 21.79 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.507 -0.77 . . . . 74.299999999999997 109.289 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 20' ' ' LEU . 25.7 mm -117.29 120.01 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.387 1.075 . . . . 74.120000000000005 109.892 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.4 pttp . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 107.574 -1.269 . . . . 73.120000000000005 107.574 167.121 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.559 1.762 0 N-CA-C 113.922 0.701 . . . . 64.109999999999999 113.922 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -90.46 40.16 1.0 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.824 0.85 . . . . 71.510000000000005 111.672 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 57.4 tp -83.72 112.55 20.17 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.512 0.672 . . . . 74.25 110.553 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.41 173.33 6.37 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.813 1.645 . . . . 65.140000000000001 108.766 170.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.6 p -144.96 143.16 22.63 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 N-CA-C 108.706 -0.85 . . . . 74.25 108.706 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.588 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -80.26 135.84 36.32 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.858 0.463 . . . . 73.329999999999998 110.201 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.3 mt -95.12 -16.56 22.52 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.315 1.046 . . . . 61.299999999999997 110.767 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -138.98 145.96 40.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.838 0.855 . . . . 72.549999999999997 108.915 -177.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -79.43 117.82 20.74 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.07 -0.715 . . . . 51.140000000000001 109.07 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -121.18 117.74 27.89 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.024 0.93 . . . . 72.040000000000006 109.247 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.8 t -79.96 138.74 19.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 C-N-CA 123.659 0.784 . . . . 51.100000000000001 109.262 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.71 115.09 3.69 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.818 -0.808 . . . . 73.019999999999996 108.818 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.4 m -74.59 -11.92 60.32 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.926 0.891 . . . . 71.25 110.753 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.79 -163.34 28.9 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 110.554 -1.018 . . . . 75.329999999999998 110.554 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -73.6 -23.92 59.98 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.219 0.608 . . . . 52.119999999999997 111.043 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -72.67 -24.19 60.99 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.438 1.095 . . . . 63.340000000000003 112.282 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.1 p -110.41 158.63 18.26 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.836 0.854 . . . . 74.299999999999997 110.013 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.9 tp -109.17 132.73 53.84 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.223 -0.898 . . . . 73.019999999999996 109.226 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.2 t -82.0 124.84 30.14 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.767 -0.827 . . . . 50.450000000000003 108.767 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.1 pt -128.86 140.59 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 108.094 -1.076 . . . . 72.5 108.094 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 16.0 m -98.31 151.96 19.94 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.024 0.375 . . . . 72.120000000000005 110.211 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -60.12 111.4 1.5 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.199 0.6 . . . . 70.120000000000005 110.799 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.82 3.7 55.93 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 115.405 -0.816 . . . . 50.020000000000003 113.183 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -83.41 145.97 28.7 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.481 0.712 . . . . 61.539999999999999 110.346 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -87.92 113.32 23.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.398 1.079 . . . . 73.329999999999998 109.306 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.588 HD11 ' HB2' ' A' ' 87' ' ' ALA . 15.2 mt -108.07 133.84 51.8 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.464 -0.939 . . . . 53.240000000000002 108.464 -170.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -104.17 106.93 17.61 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.337 -0.616 . . . . 72.109999999999999 109.337 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 92.8 t -98.73 119.4 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 109.07 -0.715 . . . . 73.109999999999999 109.07 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.9 mt -67.83 -37.49 81.97 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.762 0.825 . . . . 73.239999999999995 109.924 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.05 -178.6 44.17 Favored Glycine 0 C--O 1.244 0.727 0 CA-C-N 114.431 -1.259 . . . . 44.219999999999999 111.167 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 14.4 m-30 -95.99 169.81 9.72 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.256 -0.646 . . . . 74.140000000000001 109.256 177.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -60.28 145.82 46.11 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.631 -1.248 . . . . 74.430000000000007 107.631 168.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -65.53 -25.59 67.52 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.46 0.304 . . . . 74.120000000000005 110.896 -176.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -81.76 -18.51 43.94 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.694 0.797 . . . . 74.219999999999999 110.56 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 174' ' ' GLU . . . 85.93 34.25 13.5 Favored Glycine 0 C--N 1.35 1.353 0 C-N-CA 123.484 0.564 . . . . 74.420000000000002 113.607 174.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -96.27 -64.14 1.08 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.577 0.703 . . . . 73.230000000000004 110.583 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -103.49 -179.0 3.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.589 1.156 . . . . 74.319999999999993 109.633 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -142.18 122.19 13.69 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.668 0.787 . . . . 72.349999999999994 109.477 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -79.98 101.77 8.84 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.179 0.514 . . . . 74.0 109.623 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -103.88 167.65 9.64 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.139 -0.937 . . . . 61.310000000000002 109.998 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -141.4 125.62 17.45 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 124.449 1.1 . . . . 74.530000000000001 108.502 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.8 p -138.15 -168.6 2.39 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.029 0.932 . . . . 73.420000000000002 110.661 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 124' ' ' LYS . 31.6 mtmt -54.41 -35.14 62.59 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.895 1.278 . . . . 73.409999999999997 111.159 175.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -83.92 8.01 16.44 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.556 -1.202 . . . . 61.420000000000002 111.424 -175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.55 -126.14 7.42 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 111.499 -0.64 . . . . 75.409999999999997 111.499 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -151.02 139.8 20.8 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.305 0.642 . . . . 75.439999999999998 109.324 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 179.2 -178.76 48.86 Favored Glycine 0 C--N 1.344 1.0 0 O-C-N 123.263 0.352 . . . . 71.310000000000002 112.338 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -89.66 131.97 35.38 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.255 0.622 . . . . 63.340000000000003 110.835 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.67 152.08 76.29 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 125.322 1.449 . . . . 75.150000000000006 109.095 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.08 132.98 23.93 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.272 1.982 . . . . 74.430000000000007 111.462 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.506 ' HA ' HG12 ' A' ' 135' ' ' ILE . 20.0 m -62.3 -17.81 59.66 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.11 0.964 . . . . 65.150000000000006 112.724 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -74.65 -20.81 59.74 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.03 0.932 . . . . 75.420000000000002 111.526 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -95.17 -6.51 41.56 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.828 0.851 . . . . 74.310000000000002 112.023 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.506 HG12 ' HA ' ' A' ' 132' ' ' SER . 14.8 pt -125.06 156.68 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.158 0.583 . . . . 72.310000000000002 110.059 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 11.3 t -149.86 136.38 10.75 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 122.701 0.4 . . . . 65.340000000000003 110.375 172.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.534 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 73.6 Cg_endo -75.38 140.19 24.17 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.487 2.125 . . . . 75.540000000000006 111.765 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.85 -36.54 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.002 0.521 . . . . 71.040000000000006 111.414 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 59.2 t30 -98.74 -9.39 24.58 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.71 0.404 . . . . 71.409999999999997 111.149 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 32.5 t -73.34 177.04 5.46 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.919 0.488 . . . . 64.420000000000002 109.902 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 64.4 mt -61.15 -16.24 42.37 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.698 0.999 . . . . 73.329999999999998 113.698 -172.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -59.37 -24.13 63.14 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.574 1.15 . . . . 71.109999999999999 112.666 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -67.19 -8.37 30.9 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.438 0.695 . . . . 74.310000000000002 112.135 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -89.1 151.76 22.04 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.765 0.826 . . . . 75.340000000000003 110.549 170.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 56.8 p -69.24 -36.21 76.95 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 123.625 0.77 . . . . 72.530000000000001 111.13 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -72.44 -31.35 65.4 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.607 -0.724 . . . . 73.420000000000002 112.638 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -97.27 120.95 38.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.873 -0.788 . . . . 74.349999999999994 108.873 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -103.13 5.05 37.65 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.87 -0.605 . . . . 75.209999999999994 111.663 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.81 -154.5 35.86 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.67 -0.517 . . . . 63.329999999999998 112.948 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.4 106.39 1.59 Allowed 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 123.152 2.568 . . . . 45.329999999999998 111.028 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.6 t -140.34 143.86 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.405 0.682 . . . . 73.030000000000001 109.404 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.2 t -64.54 161.88 16.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.061 0.944 . . . . 61.329999999999998 112.121 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -69.58 -31.86 70.26 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.673 0.789 . . . . 73.140000000000001 110.739 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -76.17 -43.89 40.6 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.23 0.612 . . . . 72.099999999999994 109.527 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.07 79.14 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.396 -0.82 . . . . 72.109999999999999 110.387 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.75 -56.23 24.64 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.715 -0.675 . . . . 75.040000000000006 110.214 171.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -60.49 -32.33 71.33 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.618 -0.719 . . . . 71.209999999999994 110.968 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -65.73 -52.22 52.94 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.222 1.009 . . . . 55.240000000000002 110.975 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.5 ' HB2' HD11 ' A' ' 169' ' ' LEU . 81.5 mt -67.03 -39.37 87.0 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.439 0.637 . . . . 71.450000000000003 110.788 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.452 HD23 HG13 ' A' ' 190' ' ' VAL . 27.2 tp -73.73 -20.14 60.6 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.682 -1.145 . . . . 72.329999999999998 111.604 -174.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.6 t -61.62 -27.22 68.5 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.842 0.857 . . . . 34.439999999999998 111.83 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.4 p -86.45 8.53 21.43 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.918 0.887 . . . . 74.299999999999997 111.719 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -97.39 170.16 25.51 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 116.374 -0.375 . . . . 72.340000000000003 112.605 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 32.4 pt -121.92 -163.59 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.95 0.9 . . . . 71.319999999999993 109.66 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.736 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 27.1 p-10 -49.48 118.15 2.6 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.729 0.811 . . . . 71.239999999999995 112.412 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.18 14.0 72.83 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.297 -0.41 . . . . 44.439999999999998 113.288 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 20.2 t -75.23 136.02 40.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.035 -0.728 . . . . 60.130000000000003 109.035 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.488 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 22.2 p90 -135.65 164.97 26.65 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.948 0.721 . . . . 74.340000000000003 112.948 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 159' ' ' LEU . 86.0 mt -137.41 135.48 36.97 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.549 1.139 . . . . 74.439999999999998 108.353 169.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.401 HG22 HG12 ' A' ' 182' ' ' ILE . 39.0 t -114.55 128.46 71.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 107.851 -1.166 . . . . 74.450000000000003 107.851 171.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 12.9 mtm105 -143.05 172.34 12.85 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.769 0.828 . . . . 73.310000000000002 109.483 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 13.9 pt-20 -116.25 163.06 16.54 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.642 -0.873 . . . . 74.400000000000006 108.642 160.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.5 m -88.58 134.85 33.75 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.155 0.582 . . . . 62.299999999999997 110.141 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.418 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 27.9 mt-10 -78.68 -26.27 44.95 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.115 0.966 . . . . 75.420000000000002 109.224 174.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.1 p -70.61 -37.24 73.81 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.619 -1.173 . . . . 54.229999999999997 110.584 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.9 m -140.48 94.38 8.45 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.056 0.942 . . . . 74.150000000000006 109.433 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.34 135.25 52.85 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.969 2.446 . . . . 70.219999999999999 111.501 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 91.33 -23.51 24.3 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 115.97 -0.559 . . . . 64.200000000000003 113.46 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -82.83 115.62 21.8 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.727 -1.212 . . . . 73.430000000000007 107.727 172.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 82.9 mtt-85 -112.31 159.87 18.23 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.066 0.546 . . . . 74.530000000000001 109.698 -171.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.9 t -152.44 146.67 25.48 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 122.837 0.455 . . . . 72.239999999999995 110.775 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 170' ' ' VAL . 52.9 mt -113.94 150.9 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.112 0.965 . . . . 73.049999999999997 108.476 173.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.2 m -132.36 128.42 37.61 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.721 -0.844 . . . . 75.540000000000006 108.721 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.462 HD21 HD23 ' A' ' 232' ' ' LEU . 38.8 mt -110.66 147.44 34.31 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.328 1.451 . . . . 75.129999999999995 111.382 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -133.5 130.88 39.15 Favored 'General case' 0 C--O 1.253 1.255 0 C-N-CA 124.429 1.092 . . . . 64.209999999999994 108.434 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.736 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 3.7 p90 -154.66 143.55 20.92 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 124.146 0.904 . . . . 73.230000000000004 108.646 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 58.13 19.28 5.94 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 124.389 1.075 . . . . 71.319999999999993 112.941 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 76.65 30.06 56.83 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.984 -0.553 . . . . 61.240000000000002 112.663 -175.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -128.52 123.24 33.03 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.115 0.966 . . . . 52.539999999999999 108.569 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.452 HG13 HD23 ' A' ' 160' ' ' LEU . 48.8 t -104.13 138.2 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.257 1.023 . . . . 63.140000000000001 109.79 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.467 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 28.7 p90 -143.15 157.94 44.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.939 0.895 . . . . 54.210000000000001 109.215 171.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -128.09 144.16 51.1 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.125 -1.065 . . . . 73.010000000000005 108.125 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -145.67 147.57 32.13 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.062 0.458 . . . . 73.409999999999997 110.644 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 20.9 tpp180 -82.35 133.43 35.23 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.056 -0.975 . . . . 73.25 110.431 -174.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 93.5 mt -75.1 102.68 2.51 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 N-CA-C 106.979 -1.489 . . . . 73.310000000000002 106.979 165.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -68.15 111.62 4.61 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.531 -1.213 . . . . 71.420000000000002 108.063 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 37.7 m -97.28 113.45 25.07 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.873 -0.603 . . . . 62.530000000000001 109.527 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.1 160.03 10.81 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.197 0.999 . . . . 71.420000000000002 111.862 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.3 m -62.09 -23.62 66.63 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.2 -0.909 . . . . 72.200000000000003 111.47 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.405 ' HB2' ' HE2' ' A' ' 202' ' ' LYS . 15.7 m-20 -87.28 3.56 46.26 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.182 0.993 . . . . 74.409999999999997 111.104 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 83.83 -1.76 88.34 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 122.933 0.302 . . . . 61.43 113.35 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' A' ' 200' ' ' ASP . 54.1 mtmt -77.19 131.19 38.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.518 0.727 . . . . 74.349999999999994 110.274 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.72 147.45 22.98 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.836 -0.802 . . . . 54.549999999999997 108.836 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -166.14 176.24 7.81 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.406 0.682 . . . . 75.349999999999994 110.143 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 75.7 t -140.38 -50.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 107.004 -1.48 . . . . 51.43 107.004 172.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 22.0 m -74.83 145.99 42.37 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.347 -0.842 . . . . 74.25 109.933 171.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.8 m -70.83 -26.15 63.16 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.521 0.728 . . . . 73.549999999999997 110.922 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -71.85 -41.75 67.72 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.319 -0.623 . . . . 55.539999999999999 109.319 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 m -91.67 135.13 34.11 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.284 -0.871 . . . . 61.210000000000001 110.865 -165.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -137.26 118.38 14.43 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 107.956 -1.128 . . . . 71.239999999999995 107.956 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 9.0 m-85 -120.85 142.88 49.24 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 109.484 -0.561 . . . . 71.099999999999994 109.484 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -89.46 -24.18 21.91 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.778 -0.453 . . . . 73.019999999999996 109.778 171.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.8 p -124.53 144.81 49.91 Favored 'General case' 0 C--O 1.253 1.246 0 CA-C-O 121.87 0.843 . . . . 72.540000000000006 111.696 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 18.1 tp -69.57 -29.18 66.68 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 113.992 -1.458 . . . . 74.129999999999995 110.961 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.86 -37.12 85.33 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.324 0.649 . . . . 61.039999999999999 111.373 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -76.48 -31.93 58.06 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.884 0.474 . . . . 74.439999999999998 111.344 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.45 -45.88 90.34 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 110.118 -0.327 . . . . 74.209999999999994 110.118 170.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.9 t -70.8 -40.51 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.094 0.958 . . . . 74.239999999999995 110.971 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -59.74 -53.94 52.13 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.7 0.8 . . . . 64.420000000000002 109.583 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.407 ' O ' HG22 ' A' ' 224' ' ' VAL . 54.2 t-80 -53.69 -54.24 40.64 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.966 -1.015 . . . . 65.430000000000007 109.349 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -61.39 -26.33 67.77 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.609 -0.723 . . . . 72.409999999999997 112.286 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 32.4 t -75.17 -28.24 59.98 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 122.756 0.422 . . . . 61.030000000000001 111.236 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 15.4 t -117.56 1.43 12.27 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 116.094 1.887 . . . . 74.120000000000005 116.094 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.429 ' O ' HG22 ' A' ' 231' ' ' THR . 35.8 m -107.14 144.27 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.524 0 CA-C-N 121.465 1.938 . . . . 72.420000000000002 116.19 -175.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -82.11 -2.65 52.7 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 129.07 2.948 . . . . 73.010000000000005 112.187 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -79.34 14.25 1.62 Allowed 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 129.202 3.001 . . . . 53.299999999999997 113.354 -140.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.63 18.16 4.09 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 110.947 -0.861 . . . . 44.420000000000002 110.947 -169.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 86.0 mt -93.63 132.94 37.47 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.993 0.917 . . . . 62.240000000000002 109.951 160.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.467 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 85.3 mt -60.42 -60.06 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 108.749 -0.834 . . . . 75.109999999999999 108.749 170.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.5 t -119.65 141.63 49.17 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.149 -0.932 . . . . 72.409999999999997 108.668 173.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 224' ' ' VAL . 82.1 p -73.19 158.84 34.47 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 108.834 -0.802 . . . . 72.420000000000002 108.834 170.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.488 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 26.2 mt -69.47 99.54 1.26 Allowed 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 108.828 -0.805 . . . . 73.409999999999997 108.828 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -77.9 -45.76 23.22 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.28 0.632 . . . . 65.420000000000002 110.056 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 167' ' ' SER . 12.9 p90 -164.01 153.1 11.91 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 109.541 -0.54 . . . . 61.140000000000001 109.541 172.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.22 139.04 14.6 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 121.698 1.599 . . . . 61.229999999999997 112.273 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.98 118.17 39.93 Favored Pre-proline 0 C--N 1.352 0.689 0 N-CA-C 108.155 -1.054 . . . . 51.450000000000003 108.155 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -66.07 142.1 66.6 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.131 1.887 . . . . 51.310000000000002 112.188 -169.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt . . . . . 0 N--CA 1.477 0.901 0 C-N-CA 123.842 0.857 . . . . 72.219999999999999 110.745 176.333 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.8 m . . . . . 0 C--O 1.247 0.948 0 CA-C-O 121.308 0.575 . . . . 63.109999999999999 111.0 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.1 mt -103.45 125.26 35.43 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 107.88 -1.155 . . . . 62.439999999999998 107.88 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 67.0 Cg_endo -72.08 176.61 8.21 Favored 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 123.114 2.543 . . . . 74.530000000000001 112.437 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.08 141.69 38.64 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 116.395 -0.366 . . . . 71.230000000000004 111.073 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.57 ' HB3' HD11 ' A' ' 23' ' ' ILE . 66.7 mt -87.93 91.49 8.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.109 -0.7 . . . . 65.230000000000004 109.109 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -97.0 -48.49 5.39 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.676 0.79 . . . . 74.540000000000006 110.22 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -100.75 109.46 21.47 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.857 -1.065 . . . . 73.0 108.732 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.57 HD11 ' HB3' ' A' ' 20' ' ' LEU . 48.3 mm -118.69 119.35 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.697 0.799 . . . . 73.409999999999997 109.325 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.578 ' H ' ' HE1' ' A' ' 129' ' ' TRP . 75.0 mmtt . . . . . 0 C--O 1.241 0.633 0 N-CA-C 108.634 -0.876 . . . . 72.239999999999995 108.634 169.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo . . . . . 0 N--CA 1.493 1.473 0 N-CA-C 114.104 0.771 . . . . 62.409999999999997 114.104 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -92.35 41.96 1.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.531 0.732 . . . . 74.310000000000002 111.098 -174.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.1 tp -91.58 112.36 24.24 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.445 -0.798 . . . . 71.209999999999994 110.308 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -107.43 176.28 5.21 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.65 1.58 . . . . 63.100000000000001 109.549 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 9.9 p -147.73 149.34 15.5 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 C-N-CA 123.014 0.526 . . . . 73.409999999999997 109.868 171.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.58 113.66 20.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.624 0.77 . . . . 72.329999999999998 109.345 171.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.65 -12.59 53.62 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.058 0.543 . . . . 73.239999999999995 110.568 174.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -135.01 146.49 49.08 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.33 0.652 . . . . 70.430000000000007 110.091 -173.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -60.28 137.73 58.07 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.138 -0.937 . . . . 61.240000000000002 110.439 168.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -152.27 116.24 4.89 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.923 -0.399 . . . . 73.040000000000006 109.923 174.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.94 139.03 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 108.002 -1.11 . . . . 64.519999999999996 108.002 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.79 116.13 8.12 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 110.07 -0.345 . . . . 62.210000000000001 110.07 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.1 m -74.99 -17.66 60.5 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.313 0.645 . . . . 75.099999999999994 110.743 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -156.3 -177.54 29.57 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.611 -0.722 . . . . 42.329999999999998 111.747 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -73.57 -27.55 61.38 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.331 0.652 . . . . 71.519999999999996 110.575 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.431 HD21 HD13 ' A' ' 20' ' ' LEU . 25.2 p-10 -69.7 -23.64 63.46 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.863 0.865 . . . . 74.109999999999999 111.922 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.4 p -99.83 157.14 16.72 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.284 0.634 . . . . 61.549999999999997 110.754 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.5 tp -110.32 117.16 32.88 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.531 0.733 . . . . 75.0 109.87 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -66.89 117.59 9.2 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.031 -0.729 . . . . 63.140000000000001 109.031 172.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.4 pt -122.39 130.76 74.28 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 N-CA-C 109.244 -0.65 . . . . 52.229999999999997 109.244 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.0 m -90.53 141.26 28.94 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.503 -0.554 . . . . 72.439999999999998 109.503 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -57.51 116.64 3.49 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.012 0.525 . . . . 60.100000000000001 110.794 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.16 -20.13 21.81 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 115.417 -0.81 . . . . 63.439999999999998 112.38 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -72.55 128.54 35.9 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.017 -0.735 . . . . 71.319999999999993 109.017 176.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 54.5 mtmt -84.0 126.99 33.56 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.165 0.507 . . . . 72.140000000000001 109.909 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.41 ' HA ' HG22 ' A' ' 123' ' ' THR . 14.5 mt -102.1 166.76 10.43 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.981 -1.008 . . . . 73.430000000000007 108.592 -169.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -128.34 107.4 9.73 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.728 -1.212 . . . . 71.310000000000002 107.728 168.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 98.3 t -96.46 116.52 38.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.625 -0.88 . . . . 43.109999999999999 108.625 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.423 HD12 ' NE2' ' A' ' 127' ' ' GLN . 47.5 mt -78.46 -25.42 45.85 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.065 -0.971 . . . . 52.030000000000001 110.116 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.03 161.02 25.9 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.458 -0.792 . . . . 74.219999999999999 111.421 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 3.8 m-30 -95.4 171.84 8.45 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.473 0.654 . . . . 73.219999999999999 109.424 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -66.84 144.87 56.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.668 1.187 . . . . 71.430000000000007 107.979 164.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -60.89 -38.09 84.47 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.43 0.692 . . . . 73.340000000000003 112.158 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -79.35 -11.94 59.93 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.75 0.82 . . . . 52.409999999999997 110.98 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.35 23.17 48.92 Favored Glycine 0 C--N 1.349 1.281 0 C-N-CA 123.529 0.585 . . . . 72.019999999999996 113.281 177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . 46.5 mt-10 -78.28 -72.21 0.38 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.722 0.772 . . . . 64.109999999999999 110.729 -177.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -104.33 -177.43 3.36 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.534 1.133 . . . . 73.150000000000006 109.439 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -149.23 126.82 11.65 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.338 0.655 . . . . 63.329999999999998 110.07 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -71.03 94.26 1.08 Allowed 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.078 -0.712 . . . . 72.239999999999995 109.078 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -104.88 162.57 13.21 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 124.005 0.922 . . . . 72.109999999999999 110.402 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -144.06 133.72 23.63 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.555 0.742 . . . . 64.409999999999997 109.241 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 107' ' ' LEU . 62.9 p -139.67 -171.37 3.13 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.556 1.143 . . . . 75.439999999999998 110.454 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -61.6 -19.77 62.59 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.382 -0.827 . . . . 72.120000000000005 111.196 170.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -85.69 1.93 47.36 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.882 0.873 . . . . 73.420000000000002 111.353 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.5 -130.4 9.54 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.619 -0.593 . . . . 61.409999999999997 111.619 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.423 ' NE2' HD12 ' A' ' 110' ' ' LEU . 57.2 tt0 -145.76 154.38 41.98 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.458 0.703 . . . . 74.219999999999999 109.837 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 166.54 -178.89 40.78 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 112.685 -0.166 . . . . 74.420000000000002 112.685 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.578 ' HE1' ' H ' ' A' ' 24' ' ' LYS . 86.4 m95 -89.85 127.07 35.92 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.767 0.827 . . . . 73.420000000000002 110.688 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.6 m -125.34 146.19 53.4 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.797 1.239 . . . . 54.229999999999997 108.68 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.41 141.5 42.73 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 121.937 1.758 . . . . 72.519999999999996 111.616 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.6 m -60.64 -19.94 59.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.931 0.892 . . . . 75.340000000000003 112.108 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -72.27 -27.49 62.52 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.503 0.721 . . . . 53.229999999999997 111.705 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -88.85 -11.75 43.85 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.661 0.784 . . . . 73.409999999999997 112.073 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.483 HD12 HG21 ' A' ' 109' ' ' VAL . 18.2 pt -122.64 161.43 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.002 0.521 . . . . 72.409999999999997 110.928 -170.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.0 t -155.9 143.05 13.7 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 122.727 0.411 . . . . 65.409999999999997 110.291 168.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.548 ' HB2' ' HB2' ' A' ' 140' ' ' SER . 5.7 Cg_exo -75.63 126.45 9.57 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.579 2.186 . . . . 52.219999999999999 111.217 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.0 m -94.28 -51.26 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 111.945 0.35 . . . . 53.109999999999999 111.945 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -92.52 18.91 7.88 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.175 0.512 . . . . 74.239999999999995 111.305 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.548 ' HB2' ' HB2' ' A' ' 137' ' ' PRO . 22.7 t -64.45 177.51 0.87 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.818 0.847 . . . . 32.329999999999998 112.691 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 49.5 mt -65.31 -13.49 58.59 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.055 1.342 . . . . 52.200000000000003 111.98 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 42.6 tt0 -63.87 -8.9 12.4 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.856 0.863 . . . . 74.420000000000002 111.491 174.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -55.16 -23.76 23.05 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.921 1.289 . . . . 72.140000000000001 110.515 167.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -99.36 143.64 29.38 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.974 0.909 . . . . 74.019999999999996 109.824 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.0 p -66.25 -15.41 63.17 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.369 0.668 . . . . 71.420000000000002 112.771 -175.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.409 ' CZ3' ' HB2' ' A' ' 147' ' ' TYR . 44.3 p-90 -80.29 -38.16 31.33 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 112.592 0.59 . . . . 74.219999999999999 112.592 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.409 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 28.8 t80 -91.67 140.47 29.69 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.81 -0.441 . . . . 71.549999999999997 109.81 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.489 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 63.3 m-70 -137.97 29.55 2.54 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.136 0.421 . . . . 70.140000000000001 112.136 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.63 -170.88 54.49 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 115.652 1.021 . . . . 51.020000000000003 115.652 165.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.04 102.77 1.49 Allowed 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.276 2.651 . . . . 61.43 111.341 172.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.414 HG21 ' NH2' ' A' ' 171' ' ' ARG . 60.4 t -140.02 156.9 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.458 0.703 . . . . 71.329999999999998 110.023 -175.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.6 t -61.62 145.15 53.09 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.965 1.306 . . . . 41.409999999999997 112.717 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -55.19 -32.87 62.54 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.506 -1.225 . . . . 72.510000000000005 112.019 171.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -66.3 -52.08 50.95 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.442 0.697 . . . . 65.209999999999994 110.553 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.84 75.69 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.228 0.611 . . . . 61.539999999999999 111.262 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.557 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.28 -53.44 58.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.141 -0.936 . . . . 72.019999999999996 110.416 173.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.575 ' HG3' HG11 ' A' ' 190' ' ' VAL . 34.6 tt0 -68.67 -27.46 66.0 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.661 -0.699 . . . . 64.439999999999998 111.079 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -67.62 -45.99 73.79 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.877 0.471 . . . . 72.409999999999997 111.45 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.2 mt -67.76 -38.4 83.39 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 110.146 -0.316 . . . . 64.430000000000007 110.146 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 183' ' ' SER . 29.3 tp -68.15 -21.29 64.92 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.292 0.637 . . . . 73.230000000000004 111.658 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.464 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 33.2 t -64.93 -24.35 67.5 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.505 0.722 . . . . 72.450000000000003 110.603 176.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.8 t -85.62 -2.54 58.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.903 0.881 . . . . 54.420000000000002 111.604 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -86.2 170.91 43.61 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 114.073 0.389 . . . . 61.420000000000002 114.073 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.4 pt -132.31 -165.05 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 124.568 1.147 . . . . 64.129999999999995 111.023 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.666 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 14.3 p-10 -58.09 102.81 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.03 0.932 . . . . 65.109999999999999 113.362 -172.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 104.06 11.79 31.19 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 115.977 -0.556 . . . . 54.119999999999997 112.776 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 23.0 t -75.76 142.35 42.38 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 109.853 -0.425 . . . . 42.25 109.853 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 235' ' ' PRO . 14.9 p90 -144.07 161.47 38.71 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.84 0.682 . . . . 73.430000000000007 112.84 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' A' ' 236' ' ' ALA . 95.7 mt -142.45 135.51 28.53 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.489 1.116 . . . . 74.239999999999995 108.358 170.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.5 t -110.91 113.52 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.327 -1.36 . . . . 74.200000000000003 107.327 174.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.557 HH11 ' HA ' ' A' ' 156' ' ' ALA . 17.2 mtp180 -141.12 143.28 34.21 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 107.602 -1.258 . . . . 73.230000000000004 107.602 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.701 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 15.3 pt-20 -95.14 161.29 14.18 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.074 0.397 . . . . 60.399999999999999 110.506 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 37.4 m -82.81 134.47 35.11 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 116.308 -0.406 . . . . 74.040000000000006 110.284 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -70.16 -41.67 73.53 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.214 1.006 . . . . 73.120000000000005 109.975 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 72.0 p -84.26 -9.17 58.72 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.366 1.066 . . . . 71.510000000000005 111.864 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.2 m -141.64 67.45 24.07 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.499 1.12 . . . . 75.409999999999997 108.812 173.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.71 149.11 42.71 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.655 2.237 . . . . 63.32 112.817 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.66 -26.01 6.17 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 114.665 -1.152 . . . . 74.329999999999998 112.049 -168.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -90.84 119.17 30.83 Favored 'General case' 0 C--O 1.259 1.574 0 N-CA-C 108.151 -1.055 . . . . 63.520000000000003 108.151 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.701 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 26.0 mtt85 -105.95 170.24 8.02 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.36 -0.836 . . . . 72.120000000000005 110.77 -173.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.8 m -144.11 144.14 31.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.699 0.8 . . . . 75.450000000000003 110.22 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 56.7 mt -112.91 139.25 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.18 -1.045 . . . . 71.230000000000004 108.18 168.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.575 ' HB3' HD22 ' A' ' 160' ' ' LEU . 23.6 m -116.04 115.09 25.5 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 124.661 1.184 . . . . 55.100000000000001 107.981 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.462 HD21 HD23 ' A' ' 232' ' ' LEU . 57.2 mt -104.77 142.99 33.73 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.474 0.71 . . . . 71.209999999999994 111.088 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.464 ' NH1' ' HA ' ' A' ' 161' ' ' SER . 20.3 ttt180 -131.99 126.55 34.25 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.61 -1.177 . . . . 72.230000000000004 108.773 170.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -150.21 141.46 23.19 Favored 'General case' 0 C--O 1.211 -0.945 0 N-CA-C 107.154 -1.424 . . . . 74.510000000000005 107.154 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 54.29 18.61 1.91 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 125.759 1.624 . . . . 74.519999999999996 113.442 -174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.49 14.01 80.74 Favored Glycine 0 N--CA 1.475 1.294 0 O-C-N 122.284 -0.26 . . . . 45.100000000000001 113.049 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -103.21 127.73 50.42 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 125.4 1.48 . . . . 73.340000000000003 108.763 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.575 HG11 ' HG3' ' A' ' 157' ' ' GLU . 86.2 t -107.79 116.82 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.887 0.875 . . . . 73.129999999999995 110.304 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -139.55 141.13 37.26 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.44 1.096 . . . . 65.040000000000006 109.275 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -124.57 151.19 45.07 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.139 0.975 . . . . 73.349999999999994 108.963 -170.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -142.94 141.49 31.47 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.213 0.53 . . . . 70.109999999999999 110.752 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -77.68 131.28 37.65 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.815 -1.084 . . . . 71.319999999999993 110.828 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 80.4 mt -75.2 108.52 7.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 107.48 -1.304 . . . . 71.349999999999994 107.48 165.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -73.17 106.76 5.15 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.799 -1.185 . . . . 75.349999999999994 107.799 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . 0.511 HG23 HD23 ' A' ' 203' ' ' LEU . 30.9 m -92.37 121.65 34.06 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.255 0.622 . . . . 74.140000000000001 109.717 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.21 153.52 34.28 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.454 0.702 . . . . 72.430000000000007 110.236 172.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 51.3 p -61.37 -22.36 64.88 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.405 0.682 . . . . 61.310000000000002 112.005 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.401 ' HB2' ' HE2' ' A' ' 202' ' ' LYS . 67.8 m-20 -71.54 -14.99 62.27 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.883 1.273 . . . . 75.0 112.373 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 101.77 -2.68 52.56 Favored Glycine 0 C--N 1.348 1.223 0 C-N-CA 122.901 0.286 . . . . 63.140000000000001 112.671 -176.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 200' ' ' ASP . 48.5 mtmt -82.65 156.07 24.05 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.652 0.781 . . . . 70.409999999999997 109.79 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.511 HD23 HG23 ' A' ' 197' ' ' THR . 79.0 mt -113.69 151.2 32.18 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.581 0.752 . . . . 75.329999999999998 110.73 -171.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -163.78 171.97 14.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.888 0.875 . . . . 62.520000000000003 110.413 170.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.3 t -131.46 -56.34 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.414 -1.328 . . . . 72.340000000000003 107.414 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 8.9 m -76.25 153.12 36.27 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.508 -0.769 . . . . 62.140000000000001 108.932 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.9 m -61.32 -36.82 81.19 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.131 0.573 . . . . 72.299999999999997 111.067 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -82.67 -20.67 35.75 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.451 0.7 . . . . 71.200000000000003 111.461 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 68.7 m -63.49 135.91 57.21 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 122.707 0.403 . . . . 52.219999999999999 110.764 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -141.13 108.52 5.55 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.368 -0.975 . . . . 71.319999999999993 108.368 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -121.39 135.76 55.04 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.285 -0.635 . . . . 74.430000000000007 109.285 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -84.25 -30.5 25.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.956 0.502 . . . . 72.530000000000001 110.04 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 216' ' ' GLU . 81.5 p -132.36 161.49 33.45 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-O 122.209 1.004 . . . . 75.420000000000002 111.609 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 37.6 tp -71.24 -24.5 62.2 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 114.159 -1.382 . . . . 42.039999999999999 110.992 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.18 -42.03 89.45 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.434 0.693 . . . . 71.129999999999995 109.93 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.4 ' HG2' ' OG1' ' A' ' 213' ' ' THR . 31.7 mm-40 -65.02 -43.8 91.24 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.341 -0.845 . . . . 71.310000000000002 109.637 174.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.22 -46.25 86.23 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 124.077 0.861 . . . . 71.010000000000005 111.686 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 42.2 t -74.41 -40.55 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.084 0.553 . . . . 74.450000000000003 111.236 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -62.59 -47.07 85.4 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.107 0.479 . . . . 74.230000000000004 110.591 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.428 ' O ' HG22 ' A' ' 224' ' ' VAL . 52.9 t-80 -54.98 -54.46 42.6 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.066 -0.97 . . . . 70.439999999999998 109.961 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.485 ' HD2' HD21 ' A' ' 228' ' ' LEU . 40.3 m80 -65.85 -23.86 66.76 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.676 -0.693 . . . . 63.25 111.65 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 44.2 t -74.4 -24.44 59.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.019 0.528 . . . . 61.32 111.298 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.7 t -110.44 -21.73 12.03 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 116.336 1.976 . . . . 72.310000000000002 116.336 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 220' ' ' HIS . 26.9 m -93.84 157.35 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 115.435 1.643 . . . . 61.219999999999999 115.435 -164.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.16 -1.44 57.73 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.378 2.671 . . . . 73.349999999999994 112.666 -175.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -78.92 15.86 1.01 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 128.357 2.663 . . . . 70.150000000000006 113.751 -140.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.93 18.11 4.4 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 124.819 1.2 . . . . 54.530000000000001 110.529 -170.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.485 HD21 ' HD2' ' A' ' 221' ' ' HIS . 95.2 mt -93.19 126.73 38.45 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.989 1.315 . . . . 65.239999999999995 109.713 164.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 81.0 mt -67.01 -39.9 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 109.21 -0.663 . . . . 71.329999999999998 109.21 173.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.8 t -133.28 141.98 48.26 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 115.08 -0.964 . . . . 71.310000000000002 108.803 168.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 65.1 p -66.3 151.84 46.21 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 108.791 -0.818 . . . . 71.099999999999994 108.791 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.462 HD23 HD21 ' A' ' 184' ' ' LEU . 28.5 mt -62.11 102.69 0.31 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 108.126 -1.064 . . . . 73.310000000000002 108.126 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -89.43 -58.18 2.62 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.818 -0.808 . . . . 74.099999999999994 108.818 -173.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.583 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -151.95 141.34 14.24 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 123.058 0.543 . . . . 75.230000000000004 111.82 -178.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 65.5 Cg_endo -71.76 156.76 56.66 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 121.494 1.463 . . . . 71.239999999999995 112.45 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.474 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -70.72 133.31 86.62 Favored Pre-proline 0 C--O 1.244 0.81 0 CA-C-N 115.935 -0.575 . . . . 63.039999999999999 109.752 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 236' ' ' ALA . 31.3 Cg_exo -61.45 132.1 39.24 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.22 2.614 . . . . 60.140000000000001 113.602 -175.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt . . . . . 0 N--CA 1.476 0.85 0 C-N-CA 123.761 0.825 . . . . 65.349999999999994 110.829 171.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.7 p . . . . . 0 C--O 1.244 0.802 0 CA-C-O 121.169 0.509 . . . . 73.109999999999999 111.006 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.6 mt -108.31 130.62 22.53 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 109.064 -0.717 . . . . 74.409999999999997 109.064 -176.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.27 172.7 9.7 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.301 2.001 . . . . 74.530000000000001 111.206 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.86 144.45 36.97 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 122.329 -0.232 . . . . 62.420000000000002 110.439 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.629 ' HB3' HD11 ' A' ' 23' ' ' ILE . 72.6 mt -84.84 92.38 8.25 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.486 -0.931 . . . . 62.43 108.486 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -96.27 -49.07 5.36 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.203 -0.908 . . . . 74.430000000000007 109.379 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -103.2 110.96 23.11 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.561 -1.2 . . . . 63.25 109.228 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 20' ' ' LEU . 37.2 mm -116.99 113.01 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.954 0.902 . . . . 64.439999999999998 109.491 -177.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.681 ' HA ' ' HE1' ' A' ' 129' ' ' TRP . 2.2 tppp? . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 125.166 1.386 . . . . 73.25 112.739 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo . . . . . 0 CA--C 1.555 1.539 0 N-CA-C 112.817 0.276 . . . . 72.019999999999996 112.817 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -88.61 38.14 0.86 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.464 1.105 . . . . 75.430000000000007 110.738 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.587 HD21 ' HD2' ' A' ' 106' ' ' LYS . 20.8 tp -89.53 113.63 25.06 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-N 115.378 -0.828 . . . . 71.129999999999995 110.184 -173.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 3.0 m-85 -103.83 176.56 5.11 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.877 1.271 . . . . 72.099999999999994 108.78 174.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.1 p -141.58 148.46 20.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 108.624 -0.88 . . . . 65.510000000000005 108.624 170.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.88 127.96 33.14 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.162 0.585 . . . . 74.439999999999998 109.55 173.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.25 -22.78 24.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.45 1.1 . . . . 71.040000000000006 111.067 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -136.79 160.25 39.41 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.377 0.671 . . . . 74.409999999999997 109.924 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -81.53 123.09 28.34 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.415 -0.957 . . . . 72.439999999999998 108.415 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.441 ' HB3' HG12 ' A' ' 101' ' ' ILE . 91.8 t80 -125.8 116.68 21.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.417 -0.957 . . . . 72.430000000000007 108.417 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.6 p -80.67 139.03 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.072 0.549 . . . . 74.239999999999995 110.211 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.06 132.27 42.15 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.934 0.494 . . . . 45.149999999999999 110.917 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 t -74.36 -27.53 60.71 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.377 0.671 . . . . 50.219999999999999 109.737 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.48 -144.51 7.25 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.516 -0.634 . . . . 73.150000000000006 111.516 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -71.24 -24.23 62.15 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.692 0.797 . . . . 72.530000000000001 110.952 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.424 ' HB2' HD12 ' A' ' 23' ' ' ILE . 27.4 p-10 -67.93 -22.61 65.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.04 0.936 . . . . 75.409999999999997 111.238 -177.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.5 p -129.87 158.54 39.21 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.298 1.039 . . . . 62.229999999999997 110.226 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.2 tp -110.08 136.46 49.29 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.131 -0.692 . . . . 74.129999999999995 109.131 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.4 t -81.73 112.9 19.32 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 107.503 -1.295 . . . . 50.530000000000001 107.503 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.441 HG12 ' HB3' ' A' ' 91' ' ' PHE . 37.1 pt -119.95 157.8 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.569 0.748 . . . . 71.209999999999994 109.452 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.5 m -131.32 143.84 50.82 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.545 -0.539 . . . . 63.210000000000001 109.545 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -52.07 123.84 11.47 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.778 0.831 . . . . 64.310000000000002 111.533 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.92 -22.69 34.5 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.054 -0.521 . . . . 62.32 112.935 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -76.9 132.33 39.05 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 117.119 0.46 . . . . 31.129999999999999 110.26 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.587 ' HD2' HD21 ' A' ' 84' ' ' LEU . 41.2 mtmt -82.25 127.9 33.65 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 124.11 0.881 . . . . 61.240000000000002 109.661 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.9 mt -108.21 130.98 55.12 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.829 0.852 . . . . 74.400000000000006 109.241 -171.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -91.82 106.23 18.31 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.777 -0.823 . . . . 72.230000000000004 108.777 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 89.7 t -96.89 117.03 40.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.871 -0.789 . . . . 75.209999999999994 108.871 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.4 mt -71.38 -27.46 63.35 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.328 0.651 . . . . 72.329999999999998 110.418 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.79 175.61 34.87 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.482 -0.781 . . . . 71.129999999999995 111.792 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.59 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 2.1 m-30 -95.2 171.17 8.89 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.006 -1.109 . . . . 74.010000000000005 108.006 173.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.525 HD21 ' HB2' ' A' ' 117' ' ' GLU . 32.0 p30 -76.05 178.58 6.22 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.923 -0.399 . . . . 73.430000000000007 109.923 172.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -65.03 -16.65 63.69 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.331 0.493 . . . . 72.230000000000004 112.331 -172.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -109.7 -8.27 14.97 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-O 120.859 0.361 . . . . 54.340000000000003 111.564 176.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 74.18 21.92 78.4 Favored Glycine 0 N--CA 1.469 0.838 0 N-CA-C 114.185 0.434 . . . . 73.019999999999996 114.185 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.525 ' HB2' HD21 ' A' ' 113' ' ' ASN . 25.5 mt-10 -74.67 -55.52 5.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.993 0.902 . . . . 71.420000000000002 110.118 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -118.72 133.01 56.16 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 113.998 -1.455 . . . . 73.420000000000002 108.513 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -110.97 127.52 55.53 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.917 1.287 . . . . 71.129999999999995 110.401 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -77.58 106.43 9.37 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.033 0.444 . . . . 71.519999999999996 110.325 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.48 163.48 12.83 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.336 -0.847 . . . . 74.019999999999996 110.61 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -142.78 131.53 22.7 Favored 'General case' 0 C--O 1.249 1.051 0 C-N-CA 124.24 1.016 . . . . 73.329999999999998 108.581 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 81.4 p -143.66 -167.86 2.69 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.697 1.199 . . . . 74.049999999999997 109.463 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -57.93 -18.79 25.49 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.671 1.188 . . . . 72.310000000000002 112.028 173.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -89.62 -6.51 56.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.598 1.159 . . . . 65.439999999999998 111.692 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.38 -141.85 16.86 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 111.392 -0.683 . . . . 64.209999999999994 111.392 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -142.77 138.92 30.79 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.421 0.688 . . . . 72.200000000000003 110.63 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 176.32 -177.02 47.91 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 111.622 -0.591 . . . . 44.25 111.622 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.681 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 33.9 m95 -100.4 136.91 39.55 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.349 0.66 . . . . 64.230000000000004 110.816 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.23 149.85 74.83 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.331 1.053 . . . . 73.439999999999998 109.27 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.95 137.02 33.94 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 121.74 1.627 . . . . 75.5 110.94 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.471 ' HA ' HG12 ' A' ' 135' ' ' ILE . 26.3 m -61.4 -17.1 52.55 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.729 0.812 . . . . 55.200000000000003 112.64 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -71.1 -26.75 63.17 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.024 0.93 . . . . 63.32 111.175 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -98.94 3.94 47.22 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.923 0.889 . . . . 73.099999999999994 111.658 -173.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 132' ' ' SER . 16.2 pt -130.63 157.62 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.779 0.432 . . . . 74.340000000000003 110.047 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.426 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 14.2 t -155.76 135.07 7.88 Favored Pre-proline 0 CA--C 1.555 1.159 0 O-C-N 123.349 0.406 . . . . 74.439999999999998 110.005 172.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 3.0 Cg_exo -74.94 117.03 4.77 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.955 2.437 . . . . 64.219999999999999 111.953 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.2 m -91.89 -34.37 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 122.988 0.515 . . . . 71.299999999999997 112.137 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -99.84 16.75 22.72 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.641 0.734 . . . . 64.310000000000002 110.077 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.1 t -92.74 -176.8 4.35 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.736 0.779 . . . . 62.229999999999997 110.649 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.428 HD13 HD23 ' A' ' 214' ' ' LEU . 51.7 mt -64.91 -12.59 50.96 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.441 1.496 . . . . 63.340000000000003 112.151 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -55.86 -23.36 30.45 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.65 1.18 . . . . 72.310000000000002 112.524 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -58.58 -19.66 40.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.538 0.735 . . . . 74.319999999999993 111.368 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -95.74 131.99 41.43 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.254 1.022 . . . . 73.349999999999994 108.332 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.2 m -70.8 -6.9 41.28 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.081 0.771 . . . . 71.430000000000007 113.081 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 33.4 p-90 -81.05 -27.6 35.69 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.258 0.223 . . . . 73.219999999999999 111.498 173.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -94.91 120.49 35.21 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.126 -0.694 . . . . 63.100000000000001 109.126 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -112.81 6.88 18.24 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 116.346 -0.388 . . . . 64.340000000000003 111.368 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 151' ' ' VAL . . . 70.73 -150.8 48.52 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 119.032 -0.871 . . . . 63.119999999999997 113.461 177.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.55 104.28 0.92 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.279 2.652 . . . . 73.129999999999995 111.6 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 149' ' ' GLY . 40.4 t -124.32 140.1 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 120.761 0.315 . . . . 63.420000000000002 110.838 -173.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.0 t -71.1 160.14 33.42 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.875 0.87 . . . . 74.400000000000006 111.088 172.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -62.91 -36.89 84.85 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.66 -0.7 . . . . 71.299999999999997 110.874 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -66.51 -51.62 54.7 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 123.714 0.634 . . . . 73.549999999999997 109.991 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.33 -42.27 81.57 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 124.002 0.814 . . . . 74.140000000000001 110.734 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.9 -59.63 4.77 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.694 -1.139 . . . . 60.030000000000001 111.257 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -67.11 -29.26 68.95 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 116.065 -0.516 . . . . 73.549999999999997 111.317 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -61.82 -53.78 51.25 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.453 0.701 . . . . 61.119999999999997 110.113 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.492 ' HB2' HD11 ' A' ' 169' ' ' LEU . 77.8 mt -67.35 -38.05 84.23 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.044 -0.526 . . . . 73.439999999999998 110.848 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.508 HD23 HG13 ' A' ' 190' ' ' VAL . 25.4 tp -71.22 -30.65 66.61 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.359 -0.837 . . . . 75.019999999999996 112.184 -172.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.4 m -68.35 -16.72 64.04 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.368 0.667 . . . . 72.340000000000003 111.963 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.3 m -82.23 3.86 25.78 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.703 0.801 . . . . 74.329999999999998 111.027 172.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -101.82 -178.89 28.04 Favored Glycine 0 C--N 1.344 0.978 0 C-N-CA 123.244 0.449 . . . . 70.329999999999998 113.228 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.4 pt -132.05 -163.89 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.508 1.123 . . . . 74.109999999999999 108.884 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.677 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 26.8 p-10 -50.75 112.09 0.65 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.452 0.701 . . . . 73.010000000000005 112.424 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 92.76 14.26 55.43 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.749 -0.659 . . . . 42.340000000000003 113.36 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 60.8 p -77.95 135.52 37.85 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.993 -0.743 . . . . 62.310000000000002 108.993 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.439 ' CE2' ' HB3' ' A' ' 232' ' ' LEU . 21.3 p90 -136.62 162.2 33.79 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.019 0.748 . . . . 62.439999999999998 113.019 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' A' ' 159' ' ' LEU . 84.3 mt -137.78 133.99 34.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.179 0.991 . . . . 72.010000000000005 108.582 169.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.93 118.27 56.13 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 107.698 -1.223 . . . . 72.530000000000001 107.698 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -128.99 165.6 20.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.899 -1.046 . . . . 72.5 108.988 -171.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 17.0 pt-20 -117.06 161.89 18.68 Favored 'General case' 0 C--O 1.261 1.674 0 N-CA-C 108.214 -1.032 . . . . 73.200000000000003 108.214 161.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.8 t -77.68 144.61 37.19 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.415 0.686 . . . . 71.230000000000004 110.263 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.417 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 29.3 mt-10 -71.03 -44.0 66.73 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.609 -1.178 . . . . 71.239999999999995 109.701 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 18.8 m -91.46 3.14 55.68 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.23 -0.896 . . . . 54.420000000000002 111.702 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.4 t -155.89 77.86 4.5 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 109.256 -0.646 . . . . 71.040000000000006 109.256 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.49 ' HG2' ' HB2' ' A' ' 112' ' ' TYR . 36.1 Cg_exo -62.18 138.16 70.6 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.173 2.582 . . . . 73.409999999999997 112.559 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.07 -24.34 27.19 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.808 -0.633 . . . . 62.299999999999997 112.335 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -88.9 118.58 28.71 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.428 -1.323 . . . . 74.540000000000006 107.428 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 82.0 mtt85 -115.7 165.4 13.09 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 123.067 0.547 . . . . 74.420000000000002 112.298 -165.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 40.3 t -151.91 136.98 17.34 Favored 'General case' 0 C--O 1.247 0.972 0 C-N-CA 124.478 1.111 . . . . 35.409999999999997 109.437 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 58.1 mt -105.43 141.92 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 109.016 -0.735 . . . . 64.439999999999998 109.016 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 12.9 m -117.94 115.73 25.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.575 1.15 . . . . 61.229999999999997 108.508 -177.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.427 HD21 ' CD2' ' A' ' 232' ' ' LEU . 58.6 mt -105.31 143.96 32.75 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.909 0.883 . . . . 73.030000000000001 111.219 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 46.3 ttt-85 -133.64 131.12 39.19 Favored 'General case' 0 C--O 1.26 1.621 0 CA-C-N 114.818 -1.083 . . . . 74.129999999999995 109.564 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.677 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 9.2 p90 -152.44 139.7 19.4 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 124.503 1.127 . . . . 75.140000000000001 108.733 173.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 56.73 24.86 9.5 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 124.766 1.226 . . . . 71.239999999999995 112.937 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.85 8.04 80.16 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 116.651 -0.249 . . . . 71.319999999999993 112.973 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 26.5 tpt180 -102.35 123.35 45.98 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.394 1.078 . . . . 71.439999999999998 109.359 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.508 HG13 HD23 ' A' ' 160' ' ' LEU . 77.1 t -110.76 128.49 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.723 1.209 . . . . 63.530000000000001 109.149 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.434 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 31.2 p90 -145.43 158.28 43.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.46 0.704 . . . . 71.030000000000001 109.135 173.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -130.9 141.53 50.3 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.509 -1.293 . . . . 73.230000000000004 107.509 -173.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -138.45 149.43 45.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.691 0.396 . . . . 74.209999999999994 110.002 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 13.3 tpp85 -84.38 137.2 33.53 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.262 -0.881 . . . . 75.519999999999996 111.088 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 65.0 mt -83.07 110.09 17.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 N-CA-C 108.321 -0.992 . . . . 70.349999999999994 108.321 166.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -68.04 119.43 12.65 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.341 1.056 . . . . 71.219999999999999 109.117 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.1 m -102.89 116.68 33.03 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.685 0.394 . . . . 65.420000000000002 109.971 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 202' ' ' LYS . . . -67.16 167.08 12.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.462 1.105 . . . . 64.120000000000005 111.986 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.2 m -61.71 -30.15 70.57 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.685 0.794 . . . . 74.409999999999997 110.883 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.403 ' HB2' ' HG3' ' A' ' 202' ' ' LYS . 29.0 m-20 -70.76 -12.66 61.68 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.705 1.202 . . . . 71.540000000000006 111.783 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 87.77 2.73 81.24 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 111.818 -0.513 . . . . 45.310000000000002 111.818 -169.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 198' ' ' ALA . 64.6 mttp -68.27 159.38 31.39 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 123.073 0.549 . . . . 62.450000000000003 110.111 175.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 79.6 mt -121.38 145.61 47.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.447 -0.945 . . . . 71.200000000000003 108.447 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -165.87 174.83 9.18 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.628 0.771 . . . . 72.219999999999999 110.018 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 78.2 t -138.47 -53.84 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 107.715 -1.217 . . . . 72.340000000000003 107.715 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 17.3 m -73.19 148.75 43.48 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.414 -0.812 . . . . 71.409999999999997 110.026 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.3 m -61.22 -42.2 98.19 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.239 1.016 . . . . 63.109999999999999 112.312 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -84.52 -36.52 22.14 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 122.742 0.417 . . . . 54.439999999999998 111.333 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.9 m -67.65 138.68 56.55 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.659 0.784 . . . . 75.019999999999996 111.665 -177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -142.37 119.85 11.68 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.555 1.142 . . . . 73.200000000000003 109.067 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -117.94 136.61 53.38 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 109.634 -0.506 . . . . 73.019999999999996 109.634 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -84.29 -26.25 28.71 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.347 0.659 . . . . 62.32 109.943 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 81.8 p -130.47 147.64 52.19 Favored 'General case' 0 C--O 1.256 1.411 0 CA-C-O 121.694 0.759 . . . . 73.239999999999995 111.115 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.428 HD23 HD13 ' A' ' 141' ' ' LEU . 35.2 tp -67.65 -29.27 68.53 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 114.529 -1.214 . . . . 72.040000000000006 111.08 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.74 92.02 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.609 0.363 . . . . 75.140000000000001 110.836 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -75.19 -32.38 61.22 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 116.522 -0.308 . . . . 54.439999999999998 110.763 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.53 -47.17 85.07 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 110.16 -0.311 . . . . 72.239999999999995 110.16 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 43.0 t -69.42 -44.65 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.061 0.945 . . . . 71.140000000000001 110.359 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -61.78 -45.43 93.92 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.249 0.547 . . . . 55.229999999999997 110.869 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.459 ' O ' HG22 ' A' ' 224' ' ' VAL . 49.7 t-80 -53.03 -54.48 34.77 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.843 -1.072 . . . . 74.430000000000007 108.727 175.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -61.99 -26.08 68.01 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.544 -0.753 . . . . 74.430000000000007 112.426 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 50.5 m -72.44 -30.15 64.34 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.8 0.44 . . . . 74.109999999999999 111.188 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -108.74 -17.04 14.04 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 115.578 1.696 . . . . 64.409999999999997 115.578 -176.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 220' ' ' HIS . 30.8 m -98.38 148.02 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 115.936 1.828 . . . . 72.340000000000003 115.936 -165.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -83.51 -2.44 55.95 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 129.337 3.055 . . . . 60.030000000000001 112.635 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -79.11 13.41 1.82 Allowed 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 129.252 3.021 . . . . 52.439999999999998 113.331 -138.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.76 16.19 4.18 Favored Glycine 0 N--CA 1.466 0.687 0 N-CA-C 110.091 -1.204 . . . . 63.109999999999999 110.091 -169.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 69.1 mt -90.72 135.05 33.97 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.83 0.852 . . . . 73.019999999999996 109.766 163.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.434 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 84.2 mt -67.66 -44.38 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.868 -0.79 . . . . 53.329999999999998 108.868 172.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.3 t -137.7 142.86 41.04 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.327 -0.851 . . . . 50.530000000000001 109.491 174.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 73.5 p -74.77 157.55 35.0 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.24 0.616 . . . . 62.420000000000002 109.565 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.439 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . 23.5 mt -70.85 101.74 2.2 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 109.567 -0.531 . . . . 61.140000000000001 109.567 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -79.0 -49.7 12.29 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.46 0.704 . . . . 62.049999999999997 110.224 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 167' ' ' SER . 4.3 p90 -164.76 152.72 10.45 Favored Pre-proline 0 N--CA 1.494 1.741 0 CA-C-O 119.61 -0.233 . . . . 70.150000000000006 110.511 173.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.18 146.63 32.25 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 121.936 1.757 . . . . 74.540000000000006 112.505 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -76.25 144.91 75.66 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.242 0.617 . . . . 61.240000000000002 109.409 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -84.7 170.34 10.2 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.548 2.165 . . . . 71.430000000000007 113.733 -171.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? . . . . . 0 N--CA 1.48 1.026 0 C-N-CA 124.254 1.022 . . . . 72.129999999999995 109.204 169.443 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.548 0.88 0 CA-C-O 121.201 0.524 . . . . 75.140000000000001 111.936 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.4 mt -102.66 127.22 30.73 Favored Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 108.764 -0.828 . . . . 54.340000000000003 108.764 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.13 171.16 17.35 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.187 1.925 . . . . 71.400000000000006 111.31 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.68 146.87 27.99 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 122.409 0.283 . . . . 73.329999999999998 110.642 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.531 ' HB3' HD11 ' A' ' 23' ' ' ILE . 70.5 mt -85.54 92.51 8.55 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 107.89 -1.152 . . . . 74.209999999999994 107.89 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -97.71 -48.42 5.23 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.725 -0.472 . . . . 75.340000000000003 109.725 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -101.56 114.18 27.97 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.354 -0.839 . . . . 71.310000000000002 109.451 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 20' ' ' LEU . 41.8 mm -117.65 113.62 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.588 -0.893 . . . . 63.310000000000002 108.588 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.553 ' HB3' ' HZ2' ' A' ' 129' ' ' TRP . 49.0 tttm . . . . . 0 C--O 1.243 0.747 0 CA-C-N 114.881 -1.054 . . . . 54.130000000000003 109.453 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 N--CA 1.488 1.173 0 CA-C-O 121.059 0.358 . . . . 74.450000000000003 111.786 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -82.36 27.01 0.52 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.415 1.086 . . . . 72.109999999999999 111.182 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 28.3 tp -86.09 116.24 24.18 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.391 0.676 . . . . 71.219999999999999 109.702 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 3.6 m-85 -104.62 177.18 4.92 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.816 1.646 . . . . 73.450000000000003 109.202 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.8 p -140.82 142.85 29.59 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 108.277 -1.008 . . . . 74.219999999999999 108.277 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.99 116.62 16.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.997 0.519 . . . . 74.239999999999995 109.825 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.52 -24.11 50.08 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.859 0.864 . . . . 73.450000000000003 110.689 172.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -130.83 158.75 39.33 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.983 0.513 . . . . 71.209999999999994 110.17 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.02 151.64 37.11 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.911 -0.586 . . . . 72.209999999999994 109.459 172.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.531 ' HB3' HG12 ' A' ' 101' ' ' ILE . 81.1 t80 -155.8 116.58 3.82 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.298 -0.63 . . . . 74.230000000000004 109.298 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.56 138.78 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 108.988 -0.745 . . . . 73.239999999999995 108.988 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.408 ' HB2' ' N ' ' A' ' 100' ' ' SER . . . -75.53 129.51 37.36 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 122.178 -0.326 . . . . 63.020000000000003 110.862 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 m -66.07 -23.95 66.62 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.385 0.674 . . . . 75.319999999999993 110.607 173.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.96 -153.33 12.93 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.42 -0.809 . . . . 73.549999999999997 111.261 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.6 -26.14 60.66 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.219 0.608 . . . . 74.510000000000005 110.58 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -69.73 -21.68 63.44 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.756 0.822 . . . . 70.219999999999999 112.014 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.0 p -117.02 155.0 29.94 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.407 1.083 . . . . 72.040000000000006 109.036 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.2 tp -108.93 123.93 49.86 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.242 -0.651 . . . . 74.310000000000002 109.242 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.408 ' N ' ' HB2' ' A' ' 93' ' ' ALA . 31.2 p -69.46 115.38 8.66 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.653 -0.869 . . . . 75.25 108.653 171.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.531 HG12 ' HB3' ' A' ' 91' ' ' PHE . 34.5 pt -119.59 143.68 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.271 -0.64 . . . . 50.439999999999998 109.271 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 m -112.38 144.73 41.33 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.977 -0.749 . . . . 62.240000000000002 108.977 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -56.07 119.65 6.23 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.668 0.387 . . . . 74.409999999999997 110.148 173.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.13 -17.29 44.63 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.301 -0.409 . . . . 73.209999999999994 113.219 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -78.8 129.51 34.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.143 0.577 . . . . 64.010000000000005 110.226 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.401 ' HD2' HD21 ' A' ' 84' ' ' LEU . 48.0 mtmt -87.48 130.14 34.81 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.024 0.529 . . . . 65.530000000000001 110.566 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.47 ' HB3' ' HB1' ' A' ' 121' ' ' ALA . 18.8 mt -107.3 148.1 29.43 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.232 1.013 . . . . 54.299999999999997 108.937 -172.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -111.04 107.92 17.47 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.386 -0.968 . . . . 63.329999999999998 108.386 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.2 t -99.78 123.44 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.243 0.617 . . . . 54.340000000000003 110.078 -171.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.5 mt -94.86 -4.45 47.0 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.506 0.722 . . . . 74.230000000000004 111.457 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.48 165.33 18.11 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 112.5 -0.24 . . . . 54.539999999999999 112.5 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.45 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 2.4 m-85 -97.06 174.53 6.71 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.665 0.786 . . . . 63.329999999999998 109.993 172.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -72.5 150.33 43.34 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.131 -0.94 . . . . 64.120000000000005 108.687 171.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -63.0 -27.17 69.24 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.237 0.458 . . . . 64.340000000000003 112.237 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.418 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 64.0 t30 -92.22 -10.96 36.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.041 0.536 . . . . 73.230000000000004 110.689 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 81.61 22.32 60.3 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 116.199 -0.455 . . . . 73.019999999999996 113.419 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.418 ' HG3' ' HB3' ' A' ' 115' ' ' ASN . 78.8 mt-10 -67.42 -62.38 1.45 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.836 0.854 . . . . 73.409999999999997 110.332 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -120.17 -179.12 3.84 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.928 -1.033 . . . . 53.020000000000003 109.781 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -144.36 123.45 12.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.574 0.75 . . . . 60.439999999999998 109.703 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -70.94 95.04 1.12 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.499 0.72 . . . . 70.239999999999995 110.693 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' A' ' 107' ' ' LEU . . . -105.45 145.21 31.16 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.444 0.698 . . . . 55.219999999999999 110.263 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.9 130.77 45.58 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.397 0.679 . . . . 64.329999999999998 110.195 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.9 p -133.93 -173.49 3.27 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.12 0.968 . . . . 73.439999999999998 109.643 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -61.94 -21.53 64.85 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.21 0.604 . . . . 63.039999999999999 111.339 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -76.07 -5.86 48.47 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.158 0.983 . . . . 73.040000000000006 111.836 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 116.41 -135.65 12.23 Favored Glycine 0 C--N 1.342 0.903 0 N-CA-C 110.316 -1.114 . . . . 53.219999999999999 110.316 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -151.13 156.63 41.39 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.541 0.67 . . . . 65.319999999999993 111.493 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 174.32 176.47 42.73 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.726 -0.67 . . . . 52.329999999999998 112.727 170.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.553 ' HZ2' ' HB3' ' A' ' 24' ' ' LYS . 86.9 m95 -84.54 118.7 24.49 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.495 -0.853 . . . . 74.549999999999997 110.037 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.91 153.93 47.01 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.742 1.217 . . . . 63.399999999999999 109.265 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -69.93 131.14 20.39 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 121.529 1.486 . . . . 73.430000000000007 111.059 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 27.4 p -59.63 -25.48 64.71 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.832 0.853 . . . . 75.120000000000005 111.828 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -74.91 -17.81 60.51 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.544 1.138 . . . . 72.150000000000006 112.094 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -95.34 -4.68 44.98 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.694 0.798 . . . . 65.430000000000007 112.386 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.7 pt -128.33 156.93 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.51 0.324 . . . . 63.350000000000001 110.721 -170.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.3 t -148.81 134.28 9.54 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 122.792 0.437 . . . . 62.509999999999998 109.957 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 74.3 Cg_endo -75.59 123.1 7.32 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.457 2.105 . . . . 64.209999999999994 112.918 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.9 m -98.3 -40.38 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.283 0.633 . . . . 65.040000000000006 111.825 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.468 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.0 t30 -99.01 5.39 47.15 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.104 0.562 . . . . 75.299999999999997 111.832 -172.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.8 p -83.9 -166.29 1.37 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.981 0.513 . . . . 64.340000000000003 110.655 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.408 HD13 ' HB3' ' A' ' 214' ' ' LEU . 71.7 mt -77.38 -12.16 59.92 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.804 0.841 . . . . 73.409999999999997 111.998 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.21 -21.12 66.45 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.497 0.719 . . . . 64.25 111.56 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.68 -29.4 64.62 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.994 0.918 . . . . 54.530000000000001 110.604 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -79.57 137.71 37.24 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.66 0.784 . . . . 73.310000000000002 109.633 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.0 m -63.39 -17.96 63.19 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.59 0.756 . . . . 71.430000000000007 112.778 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 51.9 p-90 -77.42 -35.55 54.04 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.324 0.49 . . . . 64.129999999999995 112.324 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -97.64 130.1 44.68 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.531 -0.544 . . . . 71.340000000000003 109.531 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -122.64 19.92 10.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.789 0.436 . . . . 75.040000000000006 111.574 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.5 -155.32 49.94 Favored Glycine 0 CA--C 1.536 1.366 0 N-CA-C 114.839 0.696 . . . . 72.349999999999994 114.839 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.26 99.06 1.24 Allowed 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 123.587 2.858 . . . . 73.430000000000007 112.049 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.5 t -142.7 145.92 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.188 0.995 . . . . 64.209999999999994 109.298 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.9 m -82.64 169.28 16.43 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.843 0.683 . . . . 72.010000000000005 112.843 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -53.71 -37.99 63.84 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 124.014 0.926 . . . . 72.299999999999997 112.488 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -56.04 -50.17 71.67 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.858 0.463 . . . . 73.219999999999999 111.746 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.89 -30.23 40.09 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 123.478 0.711 . . . . 62.450000000000003 110.465 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.716 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -59.57 -48.22 82.5 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.915 -0.584 . . . . 42.420000000000002 111.212 172.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.526 ' HG3' HG11 ' A' ' 190' ' ' VAL . 28.5 tt0 -78.85 -25.95 44.04 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.618 0.767 . . . . 73.109999999999999 109.574 -176.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.71 -52.78 63.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.665 0.786 . . . . 73.030000000000001 111.645 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.446 ' HB2' HD11 ' A' ' 169' ' ' LEU . 48.5 mt -72.22 -34.57 68.44 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 120.728 0.299 . . . . 75.439999999999998 111.042 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.453 HD22 ' HB3' ' A' ' 183' ' ' SER . 33.2 tp -66.72 -26.72 67.14 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.145 0.578 . . . . 62.450000000000003 111.898 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.3 t -64.28 -17.53 63.72 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.855 0.862 . . . . 75.420000000000002 111.715 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.0 m -89.26 -6.51 56.75 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.72 0.808 . . . . 73.109999999999999 111.565 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -97.62 161.11 21.18 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 114.616 0.606 . . . . 73.319999999999993 114.616 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.7 pt -102.59 -164.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.904 0.882 . . . . 63.140000000000001 110.221 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.862 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 13.3 p-10 -51.34 118.56 3.36 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.766 0.827 . . . . 74.319999999999993 113.124 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.59 14.37 68.2 Favored Glycine 0 C--O 1.256 1.499 0 CA-C-N 115.574 -0.739 . . . . 63.420000000000002 113.227 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.6 t -69.49 134.04 48.42 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.075 -0.713 . . . . 73.519999999999996 109.075 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.547 ' HA ' ' O ' ' A' ' 183' ' ' SER . 20.1 p90 -139.97 154.13 47.09 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.879 0.696 . . . . 72.439999999999998 112.879 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 159' ' ' LEU . 97.8 mt -133.08 133.73 43.36 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.708 -0.849 . . . . 44.32 108.708 169.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.416 HG22 HG12 ' A' ' 182' ' ' ILE . 22.7 t -106.55 118.0 53.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 107.363 -1.347 . . . . 71.209999999999994 107.363 174.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.716 HH11 ' HA ' ' A' ' 156' ' ' ALA . 28.9 mtt180 -147.42 152.03 37.44 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.198 0.999 . . . . 74.239999999999995 109.527 -174.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 16.1 pt-20 -106.76 162.6 13.64 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.8 -0.815 . . . . 62.530000000000001 108.8 172.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.5 t -77.27 134.54 38.53 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.657 0.383 . . . . 65.519999999999996 110.262 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -60.76 -43.78 97.56 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.404 0.682 . . . . 73.439999999999998 109.962 175.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 62.5 p -90.6 5.73 46.69 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.67 -1.15 . . . . 70.040000000000006 112.188 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.0 m -150.69 87.96 4.68 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.443 0.697 . . . . 73.129999999999995 109.333 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.45 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 27.1 Cg_endo -60.84 138.98 82.75 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.827 2.351 . . . . 61.140000000000001 111.89 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.83 -23.07 11.19 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 116.066 -0.516 . . . . 70.129999999999995 113.652 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -83.52 113.76 21.02 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.141 -0.689 . . . . 63.109999999999999 109.141 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.692 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 67.6 mtt-85 -114.77 170.71 8.13 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.088 -0.505 . . . . 74.230000000000004 110.124 -170.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.472 ' HB2' ' HD3' ' A' ' 194' ' ' ARG . 33.0 t -161.02 148.56 15.48 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.397 0.679 . . . . 60.340000000000003 110.048 -177.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.416 HG12 HG22 ' A' ' 170' ' ' VAL . 55.3 mt -112.78 141.06 29.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 107.955 -1.128 . . . . 51.329999999999998 107.955 166.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 20.0 m -118.12 112.29 19.99 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 124.287 1.035 . . . . 74.209999999999994 108.849 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.465 HD21 HD23 ' A' ' 232' ' ' LEU . 38.2 mt -104.78 142.25 35.04 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.486 0.585 . . . . 75.299999999999997 112.424 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -129.99 125.65 35.87 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 114.565 -1.198 . . . . 74.409999999999997 108.182 168.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.862 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 6.3 p90 -140.65 134.97 31.2 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 109.162 -0.681 . . . . 74.530000000000001 109.162 174.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 58.15 22.95 9.64 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.664 1.186 . . . . 73.400000000000006 112.48 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 84.07 7.99 84.56 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.203 -0.453 . . . . 45.200000000000003 113.654 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -102.49 124.99 49.04 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.422 0.689 . . . . 74.209999999999994 109.543 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.526 HG11 ' HG3' ' A' ' 157' ' ' GLU . 98.1 t -104.96 134.77 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.236 1.014 . . . . 63.340000000000003 110.478 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.461 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 32.4 p90 -147.0 151.84 37.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.34 1.056 . . . . 63.219999999999999 108.811 168.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -121.47 150.94 40.83 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.588 -0.893 . . . . 72.099999999999994 108.588 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -146.19 139.62 26.01 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.631 0.373 . . . . 74.109999999999999 110.464 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.472 ' HD3' ' HB2' ' A' ' 181' ' ' SER . 32.5 mmt180 -82.76 140.6 32.92 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.75 0.786 . . . . 74.109999999999999 112.913 -172.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 84.9 mt -93.04 111.2 24.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-N 114.284 -1.325 . . . . 73.129999999999995 107.539 165.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -87.98 133.35 33.96 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 109.395 -0.594 . . . . 74.120000000000005 109.395 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.7 m -94.19 116.46 28.87 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.265 0.626 . . . . 72.0 109.717 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.51 160.36 27.78 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.433 0.693 . . . . 75.140000000000001 110.997 171.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.3 t -66.4 -10.16 40.96 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.796 0.839 . . . . 74.129999999999995 111.957 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -90.61 5.19 48.98 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.79 0.836 . . . . 64.230000000000004 111.8 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 81.08 -3.5 76.26 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 122.796 0.236 . . . . 72.030000000000001 113.097 -175.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -83.5 135.19 34.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.692 0.797 . . . . 64.230000000000004 110.136 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.9 mt -92.97 157.32 16.39 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.508 0.723 . . . . 73.530000000000001 110.052 -177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -164.4 156.95 16.92 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.161 0.505 . . . . 64.140000000000001 111.29 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.3 t -117.04 -67.03 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 106.904 -1.517 . . . . 71.340000000000003 106.904 170.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.8 m -68.44 140.81 55.77 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.07 0.948 . . . . 51.530000000000001 110.257 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 54.7 p -62.86 -31.49 72.53 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.329 0.652 . . . . 45.149999999999999 111.666 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -88.08 3.31 49.46 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.513 0.725 . . . . 74.439999999999998 112.084 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.5 m -123.1 144.12 49.52 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.762 0.425 . . . . 61.450000000000003 111.453 -174.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 81.0 mmt-85 -143.03 135.43 27.39 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 107.609 -1.256 . . . . 74.310000000000002 107.609 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -131.33 135.73 47.51 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.708 -1.219 . . . . 75.219999999999999 107.708 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -75.07 -35.91 61.81 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 122.551 0.34 . . . . 72.319999999999993 110.122 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 77.4 p -124.26 150.51 45.26 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.479 0.712 . . . . 62.210000000000001 111.848 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.408 ' HB3' HD13 ' A' ' 141' ' ' LEU . 33.2 tp -69.64 -28.15 65.66 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.974 -1.012 . . . . 71.019999999999996 110.523 174.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.87 -44.58 91.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.042 0.537 . . . . 73.420000000000002 110.486 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -77.56 -29.32 52.13 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.815 -0.63 . . . . 74.129999999999995 112.273 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.3 tt -61.27 -46.34 90.74 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 118.363 0.529 . . . . 74.319999999999993 109.898 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 67.0 t -74.1 -42.09 51.99 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 C-N-CA 123.891 0.876 . . . . 64.200000000000003 111.129 -176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -58.77 -52.4 65.86 Favored 'General case' 0 C--O 1.262 1.74 0 CA-C-O 121.289 0.566 . . . . 63.229999999999997 111.223 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.483 ' O ' HG22 ' A' ' 224' ' ' VAL . 37.9 t-80 -54.67 -56.99 13.33 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 114.646 -1.161 . . . . 55.299999999999997 108.377 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.405 ' HA ' HG22 ' A' ' 224' ' ' VAL . 10.4 m170 -68.05 -14.65 63.14 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.17 0.804 . . . . 70.040000000000006 113.17 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.493 ' HA ' ' HB2' ' A' ' 232' ' ' LEU . 42.0 t -73.77 -34.65 64.77 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 110.169 -0.308 . . . . 71.310000000000002 110.169 171.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.9 t -108.5 -13.42 14.84 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 116.144 1.905 . . . . 72.329999999999998 116.144 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 220' ' ' HIS . 34.1 m -103.63 165.84 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 116.316 1.969 . . . . 72.510000000000005 116.316 -165.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.85 -1.71 58.05 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.829 3.252 . . . . 62.140000000000001 113.854 -172.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -78.67 14.36 1.34 Allowed 'General case' 0 CA--C 1.576 1.955 0 C-N-CA 130.322 3.449 . . . . 63.420000000000002 113.519 -138.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.11 17.61 4.46 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 110.856 -0.897 . . . . 42.200000000000003 110.856 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 92.8 mt -92.36 124.03 36.12 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.828 1.251 . . . . 62.200000000000003 110.34 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.461 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 89.5 mt -61.73 -40.78 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 109.303 -0.628 . . . . 65.140000000000001 109.303 172.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.5 t -138.19 142.61 40.02 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.275 -0.875 . . . . 75.329999999999998 109.392 166.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 224' ' ' VAL . 82.3 p -66.65 149.59 50.28 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.989 -0.55 . . . . 72.010000000000005 109.547 169.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 222' ' ' SER . 40.9 mt -65.48 103.32 0.82 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.001 0.521 . . . . 74.420000000000002 109.956 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -75.62 -59.42 2.76 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.518 0.727 . . . . 65.540000000000006 109.809 -176.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -156.44 150.67 19.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 CA-C-O 119.326 -0.368 . . . . 73.349999999999994 110.212 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 31.2 Cg_endo -62.81 137.3 62.31 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.116 1.877 . . . . 63.520000000000003 111.855 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -59.59 135.74 89.29 Favored Pre-proline 0 C--O 1.243 0.747 0 C-N-CA 123.333 0.653 . . . . 63.530000000000001 111.045 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.01 117.21 3.88 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.387 2.058 . . . . 73.310000000000002 112.617 -174.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt . . . . . 0 CA--C 1.547 0.837 0 CA-C-N 114.542 -1.208 . . . . 73.420000000000002 109.843 170.308 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 121.073 0.463 . . . . 71.0 111.355 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.9 mt -104.79 128.46 26.75 Favored Pre-proline 0 C--O 1.241 0.644 0 N-CA-C 109.205 -0.665 . . . . 52.030000000000001 109.205 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -66.32 165.95 22.99 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.566 2.177 . . . . 63.020000000000003 111.865 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.98 146.71 31.9 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 120.809 0.337 . . . . 63.530000000000001 110.53 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.611 ' HB3' HD11 ' A' ' 23' ' ' ILE . 75.6 mt -87.02 93.17 9.28 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.524 -0.917 . . . . 75.299999999999997 108.524 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -95.26 -45.24 7.24 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.942 -1.026 . . . . 54.43 109.389 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -105.85 115.36 30.1 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.144 -0.935 . . . . 72.0 110.084 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.611 HD11 ' HB3' ' A' ' 20' ' ' LEU . 45.9 mm -116.47 113.84 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.298 -1.001 . . . . 50.399999999999999 108.298 175.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt . . . . . 0 N--CA 1.472 0.667 0 C-N-CA 123.81 0.844 . . . . 74.209999999999994 109.185 175.528 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.482 ' HG3' ' NH1' ' A' ' 108' ' ' ARG . 74.2 Cg_endo . . . . . 0 N--CA 1.502 1.979 0 N-CA-C 111.587 -0.197 . . . . 73.540000000000006 111.587 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.633 ' HA ' ' HA ' ' A' ' 140' ' ' SER . 48.8 m-80 -66.14 85.99 0.1 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.898 0.856 . . . . 53.049999999999997 108.751 167.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 30.2 tp -87.4 122.91 31.77 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.306 -1.315 . . . . 54.329999999999998 109.865 -173.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -107.22 174.7 5.77 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.556 1.142 . . . . 74.439999999999998 109.225 174.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.24 142.55 19.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 108.464 -0.939 . . . . 72.040000000000006 108.464 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.449 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -78.39 123.28 26.83 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.513 0.508 . . . . 70.219999999999999 110.398 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.08 -22.92 41.7 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.34 0.656 . . . . 60.240000000000002 110.499 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.496 ' CD1' ' HA ' ' A' ' 134' ' ' TYR . 22.0 m-85 -127.15 162.0 27.15 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.939 0.896 . . . . 74.409999999999997 109.012 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.11 150.39 25.58 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.054 -1.091 . . . . 74.219999999999999 108.054 166.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -156.26 108.58 2.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.83 -1.174 . . . . 74.420000000000002 107.83 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 p -80.44 135.77 24.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.779 -0.823 . . . . 53.520000000000003 108.779 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.83 123.27 16.49 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.169 0.588 . . . . 21.440000000000001 110.687 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.2 t -84.39 8.26 16.82 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.554 0.742 . . . . 72.310000000000002 110.778 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.51 -171.64 44.14 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.789 -0.524 . . . . 74.530000000000001 111.789 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.5 -27.59 62.36 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.683 0.793 . . . . 45.439999999999998 110.682 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -74.84 -24.3 58.58 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.794 0.838 . . . . 55.219999999999999 112.74 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.9 p -102.03 157.58 16.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.603 0.761 . . . . 60.0 110.731 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.8 tp -110.0 131.83 54.71 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.516 0.727 . . . . 70.319999999999993 110.319 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.0 m -71.28 118.69 14.4 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.08 -0.711 . . . . 74.230000000000004 109.08 168.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.7 pt -124.03 147.18 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.566 0.746 . . . . 72.329999999999998 109.016 173.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.3 m -115.46 145.02 42.98 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.67 -0.493 . . . . 74.340000000000003 109.67 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -55.25 114.8 1.94 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.747 0.819 . . . . 63.130000000000003 110.856 174.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.78 -16.16 37.0 Favored Glycine 0 C--N 1.35 1.361 0 O-C-N 123.167 0.292 . . . . 73.400000000000006 112.763 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -78.38 137.24 37.92 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 124.153 0.981 . . . . 71.409999999999997 110.973 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.59 ' HB3' HD11 ' A' ' 84' ' ' LEU . 29.8 mtmt -77.44 134.72 38.31 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 124.044 0.84 . . . . 70.430000000000007 109.777 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 87' ' ' ALA . 19.0 mt -120.3 135.87 54.87 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.38 0.672 . . . . 73.129999999999995 109.255 -173.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.482 ' NH1' ' HG3' ' A' ' 82' ' ' PRO . 50.9 mtp85 -93.56 108.14 19.89 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.718 -0.845 . . . . 74.209999999999994 108.718 167.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.459 HG21 HD12 ' A' ' 135' ' ' ILE . 95.6 t -95.27 108.94 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.565 -0.902 . . . . 41.219999999999999 108.565 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.86 -28.97 64.97 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.025 0.93 . . . . 74.200000000000003 110.224 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.85 173.12 37.05 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-N 114.648 -1.16 . . . . 71.010000000000005 111.013 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 51.3 m-85 -96.8 175.02 6.51 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.648 -0.871 . . . . 55.229999999999997 108.648 176.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.496 ' HB3' ' H ' ' A' ' 117' ' ' GLU . 49.8 t-20 -63.4 144.39 57.01 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.69 -1.226 . . . . 72.340000000000003 107.69 173.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -54.37 -32.65 57.47 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.688 0.795 . . . . 72.230000000000004 110.905 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.53 -19.83 28.89 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.441 1.097 . . . . 74.299999999999997 111.797 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.07 34.46 7.18 Favored Glycine 0 N--CA 1.477 1.418 0 C-N-CA 123.121 0.391 . . . . 63.32 113.854 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.496 ' H ' ' HB3' ' A' ' 113' ' ' ASN . 28.5 mt-10 -99.4 -65.86 0.94 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.466 0.706 . . . . 64.349999999999994 111.043 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -103.01 -176.77 3.18 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.668 1.187 . . . . 73.219999999999999 110.207 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -143.66 117.16 9.14 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.563 0.745 . . . . 63.240000000000002 110.032 -177.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -73.81 97.96 2.85 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.615 -0.513 . . . . 54.25 109.615 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.78 168.14 9.33 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.145 -0.934 . . . . 74.030000000000001 110.718 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -147.48 127.81 13.94 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 108.57 -0.9 . . . . 72.120000000000005 108.57 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.6 p -139.71 -172.57 3.41 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.025 0.93 . . . . 75.519999999999996 109.785 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -63.02 -20.68 65.55 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.509 -0.768 . . . . 74.329999999999998 111.307 171.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -81.72 -4.11 55.43 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.056 0.943 . . . . 71.219999999999999 111.269 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 125.47 -135.07 9.07 Favored Glycine 0 C--N 1.355 1.589 0 N-CA-C 112.354 -0.298 . . . . 72.120000000000005 112.354 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -150.65 133.88 16.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.997 0.919 . . . . 70.010000000000005 109.155 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 176.18 -177.91 47.68 Favored Glycine 0 C--N 1.348 1.25 0 O-C-N 123.214 0.321 . . . . 41.43 112.867 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -88.37 126.53 35.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.374 1.07 . . . . 75.430000000000007 111.149 -174.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.05 154.7 55.79 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.914 1.286 . . . . 72.230000000000004 109.138 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.95 132.82 23.81 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 121.744 1.63 . . . . 71.430000000000007 110.398 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.3 m -63.8 -19.33 64.93 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.571 0.748 . . . . 74.340000000000003 112.108 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -72.22 -22.05 61.31 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.977 0.911 . . . . 73.319999999999993 111.302 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.496 ' HA ' ' CD1' ' A' ' 89' ' ' TYR . 2.5 m-85 -90.61 -7.4 52.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.763 0.825 . . . . 72.5 113.024 -175.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.459 HD12 HG21 ' A' ' 109' ' ' VAL . 16.1 pt -121.57 157.35 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 122.808 0.443 . . . . 74.420000000000002 110.409 -171.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.5 t -147.35 141.55 15.94 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 122.917 0.487 . . . . 55.340000000000003 110.248 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.81 147.15 43.93 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.632 2.221 . . . . 74.140000000000001 112.111 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 m -130.94 -59.96 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.55 0.74 . . . . 73.430000000000007 110.666 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.629 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.1 t30 -103.06 16.08 27.6 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 122.945 0.498 . . . . 74.25 111.06 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 41.3 m -60.62 170.78 1.31 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.028 0.531 . . . . 72.140000000000001 111.034 172.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 69.7 mt -55.65 -16.09 3.76 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.921 1.082 . . . . 74.299999999999997 113.921 -173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.532 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 31.4 tt0 -65.97 -6.29 12.15 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.536 1.134 . . . . 73.219999999999999 111.478 175.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -56.53 -31.11 63.83 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.271 1.428 . . . . 72.200000000000003 110.496 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -100.29 141.77 32.68 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.566 -0.743 . . . . 72.5 109.262 173.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.3 p -70.42 -5.81 31.14 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.242 0.83 . . . . 74.439999999999998 113.242 -170.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.402 ' CE3' HG21 ' A' ' 218' ' ' VAL . 42.5 p-90 -77.94 -33.64 51.55 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 111.806 0.299 . . . . 72.319999999999993 111.806 174.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.4 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 37.3 t80 -99.27 139.25 35.19 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.281 -0.637 . . . . 74.530000000000001 109.281 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.532 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 25.1 m-70 -134.12 38.51 3.15 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.894 0.478 . . . . 72.200000000000003 110.372 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 68.59 -171.16 38.04 Favored Glycine 0 CA--C 1.542 1.732 0 N-CA-C 116.305 1.282 . . . . 70.109999999999999 116.305 165.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.11 100.65 0.88 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.635 2.89 . . . . 73.200000000000003 111.553 171.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.464 ' HB ' ' HD2' ' A' ' 171' ' ' ARG . 78.0 t -142.66 148.47 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.772 0.829 . . . . 73.329999999999998 109.352 -174.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.5 m -70.83 151.34 44.89 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 123.93 0.892 . . . . 70.530000000000001 111.288 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -20.59 55.26 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.228 -0.896 . . . . 72.049999999999997 112.186 176.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.83 -59.13 5.6 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.303 1.041 . . . . 75.140000000000001 109.822 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 158' ' ' TYR . . . -70.12 -31.72 69.39 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.842 0.857 . . . . 71.239999999999995 110.81 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.497 ' HA ' HH21 ' A' ' 171' ' ' ARG . . . -57.25 -54.06 51.08 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.43 -0.804 . . . . 70.439999999999998 110.738 171.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -73.1 -23.34 60.51 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.862 -0.608 . . . . 54.539999999999999 110.762 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.411 ' HB3' ' HA ' ' A' ' 155' ' ' ALA . 71.1 t80 -63.58 -49.37 73.66 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.743 0.817 . . . . 72.310000000000002 110.398 175.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.495 HD12 ' NH2' ' A' ' 171' ' ' ARG . 67.3 mt -71.32 -37.52 71.76 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.058 0.456 . . . . 72.299999999999997 110.79 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.438 HD23 HG13 ' A' ' 190' ' ' VAL . 29.1 tp -73.98 -17.27 61.02 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.854 -0.612 . . . . 73.310000000000002 112.269 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 38.9 t -68.86 -19.84 64.26 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.371 0.669 . . . . 63.43 110.651 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.9 t -99.82 6.82 45.34 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.472 0.709 . . . . 70.120000000000005 110.6 174.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.15 163.27 43.11 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 116.089 -0.505 . . . . 62.229999999999997 113.068 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.2 pt -126.35 -166.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.442 1.497 . . . . 64.010000000000005 110.396 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.698 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 24.7 p-10 -58.78 110.12 0.95 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.63 0.604 . . . . 73.129999999999995 112.63 -169.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 91.91 13.37 57.92 Favored Glycine 0 C--O 1.256 1.477 0 CA-C-N 115.91 -0.587 . . . . 53.32 113.168 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 67.4 m -77.69 131.35 37.67 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.023 -0.362 . . . . 74.150000000000006 110.023 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.477 ' HB3' HD23 ' A' ' 184' ' ' LEU . 16.2 p90 -133.13 154.88 50.18 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.834 0.679 . . . . 64.209999999999994 112.834 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.6 mt -135.46 133.82 38.94 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.931 -1.032 . . . . 74.230000000000004 108.459 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.74 118.07 54.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 107.838 -1.171 . . . . 73.420000000000002 107.838 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.497 HH21 ' HA ' ' A' ' 156' ' ' ALA . 18.7 mmt180 -118.62 167.58 11.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.059 0.944 . . . . 60.219999999999999 108.798 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.581 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 15.7 pt-20 -117.89 160.76 20.87 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 109.575 -0.528 . . . . 74.319999999999993 109.575 158.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 59.3 m -87.33 135.24 33.4 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.749 -0.66 . . . . 44.340000000000003 110.326 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -74.44 -36.42 63.38 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.007 0.923 . . . . 74.239999999999995 110.872 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 26.5 t -89.37 -16.26 31.41 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.551 0.741 . . . . 61.340000000000003 111.031 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 32.7 t -127.19 85.25 61.43 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 108.387 -0.968 . . . . 61.240000000000002 108.387 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.47 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 51.6 Cg_endo -65.64 140.38 62.09 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.161 2.574 . . . . 72.019999999999996 112.289 -176.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.6 -25.37 5.16 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 115.771 -0.649 . . . . 74.150000000000006 113.102 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -79.95 119.11 22.35 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 108.741 -0.837 . . . . 73.310000000000002 108.741 173.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.581 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 47.9 mtt85 -114.21 165.46 12.65 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 115.019 -0.991 . . . . 75.209999999999994 109.167 -176.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.3 m -146.71 139.01 24.87 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.495 -0.557 . . . . 72.150000000000006 109.495 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 47.4 mt -103.84 140.99 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.1 -1.074 . . . . 73.540000000000006 108.1 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 18.1 m -121.21 111.86 17.92 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.103 -0.953 . . . . 64.25 108.505 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 168' ' ' PHE . 33.9 mt -103.79 143.91 32.19 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.17 0.988 . . . . 53.509999999999998 111.212 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -131.71 133.6 45.01 Favored 'General case' 0 C--O 1.257 1.496 0 CA-C-N 114.825 -1.08 . . . . 75.239999999999995 108.536 168.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.698 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 24.3 p90 -143.73 133.52 23.85 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.862 -1.063 . . . . 74.420000000000002 108.21 173.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 47.64 37.47 6.81 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.674 1.19 . . . . 63.520000000000003 113.817 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 92.18 -5.41 78.3 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.621 -0.718 . . . . 55.020000000000003 113.779 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -102.93 123.99 47.59 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.1 0.56 . . . . 72.340000000000003 109.738 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.438 HG13 HD23 ' A' ' 160' ' ' LEU . 84.7 t -106.27 137.55 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.238 1.015 . . . . 61.219999999999999 109.547 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.402 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 24.3 p90 -145.73 151.33 37.82 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.751 0.821 . . . . 72.200000000000003 109.572 169.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -128.38 134.13 48.77 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.544 -1.28 . . . . 75.409999999999997 107.544 -173.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -136.8 139.36 41.72 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.242 0.544 . . . . 70.219999999999999 110.436 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.544 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 22.2 tpp180 -81.76 122.46 27.7 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.588 -1.187 . . . . 72.140000000000001 111.58 -171.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.491 ' HA ' HG22 ' A' ' 205' ' ' VAL . 73.4 mt -72.69 115.56 13.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 108.308 -0.997 . . . . 75.109999999999999 108.308 162.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -93.46 132.47 37.7 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 109.016 -0.735 . . . . 75.230000000000004 109.016 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.7 m -95.6 116.45 28.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.407 -0.815 . . . . 73.049999999999997 108.909 172.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.35 161.27 22.82 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.138 0.975 . . . . 72.430000000000007 111.693 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.3 t -70.06 -10.76 59.77 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.654 0.782 . . . . 64.109999999999999 110.803 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -71.77 -17.12 62.2 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.463 1.105 . . . . 70.340000000000003 111.206 172.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 88.25 2.28 80.41 Favored Glycine 0 C--N 1.355 1.62 0 C-N-CA 123.169 0.414 . . . . 62.100000000000001 112.081 -171.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -90.47 145.33 24.99 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.913 0.885 . . . . 74.140000000000001 110.773 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 86.8 mt -94.23 149.2 21.46 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 123.195 0.598 . . . . 74.299999999999997 109.621 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -162.43 166.94 24.37 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.668 0.605 . . . . 74.230000000000004 111.182 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 195' ' ' ILE . 92.8 t -140.88 -62.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.301 1.041 . . . . 71.319999999999993 108.632 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 12.7 m -98.79 -169.96 1.86 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.628 1.171 . . . . 74.329999999999998 111.196 -172.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.8 m -69.99 -47.68 61.22 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.532 0.733 . . . . 65.230000000000004 112.859 -169.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -84.36 -16.77 41.68 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.455 0.702 . . . . 73.140000000000001 109.257 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 71.6 m -64.41 106.59 1.16 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.32 0.648 . . . . 74.150000000000006 111.376 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 210' ' ' ARG . 8.7 mmt180 -146.1 117.57 8.0 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.393 1.077 . . . . 75.120000000000005 109.18 169.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -136.54 152.71 50.8 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.145 0.578 . . . . 75.430000000000007 110.616 -171.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -82.07 -36.28 27.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.197 -0.668 . . . . 75.450000000000003 109.197 168.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 82.8 p -130.73 160.13 35.23 Favored 'General case' 0 C--O 1.252 1.2 0 CA-C-O 122.247 1.022 . . . . 71.5 112.598 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 21.4 tp -74.14 -22.04 59.61 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.15 -1.386 . . . . 72.239999999999995 110.807 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.23 -49.64 76.29 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.44 0.638 . . . . 51.329999999999998 110.41 171.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -62.23 -41.96 98.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.521 -1.218 . . . . 72.040000000000006 110.504 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.9 tt -57.88 -48.92 78.41 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.02 0.825 . . . . 64.129999999999995 111.612 177.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.402 HG21 ' CE3' ' A' ' 146' ' ' TRP . 55.7 t -72.08 -38.47 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.083 0.553 . . . . 62.409999999999997 111.19 -174.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -65.43 -46.75 78.69 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.128 0.49 . . . . 73.310000000000002 110.938 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.478 ' O ' HG22 ' A' ' 224' ' ' VAL . 40.6 t-80 -56.07 -52.35 64.58 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.672 -0.695 . . . . 74.540000000000006 109.322 176.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.557 ' HD1' HD21 ' A' ' 228' ' ' LEU . 18.1 m-70 -70.19 -19.15 63.19 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.531 -0.759 . . . . 74.030000000000001 112.535 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.2 p -81.29 -20.2 41.36 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.127 0.421 . . . . 70.040000000000006 110.715 172.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 7.0 t -111.53 -12.99 13.9 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.251 1.945 . . . . 75.0 116.251 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 220' ' ' HIS . 30.3 m -105.59 158.34 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 121.145 1.793 . . . . 74.219999999999999 115.733 -167.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -90.7 0.61 57.35 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.855 2.862 . . . . 74.129999999999995 113.523 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -81.16 15.03 2.06 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 128.191 2.596 . . . . 64.510000000000005 113.157 -139.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.02 19.88 3.87 Favored Glycine 0 N--CA 1.464 0.563 0 N-CA-C 110.35 -1.1 . . . . 40.420000000000002 110.35 -170.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.557 HD21 ' HD1' ' A' ' 221' ' ' HIS . 95.7 mt -93.59 128.4 39.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.626 -1.287 . . . . 74.219999999999999 109.102 163.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.402 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 95.3 mt -64.04 -49.0 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.871 -0.788 . . . . 71.010000000000005 108.871 170.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.2 t -130.97 147.83 52.65 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.104 -1.072 . . . . 73.329999999999998 108.104 170.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.0 p -75.29 155.75 36.32 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.913 -0.403 . . . . 72.209999999999994 109.913 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.406 HD23 HD21 ' A' ' 184' ' ' LEU . 27.5 mt -64.58 103.32 0.66 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.397 -0.964 . . . . 74.239999999999995 108.397 176.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -88.28 -58.29 2.61 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.047 -0.723 . . . . 74.400000000000006 109.047 -172.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.563 ' O ' ' HA ' ' A' ' 167' ' ' SER . 14.5 p90 -152.3 149.14 22.29 Favored Pre-proline 0 N--CA 1.484 1.257 0 CA-C-N 116.017 -0.538 . . . . 74.439999999999998 110.272 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 26.8 Cg_exo -63.31 148.88 92.53 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.116 1.877 . . . . 74.340000000000003 112.958 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.72 134.22 78.92 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 108.378 -0.971 . . . . 73.209999999999994 108.378 169.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.07 137.99 59.88 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.417 2.078 . . . . 74.430000000000007 113.379 -171.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 65.3 tttm . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 108.284 -1.006 . . . . 74.019999999999996 108.284 170.149 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.6 p . . . . . 0 CA--C 1.546 0.806 0 CA-C-O 121.563 0.697 . . . . 75.299999999999997 111.297 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.4 mt -106.48 135.16 19.53 Favored Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 115.478 -0.783 . . . . 73.010000000000005 109.946 -173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.72 173.72 13.91 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.602 2.201 . . . . 63.020000000000003 111.874 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.06 148.85 26.6 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.957 0.503 . . . . 74.329999999999998 110.776 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.489 HD22 HD11 ' A' ' 23' ' ' ILE . 79.2 mt -86.3 93.48 9.09 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.79 -0.818 . . . . 72.209999999999994 108.79 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -97.17 -48.83 5.21 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.977 0.511 . . . . 74.209999999999994 110.427 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.473 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 64.1 m-85 -104.16 114.83 29.35 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.313 -0.625 . . . . 51.109999999999999 109.313 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.489 HD11 HD22 ' A' ' 20' ' ' LEU . 47.1 mm -121.77 120.99 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 109.4 -0.593 . . . . 50.329999999999998 109.4 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.5 ' H ' ' HE1' ' A' ' 129' ' ' TRP . 63.8 mttm . . . . . 0 N--CA 1.481 1.084 0 C-N-CA 123.917 0.887 . . . . 73.450000000000003 109.763 172.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 N--CA 1.5 1.888 0 N-CA-C 114.17 0.796 . . . . 63.130000000000003 114.17 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -91.21 17.03 8.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.795 0.838 . . . . 44.240000000000002 111.484 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.91 109.66 18.3 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 108.701 -0.852 . . . . 72.319999999999993 108.701 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 4.4 m-85 -105.69 175.79 5.38 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.49 1.516 . . . . 71.299999999999997 110.421 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.97 148.07 27.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.798 -1.186 . . . . 73.040000000000006 107.798 169.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.52 107.77 14.56 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.754 -0.832 . . . . 53.32 108.754 170.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.4 mt -62.52 -27.4 69.13 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.058 0.943 . . . . 64.109999999999999 111.198 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -141.17 166.35 25.01 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.699 0.8 . . . . 62.409999999999997 109.728 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.52 147.47 29.65 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.518 -0.764 . . . . 52.329999999999998 109.812 175.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -155.93 118.09 4.07 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.347 1.059 . . . . 75.140000000000001 108.496 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.44 140.73 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.79 -0.819 . . . . 51.140000000000001 108.79 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.92 117.46 3.98 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.073 0.549 . . . . 63.340000000000003 110.526 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 m -59.46 -44.17 93.06 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.313 1.045 . . . . 73.310000000000002 110.386 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -160.26 -147.6 4.97 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 114.712 -1.131 . . . . 62.049999999999997 111.752 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -69.56 -34.87 74.8 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.312 1.045 . . . . 74.140000000000001 111.775 -175.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -84.91 8.69 16.66 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 113.252 0.834 . . . . 74.319999999999993 113.252 -175.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.6 p -127.26 156.84 41.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.299 0.64 . . . . 73.400000000000006 110.552 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.4 tp -109.97 137.13 48.18 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.571 0.749 . . . . 64.200000000000003 109.579 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.4 t -82.86 115.22 21.65 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.369 -0.975 . . . . 74.230000000000004 108.369 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.6 pt -123.48 144.29 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.256 1.022 . . . . 43.329999999999998 109.966 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.2 m -110.73 151.39 27.8 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 109.732 -0.469 . . . . 72.530000000000001 109.732 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -54.82 111.17 0.77 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.353 0.661 . . . . 72.019999999999996 111.682 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.55 -14.69 24.87 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 123.291 0.472 . . . . 55.399999999999999 112.765 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.48 120.91 14.71 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.971 0.908 . . . . 74.129999999999995 109.467 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 106' ' ' LYS . 8.0 mtmp? -80.87 118.19 22.16 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.665 -0.865 . . . . 73.25 108.665 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 21.7 mt -99.42 160.59 14.17 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.394 -0.965 . . . . 74.340000000000003 108.394 -174.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -121.12 107.3 12.43 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.206 -1.035 . . . . 75.439999999999998 108.206 164.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 74.1 t -94.6 115.18 32.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 108.573 -0.899 . . . . 75.120000000000005 108.573 -176.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.46 -35.34 80.04 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 123.588 0.555 . . . . 74.310000000000002 109.691 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.66 174.57 46.2 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.735 -0.666 . . . . 75.329999999999998 112.209 173.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.54 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 21.5 m-85 -92.91 174.88 7.02 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 108.808 -0.812 . . . . 71.409999999999997 108.808 176.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.473 ' ND2' ' HB2' ' A' ' 22' ' ' PHE . 12.8 m120 -64.07 167.85 5.98 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.945 -0.57 . . . . 74.400000000000006 110.13 164.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -72.31 -4.48 30.02 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 120.707 0.289 . . . . 62.539999999999999 110.324 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -105.21 -19.88 13.68 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.775 0.83 . . . . 74.530000000000001 110.754 170.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 80.15 12.93 82.71 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-N 116.633 -0.258 . . . . 71.219999999999999 113.603 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.406 ' HG3' ' OD1' ' A' ' 113' ' ' ASN . 9.5 pt-20 -68.4 -54.58 16.26 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.948 1.299 . . . . 71.430000000000007 111.794 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -116.18 173.19 6.72 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.796 0.838 . . . . 72.129999999999995 109.331 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.28 120.66 10.96 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.494 0.717 . . . . 64.530000000000001 110.735 -170.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -75.93 97.14 3.9 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.554 -0.536 . . . . 75.129999999999995 109.554 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -102.14 150.59 23.11 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.507 -0.77 . . . . 62.240000000000002 110.156 -174.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -132.22 122.54 25.39 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 124.047 0.939 . . . . 72.209999999999994 109.105 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 58.3 p -133.88 -176.73 4.27 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.275 1.43 . . . . 72.120000000000005 108.874 171.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -72.67 -3.19 23.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.982 0.513 . . . . 71.510000000000005 111.759 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -89.22 -1.18 57.97 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.786 0.834 . . . . 73.530000000000001 110.785 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.66 -156.23 15.89 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 111.759 -0.537 . . . . 63.420000000000002 111.759 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -144.6 131.53 20.32 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.173 0.589 . . . . 71.310000000000002 110.191 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -179.42 173.48 45.41 Favored Glycine 0 C--N 1.346 1.129 0 O-C-N 123.329 0.393 . . . . 62.539999999999999 112.694 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.5 ' HE1' ' H ' ' A' ' 24' ' ' LYS . 91.0 m95 -76.77 121.24 23.05 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.344 1.058 . . . . 64.319999999999993 111.517 -176.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.19 150.7 44.8 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 124.717 1.207 . . . . 70.239999999999995 108.904 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.51 126.08 14.94 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 121.799 1.666 . . . . 72.239999999999995 109.772 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 m -57.62 -26.79 62.08 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.723 0.809 . . . . 63.310000000000002 111.539 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -63.22 -28.68 70.2 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.657 1.183 . . . . 73.349999999999994 111.879 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -93.67 1.3 56.64 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.97 0.908 . . . . 74.299999999999997 112.774 -175.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 25.2 pt -133.75 164.68 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.347 0.521 . . . . 62.030000000000001 111.022 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.7 t -159.28 140.94 9.69 Favored Pre-proline 0 N--CA 1.484 1.241 0 O-C-N 123.455 0.472 . . . . 62.420000000000002 110.145 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 62.8 Cg_endo -71.68 114.54 3.98 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.269 1.98 . . . . 62.219999999999999 112.172 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.11 -36.04 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.757 0.823 . . . . 62.340000000000003 112.117 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -93.06 16.84 11.91 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.662 0.785 . . . . 72.540000000000006 110.111 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 137' ' ' PRO . 22.5 t -63.23 165.3 7.55 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.742 0.817 . . . . 75.219999999999999 110.808 175.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.4 mt -66.99 -10.24 47.46 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.35 1.06 . . . . 54.109999999999999 111.878 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.596 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 29.4 tt0 -66.0 -12.21 53.46 Favored 'General case' 0 C--N 1.369 1.439 0 C-N-CA 123.391 0.676 . . . . 72.25 111.922 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -61.25 -12.29 12.69 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 123.582 0.753 . . . . 74.109999999999999 110.428 167.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -105.85 150.12 25.89 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.979 1.711 . . . . 61.219999999999999 109.222 167.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.4 p -69.33 -20.49 63.87 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.61 0.967 . . . . 73.25 113.61 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.468 ' CE3' HG21 ' A' ' 218' ' ' VAL . 53.0 p-90 -77.38 -43.38 32.98 Favored 'General case' 0 C--O 1.25 1.108 0 N-CA-C 112.681 0.623 . . . . 73.040000000000006 112.681 -175.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -87.56 146.94 25.55 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.703 -0.48 . . . . 74.040000000000006 109.703 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.596 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 65.3 m-70 -143.21 39.59 1.45 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.12 0.968 . . . . 75.439999999999998 111.352 -174.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.25 -169.05 54.77 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 115.919 1.128 . . . . 73.549999999999997 115.919 163.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.464 ' HB2' ' HB2' ' A' ' 174' ' ' GLU . 8.3 Cg_endo -89.09 95.66 0.34 Allowed 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 124.083 3.188 . . . . 74.409999999999997 111.23 171.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.08 153.04 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.389 1.076 . . . . 75.140000000000001 110.82 -170.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.7 m -75.68 156.87 34.35 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.437 1.095 . . . . 64.510000000000005 112.069 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -62.39 -33.51 74.89 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.769 0.828 . . . . 70.420000000000002 112.162 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -66.75 -45.18 79.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.686 0.795 . . . . 75.540000000000006 110.026 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.23 -31.97 70.89 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.571 0.748 . . . . 61.340000000000003 111.043 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.78 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.39 -51.09 71.29 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.699 -0.682 . . . . 51.009999999999998 110.31 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.47 -31.27 71.9 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.994 0.918 . . . . 74.150000000000006 111.562 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -63.99 -45.75 87.61 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.482 0.713 . . . . 73.340000000000003 111.319 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.477 HD12 HH12 ' A' ' 171' ' ' ARG . 66.5 mt -77.43 -39.08 48.17 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 120.867 0.365 . . . . 74.140000000000001 111.375 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.61 HD23 HG13 ' A' ' 190' ' ' VAL . 34.0 tp -74.85 -20.95 59.53 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.732 -0.667 . . . . 72.409999999999997 112.194 -171.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.1 p -60.21 -28.28 67.85 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.052 0.541 . . . . 71.519999999999996 111.456 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.8 m -75.31 -15.26 60.51 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.039 0.935 . . . . 60.310000000000002 112.353 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.15 165.31 50.54 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 113.785 0.274 . . . . 74.219999999999999 113.785 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.3 pt -113.35 -164.74 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.23 1.012 . . . . 74.299999999999997 109.465 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.749 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 25.3 p-10 -49.32 114.12 0.96 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.909 0.884 . . . . 72.349999999999994 112.375 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.39 14.22 60.45 Favored Glycine 0 C--O 1.258 1.605 0 CA-C-N 116.46 -0.337 . . . . 64.519999999999996 113.498 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 70.4 p -74.85 139.49 43.23 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 108.989 -0.745 . . . . 73.409999999999997 108.989 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 232' ' ' LEU . 28.9 p90 -138.32 160.35 39.7 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.215 0.82 . . . . 75.450000000000003 113.215 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.443 HD13 ' NH1' ' A' ' 171' ' ' ARG . 96.4 mt -132.62 132.82 42.89 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.137 -1.431 . . . . 61.32 107.137 166.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 56.6 t -107.72 115.4 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 106.949 -1.501 . . . . 74.450000000000003 106.949 171.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.78 HH11 ' HA ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -159.1 152.34 22.44 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.204 0.602 . . . . 75.420000000000002 110.236 -175.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.657 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 10.9 pt-20 -107.7 156.55 18.96 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.942 0.401 . . . . 64.409999999999997 111.238 -177.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.9 m -90.71 113.45 25.55 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.065 -0.717 . . . . 62.539999999999999 109.065 173.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 33.0 tt0 -70.44 -26.47 63.67 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.427 0.691 . . . . 74.310000000000002 110.626 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.1 p -79.24 5.51 12.09 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.764 1.225 . . . . 62.43 112.183 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 37.5 m -142.93 123.22 7.99 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.668 0.787 . . . . 74.340000000000003 109.88 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.23 111.47 1.28 Allowed 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.298 2.665 . . . . 65.040000000000006 113.528 -171.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.58 9.83 52.25 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-N 115.774 -0.648 . . . . 75.129999999999995 114.552 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -87.53 115.31 24.87 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 109.175 -0.676 . . . . 72.430000000000007 109.175 -176.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.781 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 50.6 mtt85 -110.12 165.71 11.53 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.963 0.905 . . . . 72.019999999999996 108.825 176.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 65.9 m -149.85 142.71 24.76 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.754 0.421 . . . . 63.310000000000002 110.951 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 60.8 mt -111.93 130.77 64.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 N-CA-C 107.409 -1.33 . . . . 73.310000000000002 107.409 161.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 11.4 m -107.92 118.96 38.11 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.498 -1.228 . . . . 60.240000000000002 107.92 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.429 HD21 HD23 ' A' ' 232' ' ' LEU . 47.3 mt -110.03 135.78 50.32 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.334 1.054 . . . . 75.129999999999995 111.289 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 37.3 ttt-85 -121.18 130.78 53.88 Favored 'General case' 0 C--O 1.257 1.453 0 O-C-N 123.766 0.666 . . . . 75.25 109.276 169.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.749 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 15.6 p90 -147.65 136.85 22.34 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.366 1.041 . . . . 73.219999999999999 108.827 173.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 56.28 26.26 10.29 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 124.514 1.126 . . . . 74.540000000000006 113.263 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 97.04 -9.57 65.6 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.168 0.413 . . . . 43.119999999999997 113.222 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 18.9 ttm180 -98.89 124.28 43.72 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.275 0.63 . . . . 75.439999999999998 109.961 -171.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.61 HG13 HD23 ' A' ' 160' ' ' LEU . 59.1 t -104.87 132.96 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.494 1.117 . . . . 65.540000000000006 108.873 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.48 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 40.8 p90 -145.29 163.08 35.58 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.551 0.741 . . . . 74.230000000000004 109.423 171.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -128.62 151.77 49.11 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.006 0.923 . . . . 73.219999999999999 108.784 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.423 ' HE2' HD12 ' A' ' 184' ' ' LEU . 32.9 p90 -143.13 140.48 30.86 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 122.689 0.396 . . . . 74.420000000000002 110.056 168.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -73.72 134.19 43.47 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.257 -0.883 . . . . 73.219999999999999 111.504 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.781 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 80.5 mt -84.68 109.05 17.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 107.224 -1.399 . . . . 63.399999999999999 107.224 163.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -80.2 125.96 30.5 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.435 -0.802 . . . . 73.230000000000004 109.181 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 27.2 m -90.43 113.55 25.5 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.894 -0.78 . . . . 71.150000000000006 108.894 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -58.6 157.98 8.41 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.91 0.884 . . . . 71.400000000000006 111.082 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 23.3 t -68.27 -11.99 60.29 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.361 0.664 . . . . 74.540000000000006 111.569 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -71.46 -13.21 61.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.455 0.702 . . . . 73.219999999999999 111.436 170.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.9 5.47 86.19 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.984 -0.446 . . . . 64.129999999999995 111.984 -170.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -87.72 153.48 21.33 Favored 'General case' 0 C--N 1.346 0.444 0 C-N-CA 124.219 1.008 . . . . 74.140000000000001 109.29 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.427 HD21 HH11 ' A' ' 180' ' ' ARG . 97.3 mt -99.87 153.71 18.93 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.59 0.756 . . . . 71.430000000000007 110.19 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -166.4 169.53 13.89 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.953 0.783 . . . . 75.349999999999994 110.11 172.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 195' ' ' ILE . 73.2 t -132.52 -58.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 105.996 -1.853 . . . . 63.43 105.996 172.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 37.8 t -81.61 131.98 35.29 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.374 -1.285 . . . . 71.219999999999999 107.587 168.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 74.2 p -65.28 -32.59 74.33 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.407 0.683 . . . . 60.43 112.4 -171.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -74.12 -23.92 59.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.721 0.809 . . . . 72.329999999999998 111.219 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 68.6 m -97.37 104.45 16.47 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.153 0.981 . . . . 75.530000000000001 110.104 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 20.2 mmt85 -114.51 137.49 51.79 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.749 0.819 . . . . 63.439999999999998 109.192 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 8.3 m-85 -132.89 133.58 43.45 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.652 0.595 . . . . 64.540000000000006 109.639 -173.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -72.29 -40.71 67.34 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.217 0.607 . . . . 71.230000000000004 110.037 169.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.0 p -123.02 153.87 39.25 Favored 'General case' 0 C--N 1.368 1.371 0 CA-C-O 121.903 0.859 . . . . 70.120000000000005 112.201 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 24.9 tp -70.19 -28.75 65.55 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.118 -1.401 . . . . 71.230000000000004 111.002 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.92 99.57 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.236 0.614 . . . . 43.5 110.852 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -75.82 -31.69 59.49 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.424 -0.807 . . . . 63.5 111.33 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tt -56.95 -46.83 81.83 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 123.856 0.722 . . . . 73.349999999999994 110.544 169.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.468 HG21 ' CE3' ' A' ' 146' ' ' TRP . 51.3 t -72.47 -37.63 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.892 0.877 . . . . 74.510000000000005 111.444 -175.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -60.14 -50.59 73.07 Favored 'General case' 0 C--O 1.258 1.528 0 CA-C-O 121.622 0.725 . . . . 75.109999999999999 110.033 173.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.43 ' CE1' HG11 ' A' ' 224' ' ' VAL . 50.0 t60 -52.51 -54.72 28.79 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.136 -1.393 . . . . 74.140000000000001 109.787 177.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -64.29 -25.42 68.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.866 -1.061 . . . . 63.109999999999999 112.051 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.2 t -74.0 -28.54 61.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.743 0.417 . . . . 63.240000000000002 111.793 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.7 t -109.86 -17.44 13.64 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.299 1.962 . . . . 73.420000000000002 116.299 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.43 HG11 ' CE1' ' A' ' 220' ' ' HIS . 36.0 m -96.04 152.47 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 115.371 1.619 . . . . 60.140000000000001 115.371 -166.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -90.98 -1.76 57.78 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.409 2.683 . . . . 71.439999999999998 112.523 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.17 13.94 1.33 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 128.326 2.65 . . . . 63.439999999999998 112.751 -141.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.1 18.0 3.94 Favored Glycine 0 C--N 1.346 1.139 0 C-N-CA 125.443 1.497 . . . . 73.530000000000001 110.933 -171.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.11 120.75 33.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.214 1.006 . . . . 72.030000000000001 109.84 165.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.48 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 80.1 mt -60.15 -40.36 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.391 1.077 . . . . 74.450000000000003 109.497 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.9 t -137.58 140.38 40.96 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 114.835 -1.075 . . . . 74.140000000000001 108.756 170.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 80.6 p -71.77 155.77 40.08 Favored 'General case' 0 C--O 1.247 0.93 0 N-CA-C 108.567 -0.901 . . . . 65.510000000000005 108.567 170.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.453 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . 27.8 mt -67.82 100.8 0.98 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 108.661 -0.866 . . . . 61.439999999999998 108.661 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -80.28 -49.99 10.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.309 0.644 . . . . 72.430000000000007 109.886 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 167' ' ' SER . 9.6 p90 -160.57 150.41 14.49 Favored Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 109.675 -0.491 . . . . 75.329999999999998 109.675 173.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.89 138.95 17.09 Favored 'Trans proline' 0 C--N 1.365 1.436 0 C-N-CA 121.964 1.776 . . . . 71.219999999999999 112.495 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.31 142.94 97.1 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 108.68 -0.859 . . . . 62.520000000000003 108.68 168.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -69.09 169.55 17.79 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.795 2.33 . . . . 64.099999999999994 114.452 -170.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.483 ' NZ ' ' HG2' ' A' ' 142' ' ' GLU . 67.1 mttm . . . . . 0 N--CA 1.475 0.79 0 CA-C-N 114.536 -1.211 . . . . 44.130000000000003 109.678 165.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.6 p . . . . . 0 N--CA 1.475 0.798 0 CA-C-O 121.006 0.431 . . . . 34.43 111.299 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.8 mt -102.58 126.56 32.6 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 109.13 -0.693 . . . . 41.340000000000003 109.13 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.561 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 75.8 Cg_endo -74.03 174.49 12.32 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.785 2.323 . . . . 71.549999999999997 112.371 177.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.71 147.66 28.34 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.836 0.455 . . . . 64.310000000000002 111.491 -174.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HB3' HD11 ' A' ' 23' ' ' ILE . 85.1 mt -88.19 93.69 9.58 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.366 -0.976 . . . . 72.340000000000003 108.366 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -96.84 -48.68 5.36 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.109 0.564 . . . . 54.450000000000003 110.876 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.518 ' HE1' ' HB2' ' A' ' 115' ' ' ASN . 84.0 m-85 -105.93 111.04 23.53 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.092 0.557 . . . . 73.430000000000007 110.183 178.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' A' ' 20' ' ' LEU . 47.2 mm -118.08 110.44 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.006 0.523 . . . . 51.149999999999999 109.614 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' NZ ' ' HB2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.827 0 C-N-CA 124.868 1.267 . . . . 63.340000000000003 108.724 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 CA--C 1.548 1.219 0 N-CA-C 113.139 0.399 . . . . 60.340000000000003 113.139 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.498 ' HA ' ' HB3' ' A' ' 140' ' ' SER . 59.8 t30 -94.15 78.96 4.02 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 109.408 -0.59 . . . . 71.209999999999994 109.408 -176.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.658 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 33.5 tp -107.96 123.15 48.21 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.306 -0.861 . . . . 65.409999999999997 111.203 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.71 176.08 5.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.126 1.771 . . . . 75.040000000000006 108.879 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.43 148.88 24.34 Favored 'Isoleucine or valine' 0 C--O 1.252 1.234 0 N-CA-C 108.507 -0.923 . . . . 73.5 108.507 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.16 118.44 20.4 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 123.67 0.606 . . . . 61.299999999999997 109.654 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.2 mt -82.01 -25.23 34.87 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.969 0.908 . . . . 64.420000000000002 110.611 173.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -132.47 155.92 47.68 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.226 0.61 . . . . 73.209999999999994 110.614 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -72.61 146.05 46.9 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.012 -0.995 . . . . 63.299999999999997 110.542 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -160.65 112.31 1.9 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.693 0.797 . . . . 61.450000000000003 109.238 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.4 t -85.45 137.97 19.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.671 -0.863 . . . . 61.520000000000003 108.671 172.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.56 119.58 7.3 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.399 0.68 . . . . 75.530000000000001 110.576 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.6 m -70.69 -22.62 62.44 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.474 0.709 . . . . 75.340000000000003 110.626 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -159.11 -173.67 27.83 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.94 -0.864 . . . . 61.039999999999999 110.94 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.17 -32.42 73.99 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.938 0.895 . . . . 64.049999999999997 111.312 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.417 HD22 HD12 ' A' ' 23' ' ' ILE . 23.2 p-10 -68.63 -24.47 64.56 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.125 0.97 . . . . 53.340000000000003 112.367 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.4 p -101.43 162.94 12.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.18 0.592 . . . . 62.119999999999997 110.065 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.443 HD21 HG23 ' A' ' 123' ' ' THR . 64.7 tp -114.75 137.94 51.33 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.555 0.342 . . . . 74.239999999999995 110.875 -177.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.7 m -78.11 116.11 18.33 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.885 -0.598 . . . . 74.310000000000002 110.051 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 pt -123.69 140.82 46.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.638 0.775 . . . . 73.109999999999999 110.334 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.7 m -115.88 148.14 40.31 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.498 -0.926 . . . . 65.340000000000003 108.498 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -53.89 130.99 39.17 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.954 0.502 . . . . 73.040000000000006 111.284 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.47 -21.61 45.11 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.584 -0.28 . . . . 63.329999999999998 112.806 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -76.84 130.26 37.36 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.309 -0.997 . . . . 71.219999999999999 108.309 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.492 ' HB3' HD11 ' A' ' 84' ' ' LEU . 43.7 mttp -89.87 130.58 36.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.779 0.432 . . . . 71.519999999999996 109.885 -175.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.02 133.82 53.11 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.97 0.908 . . . . 71.25 109.174 -166.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.7 mtm-85 -94.9 108.03 20.06 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 118.736 0.698 . . . . 62.399999999999999 109.429 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 76.8 t -95.11 129.52 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 117.948 0.34 . . . . 72.430000000000007 110.111 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -105.23 -3.77 22.49 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.079 0.952 . . . . 73.420000000000002 111.321 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.31 164.79 16.86 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.919 -0.872 . . . . 63.030000000000001 110.919 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -95.44 171.79 8.48 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.065 -0.717 . . . . 73.239999999999995 109.065 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -63.5 150.11 44.6 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.831 -0.803 . . . . 63.119999999999997 108.831 175.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -70.61 -11.04 60.69 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 122.872 0.469 . . . . 74.109999999999999 110.845 -176.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.518 ' HB2' ' HE1' ' A' ' 22' ' ' PHE . 62.9 t30 -109.44 -2.98 17.36 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.342 1.057 . . . . 45.039999999999999 110.567 169.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.23 -16.32 59.07 Favored Glycine 0 N--CA 1.48 1.616 0 C-N-CA 123.775 0.703 . . . . 35.240000000000002 114.375 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . 33.7 mt-10 -54.17 -59.9 4.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.847 1.259 . . . . 71.129999999999995 112.955 -172.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -102.8 -179.88 4.09 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.814 -1.085 . . . . 75.340000000000003 109.026 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.63 129.6 12.56 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.52 0.728 . . . . 64.140000000000001 109.226 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -74.96 107.19 6.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.844 0.458 . . . . 73.310000000000002 110.555 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -110.58 160.14 16.93 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.547 0.739 . . . . 73.25 110.386 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -133.88 117.94 17.37 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.592 0.757 . . . . 75.120000000000005 109.732 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.443 HG23 HD21 ' A' ' 99' ' ' LEU . 68.4 p -113.46 -177.36 3.11 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.786 0.834 . . . . 74.129999999999995 110.273 175.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -70.73 -8.89 55.52 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.117 0.567 . . . . 64.530000000000001 110.849 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -79.77 -27.36 40.43 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.86 1.264 . . . . 60.200000000000003 110.598 173.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.3 -150.73 21.78 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.164 -0.774 . . . . 50.450000000000003 111.164 -173.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -128.25 154.1 46.24 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 117.724 0.762 . . . . 75.109999999999999 109.701 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 171.66 178.68 42.19 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 123.41 0.444 . . . . 72.040000000000006 112.018 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -89.94 120.57 31.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.383 0.673 . . . . 73.219999999999999 110.712 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.8 m -113.99 154.09 46.08 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 124.106 0.962 . . . . 73.200000000000003 109.475 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.24 127.98 17.63 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 121.502 1.468 . . . . 55.409999999999997 111.058 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.4 m -58.63 -19.52 39.64 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.822 0.849 . . . . 74.25 111.956 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -70.73 -24.63 62.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.585 1.154 . . . . 65.219999999999999 111.604 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -98.99 -0.7 41.54 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.09 0.956 . . . . 74.230000000000004 112.639 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.3 pt -126.92 153.21 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 118.231 0.468 . . . . 75.010000000000005 110.83 -171.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.5 t -148.73 134.4 9.64 Favored Pre-proline 0 N--CA 1.484 1.259 0 CA-C-O 119.613 -0.232 . . . . 61.219999999999999 110.717 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.97 131.82 32.23 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.434 2.09 . . . . 72.230000000000004 112.404 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.8 m -119.6 -61.1 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.613 0.765 . . . . 73.409999999999997 112.089 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.658 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 66.1 t30 -89.96 -16.85 29.03 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.508 0.723 . . . . 74.5 109.732 -175.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.498 ' HB3' ' HA ' ' A' ' 83' ' ' ASN . 4.6 p -72.42 -157.75 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.382 1.473 . . . . 72.109999999999999 111.563 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.498 HD13 HD23 ' A' ' 214' ' ' LEU . 76.5 mt -57.35 -25.54 59.59 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.145 1.165 . . . . 73.510000000000005 114.145 -175.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -71.41 -14.2 62.08 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 119.054 0.843 . . . . 73.409999999999997 111.187 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -62.35 -22.36 66.03 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.424 0.69 . . . . 75.219999999999999 109.997 168.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -75.37 131.35 40.18 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 108.542 -0.91 . . . . 74.420000000000002 108.542 163.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.1 m -66.36 -15.51 63.33 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 112.55 0.574 . . . . 41.140000000000001 112.55 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.607 ' HB3' ' HG3' ' A' ' 235' ' ' PRO . 29.7 p-90 -85.31 -26.8 26.36 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 113.204 0.816 . . . . 73.420000000000002 113.204 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 42.2 t80 -94.01 132.22 38.71 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.311 -0.625 . . . . 73.349999999999994 109.311 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -126.25 13.42 7.72 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.944 0.72 . . . . 71.109999999999999 112.944 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.26 -159.25 53.53 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-O 119.548 -0.585 . . . . 40.100000000000001 114.54 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.21 104.22 1.75 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.302 2.668 . . . . 64.439999999999998 112.951 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.458 ' HB ' ' HD3' ' A' ' 171' ' ' ARG . 17.3 t -139.86 152.64 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 122.936 0.494 . . . . 64.430000000000007 109.782 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.7 m -73.87 158.48 34.42 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 123.831 0.852 . . . . 71.200000000000003 112.397 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 157' ' ' GLU . 52.7 ptt85 -65.97 -32.48 73.99 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.506 -1.225 . . . . 71.219999999999999 112.088 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -72.44 -42.17 65.34 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.106 0.562 . . . . 54.409999999999997 110.365 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.64 -39.58 93.96 Favored 'General case' 0 C--O 1.251 1.167 0 C-N-CA 123.242 0.617 . . . . 34.299999999999997 110.484 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.518 ' HB2' ' HD2' ' A' ' 171' ' ' ARG . . . -55.45 -47.96 75.24 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.087 -0.961 . . . . 63.439999999999998 111.105 172.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 43.8 mt-10 -71.99 -26.96 62.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.958 0.503 . . . . 65.230000000000004 112.064 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -62.52 -43.52 98.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.772 0.429 . . . . 73.439999999999998 110.343 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.605 HD12 HH22 ' A' ' 171' ' ' ARG . 66.8 mt -78.12 -30.1 49.25 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.955 -0.566 . . . . 73.329999999999998 112.258 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.531 HD23 HG13 ' A' ' 190' ' ' VAL . 37.4 tp -78.93 -31.07 45.02 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.916 0.486 . . . . 64.310000000000002 111.487 -174.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 67.8 p -63.53 -19.88 65.15 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.663 0.785 . . . . 52.509999999999998 111.158 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.4 m -80.59 20.65 0.71 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.124 1.37 . . . . 62.5 111.781 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.63 177.81 16.88 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 114.613 0.605 . . . . 75.239999999999995 114.613 -174.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.7 pt -123.58 -164.55 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 124.819 1.248 . . . . 73.409999999999997 108.757 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.76 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 26.5 p-10 -48.19 120.41 3.55 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.6 0.76 . . . . 72.329999999999998 112.566 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.42 13.81 75.38 Favored Glycine 0 C--O 1.258 1.633 0 CA-C-N 116.621 -0.263 . . . . 70.239999999999995 113.335 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.1 t -73.14 127.79 33.6 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.368 -0.975 . . . . 73.239999999999995 108.368 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' ' 232' ' ' LEU . 23.9 p90 -137.95 152.76 49.27 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.706 0.684 . . . . 75.299999999999997 112.575 -174.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.569 HD22 HH21 ' A' ' 171' ' ' ARG . 87.6 mt -131.2 131.72 44.18 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.91 -1.041 . . . . 74.530000000000001 108.59 171.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.501 HG22 HG12 ' A' ' 182' ' ' ILE . 38.9 t -109.09 120.53 60.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.199 -1.408 . . . . 72.409999999999997 107.199 174.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.605 HH22 HD12 ' A' ' 159' ' ' LEU . 16.9 ptp180 -159.17 153.32 23.65 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.707 -0.479 . . . . 63.009999999999998 109.707 -176.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 13.1 pt-20 -97.42 157.41 16.01 Favored 'General case' 0 C--O 1.25 1.096 0 O-C-N 123.704 0.628 . . . . 75.209999999999994 109.862 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.618 ' HB3' ' HB2' ' A' ' 176' ' ' SER . 34.0 t -79.93 144.86 32.99 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.479 -0.782 . . . . 54.409999999999997 109.337 174.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -71.55 -42.79 67.43 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.63 -0.714 . . . . 72.25 110.805 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.8 t -89.52 -1.87 58.17 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.291 0.636 . . . . 62.219999999999999 112.03 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.618 ' HB2' ' HB3' ' A' ' 173' ' ' SER . 15.0 m -116.85 104.24 51.27 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 109.344 -0.613 . . . . 73.219999999999999 109.344 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.24 113.37 1.32 Allowed 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 123.402 2.735 . . . . 60.229999999999997 112.635 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.27 14.28 46.98 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 114.646 0.618 . . . . 62.109999999999999 114.646 173.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -89.55 112.93 24.26 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.25 -1.019 . . . . 72.439999999999998 108.25 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 78.2 mtt85 -104.3 161.23 14.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.904 -1.044 . . . . 73.530000000000001 108.807 -168.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.3 m -151.77 152.91 33.32 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 123.278 0.631 . . . . 75.409999999999997 109.763 -175.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.501 HG12 HG22 ' A' ' 170' ' ' VAL . 28.4 mt -118.8 137.68 51.97 Favored 'Isoleucine or valine' 0 C--O 1.25 1.123 0 N-CA-C 108.226 -1.027 . . . . 63.439999999999998 108.226 173.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.8 m -119.47 120.7 37.59 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.198 -1.038 . . . . 71.340000000000003 108.198 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.438 HD21 HD23 ' A' ' 232' ' ' LEU . 62.1 mt -103.61 141.3 36.28 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.528 0.731 . . . . 71.299999999999997 111.246 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -117.93 134.36 55.03 Favored 'General case' 0 C--O 1.26 1.636 0 N-CA-C 107.253 -1.388 . . . . 71.439999999999998 107.253 166.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.76 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 34.7 t80 -157.81 111.71 2.55 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.719 -1.128 . . . . 72.040000000000006 109.503 -172.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 50.96 44.17 28.54 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.881 1.272 . . . . 72.340000000000003 112.718 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.55 -1.5 87.23 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 114.717 0.647 . . . . 61.240000000000002 114.717 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -102.65 125.95 49.56 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.271 0.629 . . . . 71.439999999999998 109.448 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.531 HG13 HD23 ' A' ' 160' ' ' LEU . 72.1 t -115.1 117.35 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.961 0.904 . . . . 71.200000000000003 108.711 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -136.58 144.52 44.2 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.413 0.625 . . . . 53.119999999999997 110.637 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -122.92 136.36 54.83 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.231 1.012 . . . . 72.040000000000006 109.766 -167.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -145.34 141.95 28.97 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.842 0.353 . . . . 71.540000000000006 111.343 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -80.03 134.39 36.22 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.756 0.822 . . . . 72.299999999999997 111.081 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 91.3 mt -77.24 101.99 3.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 N-CA-C 107.58 -1.267 . . . . 71.510000000000005 107.58 161.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -72.7 122.9 22.23 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.177 -0.92 . . . . 74.519999999999996 109.152 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 21.6 m -100.34 111.14 23.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.143 0.577 . . . . 71.319999999999993 109.77 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.16 157.97 27.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.893 0.877 . . . . 63.520000000000003 111.499 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 77.9 p -62.74 -18.8 63.18 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.315 -0.857 . . . . 72.219999999999999 111.413 174.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -69.05 -15.85 63.56 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.894 1.678 . . . . 72.420000000000002 111.803 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 86.5 2.52 84.91 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 111.605 -0.598 . . . . 55.509999999999998 111.605 -170.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -89.93 143.12 27.06 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.082 0.553 . . . . 72.030000000000001 111.036 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 83.3 mt -95.57 150.15 20.65 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.196 0.998 . . . . 73.409999999999997 110.059 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -164.87 158.37 17.21 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.214 0.606 . . . . 74.510000000000005 111.01 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 94.9 t -127.18 -56.67 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 124.564 1.146 . . . . 71.420000000000002 108.985 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.3 t -100.75 -169.08 1.66 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.902 1.281 . . . . 63.310000000000002 110.433 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 50.9 m -76.81 -43.34 36.96 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.475 0.71 . . . . 75.420000000000002 112.153 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.56 -29.86 63.91 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.242 0.544 . . . . 75.310000000000002 111.368 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.523 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 83.6 p -68.65 118.17 11.31 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.411 -0.813 . . . . 53.240000000000002 111.813 -173.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -147.16 114.48 6.28 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.983 1.313 . . . . 65.230000000000004 107.653 170.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.523 ' CE2' ' HB2' ' A' ' 209' ' ' SER . 21.3 m-85 -130.53 138.83 50.4 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 118.449 0.568 . . . . 65.230000000000004 111.805 -171.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -79.95 -31.11 40.0 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.963 0.505 . . . . 73.129999999999995 109.968 169.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 60.1 p -126.59 148.09 49.81 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.734 0.778 . . . . 72.0 111.966 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.498 HD23 HD13 ' A' ' 141' ' ' LEU . 24.9 tp -69.87 -21.67 63.31 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.22 -1.355 . . . . 63.439999999999998 111.194 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.87 -47.49 77.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.394 0.678 . . . . 72.129999999999995 110.515 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -70.14 -31.74 69.4 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 115.705 -0.68 . . . . 74.329999999999998 111.008 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 10.1 tt -55.47 -56.28 22.06 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 123.699 0.625 . . . . 72.439999999999998 109.859 172.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.58 -39.15 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.736 0.814 . . . . 64.430000000000007 111.622 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -59.83 -57.04 14.61 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.692 0.758 . . . . 73.230000000000004 111.222 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.436 ' CE1' HG11 ' A' ' 224' ' ' VAL . 40.4 t-80 -56.52 -44.16 80.53 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.771 -1.104 . . . . 74.510000000000005 109.854 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 217' ' ' LEU . 1.9 t60 -72.28 -19.96 61.6 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.535 1.134 . . . . 73.109999999999999 110.417 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 29.1 t -82.76 -20.26 36.26 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.016 0.926 . . . . 74.239999999999995 110.895 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.8 t -115.92 -8.52 11.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.401 2.0 . . . . 72.150000000000006 116.401 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.436 HG11 ' CE1' ' A' ' 220' ' ' HIS . 15.3 m -89.54 143.11 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 120.95 1.705 . . . . 72.299999999999997 114.505 -171.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.58 -0.53 57.58 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 128.713 2.805 . . . . 64.049999999999997 111.883 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -78.23 13.85 1.37 Allowed 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 130.066 3.347 . . . . 61.109999999999999 112.621 -146.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.83 18.68 3.51 Favored Glycine 0 C--N 1.343 0.928 0 C-N-CA 124.038 0.828 . . . . 51.32 111.43 -172.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 71.4 mt -92.06 121.47 33.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.627 0.771 . . . . 72.319999999999993 110.617 163.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 76.6 mt -53.76 -42.58 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.779 0.832 . . . . 61.509999999999998 109.546 169.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -140.87 140.42 34.57 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.673 -1.149 . . . . 53.439999999999998 108.446 173.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.1 p -69.45 162.98 26.32 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.933 -0.576 . . . . 74.310000000000002 109.565 171.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.438 HD23 HD21 ' A' ' 184' ' ' LEU . 57.2 mt -65.55 103.84 0.91 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 110.073 -0.343 . . . . 71.209999999999994 110.073 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -77.99 -60.91 2.18 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.194 -0.669 . . . . 71.549999999999997 109.194 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -158.36 149.53 16.49 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 120.492 -0.483 . . . . 74.400000000000006 112.143 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.607 ' HG3' ' HB3' ' A' ' 146' ' ' TRP . 46.5 Cg_exo -58.33 123.01 12.64 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.882 2.388 . . . . 53.109999999999999 112.195 172.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -58.27 135.21 84.86 Favored Pre-proline 0 C--O 1.246 0.893 0 O-C-N 123.665 0.603 . . . . 53.130000000000003 109.981 175.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.96 135.74 42.13 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.887 1.725 . . . . 75.25 113.979 -175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.524 ' HA ' HD22 ' A' ' 159' ' ' LEU . 18.3 ptpt . . . . . 0 CA--C 1.548 0.887 0 CA-C-N 114.71 -1.132 . . . . 70.209999999999994 109.235 162.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.1 m . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 121.218 0.532 . . . . 71.5 110.303 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.3 mt -107.23 125.15 33.14 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.103 -1.073 . . . . 72.549999999999997 108.103 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.17 174.51 8.89 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.786 2.324 . . . . 75.349999999999994 112.158 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.43 145.67 39.14 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.54 0.336 . . . . 64.299999999999997 110.124 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.487 ' HB3' HD11 ' A' ' 23' ' ' ILE . 64.6 mt -89.46 101.96 14.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.373 1.069 . . . . 72.040000000000006 109.684 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -96.05 -50.92 4.65 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.419 0.688 . . . . 71.120000000000005 110.074 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -104.45 116.54 32.29 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.197 0.999 . . . . 74.329999999999998 110.077 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 20' ' ' LEU . 37.3 mm -118.38 114.05 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.617 0.767 . . . . 54.329999999999998 111.124 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.63 ' H ' ' HE1' ' A' ' 129' ' ' TRP . 75.5 mmtt . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 125.07 1.348 . . . . 74.219999999999999 109.085 166.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 CA--C 1.556 1.614 0 N-CA-C 115.008 1.118 . . . . 64.140000000000001 115.008 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.03 73.94 0.7 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.771 0.796 . . . . 73.319999999999993 111.232 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.1 tp -91.11 119.53 31.31 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.668 0.747 . . . . 73.409999999999997 110.939 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -111.96 173.86 6.16 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.293 1.437 . . . . 74.219999999999999 109.417 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.31 154.18 12.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.633 -1.247 . . . . 71.129999999999995 107.633 174.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.475 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -94.85 132.89 39.17 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.334 -0.247 . . . . 72.109999999999999 110.334 173.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.472 ' HG ' ' OG1' ' A' ' 136' ' ' THR . 79.3 mt -86.21 -20.94 27.78 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.479 0.711 . . . . 71.530000000000001 110.587 172.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -129.09 153.21 47.87 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.631 -0.713 . . . . 71.129999999999995 109.474 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.67 160.54 32.42 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.363 -0.835 . . . . 74.319999999999993 108.777 163.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.496 ' HB3' HG12 ' A' ' 101' ' ' ILE . 56.3 t80 -159.87 111.18 1.98 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.457 -0.942 . . . . 74.230000000000004 108.457 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.0 t -81.21 124.26 38.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 107.235 -1.394 . . . . 54.409999999999997 107.235 170.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB2' ' N ' ' A' ' 100' ' ' SER . . . -66.14 143.99 56.95 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.993 0.517 . . . . 74.519999999999996 110.799 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.5 m -76.59 -13.62 60.06 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.735 0.814 . . . . 52.130000000000003 110.655 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.68 -155.14 26.36 Favored Glycine 0 C--N 1.353 1.481 0 N-CA-C 111.823 -0.511 . . . . 71.019999999999996 111.823 176.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -65.91 -28.92 69.29 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.253 1.021 . . . . 54.240000000000002 111.416 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -69.38 -13.73 62.53 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.984 1.314 . . . . 55.130000000000003 112.419 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.0 p -128.82 162.8 26.62 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.348 1.059 . . . . 60.32 109.707 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.456 ' HB3' HG13 ' A' ' 130' ' ' VAL . 53.7 tp -111.39 121.61 45.67 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.198 0.599 . . . . 74.099999999999994 110.382 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.419 ' N ' ' HB2' ' A' ' 93' ' ' ALA . 16.0 p -72.12 116.08 12.12 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.524 -0.547 . . . . 60.43 109.524 173.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.496 HG12 ' HB3' ' A' ' 91' ' ' PHE . 33.5 pt -122.18 161.51 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.145 0.578 . . . . 75.329999999999998 109.735 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 33.3 m -121.54 148.33 44.62 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.364 0.666 . . . . 75.010000000000005 110.172 -177.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -57.47 128.31 36.38 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.665 0.386 . . . . 72.030000000000001 110.255 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.06 -21.39 37.36 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 120.19 -0.228 . . . . 72.120000000000005 112.923 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -67.91 131.16 44.99 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.516 0.726 . . . . 72.109999999999999 110.282 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -78.71 121.21 24.44 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.146 0.578 . . . . 64.530000000000001 110.367 177.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.518 ' HA ' HG22 ' A' ' 123' ' ' THR . 14.7 mt -103.66 152.39 21.85 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.166 0.986 . . . . 54.119999999999997 108.424 -175.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 72.5 mtt-85 -123.25 104.74 9.34 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.809 -1.182 . . . . 72.430000000000007 107.809 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 53.9 t -96.01 114.22 32.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 108.449 -0.945 . . . . 54.25 108.449 -172.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.4 mt -79.74 -10.81 59.84 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.608 -1.178 . . . . 62.140000000000001 110.59 -174.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.89 157.19 9.2 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 110.521 -1.032 . . . . 62.229999999999997 110.521 173.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -94.11 168.01 11.21 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.601 -0.889 . . . . 74.430000000000007 108.601 174.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -77.63 147.46 35.56 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.578 -1.267 . . . . 53.350000000000001 107.578 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -70.04 -17.07 63.24 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.584 0.754 . . . . 74.040000000000006 112.371 -175.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.505 ' HB3' ' HG2' ' A' ' 117' ' ' GLU . 65.2 t30 -86.05 -11.49 52.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.79 0.436 . . . . 72.430000000000007 110.527 174.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.38 14.06 77.13 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.385 -0.37 . . . . 42.240000000000002 113.137 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.505 ' HG2' ' HB3' ' A' ' 115' ' ' ASN . 7.9 pt-20 -75.38 -56.02 5.12 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.519 1.128 . . . . 75.239999999999995 110.629 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -124.59 179.09 5.1 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.796 1.238 . . . . 73.209999999999994 108.813 -176.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.3 133.88 16.59 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.243 0.617 . . . . 74.230000000000004 110.154 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -81.11 95.65 6.93 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 109.099 -0.704 . . . . 73.430000000000007 109.099 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -104.91 170.26 7.97 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.158 -0.928 . . . . 74.239999999999995 110.854 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -148.61 129.5 14.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.897 -1.047 . . . . 72.319999999999993 108.544 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 107' ' ' LEU . 72.1 p -131.92 -171.13 2.55 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.526 1.13 . . . . 52.530000000000001 108.995 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -68.72 -8.55 43.78 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.607 0.763 . . . . 65.530000000000001 111.048 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.437 ' HB2' HD11 ' A' ' 99' ' ' LEU . 42.0 m-20 -83.16 -24.26 32.57 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.278 1.031 . . . . 75.400000000000006 110.144 173.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 127.99 -167.91 20.12 Favored Glycine 0 C--N 1.354 1.574 0 CA-C-O 119.668 -0.518 . . . . 72.430000000000007 112.183 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -100.14 157.76 16.34 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 117.699 0.749 . . . . 61.32 109.889 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.47 177.87 36.7 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 112.021 -0.432 . . . . 62.520000000000003 112.021 174.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.63 ' HE1' ' H ' ' A' ' 24' ' ' LYS . 84.3 m95 -91.08 134.67 34.33 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.367 0.603 . . . . 72.140000000000001 111.383 -176.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 99' ' ' LEU . 5.4 m -136.47 140.4 32.31 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.726 1.61 . . . . 62.329999999999998 108.551 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.81 143.95 47.14 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.012 1.808 . . . . 64.450000000000003 111.679 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.412 ' HA ' HG12 ' A' ' 135' ' ' ILE . 23.1 m -60.32 -19.62 55.99 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 124.352 1.061 . . . . 74.25 113.12 -173.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -79.38 -27.03 41.89 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 112.298 0.481 . . . . 71.25 112.298 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -79.37 -18.92 51.43 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.507 0.504 . . . . 61.119999999999997 110.509 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.551 HD12 HG21 ' A' ' 109' ' ' VAL . 18.7 pt -118.65 146.0 23.86 Favored 'Isoleucine or valine' 0 C--N 1.364 1.201 0 C-N-CA 123.463 0.705 . . . . 74.129999999999995 110.278 -165.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.472 ' OG1' ' HG ' ' A' ' 88' ' ' LEU . 9.6 m -149.66 112.14 3.41 Favored Pre-proline 0 CA--C 1.559 1.291 0 CA-C-O 119.196 -0.431 . . . . 52.009999999999998 112.145 -163.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.92 116.35 4.25 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.426 2.084 . . . . 75.109999999999999 112.608 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.5 m -84.99 -26.63 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.089 0.471 . . . . 63.210000000000001 110.04 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -86.74 16.81 4.42 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.947 -1.024 . . . . 75.219999999999999 110.54 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.0 t -49.54 125.9 12.32 Favored 'General case' 0 C--N 1.361 1.081 0 C-N-CA 123.938 0.895 . . . . 61.439999999999998 110.833 177.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.3 mt -60.85 -11.28 7.28 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.595 1.158 . . . . 70.349999999999994 112.0 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -53.6 -14.45 0.86 Allowed 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.527 1.531 . . . . 71.439999999999998 113.593 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -55.81 -35.04 65.91 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 109.483 -0.562 . . . . 75.329999999999998 109.483 172.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -89.37 123.24 33.35 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.283 -1.377 . . . . 72.219999999999999 107.283 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.4 m -67.04 -6.56 17.69 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 114.197 1.184 . . . . 54.310000000000002 114.197 -166.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 38.7 p-90 -69.2 -35.68 76.49 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.04 0.385 . . . . 75.400000000000006 112.04 174.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.401 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 52.2 t80 -93.25 145.69 24.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.469 0.708 . . . . 62.329999999999998 109.187 177.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -135.38 7.16 3.32 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 112.986 0.735 . . . . 74.200000000000003 112.986 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 89.92 -167.57 33.42 Favored Glycine 0 N--CA 1.477 1.389 0 N-CA-C 115.091 0.797 . . . . 73.299999999999997 115.091 168.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.85 101.04 1.14 Allowed 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 123.399 2.733 . . . . 52.32 111.464 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.671 HG21 HH21 ' A' ' 171' ' ' ARG . 35.0 t -141.34 150.14 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 CA-C-N 116.065 -0.516 . . . . 72.340000000000003 110.027 -172.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.7 m -67.49 149.4 50.24 Favored 'General case' 0 C--O 1.252 1.205 0 C-N-CA 124.624 1.17 . . . . 71.049999999999997 111.965 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -57.72 -34.23 69.26 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.327 -0.851 . . . . 75.049999999999997 110.801 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -57.53 -55.15 38.6 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.379 0.672 . . . . 54.350000000000001 110.595 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.5 91.2 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.723 0.809 . . . . 54.25 111.005 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.18 -52.35 65.93 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.206 -0.907 . . . . 73.120000000000005 111.383 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -72.11 -27.72 62.82 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.953 0.901 . . . . 52.43 110.293 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -62.52 -47.65 82.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.043 0.537 . . . . 75.209999999999994 110.933 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.737 HD12 HH12 ' A' ' 171' ' ' ARG . 81.8 mt -66.88 -41.86 86.53 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.091 0.472 . . . . 73.420000000000002 110.746 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.473 HD23 HG13 ' A' ' 190' ' ' VAL . 31.5 tp -66.44 -24.29 66.42 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.273 -0.876 . . . . 64.319999999999993 111.984 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 36.5 t -63.97 -20.41 65.86 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.086 0.954 . . . . 64.430000000000007 112.432 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.8 p -105.73 15.83 26.22 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.337 0.655 . . . . 61.340000000000003 111.229 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -99.75 157.98 19.74 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 116.223 -0.444 . . . . 75.349999999999994 112.66 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 20.7 pt -107.14 -163.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.044 0.938 . . . . 54.329999999999998 110.172 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.808 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 26.7 p-10 -47.82 115.53 1.19 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.225 1.01 . . . . 75.430000000000007 113.125 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 86.04 13.65 68.57 Favored Glycine 0 C--O 1.255 1.419 0 CA-C-N 116.168 -0.469 . . . . 51.0 112.581 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 22.2 t -72.66 133.72 44.76 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.623 -0.88 . . . . 73.310000000000002 108.623 176.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.555 ' HB3' HD23 ' A' ' 184' ' ' LEU . 14.5 p90 -142.25 162.55 35.18 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.405 0.52 . . . . 52.119999999999997 112.405 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.532 ' HB3' ' HD3' ' A' ' 171' ' ' ARG . 80.4 mt -141.93 133.15 26.31 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.253 -1.017 . . . . 43.149999999999999 108.253 172.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.43 110.9 32.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 107.543 -1.281 . . . . 71.450000000000003 107.543 174.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.737 HH12 HD12 ' A' ' 159' ' ' LEU . 4.4 mmm-85 -120.68 162.51 19.57 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.048 -1.093 . . . . 63.329999999999998 108.048 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.616 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 21.4 pt-20 -117.15 155.33 29.54 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.038 0.447 . . . . 75.239999999999995 110.099 165.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 37.2 m -86.02 127.73 34.71 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.95 -1.023 . . . . 74.319999999999993 110.424 -176.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -70.63 -34.71 72.39 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.103 1.361 . . . . 63.130000000000003 110.565 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 36.0 p -91.15 -14.76 30.54 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.577 1.151 . . . . 55.509999999999998 111.882 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 44.7 m -135.42 76.25 56.36 Favored Pre-proline 0 N--CA 1.477 0.924 0 N-CA-C 108.117 -1.068 . . . . 63.119999999999997 108.117 171.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.63 141.85 46.91 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.879 2.386 . . . . 72.019999999999996 112.968 -174.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.93 -22.65 27.65 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.726 -0.67 . . . . 75.040000000000006 111.903 -171.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -93.07 120.05 32.95 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.717 0.807 . . . . 73.409999999999997 109.104 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.616 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 52.1 mtt180 -110.52 169.57 8.66 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.205 -0.907 . . . . 73.5 109.724 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.7 t -152.18 137.3 17.36 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 123.731 0.812 . . . . 62.420000000000002 109.204 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.64 133.06 53.54 Favored 'Isoleucine or valine' 0 C--O 1.247 0.933 0 N-CA-C 107.601 -1.259 . . . . 75.120000000000005 107.601 171.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 19.8 m -111.49 117.28 32.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.661 -1.237 . . . . 75.400000000000006 107.661 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.555 HD23 ' HB3' ' A' ' 168' ' ' PHE . 43.5 mt -103.84 143.26 33.06 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.508 1.123 . . . . 65.420000000000002 110.863 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 29.7 ttt180 -132.27 129.87 40.15 Favored 'General case' 0 C--O 1.256 1.442 0 C-N-CA 124.059 0.944 . . . . 73.519999999999996 108.47 169.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.808 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 4.4 p90 -147.74 137.52 22.68 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.418 -0.956 . . . . 74.030000000000001 108.418 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 55.12 33.61 20.82 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.172 0.989 . . . . 54.340000000000003 111.864 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.47 -7.01 80.81 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.556 -0.747 . . . . 74.310000000000002 113.816 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 18.6 tpp180 -99.83 123.44 44.09 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.564 0.746 . . . . 75.439999999999998 110.281 -171.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.473 HG13 HD23 ' A' ' 160' ' ' LEU . 72.6 t -101.23 133.57 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.694 1.197 . . . . 74.319999999999993 109.602 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.401 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 33.9 p90 -146.0 156.96 43.85 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.787 0.835 . . . . 63.350000000000001 109.532 169.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -127.74 140.39 52.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.825 0.85 . . . . 74.329999999999998 108.842 -172.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -141.47 140.09 33.47 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 110.135 -0.321 . . . . 51.43 110.135 174.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -79.18 137.67 37.54 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.405 -0.816 . . . . 71.540000000000006 111.183 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 91.1 mt -78.39 102.49 4.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 107.045 -1.465 . . . . 74.420000000000002 107.045 162.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -75.57 124.64 27.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.391 -1.337 . . . . 75.239999999999995 107.391 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 56.6 m -102.67 121.01 41.56 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.03 0.532 . . . . 72.230000000000004 109.86 -174.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -74.62 145.41 43.3 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.749 -1.204 . . . . 64.329999999999998 107.749 170.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.7 m -69.24 -9.78 54.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.197 0.599 . . . . 75.120000000000005 111.492 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -65.74 -18.96 65.7 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.751 1.22 . . . . 65.019999999999996 110.709 172.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 97.8 -1.17 59.6 Favored Glycine 0 C--N 1.355 1.627 0 C-N-CA 123.809 0.718 . . . . 40.409999999999997 111.622 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -90.83 137.85 32.05 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 123.571 0.749 . . . . 63.130000000000003 110.049 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 89.2 mt -96.58 157.83 15.71 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.412 0.685 . . . . 71.010000000000005 110.149 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -164.83 174.28 10.8 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 123.913 0.758 . . . . 70.310000000000002 110.595 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.6 t -138.86 -65.68 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.487 -1.301 . . . . 74.450000000000003 107.487 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.0 t -91.48 -175.98 4.38 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.326 1.05 . . . . 75.120000000000005 110.797 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 32.7 t -66.47 -48.11 70.93 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.535 0.734 . . . . 74.129999999999995 111.761 -174.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -87.04 -3.78 59.11 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.229 0.612 . . . . 71.340000000000003 111.684 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 74.4 m -69.18 116.57 9.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.692 0.797 . . . . 62.32 110.555 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -144.85 106.83 4.3 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.786 1.234 . . . . 75.340000000000003 108.389 172.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -127.37 140.38 52.22 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 122.926 0.49 . . . . 74.219999999999999 110.697 -173.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -74.84 -37.78 62.17 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.727 0.642 . . . . 74.319999999999993 110.364 173.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 66.9 p -133.43 165.01 25.85 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.983 0.897 . . . . 44.420000000000002 112.15 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 23.4 tp -70.57 -27.88 64.46 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 113.855 -1.52 . . . . 72.439999999999998 110.999 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.34 -41.84 98.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.079 0.552 . . . . 74.349999999999994 110.22 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -69.03 -42.08 76.85 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.798 -1.092 . . . . 61.310000000000002 110.662 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.04 -42.75 90.97 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.811 0.695 . . . . 72.299999999999997 110.935 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.6 t -76.75 -41.22 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.705 0.802 . . . . 65.340000000000003 110.9 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -59.63 -50.34 74.26 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.358 0.526 . . . . 73.400000000000006 110.161 173.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -53.42 -54.82 31.34 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.696 -1.138 . . . . 73.439999999999998 109.499 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -63.16 -26.22 68.71 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.643 -0.708 . . . . 72.319999999999993 112.012 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 26.8 t -77.77 -21.2 52.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.85 0.46 . . . . 73.209999999999994 111.711 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.9 t -115.43 -18.85 10.9 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.22 1.933 . . . . 74.549999999999997 116.22 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 35.0 m -92.77 143.65 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 120.745 1.611 . . . . 65.319999999999993 114.277 -166.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.38 -1.96 57.45 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.23 2.212 . . . . 73.430000000000007 112.393 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -78.56 13.66 1.54 Allowed 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 128.158 2.583 . . . . 72.439999999999998 114.087 -143.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.21 17.39 4.06 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 123.932 0.777 . . . . 62.219999999999999 111.242 -167.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 52.1 mt -91.3 135.39 33.84 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.093 0.557 . . . . 70.430000000000007 109.742 157.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.401 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 77.3 mt -65.74 -44.8 93.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 O-C-N 124.176 0.922 . . . . 62.520000000000003 109.273 174.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.6 t -138.44 149.32 45.36 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.807 0.443 . . . . 62.039999999999999 109.909 169.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 82.7 p -74.28 156.13 37.51 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 109.076 -0.712 . . . . 75.430000000000007 109.076 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.502 HD23 HD21 ' A' ' 184' ' ' LEU . 38.8 mt -68.6 101.7 1.34 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 108.878 -0.786 . . . . 74.209999999999994 108.878 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -80.05 -57.5 3.6 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.077 0.551 . . . . 72.510000000000005 110.095 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 167' ' ' SER . 7.9 p90 -155.64 152.29 23.99 Favored Pre-proline 0 N--CA 1.484 1.229 0 N-CA-C 109.131 -0.692 . . . . 72.329999999999998 109.131 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.471 ' HB3' ' HA ' ' A' ' 146' ' ' TRP . 58.8 Cg_endo -70.62 138.63 35.49 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 121.666 1.577 . . . . 73.319999999999993 111.438 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -57.99 146.91 66.69 Favored Pre-proline 0 C--O 1.245 0.844 0 CA-C-O 118.671 -0.68 . . . . 73.519999999999996 110.761 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -52.35 118.33 4.51 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.627 2.218 . . . . 72.340000000000003 112.132 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.9 pttt . . . . . 0 CA--C 1.542 0.646 0 CA-C-N 114.733 -1.122 . . . . 73.329999999999998 110.929 174.877 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 C--O 1.246 0.869 0 CA-C-O 121.508 0.671 . . . . 65.129999999999995 111.069 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.1 mt -103.31 126.69 31.5 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 115.066 -0.97 . . . . 70.019999999999996 108.538 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.89 167.84 22.1 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.7 2.267 . . . . 63.130000000000003 112.147 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.83 145.2 32.9 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.961 0.41 . . . . 54.039999999999999 110.646 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.657 ' HB3' HD11 ' A' ' 23' ' ' ILE . 75.1 mt -87.6 92.57 9.15 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.465 -0.939 . . . . 75.430000000000007 108.465 177.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -91.14 -46.83 7.88 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.454 -0.943 . . . . 64.219999999999999 108.454 177.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -98.52 110.16 22.8 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.158 -1.383 . . . . 70.019999999999996 109.58 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 20' ' ' LEU . 30.9 mm -116.62 112.12 38.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.673 -0.862 . . . . 75.540000000000006 108.673 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.499 ' HB3' ' HZ2' ' A' ' 129' ' ' TRP . 66.1 tttt . . . . . 0 CA--C 1.541 0.632 0 CA-C-N 114.768 -1.106 . . . . 72.519999999999996 109.187 173.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo . . . . . 0 CA--C 1.543 0.928 0 N-CA-C 111.58 -0.2 . . . . 64.329999999999998 111.58 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -96.65 56.2 1.48 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.927 -0.768 . . . . 75.230000000000004 108.927 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.723 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 24.8 tp -89.11 115.48 26.67 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.952 -0.758 . . . . 74.439999999999998 108.952 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -104.41 175.71 5.4 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.188 1.795 . . . . 71.329999999999998 109.327 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.96 146.52 33.83 Favored 'Isoleucine or valine' 0 C--O 1.256 1.447 0 N-CA-C 108.314 -0.995 . . . . 53.109999999999999 108.314 171.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.43 110.46 12.22 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 123.816 0.698 . . . . 60.109999999999999 110.048 173.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 90.3 mt -69.35 -28.55 66.31 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.481 1.112 . . . . 70.329999999999998 111.587 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.472 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 64.7 m-85 -135.43 152.66 51.6 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.054 -1.091 . . . . 64.0 108.054 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -71.37 146.02 49.02 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.167 -0.679 . . . . 72.319999999999993 109.167 169.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -149.37 108.25 3.87 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.165 -1.05 . . . . 71.519999999999996 108.165 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.47 133.93 28.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.133 -1.062 . . . . 70.109999999999999 108.133 170.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.401 ' HB2' ' N ' ' A' ' 100' ' ' SER . . . -64.86 128.9 37.72 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.837 0.455 . . . . 63.329999999999998 110.535 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.0 m -86.58 12.36 10.68 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.134 0.974 . . . . 75.400000000000006 111.215 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.58 179.34 37.9 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 110.586 -1.006 . . . . 74.129999999999995 110.586 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.81 -28.68 67.79 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.947 0.499 . . . . 72.329999999999998 110.689 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -68.09 -23.94 64.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.855 0.862 . . . . 73.310000000000002 111.798 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.2 p -103.98 158.51 16.37 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.36 0.664 . . . . 71.319999999999993 110.484 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.507 HD21 HG23 ' A' ' 123' ' ' THR . 49.8 tp -114.49 123.45 49.44 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.206 0.602 . . . . 65.319999999999993 110.488 -178.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.401 ' N ' ' HB2' ' A' ' 93' ' ' ALA . 27.0 p -67.55 119.52 12.47 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.537 0.735 . . . . 74.400000000000006 109.807 173.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.482 HG22 HG21 ' A' ' 123' ' ' THR . 38.2 pt -128.53 129.27 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.483 -0.932 . . . . 64.329999999999998 108.483 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.7 m -95.64 137.85 34.13 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.457 -0.571 . . . . 71.400000000000006 109.457 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -51.16 119.25 3.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.54 0.736 . . . . 70.019999999999996 111.471 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.97 -3.46 48.47 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 116.015 -0.539 . . . . 71.310000000000002 113.198 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -86.05 143.98 27.8 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 117.411 0.606 . . . . 73.109999999999999 110.101 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.537 ' HB3' HD11 ' A' ' 84' ' ' LEU . 56.9 mttm -81.91 135.96 35.36 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.205 1.002 . . . . 63.049999999999997 109.157 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.466 ' HA ' HG22 ' A' ' 123' ' ' THR . 14.8 mt -126.98 135.41 50.82 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 107.99 -1.115 . . . . 74.450000000000003 107.99 -168.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -98.69 108.96 21.77 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.857 0.753 . . . . 74.329999999999998 109.141 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 88.0 t -98.24 113.91 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 118.77 0.714 . . . . 70.140000000000001 109.82 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.37 -37.88 68.66 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.835 0.854 . . . . 71.030000000000001 110.238 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.3 176.22 47.88 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.245 -0.889 . . . . 43.100000000000001 111.708 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 0.8 OUTLIER -98.98 174.42 6.36 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.515 -0.92 . . . . 61.030000000000001 108.515 176.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -74.61 165.71 24.76 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.801 0.44 . . . . 71.230000000000004 110.341 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -58.9 -34.3 71.5 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.21 1.004 . . . . 70.409999999999997 111.632 177.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.402 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 55.0 t30 -107.21 7.33 29.38 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.87 0.868 . . . . 74.519999999999996 110.253 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.654 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 61.22 24.08 62.87 Favored Glycine 0 C--N 1.356 1.69 0 CA-C-N 115.66 -0.7 . . . . 50.409999999999997 114.407 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.402 ' HG3' ' HB3' ' A' ' 115' ' ' ASN . 15.6 mt-10 -69.66 -58.25 4.16 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.257 1.027 . . . . 64.430000000000007 108.689 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -112.4 -179.39 3.66 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.355 -1.748 . . . . 62.240000000000002 108.778 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -142.45 124.26 15.14 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.701 0.801 . . . . 40.210000000000001 108.854 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -72.39 100.91 2.78 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 109.403 -0.592 . . . . 70.430000000000007 109.403 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.7 170.11 8.56 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.316 -0.856 . . . . 61.420000000000002 111.246 -177.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.426 ' HG3' ' HB2' ' A' ' 127' ' ' GLN . 44.4 tt0 -148.03 125.13 11.4 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.342 -1.355 . . . . 72.310000000000002 107.342 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.507 HG23 HD21 ' A' ' 99' ' ' LEU . 67.7 p -128.27 -175.02 3.38 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.852 0.835 . . . . 62.109999999999999 111.585 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -64.13 -23.83 67.46 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 113.85 -1.523 . . . . 75.109999999999999 109.722 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -85.79 -4.7 59.23 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.697 1.199 . . . . 63.32 111.931 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 131.19 -131.57 6.46 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-O 120.034 -0.314 . . . . 61.329999999999998 112.393 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.426 ' HB2' ' HG3' ' A' ' 122' ' ' GLN . 61.0 tt0 -152.21 153.18 33.29 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.444 0.698 . . . . 74.400000000000006 110.363 177.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.74 -170.0 38.14 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 112.187 -0.365 . . . . 71.319999999999993 112.187 176.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.499 ' HZ2' ' HB3' ' A' ' 24' ' ' LYS . 77.2 m95 -96.0 129.72 43.19 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.422 0.689 . . . . 74.450000000000003 110.494 -176.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 99' ' ' LEU . 30.7 m -121.4 148.33 49.64 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 124.25 1.02 . . . . 63.439999999999998 109.915 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.27 132.67 19.75 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 121.868 1.712 . . . . 63.329999999999998 111.244 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.6 m -62.05 -18.59 61.1 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.987 0.915 . . . . 74.150000000000006 112.758 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -72.91 -23.38 60.7 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.015 0.926 . . . . 73.019999999999996 111.742 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.472 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.2 m-85 -96.74 -0.42 48.21 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.541 0.736 . . . . 74.400000000000006 112.179 -174.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.1 pt -129.15 154.23 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 122.879 0.471 . . . . 75.319999999999993 110.552 -173.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.1 t -154.35 138.57 11.2 Favored Pre-proline 0 N--CA 1.491 1.611 0 CA-C-O 119.467 -0.301 . . . . 70.219999999999999 110.801 172.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.461 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 56.6 Cg_endo -69.47 130.92 20.57 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 122.594 2.196 . . . . 74.409999999999997 113.267 -175.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.3 m -108.37 -58.63 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.802 0.841 . . . . 74.129999999999995 110.733 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.723 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.6 t30 -93.49 1.13 56.9 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.205 0.602 . . . . 72.209999999999994 110.957 -174.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 25.5 t -73.84 -178.43 3.22 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.022 0.529 . . . . 74.439999999999998 109.883 173.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.0 mt -58.03 -18.66 25.74 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.886 0.874 . . . . 62.030000000000001 112.933 -174.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.589 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 29.7 tt0 -64.69 -14.49 58.62 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.298 1.039 . . . . 71.239999999999995 112.137 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.67 -21.86 55.51 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.81 0.844 . . . . 73.430000000000007 111.037 173.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -100.4 139.06 36.62 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.095 -0.705 . . . . 73.239999999999995 109.095 170.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.9 p -63.57 -12.41 32.52 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.182 1.178 . . . . 54.219999999999999 114.182 -171.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -75.93 -42.28 49.27 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 111.814 0.301 . . . . 74.430000000000007 111.814 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 29.0 t80 -89.74 139.31 30.7 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.434 -0.58 . . . . 74.109999999999999 109.434 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.589 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 72.3 m-70 -131.23 16.75 5.02 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.469 0.544 . . . . 75.099999999999994 112.469 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 72.44 -159.04 53.53 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-O 119.466 -0.63 . . . . 62.200000000000003 114.44 174.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 68.5 Cg_endo -72.07 109.6 2.74 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.322 2.681 . . . . 73.25 111.848 176.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.562 ' HB ' ' HD3' ' A' ' 171' ' ' ARG . 6.5 t -136.92 155.56 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.258 0.551 . . . . 64.329999999999998 111.076 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.2 m -68.26 148.56 50.63 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 124.909 1.283 . . . . 60.229999999999997 111.803 171.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -30.56 70.77 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.744 0.818 . . . . 62.240000000000002 111.09 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.89 -52.75 54.81 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.215 0.606 . . . . 71.129999999999995 109.934 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.83 87.09 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.55 0.74 . . . . 63.130000000000003 111.042 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.53 ' HB2' ' HD2' ' A' ' 171' ' ' ARG . . . -55.41 -59.6 4.59 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.166 -0.925 . . . . 75.109999999999999 111.337 173.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.631 ' HG3' HG11 ' A' ' 190' ' ' VAL . 33.0 tt0 -64.84 -28.19 69.39 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.31 -0.859 . . . . 61.140000000000001 111.29 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -66.43 -50.82 62.13 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.295 1.038 . . . . 75.120000000000005 110.964 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.78 -40.05 84.0 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.933 -0.576 . . . . 71.0 110.919 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.667 HD23 HG13 ' A' ' 190' ' ' VAL . 37.4 tp -68.53 -29.16 67.68 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.485 -0.779 . . . . 72.409999999999997 112.227 -177.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 13.2 t -62.63 -23.25 66.97 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.538 0.735 . . . . 71.430000000000007 110.856 177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.8 m -82.43 -20.5 36.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.046 0.938 . . . . 72.040000000000006 110.968 176.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.73 -175.43 23.61 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.932 -0.576 . . . . 70.439999999999998 112.851 175.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.4 pt -141.04 -165.92 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 124.988 1.315 . . . . 54.200000000000003 111.159 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.731 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 14.6 p-10 -52.52 106.06 0.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.532 1.133 . . . . 64.549999999999997 113.487 -175.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.22 13.3 52.72 Favored Glycine 0 C--O 1.257 1.543 0 CA-C-N 116.132 -0.486 . . . . 74.209999999999994 113.497 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 74.1 m -80.56 140.12 35.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.971 0.386 . . . . 72.120000000000005 110.684 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 183' ' ' SER . 23.1 p90 -136.73 159.66 41.16 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.441 0.639 . . . . 64.239999999999995 112.584 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.592 HD22 HH21 ' A' ' 171' ' ' ARG . 91.5 mt -136.29 133.31 36.81 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.608 -1.178 . . . . 73.150000000000006 108.266 170.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 22.6 t -114.98 127.05 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 107.616 -1.253 . . . . 71.409999999999997 107.616 176.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.592 HH21 HD22 ' A' ' 169' ' ' LEU . 14.7 ptp180 -162.1 148.88 13.67 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.452 0.301 . . . . 72.140000000000001 111.041 -176.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 15.5 pt-20 -93.53 165.8 12.57 Favored 'General case' 0 C--O 1.253 1.248 0 CA-C-O 121.398 0.618 . . . . 72.25 111.693 -178.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.7 t -73.36 154.42 40.08 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.339 -1.3 . . . . 53.310000000000002 111.087 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -77.73 -40.02 42.54 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.39 -1.277 . . . . 73.439999999999998 110.653 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.654 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 72.5 p -100.62 -14.12 18.29 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.327 0.651 . . . . 72.010000000000005 112.446 -175.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 46.9 m -124.28 101.72 34.34 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.021 0.528 . . . . 73.310000000000002 110.439 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.74 131.65 28.22 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.226 2.618 . . . . 72.040000000000006 112.111 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.33 -24.04 8.91 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 116.237 -0.438 . . . . 53.43 113.882 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -75.19 118.2 17.85 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.207 -1.034 . . . . 64.129999999999995 108.207 172.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.576 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 82.9 mtt85 -123.29 172.86 8.32 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.274 0.63 . . . . 63.420000000000002 111.074 -169.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 15.9 m -147.51 144.45 28.56 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.039 0.936 . . . . 62.229999999999997 109.461 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.424 HG12 HG22 ' A' ' 170' ' ' VAL . 52.1 mt -119.06 139.58 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 107.967 -1.123 . . . . 74.25 107.967 167.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 17.5 m -119.82 122.78 42.11 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.196 -1.038 . . . . 44.32 108.196 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.511 HD21 HD23 ' A' ' 232' ' ' LEU . 59.6 mt -105.45 142.18 35.65 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.367 1.067 . . . . 62.5 111.593 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 20.4 ttt180 -128.56 131.47 48.21 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-N 115.05 -0.977 . . . . 75.299999999999997 109.473 169.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.731 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 3.4 p90 -150.83 142.08 23.25 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.215 -1.032 . . . . 71.310000000000002 108.215 171.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 58.44 18.89 5.99 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 124.164 0.986 . . . . 74.230000000000004 113.343 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.56 12.12 73.17 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 122.882 0.277 . . . . 45.32 113.157 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 4.0 tpm_? -105.14 124.01 48.8 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.37 1.068 . . . . 72.439999999999998 109.151 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.667 HG13 HD23 ' A' ' 160' ' ' LEU . 98.3 t -112.9 110.41 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.145 0.978 . . . . 34.43 110.177 -177.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.466 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 30.6 p90 -125.85 156.63 39.3 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.533 0.733 . . . . 75.540000000000006 109.245 175.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -131.82 146.94 52.42 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.714 0.806 . . . . 63.420000000000002 109.044 -167.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -145.06 148.74 34.02 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.811 0.444 . . . . 75.450000000000003 110.429 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 15.4 tpp180 -89.94 138.36 31.57 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.525 0.73 . . . . 73.340000000000003 110.817 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.4 HD11 HG13 ' A' ' 182' ' ' ILE . 84.7 mt -88.99 120.47 37.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.217 -1.031 . . . . 71.420000000000002 108.217 165.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.1 m-20 -95.86 137.5 34.84 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.004 0.922 . . . . 55.109999999999999 109.358 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 25.8 m -105.24 110.46 22.83 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.339 0.656 . . . . 43.140000000000001 109.478 176.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.81 171.93 1.91 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.495 1.118 . . . . 73.310000000000002 112.041 173.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.4 p -67.07 -29.24 68.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.375 0.67 . . . . 74.140000000000001 111.966 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -71.21 -17.79 62.49 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.028 0.531 . . . . 63.520000000000003 111.282 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 103.5 -5.99 48.89 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 111.786 -0.526 . . . . 72.340000000000003 111.786 -171.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -64.16 130.7 44.96 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.728 0.811 . . . . 73.150000000000006 111.797 -177.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 89.4 mt -89.51 147.33 24.03 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.101 -0.703 . . . . 72.140000000000001 109.101 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -165.2 161.75 19.56 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.586 0.554 . . . . 75.349999999999994 110.724 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.75 -46.75 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.925 0.89 . . . . 74.0 109.844 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . 0.622 ' H ' ' HB2' ' A' ' 209' ' ' SER . 27.1 t -139.12 -172.73 3.4 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.559 0.743 . . . . 73.430000000000007 110.397 -170.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.9 m -60.62 -49.05 79.09 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.706 1.202 . . . . 54.539999999999999 113.826 -167.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -85.81 -0.08 54.33 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.023 0.529 . . . . 74.549999999999997 110.832 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.622 ' HB2' ' H ' ' A' ' 206' ' ' SER . 72.4 m -97.84 106.62 18.95 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.6 0.76 . . . . 74.209999999999994 110.711 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -145.23 118.37 8.88 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 125.145 1.378 . . . . 74.150000000000006 107.759 170.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -136.85 145.67 44.7 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 118.095 0.407 . . . . 71.430000000000007 111.736 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -87.57 -21.65 25.27 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 123.743 0.652 . . . . 75.510000000000005 109.919 168.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 72.2 p -135.34 148.76 49.54 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-O 121.697 0.761 . . . . 71.140000000000001 112.02 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 38.1 tp -66.79 -27.68 67.77 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.334 -1.303 . . . . 65.450000000000003 111.105 176.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.98 -50.0 75.74 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.69 0.796 . . . . 75.319999999999993 110.781 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -69.93 -32.49 70.79 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.056 -0.975 . . . . 75.310000000000002 110.807 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.45 -48.78 78.25 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.315 0.384 . . . . 73.420000000000002 110.811 172.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 56.0 t -68.77 -42.43 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.751 0.821 . . . . 71.319999999999993 110.443 -176.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -58.81 -52.79 64.2 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.799 0.809 . . . . 65.430000000000007 111.594 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.431 ' O ' HG22 ' A' ' 224' ' ' VAL . 48.2 t60 -55.05 -50.07 70.04 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.408 -1.269 . . . . 73.129999999999995 109.783 177.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -65.16 -24.92 67.53 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.686 -0.688 . . . . 75.209999999999994 112.112 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.4 m -73.13 -27.87 61.93 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.034 -0.416 . . . . 64.209999999999994 110.983 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 15.2 t -110.12 -14.52 14.19 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.659 2.096 . . . . 64.319999999999993 116.659 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 220' ' ' HIS . 27.0 m -99.84 156.97 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 N-CA-C 115.925 1.824 . . . . 72.0 115.925 -166.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.47 -0.25 57.59 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 110.738 -2.937 . . . . 71.540000000000006 113.358 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -77.89 13.05 1.48 Allowed 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 128.436 2.694 . . . . 74.239999999999995 113.371 -144.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.16 17.99 4.33 Favored Glycine 0 N--CA 1.46 0.286 0 C-N-CA 124.802 1.191 . . . . 62.409999999999997 111.183 -169.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 91.4 mt -92.51 117.25 29.75 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 113.832 -1.184 . . . . 43.32 109.767 163.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.466 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 85.6 mt -63.01 -41.2 91.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.481 0.712 . . . . 75.420000000000002 109.322 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.0 t -129.66 142.66 50.69 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.46 -0.941 . . . . 73.219999999999999 108.46 165.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 63.5 p -71.28 156.42 39.55 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 109.359 -0.608 . . . . 73.540000000000006 109.359 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.511 HD23 HD21 ' A' ' 184' ' ' LEU . 25.0 mt -65.92 103.6 0.96 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.913 -0.773 . . . . 62.020000000000003 108.913 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.0 -49.53 7.28 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.159 0.583 . . . . 72.329999999999998 109.579 -176.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.602 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -161.66 144.44 9.11 Favored Pre-proline 0 N--CA 1.492 1.636 0 C-N-CA 123.177 0.591 . . . . 71.230000000000004 112.418 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.65 140.08 18.49 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.724 1.616 . . . . 72.140000000000001 112.461 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -66.96 120.72 73.87 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 108.847 -0.797 . . . . 73.319999999999993 108.847 172.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.07 145.0 59.65 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 121.952 1.768 . . . . 72.099999999999994 112.095 -175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 109.188 -0.671 . . . . 72.329999999999998 109.188 169.639 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.242 0.669 0 CA-C-O 120.864 0.364 . . . . 74.409999999999997 111.476 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.7 mt -103.46 126.57 31.73 Favored Pre-proline 0 C--O 1.239 0.518 0 N-CA-C 109.014 -0.735 . . . . 72.439999999999998 109.014 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.16 169.75 21.87 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.999 2.466 . . . . 65.120000000000005 111.954 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.54 149.94 32.96 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.903 0.481 . . . . 60.32 110.551 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.57 ' HB3' HD11 ' A' ' 23' ' ' ILE . 80.7 mt -86.14 94.52 9.3 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.686 -0.857 . . . . 71.420000000000002 108.686 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -97.34 -48.76 5.19 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.047 -0.979 . . . . 72.409999999999997 110.667 -177.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.611 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 60.4 m-85 -103.65 108.52 19.84 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.953 -0.758 . . . . 72.230000000000004 108.953 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.57 HD11 ' HB3' ' A' ' 20' ' ' LEU . 37.7 mm -118.6 112.94 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.863 0.865 . . . . 73.140000000000001 110.226 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.211 -0.962 0 C-N-CA 124.229 1.012 . . . . 75.030000000000001 108.552 167.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo . . . . . 0 CA--C 1.553 1.453 0 CA-C-O 121.39 0.496 . . . . 75.209999999999994 111.161 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -104.62 80.69 1.69 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.504 1.122 . . . . 62.210000000000001 110.252 -177.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 35.0 tp -128.06 112.77 14.97 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.114 -0.699 . . . . 61.149999999999999 109.114 167.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -116.1 173.91 6.32 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.379 1.472 . . . . 73.540000000000006 110.043 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.5 p -147.56 144.85 19.33 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 C-N-CA 124.281 1.033 . . . . 74.230000000000004 108.674 171.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.544 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -81.73 128.68 34.23 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.711 0.404 . . . . 71.109999999999999 110.161 175.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.8 mt -86.15 -20.57 28.43 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.513 0.725 . . . . 72.030000000000001 110.837 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.554 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 74.9 m-85 -130.59 158.38 40.16 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.782 0.833 . . . . 60.25 109.335 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -83.55 140.23 32.39 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.757 -0.831 . . . . 63.25 108.757 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -155.13 111.91 3.26 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.676 -0.861 . . . . 72.230000000000004 108.676 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.43 140.67 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 109.304 -0.628 . . . . 73.409999999999997 109.304 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.21 115.95 2.75 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.336 0.654 . . . . 74.150000000000006 110.623 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.0 p -72.21 -27.93 62.86 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.535 0.734 . . . . 73.150000000000006 110.392 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -152.91 -173.36 22.19 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 114.85 -1.068 . . . . 43.439999999999998 110.984 175.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.22 -28.89 65.63 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.306 0.643 . . . . 64.340000000000003 110.855 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.477 HD22 HD12 ' A' ' 23' ' ' ILE . 26.1 p-10 -70.02 -22.42 63.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.567 1.147 . . . . 71.420000000000002 111.967 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 74.3 p -105.77 160.92 14.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.283 1.033 . . . . 71.329999999999998 110.271 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.0 tp -109.41 144.29 37.83 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.164 0.586 . . . . 71.140000000000001 110.44 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.2 p -83.09 111.61 19.05 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.513 -0.921 . . . . 55.119999999999997 108.513 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.7 pt -117.89 139.07 46.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 123.836 0.854 . . . . 61.509999999999998 109.014 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 20.5 m -101.34 150.24 23.2 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.731 -0.47 . . . . 42.310000000000002 109.731 176.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -56.74 112.04 1.19 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 122.622 0.369 . . . . 65.340000000000003 110.082 167.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.38 -4.31 43.95 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.328 -0.396 . . . . 51.0 112.916 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.92 134.03 36.89 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.555 0.742 . . . . 75.129999999999995 109.624 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -83.31 112.52 19.97 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.934 -0.765 . . . . 64.310000000000002 108.934 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 87' ' ' ALA . 18.8 mt -101.37 156.72 17.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.005 0.522 . . . . 73.329999999999998 109.818 -171.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -124.72 108.64 12.2 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.601 -0.518 . . . . 65.530000000000001 109.601 167.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 135' ' ' ILE . 85.4 t -96.81 106.92 19.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.152 -0.931 . . . . 64.530000000000001 109.843 -176.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.413 HD12 ' NE2' ' A' ' 127' ' ' GLN . 69.1 mt -73.57 -14.56 61.22 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.365 -0.834 . . . . 75.319999999999993 111.427 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.37 163.24 21.99 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 116.252 -0.431 . . . . 71.239999999999995 112.419 172.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 7.4 m-30 -95.29 173.31 7.6 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.845 -0.798 . . . . 74.430000000000007 108.845 173.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.611 ' ND2' ' HB2' ' A' ' 22' ' ' PHE . 10.1 m120 -64.01 150.94 44.2 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.584 -1.265 . . . . 74.340000000000003 107.584 161.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -65.19 -22.64 66.92 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.041 0.382 . . . . 62.140000000000001 110.526 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -86.15 -14.89 42.76 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 122.793 0.437 . . . . 71.129999999999995 110.441 174.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 174' ' ' GLU . . . 84.41 25.91 41.54 Favored Glycine 0 C--N 1.355 1.603 0 C-N-CA 123.452 0.549 . . . . 62.329999999999998 113.59 175.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -79.81 -71.33 0.46 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.391 0.677 . . . . 73.420000000000002 110.779 -175.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -104.77 175.56 5.45 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.336 1.054 . . . . 70.019999999999996 109.013 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -151.22 116.0 5.2 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.825 0.85 . . . . 33.229999999999997 109.445 -172.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 36.5 tt0 -67.91 97.38 0.66 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.677 0.391 . . . . 62.119999999999997 110.162 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.31 153.74 19.38 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.246 -0.65 . . . . 53.340000000000003 109.246 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -138.48 131.86 30.36 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.713 0.805 . . . . 63.450000000000003 109.681 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 63.9 p -140.38 -170.7 3.05 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.635 1.174 . . . . 74.299999999999997 109.423 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -64.67 -14.59 58.95 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.279 0.632 . . . . 64.109999999999999 112.098 170.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -80.14 -11.66 59.73 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.73 0.812 . . . . 43.229999999999997 111.304 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 121.09 -133.63 9.73 Favored Glycine 0 C--N 1.35 1.317 0 N-CA-C 111.415 -0.674 . . . . 52.32 111.415 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.413 ' NE2' HD12 ' A' ' 110' ' ' LEU . 58.2 tt0 -151.51 144.99 24.86 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 117.182 0.491 . . . . 74.420000000000002 111.103 -175.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 171.43 168.93 33.73 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.542 0.526 . . . . 72.519999999999996 112.709 174.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -82.48 117.48 22.53 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.527 1.131 . . . . 74.239999999999995 111.408 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.54 154.52 47.81 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.997 1.319 . . . . 53.240000000000002 109.136 177.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.54 132.47 33.34 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 121.585 1.523 . . . . 74.430000000000007 111.326 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 31.6 m -62.22 -17.74 59.14 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.707 0.803 . . . . 75.120000000000005 112.489 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -82.18 -14.99 54.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.976 0.91 . . . . 60.420000000000002 111.619 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.554 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.7 m-85 -93.95 -3.84 50.84 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.854 0.862 . . . . 64.549999999999997 112.306 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.56 HD12 HG21 ' A' ' 109' ' ' VAL . 18.2 pt -125.95 169.93 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.251 0.62 . . . . 70.409999999999997 110.362 -172.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.5 t -158.04 141.03 10.8 Favored Pre-proline 0 CA--C 1.554 1.106 0 O-C-N 123.563 0.539 . . . . 72.540000000000006 109.963 171.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.14 136.78 14.81 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.573 2.182 . . . . 45.219999999999999 111.841 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.7 m -108.25 -45.53 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.668 0.387 . . . . 75.420000000000002 111.162 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.577 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 67.2 t30 -101.25 20.12 16.38 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.473 0.654 . . . . 63.32 110.699 -174.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.5 p -73.97 -171.24 1.06 Allowed 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 121.471 0.653 . . . . 74.430000000000007 110.746 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.483 HD13 ' HB3' ' A' ' 214' ' ' LEU . 67.1 mt -69.95 -13.81 62.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.916 0.886 . . . . 74.519999999999996 111.669 176.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.8 -6.73 17.21 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.86 1.264 . . . . 72.540000000000006 111.524 176.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -55.6 -35.69 66.1 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.214 1.005 . . . . 52.420000000000002 109.902 168.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -93.49 135.44 34.74 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.0 -1.0 . . . . 75.120000000000005 108.812 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.8 m -67.84 -12.07 59.87 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.526 0.935 . . . . 75.430000000000007 113.526 -171.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -75.19 -34.04 61.49 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 111.881 0.326 . . . . 73.319999999999993 111.881 175.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -94.24 134.33 36.82 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.396 -0.594 . . . . 70.150000000000006 109.396 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -125.17 5.12 7.84 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 111.793 0.294 . . . . 71.049999999999997 111.793 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.25 -159.48 50.33 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 119.462 -0.632 . . . . 72.040000000000006 114.446 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 38.1 Cg_endo -67.27 104.85 0.93 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.369 2.713 . . . . 63.299999999999997 112.297 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.587 HG11 HH21 ' A' ' 171' ' ' ARG . 32.6 t -140.56 153.51 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.137 0.575 . . . . 54.340000000000003 110.545 -174.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.9 m -68.83 148.17 50.67 Favored 'General case' 0 C--O 1.249 1.027 0 C-N-CA 124.555 1.142 . . . . 73.219999999999999 112.028 173.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -62.62 -29.72 70.82 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.486 0.714 . . . . 74.400000000000006 110.616 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -57.05 -57.11 13.99 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.552 1.141 . . . . 51.020000000000003 110.453 175.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.16 -39.31 89.69 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.049 0.94 . . . . 75.310000000000002 111.189 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.48 -53.54 56.32 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.888 -1.051 . . . . 74.510000000000005 110.751 174.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -69.39 -26.88 64.86 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.378 1.071 . . . . 52.119999999999997 110.882 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -67.88 -49.95 59.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.371 0.668 . . . . 75.129999999999995 110.573 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.55 HD12 HH12 ' A' ' 171' ' ' ARG . 66.6 mt -66.31 -37.26 85.0 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 120.802 0.334 . . . . 62.43 110.265 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 183' ' ' SER . 39.6 tp -65.54 -34.32 77.99 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.191 -0.913 . . . . 63.530000000000001 111.435 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.9 t -57.82 -24.79 59.01 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.905 1.282 . . . . 74.230000000000004 112.049 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.612 ' HB2' ' HG2' ' A' ' 237' ' ' PRO . 3.8 m -87.91 -4.82 58.8 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.028 0.931 . . . . 64.209999999999994 111.895 -175.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -94.09 175.97 35.5 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.197 0.427 . . . . 73.409999999999997 113.912 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.6 pt -118.42 -165.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 124.531 1.133 . . . . 60.399999999999999 109.726 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.677 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 16.8 p-10 -57.58 110.69 0.92 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 113.007 0.743 . . . . 72.310000000000002 113.007 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.89 12.11 35.5 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 115.001 -0.999 . . . . 65.340000000000003 112.493 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 23.4 t -74.25 130.13 39.13 Favored 'General case' 0 C--N 1.349 0.579 0 N-CA-C 109.01 -0.737 . . . . 72.420000000000002 109.01 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 235' ' ' PRO . 19.0 p90 -136.78 155.96 49.14 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.29 0.848 . . . . 74.450000000000003 113.29 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.557 HD13 ' NH1' ' A' ' 171' ' ' ARG . 89.0 mt -142.29 135.64 28.95 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.114 0.966 . . . . 43.310000000000002 109.345 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.423 HG22 HG12 ' A' ' 182' ' ' ILE . 15.7 t -109.8 115.61 50.1 Favored 'Isoleucine or valine' 0 C--O 1.252 1.194 0 N-CA-C 108.29 -1.004 . . . . 74.239999999999995 108.29 176.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.587 HH21 HG11 ' A' ' 151' ' ' VAL . 1.4 mmm180 -126.7 159.99 32.08 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.592 -1.262 . . . . 64.239999999999995 107.592 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.674 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 16.9 pt-20 -116.99 163.31 16.41 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 109.482 -0.562 . . . . 74.150000000000006 109.482 167.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.5 t -78.78 138.0 38.0 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.712 -0.677 . . . . 73.430000000000007 110.287 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.407 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 27.1 mt-10 -75.94 -37.84 58.23 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.306 -0.861 . . . . 63.409999999999997 108.989 172.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 47.3 m -83.28 -3.78 57.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.288 1.035 . . . . 61.409999999999997 111.615 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.3 t -157.81 75.14 3.97 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 109.148 -0.686 . . . . 65.019999999999996 109.148 173.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.35 141.39 89.16 Favored 'Trans proline' 0 C--N 1.386 2.508 0 C-N-CA 122.987 2.458 . . . . 74.150000000000006 112.395 175.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 96.8 -25.19 27.66 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 115.098 -0.956 . . . . 53.520000000000003 112.009 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -91.69 117.59 29.88 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.486 -0.931 . . . . 63.229999999999997 108.486 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.674 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 56.0 mtt180 -115.64 170.21 8.61 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 123.77 0.828 . . . . 74.439999999999998 110.562 -172.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.5 t -153.97 143.29 21.44 Favored 'General case' 0 C--O 1.25 1.09 0 C-N-CA 123.956 0.902 . . . . 75.430000000000007 109.09 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 170' ' ' VAL . 45.1 mt -110.72 132.82 58.09 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 N-CA-C 108.098 -1.075 . . . . 73.340000000000003 108.098 170.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.596 ' HB3' HD22 ' A' ' 160' ' ' LEU . 13.8 m -106.08 135.94 46.65 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 124.854 1.262 . . . . 63.310000000000002 108.082 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.429 HD21 HD23 ' A' ' 232' ' ' LEU . 36.4 mt -125.89 137.19 53.72 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.607 1.163 . . . . 74.099999999999994 110.335 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.476 ' HB2' ' HG ' ' A' ' 160' ' ' LEU . 71.4 ttt-85 -120.42 133.77 55.37 Favored 'General case' 0 C--O 1.263 1.804 0 O-C-N 124.472 1.108 . . . . 73.340000000000003 108.848 169.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.677 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 21.4 p90 -147.57 133.97 19.65 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.759 1.287 . . . . 74.140000000000001 108.295 167.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 37.76 59.77 1.25 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 126.378 1.871 . . . . 74.219999999999999 114.116 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.458 ' HA2' ' NH2' ' A' ' 185' ' ' ARG . . . 79.57 -2.52 72.37 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.823 -0.626 . . . . 53.340000000000003 114.6 173.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 42.0 ttm180 -109.78 125.51 52.78 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.501 0.72 . . . . 74.319999999999993 110.393 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 28.7 m -111.51 143.8 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.075 0.95 . . . . 74.040000000000006 110.42 172.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -147.27 150.1 34.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.948 0.899 . . . . 63.520000000000003 109.778 172.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -125.02 116.46 22.17 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.212 -1.032 . . . . 73.200000000000003 108.212 -173.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -115.07 145.81 41.94 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.31 0.576 . . . . 73.209999999999994 110.475 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.511 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 18.9 tpp180 -84.45 128.6 34.68 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 114.681 -1.145 . . . . 62.420000000000002 111.522 -169.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 79.2 mt -80.43 107.22 12.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 107.418 -1.327 . . . . 72.319999999999993 107.418 164.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -77.73 131.26 37.58 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.491 -0.929 . . . . 44.130000000000003 108.491 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.1 m -105.63 141.2 37.5 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.15 0.58 . . . . 74.530000000000001 109.529 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 202' ' ' LYS . . . -95.81 174.8 6.78 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.463 1.105 . . . . 63.450000000000003 109.757 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.0 m -59.79 -39.03 83.58 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.266 0.627 . . . . 64.400000000000006 111.762 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -83.54 12.67 5.34 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.658 0.783 . . . . 75.219999999999999 112.129 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 76.43 12.66 84.1 Favored Glycine 0 C--N 1.352 1.421 0 C-N-CA 122.828 0.252 . . . . 71.219999999999999 112.609 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 198' ' ' ALA . 28.9 mtpp -73.35 126.74 30.84 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 109.871 -0.418 . . . . 72.209999999999994 109.871 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.498 HD11 HH11 ' A' ' 180' ' ' ARG . 80.9 mt -94.72 145.37 24.91 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.457 -0.942 . . . . 73.319999999999993 108.457 -178.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -166.85 136.2 2.92 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.329 0.652 . . . . 73.030000000000001 109.611 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.7 t -92.93 -56.99 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 107.677 -1.231 . . . . 63.200000000000003 107.677 169.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 2.8 p -83.84 147.06 27.76 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.146 -1.388 . . . . 74.430000000000007 109.679 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 20.7 t -68.76 -46.21 69.38 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.848 0.859 . . . . 60.340000000000003 112.37 -165.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -77.09 -4.02 42.27 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.425 0.69 . . . . 75.420000000000002 111.601 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 70.2 m -91.32 140.37 29.84 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 123.587 0.755 . . . . 71.549999999999997 110.128 173.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -142.75 110.36 5.8 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.014 -1.106 . . . . 74.340000000000003 108.014 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 14.6 m-85 -117.0 141.91 47.64 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 109.674 -0.491 . . . . 63.509999999999998 109.674 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -91.2 -18.69 24.03 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.358 0.663 . . . . 74.510000000000005 109.958 168.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 29.5 p -128.64 138.29 52.1 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.956 0.884 . . . . 55.350000000000001 111.715 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.483 ' HB3' HD13 ' A' ' 141' ' ' LEU . 29.3 tp -67.59 -26.43 66.26 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.031 -1.441 . . . . 72.129999999999995 110.831 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.33 -45.79 92.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.533 0.733 . . . . 74.219999999999999 110.445 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -74.7 -30.54 61.59 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.707 -0.679 . . . . 74.150000000000006 111.932 177.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.73 -51.21 70.73 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 110.133 -0.321 . . . . 75.540000000000006 110.133 172.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.38 -42.48 93.68 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 C-N-CA 124.069 0.948 . . . . 74.349999999999994 110.717 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -60.79 -51.52 68.97 Favored 'General case' 0 C--O 1.262 1.734 0 C-N-CA 123.963 0.905 . . . . 74.25 111.033 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.401 ' O ' HG22 ' A' ' 224' ' ' VAL . 47.0 t-80 -55.23 -53.15 59.69 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.72 -1.127 . . . . 72.299999999999997 109.748 177.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -73.1 -12.24 60.83 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.245 -0.434 . . . . 61.420000000000002 112.134 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.0 t -78.44 -27.4 46.48 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.835 0.454 . . . . 63.240000000000002 110.472 172.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -109.84 -22.48 11.86 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.974 1.842 . . . . 71.310000000000002 115.974 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 220' ' ' HIS . 30.9 m -88.69 152.64 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 120.552 1.523 . . . . 73.530000000000001 114.379 -165.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.09 -1.14 57.96 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 111.905 -2.407 . . . . 70.030000000000001 112.866 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -78.7 14.91 1.16 Allowed 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 128.132 2.573 . . . . 54.530000000000001 113.512 -140.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.89 17.36 4.63 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 110.773 -0.931 . . . . 74.219999999999999 110.773 -168.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.68 125.7 35.75 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.35 -0.925 . . . . 75.140000000000001 109.7 165.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 77.7 mt -61.67 -44.17 98.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 O-C-N 124.133 0.896 . . . . 71.439999999999998 109.427 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.4 t -137.16 144.91 43.2 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.19 -0.914 . . . . 64.310000000000002 108.582 169.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 60.4 p -73.99 151.11 40.37 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.228 -0.656 . . . . 73.420000000000002 109.228 172.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.438 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 33.5 mt -64.48 101.19 0.42 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.244 -0.65 . . . . 51.520000000000003 109.244 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -80.81 -55.72 4.62 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.845 0.458 . . . . 63.210000000000001 109.972 -174.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -155.24 149.87 20.11 Favored Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 109.824 -0.435 . . . . 44.130000000000003 109.824 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 32.8 Cg_endo -63.08 142.54 87.78 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.192 1.928 . . . . 53.530000000000001 111.628 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.02 140.37 95.98 Favored Pre-proline 0 C--O 1.244 0.785 0 CA-C-O 119.255 -0.402 . . . . 73.099999999999994 110.511 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.612 ' HG2' ' HB2' ' A' ' 162' ' ' SER . 17.9 Cg_endo -57.52 118.61 5.51 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 123.012 2.475 . . . . 52.350000000000001 113.811 -174.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 108.055 -1.091 . . . . 71.049999999999997 108.055 166.073 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.0 p . . . . . 0 CA--C 1.55 0.979 0 CA-C-O 121.304 0.573 . . . . 71.140000000000001 111.188 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.3 mt -108.3 134.68 20.11 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 123.981 0.912 . . . . 65.129999999999995 109.604 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -69.3 166.03 28.42 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.379 2.053 . . . . 71.430000000000007 110.908 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.8 142.87 29.47 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.727 0.299 . . . . 63.109999999999999 110.217 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.659 ' HB3' HD11 ' A' ' 23' ' ' ILE . 71.3 mt -87.01 95.54 9.97 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.934 0.893 . . . . 62.32 109.068 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -99.49 -49.66 4.35 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.49 0.662 . . . . 73.340000000000003 110.053 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -99.62 114.92 28.27 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.809 -1.087 . . . . 74.230000000000004 108.901 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 20' ' ' LEU . 49.5 mm -116.29 117.84 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 108.609 -0.885 . . . . 63.119999999999997 108.609 -174.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.531 ' HB2' ' HE1' ' A' ' 129' ' ' TRP . 9.5 tmtt? . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.115 -0.698 . . . . 53.329999999999998 109.115 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo . . . . . 0 CA--C 1.55 1.303 0 N-CA-C 112.627 0.203 . . . . 71.209999999999994 112.627 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -96.71 33.32 1.87 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.674 0.79 . . . . 71.230000000000004 110.537 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 25.7 tp -80.83 113.6 19.14 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.919 -0.771 . . . . 72.209999999999994 108.919 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -103.5 176.42 5.15 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.927 1.691 . . . . 71.040000000000006 108.808 173.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.48 144.28 35.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 N-CA-C 108.721 -0.844 . . . . 74.129999999999995 108.721 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.91 113.3 12.06 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 123.532 0.52 . . . . 73.019999999999996 109.954 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.58 -26.2 62.51 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.006 0.922 . . . . 72.040000000000006 111.023 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.465 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 71.8 m-85 -134.95 155.46 50.69 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.85 -0.796 . . . . 74.209999999999994 108.85 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -74.41 141.68 45.05 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.88 -0.785 . . . . 73.340000000000003 108.88 170.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -143.44 112.59 6.72 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.94 -0.763 . . . . 72.25 108.94 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.6 t -79.47 129.64 37.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 107.877 -1.157 . . . . 62.219999999999999 107.877 172.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.58 146.68 54.24 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.397 0.679 . . . . 74.230000000000004 111.122 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.3 m -70.36 -25.31 63.21 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.858 0.863 . . . . 71.439999999999998 110.136 169.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.04 -140.55 6.21 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 115.723 -0.671 . . . . 41.119999999999997 112.245 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.17 -35.15 73.79 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.544 0.737 . . . . 71.319999999999993 111.013 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.535 ' HB2' HD12 ' A' ' 23' ' ' ILE . 28.7 p30 -70.08 -4.68 22.26 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.66 0.784 . . . . 74.129999999999995 112.676 -177.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.3 p -134.5 160.15 38.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.399 1.08 . . . . 72.329999999999998 109.047 177.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.5 tp -110.58 125.97 53.94 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.724 -0.473 . . . . 72.030000000000001 109.724 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.1 p -74.6 114.17 12.71 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 108.603 -0.888 . . . . 74.439999999999998 108.603 173.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.0 pt -117.23 155.23 18.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.971 -0.751 . . . . 64.239999999999995 108.971 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.8 m -120.71 145.71 47.2 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.151 -0.685 . . . . 72.099999999999994 109.151 175.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -53.3 114.84 1.63 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.552 0.741 . . . . 62.420000000000002 110.972 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.39 -14.34 33.06 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-O 119.87 -0.406 . . . . 74.310000000000002 112.828 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -76.33 132.41 39.77 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.209 0.604 . . . . 72.409999999999997 109.687 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HB3' HD11 ' A' ' 84' ' ' LEU . 50.2 mtmt -84.7 119.69 25.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.685 0.794 . . . . 75.109999999999999 109.371 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.3 mt -104.29 139.48 39.22 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.523 1.129 . . . . 72.040000000000006 108.858 -170.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -101.39 106.93 18.14 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.416 -0.957 . . . . 75.510000000000005 108.416 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 93.9 t -93.07 109.18 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 109.235 -0.654 . . . . 72.109999999999999 109.235 -174.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.7 mt -68.02 -34.75 77.08 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.644 0.778 . . . . 72.230000000000004 110.376 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.66 173.6 38.65 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.337 -0.847 . . . . 60.119999999999997 111.887 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.687 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 14.2 m-85 -98.21 168.84 9.99 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.319 0.648 . . . . 72.439999999999998 109.536 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -71.38 152.15 43.42 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.059 -0.719 . . . . 74.109999999999999 109.059 172.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -58.11 -44.37 87.68 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.229 0.612 . . . . 74.329999999999998 111.472 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -79.13 -5.44 54.14 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 122.949 0.499 . . . . 72.430000000000007 110.315 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 72.6 34.31 60.09 Favored Glycine 0 C--N 1.352 1.44 0 C-N-CA 123.22 0.438 . . . . 72.109999999999999 113.349 174.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -85.44 -61.86 1.66 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.535 0.684 . . . . 71.439999999999998 109.498 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.408 ' HB3' ' HB3' ' A' ' 129' ' ' TRP . 74.5 m95 -111.56 178.11 4.43 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.871 -1.059 . . . . 75.129999999999995 109.974 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -144.45 116.01 8.13 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.98 0.912 . . . . 73.230000000000004 108.658 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -76.58 110.83 11.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.89 0.376 . . . . 74.430000000000007 111.11 -174.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -105.5 165.35 11.2 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.223 -0.899 . . . . 51.439999999999998 110.195 177.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -142.61 125.27 15.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.34 0.656 . . . . 75.340000000000003 109.409 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.7 p -135.86 -164.31 1.53 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.315 1.046 . . . . 44.0 110.416 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -53.99 -33.28 56.64 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.487 1.515 . . . . 73.129999999999995 111.214 172.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -77.52 -1.85 32.59 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.88 1.272 . . . . 72.019999999999996 112.093 -177.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.09 -135.4 12.74 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.262 -0.735 . . . . 72.430000000000007 111.262 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -141.56 135.08 29.73 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.68 0.74 . . . . 73.140000000000001 110.63 -172.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -179.07 176.86 48.21 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 112.215 -0.354 . . . . 74.030000000000001 112.215 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.531 ' HE1' ' HB2' ' A' ' 24' ' ' LYS . 79.8 m95 -87.15 131.64 34.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.538 0.735 . . . . 71.239999999999995 111.309 -174.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.45 152.14 60.76 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.492 1.117 . . . . 73.230000000000004 109.294 175.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.71 131.52 17.34 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 121.819 1.68 . . . . 74.430000000000007 109.896 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.1 m -61.63 -18.73 60.64 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.988 0.915 . . . . 72.329999999999998 112.402 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -74.68 -18.73 60.48 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.322 1.049 . . . . 73.219999999999999 111.638 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.465 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 5.4 m-85 -97.93 1.24 47.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.595 0.758 . . . . 74.030000000000001 111.862 -177.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.3 pt -133.12 158.96 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 122.873 0.469 . . . . 62.5 110.435 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.3 t -150.61 140.86 14.23 Favored Pre-proline 0 N--CA 1.49 1.56 0 C-N-CA 122.527 0.331 . . . . 61.299999999999997 110.436 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.499 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 74.3 Cg_endo -72.85 132.37 18.4 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.91 2.407 . . . . 63.240000000000002 113.055 -177.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.7 m -113.86 -40.95 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 122.811 0.444 . . . . 74.019999999999996 111.693 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 62.8 t30 -100.97 0.42 38.21 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 122.859 0.464 . . . . 60.020000000000003 111.713 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.499 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 33.2 t -75.54 -178.94 4.34 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.11 0.564 . . . . 54.439999999999998 110.33 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 50.0 mt -56.86 -18.23 12.3 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.548 1.139 . . . . 72.329999999999998 112.708 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.562 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 28.2 tt0 -62.07 -19.13 62.6 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.89 0.876 . . . . 71.099999999999994 112.4 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -58.65 -23.73 59.71 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.419 0.688 . . . . 61.509999999999998 111.427 174.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -90.67 134.19 34.59 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.485 -0.931 . . . . 63.25 108.485 173.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.8 p -62.19 -20.56 64.29 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.013 0.745 . . . . 64.409999999999997 113.013 -172.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -73.51 -30.21 62.97 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.118 0.414 . . . . 63.530000000000001 112.118 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -103.33 135.02 45.74 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.553 -0.536 . . . . 74.450000000000003 109.553 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.562 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 16.6 m-70 -130.74 44.49 2.95 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.899 0.479 . . . . 74.329999999999998 110.667 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.45 -160.3 36.61 Favored Glycine 0 CA--C 1.541 1.669 0 N-CA-C 116.45 1.34 . . . . 64.409999999999997 116.45 164.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -83.37 108.97 1.56 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 124.178 3.252 . . . . 64.540000000000006 112.663 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 20.5 m -144.4 172.7 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 109.463 -0.569 . . . . 74.030000000000001 109.463 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.9 m -95.64 171.88 8.4 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 115.834 -0.621 . . . . 70.400000000000006 111.134 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -58.2 -25.29 61.41 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.002 0.921 . . . . 72.040000000000006 111.831 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -66.04 -56.45 11.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.068 0.947 . . . . 74.140000000000001 110.661 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.56 93.37 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.476 0.71 . . . . 72.120000000000005 110.614 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.459 ' HA ' ' NH2' ' A' ' 171' ' ' ARG . . . -56.59 -55.1 38.17 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-N 114.973 -1.012 . . . . 72.099999999999994 110.737 175.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.565 ' HG3' HG11 ' A' ' 190' ' ' VAL . 39.9 tt0 -68.59 -28.98 67.42 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.628 0.771 . . . . 71.129999999999995 110.927 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -61.17 -49.81 75.7 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.358 0.663 . . . . 74.420000000000002 110.5 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.591 HD12 HH22 ' A' ' 171' ' ' ARG . 38.4 mt -73.41 -32.98 64.73 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.85 -0.614 . . . . 72.109999999999999 111.811 177.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 183' ' ' SER . 44.4 tp -69.88 -26.01 63.98 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.186 0.994 . . . . 74.409999999999997 111.326 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.7 t -69.52 -8.87 50.88 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.847 0.859 . . . . 75.450000000000003 111.594 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.9 t -95.94 12.03 31.79 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.588 0.755 . . . . 64.409999999999997 110.762 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.93 174.02 18.0 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 114.155 0.422 . . . . 64.25 114.155 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.6 pt -123.9 -165.55 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.512 1.125 . . . . 73.349999999999994 109.984 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.875 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 13.8 p-10 -52.64 108.65 0.32 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.08 0.952 . . . . 72.540000000000006 112.66 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 100.49 11.59 40.97 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.42 -0.809 . . . . 71.219999999999999 112.904 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.3 t -77.4 129.33 35.64 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.477 -0.934 . . . . 63.509999999999998 108.477 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -136.52 153.27 51.06 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.811 0.671 . . . . 74.340000000000003 112.811 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.744 HD13 HH21 ' A' ' 171' ' ' ARG . 88.9 mt -131.05 132.16 44.74 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.73 -1.211 . . . . 75.329999999999998 107.73 168.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.71 121.68 56.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 106.663 -1.606 . . . . 73.439999999999998 106.663 172.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.744 HH21 HD13 ' A' ' 169' ' ' LEU . 13.1 mmt180 -128.37 165.99 19.54 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.091 0.957 . . . . 64.129999999999995 108.781 -172.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 13.2 pt-20 -114.94 150.87 35.05 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 107.622 -1.251 . . . . 65.030000000000001 107.622 158.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.6 p -86.44 133.08 33.79 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.347 0.404 . . . . 75.150000000000006 109.915 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.76 -38.19 88.4 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.008 0.923 . . . . 52.530000000000001 110.869 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.454 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 32.9 p -81.31 -10.92 59.47 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.001 0.92 . . . . 70.549999999999997 112.418 -175.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 39.8 m -138.27 101.04 8.42 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 122.915 0.486 . . . . 74.049999999999997 110.477 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.687 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 56.5 Cg_endo -66.55 137.86 47.87 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.715 2.943 . . . . 74.329999999999998 112.462 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.36 -22.41 4.58 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 116.224 -0.443 . . . . 75.420000000000002 113.537 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -82.85 119.44 24.39 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.734 0.814 . . . . 61.229999999999997 109.335 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.575 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 77.8 mtt-85 -116.97 163.24 16.52 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 115.184 -0.916 . . . . 74.420000000000002 108.924 -176.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.2 m -147.92 148.0 30.33 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.143 0.577 . . . . 65.120000000000005 110.098 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 66.1 mt -110.58 137.74 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 108.864 -0.791 . . . . 70.109999999999999 108.864 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.529 ' HB3' HD22 ' A' ' 160' ' ' LEU . 29.1 m -114.01 115.51 27.73 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.665 1.186 . . . . 52.399999999999999 108.348 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.5 mt -105.0 144.95 31.11 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.808 0.843 . . . . 72.109999999999999 111.511 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.44 ' HB2' ' HG ' ' A' ' 160' ' ' LEU . 28.3 ttt180 -126.97 138.99 53.36 Favored 'General case' 0 C--O 1.256 1.405 0 N-CA-C 107.071 -1.455 . . . . 63.43 107.071 168.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.875 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 10.3 t80 -149.9 103.98 3.26 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.504 -1.225 . . . . 75.340000000000003 108.328 -168.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 56.02 35.66 25.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.682 1.193 . . . . 73.140000000000001 112.321 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.3 78.76 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.503 -0.771 . . . . 34.439999999999998 113.264 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -98.22 124.39 42.78 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.735 -0.839 . . . . 75.340000000000003 108.735 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.565 HG11 ' HG3' ' A' ' 157' ' ' GLU . 48.4 t -109.18 129.51 63.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.47 1.108 . . . . 73.310000000000002 108.78 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.456 ' HE2' ' HB3' ' A' ' 186' ' ' TYR . 13.1 p90 -146.85 143.85 28.88 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.231 1.013 . . . . 73.299999999999997 109.156 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -126.53 140.66 52.28 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.186 0.994 . . . . 62.409999999999997 108.814 -170.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -139.16 140.65 37.92 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.957 0.408 . . . . 75.349999999999994 111.056 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.442 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 23.1 tpp180 -77.04 131.2 38.29 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.903 -1.044 . . . . 72.25 110.705 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 96.3 mt -78.36 106.18 8.63 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 N-CA-C 107.555 -1.276 . . . . 63.119999999999997 107.555 164.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -75.5 124.94 28.04 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.531 -0.914 . . . . 62.119999999999997 108.531 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.3 m -99.7 115.46 29.53 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.931 0.893 . . . . 60.299999999999997 109.604 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.07 148.63 51.52 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.603 0.761 . . . . 64.340000000000003 109.033 167.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 75.1 p -66.71 -8.75 30.09 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.149 0.58 . . . . 71.430000000000007 112.382 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -83.58 -0.66 51.38 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.03 0.932 . . . . 74.519999999999996 111.14 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 86.83 -0.91 86.74 Favored Glycine 0 C--N 1.349 1.301 0 C-N-CA 123.12 0.39 . . . . 54.25 112.631 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -76.52 129.35 36.35 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 116.903 0.351 . . . . 72.200000000000003 110.105 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.5 mt -96.61 148.23 23.07 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.397 0.679 . . . . 72.519999999999996 109.261 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -164.61 167.49 19.18 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 123.747 0.655 . . . . 74.310000000000002 110.798 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.4 t -136.62 -63.47 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.815 -1.179 . . . . 64.519999999999996 107.815 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 30.2 t -86.38 167.49 14.68 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.179 0.992 . . . . 74.0 109.484 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 42.8 p -67.75 -39.79 84.15 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.585 0.754 . . . . 73.010000000000005 109.907 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -82.76 -2.52 54.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.841 0.856 . . . . 74.219999999999999 112.062 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 58.1 m -92.77 118.15 30.78 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.978 0.911 . . . . 75.299999999999997 109.581 171.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -144.87 118.19 9.0 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 124.684 1.193 . . . . 73.430000000000007 108.545 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 209' ' ' SER . 10.7 m-85 -135.39 150.43 49.9 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 118.295 0.498 . . . . 71.25 111.505 -172.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -92.03 -29.91 16.33 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.567 0.747 . . . . 61.409999999999997 110.47 171.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.1 p -124.4 147.42 48.27 Favored 'General case' 0 C--O 1.248 1.025 0 C-N-CA 123.527 0.731 . . . . 53.0 111.074 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 32.9 tp -65.56 -31.68 72.86 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 114.37 -1.287 . . . . 72.200000000000003 110.657 175.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.87 98.14 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.447 0.699 . . . . 71.310000000000002 111.154 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -73.7 -30.54 62.92 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 119.069 -0.491 . . . . 71.310000000000002 111.693 175.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.96 -47.54 84.73 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.514 0.509 . . . . 74.340000000000003 110.446 172.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.2 t -71.4 -37.32 64.51 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 C-N-CA 124.022 0.929 . . . . 74.010000000000005 110.808 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 14.4 t-160 -62.35 -56.14 21.23 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.719 0.807 . . . . 72.219999999999999 111.108 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.428 ' O ' HG22 ' A' ' 224' ' ' VAL . 49.8 t-80 -52.75 -53.53 46.65 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.641 -1.163 . . . . 70.209999999999994 109.393 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.41 ' HB3' ' HG ' ' A' ' 232' ' ' LEU . 8.0 m-70 -63.09 -27.72 69.59 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.979 -0.555 . . . . 65.430000000000007 112.388 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.5 t -71.23 -23.66 62.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.846 0.459 . . . . 64.200000000000003 110.841 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 15.4 t -119.07 -3.69 10.63 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 116.407 2.002 . . . . 71.030000000000001 116.407 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 220' ' ' HIS . 27.0 m -106.03 154.67 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 116.422 2.008 . . . . 74.519999999999996 116.422 -172.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.7 -0.73 56.84 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 110.793 -2.912 . . . . 53.109999999999999 113.285 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -76.25 13.72 0.87 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 129.596 3.158 . . . . 71.150000000000006 113.56 -140.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.45 16.87 4.99 Favored Glycine 0 N--CA 1.464 0.545 0 C-N-CA 126.253 1.882 . . . . 63.240000000000002 111.629 -169.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.06 126.69 38.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.609 -1.295 . . . . 43.119999999999997 109.551 166.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 76.9 mt -58.36 -49.55 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.581 0.752 . . . . 72.439999999999998 109.428 170.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . 0.405 HG22 ' OH ' ' A' ' 191' ' ' TYR . 12.8 t -134.24 148.13 50.79 Favored 'General case' 0 C--O 1.249 1.064 0 N-CA-C 107.826 -1.175 . . . . 71.329999999999998 107.826 169.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 224' ' ' VAL . 67.0 p -70.52 162.93 27.91 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 109.53 -0.544 . . . . 61.219999999999999 109.53 175.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.41 ' HG ' ' HB3' ' A' ' 221' ' ' HIS . 21.5 mt -68.58 100.52 1.13 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.154 -1.054 . . . . 51.049999999999997 108.154 176.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -90.89 -47.18 7.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.767 0.427 . . . . 64.340000000000003 111.253 -168.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -157.12 147.8 16.24 Favored Pre-proline 0 N--CA 1.485 1.319 0 N-CA-C 109.676 -0.49 . . . . 74.209999999999994 109.676 174.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.14 133.69 34.02 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.656 2.237 . . . . 62.240000000000002 112.626 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.409 ' HB3' ' HG ' ' A' ' 169' ' ' LEU . . . -67.71 150.25 97.9 Favored Pre-proline 0 C--O 1.246 0.882 0 C-N-CA 123.555 0.742 . . . . 72.219999999999999 110.414 174.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.441 ' O ' ' HB3' ' A' ' 159' ' ' LEU . 51.6 Cg_exo -56.95 132.57 52.44 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.341 2.694 . . . . 73.420000000000002 114.908 -172.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.3 tttp . . . . . 0 CA--C 1.549 0.917 0 N-CA-C 106.721 -1.585 . . . . 60.439999999999998 106.721 158.238 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.0 p . . . . . 0 C--O 1.247 0.932 0 CA-C-O 121.325 0.583 . . . . 53.140000000000001 110.861 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.6 mt -107.9 123.71 36.97 Favored Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 108.405 -0.961 . . . . 42.329999999999998 108.405 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HG3' ' HB3' ' A' ' 117' ' ' GLU . 55.5 Cg_endo -71.73 173.77 12.13 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.812 2.341 . . . . 73.439999999999998 112.253 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.79 149.28 29.67 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.16 0.584 . . . . 53.140000000000001 111.32 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.573 HD22 HD11 ' A' ' 23' ' ' ILE . 89.2 mt -87.43 95.23 9.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.322 0.649 . . . . 64.049999999999997 109.767 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -97.44 -49.15 5.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.147 0.579 . . . . 70.349999999999994 110.485 175.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -99.87 107.78 19.87 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.91 -0.404 . . . . 74.409999999999997 109.91 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.638 HD12 ' HB2' ' A' ' 97' ' ' ASN . 46.6 mm -124.26 121.04 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.103 0.961 . . . . 74.230000000000004 109.551 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 109.376 -0.602 . . . . 75.420000000000002 109.376 174.076 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo . . . . . 0 N--CA 1.499 1.837 0 N-CA-C 113.647 0.595 . . . . 70.150000000000006 113.647 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -88.67 72.6 8.66 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.638 0.732 . . . . 63.439999999999998 109.062 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.58 HD11 ' HB3' ' A' ' 106' ' ' LYS . 29.8 tp -89.95 130.92 36.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.952 -1.022 . . . . 75.019999999999996 108.878 177.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 13.0 m-85 -113.84 174.97 5.67 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.008 1.723 . . . . 73.409999999999997 109.015 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.96 149.1 19.95 Favored 'Isoleucine or valine' 0 C--O 1.256 1.395 0 N-CA-C 109.081 -0.711 . . . . 71.129999999999995 109.081 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.25 124.5 33.92 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.387 -0.824 . . . . 74.420000000000002 109.828 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.4 mt -83.13 -17.74 41.97 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.264 1.026 . . . . 74.25 111.619 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.479 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 57.8 m-85 -135.44 166.37 23.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.71 0.804 . . . . 64.019999999999996 109.336 -175.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -78.79 145.8 34.13 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.271 -0.877 . . . . 70.430000000000007 109.172 168.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -155.46 112.75 3.29 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.687 -0.486 . . . . 65.510000000000005 109.687 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.98 139.12 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.192 -0.67 . . . . 60.009999999999998 109.192 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.13 127.74 34.18 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.963 -0.384 . . . . 73.040000000000006 109.963 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.6 p -65.66 -24.37 67.01 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.648 0.779 . . . . 64.049999999999997 110.919 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.97 -149.78 8.47 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.53 -1.028 . . . . 61.32 110.53 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.24 -30.59 69.67 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.819 0.848 . . . . 72.209999999999994 111.578 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.638 ' HB2' HD12 ' A' ' 23' ' ' ILE . 20.1 p30 -71.24 -23.31 61.97 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.029 0.932 . . . . 63.530000000000001 113.51 -172.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.6 p -113.26 163.12 15.21 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.747 0.819 . . . . 61.539999999999999 110.217 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.402 ' HB3' HG13 ' A' ' 130' ' ' VAL . 59.3 tp -111.06 125.72 54.05 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.13 -0.693 . . . . 61.32 109.13 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -74.43 119.66 18.92 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.677 -0.86 . . . . 65.310000000000002 108.677 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.0 pt -123.87 138.71 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.273 0.629 . . . . 52.409999999999997 109.546 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.4 m -97.23 150.06 21.34 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.336 -0.847 . . . . 65.310000000000002 109.756 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -61.22 113.58 2.68 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 109.484 -0.562 . . . . 71.329999999999998 109.484 172.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.25 -11.11 47.69 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.198 -0.455 . . . . 44.439999999999998 113.697 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -72.68 134.56 45.13 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.537 0.735 . . . . 72.030000000000001 110.387 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.58 ' HB3' HD11 ' A' ' 84' ' ' LEU . 34.8 mtmm -85.75 123.27 30.94 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.877 0.871 . . . . 74.239999999999995 109.7 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.601 ' HA ' HG22 ' A' ' 123' ' ' THR . 13.0 mt -107.88 158.36 17.4 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.898 -0.779 . . . . 74.120000000000005 108.898 -170.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtm-85 -123.07 108.64 13.12 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.846 -0.798 . . . . 75.049999999999997 108.846 164.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.505 HG21 HD12 ' A' ' 135' ' ' ILE . 98.6 t -88.71 109.46 20.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.334 -0.617 . . . . 61.210000000000001 109.334 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.476 HD12 ' NE2' ' A' ' 127' ' ' GLN . 75.8 mt -81.68 -12.23 58.75 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.198 -0.91 . . . . 65.409999999999997 111.092 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.72 159.13 18.67 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.39 -0.684 . . . . 54.25 111.39 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 4.1 m-85 -96.93 173.61 7.2 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.686 0.794 . . . . 74.310000000000002 110.28 178.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.468 HD22 ' HB2' ' A' ' 118' ' ' TRP . 32.3 t-20 -77.76 147.19 35.45 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.176 0.991 . . . . 72.239999999999995 108.555 173.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.52 ' HD2' ' HG2' ' A' ' 177' ' ' PRO . 34.0 m170 -63.7 -26.28 68.58 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.117 0.567 . . . . 71.430000000000007 111.645 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -87.66 -16.85 33.21 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.389 1.075 . . . . 52.310000000000002 110.512 175.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.94 0.68 77.59 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 123.911 0.767 . . . . 75.299999999999997 113.68 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.403 ' HB3' ' HG3' ' A' ' 18' ' ' PRO . 17.2 mm-40 -78.0 -47.29 18.8 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.158 0.983 . . . . 71.239999999999995 112.098 -172.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.468 ' HB2' HD22 ' A' ' 113' ' ' ASN . 83.2 m95 -105.61 174.63 5.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.857 0.863 . . . . 62.420000000000002 109.637 177.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -153.49 127.14 8.75 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.175 -1.046 . . . . 74.230000000000004 108.175 175.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -74.28 106.63 6.01 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.232 0.469 . . . . 73.420000000000002 110.409 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.66 163.65 12.18 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.317 -0.856 . . . . 74.340000000000003 109.698 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -139.71 122.78 16.78 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.6 -1.259 . . . . 54.210000000000001 107.6 178.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 107' ' ' LEU . 78.9 p -131.81 -169.56 2.23 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.379 0.672 . . . . 75.120000000000005 110.611 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -54.1 -28.52 39.87 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.098 -1.41 . . . . 53.32 111.708 170.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -84.64 -2.36 57.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.33 1.052 . . . . 64.010000000000005 111.84 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.51 -132.79 10.15 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 111.418 -0.673 . . . . 72.209999999999994 111.418 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.476 ' NE2' HD12 ' A' ' 110' ' ' LEU . 63.3 tt0 -142.99 143.74 32.04 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.243 0.617 . . . . 52.329999999999998 110.29 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 174.91 -178.13 46.76 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.843 -0.617 . . . . 54.409999999999997 111.58 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -95.97 123.87 39.74 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.017 0.527 . . . . 72.439999999999998 110.762 -173.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 99' ' ' LEU . 35.1 m -117.64 149.02 44.24 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.978 1.311 . . . . 41.229999999999997 109.601 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.78 132.53 23.48 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 121.669 1.579 . . . . 74.310000000000002 111.234 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.6 m -60.74 -21.56 63.1 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.177 0.991 . . . . 75.040000000000006 112.364 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -68.55 -24.65 64.65 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.879 0.872 . . . . 73.209999999999994 111.741 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.479 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.2 m-85 -94.94 0.84 55.06 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.791 0.836 . . . . 63.420000000000002 112.78 -177.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.505 HD12 HG21 ' A' ' 109' ' ' VAL . 15.9 pt -127.72 160.88 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 118.98 0.809 . . . . 74.25 111.365 -171.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.1 t -157.89 145.09 13.39 Favored Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 119.108 -0.472 . . . . 71.349999999999994 110.599 169.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.37 139.27 37.73 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.714 2.276 . . . . 44.43 111.804 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.28 -50.01 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.001 0.52 . . . . 74.239999999999995 112.037 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -100.74 -6.04 25.56 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.397 0.544 . . . . 75.439999999999998 110.916 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.5 t -60.32 177.75 0.25 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.27 1.028 . . . . 75.030000000000001 111.891 -176.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 84.7 mt -57.13 -17.66 11.75 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.981 0.912 . . . . 73.140000000000001 112.678 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -57.7 -24.7 58.18 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.506 1.122 . . . . 55.340000000000003 112.04 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -56.71 -36.19 69.39 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.409 1.083 . . . . 70.109999999999999 111.25 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 -74.33 141.71 45.2 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.369 -0.832 . . . . 75.230000000000004 109.342 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.1 t -62.69 -21.81 66.02 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.812 0.845 . . . . 75.010000000000005 112.075 -176.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.425 ' CE3' ' HB2' ' A' ' 147' ' ' TYR . 58.8 p-90 -80.05 -41.53 25.52 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.382 0.512 . . . . 73.510000000000005 112.382 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.425 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 29.5 t80 -99.98 138.04 37.6 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.375 0.534 . . . . 74.420000000000002 109.566 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.404 ' HB2' ' NE ' ' A' ' 171' ' ' ARG . 22.1 m-70 -126.7 14.06 7.5 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 112.172 0.434 . . . . 64.109999999999999 112.172 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.15 -162.65 50.02 Favored Glycine 0 N--CA 1.474 1.23 0 CA-C-O 119.581 -0.566 . . . . 62.439999999999998 114.403 171.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.07 100.38 0.97 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.785 2.99 . . . . 61.439999999999998 111.558 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.55 HG11 ' NH2' ' A' ' 171' ' ' ARG . 84.1 t -138.93 150.92 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.818 0.447 . . . . 74.420000000000002 110.595 -172.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 18.4 m -59.2 139.34 57.04 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.598 1.159 . . . . 71.230000000000004 111.411 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -62.8 -27.59 69.41 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.736 0.814 . . . . 74.450000000000003 111.483 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -62.4 -50.3 72.07 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.529 0.732 . . . . 73.420000000000002 110.2 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.62 -33.83 76.81 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.461 0.705 . . . . 64.409999999999997 111.54 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 171' ' ' ARG . . . -58.5 -52.36 65.97 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.256 -0.884 . . . . 60.539999999999999 110.573 173.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.462 ' HG3' HG11 ' A' ' 190' ' ' VAL . 35.0 tt0 -69.62 -27.41 65.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.537 0.735 . . . . 65.540000000000006 111.195 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -64.91 -49.42 70.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.856 0.862 . . . . 74.319999999999993 110.983 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.498 HD12 HH12 ' A' ' 171' ' ' ARG . 63.8 mt -70.77 -37.23 73.35 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 120.88 0.371 . . . . 71.040000000000006 110.739 175.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.7 tp -64.53 -25.38 67.96 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.547 -0.751 . . . . 75.349999999999994 112.094 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.6 t -59.96 -29.26 68.31 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.173 0.989 . . . . 62.119999999999997 111.228 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.2 t -77.17 -12.93 60.01 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.97 0.908 . . . . 74.340000000000003 111.969 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.59 165.61 32.43 Favored Glycine 0 C--N 1.344 1.001 0 N-CA-C 113.811 0.284 . . . . 61.539999999999999 113.811 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.0 pt -113.5 -164.28 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.58 1.152 . . . . 71.450000000000003 109.909 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.763 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 21.5 p-10 -52.99 115.18 1.72 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.725 0.81 . . . . 72.25 112.378 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.06 12.79 57.25 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 115.472 -0.785 . . . . 74.310000000000002 113.013 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 21.9 t -76.3 138.78 40.73 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.911 -0.774 . . . . 60.310000000000002 108.911 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 16.1 p90 -138.42 158.15 44.84 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.095 0.474 . . . . 72.25 111.979 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.506 HD13 ' NH1' ' A' ' 171' ' ' ARG . 84.9 mt -141.27 134.37 29.27 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.216 -1.031 . . . . 73.420000000000002 108.216 168.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 214' ' ' LEU . 16.0 t -106.93 123.18 61.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.947 -1.131 . . . . 61.030000000000001 107.947 175.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.55 ' NH2' HG11 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -130.86 157.87 41.73 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.298 -1.371 . . . . 63.119999999999997 107.298 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 11.7 pt-20 -108.22 162.97 13.58 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 109.29 -0.633 . . . . 74.109999999999999 109.29 166.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 176' ' ' SER . 48.1 t -82.67 136.94 34.62 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.22 -0.9 . . . . 63.420000000000002 111.038 -175.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.62 -22.35 63.5 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.139 -1.392 . . . . 50.229999999999997 111.567 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 30.1 t -111.24 -0.53 16.42 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.834 0.854 . . . . 73.230000000000004 111.384 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 173' ' ' SER . 24.2 m -139.68 119.67 9.19 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 119.091 -0.481 . . . . 73.150000000000006 109.798 -178.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.52 ' HG2' ' HD2' ' A' ' 114' ' ' HIS . 21.4 Cg_exo -67.11 112.86 2.64 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 123.888 3.059 . . . . 74.319999999999993 113.401 -169.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.95 9.26 52.94 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.54 0.525 . . . . 62.43 114.024 175.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -85.05 114.55 22.28 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 107.71 -1.218 . . . . 63.109999999999999 107.71 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 57.2 mtt-85 -104.67 169.46 8.44 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.379 -0.6 . . . . 71.439999999999998 109.379 -169.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.0 m -155.0 136.42 14.15 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 123.875 0.87 . . . . 75.329999999999998 108.949 -173.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.428 HG12 HG22 ' A' ' 170' ' ' VAL . 54.7 mt -104.13 135.99 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 108.459 -0.941 . . . . 74.340000000000003 108.459 173.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.9 m -113.25 111.83 22.7 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.62 -1.173 . . . . 64.239999999999995 107.875 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.444 HD21 HD23 ' A' ' 232' ' ' LEU . 53.4 mt -105.0 139.81 39.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.753 0.821 . . . . 74.329999999999998 111.419 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -126.37 130.33 50.56 Favored 'General case' 0 C--O 1.261 1.685 0 O-C-N 124.056 0.848 . . . . 74.420000000000002 109.141 172.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.763 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 14.4 p90 -151.7 137.84 18.31 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 124.362 1.039 . . . . 75.5 108.492 172.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 55.36 28.94 12.18 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.044 1.338 . . . . 74.010000000000005 113.227 177.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.8 14.77 81.68 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 116.012 -0.54 . . . . 73.530000000000001 113.394 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -109.08 126.12 52.84 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.317 1.047 . . . . 74.409999999999997 108.698 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.462 HG11 ' HG3' ' A' ' 157' ' ' GLU . 91.5 t -109.81 135.58 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.509 0.724 . . . . 74.25 109.289 174.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.442 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 22.5 p90 -144.31 155.07 43.66 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.207 0.603 . . . . 74.019999999999996 109.538 171.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -129.17 136.34 50.03 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.156 -1.053 . . . . 72.150000000000006 108.156 -171.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -136.24 144.57 44.92 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 121.001 0.429 . . . . 75.530000000000001 110.738 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -76.91 131.71 38.71 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.73 -1.123 . . . . 71.129999999999995 110.365 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 77.8 mt -80.6 106.86 12.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 N-CA-C 108.298 -1.001 . . . . 72.530000000000001 108.298 164.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -69.74 123.72 22.12 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.436 -0.802 . . . . 70.209999999999994 109.558 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.3 m -104.88 107.99 19.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.427 0.691 . . . . 62.130000000000003 110.497 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.42 170.66 4.64 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.348 1.059 . . . . 62.43 111.293 173.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 41.2 p -59.21 -37.48 77.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.058 0.943 . . . . 75.540000000000006 112.191 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -76.1 -2.67 32.02 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.962 0.505 . . . . 75.340000000000003 111.862 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.92 6.89 84.65 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 111.811 -0.516 . . . . 74.530000000000001 111.811 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -69.83 128.29 35.88 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.74 -0.467 . . . . 62.549999999999997 109.74 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 80.8 mt -95.33 147.44 23.5 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.461 0.704 . . . . 62.200000000000003 109.784 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -163.6 164.88 23.96 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.425 0.69 . . . . 75.209999999999994 110.42 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 78.7 t -138.04 -52.64 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.11 0.964 . . . . 75.230000000000004 109.23 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 33.0 t -100.25 -178.28 3.78 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.774 0.83 . . . . 75.409999999999997 110.853 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.8 m -63.93 -46.23 85.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.641 1.177 . . . . 72.319999999999993 111.986 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.92 -14.42 41.91 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.263 0.625 . . . . 65.230000000000004 112.095 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 74.7 m -64.15 117.31 6.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.187 0.595 . . . . 63.130000000000003 111.186 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -146.53 112.73 5.83 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.654 1.182 . . . . 63.240000000000002 108.665 168.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -130.86 142.53 50.39 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.387 0.675 . . . . 74.439999999999998 109.417 -176.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -81.66 -34.81 30.55 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.661 0.384 . . . . 71.349999999999994 110.016 173.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 60.4 p -124.2 152.93 42.31 Favored 'General case' 0 C--O 1.255 1.363 0 CA-C-O 122.112 0.958 . . . . 72.109999999999999 111.287 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 170' ' ' VAL . 35.9 tp -63.45 -31.14 72.21 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 113.671 -1.604 . . . . 61.539999999999999 111.266 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.96 95.65 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.497 0.719 . . . . 72.230000000000004 110.918 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -61.69 -44.13 97.54 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.478 0.711 . . . . 53.439999999999998 110.598 173.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.75 -41.08 85.67 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.709 0.631 . . . . 61.539999999999999 111.769 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.7 t -74.28 -41.99 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.645 0.778 . . . . 74.25 111.016 -175.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -58.81 -51.38 70.26 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.438 0.637 . . . . 70.129999999999995 110.1 174.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.422 ' O ' HG22 ' A' ' 224' ' ' VAL . 48.3 t-80 -54.14 -57.83 9.62 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.495 -1.229 . . . . 50.109999999999999 109.905 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -61.04 -26.7 67.81 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.337 0.655 . . . . 74.409999999999997 112.046 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 37.4 t -73.07 -27.76 61.92 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 122.913 0.485 . . . . 65.400000000000006 111.706 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.5 t -120.96 7.2 10.35 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 115.443 1.645 . . . . 71.010000000000005 115.443 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 220' ' ' HIS . 34.1 m -113.74 156.14 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 121.069 1.759 . . . . 53.130000000000003 115.431 -176.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.77 -2.47 58.25 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 129.986 3.314 . . . . 74.439999999999998 113.168 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -77.76 14.82 0.96 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 129.381 3.072 . . . . 73.439999999999998 113.51 -141.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.66 18.53 3.98 Favored Glycine 0 N--CA 1.47 0.921 0 C-N-CA 125.274 1.416 . . . . 75.409999999999997 111.377 -171.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 88.3 mt -91.26 134.49 34.53 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.206 1.002 . . . . 71.239999999999995 110.129 165.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.442 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 95.0 mt -67.83 -44.86 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 124.421 1.076 . . . . 65.420000000000002 108.695 170.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.5 t -135.04 142.13 46.3 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 114.992 -1.004 . . . . 71.299999999999997 108.866 173.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 67.4 p -70.38 155.98 39.95 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 108.606 -0.887 . . . . 75.129999999999995 108.606 171.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.446 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 32.1 mt -67.13 100.62 0.79 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.142 -1.058 . . . . 74.200000000000003 108.142 177.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -77.96 -50.29 12.46 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.066 0.547 . . . . 63.420000000000002 109.981 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 167' ' ' SER . 6.3 p90 -161.63 152.2 14.77 Favored Pre-proline 0 N--CA 1.488 1.455 0 C-N-CA 121.006 -0.278 . . . . 75.519999999999996 110.419 174.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 53.4 Cg_endo -69.06 137.06 36.52 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.238 1.959 . . . . 74.129999999999995 111.538 173.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -57.99 130.7 83.12 Favored Pre-proline 0 C--O 1.246 0.9 0 O-C-N 123.558 0.536 . . . . 73.030000000000001 109.894 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.39 145.26 87.81 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.28 1.987 . . . . 72.209999999999994 112.143 -172.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt . . . . . 0 CA--C 1.545 0.766 0 CA-C-N 115.555 -0.748 . . . . 60.420000000000002 109.149 171.033 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.24 0.599 0 CA-C-O 121.796 0.808 . . . . 64.209999999999994 112.428 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.9 mt -107.72 133.28 20.5 Favored Pre-proline 0 C--O 1.241 0.62 0 CA-C-N 114.636 -1.165 . . . . 74.140000000000001 108.545 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.92 170.22 14.67 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.511 2.14 . . . . 75.25 111.99 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.89 144.67 29.06 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.051 0.541 . . . . 63.539999999999999 110.499 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.63 ' HB3' HD11 ' A' ' 23' ' ' ILE . 74.1 mt -87.43 94.85 9.81 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.557 0.743 . . . . 75.140000000000001 109.175 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -96.22 -47.09 6.18 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.023 -0.732 . . . . 64.319999999999993 109.023 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -99.77 113.77 26.47 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.143 -0.935 . . . . 72.230000000000004 109.815 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.63 HD11 ' HB3' ' A' ' 20' ' ' LEU . 39.1 mm -116.51 114.11 45.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 107.904 -1.147 . . . . 70.010000000000005 107.904 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.1 mttm . . . . . 0 N--CA 1.471 0.59 0 C-N-CA 123.202 0.601 . . . . 63.439999999999998 109.627 -175.861 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo . . . . . 0 CA--C 1.549 1.269 0 CA-C-O 120.608 0.17 . . . . 72.329999999999998 112.183 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -96.12 33.7 1.69 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.938 0.895 . . . . 73.209999999999994 110.368 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 33.9 tp -81.03 112.47 18.45 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.815 -0.809 . . . . 65.540000000000006 108.815 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.6 m-85 -104.45 177.73 4.76 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.918 1.687 . . . . 75.430000000000007 109.505 175.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 11.3 p -144.28 138.93 24.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.47 0.708 . . . . 73.340000000000003 109.161 171.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -78.23 112.8 15.58 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.98 0.912 . . . . 62.340000000000003 109.431 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.4 mt -74.72 -22.2 58.95 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.193 0.997 . . . . 64.230000000000004 111.925 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -130.88 152.55 50.08 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.103 0.961 . . . . 75.299999999999997 109.214 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -77.84 130.85 37.17 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.226 -1.027 . . . . 72.450000000000003 108.226 173.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.49 ' HB3' HG12 ' A' ' 101' ' ' ILE . 74.7 t80 -133.21 114.83 14.27 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 108.916 -0.772 . . . . 74.239999999999995 108.916 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.3 136.76 22.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 108.904 -0.776 . . . . 65.319999999999993 108.904 171.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.8 137.96 57.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.762 0.425 . . . . 62.399999999999999 110.537 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.1 t -75.73 -9.93 59.01 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.064 0.546 . . . . 75.010000000000005 110.152 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.12 -154.63 25.12 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 115.866 -0.606 . . . . 55.340000000000003 111.759 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.99 -40.25 95.0 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.258 1.023 . . . . 70.540000000000006 111.789 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -67.86 -25.06 65.34 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.769 0.828 . . . . 72.109999999999999 112.467 -172.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.9 p -106.29 158.49 16.83 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.626 0.77 . . . . 71.109999999999999 109.702 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.8 tp -109.66 124.94 52.05 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 122.999 0.52 . . . . 73.200000000000003 109.991 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 p -70.57 114.88 9.11 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.279 -0.873 . . . . 74.010000000000005 109.356 170.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 91' ' ' PHE . 24.8 pt -119.7 156.98 22.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.023 -0.732 . . . . 60.420000000000002 109.023 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 1.9 m -117.35 143.65 45.74 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.318 -0.623 . . . . 53.109999999999999 109.318 -174.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -57.56 120.22 7.91 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 122.807 0.443 . . . . 74.219999999999999 110.367 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.53 -13.84 63.82 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.323 0.389 . . . . 73.349999999999994 113.455 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -85.74 130.98 34.41 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.846 0.858 . . . . 71.040000000000006 110.235 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HB3' HD11 ' A' ' 84' ' ' LEU . 9.1 mtmp? -83.7 142.72 30.53 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.813 0.845 . . . . 74.120000000000005 110.886 -177.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.1 mt -120.46 150.96 39.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.519 1.128 . . . . 71.129999999999995 108.282 -171.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -113.89 107.37 15.61 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.941 -1.133 . . . . 64.030000000000001 107.941 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.08 121.94 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 109.935 -0.394 . . . . 53.340000000000003 109.935 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 72.3 mt -83.38 -41.57 18.02 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.098 0.475 . . . . 74.450000000000003 109.95 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.52 172.34 44.07 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.58 -0.736 . . . . 70.140000000000001 111.828 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.483 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 13.3 m-85 -99.28 169.13 9.58 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.046 -0.724 . . . . 71.349999999999994 109.046 175.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -66.39 146.53 54.47 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.877 -1.156 . . . . 75.219999999999999 107.877 172.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . 0.689 ' HA ' ' HG3' ' A' ' 177' ' ' PRO . 31.0 m170 -68.59 -21.27 64.52 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.939 0.496 . . . . 62.100000000000001 112.217 -174.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -94.57 -12.23 27.92 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.17 0.588 . . . . 71.299999999999997 110.673 174.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 82.33 35.23 21.07 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 116.453 -0.339 . . . . 41.439999999999998 112.794 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -85.59 -65.68 0.98 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.518 0.727 . . . . 65.239999999999995 110.256 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -115.83 179.46 3.97 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.654 1.181 . . . . 71.439999999999998 109.5 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -135.31 127.45 29.91 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.91 0.884 . . . . 34.119999999999997 108.664 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -83.46 113.84 21.05 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.199 0.523 . . . . 73.310000000000002 110.668 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.76 163.49 18.04 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 114.966 -1.016 . . . . 63.020000000000003 110.47 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -133.16 141.64 48.23 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.103 0.961 . . . . 73.120000000000005 109.596 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.3 p -137.33 179.77 6.2 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.54 1.536 . . . . 74.420000000000002 108.053 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -73.96 -6.51 47.78 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.437 0.295 . . . . 54.420000000000002 110.753 172.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -76.88 -22.93 52.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.061 0.945 . . . . 75.049999999999997 110.177 169.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 130.13 -171.1 20.59 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 111.109 -0.796 . . . . 44.329999999999998 111.109 -174.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -115.96 147.05 41.58 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.642 0.777 . . . . 60.509999999999998 110.245 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 175.45 -176.81 47.4 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 123.442 0.464 . . . . 75.219999999999999 112.767 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -89.42 136.01 33.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.833 0.853 . . . . 70.230000000000004 110.631 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.76 154.95 80.78 Favored Pre-proline 0 N--CA 1.482 1.163 0 C-N-CA 124.465 1.106 . . . . 54.310000000000002 110.206 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.68 130.1 11.36 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.481 2.12 . . . . 42.009999999999998 111.236 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.512 ' HA ' HG12 ' A' ' 135' ' ' ILE . 13.6 p -63.43 -20.93 65.98 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.61 0.764 . . . . 71.219999999999999 111.897 178.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -70.73 -27.02 63.65 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.872 0.869 . . . . 70.420000000000002 111.537 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -95.39 2.25 54.53 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.554 0.742 . . . . 63.210000000000001 111.955 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.512 HG12 ' HA ' ' A' ' 132' ' ' SER . 14.4 pt -134.92 152.33 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 118.029 0.377 . . . . 52.329999999999998 110.544 -173.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.4 t -143.3 139.56 16.71 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.455 0.702 . . . . 51.149999999999999 109.117 171.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.567 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 56.0 Cg_endo -71.05 140.36 37.69 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 122.26 1.974 . . . . 71.549999999999997 112.058 175.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.4 m -111.1 -45.05 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.152 0.981 . . . . 74.310000000000002 110.613 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.551 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.5 t30 -100.04 6.8 45.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.964 0.506 . . . . 53.340000000000003 111.22 -174.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 31.0 t -86.42 176.19 8.0 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.241 0.543 . . . . 65.25 110.127 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.456 ' O ' ' HB3' ' A' ' 147' ' ' TYR . 80.7 mt -66.21 -13.93 61.08 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.129 0.971 . . . . 74.409999999999997 112.585 -176.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.87 -28.79 64.47 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.521 0.728 . . . . 74.019999999999996 111.785 176.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -64.18 -25.37 68.05 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.088 -0.505 . . . . 54.399999999999999 110.853 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -78.54 134.29 37.27 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.57 -0.9 . . . . 74.439999999999998 108.57 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.1 t -67.89 -18.87 64.93 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.167 0.803 . . . . 74.319999999999993 113.167 -171.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 61.4 p-90 -78.99 -26.46 43.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.073 0.549 . . . . 75.400000000000006 111.849 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 46.7 t80 -109.72 125.62 52.86 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.244 0.618 . . . . 64.409999999999997 109.389 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -113.11 25.89 10.97 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.669 0.388 . . . . 63.509999999999998 111.482 -172.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 64.61 -156.6 46.05 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.769 -0.65 . . . . 63.240000000000002 114.323 172.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.425 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 56.6 Cg_endo -70.52 101.58 1.04 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 123.009 2.473 . . . . 70.439999999999998 111.008 173.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.3 p -143.19 145.1 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 120.911 0.386 . . . . 73.219999999999999 110.289 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 70.5 m -73.62 166.73 22.74 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.449 1.1 . . . . 75.540000000000006 112.747 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 44.6 mtt85 -65.35 -40.94 94.24 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.52 -1.218 . . . . 72.319999999999993 111.359 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -70.13 -42.93 71.95 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.059 0.849 . . . . 72.200000000000003 111.186 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.64 -42.72 86.25 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.127 0.971 . . . . 72.140000000000001 110.135 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.35 -52.71 64.46 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.728 -1.124 . . . . 73.140000000000001 110.02 173.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.534 ' HG3' HG11 ' A' ' 190' ' ' VAL . 37.9 tt0 -61.07 -29.17 69.58 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.322 0.649 . . . . 75.409999999999997 111.272 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -63.68 -52.71 59.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.664 0.785 . . . . 55.049999999999997 110.277 173.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.62 -33.85 75.86 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.806 -0.634 . . . . 73.019999999999996 111.162 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.662 HD23 HG13 ' A' ' 190' ' ' VAL . 28.9 tp -78.55 -23.39 46.18 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.092 -0.958 . . . . 74.329999999999998 111.595 -177.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 t -64.28 -23.6 67.36 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.66 0.784 . . . . 42.549999999999997 111.374 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.0 m -82.88 -7.97 59.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.016 0.926 . . . . 65.030000000000001 112.091 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.15 174.03 41.67 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 114.26 0.464 . . . . 43.229999999999997 114.26 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.0 pt -121.29 -164.24 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.027 0.931 . . . . 52.109999999999999 109.91 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.769 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 22.7 p-10 -49.56 117.18 2.08 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.163 0.985 . . . . 72.140000000000001 112.236 177.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.97 13.99 68.06 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-N 115.562 -0.744 . . . . 71.519999999999996 113.617 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 23.3 t -73.54 132.96 43.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.569 -0.901 . . . . 72.209999999999994 108.569 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.495 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 19.4 p90 -134.87 161.32 35.55 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.176 0.806 . . . . 75.430000000000007 113.176 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 76.9 mt -137.87 135.47 36.19 Favored 'General case' 0 C--O 1.215 -0.754 0 C-N-CA 124.901 1.281 . . . . 73.340000000000003 108.978 172.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 14.3 t -114.83 140.06 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 106.467 -1.679 . . . . 75.040000000000006 106.467 167.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.2 ptt85 -158.72 168.85 25.77 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.955 0.502 . . . . 73.310000000000002 110.474 -172.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.473 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 12.2 pt-20 -115.46 153.44 31.1 Favored 'General case' 0 C--O 1.257 1.448 0 C-N-CA 123.09 0.556 . . . . 63.520000000000003 109.543 167.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 176' ' ' SER . 17.1 m -88.43 123.76 33.29 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.072 -0.967 . . . . 72.200000000000003 109.291 -178.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' A' ' 150' ' ' PRO . 38.3 mt-10 -57.56 -39.36 76.51 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.421 1.089 . . . . 71.5 111.674 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.614 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 8.5 t -87.41 -6.26 58.51 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 115.167 -0.924 . . . . 74.219999999999999 111.969 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 173' ' ' SER . 14.9 m -131.72 100.21 16.38 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.425 0.69 . . . . 73.109999999999999 109.324 -176.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.689 ' HG3' ' HA ' ' A' ' 114' ' ' HIS . 36.3 Cg_endo -60.35 113.55 1.73 Allowed 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.745 2.963 . . . . 74.209999999999994 112.061 -174.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.72 -20.38 19.56 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 116.101 -0.5 . . . . 44.43 113.666 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -73.79 116.84 14.87 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.648 0.724 . . . . 75.340000000000003 109.305 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.473 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 66.9 mtt85 -113.23 160.23 18.5 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 124.186 0.995 . . . . 71.129999999999995 110.279 -171.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 44.4 t -143.92 151.58 40.0 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.093 0.957 . . . . 74.430000000000007 110.48 -174.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.432 HD11 HD21 ' A' ' 217' ' ' LEU . 52.1 mt -119.06 145.85 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.214 1.006 . . . . 71.319999999999993 108.519 169.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.5 m -125.18 127.34 46.65 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.629 1.172 . . . . 61.340000000000003 108.148 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.449 HD21 HD23 ' A' ' 232' ' ' LEU . 57.9 mt -113.67 147.78 37.53 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.624 0.77 . . . . 75.420000000000002 111.891 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 19.7 ttt180 -133.86 131.01 38.68 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-N 114.536 -1.211 . . . . 74.299999999999997 109.651 172.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.769 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 9.5 p90 -149.38 141.03 23.49 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.562 1.145 . . . . 74.049999999999997 108.022 173.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 54.07 31.67 14.18 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.224 1.01 . . . . 53.200000000000003 113.232 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.19 3.68 90.62 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 116.343 -0.389 . . . . 64.230000000000004 112.782 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 10.3 tpp180 -102.13 124.21 47.33 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.151 0.98 . . . . 74.030000000000001 109.72 -176.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.662 HG13 HD23 ' A' ' 160' ' ' LEU . 81.0 t -107.45 135.89 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.265 1.026 . . . . 72.120000000000005 109.578 177.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.472 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 26.7 p90 -145.87 163.11 36.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.202 1.001 . . . . 74.439999999999998 109.744 171.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -133.45 141.98 48.07 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.194 0.997 . . . . 75.140000000000001 108.477 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -143.17 152.62 41.97 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.43 0.692 . . . . 75.219999999999999 109.57 175.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -95.85 138.01 34.1 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.452 0.701 . . . . 72.200000000000003 111.62 -170.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 69.4 mt -83.58 113.8 23.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 124.229 1.012 . . . . 61.130000000000003 108.347 165.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -88.38 134.87 33.71 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.194 0.598 . . . . 73.329999999999998 109.686 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.2 m -104.35 120.34 40.97 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.13 0.972 . . . . 55.210000000000001 109.518 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -72.48 164.82 25.77 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.304 1.042 . . . . 62.119999999999997 111.697 175.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 52.6 p -68.94 -17.05 63.89 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.645 0.778 . . . . 71.510000000000005 111.068 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.57 -19.19 65.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.407 1.083 . . . . 63.32 111.577 173.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 91.93 -6.06 79.18 Favored Glycine 0 C--N 1.353 1.517 0 CA-C-N 115.848 -0.615 . . . . 70.230000000000004 111.921 -168.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -76.25 144.23 40.49 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.351 0.66 . . . . 72.129999999999995 110.934 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 47.1 mt -95.65 152.48 18.41 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.598 1.159 . . . . 73.030000000000001 108.518 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -166.5 172.28 10.98 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.661 0.6 . . . . 74.540000000000006 111.084 174.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.4 t -131.84 -41.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.377 1.071 . . . . 51.32 108.758 174.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.6 t -92.39 153.83 18.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.331 -0.618 . . . . 71.530000000000001 109.331 173.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.4 p -66.48 -29.35 69.45 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.122 0.569 . . . . 65.409999999999997 110.957 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -92.56 2.92 56.43 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.4 0.68 . . . . 71.310000000000002 112.144 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 211' ' ' PHE . 86.7 p -105.67 137.9 42.76 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.913 -0.773 . . . . 72.129999999999995 108.913 176.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -143.43 126.83 16.76 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.302 1.041 . . . . 74.430000000000007 108.194 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 209' ' ' SER . 14.4 m-85 -133.74 133.94 42.38 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.175 0.59 . . . . 74.310000000000002 109.422 -178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -74.88 -35.54 62.29 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.08 0.552 . . . . 72.510000000000005 110.403 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 61.9 p -123.22 147.44 46.89 Favored 'General case' 0 C--O 1.256 1.41 0 CA-C-O 122.267 1.032 . . . . 63.420000000000002 111.637 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.444 ' O ' HG23 ' A' ' 218' ' ' VAL . 25.1 tp -64.32 -28.62 69.84 Favored 'General case' 0 C--O 1.213 -0.832 0 CA-C-N 113.655 -1.611 . . . . 73.200000000000003 111.205 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.68 -42.53 95.28 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.316 0.646 . . . . 54.109999999999999 111.452 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -71.7 -35.03 70.11 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.975 0.51 . . . . 70.0 110.347 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.432 HD21 HD11 ' A' ' 182' ' ' ILE . 9.5 tt -56.54 -46.58 80.58 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.901 0.751 . . . . 72.150000000000006 110.384 170.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 214' ' ' LEU . 44.4 t -66.27 -44.97 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.738 0.815 . . . . 73.040000000000006 110.586 -177.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -61.78 -45.45 93.81 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.91 0.484 . . . . 63.530000000000001 110.145 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -52.35 -61.67 2.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.244 -0.889 . . . . 63.420000000000002 108.855 175.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -59.71 -23.45 63.16 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.88 -0.6 . . . . 61.350000000000001 111.92 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.406 ' O ' ' HB ' ' A' ' 231' ' ' THR . 35.6 t -75.21 -28.04 59.81 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.109 0.563 . . . . 72.549999999999997 111.713 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.8 t -118.17 -9.83 10.41 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.447 1.647 . . . . 51.310000000000002 115.447 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 27.6 m -92.71 148.45 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 123.632 1.682 . . . . 62.32 115.058 -167.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.6 0.16 54.99 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 110.96 -2.836 . . . . 74.25 111.359 173.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -78.9 15.46 1.08 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 128.959 2.904 . . . . 72.439999999999998 112.478 -143.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.05 18.39 4.67 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 124.525 1.059 . . . . 71.140000000000001 111.794 -170.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 56.0 mt -93.06 145.59 24.27 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.763 0.825 . . . . 75.409999999999997 111.47 162.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.472 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 63.9 mt -75.34 -43.42 43.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.644 -0.873 . . . . 62.439999999999998 108.644 170.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t -139.02 144.62 38.94 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.323 -0.853 . . . . 75.010000000000005 109.217 177.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 222' ' ' SER . 40.8 p -75.49 155.17 36.45 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.597 0.759 . . . . 71.450000000000003 109.73 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.495 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 21.2 mt -67.72 101.78 1.1 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.554 -0.906 . . . . 74.319999999999993 108.554 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -83.1 -47.43 11.66 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.49 0.716 . . . . 62.399999999999999 110.075 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -163.3 152.3 12.29 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 109.572 -0.529 . . . . 74.430000000000007 109.572 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.404 ' HB3' ' HA ' ' A' ' 146' ' ' TRP . 53.0 Cg_endo -68.51 144.39 60.83 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 121.932 1.755 . . . . 75.329999999999998 111.973 175.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -60.54 137.71 92.56 Favored Pre-proline 0 C--O 1.248 0.992 0 C-N-CA 123.359 0.664 . . . . 73.209999999999994 109.981 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.06 116.4 3.15 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.914 2.409 . . . . 61.439999999999998 111.742 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? . . . . . 0 C--O 1.241 0.617 0 N-CA-C 107.85 -1.166 . . . . 64.420000000000002 107.85 174.085 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.2 m . . . . . 0 C--O 1.246 0.905 0 CA-C-O 121.095 0.474 . . . . 71.129999999999995 110.75 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.7 mt -104.27 133.5 20.19 Favored Pre-proline 0 C--O 1.238 0.449 0 N-CA-C 108.092 -1.077 . . . . 75.340000000000003 108.092 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.22 169.36 13.92 Favored 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 122.493 2.129 . . . . 72.140000000000001 112.025 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.3 147.03 27.43 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.933 -0.766 . . . . 65.200000000000003 108.933 170.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 23' ' ' ILE . 83.4 mt -88.04 93.57 9.52 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.228 -0.656 . . . . 41.140000000000001 109.228 -177.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -98.23 -53.0 3.49 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.576 0.35 . . . . 71.519999999999996 110.281 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.428 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 61.0 m-85 -106.3 108.97 20.75 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.051 0.541 . . . . 75.430000000000007 110.124 -175.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.469 HD11 HD22 ' A' ' 20' ' ' LEU . 49.8 mm -123.79 120.76 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.754 0.822 . . . . 71.129999999999995 111.003 -175.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt . . . . . 0 CA--C 1.542 0.64 0 C-N-CA 123.486 0.714 . . . . 74.329999999999998 110.531 169.301 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 CA--C 1.542 0.883 0 N-CA-C 114.045 0.748 . . . . 74.409999999999997 114.045 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -64.96 83.48 0.04 OUTLIER 'General case' 0 C--N 1.353 0.719 0 CA-C-O 121.766 0.793 . . . . 75.530000000000001 109.85 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.62 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 33.6 tp -125.07 119.01 27.44 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.363 -1.29 . . . . 74.329999999999998 107.904 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -105.14 176.23 5.23 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.646 1.579 . . . . 52.329999999999998 109.226 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.62 144.73 25.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 N-CA-C 108.641 -0.874 . . . . 71.239999999999995 108.641 172.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.28 118.52 19.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.433 0.693 . . . . 74.209999999999994 109.748 174.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.29 -21.29 39.43 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.91 0.884 . . . . 71.129999999999995 111.073 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.572 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 93.1 m-85 -134.46 169.28 17.5 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.405 0.682 . . . . 74.099999999999994 110.15 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.39 145.76 27.32 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.177 -0.919 . . . . 63.240000000000002 109.133 170.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.444 ' HB3' HG12 ' A' ' 101' ' ' ILE . 86.2 t80 -151.93 104.81 3.03 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.457 -0.942 . . . . 65.430000000000007 108.457 176.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.6 t -80.37 133.92 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 107.878 -1.156 . . . . 72.519999999999996 107.878 172.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.41 114.77 10.89 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.595 -0.52 . . . . 75.140000000000001 109.595 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.1 m -77.03 -23.19 52.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.009 0.524 . . . . 63.009999999999998 110.663 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.75 168.28 19.8 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 123.796 0.685 . . . . 51.020000000000003 111.734 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.52 -29.88 63.99 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.529 0.732 . . . . 62.43 110.29 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -71.43 -19.92 62.18 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.993 1.317 . . . . 72.010000000000005 112.235 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.3 p -98.47 154.87 17.57 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.256 0.622 . . . . 74.409999999999997 109.998 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.6 tp -107.08 128.35 54.3 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.877 -0.786 . . . . 74.0 108.877 -177.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.1 t -82.56 118.15 23.07 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 109.782 -0.451 . . . . 62.350000000000001 109.782 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.444 HG12 ' HB3' ' A' ' 91' ' ' PHE . 28.6 pt -119.6 165.42 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.075 0.95 . . . . 75.109999999999999 110.066 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.5 m -138.59 145.64 40.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.465 0.706 . . . . 75.140000000000001 109.214 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -54.54 118.67 4.36 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.813 0.845 . . . . 74.120000000000005 111.778 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.85 -14.87 29.08 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.032 -0.531 . . . . 64.409999999999997 112.842 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -78.49 124.36 28.05 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.596 0.758 . . . . 73.150000000000006 110.258 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.456 ' HB3' HD11 ' A' ' 84' ' ' LEU . 31.8 mtmm -75.01 116.9 16.27 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.364 0.666 . . . . 72.310000000000002 109.574 176.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.9 mt -101.14 163.61 12.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.694 -0.854 . . . . 64.430000000000007 108.694 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -126.38 110.12 12.99 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.56 -0.904 . . . . 74.049999999999997 108.56 163.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.485 HG21 HD12 ' A' ' 135' ' ' ILE . 99.1 t -90.23 124.35 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.127 -0.694 . . . . 72.430000000000007 109.127 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.4 mt -81.78 -37.83 26.55 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.567 1.147 . . . . 71.209999999999994 109.273 -174.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.81 176.28 47.88 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 113.936 -1.484 . . . . 43.340000000000003 110.51 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 56.7 m-85 -103.95 175.05 5.61 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 109.386 -0.598 . . . . 75.109999999999999 109.386 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 22' ' ' PHE . 43.7 t-20 -68.98 148.74 49.69 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.428 -0.953 . . . . 73.530000000000001 108.428 169.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -66.09 -17.81 64.94 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.758 0.823 . . . . 70.120000000000005 112.578 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -95.84 -5.28 42.07 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.493 0.717 . . . . 65.319999999999993 111.062 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.3 34.69 63.95 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.378 -0.689 . . . . 60.409999999999997 111.378 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.463 ' HG2' ' CD1' ' A' ' 118' ' ' TRP . 36.8 tt0 -89.03 -58.36 2.57 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.202 1.401 . . . . 73.420000000000002 109.282 -170.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.463 ' CD1' ' HG2' ' A' ' 117' ' ' GLU . 87.5 m95 -126.24 -176.96 3.8 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.587 1.155 . . . . 74.409999999999997 110.086 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -132.28 116.54 17.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.338 1.055 . . . . 64.510000000000005 109.698 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.46 107.53 14.3 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.795 -0.817 . . . . 74.129999999999995 108.795 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.464 ' HB2' HG22 ' A' ' 109' ' ' VAL . . . -121.12 165.42 15.37 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.939 0.896 . . . . 60.219999999999999 111.58 -172.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -143.42 131.31 21.56 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.101 0.96 . . . . 72.400000000000006 110.138 -175.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 45.1 p -141.06 -176.99 4.89 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.634 1.174 . . . . 54.439999999999998 110.973 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -60.79 -21.58 63.24 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.229 1.012 . . . . 71.120000000000005 111.41 171.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -72.71 -26.87 61.75 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.759 0.824 . . . . 72.439999999999998 110.127 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.22 -135.1 6.88 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.203 -0.759 . . . . 42.130000000000003 111.203 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -152.88 148.55 27.29 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 122.924 0.489 . . . . 73.230000000000004 110.116 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 161.49 -177.7 37.68 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 121.088 0.271 . . . . 62.549999999999997 113.137 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -84.34 134.78 34.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.528 0.731 . . . . 50.210000000000001 111.781 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.66 155.23 80.65 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.085 1.354 . . . . 74.200000000000003 108.766 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -69.66 129.65 18.08 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 121.789 1.659 . . . . 75.129999999999995 110.846 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.4 m -60.25 -20.55 59.45 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.773 0.829 . . . . 32.329999999999998 112.539 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -84.66 -19.02 33.55 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.635 0.774 . . . . 64.439999999999998 111.615 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.572 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.4 m-85 -89.66 5.05 47.49 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.548 0.739 . . . . 73.310000000000002 112.107 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.485 HD12 HG21 ' A' ' 109' ' ' VAL . 21.3 pt -134.32 167.43 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.442 0.697 . . . . 63.329999999999998 110.695 -174.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.3 t -160.88 141.9 8.73 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 122.781 0.432 . . . . 73.319999999999993 111.11 168.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.04 133.21 22.76 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.978 2.452 . . . . 73.120000000000005 112.285 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.6 m -113.89 -49.15 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.109 0.564 . . . . 72.25 111.459 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.62 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.2 t30 -100.97 -11.7 19.5 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.92 0.488 . . . . 55.350000000000001 111.058 -176.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.1 t -65.39 177.62 1.1 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.549 0.74 . . . . 73.120000000000005 111.044 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.72 -21.95 21.22 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.194 1.183 . . . . 55.409999999999997 114.194 -171.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.59 -13.29 60.88 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.004 0.922 . . . . 74.510000000000005 112.028 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -63.33 -22.46 66.89 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.979 0.912 . . . . 73.450000000000003 110.692 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -85.07 145.22 27.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.612 0.765 . . . . 75.430000000000007 110.431 171.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.7 t -66.51 -20.76 66.11 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.861 0.865 . . . . 64.319999999999993 112.261 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -83.61 -34.87 25.02 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.097 0.406 . . . . 63.210000000000001 112.097 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 33.7 t80 -93.8 138.71 31.69 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 109.494 -0.558 . . . . 74.219999999999999 109.494 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.671 ' HB3' HH21 ' A' ' 171' ' ' ARG . 75.9 m-70 -134.27 26.39 3.83 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.448 0.536 . . . . 73.209999999999994 112.448 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 67.86 -163.5 47.31 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 115.585 0.994 . . . . 65.549999999999997 115.585 170.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.21 102.68 1.59 Allowed 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.499 2.799 . . . . 74.430000000000007 112.874 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.9 t -138.05 157.58 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 123.247 0.619 . . . . 64.349999999999994 110.363 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.0 m -75.24 153.67 37.92 Favored 'General case' 0 C--O 1.256 1.435 0 C-N-CA 124.581 1.152 . . . . 75.030000000000001 112.09 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -62.81 -31.92 73.01 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.523 -0.762 . . . . 53.43 111.085 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -54.93 -53.6 53.51 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.022 0.929 . . . . 72.219999999999999 110.264 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.04 77.56 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.409 -0.814 . . . . 74.5 110.848 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.498 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.08 -50.53 73.13 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.345 0.593 . . . . 74.319999999999993 111.69 176.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.467 ' HG3' HG11 ' A' ' 190' ' ' VAL . 33.0 tt0 -78.2 -25.05 46.89 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.106 -0.952 . . . . 64.040000000000006 110.263 -175.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -60.25 -53.46 57.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.112 0.565 . . . . 64.120000000000005 110.269 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 64.8 mt -65.23 -39.33 92.58 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 116.237 -0.438 . . . . 72.420000000000002 110.854 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.58 HD23 HG13 ' A' ' 190' ' ' VAL . 36.4 tp -73.08 -24.21 60.63 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.878 -0.601 . . . . 75.329999999999998 112.105 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 35.4 t -65.77 -23.81 66.8 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.109 0.564 . . . . 54.409999999999997 111.322 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 80.6 p -91.8 -0.64 57.54 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.155 0.582 . . . . 72.519999999999996 111.129 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -83.96 163.23 39.7 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.941 -0.572 . . . . 64.400000000000006 112.89 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.1 pt -120.15 -166.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.317 1.047 . . . . 72.209999999999994 111.095 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -58.58 107.36 0.5 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.899 0.879 . . . . 75.510000000000005 112.777 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 98.2 13.53 42.0 Favored Glycine 0 C--O 1.259 1.658 0 CA-C-N 116.03 -0.532 . . . . 75.299999999999997 112.617 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 31.5 t -74.35 134.79 42.49 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 119.126 -0.464 . . . . 52.149999999999999 109.961 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 183' ' ' SER . 22.3 p90 -135.25 153.7 51.82 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 121.51 0.671 . . . . 73.299999999999997 112.669 177.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' A' ' 236' ' ' ALA . 97.5 mt -134.49 133.81 40.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.908 -1.042 . . . . 61.32 108.302 169.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 20.0 t -112.87 120.5 63.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.394 -1.336 . . . . 74.019999999999996 107.394 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.671 HH21 ' HB3' ' A' ' 148' ' ' HIS . 0.6 OUTLIER -159.37 148.89 18.5 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.469 -0.567 . . . . 72.150000000000006 109.469 177.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.808 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 15.0 pt-20 -92.3 157.77 16.47 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-O 121.224 0.535 . . . . 72.310000000000002 111.258 -176.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 p -76.72 115.97 16.97 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.975 -1.011 . . . . 71.439999999999998 108.53 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.21 -31.33 67.23 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.796 0.838 . . . . 65.430000000000007 112.429 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.8 t -95.67 8.46 43.37 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.81 0.844 . . . . 72.319999999999993 111.4 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 57.0 m -149.86 83.21 6.33 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 108.434 -0.95 . . . . 55.149999999999999 108.434 172.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.517 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 42.8 Cg_endo -63.57 140.55 75.85 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.47 2.78 . . . . 73.430000000000007 112.491 -173.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.65 -23.54 10.14 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.924 -0.58 . . . . 74.340000000000003 112.9 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -86.65 115.87 24.39 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 108.818 -0.808 . . . . 74.140000000000001 108.818 174.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.808 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 42.8 mtt85 -114.57 153.15 30.6 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.025 -0.989 . . . . 75.129999999999995 108.957 -173.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.1 m -134.18 142.72 47.53 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 109.945 -0.391 . . . . 63.119999999999997 109.945 -177.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.411 HG12 HG22 ' A' ' 170' ' ' VAL . 50.6 mt -106.48 136.25 41.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.365 -0.976 . . . . 70.040000000000006 108.365 169.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.576 ' HB3' HD22 ' A' ' 160' ' ' LEU . 20.4 m -115.77 113.95 24.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.99 -1.115 . . . . 72.25 107.99 -177.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 52.7 mt -104.58 141.09 37.03 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.5 0.72 . . . . 73.310000000000002 111.167 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 26.7 ttt180 -124.2 120.91 33.64 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 107.361 -1.348 . . . . 75.310000000000002 107.361 165.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.79 127.38 28.87 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.588 -1.264 . . . . 74.420000000000002 107.588 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 54.85 28.86 10.99 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.039 0.936 . . . . 64.329999999999998 112.282 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 89.31 1.25 78.88 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.155 0.407 . . . . 73.129999999999995 113.433 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 8.7 tpm_? -100.57 123.26 44.54 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.035 0.934 . . . . 65.230000000000004 109.455 -174.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.58 HG13 HD23 ' A' ' 160' ' ' LEU . 95.0 t -98.58 124.3 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.135 0.974 . . . . 44.030000000000001 109.978 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -145.95 149.99 35.21 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.062 0.945 . . . . 60.240000000000002 109.75 176.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -125.86 148.78 49.07 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.961 0.904 . . . . 74.129999999999995 109.361 -171.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -145.39 148.4 33.3 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.215 0.531 . . . . 74.049999999999997 111.106 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -93.77 125.88 38.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.932 -1.031 . . . . 73.329999999999998 111.785 -171.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 68.9 mt -77.65 111.0 13.97 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 124.397 1.079 . . . . 75.540000000000006 108.536 162.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -87.46 139.27 30.71 Favored 'General case' 0 C--O 1.249 1.051 0 N-CA-C 109.417 -0.586 . . . . 73.219999999999999 109.417 173.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 46.5 m -110.6 132.16 54.43 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.974 0.796 . . . . 65.200000000000003 110.1 -176.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.58 169.19 18.74 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.059 0.944 . . . . 75.310000000000002 111.1 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 72.1 p -75.92 -8.59 57.29 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.841 0.456 . . . . 74.120000000000005 111.461 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -93.33 -7.55 44.49 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.062 0.945 . . . . 73.219999999999999 110.821 170.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 91.8 -1.27 74.63 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-O 119.501 -0.61 . . . . 31.030000000000001 113.324 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -70.61 128.85 37.52 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.538 0.669 . . . . 73.450000000000003 111.164 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 29.0 mt -91.77 148.59 22.13 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.925 0.89 . . . . 52.420000000000002 110.535 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -160.74 148.74 16.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.301 0.572 . . . . 74.030000000000001 111.149 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.7 t -112.7 -45.32 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 114.721 -1.127 . . . . 63.130000000000003 109.371 176.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 22.2 t -121.75 178.94 4.65 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.009 0.524 . . . . 61.210000000000001 109.976 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.2 t -68.05 -26.72 66.0 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.577 0.751 . . . . 71.150000000000006 112.04 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -86.48 -3.97 59.1 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.604 0.761 . . . . 74.239999999999995 110.663 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.484 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 19.9 m -94.72 121.76 36.62 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.893 0.877 . . . . 71.439999999999998 110.976 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -143.49 109.29 5.2 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 107.869 -1.16 . . . . 72.219999999999999 107.869 168.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.484 ' CE2' ' HB3' ' A' ' 209' ' ' SER . 17.7 m-85 -123.42 136.26 54.53 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.291 -0.633 . . . . 73.430000000000007 109.291 -178.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.24 -10.17 45.29 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 122.625 0.37 . . . . 71.420000000000002 110.182 175.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 57.7 p -141.36 152.55 44.47 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.587 0.708 . . . . 65.200000000000003 111.141 173.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.26 -25.4 63.35 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.483 -1.235 . . . . 63.039999999999999 110.474 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.61 -50.14 73.76 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 123.723 0.809 . . . . 72.109999999999999 110.382 174.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -72.11 -29.22 63.87 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.416 -0.811 . . . . 72.230000000000004 111.62 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.49 -52.7 64.55 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.354 0.409 . . . . 73.430000000000007 110.065 171.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.69 -40.5 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.273 0.629 . . . . 73.329999999999998 111.221 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -64.06 -47.5 79.9 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.091 0.472 . . . . 63.329999999999998 110.949 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -63.26 -46.69 85.65 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.151 -0.685 . . . . 74.040000000000006 109.151 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.434 ' HA ' HG22 ' A' ' 224' ' ' VAL . 46.1 m80 -66.24 -25.22 66.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.969 0.508 . . . . 72.319999999999993 111.489 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.407 ' O ' ' HB ' ' A' ' 231' ' ' THR . 45.9 t -71.07 -28.65 64.51 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.658 0.383 . . . . 62.439999999999998 111.114 174.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -106.72 -18.02 14.06 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 115.433 1.642 . . . . 75.420000000000002 115.433 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 221' ' ' HIS . 23.9 m -87.34 122.41 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-N 120.251 1.387 . . . . 74.209999999999994 114.232 -169.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.55 -1.54 19.05 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.315 2.246 . . . . 74.420000000000002 113.17 170.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -79.5 15.51 1.28 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 127.986 2.514 . . . . 75.099999999999994 112.914 -144.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.07 16.84 4.26 Favored Glycine 0 C--O 1.25 1.129 0 C-N-CA 123.507 0.575 . . . . 70.430000000000007 112.133 -168.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 46.9 mt -88.78 131.51 35.03 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.978 -0.611 . . . . 75.349999999999994 109.59 158.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 77.5 mt -59.24 -41.2 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 O-C-N 124.03 0.832 . . . . 65.109999999999999 109.694 172.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.7 t -141.17 144.43 34.8 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.969 -1.014 . . . . 63.399999999999999 109.536 168.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 222' ' ' SER . 67.3 p -71.84 151.33 43.52 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.791 -0.818 . . . . 74.530000000000001 108.791 168.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.22 100.23 0.33 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.543 -0.91 . . . . 61.43 108.543 178.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -85.86 -50.73 6.89 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.21 -0.663 . . . . 53.409999999999997 109.21 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.1 OUTLIER -163.24 148.08 9.19 Favored Pre-proline 0 N--CA 1.482 1.151 0 CA-C-N 115.376 -0.829 . . . . 70.420000000000002 110.922 179.308 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 52.3 Cg_endo -67.47 155.86 68.52 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 121.738 1.625 . . . . 71.219999999999999 112.293 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.523 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -63.41 134.56 95.89 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-O 118.779 -0.629 . . . . 71.549999999999997 109.779 173.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.11 120.47 7.29 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.967 2.445 . . . . 62.130000000000003 111.689 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' A' ' 238' ' ' LYS . 46.9 mtmt . . . . . 0 N--CA 1.472 0.657 0 O-C-N 123.931 0.769 . . . . 75.420000000000002 110.477 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.245 0.867 0 CA-C-O 121.415 0.626 . . . . 72.200000000000003 111.322 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.6 mt -107.24 126.84 29.14 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 107.975 -1.12 . . . . 64.109999999999999 107.975 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.51 171.95 11.06 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.391 2.061 . . . . 64.299999999999997 111.632 173.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.23 144.35 32.99 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.847 0.459 . . . . 54.310000000000002 111.085 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.638 ' HB3' HD11 ' A' ' 23' ' ' ILE . 56.4 mt -86.1 93.89 9.12 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.073 0.949 . . . . 64.239999999999995 108.699 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -98.25 -42.15 7.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.815 -1.084 . . . . 75.420000000000002 109.285 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -96.85 111.86 23.87 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 114.583 -1.189 . . . . 72.209999999999994 108.547 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.638 HD11 ' HB3' ' A' ' 20' ' ' LEU . 44.1 mm -116.08 120.88 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.991 -1.114 . . . . 74.239999999999995 107.991 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? . . . . . 0 C--O 1.24 0.573 0 N-CA-C 108.45 -0.945 . . . . 75.310000000000002 108.45 -177.795 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo . . . . . 0 N--CA 1.489 1.22 0 CA-C-O 120.868 0.278 . . . . 75.409999999999997 112.774 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -93.05 66.7 4.17 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-O 121.792 0.806 . . . . 60.43 109.543 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.542 HD11 ' HB3' ' A' ' 106' ' ' LYS . 42.5 tp -85.78 117.63 24.77 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.797 -1.092 . . . . 73.420000000000002 109.007 175.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -109.09 176.51 5.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.694 1.598 . . . . 70.230000000000004 109.373 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.82 146.24 24.29 Favored 'Isoleucine or valine' 0 C--O 1.25 1.103 0 N-CA-C 108.722 -0.844 . . . . 64.010000000000005 108.722 170.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.03 120.64 25.06 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.282 0.633 . . . . 62.25 109.776 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.1 mt -77.05 -20.48 55.8 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.872 0.869 . . . . 74.219999999999999 111.446 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -141.78 149.11 39.98 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.831 -0.804 . . . . 71.239999999999995 108.831 -174.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.76 146.54 46.31 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.02 -0.733 . . . . 71.439999999999998 109.02 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -151.87 108.46 3.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.691 -1.226 . . . . 65.310000000000002 107.691 -176.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.7 t -79.17 138.63 19.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 107.263 -1.384 . . . . 51.43 107.263 173.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.85 125.86 25.3 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.928 0.491 . . . . 64.409999999999997 110.867 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.2 t -72.52 -17.74 61.71 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.937 0.895 . . . . 74.349999999999994 110.283 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.36 -166.72 37.39 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 115.698 -0.683 . . . . 44.329999999999998 112.129 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -64.58 -32.33 73.94 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.635 1.174 . . . . 51.229999999999997 112.059 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -69.79 -25.7 63.91 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.866 0.866 . . . . 74.349999999999994 112.05 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.1 p -103.35 160.31 14.8 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.59 0.756 . . . . 73.129999999999995 110.777 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.1 tp -109.22 130.5 55.49 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.384 0.673 . . . . 74.329999999999998 109.21 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -77.02 117.44 18.61 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 108.345 -0.984 . . . . 71.129999999999995 108.345 172.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.8 pt -119.68 138.26 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.538 0.735 . . . . 51.43 109.194 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.1 m -94.07 145.82 24.4 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.507 -0.553 . . . . 73.129999999999995 109.507 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -58.2 111.86 1.34 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.619 0.368 . . . . 74.200000000000003 110.705 171.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.71 5.93 50.47 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.122 0.391 . . . . 74.010000000000005 112.627 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -87.25 137.83 32.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.24 1.016 . . . . 75.349999999999994 109.83 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HB3' HD11 ' A' ' 84' ' ' LEU . 63.0 mttm -88.33 123.77 33.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.288 0.635 . . . . 74.219999999999999 109.825 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 21.4 mt -108.64 139.96 42.69 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.053 0.941 . . . . 74.219999999999999 110.299 -168.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -95.26 107.15 19.24 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 106.002 -1.851 . . . . 61.5 106.002 172.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 68.7 t -100.19 111.56 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 119.364 0.984 . . . . 72.430000000000007 109.571 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.11 -25.62 64.5 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.484 -1.235 . . . . 74.120000000000005 111.018 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.51 173.05 22.98 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.675 -0.693 . . . . 24.140000000000001 112.104 173.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.457 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 1.8 m-30 -95.23 148.93 21.88 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 106.668 -1.605 . . . . 74.099999999999994 106.668 172.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.459 HD21 ' HB2' ' A' ' 117' ' ' GLU . 29.5 p30 -66.44 167.5 10.56 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 110.25 -0.278 . . . . 74.400000000000006 110.25 173.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -56.5 -32.04 64.66 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.508 0.929 . . . . 70.299999999999997 113.508 -167.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -96.93 -2.59 43.42 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.562 0.345 . . . . 64.310000000000002 111.617 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.77 18.58 79.57 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 123.157 0.408 . . . . 62.32 113.397 174.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.459 ' HB2' HD21 ' A' ' 113' ' ' ASN . 6.0 mm-40 -65.72 -65.65 0.65 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.522 1.129 . . . . 72.510000000000005 110.136 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -122.97 152.53 40.79 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.227 -1.351 . . . . 70.299999999999997 108.291 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -115.87 127.38 54.98 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.326 1.051 . . . . 74.019999999999996 109.379 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -76.72 101.44 5.8 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.04 -0.726 . . . . 53.439999999999998 109.04 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -104.87 169.02 8.68 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.315 -0.857 . . . . 74.239999999999995 110.298 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -148.08 138.24 22.7 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.219 1.008 . . . . 72.239999999999995 108.953 178.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 37.5 p -144.23 -171.02 3.49 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.403 1.081 . . . . 63.210000000000001 108.901 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -64.95 -16.48 63.39 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 122.971 0.508 . . . . 73.340000000000003 111.098 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -76.39 -14.11 60.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.712 0.805 . . . . 73.439999999999998 111.722 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 129.64 -137.06 9.3 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 111.866 -0.493 . . . . 74.420000000000002 111.866 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -149.91 144.21 25.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.355 0.662 . . . . 75.349999999999994 109.755 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 166.43 179.61 39.85 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-O 121.245 0.358 . . . . 34.310000000000002 113.235 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -79.85 130.79 35.6 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.09 0.956 . . . . 74.430000000000007 110.695 -176.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.7 m -124.36 146.86 53.32 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.75 1.22 . . . . 75.329999999999998 108.22 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.98 131.64 26.0 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 121.599 1.533 . . . . 71.430000000000007 110.889 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.7 m -59.22 -21.38 59.44 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.791 0.836 . . . . 75.239999999999995 111.898 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -73.16 -18.95 61.22 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.485 1.114 . . . . 61.140000000000001 112.184 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -102.18 -3.63 27.09 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.419 0.688 . . . . 75.219999999999999 112.603 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.0 pt -122.05 155.88 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 118.478 0.581 . . . . 71.319999999999993 111.134 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.1 t -153.58 136.12 9.53 Favored Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 123.309 0.381 . . . . 61.43 110.708 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -76.44 132.7 13.78 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.805 2.337 . . . . 63.350000000000001 113.163 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.1 m -109.36 -31.34 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.891 0.876 . . . . 71.040000000000006 111.741 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 84' ' ' LEU . 63.9 t30 -97.64 0.07 46.55 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.24 0.616 . . . . 55.149999999999999 111.594 -175.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 97.7 p -80.12 -171.0 2.74 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.835 0.826 . . . . 74.540000000000006 111.318 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.14 -9.77 12.22 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.569 1.148 . . . . 64.530000000000001 113.298 171.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -59.35 -20.57 55.72 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.252 0.834 . . . . 62.520000000000003 113.252 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.96 -8.14 52.74 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.253 0.621 . . . . 65.120000000000005 111.959 175.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -88.37 135.51 33.43 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 107.886 -1.153 . . . . 75.430000000000007 107.886 170.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.5 m -64.44 -28.0 69.37 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.584 0.754 . . . . 74.340000000000003 112.322 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -73.49 -32.15 64.12 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.117 0.414 . . . . 72.519999999999996 112.117 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -91.51 128.18 37.24 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.084 0.554 . . . . 74.239999999999995 109.572 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -121.03 2.16 10.43 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 112.303 0.483 . . . . 73.109999999999999 112.303 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.06 -155.56 33.13 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 119.584 -0.565 . . . . 63.229999999999997 114.11 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.12 101.43 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.988 2.459 . . . . 71.140000000000001 111.159 173.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.554 ' HB ' ' HD2' ' A' ' 171' ' ' ARG . 15.9 t -118.79 142.81 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 110.231 -0.285 . . . . 74.200000000000003 110.231 -173.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.6 m -73.94 161.99 29.54 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.967 0.907 . . . . 64.019999999999996 110.772 172.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -63.38 -44.59 94.31 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.234 0.614 . . . . 75.549999999999997 111.361 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -58.87 -51.89 68.1 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.071 0.948 . . . . 74.329999999999998 110.192 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.06 86.73 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.946 0.898 . . . . 44.229999999999997 111.59 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.97 -53.86 53.63 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.077 -0.965 . . . . 41.520000000000003 111.588 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.55 ' HG3' HG11 ' A' ' 190' ' ' VAL . 30.4 tt0 -70.87 -24.87 62.59 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.945 -1.025 . . . . 63.039999999999999 110.52 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -66.52 -43.22 85.83 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.143 0.577 . . . . 71.439999999999998 111.098 173.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 238' ' ' LYS . 44.8 mt -72.85 -36.78 67.51 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.473 0.654 . . . . 65.129999999999995 110.789 175.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.576 HD22 ' HB3' ' A' ' 183' ' ' SER . 39.5 tp -77.76 -19.81 54.48 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.223 -0.899 . . . . 60.039999999999999 112.28 -174.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 81.0 p -64.94 -26.06 68.14 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 120.861 0.362 . . . . 72.219999999999999 110.184 174.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.4 t -82.02 -5.85 58.68 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.416 1.086 . . . . 60.520000000000003 111.076 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.77 171.81 55.16 Favored Glycine 0 C--N 1.346 1.118 0 C-N-CA 122.917 0.294 . . . . 72.230000000000004 113.436 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.6 pt -133.95 -169.58 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.598 1.159 . . . . 73.120000000000005 110.09 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 18.1 p-10 -59.75 103.26 0.19 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.442 0.697 . . . . 64.329999999999998 112.435 -172.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 102.73 12.88 31.31 Favored Glycine 0 C--O 1.261 1.816 0 CA-C-N 116.184 -0.462 . . . . 63.030000000000001 113.082 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 78.7 p -79.75 137.78 37.11 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 109.991 -0.374 . . . . 72.25 109.991 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -137.01 155.91 49.1 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.282 0.563 . . . . 74.420000000000002 112.264 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.0 mt -131.74 134.22 45.64 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.994 -1.113 . . . . 74.329999999999998 107.994 170.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.404 HG21 HG22 ' A' ' 218' ' ' VAL . 52.2 t -114.0 126.25 71.45 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 108.354 -0.98 . . . . 74.310000000000002 108.354 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.554 ' HD2' ' HB ' ' A' ' 151' ' ' VAL . 17.9 mtm180 -140.32 170.19 16.27 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.741 -1.118 . . . . 62.009999999999998 109.005 -167.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 9.0 pm0 -117.4 163.5 16.28 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 108.695 -0.854 . . . . 74.340000000000003 108.695 153.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 176' ' ' SER . 48.8 m -82.68 131.92 35.19 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.434 -0.803 . . . . 71.319999999999993 110.308 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -53.6 -40.09 65.42 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.087 1.355 . . . . 72.400000000000006 112.205 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.8 t -98.49 6.25 47.33 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.558 0.743 . . . . 62.439999999999998 111.376 -174.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 173' ' ' SER . 28.8 m -147.08 86.97 6.31 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.32 0.648 . . . . 72.230000000000004 109.489 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.457 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 34.9 Cg_endo -62.58 136.73 60.17 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 123.327 2.684 . . . . 75.340000000000003 111.331 177.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.85 -24.92 5.57 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.901 -0.59 . . . . 74.439999999999998 113.306 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -84.11 116.35 22.85 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.002 -1.11 . . . . 72.239999999999995 108.002 175.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.654 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 58.2 mtt-85 -109.17 168.56 9.29 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.308 -0.86 . . . . 61.130000000000003 110.633 -170.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.4 t -155.91 145.91 21.4 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.323 0.649 . . . . 63.32 110.063 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 65.9 mt -115.94 147.91 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.587 0.755 . . . . 72.120000000000005 109.081 173.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.576 ' HB3' HD22 ' A' ' 160' ' ' LEU . 24.5 m -125.89 114.2 18.22 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.869 1.268 . . . . 73.120000000000005 108.602 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.403 HD21 ' CD2' ' A' ' 232' ' ' LEU . 76.7 mt -105.01 139.1 40.19 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.629 1.171 . . . . 74.5 111.448 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -120.79 132.18 54.88 Favored 'General case' 0 C--O 1.257 1.475 0 N-CA-C 107.24 -1.393 . . . . 74.140000000000001 107.24 161.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 28.5 t80 -151.94 123.6 7.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.736 -1.12 . . . . 74.400000000000006 108.678 -171.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 51.29 36.13 15.42 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.435 1.494 . . . . 73.239999999999995 112.359 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 89.23 3.34 75.83 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 114.995 -1.002 . . . . 64.349999999999994 114.088 173.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -115.02 127.73 55.83 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 117.722 0.761 . . . . 75.010000000000005 111.224 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.55 HG11 ' HG3' ' A' ' 157' ' ' GLU . 46.3 t -88.26 132.79 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 124.636 1.174 . . . . 72.129999999999995 109.854 171.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -146.39 153.35 40.38 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.118 1.367 . . . . 71.200000000000003 109.174 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -131.21 149.31 52.63 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.083 0.953 . . . . 75.400000000000006 109.335 -170.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -146.3 154.58 41.86 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.285 0.564 . . . . 70.219999999999999 111.713 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.505 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 20.8 tpp180 -85.75 135.26 33.82 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.761 1.224 . . . . 74.030000000000001 111.001 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.461 ' HA ' HG22 ' A' ' 205' ' ' VAL . 90.9 mt -85.69 110.27 19.45 Favored 'Isoleucine or valine' 0 C--O 1.245 0.858 0 N-CA-C 107.888 -1.153 . . . . 75.219999999999999 107.888 163.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -75.72 119.03 19.17 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.515 -0.766 . . . . 72.209999999999994 109.5 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 25.9 m -99.43 114.3 27.15 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.165 0.586 . . . . 74.450000000000003 109.892 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.02 163.18 12.72 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.198 0.999 . . . . 75.0 111.405 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 82.1 p -62.0 -24.72 67.21 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.384 0.674 . . . . 74.340000000000003 111.514 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.0 -5.79 50.1 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.145 0.978 . . . . 63.210000000000001 111.778 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 88.34 -3.97 85.35 Favored Glycine 0 C--N 1.352 1.465 0 C-N-CA 123.057 0.36 . . . . 21.300000000000001 112.56 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -74.42 142.46 44.97 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.578 0.751 . . . . 75.239999999999995 109.657 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 80.4 mt -98.05 153.57 18.31 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.672 0.789 . . . . 73.25 109.762 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -167.56 163.73 14.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.737 0.815 . . . . 64.310000000000002 109.648 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 195' ' ' ILE . 71.5 t -131.92 -56.98 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 107.699 -1.223 . . . . 74.299999999999997 107.699 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 40.0 t -83.65 155.18 23.31 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.541 -0.754 . . . . 70.299999999999997 109.478 171.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.3 m -68.66 -33.63 74.32 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.309 0.643 . . . . 74.099999999999994 110.327 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -75.06 -19.11 60.15 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.302 -0.863 . . . . 72.310000000000002 111.408 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 48.0 m -104.58 127.36 52.29 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.245 1.018 . . . . 65.010000000000005 110.17 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -138.59 133.94 33.16 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.569 1.147 . . . . 63.549999999999997 108.721 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.505 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 11.2 m-85 -133.76 135.84 44.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.255 0.622 . . . . 74.019999999999996 110.639 -172.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -83.15 -30.35 27.93 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.622 0.769 . . . . 63.329999999999998 110.261 169.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 40.1 p -128.84 150.36 50.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.579 0.752 . . . . 52.32 111.502 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 38.2 tp -70.17 -31.31 68.73 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.57 -1.195 . . . . 72.349999999999994 110.824 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.87 -41.73 87.79 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.404 0.682 . . . . 62.25 110.435 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -80.85 -24.63 38.26 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.842 -0.617 . . . . 53.219999999999999 111.536 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.65 -49.06 79.04 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.728 -0.471 . . . . 70.230000000000004 109.728 168.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.404 HG22 HG21 ' A' ' 170' ' ' VAL . 76.3 t -67.29 -40.13 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.125 0.97 . . . . 64.219999999999999 110.588 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -63.94 -52.93 57.48 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.984 0.914 . . . . 71.310000000000002 111.312 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.453 ' CE1' HG11 ' A' ' 224' ' ' VAL . 26.9 t-80 -60.18 -47.79 84.47 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 115.054 -0.975 . . . . 63.229999999999997 109.086 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.464 ' HB3' ' HG ' ' A' ' 232' ' ' LEU . 7.9 m-70 -62.19 -29.6 70.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.337 0.655 . . . . 74.439999999999998 111.932 175.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 33.7 t -69.9 -26.15 64.03 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.157 0.583 . . . . 45.009999999999998 111.316 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.3 t -112.93 -11.3 13.43 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 115.902 1.815 . . . . 71.319999999999993 115.902 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 221' ' ' HIS . 24.1 m -92.47 139.4 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 120.982 1.719 . . . . 70.420000000000002 114.143 -171.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.38 -1.0 57.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.021 2.528 . . . . 65.409999999999997 112.295 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -79.22 15.87 1.1 Allowed 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 127.621 2.368 . . . . 74.219999999999999 112.009 -145.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 117.58 19.62 4.91 Favored Glycine 0 C--O 1.245 0.825 0 C-N-CA 125.028 1.299 . . . . 71.239999999999995 112.403 -172.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 52.0 mt -90.87 121.67 32.92 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.145 -1.028 . . . . 62.329999999999998 109.124 158.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 59.4 mt -53.0 -43.09 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 124.357 1.035 . . . . 71.129999999999995 110.307 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.1 t -133.14 142.77 48.84 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.428 -0.805 . . . . 73.219999999999999 109.172 171.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 41.6 p -70.14 145.39 51.59 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.684 -0.858 . . . . 61.100000000000001 108.684 166.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' A' ' 221' ' ' HIS . 21.2 mt -61.76 102.67 0.28 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.049 -0.723 . . . . 41.549999999999997 109.049 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 -87.1 -54.34 4.38 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.29 -0.633 . . . . 72.519999999999996 109.29 -171.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -157.58 150.12 17.97 Favored Pre-proline 0 N--CA 1.487 1.385 0 C-N-CA 123.503 0.721 . . . . 61.310000000000002 111.443 -177.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.99 145.55 45.2 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 121.903 1.735 . . . . 73.109999999999999 112.402 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.19 131.79 82.91 Favored Pre-proline 0 C--O 1.243 0.751 0 N-CA-C 109.199 -0.667 . . . . 72.540000000000006 109.199 173.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.1 147.45 54.37 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 121.874 1.716 . . . . 72.340000000000003 111.63 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.47 ' HA ' HD22 ' A' ' 159' ' ' LEU . 38.6 ttpt . . . . . 0 CA--C 1.553 1.075 0 CA-C-N 115.296 -0.865 . . . . 75.319999999999993 109.344 171.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 121.547 0.689 . . . . 72.519999999999996 112.612 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.4 mt -103.05 125.83 34.13 Favored Pre-proline 0 C--O 1.239 0.511 0 N-CA-C 108.041 -1.096 . . . . 73.319999999999993 108.041 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.525 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 39.2 Cg_endo -69.57 171.58 14.01 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.367 2.045 . . . . 64.430000000000007 113.602 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.29 140.07 31.11 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.178 0.591 . . . . 34.229999999999997 111.39 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.491 HD22 HD11 ' A' ' 23' ' ' ILE . 78.4 mt -88.65 91.99 9.02 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.078 -1.082 . . . . 74.209999999999994 108.078 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -98.99 -43.5 6.67 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.383 -0.826 . . . . 71.319999999999993 109.81 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -103.34 108.61 19.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.474 -0.785 . . . . 55.020000000000003 109.714 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.491 HD11 HD22 ' A' ' 20' ' ' LEU . 41.7 mm -118.05 121.32 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 107.566 -1.272 . . . . 73.420000000000002 107.566 172.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt . . . . . 0 N--CA 1.471 0.588 0 C-N-CA 123.592 0.757 . . . . 75.319999999999993 110.988 -176.893 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo . . . . . 0 CA--C 1.547 1.135 0 N-CA-C 111.322 -0.299 . . . . 64.019999999999996 111.322 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 140' ' ' SER . 82.3 m-20 -87.76 66.67 8.91 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.686 0.755 . . . . 75.510000000000005 109.461 176.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.1 tp -92.32 125.84 37.15 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 108.168 -1.049 . . . . 74.439999999999998 108.168 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 4.5 m-85 -104.0 175.46 5.48 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.583 1.153 . . . . 74.530000000000001 109.556 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 p -145.04 141.34 22.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 108.779 -0.823 . . . . 61.219999999999999 108.779 171.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -77.93 108.7 11.38 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.082 -0.711 . . . . 64.329999999999998 109.082 173.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.54 -26.51 66.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.901 0.881 . . . . 71.420000000000002 111.212 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -126.98 155.89 42.44 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.961 0.904 . . . . 74.25 109.127 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -69.81 145.46 52.12 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.37 -0.832 . . . . 73.230000000000004 109.485 169.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -153.3 108.47 3.21 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.497 -0.927 . . . . 63.240000000000002 108.497 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 52.8 t -81.56 131.95 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.952 -1.129 . . . . 70.310000000000002 107.952 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.84 136.62 57.95 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.454 0.472 . . . . 72.109999999999999 110.896 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.5 t -62.31 -25.06 67.66 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.696 0.798 . . . . 52.409999999999997 109.824 172.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.51 -133.42 3.75 Favored Glycine 0 C--N 1.353 1.513 0 CA-C-N 115.557 -0.747 . . . . 34.229999999999997 112.305 172.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.06 -25.86 66.46 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.785 1.234 . . . . 65.230000000000004 111.926 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -79.87 -11.28 59.82 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.381 1.072 . . . . 75.329999999999998 112.511 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.8 p -137.74 169.7 17.34 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.574 0.75 . . . . 31.210000000000001 111.441 -171.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.9 tp -115.65 134.72 54.76 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.933 0.893 . . . . 74.019999999999996 109.781 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.0 t -85.59 117.33 24.42 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.829 -0.804 . . . . 62.119999999999997 108.829 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.4 pt -119.51 131.94 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.648 0.779 . . . . 71.319999999999993 109.52 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.438 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 50.3 m -90.34 146.42 24.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.375 0.67 . . . . 72.209999999999994 110.111 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -52.94 112.95 0.94 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 122.84 0.456 . . . . 64.230000000000004 110.408 164.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 106.27 -13.12 44.17 Favored Glycine 0 N--CA 1.472 1.082 0 CA-C-N 116.701 -0.227 . . . . 32.409999999999997 112.901 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -76.67 126.96 31.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.183 0.993 . . . . 72.409999999999997 109.462 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -90.2 133.03 35.16 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.157 0.583 . . . . 71.140000000000001 110.733 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.8 mt -116.71 150.0 38.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.911 0.884 . . . . 73.049999999999997 110.731 -161.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -102.58 109.02 20.5 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.642 -0.873 . . . . 54.32 108.642 169.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.6 t -87.66 106.25 16.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 108.571 -0.9 . . . . 55.219999999999999 108.571 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 76.2 mt -72.4 -31.49 65.58 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 115.375 -0.83 . . . . 55.310000000000002 109.441 176.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.31 -174.61 42.96 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.093 -0.958 . . . . 73.420000000000002 111.259 172.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.3 m-30 -113.31 174.08 6.09 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.539 0.736 . . . . 74.209999999999994 109.427 167.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -64.95 145.99 55.57 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.066 -1.087 . . . . 72.200000000000003 108.066 166.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -65.22 -29.91 70.76 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.355 0.662 . . . . 71.430000000000007 111.62 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -85.95 -5.98 59.14 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.633 0.773 . . . . 73.310000000000002 111.253 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.17 33.07 41.51 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.805 -0.634 . . . . 43.43 113.274 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . 29.8 mt-10 -89.34 -73.09 0.52 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.129 0.572 . . . . 64.439999999999998 110.117 -177.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -100.53 -178.87 3.93 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.69 0.796 . . . . 75.310000000000002 109.64 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.28 117.91 22.33 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.165 0.986 . . . . 73.540000000000006 108.854 -177.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.62 92.72 1.17 Allowed 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.555 -1.276 . . . . 72.450000000000003 107.555 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -112.24 164.08 13.62 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.873 0.844 . . . . 74.209999999999994 111.111 -171.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -151.67 138.74 19.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.522 -1.217 . . . . 74.25 108.254 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 43.4 p -132.21 175.93 8.83 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.633 0.773 . . . . 64.340000000000003 109.638 171.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -70.53 -6.66 37.96 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 121.212 0.53 . . . . 74.230000000000004 110.168 174.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -89.33 -18.93 25.95 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.823 1.249 . . . . 73.230000000000004 111.217 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 154.91 -148.14 18.14 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 118.041 0.382 . . . . 75.420000000000002 113.034 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -151.15 157.25 42.47 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.44 0.62 . . . . 74.129999999999995 110.295 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 153.25 -171.17 32.18 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 122.966 0.317 . . . . 52.0 112.494 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -91.34 133.7 35.22 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.065 0.546 . . . . 51.210000000000001 110.53 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.31 156.19 72.9 Favored Pre-proline 0 N--CA 1.479 1.025 0 C-N-CA 124.484 1.114 . . . . 73.319999999999993 109.43 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.36 123.91 11.07 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.063 1.842 . . . . 42.439999999999998 110.92 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.4 m -59.41 -22.09 60.92 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.679 0.792 . . . . 75.310000000000002 111.47 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -73.33 -23.26 60.22 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.571 1.148 . . . . 72.219999999999999 111.719 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -94.58 -4.17 48.36 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.671 0.788 . . . . 71.219999999999999 112.393 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.4 pt -123.08 151.74 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 118.363 0.529 . . . . 73.420000000000002 110.397 -172.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.0 t -145.16 135.45 11.93 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.019 0.528 . . . . 53.219999999999999 109.639 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.567 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 59.3 Cg_endo -74.18 115.17 4.23 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.334 2.023 . . . . 72.530000000000001 111.938 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.1 m -87.64 -54.62 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.023 0.529 . . . . 74.420000000000002 111.028 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -80.97 -18.29 47.47 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.329 0.651 . . . . 73.519999999999996 111.308 -171.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 32.8 t -71.34 -179.87 2.63 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.609 0.763 . . . . 73.209999999999994 111.228 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.51 -14.6 43.63 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.406 1.082 . . . . 63.020000000000003 113.266 -174.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.86 -25.55 67.6 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.979 0.512 . . . . 71.420000000000002 111.63 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.14 -26.53 62.79 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.286 1.034 . . . . 73.430000000000007 111.337 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -78.86 169.6 17.97 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.918 0.887 . . . . 71.140000000000001 111.764 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.5 p -84.58 -26.18 28.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.364 0.666 . . . . 43.43 112.097 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . 0.453 ' CE3' HG21 ' A' ' 218' ' ' VAL . 55.3 p-90 -83.89 -42.36 16.43 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.066 -0.515 . . . . 72.099999999999994 111.485 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -95.42 126.36 40.67 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.847 -0.797 . . . . 75.329999999999998 108.847 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -110.57 5.3 21.03 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.8 -0.637 . . . . 72.239999999999995 111.259 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.82 -155.09 36.58 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.475 -0.625 . . . . 74.040000000000006 113.418 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.75 106.07 1.77 Allowed 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 123.196 2.597 . . . . 53.310000000000002 110.408 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.3 t -128.39 150.54 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 123.631 0.773 . . . . 60.32 109.154 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.2 t -86.3 167.27 14.95 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.849 0.86 . . . . 52.439999999999998 110.066 173.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -63.71 -33.33 75.41 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.33 0.652 . . . . 73.420000000000002 111.903 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -67.52 -55.21 14.42 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.291 0.636 . . . . 44.140000000000001 110.284 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.42 -37.37 80.66 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.965 0.79 . . . . 74.519999999999996 111.226 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.54 -57.54 12.24 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.66 -0.7 . . . . 54.32 110.849 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.51 -21.12 63.69 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.359 -0.837 . . . . 70.239999999999995 111.118 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -68.22 -53.25 26.08 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.687 0.795 . . . . 75.420000000000002 110.591 174.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.439 ' HB2' HD11 ' A' ' 169' ' ' LEU . 74.6 mt -68.06 -37.33 81.18 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.946 -0.57 . . . . 75.349999999999994 110.957 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.8 tp -73.51 -22.48 60.11 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.381 -0.827 . . . . 71.329999999999998 111.349 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.9 t -59.76 -26.84 66.03 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.48 0.712 . . . . 61.030000000000001 111.787 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.8 m -79.16 9.66 4.3 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.363 1.065 . . . . 62.539999999999999 112.246 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.04 159.24 14.46 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 122.98 0.324 . . . . 73.329999999999998 113.53 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.1 pt -115.57 -164.47 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.347 1.059 . . . . 65.329999999999998 109.859 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.699 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 17.4 p-10 -52.65 99.62 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.516 1.126 . . . . 52.530000000000001 113.142 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 107.85 13.71 19.31 Favored Glycine 0 C--N 1.355 1.632 0 CA-C-N 116.174 -0.466 . . . . 44.399999999999999 113.538 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 185' ' ' ARG . 37.9 p -79.0 137.45 37.59 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.998 -0.707 . . . . 74.400000000000006 109.98 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.492 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 27.1 p90 -134.08 160.7 36.97 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 112.452 0.538 . . . . 74.209999999999994 112.452 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 159' ' ' LEU . 82.4 mt -134.65 134.15 40.85 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.337 1.055 . . . . 32.539999999999999 108.292 166.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.401 HG21 HG22 ' A' ' 218' ' ' VAL . 32.3 t -106.14 128.45 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.113 -1.44 . . . . 64.319999999999993 107.113 171.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -158.43 161.11 37.45 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.908 0.483 . . . . 73.030000000000001 110.07 -174.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.701 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 12.5 pt-20 -109.21 161.62 15.06 Favored 'General case' 0 C--O 1.244 0.812 0 O-C-N 123.409 0.443 . . . . 62.130000000000003 109.806 169.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 176' ' ' SER . 16.2 m -83.41 135.53 34.66 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.627 -0.715 . . . . 70.319999999999993 109.395 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -71.19 -41.86 69.74 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.388 0.675 . . . . 50.420000000000002 110.213 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 25.0 m -78.57 -17.16 56.55 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.115 -0.948 . . . . 72.329999999999998 111.431 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 28.3 t -130.49 80.9 69.33 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.423 -0.954 . . . . 72.030000000000001 108.423 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.24 141.44 93.19 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.621 2.881 . . . . 53.140000000000001 112.837 -173.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 77.66 -23.07 2.55 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 116.208 -0.451 . . . . 31.41 114.071 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -84.25 116.38 22.94 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 108.177 -1.045 . . . . 72.129999999999995 108.177 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.701 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 44.5 mtt180 -110.88 169.78 8.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.168 -0.923 . . . . 75.329999999999998 111.209 -168.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.401 ' HB2' ' HD3' ' A' ' 194' ' ' ARG . 47.8 t -154.59 144.38 21.63 Favored 'General case' 0 C--O 1.253 1.244 0 C-N-CA 124.982 1.313 . . . . 74.409999999999997 108.722 -176.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.475 HD11 HD21 ' A' ' 217' ' ' LEU . 58.6 mt -109.33 135.38 48.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 107.221 -1.4 . . . . 74.450000000000003 107.221 166.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 19.3 m -112.26 114.06 26.63 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.229 -1.026 . . . . 75.420000000000002 108.229 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.3 mt -105.14 144.31 32.11 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.107 0.963 . . . . 63.200000000000003 111.035 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.455 ' HB3' ' OG ' ' A' ' 167' ' ' SER . 27.1 ttt85 -132.74 133.27 43.26 Favored 'General case' 0 C--O 1.259 1.579 0 CA-C-N 114.357 -1.292 . . . . 74.010000000000005 108.895 175.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 28.2 p90 -148.1 138.83 23.06 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 124.616 1.198 . . . . 71.209999999999994 108.804 171.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 58.58 19.1 6.34 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.934 1.293 . . . . 75.310000000000002 113.534 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.62 21.1 69.95 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 116.626 -0.261 . . . . 71.420000000000002 112.814 -175.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -118.16 126.9 53.14 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.511 1.125 . . . . 64.439999999999998 108.553 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 51.4 t -119.04 141.88 36.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 124.13 0.972 . . . . 71.530000000000001 110.722 -168.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.485 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 18.2 p90 -145.19 151.13 37.94 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.507 1.123 . . . . 74.140000000000001 109.403 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -126.36 115.39 19.58 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 107.918 -1.141 . . . . 71.409999999999997 107.918 -173.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -117.46 132.63 56.52 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.637 -0.505 . . . . 64.409999999999997 109.637 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.401 ' HD3' ' HB2' ' A' ' 181' ' ' SER . 10.8 mmt85 -72.68 131.5 42.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.777 0.831 . . . . 73.310000000000002 112.07 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 82.0 mt -71.45 110.63 4.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 108.107 -1.071 . . . . 74.239999999999995 108.107 163.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -69.33 120.92 15.88 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.274 -0.875 . . . . 43.32 108.641 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.4 m -103.47 110.64 22.75 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 122.969 0.508 . . . . 63.329999999999998 109.804 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.402 ' HB2' ' HE1' ' A' ' 204' ' ' TYR . . . -61.38 156.53 18.82 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.959 0.904 . . . . 62.5 111.606 172.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.1 m -71.22 -12.47 61.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.707 0.803 . . . . 71.120000000000005 112.196 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -86.55 12.38 10.59 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.468 0.707 . . . . 72.019999999999996 111.16 171.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 75.05 4.91 74.1 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 123.179 0.419 . . . . 72.409999999999997 113.266 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -81.64 140.06 34.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.605 0.762 . . . . 73.409999999999997 109.991 -175.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.519 HD13 HD13 ' A' ' 214' ' ' LEU . 85.8 mt -103.13 147.29 27.19 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.515 0.726 . . . . 65.0 109.481 -175.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.402 ' HE1' ' HB2' ' A' ' 198' ' ' ALA . 28.7 p90 -167.49 177.39 5.99 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.118 0.967 . . . . 73.400000000000006 110.819 173.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 74.9 t -131.3 -54.89 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 107.452 -1.314 . . . . 75.049999999999997 107.452 174.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 12.1 t -86.08 153.55 22.03 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.916 -1.038 . . . . 62.149999999999999 108.961 172.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.1 t -68.88 -25.58 64.68 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.728 0.411 . . . . 71.109999999999999 110.424 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.75 -34.13 62.45 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.568 -0.742 . . . . 73.540000000000006 110.492 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.455 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 74.8 m -64.32 126.32 27.4 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.528 0.731 . . . . 62.350000000000001 109.28 172.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -144.65 112.56 6.32 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.202 1.001 . . . . 74.150000000000006 108.645 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 209' ' ' SER . 17.4 m-85 -129.66 142.76 50.67 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 118.683 0.674 . . . . 74.519999999999996 111.315 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -90.58 -22.51 21.22 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.382 0.673 . . . . 74.409999999999997 109.66 172.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.0 p -129.87 147.02 51.59 Favored 'General case' 0 C--O 1.253 1.272 0 CA-C-O 122.182 0.992 . . . . 71.109999999999999 111.459 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.519 HD13 HD13 ' A' ' 203' ' ' LEU . 27.1 tp -67.23 -29.02 68.56 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 114.047 -1.433 . . . . 54.420000000000002 110.841 177.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.46 90.51 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.487 0.715 . . . . 72.540000000000006 111.029 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -66.53 -37.98 86.19 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.545 -0.752 . . . . 64.230000000000004 110.762 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.475 HD21 HD11 ' A' ' 182' ' ' ILE . 9.2 tt -55.64 -47.53 76.5 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.885 0.74 . . . . 74.109999999999999 111.486 174.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.453 HG21 ' CE3' ' A' ' 146' ' ' TRP . 70.4 t -70.53 -44.04 77.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 123.262 0.625 . . . . 53.439999999999998 111.263 -175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -59.72 -49.63 76.98 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.632 0.73 . . . . 71.099999999999994 110.577 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -56.6 -56.47 20.88 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.961 -1.018 . . . . 72.439999999999998 109.684 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . 0.446 ' HA ' HG22 ' A' ' 224' ' ' VAL . 36.0 m80 -67.32 -16.74 64.43 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.168 0.433 . . . . 73.340000000000003 112.168 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . 0.434 ' HA ' ' HB2' ' A' ' 232' ' ' LEU . 35.9 t -73.59 -31.57 63.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.555 0.342 . . . . 73.430000000000007 111.047 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.6 t -112.04 -6.62 14.17 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.27 1.952 . . . . 64.430000000000007 116.27 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.446 HG22 ' HA ' ' A' ' 221' ' ' HIS . 33.8 m -104.21 158.4 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 116.199 1.925 . . . . 64.450000000000003 116.199 -171.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -90.89 -0.99 57.88 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 129.25 3.02 . . . . 54.0 113.543 -175.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -77.9 14.98 0.95 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 128.734 2.814 . . . . 71.409999999999997 113.766 -141.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.77 18.78 3.87 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 124.571 1.081 . . . . 42.32 111.817 -168.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.91 135.37 33.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.957 0.903 . . . . 73.239999999999995 110.555 167.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.485 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 85.8 mt -72.96 -34.86 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 109.321 -0.622 . . . . 72.420000000000002 109.321 171.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.8 t -143.25 142.24 31.31 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.59 -0.893 . . . . 73.219999999999999 108.59 168.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 224' ' ' VAL . 67.8 p -67.92 147.48 52.43 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.802 -0.814 . . . . 73.209999999999994 108.802 171.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.492 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 28.6 mt -62.68 99.91 0.17 Allowed 'General case' 0 CA--C 1.555 1.147 0 N-CA-C 108.89 -0.781 . . . . 64.129999999999995 108.89 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -81.8 -50.93 8.66 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.702 0.401 . . . . 72.209999999999994 110.277 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -156.76 148.37 17.1 Favored Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 120.689 -0.405 . . . . 74.010000000000005 110.191 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.05 138.78 20.96 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 121.843 1.696 . . . . 64.310000000000002 111.97 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . 0.426 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -67.67 140.63 94.53 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 108.793 -0.817 . . . . 72.5 108.793 171.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.77 156.4 64.23 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.833 2.356 . . . . 64.439999999999998 114.67 -164.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp . . . . . 0 N--CA 1.477 0.905 0 CA-C-N 114.567 -1.197 . . . . 72.099999999999994 109.898 170.618 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.7 p . . . . . 0 CA--C 1.545 0.756 0 CA-C-O 121.312 0.577 . . . . 65.430000000000007 111.116 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 94.6 mt -104.98 131.65 21.59 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.884 -0.598 . . . . 64.140000000000001 109.432 -176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 17' ' ' LEU . 8.2 Cg_exo -69.13 171.83 13.08 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.102 2.535 . . . . 52.039999999999999 112.267 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HB3' ' NE2' ' A' ' 21' ' ' HIS . . . -85.56 149.15 25.56 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.867 0.467 . . . . 74.099999999999994 110.401 170.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.576 HD22 HD11 ' A' ' 23' ' ' ILE . 84.8 mt -86.05 94.2 9.18 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.938 -1.134 . . . . 53.409999999999997 107.938 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.406 ' NE2' ' HB3' ' A' ' 19' ' ' ALA . 29.3 m170 -97.31 -52.9 3.65 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.632 0.373 . . . . 64.019999999999996 110.948 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -105.16 102.87 12.33 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.925 -1.139 . . . . 74.040000000000006 107.925 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.576 HD11 HD22 ' A' ' 20' ' ' LEU . 48.0 mm -126.1 111.57 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.923 -0.769 . . . . 60.25 108.923 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.934 0 O-C-N 124.352 1.033 . . . . 54.439999999999998 108.714 173.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo . . . . . 0 N--CA 1.498 1.739 0 N-CA-C 114.32 0.854 . . . . 63.530000000000001 114.32 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.69 22.2 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.287 1.835 . . . . 74.319999999999993 109.24 176.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.5 tp -85.3 132.84 34.19 Favored 'General case' 0 C--N 1.359 1.007 0 CA-C-O 121.017 0.437 . . . . 75.129999999999995 109.894 -178.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 14.3 m-85 -106.65 173.9 6.12 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.191 1.396 . . . . 64.120000000000005 110.086 177.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.49 145.96 25.06 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 107.925 -1.139 . . . . 71.400000000000006 107.925 171.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -74.95 117.93 17.34 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 123.039 0.212 . . . . 70.439999999999998 110.606 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.3 mt -65.41 -33.69 76.53 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.222 1.009 . . . . 55.0 111.556 171.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -140.35 159.0 43.16 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.172 0.589 . . . . 74.439999999999998 109.418 -175.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -74.7 152.19 39.15 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.107 -0.701 . . . . 75.230000000000004 109.107 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -156.04 115.93 3.63 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.602 0.761 . . . . 72.439999999999998 109.1 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.72 133.21 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.339 -0.985 . . . . 71.109999999999999 108.339 170.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.69 134.63 52.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.811 0.444 . . . . 73.150000000000006 110.91 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.9 m -67.59 -20.94 65.43 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.943 0.897 . . . . 73.219999999999999 111.391 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.35 -165.65 38.27 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.69 -0.686 . . . . 34.340000000000003 112.008 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -52.3 -38.77 59.34 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.7 1.2 . . . . 51.340000000000003 112.852 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.457 HD21 HD13 ' A' ' 20' ' ' LEU . 31.3 p-10 -72.19 -24.71 61.46 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.178 0.991 . . . . 74.049999999999997 112.69 -175.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 p -104.23 157.75 16.92 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.301 0.641 . . . . 53.509999999999998 110.022 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.468 ' HB3' HG13 ' A' ' 130' ' ' VAL . 64.2 tp -110.55 132.74 53.93 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.797 -0.638 . . . . 71.430000000000007 109.808 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.2 t -80.16 136.54 36.53 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.36 -0.608 . . . . 74.140000000000001 109.36 173.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 28.6 pt -137.89 144.55 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.484 0.713 . . . . 62.219999999999999 109.652 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 9.3 m -105.65 143.91 33.13 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.231 -0.655 . . . . 74.400000000000006 109.231 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -56.38 111.91 1.11 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 118.536 0.607 . . . . 62.450000000000003 111.046 174.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.13 1.8 35.91 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 116.707 -0.224 . . . . 41.409999999999997 113.254 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.552 ' HG3' ' HE2' ' A' ' 124' ' ' LYS . 36.5 tt0 -85.66 137.64 32.7 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.029 0.931 . . . . 64.340000000000003 110.511 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -76.4 119.14 19.85 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.603 0.761 . . . . 75.420000000000002 110.338 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.658 ' HA ' HG22 ' A' ' 123' ' ' THR . 11.4 mt -112.43 123.68 50.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.405 -0.961 . . . . 72.329999999999998 108.405 -173.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -95.6 106.76 18.89 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 107.769 -1.197 . . . . 73.040000000000006 107.769 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 67.1 t -99.66 114.55 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 109.229 -0.656 . . . . 61.130000000000003 109.229 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.38 -34.77 68.18 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.62 0.768 . . . . 71.540000000000006 109.934 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.35 167.09 35.69 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 114.783 -1.098 . . . . 54.210000000000001 111.422 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 3.0 m-30 -97.5 175.0 6.38 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.781 0.8 . . . . 74.239999999999995 110.063 177.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -75.13 147.1 40.8 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 114.411 -1.268 . . . . 73.319999999999993 108.304 169.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -60.08 -37.17 79.12 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.7 0.8 . . . . 75.319999999999993 112.328 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -92.92 7.52 43.6 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 121.07 0.462 . . . . 72.239999999999995 110.94 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 174' ' ' GLU . . . 70.91 27.96 71.4 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 116.079 -0.51 . . . . 72.019999999999996 113.898 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -68.41 -70.72 0.25 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 122.126 0.965 . . . . 74.329999999999998 110.245 178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -131.04 -178.58 4.88 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.57 1.148 . . . . 73.010000000000005 108.859 -172.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -138.48 122.22 17.56 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.973 0.509 . . . . 64.439999999999998 109.99 -175.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -72.23 96.84 1.87 Allowed 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.648 0.737 . . . . 70.120000000000005 109.816 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -109.68 165.69 11.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.709 -1.132 . . . . 65.5 111.097 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -140.75 118.65 11.8 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.608 -1.256 . . . . 74.120000000000005 107.608 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.658 HG22 ' HA ' ' A' ' 107' ' ' LEU . 71.7 p -132.05 -172.28 2.84 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.58 0.705 . . . . 73.530000000000001 111.123 -176.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.552 ' HE2' ' HG3' ' A' ' 105' ' ' GLU . 40.0 mtmt -57.44 -30.52 65.07 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 114.242 -1.344 . . . . 74.409999999999997 110.862 170.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -85.51 3.25 41.28 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.07 0.948 . . . . 75.430000000000007 111.759 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 118.97 -127.38 7.2 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 122.21 -0.306 . . . . 73.129999999999995 112.835 173.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -151.97 140.99 21.18 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.57 0.748 . . . . 54.130000000000003 110.384 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 167.72 -171.77 42.33 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.143 0.277 . . . . 51.100000000000001 112.446 176.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -88.57 125.24 34.7 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.113 0.565 . . . . 74.299999999999997 111.216 -175.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 99' ' ' LEU . 30.8 m -120.62 152.26 55.36 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.724 1.21 . . . . 52.310000000000002 110.098 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.64 129.14 13.28 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 121.654 1.569 . . . . 75.310000000000002 111.347 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 43.8 t -57.74 -27.14 62.74 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.648 0.779 . . . . 53.5 111.799 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -67.87 -21.25 65.17 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.312 1.045 . . . . 72.120000000000005 112.191 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -107.06 8.52 30.34 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.613 0.765 . . . . 75.420000000000002 111.681 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.5 pt -128.26 155.2 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-N 118.545 0.611 . . . . 75.219999999999999 109.958 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.3 t -150.36 134.97 9.53 Favored Pre-proline 0 N--CA 1.495 1.779 0 C-N-CA 122.849 0.459 . . . . 73.25 110.175 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.587 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 74.4 Cg_endo -76.21 117.46 4.64 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.879 2.386 . . . . 64.510000000000005 114.282 -176.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.7 m -90.29 -49.7 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 122.841 0.457 . . . . 51.43 111.618 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -94.36 6.36 48.94 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.114 0.483 . . . . 75.319999999999993 111.405 -173.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.587 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 25.0 t -83.59 -178.69 7.11 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.126 0.489 . . . . 65.340000000000003 109.807 173.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 62.4 mt -63.16 -13.79 41.13 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.235 1.014 . . . . 44.219999999999999 112.644 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.555 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 36.5 tt0 -58.75 -24.59 61.88 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.856 0.862 . . . . 72.310000000000002 112.519 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.2 -25.3 66.95 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 123.469 0.708 . . . . 71.109999999999999 110.837 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -79.57 148.33 31.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.718 0.807 . . . . 74.219999999999999 110.705 170.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.6 p -65.72 -22.65 66.63 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.924 0.713 . . . . 74.099999999999994 112.924 -175.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 59.5 p-90 -81.6 -46.48 14.35 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.965 0.506 . . . . 65.340000000000003 112.32 -178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 30.5 t80 -88.37 137.37 32.39 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.441 -0.578 . . . . 72.040000000000006 109.441 -177.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' HIS . . . . . 0.555 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 25.0 m-70 -130.45 26.82 5.07 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 111.97 0.359 . . . . 72.099999999999994 111.97 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.93 -154.63 46.39 Favored Glycine 0 CA--C 1.54 1.644 0 N-CA-C 114.766 0.667 . . . . 71.530000000000001 114.766 171.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.469 ' HG3' ' OH ' ' A' ' 112' ' ' TYR . 72.2 Cg_endo -75.03 108.62 2.76 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 123.478 2.785 . . . . 64.230000000000004 111.901 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.481 HG13 ' HD3' ' A' ' 171' ' ' ARG . 1.6 p -155.23 138.5 7.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 115.493 -0.776 . . . . 43.130000000000003 109.659 -177.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.3 p -80.83 170.74 15.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.999 0.74 . . . . 51.43 112.999 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -63.41 -27.62 69.42 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 114.94 -1.027 . . . . 65.400000000000006 112.694 -169.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -68.54 -57.33 5.94 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.552 0.741 . . . . 74.540000000000006 110.072 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.12 -36.62 84.85 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.338 0.655 . . . . 64.239999999999995 110.695 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.432 ' HA ' ' NH1' ' A' ' 171' ' ' ARG . . . -53.26 -52.25 59.61 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.824 -1.08 . . . . 73.239999999999995 112.03 171.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.547 ' HG3' HG11 ' A' ' 190' ' ' VAL . 29.7 tt0 -76.9 -19.65 57.17 Favored 'General case' 0 C--O 1.212 -0.871 0 CA-C-N 114.856 -1.065 . . . . 74.140000000000001 110.71 -175.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -67.53 -51.16 54.19 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.873 0.469 . . . . 55.310000000000002 109.974 172.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.593 HD12 HH22 ' A' ' 171' ' ' ARG . 82.7 mt -64.93 -42.16 94.91 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.864 -0.607 . . . . 70.450000000000003 110.965 178.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.653 HD23 HG13 ' A' ' 190' ' ' VAL . 32.4 tp -71.77 -28.8 63.88 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.214 -0.903 . . . . 62.229999999999997 112.024 -177.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.5 t -57.03 -40.13 76.14 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.641 0.776 . . . . 61.109999999999999 110.327 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.45 ' HB2' ' HG2' ' A' ' 237' ' ' PRO . 10.5 m -81.93 -0.21 42.83 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 114.636 -1.166 . . . . 64.310000000000002 111.585 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -93.23 154.53 21.89 Favored Glycine 0 C--N 1.349 1.271 0 C-N-CA 123.068 0.366 . . . . 74.420000000000002 113.055 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 20.5 pt -103.76 -167.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 123.798 0.839 . . . . 72.040000000000006 112.13 -173.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.664 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 16.3 p-10 -59.52 103.94 0.23 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.008 0.923 . . . . 72.010000000000005 113.486 -171.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 103.82 13.25 28.08 Favored Glycine 0 C--O 1.26 1.768 0 CA-C-N 116.288 -0.414 . . . . 73.120000000000005 112.847 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 22.6 t -71.72 136.73 47.31 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-O 119.227 -0.416 . . . . 74.230000000000004 110.132 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 183' ' ' SER . 21.6 p90 -135.22 156.35 49.13 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.932 0.716 . . . . 71.120000000000005 112.932 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.581 HD22 HH21 ' A' ' 171' ' ' ARG . 84.0 mt -140.01 132.84 29.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.419 -1.264 . . . . 74.420000000000002 108.184 171.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 23.0 t -110.07 130.73 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 107.613 -1.255 . . . . 73.150000000000006 107.613 172.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.593 HH22 HD12 ' A' ' 159' ' ' LEU . 11.9 ptp180 -163.38 164.66 24.59 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.165 0.586 . . . . 74.219999999999999 110.206 -174.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 16.1 pt-20 -111.48 156.93 20.93 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.568 0.347 . . . . 75.329999999999998 110.068 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.2 t -75.06 139.1 42.59 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 116.065 -0.516 . . . . 72.25 110.582 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.418 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 94.4 mt-10 -65.51 -42.43 92.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.941 0.497 . . . . 72.319999999999993 110.01 172.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 54.7 p -77.75 -21.97 51.0 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.106 0.962 . . . . 74.209999999999994 111.852 -176.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 36.9 t -140.03 79.89 21.53 Favored Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 109.33 -0.618 . . . . 51.140000000000001 109.33 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -71.43 148.08 53.71 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 123.028 2.485 . . . . 74.349999999999994 111.675 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 88.43 -25.03 9.83 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 115.414 -0.812 . . . . 51.210000000000001 111.843 -170.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -90.46 118.07 29.65 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 108.687 -0.857 . . . . 63.439999999999998 108.687 168.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 61.2 mtt180 -103.44 172.41 6.82 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 114.7 -1.136 . . . . 44.109999999999999 110.252 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.5 m -155.96 140.18 16.56 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.512 1.125 . . . . 70.409999999999997 108.462 -169.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.446 HD11 ' CD2' ' A' ' 217' ' ' LEU . 53.1 mt -112.78 137.98 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.243 -1.021 . . . . 71.409999999999997 108.243 167.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.599 ' HB3' HD22 ' A' ' 160' ' ' LEU . 17.0 m -117.19 112.58 21.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.283 1.433 . . . . 72.329999999999998 107.735 -175.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.414 HD12 ' HE2' ' A' ' 193' ' ' TYR . 42.1 mt -110.62 139.46 45.87 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.138 0.975 . . . . 74.319999999999993 111.459 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 45.4 ttt-85 -129.0 134.92 48.34 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 115.649 -0.705 . . . . 75.510000000000005 109.726 171.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 12.2 p90 -153.19 139.85 18.88 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 124.67 1.231 . . . . 72.129999999999995 107.823 175.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 54.66 23.11 4.48 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 125.026 1.33 . . . . 73.510000000000005 114.233 176.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.56 6.22 73.82 Favored Glycine 0 N--CA 1.475 1.282 0 O-C-N 122.206 -0.309 . . . . 75.319999999999993 113.189 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 15.7 tpp180 -101.03 124.47 46.81 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.218 1.007 . . . . 72.310000000000002 108.746 177.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.653 HG13 HD23 ' A' ' 160' ' ' LEU . 97.0 t -106.85 133.52 51.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.64 1.176 . . . . 73.420000000000002 108.624 174.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.478 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 27.4 p90 -146.3 155.7 42.83 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.238 0.615 . . . . 74.329999999999998 109.986 169.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -134.66 122.22 21.95 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.842 -1.17 . . . . 74.510000000000005 107.842 -174.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.414 ' HE2' HD12 ' A' ' 184' ' ' LEU . 37.1 p90 -119.19 155.11 32.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.026 0.53 . . . . 71.420000000000002 109.917 176.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -99.72 135.0 41.8 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.15 0.5 . . . . 75.25 111.381 -169.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 71.3 mt -82.74 111.79 19.58 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 CA-C-N 114.932 -1.031 . . . . 74.129999999999995 108.607 167.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -81.04 130.99 35.28 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.49 0.716 . . . . 73.409999999999997 109.185 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 48.1 m -97.31 125.55 41.96 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.323 0.649 . . . . 44.240000000000002 110.202 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.56 178.54 6.58 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.48 1.112 . . . . 74.209999999999994 111.727 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 45.3 t -60.7 -36.0 77.71 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.122 0.969 . . . . 73.219999999999999 112.059 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -74.07 -14.17 60.95 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.691 -0.686 . . . . 71.439999999999998 112.318 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 93.66 3.38 64.49 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.513 -0.635 . . . . 64.120000000000005 111.513 -170.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -72.27 160.61 32.1 Favored 'General case' 0 C--N 1.346 0.455 0 C-N-CA 124.123 0.969 . . . . 63.240000000000002 110.404 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.42 HD13 HD13 ' A' ' 214' ' ' LEU . 72.7 mt -113.84 147.19 38.83 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.006 0.923 . . . . 64.310000000000002 110.359 -173.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -163.19 153.77 16.35 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.715 0.635 . . . . 72.519999999999996 109.977 175.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 195' ' ' ILE . 71.7 t -125.26 -62.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.999 -1.112 . . . . 73.150000000000006 107.999 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.0 t -102.4 -178.4 3.68 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.253 1.021 . . . . 64.310000000000002 111.071 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.6 t -61.5 -47.41 85.75 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.333 1.053 . . . . 74.049999999999997 112.044 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -90.34 12.81 17.18 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.486 0.714 . . . . 71.430000000000007 111.643 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 66.8 m -98.51 111.54 23.87 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.373 0.669 . . . . 74.329999999999998 109.782 173.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -146.71 115.13 6.71 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.257 1.023 . . . . 73.420000000000002 109.304 171.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -135.8 142.26 44.85 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 117.843 0.292 . . . . 72.209999999999994 111.105 -171.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -83.85 -34.78 24.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.264 -0.643 . . . . 71.319999999999993 109.264 169.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 66.8 p -121.13 145.47 47.78 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-O 122.039 0.923 . . . . 51.43 111.72 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.42 HD13 HD13 ' A' ' 203' ' ' LEU . 30.2 tp -68.3 -24.68 64.88 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.472 -1.24 . . . . 73.230000000000004 110.811 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.44 85.96 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.457 0.703 . . . . 73.510000000000005 110.542 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -67.89 -34.39 76.56 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 116.053 -0.521 . . . . 75.129999999999995 111.382 175.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.446 ' CD2' HD11 ' A' ' 182' ' ' ILE . 10.0 tt -58.6 -46.22 87.47 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.42 0.45 . . . . 74.209999999999994 110.981 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.94 -39.11 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.166 0.587 . . . . 61.350000000000001 110.828 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -61.66 -55.1 34.11 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.318 0.58 . . . . 74.549999999999997 111.328 176.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.422 ' O ' HG22 ' A' ' 224' ' ' VAL . 46.9 t60 -51.14 -54.77 22.19 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 114.589 -1.187 . . . . 64.329999999999998 109.662 177.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -65.23 -24.94 67.48 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.608 -0.724 . . . . 54.149999999999999 112.709 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.6 t -72.51 -25.41 61.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.854 0.462 . . . . 63.130000000000003 111.064 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.3 t -122.47 -2.9 8.9 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 116.408 2.003 . . . . 61.409999999999997 116.408 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 220' ' ' HIS . 27.8 m -101.61 154.17 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-N 121.123 1.783 . . . . 61.219999999999999 115.421 -172.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.66 -0.73 57.29 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 129.248 3.019 . . . . 63.140000000000001 113.487 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.23 14.56 0.89 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 129.027 2.931 . . . . 72.230000000000004 113.677 -145.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.4 16.42 4.7 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 122.225 0.903 . . . . 42.43 111.725 -170.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.14 120.02 32.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.257 -0.972 . . . . 73.430000000000007 110.927 169.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.478 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 92.7 mt -59.23 -43.26 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 123.97 0.794 . . . . 61.530000000000001 109.39 172.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.8 t -136.09 148.74 48.42 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.694 -0.854 . . . . 73.450000000000003 108.694 165.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 80.7 p -72.4 159.71 33.54 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.566 -0.531 . . . . 65.430000000000007 109.566 171.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 20.4 mt -69.33 102.31 1.71 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.202 -1.036 . . . . 71.299999999999997 108.202 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -87.83 -50.52 6.4 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.461 -0.57 . . . . 73.019999999999996 109.461 -174.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -161.43 147.14 10.81 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 112.444 0.535 . . . . 73.439999999999998 112.444 -177.784 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.36 152.4 71.4 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.122 1.882 . . . . 74.239999999999995 112.736 -176.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.56 155.61 89.22 Favored Pre-proline 0 C--O 1.244 0.81 0 CA-C-N 115.774 -0.648 . . . . 64.409999999999997 110.667 175.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.45 ' HG2' ' HB2' ' A' ' 162' ' ' SER . 17.7 Cg_endo -56.85 140.02 90.58 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.801 2.334 . . . . 74.040000000000006 113.309 177.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt . . . . . 0 CA--C 1.543 0.709 0 CA-C-N 114.834 -1.075 . . . . 64.219999999999999 108.657 169.145 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.856 -0.424 . . . . 75.099999999999994 109.856 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.64 38.29 61.45 Favored Glycine 0 C--N 1.35 1.35 0 O-C-N 123.167 0.292 . . . . 73.329999999999998 113.198 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -85.24 129.52 34.79 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.836 0.455 . . . . 71.439999999999998 110.351 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.86 68.7 3.42 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 123.914 0.886 . . . . 72.549999999999997 110.94 172.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.45 -12.18 22.69 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.723 2.282 . . . . 65.230000000000004 112.272 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.31 148.49 51.35 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-N 115.843 -0.617 . . . . 23.219999999999999 113.034 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -77.14 81.82 3.64 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.324 0.65 . . . . 73.120000000000005 110.886 -173.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.9 m -79.02 169.94 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-N 115.824 -0.626 . . . . 70.140000000000001 109.71 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.5 tp 63.25 93.58 0.05 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.886 0.875 . . . . 74.030000000000001 110.886 -175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.27 167.57 13.75 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.626 -0.716 . . . . 53.350000000000001 111.611 176.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.62 95.14 4.51 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 122.779 0.431 . . . . 72.430000000000007 110.045 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -164.31 153.86 13.94 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.041 0.537 . . . . 72.549999999999997 110.446 -175.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -66.06 143.44 57.33 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.917 -0.583 . . . . 72.010000000000005 109.474 167.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 52.05 71.71 1.4 Allowed Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 123.105 0.562 . . . . 72.310000000000002 109.864 -168.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.446 ' HG2' ' HB3' ' A' ' 133' ' ' ASN . 9.8 Cg_exo -68.29 168.78 18.45 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.284 1.989 . . . . 73.340000000000003 111.063 174.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.2 p -67.41 165.81 15.83 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 121.352 0.596 . . . . 33.409999999999997 111.639 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 85.9 mt -106.56 130.56 22.73 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 108.542 -0.91 . . . . 72.230000000000004 108.542 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -66.58 165.46 25.18 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 121.982 1.788 . . . . 62.43 110.618 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.18 147.2 31.39 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.601 0.239 . . . . 55.020000000000003 110.407 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.568 ' HB3' HD11 ' A' ' 23' ' ' ILE . 63.5 mt -85.85 94.07 9.07 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.249 -1.019 . . . . 64.129999999999995 108.249 176.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -98.15 -47.73 5.37 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.878 -1.055 . . . . 75.109999999999999 109.057 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -101.79 113.59 26.92 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 114.345 -1.298 . . . . 74.400000000000006 109.9 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.568 HD11 ' HB3' ' A' ' 20' ' ' LEU . 46.5 mm -115.75 120.18 64.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 106.083 -1.821 . . . . 72.409999999999997 106.083 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HB2' ' HE1' ' A' ' 129' ' ' TRP . 16.8 tptm -63.83 -47.43 80.81 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.478 0.656 . . . . 75.150000000000006 109.84 -177.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.39 -48.66 0.92 Allowed Glycine 0 C--N 1.342 0.911 0 CA-C-N 115.008 -0.996 . . . . 75.109999999999999 111.278 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -138.36 -59.62 0.63 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.204 0.602 . . . . 75.340000000000003 110.001 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.417 ' HA2' ' HG2' ' A' ' 24' ' ' LYS . . . 91.49 -156.88 24.31 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 115.792 -0.64 . . . . 72.349999999999994 112.205 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.695 ' HB2' HD13 ' A' ' 110' ' ' LEU . 88.9 mttt -86.92 -166.33 1.54 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.996 0.518 . . . . 74.299999999999997 110.198 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.73 161.45 6.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.927 0.891 . . . . 43.200000000000003 109.948 171.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 61.62 80.38 0.22 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.52 1.128 . . . . 74.439999999999998 111.972 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 p -92.35 -60.6 1.8 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.266 -0.879 . . . . 53.439999999999998 110.255 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.1 t -178.82 138.04 0.15 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.754 1.222 . . . . 72.030000000000001 109.234 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -100.18 85.2 2.97 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 109.164 -0.68 . . . . 71.530000000000001 109.164 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -159.53 150.44 19.54 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.475 -0.784 . . . . 64.129999999999995 109.451 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.92 -108.25 1.82 Allowed Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.851 -0.9 . . . . 60.119999999999997 110.851 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.64 162.35 10.87 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-O 119.332 -0.705 . . . . 64.019999999999996 111.7 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.53 146.71 31.12 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.798 2.332 . . . . 73.329999999999998 111.792 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -96.76 43.14 1.08 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 122.123 0.963 . . . . 75.540000000000006 109.59 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.1 p -84.13 134.13 34.6 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.766 -1.198 . . . . 63.409999999999997 107.766 169.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -75.55 -22.77 56.75 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.394 0.278 . . . . 65.430000000000007 111.62 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.2 t -113.98 112.53 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 123.696 0.798 . . . . 61.200000000000003 109.532 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.57 140.96 1.08 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.981 0.912 . . . . 74.329999999999998 110.189 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.3 m -105.46 178.05 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.403 0.681 . . . . 73.040000000000006 111.107 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -89.82 161.9 15.76 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.204 0.602 . . . . 70.340000000000003 111.304 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.4 ' ND1' ' HG2' ' A' ' 46' ' ' GLU . 42.2 t-80 -106.31 -50.17 3.2 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.941 -0.572 . . . . 60.420000000000002 109.983 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.4 ' HG2' ' ND1' ' A' ' 45' ' ' HIS . 60.7 mm-40 -126.9 -168.77 1.92 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.399 1.08 . . . . 73.219999999999999 109.709 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.17 149.57 50.1 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.049 0.54 . . . . 51.539999999999999 110.58 172.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.5 mt -96.73 122.72 39.98 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.071 -1.085 . . . . 60.530000000000001 108.071 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -73.32 107.49 5.66 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 113.951 1.093 . . . . 74.310000000000002 113.951 -164.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.407 ' HB2' ' OD1' ' A' ' 83' ' ' ASN . 20.5 ttm180 -129.72 89.75 45.51 Favored Pre-proline 0 C--O 1.245 0.842 0 N-CA-C 107.018 -1.475 . . . . 74.010000000000005 107.018 155.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.613 ' HA ' HG22 ' A' ' 213' ' ' THR . 52.8 Cg_endo -82.51 -139.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.629 2.219 . . . . 73.140000000000001 111.15 174.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.4 t -54.71 117.1 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.268 0 C-N-CA 123.615 0.766 . . . . 65.010000000000005 109.626 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.21 121.44 7.52 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.238 1.415 . . . . 73.409999999999997 113.74 -166.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.9 t -77.1 -29.64 54.94 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.983 0.913 . . . . 74.549999999999997 110.015 175.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -81.89 107.08 14.33 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.707 0.803 . . . . 70.450000000000003 110.145 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -124.46 -174.18 2.95 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.986 1.314 . . . . 72.530000000000001 108.331 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.709 ' HG2' ' HB3' ' A' ' 114' ' ' HIS . 29.4 tt0 71.12 73.02 0.27 Allowed Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.42 1.088 . . . . 74.510000000000005 109.588 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -95.55 139.33 0.87 Allowed 'Trans proline' 0 CA--C 1.558 1.688 0 C-N-CA 123.538 2.825 . . . . 73.219999999999999 114.885 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -135.9 114.22 11.59 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.822 0.849 . . . . 74.040000000000006 109.588 171.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.89 78.05 1.25 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.924 -0.471 . . . . 75.200000000000003 111.924 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.722 HD11 ' HA ' ' A' ' 115' ' ' ASN . 75.9 mt -73.1 143.06 47.52 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.701 0.801 . . . . 73.140000000000001 111.003 -177.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 57.7 p -66.16 94.05 0.23 Allowed 'General case' 0 CA--C 1.553 1.087 0 O-C-N 123.712 0.632 . . . . 52.229999999999997 110.717 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.85 130.61 41.47 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.213 -0.662 . . . . 73.049999999999997 109.213 176.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.79 -89.27 0.12 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.977 0.511 . . . . 55.329999999999998 111.69 -168.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -167.89 75.88 0.13 Allowed 'General case' 0 C--N 1.348 0.538 0 C-N-CA 123.132 0.573 . . . . 73.420000000000002 109.853 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -80.04 75.53 6.79 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.637 -0.875 . . . . 72.140000000000001 108.637 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -75.13 97.43 3.47 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 114.911 -1.04 . . . . 74.010000000000005 110.016 -177.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -173.49 155.8 2.88 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.601 -1.181 . . . . 73.230000000000004 108.309 174.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.2 m -149.64 85.98 1.45 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.027 0.531 . . . . 35.439999999999998 109.901 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -84.77 163.32 19.19 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.713 -0.847 . . . . 65.409999999999997 108.713 164.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -79.06 139.66 38.08 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.149 0.5 . . . . 64.310000000000002 111.772 -174.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -63.94 109.29 1.73 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-N 114.931 -1.031 . . . . 53.210000000000001 109.494 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.447 HD12 HD13 ' A' ' 88' ' ' LEU . 92.5 mt -82.54 63.85 6.9 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.634 0.731 . . . . 60.119999999999997 110.764 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 59.6 mt -84.87 108.73 17.66 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.333 -0.988 . . . . 74.209999999999994 108.333 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.513 ' H ' HG12 ' A' ' 138' ' ' VAL . . . -75.47 -57.31 3.96 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.036 0.535 . . . . 72.409999999999997 111.047 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.75 178.74 36.84 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 115.733 -0.667 . . . . 71.120000000000005 112.52 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -95.86 -153.86 0.04 OUTLIER 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 123.343 2.696 . . . . 62.439999999999998 113.999 -166.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.0 t -137.85 -167.51 2.16 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 106.904 -1.517 . . . . 73.439999999999998 106.904 167.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -74.45 -53.96 8.5 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.737 0.698 . . . . 74.409999999999997 111.567 -168.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -160.48 26.9 0.16 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.069 0.948 . . . . 62.549999999999997 109.426 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.04 158.96 33.26 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 115.158 -0.928 . . . . 74.230000000000004 110.989 -165.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.65 159.0 14.77 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 123.174 2.583 . . . . 74.319999999999993 113.144 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 50' ' ' ARG . 9.6 m120 -56.36 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.951 0.782 . . . . 70.310000000000002 111.987 -175.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.66 ' H ' ' HB3' ' A' ' 139' ' ' ASN . 50.3 tp -81.55 135.77 35.59 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.538 -1.21 . . . . 74.409999999999997 109.165 177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -105.49 176.08 5.28 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.948 1.299 . . . . 75.299999999999997 109.359 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.35 143.13 23.52 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 N-CA-C 108.503 -0.925 . . . . 61.539999999999999 108.503 171.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -76.05 121.67 23.12 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.627 -0.508 . . . . 63.539999999999999 109.627 173.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.447 HD13 HD12 ' A' ' 73' ' ' LEU . 74.4 mt -82.42 -21.63 35.65 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.703 0.801 . . . . 74.239999999999995 111.252 173.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.574 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 84.5 m-85 -136.16 158.14 45.14 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.114 0.565 . . . . 74.319999999999993 109.585 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.51 145.58 39.04 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.689 -0.687 . . . . 73.219999999999999 109.835 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -153.23 111.16 3.59 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.236 -1.024 . . . . 74.019999999999996 108.236 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.4 t -82.54 138.71 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 109.074 -0.713 . . . . 65.099999999999994 109.074 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.65 116.25 4.61 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.087 0.555 . . . . 71.230000000000004 110.194 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.5 m -78.79 -11.05 59.97 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.718 0.807 . . . . 73.430000000000007 110.717 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.74 -172.68 41.62 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.587 -0.733 . . . . 63.310000000000002 111.28 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.53 -25.68 66.78 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.436 0.694 . . . . 72.030000000000001 110.719 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -70.2 -22.99 62.88 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.588 0.755 . . . . 71.340000000000003 112.456 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.7 p -113.71 157.74 21.81 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.408 0.683 . . . . 64.219999999999999 110.915 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.2 tp -109.93 131.15 55.32 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.734 0.814 . . . . 62.0 109.927 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.8 t -74.05 120.01 19.04 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 108.892 -0.781 . . . . 34.119999999999997 108.892 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.5 pt -127.32 159.53 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.244 1.018 . . . . 41.210000000000001 108.775 174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 60.0 m -135.78 148.15 48.64 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.265 -0.643 . . . . 74.310000000000002 109.265 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -54.84 123.38 13.21 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.095 0.558 . . . . 74.230000000000004 111.646 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.29 -9.54 49.81 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 116.388 -0.369 . . . . 54.210000000000001 113.095 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -85.01 131.89 34.41 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.557 0.743 . . . . 72.019999999999996 110.445 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.45 ' HB3' HD11 ' A' ' 84' ' ' LEU . 8.7 mtmp? -83.52 115.48 22.11 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.773 0.829 . . . . 71.299999999999997 110.302 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.505 ' HA ' HG22 ' A' ' 123' ' ' THR . 15.7 mt -103.14 145.74 29.45 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.956 0.903 . . . . 73.510000000000005 109.965 -169.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.472 ' NH2' ' HG2' ' A' ' 122' ' ' GLN . 84.5 mtm180 -108.65 108.95 20.02 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.605 -0.887 . . . . 70.129999999999995 108.605 173.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 71.6 t -95.56 117.28 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 121.298 0.571 . . . . 73.299999999999997 110.249 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.695 HD13 ' HB2' ' A' ' 28' ' ' LYS . 48.5 mt -77.16 -28.73 54.25 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.251 1.421 . . . . 73.109999999999999 111.207 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.3 177.51 39.46 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.127 -0.488 . . . . 41.310000000000002 113.016 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.484 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 2.8 m-85 -107.15 168.41 9.23 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.833 0.853 . . . . 72.340000000000003 109.398 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -85.9 151.77 23.51 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 110.018 -0.364 . . . . 72.239999999999995 110.018 170.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.709 ' HB3' ' HG2' ' A' ' 57' ' ' GLU . 18.1 p-80 -57.87 -32.29 67.53 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 113.185 0.809 . . . . 73.439999999999998 113.185 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.722 ' HA ' HD11 ' A' ' 61' ' ' LEU . 67.3 t30 -90.16 3.88 52.1 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.129 0.572 . . . . 72.150000000000006 110.465 -176.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 61.59 31.16 76.77 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 111.03 -0.828 . . . . 73.549999999999997 111.03 -174.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -67.65 -70.45 0.26 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 107.934 -1.136 . . . . 64.319999999999993 107.934 -174.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 50.3 m95 -135.54 178.46 7.02 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 108.337 -0.986 . . . . 72.540000000000006 108.337 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -125.16 117.81 24.71 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.67 0.788 . . . . 63.310000000000002 109.058 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -68.92 108.65 3.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.279 0.632 . . . . 62.340000000000003 109.711 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -117.37 168.23 10.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.634 0.773 . . . . 53.310000000000002 110.784 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.472 ' HG2' ' NH2' ' A' ' 108' ' ' ARG . 61.6 tt0 -149.09 128.09 12.69 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.149 -1.056 . . . . 72.109999999999999 108.149 -177.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.505 HG22 ' HA ' ' A' ' 107' ' ' LEU . 81.6 p -139.31 -174.46 3.87 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.701 0.801 . . . . 72.219999999999999 110.701 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -55.53 -28.87 57.31 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.6 0.76 . . . . 72.530000000000001 111.336 169.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -76.1 -13.3 60.21 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.547 0.739 . . . . 61.219999999999999 111.573 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 132.02 -130.95 6.09 Favored Glycine 0 C--N 1.352 1.462 0 N-CA-C 111.905 -0.478 . . . . 70.450000000000003 111.905 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -150.73 146.58 26.53 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.338 0.655 . . . . 71.209999999999994 110.072 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 166.94 177.79 38.93 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 112.1 -0.4 . . . . 71.519999999999996 112.1 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.438 ' HE1' ' HB2' ' A' ' 24' ' ' LYS . 90.9 m95 -80.62 130.3 35.03 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.589 0.756 . . . . 72.409999999999997 110.887 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.03 151.54 61.65 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 124.286 1.034 . . . . 74.209999999999994 109.767 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.54 132.02 14.28 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 121.748 1.632 . . . . 62.310000000000002 111.636 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.501 ' HA ' HG12 ' A' ' 135' ' ' ILE . 41.8 p -61.58 -22.01 64.82 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.703 0.801 . . . . 71.510000000000005 111.901 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.446 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 43.6 m-20 -68.36 -24.5 64.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.429 1.092 . . . . 61.439999999999998 111.926 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.574 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.1 m-85 -101.7 2.19 38.34 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.593 0.757 . . . . 74.329999999999998 112.153 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.501 HG12 ' HA ' ' A' ' 132' ' ' SER . 16.4 pt -131.21 161.92 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.66 0.384 . . . . 75.340000000000003 110.056 -173.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 11.0 t -151.16 147.92 21.55 Favored Pre-proline 0 N--CA 1.481 1.113 0 N-CA-C 108.593 -0.891 . . . . 75.400000000000006 108.593 170.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.94 150.59 38.68 Favored 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 121.971 1.781 . . . . 64.140000000000001 111.564 172.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.513 HG12 ' H ' ' A' ' 75' ' ' ALA . 15.1 m -131.13 -44.52 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.155 0.582 . . . . 74.010000000000005 111.185 176.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.66 ' HB3' ' H ' ' A' ' 84' ' ' LEU . 58.2 t30 -95.5 17.96 13.66 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.411 1.101 . . . . 75.329999999999998 110.491 177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.406 ' HA ' ' ND2' ' A' ' 83' ' ' ASN . 75.6 p -76.24 168.86 19.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.483 -0.78 . . . . 74.109999999999999 110.677 172.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 63.2 mt -62.98 -15.84 57.48 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 114.957 -1.019 . . . . 73.340000000000003 111.166 172.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.4 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 82.4 tt0 -61.74 -26.77 68.27 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.269 1.428 . . . . 73.310000000000002 112.999 -176.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -67.78 -18.11 64.76 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 122.768 0.427 . . . . 64.140000000000001 110.819 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -82.0 145.05 30.46 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.02 -0.733 . . . . 72.430000000000007 109.02 168.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.3 p -64.3 -19.91 65.73 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 112.884 0.698 . . . . 75.329999999999998 112.884 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.435 ' CE3' HG21 ' A' ' 218' ' ' VAL . 65.3 p-90 -77.72 -37.81 48.59 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 112.445 0.535 . . . . 64.120000000000005 112.445 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.408 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 22.7 t80 -102.22 138.6 38.94 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.143 -0.688 . . . . 71.129999999999995 109.143 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.4 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 22.3 m-70 -129.56 22.37 5.51 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.682 0.393 . . . . 71.439999999999998 111.446 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 62.81 -156.19 40.57 Favored Glycine 0 CA--C 1.536 1.385 0 N-CA-C 115.092 0.797 . . . . 72.209999999999994 115.092 169.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 6.3 Cg_exo -76.37 104.59 1.93 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.391 2.727 . . . . 62.229999999999997 111.044 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.55 160.98 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.293 0.568 . . . . 75.140000000000001 112.02 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 18.2 m -71.26 161.73 30.6 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 114.924 -1.035 . . . . 60.530000000000001 110.916 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -64.02 -32.65 74.28 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.109 0.564 . . . . 73.549999999999997 110.114 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -65.11 -49.72 68.86 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.524 1.129 . . . . 60.509999999999998 110.416 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.02 -43.51 87.45 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.597 0.759 . . . . 73.310000000000002 110.406 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.46 -59.9 4.46 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.387 -1.279 . . . . 53.229999999999997 110.944 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.595 ' HG3' HG11 ' A' ' 190' ' ' VAL . 31.7 tt0 -67.73 -22.73 65.22 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.835 -0.62 . . . . 54.329999999999998 111.281 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -65.42 -56.38 12.83 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.996 0.519 . . . . 75.239999999999995 109.706 173.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.27 -35.91 80.44 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 116.431 -0.349 . . . . 75.209999999999994 111.148 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.657 HD23 HG13 ' A' ' 190' ' ' VAL . 34.4 tp -72.25 -26.72 62.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.013 0.525 . . . . 73.120000000000005 111.66 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.5 t -70.06 -16.28 63.12 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.976 0.51 . . . . 74.409999999999997 111.162 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.3 m -83.07 -17.79 41.94 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.263 0.625 . . . . 72.310000000000002 111.052 170.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.36 -179.64 51.02 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 116.154 -0.475 . . . . 64.420000000000002 113.431 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 6.1 pt -133.37 -166.45 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 125.864 1.666 . . . . 74.109999999999999 110.503 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 24.3 p-10 -60.15 129.95 44.24 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.62 0.368 . . . . 73.219999999999999 111.229 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 81.88 10.03 84.61 Favored Glycine 0 C--O 1.264 1.982 0 CA-C-O 119.997 -0.335 . . . . 51.409999999999997 113.061 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 75.2 m -82.58 141.2 32.76 Favored 'General case' 0 C--N 1.371 1.532 0 N-CA-C 110.086 -0.338 . . . . 74.209999999999994 110.086 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 183' ' ' SER . 16.4 p90 -136.68 161.48 35.8 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.756 0.789 . . . . 64.319999999999993 112.918 178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 79.6 mt -135.13 131.96 37.48 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 114.213 -1.358 . . . . 74.420000000000002 108.04 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.461 HG21 HG22 ' A' ' 218' ' ' VAL . 32.5 t -108.02 130.05 61.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 106.053 -1.832 . . . . 70.129999999999995 106.053 170.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.55 163.48 39.92 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.999 0.52 . . . . 71.0 110.261 -171.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 15.7 pt-20 -117.91 164.49 14.99 Favored 'General case' 0 C--O 1.26 1.625 0 C-N-CA 123.263 0.625 . . . . 64.239999999999995 110.368 172.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.1 m -80.29 146.93 31.37 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.73 -1.123 . . . . 44.32 110.209 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -78.74 -43.46 25.66 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.694 1.197 . . . . 73.319999999999993 110.293 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.476 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 27.3 m -99.29 9.48 43.29 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.531 -1.213 . . . . 74.299999999999997 112.032 -173.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.4 t -147.61 108.73 3.82 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 122.521 0.328 . . . . 63.109999999999999 110.709 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.484 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 68.4 Cg_endo -74.5 135.21 19.78 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 123.003 2.469 . . . . 74.420000000000002 111.551 173.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.71 -25.74 12.67 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 116.172 -0.467 . . . . 52.350000000000001 113.509 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.404 ' OE1' ' HD2' ' A' ' 194' ' ' ARG . 83.3 mm-40 -81.3 116.54 21.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.03 0.915 . . . . 75.239999999999995 109.192 174.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 41.1 mtt-85 -129.41 157.14 42.8 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.099 -1.075 . . . . 72.430000000000007 108.099 -177.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 28.6 m -140.08 144.89 37.05 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 123.225 0.61 . . . . 72.340000000000003 109.825 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 55.3 mt -109.67 143.88 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.021 -1.103 . . . . 70.420000000000002 108.021 165.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.447 ' HB3' HD22 ' A' ' 160' ' ' LEU . 16.8 m -125.37 112.31 16.16 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.375 1.07 . . . . 64.140000000000001 108.349 -174.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.463 HD21 HD23 ' A' ' 232' ' ' LEU . 47.1 mt -102.81 143.38 32.51 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.362 0.665 . . . . 74.150000000000006 111.341 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -122.16 128.11 50.84 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 107.224 -1.398 . . . . 72.230000000000004 107.224 167.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 1.3 t80 -152.48 123.94 7.74 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.066 1.346 . . . . 75.019999999999996 107.991 -171.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 62.49 18.98 10.86 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.905 1.282 . . . . 65.439999999999998 112.33 -172.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.66 1.63 85.27 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-O 120.019 -0.323 . . . . 73.230000000000004 113.099 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -97.34 125.43 41.94 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.071 -0.714 . . . . 75.420000000000002 109.071 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.657 HG13 HD23 ' A' ' 160' ' ' LEU . 73.1 t -98.43 118.77 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.328 1.051 . . . . 74.430000000000007 109.506 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -138.73 140.23 38.64 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.972 0.909 . . . . 55.32 109.389 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -120.19 146.32 46.12 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.779 0.832 . . . . 73.25 109.059 -171.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -139.68 150.03 44.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.974 0.509 . . . . 73.409999999999997 110.478 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 12.4 tpp85 -88.37 132.44 34.43 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.108 -0.951 . . . . 72.439999999999998 111.308 -171.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 68.4 mt -81.45 113.51 20.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 108.159 -1.052 . . . . 74.120000000000005 108.159 164.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -83.78 132.05 34.86 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.375 -0.602 . . . . 65.200000000000003 109.375 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 92.0 m -110.79 116.96 32.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.505 0.722 . . . . 74.049999999999997 109.714 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -68.5 178.42 2.03 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.363 1.065 . . . . 41.32 112.035 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 79.8 p -58.56 -41.48 85.76 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.9 0.88 . . . . 71.439999999999998 113.035 -170.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -79.46 -20.12 48.17 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 116.24 -0.436 . . . . 73.329999999999998 110.67 -175.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 113.37 5.5 22.81 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.013 -0.54 . . . . 53.420000000000002 113.53 -174.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -66.26 142.12 57.79 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.625 0.713 . . . . 53.149999999999999 110.502 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 78.3 mt -103.46 146.13 28.97 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.427 0.691 . . . . 64.310000000000002 109.501 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -165.76 140.61 4.78 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.149 0.579 . . . . 74.230000000000004 110.531 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.4 t -97.91 -38.68 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.316 0.646 . . . . 63.210000000000001 109.722 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 40.7 t -109.05 154.69 21.87 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.614 0.766 . . . . 74.340000000000003 110.96 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.1 m -69.96 -21.13 63.28 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.143 -0.935 . . . . 71.409999999999997 111.04 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -84.64 -6.9 59.39 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.538 0.735 . . . . 72.120000000000005 111.497 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 59.1 m -136.69 147.9 47.06 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.888 0.475 . . . . 64.239999999999995 112.044 -168.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -140.65 134.05 29.86 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.791 1.236 . . . . 75.329999999999998 108.326 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -127.82 132.62 49.43 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.916 0.486 . . . . 74.299999999999997 110.117 -176.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -83.8 -25.02 30.77 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.323 0.649 . . . . 73.439999999999998 110.236 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.613 HG22 ' HA ' ' A' ' 51' ' ' PRO . 71.0 p -128.99 150.31 50.45 Favored 'General case' 0 C--O 1.253 1.263 0 C-N-CA 123.185 0.594 . . . . 75.409999999999997 110.973 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 31.3 tp -69.71 -27.73 65.23 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.407 -0.815 . . . . 63.25 110.047 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.25 -44.92 92.36 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.345 0.658 . . . . 50.340000000000003 110.847 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -75.78 -29.63 58.83 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 116.191 -0.459 . . . . 62.210000000000001 111.377 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tt -58.17 -51.3 70.32 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 123.301 0.375 . . . . 41.030000000000001 110.51 172.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.461 HG22 HG21 ' A' ' 170' ' ' VAL . 94.9 t -69.47 -42.9 81.03 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 CA-C-N 115.41 -0.814 . . . . 73.129999999999995 111.097 -176.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -57.71 -53.93 52.57 Favored 'General case' 0 C--O 1.259 1.568 0 C-N-CA 123.386 0.674 . . . . 74.200000000000003 111.151 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.497 ' O ' HG22 ' A' ' 224' ' ' VAL . 35.9 t-80 -55.65 -54.75 40.31 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 114.846 -1.07 . . . . 75.450000000000003 109.585 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.402 ' HA ' HG22 ' A' ' 224' ' ' VAL . 4.5 m-70 -68.15 -16.54 64.04 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.758 0.651 . . . . 64.140000000000001 112.758 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.451 ' HA ' ' HB2' ' A' ' 232' ' ' LEU . 44.4 t -74.56 -31.32 62.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.564 0.345 . . . . 54.229999999999997 110.243 173.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.4 t -107.56 -12.34 15.29 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 116.501 2.037 . . . . 71.239999999999995 116.501 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 220' ' ' HIS . 27.7 m -105.86 167.2 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 N-CA-C 117.512 2.412 . . . . 71.530000000000001 117.512 -166.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.02 -1.49 58.02 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 130.075 3.35 . . . . 52.439999999999998 113.663 -173.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -77.58 12.77 1.48 Allowed 'General case' 0 CA--C 1.567 1.619 0 C-N-CA 130.532 3.533 . . . . 70.099999999999994 114.031 -136.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.48 16.5 4.63 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 124.95 1.262 . . . . 61.140000000000001 110.58 -170.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 90.6 mt -90.79 123.38 34.31 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.122 1.369 . . . . 70.150000000000006 110.8 173.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 68.5 mt -62.5 -39.54 84.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.795 -0.639 . . . . 73.329999999999998 109.384 170.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 13.9 t -138.44 144.46 40.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.431 -0.951 . . . . 70.299999999999997 108.431 166.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 224' ' ' VAL . 59.6 p -65.68 150.68 48.08 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 109.22 -0.659 . . . . 74.209999999999994 109.22 170.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.463 HD23 HD21 ' A' ' 184' ' ' LEU . 31.4 mt -64.36 100.16 0.34 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 108.044 -1.095 . . . . 74.239999999999995 108.044 176.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -90.23 -53.42 4.47 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 109.619 -0.511 . . . . 65.430000000000007 109.619 -169.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.628 ' O ' ' HA ' ' A' ' 167' ' ' SER . 1.0 OUTLIER -151.8 145.33 17.65 Favored Pre-proline 0 N--CA 1.479 0.983 0 CA-C-N 115.495 -0.775 . . . . 72.209999999999994 110.451 177.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -85.3 158.07 11.09 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 121.626 1.551 . . . . 73.409999999999997 113.809 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.39 128.29 87.59 Favored Pre-proline 0 C--O 1.245 0.842 0 N-CA-C 108.923 -0.769 . . . . 51.200000000000003 108.923 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.93 171.15 18.06 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.482 2.121 . . . . 64.450000000000003 114.185 -167.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -79.02 152.99 30.61 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.265 -1.334 . . . . 62.520000000000003 108.664 172.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.9 mtt180 -49.69 -44.62 48.15 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 123.234 0.614 . . . . 73.049999999999997 111.642 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -86.93 124.06 32.72 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.01 -1.107 . . . . 74.239999999999995 108.01 169.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -67.33 116.65 38.86 Favored Pre-proline 0 CA--C 1.554 1.122 0 O-C-N 123.905 0.753 . . . . 73.140000000000001 110.257 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -89.68 165.6 5.11 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.919 2.413 . . . . 74.310000000000002 112.703 174.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 29.5 m -124.7 93.89 4.03 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.353 0.596 . . . . 74.239999999999995 110.454 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.51 146.66 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.274 1.03 . . . . 74.340000000000003 108.284 171.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -146.93 178.88 8.0 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.863 0.465 . . . . 71.019999999999996 110.575 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 164.19 142.94 3.55 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 111.201 -0.76 . . . . 72.340000000000003 111.201 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 60.1 t -129.58 -67.47 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.373 -0.973 . . . . 73.530000000000001 108.373 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 18.3 t 58.25 80.31 0.29 Allowed Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 124.163 0.985 . . . . 70.540000000000006 109.704 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -59.62 133.92 54.57 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.499 2.799 . . . . 73.129999999999995 113.106 -173.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -74.52 112.38 10.65 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.734 0.814 . . . . 63.030000000000001 111.134 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -103.49 106.03 16.44 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.03 -1.1 . . . . 74.239999999999995 108.03 168.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.08 151.42 43.13 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.692 0.797 . . . . 64.409999999999997 112.668 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -157.15 118.57 3.71 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.553 -0.906 . . . . 71.510000000000005 108.553 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -86.08 -77.5 0.3 Allowed 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.651 -0.87 . . . . 71.299999999999997 108.651 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 CA--C 1.552 1.052 0 C-N-CA 124.576 1.151 . . . . 74.230000000000004 108.103 177.583 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptm . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 110.337 -0.246 . . . . 71.409999999999997 110.337 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.86 -152.99 35.76 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.973 -0.558 . . . . 74.209999999999994 112.599 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -149.35 134.98 18.61 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.473 0.709 . . . . 63.109999999999999 109.658 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -73.06 124.19 90.4 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-O 118.791 -0.623 . . . . 75.349999999999994 109.653 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.82 -15.46 42.81 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.112 2.541 . . . . 73.25 113.755 174.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.52 -118.54 5.94 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 111.038 -0.825 . . . . 55.340000000000003 111.038 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -128.93 137.5 51.44 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.627 0.771 . . . . 54.439999999999998 109.476 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.6 154.21 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.104 0.961 . . . . 43.119999999999997 108.558 174.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -68.91 -10.52 57.62 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.864 0.465 . . . . 75.230000000000004 111.512 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.11 -162.84 20.09 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 115.913 -0.585 . . . . 73.5 111.676 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.43 91.57 2.26 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.736 0.779 . . . . 72.120000000000005 109.811 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -145.81 68.58 1.21 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.946 1.298 . . . . 73.040000000000006 109.072 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 64.43 125.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.684 1.194 . . . . 63.109999999999999 110.804 -174.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 59.07 66.22 2.43 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.137 0.975 . . . . 64.109999999999999 110.198 -171.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -60.36 162.05 18.51 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.375 2.05 . . . . 71.129999999999995 111.825 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.9 p -68.1 167.23 14.46 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.143 0.497 . . . . 74.230000000000004 111.743 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.0 mt -105.76 129.35 24.78 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 123.183 0.593 . . . . 73.519999999999996 109.455 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -73.63 171.62 17.42 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.477 2.118 . . . . 75.040000000000006 111.902 172.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.14 148.87 26.54 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.992 0.517 . . . . 71.329999999999998 111.236 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.647 HD22 HD11 ' A' ' 23' ' ' ILE . 83.6 mt -85.84 95.72 9.53 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.278 -1.008 . . . . 60.210000000000001 108.278 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -97.6 -53.42 3.44 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 120.762 0.315 . . . . 72.129999999999995 110.779 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -106.87 108.39 19.88 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.624 -0.717 . . . . 72.150000000000006 109.378 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.647 HD11 HD22 ' A' ' 20' ' ' LEU . 46.9 mm -124.3 114.07 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.291 0.636 . . . . 72.329999999999998 109.573 176.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.51 ' HE2' ' HG3' ' A' ' 58' ' ' PRO . 20.0 pttp -94.26 70.82 3.81 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 122.514 1.149 . . . . 64.109999999999999 108.509 169.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.45 -17.57 66.66 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 114.592 -1.186 . . . . 43.310000000000002 113.079 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.15 -12.73 20.2 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.048 0.939 . . . . 64.120000000000005 111.322 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.61 52.97 4.52 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-O 121.345 0.414 . . . . 34.140000000000001 112.685 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -111.97 22.97 14.29 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.354 1.062 . . . . 74.510000000000005 110.348 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -89.45 -11.08 44.09 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.218 0.607 . . . . 63.409999999999997 109.949 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 56' ' ' PHE . 25.8 mt-10 -80.05 -13.82 59.01 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.855 1.262 . . . . 55.399999999999999 110.163 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 m -78.3 139.96 38.84 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 124.284 1.034 . . . . 65.439999999999998 111.526 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.9 p -99.67 124.11 44.59 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 107.665 -1.235 . . . . 70.299999999999997 107.665 169.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 74.56 96.94 0.07 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.774 1.23 . . . . 72.209999999999994 108.378 -161.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -153.27 137.93 16.93 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.617 -0.72 . . . . 75.0 109.828 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.51 -59.96 0.01 OUTLIER Glycine 0 C--N 1.34 0.768 0 N-CA-C 110.75 -0.94 . . . . 74.540000000000006 110.75 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.97 -112.5 3.95 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 118.739 -1.034 . . . . 70.340000000000003 112.181 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.77 135.48 38.55 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.922 2.414 . . . . 72.400000000000006 112.503 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -136.29 115.17 12.19 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.484 0.713 . . . . 64.099999999999994 109.396 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.7 p -84.17 178.52 7.78 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.908 0.883 . . . . 75.530000000000001 110.447 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -64.73 104.25 0.8 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.362 0.665 . . . . 64.209999999999994 109.948 175.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.0 t -127.82 125.35 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.718 -1.216 . . . . 73.239999999999995 107.718 175.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -69.81 90.31 0.6 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.6 0.714 . . . . 71.019999999999996 109.571 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -140.49 119.76 11.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 107.305 -1.368 . . . . 72.230000000000004 107.305 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.457 ' HG3' ' CD2' ' A' ' 45' ' ' HIS . 15.2 tp10 -63.99 -48.91 74.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.535 0.734 . . . . 61.229999999999997 111.01 -171.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.457 ' CD2' ' HG3' ' A' ' 44' ' ' GLU . 98.6 m-70 -145.68 137.76 25.43 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.017 0.927 . . . . 75.129999999999995 109.007 175.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -107.6 152.53 24.15 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.603 0.761 . . . . 73.329999999999998 110.65 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.48 72.79 1.5 Allowed 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.757 -1.201 . . . . 65.219999999999999 107.757 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.0 mt -72.63 122.86 22.11 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.75 -0.659 . . . . 61.130000000000003 111.685 -171.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -143.82 -63.14 0.39 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.645 1.178 . . . . 75.340000000000003 108.028 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 59.06 105.1 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 125.386 1.475 . . . . 72.420000000000002 110.883 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.62 122.98 9.7 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.517 2.811 . . . . 60.240000000000002 113.339 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.7 t -58.28 117.9 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.309 0.643 . . . . 75.349999999999994 109.63 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.54 -51.12 68.62 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.39 0.676 . . . . 63.399999999999999 110.125 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.1 p -178.28 160.47 1.34 Allowed 'General case' 0 C--O 1.245 0.868 0 C-N-CA 124.839 1.256 . . . . 63.109999999999999 109.242 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.66 138.5 39.12 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.9 -0.591 . . . . 64.129999999999995 109.963 172.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.42 ' H ' ' HG2' ' A' ' 30' ' ' GLU . 37.5 m-85 -76.46 -8.27 56.81 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.217 0.607 . . . . 73.209999999999994 109.885 169.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 67.17 76.93 0.26 Allowed Pre-proline 0 C--N 1.363 1.171 0 C-N-CA 123.812 0.845 . . . . 75.430000000000007 111.052 165.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.51 ' HG3' ' HE2' ' A' ' 24' ' ' LYS . 32.0 Cg_exo -58.28 96.86 0.08 OUTLIER 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.945 2.43 . . . . 40.130000000000003 111.969 -177.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 114' ' ' HIS . 14.0 mm100 -70.07 153.33 43.31 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.754 -0.657 . . . . 72.329999999999998 110.756 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.24 147.92 19.44 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 123.452 0.47 . . . . 64.200000000000003 112.844 -175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.68 -172.83 2.11 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.215 1.006 . . . . 70.329999999999998 109.472 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.8 p -106.52 129.31 54.49 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.597 0.759 . . . . 62.549999999999997 109.543 174.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.06 160.43 32.49 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.817 0.447 . . . . 62.409999999999997 111.116 174.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.55 151.04 40.78 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.903 0.881 . . . . 51.439999999999998 109.621 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 63.83 26.47 14.35 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.262 1.025 . . . . 63.200000000000003 111.991 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.455 ' HG3' ' HB3' ' A' ' 175' ' ' SER . 0.0 OUTLIER -66.95 98.1 0.53 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.277 1.031 . . . . 74.329999999999998 110.967 -173.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 25.5 t90 -117.7 157.26 26.8 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.021 0.929 . . . . 65.099999999999994 109.66 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 62.46 78.77 0.28 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.704 1.201 . . . . 55.030000000000001 109.957 -173.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.1 m -145.55 86.75 1.76 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-N 115.032 -0.985 . . . . 73.329999999999998 109.607 -173.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -170.13 127.15 0.84 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.84 0.856 . . . . 55.329999999999998 109.461 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -161.27 148.52 15.0 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.078 -0.712 . . . . 74.420000000000002 109.078 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -80.75 96.2 6.87 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.116 0.566 . . . . 70.140000000000001 109.843 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.3 mt -72.84 139.63 47.08 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.038 0.535 . . . . 73.129999999999995 110.043 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 98.3 mt -126.7 87.91 2.74 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.822 0.849 . . . . 72.230000000000004 109.695 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' A' ' 138' ' ' VAL . . . -90.81 137.77 32.11 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.149 0.58 . . . . 65.040000000000006 110.273 173.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -166.11 -83.65 0.05 OUTLIER Glycine 0 C--N 1.346 1.111 0 CA-C-O 119.178 -0.79 . . . . 74.209999999999994 112.251 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.2 122.75 12.08 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 123.518 2.812 . . . . 74.310000000000002 112.999 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.4 m -144.82 125.44 14.11 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.027 0.931 . . . . 74.409999999999997 109.494 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -100.1 -76.13 0.56 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.651 0.38 . . . . 74.120000000000005 111.092 -173.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.417 ' N ' HD22 ' A' ' 80' ' ' ASN . 0.1 OUTLIER -171.47 5.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.642 0.777 . . . . 72.340000000000003 110.902 -171.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.408 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 6.4 p-10 -83.86 173.45 7.34 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 125.385 1.474 . . . . 62.229999999999997 110.456 -174.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 81' ' ' ASP . 55.9 Cg_endo -71.12 -63.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.008 1.806 . . . . 71.239999999999995 113.3 172.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -142.74 99.07 3.4 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.628 0.771 . . . . 62.219999999999999 110.687 -172.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.583 ' H ' ' HB3' ' A' ' 139' ' ' ASN . 24.1 tp -102.62 137.6 40.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.412 0.685 . . . . 63.43 109.483 174.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 8.8 m-85 -120.02 176.52 5.39 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.826 1.651 . . . . 70.439999999999998 108.54 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.12 143.75 21.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 109.057 -0.72 . . . . 75.209999999999994 109.057 169.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.28 113.31 11.35 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.494 0.718 . . . . 64.409999999999997 109.112 172.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.2 mt -79.26 -20.14 48.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.516 0.726 . . . . 62.530000000000001 110.006 171.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.562 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 71.5 m-85 -136.1 151.61 49.98 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.06 0.544 . . . . 74.150000000000006 109.548 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -70.52 141.8 51.9 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.5 -0.773 . . . . 70.239999999999995 110.304 174.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.527 ' HB3' HG12 ' A' ' 101' ' ' ILE . 87.8 t80 -138.67 115.58 10.83 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.461 -0.57 . . . . 75.420000000000002 109.461 174.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.3 t -81.0 134.34 27.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 107.986 -1.116 . . . . 74.5 107.986 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.23 116.64 8.24 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.763 -0.458 . . . . 75.239999999999995 109.763 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.2 p -71.45 -23.87 61.91 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.465 0.706 . . . . 71.400000000000006 110.501 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -162.75 -172.01 29.67 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.273 -0.876 . . . . 75.510000000000005 112.097 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -66.44 -28.8 68.89 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.325 1.05 . . . . 75.439999999999998 110.72 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -75.25 -16.85 60.43 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.292 1.037 . . . . 71.150000000000006 113.019 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.5 p -109.3 158.6 17.71 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.679 0.792 . . . . 72.409999999999997 110.607 -178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 125' ' ' ASN . 66.8 tp -107.88 130.72 54.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.33 0.652 . . . . 74.230000000000004 109.701 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 p -78.12 113.38 16.01 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.308 -0.627 . . . . 62.130000000000003 109.308 172.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 91' ' ' PHE . 34.2 pt -122.22 161.7 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.68 -0.859 . . . . 74.400000000000006 108.68 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 91.7 m -135.4 151.66 50.66 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 109.304 -0.628 . . . . 75.409999999999997 109.304 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -53.37 117.22 2.9 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.224 0.61 . . . . 71.450000000000003 111.089 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.59 -27.5 7.94 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.973 -0.558 . . . . 70.099999999999994 113.218 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -72.25 122.57 21.31 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.31 0.644 . . . . 72.430000000000007 110.323 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -84.31 124.61 31.44 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.935 0.494 . . . . 75.239999999999995 110.27 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 19.7 mt -105.55 135.28 47.23 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.702 0.801 . . . . 73.329999999999998 110.365 -168.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 56.6 mtm180 -95.35 107.53 19.67 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.111 -1.44 . . . . 72.450000000000003 107.111 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.7 t -97.51 124.47 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.987 -0.746 . . . . 72.239999999999995 108.987 -176.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.412 HD13 ' HB2' ' A' ' 30' ' ' GLU . 64.4 mt -70.56 -36.27 73.55 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.529 0.681 . . . . 74.120000000000005 109.58 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.13 178.63 41.76 Favored Glycine 0 C--N 1.336 0.582 0 CA-C-N 114.66 -1.155 . . . . 51.420000000000002 111.357 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 2.4 m-30 -94.99 174.33 7.14 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.785 -0.82 . . . . 72.349999999999994 108.785 177.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -72.33 159.12 34.56 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.612 -0.722 . . . . 71.219999999999999 109.795 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.436 ' HA ' ' O ' ' A' ' 59' ' ' GLN . 47.6 t60 -58.07 -24.81 59.95 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.526 1.13 . . . . 65.430000000000007 111.76 175.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.434 ' HB3' ' HG2' ' A' ' 117' ' ' GLU . 56.5 t30 -95.98 -21.97 17.68 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.924 0.49 . . . . 74.049999999999997 111.144 174.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 88.04 -0.18 83.8 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 122.7 0.191 . . . . 63.210000000000001 113.025 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.434 ' HG2' ' HB3' ' A' ' 115' ' ' ASN . 8.4 pt-20 -57.68 -52.42 65.5 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.008 1.323 . . . . 71.409999999999997 112.081 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -118.58 177.28 4.89 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.28 1.032 . . . . 75.319999999999993 110.12 -177.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -146.93 124.46 11.72 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.649 0.78 . . . . 65.310000000000002 109.411 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -85.24 105.8 16.19 Favored 'General case' 0 C--O 1.249 1.064 0 CA-C-O 121.071 0.462 . . . . 63.420000000000002 110.537 -173.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.11 153.21 20.53 Favored 'General case' 0 C--N 1.346 0.433 0 CA-C-N 115.102 -0.953 . . . . 53.100000000000001 110.086 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -141.8 124.72 16.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.789 0.836 . . . . 71.409999999999997 110.081 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 59.6 p -133.7 -167.3 1.92 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.563 0.745 . . . . 52.340000000000003 110.47 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -58.48 -22.5 55.09 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.539 1.135 . . . . 55.520000000000003 111.116 170.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.457 ' HB2' HD11 ' A' ' 99' ' ' LEU . 53.5 m-20 -84.99 6.11 26.47 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.894 1.278 . . . . 42.299999999999997 111.754 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 100.77 -128.98 9.75 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 111.001 -0.84 . . . . 72.400000000000006 111.001 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -151.53 162.17 41.42 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.53 0.665 . . . . 63.240000000000002 111.736 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 165.23 171.51 31.55 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.777 -0.647 . . . . 35.509999999999998 112.9 170.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.448 ' HZ2' ' HG2' ' A' ' 24' ' ' LYS . 94.7 m95 -79.29 117.55 20.39 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.549 0.74 . . . . 70.209999999999994 110.92 -177.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.2 m -117.58 154.88 50.84 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.373 1.069 . . . . 73.239999999999995 108.564 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.38 131.57 15.24 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 121.557 1.505 . . . . 64.310000000000002 111.152 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.569 ' HA ' HG12 ' A' ' 135' ' ' ILE . 23.9 t -63.53 -14.97 56.46 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.921 0.488 . . . . 63.210000000000001 111.547 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -69.89 -25.46 63.71 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.22 1.008 . . . . 70.530000000000001 111.016 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.562 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 6.5 m-30 -95.58 -3.09 47.07 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.577 0.751 . . . . 74.120000000000005 112.739 -177.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.569 HG12 ' HA ' ' A' ' 132' ' ' SER . 12.6 pt -129.42 161.06 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 118.113 0.415 . . . . 74.219999999999999 110.847 -171.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 10.0 t -145.72 139.24 14.58 Favored Pre-proline 0 N--CA 1.483 1.218 0 C-N-CA 123.075 0.55 . . . . 72.310000000000002 110.045 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.501 ' HB2' ' HB2' ' A' ' 140' ' ' SER . 74.1 Cg_endo -74.52 116.64 4.68 Favored 'Trans proline' 0 C--N 1.375 1.941 0 C-N-CA 122.3 2.0 . . . . 53.149999999999999 111.889 177.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 17.9 m -89.51 -25.76 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.069 0.547 . . . . 63.200000000000003 111.492 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.583 ' HB3' ' H ' ' A' ' 84' ' ' LEU . 65.6 t30 -94.17 18.67 10.45 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-O 122.01 0.91 . . . . 75.310000000000002 110.142 173.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.501 ' HB2' ' HB2' ' A' ' 137' ' ' PRO . 32.3 t -64.84 162.84 15.41 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.445 0.698 . . . . 72.129999999999995 110.515 170.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.6 mt -73.6 -12.11 60.65 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 123.568 0.747 . . . . 75.400000000000006 109.828 173.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.69 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 39.2 tt0 -49.51 -27.65 4.57 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 127.38 2.272 . . . . 75.409999999999997 115.68 -175.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.408 ' H ' ' HD3' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -60.65 -31.04 70.27 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 118.625 0.648 . . . . 71.299999999999997 110.314 177.257 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -79.63 123.59 27.77 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.047 -1.094 . . . . 61.140000000000001 108.047 166.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.0 p -61.11 -10.74 6.76 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.96 1.096 . . . . 73.219999999999999 113.96 -168.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.471 ' CE3' HG21 ' A' ' 218' ' ' VAL . 61.7 p-90 -71.17 -40.58 71.19 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 111.885 0.328 . . . . 72.209999999999994 111.885 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 142' ' ' GLU . 36.1 t80 -97.62 146.78 24.97 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 110.172 -0.307 . . . . 74.129999999999995 110.172 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.69 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 61.6 m-70 -146.06 60.97 1.25 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.001 0.52 . . . . 73.329999999999998 110.687 175.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 57.53 -165.58 6.21 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 116.97 1.548 . . . . 55.509999999999998 116.97 164.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 71.6 Cg_endo -80.09 102.86 1.48 Allowed 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.433 2.756 . . . . 45.539999999999999 112.263 168.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.434 HG21 HH21 ' A' ' 171' ' ' ARG . 21.3 t -139.31 155.36 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.132 0.973 . . . . 72.109999999999999 110.24 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.3 m -89.52 173.03 8.55 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.245 1.018 . . . . 53.439999999999998 113.425 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -62.96 -34.17 76.93 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.646 -1.161 . . . . 53.130000000000003 113.16 -173.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -61.64 -57.93 10.08 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 123.607 0.567 . . . . 75.420000000000002 110.595 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.91 -31.34 71.86 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.4 0.68 . . . . 60.039999999999999 111.017 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.75 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.1 -56.99 14.92 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.365 0.603 . . . . 75.109999999999999 111.255 173.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -71.75 -23.98 61.69 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.249 -0.887 . . . . 74.150000000000006 110.797 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -63.98 -51.79 62.63 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.981 0.912 . . . . 65.409999999999997 110.33 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.56 HD12 HH12 ' A' ' 171' ' ' ARG . 79.2 mt -68.9 -40.89 78.91 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.024 0.44 . . . . 53.43 110.931 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.47 HD23 HG13 ' A' ' 190' ' ' VAL . 34.2 tp -67.09 -22.65 65.82 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.479 -0.782 . . . . 72.040000000000006 112.272 -177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.9 t -58.26 -30.09 66.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.979 0.911 . . . . 63.240000000000002 111.447 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.8 t -88.11 8.5 26.53 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.419 0.687 . . . . 62.229999999999997 111.571 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -100.49 150.6 18.87 Favored Glycine 0 C--N 1.346 1.125 0 O-C-N 122.324 -0.235 . . . . 44.030000000000001 113.481 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 23.6 pt -97.43 -166.32 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.044 0.938 . . . . 74.420000000000002 109.47 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 25.4 p-10 -51.21 118.65 3.38 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.798 0.839 . . . . 53.25 112.619 -176.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.73 14.01 68.63 Favored Glycine 0 C--O 1.257 1.542 0 CA-C-N 116.253 -0.43 . . . . 42.549999999999997 113.768 176.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 63.2 p -70.94 138.78 50.34 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.316 -0.624 . . . . 65.209999999999994 109.316 174.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.415 ' HB3' HD23 ' A' ' 184' ' ' LEU . 18.5 p90 -139.28 156.24 47.19 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.231 0.826 . . . . 71.420000000000002 113.231 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 236' ' ' ALA . 96.8 mt -134.16 134.5 42.22 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.428 -1.26 . . . . 62.420000000000002 108.581 169.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.41 HG22 HG12 ' A' ' 182' ' ' ILE . 25.8 t -114.63 126.98 72.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 107.057 -1.46 . . . . 54.100000000000001 107.057 174.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.75 HH11 ' HA ' ' A' ' 156' ' ' ALA . 0.0 OUTLIER -159.84 150.04 18.65 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.226 0.61 . . . . 65.439999999999998 110.019 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 14.1 pt-20 -94.77 163.96 13.14 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.973 -0.751 . . . . 52.030000000000001 108.973 177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 176' ' ' SER . 35.4 m -87.03 141.12 28.9 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.645 0.26 . . . . 65.439999999999998 111.532 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.55 -37.46 86.2 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.849 0.859 . . . . 73.349999999999994 110.416 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.455 ' HB3' ' HG3' ' A' ' 66' ' ' ARG . 63.0 p -86.07 -10.2 55.37 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.207 -1.36 . . . . 61.340000000000003 112.471 -176.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.522 ' HB2' ' HB2' ' A' ' 173' ' ' SER . 12.0 m -139.28 88.31 13.04 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.338 0.655 . . . . 72.439999999999998 109.533 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.39 124.25 13.48 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.96 2.44 . . . . 75.530000000000001 112.11 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.84 -22.25 29.42 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.868 -0.606 . . . . 71.140000000000001 113.744 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -82.8 117.67 22.85 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 108.878 -0.786 . . . . 75.140000000000001 108.878 176.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 70.1 mtt-85 -111.15 169.07 9.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.137 -0.938 . . . . 73.340000000000003 110.842 -170.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.5 m -152.0 149.75 29.22 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.722 0.809 . . . . 54.240000000000002 110.136 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.41 HG12 HG22 ' A' ' 170' ' ' VAL . 48.7 mt -116.95 139.96 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 108.732 -0.84 . . . . 52.520000000000003 108.732 169.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.417 ' HB3' HD22 ' A' ' 160' ' ' LEU . 18.6 m -118.75 111.64 18.74 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.13 1.372 . . . . 75.120000000000005 107.908 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.467 HD21 HD23 ' A' ' 232' ' ' LEU . 29.9 mt -106.14 137.94 43.2 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.317 1.047 . . . . 75.439999999999998 111.256 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -126.92 126.15 42.76 Favored 'General case' 0 C--O 1.256 1.401 0 N-CA-C 108.656 -0.868 . . . . 74.340000000000003 108.656 170.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.79 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 6.2 p90 -138.35 141.69 39.7 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.143 -1.058 . . . . 73.409999999999997 108.143 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 52.38 23.61 2.55 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 124.104 0.961 . . . . 74.510000000000005 113.547 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 96.82 -11.18 66.34 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 123.05 0.357 . . . . 74.109999999999999 113.576 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -101.98 126.76 48.97 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.751 0.82 . . . . 61.329999999999998 111.149 -173.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.47 HG13 HD23 ' A' ' 160' ' ' LEU . 80.0 t -95.14 142.42 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.199 1.0 . . . . 75.430000000000007 110.461 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.402 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 23.2 p90 -146.41 154.5 41.69 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.325 1.05 . . . . 74.329999999999998 109.431 165.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -128.05 142.39 51.23 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.829 0.852 . . . . 74.549999999999997 108.732 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -141.76 151.55 42.98 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 120.985 0.421 . . . . 71.239999999999995 110.341 174.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -78.95 145.29 34.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.29 -0.868 . . . . 74.5 111.304 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 79.8 mt -89.49 104.23 14.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 N-CA-C 106.754 -1.573 . . . . 62.520000000000003 106.754 161.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -71.22 127.06 31.33 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.193 -0.912 . . . . 74.319999999999993 108.668 -177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 31.8 m -99.52 116.58 31.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.168 0.587 . . . . 73.400000000000006 109.862 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.09 166.61 4.59 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.557 1.143 . . . . 74.549999999999997 111.575 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 55.9 p -62.29 -35.72 79.9 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.153 -0.476 . . . . 74.310000000000002 110.487 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -69.05 -12.77 61.98 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.533 0.733 . . . . 34.420000000000002 111.775 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 96.27 -5.49 65.42 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 116.458 -0.337 . . . . 62.32 112.313 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -62.49 141.93 58.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.561 0.744 . . . . 64.109999999999999 110.798 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 81.4 mt -93.87 144.36 25.51 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.195 -0.669 . . . . 74.150000000000006 109.195 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -162.78 161.49 26.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.094 0.558 . . . . 73.010000000000005 109.891 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 70.7 t -135.54 -55.29 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.375 -0.972 . . . . 74.120000000000005 108.375 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 9.9 m -90.96 169.86 10.54 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.379 0.671 . . . . 63.329999999999998 109.699 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 61.3 m -69.66 -48.22 60.55 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 112.509 0.559 . . . . 43.119999999999997 112.509 -171.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -73.62 -26.41 60.77 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.271 0.629 . . . . 63.530000000000001 110.795 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 58.0 m -67.91 118.19 10.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.234 1.014 . . . . 65.299999999999997 110.684 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -142.48 126.9 17.74 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.432 1.093 . . . . 75.219999999999999 108.324 175.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -135.64 141.26 45.02 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 118.033 0.379 . . . . 62.439999999999998 111.056 -173.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -91.58 -21.72 20.69 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.471 -0.786 . . . . 75.120000000000005 109.94 169.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 48.4 p -127.7 142.46 51.32 Favored 'General case' 0 C--N 1.363 1.185 0 CA-C-O 121.674 0.749 . . . . 74.099999999999994 111.88 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.4 HD11 HG11 ' A' ' 170' ' ' VAL . 30.1 tp -65.57 -28.7 69.34 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.404 -1.271 . . . . 74.200000000000003 110.764 175.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.89 97.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.408 0.683 . . . . 64.25 110.521 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.9 -30.27 63.8 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 122.474 0.31 . . . . 74.510000000000005 111.518 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.0 tt -61.04 -44.0 98.05 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.271 0.357 . . . . 75.310000000000002 110.555 170.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.471 HG21 ' CE3' ' A' ' 146' ' ' TRP . 42.5 t -70.18 -40.07 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.334 0.653 . . . . 53.109999999999999 111.006 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -60.42 -50.81 72.1 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.784 0.802 . . . . 74.439999999999998 110.486 176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.415 ' O ' HG22 ' A' ' 224' ' ' VAL . 49.6 t60 -56.32 -54.65 42.95 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.285 -1.325 . . . . 73.340000000000003 110.335 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -63.52 -25.18 68.14 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.137 0.575 . . . . 75.409999999999997 112.141 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 23.0 t -74.61 -28.2 60.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.272 0.229 . . . . 44.539999999999999 110.994 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.8 t -103.9 -22.49 13.49 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.021 1.86 . . . . 63.100000000000001 116.021 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 220' ' ' HIS . 29.0 m -90.83 120.42 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-N 120.495 1.498 . . . . 74.439999999999998 114.344 -165.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.2 -1.32 9.87 Favored 'General case' 0 CA--C 1.57 1.715 0 C-N-CA 127.783 2.433 . . . . 73.340000000000003 112.745 171.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.19 14.72 1.1 Allowed 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 128.142 2.577 . . . . 65.409999999999997 114.311 -145.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.76 17.23 4.28 Favored Glycine 0 N--CA 1.467 0.755 0 O-C-N 121.805 -0.559 . . . . 64.530000000000001 111.926 -166.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 64.2 mt -91.36 133.73 35.2 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.045 -0.724 . . . . 74.209999999999994 109.045 156.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.402 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 93.4 mt -57.91 -52.48 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 109.233 -0.655 . . . . 74.540000000000006 109.233 172.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.3 t -130.52 150.35 51.77 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.944 -1.026 . . . . 72.439999999999998 108.282 167.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 69.8 p -80.02 170.6 16.24 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 109.05 -0.722 . . . . 75.019999999999996 109.05 171.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.467 HD23 HD21 ' A' ' 184' ' ' LEU . 26.2 mt -74.88 102.59 4.8 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 108.896 -0.779 . . . . 64.299999999999997 108.896 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -78.64 -57.62 3.67 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 109.16 -0.682 . . . . 75.510000000000005 109.16 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 167' ' ' SER . 7.3 p90 -154.8 151.17 22.8 Favored Pre-proline 0 N--CA 1.483 1.184 0 N-CA-C 109.832 -0.433 . . . . 72.329999999999998 109.832 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.82 138.52 44.98 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.105 1.87 . . . . 72.310000000000002 111.578 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.472 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -58.83 127.06 82.45 Favored Pre-proline 0 C--O 1.245 0.854 0 N-CA-C 109.231 -0.655 . . . . 64.549999999999997 109.231 173.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -60.06 158.69 28.82 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.853 2.368 . . . . 64.219999999999999 113.281 -172.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -63.49 141.6 58.7 Favored 'General case' 0 C--N 1.348 0.511 0 N-CA-C 109.052 -0.722 . . . . 61.229999999999997 109.052 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -46.3 -33.93 4.12 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.975 1.31 . . . . 74.019999999999996 112.748 -174.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -56.49 -66.12 0.49 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 124.119 0.968 . . . . 71.129999999999995 110.371 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -175.67 160.34 2.05 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 123.73 0.812 . . . . 63.329999999999998 111.168 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.95 -178.81 4.79 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.925 2.416 . . . . 71.530000000000001 112.811 167.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 41.4 p -105.29 -72.81 0.7 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.552 0.741 . . . . 52.409999999999997 109.76 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 18.4 m -138.77 152.8 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 124.504 1.122 . . . . 52.119999999999997 110.204 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -99.54 -57.21 2.2 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.997 0.519 . . . . 64.420000000000002 109.993 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 144.94 -178.16 22.92 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-O 119.973 -0.348 . . . . 74.239999999999995 113.116 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.9 m -130.74 143.49 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 117.348 0.574 . . . . 73.019999999999996 111.622 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.0 m -88.47 120.35 70.34 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.003 0.921 . . . . 71.230000000000004 109.452 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.93 132.68 46.17 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.931 2.42 . . . . 75.129999999999995 112.803 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -80.85 162.66 23.89 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.932 0.493 . . . . 74.040000000000006 110.79 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -157.47 159.15 36.97 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.68 0.792 . . . . 71.200000000000003 110.479 -173.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -90.23 118.08 29.47 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.786 -0.82 . . . . 63.530000000000001 108.786 171.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.82 141.31 56.52 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.699 0.4 . . . . 61.130000000000003 110.858 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -70.8 164.77 24.53 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.191 0.596 . . . . 70.140000000000001 110.942 178.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 . . . . . 0 CA--C 1.561 1.394 0 C-N-CA 125.158 1.383 . . . . 72.019999999999996 111.848 174.343 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtm . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 109.348 -0.612 . . . . 72.420000000000002 109.348 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.24 68.72 1.1 Allowed Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.323 -0.711 . . . . 54.409999999999997 111.323 -177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -70.64 -68.68 0.41 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.264 0.626 . . . . 74.409999999999997 109.812 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 65.48 129.43 0.03 OUTLIER Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 125.161 1.384 . . . . 52.310000000000002 110.896 -171.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -61.46 -31.46 87.96 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.701 2.268 . . . . 50.210000000000001 111.878 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.33 -175.86 50.69 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.552 -0.749 . . . . 74.120000000000005 113.168 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' HD2' ' HA ' ' A' ' 68' ' ' ASN . 23.1 ttpp -88.89 148.88 23.61 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.921 -0.77 . . . . 74.310000000000002 108.921 173.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.7 m -70.93 158.42 6.21 Favored 'Isoleucine or valine' 0 C--O 1.248 0.983 0 CA-C-O 121.011 0.434 . . . . 61.420000000000002 110.682 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.1 tp -63.17 131.47 48.57 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.063 -0.972 . . . . 72.409999999999997 111.175 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.544 ' HA2' HD21 ' A' ' 68' ' ' ASN . . . -100.84 49.81 1.06 Allowed Glycine 0 C--N 1.345 1.044 0 CA-C-N 115.999 -0.546 . . . . 71.209999999999994 111.746 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -136.89 174.45 10.6 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.706 0.802 . . . . 55.109999999999999 111.146 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -79.73 179.78 7.34 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.611 -1.177 . . . . 73.25 111.603 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.3 ttm105 61.84 83.59 0.15 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.887 1.275 . . . . 73.329999999999998 110.721 -176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 46.25 77.96 0.43 Allowed Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 114.435 1.272 . . . . 74.120000000000005 114.435 177.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.64 165.81 31.39 Favored 'Trans proline' 0 C--N 1.365 1.411 0 C-N-CA 121.752 1.634 . . . . 64.420000000000002 109.689 161.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.8 m -66.13 169.23 7.27 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.29 0.566 . . . . 64.230000000000004 111.801 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.9 mt -103.32 124.63 37.57 Favored Pre-proline 0 C--O 1.242 0.658 0 N-CA-C 108.1 -1.074 . . . . 64.25 108.1 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.02 168.62 21.37 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.289 1.993 . . . . 62.020000000000003 111.244 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' HB3' ' NE2' ' A' ' 21' ' ' HIS . . . -83.03 148.22 27.68 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.773 0.32 . . . . 74.140000000000001 110.446 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.559 HD22 HD11 ' A' ' 23' ' ' ILE . 73.6 mt -84.58 94.77 8.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.86 -1.163 . . . . 63.43 107.86 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.423 ' NE2' ' HB3' ' A' ' 19' ' ' ALA . 34.1 m170 -96.24 -50.12 4.93 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.684 -0.689 . . . . 73.409999999999997 110.522 -174.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.488 ' HB2' ' OD1' ' A' ' 113' ' ' ASN . 73.8 m-85 -102.76 107.35 18.19 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.875 -0.787 . . . . 75.010000000000005 108.875 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.559 HD11 HD22 ' A' ' 20' ' ' LEU . 45.4 mm -122.6 114.05 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 108.034 -1.098 . . . . 73.209999999999994 108.034 175.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 21.09 15.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.346 0.658 . . . . 75.310000000000002 110.161 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.85 -91.6 0.27 Allowed Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.21 -0.905 . . . . 64.340000000000003 111.32 -175.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -166.44 -23.21 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.22 1.008 . . . . 74.439999999999998 111.073 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.45 -168.14 53.6 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.379 0.425 . . . . 74.540000000000006 112.682 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -96.85 104.49 16.5 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.465 -0.939 . . . . 61.310000000000002 108.465 170.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.54 ' HD3' ' H ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -135.07 160.0 39.74 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.271 1.028 . . . . 71.340000000000003 109.505 -172.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -151.04 149.1 29.14 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.547 0.739 . . . . 71.430000000000007 109.554 174.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.0 t -153.73 93.56 1.68 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.349 -0.982 . . . . 61.25 108.349 176.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 p -90.04 79.85 6.46 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.821 0.848 . . . . 71.310000000000002 110.384 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.419 ' HG2' ' HD2' ' A' ' 82' ' ' PRO . 5.4 mpt_? -119.46 -156.88 0.68 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.112 0.965 . . . . 70.439999999999998 109.796 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.404 ' H ' ' HB3' ' A' ' 33' ' ' ARG . 11.5 p80 -61.39 124.62 21.12 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.2 0.6 . . . . 65.319999999999993 111.255 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.47 163.61 19.18 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.832 -0.907 . . . . 71.049999999999997 110.832 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.67 -75.76 0.41 Allowed Glycine 0 C--N 1.344 0.998 0 CA-C-O 118.643 -1.087 . . . . 40.25 112.688 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HD3' HG11 ' A' ' 43' ' ' VAL . 11.8 Cg_endo -51.93 108.96 0.28 Allowed 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 123.992 3.128 . . . . 55.409999999999997 114.473 -172.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.485 ' HB2' ' HE2' ' A' ' 124' ' ' LYS . 14.4 t-160 -158.81 10.35 0.14 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.104 1.361 . . . . 74.439999999999998 109.304 174.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 19.9 t -158.51 156.52 30.38 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.834 0.854 . . . . 72.239999999999995 109.05 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -75.84 87.84 2.85 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.249 0.547 . . . . 54.130000000000003 110.005 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.5 p -153.37 148.88 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.114 0.966 . . . . 71.099999999999994 109.199 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -58.97 110.96 1.14 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.65 0.78 . . . . 65.109999999999999 110.777 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.429 HG11 ' HD3' ' A' ' 37' ' ' PRO . 41.8 t -89.86 116.07 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.916 -0.772 . . . . 75.430000000000007 108.916 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -94.3 -37.71 11.37 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.101 0.56 . . . . 63.329999999999998 111.772 -175.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 29.8 m170 59.83 22.12 11.04 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 124.073 0.949 . . . . 70.400000000000006 111.572 -172.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.45 139.65 47.84 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.765 -0.652 . . . . 62.420000000000002 110.253 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.22 148.44 11.46 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.77 0.828 . . . . 44.409999999999997 109.568 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.6 mt -116.61 111.45 19.9 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.289 -1.004 . . . . 33.32 108.289 177.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -65.59 135.67 55.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.008 0.523 . . . . 74.25 110.245 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -78.18 120.72 82.26 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.589 0.756 . . . . 72.439999999999998 109.132 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.37 -21.12 12.89 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 123.967 3.111 . . . . 65.25 115.031 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.41 -56.06 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 109.156 -0.683 . . . . 72.439999999999998 109.156 172.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 52.25 31.14 8.81 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.527 1.131 . . . . 71.420000000000002 112.198 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.3 t -155.46 162.7 40.68 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.353 1.061 . . . . 65.010000000000005 109.036 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -144.85 160.42 41.31 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.262 0.625 . . . . 75.030000000000001 109.595 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -59.65 -36.01 75.56 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.025 0.93 . . . . 73.310000000000002 111.429 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.253 5.0 pt-20 53.59 73.38 0.93 Allowed Pre-proline 0 N--CA 1.485 1.295 0 C-N-CA 125.883 1.673 . . . . 74.239999999999995 112.27 175.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.39 86.57 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.932 2.422 . . . . 65.329999999999998 111.979 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -86.85 175.9 7.96 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.166 -0.924 . . . . 73.519999999999996 111.605 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.56 157.46 30.11 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 115.695 -0.684 . . . . 75.010000000000005 113.566 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.6 mt -116.38 -50.5 2.64 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.863 0.865 . . . . 73.040000000000006 109.953 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.8 p -172.74 71.46 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.632 0.773 . . . . 72.450000000000003 109.808 -174.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.21 140.1 26.34 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.885 0.874 . . . . 75.140000000000001 109.826 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -169.73 73.51 0.08 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.172 0.989 . . . . 70.200000000000003 109.401 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.22 95.88 5.08 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.862 -1.162 . . . . 71.430000000000007 107.862 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -72.55 81.04 1.08 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.656 0.782 . . . . 75.400000000000006 111.031 -165.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.454 ' H ' ' HE3' ' A' ' 67' ' ' TRP . 4.1 p90 -59.45 -38.17 80.05 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.692 1.197 . . . . 75.040000000000006 111.197 -177.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.553 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 56.9 t30 -168.87 137.07 2.03 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.753 0.821 . . . . 74.530000000000001 109.65 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.4 t -159.61 125.67 4.32 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 108.029 -1.1 . . . . 75.310000000000002 108.029 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.407 ' HB3' ' HA3' ' A' ' 10' ' ' GLY . 61.5 tttm -161.47 -59.03 0.05 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.365 0.666 . . . . 70.040000000000006 110.39 -176.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -167.78 164.22 14.2 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.458 0.703 . . . . 63.240000000000002 110.443 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -156.26 147.87 22.76 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.686 0.794 . . . . 60.310000000000002 109.977 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.9 mt -124.24 92.36 3.65 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.01 0.924 . . . . 70.299999999999997 108.706 176.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 79.1 mt -93.46 125.34 38.02 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.183 0.593 . . . . 72.140000000000001 109.676 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.85 169.68 19.97 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.795 0.838 . . . . 52.130000000000003 111.016 -178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.468 ' HA3' HG12 ' A' ' 138' ' ' VAL . . . 142.28 160.38 8.32 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.524 -0.762 . . . . 75.439999999999998 112.418 175.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.96 137.29 17.37 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 123.022 2.481 . . . . 71.019999999999996 111.46 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.689 ' HB2' ' HG3' ' A' ' 143' ' ' LYS . 7.9 t -68.0 95.31 0.54 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.057 0.543 . . . . 74.219999999999999 109.861 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.59 ' HB2' HD23 ' A' ' 84' ' ' LEU . 41.3 mt-10 -102.71 170.24 8.13 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.791 0.837 . . . . 65.209999999999994 110.985 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -94.67 96.08 9.18 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.245 0.618 . . . . 74.439999999999998 111.44 -169.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.828 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 13.9 t70 179.08 129.96 0.23 Allowed Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 125.572 1.549 . . . . 61.450000000000003 107.552 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.419 ' HD2' ' HG2' ' A' ' 33' ' ' ARG . 9.6 Cg_endo -46.03 -47.56 14.22 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 124.239 3.293 . . . . 73.099999999999994 114.025 -168.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -135.48 67.07 1.49 Allowed 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.086 -1.079 . . . . 62.240000000000002 108.086 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.828 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 18.0 tp -85.83 114.53 22.84 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 121.275 0.559 . . . . 75.510000000000005 109.526 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 5.1 m-85 -104.8 175.09 5.61 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.777 1.631 . . . . 70.0 109.401 173.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.93 142.73 31.51 Favored 'Isoleucine or valine' 0 C--O 1.251 1.133 0 N-CA-C 108.073 -1.084 . . . . 65.140000000000001 108.073 169.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.466 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -77.42 117.65 19.1 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.548 0.53 . . . . 71.340000000000003 109.814 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.2 mt -80.67 -11.11 59.68 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.269 0.628 . . . . 63.43 111.284 175.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.434 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 54.1 m-85 -138.79 156.64 47.18 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.911 0.884 . . . . 74.25 109.025 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.84 130.88 35.29 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 108.066 -1.087 . . . . 65.340000000000003 108.066 168.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -141.0 124.1 16.41 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.563 -0.902 . . . . 74.409999999999997 108.563 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.31 138.95 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.037 -0.727 . . . . 75.340000000000003 109.037 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.02 133.89 56.49 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.297 0.639 . . . . 52.509999999999998 111.743 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.5 t -81.01 -6.17 58.47 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.355 1.062 . . . . 61.43 110.855 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.33 -162.11 35.91 Favored Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.649 -0.58 . . . . 54.310000000000002 111.649 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.52 -34.21 76.65 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.302 1.041 . . . . 51.310000000000002 111.084 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.474 ' ND2' HD13 ' A' ' 20' ' ' LEU . 30.0 p-10 -82.53 9.96 8.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.047 0.939 . . . . 74.349999999999994 112.59 -177.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.1 p -135.49 153.96 51.56 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.335 1.054 . . . . 75.099999999999994 108.833 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.0 tp -110.25 135.7 50.59 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.869 0.468 . . . . 73.439999999999998 110.463 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.4 m -78.54 114.56 17.56 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.404 -0.962 . . . . 72.129999999999995 108.404 169.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.5 pt -118.87 144.72 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.611 0.765 . . . . 71.430000000000007 109.3 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.407 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 4.8 m -107.78 146.29 32.39 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.351 -0.611 . . . . 74.329999999999998 109.351 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -63.42 109.11 1.5 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.735 0.414 . . . . 53.450000000000003 110.995 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.73 1.69 34.56 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 116.064 -0.516 . . . . 31.120000000000001 112.748 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.62 136.36 33.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.326 1.05 . . . . 43.0 110.181 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.547 ' HB3' HD11 ' A' ' 84' ' ' LEU . 66.4 mttm -82.8 112.99 20.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.832 0.853 . . . . 65.5 109.55 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 87' ' ' ALA . 16.8 mt -100.72 138.05 38.3 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.781 0.832 . . . . 71.230000000000004 108.925 -173.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.2 mtm180 -108.59 107.32 17.77 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.139 -1.06 . . . . 70.109999999999999 108.139 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 88.1 t -100.14 129.88 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.422 0.689 . . . . 54.210000000000001 109.221 -173.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.4 mt -85.1 -22.82 28.74 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.7 0.4 . . . . 65.519999999999996 110.844 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.73 174.88 37.1 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.779 -0.646 . . . . 73.129999999999995 111.839 177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 13.4 m-30 -94.84 174.92 6.86 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.267 0.627 . . . . 75.200000000000003 109.633 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.488 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 57.4 t30 -62.03 159.5 14.27 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.494 1.118 . . . . 71.150000000000006 109.572 173.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -65.91 -18.26 65.22 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 122.487 0.315 . . . . 73.099999999999994 110.696 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -111.44 5.89 19.91 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 123.555 0.742 . . . . 72.019999999999996 111.398 171.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.87 2.87 53.6 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 115.427 0.931 . . . . 72.310000000000002 115.427 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -60.67 -59.05 6.01 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.345 1.058 . . . . 65.409999999999997 110.907 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -104.49 179.34 4.3 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.142 -1.39 . . . . 73.340000000000003 109.55 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -150.89 121.46 7.44 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.996 0.918 . . . . 70.5 109.376 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.406 ' HG2' HE21 ' A' ' 127' ' ' GLN . 36.4 tt0 -75.75 100.33 4.68 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-O 120.985 0.421 . . . . 73.019999999999996 110.207 -176.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -103.86 157.41 17.11 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.944 0.898 . . . . 73.340000000000003 110.242 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -142.92 126.78 17.17 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.86 0.864 . . . . 74.530000000000001 109.471 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.2 p -136.1 -171.61 2.92 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.49 1.116 . . . . 62.130000000000003 109.686 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.485 ' HE2' ' HB2' ' A' ' 38' ' ' HIS . 27.3 mtpp -70.01 -7.3 39.79 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.363 0.665 . . . . 73.129999999999995 111.504 175.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -84.61 -13.19 52.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.116 0.967 . . . . 75.5 111.316 173.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 128.07 -142.36 13.45 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.853 -0.499 . . . . 52.229999999999997 111.853 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.406 HE21 ' HG2' ' A' ' 120' ' ' GLU . 55.2 tt0 -151.69 145.68 25.22 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.376 0.67 . . . . 72.329999999999998 110.833 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 173.58 179.01 43.96 Favored Glycine 0 C--N 1.34 0.757 0 CA-C-N 115.442 -0.799 . . . . 73.120000000000005 111.717 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -82.07 123.37 28.88 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.693 0.797 . . . . 73.349999999999994 110.433 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.88 148.32 41.87 Favored Pre-proline 0 N--CA 1.477 0.897 0 C-N-CA 124.738 1.215 . . . . 71.010000000000005 109.025 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.95 130.69 25.08 Favored 'Trans proline' 0 C--N 1.372 1.764 0 C-N-CA 121.871 1.714 . . . . 54.25 111.008 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.1 m -61.42 -19.37 61.86 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.942 0.897 . . . . 63.43 112.698 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -72.97 -21.39 60.86 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.941 0.896 . . . . 61.240000000000002 111.537 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.434 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.1 m-85 -94.36 -3.99 49.33 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.566 0.746 . . . . 64.310000000000002 112.608 -175.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.4 pt -128.36 151.74 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.039 0.536 . . . . 75.129999999999995 110.525 -171.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 8.2 t -141.28 133.54 13.97 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 122.602 0.361 . . . . 44.25 110.637 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 59.2 Cg_endo -72.43 117.78 5.29 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.522 2.148 . . . . 70.120000000000005 112.116 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.468 HG12 ' HA3' ' A' ' 76' ' ' GLY . 22.9 m -80.22 -36.92 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.158 0.583 . . . . 73.409999999999997 110.11 176.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -73.43 -9.76 59.02 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.365 0.666 . . . . 72.239999999999995 111.295 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 143' ' ' LYS . 28.6 t -39.16 129.28 1.69 Allowed 'General case' 0 C--N 1.363 1.174 0 C-N-CA 125.281 1.433 . . . . 73.200000000000003 112.447 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 72.0 mt -60.82 -10.07 5.01 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.482 0.713 . . . . 61.0 111.591 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -57.1 -19.59 20.52 Favored 'General case' 0 C--N 1.365 1.246 0 C-N-CA 124.732 1.213 . . . . 74.420000000000002 112.634 173.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.689 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 2.4 mmmp? -61.09 -24.99 66.64 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-O 121.164 0.506 . . . . 73.099999999999994 110.243 171.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -94.0 120.74 34.68 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 106.371 -1.714 . . . . 74.25 106.371 163.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.5 t -57.32 -17.42 12.15 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.257 1.206 . . . . 73.019999999999996 114.257 -166.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.503 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 51.2 p-90 -66.74 -50.43 62.8 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.689 0.626 . . . . 62.539999999999999 112.689 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.427 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 75.7 t80 -79.42 148.0 32.11 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.898 0.479 . . . . 75.200000000000003 110.426 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.45 ' CD2' HD22 ' A' ' 169' ' ' LEU . 87.9 m-70 -135.85 -27.16 1.15 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.203 0.601 . . . . 73.120000000000005 110.47 171.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 100.15 -151.28 19.11 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-O 119.139 -0.812 . . . . 73.400000000000006 114.609 171.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 33.6 Cg_endo -63.04 89.47 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.273 2.649 . . . . 72.049999999999997 110.781 175.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 86.9 t -130.43 149.56 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 115.708 -0.678 . . . . 71.400000000000006 110.244 -170.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.6 m -60.91 148.63 39.02 Favored 'General case' 0 C--O 1.246 0.921 0 C-N-CA 124.744 1.217 . . . . 71.400000000000006 112.333 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 41.0 ttt-85 -57.16 -39.35 75.1 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.451 -0.795 . . . . 55.020000000000003 110.033 172.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -60.27 -58.59 7.87 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 114.735 -1.121 . . . . 41.520000000000003 110.554 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -56.72 -39.08 73.26 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.035 0.835 . . . . 63.210000000000001 111.328 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.06 -61.54 2.56 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.362 -0.835 . . . . 63.299999999999997 111.776 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -70.5 -20.0 62.88 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.245 -0.889 . . . . 75.0 110.805 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.481 ' HE2' HH21 ' A' ' 239' ' ' ARG . 50.6 t80 -74.11 -51.29 16.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.701 0.8 . . . . 74.540000000000006 110.691 176.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 71.1 mt -63.8 -39.44 94.25 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.111 0.482 . . . . 74.340000000000003 109.892 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.435 HD23 HG13 ' A' ' 190' ' ' VAL . 27.4 tp -72.34 -18.61 61.75 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.142 -0.936 . . . . 63.409999999999997 111.197 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.492 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 17.3 t -67.17 -23.13 65.74 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.934 0.494 . . . . 73.430000000000007 110.902 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.1 t -91.12 8.63 34.64 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.89 0.876 . . . . 75.209999999999994 110.52 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.21 159.64 30.07 Favored Glycine 0 C--N 1.343 0.958 0 C-N-CA 123.088 0.375 . . . . 73.409999999999997 112.67 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 18.9 pt -126.09 -165.24 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 C-N-CA 124.184 0.994 . . . . 74.219999999999999 110.424 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 14.0 p-10 -56.86 99.66 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.815 1.043 . . . . 71.120000000000005 113.815 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 103.65 13.54 27.67 Favored Glycine 0 C--O 1.259 1.696 0 CA-C-N 116.162 -0.472 . . . . 63.530000000000001 112.818 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 23.0 t -77.65 136.47 38.22 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.854 -0.424 . . . . 63.509999999999998 109.854 -177.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.472 ' HB3' HD23 ' A' ' 184' ' ' LEU . 17.1 p90 -139.49 159.87 41.16 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.125 0.787 . . . . 75.219999999999999 113.125 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 236' ' ' ALA . 95.4 mt -137.61 134.4 35.5 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.33 1.052 . . . . 71.109999999999999 108.578 170.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 43.9 t -109.68 124.62 66.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 108.685 -0.857 . . . . 71.040000000000006 108.685 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.8 mtp-105 -142.81 168.38 19.86 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.936 0.894 . . . . 71.030000000000001 111.03 -174.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.794 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 2.9 pt-20 -120.46 166.1 14.05 Favored 'General case' 0 C--O 1.26 1.645 0 C-N-CA 124.547 1.139 . . . . 65.329999999999998 110.679 159.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.2 m -74.61 146.3 42.59 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.339 -1.3 . . . . 52.109999999999999 110.505 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -68.9 -43.16 75.8 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.67 0.788 . . . . 71.519999999999996 111.105 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.2 m -84.66 -43.91 13.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.483 -0.78 . . . . 62.32 111.709 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.6 t -112.56 97.09 39.25 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 109.289 -0.634 . . . . 44.420000000000002 109.289 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -69.18 147.17 65.98 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.074 2.516 . . . . 71.319999999999993 111.593 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.52 -23.85 8.14 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 116.329 -0.396 . . . . 41.32 112.996 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -80.69 116.12 20.54 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 107.127 -1.434 . . . . 73.109999999999999 107.127 170.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.794 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 83.7 mtt85 -122.45 166.48 14.69 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.13 0.572 . . . . 64.019999999999996 111.228 -168.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 65.4 m -151.84 138.03 18.35 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.235 1.014 . . . . 71.409999999999997 109.838 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 63.0 mt -105.17 140.37 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 107.849 -1.167 . . . . 71.120000000000005 107.849 165.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 15.5 m -116.29 113.6 23.2 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.384 1.074 . . . . 73.329999999999998 108.388 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.489 HD21 HD23 ' A' ' 232' ' ' LEU . 39.5 mt -104.3 144.01 32.2 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.153 0.981 . . . . 63.439999999999998 111.301 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.492 ' NH1' ' HA ' ' A' ' 161' ' ' SER . 21.1 ttt180 -134.48 138.16 44.5 Favored 'General case' 0 C--O 1.25 1.132 0 CA-C-N 114.637 -1.165 . . . . 74.310000000000002 110.03 172.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 10.2 p90 -157.71 139.18 13.73 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.838 -1.074 . . . . 71.219999999999999 108.108 171.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 54.49 31.37 14.65 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.583 1.153 . . . . 74.439999999999998 113.537 175.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.73 9.53 86.26 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.343 -0.39 . . . . 74.420000000000002 113.817 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 28.7 tpt180 -102.9 127.09 50.24 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.501 1.12 . . . . 73.099999999999994 109.411 175.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.435 HG13 HD23 ' A' ' 160' ' ' LEU . 94.9 t -114.08 129.85 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.78 1.232 . . . . 73.010000000000005 108.971 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.407 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 22.5 p90 -145.36 160.73 41.09 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.051 0.941 . . . . 74.329999999999998 109.061 174.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 37.6 m-70 -134.42 148.27 50.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.104 0.962 . . . . 75.219999999999999 108.506 -171.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -145.29 145.67 31.34 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.68 0.392 . . . . 71.25 110.867 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -76.82 146.31 37.87 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.375 1.07 . . . . 75.450000000000003 112.149 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.763 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 64.3 mt -104.52 119.18 53.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 N-CA-C 107.393 -1.336 . . . . 74.409999999999997 107.393 163.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -91.02 145.04 25.03 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 109.637 -0.505 . . . . 70.540000000000006 109.637 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 18.1 m -106.02 128.07 53.59 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.969 0.908 . . . . 72.340000000000003 109.449 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 202' ' ' LYS . . . -85.37 158.66 20.19 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.709 0.803 . . . . 73.340000000000003 109.432 170.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 15.8 t -65.6 -9.64 28.59 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.842 1.053 . . . . 63.210000000000001 113.842 -169.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.42 ' HB2' ' HG3' ' A' ' 202' ' ' LYS . 80.9 m-20 -87.46 11.73 13.99 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.117 0.567 . . . . 73.450000000000003 111.833 175.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 75.2 12.48 83.47 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 111.954 -0.458 . . . . 71.409999999999997 111.954 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.639 ' HB2' ' HB3' ' A' ' 198' ' ' ALA . 98.4 mttt -79.65 153.33 29.44 Favored 'General case' 0 C--O 1.218 -0.59 0 C-N-CA 123.88 0.872 . . . . 65.109999999999999 110.441 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 90.5 mt -118.37 148.14 42.82 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.342 0.657 . . . . 73.219999999999999 109.41 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -162.91 154.99 18.33 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.193 0.597 . . . . 72.040000000000006 109.981 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 79.2 t -125.01 -63.59 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.09 -1.078 . . . . 51.43 108.09 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.4 t -113.02 -175.54 2.69 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.15 -0.932 . . . . 74.129999999999995 110.035 -174.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 49.9 m -62.33 -47.8 82.62 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.45 1.1 . . . . 64.310000000000002 112.979 -170.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -85.57 3.17 41.85 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 122.182 0.193 . . . . 70.129999999999995 111.124 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 73.0 m -98.81 106.41 18.67 Favored 'General case' 0 C--O 1.215 -0.732 0 C-N-CA 123.608 0.763 . . . . 74.120000000000005 109.97 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -143.31 118.37 10.07 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.842 1.257 . . . . 64.239999999999995 107.685 171.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -134.99 154.93 51.56 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.073 0.549 . . . . 74.049999999999997 110.659 -170.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -91.53 -31.39 15.96 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 123.677 0.611 . . . . 65.310000000000002 109.907 169.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.413 ' OG1' ' HG2' ' A' ' 216' ' ' GLU . 48.5 p -131.14 157.92 41.86 Favored 'General case' 0 C--O 1.253 1.289 0 CA-C-O 122.324 1.059 . . . . 64.109999999999999 112.104 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.419 ' O ' HG23 ' A' ' 218' ' ' VAL . 23.1 tp -72.78 -27.92 62.29 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 113.765 -1.561 . . . . 72.140000000000001 111.396 -176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.84 -43.27 93.56 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.878 0.471 . . . . 74.439999999999998 110.521 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.413 ' HG2' ' OG1' ' A' ' 213' ' ' THR . 21.0 mm-40 -68.9 -35.04 76.38 Favored 'General case' 0 C--O 1.246 0.889 0 CA-C-N 115.768 -0.651 . . . . 72.230000000000004 110.146 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tt -55.78 -50.01 71.6 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 123.951 0.782 . . . . 64.150000000000006 110.91 171.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 214' ' ' LEU . 55.4 t -63.8 -45.75 96.3 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.547 0 O-C-N 123.956 0.785 . . . . 63.299999999999997 111.055 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -58.01 -53.32 59.59 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.581 0.705 . . . . 71.409999999999997 111.14 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.435 ' CE1' HG11 ' A' ' 224' ' ' VAL . 61.5 t60 -54.48 -51.68 64.29 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.016 -0.993 . . . . 73.340000000000003 109.425 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -66.54 -22.77 66.16 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.265 -0.88 . . . . 73.319999999999993 112.077 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 73.2 m -72.98 -27.05 61.57 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.745 0.418 . . . . 71.120000000000005 110.583 173.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.8 t -120.25 4.22 10.81 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 116.206 1.928 . . . . 63.219999999999999 116.206 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.435 HG11 ' CE1' ' A' ' 220' ' ' HIS . 26.8 m -107.92 156.44 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 116.085 1.883 . . . . 73.510000000000005 116.085 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -92.56 -0.49 57.32 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 111.111 -2.768 . . . . 63.420000000000002 113.274 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -77.62 14.3 1.06 Allowed 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 128.169 2.588 . . . . 72.25 113.999 -143.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.46 17.52 4.77 Favored Glycine 0 N--CA 1.467 0.751 0 O-C-N 120.724 -1.235 . . . . 72.420000000000002 111.321 -169.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 97.1 mt -92.17 118.08 30.5 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.731 -1.234 . . . . 63.329999999999998 108.605 165.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.407 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 76.8 mt -59.74 -46.42 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 123.868 0.73 . . . . 43.340000000000003 109.478 173.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 15.1 t -130.77 142.7 50.42 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.109 -1.071 . . . . 71.349999999999994 108.109 167.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 55.6 p -69.02 157.35 36.97 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.777 0.431 . . . . 75.129999999999995 110.524 174.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.489 HD23 HD21 ' A' ' 184' ' ' LEU . 23.1 mt -66.96 101.37 0.84 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 108.729 -0.841 . . . . 72.219999999999999 108.729 177.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -88.26 -53.64 4.6 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.838 -0.801 . . . . 73.310000000000002 108.838 -173.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -158.91 145.43 12.63 Favored Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 115.083 -0.962 . . . . 63.210000000000001 110.793 -177.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.503 ' HB3' ' HA ' ' A' ' 146' ' ' TRP . 51.6 Cg_endo -68.59 163.43 36.91 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 121.781 1.654 . . . . 73.010000000000005 113.096 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.537 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -73.42 125.57 90.61 Favored Pre-proline 0 C--O 1.244 0.812 0 N-CA-C 108.861 -0.792 . . . . 73.120000000000005 108.861 170.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.36 132.43 27.48 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.058 1.839 . . . . 73.420000000000002 111.642 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -63.32 149.57 45.38 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.62 0.768 . . . . 61.32 109.976 175.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.481 HH21 ' HE2' ' A' ' 158' ' ' TYR . 4.5 ptp180 -50.85 -46.66 60.24 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.249 1.019 . . . . 62.310000000000002 113.603 -171.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -82.82 139.57 33.43 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.553 -0.906 . . . . 63.140000000000001 108.553 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.68 143.78 86.21 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 122.364 0.266 . . . . 74.430000000000007 111.454 -174.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -85.17 -144.87 0.03 OUTLIER 'Trans proline' 0 CA--C 1.555 1.57 0 C-N-CA 122.816 2.344 . . . . 62.5 110.128 168.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 77.6 m -67.94 126.92 30.97 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 109.283 -0.636 . . . . 62.350000000000001 109.283 170.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.54 -43.45 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.152 0.581 . . . . 71.319999999999993 111.273 -173.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -94.85 136.53 35.06 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.098 0.559 . . . . 73.439999999999998 109.909 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -155.51 36.36 0.64 Allowed Glycine 0 N--CA 1.464 0.563 0 N-CA-C 110.367 -1.093 . . . . 52.539999999999999 110.367 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.4 m -107.59 164.92 4.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 124.272 1.029 . . . . 72.040000000000006 110.144 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 249' ' ' PRO . 71.9 p -143.43 134.51 12.55 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.321 0.648 . . . . 71.329999999999998 109.884 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 248' ' ' SER . 19.7 Cg_exo -67.33 154.05 75.16 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.202 2.601 . . . . 70.340000000000003 112.528 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -143.85 154.44 43.38 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.376 0.607 . . . . 75.340000000000003 110.897 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -134.08 140.64 46.76 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.892 -1.521 . . . . 72.120000000000005 106.892 169.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -137.28 129.31 29.2 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.653 0.381 . . . . 53.140000000000001 110.079 -172.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -150.65 130.79 13.54 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.601 0.76 . . . . 63.32 110.034 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -135.4 -179.01 5.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.57 1.148 . . . . 72.319999999999993 109.891 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 . . . . . 0 C--O 1.253 1.252 0 C-N-CA 123.989 0.916 . . . . 71.439999999999998 108.769 173.545 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 109.198 -0.667 . . . . 63.140000000000001 109.198 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -88.88 167.04 34.39 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.507 0.505 . . . . 64.030000000000001 111.945 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -91.77 65.21 4.97 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.591 0.71 . . . . 73.329999999999998 110.726 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.84 67.23 7.1 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 115.196 -0.911 . . . . 70.120000000000005 109.404 171.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.61 -13.84 35.66 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.53 2.153 . . . . 63.409999999999997 111.663 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.43 -173.92 55.15 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 115.349 -0.841 . . . . 70.329999999999998 112.899 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -150.03 96.29 2.41 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.907 -1.146 . . . . 65.049999999999997 107.907 172.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 m -117.75 -176.94 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.824 0 C-N-CA 124.498 1.119 . . . . 75.219999999999999 109.615 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.472 HD11 ' HA ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -91.34 41.82 1.08 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.968 0.907 . . . . 72.099999999999994 110.588 -175.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.21 37.15 0.17 Allowed Glycine 0 C--N 1.347 1.151 0 C-N-CA 121.303 -0.475 . . . . 73.099999999999994 113.074 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -97.86 -178.11 3.99 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.949 0.5 . . . . 75.099999999999994 111.083 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -86.05 -144.83 0.11 Allowed 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 107.436 -1.32 . . . . 75.150000000000006 107.436 164.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 49.64 38.05 14.16 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 125.24 1.416 . . . . 74.430000000000007 113.479 163.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 61.56 80.63 0.25 Allowed Pre-proline 0 C--N 1.365 1.275 0 C-N-CA 124.205 1.002 . . . . 75.5 109.643 -173.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.04 166.88 21.46 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.83 2.353 . . . . 73.430000000000007 112.203 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.6 p -67.84 168.65 11.17 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-O 121.143 0.497 . . . . 60.310000000000002 111.397 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.7 mt -103.89 133.28 20.34 Favored Pre-proline 0 N--CA 1.476 0.86 0 N-CA-C 108.77 -0.826 . . . . 62.439999999999998 108.77 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.472 ' HA ' HD11 ' A' ' 9' ' ' LEU . 36.8 Cg_endo -71.26 169.8 19.84 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.387 2.058 . . . . 72.120000000000005 112.688 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.64 142.19 30.98 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.098 0.559 . . . . 74.010000000000005 110.63 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HB3' HD11 ' A' ' 23' ' ' ILE . 75.6 mt -88.35 96.93 10.77 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.636 0.774 . . . . 73.219999999999999 109.035 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -97.04 -47.79 5.65 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.57 -0.741 . . . . 74.540000000000006 109.75 177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -103.46 109.95 21.79 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.507 -0.77 . . . . 74.299999999999997 109.289 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 20' ' ' LEU . 25.7 mm -117.29 120.01 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.387 1.075 . . . . 74.120000000000005 109.892 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -142.15 127.33 18.58 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.574 -1.269 . . . . 73.120000000000005 107.574 167.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -130.73 -159.12 9.51 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 111.961 -0.455 . . . . 43.100000000000001 111.961 -172.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 59.25 26.06 14.78 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.22 1.008 . . . . 63.119999999999997 111.414 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' HA3' HE21 ' A' ' 127' ' ' GLN . . . -78.09 117.37 4.67 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 115.236 -0.893 . . . . 71.540000000000006 112.256 -175.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -145.23 -47.48 0.23 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.152 0.981 . . . . 72.239999999999995 109.685 -170.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -78.66 -3.01 41.88 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 114.797 -1.092 . . . . 65.319999999999993 112.513 -170.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -72.01 2.32 5.89 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.935 0.894 . . . . 71.319999999999993 112.166 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.9 p -143.71 172.33 12.97 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.617 0.767 . . . . 72.299999999999997 110.762 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.3 p -70.31 -67.94 0.46 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.06 0.944 . . . . 73.450000000000003 111.144 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -158.7 110.96 2.23 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.415 0.686 . . . . 73.209999999999994 109.176 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -140.8 147.0 38.36 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.749 0.819 . . . . 75.299999999999997 110.076 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.75 -161.06 29.69 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 124.085 0.865 . . . . 75.510000000000005 111.04 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -171.12 171.53 43.97 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 119.477 -0.624 . . . . 72.439999999999998 112.512 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.28 144.09 55.41 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.361 2.708 . . . . 74.120000000000005 111.44 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -84.0 99.76 10.63 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.322 -0.621 . . . . 62.43 109.322 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.1 t -68.68 148.35 50.53 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.027 0.531 . . . . 74.230000000000004 109.912 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -84.32 82.79 8.23 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.379 0.609 . . . . 62.539999999999999 109.532 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.59 95.16 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.31 -0.859 . . . . 65.430000000000007 109.046 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -114.98 100.64 8.34 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.618 -0.882 . . . . 74.040000000000006 108.618 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.3 t -104.44 137.43 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.5 -1.296 . . . . 65.150000000000006 107.5 169.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.22 174.16 11.05 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.345 0.658 . . . . 74.310000000000002 111.494 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -114.99 154.92 27.92 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.313 -0.858 . . . . 75.140000000000001 110.189 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -151.08 145.9 25.8 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.5 -0.926 . . . . 70.530000000000001 108.5 170.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -55.4 104.76 0.14 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.717 0.807 . . . . 60.409999999999997 110.096 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 75.3 mt -68.18 79.8 0.24 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.614 0.766 . . . . 54.32 110.123 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.473 ' HG2' ' HG3' ' A' ' 50' ' ' ARG . 34.6 tt0 -98.43 142.07 30.51 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.517 -1.29 . . . . 71.219999999999999 107.517 177.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.473 ' HG3' ' HG2' ' A' ' 49' ' ' GLN . 66.8 mtm180 57.56 55.11 7.05 Favored Pre-proline 0 CA--C 1.564 1.515 0 O-C-N 123.878 0.737 . . . . 61.219999999999999 110.803 -177.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 50' ' ' ARG . 24.2 Cg_exo -64.13 -25.89 65.42 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.596 2.197 . . . . 73.239999999999995 112.578 -175.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.8 t -91.16 50.14 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 CA-C-O 122.428 1.109 . . . . 52.229999999999997 108.956 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.44 11.95 34.97 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.098 0.959 . . . . 51.219999999999999 110.314 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.8 p -66.23 -46.53 76.86 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.996 0.918 . . . . 74.430000000000007 110.251 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -161.25 164.45 30.3 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.854 -1.066 . . . . 72.400000000000006 109.386 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -141.03 141.44 34.33 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.434 1.094 . . . . 74.099999999999994 108.647 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 60.76 72.7 0.69 Allowed Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 124.425 1.09 . . . . 65.430000000000007 111.166 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.39 98.13 0.22 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.727 2.285 . . . . 73.409999999999997 112.504 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -102.31 87.9 3.16 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.85 -1.167 . . . . 75.329999999999998 107.85 172.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.94 -159.79 25.75 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.009 -0.996 . . . . 71.530000000000001 112.226 -174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 62.8 mt -122.28 151.64 40.89 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.422 0.689 . . . . 55.450000000000003 110.397 -176.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.9 t -61.72 -37.53 84.53 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.469 1.108 . . . . 65.219999999999999 110.637 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -98.21 33.82 2.1 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.593 -0.731 . . . . 73.129999999999995 111.392 -174.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.4 123.96 21.84 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 108.455 -0.943 . . . . 73.549999999999997 108.455 167.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.65 104.46 0.66 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.347 0.659 . . . . 70.430000000000007 110.771 -175.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -81.52 94.16 6.81 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.23 -1.026 . . . . 74.510000000000005 108.23 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -76.79 136.44 38.97 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.632 -0.713 . . . . 75.239999999999995 111.423 -173.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -77.15 141.48 40.12 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.667 -0.697 . . . . 61.409999999999997 109.766 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.3 p -160.86 161.75 31.95 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.356 1.062 . . . . 73.409999999999997 109.066 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.7 tttp 75.06 -4.4 2.39 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.997 1.319 . . . . 72.140000000000001 112.435 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -75.63 90.98 2.82 Favored 'General case' 0 C--N 1.355 0.818 0 CA-C-O 121.575 0.702 . . . . 73.299999999999997 110.136 -174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -106.07 106.08 16.42 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.48 -1.304 . . . . 64.349999999999994 107.48 172.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.9 mt -79.69 136.4 36.78 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.31 0.644 . . . . 64.430000000000007 111.19 -173.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.6 mt -78.96 165.86 23.0 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.005 0.922 . . . . 74.019999999999996 110.21 174.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.53 84.42 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.684 0.794 . . . . 72.439999999999998 110.559 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 64.43 -151.43 50.42 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 115.377 -0.829 . . . . 44.310000000000002 113.157 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.9 120.71 7.03 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.593 2.195 . . . . 75.409999999999997 111.1 171.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.4 p -60.88 117.39 5.37 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.404 0.682 . . . . 73.109999999999999 110.518 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.463 ' HA ' HH21 ' A' ' 108' ' ' ARG . 1.8 mp0 -83.09 131.08 35.17 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.904 0.882 . . . . 61.240000000000002 110.651 -169.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -155.83 32.37 0.35 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.726 1.21 . . . . 63.5 108.215 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -145.76 144.15 21.59 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 114.19 -1.368 . . . . 62.140000000000001 109.287 -170.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.48 -19.8 18.82 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 123.103 2.535 . . . . 64.109999999999999 113.922 -174.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -90.46 40.16 1.0 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.824 0.85 . . . . 71.510000000000005 111.672 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 57.4 tp -83.72 112.55 20.17 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.512 0.672 . . . . 74.25 110.553 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.41 173.33 6.37 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.813 1.645 . . . . 65.140000000000001 108.766 170.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.6 p -144.96 143.16 22.63 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 N-CA-C 108.706 -0.85 . . . . 74.25 108.706 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.588 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -80.26 135.84 36.32 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.858 0.463 . . . . 73.329999999999998 110.201 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 88.3 mt -95.12 -16.56 22.52 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.315 1.046 . . . . 61.299999999999997 110.767 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -138.98 145.96 40.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.838 0.855 . . . . 72.549999999999997 108.915 -177.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -79.43 117.82 20.74 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.07 -0.715 . . . . 51.140000000000001 109.07 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -121.18 117.74 27.89 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.024 0.93 . . . . 72.040000000000006 109.247 -176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.8 t -79.96 138.74 19.34 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 C-N-CA 123.659 0.784 . . . . 51.100000000000001 109.262 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.71 115.09 3.69 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.818 -0.808 . . . . 73.019999999999996 108.818 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.4 m -74.59 -11.92 60.32 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.926 0.891 . . . . 71.25 110.753 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.79 -163.34 28.9 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 110.554 -1.018 . . . . 75.329999999999998 110.554 174.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -73.6 -23.92 59.98 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.219 0.608 . . . . 52.119999999999997 111.043 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -72.67 -24.19 60.99 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.438 1.095 . . . . 63.340000000000003 112.282 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.1 p -110.41 158.63 18.26 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 123.836 0.854 . . . . 74.299999999999997 110.013 -176.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.9 tp -109.17 132.73 53.84 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.223 -0.898 . . . . 73.019999999999996 109.226 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.2 t -82.0 124.84 30.14 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.767 -0.827 . . . . 50.450000000000003 108.767 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.1 pt -128.86 140.59 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 108.094 -1.076 . . . . 72.5 108.094 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 16.0 m -98.31 151.96 19.94 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.024 0.375 . . . . 72.120000000000005 110.211 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -60.12 111.4 1.5 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.199 0.6 . . . . 70.120000000000005 110.799 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.82 3.7 55.93 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 115.405 -0.816 . . . . 50.020000000000003 113.183 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -83.41 145.97 28.7 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.481 0.712 . . . . 61.539999999999999 110.346 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -87.92 113.32 23.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.398 1.079 . . . . 73.329999999999998 109.306 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.588 HD11 ' HB2' ' A' ' 87' ' ' ALA . 15.2 mt -108.07 133.84 51.8 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.464 -0.939 . . . . 53.240000000000002 108.464 -170.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.463 HH21 ' HA ' ' A' ' 79' ' ' GLU . 65.9 mtt180 -104.17 106.93 17.61 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.337 -0.616 . . . . 72.109999999999999 109.337 175.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 92.8 t -98.73 119.4 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 109.07 -0.715 . . . . 73.109999999999999 109.07 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.9 mt -67.83 -37.49 81.97 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.762 0.825 . . . . 73.239999999999995 109.924 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.05 -178.6 44.17 Favored Glycine 0 C--O 1.244 0.727 0 CA-C-N 114.431 -1.259 . . . . 44.219999999999999 111.167 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 14.4 m-30 -95.99 169.81 9.72 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.256 -0.646 . . . . 74.140000000000001 109.256 177.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -60.28 145.82 46.11 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.631 -1.248 . . . . 74.430000000000007 107.631 168.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -65.53 -25.59 67.52 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.46 0.304 . . . . 74.120000000000005 110.896 -176.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -81.76 -18.51 43.94 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.694 0.797 . . . . 74.219999999999999 110.56 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 174' ' ' GLU . . . 85.93 34.25 13.5 Favored Glycine 0 C--N 1.35 1.353 0 C-N-CA 123.484 0.564 . . . . 74.420000000000002 113.607 174.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -96.27 -64.14 1.08 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.577 0.703 . . . . 73.230000000000004 110.583 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -103.49 -179.0 3.82 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.589 1.156 . . . . 74.319999999999993 109.633 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -142.18 122.19 13.69 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.668 0.787 . . . . 72.349999999999994 109.477 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -79.98 101.77 8.84 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.179 0.514 . . . . 74.0 109.623 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -103.88 167.65 9.64 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.139 -0.937 . . . . 61.310000000000002 109.998 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -141.4 125.62 17.45 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 124.449 1.1 . . . . 74.530000000000001 108.502 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.8 p -138.15 -168.6 2.39 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.029 0.932 . . . . 73.420000000000002 110.661 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 124' ' ' LYS . 31.6 mtmt -54.41 -35.14 62.59 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.895 1.278 . . . . 73.409999999999997 111.159 175.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -83.92 8.01 16.44 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.556 -1.202 . . . . 61.420000000000002 111.424 -175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.55 -126.14 7.42 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 111.499 -0.64 . . . . 75.409999999999997 111.499 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.44 HE21 ' HA3' ' A' ' 27' ' ' GLY . 29.9 tt0 -151.02 139.8 20.8 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.305 0.642 . . . . 75.439999999999998 109.324 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 179.2 -178.76 48.86 Favored Glycine 0 C--N 1.344 1.0 0 O-C-N 123.263 0.352 . . . . 71.310000000000002 112.338 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -89.66 131.97 35.38 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.255 0.622 . . . . 63.340000000000003 110.835 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.67 152.08 76.29 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 125.322 1.449 . . . . 75.150000000000006 109.095 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.08 132.98 23.93 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.272 1.982 . . . . 74.430000000000007 111.462 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.506 ' HA ' HG12 ' A' ' 135' ' ' ILE . 20.0 m -62.3 -17.81 59.66 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.11 0.964 . . . . 65.150000000000006 112.724 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -74.65 -20.81 59.74 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.03 0.932 . . . . 75.420000000000002 111.526 177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -95.17 -6.51 41.56 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.828 0.851 . . . . 74.310000000000002 112.023 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.506 HG12 ' HA ' ' A' ' 132' ' ' SER . 14.8 pt -125.06 156.68 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.158 0.583 . . . . 72.310000000000002 110.059 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 11.3 t -149.86 136.38 10.75 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 122.701 0.4 . . . . 65.340000000000003 110.375 172.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.534 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 73.6 Cg_endo -75.38 140.19 24.17 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.487 2.125 . . . . 75.540000000000006 111.765 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.5 m -120.85 -36.54 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.002 0.521 . . . . 71.040000000000006 111.414 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 59.2 t30 -98.74 -9.39 24.58 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.71 0.404 . . . . 71.409999999999997 111.149 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 32.5 t -73.34 177.04 5.46 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.919 0.488 . . . . 64.420000000000002 109.902 176.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 64.4 mt -61.15 -16.24 42.37 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.698 0.999 . . . . 73.329999999999998 113.698 -172.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -59.37 -24.13 63.14 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.574 1.15 . . . . 71.109999999999999 112.666 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -67.19 -8.37 30.9 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.438 0.695 . . . . 74.310000000000002 112.135 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -89.1 151.76 22.04 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.765 0.826 . . . . 75.340000000000003 110.549 170.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 56.8 p -69.24 -36.21 76.95 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 123.625 0.77 . . . . 72.530000000000001 111.13 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -72.44 -31.35 65.4 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.607 -0.724 . . . . 73.420000000000002 112.638 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -97.27 120.95 38.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.873 -0.788 . . . . 74.349999999999994 108.873 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -103.13 5.05 37.65 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.87 -0.605 . . . . 75.209999999999994 111.663 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.81 -154.5 35.86 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 119.67 -0.517 . . . . 63.329999999999998 112.948 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.4 106.39 1.59 Allowed 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 123.152 2.568 . . . . 45.329999999999998 111.028 173.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.6 t -140.34 143.86 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.405 0.682 . . . . 73.030000000000001 109.404 -177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.2 t -64.54 161.88 16.55 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.061 0.944 . . . . 61.329999999999998 112.121 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -69.58 -31.86 70.26 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.673 0.789 . . . . 73.140000000000001 110.739 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -76.17 -43.89 40.6 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.23 0.612 . . . . 72.099999999999994 109.527 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.07 79.14 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.396 -0.82 . . . . 72.109999999999999 110.387 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.75 -56.23 24.64 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.715 -0.675 . . . . 75.040000000000006 110.214 171.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -60.49 -32.33 71.33 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.618 -0.719 . . . . 71.209999999999994 110.968 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -65.73 -52.22 52.94 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.222 1.009 . . . . 55.240000000000002 110.975 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.5 ' HB2' HD11 ' A' ' 169' ' ' LEU . 81.5 mt -67.03 -39.37 87.0 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.439 0.637 . . . . 71.450000000000003 110.788 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.452 HD23 HG13 ' A' ' 190' ' ' VAL . 27.2 tp -73.73 -20.14 60.6 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.682 -1.145 . . . . 72.329999999999998 111.604 -174.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.6 t -61.62 -27.22 68.5 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.842 0.857 . . . . 34.439999999999998 111.83 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.4 p -86.45 8.53 21.43 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.918 0.887 . . . . 74.299999999999997 111.719 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -97.39 170.16 25.51 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 116.374 -0.375 . . . . 72.340000000000003 112.605 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 32.4 pt -121.92 -163.59 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.95 0.9 . . . . 71.319999999999993 109.66 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.736 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 27.1 p-10 -49.48 118.15 2.6 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.729 0.811 . . . . 71.239999999999995 112.412 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.18 14.0 72.83 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.297 -0.41 . . . . 44.439999999999998 113.288 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 20.2 t -75.23 136.02 40.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.035 -0.728 . . . . 60.130000000000003 109.035 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.488 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 22.2 p90 -135.65 164.97 26.65 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.948 0.721 . . . . 74.340000000000003 112.948 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 159' ' ' LEU . 86.0 mt -137.41 135.48 36.97 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.549 1.139 . . . . 74.439999999999998 108.353 169.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.401 HG22 HG12 ' A' ' 182' ' ' ILE . 39.0 t -114.55 128.46 71.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 107.851 -1.166 . . . . 74.450000000000003 107.851 171.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 12.9 mtm105 -143.05 172.34 12.85 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.769 0.828 . . . . 73.310000000000002 109.483 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 13.9 pt-20 -116.25 163.06 16.54 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.642 -0.873 . . . . 74.400000000000006 108.642 160.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.5 m -88.58 134.85 33.75 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.155 0.582 . . . . 62.299999999999997 110.141 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.418 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 27.9 mt-10 -78.68 -26.27 44.95 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.115 0.966 . . . . 75.420000000000002 109.224 174.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.1 p -70.61 -37.24 73.81 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.619 -1.173 . . . . 54.229999999999997 110.584 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.9 m -140.48 94.38 8.45 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.056 0.942 . . . . 74.150000000000006 109.433 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.34 135.25 52.85 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.969 2.446 . . . . 70.219999999999999 111.501 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 91.33 -23.51 24.3 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-N 115.97 -0.559 . . . . 64.200000000000003 113.46 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -82.83 115.62 21.8 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 107.727 -1.212 . . . . 73.430000000000007 107.727 172.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 82.9 mtt-85 -112.31 159.87 18.23 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.066 0.546 . . . . 74.530000000000001 109.698 -171.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.9 t -152.44 146.67 25.48 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 122.837 0.455 . . . . 72.239999999999995 110.775 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 170' ' ' VAL . 52.9 mt -113.94 150.9 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.112 0.965 . . . . 73.049999999999997 108.476 173.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.2 m -132.36 128.42 37.61 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.721 -0.844 . . . . 75.540000000000006 108.721 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.462 HD21 HD23 ' A' ' 232' ' ' LEU . 38.8 mt -110.66 147.44 34.31 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.328 1.451 . . . . 75.129999999999995 111.382 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -133.5 130.88 39.15 Favored 'General case' 0 C--O 1.253 1.255 0 C-N-CA 124.429 1.092 . . . . 64.209999999999994 108.434 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.736 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 3.7 p90 -154.66 143.55 20.92 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 124.146 0.904 . . . . 73.230000000000004 108.646 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 58.13 19.28 5.94 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 124.389 1.075 . . . . 71.319999999999993 112.941 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 76.65 30.06 56.83 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 115.984 -0.553 . . . . 61.240000000000002 112.663 -175.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -128.52 123.24 33.03 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.115 0.966 . . . . 52.539999999999999 108.569 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.452 HG13 HD23 ' A' ' 160' ' ' LEU . 48.8 t -104.13 138.2 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.257 1.023 . . . . 63.140000000000001 109.79 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.467 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 28.7 p90 -143.15 157.94 44.06 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.939 0.895 . . . . 54.210000000000001 109.215 171.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -128.09 144.16 51.1 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.125 -1.065 . . . . 73.010000000000005 108.125 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -145.67 147.57 32.13 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.062 0.458 . . . . 73.409999999999997 110.644 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 20.9 tpp180 -82.35 133.43 35.23 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.056 -0.975 . . . . 73.25 110.431 -174.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 93.5 mt -75.1 102.68 2.51 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 N-CA-C 106.979 -1.489 . . . . 73.310000000000002 106.979 165.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -68.15 111.62 4.61 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.531 -1.213 . . . . 71.420000000000002 108.063 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 37.7 m -97.28 113.45 25.07 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.873 -0.603 . . . . 62.530000000000001 109.527 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -61.1 160.03 10.81 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.197 0.999 . . . . 71.420000000000002 111.862 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 22.3 m -62.09 -23.62 66.63 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.2 -0.909 . . . . 72.200000000000003 111.47 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.405 ' HB2' ' HE2' ' A' ' 202' ' ' LYS . 15.7 m-20 -87.28 3.56 46.26 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.182 0.993 . . . . 74.409999999999997 111.104 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 83.83 -1.76 88.34 Favored Glycine 0 C--N 1.353 1.483 0 C-N-CA 122.933 0.302 . . . . 61.43 113.35 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' A' ' 200' ' ' ASP . 54.1 mtmt -77.19 131.19 38.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.518 0.727 . . . . 74.349999999999994 110.274 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.72 147.45 22.98 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.836 -0.802 . . . . 54.549999999999997 108.836 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -166.14 176.24 7.81 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.406 0.682 . . . . 75.349999999999994 110.143 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 75.7 t -140.38 -50.35 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 107.004 -1.48 . . . . 51.43 107.004 172.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 22.0 m -74.83 145.99 42.37 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.347 -0.842 . . . . 74.25 109.933 171.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.8 m -70.83 -26.15 63.16 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.521 0.728 . . . . 73.549999999999997 110.922 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -71.85 -41.75 67.72 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.319 -0.623 . . . . 55.539999999999999 109.319 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 m -91.67 135.13 34.11 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.284 -0.871 . . . . 61.210000000000001 110.865 -165.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -137.26 118.38 14.43 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 107.956 -1.128 . . . . 71.239999999999995 107.956 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 9.0 m-85 -120.85 142.88 49.24 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 109.484 -0.561 . . . . 71.099999999999994 109.484 -177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -89.46 -24.18 21.91 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.778 -0.453 . . . . 73.019999999999996 109.778 171.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 76.8 p -124.53 144.81 49.91 Favored 'General case' 0 C--O 1.253 1.246 0 CA-C-O 121.87 0.843 . . . . 72.540000000000006 111.696 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 18.1 tp -69.57 -29.18 66.68 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 113.992 -1.458 . . . . 74.129999999999995 110.961 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.86 -37.12 85.33 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.324 0.649 . . . . 61.039999999999999 111.373 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -76.48 -31.93 58.06 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.884 0.474 . . . . 74.439999999999998 111.344 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.45 -45.88 90.34 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 110.118 -0.327 . . . . 74.209999999999994 110.118 170.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 52.9 t -70.8 -40.51 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.094 0.958 . . . . 74.239999999999995 110.971 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -59.74 -53.94 52.13 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.7 0.8 . . . . 64.420000000000002 109.583 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.407 ' O ' HG22 ' A' ' 224' ' ' VAL . 54.2 t-80 -53.69 -54.24 40.64 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.966 -1.015 . . . . 65.430000000000007 109.349 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -61.39 -26.33 67.77 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.609 -0.723 . . . . 72.409999999999997 112.286 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 32.4 t -75.17 -28.24 59.98 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 122.756 0.422 . . . . 61.030000000000001 111.236 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 15.4 t -117.56 1.43 12.27 Favored 'General case' 0 CA--C 1.566 1.572 0 N-CA-C 116.094 1.887 . . . . 74.120000000000005 116.094 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.429 ' O ' HG22 ' A' ' 231' ' ' THR . 35.8 m -107.14 144.27 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.524 0 CA-C-N 121.465 1.938 . . . . 72.420000000000002 116.19 -175.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -82.11 -2.65 52.7 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 129.07 2.948 . . . . 73.010000000000005 112.187 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -79.34 14.25 1.62 Allowed 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 129.202 3.001 . . . . 53.299999999999997 113.354 -140.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.63 18.16 4.09 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 110.947 -0.861 . . . . 44.420000000000002 110.947 -169.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 86.0 mt -93.63 132.94 37.47 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.993 0.917 . . . . 62.240000000000002 109.951 160.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.467 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 85.3 mt -60.42 -60.06 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 108.749 -0.834 . . . . 75.109999999999999 108.749 170.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.5 t -119.65 141.63 49.17 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.149 -0.932 . . . . 72.409999999999997 108.668 173.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 224' ' ' VAL . 82.1 p -73.19 158.84 34.47 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 108.834 -0.802 . . . . 72.420000000000002 108.834 170.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.488 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 26.2 mt -69.47 99.54 1.26 Allowed 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 108.828 -0.805 . . . . 73.409999999999997 108.828 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -77.9 -45.76 23.22 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.28 0.632 . . . . 65.420000000000002 110.056 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 167' ' ' SER . 12.9 p90 -164.01 153.1 11.91 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 109.541 -0.54 . . . . 61.140000000000001 109.541 172.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.22 139.04 14.6 Favored 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 121.698 1.599 . . . . 61.229999999999997 112.273 173.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -62.98 118.17 39.93 Favored Pre-proline 0 C--N 1.352 0.689 0 N-CA-C 108.155 -1.054 . . . . 51.450000000000003 108.155 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.411 ' HB2' ' HG2' ' A' ' 241' ' ' LYS . 54.1 Cg_endo -66.07 142.1 66.6 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.131 1.887 . . . . 51.310000000000002 112.188 -169.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -65.23 157.45 28.86 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.842 0.857 . . . . 72.219999999999999 110.745 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -46.76 -32.95 3.97 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.344 1.058 . . . . 75.430000000000007 113.171 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -94.24 75.46 3.98 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 108.289 -1.004 . . . . 54.299999999999997 108.289 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.411 ' HG2' ' HB2' ' A' ' 237' ' ' PRO . 10.3 mtmp? -70.48 148.8 95.5 Favored Pre-proline 0 N--CA 1.478 0.952 0 CA-C-N 114.714 -1.13 . . . . 75.319999999999993 111.26 -174.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.32 155.23 71.36 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.84 2.36 . . . . 73.420000000000002 111.958 173.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 17.0 m -62.54 -36.42 82.56 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.476 0.71 . . . . 61.140000000000001 111.445 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.2 p -151.71 131.33 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.047 0.539 . . . . 71.409999999999997 110.022 176.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -163.57 121.54 1.9 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.984 0.913 . . . . 74.200000000000003 109.212 168.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 162.67 94.36 0.1 OUTLIER Glycine 0 C--N 1.344 0.973 0 O-C-N 123.441 0.463 . . . . 72.430000000000007 111.954 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 3.5 m -118.14 125.15 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.395 0.678 . . . . 73.420000000000002 109.371 173.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 34.1 p -135.86 75.27 55.75 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 107.937 -1.134 . . . . 73.140000000000001 107.937 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.73 -8.41 19.2 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.913 2.409 . . . . 72.200000000000003 113.501 -172.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.76 95.39 3.44 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 122.853 0.461 . . . . 75.349999999999994 110.154 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -76.22 117.12 17.58 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.267 1.027 . . . . 73.019999999999996 109.194 171.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -89.18 123.55 33.53 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.871 0.693 . . . . 71.120000000000005 112.871 -168.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.48 115.73 4.07 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 106.75 -1.574 . . . . 72.450000000000003 106.75 170.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 28.5 p90 -111.09 -49.8 2.99 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.65 0.78 . . . . 74.430000000000007 110.054 -172.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--O 1.249 1.032 0 N-CA-C 106.398 -1.704 . . . . 53.210000000000001 106.398 -179.555 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 mmt . . . . . 0 N--CA 1.485 1.292 0 N-CA-C 109.501 -0.555 . . . . 73.549999999999997 109.501 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.37 179.88 46.6 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 116.377 -0.374 . . . . 43.240000000000002 113.05 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -166.02 -62.55 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.196 0.998 . . . . 62.420000000000002 109.513 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 54.87 83.03 0.23 Allowed Pre-proline 0 N--CA 1.482 1.132 0 C-N-CA 124.608 1.163 . . . . 74.439999999999998 110.238 -167.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.04 111.18 3.27 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.56 2.173 . . . . 53.520000000000003 111.621 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.99 -130.59 0.19 Allowed Glycine 0 C--N 1.341 0.843 0 CA-C-N 116.309 -0.405 . . . . 73.200000000000003 113.104 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HA ' ' HE3' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -121.26 166.28 14.24 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.719 0.808 . . . . 74.519999999999996 109.415 174.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.0 t -72.87 96.33 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.73 -1.211 . . . . 74.400000000000006 107.73 171.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.06 130.82 48.33 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.448 -0.796 . . . . 74.420000000000002 110.87 178.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' H ' ' HB2' ' A' ' 16' ' ' SER . . . -60.46 144.49 47.56 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.473 -0.651 . . . . 62.229999999999997 111.473 173.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -117.35 23.61 11.69 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.709 0.804 . . . . 74.219999999999999 110.851 -174.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -74.9 -169.72 0.95 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.385 0.674 . . . . 73.129999999999995 111.508 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.61 ' HB2' ' HA ' ' A' ' 46' ' ' GLU . 3.7 tmm_? -65.48 130.67 44.14 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.811 -0.811 . . . . 74.450000000000003 108.811 171.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 50.42 68.42 3.43 Favored Pre-proline 0 C--O 1.243 0.762 0 O-C-N 124.177 0.923 . . . . 52.240000000000002 108.608 -165.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.05 158.81 20.2 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 123.104 2.536 . . . . 63.32 111.815 -170.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.415 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 28.8 m -65.92 165.35 13.29 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 121.308 0.575 . . . . 63.109999999999999 111.0 -171.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.1 mt -103.45 125.26 35.43 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 107.88 -1.155 . . . . 62.439999999999998 107.88 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 67.0 Cg_endo -72.08 176.61 8.21 Favored 'Trans proline' 0 C--N 1.364 1.381 0 C-N-CA 123.114 2.543 . . . . 74.530000000000001 112.437 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.08 141.69 38.64 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 116.395 -0.366 . . . . 71.230000000000004 111.073 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.57 ' HB3' HD11 ' A' ' 23' ' ' ILE . 66.7 mt -87.93 91.49 8.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.109 -0.7 . . . . 65.230000000000004 109.109 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -97.0 -48.49 5.39 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.676 0.79 . . . . 74.540000000000006 110.22 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -100.75 109.46 21.47 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.857 -1.065 . . . . 73.0 108.732 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.57 HD11 ' HB3' ' A' ' 20' ' ' LEU . 48.3 mm -118.69 119.35 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 123.697 0.799 . . . . 73.409999999999997 109.325 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.578 ' H ' ' HE1' ' A' ' 129' ' ' TRP . 75.0 mmtt -110.42 142.02 42.7 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.634 -0.876 . . . . 72.239999999999995 108.634 169.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.27 143.54 42.99 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.445 0.466 . . . . 71.329999999999998 112.493 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.56 80.34 2.57 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.372 0.606 . . . . 72.209999999999994 110.706 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.36 -42.18 28.65 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.179 -0.919 . . . . 53.229999999999997 112.423 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 71.3 142.09 0.05 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.916 1.686 . . . . 64.409999999999997 111.974 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -132.36 163.71 28.08 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.714 0.806 . . . . 74.530000000000001 110.859 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -80.38 83.22 6.25 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.679 -1.23 . . . . 75.299999999999997 107.679 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.3 p -111.09 124.6 52.5 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.629 0.772 . . . . 53.109999999999999 110.35 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.2 m 68.34 -177.04 0.21 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.778 1.231 . . . . 74.430000000000007 112.938 173.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 -101.96 149.8 23.86 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.278 1.031 . . . . 74.120000000000005 109.403 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -64.37 155.65 31.73 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.983 0.513 . . . . 75.349999999999994 111.517 176.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.52 148.72 16.69 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.185 0.303 . . . . 72.310000000000002 112.685 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.94 110.69 3.08 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-O 119.126 -0.819 . . . . 70.450000000000003 112.724 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.578 ' HB2' ' HA ' ' A' ' 105' ' ' GLU . 20.6 Cg_endo -84.57 -159.55 0.1 Allowed 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.91 2.407 . . . . 65.209999999999994 112.828 -173.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -120.43 149.25 42.66 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.795 -0.817 . . . . 73.530000000000001 108.795 172.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.8 m -143.78 10.98 1.61 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.002 0.921 . . . . 72.150000000000006 109.492 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -69.72 166.59 18.9 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 123.816 0.847 . . . . 73.0 111.526 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 m -77.78 71.38 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.059 0.933 . . . . 71.549999999999997 111.224 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -74.26 158.6 33.77 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.982 -1.008 . . . . 65.129999999999995 110.229 175.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.519 HG11 ' HB3' ' A' ' 71' ' ' GLU . 30.7 m -75.74 168.8 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 C-N-CA 123.623 0.769 . . . . 44.210000000000001 113.038 -175.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -156.78 158.21 36.42 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.482 1.113 . . . . 73.299999999999997 108.4 167.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.98 90.15 0.44 Allowed 'General case' 0 N--CA 1.484 1.231 0 CA-C-O 121.05 0.452 . . . . 53.420000000000002 111.969 -173.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.61 ' HA ' ' HB2' ' A' ' 13' ' ' ARG . 12.5 tp10 -63.92 120.09 11.29 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.228 0.537 . . . . 72.140000000000001 111.438 -176.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -161.97 138.41 7.99 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.011 -0.995 . . . . 63.439999999999998 109.601 -170.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.459 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 92.9 mt -113.6 94.92 5.08 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.052 -0.721 . . . . 44.109999999999999 109.052 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -62.26 -56.08 22.05 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.331 -0.989 . . . . 61.240000000000002 108.331 170.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -161.3 110.2 1.24 Allowed Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 114.734 -1.121 . . . . 60.350000000000001 108.621 168.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 48' ' ' LEU . 84.1 Cg_endo -77.19 -156.98 0.07 OUTLIER 'Trans proline' 0 CA--C 1.554 1.522 0 C-N-CA 122.671 2.247 . . . . 63.240000000000002 112.249 173.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.6 p 47.58 56.95 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 126.023 1.729 . . . . 64.5 112.403 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.68 105.12 2.2 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.487 -1.233 . . . . 71.310000000000002 110.054 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -144.1 80.07 1.64 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.95 0.9 . . . . 70.129999999999995 108.778 173.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -75.69 -67.21 0.69 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.071 -0.715 . . . . 72.540000000000006 109.071 173.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -74.28 131.26 41.02 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.91 -1.144 . . . . 74.349999999999994 107.91 171.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 59.57 66.37 2.19 Favored Pre-proline 0 CA--C 1.556 1.184 0 O-C-N 124.445 1.091 . . . . 75.349999999999994 109.179 -164.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.44 -8.19 22.2 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.238 2.625 . . . . 64.209999999999994 112.758 -173.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -63.21 -37.42 87.15 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.101 0.961 . . . . 73.129999999999995 109.706 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.4 49.44 72.97 Favored Glycine 0 C--N 1.359 1.808 0 O-C-N 124.399 1.062 . . . . 74.129999999999995 112.674 176.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 92.4 mt -81.07 100.91 9.26 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.312 0.577 . . . . 54.32 110.651 -175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 54.2 m -103.34 77.58 1.53 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.237 -0.892 . . . . 74.540000000000006 109.575 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.74 -24.99 64.52 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.327 -0.851 . . . . 64.409999999999997 110.51 174.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.95 130.77 38.98 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.946 0.899 . . . . 71.010000000000005 110.321 171.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.82 167.95 20.71 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.222 0.609 . . . . 64.129999999999995 111.372 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -83.88 77.61 9.87 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 121.753 0.787 . . . . 63.240000000000002 110.068 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -90.03 96.06 10.5 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.083 -1.08 . . . . 72.230000000000004 108.083 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.533 ' HA ' ' HG2' ' A' ' 46' ' ' GLU . 33.8 m-80 -71.43 87.85 0.88 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.102 -0.954 . . . . 71.019999999999996 109.562 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.5 p -93.24 134.05 35.83 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.188 0.995 . . . . 61.200000000000003 110.866 -175.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -139.25 96.1 3.05 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.198 0.999 . . . . 72.530000000000001 109.247 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.519 ' HB3' HG11 ' A' ' 43' ' ' VAL . 10.5 tp10 -168.64 151.39 5.2 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.479 1.512 . . . . 73.010000000000005 107.434 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -147.18 150.1 34.25 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.313 -0.995 . . . . 63.140000000000001 108.313 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.8 mt -126.1 149.5 48.87 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.424 -0.584 . . . . 61.439999999999998 109.424 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.6 mt -69.57 159.76 32.78 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.47 0.481 . . . . 53.409999999999997 111.025 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.597 ' HB1' ' HA ' ' A' ' 138' ' ' VAL . . . -67.07 152.44 45.77 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.753 0.821 . . . . 62.43 111.496 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -53.48 113.86 3.38 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-O 118.446 -1.197 . . . . 64.420000000000002 112.574 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -50.29 -59.59 1.14 Allowed 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 123.833 3.022 . . . . 71.340000000000003 114.207 -170.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 62.8 m -152.25 139.33 19.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.179 0.592 . . . . 71.439999999999998 111.556 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -159.99 174.22 14.69 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.618 0.767 . . . . 72.219999999999999 109.352 175.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -92.1 35.28 0.99 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.97 0.908 . . . . 73.109999999999999 112.644 -173.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -141.94 107.17 5.82 Favored Pre-proline 0 N--CA 1.484 1.265 0 CA-C-O 119.257 -0.401 . . . . 75.430000000000007 111.421 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.77 -48.8 9.91 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.695 2.93 . . . . 62.409999999999997 114.104 -176.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -92.35 41.96 1.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.531 0.732 . . . . 74.310000000000002 111.098 -174.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.1 tp -91.58 112.36 24.24 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.445 -0.798 . . . . 71.209999999999994 110.308 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -107.43 176.28 5.21 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.65 1.58 . . . . 63.100000000000001 109.549 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 9.9 p -147.73 149.34 15.5 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 C-N-CA 123.014 0.526 . . . . 73.409999999999997 109.868 171.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.58 113.66 20.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.624 0.77 . . . . 72.329999999999998 109.345 171.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 86.3 mt -84.65 -12.59 53.62 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.058 0.543 . . . . 73.239999999999995 110.568 174.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -135.01 146.49 49.08 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.33 0.652 . . . . 70.430000000000007 110.091 -173.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -60.28 137.73 58.07 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.138 -0.937 . . . . 61.240000000000002 110.439 168.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -152.27 116.24 4.89 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 109.923 -0.399 . . . . 73.040000000000006 109.923 174.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.94 139.03 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 108.002 -1.11 . . . . 64.519999999999996 108.002 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.79 116.13 8.12 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 110.07 -0.345 . . . . 62.210000000000001 110.07 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.1 m -74.99 -17.66 60.5 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.313 0.645 . . . . 75.099999999999994 110.743 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -156.3 -177.54 29.57 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.611 -0.722 . . . . 42.329999999999998 111.747 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -73.57 -27.55 61.38 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.331 0.652 . . . . 71.519999999999996 110.575 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.431 HD21 HD13 ' A' ' 20' ' ' LEU . 25.2 p-10 -69.7 -23.64 63.46 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.863 0.865 . . . . 74.109999999999999 111.922 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.4 p -99.83 157.14 16.72 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.284 0.634 . . . . 61.549999999999997 110.754 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.5 tp -110.32 117.16 32.88 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.531 0.733 . . . . 75.0 109.87 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -66.89 117.59 9.2 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.031 -0.729 . . . . 63.140000000000001 109.031 172.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.4 pt -122.39 130.76 74.28 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 N-CA-C 109.244 -0.65 . . . . 52.229999999999997 109.244 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.0 m -90.53 141.26 28.94 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.503 -0.554 . . . . 72.439999999999998 109.503 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -57.51 116.64 3.49 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.012 0.525 . . . . 60.100000000000001 110.794 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.16 -20.13 21.81 Favored Glycine 0 C--N 1.34 0.758 0 CA-C-N 115.417 -0.81 . . . . 63.439999999999998 112.38 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.578 ' HA ' ' HB2' ' A' ' 37' ' ' PRO . 69.9 tt0 -72.55 128.54 35.9 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.017 -0.735 . . . . 71.319999999999993 109.017 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . 54.5 mtmt -84.0 126.99 33.56 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.165 0.507 . . . . 72.140000000000001 109.909 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.41 ' HA ' HG22 ' A' ' 123' ' ' THR . 14.5 mt -102.1 166.76 10.43 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.981 -1.008 . . . . 73.430000000000007 108.592 -169.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -128.34 107.4 9.73 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.728 -1.212 . . . . 71.310000000000002 107.728 168.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 98.3 t -96.46 116.52 38.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.625 -0.88 . . . . 43.109999999999999 108.625 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.423 HD12 ' NE2' ' A' ' 127' ' ' GLN . 47.5 mt -78.46 -25.42 45.85 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.065 -0.971 . . . . 52.030000000000001 110.116 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 179.03 161.02 25.9 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.458 -0.792 . . . . 74.219999999999999 111.421 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 3.8 m-30 -95.4 171.84 8.45 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.473 0.654 . . . . 73.219999999999999 109.424 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -66.84 144.87 56.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.668 1.187 . . . . 71.430000000000007 107.979 164.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -60.89 -38.09 84.47 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.43 0.692 . . . . 73.340000000000003 112.158 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -79.35 -11.94 59.93 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.75 0.82 . . . . 52.409999999999997 110.98 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 85.35 23.17 48.92 Favored Glycine 0 C--N 1.349 1.281 0 C-N-CA 123.529 0.585 . . . . 72.019999999999996 113.281 177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . 46.5 mt-10 -78.28 -72.21 0.38 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.722 0.772 . . . . 64.109999999999999 110.729 -177.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -104.33 -177.43 3.36 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.534 1.133 . . . . 73.150000000000006 109.439 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -149.23 126.82 11.65 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.338 0.655 . . . . 63.329999999999998 110.07 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -71.03 94.26 1.08 Allowed 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.078 -0.712 . . . . 72.239999999999995 109.078 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -104.88 162.57 13.21 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 124.005 0.922 . . . . 72.109999999999999 110.402 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -144.06 133.72 23.63 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.555 0.742 . . . . 64.409999999999997 109.241 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.41 HG22 ' HA ' ' A' ' 107' ' ' LEU . 62.9 p -139.67 -171.37 3.13 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.556 1.143 . . . . 75.439999999999998 110.454 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -61.6 -19.77 62.59 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.382 -0.827 . . . . 72.120000000000005 111.196 170.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -85.69 1.93 47.36 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.882 0.873 . . . . 73.420000000000002 111.353 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.5 -130.4 9.54 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 111.619 -0.593 . . . . 61.409999999999997 111.619 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.423 ' NE2' HD12 ' A' ' 110' ' ' LEU . 57.2 tt0 -145.76 154.38 41.98 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.458 0.703 . . . . 74.219999999999999 109.837 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 166.54 -178.89 40.78 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 112.685 -0.166 . . . . 74.420000000000002 112.685 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.578 ' HE1' ' H ' ' A' ' 24' ' ' LYS . 86.4 m95 -89.85 127.07 35.92 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.767 0.827 . . . . 73.420000000000002 110.688 -176.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.6 m -125.34 146.19 53.4 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.797 1.239 . . . . 54.229999999999997 108.68 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.41 141.5 42.73 Favored 'Trans proline' 0 C--N 1.366 1.478 0 C-N-CA 121.937 1.758 . . . . 72.519999999999996 111.616 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.6 m -60.64 -19.94 59.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.931 0.892 . . . . 75.340000000000003 112.108 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -72.27 -27.49 62.52 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.503 0.721 . . . . 53.229999999999997 111.705 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -88.85 -11.75 43.85 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.661 0.784 . . . . 73.409999999999997 112.073 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.483 HD12 HG21 ' A' ' 109' ' ' VAL . 18.2 pt -122.64 161.43 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.002 0.521 . . . . 72.409999999999997 110.928 -170.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.0 t -155.9 143.05 13.7 Favored Pre-proline 0 N--CA 1.486 1.326 0 C-N-CA 122.727 0.411 . . . . 65.409999999999997 110.291 168.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.548 ' HB2' ' HB2' ' A' ' 140' ' ' SER . 5.7 Cg_exo -75.63 126.45 9.57 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.579 2.186 . . . . 52.219999999999999 111.217 172.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.597 ' HA ' ' HB1' ' A' ' 75' ' ' ALA . 12.0 m -94.28 -51.26 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 111.945 0.35 . . . . 53.109999999999999 111.945 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -92.52 18.91 7.88 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.175 0.512 . . . . 74.239999999999995 111.305 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.548 ' HB2' ' HB2' ' A' ' 137' ' ' PRO . 22.7 t -64.45 177.51 0.87 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.818 0.847 . . . . 32.329999999999998 112.691 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 49.5 mt -65.31 -13.49 58.59 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.055 1.342 . . . . 52.200000000000003 111.98 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.489 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 42.6 tt0 -63.87 -8.9 12.4 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.856 0.863 . . . . 74.420000000000002 111.491 174.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -55.16 -23.76 23.05 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.921 1.289 . . . . 72.140000000000001 110.515 167.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -99.36 143.64 29.38 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.974 0.909 . . . . 74.019999999999996 109.824 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.0 p -66.25 -15.41 63.17 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.369 0.668 . . . . 71.420000000000002 112.771 -175.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.409 ' CZ3' ' HB2' ' A' ' 147' ' ' TYR . 44.3 p-90 -80.29 -38.16 31.33 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 112.592 0.59 . . . . 74.219999999999999 112.592 178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.409 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 28.8 t80 -91.67 140.47 29.69 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.81 -0.441 . . . . 71.549999999999997 109.81 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.489 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 63.3 m-70 -137.97 29.55 2.54 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 112.136 0.421 . . . . 70.140000000000001 112.136 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.63 -170.88 54.49 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 115.652 1.021 . . . . 51.020000000000003 115.652 165.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.04 102.77 1.49 Allowed 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.276 2.651 . . . . 61.43 111.341 172.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.414 HG21 ' NH2' ' A' ' 171' ' ' ARG . 60.4 t -140.02 156.9 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.458 0.703 . . . . 71.329999999999998 110.023 -175.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 22.6 t -61.62 145.15 53.09 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.965 1.306 . . . . 41.409999999999997 112.717 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -55.19 -32.87 62.54 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.506 -1.225 . . . . 72.510000000000005 112.019 171.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -66.3 -52.08 50.95 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.442 0.697 . . . . 65.209999999999994 110.553 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.72 -33.84 75.69 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.228 0.611 . . . . 61.539999999999999 111.262 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.557 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.28 -53.44 58.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.141 -0.936 . . . . 72.019999999999996 110.416 173.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.575 ' HG3' HG11 ' A' ' 190' ' ' VAL . 34.6 tt0 -68.67 -27.46 66.0 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.661 -0.699 . . . . 64.439999999999998 111.079 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -67.62 -45.99 73.79 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.877 0.471 . . . . 72.409999999999997 111.45 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.2 mt -67.76 -38.4 83.39 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 110.146 -0.316 . . . . 64.430000000000007 110.146 175.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 183' ' ' SER . 29.3 tp -68.15 -21.29 64.92 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.292 0.637 . . . . 73.230000000000004 111.658 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.464 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 33.2 t -64.93 -24.35 67.5 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.505 0.722 . . . . 72.450000000000003 110.603 176.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.8 t -85.62 -2.54 58.27 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.903 0.881 . . . . 54.420000000000002 111.604 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -86.2 170.91 43.61 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 114.073 0.389 . . . . 61.420000000000002 114.073 -177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.4 pt -132.31 -165.05 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 124.568 1.147 . . . . 64.129999999999995 111.023 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.666 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 14.3 p-10 -58.09 102.81 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.03 0.932 . . . . 65.109999999999999 113.362 -172.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 104.06 11.79 31.19 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 115.977 -0.556 . . . . 54.119999999999997 112.776 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 23.0 t -75.76 142.35 42.38 Favored 'General case' 0 C--N 1.349 0.582 0 N-CA-C 109.853 -0.425 . . . . 42.25 109.853 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 235' ' ' PRO . 14.9 p90 -144.07 161.47 38.71 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.84 0.682 . . . . 73.430000000000007 112.84 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' A' ' 236' ' ' ALA . 95.7 mt -142.45 135.51 28.53 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.489 1.116 . . . . 74.239999999999995 108.358 170.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.5 t -110.91 113.52 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.327 -1.36 . . . . 74.200000000000003 107.327 174.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.557 HH11 ' HA ' ' A' ' 156' ' ' ALA . 17.2 mtp180 -141.12 143.28 34.21 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 107.602 -1.258 . . . . 73.230000000000004 107.602 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.701 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 15.3 pt-20 -95.14 161.29 14.18 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.074 0.397 . . . . 60.399999999999999 110.506 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 37.4 m -82.81 134.47 35.11 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 116.308 -0.406 . . . . 74.040000000000006 110.284 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -70.16 -41.67 73.53 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.214 1.006 . . . . 73.120000000000005 109.975 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 72.0 p -84.26 -9.17 58.72 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.366 1.066 . . . . 71.510000000000005 111.864 -177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.2 m -141.64 67.45 24.07 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.499 1.12 . . . . 75.409999999999997 108.812 173.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.71 149.11 42.71 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.655 2.237 . . . . 63.32 112.817 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.66 -26.01 6.17 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 114.665 -1.152 . . . . 74.329999999999998 112.049 -168.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -90.84 119.17 30.83 Favored 'General case' 0 C--O 1.259 1.574 0 N-CA-C 108.151 -1.055 . . . . 63.520000000000003 108.151 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.701 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 26.0 mtt85 -105.95 170.24 8.02 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.36 -0.836 . . . . 72.120000000000005 110.77 -173.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.8 m -144.11 144.14 31.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.699 0.8 . . . . 75.450000000000003 110.22 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 56.7 mt -112.91 139.25 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.18 -1.045 . . . . 71.230000000000004 108.18 168.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.575 ' HB3' HD22 ' A' ' 160' ' ' LEU . 23.6 m -116.04 115.09 25.5 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 124.661 1.184 . . . . 55.100000000000001 107.981 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.462 HD21 HD23 ' A' ' 232' ' ' LEU . 57.2 mt -104.77 142.99 33.73 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.474 0.71 . . . . 71.209999999999994 111.088 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.464 ' NH1' ' HA ' ' A' ' 161' ' ' SER . 20.3 ttt180 -131.99 126.55 34.25 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.61 -1.177 . . . . 72.230000000000004 108.773 170.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 0.0 OUTLIER -150.21 141.46 23.19 Favored 'General case' 0 C--O 1.211 -0.945 0 N-CA-C 107.154 -1.424 . . . . 74.510000000000005 107.154 -179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 54.29 18.61 1.91 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 125.759 1.624 . . . . 74.519999999999996 113.442 -174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.49 14.01 80.74 Favored Glycine 0 N--CA 1.475 1.294 0 O-C-N 122.284 -0.26 . . . . 45.100000000000001 113.049 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -103.21 127.73 50.42 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 125.4 1.48 . . . . 73.340000000000003 108.763 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.575 HG11 ' HG3' ' A' ' 157' ' ' GLU . 86.2 t -107.79 116.82 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.887 0.875 . . . . 73.129999999999995 110.304 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -139.55 141.13 37.26 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.44 1.096 . . . . 65.040000000000006 109.275 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -124.57 151.19 45.07 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.139 0.975 . . . . 73.349999999999994 108.963 -170.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -142.94 141.49 31.47 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.213 0.53 . . . . 70.109999999999999 110.752 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -77.68 131.28 37.65 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.815 -1.084 . . . . 71.319999999999993 110.828 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 80.4 mt -75.2 108.52 7.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 107.48 -1.304 . . . . 71.349999999999994 107.48 165.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -73.17 106.76 5.15 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.799 -1.185 . . . . 75.349999999999994 107.799 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.511 HG23 HD23 ' A' ' 203' ' ' LEU . 30.9 m -92.37 121.65 34.06 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.255 0.622 . . . . 74.140000000000001 109.717 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -63.21 153.52 34.28 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.454 0.702 . . . . 72.430000000000007 110.236 172.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 51.3 p -61.37 -22.36 64.88 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.405 0.682 . . . . 61.310000000000002 112.005 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.401 ' HB2' ' HE2' ' A' ' 202' ' ' LYS . 67.8 m-20 -71.54 -14.99 62.27 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.883 1.273 . . . . 75.0 112.373 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 101.77 -2.68 52.56 Favored Glycine 0 C--N 1.348 1.223 0 C-N-CA 122.901 0.286 . . . . 63.140000000000001 112.671 -176.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 200' ' ' ASP . 48.5 mtmt -82.65 156.07 24.05 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.652 0.781 . . . . 70.409999999999997 109.79 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.511 HD23 HG23 ' A' ' 197' ' ' THR . 79.0 mt -113.69 151.2 32.18 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.581 0.752 . . . . 75.329999999999998 110.73 -171.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -163.78 171.97 14.78 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.888 0.875 . . . . 62.520000000000003 110.413 170.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.3 t -131.46 -56.34 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.414 -1.328 . . . . 72.340000000000003 107.414 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 8.9 m -76.25 153.12 36.27 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.508 -0.769 . . . . 62.140000000000001 108.932 169.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 15.9 m -61.32 -36.82 81.19 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.131 0.573 . . . . 72.299999999999997 111.067 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -82.67 -20.67 35.75 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.451 0.7 . . . . 71.200000000000003 111.461 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 68.7 m -63.49 135.91 57.21 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 122.707 0.403 . . . . 52.219999999999999 110.764 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -141.13 108.52 5.55 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.368 -0.975 . . . . 71.319999999999993 108.368 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -121.39 135.76 55.04 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.285 -0.635 . . . . 74.430000000000007 109.285 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -84.25 -30.5 25.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.956 0.502 . . . . 72.530000000000001 110.04 175.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 216' ' ' GLU . 81.5 p -132.36 161.49 33.45 Favored 'General case' 0 C--O 1.253 1.271 0 CA-C-O 122.209 1.004 . . . . 75.420000000000002 111.609 177.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 37.6 tp -71.24 -24.5 62.2 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 114.159 -1.382 . . . . 42.039999999999999 110.992 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.18 -42.03 89.45 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.434 0.693 . . . . 71.129999999999995 109.93 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.4 ' HG2' ' OG1' ' A' ' 213' ' ' THR . 31.7 mm-40 -65.02 -43.8 91.24 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.341 -0.845 . . . . 71.310000000000002 109.637 174.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.22 -46.25 86.23 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 124.077 0.861 . . . . 71.010000000000005 111.686 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 42.2 t -74.41 -40.55 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.084 0.553 . . . . 74.450000000000003 111.236 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -62.59 -47.07 85.4 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.107 0.479 . . . . 74.230000000000004 110.591 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.428 ' O ' HG22 ' A' ' 224' ' ' VAL . 52.9 t-80 -54.98 -54.46 42.6 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.066 -0.97 . . . . 70.439999999999998 109.961 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.485 ' HD2' HD21 ' A' ' 228' ' ' LEU . 40.3 m80 -65.85 -23.86 66.76 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.676 -0.693 . . . . 63.25 111.65 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 44.2 t -74.4 -24.44 59.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.019 0.528 . . . . 61.32 111.298 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.7 t -110.44 -21.73 12.03 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 116.336 1.976 . . . . 72.310000000000002 116.336 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 220' ' ' HIS . 26.9 m -93.84 157.35 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 115.435 1.643 . . . . 61.219999999999999 115.435 -164.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.16 -1.44 57.73 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.378 2.671 . . . . 73.349999999999994 112.666 -175.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -78.92 15.86 1.01 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 128.357 2.663 . . . . 70.150000000000006 113.751 -140.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.93 18.11 4.4 Favored Glycine 0 C--N 1.344 0.986 0 C-N-CA 124.819 1.2 . . . . 54.530000000000001 110.529 -170.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.485 HD21 ' HD2' ' A' ' 221' ' ' HIS . 95.2 mt -93.19 126.73 38.45 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.989 1.315 . . . . 65.239999999999995 109.713 164.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 81.0 mt -67.01 -39.9 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 109.21 -0.663 . . . . 71.329999999999998 109.21 173.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.8 t -133.28 141.98 48.26 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-N 115.08 -0.964 . . . . 71.310000000000002 108.803 168.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 65.1 p -66.3 151.84 46.21 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 108.791 -0.818 . . . . 71.099999999999994 108.791 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.462 HD23 HD21 ' A' ' 184' ' ' LEU . 28.5 mt -62.11 102.69 0.31 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 108.126 -1.064 . . . . 73.310000000000002 108.126 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -89.43 -58.18 2.62 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.818 -0.808 . . . . 74.099999999999994 108.818 -173.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.583 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -151.95 141.34 14.24 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 123.058 0.543 . . . . 75.230000000000004 111.82 -178.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 65.5 Cg_endo -71.76 156.76 56.66 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 121.494 1.463 . . . . 71.239999999999995 112.45 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.474 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -70.72 133.31 86.62 Favored Pre-proline 0 C--O 1.244 0.81 0 CA-C-N 115.935 -0.575 . . . . 63.039999999999999 109.752 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.495 ' HB3' ' HD2' ' A' ' 242' ' ' PRO . 31.3 Cg_exo -61.45 132.1 39.24 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.22 2.614 . . . . 60.140000000000001 113.602 -175.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.462 ' HG2' ' HG3' ' A' ' 242' ' ' PRO . 19.3 ptpt -69.02 161.31 29.25 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.761 0.825 . . . . 65.349999999999994 110.829 171.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -53.38 -32.19 48.26 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.588 0.755 . . . . 74.040000000000006 112.284 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -79.28 83.85 5.27 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.917 -1.142 . . . . 74.150000000000006 107.917 170.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -44.23 103.91 0.35 Allowed Pre-proline 0 N--CA 1.49 1.575 0 C-N-CA 126.261 1.825 . . . . 55.420000000000002 114.519 -168.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 237' ' ' PRO . 93.2 Cg_endo -107.44 105.07 0.02 OUTLIER 'Trans proline' 0 CA--C 1.563 1.973 0 C-N-CA 123.886 3.057 . . . . 75.530000000000001 113.934 175.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 13.8 t -93.89 156.93 16.37 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.75 -0.594 . . . . 75.25 110.011 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 13.5 p -159.62 143.44 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.811 0.844 . . . . 65.329999999999998 109.642 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -104.98 104.59 14.36 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.21 1.004 . . . . 75.439999999999998 110.439 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -82.24 76.96 2.14 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.662 -0.699 . . . . 73.409999999999997 112.577 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.5 m -65.52 149.7 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.499 0.72 . . . . 74.25 111.234 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 48.4 t -151.33 140.1 13.39 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.265 0.626 . . . . 53.420000000000002 110.676 -172.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.63 146.63 67.85 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.286 1.99 . . . . 54.329999999999998 111.231 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -61.83 99.06 0.11 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.769 0.428 . . . . 50.439999999999998 110.177 175.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -146.57 17.93 1.31 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.581 0.752 . . . . 71.409999999999997 109.303 174.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -76.67 155.51 33.32 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.146 0.498 . . . . 72.019999999999996 111.121 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -115.7 166.31 12.07 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.818 0.847 . . . . 64.109999999999999 109.315 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -70.1 -55.99 8.03 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.79 -0.819 . . . . 72.510000000000005 108.79 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 . . . . . 0 C--O 1.248 0.991 0 C-N-CA 125.584 1.554 . . . . 73.239999999999995 107.676 174.203 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.3 mtt . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.339 -0.615 . . . . 74.319999999999993 109.339 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.22 79.46 0.52 Allowed Glycine 0 C--N 1.35 1.319 0 N-CA-C 110.758 -0.937 . . . . 74.510000000000005 110.758 173.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.435 ' HA ' ' OD1' ' A' ' 115' ' ' ASN . 30.0 pt20 -74.39 -14.38 60.85 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.723 0.809 . . . . 64.530000000000001 112.0 -173.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 66.23 160.25 0.13 Allowed Pre-proline 0 N--CA 1.484 1.251 0 C-N-CA 124.777 1.231 . . . . 72.140000000000001 111.783 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.24 -28.24 84.61 Favored 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.359 2.039 . . . . 60.200000000000003 111.637 166.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.08 -69.42 3.38 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.199 -0.91 . . . . 31.23 111.007 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt 58.0 52.69 7.5 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.728 1.211 . . . . 72.439999999999998 109.896 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.57 107.48 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 114.186 -1.37 . . . . 73.040000000000006 109.322 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 79.7 mt -86.87 80.33 8.5 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.505 -0.77 . . . . 73.209999999999994 109.436 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.51 -34.23 88.83 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 114.727 -1.124 . . . . 60.109999999999999 114.335 -171.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -89.12 50.51 1.96 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.376 0.608 . . . . 63.020000000000003 111.366 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -134.84 153.8 51.89 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.538 1.135 . . . . 74.510000000000005 108.799 170.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -68.68 117.09 9.96 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 107.742 -1.207 . . . . 73.319999999999993 107.742 170.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.431 ' HB3' HH11 ' A' ' 14' ' ' ARG . 1.5 mmm180 61.01 73.38 0.61 Allowed Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 124.462 1.105 . . . . 74.230000000000004 109.311 -170.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.9 161.48 12.9 Favored 'Trans proline' 0 C--N 1.387 2.581 0 C-N-CA 123.344 2.696 . . . . 71.299999999999997 112.553 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.7 p -66.05 165.15 13.94 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 121.169 0.509 . . . . 73.109999999999999 111.006 -174.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.6 mt -108.31 130.62 22.53 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 109.064 -0.717 . . . . 74.409999999999997 109.064 -176.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.27 172.7 9.7 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.301 2.001 . . . . 74.530000000000001 111.206 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.86 144.45 36.97 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 122.329 -0.232 . . . . 62.420000000000002 110.439 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.629 ' HB3' HD11 ' A' ' 23' ' ' ILE . 72.6 mt -84.84 92.38 8.25 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.486 -0.931 . . . . 62.43 108.486 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -96.27 -49.07 5.36 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.203 -0.908 . . . . 74.430000000000007 109.379 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -103.2 110.96 23.11 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.561 -1.2 . . . . 63.25 109.228 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 20' ' ' LEU . 37.2 mm -116.99 113.01 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.954 0.902 . . . . 64.439999999999998 109.491 -177.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.681 ' HA ' ' HE1' ' A' ' 129' ' ' TRP . 2.2 tppp? 49.66 53.46 12.71 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.166 1.386 . . . . 73.25 112.739 175.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.18 53.47 4.79 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 114.78 -1.1 . . . . 65.450000000000003 110.817 173.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.35 85.58 5.82 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.536 0.734 . . . . 61.109999999999999 109.796 -176.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.19 -10.41 85.38 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.503 -0.771 . . . . 62.329999999999998 111.925 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -100.5 108.5 20.48 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.178 0.991 . . . . 72.120000000000005 109.382 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -92.17 17.56 9.4 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.762 0.825 . . . . 74.310000000000002 110.629 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -96.35 19.1 12.52 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.582 1.153 . . . . 71.439999999999998 111.016 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.9 p -70.35 143.44 51.95 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.985 0.914 . . . . 70.030000000000001 110.047 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.1 m -65.22 103.67 0.81 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.768 0.427 . . . . 74.349999999999994 110.841 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -110.17 167.11 10.43 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.075 0.95 . . . . 72.209999999999994 110.642 -177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -73.03 127.8 33.61 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.209 0.604 . . . . 73.310000000000002 111.195 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.9 95.14 0.1 Allowed Glycine 0 C--N 1.341 0.857 0 N-CA-C 110.495 -1.042 . . . . 72.010000000000005 110.495 175.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -135.29 78.11 0.35 Allowed Glycine 0 C--N 1.35 1.315 0 CA-C-O 119.676 -0.514 . . . . 62.219999999999999 111.99 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.81 132.65 15.93 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.166 2.577 . . . . 62.329999999999998 111.232 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -72.81 159.91 33.01 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.007 0.432 . . . . 72.540000000000006 111.674 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.1 t -158.82 152.59 23.28 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.361 -0.836 . . . . 23.329999999999998 110.244 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -65.15 95.88 0.19 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.61 0.764 . . . . 60.299999999999997 109.462 172.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.4 t -76.35 88.25 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.454 0.702 . . . . 71.239999999999995 109.58 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -125.33 126.96 45.89 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.5 1.12 . . . . 74.299999999999997 108.269 173.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 p -102.39 153.49 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 123.265 0.626 . . . . 70.230000000000004 109.918 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.65 158.9 39.07 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 107.168 -1.419 . . . . 74.049999999999997 107.168 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -74.12 -17.7 60.9 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.657 0.662 . . . . 64.109999999999999 111.26 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -137.89 162.25 34.51 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.083 0.953 . . . . 63.409999999999997 110.079 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 70.54 24.77 4.4 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.63 1.172 . . . . 51.149999999999999 111.969 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.0 mt -86.25 75.66 9.82 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.068 0.461 . . . . 62.229999999999997 111.115 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -89.16 123.35 33.33 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.413 -0.958 . . . . 71.120000000000005 108.413 167.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -90.36 102.49 5.05 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.016 1.326 . . . . 70.019999999999996 109.83 -174.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -82.63 119.66 3.01 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.667 2.245 . . . . 63.109999999999999 111.917 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.4 t -89.58 118.56 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 109.396 -0.594 . . . . 63.450000000000003 109.396 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.77 143.42 54.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.277 0.631 . . . . 61.200000000000003 110.764 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 25.3 m -59.1 124.59 20.45 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.398 0.679 . . . . 41.439999999999998 110.695 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.85 97.06 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.854 0.862 . . . . 62.240000000000002 109.969 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -58.53 -36.95 74.65 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.843 0.857 . . . . 74.239999999999995 110.135 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 60.4 73.69 0.61 Allowed Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 114.492 -1.231 . . . . 53.009999999999998 109.934 -177.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.34 118.65 4.83 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.648 2.232 . . . . 71.0 111.279 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -62.78 -30.5 71.5 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.982 0.913 . . . . 74.409999999999997 111.045 -176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.84 130.33 2.13 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.701 -0.681 . . . . 73.340000000000003 112.657 174.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 73.2 mt -103.85 109.36 21.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.541 0.736 . . . . 54.420000000000002 109.124 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.5 p -72.3 99.37 2.39 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.538 0.735 . . . . 72.230000000000004 110.718 -176.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -123.27 122.43 38.34 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.066 0.946 . . . . 70.420000000000002 109.71 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' A' ' 96' ' ' ASP . . . -94.43 70.56 3.68 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.6 0.714 . . . . 73.439999999999998 110.353 -175.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.84 121.92 21.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.029 -0.987 . . . . 51.020000000000003 110.846 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -120.34 -0.55 10.38 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.156 0.582 . . . . 72.430000000000007 110.977 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 30.5 t90 -73.92 88.75 1.85 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.346 -0.613 . . . . 63.439999999999998 109.346 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -85.77 64.32 8.54 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.194 -0.912 . . . . 64.349999999999994 110.809 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.2 p -61.25 -33.31 73.31 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.737 0.78 . . . . 62.020000000000003 110.175 172.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -106.63 131.03 54.24 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.254 -1.339 . . . . 74.310000000000002 109.032 173.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -122.17 163.44 19.54 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.389 0.676 . . . . 73.310000000000002 110.094 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -93.93 128.89 40.49 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.146 0.578 . . . . 74.310000000000002 110.554 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.6 mt -137.65 -45.56 0.54 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.579 1.152 . . . . 72.140000000000001 108.888 173.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 78.4 mt -74.24 104.42 5.01 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 114.933 -1.031 . . . . 65.319999999999993 109.48 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.62 81.63 2.05 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.354 1.062 . . . . 71.040000000000006 110.794 -172.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.04 66.42 0.26 Allowed Glycine 0 CA--C 1.534 1.246 0 CA-C-O 119.523 -0.598 . . . . 53.530000000000001 112.9 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.85 160.92 36.92 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.55 2.166 . . . . 55.0 112.435 174.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 62.1 m -72.82 125.7 28.17 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.415 0.686 . . . . 73.329999999999998 111.305 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.749 ' HG3' HD22 ' A' ' 84' ' ' LEU . 1.1 tm-20 -102.13 145.45 29.34 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.429 0.692 . . . . 72.140000000000001 109.682 176.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -164.92 30.13 0.06 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 107.327 -1.36 . . . . 74.319999999999993 107.327 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -147.96 142.89 17.02 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-N 115.47 -0.786 . . . . 45.049999999999997 111.057 -164.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.69 -12.88 12.15 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.157 2.572 . . . . 72.019999999999996 112.817 173.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -88.61 38.14 0.86 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.464 1.105 . . . . 75.430000000000007 110.738 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.749 HD22 ' HG3' ' A' ' 79' ' ' GLU . 20.8 tp -89.53 113.63 25.06 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-N 115.378 -0.828 . . . . 71.129999999999995 110.184 -173.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 3.0 m-85 -103.83 176.56 5.11 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.877 1.271 . . . . 72.099999999999994 108.78 174.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.1 p -141.58 148.46 20.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 108.624 -0.88 . . . . 65.510000000000005 108.624 170.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.88 127.96 33.14 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.162 0.585 . . . . 74.439999999999998 109.55 173.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.25 -22.78 24.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.45 1.1 . . . . 71.040000000000006 111.067 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -136.79 160.25 39.41 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.377 0.671 . . . . 74.409999999999997 109.924 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -81.53 123.09 28.34 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.415 -0.957 . . . . 72.439999999999998 108.415 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.441 ' HB3' HG12 ' A' ' 101' ' ' ILE . 91.8 t80 -125.8 116.68 21.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.417 -0.957 . . . . 72.430000000000007 108.417 178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.6 p -80.67 139.03 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.072 0.549 . . . . 74.239999999999995 110.211 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.06 132.27 42.15 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.934 0.494 . . . . 45.149999999999999 110.917 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 t -74.36 -27.53 60.71 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.377 0.671 . . . . 50.219999999999999 109.737 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.48 -144.51 7.25 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.516 -0.634 . . . . 73.150000000000006 111.516 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.485 ' HB2' ' HA ' ' A' ' 64' ' ' ALA . 31.2 t70 -71.24 -24.23 62.15 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.692 0.797 . . . . 72.530000000000001 110.952 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.424 ' HB2' HD12 ' A' ' 23' ' ' ILE . 27.4 p-10 -67.93 -22.61 65.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.04 0.936 . . . . 75.409999999999997 111.238 -177.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.5 p -129.87 158.54 39.21 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.298 1.039 . . . . 62.229999999999997 110.226 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.2 tp -110.08 136.46 49.29 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.131 -0.692 . . . . 74.129999999999995 109.131 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 7.4 t -81.73 112.9 19.32 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 107.503 -1.295 . . . . 50.530000000000001 107.503 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.441 HG12 ' HB3' ' A' ' 91' ' ' PHE . 37.1 pt -119.95 157.8 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.569 0.748 . . . . 71.209999999999994 109.452 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.5 m -131.32 143.84 50.82 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.545 -0.539 . . . . 63.210000000000001 109.545 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -52.07 123.84 11.47 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.778 0.831 . . . . 64.310000000000002 111.533 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.92 -22.69 34.5 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.054 -0.521 . . . . 62.32 112.935 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -76.9 132.33 39.05 Favored 'General case' 0 C--N 1.354 0.795 0 CA-C-N 117.119 0.46 . . . . 31.129999999999999 110.26 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.587 ' HD2' HD21 ' A' ' 84' ' ' LEU . 41.2 mtmt -82.25 127.9 33.65 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 124.11 0.881 . . . . 61.240000000000002 109.661 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.9 mt -108.21 130.98 55.12 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.829 0.852 . . . . 74.400000000000006 109.241 -171.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -91.82 106.23 18.31 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.777 -0.823 . . . . 72.230000000000004 108.777 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 89.7 t -96.89 117.03 40.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 108.871 -0.789 . . . . 75.209999999999994 108.871 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.4 mt -71.38 -27.46 63.35 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.328 0.651 . . . . 72.329999999999998 110.418 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.79 175.61 34.87 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.482 -0.781 . . . . 71.129999999999995 111.792 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.59 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 2.1 m-30 -95.2 171.17 8.89 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.006 -1.109 . . . . 74.010000000000005 108.006 173.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.525 HD21 ' HB2' ' A' ' 117' ' ' GLU . 32.0 p30 -76.05 178.58 6.22 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.923 -0.399 . . . . 73.430000000000007 109.923 172.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -65.03 -16.65 63.69 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.331 0.493 . . . . 72.230000000000004 112.331 -172.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.435 ' OD1' ' HA ' ' A' ' 3' ' ' GLN . 63.1 t30 -109.7 -8.27 14.97 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-O 120.859 0.361 . . . . 54.340000000000003 111.564 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 74.18 21.92 78.4 Favored Glycine 0 N--CA 1.469 0.838 0 N-CA-C 114.185 0.434 . . . . 73.019999999999996 114.185 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.525 ' HB2' HD21 ' A' ' 113' ' ' ASN . 25.5 mt-10 -74.67 -55.52 5.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.993 0.902 . . . . 71.420000000000002 110.118 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -118.72 133.01 56.16 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 113.998 -1.455 . . . . 73.420000000000002 108.513 -176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -110.97 127.52 55.53 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.917 1.287 . . . . 71.129999999999995 110.401 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -77.58 106.43 9.37 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.033 0.444 . . . . 71.519999999999996 110.325 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.48 163.48 12.83 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.336 -0.847 . . . . 74.019999999999996 110.61 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -142.78 131.53 22.7 Favored 'General case' 0 C--O 1.249 1.051 0 C-N-CA 124.24 1.016 . . . . 73.329999999999998 108.581 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 81.4 p -143.66 -167.86 2.69 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.697 1.199 . . . . 74.049999999999997 109.463 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -57.93 -18.79 25.49 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.671 1.188 . . . . 72.310000000000002 112.028 173.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -89.62 -6.51 56.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.598 1.159 . . . . 65.439999999999998 111.692 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.38 -141.85 16.86 Favored Glycine 0 C--N 1.353 1.511 0 N-CA-C 111.392 -0.683 . . . . 64.209999999999994 111.392 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -142.77 138.92 30.79 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.421 0.688 . . . . 72.200000000000003 110.63 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 176.32 -177.02 47.91 Favored Glycine 0 C--N 1.345 1.066 0 N-CA-C 111.622 -0.591 . . . . 44.25 111.622 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.681 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 33.9 m95 -100.4 136.91 39.55 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.349 0.66 . . . . 64.230000000000004 110.816 -172.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.23 149.85 74.83 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.331 1.053 . . . . 73.439999999999998 109.27 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.95 137.02 33.94 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 121.74 1.627 . . . . 75.5 110.94 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.471 ' HA ' HG12 ' A' ' 135' ' ' ILE . 26.3 m -61.4 -17.1 52.55 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.729 0.812 . . . . 55.200000000000003 112.64 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -71.1 -26.75 63.17 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.024 0.93 . . . . 63.32 111.175 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -98.94 3.94 47.22 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.923 0.889 . . . . 73.099999999999994 111.658 -173.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 132' ' ' SER . 16.2 pt -130.63 157.62 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.779 0.432 . . . . 74.340000000000003 110.047 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.426 ' HA ' ' HD3' ' A' ' 137' ' ' PRO . 14.2 t -155.76 135.07 7.88 Favored Pre-proline 0 CA--C 1.555 1.159 0 O-C-N 123.349 0.406 . . . . 74.439999999999998 110.005 172.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 3.0 Cg_exo -74.94 117.03 4.77 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.955 2.437 . . . . 64.219999999999999 111.953 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.2 m -91.89 -34.37 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 122.988 0.515 . . . . 71.299999999999997 112.137 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -99.84 16.75 22.72 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.641 0.734 . . . . 64.310000000000002 110.077 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.1 t -92.74 -176.8 4.35 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.736 0.779 . . . . 62.229999999999997 110.649 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.428 HD13 HD23 ' A' ' 214' ' ' LEU . 51.7 mt -64.91 -12.59 50.96 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.441 1.496 . . . . 63.340000000000003 112.151 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -55.86 -23.36 30.45 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.65 1.18 . . . . 72.310000000000002 112.524 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -58.58 -19.66 40.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.538 0.735 . . . . 74.319999999999993 111.368 175.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -95.74 131.99 41.43 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.254 1.022 . . . . 73.349999999999994 108.332 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.2 m -70.8 -6.9 41.28 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.081 0.771 . . . . 71.430000000000007 113.081 -175.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 33.4 p-90 -81.05 -27.6 35.69 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.258 0.223 . . . . 73.219999999999999 111.498 173.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -94.91 120.49 35.21 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.126 -0.694 . . . . 63.100000000000001 109.126 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -112.81 6.88 18.24 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 116.346 -0.388 . . . . 64.340000000000003 111.368 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 151' ' ' VAL . . . 70.73 -150.8 48.52 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 119.032 -0.871 . . . . 63.119999999999997 113.461 177.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.55 104.28 0.92 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 123.279 2.652 . . . . 73.129999999999995 111.6 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 149' ' ' GLY . 40.4 t -124.32 140.1 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-O 120.761 0.315 . . . . 63.420000000000002 110.838 -173.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.0 t -71.1 160.14 33.42 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.875 0.87 . . . . 74.400000000000006 111.088 172.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -62.91 -36.89 84.85 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.66 -0.7 . . . . 71.299999999999997 110.874 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -66.51 -51.62 54.7 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 123.714 0.634 . . . . 73.549999999999997 109.991 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -57.33 -42.27 81.57 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 124.002 0.814 . . . . 74.140000000000001 110.734 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.9 -59.63 4.77 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.694 -1.139 . . . . 60.030000000000001 111.257 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -67.11 -29.26 68.95 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 116.065 -0.516 . . . . 73.549999999999997 111.317 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -61.82 -53.78 51.25 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.453 0.701 . . . . 61.119999999999997 110.113 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.492 ' HB2' HD11 ' A' ' 169' ' ' LEU . 77.8 mt -67.35 -38.05 84.23 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.044 -0.526 . . . . 73.439999999999998 110.848 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.508 HD23 HG13 ' A' ' 190' ' ' VAL . 25.4 tp -71.22 -30.65 66.61 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.359 -0.837 . . . . 75.019999999999996 112.184 -172.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 75.4 m -68.35 -16.72 64.04 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.368 0.667 . . . . 72.340000000000003 111.963 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 43.3 m -82.23 3.86 25.78 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.703 0.801 . . . . 74.329999999999998 111.027 172.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -101.82 -178.89 28.04 Favored Glycine 0 C--N 1.344 0.978 0 C-N-CA 123.244 0.449 . . . . 70.329999999999998 113.228 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.4 pt -132.05 -163.89 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.508 1.123 . . . . 74.109999999999999 108.884 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.677 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 26.8 p-10 -50.75 112.09 0.65 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.452 0.701 . . . . 73.010000000000005 112.424 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 92.76 14.26 55.43 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.749 -0.659 . . . . 42.340000000000003 113.36 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 60.8 p -77.95 135.52 37.85 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 108.993 -0.743 . . . . 62.310000000000002 108.993 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.439 ' CE2' ' HB3' ' A' ' 232' ' ' LEU . 21.3 p90 -136.62 162.2 33.79 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.019 0.748 . . . . 62.439999999999998 113.019 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' A' ' 159' ' ' LEU . 84.3 mt -137.78 133.99 34.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.179 0.991 . . . . 72.010000000000005 108.582 169.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.93 118.27 56.13 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 107.698 -1.223 . . . . 72.530000000000001 107.698 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -128.99 165.6 20.81 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.899 -1.046 . . . . 72.5 108.988 -171.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 17.0 pt-20 -117.06 161.89 18.68 Favored 'General case' 0 C--O 1.261 1.674 0 N-CA-C 108.214 -1.032 . . . . 73.200000000000003 108.214 161.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 46.8 t -77.68 144.61 37.19 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.415 0.686 . . . . 71.230000000000004 110.263 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.417 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 29.3 mt-10 -71.03 -44.0 66.73 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.609 -1.178 . . . . 71.239999999999995 109.701 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 18.8 m -91.46 3.14 55.68 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.23 -0.896 . . . . 54.420000000000002 111.702 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.4 t -155.89 77.86 4.5 Favored Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 109.256 -0.646 . . . . 71.040000000000006 109.256 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.49 ' HG2' ' HB2' ' A' ' 112' ' ' TYR . 36.1 Cg_exo -62.18 138.16 70.6 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.173 2.582 . . . . 73.409999999999997 112.559 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.07 -24.34 27.19 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.808 -0.633 . . . . 62.299999999999997 112.335 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -88.9 118.58 28.71 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.428 -1.323 . . . . 74.540000000000006 107.428 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 82.0 mtt85 -115.7 165.4 13.09 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 123.067 0.547 . . . . 74.420000000000002 112.298 -165.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 40.3 t -151.91 136.98 17.34 Favored 'General case' 0 C--O 1.247 0.972 0 C-N-CA 124.478 1.111 . . . . 35.409999999999997 109.437 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 58.1 mt -105.43 141.92 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 109.016 -0.735 . . . . 64.439999999999998 109.016 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 12.9 m -117.94 115.73 25.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.575 1.15 . . . . 61.229999999999997 108.508 -177.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.427 HD21 ' CD2' ' A' ' 232' ' ' LEU . 58.6 mt -105.31 143.96 32.75 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.909 0.883 . . . . 73.030000000000001 111.219 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 46.3 ttt-85 -133.64 131.12 39.19 Favored 'General case' 0 C--O 1.26 1.621 0 CA-C-N 114.818 -1.083 . . . . 74.129999999999995 109.564 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.677 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 9.2 p90 -152.44 139.7 19.4 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 124.503 1.127 . . . . 75.140000000000001 108.733 173.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 56.73 24.86 9.5 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 124.766 1.226 . . . . 71.239999999999995 112.937 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.85 8.04 80.16 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 116.651 -0.249 . . . . 71.319999999999993 112.973 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 26.5 tpt180 -102.35 123.35 45.98 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.394 1.078 . . . . 71.439999999999998 109.359 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.508 HG13 HD23 ' A' ' 160' ' ' LEU . 77.1 t -110.76 128.49 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.723 1.209 . . . . 63.530000000000001 109.149 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.434 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 31.2 p90 -145.43 158.28 43.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.46 0.704 . . . . 71.030000000000001 109.135 173.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -130.9 141.53 50.3 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.509 -1.293 . . . . 73.230000000000004 107.509 -173.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -138.45 149.43 45.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.691 0.396 . . . . 74.209999999999994 110.002 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 13.3 tpp85 -84.38 137.2 33.53 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.262 -0.881 . . . . 75.519999999999996 111.088 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 65.0 mt -83.07 110.09 17.65 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 N-CA-C 108.321 -0.992 . . . . 70.349999999999994 108.321 166.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -68.04 119.43 12.65 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.341 1.056 . . . . 71.219999999999999 109.117 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.1 m -102.89 116.68 33.03 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.685 0.394 . . . . 65.420000000000002 109.971 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 202' ' ' LYS . . . -67.16 167.08 12.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.462 1.105 . . . . 64.120000000000005 111.986 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.2 m -61.71 -30.15 70.57 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.685 0.794 . . . . 74.409999999999997 110.883 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.403 ' HB2' ' HG3' ' A' ' 202' ' ' LYS . 29.0 m-20 -70.76 -12.66 61.68 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.705 1.202 . . . . 71.540000000000006 111.783 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 87.77 2.73 81.24 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 111.818 -0.513 . . . . 45.310000000000002 111.818 -169.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 198' ' ' ALA . 64.6 mttp -68.27 159.38 31.39 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 123.073 0.549 . . . . 62.450000000000003 110.111 175.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 79.6 mt -121.38 145.61 47.72 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.447 -0.945 . . . . 71.200000000000003 108.447 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -165.87 174.83 9.18 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.628 0.771 . . . . 72.219999999999999 110.018 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 78.2 t -138.47 -53.84 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 107.715 -1.217 . . . . 72.340000000000003 107.715 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 17.3 m -73.19 148.75 43.48 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.414 -0.812 . . . . 71.409999999999997 110.026 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.3 m -61.22 -42.2 98.19 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.239 1.016 . . . . 63.109999999999999 112.312 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -84.52 -36.52 22.14 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 122.742 0.417 . . . . 54.439999999999998 111.333 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.9 m -67.65 138.68 56.55 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.659 0.784 . . . . 75.019999999999996 111.665 -177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -142.37 119.85 11.68 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.555 1.142 . . . . 73.200000000000003 109.067 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -117.94 136.61 53.38 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 109.634 -0.506 . . . . 73.019999999999996 109.634 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -84.29 -26.25 28.71 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.347 0.659 . . . . 62.32 109.943 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 81.8 p -130.47 147.64 52.19 Favored 'General case' 0 C--O 1.256 1.411 0 CA-C-O 121.694 0.759 . . . . 73.239999999999995 111.115 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.428 HD23 HD13 ' A' ' 141' ' ' LEU . 35.2 tp -67.65 -29.27 68.53 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 114.529 -1.214 . . . . 72.040000000000006 111.08 178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.67 -38.74 92.02 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.609 0.363 . . . . 75.140000000000001 110.836 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -75.19 -32.38 61.22 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 116.522 -0.308 . . . . 54.439999999999998 110.763 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.53 -47.17 85.07 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 110.16 -0.311 . . . . 72.239999999999995 110.16 171.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 43.0 t -69.42 -44.65 79.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.061 0.945 . . . . 71.140000000000001 110.359 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -61.78 -45.43 93.92 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.249 0.547 . . . . 55.229999999999997 110.869 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.459 ' O ' HG22 ' A' ' 224' ' ' VAL . 49.7 t-80 -53.03 -54.48 34.77 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.843 -1.072 . . . . 74.430000000000007 108.727 175.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -61.99 -26.08 68.01 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.544 -0.753 . . . . 74.430000000000007 112.426 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 50.5 m -72.44 -30.15 64.34 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.8 0.44 . . . . 74.109999999999999 111.188 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -108.74 -17.04 14.04 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 115.578 1.696 . . . . 64.409999999999997 115.578 -176.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 220' ' ' HIS . 30.8 m -98.38 148.02 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 115.936 1.828 . . . . 72.340000000000003 115.936 -165.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -83.51 -2.44 55.95 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 129.337 3.055 . . . . 60.030000000000001 112.635 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -79.11 13.41 1.82 Allowed 'General case' 0 CA--C 1.576 1.964 0 C-N-CA 129.252 3.021 . . . . 52.439999999999998 113.331 -138.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.76 16.19 4.18 Favored Glycine 0 N--CA 1.466 0.687 0 N-CA-C 110.091 -1.204 . . . . 63.109999999999999 110.091 -169.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 69.1 mt -90.72 135.05 33.97 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.83 0.852 . . . . 73.019999999999996 109.766 163.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.434 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 84.2 mt -67.66 -44.38 86.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.868 -0.79 . . . . 53.329999999999998 108.868 172.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.3 t -137.7 142.86 41.04 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.327 -0.851 . . . . 50.530000000000001 109.491 174.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 73.5 p -74.77 157.55 35.0 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.24 0.616 . . . . 62.420000000000002 109.565 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.439 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . 23.5 mt -70.85 101.74 2.2 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 109.567 -0.531 . . . . 61.140000000000001 109.567 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -79.0 -49.7 12.29 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.46 0.704 . . . . 62.049999999999997 110.224 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 167' ' ' SER . 4.3 p90 -164.76 152.72 10.45 Favored Pre-proline 0 N--CA 1.494 1.741 0 CA-C-O 119.61 -0.233 . . . . 70.150000000000006 110.511 173.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.18 146.63 32.25 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 121.936 1.757 . . . . 74.540000000000006 112.505 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -76.25 144.91 75.66 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.242 0.617 . . . . 61.240000000000002 109.409 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -84.7 170.34 10.2 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.548 2.165 . . . . 71.430000000000007 113.733 -171.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -86.02 162.86 18.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.254 1.022 . . . . 72.129999999999995 109.204 169.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 38.6 ttm105 -52.53 -30.22 29.39 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.69 0.757 . . . . 74.349999999999994 111.075 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -62.62 179.25 0.36 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 114.805 -1.089 . . . . 74.019999999999996 110.361 174.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -103.67 94.68 6.43 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.979 -0.748 . . . . 72.140000000000001 108.979 172.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.31 157.45 22.73 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.193 1.929 . . . . 63.310000000000002 111.327 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 5.1 t -124.43 107.34 11.0 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 109.204 -0.665 . . . . 74.430000000000007 109.204 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 11.2 m -134.46 142.73 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.142 0.977 . . . . 61.310000000000002 109.239 175.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -154.81 139.55 17.09 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.354 -0.98 . . . . 73.5 108.354 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 118.99 127.66 3.68 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 110.933 -0.867 . . . . 74.219999999999999 110.933 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.6 139.91 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.013 -1.106 . . . . 63.409999999999997 108.013 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 46.3 m -131.16 83.8 59.18 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.517 0.727 . . . . 75.129999999999995 109.607 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.16 130.76 7.42 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.825 2.35 . . . . 55.140000000000001 111.214 174.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -80.86 135.44 35.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.122 0.569 . . . . 74.400000000000006 110.218 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -142.49 100.88 3.78 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.112 0.965 . . . . 74.349999999999994 109.644 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -161.69 161.49 29.46 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.958 -0.756 . . . . 74.109999999999999 108.958 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.67 -35.18 78.37 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.919 0.487 . . . . 64.010000000000005 110.663 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -144.15 159.02 43.36 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.884 0.873 . . . . 73.219999999999999 109.887 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 CA--C 1.553 1.083 0 C-N-CA 124.05 0.94 . . . . 63.020000000000003 109.725 -179.12 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 tmm? . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 108.794 -0.817 . . . . 72.349999999999994 108.794 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.41 123.02 0.63 Allowed Glycine 0 C--N 1.338 0.668 0 N-CA-C 111.271 -0.731 . . . . 65.219999999999999 111.271 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -62.04 -56.3 20.35 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.213 0.506 . . . . 64.420000000000002 109.686 174.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 34.46 55.12 1.78 Allowed Pre-proline 0 CA--C 1.57 1.724 0 C-N-CA 126.563 1.945 . . . . 73.230000000000004 115.211 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.51 -33.32 3.25 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 121.842 1.695 . . . . 51.009999999999998 112.427 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.93 -84.8 0.07 OUTLIER Glycine 0 C--N 1.351 1.368 0 O-C-N 123.435 0.459 . . . . 73.230000000000004 113.608 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -159.56 27.51 0.19 Allowed 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.678 0.791 . . . . 72.219999999999999 110.193 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.816 ' HA ' ' HB2' ' A' ' 16' ' ' SER . 27.9 m -61.28 -31.33 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 122.449 0.3 . . . . 73.150000000000006 111.448 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.2 tp -108.07 137.43 46.08 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.996 0.918 . . . . 73.040000000000006 109.184 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.11 -176.15 43.16 Favored Glycine 0 C--O 1.24 0.512 0 N-CA-C 111.077 -0.809 . . . . 64.099999999999994 111.077 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -75.99 -15.35 60.16 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.037 0.535 . . . . 54.439999999999998 111.062 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -57.75 129.21 40.86 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.094 0.958 . . . . 53.200000000000003 111.94 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 137.73 58.34 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.962 -0.755 . . . . 72.319999999999993 108.962 172.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 54.85 69.59 1.99 Allowed Pre-proline 0 CA--C 1.555 1.151 0 O-C-N 123.859 0.725 . . . . 72.120000000000005 109.918 -168.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.5 160.72 22.93 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.674 2.249 . . . . 75.530000000000001 110.909 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.816 ' HB2' ' HA ' ' A' ' 8' ' ' VAL . 14.5 m -68.76 166.59 17.17 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 121.201 0.524 . . . . 75.140000000000001 111.936 -168.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.4 mt -102.66 127.22 30.73 Favored Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 108.764 -0.828 . . . . 54.340000000000003 108.764 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.13 171.16 17.35 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.187 1.925 . . . . 71.400000000000006 111.31 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.68 146.87 27.99 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 122.409 0.283 . . . . 73.329999999999998 110.642 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.531 ' HB3' HD11 ' A' ' 23' ' ' ILE . 70.5 mt -85.54 92.51 8.55 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 107.89 -1.152 . . . . 74.209999999999994 107.89 175.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -97.71 -48.42 5.23 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.725 -0.472 . . . . 75.340000000000003 109.725 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -101.56 114.18 27.97 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.354 -0.839 . . . . 71.310000000000002 109.451 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 20' ' ' LEU . 41.8 mm -117.65 113.62 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 108.588 -0.893 . . . . 63.310000000000002 108.588 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.553 ' HB3' ' HZ2' ' A' ' 129' ' ' TRP . 49.0 tttm -100.24 120.37 39.81 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 114.881 -1.054 . . . . 54.130000000000003 109.453 -178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -71.91 118.18 6.84 Favored Glycine 0 C--N 1.347 1.194 0 O-C-N 123.648 0.592 . . . . 54.329999999999998 112.139 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.52 ' HB1' ' HD2' ' A' ' 29' ' ' ARG . . . -77.45 -43.83 31.05 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.153 0.581 . . . . 73.409999999999997 112.001 -175.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.01 -99.15 0.29 Allowed Glycine 0 C--N 1.347 1.171 0 O-C-N 123.491 0.495 . . . . 31.120000000000001 112.25 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -121.57 155.63 34.63 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.276 -1.009 . . . . 74.349999999999994 108.276 169.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -128.0 156.95 41.9 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.558 0.343 . . . . 75.019999999999996 111.146 -172.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -91.74 10.78 26.97 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.16 0.584 . . . . 60.009999999999998 110.893 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 m -63.13 109.32 1.48 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.086 0.555 . . . . 43.5 109.591 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.4 p -57.38 118.11 4.81 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.288 1.035 . . . . 70.209999999999994 111.941 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -112.33 169.29 8.97 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.316 0.646 . . . . 62.0 110.83 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -154.79 168.71 25.96 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.45 -0.796 . . . . 72.420000000000002 110.01 173.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.37 168.65 54.6 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 123.737 0.648 . . . . 71.219999999999999 112.911 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -176.57 -169.13 37.58 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-O 118.836 -0.98 . . . . 60.340000000000003 112.568 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -42.67 131.09 5.44 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 124.524 3.483 . . . . 42.109999999999999 114.709 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -56.43 106.13 0.26 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.193 0.997 . . . . 72.200000000000003 111.811 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.2 t -83.38 143.97 29.96 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.082 -1.081 . . . . 74.129999999999995 108.082 166.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -76.2 76.56 3.01 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.406 0.622 . . . . 64.519999999999996 110.407 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.4 m -97.39 145.47 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.134 -0.939 . . . . 72.329999999999998 108.911 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.48 138.03 31.88 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 109.625 -0.509 . . . . 73.040000000000006 109.625 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.519 HG22 ' H ' ' A' ' 46' ' ' GLU . 4.2 p -70.73 111.21 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 123.255 0.622 . . . . 63.310000000000002 110.58 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -80.53 -34.16 35.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.473 0.709 . . . . 71.25 110.777 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -68.08 -22.67 64.91 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.84 0.456 . . . . 75.219999999999999 111.484 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.519 ' H ' HG22 ' A' ' 43' ' ' VAL . 10.6 tp10 -72.94 125.11 26.83 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 109.275 -0.639 . . . . 54.009999999999998 109.275 173.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.41 -97.2 0.08 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.72 -0.844 . . . . 64.200000000000003 108.72 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.0 mt 46.78 -78.56 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 125.927 1.691 . . . . 61.450000000000003 113.453 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -55.72 -39.54 71.22 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 125.058 1.343 . . . . 64.099999999999994 111.546 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 58.95 87.22 0.14 Allowed Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 124.244 1.018 . . . . 74.420000000000002 109.824 -171.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -63.08 89.07 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.642 2.228 . . . . 71.409999999999997 111.466 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 61.9 t -83.43 74.32 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.784 0 N-CA-C 108.303 -0.999 . . . . 63.229999999999997 108.303 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.52 115.43 16.26 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 114.921 -1.036 . . . . 42.329999999999998 108.785 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.0 p -67.53 92.07 0.3 Allowed 'General case' 0 CA--C 1.547 0.85 0 O-C-N 123.892 0.745 . . . . 34.32 109.809 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -72.33 96.06 1.81 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-N 114.705 -1.134 . . . . 73.510000000000005 110.631 -173.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -120.71 103.47 9.14 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.751 -0.659 . . . . 74.420000000000002 109.629 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 61.6 75.84 0.42 Allowed Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.592 1.157 . . . . 41.329999999999998 112.267 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.23 95.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.384 2.723 . . . . 64.129999999999995 113.157 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -118.79 107.99 14.31 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.49 1.116 . . . . 71.129999999999995 108.78 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.97 171.02 33.81 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.38 -0.688 . . . . 64.329999999999998 111.38 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 74.6 mt -99.13 135.66 40.21 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.131 0.572 . . . . 72.299999999999997 110.153 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.2 m -78.24 79.42 4.68 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.413 0.625 . . . . 51.310000000000002 109.441 171.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -76.39 136.1 39.48 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.757 -1.11 . . . . 74.109999999999999 111.028 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.8 82.6 7.78 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.488 0.715 . . . . 71.219999999999999 110.184 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.93 104.82 3.07 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.918 -0.583 . . . . 53.109999999999999 109.456 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -82.5 50.25 1.61 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.271 1.028 . . . . 74.120000000000005 111.3 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -110.62 100.71 9.45 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.025 0.93 . . . . 73.319999999999993 109.938 -176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -124.46 93.2 3.84 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.337 -1.357 . . . . 62.229999999999997 107.337 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.3 t -90.71 108.67 19.97 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.827 0.451 . . . . 53.219999999999999 109.915 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.77 -18.28 64.18 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.156 0.583 . . . . 70.310000000000002 112.104 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -89.1 56.72 3.79 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.8 0.84 . . . . 60.450000000000003 110.949 -171.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -167.44 153.69 7.91 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.463 0.705 . . . . 65.129999999999995 109.443 -176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.1 mt -122.16 82.41 1.96 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.111 0.564 . . . . 64.540000000000006 110.287 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.3 mt -96.84 -73.96 0.58 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 109.615 -0.513 . . . . 72.209999999999994 109.615 169.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -146.16 123.02 11.29 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.05 0.54 . . . . 53.229999999999997 109.686 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -118.97 167.54 13.17 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-O 119.37 -0.683 . . . . 63.539999999999999 112.446 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -62.09 95.98 0.14 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 123.588 2.859 . . . . 71.019999999999996 111.786 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.7 m -77.5 98.28 5.29 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.372 -0.831 . . . . 75.219999999999999 110.511 -174.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -96.61 108.6 21.22 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.408 1.083 . . . . 74.329999999999998 110.408 -175.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -173.26 165.7 4.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 123.642 0.589 . . . . 74.510000000000005 110.892 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 79.85 137.36 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 126.245 1.818 . . . . 75.340000000000003 112.649 173.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -70.43 -7.89 22.31 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.311 2.674 . . . . 74.450000000000003 111.786 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -82.36 27.01 0.52 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.415 1.086 . . . . 72.109999999999999 111.182 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 28.3 tp -86.09 116.24 24.18 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.391 0.676 . . . . 71.219999999999999 109.702 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 3.6 m-85 -104.62 177.18 4.92 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.816 1.646 . . . . 73.450000000000003 109.202 174.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.8 p -140.82 142.85 29.59 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 108.277 -1.008 . . . . 74.219999999999999 108.277 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.99 116.62 16.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.997 0.519 . . . . 74.239999999999995 109.825 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.52 -24.11 50.08 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.859 0.864 . . . . 73.450000000000003 110.689 172.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -130.83 158.75 39.33 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.983 0.513 . . . . 71.209999999999994 110.17 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.02 151.64 37.11 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.911 -0.586 . . . . 72.209999999999994 109.459 172.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.531 ' HB3' HG12 ' A' ' 101' ' ' ILE . 81.1 t80 -155.8 116.58 3.82 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.298 -0.63 . . . . 74.230000000000004 109.298 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.56 138.78 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 108.988 -0.745 . . . . 73.239999999999995 108.988 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.408 ' HB2' ' N ' ' A' ' 100' ' ' SER . . . -75.53 129.51 37.36 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 122.178 -0.326 . . . . 63.020000000000003 110.862 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 m -66.07 -23.95 66.62 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.385 0.674 . . . . 75.319999999999993 110.607 173.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.96 -153.33 12.93 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.42 -0.809 . . . . 73.549999999999997 111.261 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.6 -26.14 60.66 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.219 0.608 . . . . 74.510000000000005 110.58 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -69.73 -21.68 63.44 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.756 0.822 . . . . 70.219999999999999 112.014 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.0 p -117.02 155.0 29.94 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.407 1.083 . . . . 72.040000000000006 109.036 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.2 tp -108.93 123.93 49.86 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.242 -0.651 . . . . 74.310000000000002 109.242 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.408 ' N ' ' HB2' ' A' ' 93' ' ' ALA . 31.2 p -69.46 115.38 8.66 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.653 -0.869 . . . . 75.25 108.653 171.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.531 HG12 ' HB3' ' A' ' 91' ' ' PHE . 34.5 pt -119.59 143.68 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.271 -0.64 . . . . 50.439999999999998 109.271 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 m -112.38 144.73 41.33 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.977 -0.749 . . . . 62.240000000000002 108.977 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -56.07 119.65 6.23 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.668 0.387 . . . . 74.409999999999997 110.148 173.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.13 -17.29 44.63 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.301 -0.409 . . . . 73.209999999999994 113.219 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -78.8 129.51 34.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.143 0.577 . . . . 64.010000000000005 110.226 176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.401 ' HD2' HD21 ' A' ' 84' ' ' LEU . 48.0 mtmt -87.48 130.14 34.81 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.024 0.529 . . . . 65.530000000000001 110.566 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.47 ' HB3' ' HB1' ' A' ' 121' ' ' ALA . 18.8 mt -107.3 148.1 29.43 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.232 1.013 . . . . 54.299999999999997 108.937 -172.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -111.04 107.92 17.47 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.386 -0.968 . . . . 63.329999999999998 108.386 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.2 t -99.78 123.44 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.243 0.617 . . . . 54.340000000000003 110.078 -171.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.429 HD12 ' HD3' ' A' ' 29' ' ' ARG . 91.5 mt -94.86 -4.45 47.0 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.506 0.722 . . . . 74.230000000000004 111.457 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.48 165.33 18.11 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 112.5 -0.24 . . . . 54.539999999999999 112.5 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.45 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 2.4 m-85 -97.06 174.53 6.71 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.665 0.786 . . . . 63.329999999999998 109.993 172.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -72.5 150.33 43.34 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.131 -0.94 . . . . 64.120000000000005 108.687 171.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -63.0 -27.17 69.24 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.237 0.458 . . . . 64.340000000000003 112.237 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.418 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 64.0 t30 -92.22 -10.96 36.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.041 0.536 . . . . 73.230000000000004 110.689 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 81.61 22.32 60.3 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 116.199 -0.455 . . . . 73.019999999999996 113.419 178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.418 ' HG3' ' HB3' ' A' ' 115' ' ' ASN . 78.8 mt-10 -67.42 -62.38 1.45 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.836 0.854 . . . . 73.409999999999997 110.332 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -120.17 -179.12 3.84 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.928 -1.033 . . . . 53.020000000000003 109.781 -175.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -144.36 123.45 12.87 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.574 0.75 . . . . 60.439999999999998 109.703 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -70.94 95.04 1.12 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.499 0.72 . . . . 70.239999999999995 110.693 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' A' ' 107' ' ' LEU . . . -105.45 145.21 31.16 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.444 0.698 . . . . 55.219999999999999 110.263 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.9 130.77 45.58 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.397 0.679 . . . . 64.329999999999998 110.195 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.9 p -133.93 -173.49 3.27 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.12 0.968 . . . . 73.439999999999998 109.643 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -61.94 -21.53 64.85 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.21 0.604 . . . . 63.039999999999999 111.339 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -76.07 -5.86 48.47 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.158 0.983 . . . . 73.040000000000006 111.836 178.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 116.41 -135.65 12.23 Favored Glycine 0 C--N 1.342 0.903 0 N-CA-C 110.316 -1.114 . . . . 53.219999999999999 110.316 -176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -151.13 156.63 41.39 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.541 0.67 . . . . 65.319999999999993 111.493 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 174.32 176.47 42.73 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.726 -0.67 . . . . 52.329999999999998 112.727 170.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.553 ' HZ2' ' HB3' ' A' ' 24' ' ' LYS . 86.9 m95 -84.54 118.7 24.49 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.495 -0.853 . . . . 74.549999999999997 110.037 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.91 153.93 47.01 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.742 1.217 . . . . 63.399999999999999 109.265 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -69.93 131.14 20.39 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 121.529 1.486 . . . . 73.430000000000007 111.059 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 27.4 p -59.63 -25.48 64.71 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.832 0.853 . . . . 75.120000000000005 111.828 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -74.91 -17.81 60.51 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.544 1.138 . . . . 72.150000000000006 112.094 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -95.34 -4.68 44.98 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.694 0.798 . . . . 65.430000000000007 112.386 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.7 pt -128.33 156.93 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 122.51 0.324 . . . . 63.350000000000001 110.721 -170.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.3 t -148.81 134.28 9.54 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 122.792 0.437 . . . . 62.509999999999998 109.957 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 74.3 Cg_endo -75.59 123.1 7.32 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.457 2.105 . . . . 64.209999999999994 112.918 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.9 m -98.3 -40.38 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.283 0.633 . . . . 65.040000000000006 111.825 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.468 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.0 t30 -99.01 5.39 47.15 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.104 0.562 . . . . 75.299999999999997 111.832 -172.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.8 p -83.9 -166.29 1.37 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.981 0.513 . . . . 64.340000000000003 110.655 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.408 HD13 ' HB3' ' A' ' 214' ' ' LEU . 71.7 mt -77.38 -12.16 59.92 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.804 0.841 . . . . 73.409999999999997 111.998 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.21 -21.12 66.45 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.497 0.719 . . . . 64.25 111.56 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.68 -29.4 64.62 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.994 0.918 . . . . 54.530000000000001 110.604 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -79.57 137.71 37.24 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.66 0.784 . . . . 73.310000000000002 109.633 172.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.0 m -63.39 -17.96 63.19 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.59 0.756 . . . . 71.430000000000007 112.778 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 51.9 p-90 -77.42 -35.55 54.04 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.324 0.49 . . . . 64.129999999999995 112.324 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -97.64 130.1 44.68 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.531 -0.544 . . . . 71.340000000000003 109.531 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -122.64 19.92 10.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.789 0.436 . . . . 75.040000000000006 111.574 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 73.5 -155.32 49.94 Favored Glycine 0 CA--C 1.536 1.366 0 N-CA-C 114.839 0.696 . . . . 72.349999999999994 114.839 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.26 99.06 1.24 Allowed 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 123.587 2.858 . . . . 73.430000000000007 112.049 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.5 t -142.7 145.92 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.188 0.995 . . . . 64.209999999999994 109.298 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 67.9 m -82.64 169.28 16.43 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 112.843 0.683 . . . . 72.010000000000005 112.843 -177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -53.71 -37.99 63.84 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 124.014 0.926 . . . . 72.299999999999997 112.488 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -56.04 -50.17 71.67 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.858 0.463 . . . . 73.219999999999999 111.746 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.89 -30.23 40.09 Favored 'General case' 0 C--O 1.247 0.942 0 C-N-CA 123.478 0.711 . . . . 62.450000000000003 110.465 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.716 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -59.57 -48.22 82.5 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.915 -0.584 . . . . 42.420000000000002 111.212 172.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.526 ' HG3' HG11 ' A' ' 190' ' ' VAL . 28.5 tt0 -78.85 -25.95 44.04 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.618 0.767 . . . . 73.109999999999999 109.574 -176.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.71 -52.78 63.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.665 0.786 . . . . 73.030000000000001 111.645 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.446 ' HB2' HD11 ' A' ' 169' ' ' LEU . 48.5 mt -72.22 -34.57 68.44 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 120.728 0.299 . . . . 75.439999999999998 111.042 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.453 HD22 ' HB3' ' A' ' 183' ' ' SER . 33.2 tp -66.72 -26.72 67.14 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.145 0.578 . . . . 62.450000000000003 111.898 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.3 t -64.28 -17.53 63.72 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.855 0.862 . . . . 75.420000000000002 111.715 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 7.0 m -89.26 -6.51 56.75 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.72 0.808 . . . . 73.109999999999999 111.565 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -97.62 161.11 21.18 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 114.616 0.606 . . . . 73.319999999999993 114.616 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.7 pt -102.59 -164.27 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.904 0.882 . . . . 63.140000000000001 110.221 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.862 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 13.3 p-10 -51.34 118.56 3.36 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.766 0.827 . . . . 74.319999999999993 113.124 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.59 14.37 68.2 Favored Glycine 0 C--O 1.256 1.499 0 CA-C-N 115.574 -0.739 . . . . 63.420000000000002 113.227 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.6 t -69.49 134.04 48.42 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.075 -0.713 . . . . 73.519999999999996 109.075 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.547 ' HA ' ' O ' ' A' ' 183' ' ' SER . 20.1 p90 -139.97 154.13 47.09 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.879 0.696 . . . . 72.439999999999998 112.879 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 159' ' ' LEU . 97.8 mt -133.08 133.73 43.36 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.708 -0.849 . . . . 44.32 108.708 169.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.416 HG22 HG12 ' A' ' 182' ' ' ILE . 22.7 t -106.55 118.0 53.41 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 107.363 -1.347 . . . . 71.209999999999994 107.363 174.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.716 HH11 ' HA ' ' A' ' 156' ' ' ALA . 28.9 mtt180 -147.42 152.03 37.44 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.198 0.999 . . . . 74.239999999999995 109.527 -174.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 16.1 pt-20 -106.76 162.6 13.64 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.8 -0.815 . . . . 62.530000000000001 108.8 172.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 43.5 t -77.27 134.54 38.53 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.657 0.383 . . . . 65.519999999999996 110.262 -178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -60.76 -43.78 97.56 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.404 0.682 . . . . 73.439999999999998 109.962 175.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 62.5 p -90.6 5.73 46.69 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.67 -1.15 . . . . 70.040000000000006 112.188 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.0 m -150.69 87.96 4.68 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.443 0.697 . . . . 73.129999999999995 109.333 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.45 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 27.1 Cg_endo -60.84 138.98 82.75 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.827 2.351 . . . . 61.140000000000001 111.89 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.83 -23.07 11.19 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 116.066 -0.516 . . . . 70.129999999999995 113.652 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -83.52 113.76 21.02 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.141 -0.689 . . . . 63.109999999999999 109.141 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.692 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 67.6 mtt-85 -114.77 170.71 8.13 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.088 -0.505 . . . . 74.230000000000004 110.124 -170.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.472 ' HB2' ' HD3' ' A' ' 194' ' ' ARG . 33.0 t -161.02 148.56 15.48 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.397 0.679 . . . . 60.340000000000003 110.048 -177.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.416 HG12 HG22 ' A' ' 170' ' ' VAL . 55.3 mt -112.78 141.06 29.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 107.955 -1.128 . . . . 51.329999999999998 107.955 166.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 20.0 m -118.12 112.29 19.99 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 124.287 1.035 . . . . 74.209999999999994 108.849 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.465 HD21 HD23 ' A' ' 232' ' ' LEU . 38.2 mt -104.78 142.25 35.04 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.486 0.585 . . . . 75.299999999999997 112.424 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -129.99 125.65 35.87 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 114.565 -1.198 . . . . 74.409999999999997 108.182 168.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.862 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 6.3 p90 -140.65 134.97 31.2 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 109.162 -0.681 . . . . 74.530000000000001 109.162 174.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 58.15 22.95 9.64 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.664 1.186 . . . . 73.400000000000006 112.48 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 84.07 7.99 84.56 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.203 -0.453 . . . . 45.200000000000003 113.654 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -102.49 124.99 49.04 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.422 0.689 . . . . 74.209999999999994 109.543 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.526 HG11 ' HG3' ' A' ' 157' ' ' GLU . 98.1 t -104.96 134.77 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.236 1.014 . . . . 63.340000000000003 110.478 -177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.461 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 32.4 p90 -147.0 151.84 37.63 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.34 1.056 . . . . 63.219999999999999 108.811 168.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -121.47 150.94 40.83 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.588 -0.893 . . . . 72.099999999999994 108.588 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -146.19 139.62 26.01 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.631 0.373 . . . . 74.109999999999999 110.464 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.472 ' HD3' ' HB2' ' A' ' 181' ' ' SER . 32.5 mmt180 -82.76 140.6 32.92 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.75 0.786 . . . . 74.109999999999999 112.913 -172.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.692 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 84.9 mt -93.04 111.2 24.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.863 0 CA-C-N 114.284 -1.325 . . . . 73.129999999999995 107.539 165.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -87.98 133.35 33.96 Favored 'General case' 0 C--O 1.246 0.874 0 N-CA-C 109.395 -0.594 . . . . 74.120000000000005 109.395 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.7 m -94.19 116.46 28.87 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.265 0.626 . . . . 72.0 109.717 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -67.51 160.36 27.78 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.433 0.693 . . . . 75.140000000000001 110.997 171.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.3 t -66.4 -10.16 40.96 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.796 0.839 . . . . 74.129999999999995 111.957 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -90.61 5.19 48.98 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.79 0.836 . . . . 64.230000000000004 111.8 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 81.08 -3.5 76.26 Favored Glycine 0 C--N 1.349 1.269 0 C-N-CA 122.796 0.236 . . . . 72.030000000000001 113.097 -175.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -83.5 135.19 34.74 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.692 0.797 . . . . 64.230000000000004 110.136 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.9 mt -92.97 157.32 16.39 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.508 0.723 . . . . 73.530000000000001 110.052 -177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -164.4 156.95 16.92 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.161 0.505 . . . . 64.140000000000001 111.29 174.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.3 t -117.04 -67.03 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 106.904 -1.517 . . . . 71.340000000000003 106.904 170.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 15.8 m -68.44 140.81 55.77 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.07 0.948 . . . . 51.530000000000001 110.257 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 54.7 p -62.86 -31.49 72.53 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.329 0.652 . . . . 45.149999999999999 111.666 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -88.08 3.31 49.46 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.513 0.725 . . . . 74.439999999999998 112.084 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 70.5 m -123.1 144.12 49.52 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.762 0.425 . . . . 61.450000000000003 111.453 -174.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 81.0 mmt-85 -143.03 135.43 27.39 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 107.609 -1.256 . . . . 74.310000000000002 107.609 176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -131.33 135.73 47.51 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 107.708 -1.219 . . . . 75.219999999999999 107.708 -176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -75.07 -35.91 61.81 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 122.551 0.34 . . . . 72.319999999999993 110.122 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 77.4 p -124.26 150.51 45.26 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.479 0.712 . . . . 62.210000000000001 111.848 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.408 ' HB3' HD13 ' A' ' 141' ' ' LEU . 33.2 tp -69.64 -28.15 65.66 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.974 -1.012 . . . . 71.019999999999996 110.523 174.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.87 -44.58 91.12 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.042 0.537 . . . . 73.420000000000002 110.486 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -77.56 -29.32 52.13 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.815 -0.63 . . . . 74.129999999999995 112.273 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.3 tt -61.27 -46.34 90.74 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 118.363 0.529 . . . . 74.319999999999993 109.898 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 67.0 t -74.1 -42.09 51.99 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 C-N-CA 123.891 0.876 . . . . 64.200000000000003 111.129 -176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -58.77 -52.4 65.86 Favored 'General case' 0 C--O 1.262 1.74 0 CA-C-O 121.289 0.566 . . . . 63.229999999999997 111.223 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.483 ' O ' HG22 ' A' ' 224' ' ' VAL . 37.9 t-80 -54.67 -56.99 13.33 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 114.646 -1.161 . . . . 55.299999999999997 108.377 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.405 ' HA ' HG22 ' A' ' 224' ' ' VAL . 10.4 m170 -68.05 -14.65 63.14 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.17 0.804 . . . . 70.040000000000006 113.17 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.493 ' HA ' ' HB2' ' A' ' 232' ' ' LEU . 42.0 t -73.77 -34.65 64.77 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 110.169 -0.308 . . . . 71.310000000000002 110.169 171.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.9 t -108.5 -13.42 14.84 Favored 'General case' 0 CA--C 1.563 1.471 0 N-CA-C 116.144 1.905 . . . . 72.329999999999998 116.144 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 220' ' ' HIS . 34.1 m -103.63 165.84 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 116.316 1.969 . . . . 72.510000000000005 116.316 -165.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.85 -1.71 58.05 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.829 3.252 . . . . 62.140000000000001 113.854 -172.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -78.67 14.36 1.34 Allowed 'General case' 0 CA--C 1.576 1.955 0 C-N-CA 130.322 3.449 . . . . 63.420000000000002 113.519 -138.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.11 17.61 4.46 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 110.856 -0.897 . . . . 42.200000000000003 110.856 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 92.8 mt -92.36 124.03 36.12 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.828 1.251 . . . . 62.200000000000003 110.34 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.461 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 89.5 mt -61.73 -40.78 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 N-CA-C 109.303 -0.628 . . . . 65.140000000000001 109.303 172.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.5 t -138.19 142.61 40.02 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.275 -0.875 . . . . 75.329999999999998 109.392 166.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 224' ' ' VAL . 82.3 p -66.65 149.59 50.28 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.989 -0.55 . . . . 72.010000000000005 109.547 169.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 222' ' ' SER . 40.9 mt -65.48 103.32 0.82 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.001 0.521 . . . . 74.420000000000002 109.956 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -75.62 -59.42 2.76 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.518 0.727 . . . . 65.540000000000006 109.809 -176.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -156.44 150.67 19.86 Favored Pre-proline 0 N--CA 1.49 1.526 0 CA-C-O 119.326 -0.368 . . . . 73.349999999999994 110.212 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 31.2 Cg_endo -62.81 137.3 62.31 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.116 1.877 . . . . 63.520000000000003 111.855 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -59.59 135.74 89.29 Favored Pre-proline 0 C--O 1.243 0.747 0 C-N-CA 123.333 0.653 . . . . 63.530000000000001 111.045 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.01 117.21 3.88 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.387 2.058 . . . . 73.310000000000002 112.617 -174.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.602 ' HE2' ' HB3' ' A' ' 240' ' ' ASN . 19.9 ptmt -63.71 158.27 22.02 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.542 -1.208 . . . . 73.420000000000002 109.843 170.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -61.51 -29.65 70.12 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 112.369 0.507 . . . . 73.409999999999997 112.369 -172.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.602 ' HB3' ' HE2' ' A' ' 238' ' ' LYS . 27.7 t-20 -82.83 137.24 34.38 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 108.426 -0.954 . . . . 62.420000000000002 108.426 169.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -56.94 108.83 1.36 Allowed Pre-proline 0 N--CA 1.486 1.361 0 C-N-CA 124.574 1.15 . . . . 74.120000000000005 113.099 -168.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -94.89 151.82 1.76 Allowed 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.045 2.496 . . . . 72.019999999999996 112.191 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 57.5 m -145.49 111.96 5.8 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.479 0.712 . . . . 73.319999999999993 109.547 -176.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.7 t -89.03 93.82 4.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 108.612 -0.885 . . . . 74.340000000000003 108.612 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -102.72 131.45 49.54 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.548 -0.751 . . . . 73.420000000000002 108.988 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -167.84 -74.61 0.03 OUTLIER Glycine 0 C--N 1.347 1.185 0 CA-C-O 119.786 -0.452 . . . . 75.540000000000006 112.281 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 92.2 t 63.71 100.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 125.0 1.32 . . . . 53.299999999999997 111.341 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 33.3 t -135.93 83.93 33.1 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 123.636 0.774 . . . . 44.310000000000002 109.16 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -82.16 76.66 4.13 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.853 2.369 . . . . 73.299999999999997 112.542 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -96.12 127.77 42.42 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.186 -0.672 . . . . 73.420000000000002 109.186 174.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -125.96 86.68 2.56 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.612 -0.884 . . . . 72.319999999999993 108.612 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -98.98 -177.9 3.77 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.392 -1.276 . . . . 65.329999999999998 110.045 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -159.29 -178.72 7.38 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.242 -0.89 . . . . 74.340000000000003 109.25 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -154.94 -68.55 0.13 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.43 -0.952 . . . . 61.140000000000001 108.43 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 124.174 0.99 . . . . 73.439999999999998 108.384 -179.01 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.9 tpp . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.892 -0.41 . . . . 54.32 109.892 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.69 178.97 19.27 Favored Glycine 0 C--N 1.342 0.916 0 O-C-N 123.405 0.441 . . . . 70.510000000000005 113.171 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.493 HE22 ' HG3' ' A' ' 5' ' ' PRO . 8.5 tm0? -168.71 109.19 0.5 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.223 -1.399 . . . . 71.430000000000007 107.223 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -159.95 86.83 1.99 Allowed Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 124.733 1.213 . . . . 74.209999999999994 108.276 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.493 ' HG3' HE22 ' A' ' 3' ' ' GLN . 13.2 Cg_exo -68.59 114.41 3.49 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.962 2.442 . . . . 73.239999999999995 112.186 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.468 ' O ' ' HG2' ' A' ' 7' ' ' LYS . . . 147.15 -146.74 16.91 Favored Glycine 0 C--N 1.341 0.826 0 O-C-N 123.93 0.769 . . . . 54.340000000000003 112.1 173.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 6' ' ' GLY . 3.4 ptpp? 61.73 15.02 6.6 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 126.318 1.847 . . . . 71.310000000000002 112.205 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.5 m -121.38 52.6 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.955 1.302 . . . . 72.219999999999999 109.599 -178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.06 124.48 24.19 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.741 -1.118 . . . . 61.240000000000002 110.078 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.76 62.53 4.59 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.557 -1.017 . . . . 75.549999999999997 110.557 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.75 -58.3 3.6 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.768 0.827 . . . . 71.400000000000006 110.579 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.52 ' HB3' ' HA ' ' A' ' 66' ' ' ARG . 12.1 pt20 -141.62 -177.35 5.13 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.64 -0.709 . . . . 75.230000000000004 110.801 -176.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.514 ' HG3' ' HE2' ' A' ' 89' ' ' TYR . 13.5 ttt85 -75.5 127.01 32.16 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.208 -1.034 . . . . 74.329999999999998 108.208 170.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 61.64 76.82 0.38 Allowed Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.871 1.269 . . . . 62.140000000000001 110.655 -158.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -79.93 169.86 17.37 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.991 2.461 . . . . 71.239999999999995 110.439 167.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.9 m -65.08 167.03 8.53 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.073 0.463 . . . . 71.0 111.355 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.9 mt -104.79 128.46 26.75 Favored Pre-proline 0 C--O 1.241 0.644 0 N-CA-C 109.205 -0.665 . . . . 52.030000000000001 109.205 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -66.32 165.95 22.99 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.566 2.177 . . . . 63.020000000000003 111.865 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.98 146.71 31.9 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 120.809 0.337 . . . . 63.530000000000001 110.53 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.611 ' HB3' HD11 ' A' ' 23' ' ' ILE . 75.6 mt -87.02 93.17 9.28 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.524 -0.917 . . . . 75.299999999999997 108.524 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -95.26 -45.24 7.24 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.942 -1.026 . . . . 54.43 109.389 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -105.85 115.36 30.1 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.144 -0.935 . . . . 72.0 110.084 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.611 HD11 ' HB3' ' A' ' 20' ' ' LEU . 45.9 mm -116.47 113.84 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.298 -1.001 . . . . 50.399999999999999 108.298 175.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -117.37 150.17 39.3 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.81 0.844 . . . . 74.209999999999994 109.185 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -171.18 58.46 0.18 Allowed Glycine 0 C--O 1.241 0.588 0 N-CA-C 110.161 -1.176 . . . . 70.209999999999994 110.161 -177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.06 -46.69 84.98 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.785 0.834 . . . . 65.430000000000007 110.787 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.97 171.31 13.97 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 115.753 -0.658 . . . . 63.399999999999999 112.176 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -77.38 73.44 3.95 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.102 0.561 . . . . 71.239999999999995 109.863 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -93.97 -28.05 16.0 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.375 0.67 . . . . 73.310000000000002 109.646 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.93 -162.05 1.2 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.526 1.131 . . . . 73.219999999999999 109.048 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.4 m 71.81 99.29 0.07 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.413 1.085 . . . . 64.230000000000004 111.71 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m -69.87 144.78 52.42 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.774 -0.648 . . . . 73.340000000000003 111.145 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 -98.72 95.8 7.48 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.035 0.934 . . . . 43.130000000000003 109.735 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -73.39 -38.19 65.72 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.663 -0.699 . . . . 63.310000000000002 110.738 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.13 -164.97 23.84 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 115.76 -0.655 . . . . 44.549999999999997 112.41 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.23 159.19 7.91 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-O 119.384 -0.676 . . . . 62.340000000000003 111.79 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -78.92 136.63 13.35 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.779 2.32 . . . . 73.239999999999995 111.919 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -76.25 112.82 13.14 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.784 -1.191 . . . . 71.239999999999995 107.784 167.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 63.8 m -63.65 108.59 1.44 Allowed 'General case' 0 C--O 1.243 0.74 0 O-C-N 123.615 0.572 . . . . 73.230000000000004 110.443 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -69.22 128.29 36.08 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.971 -0.751 . . . . 75.040000000000006 108.971 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.6 t -88.21 127.39 41.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 116.357 -0.383 . . . . 64.420000000000002 111.0 -168.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -94.17 -47.28 6.72 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.097 0.959 . . . . 74.010000000000005 108.925 173.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.0 m -68.59 78.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 124.058 0.943 . . . . 62.32 112.337 -174.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -137.61 127.71 25.96 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.974 -0.557 . . . . 73.140000000000001 110.774 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -165.13 134.13 3.42 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 124.074 0.95 . . . . 75.25 108.444 171.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -84.12 130.56 34.84 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.507 -0.553 . . . . 73.25 109.507 174.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.98 107.48 9.12 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.15 -1.056 . . . . 75.310000000000002 108.15 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.5 mt 61.76 84.21 0.14 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.199 1.0 . . . . 71.209999999999994 110.3 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -72.29 131.58 42.89 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.416 -0.587 . . . . 60.299999999999997 109.416 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -101.42 94.65 4.28 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 108.577 -0.897 . . . . 72.349999999999994 108.577 172.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -94.4 179.15 0.85 Allowed 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.533 2.155 . . . . 75.310000000000002 112.863 172.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 51.1 t -124.25 85.97 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 107.149 -1.426 . . . . 53.329999999999998 107.149 175.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.63 104.17 3.72 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.793 0.837 . . . . 65.299999999999997 110.144 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.1 m 62.74 19.31 11.32 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.656 1.182 . . . . 72.109999999999999 112.893 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -70.14 100.57 1.68 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.103 0.561 . . . . 62.409999999999997 110.588 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -79.13 79.8 5.52 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.483 -0.932 . . . . 73.019999999999996 108.483 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 60.09 72.57 0.74 Allowed Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.983 0.913 . . . . 73.439999999999998 111.04 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -76.65 21.07 0.58 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.423 2.748 . . . . 34.299999999999997 114.138 -170.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -73.08 89.85 1.5 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 109.567 -0.531 . . . . 54.140000000000001 109.567 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -144.3 28.6 1.94 Allowed Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.915 -0.874 . . . . 20.030000000000001 110.915 176.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 89.0 mt -74.8 96.11 3.03 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.034 0.934 . . . . 51.009999999999998 109.962 -174.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 t -123.79 13.41 9.24 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.002 0.921 . . . . 54.039999999999999 110.453 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -70.3 -64.38 0.9 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.425 0.69 . . . . 62.119999999999997 110.361 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 55.53 40.86 31.19 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.91 1.284 . . . . 61.219999999999999 111.227 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.0 105.4 17.12 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.644 -0.707 . . . . 45.439999999999998 110.349 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.52 ' HA ' ' HB3' ' A' ' 12' ' ' GLN . 7.0 mpt_? -80.88 82.55 6.83 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.151 0.58 . . . . 64.439999999999998 109.985 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -76.55 135.29 39.26 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.665 -0.865 . . . . 63.329999999999998 108.665 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -97.09 162.79 13.21 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 120.998 0.428 . . . . 54.509999999999998 110.913 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.7 m -125.49 137.16 53.95 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.986 0.914 . . . . 74.129999999999995 109.703 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -71.8 115.31 10.85 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.571 0.749 . . . . 74.340000000000003 111.004 -176.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -75.92 -55.16 5.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.85 0.86 . . . . 73.310000000000002 111.513 -172.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -78.99 75.88 5.48 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.111 0.565 . . . . 74.200000000000003 111.373 -174.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.5 mt -92.63 54.22 2.21 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.146 -1.057 . . . . 70.230000000000004 108.146 167.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.8 mt -74.79 82.73 2.13 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.635 -1.166 . . . . 70.430000000000007 109.663 -175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -125.67 95.95 4.62 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.885 -1.154 . . . . 73.230000000000004 107.885 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.73 81.82 0.35 Allowed Glycine 0 C--N 1.346 1.115 0 CA-C-O 119.488 -0.618 . . . . 53.450000000000003 112.498 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.92 -25.8 44.67 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.282 1.988 . . . . 64.439999999999998 111.106 169.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.7 t -107.03 96.98 6.82 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 114.759 -1.109 . . . . 53.149999999999999 109.759 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -87.82 -9.97 52.27 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.962 0.505 . . . . 62.530000000000001 111.945 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -89.51 9.43 26.6 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.624 0.37 . . . . 64.25 111.611 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.552 ' HB2' HD22 ' A' ' 139' ' ' ASN . 17.0 m-20 -69.73 155.73 92.98 Favored Pre-proline 0 N--CA 1.48 1.054 0 N-CA-C 109.454 -0.572 . . . . 75.420000000000002 109.454 166.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.482 ' HG3' ' NH1' ' A' ' 108' ' ' ARG . 74.2 Cg_endo -69.12 -145.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.377 2.718 . . . . 73.540000000000006 111.587 173.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.633 ' HA ' ' HA ' ' A' ' 140' ' ' SER . 48.8 m-80 -66.14 85.99 0.1 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.898 0.856 . . . . 53.049999999999997 108.751 167.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 30.2 tp -87.4 122.91 31.77 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.306 -1.315 . . . . 54.329999999999998 109.865 -173.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -107.22 174.7 5.77 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.556 1.142 . . . . 74.439999999999998 109.225 174.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 p -148.24 142.55 19.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 108.464 -0.939 . . . . 72.040000000000006 108.464 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.449 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -78.39 123.28 26.83 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.513 0.508 . . . . 70.219999999999999 110.398 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.08 -22.92 41.7 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.34 0.656 . . . . 60.240000000000002 110.499 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.514 ' HE2' ' HG3' ' A' ' 13' ' ' ARG . 22.0 m-85 -127.15 162.0 27.15 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.939 0.896 . . . . 74.409999999999997 109.012 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.11 150.39 25.58 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.054 -1.091 . . . . 74.219999999999999 108.054 166.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -156.26 108.58 2.57 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.83 -1.174 . . . . 74.420000000000002 107.83 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.4 p -80.44 135.77 24.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.779 -0.823 . . . . 53.520000000000003 108.779 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.83 123.27 16.49 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.169 0.588 . . . . 21.440000000000001 110.687 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.2 t -84.39 8.26 16.82 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.554 0.742 . . . . 72.310000000000002 110.778 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 171.51 -171.64 44.14 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.789 -0.524 . . . . 74.530000000000001 111.789 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.5 -27.59 62.36 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.683 0.793 . . . . 45.439999999999998 110.682 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -74.84 -24.3 58.58 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.794 0.838 . . . . 55.219999999999999 112.74 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.9 p -102.03 157.58 16.77 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.603 0.761 . . . . 60.0 110.731 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.8 tp -110.0 131.83 54.71 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.516 0.727 . . . . 70.319999999999993 110.319 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.0 m -71.28 118.69 14.4 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.08 -0.711 . . . . 74.230000000000004 109.08 168.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.7 pt -124.03 147.18 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.566 0.746 . . . . 72.329999999999998 109.016 173.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.3 m -115.46 145.02 42.98 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.67 -0.493 . . . . 74.340000000000003 109.67 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -55.25 114.8 1.94 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.747 0.819 . . . . 63.130000000000003 110.856 174.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.78 -16.16 37.0 Favored Glycine 0 C--N 1.35 1.361 0 O-C-N 123.167 0.292 . . . . 73.400000000000006 112.763 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -78.38 137.24 37.92 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 124.153 0.981 . . . . 71.409999999999997 110.973 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.59 ' HB3' HD11 ' A' ' 84' ' ' LEU . 29.8 mtmt -77.44 134.72 38.31 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 124.044 0.84 . . . . 70.430000000000007 109.777 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 87' ' ' ALA . 19.0 mt -120.3 135.87 54.87 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.38 0.672 . . . . 73.129999999999995 109.255 -173.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.482 ' NH1' ' HG3' ' A' ' 82' ' ' PRO . 50.9 mtp85 -93.56 108.14 19.89 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.718 -0.845 . . . . 74.209999999999994 108.718 167.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.459 HG21 HD12 ' A' ' 135' ' ' ILE . 95.6 t -95.27 108.94 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.565 -0.902 . . . . 41.219999999999999 108.565 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 62.2 mt -70.86 -28.97 64.97 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.025 0.93 . . . . 74.200000000000003 110.224 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.85 173.12 37.05 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-N 114.648 -1.16 . . . . 71.010000000000005 111.013 176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 51.3 m-85 -96.8 175.02 6.51 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.648 -0.871 . . . . 55.229999999999997 108.648 176.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.496 ' HB3' ' H ' ' A' ' 117' ' ' GLU . 49.8 t-20 -63.4 144.39 57.01 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.69 -1.226 . . . . 72.340000000000003 107.69 173.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -54.37 -32.65 57.47 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.688 0.795 . . . . 72.230000000000004 110.905 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -86.53 -19.83 28.89 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.441 1.097 . . . . 74.299999999999997 111.797 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.07 34.46 7.18 Favored Glycine 0 N--CA 1.477 1.418 0 C-N-CA 123.121 0.391 . . . . 63.32 113.854 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.496 ' H ' ' HB3' ' A' ' 113' ' ' ASN . 28.5 mt-10 -99.4 -65.86 0.94 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.466 0.706 . . . . 64.349999999999994 111.043 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -103.01 -176.77 3.18 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.668 1.187 . . . . 73.219999999999999 110.207 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -143.66 117.16 9.14 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.563 0.745 . . . . 63.240000000000002 110.032 -177.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -73.81 97.96 2.85 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.615 -0.513 . . . . 54.25 109.615 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.78 168.14 9.33 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.145 -0.934 . . . . 74.030000000000001 110.718 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -147.48 127.81 13.94 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 108.57 -0.9 . . . . 72.120000000000005 108.57 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.6 p -139.71 -172.57 3.41 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.025 0.93 . . . . 75.519999999999996 109.785 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -63.02 -20.68 65.55 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.509 -0.768 . . . . 74.329999999999998 111.307 171.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -81.72 -4.11 55.43 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.056 0.943 . . . . 71.219999999999999 111.269 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 125.47 -135.07 9.07 Favored Glycine 0 C--N 1.355 1.589 0 N-CA-C 112.354 -0.298 . . . . 72.120000000000005 112.354 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -150.65 133.88 16.2 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.997 0.919 . . . . 70.010000000000005 109.155 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 176.18 -177.91 47.68 Favored Glycine 0 C--N 1.348 1.25 0 O-C-N 123.214 0.321 . . . . 41.43 112.867 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -88.37 126.53 35.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.374 1.07 . . . . 75.430000000000007 111.149 -174.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.7 m -120.05 154.7 55.79 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.914 1.286 . . . . 72.230000000000004 109.138 176.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.95 132.82 23.81 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 121.744 1.63 . . . . 71.430000000000007 110.398 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.3 m -63.8 -19.33 64.93 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.571 0.748 . . . . 74.340000000000003 112.108 -179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -72.22 -22.05 61.31 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.977 0.911 . . . . 73.319999999999993 111.302 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.496 ' HA ' ' CD1' ' A' ' 89' ' ' TYR . 2.5 m-85 -90.61 -7.4 52.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.763 0.825 . . . . 72.5 113.024 -175.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.459 HD12 HG21 ' A' ' 109' ' ' VAL . 16.1 pt -121.57 157.35 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 122.808 0.443 . . . . 74.420000000000002 110.409 -171.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.5 t -147.35 141.55 15.94 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 122.917 0.487 . . . . 55.340000000000003 110.248 173.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.81 147.15 43.93 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.632 2.221 . . . . 74.140000000000001 112.111 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 m -130.94 -59.96 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.55 0.74 . . . . 73.430000000000007 110.666 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.629 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.1 t30 -103.06 16.08 27.6 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 122.945 0.498 . . . . 74.25 111.06 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 83' ' ' ASN . 41.3 m -60.62 170.78 1.31 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.028 0.531 . . . . 72.140000000000001 111.034 172.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 69.7 mt -55.65 -16.09 3.76 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 113.921 1.082 . . . . 74.299999999999997 113.921 -173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.532 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 31.4 tt0 -65.97 -6.29 12.15 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.536 1.134 . . . . 73.219999999999999 111.478 175.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -56.53 -31.11 63.83 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.271 1.428 . . . . 72.200000000000003 110.496 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -100.29 141.77 32.68 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.566 -0.743 . . . . 72.5 109.262 173.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.3 p -70.42 -5.81 31.14 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.242 0.83 . . . . 74.439999999999998 113.242 -170.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.402 ' CE3' HG21 ' A' ' 218' ' ' VAL . 42.5 p-90 -77.94 -33.64 51.55 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 111.806 0.299 . . . . 72.319999999999993 111.806 174.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.4 ' HB2' ' CZ3' ' A' ' 146' ' ' TRP . 37.3 t80 -99.27 139.25 35.19 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.281 -0.637 . . . . 74.530000000000001 109.281 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.532 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 25.1 m-70 -134.12 38.51 3.15 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.894 0.478 . . . . 72.200000000000003 110.372 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 68.59 -171.16 38.04 Favored Glycine 0 CA--C 1.542 1.732 0 N-CA-C 116.305 1.282 . . . . 70.109999999999999 116.305 165.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.11 100.65 0.88 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 123.635 2.89 . . . . 73.200000000000003 111.553 171.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.464 ' HB ' ' HD2' ' A' ' 171' ' ' ARG . 78.0 t -142.66 148.47 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.772 0.829 . . . . 73.329999999999998 109.352 -174.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.5 m -70.83 151.34 44.89 Favored 'General case' 0 C--O 1.248 1.007 0 C-N-CA 123.93 0.892 . . . . 70.530000000000001 111.288 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -20.59 55.26 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.228 -0.896 . . . . 72.049999999999997 112.186 176.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.83 -59.13 5.6 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.303 1.041 . . . . 75.140000000000001 109.822 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 158' ' ' TYR . . . -70.12 -31.72 69.39 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.842 0.857 . . . . 71.239999999999995 110.81 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.497 ' HA ' HH21 ' A' ' 171' ' ' ARG . . . -57.25 -54.06 51.08 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.43 -0.804 . . . . 70.439999999999998 110.738 171.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -73.1 -23.34 60.51 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.862 -0.608 . . . . 54.539999999999999 110.762 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.411 ' HB3' ' HA ' ' A' ' 155' ' ' ALA . 71.1 t80 -63.58 -49.37 73.66 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.743 0.817 . . . . 72.310000000000002 110.398 175.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.495 HD12 ' NH2' ' A' ' 171' ' ' ARG . 67.3 mt -71.32 -37.52 71.76 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.058 0.456 . . . . 72.299999999999997 110.79 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.438 HD23 HG13 ' A' ' 190' ' ' VAL . 29.1 tp -73.98 -17.27 61.02 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.854 -0.612 . . . . 73.310000000000002 112.269 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 38.9 t -68.86 -19.84 64.26 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.371 0.669 . . . . 63.43 110.651 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.9 t -99.82 6.82 45.34 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.472 0.709 . . . . 70.120000000000005 110.6 174.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.15 163.27 43.11 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 116.089 -0.505 . . . . 62.229999999999997 113.068 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 7.2 pt -126.35 -166.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.442 1.497 . . . . 64.010000000000005 110.396 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.698 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 24.7 p-10 -58.78 110.12 0.95 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.63 0.604 . . . . 73.129999999999995 112.63 -169.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 91.91 13.37 57.92 Favored Glycine 0 C--O 1.256 1.477 0 CA-C-N 115.91 -0.587 . . . . 53.32 113.168 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 67.4 m -77.69 131.35 37.67 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.023 -0.362 . . . . 74.150000000000006 110.023 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.477 ' HB3' HD23 ' A' ' 184' ' ' LEU . 16.2 p90 -133.13 154.88 50.18 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.834 0.679 . . . . 64.209999999999994 112.834 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.6 mt -135.46 133.82 38.94 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.931 -1.032 . . . . 74.230000000000004 108.459 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.6 t -107.74 118.07 54.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 107.838 -1.171 . . . . 73.420000000000002 107.838 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.497 HH21 ' HA ' ' A' ' 156' ' ' ALA . 18.7 mmt180 -118.62 167.58 11.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.059 0.944 . . . . 60.219999999999999 108.798 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.581 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 15.7 pt-20 -117.89 160.76 20.87 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 109.575 -0.528 . . . . 74.319999999999993 109.575 158.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 59.3 m -87.33 135.24 33.4 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.749 -0.66 . . . . 44.340000000000003 110.326 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -74.44 -36.42 63.38 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.007 0.923 . . . . 74.239999999999995 110.872 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 26.5 t -89.37 -16.26 31.41 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.551 0.741 . . . . 61.340000000000003 111.031 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 32.7 t -127.19 85.25 61.43 Favored Pre-proline 0 N--CA 1.478 0.947 0 N-CA-C 108.387 -0.968 . . . . 61.240000000000002 108.387 175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.47 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 51.6 Cg_endo -65.64 140.38 62.09 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.161 2.574 . . . . 72.019999999999996 112.289 -176.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.6 -25.37 5.16 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 115.771 -0.649 . . . . 74.150000000000006 113.102 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -79.95 119.11 22.35 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 108.741 -0.837 . . . . 73.310000000000002 108.741 173.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.581 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 47.9 mtt85 -114.21 165.46 12.65 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 115.019 -0.991 . . . . 75.209999999999994 109.167 -176.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.3 m -146.71 139.01 24.87 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.495 -0.557 . . . . 72.150000000000006 109.495 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 47.4 mt -103.84 140.99 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.1 -1.074 . . . . 73.540000000000006 108.1 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 18.1 m -121.21 111.86 17.92 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.103 -0.953 . . . . 64.25 108.505 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 168' ' ' PHE . 33.9 mt -103.79 143.91 32.19 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.17 0.988 . . . . 53.509999999999998 111.212 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -131.71 133.6 45.01 Favored 'General case' 0 C--O 1.257 1.496 0 CA-C-N 114.825 -1.08 . . . . 75.239999999999995 108.536 168.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.698 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 24.3 p90 -143.73 133.52 23.85 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.862 -1.063 . . . . 74.420000000000002 108.21 173.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 47.64 37.47 6.81 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.674 1.19 . . . . 63.520000000000003 113.817 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 92.18 -5.41 78.3 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.621 -0.718 . . . . 55.020000000000003 113.779 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -102.93 123.99 47.59 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.1 0.56 . . . . 72.340000000000003 109.738 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.438 HG13 HD23 ' A' ' 160' ' ' LEU . 84.7 t -106.27 137.55 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.238 1.015 . . . . 61.219999999999999 109.547 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.402 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 24.3 p90 -145.73 151.33 37.82 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.751 0.821 . . . . 72.200000000000003 109.572 169.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -128.38 134.13 48.77 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.544 -1.28 . . . . 75.409999999999997 107.544 -173.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -136.8 139.36 41.72 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.242 0.544 . . . . 70.219999999999999 110.436 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.544 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 22.2 tpp180 -81.76 122.46 27.7 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.588 -1.187 . . . . 72.140000000000001 111.58 -171.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.491 ' HA ' HG22 ' A' ' 205' ' ' VAL . 73.4 mt -72.69 115.56 13.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 108.308 -0.997 . . . . 75.109999999999999 108.308 162.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -93.46 132.47 37.7 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 109.016 -0.735 . . . . 75.230000000000004 109.016 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.7 m -95.6 116.45 28.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.407 -0.815 . . . . 73.049999999999997 108.909 172.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.35 161.27 22.82 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.138 0.975 . . . . 72.430000000000007 111.693 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 38.3 t -70.06 -10.76 59.77 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.654 0.782 . . . . 64.109999999999999 110.803 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -71.77 -17.12 62.2 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.463 1.105 . . . . 70.340000000000003 111.206 172.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 88.25 2.28 80.41 Favored Glycine 0 C--N 1.355 1.62 0 C-N-CA 123.169 0.414 . . . . 62.100000000000001 112.081 -171.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -90.47 145.33 24.99 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.913 0.885 . . . . 74.140000000000001 110.773 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 86.8 mt -94.23 149.2 21.46 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 123.195 0.598 . . . . 74.299999999999997 109.621 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -162.43 166.94 24.37 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.668 0.605 . . . . 74.230000000000004 111.182 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' A' ' 195' ' ' ILE . 92.8 t -140.88 -62.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.301 1.041 . . . . 71.319999999999993 108.632 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 12.7 m -98.79 -169.96 1.86 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.628 1.171 . . . . 74.329999999999998 111.196 -172.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.8 m -69.99 -47.68 61.22 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.532 0.733 . . . . 65.230000000000004 112.859 -169.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -84.36 -16.77 41.68 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.455 0.702 . . . . 73.140000000000001 109.257 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 71.6 m -64.41 106.59 1.16 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.32 0.648 . . . . 74.150000000000006 111.376 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 210' ' ' ARG . 8.7 mmt180 -146.1 117.57 8.0 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.393 1.077 . . . . 75.120000000000005 109.18 169.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -136.54 152.71 50.8 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.145 0.578 . . . . 75.430000000000007 110.616 -171.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -82.07 -36.28 27.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.197 -0.668 . . . . 75.450000000000003 109.197 168.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 82.8 p -130.73 160.13 35.23 Favored 'General case' 0 C--O 1.252 1.2 0 CA-C-O 122.247 1.022 . . . . 71.5 112.598 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 21.4 tp -74.14 -22.04 59.61 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.15 -1.386 . . . . 72.239999999999995 110.807 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.23 -49.64 76.29 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.44 0.638 . . . . 51.329999999999998 110.41 171.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -62.23 -41.96 98.87 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.521 -1.218 . . . . 72.040000000000006 110.504 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.9 tt -57.88 -48.92 78.41 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.02 0.825 . . . . 64.129999999999995 111.612 177.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.402 HG21 ' CE3' ' A' ' 146' ' ' TRP . 55.7 t -72.08 -38.47 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.083 0.553 . . . . 62.409999999999997 111.19 -174.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -65.43 -46.75 78.69 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.128 0.49 . . . . 73.310000000000002 110.938 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.478 ' O ' HG22 ' A' ' 224' ' ' VAL . 40.6 t-80 -56.07 -52.35 64.58 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.672 -0.695 . . . . 74.540000000000006 109.322 176.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.557 ' HD1' HD21 ' A' ' 228' ' ' LEU . 18.1 m-70 -70.19 -19.15 63.19 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.531 -0.759 . . . . 74.030000000000001 112.535 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 78.2 p -81.29 -20.2 41.36 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.127 0.421 . . . . 70.040000000000006 110.715 172.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 7.0 t -111.53 -12.99 13.9 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.251 1.945 . . . . 75.0 116.251 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 220' ' ' HIS . 30.3 m -105.59 158.34 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 121.145 1.793 . . . . 74.219999999999999 115.733 -167.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -90.7 0.61 57.35 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 128.855 2.862 . . . . 74.129999999999995 113.523 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -81.16 15.03 2.06 Favored 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 128.191 2.596 . . . . 64.510000000000005 113.157 -139.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.02 19.88 3.87 Favored Glycine 0 N--CA 1.464 0.563 0 N-CA-C 110.35 -1.1 . . . . 40.420000000000002 110.35 -170.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.557 HD21 ' HD1' ' A' ' 221' ' ' HIS . 95.7 mt -93.59 128.4 39.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.626 -1.287 . . . . 74.219999999999999 109.102 163.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.402 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 95.3 mt -64.04 -49.0 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.871 -0.788 . . . . 71.010000000000005 108.871 170.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.2 t -130.97 147.83 52.65 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.104 -1.072 . . . . 73.329999999999998 108.104 170.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.0 p -75.29 155.75 36.32 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.913 -0.403 . . . . 72.209999999999994 109.913 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.406 HD23 HD21 ' A' ' 184' ' ' LEU . 27.5 mt -64.58 103.32 0.66 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.397 -0.964 . . . . 74.239999999999995 108.397 176.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -88.28 -58.29 2.61 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.047 -0.723 . . . . 74.400000000000006 109.047 -172.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.563 ' O ' ' HA ' ' A' ' 167' ' ' SER . 14.5 p90 -152.3 149.14 22.29 Favored Pre-proline 0 N--CA 1.484 1.257 0 CA-C-N 116.017 -0.538 . . . . 74.439999999999998 110.272 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 26.8 Cg_exo -63.31 148.88 92.53 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 122.116 1.877 . . . . 74.340000000000003 112.958 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.72 134.22 78.92 Favored Pre-proline 0 C--O 1.241 0.625 0 N-CA-C 108.378 -0.971 . . . . 73.209999999999994 108.378 169.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.07 137.99 59.88 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.417 2.078 . . . . 74.430000000000007 113.379 -171.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -70.26 156.77 38.81 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.284 -1.006 . . . . 74.019999999999996 108.284 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -53.8 -32.89 54.23 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.787 0.835 . . . . 72.420000000000002 112.321 -172.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -98.62 122.91 42.42 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 108.262 -1.014 . . . . 63.520000000000003 108.262 166.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -150.08 113.88 3.36 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 122.477 0.311 . . . . 72.120000000000005 111.661 -174.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.9 159.02 38.46 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.794 2.329 . . . . 63.539999999999999 112.187 166.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 15.1 t -113.12 147.35 37.51 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.643 0.777 . . . . 73.329999999999998 110.162 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 95.7 t -122.62 135.1 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.17 0.988 . . . . 54.420000000000002 108.567 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -90.98 -39.91 11.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.481 0.712 . . . . 61.350000000000001 110.059 -176.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 97.42 172.49 33.68 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.189 -0.914 . . . . 72.430000000000007 112.057 -174.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 16.8 m -139.96 155.78 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.725 0.81 . . . . 72.540000000000006 110.694 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 20.0 m 64.77 119.9 0.02 OUTLIER Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 125.045 1.338 . . . . 65.209999999999994 113.529 171.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.48 179.02 6.73 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.418 2.079 . . . . 71.519999999999996 111.503 171.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -118.72 138.69 52.47 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 109.341 -0.614 . . . . 70.519999999999996 109.341 175.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -100.59 105.66 17.08 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.599 0.76 . . . . 71.439999999999998 109.021 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -59.72 -47.53 85.3 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.938 0.495 . . . . 72.409999999999997 110.184 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -88.19 168.1 13.04 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.296 0.638 . . . . 64.319999999999993 110.291 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 82.4 m95 59.08 90.08 0.05 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.221 1.008 . . . . 70.140000000000001 111.05 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 C--O 1.248 1.023 0 N-CA-C 107.153 -1.425 . . . . 74.299999999999997 107.153 179.164 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.481 1.092 0 N-CA-C 109.599 -0.519 . . . . 64.439999999999998 109.599 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 125.27 -53.59 0.77 Allowed Glycine 0 C--N 1.347 1.148 0 N-CA-C 110.99 -0.844 . . . . 53.340000000000003 110.99 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -105.31 134.43 48.44 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.729 0.812 . . . . 74.510000000000005 109.534 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -102.61 104.54 39.08 Favored Pre-proline 0 C--O 1.241 0.643 0 N-CA-C 108.092 -1.077 . . . . 74.319999999999993 108.092 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.592 ' HG3' ' HB2' ' A' ' 62' ' ' SER . 97.1 Cg_endo -74.09 79.82 2.29 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 122.411 2.074 . . . . 73.049999999999997 111.511 -177.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.76 81.33 0.02 OUTLIER Glycine 0 C--N 1.36 1.867 0 O-C-N 124.02 0.825 . . . . 73.420000000000002 112.676 -175.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -131.73 90.32 2.82 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.827 1.251 . . . . 32.149999999999999 109.212 -170.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.5 m -120.12 159.44 21.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 CA-C-N 115.174 -0.921 . . . . 61.200000000000003 109.575 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.649 HD23 HD21 ' A' ' 133' ' ' ASN . 2.1 mm? -112.09 164.87 12.66 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.922 -1.035 . . . . 42.149999999999999 109.256 -173.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.01 53.74 0.1 OUTLIER Glycine 0 C--N 1.34 0.751 0 N-CA-C 111.144 -0.782 . . . . 44.130000000000003 111.144 -175.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.09 -160.21 0.23 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.209 1.004 . . . . 74.219999999999999 109.145 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -69.08 -157.77 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.272 0.629 . . . . 74.219999999999999 110.387 170.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -61.96 141.35 58.08 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.588 -0.695 . . . . 71.120000000000005 109.979 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 59.16 65.21 2.81 Favored Pre-proline 0 CA--C 1.558 1.285 0 O-C-N 124.327 1.017 . . . . 72.409999999999997 110.783 -170.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.7 166.93 16.53 Favored 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.329 2.019 . . . . 70.230000000000004 111.671 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.6 p -70.93 168.97 15.78 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.563 0.697 . . . . 75.299999999999997 111.297 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.4 mt -106.48 135.16 19.53 Favored Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 115.478 -0.783 . . . . 73.010000000000005 109.946 -173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.72 173.72 13.91 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.602 2.201 . . . . 63.020000000000003 111.874 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.06 148.85 26.6 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.957 0.503 . . . . 74.329999999999998 110.776 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.489 HD22 HD11 ' A' ' 23' ' ' ILE . 79.2 mt -86.3 93.48 9.09 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.79 -0.818 . . . . 72.209999999999994 108.79 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -97.17 -48.83 5.21 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.977 0.511 . . . . 74.209999999999994 110.427 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.473 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 64.1 m-85 -104.16 114.83 29.35 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.313 -0.625 . . . . 51.109999999999999 109.313 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.489 HD11 HD22 ' A' ' 20' ' ' LEU . 47.1 mm -121.77 120.99 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 109.4 -0.593 . . . . 50.329999999999998 109.4 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.5 ' H ' ' HE1' ' A' ' 129' ' ' TRP . 63.8 mttm -115.76 165.55 12.93 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.917 0.887 . . . . 73.450000000000003 109.763 172.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 179.83 44.35 0.08 OUTLIER Glycine 0 C--N 1.337 0.626 0 N-CA-C 110.961 -0.855 . . . . 42.049999999999997 110.961 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -138.64 127.7 24.0 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.144 0.978 . . . . 72.450000000000003 110.045 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 136.75 111.77 1.11 Allowed Glycine 0 C--N 1.347 1.174 0 N-CA-C 111.736 -0.546 . . . . 71.530000000000001 111.736 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -79.55 -21.81 44.67 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.711 0.805 . . . . 74.209999999999994 111.582 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -73.46 84.05 1.49 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.622 1.201 . . . . 63.200000000000003 110.2 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 32' ' ' SER . 15.2 pt-20 -78.8 -175.91 4.69 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 113.605 -1.634 . . . . 64.439999999999998 110.448 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.2 m -98.62 10.33 41.28 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.993 0.517 . . . . 72.129999999999995 111.294 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.409 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 56.4 m -140.3 -148.67 0.25 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.064 1.346 . . . . 63.340000000000003 108.884 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -156.07 93.87 1.47 Allowed 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.067 -0.716 . . . . 72.439999999999998 109.067 168.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -77.1 122.06 24.45 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.625 -0.509 . . . . 74.340000000000003 109.625 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.14 171.86 55.14 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 116.556 -0.293 . . . . 63.25 113.423 -174.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.71 -171.28 47.54 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-O 119.567 -0.574 . . . . 42.509999999999998 113.204 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.14 152.82 56.85 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.925 2.417 . . . . 74.239999999999995 112.182 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -69.24 -50.93 42.56 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.855 -0.611 . . . . 70.230000000000004 109.547 174.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 57.6 m -90.37 112.39 23.97 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.242 1.017 . . . . 74.319999999999993 110.073 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -85.0 112.0 20.21 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.486 0.714 . . . . 73.319999999999993 109.821 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.5 m -74.94 -179.08 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 123.818 0.847 . . . . 42.310000000000002 111.703 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -62.49 143.7 56.84 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.107 0.563 . . . . 70.349999999999994 110.966 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.8 p -154.49 150.63 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.708 -0.849 . . . . 64.030000000000001 108.708 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -138.99 138.21 37.06 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.305 1.042 . . . . 70.329999999999998 108.191 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -81.86 87.84 6.36 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.432 0.634 . . . . 44.530000000000001 109.925 -176.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -114.89 100.54 8.29 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.847 -1.07 . . . . 64.400000000000006 109.1 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.36 76.03 0.95 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.614 0.766 . . . . 51.130000000000003 110.585 -175.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 92.8 mt -89.12 77.64 7.53 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.168 0.987 . . . . 71.040000000000006 110.207 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -101.83 37.03 1.92 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.675 0.79 . . . . 45.409999999999997 110.322 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -59.16 -46.18 99.31 Favored Pre-proline 0 CA--C 1.564 1.491 0 CA-C-O 118.429 -0.796 . . . . 75.420000000000002 110.925 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.14 118.42 5.37 Favored 'Trans proline' 0 C--N 1.394 2.945 0 C-N-CA 121.457 1.438 . . . . 62.109999999999999 110.741 168.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.29 -11.02 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.169 0.587 . . . . 72.129999999999995 112.166 -176.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.9 176.36 9.88 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.254 0.621 . . . . 62.240000000000002 111.487 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.4 t -150.99 -171.7 4.01 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.181 0.992 . . . . 75.120000000000005 108.799 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -142.63 136.55 29.25 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.94 -0.763 . . . . 74.140000000000001 108.94 173.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -124.26 -170.92 2.23 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.889 0.876 . . . . 75.299999999999997 109.721 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 63.84 74.14 0.44 Allowed Pre-proline 0 N--CA 1.49 1.551 0 C-N-CA 124.09 0.956 . . . . 74.530000000000001 112.172 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -85.63 -161.15 0.12 Allowed 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 123.024 2.483 . . . . 61.299999999999997 112.155 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -148.35 169.76 19.45 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.168 0.587 . . . . 73.420000000000002 110.743 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 171.5 86.63 0.06 OUTLIER Glycine 0 C--N 1.348 1.24 0 N-CA-C 111.498 -0.641 . . . . 31.309999999999999 111.498 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.5 mt -118.68 145.84 45.18 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.886 0.875 . . . . 73.450000000000003 110.58 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.592 ' HB2' ' HG3' ' A' ' 5' ' ' PRO . 38.1 m -153.87 148.27 26.06 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.594 1.158 . . . . 63.520000000000003 108.433 170.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -114.45 93.89 4.54 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.737 0.815 . . . . 63.439999999999998 109.229 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.63 133.37 13.04 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 123.959 0.903 . . . . 64.319999999999993 108.868 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.16 90.27 1.51 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.306 0.503 . . . . 61.119999999999997 111.539 -175.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.4 ppt_? -164.66 145.31 7.74 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.284 -1.006 . . . . 73.120000000000005 108.284 166.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 17.3 p90 -127.16 172.18 10.78 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.382 0.673 . . . . 72.439999999999998 109.771 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -139.66 168.81 18.98 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.412 1.085 . . . . 74.030000000000001 108.722 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 62.0 p -78.11 122.17 25.26 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.209 -1.034 . . . . 74.400000000000006 108.209 169.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -84.61 135.11 34.32 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.304 0.642 . . . . 74.230000000000004 110.221 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -74.18 137.89 43.42 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.49 -0.559 . . . . 74.099999999999994 109.49 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -135.42 112.4 10.29 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 123.871 0.868 . . . . 64.219999999999999 110.055 -174.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.5 mt -132.52 102.5 5.74 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.36 1.064 . . . . 64.340000000000003 108.42 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.5 mt -76.59 106.37 8.2 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.806 0.442 . . . . 60.399999999999999 110.342 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.14 69.05 6.47 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.667 -0.864 . . . . 40.340000000000003 108.667 169.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.25 116.41 8.8 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 114.861 -1.063 . . . . 54.240000000000002 113.555 -168.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -87.41 -147.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 123.676 2.917 . . . . 74.120000000000005 110.028 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -66.31 -85.72 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 108.75 -0.833 . . . . 65.25 108.75 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 169.22 150.36 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.079 1.352 . . . . 75.209999999999994 110.069 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.463 ' H ' ' ND2' ' A' ' 139' ' ' ASN . 94.2 m-20 -133.72 -77.28 0.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.61 0.764 . . . . 62.109999999999999 109.63 171.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -143.88 158.78 55.4 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.566 1.146 . . . . 75.310000000000002 108.835 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.27 -19.3 33.99 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.092 2.528 . . . . 63.130000000000003 114.17 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -91.21 17.03 8.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.795 0.838 . . . . 44.240000000000002 111.484 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.91 109.66 18.3 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 108.701 -0.852 . . . . 72.319999999999993 108.701 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 4.4 m-85 -105.69 175.79 5.38 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.49 1.516 . . . . 71.299999999999997 110.421 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.97 148.07 27.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.798 -1.186 . . . . 73.040000000000006 107.798 169.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.52 107.77 14.56 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.754 -0.832 . . . . 53.32 108.754 170.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.4 mt -62.52 -27.4 69.13 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.058 0.943 . . . . 64.109999999999999 111.198 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -141.17 166.35 25.01 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.699 0.8 . . . . 62.409999999999997 109.728 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -81.52 147.47 29.65 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.518 -0.764 . . . . 52.329999999999998 109.812 175.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -155.93 118.09 4.07 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.347 1.059 . . . . 75.140000000000001 108.496 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.44 140.73 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.79 -0.819 . . . . 51.140000000000001 108.79 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.92 117.46 3.98 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.073 0.549 . . . . 63.340000000000003 110.526 175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 m -59.46 -44.17 93.06 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.313 1.045 . . . . 73.310000000000002 110.386 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -160.26 -147.6 4.97 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 114.712 -1.131 . . . . 62.049999999999997 111.752 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -69.56 -34.87 74.8 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.312 1.045 . . . . 74.140000000000001 111.775 -175.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -84.91 8.69 16.66 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 113.252 0.834 . . . . 74.319999999999993 113.252 -175.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.6 p -127.26 156.84 41.27 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.299 0.64 . . . . 73.400000000000006 110.552 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.4 tp -109.97 137.13 48.18 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.571 0.749 . . . . 64.200000000000003 109.579 177.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.4 t -82.86 115.22 21.65 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.369 -0.975 . . . . 74.230000000000004 108.369 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.6 pt -123.48 144.29 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.256 1.022 . . . . 43.329999999999998 109.966 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.2 m -110.73 151.39 27.8 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 109.732 -0.469 . . . . 72.530000000000001 109.732 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -54.82 111.17 0.77 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.353 0.661 . . . . 72.019999999999996 111.682 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.55 -14.69 24.87 Favored Glycine 0 C--N 1.342 0.897 0 C-N-CA 123.291 0.472 . . . . 55.399999999999999 112.765 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -67.48 120.91 14.71 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.971 0.908 . . . . 74.129999999999995 109.467 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 106' ' ' LYS . 8.0 mtmp? -80.87 118.19 22.16 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.665 -0.865 . . . . 73.25 108.665 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 21.7 mt -99.42 160.59 14.17 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.394 -0.965 . . . . 74.340000000000003 108.394 -174.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -121.12 107.3 12.43 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.206 -1.035 . . . . 75.439999999999998 108.206 164.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 74.1 t -94.6 115.18 32.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 108.573 -0.899 . . . . 75.120000000000005 108.573 -176.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.46 -35.34 80.04 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 123.588 0.555 . . . . 74.310000000000002 109.691 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -179.66 174.57 46.2 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.735 -0.666 . . . . 75.329999999999998 112.209 173.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.54 ' HB3' ' HA2' ' A' ' 116' ' ' GLY . 21.5 m-85 -92.91 174.88 7.02 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 108.808 -0.812 . . . . 71.409999999999997 108.808 176.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.473 ' ND2' ' HB2' ' A' ' 22' ' ' PHE . 12.8 m120 -64.07 167.85 5.98 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.945 -0.57 . . . . 74.400000000000006 110.13 164.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -72.31 -4.48 30.02 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 120.707 0.289 . . . . 62.539999999999999 110.324 177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -105.21 -19.88 13.68 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.775 0.83 . . . . 74.530000000000001 110.754 170.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 112' ' ' TYR . . . 80.15 12.93 82.71 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-N 116.633 -0.258 . . . . 71.219999999999999 113.603 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.406 ' HG3' ' OD1' ' A' ' 113' ' ' ASN . 9.5 pt-20 -68.4 -54.58 16.26 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.948 1.299 . . . . 71.430000000000007 111.794 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -116.18 173.19 6.72 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.796 0.838 . . . . 72.129999999999995 109.331 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.28 120.66 10.96 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.494 0.717 . . . . 64.530000000000001 110.735 -170.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -75.93 97.14 3.9 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.554 -0.536 . . . . 75.129999999999995 109.554 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -102.14 150.59 23.11 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.507 -0.77 . . . . 62.240000000000002 110.156 -174.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -132.22 122.54 25.39 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 124.047 0.939 . . . . 72.209999999999994 109.105 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 58.3 p -133.88 -176.73 4.27 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.275 1.43 . . . . 72.120000000000005 108.874 171.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -72.67 -3.19 23.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.982 0.513 . . . . 71.510000000000005 111.759 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -89.22 -1.18 57.97 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.786 0.834 . . . . 73.530000000000001 110.785 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.66 -156.23 15.89 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 111.759 -0.537 . . . . 63.420000000000002 111.759 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -144.6 131.53 20.32 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.173 0.589 . . . . 71.310000000000002 110.191 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -179.42 173.48 45.41 Favored Glycine 0 C--N 1.346 1.129 0 O-C-N 123.329 0.393 . . . . 62.539999999999999 112.694 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.5 ' HE1' ' H ' ' A' ' 24' ' ' LYS . 91.0 m95 -76.77 121.24 23.05 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.344 1.058 . . . . 64.319999999999993 111.517 -176.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.19 150.7 44.8 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 124.717 1.207 . . . . 70.239999999999995 108.904 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.51 126.08 14.94 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 121.799 1.666 . . . . 72.239999999999995 109.772 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 m -57.62 -26.79 62.08 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.723 0.809 . . . . 63.310000000000002 111.539 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.649 HD21 HD23 ' A' ' 9' ' ' LEU . 33.5 m-20 -63.22 -28.68 70.2 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 124.657 1.183 . . . . 73.349999999999994 111.879 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -93.67 1.3 56.64 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.97 0.908 . . . . 74.299999999999997 112.774 -175.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 25.2 pt -133.75 164.68 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.347 0.521 . . . . 62.030000000000001 111.022 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.7 t -159.28 140.94 9.69 Favored Pre-proline 0 N--CA 1.484 1.241 0 O-C-N 123.455 0.472 . . . . 62.420000000000002 110.145 171.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 85' ' ' PHE . 62.8 Cg_endo -71.68 114.54 3.98 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.269 1.98 . . . . 62.219999999999999 112.172 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.6 m -82.11 -36.04 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.757 0.823 . . . . 62.340000000000003 112.117 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.463 ' ND2' ' H ' ' A' ' 80' ' ' ASN . 63.9 t30 -93.06 16.84 11.91 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.662 0.785 . . . . 72.540000000000006 110.111 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 137' ' ' PRO . 22.5 t -63.23 165.3 7.55 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.742 0.817 . . . . 75.219999999999999 110.808 175.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.4 mt -66.99 -10.24 47.46 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.35 1.06 . . . . 54.109999999999999 111.878 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.596 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 29.4 tt0 -66.0 -12.21 53.46 Favored 'General case' 0 C--N 1.369 1.439 0 C-N-CA 123.391 0.676 . . . . 72.25 111.922 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -61.25 -12.29 12.69 Favored 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 123.582 0.753 . . . . 74.109999999999999 110.428 167.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -105.85 150.12 25.89 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 125.979 1.711 . . . . 61.219999999999999 109.222 167.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.4 p -69.33 -20.49 63.87 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.61 0.967 . . . . 73.25 113.61 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.468 ' CE3' HG21 ' A' ' 218' ' ' VAL . 53.0 p-90 -77.38 -43.38 32.98 Favored 'General case' 0 C--O 1.25 1.108 0 N-CA-C 112.681 0.623 . . . . 73.040000000000006 112.681 -175.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -87.56 146.94 25.55 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.703 -0.48 . . . . 74.040000000000006 109.703 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.596 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 65.3 m-70 -143.21 39.59 1.45 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.12 0.968 . . . . 75.439999999999998 111.352 -174.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.25 -169.05 54.77 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 115.919 1.128 . . . . 73.549999999999997 115.919 163.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.464 ' HB2' ' HB2' ' A' ' 174' ' ' GLU . 8.3 Cg_endo -89.09 95.66 0.34 Allowed 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 124.083 3.188 . . . . 74.409999999999997 111.23 171.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.08 153.04 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 124.389 1.076 . . . . 75.140000000000001 110.82 -170.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.7 m -75.68 156.87 34.35 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.437 1.095 . . . . 64.510000000000005 112.069 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -62.39 -33.51 74.89 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.769 0.828 . . . . 70.420000000000002 112.162 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -66.75 -45.18 79.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.686 0.795 . . . . 75.540000000000006 110.026 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.23 -31.97 70.89 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.571 0.748 . . . . 61.340000000000003 111.043 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.78 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.39 -51.09 71.29 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.699 -0.682 . . . . 51.009999999999998 110.31 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.47 -31.27 71.9 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.994 0.918 . . . . 74.150000000000006 111.562 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -63.99 -45.75 87.61 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.482 0.713 . . . . 73.340000000000003 111.319 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.477 HD12 HH12 ' A' ' 171' ' ' ARG . 66.5 mt -77.43 -39.08 48.17 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 120.867 0.365 . . . . 74.140000000000001 111.375 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.61 HD23 HG13 ' A' ' 190' ' ' VAL . 34.0 tp -74.85 -20.95 59.53 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.732 -0.667 . . . . 72.409999999999997 112.194 -171.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.1 p -60.21 -28.28 67.85 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.052 0.541 . . . . 71.519999999999996 111.456 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.8 m -75.31 -15.26 60.51 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.039 0.935 . . . . 60.310000000000002 112.353 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.15 165.31 50.54 Favored Glycine 0 C--N 1.345 1.039 0 N-CA-C 113.785 0.274 . . . . 74.219999999999999 113.785 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.3 pt -113.35 -164.74 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.23 1.012 . . . . 74.299999999999997 109.465 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.749 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 25.3 p-10 -49.32 114.12 0.96 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.909 0.884 . . . . 72.349999999999994 112.375 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 89.39 14.22 60.45 Favored Glycine 0 C--O 1.258 1.605 0 CA-C-N 116.46 -0.337 . . . . 64.519999999999996 113.498 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 70.4 p -74.85 139.49 43.23 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 108.989 -0.745 . . . . 73.409999999999997 108.989 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 232' ' ' LEU . 28.9 p90 -138.32 160.35 39.7 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.215 0.82 . . . . 75.450000000000003 113.215 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.443 HD13 ' NH1' ' A' ' 171' ' ' ARG . 96.4 mt -132.62 132.82 42.89 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.137 -1.431 . . . . 61.32 107.137 166.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 56.6 t -107.72 115.4 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 106.949 -1.501 . . . . 74.450000000000003 106.949 171.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.78 HH11 ' HA ' ' A' ' 156' ' ' ALA . 0.2 OUTLIER -159.1 152.34 22.44 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.204 0.602 . . . . 75.420000000000002 110.236 -175.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.657 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 10.9 pt-20 -107.7 156.55 18.96 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.942 0.401 . . . . 64.409999999999997 111.238 -177.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 30.9 m -90.71 113.45 25.55 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.065 -0.717 . . . . 62.539999999999999 109.065 173.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 150' ' ' PRO . 33.0 tt0 -70.44 -26.47 63.67 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.427 0.691 . . . . 74.310000000000002 110.626 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.1 p -79.24 5.51 12.09 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.764 1.225 . . . . 62.43 112.183 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 37.5 m -142.93 123.22 7.99 Favored Pre-proline 0 CA--C 1.553 1.091 0 C-N-CA 123.668 0.787 . . . . 74.340000000000003 109.88 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.23 111.47 1.28 Allowed 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.298 2.665 . . . . 65.040000000000006 113.528 -171.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.58 9.83 52.25 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-N 115.774 -0.648 . . . . 75.129999999999995 114.552 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -87.53 115.31 24.87 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 109.175 -0.676 . . . . 72.430000000000007 109.175 -176.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.781 ' HB2' ' HB ' ' A' ' 195' ' ' ILE . 50.6 mtt85 -110.12 165.71 11.53 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.963 0.905 . . . . 72.019999999999996 108.825 176.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 65.9 m -149.85 142.71 24.76 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.754 0.421 . . . . 63.310000000000002 110.951 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 60.8 mt -111.93 130.77 64.97 Favored 'Isoleucine or valine' 0 C--O 1.246 0.877 0 N-CA-C 107.409 -1.33 . . . . 73.310000000000002 107.409 161.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 11.4 m -107.92 118.96 38.11 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.498 -1.228 . . . . 60.240000000000002 107.92 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.429 HD21 HD23 ' A' ' 232' ' ' LEU . 47.3 mt -110.03 135.78 50.32 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.334 1.054 . . . . 75.129999999999995 111.289 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 37.3 ttt-85 -121.18 130.78 53.88 Favored 'General case' 0 C--O 1.257 1.453 0 O-C-N 123.766 0.666 . . . . 75.25 109.276 169.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.749 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 15.6 p90 -147.65 136.85 22.34 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 124.366 1.041 . . . . 73.219999999999999 108.827 173.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 56.28 26.26 10.29 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 124.514 1.126 . . . . 74.540000000000006 113.263 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 97.04 -9.57 65.6 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.168 0.413 . . . . 43.119999999999997 113.222 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 18.9 ttm180 -98.89 124.28 43.72 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.275 0.63 . . . . 75.439999999999998 109.961 -171.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.61 HG13 HD23 ' A' ' 160' ' ' LEU . 59.1 t -104.87 132.96 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 124.494 1.117 . . . . 65.540000000000006 108.873 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.48 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 40.8 p90 -145.29 163.08 35.58 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.551 0.741 . . . . 74.230000000000004 109.423 171.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -128.62 151.77 49.11 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.006 0.923 . . . . 73.219999999999999 108.784 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.423 ' HE2' HD12 ' A' ' 184' ' ' LEU . 32.9 p90 -143.13 140.48 30.86 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 122.689 0.396 . . . . 74.420000000000002 110.056 168.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -73.72 134.19 43.47 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.257 -0.883 . . . . 73.219999999999999 111.504 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.781 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 80.5 mt -84.68 109.05 17.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 N-CA-C 107.224 -1.399 . . . . 63.399999999999999 107.224 163.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -80.2 125.96 30.5 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.435 -0.802 . . . . 73.230000000000004 109.181 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 27.2 m -90.43 113.55 25.5 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.894 -0.78 . . . . 71.150000000000006 108.894 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -58.6 157.98 8.41 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.91 0.884 . . . . 71.400000000000006 111.082 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 23.3 t -68.27 -11.99 60.29 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.361 0.664 . . . . 74.540000000000006 111.569 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -71.46 -13.21 61.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.455 0.702 . . . . 73.219999999999999 111.436 170.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.9 5.47 86.19 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.984 -0.446 . . . . 64.129999999999995 111.984 -170.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -87.72 153.48 21.33 Favored 'General case' 0 C--N 1.346 0.444 0 C-N-CA 124.219 1.008 . . . . 74.140000000000001 109.29 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.427 HD21 HH11 ' A' ' 180' ' ' ARG . 97.3 mt -99.87 153.71 18.93 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.59 0.756 . . . . 71.430000000000007 110.19 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -166.4 169.53 13.89 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.953 0.783 . . . . 75.349999999999994 110.11 172.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 195' ' ' ILE . 73.2 t -132.52 -58.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 105.996 -1.853 . . . . 63.43 105.996 172.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 37.8 t -81.61 131.98 35.29 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.374 -1.285 . . . . 71.219999999999999 107.587 168.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 74.2 p -65.28 -32.59 74.33 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.407 0.683 . . . . 60.43 112.4 -171.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -74.12 -23.92 59.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.721 0.809 . . . . 72.329999999999998 111.219 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 68.6 m -97.37 104.45 16.47 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.153 0.981 . . . . 75.530000000000001 110.104 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 20.2 mmt85 -114.51 137.49 51.79 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.749 0.819 . . . . 63.439999999999998 109.192 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 8.3 m-85 -132.89 133.58 43.45 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.652 0.595 . . . . 64.540000000000006 109.639 -173.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -72.29 -40.71 67.34 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.217 0.607 . . . . 71.230000000000004 110.037 169.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 71.0 p -123.02 153.87 39.25 Favored 'General case' 0 C--N 1.368 1.371 0 CA-C-O 121.903 0.859 . . . . 70.120000000000005 112.201 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 24.9 tp -70.19 -28.75 65.55 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.118 -1.401 . . . . 71.230000000000004 111.002 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.92 99.57 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.236 0.614 . . . . 43.5 110.852 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -75.82 -31.69 59.49 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.424 -0.807 . . . . 63.5 111.33 177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tt -56.95 -46.83 81.83 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 123.856 0.722 . . . . 73.349999999999994 110.544 169.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.468 HG21 ' CE3' ' A' ' 146' ' ' TRP . 51.3 t -72.47 -37.63 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.892 0.877 . . . . 74.510000000000005 111.444 -175.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -60.14 -50.59 73.07 Favored 'General case' 0 C--O 1.258 1.528 0 CA-C-O 121.622 0.725 . . . . 75.109999999999999 110.033 173.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.43 ' CE1' HG11 ' A' ' 224' ' ' VAL . 50.0 t60 -52.51 -54.72 28.79 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.136 -1.393 . . . . 74.140000000000001 109.787 177.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -64.29 -25.42 68.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.866 -1.061 . . . . 63.109999999999999 112.051 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.2 t -74.0 -28.54 61.5 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.743 0.417 . . . . 63.240000000000002 111.793 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.7 t -109.86 -17.44 13.64 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 116.299 1.962 . . . . 73.420000000000002 116.299 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.43 HG11 ' CE1' ' A' ' 220' ' ' HIS . 36.0 m -96.04 152.47 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 115.371 1.619 . . . . 60.140000000000001 115.371 -166.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -90.98 -1.76 57.78 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 128.409 2.683 . . . . 71.439999999999998 112.523 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.17 13.94 1.33 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 128.326 2.65 . . . . 63.439999999999998 112.751 -141.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.1 18.0 3.94 Favored Glycine 0 C--N 1.346 1.139 0 C-N-CA 125.443 1.497 . . . . 73.530000000000001 110.933 -171.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 72.8 mt -92.11 120.75 33.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.214 1.006 . . . . 72.030000000000001 109.84 165.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.48 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 80.1 mt -60.15 -40.36 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.391 1.077 . . . . 74.450000000000003 109.497 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 4.9 t -137.58 140.38 40.96 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 114.835 -1.075 . . . . 74.140000000000001 108.756 170.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 80.6 p -71.77 155.77 40.08 Favored 'General case' 0 C--O 1.247 0.93 0 N-CA-C 108.567 -0.901 . . . . 65.510000000000005 108.567 170.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.453 ' HB3' ' CE2' ' A' ' 168' ' ' PHE . 27.8 mt -67.82 100.8 0.98 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 108.661 -0.866 . . . . 61.439999999999998 108.661 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -80.28 -49.99 10.81 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.309 0.644 . . . . 72.430000000000007 109.886 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 167' ' ' SER . 9.6 p90 -160.57 150.41 14.49 Favored Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 109.675 -0.491 . . . . 75.329999999999998 109.675 173.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.89 138.95 17.09 Favored 'Trans proline' 0 C--N 1.365 1.436 0 C-N-CA 121.964 1.776 . . . . 71.219999999999999 112.495 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.31 142.94 97.1 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 108.68 -0.859 . . . . 62.520000000000003 108.68 168.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -69.09 169.55 17.79 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.795 2.33 . . . . 64.099999999999994 114.452 -170.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.483 ' NZ ' ' HG2' ' A' ' 142' ' ' GLU . 67.1 mttm -65.0 161.13 19.32 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.536 -1.211 . . . . 44.130000000000003 109.678 165.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -61.97 -37.55 85.2 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 109.173 -0.677 . . . . 71.25 109.173 166.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -73.34 172.0 12.04 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.36 1.064 . . . . 71.519999999999996 109.858 170.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -57.73 130.14 81.82 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 123.215 0.606 . . . . 54.43 111.527 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -86.77 -160.62 0.11 Allowed 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 123.034 2.489 . . . . 60.340000000000003 112.088 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 45.9 m -135.16 124.18 24.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.812 0.845 . . . . 73.049999999999997 108.99 175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 29.4 m -75.62 150.43 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.237 0.615 . . . . 71.140000000000001 109.795 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -129.57 155.7 45.37 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.015 -0.735 . . . . 73.420000000000002 109.015 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -140.79 -107.41 0.68 Allowed Glycine 0 N--CA 1.468 0.777 0 CA-C-O 119.28 -0.733 . . . . 51.009999999999998 111.754 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 65.0 t 56.38 88.9 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.703 1.201 . . . . 74.239999999999995 110.169 -174.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.2 t -89.45 111.31 44.87 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 123.863 0.865 . . . . 75.209999999999994 110.09 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -55.63 140.27 83.74 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.281 2.654 . . . . 64.140000000000001 112.157 171.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -141.0 -62.38 0.48 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.207 0.603 . . . . 75.340000000000003 109.696 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -94.84 71.17 3.46 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.301 0.64 . . . . 62.219999999999999 110.008 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.08 88.11 2.66 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.527 0.731 . . . . 72.010000000000005 109.33 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -168.84 119.83 0.75 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.942 0.897 . . . . 72.430000000000007 109.175 -177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 27.4 t90 -77.11 -61.96 1.81 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.79 -1.189 . . . . 44.119999999999997 107.79 170.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 . . . . . 0 N--CA 1.483 1.189 0 C-N-CA 124.359 1.063 . . . . 73.129999999999995 109.923 172.817 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 109.197 -0.668 . . . . 73.400000000000006 109.197 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 170.03 154.56 9.45 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 112.053 -0.419 . . . . 74.109999999999999 112.053 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -127.68 122.03 31.92 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.624 0.77 . . . . 75.010000000000005 111.361 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -100.42 117.2 63.41 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 108.091 -1.077 . . . . 71.519999999999996 108.091 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -48.56 -46.31 24.3 Favored 'Trans proline' 0 C--N 1.386 2.527 0 C-N-CA 124.011 3.14 . . . . 64.430000000000007 114.752 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.19 129.66 2.95 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-O 119.653 -0.526 . . . . 64.310000000000002 113.248 175.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -82.99 102.08 11.51 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.647 0.779 . . . . 51.119999999999997 109.67 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.2 t -76.37 135.47 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.563 0.745 . . . . 72.219999999999999 111.342 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -87.69 -178.35 6.06 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.595 1.158 . . . . 64.530000000000001 110.247 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.17 147.34 4.88 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.088 -0.405 . . . . 72.439999999999998 112.088 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -78.21 146.73 34.8 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.222 0.609 . . . . 75.450000000000003 109.561 177.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -169.53 141.75 2.46 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.654 0.382 . . . . 75.349999999999994 111.092 -172.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.85 147.99 48.47 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.845 -0.616 . . . . 74.349999999999994 109.952 171.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.6 mmm-85 56.87 76.72 0.46 Allowed Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 123.256 0.622 . . . . 71.310000000000002 109.324 -162.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.5 161.17 28.77 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.318 2.012 . . . . 72.25 111.443 176.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.6 p -69.65 169.72 12.22 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.006 0.431 . . . . 34.43 111.299 -174.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.8 mt -102.58 126.56 32.6 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 109.13 -0.693 . . . . 41.340000000000003 109.13 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.561 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 75.8 Cg_endo -74.03 174.49 12.32 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.785 2.323 . . . . 71.549999999999997 112.371 177.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.71 147.66 28.34 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 122.836 0.455 . . . . 64.310000000000002 111.491 -174.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HB3' HD11 ' A' ' 23' ' ' ILE . 85.1 mt -88.19 93.69 9.58 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.366 -0.976 . . . . 72.340000000000003 108.366 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -96.84 -48.68 5.36 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.109 0.564 . . . . 54.450000000000003 110.876 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.518 ' HE1' ' HB2' ' A' ' 115' ' ' ASN . 84.0 m-85 -105.93 111.04 23.53 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.092 0.557 . . . . 73.430000000000007 110.183 178.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' A' ' 20' ' ' LEU . 47.2 mm -118.08 110.44 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.006 0.523 . . . . 51.149999999999999 109.614 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' NZ ' ' HB2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -175.37 150.72 1.15 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.868 1.267 . . . . 63.340000000000003 108.724 179.05 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.27 69.88 2.93 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-O 119.886 -0.397 . . . . 64.040000000000006 113.396 -173.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -177.96 104.18 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.432 1.093 . . . . 70.299999999999997 109.537 172.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.16 -64.04 3.92 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.85 -0.5 . . . . 52.130000000000003 111.85 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.488 ' HB3' ' HG3' ' A' ' 30' ' ' GLU . 32.8 ttmt -167.5 -6.43 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.315 0.646 . . . . 74.299999999999997 111.029 173.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.438 ' H ' ' H ' ' A' ' 28' ' ' LYS . 30.3 mmm180 73.61 29.45 1.54 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.034 1.333 . . . . 70.150000000000006 111.122 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.488 ' HG3' ' HB3' ' A' ' 28' ' ' LYS . 41.9 mt-10 -77.58 149.04 34.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.076 0.55 . . . . 62.130000000000003 111.058 175.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.9 p -147.34 87.89 1.68 Allowed 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.1 -0.954 . . . . 62.340000000000003 109.546 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.8 m -66.07 93.5 0.2 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.122 -0.945 . . . . 63.409999999999997 108.513 170.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.461 ' H ' ' HG2' ' A' ' 33' ' ' ARG . 11.1 ptp180 -78.73 -168.64 1.47 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.664 0.987 . . . . 73.230000000000004 113.664 -164.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -49.82 133.57 21.75 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.644 1.177 . . . . 64.319999999999993 112.576 -169.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.775 ' HA3' ' HB3' ' A' ' 143' ' ' LYS . . . -88.1 -151.84 23.12 Favored Glycine 0 C--N 1.347 1.178 0 O-C-N 123.463 0.477 . . . . 73.409999999999997 113.719 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 168.6 113.08 0.28 Allowed Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.914 -0.937 . . . . 62.32 111.006 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -71.62 155.25 59.31 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.83 2.353 . . . . 74.040000000000006 113.345 -171.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.452 ' HE1' HD21 ' A' ' 40' ' ' ASN . 56.6 t-80 -154.67 106.86 2.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.489 0.716 . . . . 75.409999999999997 109.508 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.663 ' SG ' ' HA ' ' A' ' 69' ' ' SER . 66.5 m -86.5 144.45 27.25 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.59 0.709 . . . . 74.430000000000007 112.508 -176.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.529 ' H ' ' HE2' ' A' ' 241' ' ' LYS . 17.4 m120 -143.92 157.56 44.27 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.79 -1.55 . . . . 65.019999999999996 107.21 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.741 HG12 ' H ' ' A' ' 43' ' ' VAL . 26.3 t -61.82 145.62 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 110.017 -0.364 . . . . 72.299999999999997 110.017 174.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.447 ' H ' ' HD1' ' A' ' 42' ' ' PHE . 2.4 p90 -75.72 3.11 10.39 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.484 0.714 . . . . 62.32 111.811 174.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.741 ' H ' HG12 ' A' ' 41' ' ' VAL . 2.2 m 64.42 -1.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 128.408 2.683 . . . . 63.039999999999999 113.662 175.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 58.42 76.47 0.34 Allowed 'General case' 0 C--N 1.354 0.772 0 C-N-CA 124.587 1.155 . . . . 60.130000000000003 109.363 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -109.48 169.27 8.81 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 115.044 -0.98 . . . . 63.530000000000001 111.361 -169.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -100.2 149.8 23.18 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.976 -0.557 . . . . 73.099999999999994 109.871 168.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.05 125.37 30.75 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.024 -0.732 . . . . 72.549999999999997 109.024 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 28.3 mt -71.21 116.44 11.53 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.08 0.4 . . . . 72.030000000000001 112.08 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -86.85 171.51 10.79 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.904 -0.776 . . . . 73.420000000000002 108.904 167.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -120.76 89.51 45.27 Favored Pre-proline 0 N--CA 1.479 1.011 0 N-CA-C 109.365 -0.605 . . . . 73.519999999999996 109.365 176.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -92.41 -178.63 0.98 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.748 2.299 . . . . 75.310000000000002 112.566 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.1 p -74.4 -28.76 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.979 0.511 . . . . 73.219999999999999 110.111 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.28 165.91 21.88 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.794 0.838 . . . . 65.310000000000002 109.993 171.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.0 t -136.01 104.73 5.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.406 0.682 . . . . 70.329999999999998 109.7 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -107.08 -175.32 2.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.148 0.979 . . . . 61.310000000000002 109.809 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -121.45 -54.07 1.99 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.062 0.393 . . . . 72.519999999999996 112.062 -168.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 58.45 71.08 1.06 Allowed Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 124.294 1.038 . . . . 74.319999999999993 110.535 -169.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.02 70.21 7.16 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.953 2.435 . . . . 75.319999999999993 110.235 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -123.01 150.76 42.62 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.059 -0.973 . . . . 54.229999999999997 109.616 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 167.05 167.52 27.86 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 114.951 -1.022 . . . . 63.43 111.746 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.46 ' H ' ' HB ' ' A' ' 43' ' ' VAL . 95.7 mt -135.27 141.5 45.74 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.721 0.808 . . . . 70.420000000000002 109.735 -174.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.6 t -70.35 114.73 8.77 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.906 -0.776 . . . . 50.119999999999997 108.906 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.01 -167.25 1.82 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.803 0.841 . . . . 61.439999999999998 111.314 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -160.13 -169.59 2.55 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.778 0.831 . . . . 52.399999999999999 109.646 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.15 98.19 3.13 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.573 -0.528 . . . . 74.230000000000004 109.573 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.469 ' HG3' ' HA3' ' A' ' 246' ' ' GLY . 3.3 mmp_? -139.35 -45.57 0.46 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.393 0.677 . . . . 64.140000000000001 110.099 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -80.29 150.95 29.79 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 115.919 -0.582 . . . . 72.329999999999998 111.356 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -79.21 161.76 26.17 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.373 -0.831 . . . . 73.150000000000006 109.533 169.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.663 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 61.0 m -69.68 -6.86 34.44 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 112.477 0.547 . . . . 53.520000000000003 112.477 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? 60.63 49.64 6.28 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.747 1.219 . . . . 73.540000000000006 110.857 172.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -82.1 157.29 24.14 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 113.517 -1.674 . . . . 61.409999999999997 111.491 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -160.38 179.46 8.63 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.214 1.005 . . . . 74.310000000000002 111.053 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.3 mt 66.79 20.66 10.6 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 125.254 1.422 . . . . 72.010000000000005 112.944 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 70.8 mt -82.83 93.4 7.45 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.198 -0.667 . . . . 71.420000000000002 109.198 177.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.39 158.52 43.71 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.33 0.652 . . . . 71.25 110.963 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.28 -166.75 29.04 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.979 -0.9 . . . . 73.230000000000004 110.905 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.98 164.1 36.49 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.364 2.043 . . . . 72.519999999999996 112.265 171.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.4 p -70.1 82.91 0.51 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.111 0.564 . . . . 42.149999999999999 110.235 176.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -163.24 106.41 1.02 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.168 -1.049 . . . . 72.319999999999993 108.168 -173.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -119.55 -72.04 0.71 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.931 0.493 . . . . 61.219999999999999 111.654 -173.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 71.24 158.5 0.16 Allowed Pre-proline 0 N--CA 1.498 1.962 0 C-N-CA 124.106 0.962 . . . . 70.420000000000002 111.854 -174.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -66.55 -55.62 0.34 Allowed 'Trans proline' 0 C--N 1.39 2.711 0 C-N-CA 122.467 2.111 . . . . 60.340000000000003 113.139 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.498 ' HA ' ' HB3' ' A' ' 140' ' ' SER . 59.8 t30 -94.15 78.96 4.02 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 109.408 -0.59 . . . . 71.209999999999994 109.408 -176.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.658 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 33.5 tp -107.96 123.15 48.21 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.306 -0.861 . . . . 65.409999999999997 111.203 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -105.71 176.08 5.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.126 1.771 . . . . 75.040000000000006 108.879 172.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.43 148.88 24.34 Favored 'Isoleucine or valine' 0 C--O 1.252 1.234 0 N-CA-C 108.507 -0.923 . . . . 73.5 108.507 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.16 118.44 20.4 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 123.67 0.606 . . . . 61.299999999999997 109.654 171.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 84.2 mt -82.01 -25.23 34.87 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.969 0.908 . . . . 64.420000000000002 110.611 173.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -132.47 155.92 47.68 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.226 0.61 . . . . 73.209999999999994 110.614 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -72.61 146.05 46.9 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.012 -0.995 . . . . 63.299999999999997 110.542 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -160.65 112.31 1.9 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.693 0.797 . . . . 61.450000000000003 109.238 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.4 t -85.45 137.97 19.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.671 -0.863 . . . . 61.520000000000003 108.671 172.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.56 119.58 7.3 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.399 0.68 . . . . 75.530000000000001 110.576 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.6 m -70.69 -22.62 62.44 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.474 0.709 . . . . 75.340000000000003 110.626 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -159.11 -173.67 27.83 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.94 -0.864 . . . . 61.039999999999999 110.94 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.17 -32.42 73.99 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.938 0.895 . . . . 64.049999999999997 111.312 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.417 HD22 HD12 ' A' ' 23' ' ' ILE . 23.2 p-10 -68.63 -24.47 64.56 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.125 0.97 . . . . 53.340000000000003 112.367 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.4 p -101.43 162.94 12.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.18 0.592 . . . . 62.119999999999997 110.065 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.443 HD21 HG23 ' A' ' 123' ' ' THR . 64.7 tp -114.75 137.94 51.33 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.555 0.342 . . . . 74.239999999999995 110.875 -177.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 30.7 m -78.11 116.11 18.33 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.885 -0.598 . . . . 74.310000000000002 110.051 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 pt -123.69 140.82 46.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.638 0.775 . . . . 73.109999999999999 110.334 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.7 m -115.88 148.14 40.31 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.498 -0.926 . . . . 65.340000000000003 108.498 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -53.89 130.99 39.17 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.954 0.502 . . . . 73.040000000000006 111.284 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.47 -21.61 45.11 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 116.584 -0.28 . . . . 63.329999999999998 112.806 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -76.84 130.26 37.36 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.309 -0.997 . . . . 71.219999999999999 108.309 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.492 ' HB3' HD11 ' A' ' 84' ' ' LEU . 43.7 mttp -89.87 130.58 36.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.779 0.432 . . . . 71.519999999999996 109.885 -175.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.02 133.82 53.11 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.97 0.908 . . . . 71.25 109.174 -166.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.7 mtm-85 -94.9 108.03 20.06 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 118.736 0.698 . . . . 62.399999999999999 109.429 174.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 76.8 t -95.11 129.52 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 117.948 0.34 . . . . 72.430000000000007 110.111 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.9 mt -105.23 -3.77 22.49 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.079 0.952 . . . . 73.420000000000002 111.321 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.31 164.79 16.86 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.919 -0.872 . . . . 63.030000000000001 110.919 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -95.44 171.79 8.48 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 109.065 -0.717 . . . . 73.239999999999995 109.065 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -63.5 150.11 44.6 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.831 -0.803 . . . . 63.119999999999997 108.831 175.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -70.61 -11.04 60.69 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 122.872 0.469 . . . . 74.109999999999999 110.845 -176.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.518 ' HB2' ' HE1' ' A' ' 22' ' ' PHE . 62.9 t30 -109.44 -2.98 17.36 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.342 1.057 . . . . 45.039999999999999 110.567 169.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.23 -16.32 59.07 Favored Glycine 0 N--CA 1.48 1.616 0 C-N-CA 123.775 0.703 . . . . 35.240000000000002 114.375 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . 33.7 mt-10 -54.17 -59.9 4.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.847 1.259 . . . . 71.129999999999995 112.955 -172.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.8 m95 -102.8 -179.88 4.09 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.814 -1.085 . . . . 75.340000000000003 109.026 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.63 129.6 12.56 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.52 0.728 . . . . 64.140000000000001 109.226 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -74.96 107.19 6.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.844 0.458 . . . . 73.310000000000002 110.555 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -110.58 160.14 16.93 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.547 0.739 . . . . 73.25 110.386 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -133.88 117.94 17.37 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.592 0.757 . . . . 75.120000000000005 109.732 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.443 HG23 HD21 ' A' ' 99' ' ' LEU . 68.4 p -113.46 -177.36 3.11 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.786 0.834 . . . . 74.129999999999995 110.273 175.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -70.73 -8.89 55.52 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.117 0.567 . . . . 64.530000000000001 110.849 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -79.77 -27.36 40.43 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.86 1.264 . . . . 60.200000000000003 110.598 173.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.3 -150.73 21.78 Favored Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.164 -0.774 . . . . 50.450000000000003 111.164 -173.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -128.25 154.1 46.24 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 117.724 0.762 . . . . 75.109999999999999 109.701 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 171.66 178.68 42.19 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 123.41 0.444 . . . . 72.040000000000006 112.018 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -89.94 120.57 31.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.383 0.673 . . . . 73.219999999999999 110.712 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 29.8 m -113.99 154.09 46.08 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 124.106 0.962 . . . . 73.200000000000003 109.475 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.24 127.98 17.63 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 121.502 1.468 . . . . 55.409999999999997 111.058 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.4 m -58.63 -19.52 39.64 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.822 0.849 . . . . 74.25 111.956 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -70.73 -24.63 62.66 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.585 1.154 . . . . 65.219999999999999 111.604 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -98.99 -0.7 41.54 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.09 0.956 . . . . 74.230000000000004 112.639 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.3 pt -126.92 153.21 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 118.231 0.468 . . . . 75.010000000000005 110.83 -171.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.5 t -148.73 134.4 9.64 Favored Pre-proline 0 N--CA 1.484 1.259 0 CA-C-O 119.613 -0.232 . . . . 61.219999999999999 110.717 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.97 131.82 32.23 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.434 2.09 . . . . 72.230000000000004 112.404 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.8 m -119.6 -61.1 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.613 0.765 . . . . 73.409999999999997 112.089 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.658 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 66.1 t30 -89.96 -16.85 29.03 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.508 0.723 . . . . 74.5 109.732 -175.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.498 ' HB3' ' HA ' ' A' ' 83' ' ' ASN . 4.6 p -72.42 -157.75 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.382 1.473 . . . . 72.109999999999999 111.563 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.498 HD13 HD23 ' A' ' 214' ' ' LEU . 76.5 mt -57.35 -25.54 59.59 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 114.145 1.165 . . . . 73.510000000000005 114.145 -175.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -71.41 -14.2 62.08 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 119.054 0.843 . . . . 73.409999999999997 111.187 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.775 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 26.3 tptp -62.35 -22.36 66.03 Favored 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.424 0.69 . . . . 75.219999999999999 109.997 168.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -75.37 131.35 40.18 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 108.542 -0.91 . . . . 74.420000000000002 108.542 163.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.1 m -66.36 -15.51 63.33 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 112.55 0.574 . . . . 41.140000000000001 112.55 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.607 ' HB3' ' HG3' ' A' ' 235' ' ' PRO . 29.7 p-90 -85.31 -26.8 26.36 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 113.204 0.816 . . . . 73.420000000000002 113.204 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 42.2 t80 -94.01 132.22 38.71 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.311 -0.625 . . . . 73.349999999999994 109.311 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -126.25 13.42 7.72 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.944 0.72 . . . . 71.109999999999999 112.944 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.26 -159.25 53.53 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-O 119.548 -0.585 . . . . 40.100000000000001 114.54 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.21 104.22 1.75 Allowed 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 123.302 2.668 . . . . 64.439999999999998 112.951 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.458 ' HB ' ' HD3' ' A' ' 171' ' ' ARG . 17.3 t -139.86 152.64 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 122.936 0.494 . . . . 64.430000000000007 109.782 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.7 m -73.87 158.48 34.42 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 123.831 0.852 . . . . 71.200000000000003 112.397 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 157' ' ' GLU . 52.7 ptt85 -65.97 -32.48 73.99 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.506 -1.225 . . . . 71.219999999999999 112.088 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -72.44 -42.17 65.34 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.106 0.562 . . . . 54.409999999999997 110.365 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -64.64 -39.58 93.96 Favored 'General case' 0 C--O 1.251 1.167 0 C-N-CA 123.242 0.617 . . . . 34.299999999999997 110.484 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.518 ' HB2' ' HD2' ' A' ' 171' ' ' ARG . . . -55.45 -47.96 75.24 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.087 -0.961 . . . . 63.439999999999998 111.105 172.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 43.8 mt-10 -71.99 -26.96 62.45 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.958 0.503 . . . . 65.230000000000004 112.064 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -62.52 -43.52 98.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.772 0.429 . . . . 73.439999999999998 110.343 172.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.605 HD12 HH22 ' A' ' 171' ' ' ARG . 66.8 mt -78.12 -30.1 49.25 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.955 -0.566 . . . . 73.329999999999998 112.258 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.531 HD23 HG13 ' A' ' 190' ' ' VAL . 37.4 tp -78.93 -31.07 45.02 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.916 0.486 . . . . 64.310000000000002 111.487 -174.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 67.8 p -63.53 -19.88 65.15 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.663 0.785 . . . . 52.509999999999998 111.158 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.4 m -80.59 20.65 0.71 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 125.124 1.37 . . . . 62.5 111.781 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.63 177.81 16.88 Favored Glycine 0 C--N 1.352 1.461 0 N-CA-C 114.613 0.605 . . . . 75.239999999999995 114.613 -174.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.7 pt -123.58 -164.55 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 124.819 1.248 . . . . 73.409999999999997 108.757 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.76 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 26.5 p-10 -48.19 120.41 3.55 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.6 0.76 . . . . 72.329999999999998 112.566 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 83.42 13.81 75.38 Favored Glycine 0 C--O 1.258 1.633 0 CA-C-N 116.621 -0.263 . . . . 70.239999999999995 113.335 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.1 t -73.14 127.79 33.6 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.368 -0.975 . . . . 73.239999999999995 108.368 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' ' 232' ' ' LEU . 23.9 p90 -137.95 152.76 49.27 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.706 0.684 . . . . 75.299999999999997 112.575 -174.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.569 HD22 HH21 ' A' ' 171' ' ' ARG . 87.6 mt -131.2 131.72 44.18 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.91 -1.041 . . . . 74.530000000000001 108.59 171.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.501 HG22 HG12 ' A' ' 182' ' ' ILE . 38.9 t -109.09 120.53 60.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.199 -1.408 . . . . 72.409999999999997 107.199 174.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.605 HH22 HD12 ' A' ' 159' ' ' LEU . 16.9 ptp180 -159.17 153.32 23.65 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.707 -0.479 . . . . 63.009999999999998 109.707 -176.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 13.1 pt-20 -97.42 157.41 16.01 Favored 'General case' 0 C--O 1.25 1.096 0 O-C-N 123.704 0.628 . . . . 75.209999999999994 109.862 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.618 ' HB3' ' HB2' ' A' ' 176' ' ' SER . 34.0 t -79.93 144.86 32.99 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.479 -0.782 . . . . 54.409999999999997 109.337 174.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -71.55 -42.79 67.43 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.63 -0.714 . . . . 72.25 110.805 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.8 t -89.52 -1.87 58.17 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.291 0.636 . . . . 62.219999999999999 112.03 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.618 ' HB2' ' HB3' ' A' ' 173' ' ' SER . 15.0 m -116.85 104.24 51.27 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 109.344 -0.613 . . . . 73.219999999999999 109.344 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.24 113.37 1.32 Allowed 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 123.402 2.735 . . . . 60.229999999999997 112.635 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.27 14.28 46.98 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 114.646 0.618 . . . . 62.109999999999999 114.646 173.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -89.55 112.93 24.26 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.25 -1.019 . . . . 72.439999999999998 108.25 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 78.2 mtt85 -104.3 161.23 14.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.904 -1.044 . . . . 73.530000000000001 108.807 -168.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.3 m -151.77 152.91 33.32 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 123.278 0.631 . . . . 75.409999999999997 109.763 -175.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.501 HG12 HG22 ' A' ' 170' ' ' VAL . 28.4 mt -118.8 137.68 51.97 Favored 'Isoleucine or valine' 0 C--O 1.25 1.123 0 N-CA-C 108.226 -1.027 . . . . 63.439999999999998 108.226 173.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.8 m -119.47 120.7 37.59 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.198 -1.038 . . . . 71.340000000000003 108.198 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.438 HD21 HD23 ' A' ' 232' ' ' LEU . 62.1 mt -103.61 141.3 36.28 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.528 0.731 . . . . 71.299999999999997 111.246 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -117.93 134.36 55.03 Favored 'General case' 0 C--O 1.26 1.636 0 N-CA-C 107.253 -1.388 . . . . 71.439999999999998 107.253 166.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.76 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 34.7 t80 -157.81 111.71 2.55 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.719 -1.128 . . . . 72.040000000000006 109.503 -172.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 50.96 44.17 28.54 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.881 1.272 . . . . 72.340000000000003 112.718 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.55 -1.5 87.23 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 114.717 0.647 . . . . 61.240000000000002 114.717 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -102.65 125.95 49.56 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.271 0.629 . . . . 71.439999999999998 109.448 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.531 HG13 HD23 ' A' ' 160' ' ' LEU . 72.1 t -115.1 117.35 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.961 0.904 . . . . 71.200000000000003 108.711 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -136.58 144.52 44.2 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.413 0.625 . . . . 53.119999999999997 110.637 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -122.92 136.36 54.83 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.231 1.012 . . . . 72.040000000000006 109.766 -167.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -145.34 141.95 28.97 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.842 0.353 . . . . 71.540000000000006 111.343 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -80.03 134.39 36.22 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.756 0.822 . . . . 72.299999999999997 111.081 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 91.3 mt -77.24 101.99 3.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.926 0 N-CA-C 107.58 -1.267 . . . . 71.510000000000005 107.58 161.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -72.7 122.9 22.23 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.177 -0.92 . . . . 74.519999999999996 109.152 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 21.6 m -100.34 111.14 23.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.143 0.577 . . . . 71.319999999999993 109.77 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.16 157.97 27.28 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.893 0.877 . . . . 63.520000000000003 111.499 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 77.9 p -62.74 -18.8 63.18 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.315 -0.857 . . . . 72.219999999999999 111.413 174.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -69.05 -15.85 63.56 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.894 1.678 . . . . 72.420000000000002 111.803 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 86.5 2.52 84.91 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 111.605 -0.598 . . . . 55.509999999999998 111.605 -170.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -89.93 143.12 27.06 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.082 0.553 . . . . 72.030000000000001 111.036 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 83.3 mt -95.57 150.15 20.65 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.196 0.998 . . . . 73.409999999999997 110.059 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -164.87 158.37 17.21 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.214 0.606 . . . . 74.510000000000005 111.01 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 94.9 t -127.18 -56.67 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 124.564 1.146 . . . . 71.420000000000002 108.985 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 18.3 t -100.75 -169.08 1.66 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.902 1.281 . . . . 63.310000000000002 110.433 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 50.9 m -76.81 -43.34 36.96 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.475 0.71 . . . . 75.420000000000002 112.153 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -72.56 -29.86 63.91 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.242 0.544 . . . . 75.310000000000002 111.368 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.523 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 83.6 p -68.65 118.17 11.31 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.411 -0.813 . . . . 53.240000000000002 111.813 -173.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -147.16 114.48 6.28 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.983 1.313 . . . . 65.230000000000004 107.653 170.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.523 ' CE2' ' HB2' ' A' ' 209' ' ' SER . 21.3 m-85 -130.53 138.83 50.4 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 118.449 0.568 . . . . 65.230000000000004 111.805 -171.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -79.95 -31.11 40.0 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.963 0.505 . . . . 73.129999999999995 109.968 169.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 60.1 p -126.59 148.09 49.81 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.734 0.778 . . . . 72.0 111.966 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.498 HD23 HD13 ' A' ' 141' ' ' LEU . 24.9 tp -69.87 -21.67 63.31 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.22 -1.355 . . . . 63.439999999999998 111.194 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.87 -47.49 77.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.394 0.678 . . . . 72.129999999999995 110.515 174.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -70.14 -31.74 69.4 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 115.705 -0.68 . . . . 74.329999999999998 111.008 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 221' ' ' HIS . 10.1 tt -55.47 -56.28 22.06 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 123.699 0.625 . . . . 72.439999999999998 109.859 172.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.58 -39.15 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.736 0.814 . . . . 64.430000000000007 111.622 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -59.83 -57.04 14.61 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.692 0.758 . . . . 73.230000000000004 111.222 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.436 ' CE1' HG11 ' A' ' 224' ' ' VAL . 40.4 t-80 -56.52 -44.16 80.53 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.771 -1.104 . . . . 74.510000000000005 109.854 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 217' ' ' LEU . 1.9 t60 -72.28 -19.96 61.6 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.535 1.134 . . . . 73.109999999999999 110.417 -177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 29.1 t -82.76 -20.26 36.26 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.016 0.926 . . . . 74.239999999999995 110.895 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.8 t -115.92 -8.52 11.91 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.401 2.0 . . . . 72.150000000000006 116.401 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.436 HG11 ' CE1' ' A' ' 220' ' ' HIS . 15.3 m -89.54 143.11 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 120.95 1.705 . . . . 72.299999999999997 114.505 -171.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.58 -0.53 57.58 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 128.713 2.805 . . . . 64.049999999999997 111.883 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -78.23 13.85 1.37 Allowed 'General case' 0 CA--C 1.568 1.64 0 C-N-CA 130.066 3.347 . . . . 61.109999999999999 112.621 -146.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.83 18.68 3.51 Favored Glycine 0 C--N 1.343 0.928 0 C-N-CA 124.038 0.828 . . . . 51.32 111.43 -172.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 71.4 mt -92.06 121.47 33.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.627 0.771 . . . . 72.319999999999993 110.617 163.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 76.6 mt -53.76 -42.58 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.779 0.832 . . . . 61.509999999999998 109.546 169.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.9 t -140.87 140.42 34.57 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.673 -1.149 . . . . 53.439999999999998 108.446 173.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.1 p -69.45 162.98 26.32 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 115.933 -0.576 . . . . 74.310000000000002 109.565 171.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.438 HD23 HD21 ' A' ' 184' ' ' LEU . 57.2 mt -65.55 103.84 0.91 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 110.073 -0.343 . . . . 71.209999999999994 110.073 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -77.99 -60.91 2.18 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.194 -0.669 . . . . 71.549999999999997 109.194 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -158.36 149.53 16.49 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 120.492 -0.483 . . . . 74.400000000000006 112.143 -175.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.607 ' HG3' ' HB3' ' A' ' 146' ' ' TRP . 46.5 Cg_exo -58.33 123.01 12.64 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.882 2.388 . . . . 53.109999999999999 112.195 172.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -58.27 135.21 84.86 Favored Pre-proline 0 C--O 1.246 0.893 0 O-C-N 123.665 0.603 . . . . 53.130000000000003 109.981 175.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.448 ' HA ' ' HD2' ' A' ' 241' ' ' LYS . 36.1 Cg_endo -65.96 135.74 42.13 Favored 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 121.887 1.725 . . . . 75.25 113.979 -175.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.524 ' HA ' HD22 ' A' ' 159' ' ' LEU . 18.3 ptpt -66.85 161.34 24.1 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.71 -1.132 . . . . 70.209999999999994 109.235 162.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -36.69 -39.26 0.2 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.575 1.55 . . . . 72.530000000000001 114.005 -173.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -133.89 126.7 31.0 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 108.697 -0.853 . . . . 74.109999999999999 108.697 171.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.529 ' HE2' ' H ' ' A' ' 40' ' ' ASN . 85.7 tttt -149.28 135.76 10.43 Favored Pre-proline 0 N--CA 1.48 1.074 0 C-N-CA 123.808 0.843 . . . . 62.140000000000001 108.753 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.99 154.26 68.15 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.902 2.402 . . . . 70.109999999999999 114.174 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 87.6 m -88.75 130.38 35.36 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.726 0.81 . . . . 55.420000000000002 109.661 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.463 ' H ' HG22 ' A' ' 41' ' ' VAL . 21.8 m -126.06 160.44 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.383 0.673 . . . . 63.329999999999998 109.908 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -141.43 -171.64 3.35 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.578 -0.897 . . . . 75.010000000000005 108.578 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.469 ' HA3' ' HG3' ' A' ' 66' ' ' ARG . . . 103.98 54.73 0.8 Allowed Glycine 0 C--N 1.342 0.894 0 O-C-N 123.43 0.457 . . . . 32.310000000000002 113.591 175.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.6 m -78.55 149.92 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.131 -1.063 . . . . 63.229999999999997 108.131 166.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.3 p -150.09 108.74 3.23 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 122.662 0.385 . . . . 72.209999999999994 110.861 -169.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.15 162.67 39.18 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.368 2.712 . . . . 73.200000000000003 112.968 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 32.6 p30 -140.94 -179.57 6.15 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.692 0.797 . . . . 73.239999999999995 109.7 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -123.31 145.74 48.47 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.141 0.576 . . . . 75.540000000000006 110.037 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -135.75 159.76 40.64 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.562 0.745 . . . . 72.329999999999998 110.032 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -110.29 129.7 55.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.236 -0.893 . . . . 65.420000000000002 109.337 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -80.29 150.7 29.88 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.347 -0.612 . . . . 74.140000000000001 109.347 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 . . . . . 0 CA--C 1.558 1.277 0 C-N-CA 123.56 0.744 . . . . 74.430000000000007 110.932 -172.496 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.484 1.251 0 N-CA-C 109.533 -0.543 . . . . 75.430000000000007 109.533 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.29 29.99 0.58 Allowed Glycine 0 C--N 1.346 1.137 0 O-C-N 123.246 0.341 . . . . 62.539999999999999 112.524 -177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -73.21 112.79 9.59 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.385 -0.598 . . . . 72.310000000000002 109.385 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -129.51 70.36 81.81 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 123.808 0.843 . . . . 73.140000000000001 109.263 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -81.73 -5.41 12.37 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.175 1.917 . . . . 51.200000000000003 112.633 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.75 132.65 5.7 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-O 119.315 -0.714 . . . . 72.219999999999999 111.58 -174.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -178.47 136.88 0.16 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.928 0.891 . . . . 63.210000000000001 108.783 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.31 -168.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 123.664 0.786 . . . . 74.200000000000003 110.245 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.417 HD13 HD21 ' A' ' 133' ' ' ASN . 0.3 OUTLIER -125.7 149.25 48.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.759 1.224 . . . . 73.340000000000003 109.617 176.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.06 36.23 0.66 Allowed Glycine 0 C--N 1.342 0.882 0 N-CA-C 111.539 -0.625 . . . . 75.120000000000005 111.539 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.743 ' HB2' ' HA ' ' A' ' 15' ' ' PRO . 1.2 m-20 -123.36 178.1 5.3 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.791 0.836 . . . . 75.530000000000001 109.309 -174.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.417 ' HG3' ' H ' ' A' ' 46' ' ' GLU . 20.3 mm-40 -115.03 -74.43 0.61 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.507 0.723 . . . . 71.120000000000005 109.731 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -69.77 104.72 2.52 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.172 0.989 . . . . 72.219999999999999 109.479 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.1 mmm-85 54.17 77.13 0.46 Allowed Pre-proline 0 CA--C 1.553 1.08 0 O-C-N 124.269 0.981 . . . . 74.450000000000003 109.667 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.743 ' HA ' ' HB2' ' A' ' 11' ' ' ASP . 33.6 Cg_endo -63.86 166.53 15.91 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.252 1.968 . . . . 64.140000000000001 112.488 -177.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.1 m -65.23 170.54 4.55 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.218 0.532 . . . . 71.5 110.303 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.3 mt -107.23 125.15 33.14 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.103 -1.073 . . . . 72.549999999999997 108.103 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.17 174.51 8.89 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.786 2.324 . . . . 75.349999999999994 112.158 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.43 145.67 39.14 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.54 0.336 . . . . 64.299999999999997 110.124 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.487 ' HB3' HD11 ' A' ' 23' ' ' ILE . 64.6 mt -89.46 101.96 14.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.373 1.069 . . . . 72.040000000000006 109.684 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -96.05 -50.92 4.65 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.419 0.688 . . . . 71.120000000000005 110.074 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -104.45 116.54 32.29 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.197 0.999 . . . . 74.329999999999998 110.077 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.487 HD11 ' HB3' ' A' ' 20' ' ' LEU . 37.3 mm -118.38 114.05 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.617 0.767 . . . . 54.329999999999998 111.124 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.63 ' H ' ' HE1' ' A' ' 129' ' ' TRP . 75.5 mmtt -115.62 157.55 24.01 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.07 1.348 . . . . 74.219999999999999 109.085 166.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.83 14.17 1.96 Allowed Glycine 0 C--N 1.343 0.932 0 CA-C-N 116.272 -0.422 . . . . 73.530000000000001 112.456 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -149.73 146.38 27.18 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.696 0.799 . . . . 43.130000000000003 110.564 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 146.25 86.1 0.06 OUTLIER Glycine 0 C--N 1.35 1.325 0 N-CA-C 111.889 -0.485 . . . . 74.109999999999999 111.889 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -78.46 84.73 4.59 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.337 0.655 . . . . 53.509999999999998 111.363 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -85.48 -59.43 2.32 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.489 1.116 . . . . 63.100000000000001 110.833 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.74 159.93 39.9 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 120.911 0.386 . . . . 64.239999999999995 110.632 168.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.462 ' HA ' ' HD3' ' A' ' 108' ' ' ARG . 22.4 p -165.08 94.23 0.64 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.027 -0.988 . . . . 71.120000000000005 108.769 166.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.439 ' HB2' ' NH2' ' A' ' 108' ' ' ARG . 16.2 m -64.49 143.99 57.52 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 108.987 -0.746 . . . . 63.210000000000001 108.987 173.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 45.5 mmm-85 -74.03 -26.38 60.39 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.734 0.642 . . . . 63.109999999999999 112.734 -171.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -81.25 147.11 30.11 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 120.864 0.364 . . . . 74.230000000000004 111.769 -172.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.91 -100.61 0.5 Allowed Glycine 0 C--N 1.343 0.924 0 N-CA-C 109.006 -1.638 . . . . 64.310000000000002 109.006 172.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 37' ' ' PRO . . . 82.03 -115.55 4.04 Favored Glycine 0 CA--C 1.541 1.659 0 CA-C-O 118.469 -1.184 . . . . 24.039999999999999 115.252 166.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 36' ' ' GLY . 20.4 Cg_exo -65.19 126.59 16.67 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 123.994 3.13 . . . . 75.310000000000002 114.027 -170.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -148.39 167.17 25.97 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.939 0.895 . . . . 71.109999999999999 109.945 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.3 t -127.84 145.86 50.8 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.538 0.735 . . . . 70.540000000000006 111.478 -173.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -74.58 146.76 42.28 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.875 0.87 . . . . 75.420000000000002 110.217 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.502 HG21 HD22 ' A' ' 88' ' ' LEU . 12.2 p -127.78 155.91 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.273 0.629 . . . . 73.420000000000002 110.176 -176.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -149.46 142.32 24.72 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.373 1.069 . . . . 54.329999999999998 108.769 173.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.401 HG12 HD11 ' A' ' 73' ' ' LEU . 34.6 m -124.06 164.5 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.413 0.685 . . . . 52.200000000000003 110.817 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -87.29 150.96 23.52 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.492 -0.776 . . . . 55.100000000000001 108.943 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -119.84 98.26 6.01 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.804 0.442 . . . . 73.109999999999999 110.308 -170.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.417 ' H ' ' HG3' ' A' ' 12' ' ' GLN . 11.9 tp10 -132.38 104.94 6.98 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.435 -0.95 . . . . 54.229999999999997 108.435 170.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.85 153.47 39.19 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.074 0.95 . . . . 71.340000000000003 109.918 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.2 mt -110.95 124.84 52.92 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.34 0.656 . . . . 72.209999999999994 109.505 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.16 118.04 12.48 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.526 -0.546 . . . . 70.540000000000006 109.526 171.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -94.42 110.8 50.84 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 123.816 0.847 . . . . 74.140000000000001 109.556 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.12 -47.36 3.52 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.358 2.039 . . . . 74.329999999999998 111.949 176.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.2 m -141.07 157.75 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.236 1.014 . . . . 73.109999999999999 110.148 -178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.92 -55.81 1.68 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.217 1.007 . . . . 65.120000000000005 108.427 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.9 m -143.93 98.78 3.28 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.306 -0.998 . . . . 75.200000000000003 108.306 172.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.41 -39.36 25.06 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.007 0.432 . . . . 73.430000000000007 109.877 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -79.13 115.66 18.93 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.214 1.006 . . . . 75.420000000000002 108.652 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 58.61 71.06 1.05 Allowed Pre-proline 0 CA--C 1.551 0.986 0 O-C-N 124.573 1.17 . . . . 74.310000000000002 109.885 -176.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -83.36 36.4 0.61 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 123.722 2.948 . . . . 72.430000000000007 113.482 -170.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -76.7 86.52 3.34 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.321 0.648 . . . . 74.150000000000006 109.495 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.87 72.44 0.67 Allowed Glycine 0 C--N 1.348 1.201 0 CA-C-N 115.933 -0.576 . . . . 71.140000000000001 112.038 -177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.9 105.34 0.66 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.842 1.257 . . . . 64.409999999999997 111.846 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.3 m 64.69 5.08 2.59 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 114.141 1.163 . . . . 51.130000000000003 114.141 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -69.7 -36.72 76.19 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 118.173 0.442 . . . . 71.450000000000003 111.77 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.54 75.82 9.05 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.893 0.877 . . . . 70.319999999999993 109.381 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -162.61 146.2 11.42 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 114.823 -1.08 . . . . 73.530000000000001 110.009 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -79.89 87.46 5.34 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 106.808 -1.553 . . . . 61.130000000000003 106.808 171.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.406 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 24.5 p90 -67.82 161.68 25.68 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.827 -1.079 . . . . 70.019999999999996 111.78 -177.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -73.91 100.21 3.45 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 109.417 -0.586 . . . . 63.119999999999997 109.417 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.5 t -79.48 168.86 18.88 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 109.186 -0.672 . . . . 52.310000000000002 109.186 168.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.76 166.07 22.87 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.105 0.479 . . . . 73.129999999999995 110.85 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -129.35 140.63 51.32 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.337 -0.847 . . . . 74.310000000000002 108.797 175.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -86.26 117.47 25.09 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 108.676 -0.861 . . . . 73.230000000000004 108.676 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.401 HD11 HG12 ' A' ' 43' ' ' VAL . 81.3 mt -79.39 -174.34 4.15 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.95 0.9 . . . . 41.020000000000003 111.123 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.31 82.87 0.37 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.647 0.779 . . . . 75.519999999999996 109.408 175.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -167.83 -179.49 4.26 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.326 1.051 . . . . 74.25 109.917 -172.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.89 82.19 0.04 OUTLIER Glycine 0 CA--C 1.532 1.095 0 CA-C-O 118.919 -0.934 . . . . 44.439999999999998 111.586 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.31 112.74 1.33 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.122 2.548 . . . . 74.239999999999995 111.838 177.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.0 m -83.38 102.04 11.75 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.841 0.856 . . . . 53.539999999999999 110.794 -176.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -149.13 123.55 9.66 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.367 -0.833 . . . . 42.299999999999997 108.769 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -78.84 111.04 14.59 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 123.838 0.711 . . . . 73.299999999999997 109.793 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -151.94 148.96 22.47 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.563 1.145 . . . . 74.040000000000006 108.659 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -40.28 -57.79 1.11 Allowed 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 123.875 3.05 . . . . 64.140000000000001 115.008 172.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.03 73.94 0.7 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.771 0.796 . . . . 73.319999999999993 111.232 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.1 tp -91.11 119.53 31.31 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.668 0.747 . . . . 73.409999999999997 110.939 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -111.96 173.86 6.16 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.293 1.437 . . . . 74.219999999999999 109.417 176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.2 p -146.31 154.18 12.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.633 -1.247 . . . . 71.129999999999995 107.633 174.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.475 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -94.85 132.89 39.17 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 110.334 -0.247 . . . . 72.109999999999999 110.334 173.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.502 HD22 HG21 ' A' ' 41' ' ' VAL . 79.3 mt -86.21 -20.94 27.78 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.479 0.711 . . . . 71.530000000000001 110.587 172.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -129.09 153.21 47.87 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.631 -0.713 . . . . 71.129999999999995 109.474 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.67 160.54 32.42 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.363 -0.835 . . . . 74.319999999999993 108.777 163.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.496 ' HB3' HG12 ' A' ' 101' ' ' ILE . 56.3 t80 -159.87 111.18 1.98 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.457 -0.942 . . . . 74.230000000000004 108.457 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.0 t -81.21 124.26 38.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 107.235 -1.394 . . . . 54.409999999999997 107.235 170.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB2' ' N ' ' A' ' 100' ' ' SER . . . -66.14 143.99 56.95 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.993 0.517 . . . . 74.519999999999996 110.799 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.5 m -76.59 -13.62 60.06 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.735 0.814 . . . . 52.130000000000003 110.655 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.68 -155.14 26.36 Favored Glycine 0 C--N 1.353 1.481 0 N-CA-C 111.823 -0.511 . . . . 71.019999999999996 111.823 176.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -65.91 -28.92 69.29 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.253 1.021 . . . . 54.240000000000002 111.416 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.2 p-10 -69.38 -13.73 62.53 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.984 1.314 . . . . 55.130000000000003 112.419 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.0 p -128.82 162.8 26.62 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.348 1.059 . . . . 60.32 109.707 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.456 ' HB3' HG13 ' A' ' 130' ' ' VAL . 53.7 tp -111.39 121.61 45.67 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.198 0.599 . . . . 74.099999999999994 110.382 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.419 ' N ' ' HB2' ' A' ' 93' ' ' ALA . 16.0 p -72.12 116.08 12.12 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.524 -0.547 . . . . 60.43 109.524 173.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.496 HG12 ' HB3' ' A' ' 91' ' ' PHE . 33.5 pt -122.18 161.51 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.145 0.578 . . . . 75.329999999999998 109.735 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 33.3 m -121.54 148.33 44.62 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.364 0.666 . . . . 75.010000000000005 110.172 -177.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -57.47 128.31 36.38 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.665 0.386 . . . . 72.030000000000001 110.255 169.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.06 -21.39 37.36 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 120.19 -0.228 . . . . 72.120000000000005 112.923 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -67.91 131.16 44.99 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.516 0.726 . . . . 72.109999999999999 110.282 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -78.71 121.21 24.44 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.146 0.578 . . . . 64.530000000000001 110.367 177.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.518 ' HA ' HG22 ' A' ' 123' ' ' THR . 14.7 mt -103.66 152.39 21.85 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.166 0.986 . . . . 54.119999999999997 108.424 -175.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.462 ' HD3' ' HA ' ' A' ' 31' ' ' SER . 72.5 mtt-85 -123.25 104.74 9.34 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 107.809 -1.182 . . . . 72.430000000000007 107.809 172.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 53.9 t -96.01 114.22 32.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 108.449 -0.945 . . . . 54.25 108.449 -172.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.4 mt -79.74 -10.81 59.84 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.608 -1.178 . . . . 62.140000000000001 110.59 -174.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.89 157.19 9.2 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 110.521 -1.032 . . . . 62.229999999999997 110.521 173.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -94.11 168.01 11.21 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.601 -0.889 . . . . 74.430000000000007 108.601 174.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -77.63 147.46 35.56 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.578 -1.267 . . . . 53.350000000000001 107.578 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -70.04 -17.07 63.24 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.584 0.754 . . . . 74.040000000000006 112.371 -175.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.505 ' HB3' ' HG2' ' A' ' 117' ' ' GLU . 65.2 t30 -86.05 -11.49 52.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.79 0.436 . . . . 72.430000000000007 110.527 174.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.38 14.06 77.13 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 116.385 -0.37 . . . . 42.240000000000002 113.137 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.505 ' HG2' ' HB3' ' A' ' 115' ' ' ASN . 7.9 pt-20 -75.38 -56.02 5.12 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.519 1.128 . . . . 75.239999999999995 110.629 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -124.59 179.09 5.1 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.796 1.238 . . . . 73.209999999999994 108.813 -176.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -150.3 133.88 16.59 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.243 0.617 . . . . 74.230000000000004 110.154 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -81.11 95.65 6.93 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 109.099 -0.704 . . . . 73.430000000000007 109.099 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -104.91 170.26 7.97 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.158 -0.928 . . . . 74.239999999999995 110.854 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -148.61 129.5 14.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 114.897 -1.047 . . . . 72.319999999999993 108.544 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 107' ' ' LEU . 72.1 p -131.92 -171.13 2.55 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.526 1.13 . . . . 52.530000000000001 108.995 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -68.72 -8.55 43.78 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.607 0.763 . . . . 65.530000000000001 111.048 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.437 ' HB2' HD11 ' A' ' 99' ' ' LEU . 42.0 m-20 -83.16 -24.26 32.57 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.278 1.031 . . . . 75.400000000000006 110.144 173.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 127.99 -167.91 20.12 Favored Glycine 0 C--N 1.354 1.574 0 CA-C-O 119.668 -0.518 . . . . 72.430000000000007 112.183 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -100.14 157.76 16.34 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 117.699 0.749 . . . . 61.32 109.889 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.47 177.87 36.7 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 112.021 -0.432 . . . . 62.520000000000003 112.021 174.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.63 ' HE1' ' H ' ' A' ' 24' ' ' LYS . 84.3 m95 -91.08 134.67 34.33 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.367 0.603 . . . . 72.140000000000001 111.383 -176.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 99' ' ' LEU . 5.4 m -136.47 140.4 32.31 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.726 1.61 . . . . 62.329999999999998 108.551 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.81 143.95 47.14 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.012 1.808 . . . . 64.450000000000003 111.679 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.412 ' HA ' HG12 ' A' ' 135' ' ' ILE . 23.1 m -60.32 -19.62 55.99 Favored 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 124.352 1.061 . . . . 74.25 113.12 -173.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.417 HD21 HD13 ' A' ' 9' ' ' LEU . 75.5 m-20 -79.38 -27.03 41.89 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 112.298 0.481 . . . . 71.25 112.298 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -79.37 -18.92 51.43 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.507 0.504 . . . . 61.119999999999997 110.509 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.551 HD12 HG21 ' A' ' 109' ' ' VAL . 18.7 pt -118.65 146.0 23.86 Favored 'Isoleucine or valine' 0 C--N 1.364 1.201 0 C-N-CA 123.463 0.705 . . . . 74.129999999999995 110.278 -165.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.472 ' OG1' ' HG ' ' A' ' 88' ' ' LEU . 9.6 m -149.66 112.14 3.41 Favored Pre-proline 0 CA--C 1.559 1.291 0 CA-C-O 119.196 -0.431 . . . . 52.009999999999998 112.145 -163.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.92 116.35 4.25 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.426 2.084 . . . . 75.109999999999999 112.608 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.5 m -84.99 -26.63 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 121.089 0.471 . . . . 63.210000000000001 110.04 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -86.74 16.81 4.42 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.947 -1.024 . . . . 75.219999999999999 110.54 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.0 t -49.54 125.9 12.32 Favored 'General case' 0 C--N 1.361 1.081 0 C-N-CA 123.938 0.895 . . . . 61.439999999999998 110.833 177.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.3 mt -60.85 -11.28 7.28 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.595 1.158 . . . . 70.349999999999994 112.0 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -53.6 -14.45 0.86 Allowed 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.527 1.531 . . . . 71.439999999999998 113.593 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -55.81 -35.04 65.91 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 109.483 -0.562 . . . . 75.329999999999998 109.483 172.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -89.37 123.24 33.35 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.283 -1.377 . . . . 72.219999999999999 107.283 164.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.4 m -67.04 -6.56 17.69 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 114.197 1.184 . . . . 54.310000000000002 114.197 -166.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 38.7 p-90 -69.2 -35.68 76.49 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.04 0.385 . . . . 75.400000000000006 112.04 174.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.401 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 52.2 t80 -93.25 145.69 24.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.469 0.708 . . . . 62.329999999999998 109.187 177.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -135.38 7.16 3.32 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 112.986 0.735 . . . . 74.200000000000003 112.986 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 89.92 -167.57 33.42 Favored Glycine 0 N--CA 1.477 1.389 0 N-CA-C 115.091 0.797 . . . . 73.299999999999997 115.091 168.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.85 101.04 1.14 Allowed 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 123.399 2.733 . . . . 52.32 111.464 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.671 HG21 HH21 ' A' ' 171' ' ' ARG . 35.0 t -141.34 150.14 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 CA-C-N 116.065 -0.516 . . . . 72.340000000000003 110.027 -172.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 50.7 m -67.49 149.4 50.24 Favored 'General case' 0 C--O 1.252 1.205 0 C-N-CA 124.624 1.17 . . . . 71.049999999999997 111.965 174.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -57.72 -34.23 69.26 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.327 -0.851 . . . . 75.049999999999997 110.801 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -57.53 -55.15 38.6 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.379 0.672 . . . . 54.350000000000001 110.595 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.5 91.2 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.723 0.809 . . . . 54.25 111.005 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.18 -52.35 65.93 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.206 -0.907 . . . . 73.120000000000005 111.383 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -72.11 -27.72 62.82 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.953 0.901 . . . . 52.43 110.293 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -62.52 -47.65 82.99 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.043 0.537 . . . . 75.209999999999994 110.933 173.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.737 HD12 HH12 ' A' ' 171' ' ' ARG . 81.8 mt -66.88 -41.86 86.53 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.091 0.472 . . . . 73.420000000000002 110.746 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.473 HD23 HG13 ' A' ' 190' ' ' VAL . 31.5 tp -66.44 -24.29 66.42 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 115.273 -0.876 . . . . 64.319999999999993 111.984 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 36.5 t -63.97 -20.41 65.86 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.086 0.954 . . . . 64.430000000000007 112.432 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.8 p -105.73 15.83 26.22 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.337 0.655 . . . . 61.340000000000003 111.229 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -99.75 157.98 19.74 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 116.223 -0.444 . . . . 75.349999999999994 112.66 178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 20.7 pt -107.14 -163.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.044 0.938 . . . . 54.329999999999998 110.172 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.808 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 26.7 p-10 -47.82 115.53 1.19 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.225 1.01 . . . . 75.430000000000007 113.125 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 86.04 13.65 68.57 Favored Glycine 0 C--O 1.255 1.419 0 CA-C-N 116.168 -0.469 . . . . 51.0 112.581 174.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 22.2 t -72.66 133.72 44.76 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 108.623 -0.88 . . . . 73.310000000000002 108.623 176.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.555 ' HB3' HD23 ' A' ' 184' ' ' LEU . 14.5 p90 -142.25 162.55 35.18 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.405 0.52 . . . . 52.119999999999997 112.405 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.532 ' HB3' ' HD3' ' A' ' 171' ' ' ARG . 80.4 mt -141.93 133.15 26.31 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.253 -1.017 . . . . 43.149999999999999 108.253 172.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.43 110.9 32.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 107.543 -1.281 . . . . 71.450000000000003 107.543 174.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.737 HH12 HD12 ' A' ' 159' ' ' LEU . 4.4 mmm-85 -120.68 162.51 19.57 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 108.048 -1.093 . . . . 63.329999999999998 108.048 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.616 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 21.4 pt-20 -117.15 155.33 29.54 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.038 0.447 . . . . 75.239999999999995 110.099 165.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 37.2 m -86.02 127.73 34.71 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.95 -1.023 . . . . 74.319999999999993 110.424 -176.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -70.63 -34.71 72.39 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.103 1.361 . . . . 63.130000000000003 110.565 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 36.0 p -91.15 -14.76 30.54 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.577 1.151 . . . . 55.509999999999998 111.882 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 44.7 m -135.42 76.25 56.36 Favored Pre-proline 0 N--CA 1.477 0.924 0 N-CA-C 108.117 -1.068 . . . . 63.119999999999997 108.117 171.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.63 141.85 46.91 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.879 2.386 . . . . 72.019999999999996 112.968 -174.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 90.93 -22.65 27.65 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.726 -0.67 . . . . 75.040000000000006 111.903 -171.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -93.07 120.05 32.95 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.717 0.807 . . . . 73.409999999999997 109.104 176.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.616 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 52.1 mtt180 -110.52 169.57 8.66 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.205 -0.907 . . . . 73.5 109.724 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.7 t -152.18 137.3 17.36 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 123.731 0.812 . . . . 62.420000000000002 109.204 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 53.4 mt -107.64 133.06 53.54 Favored 'Isoleucine or valine' 0 C--O 1.247 0.933 0 N-CA-C 107.601 -1.259 . . . . 75.120000000000005 107.601 171.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 19.8 m -111.49 117.28 32.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.661 -1.237 . . . . 75.400000000000006 107.661 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.555 HD23 ' HB3' ' A' ' 168' ' ' PHE . 43.5 mt -103.84 143.26 33.06 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.508 1.123 . . . . 65.420000000000002 110.863 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 29.7 ttt180 -132.27 129.87 40.15 Favored 'General case' 0 C--O 1.256 1.442 0 C-N-CA 124.059 0.944 . . . . 73.519999999999996 108.47 169.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.808 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 4.4 p90 -147.74 137.52 22.68 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.418 -0.956 . . . . 74.030000000000001 108.418 174.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 55.12 33.61 20.82 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.172 0.989 . . . . 54.340000000000003 111.864 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 86.47 -7.01 80.81 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.556 -0.747 . . . . 74.310000000000002 113.816 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 18.6 tpp180 -99.83 123.44 44.09 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.564 0.746 . . . . 75.439999999999998 110.281 -171.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.473 HG13 HD23 ' A' ' 160' ' ' LEU . 72.6 t -101.23 133.57 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.694 1.197 . . . . 74.319999999999993 109.602 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.401 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 33.9 p90 -146.0 156.96 43.85 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.787 0.835 . . . . 63.350000000000001 109.532 169.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -127.74 140.39 52.09 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.825 0.85 . . . . 74.329999999999998 108.842 -172.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -141.47 140.09 33.47 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 110.135 -0.321 . . . . 51.43 110.135 174.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -79.18 137.67 37.54 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.405 -0.816 . . . . 71.540000000000006 111.183 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 91.1 mt -78.39 102.49 4.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 107.045 -1.465 . . . . 74.420000000000002 107.045 162.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -75.57 124.64 27.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.391 -1.337 . . . . 75.239999999999995 107.391 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 56.6 m -102.67 121.01 41.56 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.03 0.532 . . . . 72.230000000000004 109.86 -174.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -74.62 145.41 43.3 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.749 -1.204 . . . . 64.329999999999998 107.749 170.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 32.7 m -69.24 -9.78 54.67 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.197 0.599 . . . . 75.120000000000005 111.492 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -65.74 -18.96 65.7 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.751 1.22 . . . . 65.019999999999996 110.709 172.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 97.8 -1.17 59.6 Favored Glycine 0 C--N 1.355 1.627 0 C-N-CA 123.809 0.718 . . . . 40.409999999999997 111.622 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -90.83 137.85 32.05 Favored 'General case' 0 C--N 1.348 0.541 0 C-N-CA 123.571 0.749 . . . . 63.130000000000003 110.049 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 89.2 mt -96.58 157.83 15.71 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.412 0.685 . . . . 71.010000000000005 110.149 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -164.83 174.28 10.8 Favored 'General case' 0 C--N 1.348 0.503 0 O-C-N 123.913 0.758 . . . . 70.310000000000002 110.595 173.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.6 t -138.86 -65.68 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.487 -1.301 . . . . 74.450000000000003 107.487 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 23.0 t -91.48 -175.98 4.38 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.326 1.05 . . . . 75.120000000000005 110.797 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 32.7 t -66.47 -48.11 70.93 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.535 0.734 . . . . 74.129999999999995 111.761 -174.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -87.04 -3.78 59.11 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.229 0.612 . . . . 71.340000000000003 111.684 -176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 74.4 m -69.18 116.57 9.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.692 0.797 . . . . 62.32 110.555 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -144.85 106.83 4.3 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.786 1.234 . . . . 75.340000000000003 108.389 172.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -127.37 140.38 52.22 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 122.926 0.49 . . . . 74.219999999999999 110.697 -173.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -74.84 -37.78 62.17 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.727 0.642 . . . . 74.319999999999993 110.364 173.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 66.9 p -133.43 165.01 25.85 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.983 0.897 . . . . 44.420000000000002 112.15 -177.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 23.4 tp -70.57 -27.88 64.46 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 113.855 -1.52 . . . . 72.439999999999998 110.999 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.34 -41.84 98.9 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.079 0.552 . . . . 74.349999999999994 110.22 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -69.03 -42.08 76.85 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.798 -1.092 . . . . 61.310000000000002 110.662 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.04 -42.75 90.97 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.811 0.695 . . . . 72.299999999999997 110.935 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.6 t -76.75 -41.22 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.705 0.802 . . . . 65.340000000000003 110.9 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -59.63 -50.34 74.26 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.358 0.526 . . . . 73.400000000000006 110.161 173.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -53.42 -54.82 31.34 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.696 -1.138 . . . . 73.439999999999998 109.499 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -63.16 -26.22 68.71 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.643 -0.708 . . . . 72.319999999999993 112.012 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 26.8 t -77.77 -21.2 52.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.85 0.46 . . . . 73.209999999999994 111.711 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.9 t -115.43 -18.85 10.9 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.22 1.933 . . . . 74.549999999999997 116.22 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 35.0 m -92.77 143.65 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-N 120.745 1.611 . . . . 65.319999999999993 114.277 -166.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.38 -1.96 57.45 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.23 2.212 . . . . 73.430000000000007 112.393 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -78.56 13.66 1.54 Allowed 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 128.158 2.583 . . . . 72.439999999999998 114.087 -143.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.21 17.39 4.06 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 123.932 0.777 . . . . 62.219999999999999 111.242 -167.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 52.1 mt -91.3 135.39 33.84 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.093 0.557 . . . . 70.430000000000007 109.742 157.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.401 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 77.3 mt -65.74 -44.8 93.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 O-C-N 124.176 0.922 . . . . 62.520000000000003 109.273 174.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.6 t -138.44 149.32 45.36 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.807 0.443 . . . . 62.039999999999999 109.909 169.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 82.7 p -74.28 156.13 37.51 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 109.076 -0.712 . . . . 75.430000000000007 109.076 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.502 HD23 HD21 ' A' ' 184' ' ' LEU . 38.8 mt -68.6 101.7 1.34 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 108.878 -0.786 . . . . 74.209999999999994 108.878 177.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -80.05 -57.5 3.6 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.077 0.551 . . . . 72.510000000000005 110.095 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 167' ' ' SER . 7.9 p90 -155.64 152.29 23.99 Favored Pre-proline 0 N--CA 1.484 1.229 0 N-CA-C 109.131 -0.692 . . . . 72.329999999999998 109.131 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.471 ' HB3' ' HA ' ' A' ' 146' ' ' TRP . 58.8 Cg_endo -70.62 138.63 35.49 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 121.666 1.577 . . . . 73.319999999999993 111.438 175.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -57.99 146.91 66.69 Favored Pre-proline 0 C--O 1.245 0.844 0 CA-C-O 118.671 -0.68 . . . . 73.519999999999996 110.761 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -52.35 118.33 4.51 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.627 2.218 . . . . 72.340000000000003 112.132 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -58.95 159.66 6.81 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.733 -1.122 . . . . 73.329999999999998 110.929 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 62.5 ttt-85 -56.55 -34.55 67.2 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.781 0.832 . . . . 72.409999999999997 111.476 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -78.34 159.63 28.28 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.855 0.862 . . . . 74.340000000000003 109.438 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -64.08 145.01 98.19 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 123.827 0.851 . . . . 75.209999999999994 112.848 -178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.52 179.96 5.38 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.977 2.451 . . . . 72.299999999999997 110.819 167.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 12.3 t -146.16 -38.34 0.24 Allowed 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 112.645 0.609 . . . . 74.510000000000005 112.645 -175.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.3 p -151.78 145.77 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 118.406 0.548 . . . . 64.030000000000001 110.996 -177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -115.13 104.42 11.84 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.522 1.129 . . . . 74.400000000000006 108.166 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -77.06 110.66 3.08 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-O 119.488 -0.618 . . . . 64.239999999999995 111.67 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 63.7 t -61.29 122.82 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.541 0.736 . . . . 74.109999999999999 109.519 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 20.1 m -92.52 100.08 3.46 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.143 0.977 . . . . 61.340000000000003 109.983 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -70.77 135.2 27.51 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.254 1.969 . . . . 73.150000000000006 112.027 -175.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.4 169.57 17.42 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.392 0.677 . . . . 70.140000000000001 109.818 -178.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -111.67 167.97 9.93 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.923 0.889 . . . . 73.319999999999993 109.041 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.51 119.92 10.72 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 110.494 -0.188 . . . . 74.299999999999997 110.494 -176.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -98.37 -25.31 14.86 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.18 0.992 . . . . 74.129999999999995 109.936 -177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 -82.28 167.59 18.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.616 0.767 . . . . 73.409999999999997 111.902 -167.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 C--O 1.254 1.305 0 N-CA-C 108.962 -0.755 . . . . 62.539999999999999 108.962 -179.673 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 109.639 -0.504 . . . . 74.430000000000007 109.639 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 114' ' ' HIS . . . 143.2 70.59 0.02 OUTLIER Glycine 0 C--N 1.345 1.029 0 CA-C-N 116.384 -0.371 . . . . 65.409999999999997 112.735 176.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -133.98 70.09 1.46 Allowed 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 108.207 -1.035 . . . . 54.409999999999997 108.207 175.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.429 HE22 ' HA2' ' A' ' 2' ' ' GLY . 25.5 mp0 -89.37 160.81 41.57 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-N 114.222 -1.354 . . . . 75.409999999999997 109.616 177.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -58.86 -17.16 35.3 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 123.271 2.648 . . . . 75.040000000000006 114.468 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.18 119.55 3.04 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 111.779 -0.528 . . . . 60.210000000000001 111.779 176.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -74.43 94.26 2.55 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.012 0.434 . . . . 64.310000000000002 109.999 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.4 m -92.15 131.96 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 115.378 -0.828 . . . . 72.329999999999998 109.524 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -108.68 147.4 31.97 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.663 -0.866 . . . . 73.519999999999996 108.663 173.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.91 71.87 0.41 Allowed Glycine 0 C--N 1.349 1.276 0 N-CA-C 111.694 -0.563 . . . . 63.350000000000001 111.694 -175.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -128.27 176.9 7.33 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.561 0.744 . . . . 62.509999999999998 110.734 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.3 -161.29 0.49 Allowed 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 124.162 0.985 . . . . 74.120000000000005 111.119 177.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.404 ' HG3' ' HE2' ' A' ' 89' ' ' TYR . 26.8 ttm-85 -50.0 135.6 20.07 Favored 'General case' 0 C--N 1.362 1.127 0 C-N-CA 123.825 0.85 . . . . 73.430000000000007 110.151 172.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 57.25 71.64 1.08 Allowed Pre-proline 0 CA--C 1.554 1.103 0 O-C-N 124.193 0.933 . . . . 60.219999999999999 109.553 -167.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.444 ' HG2' ' HB3' ' A' ' 133' ' ' ASN . 11.9 Cg_exo -66.39 162.7 35.25 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.211 1.941 . . . . 54.530000000000001 111.137 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.2 p -69.4 168.0 15.37 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.508 0.671 . . . . 65.129999999999995 111.069 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.1 mt -103.31 126.69 31.5 Favored Pre-proline 0 C--O 1.241 0.616 0 CA-C-N 115.066 -0.97 . . . . 70.019999999999996 108.538 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.89 167.84 22.1 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.7 2.267 . . . . 63.130000000000003 112.147 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.83 145.2 32.9 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.961 0.41 . . . . 54.039999999999999 110.646 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.657 ' HB3' HD11 ' A' ' 23' ' ' ILE . 75.1 mt -87.6 92.57 9.15 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.465 -0.939 . . . . 75.430000000000007 108.465 177.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -91.14 -46.83 7.88 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.454 -0.943 . . . . 64.219999999999999 108.454 177.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -98.52 110.16 22.8 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.158 -1.383 . . . . 70.019999999999996 109.58 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 20' ' ' LEU . 30.9 mm -116.62 112.12 38.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.673 -0.862 . . . . 75.540000000000006 108.673 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.499 ' HB3' ' HZ2' ' A' ' 129' ' ' TRP . 66.1 tttt -106.26 -23.52 12.54 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 114.768 -1.106 . . . . 72.519999999999996 109.187 173.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.52 -75.62 2.21 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 110.926 -0.869 . . . . 44.149999999999999 110.926 -176.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -167.42 141.9 3.76 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.938 0.895 . . . . 72.450000000000003 110.064 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.46 -110.35 1.65 Allowed Glycine 0 C--N 1.35 1.347 0 N-CA-C 111.968 -0.453 . . . . 54.439999999999998 111.968 176.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -88.4 153.0 21.53 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.623 0.769 . . . . 74.140000000000001 110.924 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -102.54 16.54 26.07 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.828 0.451 . . . . 74.120000000000005 110.228 171.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -117.83 144.16 45.63 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.62 0.768 . . . . 73.219999999999999 110.462 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.4 t -164.3 23.55 0.07 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.985 0.914 . . . . 53.149999999999999 109.265 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.8 m 62.63 23.42 13.93 Favored 'General case' 0 C--N 1.372 1.577 0 C-N-CA 124.441 1.096 . . . . 54.420000000000002 110.591 -169.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -68.96 161.48 28.77 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.478 1.111 . . . . 64.319999999999993 112.852 -170.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -165.3 178.57 6.8 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.279 -0.873 . . . . 74.439999999999998 109.955 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.28 -166.61 10.96 Favored Glycine 0 C--O 1.243 0.677 0 N-CA-C 110.526 -1.03 . . . . 74.530000000000001 110.526 173.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.92 -153.23 6.42 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-O 118.946 -0.919 . . . . 65.019999999999996 111.91 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.6 ' HG2' ' SG ' ' A' ' 39' ' ' CYS . 60.1 Cg_endo -68.55 174.68 8.04 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 123.103 2.535 . . . . 73.430000000000007 111.964 -176.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -86.65 57.01 4.26 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 121.465 0.65 . . . . 72.420000000000002 110.014 -177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.6 ' SG ' ' HG2' ' A' ' 37' ' ' PRO . 77.8 m -72.32 -31.41 65.66 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.33 0.652 . . . . 64.5 111.133 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -92.41 125.65 37.16 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.606 -0.516 . . . . 72.450000000000003 109.606 173.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.5 m -78.12 65.92 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-O 122.06 0.933 . . . . 71.040000000000006 110.132 173.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' A' ' 105' ' ' GLU . 66.7 t80 -70.2 116.86 11.05 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.696 -1.138 . . . . 44.43 109.98 -175.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' A' ' 71' ' ' GLU . 22.1 m -122.91 163.15 22.04 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 C-N-CA 124.359 1.063 . . . . 64.120000000000005 108.832 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -82.9 176.38 9.34 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 120.736 0.303 . . . . 74.230000000000004 110.692 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -153.14 113.24 3.95 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 109.723 -0.473 . . . . 70.319999999999993 109.723 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -80.84 155.56 26.54 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.733 0.413 . . . . 74.319999999999993 109.981 171.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.14 116.41 18.42 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.929 0.492 . . . . 62.039999999999999 110.342 -173.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.09 86.18 1.04 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.751 -0.833 . . . . 65.150000000000006 108.751 166.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -118.21 149.63 40.77 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.336 -0.987 . . . . 53.43 108.336 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.481 ' H ' ' HD2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -110.17 94.79 19.14 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.029 0.931 . . . . 75.120000000000005 108.904 177.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -88.37 -5.24 6.51 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.963 2.442 . . . . 74.540000000000006 112.674 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.5 p -145.53 14.77 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 124.053 0.941 . . . . 73.329999999999998 109.839 -173.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.11 165.75 26.95 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.754 0.422 . . . . 42.100000000000001 111.209 -172.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.5 p -137.48 144.32 42.17 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.869 0.868 . . . . 73.420000000000002 110.164 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -84.66 90.84 7.78 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.287 0.635 . . . . 52.43 111.087 -174.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -116.94 126.74 53.4 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.226 -1.027 . . . . 72.329999999999998 108.226 170.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 62.83 72.47 0.59 Allowed Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.552 1.141 . . . . 74.200000000000003 110.384 -171.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.58 65.7 4.69 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.659 2.906 . . . . 72.239999999999995 111.553 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -73.7 87.52 1.7 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.366 1.067 . . . . 74.230000000000004 111.025 -173.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.98 53.08 4.78 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.487 -0.645 . . . . 72.450000000000003 111.487 176.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.8 mt -56.35 -48.85 75.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.619 1.168 . . . . 64.219999999999999 110.767 -173.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.2 t -149.36 116.19 5.95 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.957 -1.127 . . . . 74.209999999999994 107.957 172.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -132.79 134.01 44.16 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 109.335 -0.617 . . . . 73.409999999999997 109.335 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.6 88.35 2.19 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.752 -1.203 . . . . 72.230000000000004 107.752 173.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.83 74.19 8.83 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.832 -0.803 . . . . 70.409999999999997 108.832 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -84.15 116.56 22.97 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 115.649 -0.705 . . . . 75.019999999999996 109.964 -175.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -98.32 159.82 14.7 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.353 0.661 . . . . 73.510000000000005 110.37 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -93.7 -58.64 2.21 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 106.955 -1.498 . . . . 73.129999999999995 106.955 165.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.3 m 60.59 26.19 15.89 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.652 1.581 . . . . 73.200000000000003 111.066 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -128.21 105.43 8.35 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.26 1.024 . . . . 74.409999999999997 108.37 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.434 ' HB2' HG12 ' A' ' 43' ' ' VAL . 42.9 mt-10 -150.34 -179.92 7.6 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.25 1.42 . . . . 75.049999999999997 108.505 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -136.99 80.43 1.81 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.89 -0.782 . . . . 65.310000000000002 108.89 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.3 mt -96.42 -160.47 0.8 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.229 0.612 . . . . 60.219999999999999 110.628 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.2 mt -69.62 152.58 44.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.444 0.697 . . . . 71.109999999999999 112.361 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.12 172.4 12.44 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.865 0.866 . . . . 53.420000000000002 111.512 -173.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 168.9 70.82 0.03 OUTLIER Glycine 0 CA--C 1.535 1.338 0 CA-C-N 115.245 -0.888 . . . . 43.149999999999999 111.574 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.81 -39.48 1.29 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.24 2.627 . . . . 73.299999999999997 111.633 176.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 p -96.19 75.97 3.02 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.516 1.126 . . . . 55.450000000000003 108.3 175.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -101.88 -44.44 5.51 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.747 -1.115 . . . . 70.329999999999998 108.841 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.0 m120 66.52 8.91 6.14 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.906 1.446 . . . . 71.129999999999995 114.906 162.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.24 146.88 69.03 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 112.758 0.651 . . . . 65.019999999999996 112.758 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.21 -48.62 4.58 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.546 2.164 . . . . 64.329999999999998 111.58 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -96.65 56.2 1.48 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.927 -0.768 . . . . 75.230000000000004 108.927 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.723 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 24.8 tp -89.11 115.48 26.67 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.952 -0.758 . . . . 74.439999999999998 108.952 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -104.41 175.71 5.4 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.188 1.795 . . . . 71.329999999999998 109.327 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.96 146.52 33.83 Favored 'Isoleucine or valine' 0 C--O 1.256 1.447 0 N-CA-C 108.314 -0.995 . . . . 53.109999999999999 108.314 171.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.43 110.46 12.22 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 123.816 0.698 . . . . 60.109999999999999 110.048 173.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 90.3 mt -69.35 -28.55 66.31 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.481 1.112 . . . . 70.329999999999998 111.587 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.472 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 64.7 m-85 -135.43 152.66 51.6 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.054 -1.091 . . . . 64.0 108.054 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -71.37 146.02 49.02 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.167 -0.679 . . . . 72.319999999999993 109.167 169.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -149.37 108.25 3.87 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.165 -1.05 . . . . 71.519999999999996 108.165 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.47 133.93 28.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.133 -1.062 . . . . 70.109999999999999 108.133 170.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.401 ' HB2' ' N ' ' A' ' 100' ' ' SER . . . -64.86 128.9 37.72 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.837 0.455 . . . . 63.329999999999998 110.535 -178.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 30.0 m -86.58 12.36 10.68 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.134 0.974 . . . . 75.400000000000006 111.215 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.58 179.34 37.9 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 110.586 -1.006 . . . . 74.129999999999995 110.586 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -67.81 -28.68 67.79 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.947 0.499 . . . . 72.329999999999998 110.689 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -68.09 -23.94 64.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.855 0.862 . . . . 73.310000000000002 111.798 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.2 p -103.98 158.51 16.37 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.36 0.664 . . . . 71.319999999999993 110.484 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.507 HD21 HG23 ' A' ' 123' ' ' THR . 49.8 tp -114.49 123.45 49.44 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.206 0.602 . . . . 65.319999999999993 110.488 -178.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.401 ' N ' ' HB2' ' A' ' 93' ' ' ALA . 27.0 p -67.55 119.52 12.47 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.537 0.735 . . . . 74.400000000000006 109.807 173.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.482 HG22 HG21 ' A' ' 123' ' ' THR . 38.2 pt -128.53 129.27 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.483 -0.932 . . . . 64.329999999999998 108.483 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.7 m -95.64 137.85 34.13 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.457 -0.571 . . . . 71.400000000000006 109.457 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -51.16 119.25 3.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.54 0.736 . . . . 70.019999999999996 111.471 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.97 -3.46 48.47 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 116.015 -0.539 . . . . 71.310000000000002 113.198 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.413 ' HB2' ' HE2' ' A' ' 42' ' ' PHE . 59.0 tt0 -86.05 143.98 27.8 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 117.411 0.606 . . . . 73.109999999999999 110.101 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.537 ' HB3' HD11 ' A' ' 84' ' ' LEU . 56.9 mttm -81.91 135.96 35.36 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.205 1.002 . . . . 63.049999999999997 109.157 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.466 ' HA ' HG22 ' A' ' 123' ' ' THR . 14.8 mt -126.98 135.41 50.82 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 107.99 -1.115 . . . . 74.450000000000003 107.99 -168.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -98.69 108.96 21.77 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 118.857 0.753 . . . . 74.329999999999998 109.141 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 88.0 t -98.24 113.91 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 118.77 0.714 . . . . 70.140000000000001 109.82 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.37 -37.88 68.66 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.835 0.854 . . . . 71.030000000000001 110.238 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.3 176.22 47.88 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.245 -0.889 . . . . 43.100000000000001 111.708 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 0.8 OUTLIER -98.98 174.42 6.36 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.515 -0.92 . . . . 61.030000000000001 108.515 176.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -74.61 165.71 24.76 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.801 0.44 . . . . 71.230000000000004 110.341 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.495 ' HB3' ' HA3' ' A' ' 2' ' ' GLY . 22.1 m-70 -58.9 -34.3 71.5 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.21 1.004 . . . . 70.409999999999997 111.632 177.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.402 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 55.0 t30 -107.21 7.33 29.38 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.87 0.868 . . . . 74.519999999999996 110.253 178.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.654 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 61.22 24.08 62.87 Favored Glycine 0 C--N 1.356 1.69 0 CA-C-N 115.66 -0.7 . . . . 50.409999999999997 114.407 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.402 ' HG3' ' HB3' ' A' ' 115' ' ' ASN . 15.6 mt-10 -69.66 -58.25 4.16 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 122.257 1.027 . . . . 64.430000000000007 108.689 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -112.4 -179.39 3.66 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 113.355 -1.748 . . . . 62.240000000000002 108.778 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -142.45 124.26 15.14 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.701 0.801 . . . . 40.210000000000001 108.854 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -72.39 100.91 2.78 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 109.403 -0.592 . . . . 70.430000000000007 109.403 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -114.7 170.11 8.56 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.316 -0.856 . . . . 61.420000000000002 111.246 -177.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.426 ' HG3' ' HB2' ' A' ' 127' ' ' GLN . 44.4 tt0 -148.03 125.13 11.4 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.342 -1.355 . . . . 72.310000000000002 107.342 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.507 HG23 HD21 ' A' ' 99' ' ' LEU . 67.7 p -128.27 -175.02 3.38 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.852 0.835 . . . . 62.109999999999999 111.585 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -64.13 -23.83 67.46 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 113.85 -1.523 . . . . 75.109999999999999 109.722 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -85.79 -4.7 59.23 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.697 1.199 . . . . 63.32 111.931 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 131.19 -131.57 6.46 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-O 120.034 -0.314 . . . . 61.329999999999998 112.393 178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.426 ' HB2' ' HG3' ' A' ' 122' ' ' GLN . 61.0 tt0 -152.21 153.18 33.29 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.444 0.698 . . . . 74.400000000000006 110.363 177.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.74 -170.0 38.14 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 112.187 -0.365 . . . . 71.319999999999993 112.187 176.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.499 ' HZ2' ' HB3' ' A' ' 24' ' ' LYS . 77.2 m95 -96.0 129.72 43.19 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.422 0.689 . . . . 74.450000000000003 110.494 -176.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' A' ' 99' ' ' LEU . 30.7 m -121.4 148.33 49.64 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 124.25 1.02 . . . . 63.439999999999998 109.915 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.27 132.67 19.75 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 121.868 1.712 . . . . 63.329999999999998 111.244 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.6 m -62.05 -18.59 61.1 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.987 0.915 . . . . 74.150000000000006 112.758 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.444 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 71.6 m-20 -72.91 -23.38 60.7 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.015 0.926 . . . . 73.019999999999996 111.742 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.472 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.2 m-85 -96.74 -0.42 48.21 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.541 0.736 . . . . 74.400000000000006 112.179 -174.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.1 pt -129.15 154.23 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 122.879 0.471 . . . . 75.319999999999993 110.552 -173.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.1 t -154.35 138.57 11.2 Favored Pre-proline 0 N--CA 1.491 1.611 0 CA-C-O 119.467 -0.301 . . . . 70.219999999999999 110.801 172.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.461 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 56.6 Cg_endo -69.47 130.92 20.57 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 122.594 2.196 . . . . 74.409999999999997 113.267 -175.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 10.3 m -108.37 -58.63 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.802 0.841 . . . . 74.129999999999995 110.733 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.723 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.6 t30 -93.49 1.13 56.9 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.205 0.602 . . . . 72.209999999999994 110.957 -174.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 25.5 t -73.84 -178.43 3.22 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.022 0.529 . . . . 74.439999999999998 109.883 173.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.0 mt -58.03 -18.66 25.74 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.886 0.874 . . . . 62.030000000000001 112.933 -174.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.589 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 29.7 tt0 -64.69 -14.49 58.62 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.298 1.039 . . . . 71.239999999999995 112.137 178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.67 -21.86 55.51 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.81 0.844 . . . . 73.430000000000007 111.037 173.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -100.4 139.06 36.62 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 109.095 -0.705 . . . . 73.239999999999995 109.095 170.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.9 p -63.57 -12.41 32.52 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 114.182 1.178 . . . . 54.219999999999999 114.182 -171.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -75.93 -42.28 49.27 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 111.814 0.301 . . . . 74.430000000000007 111.814 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 29.0 t80 -89.74 139.31 30.7 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 109.434 -0.58 . . . . 74.109999999999999 109.434 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.589 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 72.3 m-70 -131.23 16.75 5.02 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.469 0.544 . . . . 75.099999999999994 112.469 -178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 72.44 -159.04 53.53 Favored Glycine 0 CA--C 1.539 1.549 0 CA-C-O 119.466 -0.63 . . . . 62.200000000000003 114.44 174.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 68.5 Cg_endo -72.07 109.6 2.74 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.322 2.681 . . . . 73.25 111.848 176.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.562 ' HB ' ' HD3' ' A' ' 171' ' ' ARG . 6.5 t -136.92 155.56 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.258 0.551 . . . . 64.329999999999998 111.076 -176.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.2 m -68.26 148.56 50.63 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 124.909 1.283 . . . . 60.229999999999997 111.803 171.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.87 -30.56 70.77 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.744 0.818 . . . . 62.240000000000002 111.09 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.89 -52.75 54.81 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.215 0.606 . . . . 71.129999999999995 109.934 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.83 87.09 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.55 0.74 . . . . 63.130000000000003 111.042 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.53 ' HB2' ' HD2' ' A' ' 171' ' ' ARG . . . -55.41 -59.6 4.59 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.166 -0.925 . . . . 75.109999999999999 111.337 173.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.631 ' HG3' HG11 ' A' ' 190' ' ' VAL . 33.0 tt0 -64.84 -28.19 69.39 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.31 -0.859 . . . . 61.140000000000001 111.29 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -66.43 -50.82 62.13 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.295 1.038 . . . . 75.120000000000005 110.964 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.78 -40.05 84.0 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.933 -0.576 . . . . 71.0 110.919 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.667 HD23 HG13 ' A' ' 190' ' ' VAL . 37.4 tp -68.53 -29.16 67.68 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.485 -0.779 . . . . 72.409999999999997 112.227 -177.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 13.2 t -62.63 -23.25 66.97 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.538 0.735 . . . . 71.430000000000007 110.856 177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.8 m -82.43 -20.5 36.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.046 0.938 . . . . 72.040000000000006 110.968 176.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.73 -175.43 23.61 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 115.932 -0.576 . . . . 70.439999999999998 112.851 175.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.4 pt -141.04 -165.92 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 124.988 1.315 . . . . 54.200000000000003 111.159 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.731 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 14.6 p-10 -52.52 106.06 0.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.532 1.133 . . . . 64.549999999999997 113.487 -175.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.22 13.3 52.72 Favored Glycine 0 C--O 1.257 1.543 0 CA-C-N 116.132 -0.486 . . . . 74.209999999999994 113.497 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 74.1 m -80.56 140.12 35.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.971 0.386 . . . . 72.120000000000005 110.684 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 183' ' ' SER . 23.1 p90 -136.73 159.66 41.16 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.441 0.639 . . . . 64.239999999999995 112.584 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.592 HD22 HH21 ' A' ' 171' ' ' ARG . 91.5 mt -136.29 133.31 36.81 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.608 -1.178 . . . . 73.150000000000006 108.266 170.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 22.6 t -114.98 127.05 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 107.616 -1.253 . . . . 71.409999999999997 107.616 176.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.592 HH21 HD22 ' A' ' 169' ' ' LEU . 14.7 ptp180 -162.1 148.88 13.67 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.452 0.301 . . . . 72.140000000000001 111.041 -176.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 15.5 pt-20 -93.53 165.8 12.57 Favored 'General case' 0 C--O 1.253 1.248 0 CA-C-O 121.398 0.618 . . . . 72.25 111.693 -178.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.7 t -73.36 154.42 40.08 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.339 -1.3 . . . . 53.310000000000002 111.087 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -77.73 -40.02 42.54 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 114.39 -1.277 . . . . 73.439999999999998 110.653 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.654 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 72.5 p -100.62 -14.12 18.29 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.327 0.651 . . . . 72.010000000000005 112.446 -175.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 46.9 m -124.28 101.72 34.34 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.021 0.528 . . . . 73.310000000000002 110.439 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.74 131.65 28.22 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 123.226 2.618 . . . . 72.040000000000006 112.111 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.33 -24.04 8.91 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 116.237 -0.438 . . . . 53.43 113.882 176.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -75.19 118.2 17.85 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.207 -1.034 . . . . 64.129999999999995 108.207 172.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.576 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 82.9 mtt85 -123.29 172.86 8.32 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.274 0.63 . . . . 63.420000000000002 111.074 -169.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 15.9 m -147.51 144.45 28.56 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.039 0.936 . . . . 62.229999999999997 109.461 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.424 HG12 HG22 ' A' ' 170' ' ' VAL . 52.1 mt -119.06 139.58 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 107.967 -1.123 . . . . 74.25 107.967 167.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 17.5 m -119.82 122.78 42.11 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.196 -1.038 . . . . 44.32 108.196 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.511 HD21 HD23 ' A' ' 232' ' ' LEU . 59.6 mt -105.45 142.18 35.65 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.367 1.067 . . . . 62.5 111.593 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 20.4 ttt180 -128.56 131.47 48.21 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-N 115.05 -0.977 . . . . 75.299999999999997 109.473 169.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.731 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 3.4 p90 -150.83 142.08 23.25 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.215 -1.032 . . . . 71.310000000000002 108.215 171.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 58.44 18.89 5.99 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 124.164 0.986 . . . . 74.230000000000004 113.343 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.56 12.12 73.17 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 122.882 0.277 . . . . 45.32 113.157 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 4.0 tpm_? -105.14 124.01 48.8 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.37 1.068 . . . . 72.439999999999998 109.151 -178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.667 HG13 HD23 ' A' ' 160' ' ' LEU . 98.3 t -112.9 110.41 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.145 0.978 . . . . 34.43 110.177 -177.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.466 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 30.6 p90 -125.85 156.63 39.3 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.533 0.733 . . . . 75.540000000000006 109.245 175.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -131.82 146.94 52.42 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.714 0.806 . . . . 63.420000000000002 109.044 -167.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -145.06 148.74 34.02 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.811 0.444 . . . . 75.450000000000003 110.429 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 15.4 tpp180 -89.94 138.36 31.57 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.525 0.73 . . . . 73.340000000000003 110.817 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.4 HD11 HG13 ' A' ' 182' ' ' ILE . 84.7 mt -88.99 120.47 37.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.217 -1.031 . . . . 71.420000000000002 108.217 165.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.1 m-20 -95.86 137.5 34.84 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 124.004 0.922 . . . . 55.109999999999999 109.358 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 25.8 m -105.24 110.46 22.83 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.339 0.656 . . . . 43.140000000000001 109.478 176.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -62.81 171.93 1.91 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.495 1.118 . . . . 73.310000000000002 112.041 173.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.4 p -67.07 -29.24 68.96 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.375 0.67 . . . . 74.140000000000001 111.966 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -71.21 -17.79 62.49 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.028 0.531 . . . . 63.520000000000003 111.282 175.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 103.5 -5.99 48.89 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 111.786 -0.526 . . . . 72.340000000000003 111.786 -171.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -64.16 130.7 44.96 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.728 0.811 . . . . 73.150000000000006 111.797 -177.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 89.4 mt -89.51 147.33 24.03 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.101 -0.703 . . . . 72.140000000000001 109.101 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -165.2 161.75 19.56 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.586 0.554 . . . . 75.349999999999994 110.724 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 56.0 t -134.75 -46.75 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.925 0.89 . . . . 74.0 109.844 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.622 ' H ' ' HB2' ' A' ' 209' ' ' SER . 27.1 t -139.12 -172.73 3.4 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.559 0.743 . . . . 73.430000000000007 110.397 -170.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.9 m -60.62 -49.05 79.09 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.706 1.202 . . . . 54.539999999999999 113.826 -167.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -85.81 -0.08 54.33 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.023 0.529 . . . . 74.549999999999997 110.832 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.622 ' HB2' ' H ' ' A' ' 206' ' ' SER . 72.4 m -97.84 106.62 18.95 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.6 0.76 . . . . 74.209999999999994 110.711 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -145.23 118.37 8.88 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 125.145 1.378 . . . . 74.150000000000006 107.759 170.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -136.85 145.67 44.7 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 118.095 0.407 . . . . 71.430000000000007 111.736 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -87.57 -21.65 25.27 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 123.743 0.652 . . . . 75.510000000000005 109.919 168.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 72.2 p -135.34 148.76 49.54 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-O 121.697 0.761 . . . . 71.140000000000001 112.02 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 38.1 tp -66.79 -27.68 67.77 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.334 -1.303 . . . . 65.450000000000003 111.105 176.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.98 -50.0 75.74 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.69 0.796 . . . . 75.319999999999993 110.781 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -69.93 -32.49 70.79 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.056 -0.975 . . . . 75.310000000000002 110.807 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.45 -48.78 78.25 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.315 0.384 . . . . 73.420000000000002 110.811 172.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 56.0 t -68.77 -42.43 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.751 0.821 . . . . 71.319999999999993 110.443 -176.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -58.81 -52.79 64.2 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.799 0.809 . . . . 65.430000000000007 111.594 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.431 ' O ' HG22 ' A' ' 224' ' ' VAL . 48.2 t60 -55.05 -50.07 70.04 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.408 -1.269 . . . . 73.129999999999995 109.783 177.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -65.16 -24.92 67.53 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.686 -0.688 . . . . 75.209999999999994 112.112 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.4 m -73.13 -27.87 61.93 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.034 -0.416 . . . . 64.209999999999994 110.983 174.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 15.2 t -110.12 -14.52 14.19 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.659 2.096 . . . . 64.319999999999993 116.659 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 220' ' ' HIS . 27.0 m -99.84 156.97 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 N-CA-C 115.925 1.824 . . . . 72.0 115.925 -166.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -91.47 -0.25 57.59 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 110.738 -2.937 . . . . 71.540000000000006 113.358 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -77.89 13.05 1.48 Allowed 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 128.436 2.694 . . . . 74.239999999999995 113.371 -144.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.16 17.99 4.33 Favored Glycine 0 N--CA 1.46 0.286 0 C-N-CA 124.802 1.191 . . . . 62.409999999999997 111.183 -169.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 91.4 mt -92.51 117.25 29.75 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 113.832 -1.184 . . . . 43.32 109.767 163.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.466 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 85.6 mt -63.01 -41.2 91.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.481 0.712 . . . . 75.420000000000002 109.322 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.0 t -129.66 142.66 50.69 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.46 -0.941 . . . . 73.219999999999999 108.46 165.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 63.5 p -71.28 156.42 39.55 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 109.359 -0.608 . . . . 73.540000000000006 109.359 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.511 HD23 HD21 ' A' ' 184' ' ' LEU . 25.0 mt -65.92 103.6 0.96 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.913 -0.773 . . . . 62.020000000000003 108.913 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -87.0 -49.53 7.28 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.159 0.583 . . . . 72.329999999999998 109.579 -176.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.602 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -161.66 144.44 9.11 Favored Pre-proline 0 N--CA 1.492 1.636 0 C-N-CA 123.177 0.591 . . . . 71.230000000000004 112.418 -179.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.65 140.08 18.49 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.724 1.616 . . . . 72.140000000000001 112.461 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -66.96 120.72 73.87 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 108.847 -0.797 . . . . 73.319999999999993 108.847 172.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.07 145.0 59.65 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 121.952 1.768 . . . . 72.099999999999994 112.095 -175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -64.41 152.63 40.99 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 109.188 -0.671 . . . . 72.329999999999998 109.188 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -58.62 -28.31 65.52 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.09 0.556 . . . . 70.040000000000006 112.24 -173.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -96.94 75.87 2.69 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.079 -0.711 . . . . 62.310000000000002 109.079 170.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -173.9 133.11 0.57 Allowed Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 114.871 -1.059 . . . . 64.030000000000001 109.453 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -64.24 135.39 46.55 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.806 2.337 . . . . 74.319999999999993 112.063 169.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 9.1 t -75.63 162.67 28.06 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.274 0.629 . . . . 70.239999999999995 110.35 174.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.5 p -129.86 128.0 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.108 0.563 . . . . 61.439999999999998 109.958 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -110.35 98.64 7.82 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.202 1.001 . . . . 74.109999999999999 108.562 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -106.74 110.85 3.39 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-O 119.277 -0.735 . . . . 53.140000000000001 111.902 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.78 148.6 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 117.364 0.582 . . . . 44.219999999999999 109.565 170.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 21.5 m -146.94 139.36 14.04 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.159 0.584 . . . . 61.439999999999998 109.591 -175.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.04 132.07 28.93 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.404 2.069 . . . . 64.400000000000006 110.882 173.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -68.03 -64.73 0.8 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 119.117 -0.468 . . . . 54.100000000000001 111.007 -174.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 40.1 t80 45.54 36.53 2.57 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.872 1.269 . . . . 71.129999999999995 111.071 -176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -74.48 124.71 27.08 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.044 -0.98 . . . . 63.009999999999998 110.814 -173.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -71.84 147.45 47.16 Favored 'General case' 0 C--N 1.345 0.398 0 C-N-CA 123.413 0.685 . . . . 75.439999999999998 109.163 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -72.2 142.85 49.02 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.705 -0.85 . . . . 64.420000000000002 108.705 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 CA--C 1.553 1.07 0 C-N-CA 123.718 0.807 . . . . 65.200000000000003 111.408 -175.766 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 mmt . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 109.465 -0.569 . . . . 73.239999999999995 109.465 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.68 146.75 6.01 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 111.783 -0.527 . . . . 53.340000000000003 111.783 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -124.17 121.43 35.07 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.291 1.036 . . . . 74.530000000000001 109.513 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -95.26 127.05 43.83 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.675 0.79 . . . . 63.149999999999999 110.248 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -67.73 -21.76 44.53 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.924 2.416 . . . . 75.099999999999994 112.386 172.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.31 177.95 50.57 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.572 0.545 . . . . 74.219999999999999 112.607 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -81.05 121.29 25.88 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.626 -0.509 . . . . 70.420000000000002 109.626 175.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.4 m -63.78 131.46 29.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.1 0.56 . . . . 74.420000000000002 111.045 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -80.08 137.17 36.71 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.656 -0.498 . . . . 74.450000000000003 109.656 -178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.99 76.26 0.03 OUTLIER Glycine 0 C--N 1.342 0.877 0 N-CA-C 112.192 -0.363 . . . . 61.409999999999997 112.192 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -161.02 144.74 13.26 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.617 -0.512 . . . . 75.109999999999999 109.617 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -79.45 -28.56 41.61 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.412 0.685 . . . . 75.540000000000006 111.253 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -137.58 135.37 36.59 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.89 -0.782 . . . . 74.209999999999994 108.89 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.6 mmm-85 57.27 71.16 1.16 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.541 0.736 . . . . 70.5 109.715 -170.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -69.75 166.24 28.24 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.088 1.859 . . . . 60.43 110.72 177.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.9 m -65.1 166.36 9.67 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-O 120.864 0.364 . . . . 74.409999999999997 111.476 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.7 mt -103.46 126.57 31.73 Favored Pre-proline 0 C--O 1.239 0.518 0 N-CA-C 109.014 -0.735 . . . . 72.439999999999998 109.014 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.16 169.75 21.87 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.999 2.466 . . . . 65.120000000000005 111.954 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.54 149.94 32.96 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.903 0.481 . . . . 60.32 110.551 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.57 ' HB3' HD11 ' A' ' 23' ' ' ILE . 80.7 mt -86.14 94.52 9.3 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.686 -0.857 . . . . 71.420000000000002 108.686 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -97.34 -48.76 5.19 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.047 -0.979 . . . . 72.409999999999997 110.667 -177.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.611 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 60.4 m-85 -103.65 108.52 19.84 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.953 -0.758 . . . . 72.230000000000004 108.953 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.57 HD11 ' HB3' ' A' ' 20' ' ' LEU . 37.7 mm -118.6 112.94 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.863 0.865 . . . . 73.140000000000001 110.226 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.94 73.14 0.53 Allowed 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 124.229 1.012 . . . . 75.030000000000001 108.552 167.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -78.02 77.92 1.61 Allowed Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.704 -0.559 . . . . 72.420000000000002 111.704 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -170.5 134.17 1.1 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.95 0.9 . . . . 64.310000000000002 110.28 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.63 104.95 1.02 Allowed Glycine 0 C--N 1.349 1.293 0 N-CA-C 110.285 -1.126 . . . . 74.030000000000001 110.285 175.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -73.37 -60.63 2.15 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.048 0.539 . . . . 64.510000000000005 110.608 -174.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -120.34 6.35 10.68 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.674 0.79 . . . . 73.329999999999998 110.989 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -72.09 170.31 14.2 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.912 0.885 . . . . 71.310000000000002 109.6 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.4 t -58.72 88.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.601 0.715 . . . . 55.210000000000001 111.785 -174.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.4 m -96.59 90.27 5.28 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 114.99 -1.005 . . . . 71.439999999999998 109.0 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -142.3 103.93 4.35 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.029 -0.987 . . . . 63.140000000000001 108.386 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -72.91 84.33 1.24 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.921 0.888 . . . . 72.420000000000002 110.895 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -93.28 -179.24 39.79 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 114.916 -1.038 . . . . 71.120000000000005 113.045 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.72 -157.01 53.54 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 123.988 0.464 . . . . 64.129999999999995 113.927 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -99.17 -157.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 123.662 2.908 . . . . 61.229999999999997 111.815 171.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -108.05 -174.49 2.54 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.532 0.733 . . . . 74.530000000000001 109.716 169.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.5 t -92.38 -163.06 0.99 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.569 1.147 . . . . 75.319999999999993 108.574 170.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -81.7 29.47 0.38 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.413 0.685 . . . . 73.340000000000003 111.111 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.2 75.78 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 CA-C-O 122.939 1.352 . . . . 72.400000000000006 110.283 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.585 ' HB3' HD11 ' A' ' 73' ' ' LEU . 5.2 p90 -118.36 4.69 11.83 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.949 -1.478 . . . . 64.200000000000003 108.971 167.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.5 m -96.81 135.61 30.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 124.173 0.989 . . . . 64.439999999999998 109.995 -177.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -72.43 149.76 43.94 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.578 0.751 . . . . 61.399999999999999 110.488 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -124.59 156.31 37.64 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.761 -0.829 . . . . 74.340000000000003 108.761 171.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -75.53 127.81 33.92 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 123.462 0.476 . . . . 73.030000000000001 110.288 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.61 113.67 20.09 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.738 0.815 . . . . 70.310000000000002 109.032 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.1 mt -94.57 175.71 6.57 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.611 0.719 . . . . 63.509999999999998 110.893 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -136.23 -167.5 2.06 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.653 -1.158 . . . . 73.420000000000002 108.753 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 63.22 78.85 0.27 Allowed Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 124.46 1.104 . . . . 74.129999999999995 112.294 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -84.01 167.43 12.6 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.588 2.192 . . . . 72.030000000000001 111.631 169.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.0 t -74.92 98.26 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 109.304 -0.628 . . . . 71.439999999999998 109.304 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.6 141.93 53.63 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.604 -0.725 . . . . 53.240000000000002 110.416 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.2 p -66.97 138.33 57.18 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.706 0.802 . . . . 73.010000000000005 111.166 -176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -58.71 -60.83 3.21 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.732 0.813 . . . . 53.399999999999999 109.657 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -77.38 140.89 40.02 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.918 0.887 . . . . 72.329999999999998 108.858 173.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 59.75 71.43 0.91 Allowed Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.086 0.954 . . . . 71.439999999999998 111.195 -170.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -82.18 1.23 9.33 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.001 2.467 . . . . 74.409999999999997 112.816 174.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -61.86 98.2 0.09 Allowed 'General case' 0 C--N 1.349 0.564 0 C-N-CA 125.164 1.385 . . . . 62.210000000000001 110.779 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.73 144.46 10.77 Favored Glycine 0 C--N 1.338 0.646 0 N-CA-C 111.494 -0.642 . . . . 63.530000000000001 111.494 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.5 mt -112.49 112.72 24.47 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.262 0.625 . . . . 65.409999999999997 109.726 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.4 m -90.16 71.38 7.28 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.834 -0.802 . . . . 75.129999999999995 108.834 173.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.78 151.39 40.63 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.0 -1.0 . . . . 71.239999999999995 110.253 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.6 163.94 23.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.099 0.559 . . . . 62.229999999999997 110.329 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -158.05 152.03 24.07 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.812 0.845 . . . . 70.200000000000003 109.758 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -84.8 99.05 10.63 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.347 -0.612 . . . . 63.439999999999998 109.347 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 45.2 t-105 -74.14 110.23 8.27 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.51 0.724 . . . . 74.239999999999995 110.07 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -120.73 94.2 4.28 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.632 0.729 . . . . 64.540000000000006 110.098 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 54.0 m -83.35 80.06 9.21 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.92 -0.77 . . . . 74.239999999999995 108.92 173.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -96.76 -179.17 4.49 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.474 -0.784 . . . . 62.219999999999999 111.259 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -65.91 -65.15 0.71 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.326 -0.852 . . . . 65.140000000000001 111.475 -173.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 59.77 20.25 9.04 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.51 1.124 . . . . 63.409999999999997 110.668 -173.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.585 HD11 ' HB3' ' A' ' 42' ' ' PHE . 91.5 mt -73.63 76.82 1.51 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.184 0.994 . . . . 65.040000000000006 110.005 -175.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.7 mt -119.11 154.76 32.72 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.772 0.829 . . . . 64.299999999999997 110.048 -173.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.36 165.35 27.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.26 1.024 . . . . 42.43 109.076 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.46 -70.57 0.31 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-O 118.884 -0.954 . . . . 50.310000000000002 112.088 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.84 90.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.391 2.773 0 C-N-CA 123.983 3.122 . . . . 70.239999999999995 113.995 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.7 p -106.41 48.48 0.84 Allowed 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.863 1.265 . . . . 74.340000000000003 107.986 174.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.45 140.52 58.05 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.525 -1.216 . . . . 71.450000000000003 109.929 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -65.28 -84.36 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 O-C-N 124.471 1.107 . . . . 72.340000000000003 111.539 -166.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 62.19 157.72 0.12 Allowed Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 124.476 1.11 . . . . 73.310000000000002 113.173 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.35 -25.44 56.58 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.09 1.86 . . . . 75.209999999999994 111.161 168.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -104.62 80.69 1.69 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.504 1.122 . . . . 62.210000000000001 110.252 -177.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 35.0 tp -128.06 112.77 14.97 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.114 -0.699 . . . . 61.149999999999999 109.114 167.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -116.1 173.91 6.32 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.379 1.472 . . . . 73.540000000000006 110.043 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.5 p -147.56 144.85 19.33 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 C-N-CA 124.281 1.033 . . . . 74.230000000000004 108.674 171.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.544 ' HB2' HD11 ' A' ' 107' ' ' LEU . . . -81.73 128.68 34.23 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.711 0.404 . . . . 71.109999999999999 110.161 175.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.8 mt -86.15 -20.57 28.43 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.513 0.725 . . . . 72.030000000000001 110.837 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.554 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 74.9 m-85 -130.59 158.38 40.16 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.782 0.833 . . . . 60.25 109.335 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -83.55 140.23 32.39 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.757 -0.831 . . . . 63.25 108.757 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -155.13 111.91 3.26 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.676 -0.861 . . . . 72.230000000000004 108.676 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.43 140.67 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 109.304 -0.628 . . . . 73.409999999999997 109.304 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -56.21 115.95 2.75 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.336 0.654 . . . . 74.150000000000006 110.623 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.0 p -72.21 -27.93 62.86 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.535 0.734 . . . . 73.150000000000006 110.392 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -152.91 -173.36 22.19 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 114.85 -1.068 . . . . 43.439999999999998 110.984 175.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -70.22 -28.89 65.63 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.306 0.643 . . . . 64.340000000000003 110.855 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.477 HD22 HD12 ' A' ' 23' ' ' ILE . 26.1 p-10 -70.02 -22.42 63.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.567 1.147 . . . . 71.420000000000002 111.967 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 74.3 p -105.77 160.92 14.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.283 1.033 . . . . 71.329999999999998 110.271 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.0 tp -109.41 144.29 37.83 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.164 0.586 . . . . 71.140000000000001 110.44 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.2 p -83.09 111.61 19.05 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.513 -0.921 . . . . 55.119999999999997 108.513 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.7 pt -117.89 139.07 46.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 123.836 0.854 . . . . 61.509999999999998 109.014 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.425 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 20.5 m -101.34 150.24 23.2 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.731 -0.47 . . . . 42.310000000000002 109.731 176.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -56.74 112.04 1.19 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 122.622 0.369 . . . . 65.340000000000003 110.082 167.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.38 -4.31 43.95 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.328 -0.396 . . . . 51.0 112.916 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.92 134.03 36.89 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.555 0.742 . . . . 75.129999999999995 109.624 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -83.31 112.52 19.97 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.934 -0.765 . . . . 64.310000000000002 108.934 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 87' ' ' ALA . 18.8 mt -101.37 156.72 17.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.005 0.522 . . . . 73.329999999999998 109.818 -171.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -124.72 108.64 12.2 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.601 -0.518 . . . . 65.530000000000001 109.601 167.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 135' ' ' ILE . 85.4 t -96.81 106.92 19.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 115.152 -0.931 . . . . 64.530000000000001 109.843 -176.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.413 HD12 ' NE2' ' A' ' 127' ' ' GLN . 69.1 mt -73.57 -14.56 61.22 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.365 -0.834 . . . . 75.319999999999993 111.427 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.37 163.24 21.99 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 116.252 -0.431 . . . . 71.239999999999995 112.419 172.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 7.4 m-30 -95.29 173.31 7.6 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.845 -0.798 . . . . 74.430000000000007 108.845 173.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.611 ' ND2' ' HB2' ' A' ' 22' ' ' PHE . 10.1 m120 -64.01 150.94 44.2 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.584 -1.265 . . . . 74.340000000000003 107.584 161.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -65.19 -22.64 66.92 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.041 0.382 . . . . 62.140000000000001 110.526 177.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -86.15 -14.89 42.76 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 122.793 0.437 . . . . 71.129999999999995 110.441 174.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 174' ' ' GLU . . . 84.41 25.91 41.54 Favored Glycine 0 C--N 1.355 1.603 0 C-N-CA 123.452 0.549 . . . . 62.329999999999998 113.59 175.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -79.81 -71.33 0.46 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.391 0.677 . . . . 73.420000000000002 110.779 -175.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -104.77 175.56 5.45 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.336 1.054 . . . . 70.019999999999996 109.013 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -151.22 116.0 5.2 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.825 0.85 . . . . 33.229999999999997 109.445 -172.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 36.5 tt0 -67.91 97.38 0.66 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.677 0.391 . . . . 62.119999999999997 110.162 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.31 153.74 19.38 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.246 -0.65 . . . . 53.340000000000003 109.246 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -138.48 131.86 30.36 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.713 0.805 . . . . 63.450000000000003 109.681 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 63.9 p -140.38 -170.7 3.05 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.635 1.174 . . . . 74.299999999999997 109.423 176.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -64.67 -14.59 58.95 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.279 0.632 . . . . 64.109999999999999 112.098 170.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -80.14 -11.66 59.73 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.73 0.812 . . . . 43.229999999999997 111.304 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 121.09 -133.63 9.73 Favored Glycine 0 C--N 1.35 1.317 0 N-CA-C 111.415 -0.674 . . . . 52.32 111.415 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.413 ' NE2' HD12 ' A' ' 110' ' ' LEU . 58.2 tt0 -151.51 144.99 24.86 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 117.182 0.491 . . . . 74.420000000000002 111.103 -175.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 171.43 168.93 33.73 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.542 0.526 . . . . 72.519999999999996 112.709 174.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -82.48 117.48 22.53 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.527 1.131 . . . . 74.239999999999995 111.408 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.54 154.52 47.81 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 124.997 1.319 . . . . 53.240000000000002 109.136 177.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -64.54 132.47 33.34 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 121.585 1.523 . . . . 74.430000000000007 111.326 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 31.6 m -62.22 -17.74 59.14 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.707 0.803 . . . . 75.120000000000005 112.489 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -82.18 -14.99 54.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.976 0.91 . . . . 60.420000000000002 111.619 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.554 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.7 m-85 -93.95 -3.84 50.84 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.854 0.862 . . . . 64.549999999999997 112.306 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.56 HD12 HG21 ' A' ' 109' ' ' VAL . 18.2 pt -125.95 169.93 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.251 0.62 . . . . 70.409999999999997 110.362 -172.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.5 t -158.04 141.03 10.8 Favored Pre-proline 0 CA--C 1.554 1.106 0 O-C-N 123.563 0.539 . . . . 72.540000000000006 109.963 171.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.14 136.78 14.81 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.573 2.182 . . . . 45.219999999999999 111.841 173.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.7 m -108.25 -45.53 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.668 0.387 . . . . 75.420000000000002 111.162 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.577 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 67.2 t30 -101.25 20.12 16.38 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.473 0.654 . . . . 63.32 110.699 -174.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.5 p -73.97 -171.24 1.06 Allowed 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 121.471 0.653 . . . . 74.430000000000007 110.746 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.483 HD13 ' HB3' ' A' ' 214' ' ' LEU . 67.1 mt -69.95 -13.81 62.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.916 0.886 . . . . 74.519999999999996 111.669 176.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.8 -6.73 17.21 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.86 1.264 . . . . 72.540000000000006 111.524 176.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -55.6 -35.69 66.1 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.214 1.005 . . . . 52.420000000000002 109.902 168.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -93.49 135.44 34.74 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.0 -1.0 . . . . 75.120000000000005 108.812 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.8 m -67.84 -12.07 59.87 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.526 0.935 . . . . 75.430000000000007 113.526 -171.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -75.19 -34.04 61.49 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 111.881 0.326 . . . . 73.319999999999993 111.881 175.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -94.24 134.33 36.82 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.396 -0.594 . . . . 70.150000000000006 109.396 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -125.17 5.12 7.84 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 111.793 0.294 . . . . 71.049999999999997 111.793 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.25 -159.48 50.33 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 119.462 -0.632 . . . . 72.040000000000006 114.446 176.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 38.1 Cg_endo -67.27 104.85 0.93 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.369 2.713 . . . . 63.299999999999997 112.297 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.587 HG11 HH21 ' A' ' 171' ' ' ARG . 32.6 t -140.56 153.51 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.137 0.575 . . . . 54.340000000000003 110.545 -174.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.9 m -68.83 148.17 50.67 Favored 'General case' 0 C--O 1.249 1.027 0 C-N-CA 124.555 1.142 . . . . 73.219999999999999 112.028 173.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -62.62 -29.72 70.82 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.486 0.714 . . . . 74.400000000000006 110.616 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -57.05 -57.11 13.99 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.552 1.141 . . . . 51.020000000000003 110.453 175.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.16 -39.31 89.69 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.049 0.94 . . . . 75.310000000000002 111.189 -177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.48 -53.54 56.32 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.888 -1.051 . . . . 74.510000000000005 110.751 174.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -69.39 -26.88 64.86 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.378 1.071 . . . . 52.119999999999997 110.882 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -67.88 -49.95 59.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.371 0.668 . . . . 75.129999999999995 110.573 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.55 HD12 HH12 ' A' ' 171' ' ' ARG . 66.6 mt -66.31 -37.26 85.0 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 120.802 0.334 . . . . 62.43 110.265 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 183' ' ' SER . 39.6 tp -65.54 -34.32 77.99 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.191 -0.913 . . . . 63.530000000000001 111.435 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.9 t -57.82 -24.79 59.01 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.905 1.282 . . . . 74.230000000000004 112.049 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.612 ' HB2' ' HG2' ' A' ' 237' ' ' PRO . 3.8 m -87.91 -4.82 58.8 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.028 0.931 . . . . 64.209999999999994 111.895 -175.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -94.09 175.97 35.5 Favored Glycine 0 C--N 1.354 1.546 0 C-N-CA 123.197 0.427 . . . . 73.409999999999997 113.912 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.6 pt -118.42 -165.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 124.531 1.133 . . . . 60.399999999999999 109.726 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.677 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 16.8 p-10 -57.58 110.69 0.92 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 113.007 0.743 . . . . 72.310000000000002 113.007 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 101.89 12.11 35.5 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 115.001 -0.999 . . . . 65.340000000000003 112.493 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 23.4 t -74.25 130.13 39.13 Favored 'General case' 0 C--N 1.349 0.579 0 N-CA-C 109.01 -0.737 . . . . 72.420000000000002 109.01 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 235' ' ' PRO . 19.0 p90 -136.78 155.96 49.14 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.29 0.848 . . . . 74.450000000000003 113.29 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.557 HD13 ' NH1' ' A' ' 171' ' ' ARG . 89.0 mt -142.29 135.64 28.95 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.114 0.966 . . . . 43.310000000000002 109.345 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.423 HG22 HG12 ' A' ' 182' ' ' ILE . 15.7 t -109.8 115.61 50.1 Favored 'Isoleucine or valine' 0 C--O 1.252 1.194 0 N-CA-C 108.29 -1.004 . . . . 74.239999999999995 108.29 176.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.587 HH21 HG11 ' A' ' 151' ' ' VAL . 1.4 mmm180 -126.7 159.99 32.08 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.592 -1.262 . . . . 64.239999999999995 107.592 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.674 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 16.9 pt-20 -116.99 163.31 16.41 Favored 'General case' 0 C--O 1.248 1.004 0 N-CA-C 109.482 -0.562 . . . . 74.150000000000006 109.482 167.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 40.5 t -78.78 138.0 38.0 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.712 -0.677 . . . . 73.430000000000007 110.287 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.407 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 27.1 mt-10 -75.94 -37.84 58.23 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.306 -0.861 . . . . 63.409999999999997 108.989 172.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 47.3 m -83.28 -3.78 57.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.288 1.035 . . . . 61.409999999999997 111.615 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.3 t -157.81 75.14 3.97 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 109.148 -0.686 . . . . 65.019999999999996 109.148 173.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.35 141.39 89.16 Favored 'Trans proline' 0 C--N 1.386 2.508 0 C-N-CA 122.987 2.458 . . . . 74.150000000000006 112.395 175.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 96.8 -25.19 27.66 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 115.098 -0.956 . . . . 53.520000000000003 112.009 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -91.69 117.59 29.88 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.486 -0.931 . . . . 63.229999999999997 108.486 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.674 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 56.0 mtt180 -115.64 170.21 8.61 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 123.77 0.828 . . . . 74.439999999999998 110.562 -172.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 47.5 t -153.97 143.29 21.44 Favored 'General case' 0 C--O 1.25 1.09 0 C-N-CA 123.956 0.902 . . . . 75.430000000000007 109.09 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.423 HG12 HG22 ' A' ' 170' ' ' VAL . 45.1 mt -110.72 132.82 58.09 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 N-CA-C 108.098 -1.075 . . . . 73.340000000000003 108.098 170.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.596 ' HB3' HD22 ' A' ' 160' ' ' LEU . 13.8 m -106.08 135.94 46.65 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 124.854 1.262 . . . . 63.310000000000002 108.082 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.429 HD21 HD23 ' A' ' 232' ' ' LEU . 36.4 mt -125.89 137.19 53.72 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.607 1.163 . . . . 74.099999999999994 110.335 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.476 ' HB2' ' HG ' ' A' ' 160' ' ' LEU . 71.4 ttt-85 -120.42 133.77 55.37 Favored 'General case' 0 C--O 1.263 1.804 0 O-C-N 124.472 1.108 . . . . 73.340000000000003 108.848 169.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.677 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 21.4 p90 -147.57 133.97 19.65 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.759 1.287 . . . . 74.140000000000001 108.295 167.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 37.76 59.77 1.25 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 126.378 1.871 . . . . 74.219999999999999 114.116 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.458 ' HA2' ' NH2' ' A' ' 185' ' ' ARG . . . 79.57 -2.52 72.37 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.823 -0.626 . . . . 53.340000000000003 114.6 173.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 42.0 ttm180 -109.78 125.51 52.78 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.501 0.72 . . . . 74.319999999999993 110.393 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 28.7 m -111.51 143.8 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.075 0.95 . . . . 74.040000000000006 110.42 172.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -147.27 150.1 34.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.948 0.899 . . . . 63.520000000000003 109.778 172.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -125.02 116.46 22.17 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.212 -1.032 . . . . 73.200000000000003 108.212 -173.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -115.07 145.81 41.94 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.31 0.576 . . . . 73.209999999999994 110.475 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.511 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 18.9 tpp180 -84.45 128.6 34.68 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 114.681 -1.145 . . . . 62.420000000000002 111.522 -169.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 79.2 mt -80.43 107.22 12.56 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 107.418 -1.327 . . . . 72.319999999999993 107.418 164.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 -77.73 131.26 37.58 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.491 -0.929 . . . . 44.130000000000003 108.491 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 23.1 m -105.63 141.2 37.5 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.15 0.58 . . . . 74.530000000000001 109.529 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 202' ' ' LYS . . . -95.81 174.8 6.78 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.463 1.105 . . . . 63.450000000000003 109.757 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.0 m -59.79 -39.03 83.58 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.266 0.627 . . . . 64.400000000000006 111.762 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -83.54 12.67 5.34 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.658 0.783 . . . . 75.219999999999999 112.129 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 76.43 12.66 84.1 Favored Glycine 0 C--N 1.352 1.421 0 C-N-CA 122.828 0.252 . . . . 71.219999999999999 112.609 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 198' ' ' ALA . 28.9 mtpp -73.35 126.74 30.84 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 109.871 -0.418 . . . . 72.209999999999994 109.871 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.498 HD11 HH11 ' A' ' 180' ' ' ARG . 80.9 mt -94.72 145.37 24.91 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.457 -0.942 . . . . 73.319999999999993 108.457 -178.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -166.85 136.2 2.92 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.329 0.652 . . . . 73.030000000000001 109.611 175.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.7 t -92.93 -56.99 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 107.677 -1.231 . . . . 63.200000000000003 107.677 169.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 2.8 p -83.84 147.06 27.76 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.146 -1.388 . . . . 74.430000000000007 109.679 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 20.7 t -68.76 -46.21 69.38 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.848 0.859 . . . . 60.340000000000003 112.37 -165.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -77.09 -4.02 42.27 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.425 0.69 . . . . 75.420000000000002 111.601 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 70.2 m -91.32 140.37 29.84 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 123.587 0.755 . . . . 71.549999999999997 110.128 173.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -142.75 110.36 5.8 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.014 -1.106 . . . . 74.340000000000003 108.014 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 14.6 m-85 -117.0 141.91 47.64 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 109.674 -0.491 . . . . 63.509999999999998 109.674 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -91.2 -18.69 24.03 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.358 0.663 . . . . 74.510000000000005 109.958 168.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 29.5 p -128.64 138.29 52.1 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.956 0.884 . . . . 55.350000000000001 111.715 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.483 ' HB3' HD13 ' A' ' 141' ' ' LEU . 29.3 tp -67.59 -26.43 66.26 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.031 -1.441 . . . . 72.129999999999995 110.831 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.33 -45.79 92.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.533 0.733 . . . . 74.219999999999999 110.445 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -74.7 -30.54 61.59 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.707 -0.679 . . . . 74.150000000000006 111.932 177.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.73 -51.21 70.73 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 110.133 -0.321 . . . . 75.540000000000006 110.133 172.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 39.6 t -65.38 -42.48 93.68 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 C-N-CA 124.069 0.948 . . . . 74.349999999999994 110.717 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -60.79 -51.52 68.97 Favored 'General case' 0 C--O 1.262 1.734 0 C-N-CA 123.963 0.905 . . . . 74.25 111.033 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.401 ' O ' HG22 ' A' ' 224' ' ' VAL . 47.0 t-80 -55.23 -53.15 59.69 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 114.72 -1.127 . . . . 72.299999999999997 109.748 177.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -73.1 -12.24 60.83 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.245 -0.434 . . . . 61.420000000000002 112.134 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.0 t -78.44 -27.4 46.48 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 122.835 0.454 . . . . 63.240000000000002 110.472 172.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -109.84 -22.48 11.86 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 115.974 1.842 . . . . 71.310000000000002 115.974 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 220' ' ' HIS . 30.9 m -88.69 152.64 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 120.552 1.523 . . . . 73.530000000000001 114.379 -165.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.09 -1.14 57.96 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 111.905 -2.407 . . . . 70.030000000000001 112.866 -176.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -78.7 14.91 1.16 Allowed 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 128.132 2.573 . . . . 54.530000000000001 113.512 -140.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.89 17.36 4.63 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 110.773 -0.931 . . . . 74.219999999999999 110.773 -168.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 84.1 mt -90.68 125.7 35.75 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.35 -0.925 . . . . 75.140000000000001 109.7 165.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 77.7 mt -61.67 -44.17 98.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 O-C-N 124.133 0.896 . . . . 71.439999999999998 109.427 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 9.4 t -137.16 144.91 43.2 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.19 -0.914 . . . . 64.310000000000002 108.582 169.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 60.4 p -73.99 151.11 40.37 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.228 -0.656 . . . . 73.420000000000002 109.228 172.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.438 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 33.5 mt -64.48 101.19 0.42 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.244 -0.65 . . . . 51.520000000000003 109.244 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -80.81 -55.72 4.62 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.845 0.458 . . . . 63.210000000000001 109.972 -174.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -155.24 149.87 20.11 Favored Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 109.824 -0.435 . . . . 44.130000000000003 109.824 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 32.8 Cg_endo -63.08 142.54 87.78 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.192 1.928 . . . . 53.530000000000001 111.628 176.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -67.02 140.37 95.98 Favored Pre-proline 0 C--O 1.244 0.785 0 CA-C-O 119.255 -0.402 . . . . 73.099999999999994 110.511 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.612 ' HG2' ' HB2' ' A' ' 162' ' ' SER . 17.9 Cg_endo -57.52 118.61 5.51 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 123.012 2.475 . . . . 52.350000000000001 113.811 -174.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -76.42 155.89 33.61 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 108.055 -1.091 . . . . 71.049999999999997 108.055 166.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -59.03 -25.25 63.52 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.738 0.644 . . . . 73.510000000000005 112.738 -174.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -117.35 112.02 20.16 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.137 0.575 . . . . 75.349999999999994 109.861 174.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.447 ' N ' ' HD3' ' A' ' 242' ' ' PRO . 13.3 ptmm? -161.4 56.85 0.75 Allowed Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 124.133 0.973 . . . . 75.230000000000004 110.839 171.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.447 ' HD3' ' N ' ' A' ' 241' ' ' LYS . 12.9 Cg_exo -70.44 89.92 0.59 Allowed 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.739 2.293 . . . . 74.0 111.433 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 14.7 t -163.08 159.26 23.0 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.972 0.909 . . . . 74.329999999999998 109.935 -177.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 30.6 m -116.31 144.21 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.197 0.599 . . . . 74.420000000000002 110.174 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -161.22 143.05 11.92 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.14 0.976 . . . . 62.329999999999998 110.079 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 122.01 128.19 3.44 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.759 -0.536 . . . . 72.019999999999996 111.759 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 62.0 t -112.68 -64.9 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.53 0.732 . . . . 64.430000000000007 109.799 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 35.9 t -169.81 127.84 0.83 Allowed Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.62 0.768 . . . . 63.100000000000001 109.594 -174.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -85.42 167.57 10.34 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.505 2.137 . . . . 51.530000000000001 111.563 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -140.23 90.83 2.4 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.643 -0.873 . . . . 64.150000000000006 108.643 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -95.36 121.58 37.18 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.419 -0.809 . . . . 75.319999999999993 109.063 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -93.56 166.45 12.24 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.169 0.988 . . . . 73.420000000000002 110.387 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -118.26 122.16 42.25 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.442 0.697 . . . . 72.099999999999994 110.409 -178.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -140.0 101.41 4.16 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.019 -1.475 . . . . 75.540000000000006 107.019 169.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 . . . . . 0 CA--C 1.561 1.39 0 C-N-CA 124.672 1.189 . . . . 73.040000000000006 111.965 -179.057 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 ptp . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 121.614 0.721 . . . . 74.430000000000007 110.912 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.55 17.03 0.03 OUTLIER Glycine 0 CA--C 1.526 0.741 0 CA-C-N 114.631 -1.168 . . . . 64.409999999999997 111.396 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -72.15 85.73 1.04 Allowed 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.413 1.085 . . . . 53.329999999999998 108.802 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.462 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 9.6 tt0 -86.48 125.03 68.79 Favored Pre-proline 0 C--O 1.238 0.486 0 CA-C-N 114.936 -1.029 . . . . 71.310000000000002 108.862 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.99 -28.81 87.9 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.941 2.427 . . . . 70.099999999999994 112.217 173.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.462 ' H ' ' HG2' ' A' ' 4' ' ' GLN . . . 93.25 -174.18 35.06 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.565 -0.743 . . . . 34.420000000000002 111.426 -174.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -176.75 135.61 0.23 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.568 0.747 . . . . 74.109999999999999 109.862 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.1 150.18 10.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 123.246 0.618 . . . . 71.409999999999997 111.652 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.0 pp -67.83 147.76 52.12 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.888 -0.596 . . . . 73.420000000000002 109.859 170.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 15' ' ' PRO . . . -66.34 -30.83 77.36 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-O 119.312 -0.716 . . . . 43.109999999999999 112.898 178.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.0 t70 73.75 -62.32 0.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.104 1.762 . . . . 60.219999999999999 111.567 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -79.03 -172.01 2.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.216 1.406 . . . . 74.439999999999998 111.883 -176.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -56.38 139.1 49.79 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 124.689 1.196 . . . . 74.239999999999995 111.546 175.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 51.56 70.94 1.67 Allowed Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 123.837 0.855 . . . . 75.010000000000005 110.934 -169.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.424 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 91.7 Cg_endo -75.09 167.76 26.26 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.825 2.35 . . . . 75.409999999999997 112.132 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.0 p -66.91 167.52 11.45 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 121.304 0.573 . . . . 71.140000000000001 111.188 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.3 mt -108.3 134.68 20.11 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 123.981 0.912 . . . . 65.129999999999995 109.604 -176.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -69.3 166.03 28.42 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.379 2.053 . . . . 71.430000000000007 110.908 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.8 142.87 29.47 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.727 0.299 . . . . 63.109999999999999 110.217 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.659 ' HB3' HD11 ' A' ' 23' ' ' ILE . 71.3 mt -87.01 95.54 9.97 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.934 0.893 . . . . 62.32 109.068 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -99.49 -49.66 4.35 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.49 0.662 . . . . 73.340000000000003 110.053 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -99.62 114.92 28.27 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 114.809 -1.087 . . . . 74.230000000000004 108.901 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 20' ' ' LEU . 49.5 mm -116.29 117.84 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 108.609 -0.885 . . . . 63.119999999999997 108.609 -174.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.531 ' HB2' ' HE1' ' A' ' 129' ' ' TRP . 9.5 tmtt? -66.3 -38.17 87.13 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.115 -0.698 . . . . 53.329999999999998 109.115 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.18 175.19 49.81 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.775 -0.648 . . . . 55.439999999999998 113.476 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -92.44 107.92 19.58 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 109.198 -0.667 . . . . 62.32 109.198 173.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.26 66.9 0.11 Allowed Glycine 0 C--N 1.348 1.196 0 N-CA-C 110.589 -1.004 . . . . 45.399999999999999 110.589 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp 69.93 111.31 0.05 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.534 1.534 . . . . 65.329999999999998 110.731 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -93.93 145.86 24.33 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.28 0.632 . . . . 74.450000000000003 110.011 -177.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -82.49 167.22 18.63 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.829 0.852 . . . . 71.230000000000004 111.644 -170.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.9 m 57.6 23.65 9.55 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.733 1.213 . . . . 75.109999999999999 113.052 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.7 t -84.21 99.27 10.43 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 121.871 -0.518 . . . . 64.400000000000006 109.978 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.03 -70.47 0.8 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.612 0.765 . . . . 75.239999999999995 110.944 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -146.28 -41.66 0.2 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.458 0.703 . . . . 65.530000000000001 111.031 -171.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.466 ' HA3' ' HG2' ' A' ' 77' ' ' PRO . . . 79.38 60.18 2.56 Favored Glycine 0 C--N 1.343 0.934 0 O-C-N 123.341 0.401 . . . . 75.129999999999995 113.407 176.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.74 146.59 7.18 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.567 -0.574 . . . . 65.329999999999998 112.969 177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.22 44.38 1.41 Allowed 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 123.748 2.965 . . . . 72.510000000000005 113.173 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -64.28 104.21 0.73 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.702 0.801 . . . . 71.329999999999998 111.119 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.3 t -157.28 142.85 17.4 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.143 0.977 . . . . 74.109999999999999 109.107 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -72.15 152.71 42.11 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 120.888 0.375 . . . . 71.239999999999995 111.415 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.24 173.67 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.55 0.74 . . . . 71.140000000000001 109.537 171.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.514 ' HB3' HD23 ' A' ' 61' ' ' LEU . 15.9 p90 -117.56 105.82 12.47 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.961 -1.126 . . . . 75.040000000000006 107.961 170.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.428 HG12 ' HB3' ' A' ' 62' ' ' SER . 3.6 p -72.69 89.39 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-O 122.75 1.262 . . . . 54.009999999999998 109.347 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.7 147.38 53.17 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 113.689 -1.596 . . . . 65.219999999999999 111.716 -177.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -84.95 133.37 34.28 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.751 0.821 . . . . 54.43 110.933 -172.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -73.21 97.72 2.48 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.194 0.598 . . . . 51.119999999999997 110.359 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.25 125.53 39.09 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.332 0.653 . . . . 53.439999999999998 109.965 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.9 -15.78 61.13 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.142 0.577 . . . . 71.299999999999997 110.144 170.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -79.05 141.09 37.7 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 108.98 -0.748 . . . . 61.409999999999997 108.98 168.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.17 149.66 67.41 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.915 1.286 . . . . 74.230000000000004 108.12 176.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.33 145.33 93.99 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.844 2.363 . . . . 75.439999999999998 113.145 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.48 -29.34 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.016 0.926 . . . . 74.329999999999998 110.564 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.75 148.61 38.12 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.97 0.908 . . . . 72.219999999999999 110.359 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.4 m -82.23 78.88 8.85 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.699 0.8 . . . . 65.239999999999995 109.869 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -86.94 177.59 7.21 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.403 -0.817 . . . . 74.239999999999995 110.269 176.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -131.74 171.93 12.9 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.816 0.846 . . . . 60.520000000000003 110.272 -176.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 69.07 76.05 0.25 Allowed Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 124.99 1.316 . . . . 70.430000000000007 111.602 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.19 82.24 0.5 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.501 2.134 . . . . 73.430000000000007 111.006 173.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -68.29 127.55 33.35 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.4 0.68 . . . . 72.519999999999996 110.498 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.28 70.31 0.09 OUTLIER Glycine 0 C--N 1.336 0.575 0 N-CA-C 110.224 -1.15 . . . . 74.400000000000006 110.224 -173.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 42' ' ' PHE . 88.4 mt -90.68 87.96 6.91 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.083 -0.71 . . . . 70.310000000000002 109.083 173.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.428 ' HB3' HG12 ' A' ' 43' ' ' VAL . 47.3 t -74.12 121.9 21.89 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 109.33 -0.619 . . . . 75.549999999999997 109.33 176.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.94 89.1 0.77 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.47 -0.786 . . . . 72.120000000000005 109.841 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.11 154.07 30.33 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.643 1.177 . . . . 50.409999999999997 108.591 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -153.0 118.2 5.18 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 122.982 0.513 . . . . 74.329999999999998 109.827 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -98.14 54.66 1.11 Allowed 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.796 -0.816 . . . . 71.319999999999993 108.796 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 21.3 m-90 43.07 65.22 1.0 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.912 1.685 . . . . 74.329999999999998 113.121 175.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -96.42 142.69 28.23 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.467 -0.788 . . . . 72.340000000000003 109.083 175.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.8 p -80.89 70.32 7.66 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 123.565 0.746 . . . . 61.539999999999999 110.973 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -84.31 80.09 9.33 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 107.699 -1.223 . . . . 74.230000000000004 107.699 172.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -67.84 82.24 0.2 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 114.757 -1.111 . . . . 64.409999999999997 111.531 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -72.46 132.07 43.39 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.079 -1.082 . . . . 64.209999999999994 108.079 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.4 mt -74.11 5.46 4.34 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.185 0.594 . . . . 74.239999999999995 112.264 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.23 131.77 49.5 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.561 1.144 . . . . 60.119999999999997 110.879 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.79 141.92 51.36 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.697 0.799 . . . . 72.430000000000007 111.003 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -172.9 -164.07 27.71 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-O 118.98 -0.9 . . . . 65.099999999999994 112.198 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.466 ' HG2' ' HA3' ' A' ' 35' ' ' GLY . 52.8 Cg_endo -69.42 -154.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.61 2.873 . . . . 70.150000000000006 113.527 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -84.47 139.4 32.2 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.74 1.385 . . . . 74.430000000000007 114.74 -166.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -77.52 -179.22 5.68 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-N 114.683 -1.144 . . . . 73.319999999999993 111.31 171.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -55.74 141.25 39.0 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.461 1.104 . . . . 71.510000000000005 111.877 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -148.4 152.25 38.33 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 123.816 0.846 . . . . 75.540000000000006 109.525 -174.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.45 -7.26 16.82 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.572 2.181 . . . . 71.209999999999994 112.627 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -96.71 33.32 1.87 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.674 0.79 . . . . 71.230000000000004 110.537 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 25.7 tp -80.83 113.6 19.14 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.919 -0.771 . . . . 72.209999999999994 108.919 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -103.5 176.42 5.15 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.927 1.691 . . . . 71.040000000000006 108.808 173.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.3 p -134.48 144.28 35.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 N-CA-C 108.721 -0.844 . . . . 74.129999999999995 108.721 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.91 113.3 12.06 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 123.532 0.52 . . . . 73.019999999999996 109.954 175.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 83.0 mt -71.58 -26.2 62.51 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.006 0.922 . . . . 72.040000000000006 111.023 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.465 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 71.8 m-85 -134.95 155.46 50.69 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.85 -0.796 . . . . 74.209999999999994 108.85 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -74.41 141.68 45.05 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.88 -0.785 . . . . 73.340000000000003 108.88 170.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -143.44 112.59 6.72 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.94 -0.763 . . . . 72.25 108.94 178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.6 t -79.47 129.64 37.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 107.877 -1.157 . . . . 62.219999999999999 107.877 172.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.58 146.68 54.24 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.397 0.679 . . . . 74.230000000000004 111.122 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.3 m -70.36 -25.31 63.21 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.858 0.863 . . . . 71.439999999999998 110.136 169.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 169.04 -140.55 6.21 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 115.723 -0.671 . . . . 41.119999999999997 112.245 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -70.17 -35.15 73.79 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.544 0.737 . . . . 71.319999999999993 111.013 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.535 ' HB2' HD12 ' A' ' 23' ' ' ILE . 28.7 p30 -70.08 -4.68 22.26 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.66 0.784 . . . . 74.129999999999995 112.676 -177.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.3 p -134.5 160.15 38.93 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.399 1.08 . . . . 72.329999999999998 109.047 177.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.5 tp -110.58 125.97 53.94 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 109.724 -0.473 . . . . 72.030000000000001 109.724 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.1 p -74.6 114.17 12.71 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 108.603 -0.888 . . . . 74.439999999999998 108.603 173.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.0 pt -117.23 155.23 18.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.971 -0.751 . . . . 64.239999999999995 108.971 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.8 m -120.71 145.71 47.2 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.151 -0.685 . . . . 72.099999999999994 109.151 175.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -53.3 114.84 1.63 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.552 0.741 . . . . 62.420000000000002 110.972 175.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.39 -14.34 33.06 Favored Glycine 0 C--N 1.345 1.055 0 CA-C-O 119.87 -0.406 . . . . 74.310000000000002 112.828 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -76.33 132.41 39.77 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.209 0.604 . . . . 72.409999999999997 109.687 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HB3' HD11 ' A' ' 84' ' ' LEU . 50.2 mtmt -84.7 119.69 25.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.685 0.794 . . . . 75.109999999999999 109.371 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.3 mt -104.29 139.48 39.22 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.523 1.129 . . . . 72.040000000000006 108.858 -170.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.7 mtt-85 -101.39 106.93 18.14 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.416 -0.957 . . . . 75.510000000000005 108.416 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 93.9 t -93.07 109.18 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 109.235 -0.654 . . . . 72.109999999999999 109.235 -174.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.7 mt -68.02 -34.75 77.08 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.644 0.778 . . . . 72.230000000000004 110.376 -179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.66 173.6 38.65 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-N 115.337 -0.847 . . . . 60.119999999999997 111.887 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.687 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 14.2 m-85 -98.21 168.84 9.99 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.319 0.648 . . . . 72.439999999999998 109.536 177.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -71.38 152.15 43.42 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.059 -0.719 . . . . 74.109999999999999 109.059 172.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -58.11 -44.37 87.68 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.229 0.612 . . . . 74.329999999999998 111.472 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -79.13 -5.44 54.14 Favored 'General case' 0 CA--C 1.559 1.311 0 C-N-CA 122.949 0.499 . . . . 72.430000000000007 110.315 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 72.6 34.31 60.09 Favored Glycine 0 C--N 1.352 1.44 0 C-N-CA 123.22 0.438 . . . . 72.109999999999999 113.349 174.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -85.44 -61.86 1.66 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.535 0.684 . . . . 71.439999999999998 109.498 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.408 ' HB3' ' HB3' ' A' ' 129' ' ' TRP . 74.5 m95 -111.56 178.11 4.43 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.871 -1.059 . . . . 75.129999999999995 109.974 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -144.45 116.01 8.13 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.98 0.912 . . . . 73.230000000000004 108.658 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -76.58 110.83 11.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.89 0.376 . . . . 74.430000000000007 111.11 -174.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 109' ' ' VAL . . . -105.5 165.35 11.2 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.223 -0.899 . . . . 51.439999999999998 110.195 177.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -142.61 125.27 15.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.34 0.656 . . . . 75.340000000000003 109.409 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.7 p -135.86 -164.31 1.53 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.315 1.046 . . . . 44.0 110.416 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -53.99 -33.28 56.64 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.487 1.515 . . . . 73.129999999999995 111.214 172.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -77.52 -1.85 32.59 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.88 1.272 . . . . 72.019999999999996 112.093 -177.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.09 -135.4 12.74 Favored Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.262 -0.735 . . . . 72.430000000000007 111.262 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -141.56 135.08 29.73 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.68 0.74 . . . . 73.140000000000001 110.63 -172.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -179.07 176.86 48.21 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 112.215 -0.354 . . . . 74.030000000000001 112.215 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.531 ' HE1' ' HB2' ' A' ' 24' ' ' LYS . 79.8 m95 -87.15 131.64 34.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.538 0.735 . . . . 71.239999999999995 111.309 -174.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.45 152.14 60.76 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.492 1.117 . . . . 73.230000000000004 109.294 175.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.71 131.52 17.34 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 121.819 1.68 . . . . 74.430000000000007 109.896 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.1 m -61.63 -18.73 60.64 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.988 0.915 . . . . 72.329999999999998 112.402 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -74.68 -18.73 60.48 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.322 1.049 . . . . 73.219999999999999 111.638 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.465 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 5.4 m-85 -97.93 1.24 47.8 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.595 0.758 . . . . 74.030000000000001 111.862 -177.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.3 pt -133.12 158.96 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 122.873 0.469 . . . . 62.5 110.435 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.3 t -150.61 140.86 14.23 Favored Pre-proline 0 N--CA 1.49 1.56 0 C-N-CA 122.527 0.331 . . . . 61.299999999999997 110.436 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.499 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 74.3 Cg_endo -72.85 132.37 18.4 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.91 2.407 . . . . 63.240000000000002 113.055 -177.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.7 m -113.86 -40.95 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 122.811 0.444 . . . . 74.019999999999996 111.693 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 62.8 t30 -100.97 0.42 38.21 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 122.859 0.464 . . . . 60.020000000000003 111.713 -178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.499 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 33.2 t -75.54 -178.94 4.34 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.11 0.564 . . . . 54.439999999999998 110.33 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 50.0 mt -56.86 -18.23 12.3 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.548 1.139 . . . . 72.329999999999998 112.708 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.562 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 28.2 tt0 -62.07 -19.13 62.6 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.89 0.876 . . . . 71.099999999999994 112.4 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -58.65 -23.73 59.71 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.419 0.688 . . . . 61.509999999999998 111.427 174.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -90.67 134.19 34.59 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.485 -0.931 . . . . 63.25 108.485 173.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.8 p -62.19 -20.56 64.29 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.013 0.745 . . . . 64.409999999999997 113.013 -172.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -73.51 -30.21 62.97 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.118 0.414 . . . . 63.530000000000001 112.118 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -103.33 135.02 45.74 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.553 -0.536 . . . . 74.450000000000003 109.553 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.562 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 16.6 m-70 -130.74 44.49 2.95 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.899 0.479 . . . . 74.329999999999998 110.667 -178.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.45 -160.3 36.61 Favored Glycine 0 CA--C 1.541 1.669 0 N-CA-C 116.45 1.34 . . . . 64.409999999999997 116.45 164.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -83.37 108.97 1.56 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 124.178 3.252 . . . . 64.540000000000006 112.663 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 20.5 m -144.4 172.7 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 109.463 -0.569 . . . . 74.030000000000001 109.463 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.9 m -95.64 171.88 8.4 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 115.834 -0.621 . . . . 70.400000000000006 111.134 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -58.2 -25.29 61.41 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.002 0.921 . . . . 72.040000000000006 111.831 177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -66.04 -56.45 11.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.068 0.947 . . . . 74.140000000000001 110.661 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.56 93.37 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.476 0.71 . . . . 72.120000000000005 110.614 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.459 ' HA ' ' NH2' ' A' ' 171' ' ' ARG . . . -56.59 -55.1 38.17 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-N 114.973 -1.012 . . . . 72.099999999999994 110.737 175.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.565 ' HG3' HG11 ' A' ' 190' ' ' VAL . 39.9 tt0 -68.59 -28.98 67.42 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.628 0.771 . . . . 71.129999999999995 110.927 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -61.17 -49.81 75.7 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.358 0.663 . . . . 74.420000000000002 110.5 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.591 HD12 HH22 ' A' ' 171' ' ' ARG . 38.4 mt -73.41 -32.98 64.73 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.85 -0.614 . . . . 72.109999999999999 111.811 177.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 183' ' ' SER . 44.4 tp -69.88 -26.01 63.98 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.186 0.994 . . . . 74.409999999999997 111.326 -177.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.7 t -69.52 -8.87 50.88 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.847 0.859 . . . . 75.450000000000003 111.594 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.9 t -95.94 12.03 31.79 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.588 0.755 . . . . 64.409999999999997 110.762 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.93 174.02 18.0 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 114.155 0.422 . . . . 64.25 114.155 -177.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.6 pt -123.9 -165.55 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.512 1.125 . . . . 73.349999999999994 109.984 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.875 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 13.8 p-10 -52.64 108.65 0.32 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.08 0.952 . . . . 72.540000000000006 112.66 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 100.49 11.59 40.97 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.42 -0.809 . . . . 71.219999999999999 112.904 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.3 t -77.4 129.33 35.64 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.477 -0.934 . . . . 63.509999999999998 108.477 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -136.52 153.27 51.06 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.811 0.671 . . . . 74.340000000000003 112.811 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.744 HD13 HH21 ' A' ' 171' ' ' ARG . 88.9 mt -131.05 132.16 44.74 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.73 -1.211 . . . . 75.329999999999998 107.73 168.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.71 121.68 56.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 106.663 -1.606 . . . . 73.439999999999998 106.663 172.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.744 HH21 HD13 ' A' ' 169' ' ' LEU . 13.1 mmt180 -128.37 165.99 19.54 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.091 0.957 . . . . 64.129999999999995 108.781 -172.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 13.2 pt-20 -114.94 150.87 35.05 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 107.622 -1.251 . . . . 65.030000000000001 107.622 158.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.6 p -86.44 133.08 33.79 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.347 0.404 . . . . 75.150000000000006 109.915 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.76 -38.19 88.4 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.008 0.923 . . . . 52.530000000000001 110.869 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.454 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 32.9 p -81.31 -10.92 59.47 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.001 0.92 . . . . 70.549999999999997 112.418 -175.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 39.8 m -138.27 101.04 8.42 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 122.915 0.486 . . . . 74.049999999999997 110.477 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.687 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 56.5 Cg_endo -66.55 137.86 47.87 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 123.715 2.943 . . . . 74.329999999999998 112.462 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.36 -22.41 4.58 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-N 116.224 -0.443 . . . . 75.420000000000002 113.537 -178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -82.85 119.44 24.39 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.734 0.814 . . . . 61.229999999999997 109.335 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.575 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 77.8 mtt-85 -116.97 163.24 16.52 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-N 115.184 -0.916 . . . . 74.420000000000002 108.924 -176.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.2 m -147.92 148.0 30.33 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.143 0.577 . . . . 65.120000000000005 110.098 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 66.1 mt -110.58 137.74 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 108.864 -0.791 . . . . 70.109999999999999 108.864 172.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.529 ' HB3' HD22 ' A' ' 160' ' ' LEU . 29.1 m -114.01 115.51 27.73 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.665 1.186 . . . . 52.399999999999999 108.348 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.5 mt -105.0 144.95 31.11 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.808 0.843 . . . . 72.109999999999999 111.511 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.44 ' HB2' ' HG ' ' A' ' 160' ' ' LEU . 28.3 ttt180 -126.97 138.99 53.36 Favored 'General case' 0 C--O 1.256 1.405 0 N-CA-C 107.071 -1.455 . . . . 63.43 107.071 168.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.875 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 10.3 t80 -149.9 103.98 3.26 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.504 -1.225 . . . . 75.340000000000003 108.328 -168.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 56.02 35.66 25.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.682 1.193 . . . . 73.140000000000001 112.321 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.3 78.76 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.503 -0.771 . . . . 34.439999999999998 113.264 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -98.22 124.39 42.78 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.735 -0.839 . . . . 75.340000000000003 108.735 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.565 HG11 ' HG3' ' A' ' 157' ' ' GLU . 48.4 t -109.18 129.51 63.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.47 1.108 . . . . 73.310000000000002 108.78 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.456 ' HE2' ' HB3' ' A' ' 186' ' ' TYR . 13.1 p90 -146.85 143.85 28.88 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.231 1.013 . . . . 73.299999999999997 109.156 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -126.53 140.66 52.28 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.186 0.994 . . . . 62.409999999999997 108.814 -170.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -139.16 140.65 37.92 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.957 0.408 . . . . 75.349999999999994 111.056 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.442 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 23.1 tpp180 -77.04 131.2 38.29 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.903 -1.044 . . . . 72.25 110.705 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 96.3 mt -78.36 106.18 8.63 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 N-CA-C 107.555 -1.276 . . . . 63.119999999999997 107.555 164.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -75.5 124.94 28.04 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.531 -0.914 . . . . 62.119999999999997 108.531 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 30.3 m -99.7 115.46 29.53 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.931 0.893 . . . . 60.299999999999997 109.604 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -66.07 148.63 51.52 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.603 0.761 . . . . 64.340000000000003 109.033 167.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 75.1 p -66.71 -8.75 30.09 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.149 0.58 . . . . 71.430000000000007 112.382 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -83.58 -0.66 51.38 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.03 0.932 . . . . 74.519999999999996 111.14 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 86.83 -0.91 86.74 Favored Glycine 0 C--N 1.349 1.301 0 C-N-CA 123.12 0.39 . . . . 54.25 112.631 -174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -76.52 129.35 36.35 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 116.903 0.351 . . . . 72.200000000000003 110.105 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.5 mt -96.61 148.23 23.07 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.397 0.679 . . . . 72.519999999999996 109.261 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -164.61 167.49 19.18 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 123.747 0.655 . . . . 74.310000000000002 110.798 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.4 t -136.62 -63.47 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 107.815 -1.179 . . . . 64.519999999999996 107.815 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 30.2 t -86.38 167.49 14.68 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.179 0.992 . . . . 74.0 109.484 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 42.8 p -67.75 -39.79 84.15 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.585 0.754 . . . . 73.010000000000005 109.907 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -82.76 -2.52 54.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.841 0.856 . . . . 74.219999999999999 112.062 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 58.1 m -92.77 118.15 30.78 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.978 0.911 . . . . 75.299999999999997 109.581 171.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -144.87 118.19 9.0 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 124.684 1.193 . . . . 73.430000000000007 108.545 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 209' ' ' SER . 10.7 m-85 -135.39 150.43 49.9 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 118.295 0.498 . . . . 71.25 111.505 -172.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -92.03 -29.91 16.33 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.567 0.747 . . . . 61.409999999999997 110.47 171.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.1 p -124.4 147.42 48.27 Favored 'General case' 0 C--O 1.248 1.025 0 C-N-CA 123.527 0.731 . . . . 53.0 111.074 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 32.9 tp -65.56 -31.68 72.86 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 114.37 -1.287 . . . . 72.200000000000003 110.657 175.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.34 -43.87 98.14 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.447 0.699 . . . . 71.310000000000002 111.154 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -73.7 -30.54 62.92 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 119.069 -0.491 . . . . 71.310000000000002 111.693 175.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.96 -47.54 84.73 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.514 0.509 . . . . 74.340000000000003 110.446 172.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 74.2 t -71.4 -37.32 64.51 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 C-N-CA 124.022 0.929 . . . . 74.010000000000005 110.808 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 14.4 t-160 -62.35 -56.14 21.23 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.719 0.807 . . . . 72.219999999999999 111.108 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.428 ' O ' HG22 ' A' ' 224' ' ' VAL . 49.8 t-80 -52.75 -53.53 46.65 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.641 -1.163 . . . . 70.209999999999994 109.393 177.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.41 ' HB3' ' HG ' ' A' ' 232' ' ' LEU . 8.0 m-70 -63.09 -27.72 69.59 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.979 -0.555 . . . . 65.430000000000007 112.388 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.5 t -71.23 -23.66 62.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.846 0.459 . . . . 64.200000000000003 110.841 176.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 15.4 t -119.07 -3.69 10.63 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 116.407 2.002 . . . . 71.030000000000001 116.407 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 220' ' ' HIS . 27.0 m -106.03 154.67 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 116.422 2.008 . . . . 74.519999999999996 116.422 -172.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.7 -0.73 56.84 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 110.793 -2.912 . . . . 53.109999999999999 113.285 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -76.25 13.72 0.87 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 129.596 3.158 . . . . 71.150000000000006 113.56 -140.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.45 16.87 4.99 Favored Glycine 0 N--CA 1.464 0.545 0 C-N-CA 126.253 1.882 . . . . 63.240000000000002 111.629 -169.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 95.9 mt -93.06 126.69 38.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 113.609 -1.295 . . . . 43.119999999999997 109.551 166.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 76.9 mt -58.36 -49.55 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.581 0.752 . . . . 72.439999999999998 109.428 170.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . 0.405 HG22 ' OH ' ' A' ' 191' ' ' TYR . 12.8 t -134.24 148.13 50.79 Favored 'General case' 0 C--O 1.249 1.064 0 N-CA-C 107.826 -1.175 . . . . 71.329999999999998 107.826 169.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 224' ' ' VAL . 67.0 p -70.52 162.93 27.91 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 109.53 -0.544 . . . . 61.219999999999999 109.53 175.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.41 ' HG ' ' HB3' ' A' ' 221' ' ' HIS . 21.5 mt -68.58 100.52 1.13 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.154 -1.054 . . . . 51.049999999999997 108.154 176.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -90.89 -47.18 7.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.767 0.427 . . . . 64.340000000000003 111.253 -168.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -157.12 147.8 16.24 Favored Pre-proline 0 N--CA 1.485 1.319 0 N-CA-C 109.676 -0.49 . . . . 74.209999999999994 109.676 174.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -66.14 133.69 34.02 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.656 2.237 . . . . 62.240000000000002 112.626 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.409 ' HB3' ' HG ' ' A' ' 169' ' ' LEU . . . -67.71 150.25 97.9 Favored Pre-proline 0 C--O 1.246 0.882 0 C-N-CA 123.555 0.742 . . . . 72.219999999999999 110.414 174.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.441 ' O ' ' HB3' ' A' ' 159' ' ' LEU . 51.6 Cg_exo -56.95 132.57 52.44 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.341 2.694 . . . . 73.420000000000002 114.908 -172.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -73.35 157.18 37.46 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 106.721 -1.585 . . . . 60.439999999999998 106.721 158.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -62.77 -13.72 36.41 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 118.764 0.711 . . . . 73.519999999999996 112.691 -170.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -128.67 72.99 1.47 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.222 -1.399 . . . . 62.140000000000001 107.222 164.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 242' ' ' PRO . 21.4 ptmt -64.51 143.75 98.58 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 115.838 -0.619 . . . . 73.230000000000004 112.181 -172.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 241' ' ' LYS . 1.2 Cg_endo -86.68 -164.74 0.22 Allowed 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 123.274 2.65 . . . . 71.349999999999994 110.87 166.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 9.7 t -119.64 144.65 47.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.065 0.546 . . . . 75.519999999999996 110.021 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.8 t -122.68 133.66 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.134 -1.061 . . . . 75.209999999999994 108.134 173.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -70.78 96.3 1.23 Allowed 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 109.069 -0.715 . . . . 71.099999999999994 109.069 173.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -93.28 -20.26 33.22 Favored Glycine 0 C--N 1.341 0.849 0 CA-C-N 115.658 -0.701 . . . . 51.340000000000003 113.161 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.44 77.62 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-O 121.763 0.792 . . . . 73.319999999999993 110.472 -174.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.4 p -166.64 81.82 0.97 Allowed Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 115.117 -0.947 . . . . 73.400000000000006 110.323 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.56 129.67 12.05 Favored 'Trans proline' 0 C--N 1.369 1.641 0 C-N-CA 122.555 2.17 . . . . 45.149999999999999 111.122 172.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -79.82 138.15 37.15 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.167 0.587 . . . . 75.409999999999997 109.935 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -113.32 114.23 26.37 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.613 -0.884 . . . . 73.010000000000005 108.613 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -165.18 151.37 10.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.665 -0.865 . . . . 64.030000000000001 108.665 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.561 ' HA ' ' HE2' ' A' ' 253' ' ' LYS . 10.2 mmpt? -81.84 124.18 29.46 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.937 0.399 . . . . 75.25 111.709 -176.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -95.33 -160.11 0.76 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.446 1.099 . . . . 72.329999999999998 108.704 165.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 123.057 0.543 . . . . 73.239999999999995 109.795 -175.391 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.656 -0.498 . . . . 75.519999999999996 109.656 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.21 82.38 1.66 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 110.669 -0.972 . . . . 74.219999999999999 110.669 -174.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -73.41 98.46 2.74 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.934 0.894 . . . . 53.229999999999997 110.511 -172.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -110.4 105.66 57.33 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 109.007 -0.738 . . . . 61.140000000000001 109.007 174.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -72.45 85.47 1.08 Allowed 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.063 2.509 . . . . 61.340000000000003 112.503 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -168.62 24.36 0.11 Allowed Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.423 -0.808 . . . . 55.520000000000003 113.168 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -105.17 116.34 31.79 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 109.362 -0.607 . . . . 62.530000000000001 109.362 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.9 m -118.26 163.07 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.387 0.675 . . . . 72.010000000000005 109.516 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.2 mt -126.61 120.82 30.5 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.417 0.687 . . . . 51.509999999999998 109.68 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.12 131.91 1.31 Allowed Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.494 -0.614 . . . . 63.030000000000001 113.141 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -172.39 158.62 4.39 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.614 0.766 . . . . 75.329999999999998 109.554 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -79.02 -10.23 59.77 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.696 0.798 . . . . 74.299999999999997 111.872 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -130.47 149.76 52.0 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.615 -1.254 . . . . 75.129999999999995 107.615 171.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 47.8 mmm-85 60.79 80.57 0.26 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.682 0.793 . . . . 72.299999999999997 110.508 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.73 159.48 28.44 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.419 2.079 . . . . 75.129999999999995 110.586 173.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.0 p -66.26 166.87 11.25 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.325 0.583 . . . . 53.140000000000001 110.861 -173.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.6 mt -107.9 123.71 36.97 Favored Pre-proline 0 N--CA 1.469 0.521 0 N-CA-C 108.405 -0.961 . . . . 42.329999999999998 108.405 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HG3' ' HB3' ' A' ' 117' ' ' GLU . 55.5 Cg_endo -71.73 173.77 12.13 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 122.812 2.341 . . . . 73.439999999999998 112.253 174.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.79 149.28 29.67 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.16 0.584 . . . . 53.140000000000001 111.32 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.573 HD22 HD11 ' A' ' 23' ' ' ILE . 89.2 mt -87.43 95.23 9.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.322 0.649 . . . . 64.049999999999997 109.767 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -97.44 -49.15 5.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.147 0.579 . . . . 70.349999999999994 110.485 175.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -99.87 107.78 19.87 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.91 -0.404 . . . . 74.409999999999997 109.91 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.638 HD12 ' HB2' ' A' ' 97' ' ' ASN . 46.6 mm -124.26 121.04 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.103 0.961 . . . . 74.230000000000004 109.551 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -111.95 -50.31 2.92 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.376 -0.602 . . . . 75.420000000000002 109.376 174.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.82 -135.15 12.93 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 115.944 -0.571 . . . . 73.409999999999997 112.029 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.0 79.43 8.52 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.174 0.487 . . . . 65.219999999999999 110.048 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.24 -30.77 44.7 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 115.893 -0.594 . . . . 71.5 112.031 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -140.55 177.52 7.96 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.575 1.15 . . . . 75.310000000000002 110.484 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -147.1 -3.35 0.58 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.791 0.837 . . . . 72.109999999999999 110.766 171.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -109.62 122.11 46.71 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.248 0.619 . . . . 65.439999999999998 110.194 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.7 m -153.16 -70.84 0.15 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.987 0.915 . . . . 60.200000000000003 109.648 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 69.7 m -159.22 -166.06 1.73 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.137 0.975 . . . . 52.509999999999998 109.941 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -73.94 -87.21 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.62 0.768 . . . . 60.140000000000001 111.585 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 176.73 -6.38 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.651 1.18 . . . . 70.120000000000005 111.488 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.93 172.76 49.23 Favored Glycine 0 C--N 1.351 1.407 0 C-N-CA 123.033 0.349 . . . . 75.409999999999997 113.235 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.88 68.8 0.06 OUTLIER Glycine 0 CA--C 1.537 1.46 0 CA-C-O 119.626 -0.541 . . . . 51.310000000000002 112.922 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.459 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 26.2 Cg_endo -95.77 -159.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.939 3.093 . . . . 72.409999999999997 112.42 176.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -118.41 93.67 4.21 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.954 -1.128 . . . . 70.530000000000001 107.954 172.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.99 76.66 6.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.361 0.664 . . . . 64.150000000000006 110.645 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -164.13 140.71 6.54 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.158 0.983 . . . . 45.100000000000001 109.221 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.91 103.78 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 123.836 0.854 . . . . 63.520000000000003 108.829 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -112.65 90.87 3.46 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.949 0.9 . . . . 61.310000000000002 108.993 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.53 121.18 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.883 -0.598 . . . . 60.450000000000003 109.765 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -75.47 85.85 2.59 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.743 0.817 . . . . 75.019999999999996 109.313 175.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -72.18 -50.44 27.67 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.886 0.874 . . . . 73.099999999999994 109.276 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -139.17 152.41 47.38 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.973 0.909 . . . . 74.409999999999997 109.569 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.95 -57.58 0.19 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.852 0.861 . . . . 70.230000000000004 109.905 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.9 mt -57.91 -51.87 67.84 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.114 0.884 . . . . 73.099999999999994 110.869 -175.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -72.0 107.33 4.66 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 108.471 -0.937 . . . . 60.32 108.471 172.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -136.05 130.85 18.61 Favored Pre-proline 0 C--O 1.239 0.549 0 C-N-CA 123.631 0.772 . . . . 65.120000000000005 109.219 -175.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.79 155.98 7.44 Favored 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 122.64 2.227 . . . . 52.439999999999998 111.541 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.8 t -89.55 113.98 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 107.462 -1.31 . . . . 71.519999999999996 107.462 174.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.77 86.03 0.67 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 122.941 0.496 . . . . 75.409999999999997 110.656 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.9 t -107.36 133.7 51.5 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.589 1.155 . . . . 65.310000000000002 109.1 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.9 t70 65.74 29.15 10.82 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 122.142 0.973 . . . . 71.230000000000004 109.727 -173.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -74.96 157.13 35.47 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.227 1.011 . . . . 73.430000000000007 109.417 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 67.16 75.37 0.31 Allowed Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.101 0.96 . . . . 70.129999999999995 110.749 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.97 169.18 21.08 Favored 'Trans proline' 0 C--N 1.381 2.288 0 C-N-CA 123.884 3.056 . . . . 74.109999999999999 113.45 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -65.66 99.52 0.46 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.062 0.945 . . . . 60.030000000000001 109.963 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.63 151.91 18.28 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 123.497 0.498 . . . . 72.420000000000002 111.861 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.4 146.37 51.53 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.743 0.817 . . . . 75.299999999999997 110.279 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.4 m -117.3 35.88 4.48 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.832 0.853 . . . . 43.539999999999999 110.685 -170.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.16 -85.74 0.42 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.559 0.744 . . . . 64.329999999999998 110.537 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -171.73 123.3 0.53 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.28 1.032 . . . . 75.239999999999995 110.095 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -161.42 135.97 7.15 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.13 0.572 . . . . 33.25 111.094 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HD3' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -101.2 128.84 47.12 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.589 -0.893 . . . . 74.049999999999997 108.589 172.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -89.22 134.94 33.84 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.281 0.632 . . . . 74.340000000000003 109.806 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -67.1 149.71 50.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.524 0.729 . . . . 74.420000000000002 110.297 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 82.6 p -147.05 -43.58 0.18 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.049 0.54 . . . . 34.219999999999999 109.697 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt 67.0 14.22 9.77 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 124.961 1.413 . . . . 73.109999999999999 111.379 -175.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -81.51 79.7 8.05 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-O 122.292 1.044 . . . . 62.210000000000001 108.8 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.414 ' HA ' ' HZ3' ' A' ' 103' ' ' LYS . 56.3 m-20 -105.09 -40.41 5.89 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 113.737 -1.574 . . . . 70.510000000000005 110.52 -169.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.62 120.91 10.34 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.383 1.052 . . . . 73.030000000000001 111.393 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.3 mt -130.22 153.01 49.02 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.756 1.223 . . . . 72.230000000000004 107.926 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.1 148.08 48.1 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.146 0.578 . . . . 73.400000000000006 109.628 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.02 70.46 0.1 Allowed Glycine 0 C--N 1.337 0.612 0 O-C-N 123.784 0.678 . . . . 53.43 112.855 177.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -80.04 133.7 10.14 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.821 2.347 . . . . 65.340000000000003 111.813 175.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 37' ' ' PRO . 64.6 p -147.0 133.21 19.4 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 122.738 0.415 . . . . 72.340000000000003 109.911 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.96 70.19 5.25 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 122.046 0.927 . . . . 74.430000000000007 110.598 -176.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -142.48 -43.59 0.32 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 114.061 -1.427 . . . . 71.310000000000002 108.003 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.99 112.51 24.36 Favored Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 107.743 -1.206 . . . . 51.43 107.743 -177.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.0 -70.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.884 3.056 . . . . 70.150000000000006 113.647 -174.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -88.67 72.6 8.66 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.638 0.732 . . . . 63.439999999999998 109.062 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.58 HD11 ' HB3' ' A' ' 106' ' ' LYS . 29.8 tp -89.95 130.92 36.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.952 -1.022 . . . . 75.019999999999996 108.878 177.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 13.0 m-85 -113.84 174.97 5.67 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.008 1.723 . . . . 73.409999999999997 109.015 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 p -141.96 149.1 19.95 Favored 'Isoleucine or valine' 0 C--O 1.256 1.395 0 N-CA-C 109.081 -0.711 . . . . 71.129999999999995 109.081 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.25 124.5 33.92 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.387 -0.824 . . . . 74.420000000000002 109.828 172.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 59.4 mt -83.13 -17.74 41.97 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.264 1.026 . . . . 74.25 111.619 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.479 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 57.8 m-85 -135.44 166.37 23.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.71 0.804 . . . . 64.019999999999996 109.336 -175.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -78.79 145.8 34.13 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.271 -0.877 . . . . 70.430000000000007 109.172 168.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -155.46 112.75 3.29 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.687 -0.486 . . . . 65.510000000000005 109.687 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.98 139.12 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 109.192 -0.67 . . . . 60.009999999999998 109.192 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.13 127.74 34.18 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.963 -0.384 . . . . 73.040000000000006 109.963 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.6 p -65.66 -24.37 67.01 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.648 0.779 . . . . 64.049999999999997 110.919 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -178.97 -149.78 8.47 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.53 -1.028 . . . . 61.32 110.53 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.24 -30.59 69.67 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.819 0.848 . . . . 72.209999999999994 111.578 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.638 ' HB2' HD12 ' A' ' 23' ' ' ILE . 20.1 p30 -71.24 -23.31 61.97 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.029 0.932 . . . . 63.530000000000001 113.51 -172.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.6 p -113.26 163.12 15.21 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.747 0.819 . . . . 61.539999999999999 110.217 -176.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.402 ' HB3' HG13 ' A' ' 130' ' ' VAL . 59.3 tp -111.06 125.72 54.05 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.13 -0.693 . . . . 61.32 109.13 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -74.43 119.66 18.92 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.677 -0.86 . . . . 65.310000000000002 108.677 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.0 pt -123.87 138.71 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.273 0.629 . . . . 52.409999999999997 109.546 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.4 m -97.23 150.06 21.34 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.336 -0.847 . . . . 65.310000000000002 109.756 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.414 ' HZ3' ' HA ' ' A' ' 72' ' ' ASN . 66.3 tttp -61.22 113.58 2.68 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 109.484 -0.562 . . . . 71.329999999999998 109.484 172.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.25 -11.11 47.69 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.198 -0.455 . . . . 44.439999999999998 113.697 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -72.68 134.56 45.13 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.537 0.735 . . . . 72.030000000000001 110.387 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.58 ' HB3' HD11 ' A' ' 84' ' ' LEU . 34.8 mtmm -85.75 123.27 30.94 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.877 0.871 . . . . 74.239999999999995 109.7 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.601 ' HA ' HG22 ' A' ' 123' ' ' THR . 13.0 mt -107.88 158.36 17.4 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.898 -0.779 . . . . 74.120000000000005 108.898 -170.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 76.5 mtm-85 -123.07 108.64 13.12 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.846 -0.798 . . . . 75.049999999999997 108.846 164.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.505 HG21 HD12 ' A' ' 135' ' ' ILE . 98.6 t -88.71 109.46 20.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.334 -0.617 . . . . 61.210000000000001 109.334 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.476 HD12 ' NE2' ' A' ' 127' ' ' GLN . 75.8 mt -81.68 -12.23 58.75 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.198 -0.91 . . . . 65.409999999999997 111.092 -178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 172.72 159.13 18.67 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.39 -0.684 . . . . 54.25 111.39 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 4.1 m-85 -96.93 173.61 7.2 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.686 0.794 . . . . 74.310000000000002 110.28 178.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.468 HD22 ' HB2' ' A' ' 118' ' ' TRP . 32.3 t-20 -77.76 147.19 35.45 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.176 0.991 . . . . 72.239999999999995 108.555 173.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.52 ' HD2' ' HG2' ' A' ' 177' ' ' PRO . 34.0 m170 -63.7 -26.28 68.58 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.117 0.567 . . . . 71.430000000000007 111.645 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -87.66 -16.85 33.21 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.389 1.075 . . . . 52.310000000000002 110.512 175.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.94 0.68 77.59 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 123.911 0.767 . . . . 75.299999999999997 113.68 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.403 ' HB3' ' HG3' ' A' ' 18' ' ' PRO . 17.2 mm-40 -78.0 -47.29 18.8 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.158 0.983 . . . . 71.239999999999995 112.098 -172.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.468 ' HB2' HD22 ' A' ' 113' ' ' ASN . 83.2 m95 -105.61 174.63 5.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.857 0.863 . . . . 62.420000000000002 109.637 177.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -153.49 127.14 8.75 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.175 -1.046 . . . . 74.230000000000004 108.175 175.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -74.28 106.63 6.01 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.232 0.469 . . . . 73.420000000000002 110.409 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.66 163.65 12.18 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.317 -0.856 . . . . 74.340000000000003 109.698 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -139.71 122.78 16.78 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.6 -1.259 . . . . 54.210000000000001 107.6 178.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 107' ' ' LEU . 78.9 p -131.81 -169.56 2.23 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.379 0.672 . . . . 75.120000000000005 110.611 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -54.1 -28.52 39.87 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.098 -1.41 . . . . 53.32 111.708 170.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -84.64 -2.36 57.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.33 1.052 . . . . 64.010000000000005 111.84 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 117.51 -132.79 10.15 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 111.418 -0.673 . . . . 72.209999999999994 111.418 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.476 ' NE2' HD12 ' A' ' 110' ' ' LEU . 63.3 tt0 -142.99 143.74 32.04 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.243 0.617 . . . . 52.329999999999998 110.29 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 174.91 -178.13 46.76 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.843 -0.617 . . . . 54.409999999999997 111.58 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 61.8 m95 -95.97 123.87 39.74 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.017 0.527 . . . . 72.439999999999998 110.762 -173.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.402 HG13 ' HB3' ' A' ' 99' ' ' LEU . 35.1 m -117.64 149.02 44.24 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.978 1.311 . . . . 41.229999999999997 109.601 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.78 132.53 23.48 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 121.669 1.579 . . . . 74.310000000000002 111.234 -179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.6 m -60.74 -21.56 63.1 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.177 0.991 . . . . 75.040000000000006 112.364 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -68.55 -24.65 64.65 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.879 0.872 . . . . 73.209999999999994 111.741 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.479 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.2 m-85 -94.94 0.84 55.06 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.791 0.836 . . . . 63.420000000000002 112.78 -177.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.505 HD12 HG21 ' A' ' 109' ' ' VAL . 15.9 pt -127.72 160.88 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 118.98 0.809 . . . . 74.25 111.365 -171.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.1 t -157.89 145.09 13.39 Favored Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 119.108 -0.472 . . . . 71.349999999999994 110.599 169.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.37 139.27 37.73 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.714 2.276 . . . . 44.43 111.804 175.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.0 m -122.28 -50.01 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.001 0.52 . . . . 74.239999999999995 112.037 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -100.74 -6.04 25.56 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 118.397 0.544 . . . . 75.439999999999998 110.916 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.5 t -60.32 177.75 0.25 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.27 1.028 . . . . 75.030000000000001 111.891 -176.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 84.7 mt -57.13 -17.66 11.75 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.981 0.912 . . . . 73.140000000000001 112.678 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -57.7 -24.7 58.18 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.506 1.122 . . . . 55.340000000000003 112.04 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -56.71 -36.19 69.39 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.409 1.083 . . . . 70.109999999999999 111.25 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 -74.33 141.71 45.2 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.369 -0.832 . . . . 75.230000000000004 109.342 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.1 t -62.69 -21.81 66.02 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.812 0.845 . . . . 75.010000000000005 112.075 -176.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.425 ' CE3' ' HB2' ' A' ' 147' ' ' TYR . 58.8 p-90 -80.05 -41.53 25.52 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.382 0.512 . . . . 73.510000000000005 112.382 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.425 ' HB2' ' CE3' ' A' ' 146' ' ' TRP . 29.5 t80 -99.98 138.04 37.6 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.375 0.534 . . . . 74.420000000000002 109.566 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.404 ' HB2' ' NE ' ' A' ' 171' ' ' ARG . 22.1 m-70 -126.7 14.06 7.5 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 112.172 0.434 . . . . 64.109999999999999 112.172 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.15 -162.65 50.02 Favored Glycine 0 N--CA 1.474 1.23 0 CA-C-O 119.581 -0.566 . . . . 62.439999999999998 114.403 171.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.07 100.38 0.97 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.785 2.99 . . . . 61.439999999999998 111.558 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.55 HG11 ' NH2' ' A' ' 171' ' ' ARG . 84.1 t -138.93 150.92 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 122.818 0.447 . . . . 74.420000000000002 110.595 -172.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 18.4 m -59.2 139.34 57.04 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.598 1.159 . . . . 71.230000000000004 111.411 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -62.8 -27.59 69.41 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.736 0.814 . . . . 74.450000000000003 111.483 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -62.4 -50.3 72.07 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.529 0.732 . . . . 73.420000000000002 110.2 173.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.62 -33.83 76.81 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.461 0.705 . . . . 64.409999999999997 111.54 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 171' ' ' ARG . . . -58.5 -52.36 65.97 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.256 -0.884 . . . . 60.539999999999999 110.573 173.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.462 ' HG3' HG11 ' A' ' 190' ' ' VAL . 35.0 tt0 -69.62 -27.41 65.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.537 0.735 . . . . 65.540000000000006 111.195 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -64.91 -49.42 70.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.856 0.862 . . . . 74.319999999999993 110.983 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.498 HD12 HH12 ' A' ' 171' ' ' ARG . 63.8 mt -70.77 -37.23 73.35 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 120.88 0.371 . . . . 71.040000000000006 110.739 175.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 35.7 tp -64.53 -25.38 67.96 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.547 -0.751 . . . . 75.349999999999994 112.094 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 22.6 t -59.96 -29.26 68.31 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.173 0.989 . . . . 62.119999999999997 111.228 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 29.2 t -77.17 -12.93 60.01 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.97 0.908 . . . . 74.340000000000003 111.969 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.59 165.61 32.43 Favored Glycine 0 C--N 1.344 1.001 0 N-CA-C 113.811 0.284 . . . . 61.539999999999999 113.811 -177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 15.0 pt -113.5 -164.28 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 124.58 1.152 . . . . 71.450000000000003 109.909 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.763 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 21.5 p-10 -52.99 115.18 1.72 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.725 0.81 . . . . 72.25 112.378 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 93.06 12.79 57.25 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 115.472 -0.785 . . . . 74.310000000000002 113.013 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 21.9 t -76.3 138.78 40.73 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.911 -0.774 . . . . 60.310000000000002 108.911 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 16.1 p90 -138.42 158.15 44.84 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.095 0.474 . . . . 72.25 111.979 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.506 HD13 ' NH1' ' A' ' 171' ' ' ARG . 84.9 mt -141.27 134.37 29.27 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.216 -1.031 . . . . 73.420000000000002 108.216 168.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 214' ' ' LEU . 16.0 t -106.93 123.18 61.84 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.947 -1.131 . . . . 61.030000000000001 107.947 175.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.55 ' NH2' HG11 ' A' ' 151' ' ' VAL . 0.9 OUTLIER -130.86 157.87 41.73 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.298 -1.371 . . . . 63.119999999999997 107.298 178.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 11.7 pt-20 -108.22 162.97 13.58 Favored 'General case' 0 C--O 1.253 1.263 0 N-CA-C 109.29 -0.633 . . . . 74.109999999999999 109.29 166.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 176' ' ' SER . 48.1 t -82.67 136.94 34.62 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.22 -0.9 . . . . 63.420000000000002 111.038 -175.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.62 -22.35 63.5 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.139 -1.392 . . . . 50.229999999999997 111.567 174.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 30.1 t -111.24 -0.53 16.42 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.834 0.854 . . . . 73.230000000000004 111.384 -174.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 173' ' ' SER . 24.2 m -139.68 119.67 9.19 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 119.091 -0.481 . . . . 73.150000000000006 109.798 -178.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.52 ' HG2' ' HD2' ' A' ' 114' ' ' HIS . 21.4 Cg_exo -67.11 112.86 2.64 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 123.888 3.059 . . . . 74.319999999999993 113.401 -169.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.95 9.26 52.94 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.54 0.525 . . . . 62.43 114.024 175.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -85.05 114.55 22.28 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 107.71 -1.218 . . . . 63.109999999999999 107.71 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 57.2 mtt-85 -104.67 169.46 8.44 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.379 -0.6 . . . . 71.439999999999998 109.379 -169.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.0 m -155.0 136.42 14.15 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 123.875 0.87 . . . . 75.329999999999998 108.949 -173.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.428 HG12 HG22 ' A' ' 170' ' ' VAL . 54.7 mt -104.13 135.99 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 108.459 -0.941 . . . . 74.340000000000003 108.459 173.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 16.9 m -113.25 111.83 22.7 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.62 -1.173 . . . . 64.239999999999995 107.875 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.444 HD21 HD23 ' A' ' 232' ' ' LEU . 53.4 mt -105.0 139.81 39.13 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.753 0.821 . . . . 74.329999999999998 111.419 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -126.37 130.33 50.56 Favored 'General case' 0 C--O 1.261 1.685 0 O-C-N 124.056 0.848 . . . . 74.420000000000002 109.141 172.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.763 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 14.4 p90 -151.7 137.84 18.31 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 124.362 1.039 . . . . 75.5 108.492 172.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 55.36 28.94 12.18 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.044 1.338 . . . . 74.010000000000005 113.227 177.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.8 14.77 81.68 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 116.012 -0.54 . . . . 73.530000000000001 113.394 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -109.08 126.12 52.84 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.317 1.047 . . . . 74.409999999999997 108.698 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.462 HG11 ' HG3' ' A' ' 157' ' ' GLU . 91.5 t -109.81 135.58 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.509 0.724 . . . . 74.25 109.289 174.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.442 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 22.5 p90 -144.31 155.07 43.66 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.207 0.603 . . . . 74.019999999999996 109.538 171.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -129.17 136.34 50.03 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.156 -1.053 . . . . 72.150000000000006 108.156 -171.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -136.24 144.57 44.92 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 121.001 0.429 . . . . 75.530000000000001 110.738 176.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -76.91 131.71 38.71 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.73 -1.123 . . . . 71.129999999999995 110.365 -176.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 77.8 mt -80.6 106.86 12.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.8 0 N-CA-C 108.298 -1.001 . . . . 72.530000000000001 108.298 164.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -69.74 123.72 22.12 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.436 -0.802 . . . . 70.209999999999994 109.558 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.3 m -104.88 107.99 19.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.427 0.691 . . . . 62.130000000000003 110.497 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -65.42 170.66 4.64 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.348 1.059 . . . . 62.43 111.293 173.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 41.2 p -59.21 -37.48 77.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.058 0.943 . . . . 75.540000000000006 112.191 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -76.1 -2.67 32.02 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.962 0.505 . . . . 75.340000000000003 111.862 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 84.92 6.89 84.65 Favored Glycine 0 C--N 1.346 1.106 0 N-CA-C 111.811 -0.516 . . . . 74.530000000000001 111.811 -171.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -69.83 128.29 35.88 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.74 -0.467 . . . . 62.549999999999997 109.74 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 80.8 mt -95.33 147.44 23.5 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.461 0.704 . . . . 62.200000000000003 109.784 -178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -163.6 164.88 23.96 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.425 0.69 . . . . 75.209999999999994 110.42 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 78.7 t -138.04 -52.64 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.11 0.964 . . . . 75.230000000000004 109.23 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 33.0 t -100.25 -178.28 3.78 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.774 0.83 . . . . 75.409999999999997 110.853 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.8 m -63.93 -46.23 85.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.641 1.177 . . . . 72.319999999999993 111.986 -176.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.92 -14.42 41.91 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.263 0.625 . . . . 65.230000000000004 112.095 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 74.7 m -64.15 117.31 6.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.187 0.595 . . . . 63.130000000000003 111.186 176.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -146.53 112.73 5.83 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.654 1.182 . . . . 63.240000000000002 108.665 168.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -130.86 142.53 50.39 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.387 0.675 . . . . 74.439999999999998 109.417 -176.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -81.66 -34.81 30.55 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.661 0.384 . . . . 71.349999999999994 110.016 173.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 60.4 p -124.2 152.93 42.31 Favored 'General case' 0 C--O 1.255 1.363 0 CA-C-O 122.112 0.958 . . . . 72.109999999999999 111.287 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.451 HD11 HG11 ' A' ' 170' ' ' VAL . 35.9 tp -63.45 -31.14 72.21 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 113.671 -1.604 . . . . 61.539999999999999 111.266 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.98 -44.96 95.65 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.497 0.719 . . . . 72.230000000000004 110.918 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -61.69 -44.13 97.54 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.478 0.711 . . . . 53.439999999999998 110.598 173.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 tt -58.75 -41.08 85.67 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.709 0.631 . . . . 61.539999999999999 111.769 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 41.7 t -74.28 -41.99 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.645 0.778 . . . . 74.25 111.016 -175.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -58.81 -51.38 70.26 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.438 0.637 . . . . 70.129999999999995 110.1 174.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.422 ' O ' HG22 ' A' ' 224' ' ' VAL . 48.3 t-80 -54.14 -57.83 9.62 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.495 -1.229 . . . . 50.109999999999999 109.905 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -61.04 -26.7 67.81 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.337 0.655 . . . . 74.409999999999997 112.046 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 37.4 t -73.07 -27.76 61.92 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 122.913 0.485 . . . . 65.400000000000006 111.706 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.5 t -120.96 7.2 10.35 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 115.443 1.645 . . . . 71.010000000000005 115.443 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 220' ' ' HIS . 34.1 m -113.74 156.14 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 121.069 1.759 . . . . 53.130000000000003 115.431 -176.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -89.77 -2.47 58.25 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 129.986 3.314 . . . . 74.439999999999998 113.168 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -77.76 14.82 0.96 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 129.381 3.072 . . . . 73.439999999999998 113.51 -141.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.66 18.53 3.98 Favored Glycine 0 N--CA 1.47 0.921 0 C-N-CA 125.274 1.416 . . . . 75.409999999999997 111.377 -171.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 88.3 mt -91.26 134.49 34.53 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.206 1.002 . . . . 71.239999999999995 110.129 165.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.442 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 95.0 mt -67.83 -44.86 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 124.421 1.076 . . . . 65.420000000000002 108.695 170.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.5 t -135.04 142.13 46.3 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 114.992 -1.004 . . . . 71.299999999999997 108.866 173.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 67.4 p -70.38 155.98 39.95 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 108.606 -0.887 . . . . 75.129999999999995 108.606 171.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.446 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 32.1 mt -67.13 100.62 0.79 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.142 -1.058 . . . . 74.200000000000003 108.142 177.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -77.96 -50.29 12.46 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.066 0.547 . . . . 63.420000000000002 109.981 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 167' ' ' SER . 6.3 p90 -161.63 152.2 14.77 Favored Pre-proline 0 N--CA 1.488 1.455 0 C-N-CA 121.006 -0.278 . . . . 75.519999999999996 110.419 174.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 53.4 Cg_endo -69.06 137.06 36.52 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.238 1.959 . . . . 74.129999999999995 111.538 173.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -57.99 130.7 83.12 Favored Pre-proline 0 C--O 1.246 0.9 0 O-C-N 123.558 0.536 . . . . 73.030000000000001 109.894 176.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.39 145.26 87.81 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.28 1.987 . . . . 72.209999999999994 112.143 -172.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -63.06 159.25 17.65 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.555 -0.748 . . . . 60.420000000000002 109.149 171.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -52.75 -35.07 55.58 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.469 0.707 . . . . 74.239999999999995 112.453 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -64.98 176.74 1.14 Allowed 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 115.865 -0.607 . . . . 74.439999999999998 111.387 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.556 ' HE2' ' HB ' ' A' ' 243' ' ' THR . 20.6 ptmt -55.62 127.57 67.01 Favored Pre-proline 0 CA--C 1.558 1.25 0 N-CA-C 112.462 0.541 . . . . 74.0 112.462 -176.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -75.15 78.09 3.02 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.95 2.433 . . . . 60.43 110.575 174.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.556 ' HB ' ' HE2' ' A' ' 241' ' ' LYS . 8.8 t -79.23 113.43 17.36 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.423 0.63 . . . . 74.329999999999998 109.871 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.49 122.87 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.429 0.691 . . . . 74.450000000000003 109.439 -175.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -136.36 122.53 20.39 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.157 -1.053 . . . . 64.549999999999997 108.157 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 177.1 115.69 0.44 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 112.325 -0.31 . . . . 74.150000000000006 112.325 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 39.5 t -109.18 117.44 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 107.676 -1.231 . . . . 62.5 107.676 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 62.5 m -137.04 139.21 27.84 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 123.009 0.524 . . . . 71.239999999999995 110.864 -175.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -79.24 131.63 9.83 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.792 2.328 . . . . 74.25 111.781 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -85.6 140.97 30.16 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 108.684 -0.858 . . . . 65.209999999999994 108.684 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -66.22 133.83 51.44 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.546 0.738 . . . . 72.340000000000003 110.011 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -67.43 105.26 1.75 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 121.552 0.691 . . . . 74.450000000000003 109.979 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -156.18 143.24 18.97 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.529 -0.76 . . . . 74.439999999999998 109.662 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 44.2 t-105 -74.4 108.82 7.42 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.005 -1.109 . . . . 71.140000000000001 108.005 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 C--O 1.249 1.037 0 CA-C-N 115.438 -0.801 . . . . 52.219999999999999 109.815 179.098 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.592 -0.522 . . . . 70.530000000000001 109.592 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.87 73.84 1.12 Allowed Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.371 -0.692 . . . . 74.310000000000002 111.371 -173.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -68.87 122.53 18.82 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.531 0.732 . . . . 71.239999999999995 109.791 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -138.58 77.56 33.71 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.426 0.69 . . . . 75.450000000000003 110.66 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.78 -29.61 77.1 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.063 1.842 . . . . 64.099999999999994 111.949 172.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.01 140.59 5.13 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.305 -0.407 . . . . 61.32 112.88 175.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.48 124.94 52.71 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.217 0.607 . . . . 73.349999999999994 109.694 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.0 m -84.62 141.65 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 123.539 0.736 . . . . 62.109999999999999 109.937 178.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.2 tp -82.29 -32.31 29.59 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.188 0.995 . . . . 64.120000000000005 109.942 175.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.43 163.41 25.38 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.566 -0.743 . . . . 64.540000000000006 111.69 -176.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.633 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 28.8 t70 -70.42 98.59 1.45 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.263 0.625 . . . . 53.0 110.242 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -129.22 -171.06 2.4 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.653 1.181 . . . . 74.540000000000006 109.364 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -69.84 111.77 5.81 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.231 -2.137 . . . . 75.519999999999996 105.231 161.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 62.19 81.32 0.23 Allowed Pre-proline 0 CA--C 1.542 0.647 0 O-C-N 124.219 0.949 . . . . 74.329999999999998 111.015 -162.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.633 ' HB3' ' HA ' ' A' ' 11' ' ' ASP . 68.7 Cg_endo -74.08 165.87 30.97 Favored 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.555 2.17 . . . . 75.209999999999994 110.527 170.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 p -71.76 168.75 17.16 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.796 0.808 . . . . 64.209999999999994 112.428 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.9 mt -107.72 133.28 20.5 Favored Pre-proline 0 C--O 1.241 0.62 0 CA-C-N 114.636 -1.165 . . . . 74.140000000000001 108.545 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.92 170.22 14.67 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.511 2.14 . . . . 75.25 111.99 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.89 144.67 29.06 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.051 0.541 . . . . 63.539999999999999 110.499 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.63 ' HB3' HD11 ' A' ' 23' ' ' ILE . 74.1 mt -87.43 94.85 9.81 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.557 0.743 . . . . 75.140000000000001 109.175 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -96.22 -47.09 6.18 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.023 -0.732 . . . . 64.319999999999993 109.023 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -99.77 113.77 26.47 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.143 -0.935 . . . . 72.230000000000004 109.815 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.63 HD11 ' HB3' ' A' ' 20' ' ' LEU . 39.1 mm -116.51 114.11 45.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 107.904 -1.147 . . . . 70.010000000000005 107.904 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -123.57 126.52 46.81 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.202 0.601 . . . . 63.439999999999998 109.627 -175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.27 8.84 2.67 Favored Glycine 0 CA--C 1.527 0.836 0 O-C-N 124.246 0.966 . . . . 60.219999999999999 112.101 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.75 83.16 5.24 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 109.0 -0.741 . . . . 71.209999999999994 109.0 175.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.65 100.53 1.32 Allowed Glycine 0 C--N 1.348 1.217 0 CA-C-N 115.881 -0.6 . . . . 73.230000000000004 112.335 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -125.34 -73.2 0.64 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.74 0.816 . . . . 75.409999999999997 109.214 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -151.1 -178.1 6.42 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.881 0.872 . . . . 71.230000000000004 110.254 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 58.05 47.15 15.18 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.686 1.195 . . . . 60.119999999999997 110.698 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.9 p 50.32 87.29 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.605 1.162 . . . . 74.540000000000006 111.426 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.8 p -139.67 137.74 35.48 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.49 0.716 . . . . 70.120000000000005 109.59 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.417 ' HG3' ' HG2' ' A' ' 127' ' ' GLN . 64.2 ttt-85 -64.97 106.97 1.36 Allowed 'General case' 0 C--N 1.347 0.47 0 C-N-CA 123.568 0.747 . . . . 64.340000000000003 112.318 -172.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -74.39 132.42 41.97 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.867 -0.79 . . . . 64.209999999999994 108.867 168.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.53 71.64 2.8 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-N 116.132 -0.485 . . . . 53.329999999999998 113.078 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.6 88.59 0.41 Allowed Glycine 0 C--N 1.344 0.975 0 CA-C-O 119.218 -0.768 . . . . 74.420000000000002 111.407 177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -83.38 163.0 14.95 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 123.065 2.51 . . . . 64.430000000000007 112.211 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -76.02 148.48 38.0 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.1 0.56 . . . . 61.520000000000003 110.857 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 55.7 m -98.46 132.44 43.91 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.767 -0.651 . . . . 72.209999999999994 110.001 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -113.54 133.31 55.32 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.889 0.876 . . . . 62.420000000000002 109.046 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -124.0 146.66 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.491 0.716 . . . . 70.439999999999998 110.038 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -117.75 167.3 11.49 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.366 1.066 . . . . 75.430000000000007 109.718 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -145.52 151.05 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.658 0.783 . . . . 63.130000000000003 109.447 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -67.61 148.01 51.97 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.928 0.891 . . . . 75.340000000000003 111.417 175.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -84.72 176.58 8.46 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.94 0.496 . . . . 74.209999999999994 110.229 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -134.69 139.87 45.56 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.367 0.667 . . . . 64.439999999999998 109.644 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.26 82.92 2.0 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.29 -1.004 . . . . 52.509999999999998 108.29 177.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.3 mt -67.2 -24.48 65.85 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.732 0.813 . . . . 74.030000000000001 112.167 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -80.33 168.25 19.26 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.863 0.465 . . . . 75.230000000000004 111.447 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -62.24 148.7 88.83 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 115.427 -0.806 . . . . 74.439999999999998 110.628 171.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.62 72.53 0.66 Allowed 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.919 2.413 . . . . 54.399999999999999 111.245 171.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 p -97.69 98.76 7.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.893 -1.151 . . . . 61.149999999999999 107.893 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.19 75.52 1.11 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.332 0.653 . . . . 74.409999999999997 109.747 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.2 m -88.12 -16.54 33.2 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.55 -0.75 . . . . 64.430000000000007 109.96 169.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -78.45 169.28 18.51 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.714 0.806 . . . . 74.319999999999993 110.597 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -101.68 153.92 19.35 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.889 -1.05 . . . . 74.040000000000006 108.932 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 61.49 71.11 0.81 Allowed Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 124.774 1.229 . . . . 61.43 111.641 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.83 -38.06 5.9 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.39 2.06 . . . . 71.430000000000007 112.675 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -85.83 101.29 12.7 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.8 0.84 . . . . 74.329999999999998 109.765 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.03 39.25 0.24 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 111.196 -0.761 . . . . 52.119999999999997 111.196 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.8 mt -89.47 71.18 8.03 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.162 0.985 . . . . 73.010000000000005 110.18 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.3 m -137.48 127.33 25.59 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.478 -0.783 . . . . 60.140000000000001 109.577 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -157.11 146.08 20.0 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.98 1.312 . . . . 72.239999999999995 108.374 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.69 67.82 6.71 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.511 0.725 . . . . 74.239999999999995 109.257 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.47 101.03 3.4 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-N 114.936 -1.029 . . . . 74.450000000000003 109.756 -176.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -103.55 146.72 28.12 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.508 0.723 . . . . 62.5 109.447 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 52.7 t90 -76.19 139.44 41.23 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.569 0.748 . . . . 71.420000000000002 110.263 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -111.51 122.61 48.3 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.69 0.796 . . . . 61.109999999999999 108.989 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.3 p -75.12 83.58 2.32 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.332 -0.618 . . . . 60.43 109.332 176.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -83.76 -69.78 0.61 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.821 -1.178 . . . . 73.120000000000005 107.821 176.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -67.26 -50.34 60.88 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.215 0.606 . . . . 72.230000000000004 110.406 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -63.12 108.27 1.21 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.222 -0.899 . . . . 72.409999999999997 109.071 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 86.7 mt -73.54 80.27 1.46 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.758 0.823 . . . . 64.340000000000003 109.551 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 91.9 mt -110.37 18.22 20.07 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.614 1.166 . . . . 75.510000000000005 110.421 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.52 75.94 7.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.629 0.771 . . . . 62.450000000000003 110.185 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 147.69 60.16 0.01 OUTLIER Glycine 0 CA--C 1.53 0.99 0 CA-C-N 115.391 -0.822 . . . . 75.129999999999995 111.14 178.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -84.33 90.26 0.88 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.836 2.358 . . . . 75.349999999999994 110.529 -175.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 p -110.48 114.25 27.52 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.901 0.881 . . . . 64.150000000000006 109.183 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.446 ' HB2' HD13 ' A' ' 84' ' ' LEU . 1.3 mp0 -72.31 148.54 45.29 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.612 0.765 . . . . 75.540000000000006 112.076 -174.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -87.5 75.74 9.1 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.959 0.903 . . . . 61.539999999999999 110.519 -172.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -175.19 148.47 1.08 Allowed Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 124.579 1.151 . . . . 63.530000000000001 109.052 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -81.25 -5.68 12.8 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.389 2.06 . . . . 72.329999999999998 112.183 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -96.12 33.7 1.69 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.938 0.895 . . . . 73.209999999999994 110.368 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 33.9 tp -81.03 112.47 18.45 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.815 -0.809 . . . . 65.540000000000006 108.815 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.554 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.6 m-85 -104.45 177.73 4.76 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.918 1.687 . . . . 75.430000000000007 109.505 175.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 11.3 p -144.28 138.93 24.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.47 0.708 . . . . 73.340000000000003 109.161 171.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -78.23 112.8 15.58 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.98 0.912 . . . . 62.340000000000003 109.431 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 87.4 mt -74.72 -22.2 58.95 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.193 0.997 . . . . 64.230000000000004 111.925 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -130.88 152.55 50.08 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.103 0.961 . . . . 75.299999999999997 109.214 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -77.84 130.85 37.17 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.226 -1.027 . . . . 72.450000000000003 108.226 173.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.49 ' HB3' HG12 ' A' ' 101' ' ' ILE . 74.7 t80 -133.21 114.83 14.27 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 108.916 -0.772 . . . . 74.239999999999995 108.916 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.3 136.76 22.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 108.904 -0.776 . . . . 65.319999999999993 108.904 171.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.8 137.96 57.01 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.762 0.425 . . . . 62.399999999999999 110.537 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.1 t -75.73 -9.93 59.01 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.064 0.546 . . . . 75.010000000000005 110.152 174.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.12 -154.63 25.12 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 115.866 -0.606 . . . . 55.340000000000003 111.759 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.99 -40.25 95.0 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.258 1.023 . . . . 70.540000000000006 111.789 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -67.86 -25.06 65.34 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.769 0.828 . . . . 72.109999999999999 112.467 -172.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.9 p -106.29 158.49 16.83 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.626 0.77 . . . . 71.109999999999999 109.702 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.8 tp -109.66 124.94 52.05 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 122.999 0.52 . . . . 73.200000000000003 109.991 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.2 p -70.57 114.88 9.11 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.279 -0.873 . . . . 74.010000000000005 109.356 170.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 91' ' ' PHE . 24.8 pt -119.7 156.98 22.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.023 -0.732 . . . . 60.420000000000002 109.023 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 1.9 m -117.35 143.65 45.74 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 109.318 -0.623 . . . . 53.109999999999999 109.318 -174.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -57.56 120.22 7.91 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 122.807 0.443 . . . . 74.219999999999999 110.367 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.53 -13.84 63.82 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.323 0.389 . . . . 73.349999999999994 113.455 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -85.74 130.98 34.41 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.846 0.858 . . . . 71.040000000000006 110.235 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HB3' HD11 ' A' ' 84' ' ' LEU . 9.1 mtmp? -83.7 142.72 30.53 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.813 0.845 . . . . 74.120000000000005 110.886 -177.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.1 mt -120.46 150.96 39.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.519 1.128 . . . . 71.129999999999995 108.282 -171.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -113.89 107.37 15.61 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.941 -1.133 . . . . 64.030000000000001 107.941 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 78.8 t -93.08 121.94 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 109.935 -0.394 . . . . 53.340000000000003 109.935 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 72.3 mt -83.38 -41.57 18.02 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.098 0.475 . . . . 74.450000000000003 109.95 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.52 172.34 44.07 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.58 -0.736 . . . . 70.140000000000001 111.828 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.483 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 13.3 m-85 -99.28 169.13 9.58 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.046 -0.724 . . . . 71.349999999999994 109.046 175.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -66.39 146.53 54.47 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.877 -1.156 . . . . 75.219999999999999 107.877 172.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.689 ' HA ' ' HG3' ' A' ' 177' ' ' PRO . 31.0 m170 -68.59 -21.27 64.52 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.939 0.496 . . . . 62.100000000000001 112.217 -174.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -94.57 -12.23 27.92 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.17 0.588 . . . . 71.299999999999997 110.673 174.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' ' 175' ' ' SER . . . 82.33 35.23 21.07 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 116.453 -0.339 . . . . 41.439999999999998 112.794 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -85.59 -65.68 0.98 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.518 0.727 . . . . 65.239999999999995 110.256 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -115.83 179.46 3.97 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.654 1.181 . . . . 71.439999999999998 109.5 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -135.31 127.45 29.91 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.91 0.884 . . . . 34.119999999999997 108.664 176.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -83.46 113.84 21.05 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-O 121.199 0.523 . . . . 73.310000000000002 110.668 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -120.76 163.49 18.04 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 114.966 -1.016 . . . . 63.020000000000003 110.47 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -133.16 141.64 48.23 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.103 0.961 . . . . 73.120000000000005 109.596 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.3 p -137.33 179.77 6.2 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.54 1.536 . . . . 74.420000000000002 108.053 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -73.96 -6.51 47.78 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.437 0.295 . . . . 54.420000000000002 110.753 172.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -76.88 -22.93 52.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.061 0.945 . . . . 75.049999999999997 110.177 169.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 130.13 -171.1 20.59 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 111.109 -0.796 . . . . 44.329999999999998 111.109 -174.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.417 ' HG2' ' HG3' ' A' ' 33' ' ' ARG . 57.2 tt0 -115.96 147.05 41.58 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.642 0.777 . . . . 60.509999999999998 110.245 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 175.45 -176.81 47.4 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 123.442 0.464 . . . . 75.219999999999999 112.767 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -89.42 136.01 33.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.833 0.853 . . . . 70.230000000000004 110.631 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.76 154.95 80.78 Favored Pre-proline 0 N--CA 1.482 1.163 0 C-N-CA 124.465 1.106 . . . . 54.310000000000002 110.206 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.68 130.1 11.36 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.481 2.12 . . . . 42.009999999999998 111.236 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.512 ' HA ' HG12 ' A' ' 135' ' ' ILE . 13.6 p -63.43 -20.93 65.98 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.61 0.764 . . . . 71.219999999999999 111.897 178.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -70.73 -27.02 63.65 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.872 0.869 . . . . 70.420000000000002 111.537 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -95.39 2.25 54.53 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.554 0.742 . . . . 63.210000000000001 111.955 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.512 HG12 ' HA ' ' A' ' 132' ' ' SER . 14.4 pt -134.92 152.33 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 118.029 0.377 . . . . 52.329999999999998 110.544 -173.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.4 t -143.3 139.56 16.71 Favored Pre-proline 0 N--CA 1.482 1.136 0 C-N-CA 123.455 0.702 . . . . 51.149999999999999 109.117 171.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.567 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 56.0 Cg_endo -71.05 140.36 37.69 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 122.26 1.974 . . . . 71.549999999999997 112.058 175.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.4 m -111.1 -45.05 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.152 0.981 . . . . 74.310000000000002 110.613 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.551 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.5 t30 -100.04 6.8 45.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.964 0.506 . . . . 53.340000000000003 111.22 -174.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 31.0 t -86.42 176.19 8.0 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.241 0.543 . . . . 65.25 110.127 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.456 ' O ' ' HB3' ' A' ' 147' ' ' TYR . 80.7 mt -66.21 -13.93 61.08 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.129 0.971 . . . . 74.409999999999997 112.585 -176.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.87 -28.79 64.47 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.521 0.728 . . . . 74.019999999999996 111.785 176.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -64.18 -25.37 68.05 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.088 -0.505 . . . . 54.399999999999999 110.853 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -78.54 134.29 37.27 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.57 -0.9 . . . . 74.439999999999998 108.57 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.1 t -67.89 -18.87 64.93 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.167 0.803 . . . . 74.319999999999993 113.167 -171.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 235' ' ' PRO . 61.4 p-90 -78.99 -26.46 43.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.073 0.549 . . . . 75.400000000000006 111.849 177.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 46.7 t80 -109.72 125.62 52.86 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.244 0.618 . . . . 64.409999999999997 109.389 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -113.11 25.89 10.97 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.669 0.388 . . . . 63.509999999999998 111.482 -172.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 64.61 -156.6 46.05 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-N 115.769 -0.65 . . . . 63.240000000000002 114.323 172.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.425 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 56.6 Cg_endo -70.52 101.58 1.04 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 123.009 2.473 . . . . 70.439999999999998 111.008 173.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.3 p -143.19 145.1 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 120.911 0.386 . . . . 73.219999999999999 110.289 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 70.5 m -73.62 166.73 22.74 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.449 1.1 . . . . 75.540000000000006 112.747 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 44.6 mtt85 -65.35 -40.94 94.24 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.52 -1.218 . . . . 72.319999999999993 111.359 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -70.13 -42.93 71.95 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.059 0.849 . . . . 72.200000000000003 111.186 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.64 -42.72 86.25 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.127 0.971 . . . . 72.140000000000001 110.135 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.35 -52.71 64.46 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.728 -1.124 . . . . 73.140000000000001 110.02 173.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.534 ' HG3' HG11 ' A' ' 190' ' ' VAL . 37.9 tt0 -61.07 -29.17 69.58 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.322 0.649 . . . . 75.409999999999997 111.272 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -63.68 -52.71 59.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.664 0.785 . . . . 55.049999999999997 110.277 173.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.62 -33.85 75.86 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.806 -0.634 . . . . 73.019999999999996 111.162 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.662 HD23 HG13 ' A' ' 190' ' ' VAL . 28.9 tp -78.55 -23.39 46.18 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.092 -0.958 . . . . 74.329999999999998 111.595 -177.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 t -64.28 -23.6 67.36 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.66 0.784 . . . . 42.549999999999997 111.374 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.0 m -82.88 -7.97 59.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.016 0.926 . . . . 65.030000000000001 112.091 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.15 174.03 41.67 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 114.26 0.464 . . . . 43.229999999999997 114.26 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.0 pt -121.29 -164.24 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 124.027 0.931 . . . . 52.109999999999999 109.91 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.769 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 22.7 p-10 -49.56 117.18 2.08 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.163 0.985 . . . . 72.140000000000001 112.236 177.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 85.97 13.99 68.06 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-N 115.562 -0.744 . . . . 71.519999999999996 113.617 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 23.3 t -73.54 132.96 43.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.569 -0.901 . . . . 72.209999999999994 108.569 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.495 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 19.4 p90 -134.87 161.32 35.55 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.176 0.806 . . . . 75.430000000000007 113.176 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 76.9 mt -137.87 135.47 36.19 Favored 'General case' 0 C--O 1.215 -0.754 0 C-N-CA 124.901 1.281 . . . . 73.340000000000003 108.978 172.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 14.3 t -114.83 140.06 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 106.467 -1.679 . . . . 75.040000000000006 106.467 167.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.2 ptt85 -158.72 168.85 25.77 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.955 0.502 . . . . 73.310000000000002 110.474 -172.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.473 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 12.2 pt-20 -115.46 153.44 31.1 Favored 'General case' 0 C--O 1.257 1.448 0 C-N-CA 123.09 0.556 . . . . 63.520000000000003 109.543 167.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 176' ' ' SER . 17.1 m -88.43 123.76 33.29 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.072 -0.967 . . . . 72.200000000000003 109.291 -178.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' A' ' 150' ' ' PRO . 38.3 mt-10 -57.56 -39.36 76.51 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.421 1.089 . . . . 71.5 111.674 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.614 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 8.5 t -87.41 -6.26 58.51 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 115.167 -0.924 . . . . 74.219999999999999 111.969 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 173' ' ' SER . 14.9 m -131.72 100.21 16.38 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 123.425 0.69 . . . . 73.109999999999999 109.324 -176.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.689 ' HG3' ' HA ' ' A' ' 114' ' ' HIS . 36.3 Cg_endo -60.35 113.55 1.73 Allowed 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.745 2.963 . . . . 74.209999999999994 112.061 -174.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 85.72 -20.38 19.56 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 116.101 -0.5 . . . . 44.43 113.666 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -73.79 116.84 14.87 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.648 0.724 . . . . 75.340000000000003 109.305 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.473 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 66.9 mtt85 -113.23 160.23 18.5 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 124.186 0.995 . . . . 71.129999999999995 110.279 -171.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 44.4 t -143.92 151.58 40.0 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.093 0.957 . . . . 74.430000000000007 110.48 -174.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.432 HD11 HD21 ' A' ' 217' ' ' LEU . 52.1 mt -119.06 145.85 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.214 1.006 . . . . 71.319999999999993 108.519 169.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.5 m -125.18 127.34 46.65 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.629 1.172 . . . . 61.340000000000003 108.148 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.449 HD21 HD23 ' A' ' 232' ' ' LEU . 57.9 mt -113.67 147.78 37.53 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.624 0.77 . . . . 75.420000000000002 111.891 178.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 19.7 ttt180 -133.86 131.01 38.68 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-N 114.536 -1.211 . . . . 74.299999999999997 109.651 172.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.769 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 9.5 p90 -149.38 141.03 23.49 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.562 1.145 . . . . 74.049999999999997 108.022 173.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 54.07 31.67 14.18 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.224 1.01 . . . . 53.200000000000003 113.232 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.19 3.68 90.62 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 116.343 -0.389 . . . . 64.230000000000004 112.782 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 10.3 tpp180 -102.13 124.21 47.33 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.151 0.98 . . . . 74.030000000000001 109.72 -176.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.662 HG13 HD23 ' A' ' 160' ' ' LEU . 81.0 t -107.45 135.89 44.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.265 1.026 . . . . 72.120000000000005 109.578 177.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.472 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 26.7 p90 -145.87 163.11 36.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.202 1.001 . . . . 74.439999999999998 109.744 171.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -133.45 141.98 48.07 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.194 0.997 . . . . 75.140000000000001 108.477 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -143.17 152.62 41.97 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.43 0.692 . . . . 75.219999999999999 109.57 175.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -95.85 138.01 34.1 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.452 0.701 . . . . 72.200000000000003 111.62 -170.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 69.4 mt -83.58 113.8 23.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 124.229 1.012 . . . . 61.130000000000003 108.347 165.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -88.38 134.87 33.71 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.194 0.598 . . . . 73.329999999999998 109.686 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.2 m -104.35 120.34 40.97 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.13 0.972 . . . . 55.210000000000001 109.518 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -72.48 164.82 25.77 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.304 1.042 . . . . 62.119999999999997 111.697 175.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 52.6 p -68.94 -17.05 63.89 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.645 0.778 . . . . 71.510000000000005 111.068 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.57 -19.19 65.82 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.407 1.083 . . . . 63.32 111.577 173.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 91.93 -6.06 79.18 Favored Glycine 0 C--N 1.353 1.517 0 CA-C-N 115.848 -0.615 . . . . 70.230000000000004 111.921 -168.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -76.25 144.23 40.49 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.351 0.66 . . . . 72.129999999999995 110.934 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 47.1 mt -95.65 152.48 18.41 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.598 1.159 . . . . 73.030000000000001 108.518 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -166.5 172.28 10.98 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.661 0.6 . . . . 74.540000000000006 111.084 174.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.4 t -131.84 -41.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.377 1.071 . . . . 51.32 108.758 174.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.6 t -92.39 153.83 18.92 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.331 -0.618 . . . . 71.530000000000001 109.331 173.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.4 p -66.48 -29.35 69.45 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.122 0.569 . . . . 65.409999999999997 110.957 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -92.56 2.92 56.43 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.4 0.68 . . . . 71.310000000000002 112.144 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 211' ' ' PHE . 86.7 p -105.67 137.9 42.76 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.913 -0.773 . . . . 72.129999999999995 108.913 176.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -143.43 126.83 16.76 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.302 1.041 . . . . 74.430000000000007 108.194 175.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 209' ' ' SER . 14.4 m-85 -133.74 133.94 42.38 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.175 0.59 . . . . 74.310000000000002 109.422 -178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -74.88 -35.54 62.29 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.08 0.552 . . . . 72.510000000000005 110.403 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 61.9 p -123.22 147.44 46.89 Favored 'General case' 0 C--O 1.256 1.41 0 CA-C-O 122.267 1.032 . . . . 63.420000000000002 111.637 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.444 ' O ' HG23 ' A' ' 218' ' ' VAL . 25.1 tp -64.32 -28.62 69.84 Favored 'General case' 0 C--O 1.213 -0.832 0 CA-C-N 113.655 -1.611 . . . . 73.200000000000003 111.205 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.68 -42.53 95.28 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.316 0.646 . . . . 54.109999999999999 111.452 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -71.7 -35.03 70.11 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.975 0.51 . . . . 70.0 110.347 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.432 HD21 HD11 ' A' ' 182' ' ' ILE . 9.5 tt -56.54 -46.58 80.58 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.901 0.751 . . . . 72.150000000000006 110.384 170.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 214' ' ' LEU . 44.4 t -66.27 -44.97 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.738 0.815 . . . . 73.040000000000006 110.586 -177.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -61.78 -45.45 93.81 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 122.91 0.484 . . . . 63.530000000000001 110.145 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -52.35 -61.67 2.13 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.244 -0.889 . . . . 63.420000000000002 108.855 175.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -59.71 -23.45 63.16 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.88 -0.6 . . . . 61.350000000000001 111.92 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.406 ' O ' ' HB ' ' A' ' 231' ' ' THR . 35.6 t -75.21 -28.04 59.81 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.109 0.563 . . . . 72.549999999999997 111.713 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.8 t -118.17 -9.83 10.41 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 115.447 1.647 . . . . 51.310000000000002 115.447 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 27.6 m -92.71 148.45 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 123.632 1.682 . . . . 62.32 115.058 -167.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -86.6 0.16 54.99 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 110.96 -2.836 . . . . 74.25 111.359 173.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -78.9 15.46 1.08 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 128.959 2.904 . . . . 72.439999999999998 112.478 -143.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 119.05 18.39 4.67 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 124.525 1.059 . . . . 71.140000000000001 111.794 -170.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 56.0 mt -93.06 145.59 24.27 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.763 0.825 . . . . 75.409999999999997 111.47 162.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.472 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 63.9 mt -75.34 -43.42 43.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.644 -0.873 . . . . 62.439999999999998 108.644 170.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.9 t -139.02 144.62 38.94 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.323 -0.853 . . . . 75.010000000000005 109.217 177.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 222' ' ' SER . 40.8 p -75.49 155.17 36.45 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.597 0.759 . . . . 71.450000000000003 109.73 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.495 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 21.2 mt -67.72 101.78 1.1 Allowed 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.554 -0.906 . . . . 74.319999999999993 108.554 178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -83.1 -47.43 11.66 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.49 0.716 . . . . 62.399999999999999 110.075 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -163.3 152.3 12.29 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 109.572 -0.529 . . . . 74.430000000000007 109.572 174.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.404 ' HB3' ' HA ' ' A' ' 146' ' ' TRP . 53.0 Cg_endo -68.51 144.39 60.83 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 121.932 1.755 . . . . 75.329999999999998 111.973 175.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -60.54 137.71 92.56 Favored Pre-proline 0 C--O 1.248 0.992 0 C-N-CA 123.359 0.664 . . . . 73.209999999999994 109.981 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.06 116.4 3.15 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.914 2.409 . . . . 61.439999999999998 111.742 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 240' ' ' ASN . 6.1 ttpm? -80.91 145.56 31.23 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.85 -1.166 . . . . 64.420000000000002 107.85 174.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -58.77 -39.65 81.61 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 123.624 0.578 . . . . 74.329999999999998 109.982 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.472 ' HB2' ' HE2' ' A' ' 238' ' ' LYS . 14.5 m120 -79.8 83.92 5.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 106.873 -1.528 . . . . 75.319999999999993 106.873 162.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 143.05 44.89 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 123.023 0.529 . . . . 71.430000000000007 110.833 -172.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -92.27 -174.2 0.51 Allowed 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.088 2.525 . . . . 72.049999999999997 110.817 165.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 17.9 p -87.72 103.35 15.52 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.021 -1.103 . . . . 72.019999999999996 108.021 168.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 62.5 t -68.62 105.16 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.04 0.536 . . . . 74.010000000000005 110.227 -175.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -104.14 95.09 5.74 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.145 -1.058 . . . . 75.349999999999994 108.145 174.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -117.96 31.07 5.83 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 111.353 -0.699 . . . . 42.439999999999998 111.353 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 89.4 t -74.93 93.34 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.962 0.905 . . . . 74.010000000000005 109.591 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 11.5 p -168.0 82.91 0.78 Allowed Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.87 1.268 . . . . 64.340000000000003 108.971 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -77.08 -71.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.107 2.538 . . . . 71.329999999999998 110.708 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 30.8 p30 -177.15 167.98 2.39 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 125.036 1.334 . . . . 75.140000000000001 108.955 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -89.22 163.3 15.46 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 108.259 -1.015 . . . . 53.399999999999999 108.259 166.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -55.92 -43.03 76.96 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.279 0.562 . . . . 75.230000000000004 111.368 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.459 ' HA ' ' HE2' ' A' ' 253' ' ' LYS . 11.4 mmpt? -93.49 1.02 56.93 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.154 -0.93 . . . . 72.409999999999997 111.983 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.426 ' HB3' ' HB2' ' A' ' 250' ' ' ASN . 29.4 t-105 -72.64 -54.86 7.9 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.283 -1.006 . . . . 73.209999999999994 108.283 173.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 . . . . . 0 CA--C 1.552 1.056 0 C-N-CA 123.882 0.873 . . . . 72.019999999999996 109.097 176.706 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mpp? . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 108.93 -0.767 . . . . 52.420000000000002 108.93 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.34 88.23 0.91 Allowed Glycine 0 C--N 1.346 1.136 0 O-C-N 123.324 0.39 . . . . 71.310000000000002 112.987 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -102.64 107.64 18.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.351 0.66 . . . . 63.539999999999999 109.222 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -130.57 103.61 16.19 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 123.21 0.604 . . . . 54.229999999999997 109.43 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.91 4.62 6.33 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 123.197 2.598 . . . . 71.129999999999995 112.302 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.99 152.42 40.08 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.741 0.651 . . . . 62.340000000000003 114.471 -174.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -135.15 143.58 46.59 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.046 0.938 . . . . 63.539999999999999 109.314 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.6 m -90.82 130.19 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-O 120.989 0.424 . . . . 74.319999999999993 109.866 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.5 tp -93.54 -37.59 11.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.248 0.619 . . . . 72.319999999999993 111.119 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.83 73.91 1.25 Allowed Glycine 0 C--N 1.341 0.832 0 N-CA-C 108.882 -1.687 . . . . 54.210000000000001 108.882 -164.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.94 -69.67 0.38 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.873 0.869 . . . . 70.239999999999995 112.274 -165.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -175.55 -153.54 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.517 1.127 . . . . 73.129999999999995 108.638 -173.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.4 133.34 56.01 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 109.739 -0.467 . . . . 64.129999999999995 109.739 168.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.4 mmm-85 51.29 73.74 0.92 Allowed Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.999 0.92 . . . . 73.239999999999995 110.172 -166.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.02 168.9 19.26 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.263 1.975 . . . . 74.519999999999996 110.544 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.2 m -64.45 165.21 10.19 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.095 0.474 . . . . 71.129999999999995 110.75 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.7 mt -104.27 133.5 20.19 Favored Pre-proline 0 C--O 1.238 0.449 0 N-CA-C 108.092 -1.077 . . . . 75.340000000000003 108.092 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.22 169.36 13.92 Favored 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 122.493 2.129 . . . . 72.140000000000001 112.025 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.3 147.03 27.43 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.933 -0.766 . . . . 65.200000000000003 108.933 170.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 23' ' ' ILE . 83.4 mt -88.04 93.57 9.52 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.228 -0.656 . . . . 41.140000000000001 109.228 -177.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -98.23 -53.0 3.49 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.576 0.35 . . . . 71.519999999999996 110.281 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.428 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 61.0 m-85 -106.3 108.97 20.75 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.051 0.541 . . . . 75.430000000000007 110.124 -175.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.469 HD11 HD22 ' A' ' 20' ' ' LEU . 49.8 mm -123.79 120.76 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.754 0.822 . . . . 71.129999999999995 111.003 -175.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -79.5 132.21 36.26 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.486 0.714 . . . . 74.329999999999998 110.531 169.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -134.08 -13.98 1.31 Allowed Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.603 -0.726 . . . . 24.039999999999999 111.884 173.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -145.25 150.62 37.0 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.79 0.836 . . . . 44.030000000000001 109.28 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.94 48.27 84.63 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 111.209 -0.756 . . . . 61.240000000000002 111.209 -175.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.603 ' HB2' HE22 ' A' ' 127' ' ' GLN . 19.6 pttp -61.35 -23.0 65.44 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.158 0.983 . . . . 71.010000000000005 112.98 -172.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.456 ' HE ' ' HA ' ' A' ' 29' ' ' ARG . 1.4 tpm_? 56.11 39.24 30.41 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.445 1.098 . . . . 74.120000000000005 110.501 171.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.63 164.77 25.29 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.66 -1.154 . . . . 54.409999999999997 113.18 -169.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.563 ' H ' HD22 ' A' ' 110' ' ' LEU . 30.7 t -77.28 105.32 8.32 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.457 -1.247 . . . . 75.0 108.357 172.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.4 t -54.04 99.03 0.02 OUTLIER 'General case' 0 C--N 1.353 0.72 0 O-C-N 124.34 1.025 . . . . 72.329999999999998 110.418 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.4 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . 36.7 ttt180 -67.97 106.09 2.22 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 116.037 -0.529 . . . . 75.120000000000005 109.705 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -136.4 115.6 12.52 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.634 0.774 . . . . 74.319999999999993 109.039 -174.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.616 ' HA3' ' HA ' ' A' ' 79' ' ' GLU . . . 136.69 -148.16 19.59 Favored Glycine 0 C--N 1.341 0.811 0 O-C-N 123.597 0.56 . . . . 43.450000000000003 111.876 178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.09 151.76 19.5 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 119.776 -0.458 . . . . 54.130000000000003 112.454 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.92 -2.74 12.97 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 123.21 2.607 . . . . 73.109999999999999 113.234 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.6 t60 66.23 102.77 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.389 1.476 . . . . 73.329999999999998 111.714 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 27.5 p -140.33 -177.61 5.1 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.744 0.818 . . . . 74.099999999999994 109.225 173.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -63.13 143.24 57.96 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.735 0.414 . . . . 74.319999999999993 110.551 173.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.5 p -79.77 166.74 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 109.262 -0.644 . . . . 75.340000000000003 109.262 177.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -53.93 139.54 33.64 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.537 0.735 . . . . 72.409999999999997 111.842 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.4 m -75.53 109.87 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-O 121.514 0.673 . . . . 52.140000000000001 109.54 174.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -96.02 146.13 24.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.401 0.68 . . . . 75.430000000000007 110.338 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -73.57 89.0 1.69 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.844 -0.798 . . . . 63.329999999999998 108.844 173.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -98.6 157.98 15.9 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.254 -0.885 . . . . 72.349999999999994 110.196 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.86 171.04 9.12 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.194 0.598 . . . . 63.350000000000001 110.701 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.3 mt -70.87 93.74 1.0 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.984 -0.553 . . . . 41.340000000000003 110.719 -176.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.487 ' HG3' ' HG2' ' A' ' 50' ' ' ARG . 6.7 tp-100 -78.4 132.37 37.32 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.96 -0.756 . . . . 70.299999999999997 108.96 174.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.487 ' HG2' ' HG3' ' A' ' 49' ' ' GLN . 15.7 mmt180 53.9 58.24 12.86 Favored Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 124.601 1.16 . . . . 75.409999999999997 112.126 -177.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.3 -10.18 16.26 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.772 2.315 . . . . 64.129999999999995 112.941 -173.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -70.01 -25.53 28.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.319 0.648 . . . . 64.319999999999993 111.122 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.44 82.59 1.9 Allowed 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.609 0.764 . . . . 55.409999999999997 109.179 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.2 m -85.13 113.68 21.7 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.096 -0.956 . . . . 65.019999999999996 109.851 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 64.01 10.63 5.49 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.694 1.198 . . . . 74.129999999999995 112.911 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -86.83 150.77 23.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.254 0.622 . . . . 72.400000000000006 109.55 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 60.11 70.87 0.95 Allowed Pre-proline 0 CA--C 1.547 0.84 0 O-C-N 124.353 1.033 . . . . 53.210000000000001 109.617 -170.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -56.12 143.59 83.47 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.844 2.362 . . . . 72.239999999999995 112.77 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -90.27 -1.87 57.97 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.298 0.639 . . . . 74.340000000000003 110.525 175.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.94 122.96 1.44 Allowed Glycine 0 C--N 1.347 1.17 0 N-CA-C 111.388 -0.685 . . . . 72.310000000000002 111.388 174.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.8 mt -129.02 111.47 13.02 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 107.755 -1.202 . . . . 74.439999999999998 107.755 170.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.1 t 60.29 40.1 18.15 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 124.255 0.972 . . . . 75.099999999999994 110.283 -175.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.15 1.22 9.63 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.457 1.103 . . . . 70.439999999999998 112.228 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -45.9 116.79 1.3 Allowed 'General case' 0 C--N 1.359 0.988 0 C-N-CA 124.828 1.251 . . . . 74.239999999999995 111.09 173.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.72 89.67 0.07 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.327 1.051 . . . . 62.329999999999998 111.968 -172.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -111.77 116.88 31.43 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.841 -1.17 . . . . 75.030000000000001 107.841 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 47.55 20.68 0.2 Allowed 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 125.555 1.542 . . . . 73.439999999999998 113.687 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -70.5 114.78 8.95 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 123.905 0.882 . . . . 64.319999999999993 109.494 -173.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.9 t -57.21 132.91 54.41 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.355 1.062 . . . . 73.109999999999999 111.569 -175.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.58 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -68.45 97.57 0.77 Allowed 'General case' 0 C--N 1.354 0.764 0 O-C-N 124.101 0.876 . . . . 73.450000000000003 111.797 -173.606 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -91.66 143.9 26.08 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.26 -1.015 . . . . 71.219999999999999 108.26 171.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -86.19 49.61 1.82 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.31 0.644 . . . . 64.230000000000004 111.576 -172.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.9 mt 62.75 8.12 2.88 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.681 1.192 . . . . 71.409999999999997 113.265 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.0 mt 59.09 34.65 23.49 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.644 1.178 . . . . 74.209999999999994 111.311 -172.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.53 158.49 24.44 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.397 0.679 . . . . 35.030000000000001 111.207 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -136.81 -165.39 10.46 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.488 -0.618 . . . . 63.229999999999997 112.135 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.24 80.98 2.09 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.137 2.558 . . . . 62.310000000000002 112.572 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.8 m -75.94 -20.57 57.85 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.604 -0.725 . . . . 51.109999999999999 110.444 173.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.616 ' HA ' ' HA3' ' A' ' 35' ' ' GLY . 18.5 tt0 -116.11 -166.79 1.18 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.483 1.113 . . . . 73.129999999999995 108.531 -177.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.499 ' H ' ' HG2' ' A' ' 79' ' ' GLU . 5.2 p-10 -71.16 -155.63 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 124.51 1.124 . . . . 64.400000000000006 112.385 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -49.12 137.34 14.44 Favored Pre-proline 0 N--CA 1.487 1.396 0 C-N-CA 123.665 0.786 . . . . 54.409999999999997 112.079 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.37 23.64 0.74 Allowed 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.227 2.618 . . . . 74.409999999999997 114.045 -168.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -64.96 83.48 0.04 OUTLIER 'General case' 0 C--N 1.353 0.719 0 CA-C-O 121.766 0.793 . . . . 75.530000000000001 109.85 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.62 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 33.6 tp -125.07 119.01 27.44 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.363 -1.29 . . . . 74.329999999999998 107.904 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -105.14 176.23 5.23 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.646 1.579 . . . . 52.329999999999998 109.226 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.62 144.73 25.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 N-CA-C 108.641 -0.874 . . . . 71.239999999999995 108.641 172.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.28 118.52 19.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.433 0.693 . . . . 74.209999999999994 109.748 174.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.29 -21.29 39.43 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.91 0.884 . . . . 71.129999999999995 111.073 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.572 ' HD1' ' HA ' ' A' ' 134' ' ' TYR . 93.1 m-85 -134.46 169.28 17.5 Favored 'General case' 0 C--O 1.245 0.863 0 C-N-CA 123.405 0.682 . . . . 74.099999999999994 110.15 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.39 145.76 27.32 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.177 -0.919 . . . . 63.240000000000002 109.133 170.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.444 ' HB3' HG12 ' A' ' 101' ' ' ILE . 86.2 t80 -151.93 104.81 3.03 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.457 -0.942 . . . . 65.430000000000007 108.457 176.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.6 t -80.37 133.92 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 107.878 -1.156 . . . . 72.519999999999996 107.878 172.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.41 114.77 10.89 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.595 -0.52 . . . . 75.140000000000001 109.595 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.1 m -77.03 -23.19 52.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.009 0.524 . . . . 63.009999999999998 110.663 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -127.75 168.28 19.8 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 123.796 0.685 . . . . 51.020000000000003 111.734 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.52 -29.88 63.99 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.529 0.732 . . . . 62.43 110.29 177.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -71.43 -19.92 62.18 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.993 1.317 . . . . 72.010000000000005 112.235 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.3 p -98.47 154.87 17.57 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.256 0.622 . . . . 74.409999999999997 109.998 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.6 tp -107.08 128.35 54.3 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.877 -0.786 . . . . 74.0 108.877 -177.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.1 t -82.56 118.15 23.07 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 109.782 -0.451 . . . . 62.350000000000001 109.782 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.444 HG12 ' HB3' ' A' ' 91' ' ' PHE . 28.6 pt -119.6 165.42 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.075 0.95 . . . . 75.109999999999999 110.066 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.5 m -138.59 145.64 40.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.465 0.706 . . . . 75.140000000000001 109.214 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -54.54 118.67 4.36 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.813 0.845 . . . . 74.120000000000005 111.778 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.85 -14.87 29.08 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 116.032 -0.531 . . . . 64.409999999999997 112.842 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -78.49 124.36 28.05 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.596 0.758 . . . . 73.150000000000006 110.258 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.456 ' HB3' HD11 ' A' ' 84' ' ' LEU . 31.8 mtmm -75.01 116.9 16.27 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.364 0.666 . . . . 72.310000000000002 109.574 176.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.9 mt -101.14 163.61 12.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.694 -0.854 . . . . 64.430000000000007 108.694 -177.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.1 mtp180 -126.38 110.12 12.99 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.56 -0.904 . . . . 74.049999999999997 108.56 163.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.485 HG21 HD12 ' A' ' 135' ' ' ILE . 99.1 t -90.23 124.35 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 109.127 -0.694 . . . . 72.430000000000007 109.127 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.563 HD22 ' H ' ' A' ' 31' ' ' SER . 27.4 mt -81.78 -37.83 26.55 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.567 1.147 . . . . 71.209999999999994 109.273 -174.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.81 176.28 47.88 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 113.936 -1.484 . . . . 43.340000000000003 110.51 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 56.7 m-85 -103.95 175.05 5.61 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 109.386 -0.598 . . . . 75.109999999999999 109.386 177.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.428 ' ND2' ' HB2' ' A' ' 22' ' ' PHE . 43.7 t-20 -68.98 148.74 49.69 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.428 -0.953 . . . . 73.530000000000001 108.428 169.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -66.09 -17.81 64.94 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.758 0.823 . . . . 70.120000000000005 112.578 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -95.84 -5.28 42.07 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.493 0.717 . . . . 65.319999999999993 111.062 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.3 34.69 63.95 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.378 -0.689 . . . . 60.409999999999997 111.378 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.463 ' HG2' ' CD1' ' A' ' 118' ' ' TRP . 36.8 tt0 -89.03 -58.36 2.57 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.202 1.401 . . . . 73.420000000000002 109.282 -170.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.463 ' CD1' ' HG2' ' A' ' 117' ' ' GLU . 87.5 m95 -126.24 -176.96 3.8 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.587 1.155 . . . . 74.409999999999997 110.086 178.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -132.28 116.54 17.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.338 1.055 . . . . 64.510000000000005 109.698 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.46 107.53 14.3 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.795 -0.817 . . . . 74.129999999999995 108.795 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.464 ' HB2' HG22 ' A' ' 109' ' ' VAL . . . -121.12 165.42 15.37 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.939 0.896 . . . . 60.219999999999999 111.58 -172.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -143.42 131.31 21.56 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.101 0.96 . . . . 72.400000000000006 110.138 -175.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 45.1 p -141.06 -176.99 4.89 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.634 1.174 . . . . 54.439999999999998 110.973 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -60.79 -21.58 63.24 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.229 1.012 . . . . 71.120000000000005 111.41 171.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -72.71 -26.87 61.75 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.759 0.824 . . . . 72.439999999999998 110.127 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 140.22 -135.1 6.88 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.203 -0.759 . . . . 42.130000000000003 111.203 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.603 HE22 ' HB2' ' A' ' 28' ' ' LYS . 53.4 tt0 -152.88 148.55 27.29 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 122.924 0.489 . . . . 73.230000000000004 110.116 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 161.49 -177.7 37.68 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 121.088 0.271 . . . . 62.549999999999997 113.137 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -84.34 134.78 34.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.528 0.731 . . . . 50.210000000000001 111.781 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.4 m -129.66 155.23 80.65 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.085 1.354 . . . . 74.200000000000003 108.766 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -69.66 129.65 18.08 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 121.789 1.659 . . . . 75.129999999999995 110.846 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 17.4 m -60.25 -20.55 59.45 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.773 0.829 . . . . 32.329999999999998 112.539 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -84.66 -19.02 33.55 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.635 0.774 . . . . 64.439999999999998 111.615 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.572 ' HA ' ' HD1' ' A' ' 89' ' ' TYR . 2.4 m-85 -89.66 5.05 47.49 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.548 0.739 . . . . 73.310000000000002 112.107 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.485 HD12 HG21 ' A' ' 109' ' ' VAL . 21.3 pt -134.32 167.43 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 123.442 0.697 . . . . 63.329999999999998 110.695 -174.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 7.3 t -160.88 141.9 8.73 Favored Pre-proline 0 N--CA 1.489 1.484 0 C-N-CA 122.781 0.432 . . . . 73.319999999999993 111.11 168.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.04 133.21 22.76 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.978 2.452 . . . . 73.120000000000005 112.285 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.6 m -113.89 -49.15 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.109 0.564 . . . . 72.25 111.459 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.62 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 64.2 t30 -100.97 -11.7 19.5 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.92 0.488 . . . . 55.350000000000001 111.058 -176.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.1 t -65.39 177.62 1.1 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.549 0.74 . . . . 73.120000000000005 111.044 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.72 -21.95 21.22 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 114.194 1.183 . . . . 55.409999999999997 114.194 -171.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.59 -13.29 60.88 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.004 0.922 . . . . 74.510000000000005 112.028 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -63.33 -22.46 66.89 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.979 0.912 . . . . 73.450000000000003 110.692 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -85.07 145.22 27.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.612 0.765 . . . . 75.430000000000007 110.431 171.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.7 t -66.51 -20.76 66.11 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.861 0.865 . . . . 64.319999999999993 112.261 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -83.61 -34.87 25.02 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.097 0.406 . . . . 63.210000000000001 112.097 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 33.7 t80 -93.8 138.71 31.69 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 109.494 -0.558 . . . . 74.219999999999999 109.494 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.671 ' HB3' HH21 ' A' ' 171' ' ' ARG . 75.9 m-70 -134.27 26.39 3.83 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.448 0.536 . . . . 73.209999999999994 112.448 -174.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 67.86 -163.5 47.31 Favored Glycine 0 N--CA 1.482 1.705 0 N-CA-C 115.585 0.994 . . . . 65.549999999999997 115.585 170.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.21 102.68 1.59 Allowed 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.499 2.799 . . . . 74.430000000000007 112.874 176.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 38.9 t -138.05 157.58 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 123.247 0.619 . . . . 64.349999999999994 110.363 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.0 m -75.24 153.67 37.92 Favored 'General case' 0 C--O 1.256 1.435 0 C-N-CA 124.581 1.152 . . . . 75.030000000000001 112.09 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -62.81 -31.92 73.01 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.523 -0.762 . . . . 53.43 111.085 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -54.93 -53.6 53.51 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.022 0.929 . . . . 72.219999999999999 110.264 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.04 77.56 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.409 -0.814 . . . . 74.5 110.848 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.498 ' HA ' HH11 ' A' ' 171' ' ' ARG . . . -58.08 -50.53 73.13 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.345 0.593 . . . . 74.319999999999993 111.69 176.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.467 ' HG3' HG11 ' A' ' 190' ' ' VAL . 33.0 tt0 -78.2 -25.05 46.89 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.106 -0.952 . . . . 64.040000000000006 110.263 -175.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -60.25 -53.46 57.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.112 0.565 . . . . 64.120000000000005 110.269 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 64.8 mt -65.23 -39.33 92.58 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 116.237 -0.438 . . . . 72.420000000000002 110.854 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.58 HD23 HG13 ' A' ' 190' ' ' VAL . 36.4 tp -73.08 -24.21 60.63 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.878 -0.601 . . . . 75.329999999999998 112.105 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 35.4 t -65.77 -23.81 66.8 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.109 0.564 . . . . 54.409999999999997 111.322 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 80.6 p -91.8 -0.64 57.54 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.155 0.582 . . . . 72.519999999999996 111.129 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -83.96 163.23 39.7 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.941 -0.572 . . . . 64.400000000000006 112.89 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.1 pt -120.15 -166.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.317 1.047 . . . . 72.209999999999994 111.095 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -58.58 107.36 0.5 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.899 0.879 . . . . 75.510000000000005 112.777 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 98.2 13.53 42.0 Favored Glycine 0 C--O 1.259 1.658 0 CA-C-N 116.03 -0.532 . . . . 75.299999999999997 112.617 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 31.5 t -74.35 134.79 42.49 Favored 'General case' 0 C--N 1.353 0.718 0 CA-C-O 119.126 -0.464 . . . . 52.149999999999999 109.961 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 183' ' ' SER . 22.3 p90 -135.25 153.7 51.82 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 121.51 0.671 . . . . 73.299999999999997 112.669 177.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' A' ' 236' ' ' ALA . 97.5 mt -134.49 133.81 40.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.908 -1.042 . . . . 61.32 108.302 169.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 20.0 t -112.87 120.5 63.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.394 -1.336 . . . . 74.019999999999996 107.394 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.671 HH21 ' HB3' ' A' ' 148' ' ' HIS . 0.6 OUTLIER -159.37 148.89 18.5 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.469 -0.567 . . . . 72.150000000000006 109.469 177.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.808 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 15.0 pt-20 -92.3 157.77 16.47 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-O 121.224 0.535 . . . . 72.310000000000002 111.258 -176.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.2 p -76.72 115.97 16.97 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.975 -1.011 . . . . 71.439999999999998 108.53 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -58.21 -31.33 67.23 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.796 0.838 . . . . 65.430000000000007 112.429 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.8 t -95.67 8.46 43.37 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.81 0.844 . . . . 72.319999999999993 111.4 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 57.0 m -149.86 83.21 6.33 Favored Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 108.434 -0.95 . . . . 55.149999999999999 108.434 172.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.517 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 42.8 Cg_endo -63.57 140.55 75.85 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.47 2.78 . . . . 73.430000000000007 112.491 -173.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.65 -23.54 10.14 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.924 -0.58 . . . . 74.340000000000003 112.9 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -86.65 115.87 24.39 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 108.818 -0.808 . . . . 74.140000000000001 108.818 174.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.808 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 42.8 mtt85 -114.57 153.15 30.6 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.025 -0.989 . . . . 75.129999999999995 108.957 -173.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 53.1 m -134.18 142.72 47.53 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 109.945 -0.391 . . . . 63.119999999999997 109.945 -177.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.411 HG12 HG22 ' A' ' 170' ' ' VAL . 50.6 mt -106.48 136.25 41.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.365 -0.976 . . . . 70.040000000000006 108.365 169.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.576 ' HB3' HD22 ' A' ' 160' ' ' LEU . 20.4 m -115.77 113.95 24.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.99 -1.115 . . . . 72.25 107.99 -177.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 52.7 mt -104.58 141.09 37.03 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.5 0.72 . . . . 73.310000000000002 111.167 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 26.7 ttt180 -124.2 120.91 33.64 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 107.361 -1.348 . . . . 75.310000000000002 107.361 165.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.79 127.38 28.87 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.588 -1.264 . . . . 74.420000000000002 107.588 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 54.85 28.86 10.99 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.039 0.936 . . . . 64.329999999999998 112.282 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 89.31 1.25 78.88 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.155 0.407 . . . . 73.129999999999995 113.433 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 8.7 tpm_? -100.57 123.26 44.54 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.035 0.934 . . . . 65.230000000000004 109.455 -174.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.58 HG13 HD23 ' A' ' 160' ' ' LEU . 95.0 t -98.58 124.3 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.135 0.974 . . . . 44.030000000000001 109.978 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -145.95 149.99 35.21 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.062 0.945 . . . . 60.240000000000002 109.75 176.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -125.86 148.78 49.07 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.961 0.904 . . . . 74.129999999999995 109.361 -171.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -145.39 148.4 33.3 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.215 0.531 . . . . 74.049999999999997 111.106 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -93.77 125.88 38.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.932 -1.031 . . . . 73.329999999999998 111.785 -171.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 68.9 mt -77.65 111.0 13.97 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 C-N-CA 124.397 1.079 . . . . 75.540000000000006 108.536 162.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -87.46 139.27 30.71 Favored 'General case' 0 C--O 1.249 1.051 0 N-CA-C 109.417 -0.586 . . . . 73.219999999999999 109.417 173.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 46.5 m -110.6 132.16 54.43 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.974 0.796 . . . . 65.200000000000003 110.1 -176.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.58 169.19 18.74 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.059 0.944 . . . . 75.310000000000002 111.1 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 72.1 p -75.92 -8.59 57.29 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 122.841 0.456 . . . . 74.120000000000005 111.461 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -93.33 -7.55 44.49 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.062 0.945 . . . . 73.219999999999999 110.821 170.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 91.8 -1.27 74.63 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-O 119.501 -0.61 . . . . 31.030000000000001 113.324 -177.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -70.61 128.85 37.52 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 117.538 0.669 . . . . 73.450000000000003 111.164 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 29.0 mt -91.77 148.59 22.13 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.925 0.89 . . . . 52.420000000000002 110.535 -177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -160.74 148.74 16.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.301 0.572 . . . . 74.030000000000001 111.149 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.7 t -112.7 -45.32 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 114.721 -1.127 . . . . 63.130000000000003 109.371 176.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 22.2 t -121.75 178.94 4.65 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.009 0.524 . . . . 61.210000000000001 109.976 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.2 t -68.05 -26.72 66.0 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.577 0.751 . . . . 71.150000000000006 112.04 -175.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -86.48 -3.97 59.1 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.604 0.761 . . . . 74.239999999999995 110.663 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.484 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 19.9 m -94.72 121.76 36.62 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.893 0.877 . . . . 71.439999999999998 110.976 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -143.49 109.29 5.2 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 107.869 -1.16 . . . . 72.219999999999999 107.869 168.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.484 ' CE2' ' HB3' ' A' ' 209' ' ' SER . 17.7 m-85 -123.42 136.26 54.53 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.291 -0.633 . . . . 73.430000000000007 109.291 -178.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -90.24 -10.17 45.29 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 122.625 0.37 . . . . 71.420000000000002 110.182 175.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 57.7 p -141.36 152.55 44.47 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.587 0.708 . . . . 65.200000000000003 111.141 173.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.26 -25.4 63.35 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.483 -1.235 . . . . 63.039999999999999 110.474 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.61 -50.14 73.76 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 123.723 0.809 . . . . 72.109999999999999 110.382 174.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -72.11 -29.22 63.87 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.416 -0.811 . . . . 72.230000000000004 111.62 178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.49 -52.7 64.55 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.354 0.409 . . . . 73.430000000000007 110.065 171.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 40.6 t -65.69 -40.5 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.273 0.629 . . . . 73.329999999999998 111.221 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -64.06 -47.5 79.9 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.091 0.472 . . . . 63.329999999999998 110.949 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -63.26 -46.69 85.65 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.151 -0.685 . . . . 74.040000000000006 109.151 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.434 ' HA ' HG22 ' A' ' 224' ' ' VAL . 46.1 m80 -66.24 -25.22 66.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.969 0.508 . . . . 72.319999999999993 111.489 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.407 ' O ' ' HB ' ' A' ' 231' ' ' THR . 45.9 t -71.07 -28.65 64.51 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.658 0.383 . . . . 62.439999999999998 111.114 174.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.3 t -106.72 -18.02 14.06 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 115.433 1.642 . . . . 75.420000000000002 115.433 -177.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 221' ' ' HIS . 23.9 m -87.34 122.41 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-N 120.251 1.387 . . . . 74.209999999999994 114.232 -169.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.55 -1.54 19.05 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.315 2.246 . . . . 74.420000000000002 113.17 170.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -79.5 15.51 1.28 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 127.986 2.514 . . . . 75.099999999999994 112.914 -144.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 121.07 16.84 4.26 Favored Glycine 0 C--O 1.25 1.129 0 C-N-CA 123.507 0.575 . . . . 70.430000000000007 112.133 -168.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 46.9 mt -88.78 131.51 35.03 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.978 -0.611 . . . . 75.349999999999994 109.59 158.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 77.5 mt -59.24 -41.2 83.2 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 O-C-N 124.03 0.832 . . . . 65.109999999999999 109.694 172.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 10.7 t -141.17 144.43 34.8 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.969 -1.014 . . . . 63.399999999999999 109.536 168.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 222' ' ' SER . 67.3 p -71.84 151.33 43.52 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.791 -0.818 . . . . 74.530000000000001 108.791 168.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.22 100.23 0.33 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.543 -0.91 . . . . 61.43 108.543 178.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -85.86 -50.73 6.89 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.21 -0.663 . . . . 53.409999999999997 109.21 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.1 OUTLIER -163.24 148.08 9.19 Favored Pre-proline 0 N--CA 1.482 1.151 0 CA-C-N 115.376 -0.829 . . . . 70.420000000000002 110.922 179.308 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 168' ' ' PHE . 52.3 Cg_endo -67.47 155.86 68.52 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 121.738 1.625 . . . . 71.219999999999999 112.293 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.523 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -63.41 134.56 95.89 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-O 118.779 -0.629 . . . . 71.549999999999997 109.779 173.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.11 120.47 7.29 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.967 2.445 . . . . 62.130000000000003 111.689 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' A' ' 238' ' ' LYS . 46.9 mtmt -53.83 134.82 42.53 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 123.931 0.769 . . . . 75.420000000000002 110.477 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -57.67 -25.09 59.75 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.723 0.809 . . . . 75.010000000000005 111.687 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -121.26 133.33 55.15 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.266 1.026 . . . . 75.239999999999995 108.483 172.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt 43.3 67.94 3.32 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 126.013 1.725 . . . . 64.230000000000004 113.156 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.05 104.63 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.858 2.372 . . . . 75.310000000000002 112.262 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 86.1 m -70.28 108.93 4.42 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.293 0.637 . . . . 64.230000000000004 110.348 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 39.9 t -93.22 94.53 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.752 -0.833 . . . . 74.140000000000001 108.752 176.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -88.55 118.08 27.95 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.924 -0.769 . . . . 74.129999999999995 108.924 174.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -66.64 137.93 35.12 Favored Glycine 0 C--N 1.343 0.963 0 N-CA-C 111.086 -0.806 . . . . 53.229999999999997 111.086 171.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 22.6 m -60.76 -22.77 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.515 0.726 . . . . 74.430000000000007 112.558 -173.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 28.5 t 63.71 84.91 0.18 Allowed Pre-proline 0 C--N 1.359 1.009 0 C-N-CA 125.063 1.345 . . . . 54.539999999999999 109.965 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.24 171.72 16.56 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.915 2.41 . . . . 55.140000000000001 112.788 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -136.19 165.24 26.19 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.753 0.821 . . . . 65.349999999999994 110.312 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -74.88 -58.89 3.0 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.033 0.933 . . . . 73.409999999999997 110.752 -175.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -156.18 169.56 24.23 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 121.146 0.498 . . . . 73.239999999999995 111.121 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.49 43.46 0.75 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.761 1.224 . . . . 70.109999999999999 108.772 171.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 59.61 93.05 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.013 1.325 . . . . 75.420000000000002 111.642 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 C--O 1.255 1.375 0 N-CA-C 108.816 -0.809 . . . . 74.349999999999994 108.816 175.228 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 108.837 -0.801 . . . . 62.399999999999999 108.837 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.26 177.39 9.65 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.551 0.532 . . . . 55.119999999999997 113.349 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -129.24 -36.4 1.73 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.968 -0.753 . . . . 64.109999999999999 108.968 175.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 54.63 73.39 0.9 Allowed Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.752 1.221 . . . . 73.219999999999999 108.232 -169.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.57 -58.79 0.36 Allowed 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.005 1.803 . . . . 62.340000000000003 111.585 -174.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.49 175.95 5.73 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 116.064 -0.516 . . . . 74.319999999999993 113.286 -176.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -157.98 93.09 1.23 Allowed 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.742 -0.836 . . . . 71.230000000000004 108.742 177.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.422 ' HB ' ' OG ' ' A' ' 16' ' ' SER . 18.7 m -83.45 159.74 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-N 115.404 -0.816 . . . . 63.420000000000002 110.557 174.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.5 tp -158.83 152.76 23.46 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.208 -0.664 . . . . 74.430000000000007 109.208 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.715 ' HA3' ' HB3' ' A' ' 15' ' ' PRO . . . -134.65 71.97 0.48 Allowed Glycine 0 C--N 1.347 1.14 0 N-CA-C 111.523 -0.631 . . . . 21.109999999999999 111.523 -177.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -76.54 -33.39 58.56 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.3 -0.63 . . . . 72.310000000000002 109.3 172.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -93.59 153.36 18.45 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.167 -0.924 . . . . 40.32 109.715 173.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.549 ' HD3' ' H ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -56.96 153.12 11.71 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.42 0.688 . . . . 75.310000000000002 111.33 175.232 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 56.5 73.94 0.75 Allowed Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 124.158 0.983 . . . . 72.140000000000001 109.258 -169.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.715 ' HB3' ' HA3' ' A' ' 10' ' ' GLY . 26.7 Cg_endo -63.83 166.11 16.93 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.963 2.442 . . . . 73.120000000000005 112.563 -178.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.422 ' OG ' ' HB ' ' A' ' 8' ' ' VAL . 6.2 p -72.19 168.37 18.37 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.415 0.626 . . . . 72.200000000000003 111.322 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.6 mt -107.24 126.84 29.14 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 107.975 -1.12 . . . . 64.109999999999999 107.975 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.51 171.95 11.06 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.391 2.061 . . . . 64.299999999999997 111.632 173.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.23 144.35 32.99 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.847 0.459 . . . . 54.310000000000002 111.085 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.638 ' HB3' HD11 ' A' ' 23' ' ' ILE . 56.4 mt -86.1 93.89 9.12 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.073 0.949 . . . . 64.239999999999995 108.699 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -98.25 -42.15 7.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.815 -1.084 . . . . 75.420000000000002 109.285 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -96.85 111.86 23.87 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 114.583 -1.189 . . . . 72.209999999999994 108.547 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.638 HD11 ' HB3' ' A' ' 20' ' ' LEU . 44.1 mm -116.08 120.88 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.991 -1.114 . . . . 74.239999999999995 107.991 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -147.61 149.44 32.53 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.45 -0.945 . . . . 75.310000000000002 108.45 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -160.28 -127.33 0.89 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.226 -1.15 . . . . 65.430000000000007 110.226 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 62.24 92.44 0.06 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.723 1.209 . . . . 63.43 110.657 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.81 73.9 2.05 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.272 -0.876 . . . . 32.329999999999998 112.489 -175.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.0 10.15 4.58 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.395 1.078 . . . . 62.049999999999997 110.099 178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -136.67 159.75 40.9 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 124.215 1.006 . . . . 63.329999999999998 108.665 -174.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.513 ' HA ' HE22 ' A' ' 122' ' ' GLN . 0.0 OUTLIER -149.45 178.43 8.81 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.994 -0.548 . . . . 74.450000000000003 110.693 -177.383 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 56.6 p -79.02 -158.03 0.14 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.313 1.045 . . . . 63.119999999999997 110.61 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.1 t -63.71 175.42 1.11 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 122.8 0.44 . . . . 71.219999999999999 111.238 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -64.69 -172.01 0.07 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.315 1.046 . . . . 73.530000000000001 113.503 -170.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -72.32 153.37 41.54 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.183 0.593 . . . . 73.150000000000006 111.359 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.04 -142.47 3.71 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 115.743 -0.662 . . . . 70.310000000000002 111.605 177.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -107.55 97.42 1.16 Allowed Glycine 0 C--N 1.344 0.979 0 N-CA-C 110.777 -0.929 . . . . 41.119999999999997 110.777 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.734 ' HG3' ' HA2' ' A' ' 76' ' ' GLY . 18.0 Cg_endo -86.89 50.11 2.15 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 123.457 2.772 . . . . 63.140000000000001 112.389 -171.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.434 ' HB2' ' HD3' ' A' ' 70' ' ' LYS . 19.9 p-80 -55.49 -23.56 26.59 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 124.792 1.237 . . . . 53.130000000000003 113.681 -174.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.8 m -66.25 111.58 3.54 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 107.305 -1.368 . . . . 71.549999999999997 107.305 170.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -51.98 -79.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.356 1.063 . . . . 72.120000000000005 112.939 -162.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 p -179.42 158.4 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.663 0.785 . . . . 64.010000000000005 109.717 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -134.49 95.5 3.39 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.569 -0.9 . . . . 64.409999999999997 108.569 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.7 m -112.37 176.71 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.064 0.545 . . . . 63.200000000000003 110.579 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -148.35 135.53 20.29 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.222 -1.029 . . . . 74.329999999999998 108.222 174.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -71.54 92.22 1.11 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.151 0.581 . . . . 64.430000000000007 110.039 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -76.84 139.75 40.4 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.324 -0.853 . . . . 73.430000000000007 108.984 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.73 112.96 23.65 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.5 -0.926 . . . . 72.239999999999995 108.5 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.43 90.2 0.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.351 0.66 . . . . 73.010000000000005 110.121 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -155.68 136.08 13.2 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.976 0.91 . . . . 74.030000000000001 108.775 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -61.92 136.32 95.0 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 123.645 0.59 . . . . 74.010000000000005 110.082 174.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.09 93.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.984 2.456 . . . . 64.120000000000005 113.538 175.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.03 -57.84 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 108.253 -1.017 . . . . 54.119999999999997 108.253 172.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.79 97.86 0.86 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.729 0.812 . . . . 61.399999999999999 109.449 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.4 m -82.86 167.37 18.12 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.185 0.594 . . . . 64.530000000000001 111.578 -176.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.19 145.29 44.31 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.118 0.967 . . . . 60.240000000000002 110.977 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -148.97 166.8 27.55 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.083 0.953 . . . . 75.030000000000001 109.38 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 65.75 71.63 0.49 Allowed Pre-proline 0 N--CA 1.485 1.315 0 C-N-CA 124.93 1.292 . . . . 71.439999999999998 111.862 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.06 160.16 36.89 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.206 1.937 . . . . 62.439999999999998 112.112 171.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -65.0 -42.62 94.34 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.629 0.772 . . . . 72.040000000000006 110.436 177.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 144.22 92.12 0.14 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.171 -0.772 . . . . 64.439999999999998 111.171 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.44 98.48 1.82 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.422 0.689 . . . . 64.310000000000002 110.768 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.2 t -152.98 145.95 24.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.21 -0.905 . . . . 74.310000000000002 108.934 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.79 159.99 15.54 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.328 0.651 . . . . 74.0 111.003 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.77 -38.51 8.25 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.104 0.962 . . . . 71.140000000000001 109.712 172.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -158.18 134.27 9.28 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.376 1.07 . . . . 74.400000000000006 109.509 -177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -109.45 85.69 2.15 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.195 0.598 . . . . 70.439999999999998 109.599 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -109.27 85.57 2.12 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 107.295 -1.372 . . . . 64.450000000000003 107.295 166.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -81.43 134.34 35.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 114.453 -1.249 . . . . 71.340000000000003 110.128 -178.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.1 t -71.59 97.51 1.72 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 109.701 -0.481 . . . . 71.430000000000007 109.701 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HD3' ' HB2' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -64.72 110.59 2.43 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.386 -0.824 . . . . 73.239999999999995 109.475 179.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -176.45 121.68 0.15 Allowed 'General case' 0 N--CA 1.48 1.03 0 O-C-N 124.347 1.029 . . . . 74.150000000000006 110.151 160.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -154.88 93.79 1.59 Allowed 'General case' 0 C--O 1.244 0.801 0 N-CA-C 109.066 -0.716 . . . . 74.150000000000006 109.066 170.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 99.4 mt -123.85 -178.1 3.95 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.141 0.977 . . . . 74.099999999999994 109.555 175.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 89.3 mt 62.81 18.05 10.4 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.982 1.313 . . . . 74.219999999999999 111.172 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -156.68 163.96 38.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.948 1.299 . . . . 71.200000000000003 109.3 -175.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.734 ' HA2' ' HG3' ' A' ' 37' ' ' PRO . . . 175.46 99.78 0.12 Allowed Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.084 -0.842 . . . . 63.399999999999999 113.098 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.6 170.65 13.34 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 122.836 2.357 . . . . 74.409999999999997 111.591 163.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.6 m -74.73 85.42 2.15 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.128 0.489 . . . . 61.219999999999999 109.853 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.523 ' HB3' ' NE ' ' A' ' 108' ' ' ARG . 11.1 pt-20 -146.32 92.3 2.16 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-O 122.785 1.279 . . . . 75.540000000000006 110.228 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -147.94 44.01 1.07 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 105.569 -2.011 . . . . 73.109999999999999 105.569 171.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -82.89 133.15 49.2 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 114.118 -1.401 . . . . 74.150000000000006 110.373 -170.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -59.01 -32.29 97.28 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 123.274 2.649 . . . . 75.409999999999997 112.774 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -93.05 66.7 4.17 Favored 'General case' 0 C--O 1.246 0.89 0 CA-C-O 121.792 0.806 . . . . 60.43 109.543 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.542 HD11 ' HB3' ' A' ' 106' ' ' LYS . 42.5 tp -85.78 117.63 24.77 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.797 -1.092 . . . . 73.420000000000002 109.007 175.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -109.09 176.51 5.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.694 1.598 . . . . 70.230000000000004 109.373 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.82 146.24 24.29 Favored 'Isoleucine or valine' 0 C--O 1.25 1.103 0 N-CA-C 108.722 -0.844 . . . . 64.010000000000005 108.722 170.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.03 120.64 25.06 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.282 0.633 . . . . 62.25 109.776 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 94.1 mt -77.05 -20.48 55.8 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.872 0.869 . . . . 74.219999999999999 111.446 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -141.78 149.11 39.98 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 108.831 -0.804 . . . . 71.239999999999995 108.831 -174.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.76 146.54 46.31 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.02 -0.733 . . . . 71.439999999999998 109.02 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -151.87 108.46 3.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.691 -1.226 . . . . 65.310000000000002 107.691 -176.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.7 t -79.17 138.63 19.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 107.263 -1.384 . . . . 51.43 107.263 173.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.85 125.86 25.3 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.928 0.491 . . . . 64.409999999999997 110.867 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.2 t -72.52 -17.74 61.71 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.937 0.895 . . . . 74.349999999999994 110.283 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.36 -166.72 37.39 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 115.698 -0.683 . . . . 44.329999999999998 112.129 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -64.58 -32.33 73.94 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.635 1.174 . . . . 51.229999999999997 112.059 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -69.79 -25.7 63.91 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.866 0.866 . . . . 74.349999999999994 112.05 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.1 p -103.35 160.31 14.8 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.59 0.756 . . . . 73.129999999999995 110.777 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.1 tp -109.22 130.5 55.49 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.384 0.673 . . . . 74.329999999999998 109.21 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -77.02 117.44 18.61 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 108.345 -0.984 . . . . 71.129999999999995 108.345 172.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.8 pt -119.68 138.26 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.538 0.735 . . . . 51.43 109.194 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.1 m -94.07 145.82 24.4 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.507 -0.553 . . . . 73.129999999999995 109.507 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -58.2 111.86 1.34 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.619 0.368 . . . . 74.200000000000003 110.705 171.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.71 5.93 50.47 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.122 0.391 . . . . 74.010000000000005 112.627 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -87.25 137.83 32.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.24 1.016 . . . . 75.349999999999994 109.83 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HB3' HD11 ' A' ' 84' ' ' LEU . 63.0 mttm -88.33 123.77 33.24 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.288 0.635 . . . . 74.219999999999999 109.825 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 21.4 mt -108.64 139.96 42.69 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.053 0.941 . . . . 74.219999999999999 110.299 -168.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.523 ' NE ' ' HB3' ' A' ' 79' ' ' GLU . 30.4 mtt180 -95.26 107.15 19.24 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 106.002 -1.851 . . . . 61.5 106.002 172.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 68.7 t -100.19 111.56 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 119.364 0.984 . . . . 72.430000000000007 109.571 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.11 -25.62 64.5 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.484 -1.235 . . . . 74.120000000000005 111.018 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 154.51 173.05 22.98 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-N 115.675 -0.693 . . . . 24.140000000000001 112.104 173.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.457 ' HB2' ' HB3' ' A' ' 177' ' ' PRO . 1.8 m-30 -95.23 148.93 21.88 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 106.668 -1.605 . . . . 74.099999999999994 106.668 172.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.459 HD21 ' HB2' ' A' ' 117' ' ' GLU . 29.5 p30 -66.44 167.5 10.56 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 110.25 -0.278 . . . . 74.400000000000006 110.25 173.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -56.5 -32.04 64.66 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.508 0.929 . . . . 70.299999999999997 113.508 -167.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -96.93 -2.59 43.42 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.562 0.345 . . . . 64.310000000000002 111.617 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.77 18.58 79.57 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 123.157 0.408 . . . . 62.32 113.397 174.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.459 ' HB2' HD21 ' A' ' 113' ' ' ASN . 6.0 mm-40 -65.72 -65.65 0.65 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.522 1.129 . . . . 72.510000000000005 110.136 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -122.97 152.53 40.79 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 114.227 -1.351 . . . . 70.299999999999997 108.291 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -115.87 127.38 54.98 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.326 1.051 . . . . 74.019999999999996 109.379 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -76.72 101.44 5.8 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.04 -0.726 . . . . 53.439999999999998 109.04 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -104.87 169.02 8.68 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.315 -0.857 . . . . 74.239999999999995 110.298 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.513 HE22 ' HA ' ' A' ' 30' ' ' GLU . 35.1 tt0 -148.08 138.24 22.7 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.219 1.008 . . . . 72.239999999999995 108.953 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 37.5 p -144.23 -171.02 3.49 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.403 1.081 . . . . 63.210000000000001 108.901 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -64.95 -16.48 63.39 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 122.971 0.508 . . . . 73.340000000000003 111.098 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -76.39 -14.11 60.09 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.712 0.805 . . . . 73.439999999999998 111.722 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 129.64 -137.06 9.3 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 111.866 -0.493 . . . . 74.420000000000002 111.866 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -149.91 144.21 25.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.355 0.662 . . . . 75.349999999999994 109.755 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 166.43 179.61 39.85 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-O 121.245 0.358 . . . . 34.310000000000002 113.235 175.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -79.85 130.79 35.6 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.09 0.956 . . . . 74.430000000000007 110.695 -176.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.7 m -124.36 146.86 53.32 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.75 1.22 . . . . 75.329999999999998 108.22 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.98 131.64 26.0 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 121.599 1.533 . . . . 71.430000000000007 110.889 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.7 m -59.22 -21.38 59.44 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.791 0.836 . . . . 75.239999999999995 111.898 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -73.16 -18.95 61.22 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.485 1.114 . . . . 61.140000000000001 112.184 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -102.18 -3.63 27.09 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.419 0.688 . . . . 75.219999999999999 112.603 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.0 pt -122.05 155.88 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 118.478 0.581 . . . . 71.319999999999993 111.134 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.1 t -153.58 136.12 9.53 Favored Pre-proline 0 N--CA 1.485 1.279 0 O-C-N 123.309 0.381 . . . . 61.43 110.708 174.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -76.44 132.7 13.78 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.805 2.337 . . . . 63.350000000000001 113.163 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.1 m -109.36 -31.34 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.891 0.876 . . . . 71.040000000000006 111.741 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 84' ' ' LEU . 63.9 t30 -97.64 0.07 46.55 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.24 0.616 . . . . 55.149999999999999 111.594 -175.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 97.7 p -80.12 -171.0 2.74 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.835 0.826 . . . . 74.540000000000006 111.318 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.9 mt -63.14 -9.77 12.22 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.569 1.148 . . . . 64.530000000000001 113.298 171.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -59.35 -20.57 55.72 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.252 0.834 . . . . 62.520000000000003 113.252 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.96 -8.14 52.74 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.253 0.621 . . . . 65.120000000000005 111.959 175.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -88.37 135.51 33.43 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 107.886 -1.153 . . . . 75.430000000000007 107.886 170.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.5 m -64.44 -28.0 69.37 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.584 0.754 . . . . 74.340000000000003 112.322 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 56.2 p-90 -73.49 -32.15 64.12 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.117 0.414 . . . . 72.519999999999996 112.117 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -91.51 128.18 37.24 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.084 0.554 . . . . 74.239999999999995 109.572 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -121.03 2.16 10.43 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 112.303 0.483 . . . . 73.109999999999999 112.303 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.06 -155.56 33.13 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 119.584 -0.565 . . . . 63.229999999999997 114.11 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.12 101.43 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.988 2.459 . . . . 71.140000000000001 111.159 173.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.554 ' HB ' ' HD2' ' A' ' 171' ' ' ARG . 15.9 t -118.79 142.81 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 110.231 -0.285 . . . . 74.200000000000003 110.231 -173.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.6 m -73.94 161.99 29.54 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.967 0.907 . . . . 64.019999999999996 110.772 172.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -63.38 -44.59 94.31 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.234 0.614 . . . . 75.549999999999997 111.361 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -58.87 -51.89 68.1 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.071 0.948 . . . . 74.329999999999998 110.192 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -59.22 -47.06 86.73 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.946 0.898 . . . . 44.229999999999997 111.59 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.97 -53.86 53.63 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.077 -0.965 . . . . 41.520000000000003 111.588 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.55 ' HG3' HG11 ' A' ' 190' ' ' VAL . 30.4 tt0 -70.87 -24.87 62.59 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 114.945 -1.025 . . . . 63.039999999999999 110.52 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -66.52 -43.22 85.83 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.143 0.577 . . . . 71.439999999999998 111.098 173.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 238' ' ' LYS . 44.8 mt -72.85 -36.78 67.51 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.473 0.654 . . . . 65.129999999999995 110.789 175.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.576 HD22 ' HB3' ' A' ' 183' ' ' SER . 39.5 tp -77.76 -19.81 54.48 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.223 -0.899 . . . . 60.039999999999999 112.28 -174.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 81.0 p -64.94 -26.06 68.14 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 120.861 0.362 . . . . 72.219999999999999 110.184 174.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.4 t -82.02 -5.85 58.68 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.416 1.086 . . . . 60.520000000000003 111.076 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.77 171.81 55.16 Favored Glycine 0 C--N 1.346 1.118 0 C-N-CA 122.917 0.294 . . . . 72.230000000000004 113.436 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.6 pt -133.95 -169.58 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.598 1.159 . . . . 73.120000000000005 110.09 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 18.1 p-10 -59.75 103.26 0.19 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.442 0.697 . . . . 64.329999999999998 112.435 -172.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 102.73 12.88 31.31 Favored Glycine 0 C--O 1.261 1.816 0 CA-C-N 116.184 -0.462 . . . . 63.030000000000001 113.082 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 78.7 p -79.75 137.78 37.11 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 109.991 -0.374 . . . . 72.25 109.991 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -137.01 155.91 49.1 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.282 0.563 . . . . 74.420000000000002 112.264 -179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.0 mt -131.74 134.22 45.64 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.994 -1.113 . . . . 74.329999999999998 107.994 170.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.404 HG21 HG22 ' A' ' 218' ' ' VAL . 52.2 t -114.0 126.25 71.45 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 108.354 -0.98 . . . . 74.310000000000002 108.354 178.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.554 ' HD2' ' HB ' ' A' ' 151' ' ' VAL . 17.9 mtm180 -140.32 170.19 16.27 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.741 -1.118 . . . . 62.009999999999998 109.005 -167.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 9.0 pm0 -117.4 163.5 16.28 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 108.695 -0.854 . . . . 74.340000000000003 108.695 153.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 176' ' ' SER . 48.8 m -82.68 131.92 35.19 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.434 -0.803 . . . . 71.319999999999993 110.308 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -53.6 -40.09 65.42 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.087 1.355 . . . . 72.400000000000006 112.205 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 27.8 t -98.49 6.25 47.33 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.558 0.743 . . . . 62.439999999999998 111.376 -174.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.431 ' HB2' ' HB2' ' A' ' 173' ' ' SER . 28.8 m -147.08 86.97 6.31 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.32 0.648 . . . . 72.230000000000004 109.489 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.457 ' HB3' ' HB2' ' A' ' 112' ' ' TYR . 34.9 Cg_endo -62.58 136.73 60.17 Favored 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 123.327 2.684 . . . . 75.340000000000003 111.331 177.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.85 -24.92 5.57 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.901 -0.59 . . . . 74.439999999999998 113.306 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -84.11 116.35 22.85 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.002 -1.11 . . . . 72.239999999999995 108.002 175.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.654 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 58.2 mtt-85 -109.17 168.56 9.29 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.308 -0.86 . . . . 61.130000000000003 110.633 -170.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.4 t -155.91 145.91 21.4 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.323 0.649 . . . . 63.32 110.063 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 65.9 mt -115.94 147.91 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.587 0.755 . . . . 72.120000000000005 109.081 173.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.576 ' HB3' HD22 ' A' ' 160' ' ' LEU . 24.5 m -125.89 114.2 18.22 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.869 1.268 . . . . 73.120000000000005 108.602 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.403 HD21 ' CD2' ' A' ' 232' ' ' LEU . 76.7 mt -105.01 139.1 40.19 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.629 1.171 . . . . 74.5 111.448 -179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -120.79 132.18 54.88 Favored 'General case' 0 C--O 1.257 1.475 0 N-CA-C 107.24 -1.393 . . . . 74.140000000000001 107.24 161.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 28.5 t80 -151.94 123.6 7.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.736 -1.12 . . . . 74.400000000000006 108.678 -171.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 51.29 36.13 15.42 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.435 1.494 . . . . 73.239999999999995 112.359 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 89.23 3.34 75.83 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-N 114.995 -1.002 . . . . 64.349999999999994 114.088 173.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -115.02 127.73 55.83 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 117.722 0.761 . . . . 75.010000000000005 111.224 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.55 HG11 ' HG3' ' A' ' 157' ' ' GLU . 46.3 t -88.26 132.79 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 124.636 1.174 . . . . 72.129999999999995 109.854 171.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -146.39 153.35 40.38 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.118 1.367 . . . . 71.200000000000003 109.174 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -131.21 149.31 52.63 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.083 0.953 . . . . 75.400000000000006 109.335 -170.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -146.3 154.58 41.86 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.285 0.564 . . . . 70.219999999999999 111.713 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.505 ' HD3' ' O ' ' A' ' 180' ' ' ARG . 20.8 tpp180 -85.75 135.26 33.82 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.761 1.224 . . . . 74.030000000000001 111.001 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.461 ' HA ' HG22 ' A' ' 205' ' ' VAL . 90.9 mt -85.69 110.27 19.45 Favored 'Isoleucine or valine' 0 C--O 1.245 0.858 0 N-CA-C 107.888 -1.153 . . . . 75.219999999999999 107.888 163.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -75.72 119.03 19.17 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.515 -0.766 . . . . 72.209999999999994 109.5 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 25.9 m -99.43 114.3 27.15 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.165 0.586 . . . . 74.450000000000003 109.892 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -64.02 163.18 12.72 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.198 0.999 . . . . 75.0 111.405 175.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 82.1 p -62.0 -24.72 67.21 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.384 0.674 . . . . 74.340000000000003 111.514 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.0 -5.79 50.1 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.145 0.978 . . . . 63.210000000000001 111.778 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 88.34 -3.97 85.35 Favored Glycine 0 C--N 1.352 1.465 0 C-N-CA 123.057 0.36 . . . . 21.300000000000001 112.56 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -74.42 142.46 44.97 Favored 'General case' 0 C--N 1.351 0.664 0 C-N-CA 123.578 0.751 . . . . 75.239999999999995 109.657 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 80.4 mt -98.05 153.57 18.31 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 123.672 0.789 . . . . 73.25 109.762 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -167.56 163.73 14.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.737 0.815 . . . . 64.310000000000002 109.648 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 195' ' ' ILE . 71.5 t -131.92 -56.98 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 107.699 -1.223 . . . . 74.299999999999997 107.699 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 40.0 t -83.65 155.18 23.31 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.541 -0.754 . . . . 70.299999999999997 109.478 171.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.3 m -68.66 -33.63 74.32 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.309 0.643 . . . . 74.099999999999994 110.327 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -75.06 -19.11 60.15 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.302 -0.863 . . . . 72.310000000000002 111.408 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 211' ' ' PHE . 48.0 m -104.58 127.36 52.29 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.245 1.018 . . . . 65.010000000000005 110.17 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -138.59 133.94 33.16 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.569 1.147 . . . . 63.549999999999997 108.721 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.505 ' CZ ' ' HB3' ' A' ' 209' ' ' SER . 11.2 m-85 -133.76 135.84 44.18 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.255 0.622 . . . . 74.019999999999996 110.639 -172.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -83.15 -30.35 27.93 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.622 0.769 . . . . 63.329999999999998 110.261 169.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 40.1 p -128.84 150.36 50.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.579 0.752 . . . . 52.32 111.502 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 38.2 tp -70.17 -31.31 68.73 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.57 -1.195 . . . . 72.349999999999994 110.824 177.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.87 -41.73 87.79 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.404 0.682 . . . . 62.25 110.435 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -80.85 -24.63 38.26 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.842 -0.617 . . . . 53.219999999999999 111.536 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.65 -49.06 79.04 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.728 -0.471 . . . . 70.230000000000004 109.728 168.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.404 HG22 HG21 ' A' ' 170' ' ' VAL . 76.3 t -67.29 -40.13 84.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.125 0.97 . . . . 64.219999999999999 110.588 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -63.94 -52.93 57.48 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.984 0.914 . . . . 71.310000000000002 111.312 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.453 ' CE1' HG11 ' A' ' 224' ' ' VAL . 26.9 t-80 -60.18 -47.79 84.47 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 115.054 -0.975 . . . . 63.229999999999997 109.086 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.464 ' HB3' ' HG ' ' A' ' 232' ' ' LEU . 7.9 m-70 -62.19 -29.6 70.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.337 0.655 . . . . 74.439999999999998 111.932 175.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 33.7 t -69.9 -26.15 64.03 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.157 0.583 . . . . 45.009999999999998 111.316 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.3 t -112.93 -11.3 13.43 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 115.902 1.815 . . . . 71.319999999999993 115.902 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 221' ' ' HIS . 24.1 m -92.47 139.4 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-N 120.982 1.719 . . . . 70.420000000000002 114.143 -171.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.38 -1.0 57.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.021 2.528 . . . . 65.409999999999997 112.295 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -79.22 15.87 1.1 Allowed 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 127.621 2.368 . . . . 74.219999999999999 112.009 -145.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 117.58 19.62 4.91 Favored Glycine 0 C--O 1.245 0.825 0 C-N-CA 125.028 1.299 . . . . 71.239999999999995 112.403 -172.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 52.0 mt -90.87 121.67 32.92 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.145 -1.028 . . . . 62.329999999999998 109.124 158.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 59.4 mt -53.0 -43.09 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 124.357 1.035 . . . . 71.129999999999995 110.307 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 12.1 t -133.14 142.77 48.84 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.428 -0.805 . . . . 73.219999999999999 109.172 171.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 41.6 p -70.14 145.39 51.59 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.684 -0.858 . . . . 61.100000000000001 108.684 166.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' A' ' 221' ' ' HIS . 21.2 mt -61.76 102.67 0.28 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.049 -0.723 . . . . 41.549999999999997 109.049 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 -87.1 -54.34 4.38 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.29 -0.633 . . . . 72.519999999999996 109.29 -171.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -157.58 150.12 17.97 Favored Pre-proline 0 N--CA 1.487 1.385 0 C-N-CA 123.503 0.721 . . . . 61.310000000000002 111.443 -177.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.99 145.55 45.2 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 121.903 1.735 . . . . 73.109999999999999 112.402 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.19 131.79 82.91 Favored Pre-proline 0 C--O 1.243 0.751 0 N-CA-C 109.199 -0.667 . . . . 72.540000000000006 109.199 173.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.1 147.45 54.37 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 121.874 1.716 . . . . 72.340000000000003 111.63 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.47 ' HA ' HD22 ' A' ' 159' ' ' LEU . 38.6 ttpt -69.69 158.45 35.34 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.296 -0.865 . . . . 75.319999999999993 109.344 171.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -38.43 -47.36 1.25 Allowed 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 125.275 1.43 . . . . 71.430000000000007 113.081 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -124.9 111.81 15.89 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 107.409 -1.33 . . . . 62.100000000000001 107.409 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -170.5 110.13 0.44 Allowed Pre-proline 0 N--CA 1.476 0.858 0 N-CA-C 108.558 -0.904 . . . . 73.329999999999998 108.558 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.51 137.27 18.28 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.444 2.096 . . . . 70.109999999999999 111.851 176.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 9.5 t -145.27 159.41 43.06 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.923 0.889 . . . . 74.209999999999994 110.305 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.8 p -143.75 117.65 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.173 0.989 . . . . 73.450000000000003 109.291 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -149.05 132.89 17.01 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.776 1.23 . . . . 72.430000000000007 108.745 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -148.0 147.42 18.05 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 111.334 -0.706 . . . . 70.0 111.334 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.89 146.91 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 123.633 0.773 . . . . 74.209999999999994 109.186 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 42.0 p -121.42 84.28 41.45 Favored Pre-proline 0 CA--C 1.555 1.167 0 C-N-CA 124.174 0.99 . . . . 72.129999999999995 108.634 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.79 95.27 1.07 Allowed 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 123.185 2.59 . . . . 75.340000000000003 112.137 -175.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.413 ' N ' HD22 ' A' ' 250' ' ' ASN . 0.8 OUTLIER -84.9 116.54 23.39 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.484 0.714 . . . . 75.340000000000003 110.392 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -134.37 141.95 47.03 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.723 0.809 . . . . 50.520000000000003 109.57 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -82.48 -61.68 1.82 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.996 -0.742 . . . . 62.409999999999997 108.996 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -177.63 79.29 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.446 1.098 . . . . 72.230000000000004 109.071 171.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -71.86 122.19 20.32 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.755 -0.657 . . . . 71.129999999999995 110.016 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--O 1.254 1.293 0 CA-C-O 118.748 -0.644 . . . . 74.540000000000006 109.432 -174.833 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.6 mmm . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.01 -0.737 . . . . 45.219999999999999 109.01 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.94 -130.01 1.25 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-O 118.791 -1.005 . . . . 71.129999999999995 110.646 -176.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 56.94 -1.76 0.05 Allowed 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 126.864 2.066 . . . . 75.109999999999999 115.692 176.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -100.74 115.07 65.77 Favored Pre-proline 0 N--CA 1.472 0.671 0 C-N-CA 123.485 0.714 . . . . 52.509999999999998 109.459 -175.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.4 -39.58 45.36 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 121.958 1.772 . . . . 71.230000000000004 110.83 169.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.6 -67.68 3.68 Favored Glycine 0 C--N 1.341 0.822 0 CA-C-N 115.487 -0.779 . . . . 63.240000000000002 113.443 169.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.506 ' HD3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -123.45 159.84 28.15 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.466 0.651 . . . . 71.530000000000001 112.235 -170.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.91 146.0 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 106.719 -1.585 . . . . 72.230000000000004 106.719 164.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.42 -173.11 4.1 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.578 0.351 . . . . 74.319999999999993 110.918 -172.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.88 24.57 29.63 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.995 -0.548 . . . . 53.229999999999997 111.773 -172.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -91.86 -167.9 1.89 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.391 1.076 . . . . 62.229999999999997 110.688 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -80.09 -161.05 0.32 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.003 0.921 . . . . 62.299999999999997 112.715 -170.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 72.4 mtp180 -44.96 133.33 6.4 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 124.545 1.138 . . . . 75.329999999999998 111.671 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 60.91 80.89 0.25 Allowed Pre-proline 0 N--CA 1.479 0.979 0 O-C-N 124.197 0.936 . . . . 64.409999999999997 109.037 -169.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.74 165.42 16.06 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.22 1.947 . . . . 64.040000000000006 111.828 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 54.3 m -68.24 168.04 13.14 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-O 121.547 0.689 . . . . 72.519999999999996 112.612 -171.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.4 mt -103.05 125.83 34.13 Favored Pre-proline 0 C--O 1.239 0.511 0 N-CA-C 108.041 -1.096 . . . . 73.319999999999993 108.041 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.525 ' HB2' ' HB3' ' A' ' 117' ' ' GLU . 39.2 Cg_endo -69.57 171.58 14.01 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 122.367 2.045 . . . . 64.430000000000007 113.602 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.29 140.07 31.11 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.178 0.591 . . . . 34.229999999999997 111.39 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.491 HD22 HD11 ' A' ' 23' ' ' ILE . 78.4 mt -88.65 91.99 9.02 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.078 -1.082 . . . . 74.209999999999994 108.078 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -98.99 -43.5 6.67 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.383 -0.826 . . . . 71.319999999999993 109.81 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -103.34 108.61 19.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.474 -0.785 . . . . 55.020000000000003 109.714 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.491 HD11 HD22 ' A' ' 20' ' ' LEU . 41.7 mm -118.05 121.32 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 107.566 -1.272 . . . . 73.420000000000002 107.566 172.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -132.05 159.08 39.85 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.592 0.757 . . . . 75.319999999999993 110.988 -176.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.71 -172.9 13.5 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 114.599 -1.182 . . . . 51.149999999999999 111.001 173.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 64.02 11.83 6.44 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.395 1.078 . . . . 73.209999999999994 113.204 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.62 124.57 7.62 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 109.953 -1.259 . . . . 51.530000000000001 109.953 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -169.4 -46.46 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 117.82 0.81 . . . . 73.140000000000001 111.158 -170.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 65.44 21.8 11.88 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.81 1.244 . . . . 75.310000000000002 110.475 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 50.89 28.26 3.63 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.126 0.97 . . . . 72.109999999999999 112.232 -172.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.9 t -75.07 -11.84 60.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.711 0.404 . . . . 63.399999999999999 110.652 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.5 p -64.66 82.56 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.853 0.861 . . . . 55.119999999999997 110.782 -179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -91.98 124.05 35.8 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 108.365 -0.976 . . . . 65.099999999999994 108.365 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -52.24 139.2 24.49 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 124.473 1.108 . . . . 71.230000000000004 112.883 -168.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.525 ' HA2' ' HE3' ' A' ' 124' ' ' LYS . . . -67.77 -86.21 0.09 OUTLIER Glycine 0 C--N 1.346 1.132 0 O-C-N 123.878 0.736 . . . . 62.350000000000001 113.331 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 150.69 175.98 23.19 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.426 -0.652 . . . . 75.409999999999997 112.273 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.85 97.63 0.4 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 123.523 2.815 . . . . 63.039999999999999 112.793 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -169.21 20.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.233 1.413 . . . . 72.430000000000007 109.075 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 61.7 m -72.12 110.64 6.73 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.428 1.091 . . . . 71.239999999999995 112.158 -167.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -79.21 75.41 5.76 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.761 0.791 . . . . 72.409999999999997 109.485 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.7 m -78.07 128.0 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 115.409 -0.814 . . . . 73.239999999999995 110.774 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -130.83 90.22 2.87 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.833 0.853 . . . . 72.510000000000005 108.993 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.7 m -99.45 123.44 52.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 109.42 -0.585 . . . . 70.439999999999998 109.42 172.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.59 141.86 32.87 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.768 -0.826 . . . . 75.120000000000005 108.768 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -92.22 7.76 41.16 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 122.886 0.474 . . . . 72.230000000000004 112.069 -171.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -75.54 83.49 2.59 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.289 -0.634 . . . . 61.119999999999997 109.289 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.68 96.48 2.25 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.933 0.893 . . . . 73.329999999999998 109.504 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.8 mt -99.21 108.9 21.6 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.104 -0.702 . . . . 74.310000000000002 109.104 -178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -73.73 89.06 1.77 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.448 0.699 . . . . 72.140000000000001 111.562 -174.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -72.98 -49.4 7.43 Favored Pre-proline 0 CA--C 1.562 1.442 0 CA-C-N 115.507 -0.769 . . . . 73.129999999999995 111.037 173.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.27 71.99 6.76 Favored 'Trans proline' 0 C--N 1.392 2.839 0 C-N-CA 121.763 1.642 . . . . 73.329999999999998 112.026 176.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.13 136.78 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 115.372 -0.831 . . . . 74.530000000000001 108.981 175.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.86 145.89 49.57 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.763 0.825 . . . . 72.430000000000007 110.191 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -103.46 90.96 3.85 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.071 -0.714 . . . . 72.209999999999994 109.071 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.85 110.61 15.38 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.164 -0.925 . . . . 53.219999999999999 111.237 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -68.06 145.6 54.29 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.606 0.762 . . . . 60.399999999999999 109.813 173.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 59.72 69.27 1.29 Allowed Pre-proline 0 CA--C 1.564 1.512 0 C-N-CA 123.829 0.851 . . . . 74.540000000000006 110.425 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -85.79 49.52 2.36 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 123.493 2.796 . . . . 64.219999999999999 112.413 -176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -60.85 135.01 57.65 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.63 0.772 . . . . 65.409999999999997 111.554 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.04 141.41 8.04 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.688 -0.965 . . . . 62.409999999999997 110.688 -172.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.9 mt -97.16 73.07 2.48 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.142 -0.688 . . . . 70.439999999999998 109.142 -177.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.3 t -74.28 141.19 45.32 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.752 -1.113 . . . . 72.129999999999995 110.956 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -154.72 154.09 32.32 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.893 0.877 . . . . 50.509999999999998 110.523 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.08 140.72 31.02 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.118 0.967 . . . . 71.349999999999994 109.66 177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -117.71 113.73 22.3 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.41 0.684 . . . . 64.230000000000004 110.666 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.6 74.33 2.77 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.989 0.916 . . . . 74.409999999999997 108.561 175.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -90.96 116.2 28.57 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.485 -0.78 . . . . 62.130000000000003 110.329 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -98.81 89.76 4.44 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.022 0.929 . . . . 71.420000000000002 109.202 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.0 p -142.85 95.22 2.74 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.013 -0.736 . . . . 64.200000000000003 109.013 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.0 tttm -79.18 140.53 37.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.254 1.021 . . . . 75.010000000000005 110.747 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -97.75 151.48 20.11 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 122.935 0.494 . . . . 74.120000000000005 110.104 172.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -73.11 144.86 46.82 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.774 -0.824 . . . . 71.150000000000006 108.774 174.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.08 88.65 0.17 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.367 0.667 . . . . 75.299999999999997 110.314 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.5 mt -80.57 138.44 36.48 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.545 0.738 . . . . 62.009999999999998 110.187 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.26 167.54 20.18 Favored 'General case' 0 C--O 1.242 0.669 0 O-C-N 123.804 0.69 . . . . 34.240000000000002 110.45 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.61 120.31 0.97 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-O 118.077 -1.402 . . . . 35.229999999999997 110.615 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.36 111.14 0.73 Allowed 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.081 2.521 . . . . 74.510000000000005 111.68 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.0 p -126.98 113.14 16.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.467 0.707 . . . . 72.510000000000005 111.51 -170.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -164.38 103.36 0.84 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 108.556 -0.905 . . . . 75.209999999999994 108.556 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -128.0 -51.38 1.33 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.615 0.766 . . . . 75.230000000000004 110.283 -177.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.2 142.74 41.36 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 124.165 0.986 . . . . 65.209999999999994 110.195 -170.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.03 -46.27 10.82 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.673 2.249 . . . . 64.019999999999996 111.322 176.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.458 ' HA ' ' HB2' ' A' ' 140' ' ' SER . 82.3 m-20 -87.76 66.67 8.91 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.686 0.755 . . . . 75.510000000000005 109.461 176.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.1 tp -92.32 125.84 37.15 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 108.168 -1.049 . . . . 74.439999999999998 108.168 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 4.5 m-85 -104.0 175.46 5.48 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.583 1.153 . . . . 74.530000000000001 109.556 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 p -145.04 141.34 22.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 108.779 -0.823 . . . . 61.219999999999999 108.779 171.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -77.93 108.7 11.38 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.082 -0.711 . . . . 64.329999999999998 109.082 173.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.54 -26.51 66.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.901 0.881 . . . . 71.420000000000002 111.212 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -126.98 155.89 42.44 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.961 0.904 . . . . 74.25 109.127 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -69.81 145.46 52.12 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.37 -0.832 . . . . 73.230000000000004 109.485 169.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -153.3 108.47 3.21 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.497 -0.927 . . . . 63.240000000000002 108.497 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 52.8 t -81.56 131.95 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.952 -1.129 . . . . 70.310000000000002 107.952 172.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.84 136.62 57.95 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.454 0.472 . . . . 72.109999999999999 110.896 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.5 t -62.31 -25.06 67.66 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.696 0.798 . . . . 52.409999999999997 109.824 172.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 155.51 -133.42 3.75 Favored Glycine 0 C--N 1.353 1.513 0 CA-C-N 115.557 -0.747 . . . . 34.229999999999997 112.305 172.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.06 -25.86 66.46 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.785 1.234 . . . . 65.230000000000004 111.926 -176.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -79.87 -11.28 59.82 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.381 1.072 . . . . 75.329999999999998 112.511 -177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.8 p -137.74 169.7 17.34 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.574 0.75 . . . . 31.210000000000001 111.441 -171.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.9 tp -115.65 134.72 54.76 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.933 0.893 . . . . 74.019999999999996 109.781 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.0 t -85.59 117.33 24.42 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.829 -0.804 . . . . 62.119999999999997 108.829 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.4 pt -119.51 131.94 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.648 0.779 . . . . 71.319999999999993 109.52 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.438 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 50.3 m -90.34 146.42 24.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.375 0.67 . . . . 72.209999999999994 110.111 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -52.94 112.95 0.94 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 122.84 0.456 . . . . 64.230000000000004 110.408 164.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 106.27 -13.12 44.17 Favored Glycine 0 N--CA 1.472 1.082 0 CA-C-N 116.701 -0.227 . . . . 32.409999999999997 112.901 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -76.67 126.96 31.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.183 0.993 . . . . 72.409999999999997 109.462 178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -90.2 133.03 35.16 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.157 0.583 . . . . 71.140000000000001 110.733 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 20.8 mt -116.71 150.0 38.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.911 0.884 . . . . 73.049999999999997 110.731 -161.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -102.58 109.02 20.5 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.642 -0.873 . . . . 54.32 108.642 169.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.6 t -87.66 106.25 16.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 108.571 -0.9 . . . . 55.219999999999999 108.571 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 76.2 mt -72.4 -31.49 65.58 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 115.375 -0.83 . . . . 55.310000000000002 109.441 176.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -176.31 -174.61 42.96 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.093 -0.958 . . . . 73.420000000000002 111.259 172.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.3 m-30 -113.31 174.08 6.09 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.539 0.736 . . . . 74.209999999999994 109.427 167.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -64.95 145.99 55.57 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.066 -1.087 . . . . 72.200000000000003 108.066 166.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -65.22 -29.91 70.76 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.355 0.662 . . . . 71.430000000000007 111.62 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -85.95 -5.98 59.14 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.633 0.773 . . . . 73.310000000000002 111.253 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.17 33.07 41.51 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.805 -0.634 . . . . 43.43 113.274 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 18' ' ' PRO . 29.8 mt-10 -89.34 -73.09 0.52 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.129 0.572 . . . . 64.439999999999998 110.117 -177.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -100.53 -178.87 3.93 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.69 0.796 . . . . 75.310000000000002 109.64 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -128.28 117.91 22.33 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.165 0.986 . . . . 73.540000000000006 108.854 -177.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.62 92.72 1.17 Allowed 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.555 -1.276 . . . . 72.450000000000003 107.555 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -112.24 164.08 13.62 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.873 0.844 . . . . 74.209999999999994 111.111 -171.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -151.67 138.74 19.14 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.522 -1.217 . . . . 74.25 108.254 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 43.4 p -132.21 175.93 8.83 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.633 0.773 . . . . 64.340000000000003 109.638 171.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.525 ' HE3' ' HA2' ' A' ' 35' ' ' GLY . 25.7 mtpp -70.53 -6.66 37.96 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 121.212 0.53 . . . . 74.230000000000004 110.168 174.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -89.33 -18.93 25.95 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 124.823 1.249 . . . . 73.230000000000004 111.217 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 154.91 -148.14 18.14 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 118.041 0.382 . . . . 75.420000000000002 113.034 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -151.15 157.25 42.47 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.44 0.62 . . . . 74.129999999999995 110.295 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 153.25 -171.17 32.18 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 122.966 0.317 . . . . 52.0 112.494 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -91.34 133.7 35.22 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.065 0.546 . . . . 51.210000000000001 110.53 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.31 156.19 72.9 Favored Pre-proline 0 N--CA 1.479 1.025 0 C-N-CA 124.484 1.114 . . . . 73.319999999999993 109.43 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.36 123.91 11.07 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.063 1.842 . . . . 42.439999999999998 110.92 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.4 m -59.41 -22.09 60.92 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.679 0.792 . . . . 75.310000000000002 111.47 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -73.33 -23.26 60.22 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.571 1.148 . . . . 72.219999999999999 111.719 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -94.58 -4.17 48.36 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.671 0.788 . . . . 71.219999999999999 112.393 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.4 pt -123.08 151.74 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 118.363 0.529 . . . . 73.420000000000002 110.397 -172.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.0 t -145.16 135.45 11.93 Favored Pre-proline 0 N--CA 1.48 1.031 0 C-N-CA 123.019 0.528 . . . . 53.219999999999999 109.639 174.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.567 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 59.3 Cg_endo -74.18 115.17 4.23 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.334 2.023 . . . . 72.530000000000001 111.938 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.1 m -87.64 -54.62 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.023 0.529 . . . . 74.420000000000002 111.028 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -80.97 -18.29 47.47 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.329 0.651 . . . . 73.519999999999996 111.308 -171.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.567 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 32.8 t -71.34 -179.87 2.63 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.609 0.763 . . . . 73.209999999999994 111.228 -179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 83.7 mt -62.51 -14.6 43.63 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.406 1.082 . . . . 63.020000000000003 113.266 -174.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -61.86 -25.55 67.6 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.979 0.512 . . . . 71.420000000000002 111.63 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.14 -26.53 62.79 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.286 1.034 . . . . 73.430000000000007 111.337 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -78.86 169.6 17.97 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.918 0.887 . . . . 71.140000000000001 111.764 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 73.5 p -84.58 -26.18 28.14 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.364 0.666 . . . . 43.43 112.097 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . 0.453 ' CE3' HG21 ' A' ' 218' ' ' VAL . 55.3 p-90 -83.89 -42.36 16.43 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.066 -0.515 . . . . 72.099999999999994 111.485 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -95.42 126.36 40.67 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.847 -0.797 . . . . 75.329999999999998 108.847 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -110.57 5.3 21.03 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.8 -0.637 . . . . 72.239999999999995 111.259 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.82 -155.09 36.58 Favored Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.475 -0.625 . . . . 74.040000000000006 113.418 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.75 106.07 1.77 Allowed 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 123.196 2.597 . . . . 53.310000000000002 110.408 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.3 t -128.39 150.54 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 123.631 0.773 . . . . 60.32 109.154 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 37.2 t -86.3 167.27 14.95 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.849 0.86 . . . . 52.439999999999998 110.066 173.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -63.71 -33.33 75.41 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.33 0.652 . . . . 73.420000000000002 111.903 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -67.52 -55.21 14.42 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.291 0.636 . . . . 44.140000000000001 110.284 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.42 -37.37 80.66 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 123.965 0.79 . . . . 74.519999999999996 111.226 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.54 -57.54 12.24 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.66 -0.7 . . . . 54.32 110.849 175.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -69.51 -21.12 63.69 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.359 -0.837 . . . . 70.239999999999995 111.118 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -68.22 -53.25 26.08 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.687 0.795 . . . . 75.420000000000002 110.591 174.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.439 ' HB2' HD11 ' A' ' 169' ' ' LEU . 74.6 mt -68.06 -37.33 81.18 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.946 -0.57 . . . . 75.349999999999994 110.957 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 26.8 tp -73.51 -22.48 60.11 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.381 -0.827 . . . . 71.329999999999998 111.349 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 37.9 t -59.76 -26.84 66.03 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.48 0.712 . . . . 61.030000000000001 111.787 177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 46.8 m -79.16 9.66 4.3 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.363 1.065 . . . . 62.539999999999999 112.246 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -108.04 159.24 14.46 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 122.98 0.324 . . . . 73.329999999999998 113.53 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 22.1 pt -115.57 -164.47 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.347 1.059 . . . . 65.329999999999998 109.859 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.699 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 17.4 p-10 -52.65 99.62 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.516 1.126 . . . . 52.530000000000001 113.142 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 107.85 13.71 19.31 Favored Glycine 0 C--N 1.355 1.632 0 CA-C-N 116.174 -0.466 . . . . 44.399999999999999 113.538 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 185' ' ' ARG . 37.9 p -79.0 137.45 37.59 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.998 -0.707 . . . . 74.400000000000006 109.98 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.492 ' CD2' ' HB3' ' A' ' 232' ' ' LEU . 27.1 p90 -134.08 160.7 36.97 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 112.452 0.538 . . . . 74.209999999999994 112.452 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 159' ' ' LEU . 82.4 mt -134.65 134.15 40.85 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.337 1.055 . . . . 32.539999999999999 108.292 166.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.401 HG21 HG22 ' A' ' 218' ' ' VAL . 32.3 t -106.14 128.45 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.113 -1.44 . . . . 64.319999999999993 107.113 171.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -158.43 161.11 37.45 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.908 0.483 . . . . 73.030000000000001 110.07 -174.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.701 ' HB3' ' HG2' ' A' ' 180' ' ' ARG . 12.5 pt-20 -109.21 161.62 15.06 Favored 'General case' 0 C--O 1.244 0.812 0 O-C-N 123.409 0.443 . . . . 62.130000000000003 109.806 169.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 176' ' ' SER . 16.2 m -83.41 135.53 34.66 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.627 -0.715 . . . . 70.319999999999993 109.395 177.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -71.19 -41.86 69.74 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.388 0.675 . . . . 50.420000000000002 110.213 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 25.0 m -78.57 -17.16 56.55 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.115 -0.948 . . . . 72.329999999999998 111.431 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 173' ' ' SER . 28.3 t -130.49 80.9 69.33 Favored Pre-proline 0 CA--C 1.548 0.892 0 N-CA-C 108.423 -0.954 . . . . 72.030000000000001 108.423 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.24 141.44 93.19 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.621 2.881 . . . . 53.140000000000001 112.837 -173.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 77.66 -23.07 2.55 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 116.208 -0.451 . . . . 31.41 114.071 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -84.25 116.38 22.94 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 108.177 -1.045 . . . . 72.129999999999995 108.177 177.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.701 ' HG2' ' HB3' ' A' ' 172' ' ' GLU . 44.5 mtt180 -110.88 169.78 8.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.168 -0.923 . . . . 75.329999999999998 111.209 -168.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.401 ' HB2' ' HD3' ' A' ' 194' ' ' ARG . 47.8 t -154.59 144.38 21.63 Favored 'General case' 0 C--O 1.253 1.244 0 C-N-CA 124.982 1.313 . . . . 74.409999999999997 108.722 -176.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.475 HD11 HD21 ' A' ' 217' ' ' LEU . 58.6 mt -109.33 135.38 48.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 107.221 -1.4 . . . . 74.450000000000003 107.221 166.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 168' ' ' PHE . 19.3 m -112.26 114.06 26.63 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.229 -1.026 . . . . 75.420000000000002 108.229 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 37.3 mt -105.14 144.31 32.11 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.107 0.963 . . . . 63.200000000000003 111.035 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.455 ' HB3' ' OG ' ' A' ' 167' ' ' SER . 27.1 ttt85 -132.74 133.27 43.26 Favored 'General case' 0 C--O 1.259 1.579 0 CA-C-N 114.357 -1.292 . . . . 74.010000000000005 108.895 175.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 28.2 p90 -148.1 138.83 23.06 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 124.616 1.198 . . . . 71.209999999999994 108.804 171.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 58.58 19.1 6.34 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.934 1.293 . . . . 75.310000000000002 113.534 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 78.62 21.1 69.95 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 116.626 -0.261 . . . . 71.420000000000002 112.814 -175.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -118.16 126.9 53.14 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.511 1.125 . . . . 64.439999999999998 108.553 176.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 51.4 t -119.04 141.88 36.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 124.13 0.972 . . . . 71.530000000000001 110.722 -168.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.485 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 18.2 p90 -145.19 151.13 37.94 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.507 1.123 . . . . 74.140000000000001 109.403 173.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -126.36 115.39 19.58 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 107.918 -1.141 . . . . 71.409999999999997 107.918 -173.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -117.46 132.63 56.52 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.637 -0.505 . . . . 64.409999999999997 109.637 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.401 ' HD3' ' HB2' ' A' ' 181' ' ' SER . 10.8 mmt85 -72.68 131.5 42.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.777 0.831 . . . . 73.310000000000002 112.07 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 82.0 mt -71.45 110.63 4.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 108.107 -1.071 . . . . 74.239999999999995 108.107 163.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -69.33 120.92 15.88 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.274 -0.875 . . . . 43.32 108.641 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.4 m -103.47 110.64 22.75 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 122.969 0.508 . . . . 63.329999999999998 109.804 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.402 ' HB2' ' HE1' ' A' ' 204' ' ' TYR . . . -61.38 156.53 18.82 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.959 0.904 . . . . 62.5 111.606 172.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 49.1 m -71.22 -12.47 61.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.707 0.803 . . . . 71.120000000000005 112.196 -178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -86.55 12.38 10.59 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.468 0.707 . . . . 72.019999999999996 111.16 171.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 75.05 4.91 74.1 Favored Glycine 0 C--N 1.352 1.457 0 C-N-CA 123.179 0.419 . . . . 72.409999999999997 113.266 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -81.64 140.06 34.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.605 0.762 . . . . 73.409999999999997 109.991 -175.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.519 HD13 HD13 ' A' ' 214' ' ' LEU . 85.8 mt -103.13 147.29 27.19 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.515 0.726 . . . . 65.0 109.481 -175.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.402 ' HE1' ' HB2' ' A' ' 198' ' ' ALA . 28.7 p90 -167.49 177.39 5.99 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.118 0.967 . . . . 73.400000000000006 110.819 173.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 74.9 t -131.3 -54.89 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 107.452 -1.314 . . . . 75.049999999999997 107.452 174.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 12.1 t -86.08 153.55 22.03 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.916 -1.038 . . . . 62.149999999999999 108.961 172.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.1 t -68.88 -25.58 64.68 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.728 0.411 . . . . 71.109999999999999 110.424 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.75 -34.13 62.45 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.568 -0.742 . . . . 73.540000000000006 110.492 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.455 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 74.8 m -64.32 126.32 27.4 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.528 0.731 . . . . 62.350000000000001 109.28 172.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -144.65 112.56 6.32 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.202 1.001 . . . . 74.150000000000006 108.645 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 209' ' ' SER . 17.4 m-85 -129.66 142.76 50.67 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-N 118.683 0.674 . . . . 74.519999999999996 111.315 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -90.58 -22.51 21.22 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.382 0.673 . . . . 74.409999999999997 109.66 172.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 73.0 p -129.87 147.02 51.59 Favored 'General case' 0 C--O 1.253 1.272 0 CA-C-O 122.182 0.992 . . . . 71.109999999999999 111.459 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.519 HD13 HD13 ' A' ' 203' ' ' LEU . 27.1 tp -67.23 -29.02 68.56 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 114.047 -1.433 . . . . 54.420000000000002 110.841 177.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.46 90.51 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.487 0.715 . . . . 72.540000000000006 111.029 175.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -66.53 -37.98 86.19 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.545 -0.752 . . . . 64.230000000000004 110.762 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.475 HD21 HD11 ' A' ' 182' ' ' ILE . 9.2 tt -55.64 -47.53 76.5 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.885 0.74 . . . . 74.109999999999999 111.486 174.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.453 HG21 ' CE3' ' A' ' 146' ' ' TRP . 70.4 t -70.53 -44.04 77.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 123.262 0.625 . . . . 53.439999999999998 111.263 -175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -59.72 -49.63 76.98 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.632 0.73 . . . . 71.099999999999994 110.577 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -56.6 -56.47 20.88 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.961 -1.018 . . . . 72.439999999999998 109.684 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.446 ' HA ' HG22 ' A' ' 224' ' ' VAL . 36.0 m80 -67.32 -16.74 64.43 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.168 0.433 . . . . 73.340000000000003 112.168 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.434 ' HA ' ' HB2' ' A' ' 232' ' ' LEU . 35.9 t -73.59 -31.57 63.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 122.555 0.342 . . . . 73.430000000000007 111.047 172.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 14.6 t -112.04 -6.62 14.17 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.27 1.952 . . . . 64.430000000000007 116.27 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.446 HG22 ' HA ' ' A' ' 221' ' ' HIS . 33.8 m -104.21 158.4 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 116.199 1.925 . . . . 64.450000000000003 116.199 -171.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -90.89 -0.99 57.88 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 129.25 3.02 . . . . 54.0 113.543 -175.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -77.9 14.98 0.95 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 128.734 2.814 . . . . 71.409999999999997 113.766 -141.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.77 18.78 3.87 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 124.571 1.081 . . . . 42.32 111.817 -168.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.91 135.37 33.78 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.957 0.903 . . . . 73.239999999999995 110.555 167.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.485 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 85.8 mt -72.96 -34.86 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 109.321 -0.622 . . . . 72.420000000000002 109.321 171.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 7.8 t -143.25 142.24 31.31 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.59 -0.893 . . . . 73.219999999999999 108.59 168.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 224' ' ' VAL . 67.8 p -67.92 147.48 52.43 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.802 -0.814 . . . . 73.209999999999994 108.802 171.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.492 ' HB3' ' CD2' ' A' ' 168' ' ' PHE . 28.6 mt -62.68 99.91 0.17 Allowed 'General case' 0 CA--C 1.555 1.147 0 N-CA-C 108.89 -0.781 . . . . 64.129999999999995 108.89 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -81.8 -50.93 8.66 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.702 0.401 . . . . 72.209999999999994 110.277 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -156.76 148.37 17.1 Favored Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 120.689 -0.405 . . . . 74.010000000000005 110.191 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.05 138.78 20.96 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 121.843 1.696 . . . . 64.310000000000002 111.97 176.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . 0.426 ' HB3' HD21 ' A' ' 169' ' ' LEU . . . -67.67 140.63 94.53 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 108.793 -0.817 . . . . 72.5 108.793 171.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.77 156.4 64.23 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.833 2.356 . . . . 64.439999999999998 114.67 -164.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -72.18 159.9 33.34 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.567 -1.197 . . . . 72.099999999999994 109.898 170.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 43.6 ttt180 -53.46 -39.6 64.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 123.674 0.609 . . . . 71.329999999999998 111.058 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -120.25 119.82 34.3 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.366 -0.976 . . . . 73.230000000000004 108.366 169.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -87.09 107.77 15.96 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.646 -0.872 . . . . 74.319999999999993 108.646 171.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -88.57 14.57 2.26 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.727 2.284 . . . . 74.129999999999995 112.674 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 9.1 t -154.02 151.04 28.89 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.729 0.812 . . . . 74.400000000000006 110.561 -176.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.83 105.66 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 125.291 1.436 . . . . 74.510000000000005 107.853 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -159.84 145.58 15.64 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.275 0.63 . . . . 73.5 110.036 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -169.53 116.75 0.67 Allowed Glycine 0 C--N 1.348 1.209 0 N-CA-C 112.151 -0.38 . . . . 62.229999999999997 112.151 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 80.6 t -117.58 132.36 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.613 1.165 . . . . 64.049999999999997 108.322 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.1 t -103.71 95.82 8.06 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 123.511 0.724 . . . . 64.329999999999998 109.931 176.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.03 122.15 2.17 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.069 2.512 . . . . 62.399999999999999 111.594 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.418 ' N ' HD22 ' A' ' 250' ' ' ASN . 0.9 OUTLIER -98.65 139.35 34.48 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.25 0.62 . . . . 72.200000000000003 109.432 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -137.39 103.06 4.97 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.858 0.863 . . . . 74.219999999999999 109.538 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -81.88 166.46 19.91 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.999 0.52 . . . . 73.420000000000002 109.753 170.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -156.69 141.75 17.21 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.743 0.417 . . . . 72.349999999999994 110.158 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -84.35 167.21 16.74 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.095 0.958 . . . . 73.129999999999995 111.527 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.247 0.965 0 N-CA-C 107.587 -1.264 . . . . 75.219999999999999 107.587 177.95 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mmm . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 109.19 -0.67 . . . . 70.310000000000002 109.19 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.13 120.57 6.57 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 116.004 -0.544 . . . . 70.310000000000002 112.443 -174.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.576 ' HB2' ' HG3' ' A' ' 194' ' ' ARG . 63.0 mt-30 -132.32 152.9 51.2 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.525 0.73 . . . . 72.129999999999995 109.078 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -132.2 91.31 32.16 Favored Pre-proline 0 N--CA 1.482 1.125 0 N-CA-C 108.704 -0.85 . . . . 73.430000000000007 108.704 173.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.64 -37.71 86.21 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 123.029 2.486 . . . . 64.25 112.549 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.5 138.75 2.53 Favored Glycine 0 C--O 1.245 0.813 0 CA-C-N 115.039 -0.982 . . . . 40.539999999999999 111.374 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -69.76 119.27 13.74 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 109.159 -0.682 . . . . 71.129999999999995 109.159 174.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.614 HG13 ' HB3' ' A' ' 152' ' ' SER . 8.3 p -138.93 160.78 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 N-CA-C 108.427 -0.953 . . . . 72.510000000000005 108.427 -173.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 tt -163.21 101.64 0.96 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 107.565 -1.272 . . . . 74.439999999999998 107.565 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.35 -2.16 26.22 Favored Glycine 0 N--CA 1.473 1.127 0 O-C-N 123.457 0.473 . . . . 44.130000000000003 113.671 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -82.66 91.97 7.08 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.865 0.84 . . . . 71.299999999999997 110.228 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -141.78 163.56 32.56 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.12 0.968 . . . . 75.310000000000002 108.747 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.499 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 40.7 ttm180 -80.61 108.47 14.28 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.61 -1.256 . . . . 73.010000000000005 107.61 167.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 53.06 78.63 0.38 Allowed Pre-proline 0 CA--C 1.545 0.754 0 O-C-N 124.001 0.813 . . . . 73.329999999999998 111.739 -167.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.692 ' HG2' ' HB3' ' A' ' 133' ' ' ASN . 4.7 Cg_exo -75.76 165.39 30.27 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 122.764 2.31 . . . . 73.420000000000002 110.369 172.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.7 p -70.98 169.16 15.48 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.312 0.577 . . . . 65.430000000000007 111.116 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 94.6 mt -104.98 131.65 21.59 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 115.884 -0.598 . . . . 64.140000000000001 109.432 -176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 17' ' ' LEU . 8.2 Cg_exo -69.13 171.83 13.08 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.102 2.535 . . . . 52.039999999999999 112.267 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HB3' ' NE2' ' A' ' 21' ' ' HIS . . . -85.56 149.15 25.56 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.867 0.467 . . . . 74.099999999999994 110.401 170.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.576 HD22 HD11 ' A' ' 23' ' ' ILE . 84.8 mt -86.05 94.2 9.18 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.938 -1.134 . . . . 53.409999999999997 107.938 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.406 ' NE2' ' HB3' ' A' ' 19' ' ' ALA . 29.3 m170 -97.31 -52.9 3.65 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.632 0.373 . . . . 64.019999999999996 110.948 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -105.16 102.87 12.33 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.925 -1.139 . . . . 74.040000000000006 107.925 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.576 HD11 HD22 ' A' ' 20' ' ' LEU . 48.0 mm -126.1 111.57 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.923 -0.769 . . . . 60.25 108.923 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.82 -54.17 0.01 OUTLIER 'General case' 0 C--O 1.247 0.934 0 O-C-N 124.352 1.033 . . . . 54.439999999999998 108.714 173.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 52.93 -159.59 3.39 Favored Glycine 0 C--N 1.355 1.605 0 CA-C-O 118.852 -0.971 . . . . 51.340000000000003 113.423 -173.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 42.76 81.32 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.7 1.2 . . . . 52.409999999999997 113.252 171.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.4 -35.83 0.02 OUTLIER Glycine 0 N--CA 1.467 0.732 0 O-C-N 123.161 0.288 . . . . 61.210000000000001 112.604 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.41 175.37 10.67 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.918 0.487 . . . . 61.539999999999999 110.725 177.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 40.2 ptt85 -52.7 122.16 8.55 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.725 0.81 . . . . 64.409999999999997 111.723 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.84 127.79 33.7 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.858 0.863 . . . . 72.030000000000001 110.404 -174.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.3 p -56.41 -52.53 64.27 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.345 1.058 . . . . 72.430000000000007 111.889 -174.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.2 t -120.99 109.48 15.11 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.92 -1.141 . . . . 74.400000000000006 107.92 173.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.57 ' HD2' ' HA ' ' A' ' 72' ' ' ASN . 26.3 ptt180 -117.82 -179.6 3.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.336 0.654 . . . . 60.149999999999999 109.942 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -89.99 163.27 15.0 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.02 0.528 . . . . 75.329999999999998 110.886 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 159.41 153.51 6.88 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 111.061 -0.816 . . . . 73.540000000000006 111.061 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.6 -55.66 0.46 Allowed Glycine 0 CA--C 1.537 1.451 0 CA-C-O 118.16 -1.356 . . . . 75.340000000000003 113.588 -175.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.84 102.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.387 2.593 0 C-N-CA 123.69 2.927 . . . . 72.340000000000003 113.644 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -139.72 166.01 25.75 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.549 1.14 . . . . 74.530000000000001 109.963 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 63.2 m -122.04 93.67 4.06 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.041 0.936 . . . . 74.129999999999995 109.869 -177.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -164.64 160.36 19.96 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.333 0.653 . . . . 72.519999999999996 110.271 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.3 137.71 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.089 0.956 . . . . 73.25 109.102 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -118.51 100.13 7.25 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 108.157 -1.053 . . . . 75.040000000000006 108.157 173.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m -64.08 136.22 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.434 0.693 . . . . 62.530000000000001 111.238 -178.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -80.01 132.61 36.04 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 115.545 -0.752 . . . . 74.239999999999995 110.201 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -124.8 77.31 1.59 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.796 -1.187 . . . . 74.010000000000005 107.796 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -72.83 142.75 48.0 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.989 -0.551 . . . . 72.120000000000005 112.044 -176.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.94 -49.36 10.38 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.935 -0.575 . . . . 73.129999999999995 109.645 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.5 mt 59.29 -71.82 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.326 1.851 . . . . 72.310000000000002 112.005 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -66.79 170.35 6.65 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.673 1.189 . . . . 75.540000000000006 111.059 176.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -120.0 90.74 44.65 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.177 0.591 . . . . 73.340000000000003 110.54 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -87.14 130.43 2.95 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.343 2.028 . . . . 73.450000000000003 111.608 168.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.06 -40.55 81.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 N-CA-C 109.187 -0.671 . . . . 64.310000000000002 109.187 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.54 89.91 0.53 Allowed 'General case' 0 C--N 1.351 0.641 0 CA-C-N 115.131 -0.94 . . . . 61.539999999999999 109.863 172.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.2 t -134.82 -1.85 2.69 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.095 1.358 . . . . 53.439999999999998 108.663 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -86.3 -10.67 54.05 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.655 1.582 . . . . 74.099999999999994 111.784 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -71.64 75.36 0.82 Allowed 'General case' 0 CA--C 1.555 1.145 0 CA-C-O 121.914 0.864 . . . . 75.319999999999993 111.608 -175.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 56.63 69.39 1.77 Allowed Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 125.265 1.426 . . . . 50.119999999999997 111.136 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.61 -14.58 27.42 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.348 2.032 . . . . 64.519999999999996 113.344 -175.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -116.63 106.59 13.71 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.12 0.968 . . . . 61.439999999999998 108.931 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.26 13.75 0.07 OUTLIER Glycine 0 C--N 1.349 1.273 0 O-C-N 123.447 0.467 . . . . 54.350000000000001 113.733 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 93.7 mt -129.55 137.55 50.83 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.022 0.929 . . . . 73.030000000000001 109.749 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.2 t -147.03 169.23 19.66 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.898 0.879 . . . . 73.329999999999998 108.997 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.45 170.88 19.65 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.306 0.642 . . . . 73.230000000000004 110.82 -178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -163.53 123.75 2.2 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.531 0.732 . . . . 43.229999999999997 110.686 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -166.95 146.82 5.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.183 0.993 . . . . 72.349999999999994 109.454 172.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -139.29 119.38 13.54 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.517 -0.92 . . . . 71.299999999999997 108.517 177.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -133.06 93.6 3.21 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.328 -1.36 . . . . 71.430000000000007 107.328 170.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -81.1 153.9 27.08 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.707 -0.679 . . . . 75.129999999999995 110.773 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.4 p -68.2 135.23 51.72 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.154 -0.684 . . . . 74.230000000000004 109.154 170.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -59.04 -63.39 1.32 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.389 0.676 . . . . 62.240000000000002 110.531 -177.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -173.68 176.17 2.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.616 0.766 . . . . 65.209999999999994 109.031 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.57 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 3.2 p-10 -63.89 145.9 54.98 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.009 0.523 . . . . 74.549999999999997 110.472 172.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.3 mt -121.77 -66.94 1.0 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.303 -0.999 . . . . 62.140000000000001 108.303 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.4 mt -139.73 140.94 36.9 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.947 0.899 . . . . 74.010000000000005 109.716 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.0 -178.97 6.75 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.318 1.047 . . . . 34.520000000000003 111.781 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.09 145.17 16.32 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.773 -1.015 . . . . 52.329999999999998 111.094 176.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.97 81.09 0.9 Allowed 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.061 2.508 . . . . 71.450000000000003 112.083 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.437 ' O ' ' HD3' ' A' ' 108' ' ' ARG . 29.2 t -65.84 109.23 2.41 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.597 1.159 . . . . 70.450000000000003 110.325 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 80' ' ' ASN . 9.2 pt-20 -63.18 -56.31 17.73 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.667 0.787 . . . . 62.219999999999999 112.313 -176.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.444 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 60.8 m-80 -141.94 131.28 23.61 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.794 0.837 . . . . 51.310000000000002 109.039 -171.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -164.4 145.38 6.62 Favored Pre-proline 0 N--CA 1.475 0.823 0 N-CA-C 107.641 -1.244 . . . . 72.099999999999994 107.641 -173.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -56.72 75.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.594 2.863 . . . . 63.530000000000001 114.32 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.69 22.2 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.287 1.835 . . . . 74.319999999999993 109.24 176.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.5 tp -85.3 132.84 34.19 Favored 'General case' 0 C--N 1.359 1.007 0 CA-C-O 121.017 0.437 . . . . 75.129999999999995 109.894 -178.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 14.3 m-85 -106.65 173.9 6.12 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.191 1.396 . . . . 64.120000000000005 110.086 177.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.49 145.96 25.06 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 107.925 -1.139 . . . . 71.400000000000006 107.925 171.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 102' ' ' THR . . . -74.95 117.93 17.34 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 123.039 0.212 . . . . 70.439999999999998 110.606 177.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.3 mt -65.41 -33.69 76.53 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.222 1.009 . . . . 55.0 111.556 171.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.499 ' OH ' ' HA ' ' A' ' 13' ' ' ARG . 75.6 m-85 -140.35 159.0 43.16 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.172 0.589 . . . . 74.439999999999998 109.418 -175.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -74.7 152.19 39.15 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.107 -0.701 . . . . 75.230000000000004 109.107 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -156.04 115.93 3.63 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.602 0.761 . . . . 72.439999999999998 109.1 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.7 t -82.72 133.21 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.339 -0.985 . . . . 71.109999999999999 108.339 170.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.69 134.63 52.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.811 0.444 . . . . 73.150000000000006 110.91 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.9 m -67.59 -20.94 65.43 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.943 0.897 . . . . 73.219999999999999 111.391 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.35 -165.65 38.27 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.69 -0.686 . . . . 34.340000000000003 112.008 177.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -52.3 -38.77 59.34 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.7 1.2 . . . . 51.340000000000003 112.852 -179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.457 HD21 HD13 ' A' ' 20' ' ' LEU . 31.3 p-10 -72.19 -24.71 61.46 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.178 0.991 . . . . 74.049999999999997 112.69 -175.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 p -104.23 157.75 16.92 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.301 0.641 . . . . 53.509999999999998 110.022 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.468 ' HB3' HG13 ' A' ' 130' ' ' VAL . 64.2 tp -110.55 132.74 53.93 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.797 -0.638 . . . . 71.430000000000007 109.808 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.2 t -80.16 136.54 36.53 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.36 -0.608 . . . . 74.140000000000001 109.36 173.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 28.6 pt -137.89 144.55 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.484 0.713 . . . . 62.219999999999999 109.652 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 9.3 m -105.65 143.91 33.13 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 109.231 -0.655 . . . . 74.400000000000006 109.231 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -56.38 111.91 1.11 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 118.536 0.607 . . . . 62.450000000000003 111.046 174.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.13 1.8 35.91 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 116.707 -0.224 . . . . 41.409999999999997 113.254 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.552 ' HG3' ' HE2' ' A' ' 124' ' ' LYS . 36.5 tt0 -85.66 137.64 32.7 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.029 0.931 . . . . 64.340000000000003 110.511 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -76.4 119.14 19.85 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.603 0.761 . . . . 75.420000000000002 110.338 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.658 ' HA ' HG22 ' A' ' 123' ' ' THR . 11.4 mt -112.43 123.68 50.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.405 -0.961 . . . . 72.329999999999998 108.405 -173.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 78' ' ' SER . 71.8 mtt180 -95.6 106.76 18.89 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 107.769 -1.197 . . . . 73.040000000000006 107.769 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 67.1 t -99.66 114.55 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 109.229 -0.656 . . . . 61.130000000000003 109.229 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.38 -34.77 68.18 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.62 0.768 . . . . 71.540000000000006 109.934 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 178.35 167.09 35.69 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 114.783 -1.098 . . . . 54.210000000000001 111.422 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 119' ' ' ALA . 3.0 m-30 -97.5 175.0 6.38 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.781 0.8 . . . . 74.239999999999995 110.063 177.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -75.13 147.1 40.8 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 114.411 -1.268 . . . . 73.319999999999993 108.304 169.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -60.08 -37.17 79.12 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.7 0.8 . . . . 75.319999999999993 112.328 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -92.92 7.52 43.6 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 121.07 0.462 . . . . 72.239999999999995 110.94 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 174' ' ' GLU . . . 70.91 27.96 71.4 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 116.079 -0.51 . . . . 72.019999999999996 113.898 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -68.41 -70.72 0.25 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 122.126 0.965 . . . . 74.329999999999998 110.245 178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -131.04 -178.58 4.88 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.57 1.148 . . . . 73.010000000000005 108.859 -172.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 112' ' ' TYR . . . -138.48 122.22 17.56 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.973 0.509 . . . . 64.439999999999998 109.99 -175.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -72.23 96.84 1.87 Allowed 'General case' 0 C--O 1.245 0.839 0 CA-C-O 121.648 0.737 . . . . 70.120000000000005 109.816 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -109.68 165.69 11.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.709 -1.132 . . . . 65.5 111.097 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -140.75 118.65 11.8 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.608 -1.256 . . . . 74.120000000000005 107.608 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.658 HG22 ' HA ' ' A' ' 107' ' ' LEU . 71.7 p -132.05 -172.28 2.84 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.58 0.705 . . . . 73.530000000000001 111.123 -176.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.552 ' HE2' ' HG3' ' A' ' 105' ' ' GLU . 40.0 mtmt -57.44 -30.52 65.07 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 114.242 -1.344 . . . . 74.409999999999997 110.862 170.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -85.51 3.25 41.28 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.07 0.948 . . . . 75.430000000000007 111.759 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 118.97 -127.38 7.2 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 122.21 -0.306 . . . . 73.129999999999995 112.835 173.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -151.97 140.99 21.18 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.57 0.748 . . . . 54.130000000000003 110.384 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 167.72 -171.77 42.33 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.143 0.277 . . . . 51.100000000000001 112.446 176.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -88.57 125.24 34.7 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.113 0.565 . . . . 74.299999999999997 111.216 -175.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 99' ' ' LEU . 30.8 m -120.62 152.26 55.36 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 124.724 1.21 . . . . 52.310000000000002 110.098 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.64 129.14 13.28 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 121.654 1.569 . . . . 75.310000000000002 111.347 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 43.8 t -57.74 -27.14 62.74 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.648 0.779 . . . . 53.5 111.799 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.692 ' HB3' ' HG2' ' A' ' 15' ' ' PRO . 47.3 m-20 -67.87 -21.25 65.17 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.312 1.045 . . . . 72.120000000000005 112.191 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -107.06 8.52 30.34 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.613 0.765 . . . . 75.420000000000002 111.681 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.5 pt -128.26 155.2 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 CA-C-N 118.545 0.611 . . . . 75.219999999999999 109.958 -176.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 14.3 t -150.36 134.97 9.53 Favored Pre-proline 0 N--CA 1.495 1.779 0 C-N-CA 122.849 0.459 . . . . 73.25 110.175 175.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.587 ' HB2' ' HB3' ' A' ' 140' ' ' SER . 74.4 Cg_endo -76.21 117.46 4.64 Favored 'Trans proline' 0 C--N 1.373 1.833 0 C-N-CA 122.879 2.386 . . . . 64.510000000000005 114.282 -176.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.7 m -90.29 -49.7 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 122.841 0.457 . . . . 51.43 111.618 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -94.36 6.36 48.94 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.114 0.483 . . . . 75.319999999999993 111.405 -173.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.587 ' HB3' ' HB2' ' A' ' 137' ' ' PRO . 25.0 t -83.59 -178.69 7.11 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.126 0.489 . . . . 65.340000000000003 109.807 173.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 62.4 mt -63.16 -13.79 41.13 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.235 1.014 . . . . 44.219999999999999 112.644 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.555 ' HG3' ' HA ' ' A' ' 148' ' ' HIS . 36.5 tt0 -58.75 -24.59 61.88 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.856 0.862 . . . . 72.310000000000002 112.519 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.2 -25.3 66.95 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 123.469 0.708 . . . . 71.109999999999999 110.837 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -79.57 148.33 31.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.718 0.807 . . . . 74.219999999999999 110.705 170.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.6 p -65.72 -22.65 66.63 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.924 0.713 . . . . 74.099999999999994 112.924 -175.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 59.5 p-90 -81.6 -46.48 14.35 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.965 0.506 . . . . 65.340000000000003 112.32 -178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' A' ' 170' ' ' VAL . 30.5 t80 -88.37 137.37 32.39 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.441 -0.578 . . . . 72.040000000000006 109.441 -177.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.555 ' HA ' ' HG3' ' A' ' 142' ' ' GLU . 25.0 m-70 -130.45 26.82 5.07 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 111.97 0.359 . . . . 72.099999999999994 111.97 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.93 -154.63 46.39 Favored Glycine 0 CA--C 1.54 1.644 0 N-CA-C 114.766 0.667 . . . . 71.530000000000001 114.766 171.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.469 ' HG3' ' OH ' ' A' ' 112' ' ' TYR . 72.2 Cg_endo -75.03 108.62 2.76 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 123.478 2.785 . . . . 64.230000000000004 111.901 174.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.481 HG13 ' HD3' ' A' ' 171' ' ' ARG . 1.6 p -155.23 138.5 7.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 115.493 -0.776 . . . . 43.130000000000003 109.659 -177.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.614 ' HB3' HG13 ' A' ' 8' ' ' VAL . 10.3 p -80.83 170.74 15.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.999 0.74 . . . . 51.43 112.999 -174.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -63.41 -27.62 69.42 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 114.94 -1.027 . . . . 65.400000000000006 112.694 -169.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -68.54 -57.33 5.94 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.552 0.741 . . . . 74.540000000000006 110.072 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -65.12 -36.62 84.85 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.338 0.655 . . . . 64.239999999999995 110.695 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.432 ' HA ' ' NH1' ' A' ' 171' ' ' ARG . . . -53.26 -52.25 59.61 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.824 -1.08 . . . . 73.239999999999995 112.03 171.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.547 ' HG3' HG11 ' A' ' 190' ' ' VAL . 29.7 tt0 -76.9 -19.65 57.17 Favored 'General case' 0 C--O 1.212 -0.871 0 CA-C-N 114.856 -1.065 . . . . 74.140000000000001 110.71 -175.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -67.53 -51.16 54.19 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.873 0.469 . . . . 55.310000000000002 109.974 172.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.641 HD21 ' HG3' ' A' ' 239' ' ' ARG . 82.7 mt -64.93 -42.16 94.91 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.864 -0.607 . . . . 70.450000000000003 110.965 178.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.653 HD23 HG13 ' A' ' 190' ' ' VAL . 32.4 tp -71.77 -28.8 63.88 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.214 -0.903 . . . . 62.229999999999997 112.024 -177.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.5 t -57.03 -40.13 76.14 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.641 0.776 . . . . 61.109999999999999 110.327 178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.45 ' HB2' ' HG2' ' A' ' 237' ' ' PRO . 10.5 m -81.93 -0.21 42.83 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 114.636 -1.166 . . . . 64.310000000000002 111.585 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -93.23 154.53 21.89 Favored Glycine 0 C--N 1.349 1.271 0 C-N-CA 123.068 0.366 . . . . 74.420000000000002 113.055 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 20.5 pt -103.76 -167.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 123.798 0.839 . . . . 72.040000000000006 112.13 -173.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.664 ' HA ' ' HA ' ' A' ' 186' ' ' TYR . 16.3 p-10 -59.52 103.94 0.23 Allowed 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.008 0.923 . . . . 72.010000000000005 113.486 -171.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 103.82 13.25 28.08 Favored Glycine 0 C--O 1.26 1.768 0 CA-C-N 116.288 -0.414 . . . . 73.120000000000005 112.847 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 234' ' ' TYR . 22.6 t -71.72 136.73 47.31 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-O 119.227 -0.416 . . . . 74.230000000000004 110.132 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 183' ' ' SER . 21.6 p90 -135.22 156.35 49.13 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.932 0.716 . . . . 71.120000000000005 112.932 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.581 HD22 HH21 ' A' ' 171' ' ' ARG . 84.0 mt -140.01 132.84 29.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.419 -1.264 . . . . 74.420000000000002 108.184 171.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 147' ' ' TYR . 23.0 t -110.07 130.73 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 107.613 -1.255 . . . . 73.150000000000006 107.613 172.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.593 HH22 HD12 ' A' ' 159' ' ' LEU . 11.9 ptp180 -163.38 164.66 24.59 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.165 0.586 . . . . 74.219999999999999 110.206 -174.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 180' ' ' ARG . 16.1 pt-20 -111.48 156.93 20.93 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.568 0.347 . . . . 75.329999999999998 110.068 175.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.2 t -75.06 139.1 42.59 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 116.065 -0.516 . . . . 72.25 110.582 -178.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.418 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 94.4 mt-10 -65.51 -42.43 92.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.941 0.497 . . . . 72.319999999999993 110.01 172.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 54.7 p -77.75 -21.97 51.0 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.106 0.962 . . . . 74.209999999999994 111.852 -176.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 36.9 t -140.03 79.89 21.53 Favored Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 109.33 -0.618 . . . . 51.140000000000001 109.33 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -71.43 148.08 53.71 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 123.028 2.485 . . . . 74.349999999999994 111.675 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 88.43 -25.03 9.83 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-N 115.414 -0.812 . . . . 51.210000000000001 111.843 -170.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -90.46 118.07 29.65 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 108.687 -0.857 . . . . 63.439999999999998 108.687 168.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.57 ' HA ' ' HA ' ' A' ' 172' ' ' GLU . 61.2 mtt180 -103.44 172.41 6.82 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 114.7 -1.136 . . . . 44.109999999999999 110.252 -177.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.5 m -155.96 140.18 16.56 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.512 1.125 . . . . 70.409999999999997 108.462 -169.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.446 HD11 ' CD2' ' A' ' 217' ' ' LEU . 53.1 mt -112.78 137.98 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.243 -1.021 . . . . 71.409999999999997 108.243 167.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.599 ' HB3' HD22 ' A' ' 160' ' ' LEU . 17.0 m -117.19 112.58 21.03 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.283 1.433 . . . . 72.329999999999998 107.735 -175.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.414 HD12 ' HE2' ' A' ' 193' ' ' TYR . 42.1 mt -110.62 139.46 45.87 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.138 0.975 . . . . 74.319999999999993 111.459 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 189' ' ' ARG . 45.4 ttt-85 -129.0 134.92 48.34 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 115.649 -0.705 . . . . 75.510000000000005 109.726 171.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 165' ' ' ASN . 12.2 p90 -153.19 139.85 18.88 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 124.67 1.231 . . . . 72.129999999999995 107.823 175.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 54.66 23.11 4.48 Favored 'General case' 0 N--CA 1.499 2.014 0 C-N-CA 125.026 1.33 . . . . 73.510000000000005 114.233 176.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.56 6.22 73.82 Favored Glycine 0 N--CA 1.475 1.282 0 O-C-N 122.206 -0.309 . . . . 75.319999999999993 113.189 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 185' ' ' ARG . 15.7 tpp180 -101.03 124.47 46.81 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.218 1.007 . . . . 72.310000000000002 108.746 177.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.653 HG13 HD23 ' A' ' 160' ' ' LEU . 97.0 t -106.85 133.52 51.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.64 1.176 . . . . 73.420000000000002 108.624 174.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.478 ' OH ' ' HB ' ' A' ' 229' ' ' ILE . 27.4 p90 -146.3 155.7 42.83 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.238 0.615 . . . . 74.329999999999998 109.986 169.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -134.66 122.22 21.95 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 107.842 -1.17 . . . . 74.510000000000005 107.842 -174.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.414 ' HE2' HD12 ' A' ' 184' ' ' LEU . 37.1 p90 -119.19 155.11 32.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.026 0.53 . . . . 71.420000000000002 109.917 176.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.576 ' HG3' ' HB2' ' A' ' 3' ' ' GLN . 35.0 mmt180 -99.72 135.0 41.8 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.15 0.5 . . . . 75.25 111.381 -169.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 180' ' ' ARG . 71.3 mt -82.74 111.79 19.58 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 CA-C-N 114.932 -1.031 . . . . 74.129999999999995 108.607 167.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -81.04 130.99 35.28 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.49 0.716 . . . . 73.409999999999997 109.185 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 48.1 m -97.31 125.55 41.96 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.323 0.649 . . . . 44.240000000000002 110.202 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.56 178.54 6.58 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.48 1.112 . . . . 74.209999999999994 111.727 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 45.3 t -60.7 -36.0 77.71 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.122 0.969 . . . . 73.219999999999999 112.059 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -74.07 -14.17 60.95 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.691 -0.686 . . . . 71.439999999999998 112.318 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . 93.66 3.38 64.49 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.513 -0.635 . . . . 64.120000000000005 111.513 -170.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -72.27 160.61 32.1 Favored 'General case' 0 C--N 1.346 0.455 0 C-N-CA 124.123 0.969 . . . . 63.240000000000002 110.404 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.42 HD13 HD13 ' A' ' 214' ' ' LEU . 72.7 mt -113.84 147.19 38.83 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.006 0.923 . . . . 64.310000000000002 110.359 -173.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -163.19 153.77 16.35 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.715 0.635 . . . . 72.519999999999996 109.977 175.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 195' ' ' ILE . 71.7 t -125.26 -62.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 107.999 -1.112 . . . . 73.150000000000006 107.999 177.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 36.0 t -102.4 -178.4 3.68 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.253 1.021 . . . . 64.310000000000002 111.071 -176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.6 t -61.5 -47.41 85.75 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.333 1.053 . . . . 74.049999999999997 112.044 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -90.34 12.81 17.18 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.486 0.714 . . . . 71.430000000000007 111.643 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 66.8 m -98.51 111.54 23.87 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.373 0.669 . . . . 74.329999999999998 109.782 173.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -146.71 115.13 6.71 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.257 1.023 . . . . 73.420000000000002 109.304 171.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -135.8 142.26 44.85 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 117.843 0.292 . . . . 72.209999999999994 111.105 -171.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -83.85 -34.78 24.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.264 -0.643 . . . . 71.319999999999993 109.264 169.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 66.8 p -121.13 145.47 47.78 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-O 122.039 0.923 . . . . 51.43 111.72 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.42 HD13 HD13 ' A' ' 203' ' ' LEU . 30.2 tp -68.3 -24.68 64.88 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.472 -1.24 . . . . 73.230000000000004 110.811 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.44 85.96 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.457 0.703 . . . . 73.510000000000005 110.542 173.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -67.89 -34.39 76.56 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 116.053 -0.521 . . . . 75.129999999999995 111.382 175.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.446 ' CD2' HD11 ' A' ' 182' ' ' ILE . 10.0 tt -58.6 -46.22 87.47 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 123.42 0.45 . . . . 74.209999999999994 110.981 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.94 -39.11 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.166 0.587 . . . . 61.350000000000001 110.828 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -61.66 -55.1 34.11 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.318 0.58 . . . . 74.549999999999997 111.328 176.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.422 ' O ' HG22 ' A' ' 224' ' ' VAL . 46.9 t60 -51.14 -54.77 22.19 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 114.589 -1.187 . . . . 64.329999999999998 109.662 177.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -65.23 -24.94 67.48 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.608 -0.724 . . . . 54.149999999999999 112.709 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 46.6 t -72.51 -25.41 61.39 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.854 0.462 . . . . 63.130000000000003 111.064 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 12.3 t -122.47 -2.9 8.9 Favored 'General case' 0 CA--C 1.562 1.415 0 N-CA-C 116.408 2.003 . . . . 61.409999999999997 116.408 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 220' ' ' HIS . 27.8 m -101.61 154.17 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-N 121.123 1.783 . . . . 61.219999999999999 115.421 -172.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.66 -0.73 57.29 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 129.248 3.019 . . . . 63.140000000000001 113.487 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -77.23 14.56 0.89 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 129.027 2.931 . . . . 72.230000000000004 113.677 -145.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.4 16.42 4.7 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 122.225 0.903 . . . . 42.43 111.725 -170.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.14 120.02 32.98 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.257 -0.972 . . . . 73.430000000000007 110.927 169.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.478 ' HB ' ' OH ' ' A' ' 191' ' ' TYR . 92.7 mt -59.23 -43.26 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 O-C-N 123.97 0.794 . . . . 61.530000000000001 109.39 172.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 8.8 t -136.09 148.74 48.42 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.694 -0.854 . . . . 73.450000000000003 108.694 165.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 80.7 p -72.4 159.71 33.54 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 109.566 -0.531 . . . . 65.430000000000007 109.566 171.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 20.4 mt -69.33 102.31 1.71 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.202 -1.036 . . . . 71.299999999999997 108.202 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -87.83 -50.52 6.4 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.461 -0.57 . . . . 73.019999999999996 109.461 -174.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -161.43 147.14 10.81 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 112.444 0.535 . . . . 73.439999999999998 112.444 -177.784 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.36 152.4 71.4 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.122 1.882 . . . . 74.239999999999995 112.736 -176.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -73.56 155.61 89.22 Favored Pre-proline 0 C--O 1.244 0.81 0 CA-C-N 115.774 -0.648 . . . . 64.409999999999997 110.667 175.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.45 ' HG2' ' HB2' ' A' ' 162' ' ' SER . 17.7 Cg_endo -56.85 140.02 90.58 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.801 2.334 . . . . 74.040000000000006 113.309 177.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -77.77 158.83 29.4 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.834 -1.075 . . . . 64.219999999999999 108.657 169.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.641 ' HG3' HD21 ' A' ' 159' ' ' LEU . 98.0 mtt180 -53.72 -27.86 30.72 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 122.935 0.494 . . . . 72.120000000000005 111.778 176.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -69.04 -67.71 0.45 Allowed 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.584 -0.735 . . . . 73.209999999999994 109.522 171.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -174.75 161.42 2.52 Favored Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 123.777 0.831 . . . . 74.230000000000004 111.035 177.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.21 156.77 61.41 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.743 2.295 . . . . 62.549999999999997 112.412 170.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 20.5 m -148.71 90.16 1.75 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.519 0.727 . . . . 73.329999999999998 109.68 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.5 p -171.89 137.01 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.825 0.85 . . . . 64.120000000000005 110.466 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -161.33 56.86 0.29 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.908 0.861 . . . . 74.239999999999995 110.017 173.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -69.74 114.46 5.63 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 115.171 -0.922 . . . . 72.319999999999993 112.954 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.81 126.82 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.701 0.801 . . . . 63.020000000000003 109.549 174.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 51.3 m -149.94 139.16 12.95 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.598 1.159 . . . . 74.319999999999993 108.119 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -56.96 -32.34 92.52 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.466 2.111 . . . . 72.209999999999994 112.722 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 57.63 94.71 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.793 1.237 . . . . 72.299999999999997 112.691 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -151.02 166.9 29.28 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.614 -0.721 . . . . 64.5 110.594 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -162.3 147.48 12.61 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.948 -1.024 . . . . 62.229999999999997 108.608 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -83.62 -23.81 31.7 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.514 0.325 . . . . 70.430000000000007 111.753 -172.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -74.28 143.02 45.2 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.313 -0.625 . . . . 73.530000000000001 109.313 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 CA--C 1.555 1.16 0 CA-C-O 118.107 -0.949 . . . . 73.319999999999993 108.973 -179.808 . . . . . . . . 0 0 . 1 stop_ save_